PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, SH; Zhang, Y; Wang, Y; Ye, P; Li, J; Li, HB; Ding, QQ; Xia, JH				Wang, Sihua; Zhang, Yuan; Wang, Yan; Ye, Ping; Li, Jun; Li, Huabin; Ding, Qingqing; Xia, Jiahong			Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3 beta/Foxp3 Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SYNTHASE KINASE 3-BETA; COLORECTAL-CANCER; CETUXIMAB; FOXP3; BETA; INHIBITION; IMMUNITY; PHOSPHORYLATION; DEGRADATION	Previous studies mainly focused on the role of the epidermal growth factor receptor (EGFR) in tumor cells, whereas the effects of the EGFR on immune responses has not been determined. Our study shows that the EGFR signaling pathway play a role in the regulation of regulatory T cells (Treg cells) in cancer patients. The EGF-like growth factor Amphiregulin (AREG) protein was frequently up-regulated in a tissue microarray, which was associated with worse overall survival. Additionally, in sera, tissue specimens, and effusions of lung or gastric cancer patients, up-regulated AREG protein enhanced the suppressive function of Treg cells. AREG maintained the Treg cell suppressive function via the EGFR/GSK-3 beta/Foxp3 axis in vitro and in vivo. Furthermore, inhibition of EGFR by the tyrosine kinase inhibitor gefitinib restored the activity of GSK-3 beta and attenuated Treg cell function. beta-TrCP was involved in GSK-3 beta -mediated Foxp3 degradation, and mass spectrometry identified Lys(356) as the ubiquitination site of Foxp3 by beta-TrCP. These findings demonstrate the posttranslational regulation of Foxp3 expression by AREG in cancer patients through AREG/EGFR/GSK-3 beta signaling, which could lead to Foxp3 protein degradation in Treg cells and a potential therapeutic target for cancer treatment.	[Wang, Sihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Thorac Surg, Wuhan 430022, Peoples R China; [Zhang, Yuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430022, Peoples R China; [Xia, Jiahong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Surg, Wuhan 430022, Peoples R China; [Ye, Ping; Li, Jun] Cent Hosp Wuhan, Dept Cardiovasc Surg, Wuhan 430022, Peoples R China; [Wang, Yan; Ding, Qingqing] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Li, Huabin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Surg, Shanghai 200092, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University	Ding, QQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Surg, Shanghai 200092, Peoples R China.; Xia, JH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Surg,Cent Hosp Wuhan, Wuhan 430022, Peoples R China.	allergyli@163.com; qingqing_ding@hotmail.com; jiahong.xia@hust.edu.cn			National Nature Science Foundation of China [81130056, 81401323]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Nature Science Foundation of China Grants 81130056 and 81401323. The authors declare that they have no conflicts of interest with the contents of this article.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Berasain C, 2007, CANCER LETT, V254, P30, DOI 10.1016/j.canlet.2007.01.015; Beurel E, 2011, J IMMUNOL, V186, P1391, DOI 10.4049/jimmunol.1003511; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Crane CH, 2011, J CLIN ONCOL, V29, P3037, DOI 10.1200/JCO.2010.33.8038; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2011, J CLIN INVEST, V121, P4526, DOI 10.1172/JCI45008; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; Garrido G, 2007, CANCER IMMUNOL IMMUN, V56, P1701, DOI 10.1007/s00262-007-0313-4; Graham JA, 2010, J BIOL CHEM, V285, P32852, DOI 10.1074/jbc.M110.150904; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Matsushita N, 2008, J IMMUNOL METHODS, V333, P167, DOI 10.1016/j.jim.2008.01.012; Mekori YA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00006; Morawski PA, 2013, J BIOL CHEM, V288, P24494, DOI 10.1074/jbc.M113.467704; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Qi YL, 2010, J ALLERGY CLIN IMMUN, V126, P1260, DOI 10.1016/j.jaci.2010.08.040; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Srivastava RM, 2013, CLIN CANCER RES, V19, P1858, DOI 10.1158/1078-0432.CCR-12-2426; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thienelt CD, 2005, J CLIN ONCOL, V23, P8786, DOI 10.1200/jco.2005.03.1997; van Loosdregt J, 2014, TRENDS IMMUNOL, V35, P368, DOI 10.1016/j.it.2014.06.005; Wang HZ, 2011, J IMMUNOL, V186, P675, DOI 10.4049/jimmunol.1001473; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Wu XM, 2015, J ALLERGY CLIN IMMUN, V136, P1698, DOI 10.1016/j.jaci.2015.08.014; Xie AN, 2011, TRANSPLANTATION, V91, P27, DOI 10.1097/TP.0b013e3181fdd948; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Yotsumoto F, 2010, CANCER SCI, V101, P2351, DOI 10.1111/j.1349-7006.2010.01671.x; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	43	74	82	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21085	21095		10.1074/jbc.M116.717892	http://dx.doi.org/10.1074/jbc.M116.717892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27432879	Green Published, hybrid			2022-12-28	WOS:000385406200024
J	Kohda, A; Yamazaki, S; Sumimoto, H				Kohda, Akira; Yamazaki, Soh; Sumimoto, Hideki			The Nuclear Protein IB Forms a Transcriptionally Active Complex with Nuclear Factor-B (NF-B) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; NF-B transcription factor; protein motif; protein-DNA interaction; protein-protein interaction; Bcl-3; IB; IBNS; ankyrin repeat; lipocalin-2	FACTOR-KAPPA-B; MESSENGER-RNA STABILIZATION; INDUCED IL-6 PRODUCTION; CRYSTAL-STRUCTURE; DNA-BINDING; HISTONE ACETYLTRANSFERASE; INFLAMMATORY GENES; SIGNALING PATHWAY; CELL DEVELOPMENT; DEPENDENT GENES	The nuclear protein IB, comprising the N-terminal trans-activation domain and the C-terminal ankyrin repeat (ANK) domain composed of seven ANK motifs, activates transcription of a subset of nuclear factor-B (NF-B)-dependent innate immune genes such as Lcn2 encoding the antibacterial protein lipocalin-2. Lcn2 activation requires formation of a complex containing IB and NF-B p50, a transcription factor that harbors the DNA-binding Rel homology region but lacks a trans-activation domain, on the promoter with the canonical NF-B-binding site (B site) and its downstream cytosine-rich element. Here we show that IB productively interacts with p50 via Asp-451 in the N terminus of ANK1, a residue that is evolutionarily conserved among IB and the related nuclear IB proteins Bcl-3 and IBNS. Threonine substitution for Asp-451 abrogates direct association with the B-site-binding protein p50, complex formation with the Lcn2 promoter DNA, and activation of Lcn2 transcription. The basic residues Lys-717 and Lys-719 in the C-terminal region of ANK7 contribute to IB binding to the Lcn2 promoter, probably via interaction with the cytosine-rich element required for Lcn2 activation; glutamate substitution for both lysines results in a loss of transcriptionally active complex formation without affecting direct contact of IB with p50. Both termini of the ANK domain in Bcl-3 and IBNS function in a manner similar to that of IB to interact with promoter DNA, indicating a common mechanism in which the nuclear IBs form a regulatory complex with NF-B and promoter DNA via the invariant aspartate in ANK1 and the conserved basic residues in ANK7.	[Kohda, Akira; Yamazaki, Soh; Sumimoto, Hideki] Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan	Kyushu University	Sumimoto, H (corresponding author), Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp			 [26111009]		This work was supported in part by Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a New Criterion for Integrated Understanding of Life" (no. 26111009). The authors declare that they have no conflicts of interest with the contents of this article.	Bergqvist S, 2009, P NATL ACAD SCI USA, V106, P19328, DOI 10.1073/pnas.0908797106; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Huxford T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000075; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Johansen C, 2015, P NATL ACAD SCI USA, V112, pE5825, DOI 10.1073/pnas.1509971112; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Kohda A, 2014, GENES CELLS, V19, P620, DOI 10.1111/gtc.12162; Kono H, 1999, PROTEINS, V35, P114, DOI 10.1002/(SICI)1097-0134(19990401)35:1<114::AID-PROT11>3.0.CO;2-T; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nogai H, 2013, BLOOD, V122, P2242, DOI 10.1182/blood-2013-06-508028; O'Dea E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000216; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Ryzhakov G, 2013, J BIOL CHEM, V288, P11546, DOI 10.1074/jbc.M113.451153; Schuster M, 2012, IMMUNITY, V37, P998, DOI 10.1016/j.immuni.2012.08.023; Schwarz EM, 1997, GENE DEV, V11, P187, DOI 10.1101/gad.11.2.187; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Touma M, 2007, J IMMUNOL, V179, P1681, DOI 10.4049/jimmunol.179.3.1681; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200; Yamazaki S, 2008, BBA-GENE REGUL MECH, V1779, P108, DOI 10.1016/j.bbagmi.2007.11.001; Yamazaki S, 2015, J BIOCHEM, V157, P399, DOI 10.1093/jb/mvu086; Yuzawa S, 2011, P NATL ACAD SCI USA, V108, P19210, DOI 10.1073/pnas.1110951108	58	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20739	20752		10.1074/jbc.M116.719302	http://dx.doi.org/10.1074/jbc.M116.719302			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27489104	hybrid, Green Published			2022-12-28	WOS:000384574800035
J	Boot, M; Sparrius, M; Jim, KK; Commandeur, S; Speer, A; van de Weerd, R; Bitter, W				Boot, Maikel; Sparrius, Marion; Jim, Kin Ki; Commandeur, Susanna; Speer, Alexander; van de Weerd, Robert; Bitter, Wilbert			iniBAC induction Is Vitamin B12-and MutAB-dependent in Mycobacterium marinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; gene regulation; mycobacteria; stress response; tuberculosis; iniBAC; mutAB; vitamin B12	DYNAMIN-LIKE PROTEIN; GENE-EXPRESSION; TRANSPOSON MUTAGENESIS; PROPIONATE METABOLISM; FATTY-ACIDS; BOVIS BCG; TUBERCULOSIS; IDENTIFICATION; BIOSYNTHESIS; RESISTANCE	Tuberculosis can be treated with a 6-month regimen of antibiotics. Although the targets of most of the first-line antibiotics have been identified, less research has focused on the intrabacterial stress responses that follow upon treatment with antibiotics. Studying the roles of these stress genes may lead to the identification of crucial stress-coping mechanisms that can provide additional drug targets to increase treatment efficacy. A three-gene operon with unknown function that is strongly up-regulated upon treatment with isoniazid and ethambutol is the iniBAC operon. We have reproduced these findings and show that iniBAC genes are also induced in infected host cells, although with higher variability. Next, we set out to elucidate the genetic network that results in iniBAC induction in Mycobacterium marinum. By transposon mutagenesis, we identified that the operon is highly induced by mutations in genes encoding enzymes of the vitamin B12 biosynthesis pathway and the vitamin B12-dependent methylmalonyl-CoA-mutase MutAB. Lipid analysis showed that a mutA::tn mutant has decreased phthiocerol dimycocerosates levels, suggesting a link between iniBAC induction and the production of methyl-branched lipids. Moreover, a similar screen in Mycobacterium bovis BCG identified that phthiocerol dimycocerosate biosynthesis mutants cause the up-regulation of iniBAC genes. Based on these data, we propose that iniBAC is induced in response to mutations that cause defects in the biosynthesis of methyl-branched lipids. The resulting metabolic stress caused by these mutations or caused by ethambutol or isoniazid treatment may be relieved by iniBAC to increase the chance of bacterial survival.	[Boot, Maikel; Sparrius, Marion; Jim, Kin Ki; Commandeur, Susanna; Speer, Alexander; van de Weerd, Robert; Bitter, Wilbert] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Bitter, W (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands.	w.bitter@vumc.nl	Bitter, W/CAJ-5778-2022; Bitter, Wilbert/AAA-6872-2019; Bitter, Wilbert/ABG-3726-2020	Bitter, Wilbert/0000-0001-8347-6511	Innovative Medicines Initiative Joint Undertaking from the European Union's Seventh Frame-work Programme; EFPIA (European Federation of Pharmaceutical Industries and Associations) companies (imi (Innovative Medicines Initiative)) [115337]; Joint Programme Initiative AMR programme noTBsec	Innovative Medicines Initiative Joint Undertaking from the European Union's Seventh Frame-work Programme; EFPIA (European Federation of Pharmaceutical Industries and Associations) companies (imi (Innovative Medicines Initiative)); Joint Programme Initiative AMR programme noTBsec	This work has received funding from the Innovative Medicines Initiative Joint Undertaking, resources of which are composed of financial contributions from the European Union's Seventh Frame-work Programme (FP7/2007-2013) and EFPIA (European Federation of Pharmaceutical Industries and Associations) companies (imi (Innovative Medicines Initiative)), under Grant 115337. This work has also received funding from the Joint Programme Initiative AMR programme noTBsec. The authors declare that they have no conflicts of interest with the contents of this article	Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Alland D, 1998, P NATL ACAD SCI USA, V95, P13227, DOI 10.1073/pnas.95.22.13227; Alland D, 2000, J BACTERIOL, V182, P1802, DOI 10.1128/JB.182.7.1802-1811.2000; Allen BW, 1998, METH MOL B, V101, P15, DOI 10.1385/0-89603-471-2:15; Azad AK, 1996, P NATL ACAD SCI USA, V93, P4787, DOI 10.1073/pnas.93.10.4787; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Besra GS, 1998, METH MOL B, V101, P91, DOI 10.1385/0-89603-471-2:91; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Carrere-Kremer S, 2015, MOL MICROBIOL, V96, P1085, DOI 10.1111/mmi.12992; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Colangeli R, 2007, PLOS PATHOG, V3, P780, DOI 10.1371/journal.ppat.0030087; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; Gopinath K, 2013, FUTURE MICROBIOL, V8, P1405, DOI 10.2217/fmb.13.113; Gopinath K, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120175; Hardlei TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061194; HARTMANS S, 1992, PROKARYOTES HDB BIOL, P1215; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Kieser KJ, 2015, P NATL ACAD SCI USA, V112, P13087, DOI 10.1073/pnas.1514135112; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Liu QY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17507; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Michie KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107211; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Minnikin DE, 1985, EXTRACTION CHROMATOG, P274; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Sawant P, 2016, ENVIRON MICROBIOL, V18, P2705, DOI 10.1111/1462-2920.13110; Stanley SA, 2013, P NATL ACAD SCI USA, V110, P11565, DOI 10.1073/pnas.1302114110; Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; van de Weerd R, 2016, J BIOL CHEM, V291, P11787, DOI 10.1074/jbc.M116.722454; van Leeuwen LM, 2014, DIS MODEL MECH, V7, P1111, DOI 10.1242/dmm.015453; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Warner DF, 2007, J BACTERIOL, V189, P3655, DOI 10.1128/JB.00040-07; Weerdenburg EM, 2015, INFECT IMMUN, V83, P1778, DOI 10.1128/IAI.03050-14; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; WINDER F G, 1970, Journal of General Microbiology, V63, P41; Yang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13969; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]	48	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19800	19812		10.1074/jbc.M116.724088	http://dx.doi.org/10.1074/jbc.M116.724088			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27474746	Green Published, hybrid			2022-12-28	WOS:000383243100007
J	Coulson-Thomas, VJ; Lauer, ME; Soleman, S; Zhao, C; Hascall, VC; Day, AJ; Fawcett, JW				Coulson-Thomas, Vivien J.; Lauer, Mark E.; Soleman, Sara; Zhao, Chao; Hascall, Vincent C.; Day, Anthony J.; Fawcett, James W.			Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Is Constitutively Expressed in Adult Central Nervous System (CNS) and Associated with Astrocyte-mediated Glial Scar Formation following Spinal Cord Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; glycosaminoglycan; hyaluronan; inflammation; proteoglycan; glial scar	INTER-ALPHA-INHIBITOR; SMOOTH-MUSCLE-CELLS; ANTIINFLAMMATORY PROTEIN TSG-6; HEAVY-CHAIN TRANSFER; HYALURONAN-BINDING PROTEINS; FIBRILLARY ACIDIC PROTEIN; HUMAN AMNIOTIC MEMBRANE; REACTIVE ASTROCYTES; EXTRACELLULAR-MATRIX; CD44 EXPRESSION	Tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6) binds to hyaluronan and can reorganize/stabilize its structure, also enhancing the binding of this glycosaminoglycan to its cell surface receptor, CD44. TSG-6 is rapidly up-regulated in response to inflammatory cytokines protecting tissues from the damaging effects of inflammation. Despite TSG-6 treatment having been shown to improve outcomes in an experimental model of traumatic brain injury, TSG-6 expression has not been extensively studied in the central nervous system (CNS). We hereby analyzed the expression profile of TSG-6 in the developing CNS and following injury. We show that TSG-6 is expressed in the rat CNS by GFAP(+) and CD44(+) astrocytes, solely in the mature brain and spinal cord, and is not present during the development of the CNS. TSG-6(-/-) mice present a reduced number of GFAP(+) astrocytes when compared with the littermate TSG-6(+/-) mice. TSG-6 expression is drastically up-regulated after injury, and the TSG-6 protein is present within the glial scar, potentially coordinating and stabilizing the formation of this hyaluronan-rich matrix. This study shows that TSG-6 is expressed in the CNS, suggesting a role for TSG-6 in astrocyte activation and tissue repair. We hypothesize that within this context TSG-6 could participate in the formation of the glial scar and confer anti-inflammatory properties. Further studies are required to elucidate the therapeutic potential of targeting TSG-6 after CNS injury to promote its protective effects while reducing the inhibitory properties of the glial scar in axon regeneration.	[Coulson-Thomas, Vivien J.; Soleman, Sara; Fawcett, James W.] Univ Cambridge, John Van Geest Cambridge Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge CB2 0PY, England; [Lauer, Mark E.; Hascall, Vincent C.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Zhao, Chao] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Clifford Allbutt Bldg, Cambridge CB2 0AH, England; [Zhao, Chao] Univ Cambridge, Dept Clin Neurosci, Clifford Allbutt Bldg, Cambridge CB2 0AH, England; [Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Cambridge; Cleveland Clinic Foundation; University of Cambridge; University of Cambridge; University of Manchester	Coulson-Thomas, VJ (corresponding author), Univ Houston, Coll Optometry, 505 J Davis Armistead Bldg,Rm 2103, Houston, TX 77204 USA.; Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.; Fawcett, JW (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	vcoulsonthomas@gmail.com; anthony.day@manchester.ac.uk; jf108@cam.ac.uk	Day, Anthony/O-1658-2015	Day, Anthony/0000-0002-1415-3134	European Research Council ECMneuro; National Institutes of Health NHLBI Award [PO1HL107147]; Medical Research Council [MC_PC_12009] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER	European Research Council ECMneuro; National Institutes of Health NHLBI Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the European Research Council ECMneuro and National Institutes of Health NHLBI Award PO1HL107147. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Asher RA, 2000, J NEUROSCI, V20, P2427; Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Baranova NS, 2014, J BIOL CHEM, V289, P30481, DOI 10.1074/jbc.M114.568154; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Beltran SR, 2015, J PERIODONTOL, V86, P62, DOI 10.1902/jop.2014.140187; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Bignami A, 1984, J Neurosurg Sci, V28, P127; Bogdani M, 2014, DIABETES, V63, P2727, DOI 10.2337/db13-1658; Bollyky PL, 2011, P NATL ACAD SCI USA, V108, P7938, DOI 10.1073/pnas.1017360108; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Briggs DC, 2015, J BIOL CHEM, V290, P28708, DOI 10.1074/jbc.M115.669838; Buggey H, 2013, THESIS; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; Coulson-Thomas VJ, 2016, OCUL SURF, V14, P121, DOI 10.1016/j.jtos.2015.11.004; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P23465, DOI 10.1074/jbc.M114.557447; Coulson-Thomas YA, 2008, J NEUROSCI METH, V171, P19, DOI 10.1016/j.jneumeth.2008.01.030; Cragnolini AB, 2009, GLIA, V57, P1386, DOI 10.1002/glia.20857; DAHL D, 1976, BRAIN RES, V116, P150, DOI 10.1016/0006-8993(76)90257-2; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Dyer DP, 2016, J BIOL CHEM, V291, P12627, DOI 10.1074/jbc.M116.720953; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 2006, ADV EXP MED BIOL, V557, P11; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; GIRGRAH N, 1991, J NEUROPATH EXP NEUR, V50, P779, DOI 10.1097/00005072-199111000-00009; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HATHCOCK KS, 1993, J IMMUNOL, V151, P6712; He H, 2014, INVEST OPHTH VIS SCI, V55, P1647, DOI 10.1167/iovs.13-13094; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Hull RL, 2012, J HISTOCHEM CYTOCHEM, V60, P749, DOI 10.1369/0022155412457048; HUTTON LA, 1992, J NEUROSCI RES, V32, P375, DOI 10.1002/jnr.490320309; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Jaworski DM, 1999, EXP NEUROL, V157, P327, DOI 10.1006/exnr.1999.7062; Kandel ER, 2000, SCIENCE, V290, P1113, DOI 10.1126/science.290.5494.1113; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; KUMAR S, 1993, MOL BRAIN RES, V17, P163, DOI 10.1016/0169-328X(93)90086-5; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; Lauer M. E., 2015, INT J CELL BIOL; Lauer ME, 2015, J BIOL CHEM, V290, P23124, DOI 10.1074/jbc.M115.663823; Lauer ME, 2015, METHODS MOL BIOL, V1229, P543, DOI 10.1007/978-1-4939-1714-3_42; Lauer ME, 2014, J BIOL CHEM, V289, P29171, DOI 10.1074/jbc.M114.600809; Lauer ME, 2014, J BIOL CHEM, V289, P6791, DOI 10.1074/jbc.M113.512491; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lemons ML, 2001, J NEUROSCI, V21, P4772, DOI 10.1523/JNEUROSCI.21-13-04772.2001; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; MANSOUR H, 1990, J NEUROSCI RES, V25, P300, DOI 10.1002/jnr.490250306; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Metea MR, 2006, GLIA, V54, P650, DOI 10.1002/glia.20352; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; MORETTO G, 1993, J NEUROPATH EXP NEUR, V52, P419, DOI 10.1097/00005072-199307000-00009; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Nagy N, 2015, J CLIN INVEST, V125, P3928, DOI 10.1172/JCI79271; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Niclou SP, 2006, J NEUROTRAUM, V23, P409, DOI 10.1089/neu.2006.23.409; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Oh JW, 1998, J IMMUNOL, V161, P4992; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Park Y, 2016, BIOCHEMISTRY-US, V55, P262, DOI 10.1021/acs.biochem.5b01148; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Rodriguez-Grande B, 2014, J CEREBR BLOOD F MET, V34, P480, DOI 10.1038/jcbfm.2013.224; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; Scavenius C, 2016, J BIOL CHEM, V291, P4658, DOI 10.1074/jbc.M115.678748; Shinoe T, 2010, J NEUROCHEM, V115, P1633, DOI 10.1111/j.1471-4159.2010.07072.x; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith PD, 2015, EXP NEUROL, V274, P100, DOI 10.1016/j.expneurol.2015.08.004; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Spasova MS, 2014, EXP BIOL MED, V239, P724, DOI 10.1177/1535370213519195; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tan KT, 2011, J EUR ACAD DERMATOL, V25, P317, DOI 10.1111/j.1468-3083.2010.03792.x; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Wang H, 2015, EUR J PHARMACOL, V751, P42, DOI 10.1016/j.ejphar.2015.01.040; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Ye L, 1997, CIRC RES, V81, P289, DOI 10.1161/01.RES.81.3.289; YOKOYAMA M, 1993, EXP NEUROL, V124, P377, DOI 10.1006/exnr.1993.1209; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	115	40	45	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19939	19952		10.1074/jbc.M115.710673	http://dx.doi.org/10.1074/jbc.M115.710673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27435674	hybrid, Green Published			2022-12-28	WOS:000383243100018
J	Kowalczyk-Quintas, C; Schuepbach-Mallepell, S; Vigolo, M; Willen, L; Tardivel, A; Smulski, CR; Zheng, TS; Gommerman, J; Hess, H; Gottenberg, JE; Mackay, F; Donze, O; Schneider, P				Kowalczyk-Quintas, Christine; Schuepbach-Mallepell, Sonia; Vigolo, Michele; Willen, Laure; Tardivel, Aubry; Smulski, Cristian R.; Zheng, Timothy S.; Gommerman, Jennifer; Hess, Henry; Gottenberg, Jacques-Eric; Mackay, Fabienne; Donze, Olivier; Schneider, Pascal			Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; cytokine; immunology; lymphocyte; receptor; BAFF	SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECEPTOR-BINDING; TACI; APRIL; MICE; BCMA; ECTODYSPLASIN; PROTEINS; SURVIVAL; REVEALS	B cell activating factor of the TNF family (BAFF), also known as B lymphocyte stimulator, is a ligand required for the generation and maintenance of B lymphocytes. In this study, the ability of different monoclonal antibodies to recognize, inhibit, or activate mouse BAFF was investigated. One of them, a mouse IgG1 named Sandy-2, prevented the binding of BAFF to all of its receptors, BAFF receptor, transmembrane activator and calcium modulating ligand interactor, and B cell maturation antigen, at a stoichiometric ratio; blocked the activity of mouse BAFF on a variety of cell-based reporter assays; and antagonized the prosurvival action of BAFF on primary mouse B cells in vitro. A single administration of Sandy-2 in mice induced B cell depletion within 2 weeks, down to levels close to those observed in BAFF-deficient mice. This depletion could then be maintained with a chronic treatment. Sandy-2 and a previously described rat IgG1 antibody, 5A8, also formed a pair suitable for the sensitive detection of endogenous circulating BAFF by ELISA or using a homogenous assay. Interestingly, 5A8 and Sandy-5 displayed activities opposite to that of Sandy-2 by stimulating recombinant BAFF in vitro and endogenous BAFF in vivo. These tools will prove useful for the detection and functional manipulation of endogenous mouse BAFF and provide an alternative to the widely used BAFF receptor-Fc decoy receptor for the specific depletion of BAFF in mice.	[Kowalczyk-Quintas, Christine; Schuepbach-Mallepell, Sonia; Vigolo, Michele; Willen, Laure; Tardivel, Aubry; Smulski, Cristian R.; Schneider, Pascal] Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland; [Zheng, Timothy S.] Biogen, Cambridge, MA 02142 USA; [Gommerman, Jennifer] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Hess, Henry] Merck KGaA, D-64293 Darmstadt, Germany; [Gottenberg, Jacques-Eric] Univ Strasbourg, INSERM UMR S1109, F-67085 Strasbourg, France; [Mackay, Fabienne] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Donze, Olivier] Adipogen Life Sci, CH-1066 Epalinges, Switzerland; [Zheng, Timothy S.] Boehringer Ingelheim Pharmaceut, Ridgefield, CT 06877 USA	University of Lausanne; Biogen; University of Toronto; Merck KGaA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Monash University; Boehringer Ingelheim	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch	Mackay, Fabienne/B-7440-2008	Mackay, Fabienne/0000-0002-6074-2693; Schneider, Pascal/0000-0003-0677-9409; Smulski, Cristian/0000-0003-4186-8116; Gommerman, Jennifer/0000-0003-4576-6168; Vigolo, Michele/0000-0002-4765-6598	Swiss National Science Foundation; Commission for Technology and Innovation; EMD Serono, a subsidiary of Merck, KGaA	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission for Technology and Innovation; EMD Serono, a subsidiary of Merck, KGaA	This work was supported in part by grants from the Swiss National Science Foundation (to P. S.) and the Commission for Technology and Innovation (to P. S. and O. D.). P. S. is supported by a research grant from EMD Serono, a subsidiary of Merck, KGaA. H. H. is an employee of Merck, KGaA. T. S. Z. is an employee of Biogen. O. D. is chief scientific officer at Adipogen Life Sciences.	Batten M, 2004, J IMMUNOL, V172, P812, DOI 10.4049/jimmunol.172.2.812; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Bossen C, 2011, EUR J IMMUNOL, V41, P787, DOI 10.1002/eji.201040591; Figgett WA, 2013, IMMUNITY, V39, P573, DOI 10.1016/j.immuni.2013.05.019; GRAS MP, 1995, INT IMMUNOL, V7, P1093, DOI 10.1093/intimm/7.7.1093; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Isenberg D, 2015, ANN RHEUM DIS, V74, P2006, DOI 10.1136/annrheumdis-2013-205067; Kimberley FC, 2012, J BIOL CHEM, V287, P37434, DOI 10.1074/jbc.M112.406090; Kowalczyk C, 2011, J BIOL CHEM, V286, P30769, DOI 10.1074/jbc.M111.267997; Kowalczyk-Quintas C, 2014, CYTOKINE GROWTH F R, V25, P195, DOI 10.1016/j.cytogfr.2014.01.004; Liu YF, 2003, NATURE, V423, P49, DOI 10.1038/nature01543; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Pelletier M, 2003, J BIOL CHEM, V278, P33127, DOI 10.1074/jbc.M305754200; Ramanujam M, 2010, ARTHRITIS RHEUM-US, V62, P1457, DOI 10.1002/art.27368; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 2014, METHOD ENZYMOL, V545, P103, DOI 10.1016/B978-0-12-801430-1.00005-6; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Schuepbach-Mallepell S, 2015, J BIOL CHEM, V290, P16330, DOI 10.1074/jbc.M115.661405; Stohl W, 2014, EXPERT OPIN THER TAR, V18, P473, DOI 10.1517/14728222.2014.888415; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Tak PP, 2008, ARTHRITIS RHEUM-US, V58, P61, DOI 10.1002/art.23178; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wallace DJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1168, DOI 10.1002/art.24699; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	30	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19826	19834		10.1074/jbc.M116.725929	http://dx.doi.org/10.1074/jbc.M116.725929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27451394	Green Published, hybrid			2022-12-28	WOS:000383243100009
J	Moon, SH; Mancuso, DJ; Sims, HF; Liu, XP; Nguyen, AL; Yang, K; Guan, SP; Dilthey, BG; Jenkins, CM; Weinheimer, CJ; Kovacs, A; Abendschein, D; Gross, RW				Moon, Sung Ho; Mancuso, David J.; Sims, Harold F.; Liu, Xinping; Nguyen, Annie L.; Yang, Kui; Guan, Shaoping; Dilthey, Beverly Gibson; Jenkins, Christopher M.; Weinheimer, Carla J.; Kovacs, Attila; Abendschein, Dana; Gross, Richard W.			Cardiac Myocyte-specific Knock-out of Calcium-independent Phospholipase A(2)gamma (iPLA(2)gamma) Decreases Oxidized Fatty Acids during Ischemia/Reperfusion and Reduces Infarct Size	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eicosanoid; mitochondrial membrane potential; mitochondrial permeability transition (MPT); myocardial infarction; phospholipase; docosanoid; lipidomics	MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA-REPERFUSION INJURY; SHOTGUN LIPIDOMICS; GENETIC ABLATION; CELL-DEATH; MYOCARDIAL REPERFUSION; MEMBRANE PERMEABILITY; SIGNALING PATHWAYS; ARACHIDONIC-ACID; CYTOCHROME-C	Calcium-independent phospholipase A(2) (iPLA(2)) is a mitochondrial enzyme that produces lipid second messengers that facilitate opening of the mitochondrial permeability transition pore (mPTP) and contribute to the production of oxidized fatty acids in myocardium. To specifically identify the roles of iPLA(2) in cardiac myocytes, we generated cardiac myocyte-specific iPLA(2) knock-out (CMiPLA(2)KO) mice by removing the exon encoding the active site serine (Ser-477). Hearts of CMiPLA(2)KO mice exhibited normal hemodynamic function, glycerophospholipid molecular species composition, and normal rates of mitochondrial respiration and ATP production. In contrast, CMiPLA(2)KO mice demonstrated attenuated Ca2+-induced mPTP opening that could be rapidly restored by the aolyddition of palmitate and substantially reduced production of oxidized punsaturated fatty acids (PUFAs). Furthermore, myocardial ischemia/reperfusion (I/R) in CMiPLA(2)KO mice (30 min of ischemia followed by 30 min of reperfusion in vivo) dramatically decreased oxidized fatty acid production in the ischemic border zones. Moreover, CMiPLA(2)KO mice subjected to 30 min of ischemia followed by 24 h of reperfusion in vivo developed substantially less cardiac necrosis in the area-at-risk in comparison with their WT littermates. Furthermore, we found that membrane depolarization in murine heart mitochondria was sensitized to Ca2+ by the presence of oxidized PUFAs. Because mitochondrial membrane depolarization and calcium are known to activate iPLA(2), these results are consistent with salvage of myocardium after I/R by iPLA(2) loss of function through decreasing mPTP opening, diminishing production of proinflammatory oxidized fatty acids, and attenuating the deleterious effects of abrupt increases in calcium ion on membrane potential during reperfusion.	[Moon, Sung Ho; Mancuso, David J.; Sims, Harold F.; Liu, Xinping; Yang, Kui; Guan, Shaoping; Dilthey, Beverly Gibson; Jenkins, Christopher M.; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Nguyen, Annie L.; Weinheimer, Carla J.; Kovacs, Attila; Abendschein, Dana; Gross, Richard W.] Washington Univ, Sch Med, Ctr Cardiovasc Res, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63130 USA.	rgross@wustl.edu			National Institutes of Health [RO1HL118639]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1HL118639 (to R. W. G.). R. W. G. has financial relationships with LipoSpectrum and Platomics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagai A, 2014, CIRC RES, V114, P1918, DOI 10.1161/CIRCRESAHA.114.302744; BEATRICE MC, 1980, J BIOL CHEM, V255, P8663; Chicco AJ, 2008, HYPERTENSION, V52, P549, DOI 10.1161/HYPERTENSIONAHA.108.114264; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Eaddy AC, 2012, TOXICOL SCI, V128, P544, DOI 10.1093/toxsci/kfs175; Elimam H, 2013, J BIOL CHEM, V288, P3871, DOI 10.1074/jbc.M112.396614; Fang KM, 2008, CARDIOVASC RES, V78, P533, DOI 10.1093/cvr/cvn030; Fauconnier J, 2007, DIABETES, V56, P1136, DOI 10.2337/db06-0739; Furuno T, 2001, BIOCHEM PHARMACOL, V62, P1037, DOI 10.1016/S0006-2952(01)00745-6; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Goni FM, 1996, FEBS LETT, V390, P1, DOI 10.1016/0014-5793(96)00603-5; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Han Y, 2013, CIRC J, V77, P1807, DOI 10.1253/circj.CJ-12-1211; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Haworth RA, 2010, AM J PHYSIOL-HEART C, V299, pH165, DOI 10.1152/ajpheart.00906.2009; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; Kacik M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112081; Kiebish MA, 2012, J BIOL CHEM, V287, P25086, DOI 10.1074/jbc.M112.340521; Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001; Liu XP, 2013, ANAL BIOCHEM, V442, P40, DOI 10.1016/j.ab.2013.06.014; Ma XC, 2015, MOL CELL BIOL, V35, P956, DOI 10.1128/MCB.01091-14; Ma Y, 2015, BBA-MOL BASIS DIS, V1852, P552, DOI 10.1016/j.bbadis.2014.12.010; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; MITTNACHT S, 1981, J BIOL CHEM, V256, P3199; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Morciano G, 2015, J MOL CELL CARDIOL, V78, P142, DOI 10.1016/j.yjmcc.2014.08.015; Mulligan CM, 2012, CARDIOVASC RES, V94, P460, DOI 10.1093/cvr/cvs118; Nazarewicz RR, 2007, ARCH BIOCHEM BIOPHYS, V468, P114, DOI 10.1016/j.abb.2007.09.018; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Rauckhorst AJ, 2015, FEBS LETT, V589, P2367, DOI 10.1016/j.febslet.2015.07.016; Reddy K, 2015, WORLD J CARDIOL, V7, P243, DOI 10.4330/wjc.v7.i5.243; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Sharma J, 2011, LIPIDS, V46, P391, DOI 10.1007/s11745-011-3554-0; Sluijter JPG, 2014, PHARMACOL THERAPEUT, V144, P60, DOI 10.1016/j.pharmthera.2014.05.005; Song LN, 2014, APOPTOSIS, V19, P567, DOI 10.1007/s10495-013-0946-z; Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Wojtczak L, 1999, J BIOENERG BIOMEMBR, V31, P447, DOI 10.1023/A:1005444322823; WOLKOWICZ PE, 1980, J BIOL CHEM, V255, P348; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Xu YJ, 2013, PROSTAG OTH LIPID M, V106, P29, DOI 10.1016/j.prostaglandins.2013.08.003; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yoda E, 2010, J LIPID RES, V51, P3003, DOI 10.1194/jlr.M008060	60	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19687	19700		10.1074/jbc.M116.740597	http://dx.doi.org/10.1074/jbc.M116.740597			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27453526	Green Published, hybrid			2022-12-28	WOS:000383242800041
J	Das, SN; Wagenknecht, M; Nareddy, PK; Bhuvanachandra, B; Niddana, R; Balamurugan, R; Swamy, MJ; Moerschbacher, BM; Podile, AR				Das, Subha Narayan; Wagenknecht, Martin; Nareddy, Pavan Kumar; Bhuvanachandra, Bhoopal; Niddana, Ramana; Balamurugan, Rengarajan; Swamy, Musti J.; Moerschbacher, Bruno M.; Podile, Appa Rao			Amino Groups of Chitosan Are Crucial for Binding to a Family 32 Carbohydrate Binding Module of a Chitosanase from Paenibacillus elgii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; CELL-WALLS; POLYSACCHARIDE RECOGNITION; GALACTOSE RECOGNITION; CHITIN DEACETYLASE; CELLULOMONAS-FIMI; IN-VITRO; IDENTIFICATION; OLIGOSACCHARIDES; SPECIFICITY	We report here the role and mechanism of specificity of a family 32 carbohydrate binding module (CBM32) of a glycoside hydrolase family 8 chitosanase from Paenibacillus elgii (PeCsn). Both the activity and mode of action of PeCsn toward soluble chitosan polymers were not different with/without the CBM32 domain of P. elgii (PeCBM32). The decreased activity of PeCsn without PeCBM32 on chitosan powder suggested that PeCBM32 increases the relative concentration of enzyme on the substrate and thereby enhanced enzymatic activity. PeCBM32 specifically bound to polymeric and oligomeric chitosan and showed very weak binding to chitin and cellulose. In isothermal titration calorimetry, the binding stoichiometry of 2 and 1 for glucosamine monosaccharide (GIcN) and disaccharide (GIcN)2, respectively, was indicative of two binding sites in PeCBM32. A three-dimensional model guided site-directed mutagenesis and the use of defined disaccharides varying in the pattern of acetylation suggested that the amino groups of chitosan and the polar residues Glu-16 and Glu-38 of PeCBM32 play a crucial role for the observed binding. The specificity of CBM32 has been further elucidated by a generated fusion protein PeCBM32-eGFP that binds to the chitosan exposing endophytic infection structures of Puccinia graminis f. sp. tritici. Phylogenetic analysis showed that CBM32s appended to chitosanases are highly conserved across different chitosanase families suggesting their role in chitosan recognition and degradation. We have identified and characterized a chitosan-specific CBM32 useful for in situ staining of chitosans in the fungal cell wall during plant-fungus interaction.	[Das, Subha Narayan; Bhuvanachandra, Bhoopal; Podile, Appa Rao] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India; [Nareddy, Pavan Kumar] Univ Hyderabad, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India; [Niddana, Ramana; Balamurugan, Rengarajan; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India; [Wagenknecht, Martin; Moerschbacher, Bruno M.] Univ Munster, Inst Plant Biol & Biotechnol, D-48143 Munster, Germany	University of Hyderabad; University of Hyderabad; University of Hyderabad; University of Munster	Podile, AR (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India.	podilerao@gmail.com	Balamurugan, Rengarajan/X-9584-2018; Swamy, Musti/B-9418-2009; Moerschbacher, Bruno M/C-2012-2017; Podile, Appa Rao/W-5077-2018	Balamurugan, Rengarajan/0000-0002-8373-5736; Swamy, Musti/0000-0002-3108-3633; Bhuvanachandra, Bhoopal/0000-0002-2129-009X; Podile, Appa Rao/0000-0003-3208-765X	Department of Science and Technology, Government of India; University Grants Commission	Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India)	We thank the Department of Science and Technology, Government of India, for Funds for Infrastructure in Science and Technology and Level II support to the Department of Plant Sciences and School of Chemistry, University of Hyderabad. We also thank University Grants Commission-supported University with Potential for Excellence (Phase to the University of Hyderabad for the infrastructural support. We thank Dr. Nour Eddine El Gueddari and Stefan Cord-Landwehr for the suggestions during revision of the manuscript.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Adachi W, 2004, J MOL BIOL, V343, P785, DOI 10.1016/j.jmb.2004.08.028; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Das SN, 2010, J PLANT GROWTH REGUL, V29, P409, DOI 10.1007/s00344-010-9152-1; Das SN, 2010, WORLD J MICROB BIOT, V26, P1875, DOI 10.1007/s11274-010-0369-8; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Ding R, 2011, J BACTERIOL, V193, P4537, DOI 10.1128/JB.00406-11; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Ficko-Blean E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033524; Ficko-Blean E, 2009, J MOL BIOL, V390, P208, DOI 10.1016/j.jmb.2009.04.066; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; GRENIER J, 1991, J GEN MICROBIOL, V137, P2007, DOI 10.1099/00221287-137-8-2007; Grondin JM, 2014, J MOL BIOL, V426, P869, DOI 10.1016/j.jmb.2013.11.029; Gupta V, 2010, APPL ENVIRON MICROB, V76, P2769, DOI 10.1128/AEM.02673-09; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Kormos J, 2000, BIOCHEMISTRY-US, V39, P8844, DOI 10.1021/bi000607s; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Mizutani K, 2014, FEBS LETT, V588, P1726, DOI 10.1016/j.febslet.2014.03.022; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nampally M, 2012, APPL ENVIRON MICROB, V78, P3114, DOI 10.1128/AEM.07506-11; Narahari A, 2011, J PHYS CHEM B, V115, P4110, DOI 10.1021/jp110468n; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153; Peberdy J., 1990, BIOCH CELL WALLS MEM, P5, DOI [10.1007/978-3-642-74215-6_2, DOI 10.1007/978-3-642-74215-6_2]; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Privalov PL, 2011, NUCLEIC ACIDS RES, V39, P2483, DOI 10.1093/nar/gkq984; Purushotham P, 2012, J BACTERIOL, V194, P4260, DOI 10.1128/JB.06473-11; Reyes-Ortiz V, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-93; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; Schatz C, 2003, BIOMACROMOLECULES, V4, P641, DOI 10.1021/bm025724c; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schubert M, 2010, J MICROBIOL BIOTECHN, V20, P1179, DOI 10.4014/jmb.1001.02023; Shinya S, 2013, J BIOL CHEM, V288, P30042, DOI 10.1074/jbc.M113.503243; Sorlier P, 2003, J BIOMED MATER RES A, V67A, P766, DOI 10.1002/jbm.a.10132; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tokuyasu K, 1999, CARBOHYD RES, V322, P26, DOI 10.1016/S0008-6215(99)00213-X; Tokuyasu K, 1997, CARBOHYD RES, V303, P353, DOI 10.1016/S0008-6215(97)00166-3; Vachoud L, 1997, CARBOHYD RES, V302, P169, DOI 10.1016/S0008-6215(97)00126-2; Zheng CL, 2013, J BIOL CHEM, V288, P20499, DOI 10.1074/jbc.M113.461434	54	13	13	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18977	18990		10.1074/jbc.M116.721332	http://dx.doi.org/10.1074/jbc.M116.721332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27405759	hybrid, Green Published			2022-12-28	WOS:000383242300033
J	Donovan, MR; Marr, MT				Donovan, Marissa R.; Marr, Michael T., II			dFOXO Activates Large and Small Heat Shock Protein Genes in Response to Oxidative Stress to Maintain Proteostasis in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; INSULIN; EXPRESSION; PATHWAY; DISEASE; BINDING; DOWNSTREAM; TRANSGENES; RESISTANCE	Maintaining protein homeostasis is critical for survival at the cellular and organismal level (Morimoto, R. I. (2011) Cold Spring Harb. Symp. Quaid. Biol. 76, 91-99). Cells express a family of molecular chaperones, the heat shock proteins, during times of oxidative stress to protect against proteotoxicity. We have identified a second stress responsive transcription factor, dFOXO, that works alongside the heat shock transcription factor to activate transcription of both the small heat shock protein and the large heat shock protein genes. This expression likely protects cells from protein misfolding associated with oxidative stress. Here we identify the regions of the Hsp70 promoter essential for FOXO-dependent transcription using in vitro methods and find a physiological role for FOXO-dependent expression of heat shock proteins in vivo.	[Marr, Michael T., II] Brandeis Univ, Dept Biol, Waltham, MA 02453 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02453 USA	Brandeis University; Brandeis University	Marr, MT (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02453 USA.	mmarr@brandeis.edu			National Institutes of Health [R01GM11703, T32 GM007122]; New Scholar in Aging Award from Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, R01GM117034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Scholar in Aging Award from Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM11703 (to M. T. M.). This work was also supported by a New Scholar in Aging Award from the Ellison Medical Foundation (to M. T. M.). The authors declare that they have no conflicts of interest with the contents of this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported for a portion of the work by National Institutes of Health Training Grant T32 GM007122.	Alic N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004619; Alic N, 2014, CELL REP, V6, P608, DOI 10.1016/j.celrep.2014.01.015; Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; ARKING R, 1991, DEV GENET, V12, P362, DOI 10.1002/dvg.1020120505; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BECKER J, 1990, EUR J BIOCHEM, V189, P553, DOI 10.1111/j.1432-1033.1990.tb15522.x; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Douglas PM, 2015, CELL REP, V12, P1196, DOI 10.1016/j.celrep.2015.07.026; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fernandes M, 1995, NUCLEIC ACIDS RES, V23, P4799, DOI 10.1093/nar/23.23.4799; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Giannakou ME, 2007, AGING CELL, V6, P429, DOI 10.1111/j.1474-9726.2007.00290.x; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hard F. U., 1996, NATURE, V381, P571; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; NlcColl G., 2010, CELL METAB, V12, P260; Olson CM, 2013, ELIFE, V2, DOI 10.7554/eLife.00542; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Shukla AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098886; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Spellberg MJ, 2015, P NATL ACAD SCI USA, V112, P14587, DOI 10.1073/pnas.1517124112; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wheeler JC, 1999, NEUROBIOL AGING, V20, P545, DOI 10.1016/S0197-4580(99)00088-3; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054; Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	43	25	27	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19042	19050		10.1074/jbc.M116.723049	http://dx.doi.org/10.1074/jbc.M116.723049			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27435672	Green Published, hybrid			2022-12-28	WOS:000383242300038
J	Prasad, JM; Young, PA; Strickland, DK				Prasad, Joni M.; Young, Patricia A.; Strickland, Dudley K.			High Affinity Binding of the Receptor-associated Protein D1D2 Domains with the Low Density Lipoprotein Receptor-related Protein (LRP1) Involves Bivalent Complex Formation CRITICAL ROLES OF LYSINES 60 AND 191	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; low density lipoprotein (LDL); mutagenesis; receptor endocytosis; surface plasmon resonance (SPR); LRP1; RAP; ligand	CRITICAL LYSINE RESIDUES; TRANSFER-RNA SYNTHETASE; ALPHA-2-MACROGLOBULIN RECEPTOR; LIGAND-BINDING; MOLECULAR CHAPERONE; ENDOCYTIC RECEPTORS; TERMINAL DOMAIN; ER RETENTION; RAP COMPLEX; RECOGNITION	The LDL receptor-related protein 1 (LRP1) is a large endocytic receptor that binds and mediates the endocytosis of numerous structurally diverse ligands. Currently, the basis for ligand recognition by LRP1 is not well understood. LRP1 requires a molecular chaperone, termed the receptor-associated protein (RAP), to escort the newly synthesized receptor from the endoplasmic reticulum to the Golgi. RAP is a three-domain protein that contains the following two high affinity binding sites for LRP1: one is located within domains 1 and 2, and one is located in its third domain. Studies on the interaction of the RAP third domain with LRP1 reveal critical contributions by lysine 256 and lysine 270 for this interaction. From these studies, a model for ligand recognition by this class of receptors has been proposed. Here, we employed surface plasmon resonance to investigate the binding of RAP D1D2 to LRP1. Our results reveal that the high affinity of D1D2 for LRP1 results from avidity effects mediated by the simultaneous interactions of lysine 60 in D1 and lysine 191 in D2 with sites on LRP1 to form a bivalent D1D2-LRP1 complex. When lysine 60 and 191 are both mutated to alanine, the binding of D1D2 to LRP1 is ablated. Our data also reveal that D1D2 is able to bind to a second distinct site on LRP1 to form a monovalent complex. The studies confirm the canonical model for ligand recognition by this class of receptors, which is initiated by pairs of lysine residues that dock into acidic pockets on the receptor.	Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Ctr Vasc Inflammatory Dis, Biopark 1,R219,800 W Baltimore St, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu		Prasad, Joni/0000-0001-5224-6502	National Institutes of Health [HL114379, HL120388, T32 HL007698]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114379, R01HL120388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL114379 and HL120388 (to D. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32 HL007698.	Andersen OM, 2001, BIOCHEMISTRY-US, V40, P15408, DOI 10.1021/bi0110692; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Bloem E, 2015, BIOCHEM J, V468, P65, DOI 10.1042/BJ20140977; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Boucher P, 2011, BIOCHEM PHARMACOL, V81, P1, DOI 10.1016/j.bcp.2010.09.018; Bu GJ, 1997, J CELL SCI, V110, P65; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Dagil R, 2013, J BIOL CHEM, V288, P4424, DOI 10.1074/jbc.M112.434159; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; HERZ J, 1993, CELL, V73, P428, DOI 10.1016/0092-8674(93)90130-I; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; KRAUSS G, 1976, EUR J BIOCHEM, V68, P81, DOI 10.1111/j.1432-1033.1976.tb10766.x; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; Lee D, 2007, PROTEIN SCI, V16, P1628, DOI 10.1110/ps.072865407; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Mantuano E, 2016, P NATL ACAD SCI USA, V113, P1369, DOI 10.1073/pnas.1515480113; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; Medved LV, 1999, J BIOL CHEM, V274, P717, DOI 10.1074/jbc.274.2.717; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; Muratoglu SC, 2013, ARTERIOSCL THROM VAS, V33, P2137, DOI 10.1161/ATVBAHA.113.301893; Nakajima C, 2014, DEVELOPMENT, V141, P4513, DOI 10.1242/dev.109124; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Nielsen PR, 1997, P NATL ACAD SCI USA, V94, P7521, DOI 10.1073/pnas.94.14.7521; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; RIESNER D, 1976, EUR J BIOCHEM, V68, P71, DOI 10.1111/j.1432-1033.1976.tb10765.x; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Xiao T, 2000, PROTEIN SCI, V9, P1889, DOI 10.1110/ps.9.10.1889; Yamamoto K, 2014, J BIOL CHEM, V289, P6462, DOI 10.1074/jbc.M113.545376; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104	52	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18430	18439		10.1074/jbc.M116.744904	http://dx.doi.org/10.1074/jbc.M116.744904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402839	Green Published, hybrid			2022-12-28	WOS:000383241800033
J	Chung, HJ; Park, JE; Lee, NS; Kim, H; Jang, CY				Chung, Hee Jin; Park, Ji Eun; Lee, Nam Soo; Kim, Hongtae; Jang, Chang-Young			Phosphorylation of Astrin Regulates Its Kinetochore Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cell division; cyclin-dependent kinase (Cdk); kinetochore; phosphorylation; mitosis	SPINDLE-ASSOCIATED PROTEIN; POLO-BOX DOMAIN; MITOTIC-SPINDLE; MICROTUBULE ATTACHMENTS; CHROMOSOME ALIGNMENT; MITOSIS; CENTROSOME; CELLS; CAPTURE; COMPLEX	The error-free segregation of chromosomes, which requires the precisely timed search and capture of chromosomes by spindles during early mitotic and meiotic cell division, is responsible for genomic stability and is achieved by the spindle assembly checkpoint in the metaphase-anaphase transition. Mitotic kinases orchestrate M phase events, such as the reorganization of cell architecture and kinetochore (KT) composition with the exquisite phosphorylation of mitotic regulators, to ensure timely and temporal progression. However, the molecular mechanisms underlying the changes of KT composition for stable spindle attachment during mitosis are poorly understood. Here, we show that the sequential action of the kinase Cdk1 and the phosphatase Cdc14A control spindle attachment to KTs. During prophase, the mitotic spindle protein Spag5/Astrin is transported into centrosomes by Kinastrin and phosphorylated at Ser-135 and Ser-249 by Cdk1, which, in prometaphase, is loaded onto the spindle and targeted to KTs. We also demonstrate that Cdc14A dephosphorylates Astrin, and therefore the overexpression of Cdc14A sequesters Astrin in the centrosome and results in aberrant chromosome alignment. Mechanistically, Plk1 acts as an upstream kinase for Astrin phosphorylation by Cdk1 and targeting phospho-Astrin to KTs, leading to the recruitment of outer KT components, such as Cenp-E, and the stable attachment of spindles to KTs. These comprehensive findings reveal a regulatory circuit for protein targeting to KTs that controls the KT composition change of stable spindle attachment and chromosome integrity.	[Kim, Hongtae] Sungkyunkwan Univ, Ctr Neurosci Imaging Res, Inst Basic Sci, Suwon 440746, South Korea; [Chung, Hee Jin; Lee, Nam Soo; Kim, Hongtae] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Park, Ji Eun; Jang, Chang-Young] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 04310, South Korea	Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sookmyung Women's University	Kim, H (corresponding author), Sungkyunkwan Univ, Ctr Neurosci Imaging Res, Inst Basic Sci, Suwon 440746, South Korea.; Kim, H (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea.; Jang, CY (corresponding author), Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 04310, South Korea.	khtcat@skku.edu; cyjang@sookmyung.ac.kr			Institute for Basic Science Grant [IBS-R015-D1]; National Research Foundation of Korea - Korea government [NRF-2015R1A2A2A01003975, 2011-0030074]	Institute for Basic Science Grant; National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government)	This work was supported by Institute for Basic Science Grant IBS-R015-D1 and National Research Foundation of Korea grants NRF-2015R1A2A2A01003975 and 2011-0030074 funded by the Korea government. The authors declare that they have no conflicts of interest with the contents of this article.	Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Amin MA, 2014, J CELL SCI, V127, P2818, DOI 10.1242/jcs.150755; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Cheng TS, 2008, J BIOL CHEM, V283, P2454, DOI 10.1074/jbc.M706794200; Cheng TS, 2007, EXP CELL RES, V313, P1710, DOI 10.1016/j.yexcr.2007.02.023; Chiu SC, 2014, AM J PHYSIOL-CELL PH, V307, pC466, DOI 10.1152/ajpcell.00164.2014; Cho HJ, 2010, MOL CELLS, V30, P355, DOI 10.1007/s10059-010-0134-8; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Loffler H, 2011, CANCER RES, V71, P2129, DOI 10.1158/0008-5472.CAN-10-2684; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Maia ARR, 2012, J CELL BIOL, V199, P285, DOI 10.1083/jcb.201203091; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; McEwen BF, 1998, CHROMOSOMA, V107, P366, DOI 10.1007/s004120050320; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka K, 2012, J BIOCHEM, V152, P415, DOI 10.1093/jb/mvs109; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Tavernier N, 2015, J CELL BIOL, V208, P661, DOI 10.1083/jcb.201408064; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738	43	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17579	17592		10.1074/jbc.M115.712745	http://dx.doi.org/10.1074/jbc.M115.712745			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27325694	Green Published, hybrid			2022-12-28	WOS:000383241300010
J	Hosaka, T; Yoshizawa, S; Nakajima, Y; Ohsawa, N; Hato, M; DeLong, EF; Kogure, K; Yokoyama, S; Kimura-Someya, T; Iwasaki, W; Shirouzu, M				Hosaka, Toshiaki; Yoshizawa, Susumu; Nakajima, Yu; Ohsawa, Noboru; Hato, Masakatsu; DeLong, Edward F.; Kogure, Kazuhiro; Yokoyama, Shigeyuki; Kimura-Someya, Tomomi; Iwasaki, Wataru; Shirouzu, Mikako			Structural Mechanism for Light-driven Transport by a New Type of Chloride Ion Pump, Nonlabens marinus Rhodopsin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; membrane protein; protein crystallization; structure-function; tertiary structure; cell-free protein synthesis; chloride ion pump; chloride ion-releasing residues; microbial rhodopsin	PROTON PUMP; SCHIFF-BASE; BACTERIORHODOPSIN; HALORHODOPSIN; PROTEIN; SYSTEM; MEMBRANE	The light-driven inward chloride ion-pumping rhodopsin Nonlabens marinus rhodopsin-3 (NM-R3), from a marine flavobacterium, belongs to a phylogenetic lineage distinct from the halorhodopsins known as archaeal inward chloride ion-pumping rhodopsins. NM-R3 and halorhodopsin have distinct motif sequences that are important for chloride ion binding and transport. In this study, we present the crystal structure of a new type of light-driven chloride ion pump, NM-R3, at 1.58 resolution. The structure revealed the chloride ion translocation pathway and showed that a single chloride ion resides near the Schiff base. The overall structure, chloride ion-binding site, and translocation pathway of NM-R3 are different from those of halorhodopsin. Unexpectedly, this NM-R3 structure is similar to the crystal structure of the light-driven outward sodium ion pump, Krokinobacter eikastus rhodopsin 2. Structural and mutational analyses of NM-R3 revealed that most of the important amino acid residues for chloride ion pumping exist in the ion influx region, located on the extracellular side of NM-R3. In contrast, on the opposite side, the cytoplasmic regions of K. eikastus rhodopsin 2 were reportedly important for sodium ion pumping. These results provide new insight into ion selection mechanisms in ion pumping rhodopsins, in which the ion influx regions of both the inward and outward pumps are important for their ion selectivities.	[Hosaka, Toshiaki; Ohsawa, Noboru; Hato, Masakatsu; Kimura-Someya, Tomomi; Shirouzu, Mikako] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] RIKEN Struct Biol Lab, Yokohama, Kanagawa 2300045, Japan; [Yoshizawa, Susumu; Nakajima, Yu; Kogure, Kazuhiro; Iwasaki, Wataru] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778564, Japan; [DeLong, Edward F.] Univ Hawaii, Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA; [Iwasaki, Wataru] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan	RIKEN; RIKEN; University of Tokyo; University of Hawaii System; University of Tokyo	Shirouzu, M (corresponding author), RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa 2300045, Japan.; Iwasaki, W (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778564, Japan.; Iwasaki, W (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan.	iwasaki@bs.s.u-tokyo.ac.jp; mikako.shirouzu@riken.jp	Nakajima, Yu/AAY-7947-2020; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016; Iwasaki, Wataru/O-4917-2014; Kimura-Someya, Tomomi/C-4169-2017	Yokoyama, Shigeyuki/0000-0003-3133-7338; Iwasaki, Wataru/0000-0002-9169-9245; Kimura-Someya, Tomomi/0000-0003-2232-1801; yoshizawa, susumu/0000-0001-9667-6010	Canon Foundation; Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development; CREST, Japan Science and Technology Agency; Japan Society for the Promotion of Science KAKENHI [15H02800, 15K14601, 221S0002, 15K18523]; Grants-in-Aid for Scientific Research [15K18523] Funding Source: KAKEN	Canon Foundation(Canon Foundation); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Canon Foundation (to W. I.), the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology and Japan Agency for Medical Research and Development (to S. Yokoyama), and CREST, Japan Science and Technology Agency (to K. K. and W. I.), and by Japan Society for the Promotion of Science KAKENHI Grants 15H02800 and 15K14601 (to S. Yoshizawa), 221S0002 (to W. I.) and 15K18523 (to T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Dioumaev AK, 2003, BIOCHEMISTRY-US, V42, P6582, DOI 10.1021/bi034253r; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Essen LO, 2002, CURR OPIN STRUC BIOL, V12, P516, DOI 10.1016/S0959-440X(02)00356-1; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Furuse M, 2015, ACTA CRYSTALLOGR D, V71, P2203, DOI 10.1107/S1399004715015722; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Hato Masakatsu, 2014, Journal of Structural and Functional Genomics, V15, P165, DOI 10.1007/s10969-014-9187-9; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Kubo M, 2009, PHOTOCHEM PHOTOBIOL, V85, P547, DOI 10.1111/j.1751-1097.2009.00538.x; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Sato M, 2005, BIOCHEMISTRY-US, V44, P4775, DOI 10.1021/bi047500f; Sato M, 2003, BIOPHYS CHEM, V104, P209, DOI 10.1016/S0301-4622(02)00368-X; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Shimono K, 2009, PROTEIN SCI, V18, P2160, DOI 10.1002/pro.230; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	35	29	29	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17488	17495		10.1074/jbc.M116.728220	http://dx.doi.org/10.1074/jbc.M116.728220			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365396	Green Published, hybrid			2022-12-28	WOS:000383241300001
J	Mukhopadyay, R; Sudasinghe, N; Schaub, T; Yukl, ET				Mukhopadyay, Roma; Sudasinghe, Nilusha; Schaub, Tanner; Yukl, Erik T.			Heme-independent Redox Sensing by the Heme-Nitric Oxide/Oxygen-binding Protein (H-NOX) from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; heme; histidine kinase; nitric oxide; redox signaling	DISULFIDE BOND FORMATION; BIOFILM FORMATION; MOLECULAR CHAPERONE; GUANYLYL CYCLASES; OXIDE; SWITCH; GMP; SENSOR; HSP33; FARNESYLTRANSFERASE	Heme nitric oxide/oxygen (H-NOX)-binding proteins act as nitric oxide (NO) sensors among various bacterial species. In several cases, they act to mediate communal behavior such as biofilm formation, quorum sensing, and motility by influencing the activity of downstream signaling proteins such as histidine kinases (HisKa) in a NO-dependent manner. An H-NOX/HisKa regulatory circuit was recently identified in Vibrio cholerae, and the H-NOX protein has been spectroscopically characterized. However, the influence of the H-NOX protein on HisKa autophosphorylation has not been evaluated. This process may be important for persistence and pathogenicity in this organism. Here, we have expressed and purified the V. cholerae HisKa (HnoK) and H-NOX in its heme-bound (holo) and heme-free (apo) forms. Autophosphorylation assays of HnoK in the presence of H-NOX show that the holoprotein in the Fe(II)-NO and Fe(III) forms is a potent inhibitor of HnoK. Activity of the Fe(III) form and aerobic instability of the Fe(II) form suggested that Vibrio cholerae H-NOX may act as a sensor of the redox state as well as NO. Remarkably, the apoprotein also showed robust HnoK inhibition that was dependent on the oxidation of cysteine residues to form disulfide bonds at a highly conserved zinc site. The importance of cysteine in this process was confirmed by mutagenesis, which also showed that holo Fe(III), but not Fe(II)-NO, H-NOX relied heavily upon cysteine for activation. These results highlight a heme-independent mechanism for activation of V. cholerae H-NOX that implicates this protein as a dual redox/NO sensor.	[Mukhopadyay, Roma; Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; [Sudasinghe, Nilusha; Schaub, Tanner] New Mexico State Univ, Chem Anal & Instrumentat Lab, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University	Yukl, ET (corresponding author), Dept Chem & Biochem, 1175 N Horseshoe Dr, Las Cruces, NM 88003 USA.	etyukl@nmsu.edu		Mukhopadhyay, Roma/0000-0002-6248-4763; Schaub, Tanner/0000-0002-5747-4237	Office of the Vice President for Research; Center for Animal Health and Food Safety at New Mexico State University; National Science Foundation [IIA-1301346]	Office of the Vice President for Research; Center for Animal Health and Food Safety at New Mexico State University; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Office of the Vice President for Research and the Center for Animal Health and Food Safety at New Mexico State University and National Science Foundation Grant IIA-1301346. The authors declare that they have no conflicts of interest with the contents of this article.	Allaoui A, 2009, TRENDS MOL MED, V15, P571, DOI 10.1016/j.molmed.2009.10.003; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barbirz S, 2000, J BIOL CHEM, V275, P18759, DOI 10.1074/jbc.M001089200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlson HK, 2010, MOL MICROBIOL, V77, P930, DOI 10.1111/j.1365-2958.2010.07259.x; Cremers CM, 2013, J BIOL CHEM, V288, P26489, DOI 10.1074/jbc.R113.462929; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008; Furhrhop J. H., 1975, LAB METHODS PORPHYRI, P804; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Henares BM, 2012, ACS CHEM BIOL, V7, P1331, DOI 10.1021/cb300215t; Herzik MA, 2014, P NATL ACAD SCI USA, V111, pE4156, DOI 10.1073/pnas.1416936111; Hightower KE, 1999, CURR OPIN CHEM BIOL, V3, P176, DOI 10.1016/S1367-5931(99)80030-1; HILDEBRANDT AG, 1975, ARCH BIOCHEM BIOPHYS, V171, P385, DOI 10.1016/0003-9861(75)90047-8; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Liu N, 2012, BIOCHEMISTRY-US, V51, P2087, DOI 10.1021/bi201753f; Lucas KA, 2000, PHARMACOL REV, V52, P375; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Plate L, 2013, TRENDS BIOCHEM SCI, V38, P566, DOI 10.1016/j.tibs.2013.08.008; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Pother DC, 2009, J BACTERIOL, V191, P7520, DOI 10.1128/JB.00937-09; Price MS, 2007, BIOCHEMISTRY-US, V46, P13677, DOI 10.1021/bi7019035; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rozema DB, 1999, BIOCHEMISTRY-US, V38, P13138, DOI 10.1021/bi990794y; Tennyson AG, 2011, CHEM BIOL, V18, P1211, DOI 10.1016/j.chembiol.2011.09.009; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Tsai AL, 2010, BIOCHEMISTRY-US, V49, P6587, DOI 10.1021/bi1002234; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Wu G, 2013, BIOCHEMISTRY-US, V52, P9432, DOI 10.1021/bi401408x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028	39	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17547	17556		10.1074/jbc.M116.733337	http://dx.doi.org/10.1074/jbc.M116.733337			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358409	Green Published, hybrid			2022-12-28	WOS:000383241300007
J	Kabil, O; Yadav, V; Banerjee, R				Kabil, Omer; Yadav, Vinita; Banerjee, Ruma			Heme-dependent Metabolite Switching Regulates H2S Synthesis in Response to Endoplasmic Reticulum (ER) Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE-BETA-SYNTHASE; HYDROGEN-SULFIDE; HOMOCYSTEINE METABOLISM; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; GENE-EXPRESSION; FOLIC-ACID; INJURY; HOMOCYSTINURIA; MORTALITY	Substrate ambiguity and relaxed reaction specificity underlie the diversity of reactions catalyzed by the transsulfuration pathway enzymes, cystathionine beta-synthase (CBS) and gamma-cystathionase (CSE). These enzymes either commit sulfur metabolism to cysteine synthesis from homocysteine or utilize cysteine and/or homocysteine for synthesis of H2S, a signaling molecule. We demonstrate that a kinetically controlled heme-dependent metabolite switch in CBS regulates these competing reactions where by cystathionine, the product of CBS, inhibits H2S synthesis by the second enzyme, CSE. Under endoplasmic reticulum stress conditions, induction of CSE and up-regulation of the CBS inhibitor, CO, a product of heme oxygenase-1, flip the operating preference of CSE from cystathionine to cysteine, transiently stimulating H2S production. In contrast, genetic deficiency of CBS leads to chronic stimulation of H2S production. This metabolite switch from cystathionine to cysteine and/or homocysteine renders H2S synthesis by CSE responsive to the known modulators of CBS: S-adenosylmethionine, NO, and CO. Used acutely, it regulates H2S synthesis; used chronically, it might contribute to disease pathology.	[Kabil, Omer; Yadav, Vinita; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kabil, O; Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	omerk@umich.edu; rbanerje@umich.edu	Yadav, Vinita/J-3605-2019; Kabil, Omer/AAJ-1435-2020	Yadav, Vinita/0000-0003-1026-5697; 	National Institutes of Health [HL58984]; American Heart Association [13SDG17070096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL58984 (to R. B.) and American Heart Association Grant 13SDG17070096 (to O. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 1996, J NEUROSCI, V16, P1066; Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Garg S, 2006, J BIOL CHEM, V281, P38712, DOI 10.1074/jbc.M606235200; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; LUNDQUIST P, 1980, CLIN CHEM, V26, P1178; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Niu WN, 2015, ANTIOXID REDOX SIGN, V22, P350, DOI 10.1089/ars.2014.5891; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; PERRY TL, 1966, SCIENCE, V152, P776, DOI 10.1126/science.152.3723.776; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Puranik M, 2006, J BIOL CHEM, V281, P13433, DOI 10.1074/jbc.M600246200; Ratnam S, 2002, J BIOL CHEM, V277, P42912, DOI 10.1074/jbc.M206588200; ROBILLON JF, 1994, DIABETES METAB, V20, P494; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002	39	40	41	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16418	16423		10.1074/jbc.C116.742213	http://dx.doi.org/10.1074/jbc.C116.742213			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27365395	Green Published, hybrid			2022-12-28	WOS:000380826700001
J	Yao, YF; Shi, Q; Chen, B; Wang, QS; Li, XD; Li, L; Huang, YH; Ji, JG; Shen, PP				Yao, Yongfang; Shi, Qian; Chen, Bing; Wang, Qingsong; Li, Xinda; Li, Long; Huang, Yahong; Ji, Jianguo; Shen, Pingping			Identification of Caspase-6 as a New Regulator of Alternatively Activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cytokine; immunology; macrophage; toll-like receptor (TLR); tumor immunology	TUMOR-ASSOCIATED MACROPHAGES; SUPPRESSOR-CELLS; CANCER; ANGIOGENESIS; POLARIZATION; DISTINCT; PLASTICITY; MONOCYTES; DIFFERENTIATION; DEGENERATION	Alternatively activated macrophages (AAMs) play essential roles in the promotion of tissue remodeling, vasculogenesis, and tumor progression; however, the detailed mechanisms underlying the activation of AAMs remain largely unknown. Here, by using quantitative proteomic analysis, we identified 62 proteins that were up-regulated in IL-4-induced macrophages. Among these, Caspase-6 was increased significantly. Caspase-6 is important in the apoptotic signaling pathway; however, its role in non-apoptosis is also reported. Here, we first examined the non-apoptotic role of Caspase-6 in the alternative activation of macrophages after administration of IL-4, 4T1 tumor conditional medium, or co-culture with 4T1 cells. Both treatments promoted alternative activation of RAW264.7 cells and primary macrophages, whereas disruption of caspase-6 expression and activity could markedly suppress the biomarker levels of AAMs. Overexpression of Caspase-6 could significantly promote the activation of AAMs. Importantly, we further present evidence that caspase-6 could regulate breast cancer cell invasion by modulating MMP-2 and MMP-9 expression in 4T1 tumor-associated macrophages, as ablation of protein levels or activity of caspase-6 suppressed tumor cell invasion in vitro. In conclusion, the observed results markedly expanded our views of the dynamic changes in protein composition during alternative activation of macrophages, and they revealed a critical new role of caspase-6 in regulating this cellular biological process, which suggested that caspase-6 might be a key nod molecule to regulate immunological steady-state and be a therapeutic candidate for tumor immunotherapy.	[Yao, Yongfang; Li, Xinda; Li, Long; Huang, Yahong; Shen, Pingping] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Yao, Yongfang; Li, Xinda; Li, Long; Huang, Yahong; Shen, Pingping] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210023, Jiangsu, Peoples R China; [Shi, Qian] Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol, Dept Med, San Antonio, TX 78229 USA; [Chen, Bing] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Hematol, Nanjing 210008, Peoples R China; [Wang, Qingsong; Ji, Jianguo] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Nanjing University; Nanjing University; University of Texas System; University of Texas Health San Antonio; Nanjing University; Peking University	Shen, PP (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.; Shen, PP (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210023, Jiangsu, Peoples R China.; Ji, JG (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Ji, JG (corresponding author), Peking Univ, Inst Syst Biomed, Sch Basic Med Sci, Beijing 100191, Peoples R China.	jijg@pku.edu.cn; ppshen1812@gmail.com			National Natural Science Foundation of China [81473220, 81273527, 81421091]; National Key Research and Development Program [2016YFA0500301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This work was supported by National Natural Science Foundation of China Projects 81473220, 81273527, and 81421091 and by National Key Research and Development Program no. 2016YFA0500301. The authors declare that they have no conflicts of interest with the contents of this article.	ABRAMSON SL, 1990, J IMMUNOL, V144, P625; Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Clear AJ, 2010, BLOOD, V115, P5053, DOI 10.1182/blood-2009-11-253260; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Farina AR, 2014, CANCERS, V6, P240, DOI 10.3390/cancers6010240; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gal A, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-402; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Kalhori V, 2015, MOL CELL ENDOCRINOL, V404, P113, DOI 10.1016/j.mce.2015.01.037; Kobayashi H, 2011, J IMMUNOL, V186, P403, DOI 10.4049/jimmunol.1001906; Kodumudi KN, 2010, CLIN CANCER RES, V16, P4583, DOI 10.1158/1078-0432.CCR-10-0733; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; MANTOVANI A, 1979, J NATL CANCER I, V63, P61; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Rust C, 2009, J BIOL CHEM, V284, P2908, DOI 10.1074/jbc.M804585200; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005; Uribe V, 2012, HUM MOL GENET, V21, P1954, DOI 10.1093/hmg/dds005; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang T, 2012, PIGM CELL MELANOMA R, V25, P493, DOI 10.1111/j.1755-148X.2012.01005.x; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810; Wong BKY, 2015, NEUROBIOL DIS, V76, P24, DOI 10.1016/j.nbd.2014.12.030; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	67	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17450	17466		10.1074/jbc.M116.717868	http://dx.doi.org/10.1074/jbc.M116.717868			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325699	hybrid, Green Published			2022-12-28	WOS:000382643800043
J	Young, SK; Wek, RC				Young, Sara K.; Wek, Ronald C.			Upstream Open Reading Frames Differentially Regulate Gene-specific Translation in the Integrated Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						eukaryotic translation initiation; stress response; translation; translation control; translation regulation	MESSENGER-RNA TRANSLATION; GUANINE-NUCLEOTIDE EXCHANGE; UNFOLDED PROTEIN RESPONSE; AMINO-ACID STARVATION; EVOLUTIONARY CONSERVATION; ENDOPLASMIC-RETICULUM; MEDIATED TRANSLATION; EUKARYOTIC RIBOSOMES; INITIATION COMPLEX; MASTER REGULATOR	Translation regulation largely occurs during initiation, which features ribosome assembly onto mRNAs and selection of the translation start site. Short, upstream ORFs (uORFs) located in the 5-leader of the mRNA can be selected for translation. Multiple transcripts associated with stress amelioration are preferentially translated through uORF-mediated mechanisms during activation of the integrated stress response (ISR) in which phosphorylation of the subunit of eIF2 results in a coincident global reduction in translation initiation. This review presents key features of uORFs that serve to optimize translational control that is essential for regulation of cell fate in response to environmental stresses.	[Young, Sara K.; Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Wek, RC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu		Young-Baird, Sara/0000-0002-8915-3139	National Institutes of Health Grant [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM049164 (to R.C.W.) and the Ralph W. and Grace M. Showalter Research Trust Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Aviner R, 2013, GENE DEV, V27, P1834, DOI 10.1101/gad.219105.113; Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; CALKHOVEN CF, 1994, NUCLEIC ACIDS RES, V22, P5540, DOI 10.1093/nar/22.25.5540; Calkhoven CF, 2000, GENE DEV, V14, P1920; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Col B, 2007, BBA-GENE STRUCT EXPR, V1769, P532, DOI 10.1016/j.bbaexp.2007.06.003; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Cvijovic M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-295; Dey S, 2012, J BIOL CHEM, V287, P21936, DOI 10.1074/jbc.M112.351783; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Fernandez J, 2005, MOL CELL, V17, P405, DOI 10.1016/j.molcel.2004.12.024; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Floor SN, 2016, ELIFE, V5, DOI 10.7554/eLife.10921; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; GRANT CM, 1994, MOL CELL BIOL, V14, P606, DOI 10.1128/MCB.14.1.606; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hansen MB, 2002, GENOMICS, V80, P344, DOI 10.1006/geno.2002.6838; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hussain T, 2014, CELL, V159, P597, DOI 10.1016/j.cell.2014.10.001; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011569; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jennings MD, 2014, CELL CYCLE, V13, P2660, DOI 10.4161/15384101.2014.948797; Jennings MD, 2013, GENE DEV, V27, P2696, DOI 10.1101/gad.231514.113; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Law GL, 2001, J BIOL CHEM, V276, P38036; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Malzer E, 2013, J CELL SCI, V126, P1406, DOI 10.1242/jcs.117614; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Mehta A, 2006, GENE DEV, V20, P939, DOI 10.1101/gad.1388706; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; MILLER PF, 1989, GENE DEV, V3, P1217, DOI 10.1101/gad.3.8.1217; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Neafsey DE, 2007, MOL BIOL EVOL, V24, P1744, DOI 10.1093/molbev/msm093; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Spevak CC, 2006, BIOCHEM BIOPH RES CO, V350, P834, DOI 10.1016/j.bbrc.2006.09.128; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Sundaram A, 2014, RNA, V20, P559, DOI 10.1261/rna.042267.113; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang CX, 2007, CELL RES, V17, P374, DOI 10.1038/sj.cr.7310121; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Wei JJ, 2012, MOL CELL BIOL, V32, P2396, DOI 10.1128/MCB.00136-12; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Young SK, 2016, J BIOL CHEM, V291, P10824, DOI 10.1074/jbc.M116.722256; Young SK, 2016, J BIOL CHEM, V291, P6546, DOI 10.1074/jbc.M115.705640; Young SK, 2015, J BIOL CHEM, V290, P28257, DOI 10.1074/jbc.M115.693184; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zinoviev A, 2015, MOL CELL, V57, P1059, DOI 10.1016/j.molcel.2015.01.039; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	91	170	174	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16927	16935		10.1074/jbc.R116.733899	http://dx.doi.org/10.1074/jbc.R116.733899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27358398	Green Published, hybrid			2022-12-28	WOS:000382643800001
J	Zhang, Y; Zhang, Y; Geng, LY; Yi, HW; Huo, W; Talmon, G; Kim, YC; Wang, SM; Wang, J				Zhang, Yang; Zhang, Yi; Geng, Liying; Yi, Haowei; Huo, Wei; Talmon, Geoffrey; Kim, Yeong C.; Wang, San Ming; Wang, Jing			RETRACTED: Transforming Growth Factor Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer (Retracted article. See vol. 295, pg. 4368, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						apoptosis; B cell lymphoma 2 (Bcl-2); colorectal cancer; drug resistance; pyruvate dehydrogenase kinase (PDC kinase); survivin; TGF; 5-FU; DCA	TGF-BETA RECEPTOR; CELL-LINES; DICHLOROACETATE; APOPTOSIS; 5-FLUOROURACIL; CHEMOTHERAPY; CONTRIBUTES; METASTASIS; INHIBITION; ADAPTATION	Drug resistance is one of the main causes of colon cancer recurrence. However, our understanding of the underlying mechanisms and availability of therapeutic options remains limited. Here we show that expression of pyruvate dehydrogenase kinase 4 (PDK4) is positively correlated with drug resistance of colon cancer cells and induced by 5-fluorouracil (5-FU) treatment in drug-resistant but not drug-sensitive cells. Knockdown of PDK4 expression sensitizes colon cancer cells to 5-FU or oxaliplatin-induced apoptosis in vitro and increases the effectiveness of 5-FU in the inhibition of tumor growth in a mouse xenograft model in vivo. In addition, we demonstrate for the first time that TGF mediates drug resistance by regulating PDK4 expression and that 5-FU induces PDK4 expression in a TGF signaling-dependent manner. Mechanistically, knockdown or inhibition of PDK4 significantly increases the inhibitory effect of 5-FU on expression of the anti-apoptotic factors Bcl-2 and survivin. Importantly, studies of patient samples indicate that expression of PDK4 and phosphorylation of Smad2, an indicator of TGF pathway activation, show a strong correlation and that both positively associate with chemoresistance in colorectal cancer. These findings indicate that the TGF/PDK4 signaling axis plays an important role in the response of colorectal cancer to chemotherapy. A major implication of our studies is that inhibition of PDK4 may have considerable therapeutic potential to overcome drug resistance in colorectal cancer patients, which warrants the development of PDK4-specific inhibitors.	[Zhang, Yang; Geng, Liying; Yi, Haowei; Wang, Jing] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA; [Zhang, Yang; Yi, Haowei; Kim, Yeong C.; Wang, San Ming; Wang, Jing] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Wang, Jing] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Talmon, Geoffrey] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Zhang, Yi] Third Mil Med Univ, Dept Cell Biol, Chongqing 400038, Peoples R China; [Huo, Wei] Dalian Cent Hosp, Dept Oncol, Dalian 116033, Peoples R China; [Zhang, Yang] Univ Penn, Dept Canc Biol, Perelman Sch Med, 642 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Army Medical University; University of Pennsylvania; Pennsylvania Medicine	Wang, J (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	jjwang@unmc.edu			NCI, National Institutes of Health [R01CA140988-01]; Nebraska Department of Health and Human Services [(LB506) 2014-40]; graduate studies research fellowship from University of Nebraska Medical Center; Chinese Scholar Council; Dalian Central Hospital; NATIONAL CANCER INSTITUTE [R01CA140988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Department of Health and Human Services; graduate studies research fellowship from University of Nebraska Medical Center; Chinese Scholar Council; Dalian Central Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health Grant R01CA140988-01 and Nebraska Department of Health and Human Services Grant (LB506) 2014-40 (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Partially supported by a graduate studies research fellowship from University of Nebraska Medical Center. Present address: Dept. of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, 642 BRB 2/3, 421 Curie Blvd., Philadelphia, PA 19104-6160.; Supported by the Chinese Scholar Council.; Supported by Dalian Central Hospital.	Alhopuro P, 2005, CLIN CANCER RES, V11, P6311, DOI 10.1158/1078-0432.CCR-05-0244; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boulay JL, 2002, BRIT J CANCER, V87, P630, DOI 10.1038/sj.bjc.6600511; BOYD DD, 1988, CANCER RES, V48, P2469; Chen ML, 2010, SURG ONCOL, V19, P38, DOI 10.1016/j.suronc.2009.02.015; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Chowdhury S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060299; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Geng L, 2014, ONCOGENE, V33, P5332, DOI 10.1038/onc.2013.478; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim SH, 2009, AM J CLIN ONCOL-CANC, V32, P38, DOI 10.1097/COC.0b013e31817be58e; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Liang F, 2009, SWISS MED WKLY, V139, P724, DOI smw-12754; Liu ZB, 2014, J BIOL CHEM, V289, P29739, DOI 10.1074/jbc.M114.584821; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; MOERTEL CG, 1978, NEW ENGL J MED, V299, P1049, DOI 10.1056/NEJM197811092991906; Nita ME, 1998, BRIT J CANCER, V78, P986, DOI 10.1038/bjc.1998.617; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Rougier P, 1998, LANCET, V352, P1407, DOI 10.1016/S0140-6736(98)03085-2; Schmoll HJ, 1999, SEMIN ONCOL, V26, P589; Simms NAK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-221; Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Sun Y, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-20; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Xuan Y, 2014, EXP CELL RES, V321, P219, DOI 10.1016/j.yexcr.2013.12.009; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Ye SC, 1999, CANCER RES, V59, P4725; Zhang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.200; Zhang Y, 2015, J BIOL CHEM, V290, P6215, DOI 10.1074/jbc.M114.620252; Zhao JG, 2014, TUMOR BIOL, V35, P12305, DOI 10.1007/s13277-014-2543-3	52	31	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17405	17416		10.1074/jbc.M116.713735	http://dx.doi.org/10.1074/jbc.M116.713735			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27330076	Green Published, hybrid			2022-12-28	WOS:000382643800039
J	Zhou, XH; DeLucia, M; Ahn, J				Zhou, Xiaohong; DeLucia, Maria; Ahn, Jinwoo			SLX4-SLX1 Protein-independent Down-regulation of MUS81-EME1 Protein by HIV-1 Viral Protein R (Vpr)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; human immunodeficiency virus (HIV); proteasome; protein degradation; viral protein; Western blot	CELL-CYCLE ARREST; VIRUS TYPE-1 VPR; HOLLIDAY JUNCTION RESOLUTION; CUL4-DDB1 UBIQUITIN LIGASE; PRIMATE LENTIVIRUSES; ACCESSORY PROTEINS; G(2) ARREST; PROTEASOMAL DEGRADATION; RECRUITING DCAF1/VPRBP; PREINTEGRATION COMPLEX	Evolutionarily conserved structure-selective endonuclease MUS81 forms a complex with EME1 and further associates with another endonuclease SLX4-SLX1 to form a four-subunit complex of MUS81-EME1-SLX4-SLX1, coordinating distinctive biochemical activities of both endonucleases in DNA repair. Viral protein R (Vpr), a highly conserved accessory protein in primate lentiviruses, was previously reported to bind SLX4 to mediate down-regulation of MUS81. However, the detailed mechanism underlying MUS81 down-regulation is unclear. Here, we report that HIV-1 Vpr down-regulates both MUS81 and its cofactor EME1 by hijacking the host CRL4-DCAF1 E3 ubiquitin ligase. Multiple Vpr variants, from HIV-1 and SIV, down-regulate both MUS81 and EME1. Furthermore, a C-terminally truncated Vpr mutant and point mutants R80A and Q65R, all of which lack G(2) arrest activity, are able to down-regulate MUS81-EME1, suggesting that Vpr-induced G(2) arrest is not correlated with MUS81-EME1 down-regulation. We also show that neither the interaction of MUS81-EME1 with Vpr nor their down-regulation is dependent on SLX4-SLX1. Together, these data provide new insight on a conserved function of Vpr in a host endonuclease down-regulation.	[Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	jia12@pitt.edu	Zhou, Xiaohong/B-3416-2012	Zhou, Xiaohong/0000-0003-0519-2550	National Institutes of Health [P50 GM082251, R01 GM116642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251, R01GM116642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grants P50 GM082251 and R01 GM116642 (to J.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amangyeld T, 2014, NUCLEIC ACIDS RES, V42, P5846, DOI 10.1093/nar/gku237; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Berger G, 2015, J VIROL, V89, P230, DOI 10.1128/JVI.02307-14; Blondot ML, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0117-5; Bouzar AB, 2004, VIROLOGY, V326, P47, DOI 10.1016/j.virol.2004.05.016; Cassiday PA, 2015, VIROLOGY, V476, P19, DOI 10.1016/j.virol.2014.11.024; Castor D, 2013, MOL CELL, V52, P221, DOI 10.1016/j.molcel.2013.08.036; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; DePaula-Silva AB, 2015, VIROLOGY, V477, P10, DOI 10.1016/j.virol.2014.12.040; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Gummuluru S, 1999, J VIROL, V73, P5422, DOI 10.1128/JVI.73.7.5422-5430.1999; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hiyama T, 2006, NUCLEIC ACIDS RES, V34, P880, DOI 10.1093/nar/gkj495; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Jacquot G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007514; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim K, 2013, MOL CELL, V52, P459, DOI 10.1016/j.molcel.2013.09.017; Kim K, 2012, MOL CELL BIOL, V32, P783, DOI 10.1128/MCB.06037-11; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; LEVY DN, 1993, CELL, V72, P541, DOI 10.1016/0092-8674(93)90073-Y; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Matos J, 2014, DNA REPAIR, V19, P176, DOI 10.1016/j.dnarep.2014.03.013; McCall CM, 2008, MOL CELL BIOL, V28, P5621, DOI 10.1128/MCB.00232-08; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Muthumani K, 2003, BIOCHEM BIOPH RES CO, V304, P583, DOI 10.1016/S0006-291X(03)00631-4; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Nair N, 2014, DNA REPAIR, V24, P131, DOI 10.1016/j.dnarep.2014.08.004; Nakagawa T, 2015, MOL CELL, V57, P247, DOI 10.1016/j.molcel.2014.12.002; Nakagawa T, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-22; Pepe A, 2014, CELL REP, V7, P1048, DOI 10.1016/j.celrep.2014.04.007; Pepe A, 2014, NUCLEIC ACIDS RES, V42, P3833, DOI 10.1093/nar/gkt1333; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Rueden CT, 2007, BIOTECHNIQUES, V43, P31, DOI 10.2144/000112511; Sawaya BE, 1999, GENE THER, V6, P947, DOI 10.1038/sj.gt.3300907; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Transy C, 2009, CELL CYCLE, V8, P2489, DOI 10.4161/cc.8.16.9129; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Varin A, 2005, J BIOL CHEM, V280, P42557, DOI 10.1074/jbc.M502211200; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wyatt HDM, 2013, MOL CELL, V52, P234, DOI 10.1016/j.molcel.2013.08.035; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; Zhou Y, 1998, VIROLOGY, V242, P414, DOI 10.1006/viro.1998.9028	69	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16936	16947		10.1074/jbc.M116.721183	http://dx.doi.org/10.1074/jbc.M116.721183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27354282	hybrid, Green Published			2022-12-28	WOS:000382643800002
J	Kim, D; Dai, J; Park, YH; Fai, LY; Wang, L; Pratheeshkumar, P; Son, YO; Kondo, K; Xu, M; Luo, J; Shi, XL; Zhang, Z				Kim, Donghern; Dai, Jin; Park, Youn-hee; Fai, Leonard Yenwong; Wang, Lei; Pratheeshkumar, Poyil; Son, Young-Ok; Kondo, Kazuya; Xu, Mei; Luo, Jia; Shi, Xianglin; Zhang, Zhuo			RETRACTED: Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1 alpha Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium (Retracted article. See vol. 294, pg. 15558, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							INDUCIBLE FACTOR 1-ALPHA; MATRIX METALLOPROTEINASES; FACTOR RECEPTOR; TUMOR ANGIOGENESIS; FACTOR EXPRESSION; MMP-1 EXPRESSION; PROTEIN-KINASE; LUNG-CANCER; MAP KINASE; HYPOXIA	Hexavalent chromium (Cr(VI))-containing compounds are well established environmental carcinogens. Most mechanistic investigations of Cr(VI)-induced carcinogenesis focus on oxidative stress and various cellular responses, leading to malignant cell transformation or the first stage of metal-induced carcinogenesis. The development of malignantly transformed cells into tumors that require angiogenesis is the second stage. This study focuses on the second stage, in particular, the role of EGF receptor (EGFR) signaling in angiogenesis and tumorigenesis of Cr(VI)-transformed cells. Our preliminary studies have shown that EGFR is constitutively activated in Cr(VI)-transformed cells, in lung tissue from Cr(VI)-exposed animals, and in lung tumor tissue from a non-smoking worker occupationally exposed to Cr(VI) for 19 years. Using in vitro and in vivo models, the present study has investigated the role of EGFR in angiogenesis of Cr(VI)-transformed cells. The results show that Cr(VI)transformed cells are angiogenic. Hypoxia-inducible factor-1 alpha, pro-angiogenic protein matrix metalloproteinase 1, and VEGF are all highly expressed in Cr(VI)-transformed cells, in lung tissue from animals exposed to Cr(VI), and in lung tumor tissue from a non-smoking worker occupationally exposed to Cr(VI) for 19 years. p38 MAPK is also activated in Cr(VI)-transformed cells and in human lung tumor tissue. Inhibition of EGFR reduces p38 MAPK, resulting in decreased expression of hypoxia-inducible factor-1 alpha, metalloproteinase 1, and VEGF, leading to suppressions of angiogenesis and tumorigenesis. Overall, the present study has demonstrated that EGFR plays an important role in angiogenesis and tumorigenesis of Cr(VI)-transformed cells.	[Kim, Donghern; Dai, Jin; Park, Youn-hee; Fai, Leonard Yenwong; Zhang, Zhuo] Univ Kentucky, Dept Toxicol & Canc Biol, 1095 Vet Dr, Lexington, KY 40536 USA; [Wang, Lei; Pratheeshkumar, Poyil; Son, Young-Ok; Shi, Xianglin] Univ Kentucky, Ctr Res Environm Dis, Lexington, KY 40536 USA; [Xu, Mei; Luo, Jia] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Kondo, Kazuya] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oncol Med Serv, Tokushima 7708509, Japan	University of Kentucky; University of Kentucky; University of Kentucky; Tokushima University	Zhang, Z (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, 1095 Vet Dr, Lexington, KY 40536 USA.	zhuo.zhang@uky.edu	Son, Young-Ok/P-3675-2015; Son, Youngok/AAB-1380-2021	Son, Youngok/0000-0003-0154-4061	NIEHS, National Institutes of Health [R01ES018883]; NCI, National Institutes of Health [R03CA171604]; NATIONAL CANCER INSTITUTE [P30CA177558, R03CA171604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021771, R01ES018883] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health Grant R01ES018883 and NCI, National Institutes of Health Grant R03CA171604 (to Z. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V49, P1; Artym Vira V, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1018s48; Beaver LM, 2009, ENVIRON HEALTH PERSP, V117, P1896, DOI 10.1289/ehp.0900715; Bostrom P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-348; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Covello KL, 2004, CURR TOP DEV BIOL, V62, P37; Cui SY, 2013, CELL CYCLE, V12, P2849, DOI 10.4161/cc.25916; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4; Eck SM, 2009, J AUTOIMMUN, V33, P214, DOI 10.1016/j.jaut.2009.09.011; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Esteva FJ, 2004, CANCER-AM CANCER SOC, V100, P499, DOI 10.1002/cncr.11940; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Foley CJ, 2014, ONCOGENE, V33, P2264, DOI 10.1038/onc.2013.157; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gao N, 2002, J BIOL CHEM, V277, P45041, DOI 10.1074/jbc.M202775200; Gatto C, 1999, CLIN CANCER RES, V5, P3603; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Gonzalez-Villasana V, 2015, CLIN CANCER RES, V21, P2127, DOI 10.1158/1078-0432.CCR-14-2279; Gordon MS, 2010, INT J CANCER, V126, P1777, DOI 10.1002/ijc.25026; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Herrera I, 2013, J BIOL CHEM, V288, P25964, DOI 10.1074/jbc.M113.459784; Hill R, 2008, DNA REPAIR, V7, P239, DOI 10.1016/j.dnarep.2007.10.001; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hong ZG, 2014, J MOL MED, V92, P995, DOI 10.1007/s00109-014-1162-1; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jiang H, 2015, MOL CANCER RES, V13, P1554, DOI 10.1158/1541-7786.MCR-15-0240; Jiang MC, 2001, BIOCHEM BIOPH RES CO, V282, P671, DOI 10.1006/bbrc.2001.4637; Kajanne R, 2007, J CELL PHYSIOL, V212, P489, DOI 10.1002/jcp.21041; Kanamori Y, 1999, CANCER RES, V59, P4225; Kim D, 2015, J BIOL CHEM, V290, P2213, DOI 10.1074/jbc.M114.619783; Kitano H, 2014, J HISTOCHEM CYTOCHEM, V62, P335, DOI 10.1369/0022155414523022; LANGARD S, 1990, AM J IND MED, V17, P189, DOI 10.1002/ajim.4700170205; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Leelahavanichkul K, 2014, MOL ONCOL, V8, P105, DOI 10.1016/j.molonc.2013.10.003; Lin TS, 2004, ONCOL REP, V12, P717; Lo PHY, 2010, CANCER RES, V70, P5567, DOI 10.1158/0008-5472.CAN-09-4510; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Luo L, 2005, BIOMATERIALS, V26, P5587, DOI 10.1016/j.biomaterials.2005.02.013; Maity A, 2000, CANCER RES, V60, P5879; Medhora M, 2003, AM J PHYSIOL-HEART C, V284, pH215, DOI 10.1152/ajpheart.01118.2001; National Toxicology Program, 2008, Natl Toxicol Program Tech Rep Ser, P1; Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478; OSSOWSKI L, 1992, CANCER RES, V52, P6754; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Schutz A, 2015, TRANSL ONCOL, V8, P97, DOI 10.1016/j.tranon.2015.02.002; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Smith Victoria, 2008, Cancer Genomics & Proteomics, V5, P263; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Ueda S, 2006, CANCER RES, V66, P5346, DOI 10.1158/0008-5472.CAN-05-3684; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wang X, 2011, TOXICOL SCI, V123, P399, DOI 10.1093/toxsci/kfr180; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wu WS, 2014, J PERS MED, V4, P297, DOI 10.3390/jpm4030297; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang ZF, 2009, INT J GYNECOL CANCER, V19, P998, DOI 10.1111/IGC.0b013e3181a83749	63	32	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16271	16281		10.1074/jbc.M116.715797	http://dx.doi.org/10.1074/jbc.M116.715797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27226640	Green Published, hybrid			2022-12-28	WOS:000380585400031
J	Moomau, C; Musalgaonkar, S; Khan, YA; Jones, JE; Dinman, JD				Moomau, Christine; Musalgaonkar, Sharmishtha; Khan, Yousuf A.; Jones, John E.; Dinman, Jonathan D.			Structural and Functional Characterization of Programmed Ribosomal Frameshift Signals in West Nile Virus Strains Reveals High Structural Plasticity Among cis-Acting RNA Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUDING PSEUDOKNOTS; MESSENGER-RNA; YEAST; EVOLUTION; FLAVIVIRUSES; INTERFERON; PREDICTION; ALGORITHM; VIRULENCE; SEQUENCE	West Nile virus (WNV) is a prototypical emerging virus for which no effective therapeutics currently exist. WNV uses programmed -1 ribosomal frameshifting (-1 PRF) to synthesize the NS1' protein, a C terminally extended version of its nonstructural protein 1, the expression of which enhances neuro-invasiveness and viral RNA abundance. Here, the NS1' frameshift signals derived from four WNV strains were investigated to better understand -1 PRF in this quasispecies. Sequences previously predicted to promote -1 PRF strongly promote this activity, but frameshifting was significantly more efficient upon inclusion of additional 3' sequence information. The observation of different rates of -1 PRF, and by inference differences in the expression of NS1', may account for the greater degrees of pathogenesis associated with specific WNV strains. Chemical modification and mutational analyses of the longer and shorter forms of the -1 PRF signals suggests dynamic structural rear-rangements between tandem stem-loop and mRNA pseudoknot structures in two of the strains. A model is suggested in which this is employed as a molecular switch to fine tune the relative expression of structural to non-structural proteins during different phases of the viral replication cycle.	[Moomau, Christine; Musalgaonkar, Sharmishtha; Khan, Yousuf A.; Jones, John E.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Moomau, Christine] MIT, Dept Biol, Biol Grad Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Musalgaonkar, Sharmishtha] Univ Texas Austin, Mol Biosci Dept, Austin, TX 78712 USA	University System of Maryland; University of Maryland College Park; Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin	Dinman, JD (corresponding author), 4062 Campus Dr, College Pk, MD 20742 USA.	dinman@umd.edu		Khan, Yousuf/0000-0003-0201-2796; Dinman, Jonathan/0000-0002-2402-9698	National Institutes of Health [R01HL119439, R01GM117177]; Defense Threat Reduction Agency [HDTRA1-13-1-0005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL119439 and R01GM117177 (to J. D. D.) and Defense Threat Reduction Agency Grant HDTRA1-13-1-0005. The authors declare that they have no conflicts of interest with the contents of this article. The content of this article does not necessarily reflect the position or the policy of the federal government, and no official endorsement should be inferred. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baer A, 2016, J VIROL, V90, P3558, DOI 10.1128/JVI.02827-15; Baranov PV, 2003, NUCLEIC ACIDS RES, V31, P87, DOI 10.1093/nar/gkg024; Bekaert M, 2010, NUCLEIC ACIDS RES, V38, pD69, DOI 10.1093/nar/gkp788; Belew AT, 2011, NUCLEIC ACIDS RES, V39, P2799, DOI 10.1093/nar/gkq1220; Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Craven RB, 2001, JAMA-J AM MED ASSOC, V286, P651, DOI 10.1001/jama.286.6.651; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dirks RM, 2004, J COMPUT CHEM, V25, P1295, DOI 10.1002/jcc.20057; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023; Grentzmann G, 1998, RNA, V4, P479; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Hollidge BS, 2011, VIRUSES-BASEL, V3, P629, DOI 10.3390/v3060629; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; JACOBSON AB, 1993, J MOL BIOL, V233, P261, DOI 10.1006/jmbi.1993.1504; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Melian EB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004447; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Powell D. G., 2010, EQUINE VET EDUC, V15, P66; Prow NA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00146; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Ren JH, 2005, RNA, V11, P1494, DOI 10.1261/rna.7284905; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006	36	27	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15788	15795		10.1074/jbc.M116.735613	http://dx.doi.org/10.1074/jbc.M116.735613			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226636	Green Published, hybrid			2022-12-28	WOS:000380584200031
J	Takar, M; Wu, YT; Graham, TR				Takar, Mehmet; Wu, Yuantai; Graham, Todd R.			The Essential Neo1 Protein from Budding Yeast Plays a Role in Establishing Aminophospholipid Asymmetry of the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; TRANS-GOLGI NETWORK; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID FLIPPASE; HEREDITARY CHOLESTASIS; ENDOPLASMIC-RETICULUM; TRANSLOCASE ACTIVITY; PHOSPHATIDYLSERINE; DRS2P; PHOSPHATIDYLETHANOLAMINE	Eukaryotic organisms typically express multiple type IV P-type ATPases (P4-ATPases), which establish plasma membrane asymmetry by flipping specific phospholipids from the exofacial to the cytosolic leaflet. Saccharomyces cerevisiae, for example, expresses five P4-ATPases, including Neo1, Drs2, Dnf1, Dnf2, and Dnf3. Neo1 is thought to be a phospholipid flippase, although there is currently no experimental evidence that Neo1 catalyzes this activity or helps establish membrane asymmetry. Here, we use temperature-conditional alleles (neo1(ts)) to test whether Neo1 deficiency leads to loss of plasma membrane asymmetry. Wild-type (WT) yeast normally restrict most of the phosphatidylserine (PS) and phosphatidylethanolamine (PE) to the inner cytosolic leaflet of the plasma membrane. However, the neo1-1(ts) and neo1-2(ts) mutants display a loss of PS and PE asymmetry at permissive growth temperatures as measured by hypersensitivity to pore-forming toxins that target PS (papuamide A) or PE (duramycin) exposed in the extracellular leaflet. When shifted to a semi-permissive growth temperature, the neo1-1ts mutant became extremely hypersensitive to duramycin, although the sensitivity to papuamide A was unchanged, indicating preferential exposure of PE. This loss of asymmetry occurs despite the presence of other flippases that flip PS and/or PE. Even when overexpressed, Drs2 and Dnf1 were unable to correct the loss of asymmetry caused by neo1ts. However, modest overexpression of Neo1 weakly suppressed loss of membrane asymmetry caused by drs2 Delta with a more significant correction of PE asymmetry than PS. These results indicate that Neo1 plays an important role in establishing PS and PE plasma membrane asymmetry in budding yeast.	[Takar, Mehmet; Wu, Yuantai; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu			Vanderbilt Ingram Cancer Center by National Institutes of Health [P30 CA68485]; Vanderbilt Digestive Disease Research Center by National Institutes of Health [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107978] Funding Source: NIH RePORTER	Vanderbilt Ingram Cancer Center by National Institutes of Health; Vanderbilt Digestive Disease Research Center by National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jeff Brodsky for anti-Kar2 and Amy Chang for anti-Pma1 antibodies. Flow cytometry experiments were performed in the Vanderbilt University Medical Center (VUMC) Flow Cytometry Shared Resource. We also thank Hannah M. Hankins for reviewing an earlier version of the manuscript. The VUMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center by National Institutes of Health Grant P30 CA68485 and Vanderbilt Digestive Disease Research Center by National Institutes of Health DK058404.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; AOKI Y, 1994, J BIOCHEM-TOKYO, V116, P291, DOI 10.1093/oxfordjournals.jbchem.a124522; Baldridge RD, 2013, J BIOL CHEM, V288, P19516, DOI 10.1074/jbc.M113.476911; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; BRETSCHER MS, 1972, J MOL BIOL, V71, P523, DOI 10.1016/0022-2828(72)90028-4; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; GORDESKY SE, 1975, J MEMBRANE BIOL, V20, P111, DOI 10.1007/BF01870631; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Hankins HM, 2015, MOL BIOL CELL, V26, P4674, DOI 10.1091/mbc.E15-07-0487; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hua ZL, 2003, MOL BIOL CELL, V14, P4971, DOI 10.1091/mbc.E03-07-0463; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jarmoszewicz K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039582; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Liu K, 2007, MOL BIOL CELL, V18, P487, DOI 10.1091/mbc.E06-07-0592; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Puts CF, 2012, J BIOL CHEM, V287, P30529, DOI 10.1074/jbc.M112.371088; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; SIKORSKI RS, 1989, GENETICS, V122, P19; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Veen S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00048; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004; Xu P, 2013, J CELL BIOL, V202, P875, DOI 10.1083/jcb.201305094; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	63	36	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15727	15739		10.1074/jbc.M115.686253	http://dx.doi.org/10.1074/jbc.M115.686253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27235400	Green Published, hybrid			2022-12-28	WOS:000380584200026
J	Noda, M; Doi, Y; Liang, JF; Kawanokuchi, J; Sonobe, Y; Takeuchi, H; Mizuno, T; Suzumura, A				Noda, Mariko; Doi, Yukiko; Liang, Jianfeng; Kawanokuchi, Jun; Sonobe, Yoshifumi; Takeuchi, Hideyuki; Mizuno, Tetsuya; Suzumura, Akio			Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression (vol 286, pg 2308, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Noda M, 2011, J BIOL CHEM, V286, P2308, DOI 10.1074/jbc.M110.169839	1	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14388	14388		10.1074/jbc.A110.169839	http://dx.doi.org/10.1074/jbc.A110.169839			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371564	hybrid, Green Published			2022-12-28	WOS:000379975100042
J	Seung, D; Lu, KJ; Stettler, M; Streb, S; Zeeman, SC				Seung, David; Lu, Kuan-Jen; Stettler, Michaela; Streb, Sebastian; Zeeman, Samuel C.			Degradation of Glucan Primers in the Absence of Starch Synthase 4 Disrupts Starch Granule Initiation in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; carbohydrate metabolism; chloroplast; photosynthesis; plant biochemistry; alpha-amylase; starch biosynthesis; starch granule initiation; starch synthase	RICE ENDOSPERM; ALPHA-AMYLASE; TRANSITORY STARCH; THALIANA LEAVES; MUTANTS; METABOLISM; CHLOROPLASTS; ISOAMYLASE; BREAKDOWN; GLYCOGEN	Arabidopsis leaf chloroplasts typically contain five to seven semicrystalline starch granules. It is not understood how the synthesis of each granule is initiated or how starch granule number is determined within each chloroplast. An Arabidopsis mutant lacking the glucosyl-transferase, STARCH SYNTHASE 4 (SS4) is impaired in its ability to initiate starch granules; its chloroplasts rarely contain more than one large granule, and the plants have a pale appearance and reduced growth. Here we report that the chloroplastic -amylase AMY3, a starch-degrading enzyme, interferes with granule initiation in the ss4 mutant background. The amy3 single mutant is similar in phenotype to the wild type under normal growth conditions, with comparable numbers of starch granules per chloroplast. Interestingly, the ss4 mutant displays a pleiotropic reduction in the activity of AMY3. Remarkably, complete abolition of AMY3 (in the amy3 ss4 double mutant) increases the number of starch granules produced in each chloroplast, suppresses the pale phenotype of ss4, and nearly restores normal growth. The amy3 mutation also restores starch synthesis in the ss3 ss4 double mutant, which lacks STARCH SYNTHASE 3 (SS3) in addition to SS4. The ss3 ss4 line is unable to initiate any starch granules and is thus starchless. We suggest that SS4 plays a key role in granule initiation, allowing it to proceed in a way that avoids premature degradation of primers by starch hydrolases, such as AMY3.	[Seung, David; Lu, Kuan-Jen; Stettler, Michaela; Streb, Sebastian; Zeeman, Samuel C.] Swiss Fed Inst Technol, Inst Agr Sci, Univ Str 2, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Zeeman, SC (corresponding author), Swiss Fed Inst Technol, Inst Agr Sci, Univ Str 2, CH-8092 Zurich, Switzerland.	szeeman@ethz.ch	Seung, David/D-8811-2013	Seung, David/0000-0003-3905-3647; Streb, Sebastian/0000-0002-9095-6596; Zeeman, Samuel/0000-0002-2791-0915	Heinz-Imhof Fellowship from ETH Foundation; Swiss National Science Foundation [31003A-153144/1]; ETH Zurich	Heinz-Imhof Fellowship from ETH Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	This work was supported by the Heinz-Imhof Fellowship from the ETH Foundation (to D. S.), by Swiss National Science Foundation Grant 31003A-153144/1 (to S. C. Z.), and by ETH Zurich. The authors declare that they have no conflicts of interest with the contents of this article.	Arrivault S, 2009, PLANT J, V59, P824, DOI 10.1111/j.1365-313X.2009.03902.x; Blennow A, 2015, STARCH METABOLISM ST, P399; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Crumpton-Taylor M, 2013, NEW PHYTOL, V200, P1064, DOI 10.1111/nph.12455; Crumpton-Taylor M, 2012, PLANT PHYSIOL, V158, P905, DOI 10.1104/pp.111.186957; Cuesta-Seijo JA, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01265; Cuesta-Seijo JA, 2013, ACTA CRYSTALLOGR D, V69, P1013, DOI 10.1107/S090744491300440X; D'Hulst C, 2010, NEW PHYTOL, V188, P13, DOI 10.1111/j.1469-8137.2010.03361.x; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Delvalle D, 2005, PLANT J, V43, P398, DOI 10.1111/j.1365-313X.2005.02462.x; Dumez S, 2006, PLANT CELL, V18, P2694, DOI 10.1105/tpc.105.037671; Feike D, 2016, PLANT CELL, V28, P1472, DOI 10.1105/tpc.16.00011; Fujita N, 2007, PLANT PHYSIOL, V144, P2009, DOI 10.1104/pp.107.102533; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Gamez-Arjona FM, 2014, PLANT J, V80, P305, DOI 10.1111/tpj.12633; Hejazi M, 2008, PLANT J, V55, P323, DOI [10.1111/j.1365-313X.2008.03513.x, 10.1111/j.0960-7412.2008.03513.x]; Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6; Hostettler C, 2011, METHODS MOL BIOL, V775, P387, DOI 10.1007/978-1-61779-237-3_21; Hwang SK, 2010, ARCH BIOCHEM BIOPHYS, V495, P82, DOI 10.1016/j.abb.2009.12.023; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Leterrier M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-98; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Pfister B, 2014, PLANT PHYSIOL, V165, P1457, DOI 10.1104/pp.114.241455; PITCHER J, 1988, EUR J BIOCHEM, V176, P391, DOI 10.1111/j.1432-1033.1988.tb14294.x; Ragel P, 2013, PLANT PHYSIOL, V163, P75, DOI 10.1104/pp.113.223420; Raynaud S, 2016, J BIOL CHEM, V291, P10759, DOI 10.1074/jbc.M115.698332; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Santelia D, 2015, CURR OPIN PLANT BIOL, V25, P1, DOI 10.1016/j.pbi.2015.04.003; Seung D, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002080; Seung D, 2013, J BIOL CHEM, V288, P33620, DOI 10.1074/jbc.M113.514794; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Sundberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075223; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; Toyosawa Y, 2016, PLANT PHYSIOL, V170, P1255, DOI 10.1104/pp.15.01232; Ugalde JE, 2003, P NATL ACAD SCI USA, V100, P10659, DOI 10.1073/pnas.1534787100; Whan A, 2014, J EXP BOT, V65, P5443, DOI 10.1093/jxb/eru299; Yu TS, 2005, J BIOL CHEM, V280, P9773, DOI 10.1074/jbc.M413638200; Zeeman SC, 1998, PLANT J, V15, P357, DOI 10.1046/j.1365-313X.1998.00213.x; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699; Zeeman SC, 2002, PLANT PHYSIOL, V129, P516, DOI 10.1104/pp.003756; Zhang XL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-96; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319	47	27	27	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20718	20728		10.1074/jbc.M116.730648	http://dx.doi.org/10.1074/jbc.M116.730648			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27458017	Green Published, hybrid			2022-12-28	WOS:000384574800033
J	Gleisner, M; Kroppen, B; Fricke, C; Teske, N; Kliesch, TT; Janshoff, A; Meinecke, M; Steinem, C				Gleisner, Martin; Kroppen, Benjamin; Fricke, Christian; Teske, Nelli; Kliesch, Torben-Tobias; Janshoff, Andreas; Meinecke, Michael; Steinem, Claudia			Epsin N-terminal Homology Domain (ENTH) Activity as a Function of Membrane Tension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; fluorescence; lipid vesicle; lipid-protein interaction; membrane protein	CLATHRIN-MEDIATED ENDOCYTOSIS; SURFACE-AREA REGULATION; LIPID-BILAYERS; AMPHIPATHIC HELICES; VESICLE ADSORPTION; ELASTIC PROPERTIES; GIANT VESICLES; MOVING CELLS; CURVATURE; ADHESION	The epsin N-terminal homology domain (ENTH) is a major player in clathrin-mediated endocytosis. To investigate the influence of initial membrane tension on ENTH binding and activity, we established a bilayer system based on adhered giant unilamellar vesicles (GUVs) to be able to control and adjust the membrane tension sigma covering a broad regime. The shape of each individual adhered GUV as well as its adhesion area was monitored by spinning disc confocal laser microscopy. Control of sigma in a range of 0.08-1.02 mN/m was achieved by altering the Mg2+ concentration in solution, which changes the surface adhesion energy per unit area of the GUVs. Specific binding of ENTH to phosphatidylinositol 4,5-bisphosphate leads to a substantial increase in adhesion area of the sessile GUV. At low tension (<0.1 mN/m) binding of ENTH can induce tubular structures, whereas at higher membrane tension the ENTH interaction deflates the sessile GUV and thereby increases the adhesion area. The increase in adhesion area is mainly attributed to a decrease in the area compressibility modulus K-A. We propose that the insertion of the ENTH helix-0 into the membrane is largely responsible for the observed decrease in K-A, which is supported by the observation that the mutant ENTH L6E shows a reduced increase in adhesion area. These results demonstrate that even in the absence of tubule formation, the area compressibility modulus and, as such, the bending rigidity of the membrane is considerably reduced upon ENTH binding. This renders membrane bending and tubule formation energetically less costly.	[Gleisner, Martin; Fricke, Christian; Teske, Nelli; Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, Tammannstr 2, D-37077 Gottingen, Germany; [Kroppen, Benjamin; Meinecke, Michael] Univ Gottingen, Dept Cellular Biochem, Humboldtallee 23, D-37073 Gottingen, Germany; [Meinecke, Michael] European Neurosci Inst, D-37073 Gottingen, Germany; [Kliesch, Torben-Tobias; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, Tammannstr 6, D-37077 Gottingen, Germany; [Janshoff, Andreas; Steinem, Claudia] Gottingen Ctr Mol Biosci, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen	Steinem, C (corresponding author), Univ Gottingen, Inst Organ & Biomol Chem, Tammannstr 2, D-37077 Gottingen, Germany.; Meinecke, M (corresponding author), Univ Gottingen, Dept Cellular Biochem, Humboldtallee 23, D-37073 Gottingen, Germany.	michael.meinecke@med.uni-goettingen.de; csteine@gwdg.de	Steinem, Claudia/O-4801-2019; Meinecke, Michael/C-4833-2013; Steinem, Claudia/K-7534-2018	Steinem, Claudia/0000-0001-8778-9283; Meinecke, Michael/0000-0003-1414-6951; Janshoff, Andreas/0000-0002-0773-2963; Fricke, Christian/0000-0002-0195-9411	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	M. G. thanks the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences for financial support.	Albersdorfer A, 1997, BIOPHYS J, V73, P245, DOI 10.1016/S0006-3495(97)78065-2; Bernard AL, 2000, LANGMUIR, V16, P6809, DOI 10.1021/la991341x; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Bouvrais H, 2008, BIOPHYS CHEM, V137, P7, DOI 10.1016/j.bpc.2008.06.004; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ekeroth J, 2002, LANGMUIR, V18, P7923, DOI 10.1021/la026131q; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Gleisner M, 2014, SOFT MATTER, V10, P6228, DOI 10.1039/c4sm00702f; Gruhn T, 2007, LANGMUIR, V23, P5423, DOI 10.1021/la063123r; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Horvath CAJ, 2007, INT J BIOCHEM CELL B, V39, P1765, DOI 10.1016/j.biocel.2006.12.004; JOHNSON SM, 1971, BIOCHIM BIOPHYS ACTA, V233, P820, DOI 10.1016/0005-2736(71)90184-2; Kirchhausen T, 2012, NAT CELL BIOL, V14, P906, DOI 10.1038/ncb2570; Kishimoto T, 2011, P NATL ACAD SCI USA, V108, pE979, DOI 10.1073/pnas.1113413108; Kozlov MM, 2014, CURR OPIN CELL BIOL, V29, P53, DOI 10.1016/j.ceb.2014.03.006; Kweon DH, 2006, MOL CELLS, V21, P428; Lai CL, 2012, J MOL BIOL, V423, P800, DOI 10.1016/j.jmb.2012.08.010; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Lipowsky R, 1991, MOL CRYST LIQ CRYST, V202, P17, DOI 10.1080/00268949108035656; Lundmark R, 2010, SEMIN CELL DEV BIOL, V21, P363, DOI 10.1016/j.semcdb.2009.11.014; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Pietuch A, 2013, SOFT MATTER, V9, P11490, DOI 10.1039/c3sm51610e; Puu G, 1997, BBA-BIOMEMBRANES, V1327, P149, DOI 10.1016/S0005-2736(97)00052-7; RADLER J, 1993, J PHYS II, V3, P727; RADLER JO, 1995, PHYS REV E, V51, P4526, DOI 10.1103/PhysRevE.51.4526; Ramachandran A, 2011, LANGMUIR, V27, P59, DOI 10.1021/la1023168; Rauch C, 2000, BIOPHYS J, V78, P3036, DOI 10.1016/S0006-3495(00)76842-1; Raucher D, 1999, J CELL BIOL, V144, P497, DOI 10.1083/jcb.144.3.497; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Ross M, 2001, LANGMUIR, V17, P2437, DOI 10.1021/la001617x; Rozovsky S, 2012, J PHYS CHEM B, V116, P5122, DOI 10.1021/jp210045r; Safari F, 2012, MEMBRANES, V2, DOI 10.3390/membranes2010091; Schafer E, 2015, SOFT MATTER, V11, P4487, DOI 10.1039/c5sm00191a; Schweitzer Y, 2014, BIOPHYS J, V106, P84, DOI 10.1016/j.bpj.2013.11.009; Seantier B, 2009, LANGMUIR, V25, P5767, DOI 10.1021/la804172f; Settles EI, 2010, BIOPHYS J, V99, P1539, DOI 10.1016/j.bpj.2010.06.059; Shi Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6974; Shindell O, 2015, PHYS CHEM CHEM PHYS, V17, P15598, DOI 10.1039/c4cp05877a; Simunovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8219; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stephan M, 2014, ANALYST, V139, P1987, DOI 10.1039/c4an00009a; Tourdot RW, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042715; Tristram-Nagle S, 2007, BIOPHYS J, V93, P2048, DOI 10.1529/biophysj.107.109181; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Wood LA, 2015, DEV CELL, V33, P119, DOI 10.1016/j.devcel.2015.04.007; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015	61	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19953	19961		10.1074/jbc.M116.731612	http://dx.doi.org/10.1074/jbc.M116.731612			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27466364	hybrid, Green Published			2022-12-28	WOS:000383243100019
J	Cruz-Topete, D; He, B; Xu, XJ; Cidlowski, JA				Cruz-Topete, Diana; He, Bo; Xu, Xiaojiang; Cidlowski, John A.			Kruppel-like Factor 13 Is a Major Mediator of Glucocorticoid Receptor Signaling in Cardiomyocytes and Protects These Cells from DNA Damage and Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyocyte; gene regulation; glucocorticoid receptor; hypoxia; Kruppel-like factor (KLF)	GENE-EXPRESSION; HEART-FAILURE; RAT-HEART; OXIDATIVE STRESS; APOPTOSIS; MECHANISMS; DOXORUBICIN; REGULATOR; DISEASE; HEALTH	Glucocorticoid receptor (GR) signaling has recently been shown to play a direct role in the regulation of cardiomyocyte function. In this study, we investigated the potential role of KLF13 as a downstream effector of GR action utilizing both in vivo and in vitro approaches. Our data show that KLF13 mRNA and protein levels are significantly diminished in the hearts of mice lacking GR in cardiomyocytes. Glucocorticoid administration up-regulated Klf13 mRNA in the mouse heart, in isolated primary cardiomyocytes, and in immortal cardiomyocyte cell lines. Glucocorticoid Klf13 gene expression was abolished by treatment with a GR antagonist (RU486) or by knockdown of GR in cardiomyocytes. Moreover, glucocorticoid induction of Klf13 mRNA was resistant to de novo protein synthesis inhibition, demonstrating that Klf13 is a direct glucocorticoid receptor gene target. A glucocorticoid responsive element (GRE) was identified in the Klf13 gene and its function was verified by chromatin immunoprecipitation in HL-1 cells and mouse hearts. Functional studies showed that GR regulation of Klf13 is critical to protect cardiomyocytes from DNA damage and cell death induced by cobalt(II) chloride hexahydrate (CoCl(2)6H(2)O) and the antineoplastic drug doxorubicin. These results established a novel role for GR and KLF13 signaling in adult cardiomyocytes with potential clinical implications for the prevention of cardiotoxicity induced heart failure.	[Cruz-Topete, Diana; Cidlowski, John A.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA; [He, Bo; Xu, Xiaojiang] NIEHS, Integrat Bioinformat, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, NIH, MD F3-07,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	xu, Xiaojiang/AAT-3851-2020; Cidlowski, John A/G-2548-2019	xu, Xiaojiang/0000-0001-5758-6581; Cidlowski, John A/0000-0003-1420-0516	Intramural Research Program of the National Institutes of Health, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090079, ZICES102445, ZIAES090057] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institutes of Health, NIEHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asada M, 2011, LAB INVEST, V91, P203, DOI 10.1038/labinvest.2010.170; Bagamasbad P, 2012, ENDOCRINOLOGY, V153, P5334, DOI 10.1210/en.2012-1303; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; Chen QM, 2005, MOL PHARMACOL, V67, P1861, DOI 10.1124/mol.104.003814; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Colucci WS, 2000, J CARD FAIL, V6, P1; CZERWINSKIHELMS SM, 1987, BIOCHEM BIOPH RES CO, V142, P322, DOI 10.1016/0006-291X(87)90276-2; De Mello WC, 2000, HYPERTENSION, V35, P1183, DOI 10.1161/01.HYP.35.6.1183; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gordon AR, 2008, J BIOL CHEM, V283, P11897, DOI 10.1074/jbc.M709569200; Grenier MA, 1998, SEMIN ONCOL, V25, P72; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kang PM, 2000, CIRC RES, V86, P1107; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; KATZ SE, 1988, J MOL CELL CARDIOL, V20, P323, DOI 10.1016/S0022-2828(88)80066-X; Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519; KEIZER HG, 1990, PHARMACOL THERAPEUT, V47, P219, DOI 10.1016/0163-7258(90)90088-J; Kim Nam-Ho, 2010, Korean Circ J, V40, P299, DOI 10.4070/kcj.2010.40.7.299; Kodama T, 2003, J BIOL CHEM, V278, P33384, DOI 10.1074/jbc.M302581200; Lavallee G, 2006, EMBO J, V25, P5201, DOI 10.1038/sj.emboj.7601379; LISON D, 1995, CHEM RES TOXICOL, V8, P600, DOI 10.1021/tx00046a015; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Oakley RH, 2013, P NATL ACAD SCI USA, V110, P17035, DOI 10.1073/pnas.1302546110; Oakley RH, 2012, P NATL ACAD SCI USA, V109, P17591, DOI 10.1073/pnas.1209411109; Patlolla A, 2010, MOL CELL BIOCHEM, V338, P225, DOI 10.1007/s11010-009-0356-2; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Ramamoorthy S, 2013, MOL CELL BIOL, V33, P1711, DOI 10.1128/MCB.01151-12; Ren RQ, 2012, ENDOCRINOLOGY, V153, P5346, DOI 10.1210/en.2012-1563; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rog-Zielinska EA, 2013, HUM MOL GENET, V22, P3269, DOI 10.1093/hmg/ddt182; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Sheppard KE, 2002, ENDOCRINOLOGY, V143, P198, DOI 10.1210/en.143.1.198; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Smoak K, 2006, MOL CELL BIOL, V26, P9126, DOI 10.1128/MCB.00679-06; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; Vassilopoulos A, 2005, FREE RADICAL RES, V39, P1273, DOI 10.1080/10715760500166685; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.2135; Wang XO, 2012, BIOCHEM BIOPH RES CO, V417, P1227, DOI 10.1016/j.bbrc.2011.12.115; Wenger RH, 1997, BIOL CHEM, V378, P609; Whirledge S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111054; Wu DL, 2011, JOVE-J VIS EXP, DOI 10.3791/2899; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0; ZUO P, 1991, GENE DEV, V5, P254, DOI 10.1101/gad.5.2.254	52	22	23	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19374	19386		10.1074/jbc.M116.725903	http://dx.doi.org/10.1074/jbc.M116.725903			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27451392	Green Published, hybrid			2022-12-28	WOS:000383242800017
J	Jin, S; Kedia, N; Illes-Toth, E; Haralampiev, I; Prisner, S; Herrmann, A; Wanker, EE; Bieschke, J				Jin, Sha; Kedia, Niraja; Illes-Toth, Eva; Haralampiev, Ivan; Prisner, Simon; Herrmann, Andreas; Wanker, Erich E.; Bieschke, Jan			Amyloid-(1-42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; amyloid; amyloid- (AB); kinetics; protein folding; internalization	RECEPTOR-MEDIATED ENDOCYTOSIS; ALZHEIMERS-DISEASE; BETA PROTEIN; AMYLOIDOGENESIS; INTERNALIZATION; PROPAGATION; TRANSFERRIN; MECHANISM; PEPTIDES; BINDING	The accumulation of amyloid peptide(1-42) (A(1-42)) in extracellular plaques is one of the pathological hallmarks of Alzheimer disease (AD). Several studies have suggested that cellular reuptake of A(1-42) may be a crucial step in its cytotoxicity, but the uptake mechanism is not yet understood. A may be present in an aggregated form prior to cellular uptake. Alternatively, monomeric peptide may enter the endocytic pathway and conditions in the endocytic compartments may induce the aggregation process. Our study aims to answer the question whether aggregate formation is a prerequisite or a consequence of A endocytosis. We visualized aggregate formation of fluorescently labeled A(1-42) and tracked its internalization by human neuroblastoma cells and neurons. -Sheet-rich A(1-42) aggregates entered the cells at low nanomolar concentration of A(1-42). In contrast, monomer uptake faced a concentration threshold and occurred only at concentrations and time scales that allowed A(1-42) aggregates to form. By uncoupling membrane binding from internalization, we found that A(1-42) monomers bound rapidly to the plasma membrane and formed aggregates there. These structures were subsequently taken up and accumulated in endocytic vesicles. This process correlated with metabolic inhibition. Our data therefore imply that the formation of -sheet-rich aggregates is a prerequisite for A(1-42) uptake and cytotoxicity.	[Jin, Sha; Wanker, Erich E.] Max Delbruck Ctr Mol Med, Prote & Mol Mech Neurodegenerat Dis, D-13125 Berlin, Germany; [Jin, Sha; Kedia, Niraja; Illes-Toth, Eva; Bieschke, Jan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Haralampiev, Ivan; Prisner, Simon] Humboldt Univ, Dept Biol, D-10115 Berlin, Germany; [Herrmann, Andreas] Humboldt Univ, IRI Life Sci, D-10115 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Washington University (WUSTL); Humboldt University of Berlin; Humboldt University of Berlin	Bieschke, J (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	bieschke@wustl.edu	Bieschke, Jan/AAG-2705-2019	Bieschke, Jan/0000-0002-3485-9767; Wanker, Erich/0000-0001-8072-1630; Illes-Toth, Eva/0000-0001-5232-8196	German Research Foundation Deutsche Forschungsgemeinschaft [BI1409/2-1, NGFN-Plus FKZ 01GS08132]; IG Neuronet, TP, Wissenschaftliche Plattform Interaktom Grant [FKZ 01GS0844]; National Institutes of Health [5 P30 DK020579]; SigneGene Helmholtz-Association; Einstein-Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	German Research Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IG Neuronet, TP, Wissenschaftliche Plattform Interaktom Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SigneGene Helmholtz-Association; Einstein-Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by German Research Foundation Deutsche Forschungsgemeinschaft Grant BI1409/2-1 (to S. J. and J. B.), NGFN-Plus FKZ 01GS08132 (to J. B. and E. E. W.), IG Neuronet, TP, Wissenschaftliche Plattform Interaktom Grant FKZ 01GS0844 (to E. E. W.), and National Institutes of Health Grant 5 P30 DK020579 to the Diabetes Research Center, Washington University (to E. I. T. and J. B.). This work was also supported by the SigneGene Helmholtz-Association (to S. P.) and the Einstein-Foundation (to I. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bieschke J, 2005, BIOCHEMISTRY-US, V44, P4977, DOI 10.1021/bi0501030; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Couceiro JR, 2015, J BIOL CHEM, V290, P242, DOI 10.1074/jbc.M114.586636; Curtain CC, 2003, J BIOL CHEM, V278, P2977, DOI 10.1074/jbc.M205455200; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; IACOPETTA BJ, 1983, J HISTOCHEM CYTOCHEM, V31, P336, DOI 10.1177/31.2.6300220; Ida N, 1996, FEBS LETT, V394, P174, DOI 10.1016/0014-5793(96)00948-9; Igbavboa U, 2009, NEUROSCIENCE, V162, P328, DOI 10.1016/j.neuroscience.2009.04.049; JANDL JH, 1963, J CLIN INVEST, V42, P314, DOI 10.1172/JCI104718; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Johnson RD, 2013, BIOPHYS J, V104, P894, DOI 10.1016/j.bpj.2012.12.051; Johnson RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023970; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Lai Aaron Y, 2010, Int J Alzheimers Dis, V2011, P548380, DOI 10.4061/2011/548380; LAURELL CB, 1947, ACTA CHEM SCAND, V1, P770, DOI 10.3891/acta.chem.scand.01-0770; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lodish H., 2000, MOL CELL BIOL, DOI [10.1016/S1470-8175(01)00023-6, DOI 10.1016/S1470-8175(01)00023-6]; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Omtri RS, 2012, MOL PHARMACEUT, V9, P1887, DOI 10.1021/mp200530q; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Usui K, 2009, P NATL ACAD SCI USA, V106, P18563, DOI 10.1073/pnas.0804758106; Uzman A., 2000, BIOCH MOL BIOL ED, V29; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wei Jingjun, 2005, Current Alzheimer Research, V2, P109, DOI 10.2174/1567205053585864; Winkelmann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125413; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111	43	66	67	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19590	19606		10.1074/jbc.M115.691840	http://dx.doi.org/10.1074/jbc.M115.691840			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27458018	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000383242800033
J	Kaya, AI; Lokits, AD; Gilbert, JA; Iverson, TM; Meiler, J; Hamm, HE				Kaya, Ali I.; Lokits, Alyssa D.; Gilbert, James A.; Iverson, T. M.; Meiler, Jens; Hamm, Heidi E.			A Conserved Hydrophobic Core in G(i1) Regulates G Protein Activation and Release from Activated Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computer modeling; G protein-coupled receptor (GPCR); heterotrimeric G protein; protein conformation; signal transduction; G protein activation; G protein structure; GDP release	ALPHA-SUBUNIT; BETA-GAMMA; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MECHANISM; GDP; G(I-ALPHA-1); TRANSDUCIN; HELIX	G protein-coupled receptor-mediated heterotrimeric G protein activation is a major mode of signal transduction in the cell. Previously, we and other groups reported that the 5 helix of G(i1), especially the hydrophobic interactions in this region, plays a key role during nucleotide release and G protein activation. To further investigate the effect of this hydrophobic core, we disrupted it in G(i1) by inserting 4 alanine amino acids into the 5 helix between residues Gln(333) and Phe(334) (Ins4A). This extends the length of the 5 helix without disturbing the 6-5 loop interactions. This mutant has high basal nucleotide exchange activity yet no receptor-mediated activation of nucleotide exchange. By using structural approaches, we show that this mutant loses critical hydrophobic interactions, leading to significant rearrangements of side chain residues His(57), Phe(189), Phe(191), and Phe(336); it also disturbs the rotation of the 5 helix and the - interaction between His(57) and Phe(189). In addition, the insertion mutant abolishes G protein release from the activated receptor after nucleotide binding. Our biochemical and computational data indicate that the interactions between 5, 1, and 2-3 are not only vital for GDP release during G protein activation, but they are also necessary for proper GTP binding (or GDP rebinding). Thus, our studies suggest that this hydrophobic interface is critical for accurate rearrangement of the 5 helix for G protein release from the receptor after GTP binding.	[Kaya, Ali I.; Gilbert, James A.; Iverson, T. M.; Meiler, Jens; Hamm, Heidi E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg, Nashville, TN 37232 USA; [Lokits, Alyssa D.] Vanderbilt Univ, Med Ctr, Dept Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Chem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg, Nashville, TN 37232 USA.	Heidi.hamm@vanderbilt.edu			National Institutes of Health [S10 RR026915]; United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120569, R01GM080403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jin Liao for excellent technical assistance. A portion of the experiments described here used the Vanderbilt PacVan robotic crystallization facility, which was supported by National Institutes of Health Grant S10 RR026915. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradford W, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003768; Ceruso MA, 2004, J MOL BIOL, V338, P469, DOI 10.1016/j.jmb.2004.02.064; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Conway P, 2014, PROTEIN SCI, V23, P47, DOI 10.1002/pro.2389; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Hamm HE, 2013, J STRUCT BIOL, V184, P63, DOI 10.1016/j.jsb.2013.02.016; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2008, PLANT SIGNAL BEHAV, V3, P1067, DOI 10.4161/psb.3.12.7184; Jones JC, 2011, CHEM ENG PROG, V107, P4; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kaya AI, 2014, J BIOL CHEM, V289, P24475, DOI 10.1074/jbc.M114.572875; Kaya AI, 2011, BIOCHEMISTRY-US, V50, P3193, DOI 10.1021/bi200037j; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lokits AD, 2015, AIMS BIOPHYS, V2, P630, DOI 10.3934/biophy.2015.4.630; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medkova M, 2002, BIOCHEMISTRY-US, V41, P9962, DOI 10.1021/bi0255726; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Preininger AM, 2012, BIOCHEMISTRY-US, V51, P1911, DOI 10.1021/bi201472c; QUILLIAM LA, 1995, P NATL ACAD SCI USA, V92, P1272, DOI 10.1073/pnas.92.5.1272; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rondard P, 2001, P NATL ACAD SCI USA, V98, P6150, DOI 10.1073/pnas.101136198; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sun DW, 2015, NAT STRUCT MOL BIOL, V22, P686, DOI 10.1038/nsmb.3070; Thaker TM, 2012, METHODS MOL BIOL, V796, P133, DOI 10.1007/978-1-61779-334-9_8; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	57	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19674	19686		10.1074/jbc.M116.745513	http://dx.doi.org/10.1074/jbc.M116.745513			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27462082	Green Published, hybrid			2022-12-28	WOS:000383242800040
J	Sneddon, WB; Ruiz, GW; Gallo, LI; Xiao, KH; Zhang, QM; Rbaibi, Y; Weisz, OA; Apodaca, GL; Friedman, PA				Sneddon, W. Bruce; Ruiz, Giovanni W.; Gallo, Luciana I.; Xiao, Kunhong; Zhang, Qiangmin; Rbaibi, Youssef; Weisz, Ora A.; Apodaca, Gerard L.; Friedman, Peter A.			Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PROXIMAL TUBULE; FACTOR RECEPTOR GENES; PROTEIN-KINASE-A; FGF-RECEPTOR; CALCIUM-TRANSPORT; I COTRANSPORTERS; DOWN-REGULATION; MDCK CELLS; PTH; ACTIVATION	Parathyroid hormone (PTH) and FGF23 are the primary hormones regulating acute phosphate homeostasis. Human renal proximal tubule cells (RPTECs) were used to characterize the mechanism and signaling pathways of PTH and FGF23 on phosphate transport and the role of the PDZ protein NHERF1 in mediating PTH and FGF23 effects. RPTECs express the NPT2A phosphate transporter, alpha Klotho, FGFR1, FGFR3, FGFR4, and the PTH receptor. GFGR1 isoforms are formed from alternate splicing of exon 3 and of exon 8 or 9 in Ir-like loop 3. Exon 3 was absent, but mRNA containing both exons 8 and 9 is present in cytoplasm. Using an FGFR1c-specific antibody together with mass spectrometry analysis, we show that RPTECs express FGFR-beta 1C. The data are consistent with regulated FGFR1 splicing involving a novel cytoplasmic mechanism. PTH and FGF23 inhibited phosphate transport in a concentration-dependent manner. At maximally effective concentrations, PTH and FGF23 equivalently decreased phosphate uptake and were not additive, suggesting a shared mechanism of action. Protein kinase A or C blockade prevented PTH but not FGF23 actions. Conversely, inhibiting SGK1, blocking FGFR dimerization, or knocking down Klotho expression disrupted FGF23 actions but did not interfere with PTH effects. C-terminal FGF23(180-251) competitively and selectively blocked FGF23 action without disrupting PTH effects. However, both PTH and FGF23-sensitive phosphate transport were abolished by NHERF1 shRNA knockdown. Extended treatment with PTH or FGF23 down-regulated NPT2A without affecting NHERF1. We conclude that FGFR1C and PTHR signaling pathways converge on NHERF1 to inhibit PTH- and FGF23-sensitive phosphate transport and down-regulate NPT2A.	[Sneddon, W. Bruce; Xiao, Kunhong; Zhang, Qiangmin; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Weisz, Ora A.; Apodaca, Gerard L.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Ruiz, Giovanni W.; Gallo, Luciana I.; Rbaibi, Youssef; Weisz, Ora A.; Apodaca, Gerard L.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E1356 Thomas E Starzl Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Gallo, Luciana I/S-4451-2019; Apodaca, Gerard/HCJ-0048-2022; Xiao, Kunhong/AAG-4275-2020	Xiao, Kunhong/0000-0002-1069-1226; Gallo, Luciana I./0000-0001-7050-0121	National Institutes of Health [DK069998, DK105811, DK101484, DK100357, P30 DK079307]; Imaging Core of the Pittsburgh Center for Kidney Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104287, P30DK079307, R01DK100357, R01DK105811, R01DK101484, R01DK069998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Imaging Core of the Pittsburgh Center for Kidney Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK069998 and DK105811 (to P. A. F.), DK101484 and DK100357 (to O. A. W.), and P30 DK079307 (to G. A. and O. A. W.) and the Imaging Core of the Pittsburgh Center for Kidney Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amizuka N, 1997, ENDOCRINOLOGY, V138, P469, DOI 10.1210/en.138.1.469; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Ba JM, 2003, AM J PHYSIOL-RENAL, V285, pF1233, DOI 10.1152/ajprenal.00249.2003; Belov AA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015958; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; BIBER J, 1990, METHOD ENZYMOL, V191, P494; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Buckley PT, 2014, WIRES RNA, V5, P223, DOI 10.1002/wrna.1203; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; COLE JA, 1987, AM J PHYSIOL, V253, pE221, DOI 10.1152/ajpendo.1987.253.2.E221; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Comps-Agrar L, 2015, J BIOL CHEM, V290, P24166, DOI 10.1074/jbc.M115.681395; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; Gattineni J, 2014, CURR OPIN PEDIATR, V26, P215, DOI 10.1097/MOP.0000000000000064; Gattineni J, 2014, AM J PHYSIOL-RENAL, V306, pF351, DOI 10.1152/ajprenal.00232.2013; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Gong SG, 2014, J CELL PHYSIOL, V229, P1887, DOI 10.1002/jcp.24649; Guo J, 2013, ENDOCRINOLOGY, V154, P1680, DOI 10.1210/en.2012-2240; Han XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147845; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lederer ED, 1998, AM J PHYSIOL-RENAL, V275, pF270, DOI 10.1152/ajprenal.1998.275.2.F270; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lelliott CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112109; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Lupp A, 2010, EUR J ENDOCRINOL, V162, P979, DOI 10.1530/EJE-09-0821; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Mistry N, 2003, RNA, V9, P209, DOI 10.1261/rna.2470903; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Murer H., 2008, SELDIN GIEBISCHS KID, P1979; Murer H, 2010, J NEPHROL, V23, pS145; Nagai S, 2011, J BIOL CHEM, V286, P1618, DOI 10.1074/jbc.M110.198416; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Paradis JS, 2015, P NATL ACAD SCI USA, V112, pE5160, DOI 10.1073/pnas.1508836112; Pfister MF, 1999, AM J PHYSIOL-RENAL, V276, pF720, DOI 10.1152/ajprenal.1999.276.5.F720; Potter BA, 2004, MOL BIOL CELL, V15, P1407, DOI 10.1091/mbc.E03-08-0550; Roidl A, 2010, ONCOGENE, V29, P1543, DOI 10.1038/onc.2009.432; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sneddon WB, 2007, AM J PHYSIOL-RENAL, V292, pF1028, DOI 10.1152/ajprenal.00288.2006; Sneddon WB, 2000, ENDOCRINOLOGY, V141, P4185, DOI 10.1210/en.141.11.4185; Takenaka T, 2016, J BONE MINER RES, V31, P455, DOI 10.1002/jbmr.2691; Traebert M, 2000, AM J PHYSIOL-RENAL, V278, pF792, DOI 10.1152/ajprenal.2000.278.5.F792; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang EI, 2000, TRAFFIC, V1, P480, DOI 10.1034/j.1600-0854.2000.010606.x; Weinman EJ, 2012, AM J PHYSIOL-RENAL, V303, pF321, DOI 10.1152/ajprenal.00093.2012; Weinman EJ, 2012, EXP CELL RES, V318, P1027, DOI 10.1016/j.yexcr.2012.02.037; Weinman EJ, 2011, J BIOL CHEM, V286, P37216, DOI 10.1074/jbc.M111.288357; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	66	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18632	18642		10.1074/jbc.M116.744052	http://dx.doi.org/10.1074/jbc.M116.744052			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432882	Green Published, hybrid			2022-12-28	WOS:000383242300004
J	Kaneko, K; Ohkawa, Y; Hashimoto, N; Ohmi, Y; Kotani, N; Honke, K; Ogawa, M; Okajima, T; Furukawa, K; Furukawa, K				Kaneko, Kei; Ohkawa, Yuki; Hashimoto, Noboru; Ohmi, Yuhsuke; Kotani, Norihiro; Honke, Koichi; Ogawa, Mitsutaka; Okajima, Tetsuya; Furukawa, Keiko; Furukawa, Koichi			Neogenin, Defined as a GD3-associated Molecule by Enzyme-mediated Activation of Radical Sources, Confers Malignant Properties via Intracytoplasmic Domain in Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-GD3 MONOCLONAL-ANTIBODY; AMYLOID PRECURSOR PROTEIN; PHASE-I TRIAL; GANGLIOSIDE GD3; METASTATIC MELANOMA; GAMMA-SECRETASE; LIPID RAFTS; T-CELLS; EXPRESSION; CANCER	To investigate mechanisms for increased malignant properties in malignant melanomas by ganglioside GD3, enzyme-mediated activation of radical sources and subsequent mass spectrometry were performed using an anti-GD3 antibody and GD3-positive (GD3+) and GD3-negative (GD3-) melanoma cell lines. Neogenin, defined as a GD3-neighbored molecule, was largely localized in lipid/rafts in GD3+ cells. Silencing of neogenin resulted in the reduction of cell growth and invasion activity. Physical association between GD3 and neogenin was demonstrated by immunoblotting of the immunoprecipitates with anti-neogenin antibody from GD3- cell lysates. The intracytoplasmic domain of neogenin (Ne-ICD) was detected in GD3+ cells at higher levels than in GD3- cells when cells were treated by a proteasome inhibitor but not when simultaneously treated with a gamma-secretase inhibitor. Exogenous GD3 also induced increased Ne-ICD in GD3- cells. Overexpression of Ne-ICD in GD3- cells resulted in the increased cell growth and invasion activity, suggesting that Ne-ICD plays a role as a transcriptional factor to drive malignant properties of melanomas after cleavage with gamma-secretase. gamma-Secretase was found in lipid/rafts in GD3+ cells. Accordingly, immunocyto-staining revealed that GD3, neogenin, and gamma-secretase were co-localized at the leading edge of GD3+ cells. All these results suggested that GD3 recruits gamma-secretase to lipid/rafts, allowing efficient cleavage of neogenin. ChIP-sequencing was performed to identify candidates of target genes of Ne-ICD. Some of them actually showed increased expression after expression of Ne-ICD, probably exerting malignant phenotypes of melanomas under GD3 expression.	[Kaneko, Kei; Hashimoto, Noboru; Ohmi, Yuhsuke; Ogawa, Mitsutaka; Okajima, Tetsuya; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4660065, Japan; [Ohkawa, Yuki; Furukawa, Keiko; Furukawa, Koichi] Chubu Univ, Coll Life & Hlth Sci, Dept Life Biomed Sci, Matsumoto Cho 1200, Kasuigai, Aichi 4878501, Japan; [Kotani, Norihiro] Saitama Med Univ, Fac Med, Dept Biochem, Moroyama, Saitama 3500495, Japan; [Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Kochi 7838505, Japan	Nagoya University; Chubu University; Saitama Medical University; Kochi University	Furukawa, K (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Life Biomed Sci, Matsumoto Cho 1200, Kasuigai, Aichi 4878501, Japan.	koichi@isc.chubu.ac.jp		Kotani, Norihiro/0000-0003-3739-6478	Ministry of Education, Culture, Sports, and Technology of Japan (MEXT) [15H04696, 15K15080, 25670141, 24390078]; Nakamura-Sekizen-kai; Grants-in-Aid for Scientific Research [15K15080, 16J00004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakamura-Sekizen-kai; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 15H04696, 15K15080, 25670141, and 24390078 from the Ministry of Education, Culture, Sports, and Technology of Japan (MEXT). This work was also supported by a scholarship from Nakamura-Sekizen-kai. The authors declare that they have no conflicts of interest with the contents of this article.	Akino T, 2014, CANCER RES, V74, P3716, DOI 10.1158/0008-5472.CAN-13-3116; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; CARUBIA JM, 1984, BIOCHEM BIOPH RES CO, V120, P500, DOI 10.1016/0006-291X(84)91282-8; CHANG HR, 1992, CANCER, V70, P633, DOI 10.1002/1097-0142(19920801)70:3<633::AID-CNCR2820700315>3.0.CO;2-F; CHERESH DA, 1986, CANCER RES, V46, P5112; CHEUNG NKV, 1985, CANCER RES, V45, P2642; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cole SJ, 2007, INT J BIOCHEM CELL B, V39, P1569, DOI 10.1016/j.biocel.2006.11.009; Csibi A, 2014, CURR BIOL, V24, P2274, DOI 10.1016/j.cub.2014.08.007; Cui HX, 2014, J BIOL CHEM, V289, P34871, DOI 10.1074/jbc.M114.571000; DIPPOLD WG, 1985, CANCER RES, V45, P3699; DIPPOLD WG, 1984, CANCER RES, V44, P806; Forero A, 2006, CANCER BIOTHER RADIO, V21, P561, DOI 10.1089/cbr.2006.21.561; FURUKAWA K, 1993, P NATL ACAD SCI USA, V90, P1972, DOI 10.1073/pnas.90.5.1972; FURUKAWA K, 1989, CANCER RES, V49, P191; Furukawa K, 2014, CANCER SCI, V105, P52, DOI 10.1111/cas.12310; Furukawa K, 2012, GLYCOCONJUGATE J, V29, P579, DOI 10.1007/s10719-012-9423-0; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Goldschneider D, 2008, MOL CELL BIOL, V28, P4068, DOI 10.1128/MCB.02114-07; HAKOMORI S, 1968, P NATL ACAD SCI USA, V59, P254, DOI 10.1073/pnas.59.1.254; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; HAKOMORI SI, 1991, CANCER CELL-MON REV, V3, P461; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Hamamura K, 2008, BBA-GEN SUBJECTS, V1780, P513, DOI 10.1016/j.bbagen.2007.11.002; Hamamura K, 2011, J BIOL CHEM, V286, P18526, DOI 10.1074/jbc.M110.164798; Hashimoto N, 2012, PROTEOMICS, V12, P3154, DOI 10.1002/pmic.201200279; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; HOUGHTON AN, 1985, P NATL ACAD SCI USA, V82, P1242, DOI 10.1073/pnas.82.4.1242; Hu YC, 2001, CLIN CANCER RES, V7, P2213; Johnson DB, 2015, JAMA ONCOL, V1, P380, DOI 10.1001/jamaoncol.2015.0565; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Katoh M, 2004, INT J ONCOL, V24, P737; Kim SJ, 2014, ONCOTARGET, V5, P3386, DOI 10.18632/oncotarget.1960; Kirkwood JM, 2000, CANCER, V88, P2693, DOI 10.1002/1097-0142(20000615)88:12<2693::AID-CNCR7>3.3.CO;2-V; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; LLOYD KO, 1989, CANCER RES, V49, P3445; Lo ASY, 2010, CLIN CANCER RES, V16, P2769, DOI 10.1158/1078-0432.CCR-10-0043; Luk JM, 2006, J CELL PHYSIOL, V209, P755, DOI 10.1002/jcp.20746; MERRITT WD, 1987, CANCER RES, V47, P1724; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Milla LA, 2014, INT J CANCER, V134, P21, DOI 10.1002/ijc.28330; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Ohkawa Y, 2015, J BIOL CHEM, V290, P16043, DOI 10.1074/jbc.M114.635755; Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791; PORTOUKALIAN J, 1978, BIOCHEM BIOPH RES CO, V85, P916, DOI 10.1016/0006-291X(78)90630-7; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; Raimondi C, 2011, CURR MED CHEM, V18, P2763, DOI 10.2174/092986711796011238; Scott AM, 2001, J CLIN ONCOL, V19, P3976, DOI 10.1200/JCO.2001.19.19.3976; Shibuya H, 2012, CANCER SCI, V103, P1656, DOI 10.1111/j.1349-7006.2012.02344.x; SIDDIQUI B, 1984, CANCER RES, V44, P5262; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Tatti O, 2015, CANCER RES, V75, P2083, DOI 10.1158/0008-5472.CAN-14-1923; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wargo JA, 2015, SEMIN ONCOL, V42, P601, DOI 10.1053/j.seminoncol.2015.05.007; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Wu XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038074; Xing WY, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-352; Yoshida S, 2001, CANCER RES, V61, P4244; Zha Q, 2004, MOL PSYCHIATR, V9, P946, DOI 10.1038/sj.mp.4001509; Zhang QS, 2015, ONCOL REP, V34, P258, DOI 10.3892/or.2015.4004	65	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16630	16643		10.1074/jbc.M115.708834	http://dx.doi.org/10.1074/jbc.M115.708834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288875	Green Published, hybrid			2022-12-28	WOS:000380826700022
J	Prasad, S; Yadav, VR; Sundaram, C; Reuter, S; Hema, PS; Nair, MS; Chaturvedi, MM; Aggarwal, BB				Prasad, Sahdeo; Yadav, Vivek R.; Sundaram, Chitra; Reuter, Simone; Hema, Padmanabhan S.; Nair, Mangalam S.; Chaturvedi, Madan M.; Aggarwal, Bharat B.			RETRACTION: Crotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathway (Retraction of vol 285, pg 26987, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		PRASAD S, 2012, J BIOL CHEM, V2885, P26987	1	2	2	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16921	16921		10.1074/jbc.A110.121061	http://dx.doi.org/10.1074/jbc.A110.121061			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27496962	Green Published, hybrid			2022-12-28	WOS:000380826700048
J	Maalcke, WJ; Reimann, J; de Vries, S; Butt, JN; Dietl, A; Kip, N; Mersdorf, U; Barends, TRM; Jetten, MSM; Keltjens, JT; Kartal, B				Maalcke, Wouter J.; Reimann, Joachim; de Vries, Simon; Butt, Julea N.; Dietl, Andreas; Kip, Nardy; Mersdorf, Ulrike; Barends, Thomas R. M.; Jetten, Mike S. M.; Keltjens, Jan T.; Kartal, Boran			Characterization of Anammox Hydrazine Dehydrogenase, a Key N-2-producing Enzyme in the Global Nitrogen Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron paramagnetic resonance (EPR); enzyme kinetics; enzyme purification; nitrogen metabolism; reactive nitrogen species (RNS); anaerobic ammonium oxidation; hydrazine; octaheme proteins	ANAEROBIC AMMONIUM OXIDATION; HYDROXYLAMINE OXIDOREDUCTASE; CYTOCHROME-C; NITROSOMONAS-EUROPAEA; MULTIHEME PROTEIN; OXIDIZING ENZYME; EPR SIGNALS; HEME; MECHANISM; SEDIMENTATION	Anaerobic ammonium-oxidizing (anammox) bacteria derive their energy for growth from the oxidation of ammonium with nitrite as the electron acceptor. N-2, the end product of this metabolism, is produced from the oxidation of the intermediate, hydrazine (N2H4). Previously, we identified N-2-producing hydrazine dehydrogenase (KsHDH) from the anammox organism Kuenenia stuttgartiensis as the gene product of kustc0694 and determined some of its catalytic properties. In the genome of K. stuttgartiensis, kustc0694 is one of 10 paralogs related to octaheme hydroxylamine (NH2OH) oxidoreductase (HAO). Here, we characterized KsHDH as a covalently cross-linked homotrimeric octaheme protein as found for HAO and HAO-related hydroxylamine-oxidizing enzyme kustc1061 from K. stuttgartiensis. Interestingly, the HDH trimers formed octamers in solution, each octamer harboring an amazing 192 c-type heme moieties. Whereas HAO and kustc1061 are capable of hydrazine oxidation as well, KsHDH was highly specific for this activity. To understand this specificity, we performed detailed amino acid sequence analyses and investigated the catalytic and spectroscopic (electronic absorbance, EPR) properties of KsHDH in comparison with the well defined HAO and kustc1061. We conclude that HDH specificity is most likely derived from structural changes around the catalytic heme 4 (P-460) and of the electron-wiring circuit comprising seven His/His-ligated c-type hemes in each subunit. These nuances make HDH a globally prominent N-2-producing enzyme, next to nitrous oxide (N2O) reductase from denitrifying microorganisms.	[Maalcke, Wouter J.; Reimann, Joachim; Kip, Nardy; Jetten, Mike S. M.; Keltjens, Jan T.; Kartal, Boran] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [de Vries, Simon; Jetten, Mike S. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Butt, Julea N.] Univ East Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Butt, Julea N.] Univ East Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Mersdorf, Ulrike; Barends, Thomas R. M.] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [Maalcke, Wouter J.] Dr Heinekamp Benelux, Vlasstr 12, NL-5561 AJ Riethoven, Netherlands; [Kip, Nardy] HAN Univ Appl Sci, Inst Appl Sci, Laan van Scheut 2, NL-6525 EM Nijmegen, Netherlands	Radboud University Nijmegen; Delft University of Technology; University of East Anglia; University of East Anglia; Max Planck Society	Kartal, B (corresponding author), Max Planck Inst Marine Microbiol, Microbial Physiol Grp, Celsiusstr 1, D-28359 Bremen, Germany.	bkartal@mpi-bremen.de	Butt, Julea/E-2133-2011; Jetten, Mike/B-8834-2011; Keltjens, Jan/M-3002-2013; Kartal, Boran/ABD-5400-2021	Butt, Julea/0000-0002-9624-5226; Jetten, Mike/0000-0002-4691-7039; Kartal, Boran/0000-0003-4199-952X	Netherlands Organization for Scientific Research (NWO) VENI Grant [863.11.003]; Netherlands Organization for Scientific Research (NWO) Darwin Grant [142.16.1201]; ALW-NWO Open Programme Grant [822.02.005]; Dutch Government "Zwaartekrachtsubsidie" (Gravitation Grant) to the Soehngen Institute for Anaerobic Microbiology (SIAM) [024 002 002]; European Research Council [ERC 232937, ERC 339880, ERC 640422]; Max-Planck Society	Netherlands Organization for Scientific Research (NWO) VENI Grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO) Darwin Grant(Netherlands Organization for Scientific Research (NWO)); ALW-NWO Open Programme Grant; Dutch Government "Zwaartekrachtsubsidie" (Gravitation Grant) to the Soehngen Institute for Anaerobic Microbiology (SIAM); European Research Council(European Research Council (ERC)European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by Netherlands Organization for Scientific Research (NWO) VENI Grant 863.11.003 (to B. K.), Darwin Grant 142.16.1201 (to W. J. M.), and ALW-NWO Open Programme Grant 822.02.005 (to J. R.); by the Dutch Government "Zwaartekrachtsubsidie" (Gravitation Grant) to the Soehngen Institute for Anaerobic Microbiology (SIAM 024 002 002) (to M. S. M. J.); by European Research Council advanced Grants ERC 232937 (to M. S. M. J.), ERC 339880 (to M. S. M. J.), and ERC 640422 (to B. K.); and by the Max-Planck Society (to T. R. M. B., U. M., and A. D.). The authors declare that they have no conflicts of interest with the contents of this paper.	Arciero DM, 1998, BIOCHEMISTRY-US, V37, P523, DOI 10.1021/bi972187l; Attia AAA, 2014, J PHYS CHEM B, V118, P12140, DOI 10.1021/jp507023a; Bencini A., 1990, ELECT PARAMAGNETIC R; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Cedervall P, 2013, BIOCHEMISTRY-US, V52, P6211, DOI 10.1021/bi400960w; de Almeida NM, 2015, J BACTERIOL, V197, P2432, DOI 10.1128/JB.00186-15; Devol AH, 2015, ANNU REV MAR SCI, V7, P403, DOI 10.1146/annurev-marine-010213-135040; DEVRIES S, 1979, BIOCHIM BIOPHYS ACTA, V546, P334; Dietl A, 2015, NATURE, V527, P404, DOI 10.1038/nature15517; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Fernandez ML, 2008, J INORG BIOCHEM, V102, P1523, DOI 10.1016/j.jinorgbio.2008.01.032; Hendrich MP, 2001, J AM CHEM SOC, V123, P2997, DOI 10.1021/ja002982d; Hooper AB, 1997, ANTON LEEUW INT J G, V71, P59, DOI 10.1023/A:1000133919203; HOOPER AB, 1965, J BIOL CHEM, V240, P4044; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Kartal B, 2010, SCIENCE, V328, P702, DOI 10.1126/science.1185941; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kartal B, 2012, ADV MICROB PHYSIOL, V60, P211, DOI 10.1016/B978-0-12-398264-3.00003-6; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kleingardner JG, 2015, ACCOUNTS CHEM RES, V48, P1845, DOI 10.1021/acs.accounts.5b00106; Klotz MG, 2008, ENVIRON MICROBIOL, V10, P3150, DOI 10.1111/j.1462-2920.2008.01733.x; Kostera J, 2010, BIOCHEMISTRY-US, V49, P8546, DOI 10.1021/bi1006783; Kurnikov IV, 2005, BIOCHEMISTRY-US, V44, P1856, DOI 10.1021/bi048060v; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Maalcke WJ, 2014, J BIOL CHEM, V289, P1228, DOI 10.1074/jbc.M113.525147; Schalk J, 2000, BIOCHEMISTRY-US, V39, P5405, DOI 10.1021/bi992721k; Shimamura M, 2008, J BIOSCI BIOENG, V105, P243, DOI 10.1263/jbb.105.243; Shimamura M, 2007, APPL ENVIRON MICROB, V73, P1065, DOI 10.1128/AEM.01978-06; TERRY KR, 1981, BIOCHEMISTRY-US, V20, P7026, DOI 10.1021/bi00527a039; vandeGraaf AA, 1997, MICROBIOL-SGM, V143, P2415, DOI 10.1099/00221287-143-7-2415; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; YONETANI T, 1965, J BIOL CHEM, V240, P4509	34	67	72	16	129	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17077	17092		10.1074/jbc.M116.735530	http://dx.doi.org/10.1074/jbc.M116.735530			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27317665	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000382643800014
J	Yanatori, I; Richardson, DR; Imada, K; Kishi, F				Yanatori, Izumi; Richardson, Des R.; Imada, Kiyoshi; Kishi, Fumio			Iron Export through the Transporter Ferroportin 1 Is Modulated by the Iron Chaperone PCBP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; iron; iron metabolism; protein-protein interaction; transporter; PCBP2; ferroportin1	POLY(RC) BINDING-PROTEIN; FUNCTIONAL-ANALYSIS; METABOLISM; HEPCIDIN; FAMILY; DOMAIN; GENE; LOCALIZATION; NRAMP2/DMT1; MECHANISMS	Ferroportin 1 (FPN1) is an iron export protein found in mammals. FPN1 is important for the export of iron across the basolateral membrane of absorptive enterocytes and across the plasma membrane of macrophages. The expression of FPN1 is regulated by hepcidin, which binds to FPN1 and then induces its degradation. Previously, we demonstrated that divalent metal transporter 1 (DMT1) interacts with the intracellular iron chaperone protein poly(rC)-binding protein 2 (PCBP2). Subsequently, PCBP2 receives iron from DMT1 and then disengages from the transporter. In this study, we investigated the function of PCBP2 in iron export. Mammalian genomes encode four PCBPs (i.e. PCBP1-4). Here, for the first time, we demonstrated using both yeast and mammalian cells that PCBP2, but not PCBP1, PCBP3, or PCBP4, binds with FPN1. Importantly, iron-loaded, but not iron-depleted, PCBP2 interacts with FPN1. The PCBP2-binding domain of FPN1 was identified in its C-terminal cytoplasmic region. The silencing of PCBP2 expression suppressed FPN1-dependent iron export from cells. These results suggest that FPN1 exports iron received from the iron chaperone PCBP2. Therefore, it was found that PCBP2 modulates cellular iron export, which is an important physiological process.	[Yanatori, Izumi; Imada, Kiyoshi; Kishi, Fumio] Kawasaki Med Sch, Dept Mol Genet, 577 Matsushima, Kurashiki, Okayama 7010192, Japan; [Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia	Kawasaki Medical School; University of Sydney	Kishi, F (corresponding author), Kawasaki Med Sch, Dept Mol Genet, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	fkishi-ygc@umin.ac.jp	Yanatori, Izumi/AAE-1482-2019	Yanatori, Izumi/0000-0002-1945-5473; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274	Ministry of Education, Science, and Culture of Japan [22591052]; Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED); Kawasaki Medical School [26-26, 27-50]; National Health and Medical Research Council of Australia (NHMRC); Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Kawasaki Medical School; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (ID: 22591052), the Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED), and research project grants from Kawasaki Medical School (ID: 26-26, 27-50). The authors declare that they have no conflicts of interest related to the contents of this article.; Recipient of a Senior Principal Research Fellowship and project grants from the National Health and Medical Research Council of Australia (NHMRC) and a travel fellowship from the Japan Society for the Promotion of Science (JSPS).	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Alver RC, 2014, NUCLEIC ACIDS RES, V42, P8389, DOI 10.1093/nar/gku479; Canonne-Hergaux F, 2000, BLOOD, V96, P3964; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Chkheidze AN, 2003, MOL CELL BIOL, V23, P8405, DOI 10.1128/MCB.23.23.8405-8415.2003; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; FUHRMAN B, 1994, ATHEROSCLEROSIS, V111, P65, DOI 10.1016/0021-9150(94)90192-9; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Ghanem LR, 2016, MOL CELL BIOL, V36, P304, DOI 10.1128/MCB.00936-15; Ghanem LR, 2014, GENE EXPR PATTERNS, V14, P78, DOI 10.1016/j.gep.2014.01.004; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Kalinowski DS, 2016, BBA-MOL CELL RES, V1863, P727, DOI 10.1016/j.bbamcr.2016.01.026; Kishi F, 1997, MOL IMMUNOL, V34, P839, DOI 10.1016/S0161-5890(97)00110-7; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Lane Darius J R, 2014, Biochem J, V462, pe1, DOI 10.1042/BJ20140720; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Liu FL, 2006, BIOCHEM BIOPH RES CO, V350, P472, DOI 10.1016/j.bbrc.2006.09.073; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Palumaa P, 2013, FEBS LETT, V587, P1902, DOI 10.1016/j.febslet.2013.05.019; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Philpott CC, 2012, J BIOL CHEM, V287, P13518, DOI 10.1074/jbc.R111.326876; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richardson DR, 1996, BLOOD, V87, P3477, DOI 10.1182/blood.V87.8.3477.bloodjournal8783477; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rosakis A, 2005, BIOMETALS, V18, P107, DOI 10.1007/s10534-004-2481-4; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Tabuchi M, 1999, BIOCHEM J, V344, P211, DOI 10.1042/0264-6021:3440211; Tabuchi M, 2002, MOL BIOL CELL, V13, P4371, DOI 10.1091/mbc.E02-03-0165; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; Wallace DF, 2010, AM J PHYSIOL-CELL PH, V298, pC75, DOI 10.1152/ajpcell.00621.2008; Walter BL, 1999, RNA, V5, P1570, DOI 10.1017/S1355838299991483; Walter BL, 2002, J VIROL, V76, P12008, DOI 10.1128/JVI.76.23.12008-12022.2002; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P793, DOI 10.1001/archneur.57.6.793; Yanatori I, 2015, CELL BIOL INT, V39, P427, DOI 10.1002/cbin.10403; Yanatori I, 2014, BIOCHEM J, V462, P25, DOI 10.1042/BJ20140225; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; YOSHIMORI T, 1988, CELL STRUCT FUNCT, V13, P311, DOI 10.1247/csf1975.13.311; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905	58	88	92	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17303	17318		10.1074/jbc.M116.721936	http://dx.doi.org/10.1074/jbc.M116.721936			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27302059	Green Published, hybrid			2022-12-28	WOS:000382643800031
J	Kasture, A; El-Kasaby, A; Szollosi, D; Asjad, HMM; Grimm, A; Stockner, T; Hummel, T; Freissmuth, M; Sucic, S				Kasture, Ameya; El-Kasaby, Ali; Szollosi, Daniel; Asjad, H. M. Mazhar; Grimm, Alexandra; Stockner, Thomas; Hummel, Thomas; Freissmuth, Michael; Sucic, Sonja			Functional Rescue of a Misfolded Drosophila melanogaster Dopamine Transporter Mutant Associated with a Sleepless Phenotype by Pharmacological Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED GENE-EXPRESSION; 1ST INTRACELLULAR LOOP; SEROTONIN-TRANSPORTER; MOLECULAR-DYNAMICS; GABA TRANSPORTER-1; TERMINUS; NEURONS; MOTIF; NEUROTRANSMITTER; AMPHETAMINES	Folding-defective mutants of the human dopamine transporter (DAT) cause a syndrome of infantile dystonia/parkinsonism. Here, we provide a proof-of-principle that the folding deficit is amenable to correction in vivo by two means, the cognate DAT ligand noribogaine and the HSP70 inhibitor, pifithrin-mu. We examined the Drosophila melanogaster (d) mutant dDAT-G108Q, which leads to a sleepless phenotype in flies harboring this mutation. Molecular dynamics simulations suggested an unstable structure of dDAT-G108Q consistent with a folding defect. This conjecture was verified; heterologously expressed dDAT-G108Q and the human (h) equivalent hDAT-G140Q were retained in the endoplasmic reticulum in a complex with endogenous folding sensors (calnexin and HSP70-1A). Incubation of the cells with noribogaine (a DAT ligand selective for the inward-facing state) and/or pifithrin-mu (an HSP70 inhibitor) restored folding of, and hence dopamine transport by, dDATG108Q and hDAT-G140Q. The mutated versions of DAT were confined to the cell bodies of the dopaminergic neurons in the fly brain and failed to reach the axonal compartments. Axonal delivery was restored, and sleep time was increased to normal length (from 300 to 1000 min/day) if the dDAT-G108Q-expressing flies were treated with noribogaine and/or pifithrin-mu. Rescuing misfolded versions of DAT by pharmacochaperoning is of therapeutic interest; it may provide opportunities to remedy disorders arising from folding-defective mutants of human DAT and of other related SLC6 transporters.	[Kasture, Ameya; El-Kasaby, Ali; Szollosi, Daniel; Asjad, H. M. Mazhar; Stockner, Thomas; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria; [El-Kasaby, Ali] Mansoura Univ, Fac Vet Med, Dept Pharmacol, Mansoura 35516, Egypt; [Grimm, Alexandra; Hummel, Thomas] Univ Vienna, Dept Neurobiol, A-1090 Vienna, Austria	Medical University of Vienna; Egyptian Knowledge Bank (EKB); Mansoura University; University of Vienna	Freissmuth, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Stockner, Thomas/A-9509-2014; Szöllösi, Dániel/ABH-9228-2020	Stockner, Thomas/0000-0002-7071-8283; Szöllösi, Dániel/0000-0003-4641-3065; Kasture, Ameya/0000-0002-2947-4803; Sucic, Sonja/0000-0001-5136-8022; Freissmuth, Michael/0000-0001-9398-1765; Asjad, Hafiz Muhammad Mazhar/0000-0001-6155-9113	Austrian Science Fund/FWF [SFB35-10, P27518-B27, W1205]; doctoral program Cell Communication in Health and Disease; Medical University of Vienna	Austrian Science Fund/FWF(Austrian Science Fund (FWF)); doctoral program Cell Communication in Health and Disease; Medical University of Vienna	This work was supported in part by Project Program Grant SFB35-10 (to M. F.) and Grant P27518-B27 (to S. S.) by the Austrian Science Fund/FWF. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the doctoral program Cell Communication in Health and Disease, which is jointly funded by grants from the Austrian Science Fund/FWF (W1205) and the Medical University of Vienna.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bergmayr C, 2013, J BIOL CHEM, V288, P28831, DOI 10.1074/jbc.M113.464776; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; El-Kasaby A, 2014, J BIOL CHEM, V289, P28987, DOI 10.1074/jbc.M114.595090; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hohenegger M, 1996, MOL PHARMACOL, V49, P73; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lion-Francois L, 2006, NEUROLOGY, V67, P1713, DOI 10.1212/01.wnl.0000239153.39710.81; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Montgomery TR, 2014, J NEUROSCI, V34, P6344, DOI 10.1523/JNEUROSCI.2991-13.2014; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Shang YH, 2011, NAT NEUROSCI, V14, P889, DOI 10.1038/nn.2860; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Sucic S, 2005, J NEUROCHEM, V94, P1620, DOI 10.1111/j.1471-4159.2005.03316.x; Sucic S, 2002, MOL BRAIN RES, V108, P40, DOI 10.1016/S0169-328X(02)00512-0; Sucic S, 2007, EUR J PHARMACOL, V556, P27, DOI 10.1016/j.ejphar.2006.10.058; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Tao YX, 2014, ENDOCR REV, V35, P602, DOI 10.1210/er.2013-1121; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465	47	20	20	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20876	20890		10.1074/jbc.M116.737551	http://dx.doi.org/10.1074/jbc.M116.737551			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27481941	hybrid, Green Published			2022-12-28	WOS:000385406200007
J	Rensvold, JW; Krautkramer, KA; Dowell, JA; Denu, JM; Pagliarini, DJ				Rensvold, Jarred W.; Krautkramer, Kimberly A.; Dowell, James A.; Denu, John M.; Pagliarini, David J.			Iron Deprivation Induces Transcriptional Regulation of Mitochondrial Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACKING TRANSFERRIN RECEPTOR; HISTONE MODIFICATIONS; CHROMATIN REGULATION; SULFUR PROTEINS; GENE-EXPRESSION; DISEASE; DEFICIENCY; METABOLISM; HYPOXIA; CANCER	Mitochondria are essential organelles that adapt to stress and environmental changes. Among the nutrient signals that affect mitochondrial form and function is iron, whose depletion initiates a rapid and reversible decrease in mitochondrial biogenesis through unclear means. Here we demonstrate that, unlike the canonical iron-induced alterations to transcript stability, loss of iron dampens the transcription of genes encoding mitochondrial proteins with no change to transcript half-life. Using mass spectrometry, we demonstrate that these transcriptional changes are accompanied by dynamic alterations to histone acetylation and methylation levels that are largely reversible upon readministration of iron. Moreover, histone deacetylase inhibition abrogates the decreased histone acetylation observed upon iron deprivation and restores normal transcript levels at genes encoding mitochondrial proteins. Collectively, we demonstrate that deprivation of an essential nutrient induces transcriptional repression of organellar biogenesis involving epigenetic alterations.	[Rensvold, Jarred W.; Denu, John M.; Pagliarini, David J.] Morgridge Inst Res, 2268 Discovery Bldg,330 N Orchard St, Madison, WI 53715 USA; [Krautkramer, Kimberly A.; Dowell, James A.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; [Krautkramer, Kimberly A.; Dowell, James A.; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Pagliarini, David J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Pagliarini, DJ (corresponding author), Morgridge Inst Res, 2268 Discovery Bldg,330 N Orchard St, Madison, WI 53715 USA.	dpagliarini@morgridge.org	Krautkramer, Kimberly/AAR-7014-2020	Krautkramer, Kimberly/0000-0002-9227-0977; Pagliarini, David J./0000-0002-0001-0087	Searle Scholars Award, a Shaw Scientist Award, Department of Agriculture Hatch Award [WIS01671]; National Institutes of Health [R01DK098672]; National Institutes of Health Molecular Biosciences Training Grant [T32GM007215]; University of Wisconsin-Madison, College of Agricultural and Life Sciences Louis and Elsa Thomsen Distinguished Graduate Fellowship; National Institutes of Health Molecular and Applied Nutrition Training Program Grant [T32DK007665]; National Institutes of Health University of Wisconsin Medical Scientist Training Program [T32GM008692]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098672, T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692, T32GM007215, R01GM115591] Funding Source: NIH RePORTER	Searle Scholars Award, a Shaw Scientist Award, Department of Agriculture Hatch Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Molecular Biosciences Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison, College of Agricultural and Life Sciences Louis and Elsa Thomsen Distinguished Graduate Fellowship; National Institutes of Health Molecular and Applied Nutrition Training Program Grant; National Institutes of Health University of Wisconsin Medical Scientist Training Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Searle Scholars Award, a Shaw Scientist Award, Department of Agriculture Hatch Award WIS01671, and National Institutes of Health Grant R01DK098672 (to D. J. P.); National Institutes of Health Molecular Biosciences Training Grant T32GM007215 and a University of Wisconsin-Madison, College of Agricultural and Life Sciences Louis and Elsa Thomsen Distinguished Graduate Fellowship (to J. W. R.); and National Institutes of Health Molecular and Applied Nutrition Training Program Grant T32DK007665 and National Institutes of Health University of Wisconsin Medical Scientist Training Program Grant T32GM008692 (to K. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Barrientos T, 2015, EBIOMEDICINE, V2, P1705, DOI 10.1016/j.ebiom.2015.09.041; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Burkhart RA, 2013, RNA BIOL, V10, P1312, DOI 10.4161/rna.25274; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Eisenstein RS, 2003, J NUTR, V133, p1510S, DOI 10.1093/jn/133.5.1510S; Fan J, 2015, ACS CHEM BIOL, V10, P95, DOI 10.1021/cb500846u; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190; Frey PA, 2012, ACS CHEM BIOL, V7, P1477, DOI 10.1021/cb300323q; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Hamada S, 2009, BIOORG MED CHEM LETT, V19, P2852, DOI 10.1016/j.bmcl.2009.03.098; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Matak P, 2016, P NATL ACAD SCI USA, V113, P3428, DOI 10.1073/pnas.1519473113; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Rouault TA, 2015, NAT CHEM BIOL, V11, P442, DOI 10.1038/nchembio.1843; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; von Haehling S, 2015, NAT REV CARDIOL, V12, P659, DOI 10.1038/nrcardio.2015.109; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Xu WJ, 2015, CELL REP, V13, P533, DOI 10.1016/j.celrep.2015.09.023; Yao MY, 2014, AM J PHYSIOL-LUNG C, V307, pL829, DOI 10.1152/ajplung.00081.2014; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	63	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20827	+		10.1074/jbc.M116.727701	http://dx.doi.org/10.1074/jbc.M116.727701			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27497435	hybrid, Green Published			2022-12-28	WOS:000385406200001
J	Ding, GJ; Chen, PL; Zhang, H; Huang, XJ; Zang, Y; Li, JW; Li, J; Wong, JM				Ding, Guangjin; Chen, Peilin; Zhang, Hui; Huang, Xiaojie; Zang, Yi; Li, Jiwen; Li, Jia; Wong, Jiemin			Regulation of Ubiquitin-like with Plant Homeodomain and RING Finger Domain 1 (UHRF1) Protein Stability by Heat Shock Protein 90 Chaperone Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (HSP70); cancer therapy; DNA methylation; protein degradation; ubiquitin	HEMI-METHYLATED DNA; F-BOX PROTEINS; BINDING-PROTEIN; TRIAGE DECISIONS; HSP90 INHIBITORS; CLIENT PROTEINS; CANCER-CELLS; LUNG-CANCER; LIGASE CHIP; E3 LIGASE	As a protein critical for DNA maintenance methylation and cell proliferation, UHRF1 is frequently highly expressed in various human cancers and is considered as a drug target for cancer therapy. In a high throughput screening for small molecules that induce UHRF1 protein degradation, we have identified the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG). We present evidence that UHRF1 interacts with HSP90 chaperone complex and is a novel HSP90 client protein. Pharmacological inhibition of HSP90 with 17-AAG or 17-dimethylaminoethylamino-17-demethoxygeldanamycin results in UHRF1 ubiquitination and proteasome-dependent degradation. Interestingly, this HSP90 inhibitor-induced UHRF1 degradation is independent of CHIP and CUL5, two previously identified ubiquitin E3 ligases for HSP90 client proteins. In addition, this degradation is dependent neither on the intrinsic E3 ligase of UHRF1 nor on the E3 ligase SCF-TRCP that has been implicated in regulation of UHRF1 stability. We also provide evidence that HSP90 inhibitors may suppress cancer cell proliferation in part through its induced UHRF1 degradation. Taken together, our results identify UHRF1 as a novel HSP90 client protein and shed light on the regulation of UHRF1 stability and function.	[Ding, Guangjin; Chen, Peilin; Zhang, Hui; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Ding, Guangjin; Chen, Peilin; Zhang, Hui; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Huang, Xiaojie; Zang, Yi; Li, Jia] Chinese Acad Sci, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Wong, Jiemin] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China	East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Sun Yat Sen University	Wong, JM (corresponding author), East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.; Wong, JM (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.; Li, J (corresponding author), Chinese Acad Sci, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	jli@simm.ac.cn; jmweng@bio.ecnu.edu.cn	li, jia/GVT-7587-2022; Li, Jia/F-9116-2011; Zang, Yi/C-5683-2014	Zang, Yi/0000-0001-9835-922X; Wong, Jiemin/0000-0002-5311-842X	National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2014ZX09507002-002]; Ministry of Science and Technology of China [2015CB910402]; National Natural Science Foundation of China [91419303]; Science and Technology Commission of Shanghai Municipality [14XD1401700, 11DZ2260300]	National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China Grant 2014ZX09507002-002, Ministry of Science and Technology of China Grant 2015CB910402, National Natural Science Foundation of China Grant 91419303, and Science and Technology Commission of Shanghai Municipality Grants 14XD1401700 and 11DZ2260300. The authors declare that they have no conflicts of interest with the contents of this article.	Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Bronner C, 2013, BIOCHEM PHARMACOL, V86, P1643, DOI 10.1016/j.bcp.2013.10.002; Butler LM, 2015, MOL CANCER RES, V13, P1445, DOI 10.1158/1541-7786.MCR-15-0234; Chen H, 2013, MOL CELL BIOL, V33, P1139, DOI 10.1128/MCB.01191-12; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Gelato KA, 2014, MOL CELL, V54, P905, DOI 10.1016/j.molcel.2014.04.004; Guan D, 2013, ONCOGENE, V32, P3819, DOI 10.1038/onc.2012.406; Ha K, 2011, MOL CANCER THER, V10, P1194, DOI 10.1158/1535-7163.MCT-11-0094; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hopfner R, 2000, CANCER RES, V60, P121; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Qin WH, 2015, CELL RES, V25, P911, DOI 10.1038/cr.2015.72; Rodina A, 2007, NAT CHEM BIOL, V3, P498, DOI 10.1038/nchembio.2007.10; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Samant RS, 2014, P NATL ACAD SCI USA, V111, P6834, DOI 10.1073/pnas.1322412111; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tien AL, 2011, BIOCHEM J, V435, P175, DOI 10.1042/BJ20100840; Unoki M, 2010, BRIT J CANCER, V103, P217, DOI 10.1038/sj.bjc.6605717; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	51	22	23	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20125	20135		10.1074/jbc.M116.727214	http://dx.doi.org/10.1074/jbc.M116.727214			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27489107	Green Published, hybrid			2022-12-28	WOS:000383243100033
J	Leo, JC; Oberhettinger, P; Yoshimoto, S; Udatha, DBRKG; Morth, JP; Schutz, M; Hori, K; Linke, D				Leo, Jack C.; Oberhettinger, Philipp; Yoshimoto, Shogo; Udatha, D. B. R. K. Gupta; Morth, J. Preben; Schuetz, Monika; Hori, Katsutoshi; Linke, Dirk			Secretion of the Intimin Passenger Domain Is Driven by Protein Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); bacterial pathogenesis; immunoglobulin-like domain; protein folding; protein secretion; type V secretion system	ENTEROPATHOGENIC ESCHERICHIA-COLI; BACTERIAL OUTER-MEMBRANE; IMMUNOGLOBULIN DOMAINS; STRUCTURE PREDICTION; VIRULENCE FACTOR; BETA-HELIX; AUTOTRANSPORTER; TRANSPORT; TRANSLOCATION; MUTAGENESIS	Intimin is an essential adhesin of attaching and effacing organisms such as entropathogenic Escherichia coli. It is also the prototype of type Ve secretion or inverse autotransport, where the extracellular C-terminal region or passenger is exported with the help of an N-terminal transmembrane -barrel domain. We recently reported a stalled secretion intermediate of intimin, where the passenger is located in the periplasm but the -barrel is already inserted into the membrane. Stalling of this mutant is due to the insertion of an epitope tag at the very N terminus of the passenger. Here, we examined how this insertion disrupts autotransport and found that it causes misfolding of the N-terminal immunoglobulin (Ig)-like domain D00. We could also stall the secretion by making an internal deletion in D00, and introducing the epitope tag into the second Ig-like domain, D0, also resulted in reduced passenger secretion. In contrast to many classical autotransporters, where a proximal folding core in the passenger is required for secretion, the D00 domain is dispensable, as the passenger of an intimin mutant lacking D00 entirely is efficiently exported. Furthermore, the D00 domain is slightly less stable than the D0 and D1 domains, unfolding at approximate to 200 piconewtons (pN) compared with approximate to 250 pN for D0 and D1 domains as measured by atomic force microscopy. Our results support a model where the secretion of the passenger is driven by sequential folding of the extracellular Ig-like domains, leading to vectorial transport of the passenger domain across the outer membrane in an N to C direction.	[Leo, Jack C.; Udatha, D. B. R. K. Gupta; Linke, Dirk] Univ Oslo, Dept Biosci, Evolut & Genet, N-0316 Oslo, Norway; [Oberhettinger, Philipp; Schuetz, Monika] Univ Clin Tubingen, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Yoshimoto, Shogo; Hori, Katsutoshi] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan; [Morth, J. Preben] Ctr Mol Med Norway, N-0318 Oslo, Norway; [Udatha, D. B. R. K. Gupta] Natl Hosp Norway, Norwegian PSC Res Ctr, Div Canc Med Surg & Transplantat, Dept Transplantat Med,Oslo Univ Hosp, N-0424 Oslo, Norway	University of Oslo; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Nagoya University; University of Oslo; National Hospital Norway	Linke, D (corresponding author), Univ Oslo, Dept Biosci, Evolut & Genet, N-0316 Oslo, Norway.	dirk.linke@ibv.uio.no	Linke, Dirk/F-9147-2010; Leo, Jack/HHS-7710-2022; Morth, Jens Preben/G-4450-2013; Leo, Jack C./F-2177-2011; Morth, Jens Preben/AAP-7834-2021; Hori, Katsutoshi/K-5289-2012	Linke, Dirk/0000-0003-3150-6752; Morth, Jens Preben/0000-0003-4077-0192; Leo, Jack C./0000-0002-7066-7527; Morth, Jens Preben/0000-0003-4077-0192; Udatha, D.B.R.K. Gupta/0000-0003-0163-9407; Hori, Katsutoshi/0000-0003-1994-3124; Yoshimoto, Shogo/0000-0002-1358-4362	Fortune Program [F1433253]; VISTA, a basic research program - Statoil; Norwegian Academy of Science and Letters; German Research Council [DFG SFB766]; German Center for Infection Research (DZIF); Molecular Life Science (MLS) initiative grant from the University of Oslo; Research Council of Norway [230576-BACTAD]	Fortune Program; VISTA, a basic research program - Statoil; Norwegian Academy of Science and Letters; German Research Council(German Research Foundation (DFG)); German Center for Infection Research (DZIF); Molecular Life Science (MLS) initiative grant from the University of Oslo; Research Council of Norway(Research Council of Norway)	This work was supported by the Fortune Program F1433253 (to P. O.), a grant from VISTA, a basic research program funded by Statoil in collaboration with the Norwegian Academy of Science and Letters (to J. C. L.), grants from the German Research Council (DFG SFB766) and the German Center for Infection Research (DZIF) (to M. S.), and by a Molecular Life Science (MLS) initiative grant from the University of Oslo and by the Research Council of Norway, Grant 230576-BACTAD (to D. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bodelon G, 2013, FEMS MICROBIOL REV, V37, P204, DOI 10.1111/j.1574-6976.2012.00347.x; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; BYRAPPA S, 1995, GENOME RES, V5, P404, DOI 10.1101/gr.5.4.404; Doyle MT, 2015, MOL MICROBIOL, V97, P315, DOI 10.1111/mmi.13027; Drobnak I, 2015, MOL MICROBIOL, V95, P1, DOI 10.1111/mmi.12838; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hospenthal MK, 2016, CELL, V164, P269, DOI 10.1016/j.cell.2015.11.049; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jacob-Dubuisson F, 2013, RES MICROBIOL, V164, P583, DOI 10.1016/j.resmic.2013.03.009; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kang'ethe W, 2013, J BIOL CHEM, V288, P35028, DOI 10.1074/jbc.M113.515635; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Leo JC, 2015, METHODS MOL BIOL, V1329, P157, DOI 10.1007/978-1-4939-2871-2_12; Leo JC, 2015, INT J MED MICROBIOL, V305, P276, DOI 10.1016/j.ijmm.2014.12.011; Leo JC, 2015, MOL MICROBIOL, V95, P80, DOI 10.1111/mmi.12840; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Oberhettinger P, 2015, J BIOL CHEM, V290, P1837, DOI 10.1074/jbc.M114.604769; Oberhettinger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047069; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Paramasivam N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-510; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Renn JP, 2012, CHEM BIOL, V19, P287, DOI 10.1016/j.chembiol.2011.11.009; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Shen HH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6078; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tsai JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014403; Udatha DBRKG, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0224-5; Udatha DBRKG, 2015, J STRUCT BIOL, V190, P314, DOI 10.1016/j.jsb.2015.04.009; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618	47	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20096	20112		10.1074/jbc.M116.731497	http://dx.doi.org/10.1074/jbc.M116.731497			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27466361	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000383243100031
J	Plaza, K; Kalinska, M; Bochenska, O; Meyer-Hoffert, U; Wu, ZH; Fischer, J; Falkowski, K; Sasiadek, L; Bielecka, E; Potempa, B; Kozik, A; Potempa, J; Kantyka, T				Plaza, Karolina; Kalinska, Magdalena; Bochenska, Oliwia; Meyer-Hoffert, Ulf; Wu, Zhihong; Fischer, Jan; Falkowski, Katherine; Sasiadek, Laura; Bielecka, Ewa; Potempa, Barbara; Kozik, Andrzej; Potempa, Jan; Kantyka, Tomasz			Gingipains of Porphyromonas gingivalis Affect the Stability and Function of Serine Protease Inhibitor of Kazal-type 6 (SPINK6), a Tissue Inhibitor of Human Kallikreins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR-PERMEABILITY ENHANCEMENT; CYSTEINE PROTEINASES; CHRONIC-PANCREATITIS; CANCER BIOMARKERS; VIRULENCE FACTORS; PEPTIDASES; PERIODONTITIS; ACTIVATION; SKIN; PATHOGENESIS	Periodontitis, a chronic inflammation driven by dysbiotic subgingival bacterial flora, is linked on clinical levels to the development of a number of systemic diseases and to the development of oral and gastric tract tumors. A key pathogen, Porphyromonas gingivalis, secretes gingipains, cysteine proteases implicated as the main factors in the development of periodontitis. Here we hypothesize that gingipains may be linked to systemic pathologies through the deregulation of kallikrein-like proteinase (KLK) family members, KLKs are implicated in cancer development and are clinically utilized as tumor progression markers. In tissues, KLK activity is strictly controlled by a limited number of tissue-specific inhibitors, including SPINK6, an inhibitor of these proteases in skin and oral epithelium. Here we identify gingipains as the only P. gingivalis proteases responsible for SPINK6 degradation. We further show that gingipains, even at low nanomolar concentrations, cleaved SPINK6 in concentration- and time-dependent manner. The proteolysis was accompanied by loss of inhibition against KLK13. We also mapped the cleavage by Arg-specific gingipains to the reactive site loop of the SPINK6 inhibitor. Moreover, we identified a significant fraction of SPINK6-sensitive proteases in healthy saliva and confirmed the ability of gingipains to inactivate SPINK6 under ex vivo conditions. Finally, we demonstrate the double-edge action of gingipains, which, in addition, can activate K1,Ks because of gingipain K-mediated proteolytic processing of the zymogenic proform of KLK13. Altogether, the results indicate the potential of P. gingivalis to disrupt the control system of KLKs, providing a possible mechanistic link between periodontal disease and tumor development.	[Plaza, Karolina; Kalinska, Magdalena; Falkowski, Katherine; Sasiadek, Laura; Bielecka, Ewa; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Bochenska, Oliwia; Kozik, Andrzej] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Analyt Biochem, PL-30387 Krakow, Poland; [Kantyka, Tomasz] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Meyer-Hoffert, Ulf; Wu, Zhihong; Fischer, Jan] Univ Clin Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Potempa, Barbara; Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA	Jagiellonian University; Jagiellonian University; Jagiellonian University; University of Kiel; Schleswig Holstein University Hospital; University of Louisville	Potempa, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland.; Potempa, J (corresponding author), Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA.	jan.potempa@uj.edu.pl	Wu, Zhihong/AAK-3433-2020; Bielecka, Ewa/Q-4850-2018; Meyer-Hoffert, Ulf/F-4623-2012; Potempa, Jan/AAA-6850-2021	Bielecka, Ewa/0000-0002-2631-6711; Meyer-Hoffert, Ulf/0000-0003-2305-1428; Potempa, Jan/0000-0002-3600-7461; Falkowski, Katherine/0000-0002-1470-256X; Kantyka, Tomasz/0000-0003-3023-2382	Polish National Centre of Science Research [OPUS 2012/05/B/NZ6/00581, Preludium UMO-2012/07/N/ NZ1/00006, SYMFONIA UMO-2013/08/W/NZ1/00696]; Polish Ministry of Science and Higher Education luventus+ [IP2011 022171, 2975/7.PR/13/2014/2]; German Research Foundation [ME2037/3-3]; Young Scientist Grant for Faculty of Biochemistry, Biophysics, and Biotechnology [K/DSC/003271]; European Union [POIG.02.01.00-12-064/08]; Ministry of Science and Higher Education, Poland; National Institutes of Health [DE 09761, DE 022597]; European Commission [FP7-HEALTH-F3-2012-306029]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597] Funding Source: NIH RePORTER	Polish National Centre of Science Research; Polish Ministry of Science and Higher Education luventus+; German Research Foundation(German Research Foundation (DFG)); Young Scientist Grant for Faculty of Biochemistry, Biophysics, and Biotechnology; European Union(European Commission); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by Polish National Centre of Science Research Grants OPUS 2012/05/B/NZ6/00581 (to T. K.), Preludium UMO-2012/07/N/ NZ1/00006 (to K. P.), and SYMFONIA UMO-2013/08/W/NZ1/00696 (to J. P.); Polish Ministry of Science and Higher Education luventus+ IP2011 022171 (to T. K.) and 2975/7.PR/13/2014/2 (to J. P.); German Research Foundation Grant ME2037/3-3 (to U. M. H.); and Young Scientist Grant for Faculty of Biochemistry, Biophysics, and Biotechnology K/DSC/003271 (to M. K.). The Faculty of Biochemistry, Biophysics, and Biotechnology of the Jagiellonian University in Krakow is a beneficiary of structural funds from the European Union (Grant POIG.02.01.00-12-064/08, "Molecular Biotechnology for Health") and a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education, Poland. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants DE 09761 and DE 022597 and European Commission Grant FP7-HEALTH-F3-2012-306029 "TRIGGER"). To whom correspondence should be addressed: Tel.: 48-12-6646343; Fax: 48-12-6646902; E-mail: jan.potempa@uj.edu.pl.	Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Fischer J, 2014, J INVEST DERMATOL, V134, P1305, DOI 10.1038/jid.2013.502; Fischer J, 2013, J INVEST DERMATOL, V133, P1170, DOI 10.1038/jid.2012.482; Ford PJ, 2010, PERIODONTOL 2000, V53, P111, DOI 10.1111/j.1600-0757.2010.00349.x; Gao SG, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0049-x; Gasiorowska A, 2011, DIGEST DIS SCI, V56, P894, DOI 10.1007/s10620-010-1349-4; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Ha NH, 2015, TUMOR BIOL, V36, P9947, DOI 10.1007/s13277-015-3764-9; Hoefnagel JJ, 2005, BLOOD, V105, P3671, DOI 10.1182/blood-2004-04-1594; IMAMURA T, 1995, INFECT IMMUN, V63, P4877, DOI 10.1128/IAI.63.12.4877-4882.1995; IMAMURA T, 1994, J CLIN INVEST, V94, P361, DOI 10.1172/JCI117330; IMAMURA T, 1995, INFECT IMMUN, V63, P1999, DOI 10.1128/IAI.63.5.1999-2003.1995; Imamura T, 2003, CURR PROTEIN PEPT SC, V4, P443, DOI 10.2174/1389203033487027; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Into T, 2006, CLIN EXP IMMUNOL, V145, P545, DOI 10.1111/j.1365-2249.2006.03156.x; Kadowaki T, 2004, MOL PHARMACOL, V66, P1599, DOI 10.1124/mol.104.004366; Kalinska M, 2016, BIOCHIMIE, V122, P270, DOI 10.1016/j.biochi.2015.09.023; Kantyka T, 2011, PEPTIDES, V32, P1187, DOI 10.1016/j.peptides.2011.03.009; Kantyka T, 2009, BIOL CHEM, V390, P1313, DOI 10.1515/BC.2009.136; Kapadia C, 2004, BIOCHEM BIOPH RES CO, V323, P1084, DOI 10.1016/j.bbrc.2004.08.206; Kapadia C, 2003, CLIN CHEM, V49, P77, DOI 10.1373/49.1.77; Kontos CK, 2012, CLIN CHEM LAB MED, V50, P1877, DOI 10.1515/cclm-2012-0247; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Meyer J, 1997, J PERIODONTOL, V68, P256, DOI 10.1902/jop.1997.68.3.256; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Olsen I, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.24800; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Potempa Jan, 2007, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2120s49; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rockett JC, 2004, MUTAT RES-FUND MOL M, V549, P225, DOI 10.1016/j.mrfmmm.2003.11.017; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Stenman UH, 2011, ASIAN J ANDROL, V13, P628, DOI 10.1038/aja.2011.45; Tezal M, 2005, J PERIODONTOL, V76, P406, DOI 10.1902/jop.2005.76.3.406; Tezal M, 2009, CANCER EPIDEM BIOMAR, V18, P2406, DOI 10.1158/1055-9965.EPI-09-0334; Tuysuz B, 2010, ACTA DERM-VENEREOL, V90, P95, DOI 10.2340/00015555-0769; Uehara A, 2008, J MED MICROBIOL, V57, P500, DOI 10.1099/jmm.0.47679-0; Walley AJ, 2001, NAT GENET, V29, P175, DOI 10.1038/ng728; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; Yousef GM, 2002, TUMOR BIOL, V23, P185, DOI 10.1159/000064027	47	7	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18753	18764		10.1074/jbc.M116.722942	http://dx.doi.org/10.1074/jbc.M116.722942			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27354280	hybrid, Green Published			2022-12-28	WOS:000383242300013
J	Tarutani, A; Suzuki, G; Shimozawa, A; Nonaka, T; Akiyama, H; Hisanaga, S; Hasegawa, M				Tarutani, Airi; Suzuki, Genjiro; Shimozawa, Aki; Nonaka, Takashi; Akiyama, Haruhiko; Hisanaga, Shin-ichi; Hasegawa, Masato			The Effect of Fragmented Pathogenic alpha-Synuclein Seeds on Prion-like Propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC PARKINSONS-DISEASE; MULTIPLE SYSTEM ATROPHY; LEWY BODIES; NEURODEGENERATIVE-DISEASES; IN-VIVO; FIBRILS; MICE; TAU; BODY; AGGREGATION	Aggregates of abnormal proteins are widely observed in neuronal and glial cells of patients with various neurodegenerative diseases, and it has been proposed that prion-like behavior of these proteins can account for not only the onset but also the progression of these diseases. However, it is not yet clear which abnormal protein structures function most efficiently as seeds for prion-like propagation. In this study, we aimed to identify the most pathogenic species of alpha-synuclein (alpha-syn), the main component of the Lewy bodies and Lewy neurites that are observed in alpha-synucleinopathies. We prepared various forms of alpha-syn protein and examined their seeding properties in vitro in cells and in mouse experimental models. We also characterized these alpha-syn species by means of electron microscopy and thioflavin fluorescence assays and found that fragmented beta sheet rich fibrous structures of alpha-syn with a length of 50 nm or less are the most efficient promoters of accumulation of phosphorylated alpha-syn, which is the hallmark of alpha-synucleinopathies. These results indicate that fragmented amyloid-like aggregates of short alpha-syn fibrils are the key pathogenic seeds that trigger prion-like conversion.	[Tarutani, Airi; Suzuki, Genjiro; Shimozawa, Aki; Nonaka, Takashi; Akiyama, Haruhiko; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 1568506, Japan; [Tarutani, Airi; Shimozawa, Aki; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University	Hasegawa, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan.	hasegawa-ms@igakuken.or.jp	Tarutani, Airi/AAU-7462-2021; Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403; Tarutani, Airi/0000-0003-3835-9070	Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [JP26117005, JP26111730]; Japan Society for the Promotion of Science (KAKENHI) [JP23228004]; Ministry of Health, Labor, and Welfare of Japan [JP12946221]; Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development (AMED)	Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research (KAKENHI) Grants JP26117005 (to M. H.) and JP26111730 (to T. N.), Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) Grant JP23228004 (to M. H.), Ministry of Health, Labor, and Welfare of Japan Grant JP12946221 (to M. H.), a grant-in-aid for research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis, and Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development (AMED) (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aulic S, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-69; Baba M, 1998, AM J PATHOL, V152, P879; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brahic M, 2016, ACTA NEUROPATHOL, V131, P539, DOI 10.1007/s00401-016-1538-0; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Masuda M, 2009, FEBS LETT, V583, P787, DOI 10.1016/j.febslet.2009.01.037; Masuda-Suzukake M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0088-8; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Monsellier E, 2016, SCI REP-UK, V6, DOI 10.1038/srep19180; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Sacino AN, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-17; Shimonaka S, 2016, J BIOL CHEM, V291, P8896, DOI 10.1074/jbc.M115.713552; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi M, 2015, ACTA NEUROPATHOL, V129, P895, DOI 10.1007/s00401-015-1415-2; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200	49	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18675	18688		10.1074/jbc.M116.734707	http://dx.doi.org/10.1074/jbc.M116.734707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27382062	Green Published, hybrid			2022-12-28	WOS:000383242300007
J	Zhu, YH; Liberton, M; Pakrasi, HB				Zhu, Yuehui; Liberton, Michelle; Pakrasi, Himadri B.			A Novel Redoxin in the Thylakoid Membrane Regulates the Titer of Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCOCCUS SP PCC-7002; BLUE-GREEN-ALGAE; PROTEOMIC ANALYSIS; SCAFFOLD PROTEIN; ANALYSIS REVEALS; INACTIVATION; ACCUMULATION; ARABIDOPSIS; BIOGENESIS; COMPLEX	In photosynthetic organisms like cyanobacteria and plants, the main engines of oxygenic photosynthesis are the pigment protein complexes photosystem I (PSI) and photosystem II (PSII) located in the thylakoid membrane. In the cyanobacterium Synechocystis sp. PCC 6803, the str1796 gene encodes a single cysteine thioredoxin-like protein, orthologs of which are found in multiple cyanobacterial strains as well as chloroplasts of higher plants. Targeted inactivation of slr1796 in Synechocystis 6803 resulted in compromised photoautotrophic growth. The mutant displayed decreased chlorophyll a content. These changes correlated with a decrease in the PSI titer of the mutant cells, whereas the PSII content was unaffected. In the mutant, the transcript levels of genes for PSI structural and accessory proteins remained unaffected, whereas the levels of PSI structural proteins were severely diminished, indicating that Slr1796 acts at a posttranscriptional level. Biochemical analysis indicated that Slr1796 is an integral thylakoid membrane protein. We conclude that Slr1796 is a novel regulatory factor that modulates PSI titer.	[Zhu, Yuehui; Liberton, Michelle; Pakrasi, Himadri B.] Washington Univ, Dept Biol, One Brookings Dr, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, One Brookings Dr, St Louis, MO 63130 USA.	pakrasi@wustl.edu	ZHU, YUEHUI/Q-1836-2015	ZHU, YUEHUI/0000-0003-0552-448X	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy [DE-FG02-99ER20350]	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy under Grant DE-FG02-99ER20350 (to H. B. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Albus CA, 2010, PLANT CELL, V22, P2838, DOI 10.1105/tpc.110.073908; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Amunts A, 2009, STRUCTURE, V17, P637, DOI 10.1016/j.str.2009.03.006; ARNON DI, 1974, BIOCHIM BIOPHYS ACTA, V357, P231, DOI 10.1016/0005-2728(74)90063-2; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Bartsevich VV, 1997, J BIOL CHEM, V272, P6382, DOI 10.1074/jbc.272.10.6382; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Cameron JC, 2011, PLANT SIGNAL BEHAV, V6, P89, DOI 10.4161/psb.6.1.14145; Chi W, 2012, PHILOS T R SOC B, V367, P3420, DOI 10.1098/rstb.2012.0065; CHITNIS PR, 1989, J BIOL CHEM, V264, P18374; During U, 2007, J BIOL CHEM, V282, P10915, DOI 10.1074/jbc.M609206200; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Fristedt R, 2014, J BIOL CHEM, V289, P30657, DOI 10.1074/jbc.M114.587758; Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Krech K, 2012, PLANT PHYSIOL, V159, P579, DOI 10.1104/pp.112.196642; Kubota H, 2010, BBA-BIOENERGETICS, V1797, P98, DOI 10.1016/j.bbabio.2009.09.001; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Liberton M, 2016, MOL CELL PROTEOMICS, V15, P2021, DOI 10.1074/mcp.M115.057240; Liu HJ, 2014, P NATL ACAD SCI USA, V111, P4638, DOI 10.1073/pnas.1323063111; Liu J, 2012, PLANT CELL, V24, P4992, DOI 10.1105/tpc.112.106542; Lyska D, 2013, PLANTA, V237, P413, DOI 10.1007/s00425-012-1752-5; Ng AH, 2015, APPL ENVIRON MICROB, V81, P6857, DOI 10.1128/AEM.01349-15; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Ossenbuhl F, 2006, PLANT CELL, V18, P2236, DOI 10.1105/tpc.106.043646; Ozawa S, 2009, PLANT CELL, V21, P2424, DOI 10.1105/tpc.108.063313; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Rochaix JD, 2011, PLANT PHYSIOL, V155, P1493, DOI 10.1104/pp.110.169839; Ruf S, 1997, J CELL BIOL, V139, P95, DOI 10.1083/jcb.139.1.95; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schottler MA, 2011, J PLANT PHYSIOL, V168, P1452, DOI 10.1016/j.jplph.2010.12.009; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; Stockel J, 2004, J BIOL CHEM, V279, P10243, DOI 10.1074/jbc.M309246200; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Vermaas WFJ, 2008, P NATL ACAD SCI USA, V105, P4050, DOI 10.1073/pnas.0708090105; Wilde A, 2001, BIOCHEM J, V357, P211, DOI 10.1042/0264-6021:3570211; WILDE A, 1995, PLANT CELL, V7, P649, DOI 10.1105/tpc.7.5.649; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yang HX, 2015, BBA-BIOENERGETICS, V1847, P838, DOI 10.1016/j.bbabio.2014.12.011; Zak E, 2000, PLANT PHYSIOL, V123, P215, DOI 10.1104/pp.123.1.215; Zhang SY, 2014, J BIOL CHEM, V289, P15904, DOI 10.1074/jbc.M114.555631	52	9	9	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18689	18699		10.1074/jbc.M116.721175	http://dx.doi.org/10.1074/jbc.M116.721175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27382055	Green Published, hybrid			2022-12-28	WOS:000383242300008
J	Gupta, A; Leslie, NR				Gupta, Amit; Leslie, Nicholas R.			Controlling PTEN (Phosphatase and Tensin Homolog) Stability A DOMINANT ROLE FOR LYSINE 66	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; phosphatase; phosphatase and tensin homolog (PTEN); phosphoinositide; protein stability; ubiquitylation (ubiquitination); phosphoinositide 3-kinase; tumor suppressor	TUMOR-SUPPRESSOR; UBIQUITINATION; MUTATIONS; TUMORIGENESIS; ACTIVATION; CANCER; GENE; REVEALS; AUTISM; LIGASE	Phosphatase and tensin homolog (PTEN) is a phosphoinositide lipid phosphatase and one of the most frequently disrupted tumor suppressors in many forms of cancer, with even small reductions in the expression levels of PTEN promoting cancer development. Although the post-translational ubiquitination of PTEN can control its stability, activity, and localization, a detailed understanding of how PTEN ubiquitination integrates with other cellular regulatory processes and may be dysregulated in cancer has been hampered by a poor understanding of the significance of ubiquitination at individual sites. Here we show that Lys(66) is not required for cellular activity, yet dominates over other PTEN ubiquitination sites in the regulation of protein stability. Notably, combined mutation of other sites (Lys(13), Lys(80), and Lys(289)) has relatively little effect on protein expression, protein stability, or PTEN polyubiquitination. The present work identifies a key role for Lys(66) in the regulation of PTEN expression and provides both an opportunity to improve the stability of PTEN as a protein therapy and a mechanistic basis for efforts to stabilize endogenous PTEN.	[Gupta, Amit; Leslie, Nicholas R.] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, James Nasmyth Bldg,Riccarton Campus, Edinburgh EH14 4AS, Midlothian, Scotland; [Gupta, Amit] Inst Canc Res, Chester Beatty Labs, 237 Fulham Rd, London SW3 6JB, England	Heriot Watt University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Gupta, A; Leslie, NR (corresponding author), Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, James Nasmyth Bldg,Riccarton Campus, Edinburgh EH14 4AS, Midlothian, Scotland.; Gupta, A (corresponding author), Inst Canc Res, Chester Beatty Labs, 237 Fulham Rd, London SW3 6JB, England.	amit.gupta@icr.ac.uk; n.r.leslie@hw.ac.uk		/0000-0002-7163-687X; LESLIE, Nicholas/0000-0001-5131-0541	Medical Research Council [G0801865/2, SU2P]; Medical Research Council [G0801865, G9403619] Funding Source: researchfish; MRC [G0801865, G9403619] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council Grant G0801865/2 and SU2P. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Gupta A, 2016, METHODS MOL BIOL, P155, DOI 10.1007/978-1-4939-3299-3_11; Han SY, 2000, CANCER RES, V60, P3147; He X, 2013, CANCER RES, V73, P3029, DOI 10.1158/0008-5472.CAN-12-3811; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Kwak YD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-49; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Lee JT, 2013, CELL RES, V23, P552, DOI 10.1038/cr.2013.27; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Li GQ, 2014, CANCER CELL, V25, P455, DOI 10.1016/j.ccr.2014.02.007; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Maccario H, 2010, J BIOL CHEM, V285, P12620, DOI 10.1074/jbc.M109.072280; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Singh G, 2011, CURR CANCER DRUG TAR, V11, P536, DOI 10.2174/156800911795655930; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Spinelli L, 2015, J MED GENET, V52, P128, DOI 10.1136/jmedgenet-2014-102803; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114250; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Yuan L, 2015, NAT CELL BIOL, V17, P1169, DOI 10.1038/ncb3218; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874	33	14	15	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18465	18473		10.1074/jbc.M116.727750	http://dx.doi.org/10.1074/jbc.M116.727750			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405757	Green Published, hybrid			2022-12-28	WOS:000383241800036
J	Gelis, L; Jovancevic, N; Veitinger, S; Mandal, B; Arndt, HD; Neuhaus, EM; Hatt, H				Gelis, Lian; Jovancevic, Nikolina; Veitinger, Sophie; Mandal, Bhubaneswar; Arndt, Hans-Dieter; Neuhaus, Eva M.; Hatt, Hanns			Functional Characterization of the Odorant Receptor 51E2 in Human Melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; cell differentiation; cell proliferation; cell signaling; G protein-coupled receptor (GPCR)	PROTEIN-COUPLED RECEPTOR; SIGNAL-TRANSDUCTION SYSTEM; OLFACTORY RECEPTOR; PROSTATE-CANCER; OCULAR ALBINISM; MELANOMA-CELLS; HUMAN KERATINOCYTES; SKIN PIGMENTATION; HUMAN SPERM; EXPRESSION	Olfactory receptors, which belong to the family of G-protein-coupled receptors, are found to be ectopically expressed in non-sensory tissues mediating a variety of cellular functions. In this study we detected the olfactory receptor OR51E2 at the transcript and the protein level in human epidermal melanocytes. Stimulation of primary melanocytes with the OR51E2 ligand -ionone significantly inhibited melanocyte proliferation. Our results further showed that -ionone stimulates melanogenesis and dendritogenesis. Using RNA silencing and receptor antagonists, we demonstrated that OR51E2 activation elevated cytosolic Ca2+ and cAMP, which could mediate the observed increase in melanin synthesis. Co-immunocytochemical stainings using a specific OR51E2 antibody revealed subcellular localization of the receptor in early endosomes associated with EEA-1 (early endosome antigen 1). Plasma membrane preparations showed that OR51E2 protein is present at the melanocyte cell surface. Our findings thus suggest that activation of olfactory receptor signaling by external compounds can influence melanocyte homeostasis.	[Gelis, Lian; Jovancevic, Nikolina; Veitinger, Sophie; Hatt, Hanns] Ruhr Univ Bochum, Cell Physiol, Univ Str 150, D-44801 Bochum, Germany; [Mandal, Bhubaneswar; Arndt, Hans-Dieter] Univ Jena, Organ Chem 1, Humboldtstr 10, D-07743 Jena, Germany; [Neuhaus, Eva M.] Univ Hosp Jena, Pharmacol & Toxicol, Drackendorfer Str 1, D-07747 Jena, Germany; [Mandal, Bhubaneswar] IIT Guwahati, Dept Chem, North Guwahati 781039, Assam, India	Ruhr University Bochum; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Gelis, L (corresponding author), Ruhr Univ Bochum, Cell Physiol, Univ Str 150, D-44801 Bochum, Germany.	lian.gelis@rub.de	Mandal, Bhubaneswar/K-8885-2019; Neuhaus, Eva/L-1428-2015	Mandal, Bhubaneswar/0000-0003-3435-5443; Neuhaus, Eva/0000-0003-3363-1231	Deutsche Forschungsgemeinschaft [SFB642]; Heinrich-and-Alma-Vogelsang-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinrich-and-Alma-Vogelsang-Stiftung	This study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB642; to E. M. N. and H. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Heinrich-and-Alma-Vogelsang-Stiftung.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Andreeva Alexandra V, 2007, J Mol Signal, V2, P13, DOI 10.1186/1750-2187-2-13; Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Bellono NW, 2014, ARCH BIOCHEM BIOPHYS, V563, P35, DOI 10.1016/j.abb.2014.06.020; Bellono NW, 2013, P NATL ACAD SCI USA, V110, P2383, DOI 10.1073/pnas.1215555110; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; CARSBERG CJ, 1995, J DERMATOL SCI, V9, P157, DOI 10.1016/0923-1811(94)00372-L; Choi TY, 2009, J DERMATOL SCI, V56, P128, DOI 10.1016/j.jdermsci.2009.07.002; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; De la Cruz O, 2009, MOL BIOL EVOL, V26, P491, DOI 10.1093/molbev/msn294; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; ENGLARO W, 1995, J BIOL CHEM, V270, P24315, DOI 10.1074/jbc.270.41.24315; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Falletta P, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12239; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Ghosh R, 2005, J BIOL CHEM, V280, P5812, DOI 10.1074/jbc.M411429200; Giordano F, 2011, P NATL ACAD SCI USA, V108, P11906, DOI 10.1073/pnas.1103381108; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Guo HZ, 2012, EXP DERMATOL, V21, P650, DOI 10.1111/j.1600-0625.2012.01565.x; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; HIROBE T, 1992, PIGM CELL RES, V5, P1, DOI 10.1111/j.1600-0749.1992.tb00776.x; Imokawa G, 2000, J BIOL CHEM, V275, P33321, DOI 10.1074/jbc.M004346200; Imokawa G, 1996, BIOCHEM J, V314, P305, DOI 10.1042/bj3140305; IMOKAWA G, 1992, J BIOL CHEM, V267, P24675; Innamorati G, 2006, PIGM CELL RES, V19, P125, DOI 10.1111/j.1600-0749.2006.00292.x; Kang HY, 1998, PFLUG ARCH EUR J PHY, V435, P350, DOI 10.1007/s004240050522; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; KARLSSON JOG, 1994, PIGM CELL RES, V7, P61, DOI 10.1111/j.1600-0749.1994.tb00019.x; Klasen K, 2010, CELL SIGNAL, V22, P150, DOI 10.1016/j.cellsig.2009.09.026; Lee J, 2007, BIOCHEM PHARMACOL, V74, P960, DOI 10.1016/j.bcp.2007.06.007; LERNER MR, 1988, P NATL ACAD SCI USA, V85, P261, DOI 10.1073/pnas.85.1.261; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Luttrell Louis M., 2006, V332, P3; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Oka M, 1996, J INVEST DERMATOL, V106, P377, DOI 10.1111/1523-1747.ep12343168; Palmisano I, 2008, HUM MOL GENET, V17, P3487, DOI 10.1093/hmg/ddn241; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Piccirillo R, 2006, J CELL SCI, V119, P2003, DOI 10.1242/jcs.02930; Pisano M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-8; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Rigau M, 2010, PROSTATE, V70, P1760, DOI 10.1002/pros.21211; Rodriguez M, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.29; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; Schiaffino MV, 2005, PIGM CELL RES, V18, P227, DOI 10.1111/j.1600-0749.2005.00240.x; Schiaffino MV, 1996, P NATL ACAD SCI USA, V93, P9055, DOI 10.1073/pnas.93.17.9055; Silva MR, 2007, ACTA CRYSTALLOGR E, V63, pO4824, DOI 10.1107/S1600536807057625; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Spehr J, 2011, J BIOL CHEM, V286, P13184, DOI 10.1074/jbc.M110.183525; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Staab H.A., 1962, ANGEW CHEM INT EDIT, V1, P351, DOI [10.1002/anie.196203511, DOI 10.1002/ANIE.196203511]; STAAB HA, 1956, CHEM BER-RECL, V89, P1927, DOI 10.1002/cber.19560890821; Staleva L, 2006, EXP EYE RES, V82, P311, DOI 10.1016/j.exer.2005.07.003; Stanisz H, 2012, J INVEST DERMATOL, V132, P1443, DOI 10.1038/jid.2011.478; Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524; Vilardaga JP, 2010, J CELL SCI, V123, P4215, DOI 10.1242/jcs.063354; Xia CZ, 2001, ONCOGENE, V20, P5903, DOI 10.1038/sj.onc.1204803; Xu LL, 2000, CANCER RES, V60, P6568; Xu LL, 2006, PROSTATE CANCER P D, V9, P56, DOI 10.1038/sj.pcan.4500836; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055	71	54	58	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17772	17786		10.1074/jbc.M116.734517	http://dx.doi.org/10.1074/jbc.M116.734517			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27226631	Green Published, hybrid			2022-12-28	WOS:000383241300025
J	Misawa, A; Takayama, K; Urano, T; Inoue, S				Misawa, Aya; Takayama, Ken-ichi; Urano, Tomohiko; Inoue, Satoshi			Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen; androgen receptor; apoptosis; long noncoding RNA (lncRNA); prostate cancer	INCREASED SURVIVAL; GENE-EXPRESSION; HUMAN GENOME; RECEPTOR; TRANSCRIPTION; REVEALS; ANTIANDROGEN; SUPPRESSOR; PROGRAM; SOCS-2	Long noncoding RNAs (lncRNA) have been associated with the development of cancer. However, the interplay between lncRNAs and androgen receptor (AR) signaling in prostate cancer is still unclear. Here, we identified lncRNAs induced by androgen in AR-positive prostate cancer cells, where induction was abolished by AR knockdown as well as an anti-androgen, bicalutamide. By combining these data, we identified an androgen-regulated lncRNA, suppressor of cytokine signaling 2-antisense transcript 1 (SOCS2-AS1), the expression of which was higher in castration-resistant prostate cancer model cells, i.e. long-term androgen-deprived (LTAD) cells, than in parental androgen-dependent LNCaP cells. SOCS2-AS1 promoted castration-resistant and androgen-dependent cell growth. We found that SOCS2-AS1 knockdown up-regulated genes related to the apoptosis pathway, including tumor necrosis factor superfamily 10 (TNFSF10), and sensitized prostate cancer cells to docetaxel treatment. Moreover, we also demonstrated that SOCS2-AS1 promotes androgen signaling by modulating the epigenetic control for AR target genes including TNFSF10. These findings suggest that SOCS2-AS1 plays an important role in the development of castration-resistant prostate cancer by repressing apoptosis.	[Misawa, Aya; Takayama, Ken-ichi; Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1138655, Japan; [Takayama, Ken-ichi; Inoue, Satoshi] Tokyo Metropolitan Inst Gerontol, Dept Funct Biogerontol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan; [Inoue, Satoshi] Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan	University of Tokyo; Tokyo Metropolitan Institute of Gerontology; Saitama Medical University	Inoue, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1138655, Japan.	sinoue@tmig.or.jp	Urano, Tomohiko/AFS-9574-2022; Takayama, Kenichi/AAK-9238-2020	Urano, Tomohiko/0000-0002-1771-024X	Cell innovation Program; P-DIRECT from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science, Japan [15K15581, 15K15353]; Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Information (NIBIO), Japan; Ministry of Health, Labor, and Welfare (MHLW), Japan; Takeda Science Foundation; Mochida Memorial Research Foundation Japan; Yasuda Memorial Foundation; Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research [16K09796] Funding Source: KAKEN	Cell innovation Program; P-DIRECT from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Information (NIBIO), Japan; Ministry of Health, Labor, and Welfare (MHLW), Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Research Foundation Japan; Yasuda Memorial Foundation; Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Cell innovation Program and the P-DIRECT from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to S. I.); Grants 15K15581 (to K. T.) and 15K15353 (to S. I.) from the Japan Society for the Promotion of Science, Japan; a grant from the Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Information (NIBIO), Japan (to S. I.); grants-in-aid from the Ministry of Health, Labor, and Welfare (MHLW), Japan (to S. I.); grants from the Takeda Science Foundation (to S. I. and K. T.); and grants from the Mochida Memorial Research Foundation Japan, the Yasuda Memorial Foundation, and the Princess Takamatsu Cancer Research Fund (all to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Arany I, 2001, ANTICANCER RES, V21, P425; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Beckedorff FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003705; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2012, J BIOL CHEM, V287, P8571, DOI 10.1074/jbc.M111.325290; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Kok JB, 2002, CANCER RES, V62, P2695; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Farooqi AA, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-22; Farooqi AA, 2012, MOL BIOL REP, V39, P4909, DOI 10.1007/s11033-011-1286-0; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hoefer J, 2014, ENDOCR-RELAT CANCER, V21, P175, DOI 10.1530/ERC-13-0446; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung CL, 2014, P NATL ACAD SCI USA, V111, P18697, DOI 10.1073/pnas.1415669112; Iglesias-Gato D, 2014, CARCINOGENESIS, V35, P24, DOI 10.1093/carcin/bgt304; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Lee RS, 2013, NAT GENET, V45, P1268, DOI 10.1038/ng.2805; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Marquardt S, 2014, CELL, V157, P1712, DOI 10.1016/j.cell.2014.04.036; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schultheis B, 2002, BLOOD, V99, P1766, DOI 10.1182/blood.V99.5.1766; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Smith MR, 2011, CANCER-AM CANCER SOC, V117, P2077, DOI 10.1002/cncr.25762; Srikantan V, 2000, P NATL ACAD SCI USA, V97, P12216, DOI 10.1073/pnas.97.22.12216; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Sutherland KD, 2004, ONCOGENE, V23, P7726, DOI 10.1038/sj.onc.1207787; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Takayama K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9219; Takayama K, 2014, CANCER RES, V74, P6542, DOI 10.1158/0008-5472.CAN-14-1030; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Takayama KI, 2012, MOL ENDOCRINOL, V26, P748, DOI 10.1210/me.2011-1242; Tomlins SA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001970; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wikman A, 2001, SCAND J CLIN LAB INV, V61, P307; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Zhang A, 2015, CELL REP, V13, P209, DOI 10.1016/j.celrep.2015.08.069; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016	59	106	112	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17861	17880		10.1074/jbc.M116.718536	http://dx.doi.org/10.1074/jbc.M116.718536			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27342777	Green Published, hybrid			2022-12-28	WOS:000383241300031
J	Maisonneuve, P; Caillet-Saguy, C; Vaney, MC; Bibi-Zainab, E; Sawyer, K; Raynal, B; Haouz, A; Delepierre, M; Lafon, M; Cordier, F; Wolff, N				Maisonneuve, Pierre; Caillet-Saguy, Celia; Vaney, Marie-Christine; Bibi-Zainab, Edoo; Sawyer, Kristi; Raynal, Bertrand; Haouz, Ahmed; Delepierre, Muriel; Lafon, Monique; Cordier, Florence; Wolff, Nicolas			Molecular Basis of the Interaction of the Human Protein Tyrosine Phosphatase Non-receptor Type 4 (PTPN4) with the Mitogen-activated Protein Kinase p38 gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; PDZ DOMAIN; STRUCTURE VALIDATION; CELL-DEATH; PTPMEG; DELTA-2; MAPK	The human protein tyrosine phosphatase non-receptor type 4 (PTPN4) prevents cell death induction in neuroblastoma and glioblastoma cell lines in a PDZ center dot PDZ binding motifs-dependent manner, but the cellular partners of PTPN4 involved in cell protection are unknown. Here, we described the mitogen-activated protein kinase p38 gamma as a cellular partner of PTPN4. The main contribution to the p38 gamma center dot PTPN4 complex formation is the tight interaction between the C terminus of p38 gamma and the PDZ domain of PTPN4. We solved the crystal structure of the PDZ domain of PTPN4 bound to the p38 gamma C terminus. We identified the molecular basis of recognition of the C-terminal sequence of p38 gamma that displays the highest affinity among all endogenous partners of PTPN4. We showed that the p38 gamma C terminus is also an efficient inducer of cell death after its intracellular delivery. In addition to recruiting the kinase, the binding of the C-terminal sequence of p38 gamma to PTPN4 abolishes the catalytic auto-inhibition of PTPN4 and thus activates the phosphatase, which can efficiently dephosphorylate the activation loop of p38 gamma. We presume that the p38 gamma center dot PTPN4 interaction promotes cellular signaling, preventing cell death induction.	[Maisonneuve, Pierre; Caillet-Saguy, Celia; Bibi-Zainab, Edoo; Sawyer, Kristi; Delepierre, Muriel; Cordier, Florence; Wolff, Nicolas] Inst Pasteur, Dept Biol Struct & Chim, Unite Resonance Magnet Nucl Biomol, F-75724 Paris, France; [Vaney, Marie-Christine] Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris, France; [Lafon, Monique] Inst Pasteur, Unite Neuroimmunol Virale, Dept Virol, F-75724 Paris, France; [Raynal, Bertrand] Inst Pasteur, Plate Forme Biophys Macromol, F-75724 Paris, France; [Haouz, Ahmed] Inst Pasteur, Plate Forme Cristallog, F-75724 Paris, France; [Maisonneuve, Pierre; Caillet-Saguy, Celia; Bibi-Zainab, Edoo; Sawyer, Kristi; Raynal, Bertrand; Haouz, Ahmed; Delepierre, Muriel; Cordier, Florence; Wolff, Nicolas] CNRS, UMR 3528, F-75724 Paris, France; [Vaney, Marie-Christine; Lafon, Monique] CNRS, UMR 3569, F-75724 Paris, France; [Maisonneuve, Pierre] Univ Paris 06, Cellule Pasteur UPMC, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Wolff, N (corresponding author), Inst Pasteur, CNRS, UMR 3528, Unite RMN Biomol, 28 Rue Dr Roux, F-75724 Paris, France.	nicolas.wolff@pasteur.fr	Caillet-Saguy, Célia/AAC-1249-2022	raynal, Bertrand/0000-0001-5634-0408; HAOUZ, Ahmed/0000-0003-1196-1635; Cordier, Florence/0000-0002-5963-7773; Sawyer, Kristi/0000-0003-3485-2028; Lafon, Monique/0000-0002-4423-7996; Maisonneuve, Pierre/0000-0001-8292-5741	TGIR-RMN-THC [Fr3050 CNRS]; Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale [FDT20130927999]; Bourse Roux postdoctoral fellowship from the Pasteur Institute; Erasmus+ Programme	TGIR-RMN-THC; Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Bourse Roux postdoctoral fellowship from the Pasteur Institute; Erasmus+ Programme	This work was supported by TGIR-RMN-THC Fr3050 CNRS. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by grants from the Ministere de l'Enseignement Superieur et de la Recherche and the Fondation pour la Recherche Medicale FDT20130927999.r Recipient of a Bourse Roux postdoctoral fellowship from the Pasteur Institute.r Supported by a student mobility grant through the Erasmus+ Programme.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Babault N, 2011, STRUCTURE, V19, P1518, DOI 10.1016/j.str.2011.07.007; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Caillet-Saguy C, 2015, PROG BIOPHYS MOL BIO, V119, P53, DOI 10.1016/j.pbiomolbio.2015.02.007; Chen KE, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005722; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Gu MX, 1996, J BIOL CHEM, V271, P27751, DOI 10.1074/jbc.271.44.27751; Gu MX, 1996, P NATL ACAD SCI USA, V93, P12980, DOI 10.1073/pnas.93.23.12980; Harris BZ, 2001, J CELL SCI, V114, P3219; Hironaka K, 2000, J BIOL CHEM, V275, P16167, DOI 10.1074/jbc.M909302199; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Huai WW, 2015, J IMMUNOL, V194, P4458, DOI 10.4049/jimmunol.1402183; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kina S, 2007, EUR J NEUROSCI, V26, P2269, DOI 10.1111/j.1460-9568.2007.05829.x; Kohda K, 2013, P NATL ACAD SCI USA, V110, pE948, DOI 10.1073/pnas.1218380110; Kukkonen-Macchi A, 2011, J CELL SCI, V124, P216, DOI 10.1242/jcs.068254; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maisonneuve P, 2014, FEBS J, V281, P4852, DOI 10.1111/febs.13024; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Prehaud C, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000510; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Vogtherr M, 2005, J BIOMOL NMR, V32, P175, DOI 10.1007/s10858-005-2449-x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Young JA, 2008, MOL IMMUNOL, V45, P3756, DOI 10.1016/j.molimm.2008.05.023; Zhou J, 2013, CELL MOL BIOL LETT, V18, P297, DOI 10.2478/s11658-013-0090-3	30	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16699	16708		10.1074/jbc.M115.707208	http://dx.doi.org/10.1074/jbc.M115.707208			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27246854	Green Published, hybrid			2022-12-28	WOS:000380826700027
J	Ng, HM; Wei, LZ; Lan, L; Huen, MSY				Ng, Hoi-Man; Wei, Leizhen; Lan, Li; Huen, Michael S. Y.			The Lys(63)-deubiquitylating Enzyme BRCC36 Limits DNA Break Processing and Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DAMAGE RESPONSE; GENOMIC STABILITY; TARGETS BRCA1; END RESECTION; NUCLEAR FOCI; COMPLEX; PHOSPHORYLATION; SITES; UBIQUITINATION	Multisubunit protein assemblies offer integrated functionalities for efficient cell signal transduction control. One example of such protein assemblies, the BRCA1-A macromolecular complex, couples ubiquitin recognition and metabolism and promotes cellular responses to DNA damage. Specifically, the BRCA1-A complex not only recognizes Lys(63)-linked ubiquitin (K63-Ub) adducts at the damaged chromatin but is endowed with K63-Ub deubiquitylase (DUB) activity. To explore how the BRCA1-A DUB activity contributes to its function at DNA double strand breaks (DSBs), we used RNAi and genome editing approaches to target BRCC36, the protein subunit that confers the BRCA1-A complex its DUB activity. Intriguingly, we found that the K63-Ub DUB activity, although dispensable for maintaining the integrity of the macromolecular protein assembly, is important in enforcing the accumulation of the BRCA1-A complex onto DSBs. Inactivating BRCC36 DUB attenuated BRCA1-A functions at DSBs and led to unrestrained DSB end resection and hyperactive DNA repair. Together, our findings uncover a pivotal role of BRCC36 DUB in limiting DSB processing and repair and illustrate how cells may physically couple ubiquitin recognition and metabolizing activities for fine tuning of DNA repair processes.	[Ng, Hoi-Man; Huen, Michael S. Y.] Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, L1-46,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, L1-46,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Wei, Leizhen; Lan, Li] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15213 USA	University of Hong Kong; University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huen, MSY (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, L1-46,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Huen, MSY (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, L1-46,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	huen.michael@hku.hk		Huen, Michael Shing-Yan/0000-0003-1774-2425	Research Grants Council Hong Kong Project [17104215]; Outstanding Young Researcher Award from the University of Hong Kong; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118833] Funding Source: NIH RePORTER	Research Grants Council Hong Kong Project; Outstanding Young Researcher Award from the University of Hong Kong(University of Hong Kong); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by funds from Research Grants Council Hong Kong Project 17104215 and the Outstanding Young Researcher Award from the University of Hong Kong (to M. S. Y. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aressy B, 2012, CURR BIOL, V22, pR806, DOI 10.1016/j.cub.2012.07.046; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Castillo A, 2014, CELL REP, V8, P807, DOI 10.1016/j.celrep.2014.06.050; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Guo YY, 2015, J BIOL CHEM, V290, P27545, DOI 10.1074/jbc.M115.672626; Hu X, 2011, J BIOL CHEM, V286, P11734, DOI 10.1074/jbc.M110.200857; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Jiang QQ, 2015, J BIOL CHEM, V290, P17724, DOI 10.1074/jbc.R115.667931; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tu ZW, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0427-3; Vikrant, 2014, J BIOMOL STRUCT DYN, V32, P2017, DOI 10.1080/07391102.2013.843473; Vikrant, 2014, BIOCHEM BIOPH RES CO, V446, P1139, DOI 10.1016/j.bbrc.2014.03.073; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wu Q, 2016, MOL CELL, V61, P434, DOI 10.1016/j.molcel.2015.12.017; Zeqiraj E, 2015, MOL CELL, V59, P970, DOI 10.1016/j.molcel.2015.07.028; Zhu B, 2015, ONCOGENE, V34, P2867, DOI 10.1038/onc.2014.229	40	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16197	16207		10.1074/jbc.M116.731927	http://dx.doi.org/10.1074/jbc.M116.731927			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27288411	Green Published, hybrid			2022-12-28	WOS:000380585400024
J	Yamamoto, K; Miki, Y; Sato, H; Nishito, Y; Gelb, MH; Taketomi, Y; Murakami, M				Yamamoto, Kei; Miki, Yoshimi; Sato, Hiroyasu; Nishito, Yasumasa; Gelb, Michael H.; Taketomi, Yoshitaka; Murakami, Makoto			Expression and Function of Group IIE Phospholipase A(2) in Mouse Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY BARRIER; HAIR FOLLICLE; FATTY-ACIDS; STRATUM-CORNEUM; MICE; DEFICIENCY; EPIDERMIS; GENE; INFLAMMATION; HYPERPLASIA	Recent studies using knock-out mice for various secreted phospholipase A(2) (sPLA(2)) isoforms have revealed their non-redundant roles in diverse biological events. In the skin, group IIF sPLA(2) (sPLA(2)-IIF), an "epidermal sPLA(2)" expressed in the suprabasal keratinocytes, plays a fundamental role in epidermal-hyperplasic diseases such as psoriasis and skin cancer. In this study, we found that group IIE sPLA(2) (sPLA(2)-IIE) was expressed abundantly in hair follicles and to a lesser extent in basal epidermal keratinocytes in mouse skin. Mice lacking sPLA(2)-IIE exhibited skin abnormalities distinct from those in mice lacking sPLA(2)-IIF, with perturbation of hair follicle ultrastructure, modest changes in the steady-state expression of a subset of skin genes, and no changes in the features of psoriasis or contact dermatitis. Lipidomics analysis revealed that sPLA(2)-IIE and -IIF were coupled with distinct lipid pathways in the skin. Overall, two skin sPLA(2)s, hair follicular sPLA(2)-IIE and epidermal sPLA(2)-IIF, play non-redundant roles in distinct compartments of mouse skin, underscoring the functional diversity of multiple sPLA(2)s in the coordinated regulation of skin homeostasis and diseases.	[Yamamoto, Kei; Miki, Yoshimi; Sato, Hiroyasu; Taketomi, Yoshitaka; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo 1568506, Japan; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Tokyo 1568506, Japan; [Yamamoto, Kei] Univ Tokushima, Fac Biosci & Bioind, Tokushima 7708513, Japan; [Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Yamamoto, Kei] Japan Agcy Med Res & Dev, PRIME, Tokyo 1000004, Japan; [Murakami, Makoto] Japan Agcy Med Res & Dev, AMED CREST, Tokyo 1000004, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokushima University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp		gelb, michael/0000-0001-7000-5219	Ministry of Education, Culture, Sports, Science and Technology of Japan [15H05905, 16H02613, 26461671, 26860051]; Terumo Foundation; AMED-CREST from Agency for Medical Research and Development; PRIME from Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [16H02613, 26461671, 16K15122] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Terumo Foundation; AMED-CREST from Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); PRIME from Agency for Medical Research and Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 15H05905 and 16H02613 (to M. M.), 26461671 (to K. Y.), and 26860051 (to Y. M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Terumo Foundation (to M. M.), and by AMED-CREST (to M. M.) and PRIME (to K. Y.) from the Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Bernot KM, 2002, J INVEST DERMATOL, V119, P1137, DOI 10.1046/j.1523-1747.2002.19518.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Chen J, 2008, J INVEST DERMATOL, V128, P270, DOI 10.1038/sj.jid.5701038; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; EATON BR, 1976, ARCH BIOCHEM BIOPHYS, V176, P604, DOI 10.1016/0003-9861(76)90204-6; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P314, DOI 10.1016/j.bbalip.2013.09.011; ELIAS PM, 1978, LAB INVEST, V39, P574; Fluhr JW, 2004, J INVEST DERMATOL, V123, P140, DOI 10.1111/j.0022-202X.2004.22726.x; Fluhr JW, 2001, J INVEST DERMATOL, V117, P44, DOI 10.1046/j.0022-202x.2001.01399.x; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Garza LA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003122; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Krieg P, 2014, BBA-MOL CELL BIOL L, V1841, P390, DOI 10.1016/j.bbalip.2013.08.005; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; MaoQiang M, 1996, J INVEST DERMATOL, V106, P57, DOI 10.1111/1523-1747.ep12327246; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Miki Y., 2016, J BIOL CHEM, V291; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Milora KA, 2015, J INVEST DERMATOL, V135, P2992, DOI 10.1038/jid.2015.289; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Murase R, 2016, J BIOL CHEM, V291, P6895, DOI 10.1074/jbc.M116.715672; Nagamachi M, 2007, J EXP MED, V204, P2865, DOI 10.1084/jem.20070773; Nelson AM, 2013, J INVEST DERMATOL, V133, P881, DOI 10.1038/jid.2012.398; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Providence KM, 2008, ARCH DERMATOL RES, V300, P303, DOI 10.1007/s00403-008-0845-2; PRUZANSKI W, 1991, IMMUNOL TODAY, V12, P143, DOI 10.1016/0167-5699(91)90077-7; Radner FPW, 2014, BBA-MOL CELL BIOL L, V1841, P409, DOI 10.1016/j.bbalip.2013.07.013; Sasaki S, 2005, EXP DERMATOL, V14, P323, DOI 10.1111/j.0906-6705.2005.00270.x; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sato H, 2011, J BIOL CHEM, V286, P11632, DOI 10.1074/jbc.M110.206755; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Taylor K, 2009, EUR J IMMUNOL, V39, P1353, DOI 10.1002/eji.200838566; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yamamoto K, 2011, J BIOL CHEM, V286, P11616, DOI 10.1074/jbc.M110.206714	48	15	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15602	15613		10.1074/jbc.M116.734657	http://dx.doi.org/10.1074/jbc.M116.734657			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226633	hybrid, Green Published			2022-12-28	WOS:000380584200016
J	Barrows, D; He, JZ; Parsons, R				Barrows, Douglas; He, John Z.; Parsons, Ramon			PREX1 Protein Function Is Negatively Regulated Downstream of Receptor Tyrosine Kinase Activation by p21-activated Kinases (PAKs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); guanine nucleotide exchange factor (GEF); insulin; phosphatidylinositol 3-kinase (PI 3-kinase); Rac (Rac GTPase); receptor tyrosine kinase; signal transduction; phosphatidylinositol 3; 4,5-trisphosphate-dependent Rac exchanger 1 (PREX1); p-21-activated kinase (PAK)	NUCLEOTIDE-EXCHANGE FACTOR; STIMULATED GLUCOSE-UPTAKE; BREAST-CANCER CELLS; PLECKSTRIN HOMOLOGY; NEUTROPHIL FUNCTION; SKELETAL-MUSCLE; RAC-GEF; P-REX1; INHIBITION; PKA	Downstream of receptor tyrosine kinase and G protein-coupled receptor (GPCR) stimulation, the phosphatidylinositol 3,4,5-trisphosphate (PIP3)-dependent Rac exchange factor (PREX) family of guanine nucleotide exchange factors (GEFs) activates Rho GTPases, leading to important roles for PREX proteins in numerous cellular processes and diseases, including cancer. PREX1 and PREX2 GEF activity is activated by the second messengers PIP3 and G, and further regulation of PREX GEF activity occurs by phosphorylation. Stimulation of receptor tyrosine kinases by neuregulin and insulin-like growth factor 1 (IGF1) leads to the phosphorylation of PREX1; however, the kinases that phosphorylate PREX1 downstream of these ligands are not known. We recently reported that the p21-activated kinases (PAKs), which are activated by GTP-bound Ras-related C3 botulinum toxin substrate 1 (Rac1), mediate the phosphorylation of PREX2 after insulin receptor activation. Here we show that certain phosphorylation events on PREX1 after insulin, neuregulin, and IGF1 treatment are PAK-dependent and lead to a reduction in PREX1 binding to PIP3. Like PREX2, PAK-mediated phosphorylation also negatively regulates PREX1 GEF activity. Furthermore, the onset of PREX1 phosphorylation was delayed compared with the phosphorylation of AKT, supporting a model of negative feedback downstream of PREX1 activation. We also found that the phosphorylation of PREX1 after isoproterenol and prostaglandin E2-mediated GPCR activation is partially PAK-dependent and likely also involves protein kinase A, which is known to reduce PREX1 function. Our data point to multiple mechanisms of PREX1 negative regulation by PAKs within receptor tyrosine kinase and GPCR-stimulated signaling pathways that have important roles in diseases such as diabetes and cancer.	[Barrows, Douglas; He, John Z.; Parsons, Ramon] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Barrows, Douglas] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; Columbia University	Parsons, R (corresponding author), Icahn Sch Med Mt Sinai, Hess CSM Bldg,Floor 6,Rm 116,1470 Madison Ave, New York, NY 10029 USA.	ramon.parsons@mssm.edu		Parsons, Ramon/0000-0002-6656-3514	National Institutes of Health [R01CA155117, R01CA184016]; NATIONAL CANCER INSTITUTE [R01CA184016, R01CA155117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Institutes of Health Grants R01CA155117 (to R. P.) and R01CA184016 (to R. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachmann VA, 2013, P NATL ACAD SCI USA, V110, P8531, DOI 10.1073/pnas.1215902110; Baker NM, 2014, CLIN CANCER RES, V20, P4740, DOI 10.1158/1078-0432.CCR-13-1727; Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Barber MA, 2012, BIOCHEM J, V443, P173, DOI 10.1042/BJ20112078; Barrows D, 2015, J BIOL CHEM, V290, P28915, DOI 10.1074/jbc.M115.668244; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Montero JC, 2013, CELL SIGNAL, V25, P2281, DOI 10.1016/j.cellsig.2013.07.018; Cash JN, 2016, STRUCTURE, V24, P730, DOI 10.1016/j.str.2016.02.022; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chavez-Vargas L, 2016, J BIOL CHEM, V291, P6182, DOI 10.1074/jbc.M115.712216; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Damoulakis G, 2014, J CELL SCI, V127, P2589, DOI 10.1242/jcs.153049; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; De la Mota-Peynado A, 2011, J BIOL CHEM, V286, P13603, DOI 10.1074/jbc.M110.181743; Deribe YL, 2016, P NATL ACAD SCI USA, V113, pE1296, DOI 10.1073/pnas.1513801113; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Donald S, 2008, P NATL ACAD SCI USA, V105, P4483, DOI 10.1073/pnas.0712324105; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hill K, 2006, METHOD ENZYMOL, V406, P26, DOI 10.1016/S0076-6879(06)06003-4; Hodakoski C, 2014, P NATL ACAD SCI USA, V111, P155, DOI 10.1073/pnas.1213773111; King H, 2014, INT REV CEL MOL BIO, V309, P347, DOI 10.1016/B978-0-12-800255-1.00007-7; Lewis JP, 2010, GENOMICS, V96, P211, DOI 10.1016/j.ygeno.2010.07.006; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Lucato CM, 2015, J BIOL CHEM, V290, P20827, DOI 10.1074/jbc.M115.660456; Magasawa SY, 2005, BIOCHEM J, V385, P737, DOI 10.1042/BJ20041060; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; Mense SM, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005840; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Sylow L, 2014, CELL SIGNAL, V26, P323, DOI 10.1016/j.cellsig.2013.11.007; Sylow L, 2013, DIABETES, V62, P1865, DOI 10.2337/db12-1148; Urano D, 2008, CELL SIGNAL, V20, P1545, DOI 10.1016/j.cellsig.2008.04.009; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770; Zhao TM, 2007, J LEUKOCYTE BIOL, V81, P1127, DOI 10.1189/jlb.0406251	49	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20042	20054		10.1074/jbc.M116.723882	http://dx.doi.org/10.1074/jbc.M116.723882			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27481946	Green Published, hybrid			2022-12-28	WOS:000383243100027
J	Lum, R; Ahmad, S; Hong, SJ; Chapman, DC; Kozlov, G; Williams, DB				Lum, Ronnie; Ahmad, Samar; Hong, Seo Jung; Chapman, Daniel C.; Kozlov, Guennadi; Williams, David B.			Contributions of the Lectin and Polypeptide Binding Sites of Calreticulin to Its Chaperone Functions in Vitro and in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); lectin; molecular chaperone; protein aggregation; protein folding	MAJOR HISTOCOMPATIBILITY COMPLEX; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; QUALITY-CONTROL; P-DOMAIN; STRUCTURAL BASIS; CALNEXIN; PROTEIN; PEPTIDE; ER	Calreticulin is a lectin chaperone of the endoplasmic reticulum that interacts with newly synthesized glycoproteins by binding to Glc(1)Man(9)GlcNAc(2) oligosaccharides as well as to the polypeptide chain. In vitro, the latter interaction potently suppresses the aggregation of various non-glycosylated proteins. Although the lectin-oligosaccharide association is well understood, the polypeptide-based interaction is more controversial because the binding site on calreticulin has not been identified, and its significance in the biogenesis of glycoproteins in cells remains unknown. In this study, we identified the polypeptide binding site responsible for the in vitro aggregation suppression function by mutating four candidate hydrophobic surface patches. Mutations in only one patch, P19K/I21E and Y22K/F84E, impaired the ability of calreticulin to suppress the thermally induced aggregation of non-glycosylated firefly luciferase. These mutants also failed to bind several hydrophobic peptides that act as substrate mimetics and compete in the luciferase aggregation suppression assay. To assess the relative contributions of the glycan-dependent and -independent interactions in living cells, we expressed lectin-deficient, polypeptide binding-deficient, and doubly deficient calreticulin constructs in calreticulin-negative cells and monitored the effects on the biogenesis of MHC class I molecules, the solubility of mutant forms of (1)-antitrypsin, and interactions with newly synthesized glycoproteins. In all cases, we observed a profound impairment in calreticulin function when its lectin site was inactivated. Remarkably, inactivation of the polypeptide binding site had little impact. These findings indicate that the lectin-based mode of client interaction is the predominant contributor to the chaperone functions of calreticulin within the endoplasmic reticulum.	[Lum, Ronnie; Ahmad, Samar; Hong, Seo Jung; Chapman, Daniel C.; Williams, David B.] Univ Toronto, Dept Biochem, Med Sci Bldg, Toronto, ON M5S 1A8, Canada; [Lum, Ronnie; Ahmad, Samar; Hong, Seo Jung; Chapman, Daniel C.; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Kozlov, Guennadi] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	University of Toronto; University of Toronto; McGill University	Williams, DB (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca		Ahmad, Samar/0000-0001-5015-6431	Canadian Institutes of Health Research [MOP123226]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP123226 (to D. B. W.). The authors declare that they have no conflicts of interest with the contents of this article.	ARUNACHALAM B, 1995, J BIOL CHEM, V270, P2784, DOI 10.1074/jbc.270.6.2784; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Ferris SP, 2013, MOL BIOL CELL, V24, P2597, DOI 10.1091/mbc.E13-02-0101; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; Kimura Y, 1999, EUR J BIOCHEM, V264, P168, DOI 10.1046/j.1432-1327.1999.00598.x; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Lamriben L, 2016, TRAFFIC, V17, P308, DOI 10.1111/tra.12358; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; ORA A, 1995, J BIOL CHEM, V270, P26060, DOI 10.1074/jbc.270.44.26060; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; PETERSON JR, 1995, MOL BIOL CELL, V6, P1173, DOI 10.1091/mbc.6.9.1173; Pocanschi CL, 2011, J BIOL CHEM, V286, P27266, DOI 10.1074/jbc.M111.258467; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SIFERS RN, 1989, J BIOL CHEM, V264, P2997; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Stronge VS, 2001, J BIOL CHEM, V276, P39779, DOI 10.1074/jbc.M107091200; Suh WK, 1999, J IMMUNOL, V162, P1530; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Thielmann Y, 2009, FEBS J, V276, P1140, DOI 10.1111/j.1742-4658.2008.06857.x; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Wijeyesakere SJ, 2013, J BIOL CHEM, V288, P35104, DOI 10.1074/jbc.M113.507921; Williams A, 2002, TISSUE ANTIGENS, V59, P3, DOI 10.1034/j.1399-0039.2002.590103.x; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856	50	11	12	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19631	19641		10.1074/jbc.M116.746321	http://dx.doi.org/10.1074/jbc.M116.746321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27413183	Green Published, hybrid			2022-12-28	WOS:000383242800036
J	van Dooren, GG; Yeoh, LM; Striepen, B; McFadden, GI				van Dooren, Giel G.; Yeoh, Lee M.; Striepen, Boris; McFadden, Geoffrey I.			The Import of Proteins into the Mitochondrion of Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intracellular trafficking; mitochondria; parasite; protein import; Toxoplasma gondii	PREPROTEIN TRANSLOCASE; OUTER-MEMBRANE; INTERMEMBRANE SPACE; PRESEQUENCE TRANSLOCASE; PLASMODIUM-FALCIPARUM; ORGANELLE BIOGENESIS; TARGETING SEQUENCES; TRYPANOSOMA-BRUCEI; RECEPTORS TOM20; INNER MEMBRANE	Outside of well characterized model eukaryotes, relatively little is known about the translocons that transport proteins across the two membranes that surround the mitochondrion. Apicomplexans are a phylum of intracellular parasites that cause major diseases in humans and animals and are evolutionarily distant from model eukaryotes such as yeast. Apicomplexans harbor a mitochondrion that is essential for parasite survival and is a validated drug target. Here, we demonstrate that the apicomplexan Toxoplasma gondii harbors homologues of proteins from all the major mitochondrial protein translocons present in yeast, suggesting these arose early in eukaryotic evolution. We demonstrate that a T. gondii homologue of Tom22 (TgTom22), a central component of the translocon of the outer mitochondrial membrane (TOM) complex, is essential for parasite survival, mitochondrial protein import, and assembly of the TOM complex. We also identify and characterize a T. gondii homologue of Tom7 (TgTom7) that is important for parasite survival and mitochondrial protein import. Contrary to the role of Tom7 in yeast, TgTom7 is important for TOM complex stability, suggesting the role of this protein has diverged during eukaryotic evolution. Together, our study identifies conserved and modified features of mitochondrial protein import in apicomplexan parasites.	[van Dooren, Giel G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Yeoh, Lee M.; McFadden, Geoffrey I.] Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia; [Striepen, Boris] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	Australian National University; University of Melbourne; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	van Dooren, GG (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia.	giel.vandooren@anu.edu.au	McFadden, Geoffrey McFadden I/F-7667-2014; van Dooren, Giel G/A-8896-2012; Yeoh, Lee M/K-2657-2019	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; van Dooren, Giel G/0000-0003-2455-9821; Yeoh, Lee M/0000-0001-7872-762X; Striepen, Boris/0000-0002-7426-432X	Australian Research Council [DP110103144]; National Health and Medical Research Program Grant; National Institutes of Health [RO1AI 64671]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064671] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health and Medical Research Program Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Discovery Grant DP110103144 from the Australian Research Council (to G. v. D.), a National Health and Medical Research Program Grant (to G. I. M.), and Grant RO1AI 64671 from the National Institutes of Health (to B. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Alcock F, 2012, MOL BIOL EVOL, V29, P113, DOI 10.1093/molbev/msr165; Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Becker T, 2011, J MOL BIOL, V405, P113, DOI 10.1016/j.jmb.2010.11.002; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Carey KL, 2000, MOL BIOCHEM PARASIT, V105, P25, DOI 10.1016/S0166-6851(99)00160-7; Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Deponte M, 2012, MOL BIOCHEM PARASIT, V186, P95, DOI 10.1016/j.molbiopara.2012.09.007; Doggett JS, 2012, P NATL ACAD SCI USA, V109, P15936, DOI 10.1073/pnas.1208069109; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dolezal P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000812; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; Duncan O, 2013, BBA-MOL CELL RES, V1833, P304, DOI 10.1016/j.bbamcr.2012.02.015; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Glaser S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405100; Gubbels MJ, 2003, ANTIMICROB AGENTS CH, V47, P309, DOI 10.1128/AAC.47.1.309-316.2003; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Katris NJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004074; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Macasev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; Mani J, 2016, MOL BIOL EVOL, V33, P337, DOI 10.1093/molbev/msv219; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Pusnik M, 2012, MOL BIOL CELL, V23, P3420, DOI 10.1091/mbc.E12-02-0107; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Rimmer KA, 2011, J MOL BIOL, V405, P804, DOI 10.1016/j.jmb.2010.11.017; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sheiner L, 2015, TRAFFIC, V16, P1254, DOI 10.1111/tra.12333; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Werhahn W, 2001, PLANT PHYSIOL, V125, P943, DOI 10.1104/pp.125.2.943; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Yamano K, 2010, J BIOL CHEM, V285, P41222, DOI 10.1074/jbc.M110.163238; Zarsky V, 2012, CURR BIOL, V22, pR479, DOI 10.1016/j.cub.2012.03.057	61	28	28	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19335	19350		10.1074/jbc.M116.725069	http://dx.doi.org/10.1074/jbc.M116.725069			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27458014	Green Published, hybrid			2022-12-28	WOS:000383242800014
J	Li, Z; Hwang, S; Bar-Peled, M				Li, Zi; Hwang, Soyoun; Bar-Peled, Maor			Discovery of a Unique Extracellular Polysaccharide in Members of the Pathogenic Bacillus That Can Co-form with Spores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREUS ATCC-14579; STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; CHLORINE DIOXIDE; VIRULENCE GENES; STAINLESS-STEEL; TOXIN GENES; ANTHRACIS; SUBTILIS; SPORULATION	An exopolysaccharide, produced during the late stage of stationary growth phase, was discovered and purified from the culture medium of Bacillus cereus, Bacillus anthracis, and Bacillus thuringiensis when strains were grown in a defined nutrient medium that induces biofilm. Two-dimensional NMR structural characterization of the polysaccharide, named pzX, revealed that it is composed of an unusual three amino-sugar sequence repeat of [-3)XylNAc40Ac(alpha 1-3)(GlcNAcA4OAc(alpha 1-3)XylNAc(alpha 1-](n). The sugar residue XylNAc had never been described previously in any glycan structure. The XNAC operon that contains the genes for the assembly of pzX is also unique and so far has been identified only in members of the Bacillus cereus sensu lato group. Microscopic and biochemical analyses indicate that pzX co-forms during sporulation, so that upon the release of the spore to the extracellular milieu it becomes surrounded by pzX. The relative amounts of pzX produced can be manipulated by specific nutrients in the medium, but rich medium appears to suppress pzX formation. pzX has the following unique characteristics: a surfactant property that lowers surface tension, a cell/spore antiaggregant, and an adherence property that increases spores binding to surfaces. pzX in Bacillus could represent a trait shared by many spore-producing microorganisms. It suggests pzX is an active player in spore physiology and may provide new insights to the successful survival of the B. cereus species in natural environments or in the hosts.	[Li, Zi; Hwang, Soyoun; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Li, Zi; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu			BioEnergy Science Center by Office of Biological and Environmental Research in the Department of Energy Office of Science [DE-PS02-06ER64304]	BioEnergy Science Center by Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported by the BioEnergy Science Center Grant DE-PS02-06ER64304, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The authors declare that they have no conflicts of interest with the contents of this article.	ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Avashia SB, 2007, CLIN INFECT DIS, V44, P414, DOI 10.1086/510429; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Cherkasskiy BL, 1999, J APPL MICROBIOL, V87, P192, DOI 10.1046/j.1365-2672.1999.00868.x; Clements MO, 1998, J BACTERIOL, V180, P6729, DOI 10.1128/JB.180.24.6729-6735.1998; Cliff JB, 2005, APPL ENVIRON MICROB, V71, P6524, DOI 10.1128/AEM.71.11.6524-6530.2005; Derzelle S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134699; ELLWOOD DC, 1972, J GEN MICROBIOL, V73, P395, DOI 10.1099/00221287-73-2-395; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hornstra LM, 2006, APPL ENVIRON MICROB, V72, P3746, DOI 10.1128/AEM.72.5.3746-3749.2006; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; NAKATA HM, 1964, J BACTERIOL, V88, P1522, DOI 10.1128/JB.88.5.1522-1524.1964; Nam H, 2014, INT J FOOD MICROBIOL, V188, P122, DOI 10.1016/j.ijfoodmicro.2014.07.009; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Purohit M, 2010, J MICROBIOL METH, V82, P282, DOI 10.1016/j.mimet.2010.07.004; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Ryu JH, 2005, J FOOD PROTECT, V68, P2614, DOI 10.4315/0362-028X-68.12.2614; Severson KM, 2009, J BACTERIOL, V191, P7587, DOI 10.1128/JB.01110-09; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; STERNE MAX, 1939, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V13, P307; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Thapa NK, 2014, EMERG INFECT DIS, V20, P1524, DOI 10.3201/eid2009.140181; Turgeon N, 2006, J MICROBIOL METH, V67, P543, DOI 10.1016/j.mimet.2006.05.005; Van der Auwera GA, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00380-13; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; YORK WS, 1986, METHOD ENZYMOL, V118, P3	43	11	11	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19051	19067		10.1074/jbc.M116.724708	http://dx.doi.org/10.1074/jbc.M116.724708			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402849	Green Published, hybrid			2022-12-28	WOS:000383242300039
J	Matei, E; Basu, R; Furey, W; Shi, J; Calnan, C; Aiken, C; Gronenborn, AM				Matei, Elena; Basu, Rohan; Furey, William; Shi, Jiong; Calnan, Conor; Aiken, Christopher; Gronenborn, Angela M.			Structure and Glycan Binding of a New Cyanovirin-N Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE GLYCOPROTEIN GP120; VIRUS-INACTIVATING PROTEIN; HIV ENTRY INHIBITORS; CRYSTAL-STRUCTURE; ANTIBODY 2G12; X-RAY; POTENT; BROAD; NEUTRALIZATION; OLIGOMANNOSIDES	The HIV-1 envelope glycoprotein gp120 is heavily glycosylated and bears numerous high mannose sugars. These sugars can serve as targets for HIV-inactivating compounds, such as antibodies and lectins, which bind to the glycans and interfere with viral entry into the target cell. We determined the 1.6 angstrom x-ray structure of Cyt-CVNH, a recently identified lectin from the cyanobacterium Cyanothece(7424), and elucidated its glycan specificity by NMR. The Cyt-CVNH structure and glycan recognition profile are similar to those of other CVNH proteins, with each domain specifically binding to Man alpha(1-2)Man alpha units on the D1 and D3 arms of high mannose glycans. However, in contrast to CV-N, no cross-linking and precipitation of the cross linked species in solution was observed upon Man-9 binding, allowing, for the first time, investigation of the interaction of Man-9 with a member of the CVNH family by NMR. HIV assays showed that Cyt-CVNH is able to inhibit HIV-1 with similar to 4-fold higher potency than CV-N-P51G, a stabilized version of wild type CV-N. Therefore, Cyt-CVNH may qualify as a valuable lectin for potential microbicidal use.	[Matei, Elena; Basu, Rohan; Calnan, Conor; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 Fifth Ave,BST3 Rm 1050, Pittsburgh, PA 15260 USA; [Basu, Rohan] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA; [Shi, Jiong; Aiken, Christopher] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Calnan, Conor] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 Fifth Ave,BST3 Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu	Matei, Elena/AAP-8706-2020; Aiken, Christopher/Y-9252-2019; matei, elena/HHC-6815-2022	Matei, Elena/0000-0002-1625-2814	National Institutes of Health [RO1GM080642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant RO1GM080642 (to A. M. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Barrientos LG, 2006, PROTEIN ENG DES SEL, V19, P525, DOI 10.1093/protein/gzl040; Barrientos LG, 2002, STRUCTURE, V10, P673, DOI 10.1016/S0969-2126(02)00758-X; Barrientos LG, 2005, MINI-REV MED CHEM, V5, P21, DOI 10.2174/1389557053402783; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; Bolmstedt AJ, 2001, MOL PHARMACOL, V59, P949, DOI 10.1124/mol.59.5.949; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Briz V, 2006, J ANTIMICROB CHEMOTH, V57, P619, DOI 10.1093/jac/dkl027; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Castagna A, 2005, DRUGS, V65, P879, DOI 10.2165/00003495-200565070-00001; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; CLORE GM, 1987, PROTEIN ENG, V1, P275, DOI 10.1093/protein/1.4.275; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FESIK SW, 1990, Q REV BIOPHYS, V23, P97, DOI 10.1017/S0033583500005515; Fromme R, 2007, BIOCHEMISTRY-US, V46, P9199, DOI 10.1021/bi700666m; Gupta SK, 2013, HIV AIDS-RES PALLIAT, V5, P295, DOI 10.2147/HIV.S39164; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Koharudin LMI, 2008, STRUCTURE, V16, P570, DOI 10.1016/j.str.2008.01.015; Koharudin LMI, 2014, CURR OPIN VIROL, V7, P95, DOI 10.1016/j.coviro.2014.05.006; Kuritzkes DR, 2009, CURR OPIN HIV AIDS, V4, P82, DOI 10.1097/COH.0b013e328322402e; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Matei E, 2008, STRUCTURE, V16, P1183, DOI 10.1016/j.str.2008.05.011; Matei E, 2011, PROTEINS, V79, P1538, DOI 10.1002/prot.22981; Matei E, 2010, J BIOL CHEM, V285, P13057, DOI 10.1074/jbc.M109.094938; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; Olsen JS, 2011, FUTURE MED CHEM, V3, P2101, DOI [10.4155/FMC.11.153, 10.4155/fmc.11.153]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sandstrom C, 2004, BIOCHEMISTRY-US, V43, P13926, DOI 10.1021/bi048676k; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Shenoy SR, 2002, CHEM BIOL, V9, P1109, DOI 10.1016/S1074-5521(02)00237-5; Shenoy SR, 2001, J PHARMACOL EXP THER, V297, P704; Shi J, 2015, J VIROL, V89, P208, DOI 10.1128/JVI.01411-14; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Yang RF, 2007, J VIROL, V81, P3749, DOI 10.1128/JVI.02634-06	60	10	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18967	18976		10.1074/jbc.M116.740415	http://dx.doi.org/10.1074/jbc.M116.740415			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402833	Green Published, hybrid			2022-12-28	WOS:000383242300032
J	Mathieu, C; de la Sierra-Gallay, IL; Duval, R; Xu, XM; Cocaign, A; Leger, T; Woffendin, G; Camadro, JM; Etchebest, C; Haouz, A; Dupret, JM; Rodrigues-Lima, F				Mathieu, Cecile; de la Sierra-Gallay, Ines Li; Duval, Romain; Xu, Ximing; Cocaign, Angelique; Leger, Thibaut; Woffendin, Gary; Camadro, Jean-Michel; Etchebest, Catherine; Haouz, Ahmed; Dupret, Jean-Marie; Rodrigues-Lima, Fernando			Insights into Brain Glycogen Metabolism THE STRUCTURE OF HUMAN BRAIN GLYCOGEN PHOSPHORYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; brain metabolism; crystal structure; energy metabolism; glycogen; Lafora disease (Lafora progressive myoclonic epilepsy; MELF); brain functions; glycogen metabolism	TERM-MEMORY FORMATION; HUMAN-LIVER; ACTIVATION; MECHANISM; EPILEPSY; DISEASE; HYPOGLYCEMIA; ACCUMULATION; IMPAIRMENT; ASTROCYTES	Brain glycogen metabolism plays a critical role in major brain functions such as learning or memory consolidation. However, alteration of glycogen metabolism and glycogen accumulation in the brain contributes to neurodegeneration as observed in Lafora disease. Glycogen phosphorylase (GP), a key enzyme in glycogen metabolism, catalyzes the rate-limiting step of glycogen mobilization. Moreover, the allosteric regulation of the three GP isozymes (muscle, liver, and brain) by metabolites and phosphorylation, in response to hormonal signaling, fine-tunes glycogenolysis to fulfill energetic and metabolic requirements. Whereas the structures of muscle and liver GPs have been known for decades, the structure of brain GP (bGP) has remained elusive despite its critical role in brain glycogen metabolism. Here, we report the crystal structure of human bGP in complex with PEG 400 (2.5 angstrom) and in complex with its allosteric activator AMP (3.4 angstrom). These structures demonstrate that bGP has a closer structural relationship with muscle GP, which is also activated by AMP, contrary to liver GP, which is not. Importantly, despite the structural similarities between human bGP and the two other mammalian isozymes, the bGP structures reveal molecular features unique to the brain isozyme that provide a deeper understanding of the differences in the activation properties of these allosteric enzymes by the allosteric effector AMP. Overall, our study further supports that the distinct structural and regulatory properties of GP isozymes contribute to the different functions of muscle, liver, and brain glycogen.	[Mathieu, Cecile; Duval, Romain; Xu, Ximing; Cocaign, Angelique; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, Sorbonne Paris Cite, CNRS UMR 8251, Unite BFA, F-75013 Paris, France; [de la Sierra-Gallay, Ines Li] Univ Paris 11, Inst Biol Integrat Cellule, Fonct & Architecture Assemblages Macromol, UMR 9198, F-91405 Orsay, France; [Leger, Thibaut; Camadro, Jean-Michel] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS UMR 7592, F-75013 Paris, France; [Woffendin, Gary] Thermo Fisher Sci, Hemel Hempstead HP2 7GE, England; [Etchebest, Catherine] Univ Paris Diderot, INSERM, UMR S1134, F-75015 Paris, France; [Etchebest, Catherine] Univ Paris Diderot, Sorbonne Paris Cite, F-75004 Paris, France; [Etchebest, Catherine] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Etchebest, Catherine] Lab Excellence GR Ex, F-75015 Paris, France; [Etchebest, Catherine; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France; [Haouz, Ahmed] Inst Pasteur, Plateforme Cristallog, CNRS UMR 3528, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Thermo Fisher Scientific; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS UMR 8251, Unite BFA, F-75013 Paris, France.; Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France.	fernando.rodrigues-lima@univ-paris-diderot.fr	Duval, Romain/D-7764-2015; Léger, Thibaut/GPP-5828-2022; etchebest, catherine/O-2485-2019	etchebest, catherine/0000-0002-5871-2372; Duval, Romain/0000-0002-5785-0685; Leger, Thibaut/0000-0002-6304-3433; Li de la Sierra-Gallay, Ines/0000-0003-2770-7439; HAOUZ, Ahmed/0000-0003-1196-1635; Camadro, Jean-Michel/0000-0002-8549-2707	University Paris Diderot; CNRS; Institut Pasteur; French Ministry of Research (Ecole Doctorale BioSPC); Region Ile de France (DIM); China Scholarship Council	University Paris Diderot; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); French Ministry of Research (Ecole Doctorale BioSPC); Region Ile de France (DIM)(Region Ile-de-France); China Scholarship Council(China Scholarship Council)	This work was supported by running grants from University Paris Diderot, CNRS, and Institut Pasteur. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Ph.D. fellowships from the French Ministry of Research (Ecole Doctorale BioSPC).; Supported by a Ph.D. fellowship from Region Ile de France (appel hors DIM 2013).; Supported by a fellowship from the China Scholarship Council. Present address: Institut Pasteur, Unite de Pathogenese des Infections Vasculaires, 75015 Paris, France.	Agius L, 2010, MINI-REV MED CHEM, V10, P1175, DOI 10.2174/1389557511009011175; BARFORD D, 1989, NATURE, V340, P609, DOI 10.1038/340609a0; BARFORD D, 1991, J MOL BIOL, V218, P233, DOI 10.1016/0022-2836(91)90887-C; BARFORD D, 1992, PROTEIN SCI, V1, P472; Berg J. M., 2002, BIOCHEMISTRY-US, P831; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Cloix J. -F., 2011, ISRN PATHOL, V2011, P1; Cloix JF, 2009, CURR MED CHEM, V16, P841, DOI 10.2174/092986709787549316; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; Duran J, 2015, MOL ASPECTS MED, V46, P70, DOI 10.1016/j.mam.2015.08.007; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Duran J, 2013, J CEREBR BLOOD F MET, V33, P550, DOI 10.1038/jcbfm.2012.200; Duran J, 2012, EMBO MOL MED, V4, P719, DOI 10.1002/emmm.201200241; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLETTERICK RJ, 1976, J BIOL CHEM, V251, P6142; Gaboriaud-Kolar N, 2013, EXPERT OPIN THER PAT, V23, P1017, DOI 10.1517/13543776.2013.794790; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gibbs ME, 2012, NEUROCHEM RES, V37, P2456, DOI 10.1007/s11064-012-0805-2; Hossain MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097570; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LEBO RV, 1984, SCIENCE, V225, P57, DOI 10.1126/science.6587566; Lopez-Ramos JC, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00431, 10.3389/fncel.2015.00431]; MADDAIAH VT, 1966, J BIOL CHEM, V241, P3873; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; NEWGARD CB, 1987, AM J HUM GENET, V40, P351; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Obel Linea F, 2012, Front Neuroenergetics, V4, P3, DOI 10.3389/fnene.2012.00003; Oz G, 2015, NEUROCHEM RES, V40, P2473, DOI 10.1007/s11064-015-1664-4; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Rath VL, 2000, MOL CELL, V6, P139, DOI 10.1016/S1097-2765(00)00015-0; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/NMETH.2208, 10.1038/nmeth.2208]; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; SPRANG SR, 1991, SCIENCE, V254, P1367, DOI 10.1126/science.1962195; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Swanson R A, 1989, Neurol Res, V11, P24; Vaidya HB, 2013, J PHARM PHARM SCI, V16, P530, DOI 10.18433/J3FS4F; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu L, 2010, MINI-REV MED CHEM, V10, P1188, DOI 10.2174/1389557511009011188	48	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18072	18083		10.1074/jbc.M116.738898	http://dx.doi.org/10.1074/jbc.M116.738898			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402852	Green Published, hybrid			2022-12-28	WOS:000383241800002
J	McAndrew, MJ; Gjidoda, A; Tagore, M; Miksanek, T; Floer, M				McAndrew, Michael J.; Gjidoda, Alison; Tagore, Mohita; Miksanek, Tyler; Floer, Monique			Chromatin Remodeler Recruitment during Macrophage Differentiation Facilitates Transcription Factor Binding to Enhancers in Mature Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin remodeling; gene expression; gene regulation; macrophage; nucleosome occupancy; chromatin remodeler	NUCLEOSOME OCCUPANCY; GENE-EXPRESSION; REVEALS; COMPLEX; ACTIVATION; PROMOTER; PU.1; BRG1	We show how enhancers of macrophage-specific genes are rendered accessible in differentiating macrophages to allow their induction in mature cells in response to an appropriate stimulus. Using a lentiviral knockdown approach in primary differentiating macrophages from mouse bone marrow, we demonstrate that enhancers of Il12b and Il1a are kept relatively lowly occupied by nucleosomes and accessible through recruitment of the nucleosome remodeler BAF/PBAF. Our results using an inducible cell line that expresses an estrogen receptor fusion of the macrophage-specific transcription factor PU.1 (PUER) show that BAF/PBAF recruitment to these enhancers is a consequence of translocation of PUER to the nucleus in the presence of tamoxifen, and we speculate that remodeler recruitment may be directly mediated by PU.1. In the absence of BAF/PBAF recruitment, nucleosome occupancy at the enhancer of Il12b (and to a lesser extent at Il1a) reaches high levels in bone marrow-derived macrophages (BMDMs), and the enhancers are not fully cleared of nucleosomes upon LPS induction, resulting in impaired gene expression. Analysis of Il12b expression in single cells suggests that recruitment of the remodeler is necessary for high levels of transcription from the same promoter, and we propose that remodelers function by increasing nucleosome turnover to facilitate transcription factor over nucleosome binding in a process we have termed remodeler-assisted competition.	[McAndrew, Michael J.; Gjidoda, Alison; Tagore, Mohita; Miksanek, Tyler; Floer, Monique] Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 410, E Lansing, MI 48824 USA; [McAndrew, Michael J.; Tagore, Mohita; Floer, Monique] Michigan State Univ, Genet Grad Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Floer, M (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 410, E Lansing, MI 48824 USA.	floer@msu.edu		McAndrew, Michael/0000-0003-3479-0576; Tagore, Mohita/0000-0002-2586-1427	American Heart Association [13SDG17260004]	American Heart Association(American Heart Association)	This work was supported by a Scientist-Development-Grant from the American Heart Association (to M. F.) (13SDG17260004). The authors declare that they have no conflicts of interest with the contents of this article.	Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Choi J, 2012, J IMMUNOL, V188, P3791, DOI 10.4049/jimmunol.1103390; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gjidoda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093971; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Mouse EC, 2012, GENOME BIOL, V13, P418, DOI DOI 10.1186/GB-2012-13-8-418; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Tagore M, 2015, MOL CELL BIOL, V35, P2610, DOI 10.1128/MCB.00027-15; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	31	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18058	18071		10.1074/jbc.M116.734186	http://dx.doi.org/10.1074/jbc.M116.734186			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382057	Green Published, hybrid			2022-12-28	WOS:000383241800001
J	Sumer-Bayraktar, Z; Grant, OC; Venkatakrishnan, V; Woods, RJ; Packer, NH; Thaysen-Andersen, M				Sumer-Bayraktar, Zeynep; Grant, Oliver C.; Venkatakrishnan, Vignesh; Woods, Robert J.; Packer, Nicolle H.; Thaysen-Andersen, Morten			Asn(347) Glycosylation of Corticosteroid-binding Globulin Fine-tunes the Host Immune Response by Modulating Proteolysis by Pseudomonas aeruginosa and Neutrophil Elastase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; glycosylation; molecular dynamics; proteolysis; Pseudomonas aeruginosa (P; aeruginosa); corticosteroid-binding globulin; P; aeruginosa elastase; cortisol; neutrophil elastase; reactive center loop	MOLECULAR-DYNAMICS SIMULATIONS; SERINE-PROTEASE INHIBITORS; REACTIVE CENTER LOOP; PARTICLE MESH EWALD; CYSTIC-FIBROSIS; CELL-MEMBRANES; SEPTIC SHOCK; CBG; CLEAVAGE; GLYCOPEPTIDES	Corticosteroid-binding globulin (CBG) delivers anti-inflammatory cortisol to inflamed tissues upon elastase-based proteolysis of the exposed reactive center loop (RCL). However, the molecular mechanisms that regulate the RCL proteolysis by co-existing host and bacterial elastases in inflamed/infected tissues remain unknown. We document that RCL-localized Asn(347) glycosylation fine-tunes the RCL cleavage rate by human neutrophil elastase (NE) and Pseudomonas aeruginosa elastase (PAE) by different mechanisms. NE- and PAE-generated fragments of native and exoglycosidase-treated blood-derived CBG of healthy individuals were monitored by gel electrophoresis and LC-MS/MS to determine the cleavage site(s) and Asn(347) glycosylation as a function of digestion time. The site-specific (Val(344)-Thr(345)) and rapid (seconds to minutes) NE-based RCL proteolysis was significantly antagonized by several volume-enhancing Asn(347) glycan features (i.e. occupancy, triantennary GlcNAc branching, and 1,6-fucosylation) and augmented by Asn(347) NeuAc-type sialylation (all p < 0.05). In contrast, the inefficient (minutes to hours) PAE-based RCL cleavage, which occurred equally well at Thr(345)-Leu(346) and Asn(347)-Leu(348), was abolished by the presence of Asn(347) glycosylation but was enhanced by sialoglycans on neighboring CBG N-sites. Molecular dynamics simulations of various Asn(347) glycoforms of uncleaved CBG indicated that multiple Asn(347) glycan features are modulating the RCL digestion efficiencies by NE/PAE. Finally, high concentrations of cortisol showed weak bacteriostatic effects toward virulent P. aeruginosa, which may explain the low RCL potency of the abundantly secreted PAE during host infection. In conclusion, site-specific CBG N-glycosylation regulates the bioavailability of cortisol in inflamed environments by fine-tuning the RCL proteolysis by endogenous and exogenous elastases. This study offers new molecular insight into host- and pathogen-based manipulation of the human immune system.	[Sumer-Bayraktar, Zeynep; Venkatakrishnan, Vignesh; Packer, Nicolle H.; Thaysen-Andersen, Morten] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Grant, Oliver C.; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	Macquarie University; University System of Georgia; University of Georgia	Thaysen-Andersen, M (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	morten.andersen@mq.edu.au	Packer, Nicolle/Q-8929-2019	Packer, Nicolle/0000-0002-7532-4021; Grant, Oliver/0000-0003-4835-5161; Woods, Robert/0000-0002-2400-6293; Thaysen-Andersen, Morten/0000-0001-8327-6843	International Macquarie University postgraduate student research scholarship (iMQRES); National Institutes of Health [P41 GM103390]; ARC Super Science Grant [FS110200026]; ARC Centre of Excellence in Nanoscale Biophotonics Grant [CE140100003]; Early Career Fellowship from the Cancer Institute, New South Wales, Australia; Macquarie University Research Development Grant (MQRDG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	International Macquarie University postgraduate student research scholarship (iMQRES); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Super Science Grant(Australian Research Council); ARC Centre of Excellence in Nanoscale Biophotonics Grant(Australian Research Council); Early Career Fellowship from the Cancer Institute, New South Wales, Australia; Macquarie University Research Development Grant (MQRDG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Recipient of an International Macquarie University postgraduate student research scholarship (iMQRES).; Supported by National Institutes of Health Grant P41 GM103390.; Supported by ARC Super Science Grant FS110200026 and ARC Centre of Excellence in Nanoscale Biophotonics Grant CE140100003.; Supported by an Early Career Fellowship from the Cancer Institute, New South Wales, Australia and a Macquarie University Research Development Grant (MQRDG).	AVVAKUMOV GV, 1994, BIOCHEMISTRY-US, V33, P5759, DOI 10.1021/bi00185a012; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BERNARD BA, 1982, J BIOL CHEM, V257, P8549; Brantly M, 2002, AM J RESP CELL MOL, V27, P652, DOI 10.1165/rcmb.F250; Cameron A, 2010, J CLIN ENDOCR METAB, V95, P4689, DOI 10.1210/jc.2010-0942; Case D. A., 2014, AMBER 14 REFERENCE M, V14; Chan WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113402; Chan WL, 2013, J CLIN ENDOCR METAB, V98, P3315, DOI 10.1210/jc.2012-4280; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Crocetti L, 2013, J MED CHEM, V56, P6259, DOI 10.1021/jm400742j; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deshpande N, 2010, J PROTEOME RES, V9, P1063, DOI 10.1021/pr900956x; EmptozBonneton A, 1997, J CLIN ENDOCR METAB, V82, P3758, DOI 10.1210/jc.82.11.3758; Gardill BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052759; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Groutas WC, 2011, EXPERT OPIN THER PAT, V21, P339, DOI 10.1517/13543776.2011.551115; HAMMOND GL, 1990, BIOCHEM BIOPH RES CO, V172, P172, DOI 10.1016/S0006-291X(05)80189-5; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HAMMOND GL, 1991, J STEROID BIOCHEM, V40, P755, DOI 10.1016/0960-0760(91)90300-T; Hane M, 2015, GLYCOBIOLOGY, V25, P1112, DOI 10.1093/glycob/cwv049; Hansen G, 2011, J MOL BIOL, V409, P681, DOI 10.1016/j.jmb.2011.04.047; Henke MO, 2011, INFECT IMMUN, V79, P3438, DOI 10.1128/IAI.01252-10; HEYNS W, 1988, ANN NY ACAD SCI, V538, P122, DOI 10.1111/j.1749-6632.1988.tb48857.x; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; HRYB DJ, 1986, P NATL ACAD SCI USA, V83, P3253, DOI 10.1073/pnas.83.10.3253; Jirikowski GF, 2007, J CHEM NEUROANAT, V34, P22, DOI 10.1016/j.jchemneu.2007.03.007; Kamath S, 1998, MOL MICROBIOL, V30, P933, DOI 10.1046/j.1365-2958.1998.01121.x; KHAN MS, 1984, J STEROID BIOCHEM, V20, P677, DOI 10.1016/0022-4731(84)90142-0; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lee J, 2015, PROTEIN CELL, V6, P26, DOI 10.1007/s13238-014-0100-x; Lee LY, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00404; Lewis JG, 2015, J STEROID BIOCHEM, V149, P53, DOI 10.1016/j.jsbmb.2015.01.020; Lewis JG, 2014, MOL CELL ENDOCRINOL, V384, P96, DOI 10.1016/j.mce.2014.01.005; Lewis JG, 2011, J STEROID BIOCHEM, V127, P289, DOI 10.1016/j.jsbmb.2011.08.006; Lin HY, 2009, J BIOL CHEM, V284, P884, DOI 10.1074/jbc.M807376200; LURIA SE, 1957, J BACTERIOL, V74, P461, DOI 10.1002/path.1700740226; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; MELBY JC, 1958, J CLIN INVEST, V37, P1791, DOI 10.1172/JCI103772; Meyer EJ, 2016, HORM METAB RES, V48, P359, DOI 10.1055/s-0042-108071; Mihrshahi R, 2006, J STEROID BIOCHEM, V101, P275, DOI 10.1016/j.jsbmb.2006.06.031; Misao R, 1999, HORM RES, V51, P162, DOI 10.1159/000023351; MISAO R, 1994, STEROIDS, V59, P603, DOI 10.1016/0039-128X(94)90055-8; Miska W, 2004, ANDROLOGIA, V36, P41, DOI 10.1046/j.1439-0272.2003.00601.x; Nenke MA, 2015, CLIN ENDOCRINOL, V82, P801, DOI 10.1111/cen.12680; Nenke M. A., 2016, CLIN ENDOCRINOL, V48, P359; Nenke MA, 2016, CLIN CHIM ACTA, V452, P27, DOI 10.1016/j.cca.2015.10.028; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Penesyan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138527; Perogamvros I, 2012, NAT REV ENDOCRINOL, V8, P717, DOI 10.1038/nrendo.2012.134; PERROTAPPLANAT M, 1984, ENDOCRINOLOGY, V115, P559, DOI 10.1210/endo-115-2-559; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; Rapala-Kozik M, 1999, BIOL CHEM, V380, P1211, DOI 10.1515/BC.1999.153; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Rutledge EA, 1996, J CELL PHYSIOL, V168, P284, DOI 10.1002/(SICI)1097-4652(199608)168:2<284::AID-JCP7>3.0.CO;2-L; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schafer HH, 2015, HORM METAB RES, V47, P596, DOI 10.1055/s-0034-1389957; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; Simard M, 2014, ENDOCRINOLOGY, V155, P2900, DOI 10.1210/en.2014-1055; Sivukhina EV, 2006, HORM METAB RES, V38, P253, DOI 10.1055/s-2006-925346; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Stavenhagen K, 2013, J MASS SPECTROM, V48, P627, DOI [10.1002/jms.3189, 10.1002/jms.3210]; STRELCHYONOK OA, 1991, J STEROID BIOCHEM, V40, P795, DOI 10.1016/0960-0760(91)90305-O; Sumer-Bayraktar Z, 2012, PROTEOMICS, V12, P3315, DOI 10.1002/pmic.201200354; Sumer-Bayraktar Z, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009100; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Thaysen-Andersen M, 2009, ANAL CHEM, V81, P3933, DOI 10.1021/ac900231w; Tsigos C, 1998, J CLIN ENDOCR METAB, V83, P3379, DOI 10.1210/jc.83.9.3379; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vashchenko G, 2016, J BIOL CHEM, V291, P11300, DOI 10.1074/jbc.M116.714378; Verhoog N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110702; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012	79	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17727	17742		10.1074/jbc.M116.735258	http://dx.doi.org/10.1074/jbc.M116.735258			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27339896	hybrid, Green Published			2022-12-28	WOS:000383241300022
J	Bao, HY; Li, FD; Wang, CY; Wang, N; Jiang, YY; Tang, YJ; Wu, JH; Shi, YY				Bao, Hongyu; Li, Fudong; Wang, Chongyuan; Wang, Na; Jiang, Yiyang; Tang, Yajun; Wu, Jihui; Shi, Yunyu			Structural Basis for the Specific Recognition of RhoA by the Dual GTPase-activating Protein ARAP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; RHOGAP; ARF; FAMILY; P190RHOGAP; REGULATORS; MIGRATION; ADHESION; REVEALS; COMPLEX	ARAP3 (Arf-GAP with Rho-GAP domain, ANK repeat, and PH domain-containing protein 3) is unique for its dual specificity GAPs (GTPase-activating protein) activity for Arf6 (ADP-ribosylation factor 6) and RhoA (Ras homolog gene family member A) regulated by phosphatidylinositol 3,4,5-trisphosphate and a small GTPase Rap1-GTP and is involved in regulation of cell shape and adhesion. However, the molecular interface between the ARAP3-RhoGAP domain and RhoA is unknown, as is the substrates specificity of the RhoGAP domain. In this study, we solved the crystal structure of RhoA in complex with the RhoGAP domain of ARAP3. The structure of the complex presented a clear interface between the RhoGAP domain and RhoA. By analyzing the crystal structure and in combination with in vitro GTPase activity assays and isothermal titration calorimetry experiments, we identified the crucial residues affecting RhoGAP activity and substrates specificity among RhoA, Rac1 (Ras-related C3 botulinum toxin substrate 1), and Cdc42 (cell division control protein 42 homolog).	[Wu, Jihui; Shi, Yunyu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Collaborat Innovat Ctr Chem Life Sci, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH; Shi, YY (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Collaborat Innovat Ctr Chem Life Sci, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759; Jihui, Wu/0000-0002-4339-0518; Bao, Hongyu/0000-0002-6563-1626	National Basic Research Program of China 973 Program [2012CB917201]; Chinese National Natural Science Foundation [31330018, 31170693]; Hefei Center for Physical Science and Technology Grant [2012FXZY002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010101]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hefei Center for Physical Science and Technology Grant; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China 973 Program Grant 2012CB917201; Chinese National Natural Science Foundation Grants 31330018 and 31170693; Hefei Center for Physical Science and Technology Grant 2012FXZY002; and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08010101. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BARFOD ET, 1993, J BIOL CHEM, V268, P26059; Bryan BA, 2005, CELL MOL LIFE SCI, V62, P1547, DOI 10.1007/s00018-005-5029-z; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Craig HE, 2010, CELL SIGNAL, V22, P257, DOI 10.1016/j.cellsig.2009.09.025; Csepanyi-Komi R, 2012, MOL CELL ENDOCRINOL, V353, P10, DOI 10.1016/j.mce.2011.11.005; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DeLano W, 2002, PYMOL 0 99; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gambardella L, 2011, BLOOD, V118, P1087, DOI 10.1182/blood-2010-10-312959; Gambardella L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001026; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Jeon CY, 2012, J NEUROCHEM, V120, P684, DOI 10.1111/j.1471-4159.2011.07564.x; Jeon CY, 2010, J CELL PHYSIOL, V224, P786, DOI 10.1002/jcp.22184; Jeon CY, 2010, EXP MOL MED, V42, P335, DOI 10.3858/emm.2010.42.5.035; Kong RR, 2015, J CLIN INVEST, V125, P4407, DOI 10.1172/JCI81673; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krugmann S, 2006, J CELL SCI, V119, P425, DOI 10.1242/jcs.02755; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Levay M, 2009, BIOCHEMISTRY-US, V48, P8615, DOI 10.1021/bi900667y; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Moon MY, 2013, J CELL PHYSIOL, V228, P2119, DOI 10.1002/jcp.24383; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Riching KM, 2015, INT J BIOCHEM CELL B, V59, P111, DOI 10.1016/j.biocel.2014.11.007; Ridley AJ, 2013, J MICROSC-OXFORD, V251, P242, DOI 10.1111/jmi.12025; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Wang L, 2005, P NATL ACAD SCI USA, V102, P13484, DOI 10.1073/pnas.0504420102; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Yagi R, 2011, ONCOGENE, V30, P1413, DOI 10.1038/onc.2010.522; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	44	7	7	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16709	16719		10.1074/jbc.M116.736140	http://dx.doi.org/10.1074/jbc.M116.736140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27311713	Green Published, hybrid			2022-12-28	WOS:000380826700028
J	Cornelissen, A; Sadovskaya, I; Vinogradov, E; Blangy, S; Spinelli, S; Casey, E; Mahony, J; Noben, JP; Dal Bello, F; Cambillau, C; van Sinderen, D				Cornelissen, Anneleen; Sadovskaya, Irina; Vinogradov, Evgeny; Blangy, Stephanie; Spinelli, Silvia; Casey, Eoghan; Mahony, Jennifer; Noben, Jean-Paul; Dal Bello, Fabio; Cambillau, Christian; van Sinderen, Douwe			The Baseplate of Lactobacillus delbrueckii Bacteriophage Ld17 Harbors a Glycerophosphodiesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL TEICHOIC-ACIDS; COMPLETE GENOME SEQUENCE; VI-PHAGE 2; CELL-WALL; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; PHOSPHODIESTERASE GDPD; LIPOTEICHOIC ACIDS	Glycerophosphodiester phosphodiesterases (GDPDs; EC 3.1.4.46) typically hydrolyze glycerophosphodiesters to sn-glycerol 3-phosphate (Gro3P) and their corresponding alcohol during patho/physiological processes in bacteria and eukaryotes. GDPD(-like) domains were identified in the structural particle of bacterial viruses (bacteriophages) specifically infecting Gram-positive bacteria. The GDPD of phage 17 (Ld17; GDPD(Ld17)), representative of the group b Lactobacillus delbrueckii subsp. bulgaricus (Ldb)-infecting bacteriophages, was shown to hydrolyze, besides the simple glycerophosphodiester, two complex surface-associated carbohydrates of the Ldb17 cell envelope: the Gro3P decoration of the major surface polysaccharide D-galactan and the oligo(glycerol phosphate) backbone of the partially glycosylated cell wall teichoic acid, a minor Ldb17 cell envelope component. Degradation of cell wall teichoic acid occurs according to an exolytic mechanism, and Gro3P substitution is presumed to be inhibitory for GDPD(Ld17) activity. The presence of the GDPD(Ld17) homotrimer in the viral baseplate structure involved in phage-host interaction together with the dependence of native GDPD activity, adsorption, and efficiency of plating of Ca2+ ions supports a role for GDPD(Ld17) activity during phage adsorption and/or phage genome injection. In contrast to GDPD(Ld17), we could not identify any enzymatic activity for the GDPD-like domain in the neck passage structure of phage 340, a 936-type Lactococcus lactis subsp. lactis bacteriophage.	[Cornelissen, Anneleen; Casey, Eoghan; Mahony, Jennifer; van Sinderen, Douwe] Univ Coll Cork, Sch Microbiol, Western Rd, Cork, Ireland; [van Sinderen, Douwe] Univ Coll Cork, APC Microbiome Inst, Western Rd, Cork, Ireland; [Sadovskaya, Irina] Univ Littoral Cote dOpale, Equipe Biochim Prod Aquat, Blvd Bassin Napoleon,BP 120, F-62327 Boulogne Sur Mer, France; [Vinogradov, Evgeny] CNR, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Blangy, Stephanie; Spinelli, Silvia; Cambillau, Christian] Aix Marseille Univ, Architecture & Fonct Macromol Biol, Campus Luminy, F-13288 Marseille 09, France; [Blangy, Stephanie; Spinelli, Silvia; Cambillau, Christian] CNRS, Architecture & Fonct Macromol Biol, UMR 6098, Campus Luminy, F-13288 Marseille 09, France; [Noben, Jean-Paul] Hasselt Univ, Biomed Res Inst Biomed, Agoralaan Bldg C, BE-3590 Diepenbeek, Belgium; [Noben, Jean-Paul] Hasselt Univ, Sch Life Sci, Transnat Univ Limburg, Agoralaan Bldg C, BE-3590 Diepenbeek, Belgium; [Dal Bello, Fabio] Sacco Srl, I-22071 Cadorago, CO, Italy	University College Cork; University College Cork; Universite du Littoral-Cote-d'Opale; National Research Council Canada; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Hasselt University; Hasselt University	van Sinderen, D (corresponding author), Univ Coll Cork, Sch Microbiol, Western Rd, Cork, Ireland.; van Sinderen, D (corresponding author), Univ Coll Cork, APC Microbiome Inst, Western Rd, Cork, Ireland.	d.vansinderen@ucc.ie	Van Sinderen, Douwe/A-6778-2015; Noben, Jean-Paul/E-8066-2011; mahony, jennifer/AAG-8357-2020	Van Sinderen, Douwe/0000-0003-1823-7957; Noben, Jean-Paul/0000-0003-3368-5686; mahony, jennifer/0000-0001-5846-6303	EMPOWER postdoctoral fellowship of the Irish Research Council;  [08/IN.1/B1909];  [13/IA/1953]	EMPOWER postdoctoral fellowship of the Irish Research Council; ; 	This work was supported by a Principal Investigator Awards 08/IN.1/B1909 and 13/IA/1953 (to D. v. S.) and an EMPOWER postdoctoral fellowship of the Irish Research Council (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahren IL, 2001, MICROB PATHOGENESIS, V31, P151, DOI 10.1006/mpat.2001.0456; ARCHIBALD AR, 1976, J BACTERIOL, V127, P956, DOI 10.1128/JB.127.2.956-960.1976; ARMSTRONG JJ, 1960, BIOCHEM J, V76, P610, DOI 10.1042/bj0760610; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauge T, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv229; CALDENTEY J, 1992, BIOCHIM BIOPHYS ACTA, V1159, P44, DOI 10.1016/0167-4838(92)90073-M; Casey E, 2014, APPL ENVIRON MICROB, V80, P5623, DOI 10.1128/AEM.01268-14; Castro-Nallar E, 2012, GENOME BIOL EVOL, V4, P382, DOI 10.1093/gbe/evs017; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; CHATTERJEE AN, 1969, J BACTERIOL, V98, P519, DOI 10.1128/JB.98.2.519-527.1969; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cheng LY, 2011, PLANT PHYSIOL, V156, P1131, DOI 10.1104/pp.111.173724; Cheng YX, 2011, PLANT J, V66, P781, DOI 10.1111/j.1365-313X.2011.04538.x; Corda D, 2014, FEBS J, V281, P998, DOI 10.1111/febs.12699; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; COYETTE J, 1968, BIOCHEMISTRY-US, V7, P2385, DOI 10.1021/bi00846a048; Cui ZL, 2012, J VIROL, V86, P13880, DOI 10.1128/JVI.02728-12; Douillard FP, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-66; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5825, DOI 10.1128/AEM.70.10.5825-5832.2004; ERIKSSON U, 1979, J GEN VIROL, V43, P503, DOI 10.1099/0022-1317-43-3-503; Eugster MR, 2012, J BACTERIOL, V194, P6498, DOI 10.1128/JB.00808-12; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; GIVAN AL, 1982, ARCH MICROBIOL, V133, P318, DOI 10.1007/BF00521298; Gu JM, 2012, J VIROL, V86, P8914, DOI 10.1128/JVI.01313-12; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001; Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x; KARAMATA D, 1987, MOL GEN GENET, V207, P73, DOI 10.1007/BF00331493; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kornspan JD, 2012, FEMS MICROBIOL LETT, V332, P34, DOI 10.1111/j.1574-6968.2012.02571.x; KUSSER W, 1983, J BACTERIOL, V155, P302, DOI 10.1128/JB.155.1.302-310.1983; KUSSER W, 1984, FEBS LETT, V166, P301, DOI 10.1016/0014-5793(84)80100-3; KUSSER W, 1982, FEBS LETT, V149, P67, DOI 10.1016/0014-5793(82)81073-9; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON TJ, 1988, ARCH BIOCHEM BIOPHYS, V260, P577, DOI 10.1016/0003-9861(88)90484-5; LARSON TJ, 1983, J BIOL CHEM, V258, P5428; Lavigne R, 2006, MICROBIOL-SGM, V152, P529, DOI 10.1099/mic.0.28431-0; LINDBERG AA, 1978, J VIROL, V27, P38, DOI 10.1128/JVI.27.1.38-44.1978; Mahony J, 2013, APPL ENVIRON MICROB, V79, P4385, DOI 10.1128/AEM.00653-13; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Moak M, 2000, MOL MICROBIOL, V37, P345, DOI 10.1046/j.1365-2958.2000.01995.x; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Munsch-Alatossava P, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00408; Munsch-Alatossava P, 2013, INT J MOL SCI, V14, P5668, DOI 10.3390/ijms14035668; Murphy J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21345; Raisanen L, 2004, J BACTERIOL, V186, P5529, DOI 10.1128/JB.186.16.5529-5532.2004; Raisanen L, 2007, J BACTERIOL, V189, P4135, DOI 10.1128/JB.00078-07; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Ravin V, 2002, J BACTERIOL, V184, P2455, DOI 10.1128/JB.184.9.2455-2459.2002; Riipinen KA, 2011, ARCH VIROL, V156, P1217, DOI 10.1007/s00705-011-0980-5; Rousseau GM, 2009, APPL ENVIRON MICROB, V75, P5336, DOI 10.1128/AEM.00761-09; Rydman PS, 2000, MOL MICROBIOL, V37, P356, DOI 10.1046/j.1365-2958.2000.01996.x; Sadovskaya I, 2004, CARBOHYD RES, V339, P1467, DOI 10.1016/j.carres.2004.03.017; Sadovskaya I, 2006, FEMS IMMUNOL MED MIC, V47, P75, DOI 10.1111/j.1574-695X.2006.00068.x; Sambrook J, 2001, MOL CLONING LAB MANU, P51; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; Simockova M, 2008, J BIOL CHEM, V283, P17107, DOI 10.1074/jbc.M800868200; Stockdale SR, 2013, J BIOL CHEM, V288, P5581, DOI 10.1074/jbc.M112.444901; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; SUNDARALINGAM M, 1965, SCIENCE, V150, P1035, DOI 10.1126/science.150.3699.1035; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; TAKEDA K, 1973, VIROLOGY, V52, P148, DOI 10.1016/0042-6822(73)90405-4; TAYLOR K, 1966, ACTA BIOCHIM POL, V13, P97; TAYLOR K, 1965, BIOCHEM BIOPH RES CO, V20, P752, DOI 10.1016/0006-291X(65)90081-1; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; Vinogradov E, 2006, CARBOHYD RES, V341, P738, DOI 10.1016/j.carres.2006.01.012; Vinogradov E, 2015, CARBOHYD RES, V413, P93, DOI 10.1016/j.carres.2015.06.001; Wang SH, 2010, INT J FOOD MICROBIOL, V137, P22, DOI 10.1016/j.ijfoodmicro.2009.10.024; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Wittmann Johannes, 2011, Bacteriophage, V1, P6, DOI 10.4161/bact.1.1.13873; ZOURARI A, 1992, LAIT, V72, P1	77	7	7	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16816	16827		10.1074/jbc.M116.728279	http://dx.doi.org/10.1074/jbc.M116.728279			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27268053	Green Published, hybrid			2022-12-28	WOS:000380826700037
J	Kannappan, R; Yadav, VR; Aggarwal, BB				Kannappan, Ramaswamy; Yadav, Vivek R.; Aggarwal, Bharat B.			RETRACTION: gamma-Tocotrienol but not gamma-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents (Retraction of vol 285, pg 33520, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Kannappan R, 2010, J BIOL CHEM, V285, P33520, DOI 10.1074/jbc.M110.158378	1	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16922	16922		10.1074/jbc.A110.158378	http://dx.doi.org/10.1074/jbc.A110.158378			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27496963	Green Published, hybrid			2022-12-28	WOS:000380826700049
J	Sen, A; Hongpaisan, J; Wang, DS; Nelson, TJ; Alkon, DL				Sen, Abhik; Hongpaisan, Jarin; Wang, Desheng; Nelson, Thomas J.; Alkon, Daniel L.			Protein Kinase C epsilon (PKC epsilon) Promotes Synaptogenesis through Membrane Accumulation of the Postsynaptic Density Protein PSD-95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; UP-REGULATION; NEUROTROPHIC FACTOR; STRUCTURAL BASIS; SYNAPTIC LOSS; MEMORY; ACTIVATION; PHOSPHORYLATION; TRANSLOCATION; EXPRESSION	Protein kinase C epsilon (PKC epsilon) promotes synaptic maturation and synaptogenesis via activation of synaptic growth factors such as BDNF, NGF, and IGF. However, many of the detailed mechanisms by which PKC epsilon induces synaptogenesis are not fully understood. Accumulation of PSD-95 to the postsynaptic density (PSD) is known to lead to synaptic maturation and strengthening of excitatory synapses. Here we investigated the relationship between PKC epsilon and PSD-95. We show that the PKC epsilon activators dicyclopropanated linoleic acid methyl ester and bryostatin 1 induce phosphorylation of PSD-95 at the serine 295 residue, increase the levels of PSD-95, and enhance its membrane localization. Elimination of the serine 295 residue in PSD-95 abolished PKC epsilon-induced membrane accumulation. Knockdown of either PKC epsilon or JNK1 prevented PKC epsilon activator-mediated membrane accumulation of PSD-95. PKC epsilon directly phosphorylated PSD-95 and JNK1 in vitro. Inhibiting PKC epsilon, JNK, or calcium/calmodulin-dependent kinase II activity prevented the effects of PKC epsilon activators on PSD-95 phosphorylation. Increase in membrane accumulation of PKC epsilon and phosphorylated PSD-95 (p-PSD-95(S295)) coincided with an increased number of synapses and increased amplitudes of excitatory post-synaptic potentials (EPSPs) in adult rat hippocampal slices. Knockdown of PKC epsilon also reduced the synthesis of PSD-95 and the presynaptic protein synaptophysin by 30 and 44%, respectively. Prolonged activation of PKC epsilon increased synapse number by 2-fold, increased presynaptic vesicle density, and greatly increased PSD-95 clustering. These results indicate that PKC epsilon promotes synaptogenesis by activating PSD-95 phosphorylation directly through JNK1 and calcium/calmodulin-dependent kinase II and also by inducing expression of PSD-95 and synaptophysin.	[Sen, Abhik; Hongpaisan, Jarin; Wang, Desheng; Nelson, Thomas J.; Alkon, Daniel L.] Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA		Sen, A (corresponding author), Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA.	asen@brni.org	Sen, Abhik/L-2067-2017	Sen, Abhik/0000-0003-4048-0566				AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; ALKON DL, 1988, SCIENCE, V239, P998, DOI 10.1126/science.2830669; Alkon DL, 2005, P NATL ACAD SCI USA, V102, P16432, DOI 10.1073/pnas.0508001102; BANK B, 1988, P NATL ACAD SCI USA, V85, P1988, DOI 10.1073/pnas.85.6.1988; Barker AJ, 2008, J NEUROSCI, V28, P8150, DOI 10.1523/JNEUROSCI.1744-08.2008; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bell KFS, 2011, CURR OPIN NEUROBIOL, V21, P299, DOI 10.1016/j.conb.2011.01.002; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Brooks IM, 2011, J BIOL CHEM, V286, P6697, DOI 10.1074/jbc.M110.183558; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Chen Yuan, 2011, Front Med, V5, P70, DOI 10.1007/s11684-011-0119-9; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Coffey ET, 1997, NEUROSCI LETT, V227, P177, DOI 10.1016/S0304-3940(97)00335-2; Comalada N, 2003, AM J PHYSIOL-CELL PH, V285, pC1235, DOI 10.1152/ajpcell.00228.2003; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fagerstrom S, 1996, CELL GROWTH DIFFER, V7, P775; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Ferrari LF, 2013, J NEUROSCI, V33, P11002, DOI 10.1523/JNEUROSCI.1785-13.2013; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gomes AR, 2007, TRAFFIC, V8, P259, DOI 10.1111/j.1600-0854.2006.00521.x; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Hongpaisan J, 2013, NEUROBIOL DIS, V55, P44, DOI 10.1016/j.nbd.2013.03.012; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Hurd C, 2002, ONCOGENE, V21, P2154, DOI 10.1038/sj.onc.1205290; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Kajiya M, 2009, J CELL PHYSIOL, V221, P696, DOI 10.1002/jcp.21909; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kellner Yves, 2014, Front Synaptic Neurosci, V6, P5, DOI 10.3389/fnsyn.2014.00005; Khan TK, 2015, J ALZHEIMERS DIS, V43, P491, DOI 10.3233/JAD-141221; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim H, 2013, PROG NEURO-PSYCHOPH, V41, P36, DOI 10.1016/j.pnpbp.2012.11.004; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kortmansky J, 2003, CANCER INVEST, V21, P924, DOI 10.1081/CNV-120025095; Lang WH, 2004, CELL SIGNAL, V16, P457, DOI 10.1016/j.cellsig.2003.09.002; Li YK, 1996, J BIOL CHEM, V271, P27025, DOI 10.1074/jbc.271.43.27025; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Nelson TJ, 2015, BRAIN RES, V1621, P239, DOI 10.1016/j.brainres.2014.11.054; Nelson TJ, 2014, J CHROMATOGR B, V944, P55, DOI 10.1016/j.jchromb.2013.11.020; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; NELSON TJ, 1990, SCIENCE, V247, P1479, DOI 10.1126/science.2108498; OLDS JL, 1989, SCIENCE, V245, P866, DOI 10.1126/science.2772638; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; Sen A, 2015, J NEUROSCI, V35, P7538, DOI 10.1523/JNEUROSCI.0260-15.2015; Sen A, 2012, J BIOL CHEM, V287, P15947, DOI 10.1074/jbc.M111.312710; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Stein V, 2003, J NEUROSCI, V23, P5503; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun MK, 2008, P NATL ACAD SCI USA, V105, P13620, DOI 10.1073/pnas.0805952105; Sun MK, 2015, TRENDS PHARMACOL SCI, V36, P384, DOI 10.1016/j.tips.2015.04.004; Sun MK, 2014, J PHARMACOL EXP THER, V349, P393, DOI 10.1124/jpet.114.214098; Sun MK, 2009, ARCH PHARM, V342, P689, DOI 10.1002/ardp.200900050; Tokuda K, 2013, NEUROSCI LETT, V537, P40, DOI 10.1016/j.neulet.2013.01.018; WAXHAM MN, 1993, BIOCHEMISTRY-US, V32, P2923, DOI 10.1021/bi00062a024; Yan JZ, 2011, J BIOL CHEM, V286, P25187, DOI 10.1074/jbc.M110.192708; Yang HH, 2011, EUR J NEUROSCI, V33, P1647, DOI 10.1111/j.1460-9568.2011.07661.x; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713	71	18	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16462	16476		10.1074/jbc.M116.730440	http://dx.doi.org/10.1074/jbc.M116.730440			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27330081	Green Published, hybrid			2022-12-28	WOS:000380826700005
J	Wadas, B; Borjigin, J; Huang, ZP; Oh, JH; Hwang, CS; Varshavsky, A				Wadas, Brandon; Borjigin, Jimo; Huang, Zheping; Oh, Jang-Hyun; Hwang, Cheol-Sang; Varshavsky, Alexander			Degradation of Serotonin N-Acetyltransferase, a Circadian Regulator, by the N-end Rule Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyltransferase; circadian; proteolysis; serotonin; ubiquitin	TERMINAL ACETYLATION; MELATONIN SYNTHESIS; PINEAL-GLAND; CELLULAR-PROTEINS; IN-VIVO; PROTEASOMAL PROTEOLYSIS; ANGSTROM RESOLUTION; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; UBIQUITIN LIGASE	Serotonin N-acetyltransferase (AANAT) converts serotonin to N-acetylserotonin (NAS), a distinct biological regulator and the immediate precursor of melatonin, a circulating hormone that influences circadian processes, including sleep. N-terminal sequences of AANAT enzymes vary among vertebrates. Mechanisms that regulate the levels of AANAT are incompletely understood. Previous findings were consistent with the possibility that AANAT may be controlled through its degradation by the N-end rule pathway. By expressing the rat and human AANATs and their mutants not only in mammalian cells but also in the yeast Saccharomyces cerevisiae, and by taking advantage of yeast genetics, we show here that two complementary forms of rat AANAT are targeted for degradation by two complementary branches of the N-end rule pathway. Specifically, the N-terminally acetylated (Nt-acetylated) Ac-AANAT is destroyed through the recognition of its Nt-acetylated N-terminal Met residue by the Ac/N-end rule pathway, whereas the non-Nt-acetylated AANAT is targeted by the Arg/N-end rule pathway, which recognizes the unacetylated N-terminal Met-Leu sequence of rat AANAT. We also show, by constructing lysine-to-arginine mutants of rat AANAT, that its degradation is mediated by polyubiquitylation of its Lys residue(s). Human AANAT, whose N-terminal sequence differs from that of rodent AANATs, is longer-lived than its rat counterpart and appears to be refractory to degradation by the N-end rule pathway. Together, these and related results indicate both a major involvement of the N-end rule pathway in the control of rodent AANATs and substantial differences in the regulation of rodent and human AANATs that stem from differences in their N-terminal sequences.	[Wadas, Brandon; Oh, Jang-Hyun; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Borjigin, Jimo] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Huang, Zheping] Univ Connecticut, Dept Immunol, Sch Med, Farmington, CT 06030 USA; [Hwang, Cheol-Sang] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Gyeongbuk, South Korea	California Institute of Technology; University of Michigan System; University of Michigan; University of Connecticut; Pohang University of Science & Technology (POSTECH)	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu	Hwang, Cheol-Sang/Q-7391-2019; Borjigin, Jimo/GXA-3484-2022	Hwang, Cheol-Sang/0000-0002-0105-5957; Wadas, Brandon/0000-0003-2796-2384	National Institutes of Health [R01-DK039520, R01-GM031530, R01-NS057583]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health Grants R01-DK039520 and R01-GM031530 (to A. V.) and R01-NS057583 (to J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2015, INT REV CEL MOL BIO, V316, P267, DOI 10.1016/bs.ircmb.2015.01.001; Andrews B., 2016, BUDDING YEAST LAB MA; [Anonymous], 1991, Methods Enzymol, V194, P1; Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Ausubel FM, 2010, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bernard M, 1997, J NEUROCHEM, V68, P213; BORJIGIN J, 1995, NATURE, V378, P783, DOI 10.1038/378783a0; Borjigin J, 1999, ANNU REV PHARMACOL, V39, P53, DOI 10.1146/annurev.pharmtox.39.1.53; Borjigin J, 2012, MOL CELL ENDOCRINOL, V349, P13, DOI 10.1016/j.mce.2011.07.009; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chattoraj A, 2009, REV ENDOCR METAB DIS, V10, P237, DOI 10.1007/s11154-009-9125-5; Choi BH, 2004, J NEUROCHEM, V90, P442, DOI 10.1111/j.1471-4159.2004.02495.x; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Coon SL, 2006, MOL CELL ENDOCRINOL, V252, P2, DOI 10.1016/j.mce.2006.03.039; Dorfel MJ, 2015, GENE, V567, P103, DOI 10.1016/j.gene.2015.04.085; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Falcon J, 2014, P NATL ACAD SCI USA, V111, P314, DOI 10.1073/pnas.1312634110; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gandhi AV, 2015, NEURON, V85, P1193, DOI 10.1016/j.neuron.2015.02.016; Ganguly S, 2001, J BIOL CHEM, V276, P47239, DOI 10.1074/jbc.M107222200; Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gonzalez S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001347; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Hardeland R, 2010, CURR NEUROPHARMACOL, V8, P168, DOI 10.2174/157015910792246244; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Huang ZP, 2010, J PINEAL RES, V48, P290, DOI 10.1111/j.1600-079X.2010.00753.x; Huang ZP, 2005, J PINEAL RES, V39, P84, DOI 10.1111/j.1600-079X.2005.00222.x; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jang SW, 2010, P NATL ACAD SCI USA, V107, P3876, DOI 10.1073/pnas.0912531107; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim JM, 2014, CELL CYCLE, V13, P1366, DOI 10.4161/cc.28751; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee KE, 2016, MOL CELLS, V39, P169, DOI 10.14348/molcells.2016.2329; Lee SJ, 2009, J PINEAL RES, V47, P75, DOI 10.1111/j.1600-079X.2009.00690.x; Li J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010051; Liu TC, 2005, J PINEAL RES, V39, P91, DOI 10.1111/j.1600-079X.2005.00223.x; Lynch M, 2007, ORIGINS GENOME ARCHI; Masri S, 2013, NAT REV NEUROSCI, V14, P69, DOI 10.1038/nrn3393; Matsuo M, 2013, FEBS LETT, V587, P1392, DOI 10.1016/j.febslet.2013.03.016; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Mukherjee S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00112; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Obsilova V, 2014, PHYSIOL RES, V63, pS155, DOI 10.33549/physiolres.932659; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Perrot M, 2008, YEAST, V25, P513, DOI 10.1002/yea.1602; Piatkov KI, 2015, MICROB CELL, V2, P376, DOI 10.15698/mic2015.10.231; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Rawashdeh O, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00027; Rivera-Rivera I, 2014, P NATL ACAD SCI USA, V111, pE3853, DOI 10.1073/pnas.1414933111; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; Schippers KJ, 2014, CELL, V159, P9, DOI 10.1016/j.cell.2014.09.004; Schomerus C, 2000, J NEUROCHEM, V75, P2123, DOI 10.1046/j.1471-4159.2000.0752123.x; Schomerus C, 2002, CELL TISSUE RES, V309, P417, DOI 10.1007/s00441-002-0588-x; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; SIKORSKI RS, 1989, GENETICS, V122, P19; Slater M., 2008, PROMEGA NOTES, V100, P16; Sompol P, 2011, P NATL ACAD SCI USA, V108, P8844, DOI 10.1073/pnas.1105114108; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Stehle JH, 2011, J PINEAL RES, V51, P17, DOI 10.1111/j.1600-079X.2011.00856.x; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Szewczuk LM, 2008, BIOCHEMISTRY-US, V47, P10407, DOI 10.1021/bi801189d; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Tosini G, 2012, NEUROSCIENTIST, V18, P645, DOI 10.1177/1073858412446634; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; Varland S, 2015, PROTEOMICS, V15, P2385, DOI 10.1002/pmic.201400619; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wu CG, 2009, METHODS MOL BIOL, V570, P197, DOI 10.1007/978-1-60327-394-7_8; Xiao Q, 2010, BIOCHEMISTRY-US, V49, P5588, DOI 10.1021/bi1005464; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1	102	10	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17178	17196		10.1074/jbc.M116.734640	http://dx.doi.org/10.1074/jbc.M116.734640			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339900	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000382643800022
J	Jin, X; Starke, S; Li, Y; Sethupathi, S; Kung, G; Dodhiawala, P; Wang, YQ				Jin, Xin; Starke, Samuel; Li, Yang; Sethupathi, Sheetal; Kung, George; Dodhiawala, Paarth; Wang, Yuqi			Nitrogen Starvation-induced Phosphorylation of Ras1 Protein and Its Potential Role in Nutrient Signaling and Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ADENYLATE-CYCLASE; ALPHA-SUBUNIT; BUDDING YEAST; AUTOPHAGY; MECHANISM; PATHWAY; MACHINERY; GROWTH; SITES	Ras1 is a small GTPase in the budding yeast Saccharomyces cerevisiae that regulates nutrient signaling. It has been shown that Ras1 undergoes phosphorylation, but the functional consequences and regulation of Ras1 phosphorylation remain unknown. Here we identify Ser-226 as an important residue for Ras1 phosphorylation, as mutating this residue to an alanine drastically diminishes the level of Ras1 phosphorylation. Notably, phosphorylated Ras1 accumulates as the cells approach the stationary phase of growth. Likewise, subjecting cells to nitrogen starvation also elevates the level of Ras1 phosphorylation. Interestingly, blocking Ras1 phosphorylation diminishes the level of autophagy and also renders the cells more sensitive to heat shock. Together, these data suggest a role of Ras1 phosphorylation in modulating nutrient signaling and stress response.	[Jin, Xin; Starke, Samuel; Li, Yang; Sethupathi, Sheetal; Kung, George; Dodhiawala, Paarth; Wang, Yuqi] St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA	Saint Louis University	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA.	ywang8@slu.edu		Li, Yang/0000-0001-5714-0416; Dodhiawala, Paarth/0000-0002-6362-5847	National Institutes of Health [1R15GM106330-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM106330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R15GM106330-01 (to Y. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai XJ, 2010, FEBS LETT, V584, P2333, DOI 10.1016/j.febslet.2010.04.011; Belotti F, 2012, BBA-MOL CELL RES, V1823, P1208, DOI 10.1016/j.bbamcr.2012.04.016; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; COBITZ AR, 1989, P NATL ACAD SCI USA, V86, P858, DOI 10.1073/pnas.86.3.858; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Guimaraes RS, 2015, METHODS, V75, P141, DOI 10.1016/j.ymeth.2014.11.023; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Klionsky DJ, 2013, J INNATE IMMUN, V5, P427, DOI 10.1159/000351979; Li Y, 2013, J BIOL CHEM, V288, P11358, DOI 10.1074/jbc.M112.449751; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Pereira J, 2009, YEAST, V26, P641, DOI 10.1002/yea.1711; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Tamanoi Fuyuhiko, 2011, Genes Cancer, V2, P210, DOI 10.1177/1947601911407322; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; THEVELEIN JM, 1992, ANTON LEEUW INT J G, V62, P109, DOI 10.1007/BF00584466; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Umekawa M., 2012, INT J CELL BIOL, V2012, DOI [DOI 10.1155/2012/142634, 10.1155/ 2012/142634]; Whistler JL, 1997, J BIOL CHEM, V272, P18790, DOI 10.1074/jbc.272.30.18790; Xiao Y, 2000, MOL CELL BIOL, V20, P5447, DOI 10.1128/MCB.20.15.5447-5453.2000	36	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16231	16239		10.1074/jbc.M115.713206	http://dx.doi.org/10.1074/jbc.M115.713206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27261458	hybrid, Green Published			2022-12-28	WOS:000380585400027
J	Tunc-Ozdemir, M; Urano, D; Jaiswal, DK; Clouse, SD; Jones, AM				Tunc-Ozdemir, Meral; Urano, Daisuke; Jaiswal, Dinesh Kumar; Clouse, Steven D.; Jones, Alan M.			Direct Modulation of Heterotrimeric G Protein-coupled Signaling by a Receptor Kinase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; G protein; phosphorylation; receptor protein serine; threonine kinase; regulator of G protein signaling (RGS); receptor-like kinases; BAK1; FLS2; flg22; AtRGS1	CELL-DEATH; INNATE IMMUNITY; DISEASE RESISTANCE; G-ALPHA; ARABIDOPSIS; PHOSPHORYLATION; BAK1; TRAFFICKING; ACTIVATION; INTERACTS	Plants and some protists have heterotrimeric G protein complexes that activate spontaneously without canonical G protein-coupled receptors (GPCRs). In Arabidopsis, the sole 7-transmembrane regulator of G protein signaling 1 (AtRGS1) modulates the G protein complex by keeping it in the resting state (GDP-bound). However, it remains unknown how a myriad of biological responses is achieved with a single G protein modulator. We propose that in complete contrast to G protein activation in animals, plant leucine-rich repeat receptor-like kinases (LRR RLKs), not GPCRs, provide this discrimination through phosphorylation of AtRGS1 in a ligand-dependent manner. G protein signaling is directly activated by the pathogen-associated molecular pattern flagellin peptide 22 through its LRR RLK, FLS2, and co-receptor BAK1.	[Tunc-Ozdemir, Meral; Urano, Daisuke; Jaiswal, Dinesh Kumar; Jones, Alan M.] Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Clouse, Steven D.] North Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Jaiswal, Dinesh Kumar/AAJ-7867-2020; , Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022	Jaiswal, Dinesh Kumar/0000-0003-4478-0080; Urano, Daisuke/0000-0003-4541-1076	National Institutes of Health-NCI [CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER	National Institutes of Health-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is based in part upon work conducted using the UNC Michael Hooker Proteomics Center, which is supported in part by the National Institutes of Health-NCI Grant CA016086 to the Lineberger Comprehensive Cancer Center.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; Bommert P, 2013, NATURE, V502, P555, DOI 10.1038/nature12583; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Clement ST, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004143; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Du JB, 2016, PLANT J, V85, P520, DOI 10.1111/tpj.13125; Fu Y, 2014, CELL, V156, P1084, DOI 10.1016/j.cell.2014.01.013; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Halter T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28944; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Hok S, 2011, PLANT CELL ENVIRON, V34, P1944, DOI 10.1111/j.1365-3040.2011.02390.x; Ishida T, 2014, EMBO REP, V15, P1202, DOI 10.15252/embr.201438660; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Kadota Y, 2015, PLANT CELL PHYSIOL, V56, P1472, DOI 10.1093/pcp/pcv063; Kassel KM, 2010, J BIOL CHEM, V285, P33727, DOI 10.1074/jbc.M110.178566; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Lee SM, 2015, EUR J PHARMACOL, V763, P196, DOI 10.1016/j.ejphar.2015.05.013; Li B, 2016, PROTEIN EXPRES PURIF, V126, P33, DOI 10.1016/j.pep.2016.04.016; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liang XX, 2016, ELIFE, V5, DOI 10.7554/eLife.13568; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Macho AP, 2015, TRENDS PLANT SCI, V20, P269, DOI 10.1016/j.tplants.2015.02.005; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Mitra SK, 2015, PLANT J, V82, P1042, DOI 10.1111/tpj.12863; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Duc NM, 2015, EUR J PHARMACOL, V763, P214, DOI 10.1016/j.ejphar.2015.05.016; Nurnberg B, 1996, BIOCHEM J, V318, P717; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Postel S, 2010, EUR J CELL BIOL, V89, P169, DOI 10.1016/j.ejcb.2009.11.001; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ross A, 2014, EMBO J, V33, P62, DOI 10.1002/embj.201284303; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Torres MP, 2011, J BIOL CHEM, V286, P20208, DOI 10.1074/jbc.M111.239343; Tunc-Ozdemir M, 2016, METHODS MOL BIOL, V1363, P155, DOI 10.1007/978-1-4939-3115-6_13; Urano D, 2014, ANNU REV PLANT BIOL, V65, P365, DOI 10.1146/annurev-arplant-050213-040133; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2013, PLANT PHYSIOL, V161, P1097, DOI 10.1104/pp.112.212324; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang YL, 2014, J PROTEOMICS, V108, P484, DOI 10.1016/j.jprot.2014.06.009; Wang Z, 2011, PLANT J, V67, P1081, DOI 10.1111/j.1365-313X.2011.04659.x; Zhang W, 2008, PLANT J, V56, P984, DOI 10.1111/j.1365-313X.2008.03657.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zulawski M, 2015, METHODS MOL BIOL, V1306, P1, DOI 10.1007/978-1-4939-2648-0_1	54	43	44	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13918	13925		10.1074/jbc.C116.736702	http://dx.doi.org/10.1074/jbc.C116.736702			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27235398	Green Published, hybrid			2022-12-28	WOS:000379975100002
J	Adams, G; Zhou, JJ; Wang, WW; Wu, HH; Quan, J; Liu, YY; Xia, P; Wang, ZK; Zhou, S; Jiang, JY; Mo, F; Zhuang, XX; Thomas, K; Hill, DL; Aikhionbare, FO; He, P; Liu, X; Ding, X; Yao, XB				Adams, Gregory, Jr.; Zhou, Jiajia; Wang, Wenwen; Wu, Huihui; Quan, Jie; Liu, Yingying; Xia, Peng; Wang, Zhikai; Zhou, Shu; Jiang, Jiying; Mo, Fei; Zhuang, Xiaoxuan; Thomas, Kelwyn; Hill, Donald L.; Aikhionbare, Felix O.; He, Ping; Liu, Xing; Ding, Xia; Yao, Xuebiao			The Microtubule Plus End Tracking Protein TIP150 Interacts with Cortactin to Steer Directional Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; cell migration; cell motility; cellular regulation; microtubule; microtubule-associated protein (MAP)	TYROSINE PHOSPHORYLATION; SPINDLE MICROTUBULES; DYNAMIC INSTABILITY; ACTIN CYTOSKELETON; MITOTIC CHECKPOINT; CANCER; LINK; MITOSIS; SRC; COMPLEX	Cell migration is orchestrated by dynamic interactions of microtubules with the plasma membrane cortex. How these interactions facilitate these dynamic processes is still being actively investigated. TIP150 is a newly characterized microtubule plus end tracking protein essential for mitosis and entosis (Ward, T., Wang, M., Liu, X., Wang, Z., Xia, P., Chu, Y., Wang, X., Liu, L., Jiang, K., Yu, H., Yan, M., Wang, J., Hill, D. L., Huang, Y., Zhu, T., and Yao, X. (2013) Regulation of a dynamic interaction between two microtubule-binding proteins, EB1 and TIP150, by the mitotic p300/CBP-associated factor (PCAF) orchestrates kinetochore microtubule plasticity and chromosome stability during mitosis. J. Biol. Chem. 288, 15771-15785; Xia, P., Zhou, J., Song, X., Wu, B., Liu, X., Li, D., Zhang, S., Wang, Z., Yu, H., Ward, T., Zhang, J., Li, Y., Wang, X., Chen, Y., Guo, Z., and Yao, X. (2014) Aurora A orchestrates entosis by regulating a dynamic MCAK-TIP150 interaction. J. Mol. Cell Biol. 6, 240-254). Here we show that TIP150 links dynamic microtubules to steer cell migration by interacting with cortactin. Mechanistically, TIP150 binds to cortactin via its C-terminal tail. Interestingly, the C-terminal TIP150 proline-rich region (CT150) binds to the Src homology 3 domain of cortactin specifically, and such an interaction is negatively regulated by EGF-elicited tyrosine phosphorylation of cortactin. Importantly, suppression of TIP150 or overexpression of phospho-mimicking cortactin inhibits polarized cell migration. In addition, CT150 disrupts the biochemical interaction between TIP150 and cortactin in vitro, and perturbation of the TIP150-cortactin interaction in vivo using a membrane-permeable TAT-CT150 peptide results in an inhibition of directional cell migration. We reason that a dynamic TIP150-cortactin interaction orchestrates directional cell migration via coupling dynamic microtubule plus ends to the cortical cytoskeleton.	[Adams, Gregory, Jr.; Zhou, Jiajia; Wang, Wenwen; Wu, Huihui; Quan, Jie; Liu, Yingying; Xia, Peng; Wang, Zhikai; Zhou, Shu; Jiang, Jiying; Mo, Fei; Zhuang, Xiaoxuan; Liu, Xing; Ding, Xia] Univ Sci & Technol China, BUCM Sch Basic Med Sci, BUCM MSM Joint Res Grp Cellular Dynam, Hefei 230026, Anhui, Peoples R China; [Adams, Gregory, Jr.; Zhou, Jiajia; Wang, Wenwen; Wu, Huihui; Quan, Jie; Liu, Yingying; Xia, Peng; Wang, Zhikai; Zhou, Shu; Jiang, Jiying; Mo, Fei; Zhuang, Xiaoxuan; Liu, Xing; Ding, Xia] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Anhui, Peoples R China; [Adams, Gregory, Jr.; Wang, Wenwen; Wu, Huihui; Liu, Yingying; Wang, Zhikai; He, Ping; Liu, Xing; Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, 720 Westview Dr Sw, Atlanta, GA 30310 USA; [Thomas, Kelwyn; Aikhionbare, Felix O.] Morehouse Sch Med, Dept Med & Neurobiol, Atlanta, GA 30310 USA; [Hill, Donald L.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [He, Ping] Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Morehouse School of Medicine; University of Alabama System; University of Alabama Birmingham	Liu, X; Ding, X (corresponding author), Univ Sci & Technol China, BUCM Sch Basic Med Sci, BUCM MSM Joint Res Grp Cellular Dynam, Hefei 230026, Anhui, Peoples R China.; Liu, X; Ding, X (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Anhui, Peoples R China.; He, P; Liu, X (corresponding author), Morehouse Sch Med, Dept Physiol, 720 Westview Dr Sw, Atlanta, GA 30310 USA.; He, P (corresponding author), Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.	heping-2008@163.com; xing1017@ustc.edu.cn; dingx@bucm.edu.cn	Yao, Xuebiao/P-5771-2014; Mo, Fei/R-7626-2019; Zhuang, Xiaoxuan/R-7836-2019; WANG, WENWEN/AAF-1080-2020; Liu, Xing/H-2989-2018; LIU, YING/GZL-7252-2022	Zhuang, Xiaoxuan/0000-0003-4004-5329; WANG, WENWEN/0000-0002-1545-4369; Liu, Xing/0000-0002-7480-5085; Mo, Fei/0000-0002-8601-2568	Chinese 973 Project [2012CB917204, 2013CB911203, 2012CB713704]; Chinese Academy of Science [KSCX2-YW-H-10]; Anhui Province Key Project Grant [08040102005]; Natural Science Foundation of China [31320103904, 31430054, 91313303, 31501130, 31501095]; MOE Innovative Team Grant [IRT13038]; Fundamental Research Funds for the Central Universities Grant [WK2070000066]; Chinese Academy of Sciences Center of Excellence [2015HSC-UE010]; National Institutes of Health [DK56292, CA146133]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Anhui Province Key Project Grant; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE Innovative Team Grant; Fundamental Research Funds for the Central Universities Grant(Fundamental Research Funds for the Central Universities); Chinese Academy of Sciences Center of Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Chinese 973 Project Grants 2012CB917204, 2013CB911203, and 2012CB713704; Chinese Academy of Science Grant KSCX2-YW-H-10; Anhui Province Key Project Grant 08040102005; Natural Science Foundation of China Grants 31320103904, 31430054, 91313303, 31501130, and 31501095; MOE Innovative Team Grant IRT13038, Fundamental Research Funds for the Central Universities Grant WK2070000066; Chinese Academy of Sciences Center of Excellence Grant 2015HSC-UE010; and National Institutes of Health Grants DK56292 and CA146133. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Crostella L, 2001, ONCOGENE, V20, P3735, DOI 10.1038/sj.onc.1204474; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Duplan MB, 2014, MOL CELL BIOL, V34, P16, DOI 10.1128/MCB.00578-13; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Garcia JGN, 1999, AM J PHYSIOL-LUNG C, V276, pL989, DOI 10.1152/ajplung.1999.276.6.L989; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Lopez MP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5778; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mo F, 2016, NAT CHEM BIOL, V12, P226, DOI [10.1038/NCHEMBIO.2017, 10.1038/nchembio.2017]; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Wang WQ, 2008, J CELL SCI, V121, P1334, DOI 10.1242/jcs.018176; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Ward T, 2013, J BIOL CHEM, V288, P15771, DOI 10.1074/jbc.M112.448886; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Zhang LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01681; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425	44	16	16	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20692	20706		10.1074/jbc.M116.732719	http://dx.doi.org/10.1074/jbc.M116.732719			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27451391	hybrid, Green Published			2022-12-28	WOS:000384574800031
J	Jaiswal, M; Fansa, EK; Kosling, SK; Mejuch, T; Waldmann, H; Wittinghofer, A				Jaiswal, Mamta; Fansa, Eyad K.; Koesling, Stefanie K.; Mejuch, Tom; Waldmann, Herbert; Wittinghofer, Alfred			Novel Biochemical and Structural Insights into the Interaction of Myristoylated Cargo with Unc119 Protein and Their Release by Arl2/3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cilia; lipid binding protein; protein myristoylation; small GTPase; sorting; cilia; Unc119 proteins; releasing factor; myristoylated proteins; Arl2/3	PRIMARY CILIUM; TYROSINE KINASES; SENSORY CILIA; MEMBRANE; TRAFFICKING; TRANSPORT; LOCALIZATION; DISEASE; BINDING; FAMILY	Primary cilia are highly specialized small antenna-like cellular protrusions that extend from the cell surface of many eukaryotic cell types. The protein content inside cilia and cytoplasm is very different, but details of the sorting process are not understood for most ciliary proteins. Recently, we have shown that prenylated proteins are sorted according to their affinity to the carrier protein PDE6 and the ability of Arl3 but not Arl2 to release high affinity cargo inside the cilia (Fansa, E. K., Kosling, S. K., Zent, E., Wittinghofer, A., and Ismail, S. (2016) Nat. Commun. 7, 11366). Here we address the question whether a similar principle governs the transport of myristoylated cargo by the carrier proteins Unc119a and Unc119b. We thus analyzed the binding strength of N-terminal myristoylated cargo peptides (GNAT1, NPHP3, Cystin1, RP2, and Src) to Unc119a and Unc119b proteins. The affinity between myristoylated cargo and carrier protein, Unc119, varies between subnanomolar and micromolar. Peptides derived from ciliary localizing proteins (GNAT1, NPHP3, and Cystin1) bind with high affinity to Unc119 proteins, whereas a peptide derived from a non-ciliary localizing protein (Src) has low affinity. The peptide with intermediate affinity (RP2) is localized at the ciliary transition zone as a gate keeper. We show that the low affinity peptides are released by both Arl2<bold>GppNHp and Arl</bold>3<bold>GppNHp</bold>, whereas the high affinity peptides are exclusively released by only Arl3<bold>GppNHp</bold>. Determination of the x-ray structure of myristoylated NPHP3 peptide in complex with Unc119a reveals the molecular details of high affinity binding and suggests the importance of the residues at the +2 and +3 positions relative to the myristoylated glycine for high and low affinities. The mutational analysis of swapping the residues at the +2 and +3 positions between high and low affinity peptides results in reversing their affinities for Unc119a and leads to a partial mislocalization of a low affinity mutant of NPHP3.	[Jaiswal, Mamta; Fansa, Eyad K.; Koesling, Stefanie K.; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Struct Biol Grp, Otto Hahn Str 11, D-44227 Dortmund, Germany; [Mejuch, Tom; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, Otto Hahn Str 11, D-44227 Dortmund, Germany	Max Planck Society; Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Struct Biol Grp, Otto Hahn Str 11, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Waldmann, Herbert/B-7406-2017; jaiswal, mamta/E-5148-2016	Waldmann, Herbert/0000-0002-9606-7247; jaiswal, mamta/0000-0002-5862-7506	European Research Council (ERC) [268782]; Sonderforschungsbereich-DFG Grant [SFB 642]	European Research Council (ERC)(European Research Council (ERC)); Sonderforschungsbereich-DFG Grant	This work was supported by European Research Council (ERC) Grant 268782 and Sonderforschungsbereich-DFG Grant SFB 642. The authors declare that they have no conflicts of interest with the contents of this article.	ALLEN RA, 1965, J ULTRA MOL STRUCT R, V12, P730, DOI 10.1016/S0022-5320(65)80058-2; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; Constantine R, 2012, VISION RES, V75, P26, DOI 10.1016/j.visres.2012.08.012; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Fansa EK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11366; Gorska MM, 2006, J BIOL CHEM, V281, P14429, DOI 10.1074/jbc.M512718200; Gorska MM, 2012, CURR ALLERGY ASTHM R, V12, P396, DOI 10.1007/s11882-012-0281-4; Gorska MM, 2009, J IMMUNOL, V183, P1675, DOI 10.4049/jimmunol.0900792; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; Higashide T, 1998, INVEST OPHTH VIS SCI, V39, P690; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Kapoor S, 2015, BIOPHYS J, V109, P1619, DOI 10.1016/j.bpj.2015.08.033; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; Lee Y, 2013, CELL CYCLE, V12, P1303, DOI 10.4161/cc.24404; LEREA CL, 1989, NEURON, V3, P367, DOI 10.1016/0896-6273(89)90261-4; Lokaj M, 2015, STRUCTURE, V23, P2122, DOI 10.1016/j.str.2015.08.016; Mejuch T, 2015, CHEMBIOCHEM, V16, P2460, DOI 10.1002/cbic.201500355; Nachury MV, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0465; Najafi M, 2012, VISION RES, V75, P11, DOI 10.1016/j.visres.2012.08.006; Najafi M, 2012, P NATL ACAD SCI USA, V109, P203, DOI 10.1073/pnas.1115109109; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Shiba D, 2010, CYTOSKELETON, V67, P112, DOI 10.1002/cm.20428; SILVERMAN L, 1993, CELL GROWTH DIFFER, V4, P475; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Swanson DA, 1998, INVEST OPHTH VIS SCI, V39, P2085; Tao BL, 2009, J AM SOC NEPHROL, V20, P2570, DOI 10.1681/ASN.2009020188; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Vepachedu R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005211; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Zhang HB, 2012, VISION RES, V75, P19, DOI 10.1016/j.visres.2012.08.013; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	57	34	34	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20766	20778		10.1074/jbc.M116.741827	http://dx.doi.org/10.1074/jbc.M116.741827			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27481943	Green Published, hybrid			2022-12-28	WOS:000384574800037
J	Yariswamy, M; Yoshida, T; Valente, AJ; Kandikattu, HK; Sakamuri, SSVP; Siddesha, JM; Sukhanov, S; Saifudeen, Z; Ma, LX; Siebenlist, U; Gardner, JD; Chandrasekar, B				Yariswamy, Manjunath; Yoshida, Tadashi; Valente, Anthony J.; Kandikattu, Hemanth Kumar; Sakamuri, Siva S. V. P.; Siddesha, Jalahalli M.; Sukhanov, Sergiy; Saifudeen, Zubaida; Ma, Lixin; Siebenlist, Ulrich; Gardner, Jason D.; Chandrasekar, Bysani			Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; cardiac hypertrophy; extracellular matrix; fibrosis; heart failure	NF-KAPPA-B; HEART-FAILURE; DIASTOLIC DYSFUNCTION; SIGNALING PATHWAY; ACT1; INFLAMMATION; ACTIVATION; KINASE; CARDIOMYOPATHY; CONTRIBUTES	TRAF3IP2 (TRAF3 interacting protein 2; previously known as CIKS or Act1) is a key intermediate in the normal inflammatory response and the pathogenesis of various autoimmune and inflammatory diseases. Induction of TRAF3IP2 activates IB kinase (IKK)/NF-B, JNK/AP-1, and c/EBP and stimulates the expression of various inflammatory mediators with negative myocardial inotropic effects. To investigate the role of TRAF3IP2 in heart disease, we generated a transgenic mouse model with cardiomyocyte-specific TRAF3IP2 overexpression (TRAF3IP2-Tg). Echocardiography, magnetic resonance imaging, and pressure-volume conductance catheterization revealed impaired cardiac function in 2-month-old male transgenic (Tg) mice as evidenced by decreased ejection fraction, stroke volume, cardiac output, and peak ejection rate. Moreover, the male Tg mice spontaneously developed myocardial hypertrophy (increased heart/body weight ratio, cardiomyocyte cross-sectional area, GATA4 induction, and fetal gene re-expression). Furthermore, TRAF3IP2 overexpression resulted in the activation of IKK/NF-B, JNK/AP-1, c/EBP, and p38 MAPK and induction of proinflammatory cytokines, chemokines, and extracellular matrix proteins in the heart. Although myocardial hypertrophy decreased with age, cardiac fibrosis (increased number of myofibroblasts and enhanced expression and deposition of fibrillar collagens) increased progressively. Despite these adverse changes, TRAF3IP2 overexpression did not result in cell death at any time period. Interestingly, despite increased mRNA expression, TRAF3IP2 protein levels and activation of its downstream signaling intermediates remained unchanged in the hearts of female Tg mice. The female Tg mice also failed to develop myocardial hypertrophy. In summary, these results demonstrate that overexpression of TRAF3IP2 in male mice is sufficient to induce myocardial hypertrophy, cardiac fibrosis, and contractile dysfunction.	[Yariswamy, Manjunath; Yoshida, Tadashi; Kandikattu, Hemanth Kumar; Sukhanov, Sergiy; Chandrasekar, Bysani] Univ Missouri, Dept Med, Columbia, MO 65211 USA; [Ma, Lixin] Univ Missouri, Dept Radiol, Columbia, MO 65211 USA; [Yariswamy, Manjunath; Ma, Lixin; Chandrasekar, Bysani] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Valente, Anthony J.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Sakamuri, Siva S. V. P.; Siddesha, Jalahalli M.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Saifudeen, Zubaida] Tulane Univ, Sch Med, Dept Pediat Nephrol, New Orleans, LA 70112 USA; [Siebenlist, Ulrich] NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gardner, Jason D.] Louisiana State Univ, Dept Physiol, Hlth Sci Ctr, New Orleans, LA 70112 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Texas System; University of Texas Health San Antonio; Tulane University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Chandrasekar, B (corresponding author), Univ Missouri, Sch Med, Med Cardiol, 1 Hosp Dr, Columbia, MO 65212 USA.	chandrasekarb@health.missouri.edu	Kandikattu, Hemanth Kumar/AAW-7746-2020	Kandikattu, Hemanth Kumar/0000-0001-5114-3341; Sukhanov, Sergiy/0000-0002-9223-4263; Yoshida, Tadashi/0000-0002-4544-1497; Ma, Lixin/0000-0003-2171-1226; Sakamuri, Siva Sankara Vara Prasad/0000-0003-3569-9985	Biomolecular Imaging Center at the Harry S. Truman Memorial Veterans' Hospital; University of Missouri-Columbia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106392, P20GM103629] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002255] Funding Source: NIH RePORTER	Biomolecular Imaging Center at the Harry S. Truman Memorial Veterans' Hospital; University of Missouri-Columbia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Jiao Liu and Van Ninh for assistance with immunofluorescence and echocardiography, respectively. We gratefully acknowledge the support of the Biomolecular Imaging Center at the Harry S. Truman Memorial Veterans' Hospital and the University of Missouri-Columbia.	Auger-Messier M, 2013, CIRC RES, V112, P48, DOI 10.1161/CIRCRESAHA.112.272963; Barin JG, 2012, IMMUNOBIOLOGY, V217, P468, DOI 10.1016/j.imbio.2011.06.009; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chorianopoulos E, 2010, BASIC RES CARDIOL, V105, P301, DOI 10.1007/s00395-009-0046-y; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; DeSelm CJ, 2012, J CELL BIOCHEM, V113, P2895, DOI 10.1002/jcb.24165; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Frantz S, 2006, FASEB J, V20, P1918, DOI 10.1096/fj.05-5133fje; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Fu XX, 2015, INT J MOL MED, V36, P83, DOI 10.3892/ijmm.2015.2204; Hamid T, 2011, CARDIOVASC RES, V89, P129, DOI 10.1093/cvr/cvq274; Heymans S, 2009, EUR J HEART FAIL, V11, P119, DOI 10.1093/eurjhf/hfn043; Hou JL, 2012, PHARMACOL THERAPEUT, V135, P337, DOI 10.1016/j.pharmthera.2012.06.006; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Jia GH, 2015, HYPERTENSION, V66, P1159, DOI 10.1161/HYPERTENSIONAHA.115.06015; Kanamori M, 2002, FEBS LETT, V532, P241, DOI 10.1016/S0014-5793(02)03688-8; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kawamura N, 2005, CARDIOVASC RES, V66, P520, DOI 10.1016/j.cardiores.2005.02.007; Koitabashi N, 2007, HYPERTENSION, V49, P1120, DOI 10.1161/HYPERTENSIONAHA.106.077537; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Lajiness JD, 2012, J CARDIOVASC TRANSL, V5, P739, DOI 10.1007/s12265-012-9394-3; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Liu YF, 2012, INT IMMUNOL, V24, P605, DOI 10.1093/intimm/dxs056; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lopez B, 2012, HYPERTENSION, V60, P677, DOI 10.1161/HYPERTENSIONAHA.112.196113; Lorell BH, 2000, CIRCULATION, V102, P470; Maier HJ, 2012, P NATL ACAD SCI USA, V109, P11794, DOI 10.1073/pnas.1116584109; Mann DL, 2002, J CARD FAIL, V8, pS379, DOI 10.1054/jcaf.2002.129253; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 2011, CIRC RES, V108, P277, DOI 10.1161/RES.0b013e31820ff484; Nagalla KT, 2012, EXP BIOL MED, V237, P24, DOI 10.1258/ebm.2011.011180; Papachroni KK, 2010, J CELL MOL MED, V14, P2460, DOI 10.1111/j.1582-4934.2009.00841.x; Pisitkun P, 2010, ARTHRITIS RHEUM-US, V62, P3334, DOI 10.1002/art.27653; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Ricci R, 2005, GENE DEV, V19, P208, DOI 10.1101/gad.327005; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Sakamuri SSVP, 2016, ATHEROSCLEROSIS, V252, P153, DOI 10.1016/j.atherosclerosis.2016.05.029; Sonder SU, 2012, J IMMUNOL, V188, P5906, DOI 10.4049/jimmunol.1103233; Taube D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069832; Valente AJ, 2013, CELL SIGNAL, V25, P2176, DOI 10.1016/j.cellsig.2013.07.013; Valente AJ, 2012, J MOL CELL CARDIOL, V53, P113, DOI 10.1016/j.yjmcc.2012.04.009; Valente AJ, 2012, CELL SIGNAL, V24, P560, DOI 10.1016/j.cellsig.2011.10.010; VANMOURIK JA, 1985, J BIOL CHEM, V260, P1300; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wu L, 2012, ADV EXP MED BIOL, V946, P223, DOI 10.1007/978-1-4614-0106-3_13	55	17	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19425	19436		10.1074/jbc.M116.724138	http://dx.doi.org/10.1074/jbc.M116.724138			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27466370	Green Published, hybrid			2022-12-28	WOS:000383242800021
J	Bolognini, D; Moss, CE; Nilsson, K; Petersson, AU; Donnelly, I; Sergeev, E; Konig, GM; Kostenis, E; Kurowska-Stolarska, M; Miller, A; Dekker, N; Tobin, AB; Milligan, G				Bolognini, Daniele; Moss, Catherine E.; Nilsson, Karolina; Petersson, Annika U.; Donnelly, Iona; Sergeev, Eugenia; Koenig, Gabriele M.; Kostenis, Evi; Kurowska-Stolarska, Mariola; Miller, Ashley; Dekker, Niek; Tobin, Andrew B.; Milligan, Graeme			A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique G(i)-functional Bias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; FUNCTIONAL-CHARACTERIZATION; GUT MICROBIOTA; FFA2; PHARMACOLOGY; MECHANISM; AGONISTS; BINDING; LIGAND; GPR43	The short chain fatty acid receptor FFA2 is able to stimulate signaling via both G(i)- and G(q)/G(11)-promoted pathways. These pathways are believed to control distinct physiological end points but FFA2 receptor ligands appropriate to test this hypothesis have been lacking. Herein, we characterize AZ1729, a novel 142A2 regulator that acts as a direct allosteric agonist and as a positive allosteric modulator, increasing the activity of the endogenously produced short chain fatty acid propionate in G(i)-mediated pathways, but not at those transduced by G(q)/G(11). Using AZ1729 in combination with direct inhibitors of G(i) and G(q)/G(11) family G proteins demonstrated that although both arms contribute to propionate-mediated regulation of phospho-ERK1/2 MAP kinase signaling in FFA2-expressing 293 cells, the G(q)/G(11)-mediated pathway is predominant. We extend these studies by employing AZ1729 to dissect physiological FFA2 signaling pathways. The capacity of AZ1729 to act at FFA2 receptors to inhibit beta-adrenoreceptor agonist-promoted lipolysis in primary mouse adipocytes and to promote chemotaxis of isolated human neutrophils confirmed these as FFA2 processes mediated by G(i) signaling, whereas, in concert with blockade by the G(q)/G(11) inhibitor FR900359, the inability of AZ1729 to mimic or regulate propionate-mediated release of GLP-1 from mouse colonic preparations defined this physiological response as an end point transduced via activation of G(q)/G(11).	[Bolognini, Daniele; Moss, Catherine E.; Sergeev, Eugenia] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow G12 8QQ, Lanark, Scotland; [Moss, Catherine E.; Tobin, Andrew B.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Nilsson, Karolina] AstraZeneca, Cardiovasc & Metab Dis, Pepparedsleden 1, SE-43183 Molndal, Sweden; [Nilsson, Karolina] AstraZeneca, Resp Inflammatory & Autoimmune Dis Innovat Med &, Dept Med Chem, Pepparedsleden 1, SE-43183 Molndal, Sweden; [Dekker, Niek] AstraZeneca, Discovery Sci Reagents & Assay Dev, Pepparedsleden 1, SE-43183 Molndal, Sweden; [Donnelly, Iona; Miller, Ashley] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Kostenis, Evi] Univ Bonn, Mol Cellular & Pharmacobiol Sect, D-53115 Bonn, Germany; [Koenig, Gabriele M.] Univ Bonn, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Kurowska-Stolarska, Mariola] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Leicester; AstraZeneca; AstraZeneca; AstraZeneca; University of Glasgow; University of Bonn; University of Bonn; University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Kurowska-Stolarska, Mariola/AAD-1683-2019; Bolognini, Daniele/AAF-7892-2020; Hodge, Daryl/AAL-2993-2021	Hodge, Daryl/0000-0003-2288-7020; Sergeev, Eugenia/0000-0001-8271-3693	Biotechnology and Biosciences Research Council [BB/L027887/1, BB/L02781X/1]; German Research Foundation (DFG) [FR900359, FOR2372]; BBSRC [BB/K019856/1, BB/K019856/2, BB/L02781X/1, BB/L027887/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L027887/1, BB/L02781X/1, 1653478, BB/K019856/1, BB/K019856/2] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Research Foundation (DFG)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biosciences Research Council Grants BB/L027887/1 (to G. M. and A. M. M.) and BB/L02781X/1 (to A. B. T.) and German Research Foundation (DFG) (to G. M. K. and E K.) for isolation and characterization of FR900359 Grant FOR2372. N.D., K.N., and A. U. P. are employees of AstraZeneca.	Alvarez-Curto E., 2016, BIOCH PHARM; Ang ZW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00028; Berg S., 2007, Int. Pat., Patent No. [WO2007120096, 2007120096]; Boerrigter G, 2012, CIRC-HEART FAIL, V5, P627, DOI 10.1161/CIRCHEARTFAILURE.112.969220; Bolognini D, 2016, MOL PHARMACOL, V89, P388, DOI 10.1124/mol.115.102301; Brown A. J., 2003, J BIOL; Busnelli M, 2012, J BIOL CHEM, V287, P3617, DOI 10.1074/jbc.M111.277178; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Dass NB, 2007, NEUROGASTROENT MOTIL, V19, P66, DOI 10.1111/j.1365-2982.2006.00853.x; den Besten G, 2013, AM J PHYSIOL-GASTR L, V305, pG900, DOI 10.1152/ajpgi.00265.2013; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Due-Hansen ME, 2016, ORG BIOMOL CHEM, V14, P430, DOI 10.1039/c5ob02129d; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Grundmann M, 2016, CELL CHEM BIOL, V23, P392, DOI 10.1016/j.chembiol.2016.02.014; Hii CS, 2004, J BIOL CHEM, V279, P49825, DOI 10.1074/jbc.M406892200; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Hudson BD, 2013, J BIOL CHEM, V288, P17296, DOI 10.1074/jbc.M113.455337; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Kenakin T, 2015, MOL PHARMACOL, V88, P1055, DOI 10.1124/mol.115.099770; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2010, J RECEPT SIG TRANSD, V30, P313, DOI 10.3109/10799893.2010.503964; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kimura I, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00085; Langmead CJ, 2011, METHODS MOL BIOL, V746, P195, DOI 10.1007/978-1-61779-126-0_10; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Liu Y. P., 2015, J ADV CLIN PHARM, V1, P1, DOI DOI 10.1109/TCYB.2015.2388582; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; M'Kadmi C, 2015, J BIOL CHEM, V290, P27021, DOI 10.1074/jbc.M115.659250; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Milligan G, 2017, CHEM REV, V117, P67, DOI 10.1021/acs.chemrev.6b00056; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Mohammad S, 2015, CURR DRUG TARGETS, V16, P771, DOI 10.2174/1389450116666150408103557; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Park BO, 2016, EUR J PHARMACOL, V771, P1, DOI 10.1016/j.ejphar.2015.12.010; Pizzonero M, 2014, J MED CHEM, V57, P10044, DOI 10.1021/jm5012885; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rodrigues H. G., 2015, EUR J PHARM; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sergeev E, 2016, J BIOL CHEM, V291, P303, DOI 10.1074/jbc.M115.687939; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2	56	45	45	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18915	18931		10.1074/jbc.M116.736157	http://dx.doi.org/10.1074/jbc.M116.736157			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27385588	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000383242300028
J	Serebryany, E; Woodard, JC; Adkar, BV; Shabab, M; King, JA; Shakhnovich, EI				Serebryany, Eugene; Woodard, Jaie C.; Adkar, Bharat V.; Shabab, Mohammed; King, Jonathan A.; Shakhnovich, Eugene I.			An Internal Disulfide Locks a Misfolded Aggregation-prone Intermediate in Cataract-linked Mutants of Human gamma D-Crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN AGGREGATION; IN-VITRO; HUMAN LENS; DEAMIDATION DESTABILIZES; HYDROPHOBIC INTERIOR; NUCLEAR CATARACT; FIBRIL FORMATION; ALPHA-SYNUCLEIN; KINETIC TRAP	Considerable mechanistic insight has been gained into amyloid aggregation; however, a large number of non-amyloid protein aggregates are considered "amorphous," and in most cases, little is known about their mechanisms. Amorphous aggregation of gamma-crystallins in the eye lens causes cataract, a widespread disease of aging. We combined simulations and experiments to study the mechanism of aggregation of two gamma D-crystallin mutants, W42R and W42Q: the former a congenital cataract mutation, and the latter a mimic of age-related oxidative damage. We found that formation of an internal disulfide was necessary and sufficient for aggregation under physiological conditions. Two-chain all-atom simulations predicted that one non-native disulfide in particular, between Cys(32) and Cys(41), was likely to stabilize an unfolding intermediate prone to intermolecular interactions. Mass spectrometry and mutagenesis experiments confirmed the presence of this bond in the aggregates and its necessity for oxidative aggregation under physiological conditions in vitro. Mining the simulation data linked formation of this disulfide to extrusion of the N-terminal beta-hairpin and rearrangement of the native beta-sheet topology. Specific binding between the extruded hairpin and a distal beta-sheet, in an intermolecular chain reaction similar to domain swapping, is the most probable mechanism of aggregate propagation.	[Serebryany, Eugene; Shabab, Mohammed; King, Jonathan A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Woodard, Jaie C.; Adkar, Bharat V.; Shakhnovich, Eugene I.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University	King, JA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shakhnovich, EI (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jaking@mit.edu; shakhnovich@chemistry.harvard.edu	Serebryany, Eugene/E-4595-2017; Adkar, Bharat Vighnahar/AAP-2634-2021	Adkar, Bharat Vighnahar/0000-0002-9168-051X	National Institutes of Health [R01 GM111955, R01 EY015834]; National Institutes of Health Biophysics Training Grant; MIT Biology; Whitehead Institute for Biomedical Research; NATIONAL EYE INSTITUTE [R01EY015834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111955, T32GM008313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Biology; Whitehead Institute for Biomedical Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM111955 (to E. I. S.); a National Institutes of Health Biophysics Training Grant (to J. C. W.); National Institutes of Health Grant R01 EY015834 (to J. A. K.); and fellowships from MIT Biology and the Whitehead Institute for Biomedical Research (to E. S.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Borgia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9861; Borgia MB, 2013, J AM CHEM SOC, V135, P6456, DOI 10.1021/ja308852b; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; Chang JY, 2001, J BIOL CHEM, V276, P4845, DOI 10.1074/jbc.M005160200; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Cutler TA, 2009, J MOL BIOL, V386, P854, DOI 10.1016/j.jmb.2008.10.090; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Das P, 2010, PROTEIN SCI, V19, P131, DOI 10.1002/pro.296; de Graff AMR, 2016, STRUCTURE, V24, P329, DOI 10.1016/j.str.2015.11.006; Dima RI, 2002, PROTEIN SCI, V11, P1036, DOI 10.1110/ps.4220102; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Fan XJ, 2015, MOL CELL PROTEOMICS, V14, P3211, DOI 10.1074/mcp.M115.050948; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Fraga H, 2014, J BIOL CHEM, V289, P9852, DOI 10.1074/jbc.M114.553479; FRIEDBURG D, 1973, EXP EYE RES, V15, P173, DOI 10.1016/0014-4835(73)90116-4; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Garcia-Manyes S, 2016, J BIOL CHEM, V291, P4226, DOI 10.1074/jbc.M115.673871; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Hains PG, 2008, BBA-PROTEINS PROTEOM, V1784, P1959, DOI 10.1016/j.bbapap.2008.07.016; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; Jung J., 2013, J BIOL CHEM, V288, P99; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 2014, PROG BIOPHYS MOL BIO, V115, P21, DOI 10.1016/j.pbiomolbio.2014.02.004; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Mahler B, 2011, J MOL BIOL, V405, P840, DOI 10.1016/j.jmb.2010.11.005; Maisonneuve P, 2016, J BIOL CHEM, V291, P16699, DOI 10.1074/jbc.M115.707208; Metlapally S, 2008, EXP EYE RES, V86, P434, DOI 10.1016/j.exer.2007.11.018; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Moran SD, 2013, BIOCHEMISTRY-US, V52, P6169, DOI 10.1021/bi4008353; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Narayan M, 2012, FEBS J, V279, P2272, DOI 10.1111/j.1742-4658.2012.08636.x; OZAKI Y, 1987, J BIOL CHEM, V262, P15445; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Quintanar L, 2016, ACS CHEM BIOL, V11, P263, DOI 10.1021/acschembio.5b00919; Rains P. G., 2007, J PROTEOME RES, V6, P3935; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Reddy G, 2009, J PHYS CHEM B, V113, P1162, DOI 10.1021/jp808914c; Robinson AC, 2014, P NATL ACAD SCI USA, V111, P11685, DOI 10.1073/pnas.1402900111; Robrnan L., 2005, EYE, V19, P1074; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Schafheimer N, 2013, PHOTOCHEM PHOTOBIOL, V89, P1106, DOI 10.1111/php.12096; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Serebryany E, 2016, PROTEIN SCI, V25, P1115, DOI 10.1002/pro.2924; Serebryany E, 2015, J BIOL CHEM, V290, P11491, DOI 10.1074/jbc.M114.621581; Serebryany E, 2014, PROG BIOPHYS MOL BIO, V115, P32, DOI 10.1016/j.pbiomolbio.2014.05.002; Shang F, 2004, EXP EYE RES, V78, P1, DOI 10.1016/j.exer.2003.10.003; Shu M, 2013, P NATL ACAD SCI USA, V110, pE1669, DOI 10.1073/pnas.1305475110; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Takata T, 2008, PROTEIN SCI, V17, P1565, DOI 10.1110/ps.035410.108; Tian J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004207; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Truscott RE, 2007, PROTEIN MISFOLDING A, P435; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Wommack AJ, 2014, J AM CHEM SOC, V136, P13494, DOI 10.1021/ja505957w; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Xu JB, 2011, PROTEINS, V79, P1704, DOI 10.1002/prot.22993; Yang JS, 2008, P NATL ACAD SCI USA, V105, P895, DOI 10.1073/pnas.0707284105; Yang JS, 2007, STRUCTURE, V15, P53, DOI 10.1016/j.str.2006.11.010; Zhang J, 2012, INVEST OPHTH VIS SCI, V53, P7276, DOI 10.1167/iovs.12-10482; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	78	39	39	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19172	19183		10.1074/jbc.M116.735977	http://dx.doi.org/10.1074/jbc.M116.735977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27417136	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000383242300048
J	Olenick, MA; Tokito, M; Boczkowska, M; Dominguez, R; Holzbaur, ELF				Olenick, Mara A.; Tokito, Mariko; Boczkowska, Malgorzata; Dominguez, Roberto; Holzbaur, Erika L. F.			Hook Adaptors Induce Unidirectional Processive Motility by Enhancing the Dynein-Dynactin Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; dynein; intracellular trafficking; kinesin; microtubule	CYTOPLASMIC DYNEIN; AXONAL-TRANSPORT; STRUCTURAL BASIS; EARLY ENDOSOMES; PROTEIN; CARGO; COMPLEX; BINDING; MICROTUBULES; AUTOINHIBITION	Cytoplasmic dynein drives the majority of minus end-directed vesicular and organelle motility in the cell. However, it remains unclear how dynein is spatially and temporally regulated given the variety of cargo that must be properly localized to maintain cellular function. Recent work has suggested that adaptor proteins provide a mechanism for cargo-specific regulation of motors. Of particular interest, studies in fungal systems have implicated Hook proteins in the regulation of microtubule motors. Here we investigate the role of mammalian Hook proteins, Hook1 and Hook3, as potential motor adaptors. We used optogenetic approaches to specifically recruit Hook proteins to organelles and observed rapid transport of peroxisomes to the perinuclear region of the cell. This rapid and efficient translocation of peroxisomes to microtubule minus ends indicates that mammalian Hook proteins activate dynein rather than kinesin motors. Biochemical studies indicate that Hook proteins interact with both dynein and dynactin, stabilizing the formation of a supramolecular complex. Complex formation requires the N-terminal domain of Hook proteins, which resembles the calponin-homology domain of end-binding (EB) proteins but cannot bind directly to microtubules. Single-molecule motility assays using total internal reflection fluorescence microscopy indicate that both Hook1 and Hook3 effectively activate cytoplasmic dynein, inducing longer run lengths and higher velocities than the previously characterized dynein activator bicaudal D2 (BICD2). Together, these results suggest that dynein adaptors can differentially regulate dynein to allow for organelle-specific tuning of the motor for precise intracellular trafficking.	[Olenick, Mara A.; Tokito, Mariko; Boczkowska, Malgorzata; Dominguez, Roberto; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Dept Physiol, 630 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA; [Olenick, Mara A.; Tokito, Mariko; Boczkowska, Malgorzata; Dominguez, Roberto; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Olenick, Mara A.; Dominguez, Roberto; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Holzbaur, ELF (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, 630 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu			National Institutes of Health [GM087253, T32 GM07229]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229, P01GM087253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01 domain, and a variable and predicted unstructured C-terminal GM087253 (to E. L. F. H. and R. D.) and T32 GM07229 (to M. A. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Ayloo S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5807; Ballister ER, 2015, CURR BIOL, V25, pR407, DOI 10.1016/j.cub.2015.03.056; Ballister ER, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6475; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chowdhury S, 2015, NAT STRUCT MOL BIOL, V22, P345, DOI 10.1038/nsmb.2996; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Herrmann L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119423; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Kapitein LC, 2010, BIOPHYS J, V99, P2143, DOI 10.1016/j.bpj.2010.07.055; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Maliga Z, 2013, NAT CELL BIOL, V15, P325, DOI 10.1038/ncb2689; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nicholas MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7206; Sano H, 2007, J BIOL CHEM, V282, P7973, DOI 10.1074/jbc.M611537200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlager MA, 2014, CELL REP, V8, P1248, DOI 10.1016/j.celrep.2014.07.052; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Szebenyi G, 2007, TRAFFIC, V8, P32, DOI 10.1111/j.1600-0854.2006.00511.x; Terawaki S, 2015, BIOCHEM BIOPH RES CO, V460, P451, DOI 10.1016/j.bbrc.2015.03.054; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Toropova K, 2014, ELIFE, V3, DOI 10.7554/eLife.03372; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Woody M. S., 2016, BIOPHYS J IN PRESS; Xiang X, 2015, CELL MOL LIFE SCI, V72, P3267, DOI 10.1007/s00018-015-1926-y; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161; Yao XL, 2014, MOL BIOL CELL, V25, P2181, DOI 10.1091/mbc.E14-04-0873; Yeh TY, 2012, MOL BIOL CELL, V23, P3827, DOI 10.1091/mbc.E12-07-0496; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	48	62	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18239	18251		10.1074/jbc.M116.738211	http://dx.doi.org/10.1074/jbc.M116.738211			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27365401	Green Published, hybrid			2022-12-28	WOS:000383241800017
J	Li, X; Acuff, NV; Peeks, AR; Kirkland, R; Wyatt, KD; Nagy, T; Watford, WT				Li, Xin; Acuff, Nicole V.; Peeks, Angela R.; Kirkland, Rebecca; Wyatt, Kara D.; Nagy, Tamas; Watford, Wendy T.			Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; NF-KAPPA-B; KINASE; INDUCTION; RECEPTOR; CTLA-4; DIFFERENTIATION; MACROPHAGES; THETA; ERK	The serine/threonine kinase tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF alpha, IL-1 beta, and IFN gamma. We previously demonstrated that Tpl2 regulates T cell receptor (TCR) signaling and modulates T helper cell differentiation. However, very little is known about how Tpl2 modulates the development of regulatory T cells (Tregs). Tregs are a specialized subset of T cells that express FoxP3 and possess immunosuppressive properties to limit excess inflammation. Because of the documented role of Tpl2 in promoting inflammation, we hypothesized that Tpl2 antagonizes Treg development and immunosuppressive function. Here we demonstrate that Tpl2 constrains the development of inducible Tregs. Tpl2(-/-) naive CD4(+) T cells preferentially develop into FoxP3(+) inducible Tregs in vitro as well as in vivo in a murine model of ovalbumin (OVA)-induced systemic tolerance. Treg biasing of Tpl2(-/-) T cells depended on TCR signal strength and corresponded with reduced activation of the mammalian target of rapamycin (mTOR) pathway. Importantly, Tpl2(-/-) Tregs have basally increased expression of FoxP3 and immunosuppressive molecules, IL-10 and cytotoxic T lymphocyte-associated protein 4 (CTLA-4). Furthermore, they were more immunosuppressive in vivo in a T cell transfer model of colitis, as evidenced by reduced effector T cell accumulation, systemic production of inflammatory cytokines, and colonic inflammation. These results demonstrate that Tpl2 promotes inflammation in part by constraining FoxP3 expression and Treg immunosuppressive functions. Overall, these findings suggest that Tpl2 inhibition could be used to preferentially drive Treg induction and thereby limit inflammation in a variety of autoimmune diseases.	[Li, Xin; Acuff, Nicole V.; Peeks, Angela R.; Kirkland, Rebecca; Wyatt, Kara D.; Watford, Wendy T.] Univ Georgia, Dept Infect Dis, 501 DW Brooks Dr, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Dept Pathol, 501 DW Brooks Dr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Watford, WT (corresponding author), Univ Georgia, Dept Infect Dis, 501 DW Brooks Dr, Athens, GA 30602 USA.	watfordw@uga.edu	Li, Xin V./ABA-4321-2021; Li, Xin/AAH-2983-2019	Li, Xin V./0000-0002-9444-8214; Watford, Wendy/0000-0003-4261-5399; Wyatt, Kara/0000-0002-3957-1818	NIAID, National Institutes of Health [R01AI099058]; American Association of Immunologists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099058] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Association of Immunologists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Award R01AI099058 (to W. T. W.). This study was also supported by American Association of Immunologists Careers in Immunology fellowships (to X. L. and W. T. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Gabrysova L, 2011, EUR J IMMUNOL, V41, P1242, DOI 10.1002/eji.201041073; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Guo JT, 2014, J BIOL CHEM, V289, P35139, DOI 10.1074/jbc.M114.589192; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu HP, 2013, EUR J IMMUNOL, V43, P1716, DOI 10.1002/eji.201242889; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Ma J, 2012, J IMMUNOL, V188, P5337, DOI 10.4049/jimmunol.1102979; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moss RB, 2004, EXPERT OPIN BIOL TH, V4, P1887, DOI 10.1517/14712598.4.12.1887; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Rowley SM, 2014, J BIOL CHEM, V289, P15788, DOI 10.1074/jbc.M114.559344; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Serebrennikova OB, 2012, P NATL ACAD SCI USA, V109, pE1082, DOI 10.1073/pnas.1115098109; Sojka DK, 2009, EUR J IMMUNOL, V39, P1544, DOI 10.1002/eji.200838603; Sriskantharajah S, 2014, J IMMUNOL, V192, P3518, DOI 10.4049/jimmunol.1300172; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2012, CURR OPIN ORGAN TRAN, V17, P349, DOI 10.1097/MOT.0b013e328355a992; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Verhagen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108023; Watford WT, 2010, J IMMUNOL, V184, P105, DOI 10.4049/jimmunol.0803730; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xing Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006957; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321	64	9	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16802	16815		10.1074/jbc.M116.718783	http://dx.doi.org/10.1074/jbc.M116.718783			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27261457	Green Published, hybrid			2022-12-28	WOS:000380826700036
J	Chung, S; Ghelfi, M; Atkinson, J; Parker, R; Qian, JH; Carlin, C; Manor, D				Chung, Stacey; Ghelfi, Mikel; Atkinson, Jeffrey; Parker, Robert; Qian, Jinghui; Carlin, Cathleen; Manor, Danny			Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic -Tocopherol Transfer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid trafficking; lipid transport; phosphatidylinositol signaling; phosphoinositide; vitamin E; tocopherol; tocopherol transfer protein	CASSETTE TRANSPORTER A1; ALPHA-TOCOPHEROL; E-DEFICIENCY; OXIDATIVE STRESS; PLASMA-MEMBRANE; RETINITIS-PIGMENTOSA; LIGAND TRANSFER; OMEGA-HYDROXYLASE; LIPID DROPLETS; C DISEASE	-Tocopherol (vitamin E) is an essential nutrient for all vertebrates. From the eight naturally occurring members of the vitamin E family, -tocopherol is the most biologically active species and is selectively retained in tissues. The hepatic -tocopherol transfer protein (TTP) preferentially selects dietary -tocopherol and facilitates its transport through the hepatocyte and its secretion to the circulation. In doing so, TTP regulates body-wide levels of -tocopherol. The mechanisms by which TTP facilitates -tocopherol trafficking in hepatocytes are poorly understood. We found that the intracellular localization of TTP in hepatocytes is dynamic and responds to the presence of -tocopherol. In the absence of the vitamin, TTP is localized to perinuclear vesicles that harbor CD71, transferrin, and Rab8, markers of the recycling endosomes. Upon treatment with -tocopherol, TTP- and -tocopherol-containing vesicles translocate to the plasma membrane, prior to secretion of the vitamin to the exterior of the cells. The change in TTP localization is specific to -tocopherol and is time- and dose-dependent. The aberrant intracellular localization patterns of lipid binding-defective TTP mutants highlight the importance of protein-lipid interaction in the transport of -tocopherol. These findings provide the basis for a proposed mechanistic model that describes TTP-facilitated trafficking of -tocopherol through hepatocytes.	[Chung, Stacey; Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Nutr, WG 48, Cleveland, OH 44106 USA; [Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Carlin, Cathleen] Case Western Reserve Univ, Sch Med, Dept Microbiol & Mol Biol, Cleveland, OH 44106 USA; [Ghelfi, Mikel; Atkinson, Jeffrey] Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada; [Parker, Robert; Qian, Jinghui] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Brock University; Cornell University	Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, WG 48, Cleveland, OH 44106 USA.	dxm178@case.edu		Atkinson, Jeffrey/0000-0003-3710-4893	National Institutes of Health [DK067494]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK067494 (to D. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Atkinson J, 2008, FREE RADICAL BIO MED, V44, P739, DOI 10.1016/j.freeradbiomed.2007.11.010; Azzi A, 2007, FREE RADICAL BIO MED, V43, P16, DOI 10.1016/j.freeradbiomed.2007.03.013; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; BJORNEBOE A, 1987, BIOCHIM BIOPHYS ACTA, V922, P199, DOI 10.1016/0005-2760(87)90155-X; BURTON GW, 1994, P NUTR SOC, V53, P251, DOI 10.1079/PNS19940030; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; Copp RP, 1999, BRAIN RES, V822, P80, DOI 10.1016/S0006-8993(99)01090-2; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Etzl RP, 2012, J PERINAT MED, V40, P373, DOI 10.1515/jpm-2011-0307; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Yevenes LF, 2012, BBA-MOL BASIS DIS, V1822, P150, DOI 10.1016/j.bbadis.2011.11.009; Gabsi S, 2001, EUR J NEUROL, V8, P477, DOI 10.1046/j.1468-1331.2001.00273.x; Gao Q, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00049; GOTODA T, 1995, NEW ENGL J MED, V333, P1313, DOI 10.1056/NEJM199511163332003; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hentati A, 1996, ANN NEUROL, V39, P295, DOI 10.1002/ana.410390305; Horiguchi M, 2003, GENES CELLS, V8, P789, DOI 10.1046/j.1365-2443.2003.00676.x; Hosomi A, 1998, NEUROSCI LETT, V256, P159, DOI 10.1016/S0304-3940(98)00785-X; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; INGOLD KU, 1987, ARCH BIOCHEM BIOPHYS, V259, P224, DOI 10.1016/0003-9861(87)90489-9; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Kaempf-Rotzoll DE, 2003, PLACENTA, V24, P439, DOI 10.1053/plac.2002.0966; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; Kono N, 2015, TRAFFIC, V16, P19, DOI 10.1111/tra.12231; Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; LETH T, 1977, J NUTR, V107, P2236, DOI 10.1093/jn/107.12.2236; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Morley S, 2006, BIOCHEMISTRY-US, V45, P1075, DOI 10.1021/bi052271y; Morley S, 2004, BIOCHEMISTRY-US, V43, P4143, DOI 10.1021/bi0363073; Morley S, 2008, J BIOL CHEM, V283, P17797, DOI 10.1074/jbc.M800121200; Morley S, 2010, J BIOL CHEM, V285, P35578, DOI 10.1074/jbc.M110.169664; MOWRI H, 1981, EUR J BIOCHEM, V117, P537; Muller-Schmehl K, 2004, FREE RADICAL RES, V38, P413, DOI 10.1080/10715760310001659611; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nava P, 2006, BIOORGAN MED CHEM, V14, P3721, DOI 10.1016/j.bmc.2006.01.053; Niki E, 2012, ANN NUTR METAB, V61, P207, DOI 10.1159/000343106; Olivier M, 2014, BBA-MOL CELL BIOL L, V1841, P1741, DOI 10.1016/j.bbalip.2014.10.003; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; Qian JH, 2006, BIOCHEMISTRY-US, V45, P8236, DOI 10.1021/bi060522c; SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrader M, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00056; Schuelke M, 1999, J PEDIATR-US, V134, P240, DOI 10.1016/S0022-3476(99)70424-5; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Shichiri M, 2010, J NUTR BIOCHEM, V21, P451, DOI 10.1016/j.jnutbio.2009.02.002; SOKOL RJ, 1988, ANNU REV NUTR, V8, P351, DOI 10.1146/annurev.nu.08.070188.002031; Sontag TJ, 2007, J LIPID RES, V48, P1090, DOI 10.1194/jlr.M600514-JLR200; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thakur V, 2010, BIOCHEMISTRY-US, V49, P9339, DOI 10.1021/bi100960b; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; TRABER MG, 1989, AM J CLIN NUTR, V49, P517, DOI 10.1093/ajcn/49.3.517; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; TRABER MG, 1993, J LIPID RES, V34, P201; Ulatowski L, 2011, J LIPID RES, V52, P1400, DOI 10.1194/jlr.M015560; Ulatowski L, 2012, FREE RADICAL BIO MED, V53, P2318, DOI 10.1016/j.freeradbiomed.2012.10.528; Ulatowski LM, 2015, NEUROBIOL DIS, V84, P78, DOI 10.1016/j.nbd.2015.04.002; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Wu LZ, 2014, DEV CELL, V30, P378, DOI 10.1016/j.devcel.2014.07.005; Yokota T, 1997, ANN NEUROL, V41, P826, DOI 10.1002/ana.410410621; Yokota T, 1996, NEW ENGL J MED, V335, P1770, DOI 10.1056/NEJM199612053352315; Yokota T, 2000, J NEUROL NEUROSUR PS, V68, P521, DOI 10.1136/jnnp.68.4.521; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Zhang WX, 2011, J MOL BIOL, V405, P972, DOI 10.1016/j.jmb.2010.11.028; Zhang WX, 2009, LIPIDS, V44, P631, DOI 10.1007/s11745-009-3310-x	79	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17028	17039		10.1074/jbc.M116.734210	http://dx.doi.org/10.1074/jbc.M116.734210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27307040	hybrid, Green Published			2022-12-28	WOS:000382643800010
J	Harikumar, KG; Augustine, ML; Lee, LTO; Chow, BKC; Miller, LJ				Harikumar, Kaleeckal G.; Augustine, Mary Lou; Lee, Leo T. O.; Chow, Billy K. C.; Miller, Laurence J.			Structure and Function of Cross-class Complexes of G Protein-coupled Secretin and Angiotensin 1a Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; angiotensin; bioluminescence resonance energy transfer (BRET); calcium; dimerization; G protein-coupled receptor (GPCR)	CHOLECYSTOKININ RECEPTORS; OLIGOMERIC COMPLEXES; ENERGY-TRANSFER; ACTIVATION; DIMERIZATION; HOMEOSTASIS; REVEALS	Complexes of secretin (SecR) and angiotensin 1a (Atr1a) receptors have been proposed to be functionally important in osmoregulation, providing an explanation for overlapping and interdependent functions of hormones that bind and activate different classes of GPCRs. However, the nature of these cross-class complexes has not been well characterized and their signaling properties have not been systematically explored. We now use competitive inhibition of receptor bioluminescence resonance energy transfer and bimolecular fluorescence complementation to establish the dominant functionally important state as a symmetrical homodimeric form of SecR decorated by monomeric Atr1a, interacting through lipid-exposed faces of Atr1a TM1 and TM4. Conditions increasing prevalence of this complex exhibited negative allosteric modulatory impact on secretin-stimulated cAMP responses at SecR. In contrast, activating Atr1a with full agonist in such a complex exhibited a positive allosteric modulatory impact on the same signaling event. This modulation was functionally biased, with secretin-stimulated calcium responses unaffected, whereas angiotensin-stimulated calcium responses through the complex were reduced or absent. Further supporting this interpretation, Atr1a with mutations of lipid-exposed faces of TM1 and TM4 that did not affect its ability to bind or signal, could be expressed in the same cell as SecR, yet not exhibit either the negative or positive allosteric impact on cAMP observed with the inactive or activated states of wild type Atr1a on function, and not interfere with angiotensin-stimulated calcium responses like complexes with Atr1a. This may provide a more selective means of exploring the physiologic functional impact of this cross-class receptor complex without interfering with the function of either component receptor.	[Harikumar, Kaleeckal G.; Augustine, Mary Lou; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lee, Leo T. O.] Univ Macau, Ctr Reprod Dev & Aging, Taipa, Macau, Peoples R China; [Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China	Mayo Clinic; Mayo Clinic Phoenix; University of Macau; University of Hong Kong	Miller, LJ (corresponding author), 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Chow, Billy/D-3064-2009; Lee, Leo T.O./AAB-1581-2021	Chow, Billy/0000-0003-3390-0307; Lee, Leo Tsz On/0000-0003-3691-478X; Harikumar, Kaleeckal/0000-0003-0411-5334	National Institutes of Health [DK046577]; Mayo Clinic; Fundo para o Desenvolvimento das Ciencias e da Tecnologia, Macao [FDCT101/2015/A3]; Hong Kong Government RGC [CRFHKU6/CRF/11G, HKU 764812M, HKU 765011M]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046577, R56DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; Fundo para o Desenvolvimento das Ciencias e da Tecnologia, Macao; Hong Kong Government RGC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK046577 (to L. J. M.) and the Mayo Clinic (to L. J. M.). The authors declare that they have no conflict of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Fundo para o Desenvolvimento das Ciencias e da Tecnologia Grant FDCT101/2015/A3, Macao.; Supported by Hong Kong Government RGC Grants CRFHKU6/CRF/11G, HKU 764812M, and HKU 765011M.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Chu JYS, 2006, ANN NY ACAD SCI, V1070, P196, DOI 10.1196/annals.1317.012; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2011, KIDNEY INT, V79, P280, DOI 10.1038/ki.2010.397; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Daniels D, 2012, BRAIN RES, V1486, P62, DOI 10.1016/j.brainres.2012.09.040; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Garcia GL, 2012, AM J PHYSIOL-CELL PH, V302, pC1202, DOI 10.1152/ajpcell.00273.2011; HAAS E, 1978, BIOCHEMISTRY-US, V17, P5064, DOI 10.1021/bi00616a032; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar K, 2010, GPCR MOL PHARM DRUG, P138; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Harikurnar KG, 2008, BBA-BIOMEMBRANES, V1778, P2555, DOI 10.1016/j.bbamem.2008.07.008; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Lisenbee CS, 2006, BIOCHEMISTRY-US, V45, P8216, DOI 10.1021/bi060494y; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Poger D, 2014, BIOCHEMISTRY-US, V53, P2710, DOI 10.1021/bi401632z; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	28	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17332	17344		10.1074/jbc.M116.730754	http://dx.doi.org/10.1074/jbc.M116.730754			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27330080	Green Published, hybrid			2022-12-28	WOS:000382643800033
J	Zheng, H; Miyakawa, T; Sawano, Y; Asano, A; Okumura, A; Yamagoe, S; Tanokura, M				Zheng, Hai; Miyakawa, Takuya; Sawano, Yoriko; Asano, Atsuko; Okumura, Akinori; Yamagoe, Satoshi; Tanokura, Masaru			Crystal Structure of Human Leukocyte Cell-derived Chemotaxin 2 (LECT2) Reveals a Mechanistic Basis of Functional Evolution in a Mammalian Protein with an M23 Metalloendopeptidase Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; metalloprotease; multifunctional protein; x-ray crystallography; zinc	HEPATOCELLULAR-CARCINOMA; GLYCYLGLYCINE ENDOPEPTIDASE; VAL58ILE POLYMORPHISM; BETA-CATENIN; PURIFICATION; AMYLOIDOSIS; EXPRESSION; IDENTIFICATION; LYSOSTAPHIN; COMPONENTS	Human leukocyte cell-derived chemotaxin 2 (LECT2), which is predominantly expressed in the liver, is a multifunctional protein. LECT2 is becoming a potential therapeutic target for several diseases of worldwide concern such as rheumatoid arthritis, hepatocellular carcinoma, and obesity. Here, we present the crystal structure of LECT2, the first mammalian protein whose structure contains an M23 metalloendopeptidase fold. The LECT2 structure adopts a conserved Zn(II) coordination configuration but lacks a proposed catalytic histidine residue, and its potential substrate-binding groove is blocked in the vicinity of the Zn(II)-binding site by an additional intrachain loop at the N terminus. Consistent with these structural features, LECT2 was found to be catalytically inactive as a metalloendopeptidase against various types of peptide sequences, including pentaglycine. In addition, a surface plasmon resonance analysis demonstrated that LECT2 bound to the c-Met receptor with micromolar affinity. These results indicate that LECT2 likely plays its critical roles by acting as a ligand for the corresponding protein receptors rather than as an enzymatically active peptidase. The intrachain loop together with the pseudo-active site groove in LECT2 structure may be specific for interactions between LECT2 and receptors. Our study reveals a mechanistic basis for the functional evolution of a mammalian protein with an M23 metalloendopeptidase fold and potentially broadens the implications for the biological importance of noncatalytic peptidases in the M23 family.	[Zheng, Hai; Miyakawa, Takuya; Sawano, Yoriko; Asano, Atsuko; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Sawano, Yoriko] Tokyo Med & Dent Univ, Dept Chem, Coll Liberal Arts & Sci, 2-8-30 Kounodai, Ichikawa, Chiba 2720827, Japan; [Okumura, Akinori] Natl Ctr Global Hlth & Med, Dept Diabet Complicat, Diabet Res Ctr, Res Inst,Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan; [Yamagoe, Satoshi] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID)	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp	Okumura, Akinori/AAT-4389-2021; Okumura, Akinori/B-6456-2017	Okumura, Akinori/0000-0002-3977-6207; Okumura, Akinori/0000-0002-3977-6207; Tanokura, Masaru/0000-0001-5072-2480	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26670229] Funding Source: KAKEN	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; and by a grant-in-aid for scientific research (S) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chen CK, 2014, HEPATOLOGY, V59, P974, DOI 10.1002/hep.26738; Cohen DN, 2009, J MOL BIOL, V387, P607, DOI 10.1016/j.jmb.2009.02.001; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Firczuk M, 2007, FEMS MICROBIOL REV, V31, P676, DOI 10.1111/j.1574-6976.2007.00084.x; Graessler J, 2005, J RHEUMATOL, V32, P1654; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kameoka Y, 2000, ARTHRITIS RHEUM, V43, P1419, DOI 10.1002/1529-0131(200006)43:6<1419::AID-ANR28>3.0.CO;2-I; Kirchhofer D, 2004, J BIOL CHEM, V279, P39915, DOI 10.1074/jbc.M404795200; Kowalski A, 2015, CLIN NEPHROL, V84, P236, DOI 10.5414/CN108549; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levdikov VM, 2012, P NATL ACAD SCI USA, V109, P5441, DOI 10.1073/pnas.1120087109; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Meisner J, 2012, P NATL ACAD SCI USA, V109, P5446, DOI 10.1073/pnas.1120113109; Mereuta OM, 2014, BLOOD, V123, P1479, DOI 10.1182/blood-2013-07-517938; Murphy CL, 2010, AM J KIDNEY DIS, V56, P1100, DOI 10.1053/j.ajkd.2010.08.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Okumura A, 2008, ARTHRITIS RHEUM, V58, P413, DOI 10.1002/art.23215; Okumura A, 2013, BIOSCI TRENDS, V7, P276, DOI 10.5582/bst.2013.v7.6.276; Okumura A, 2009, BIOSCI TRENDS, V3, P139; Ong HT, 2011, CANCER GENE THER, V18, P399, DOI 10.1038/cgt.2011.5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ovejero C, 2004, HEPATOLOGY, V40, P167, DOI 10.1002/hep.20286; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Park P. W., 2004, HDB PROTEOLYTIC ENZY, P1004; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Peters NT, 2013, MOL MICROBIOL, V89, P690, DOI 10.1111/mmi.12304; Phesse TJ, 2008, MOL CELL BIOL, V28, P6094, DOI 10.1128/MCB.00539-08; Ragurnani S, 2008, PROTEINS, V72, P1096, DOI 10.1002/prot.22095; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Sabala I, 2014, FEBS J, V281, P4112, DOI 10.1111/febs.12929; Saito T, 2004, J IMMUNOL, V173, P579, DOI 10.4049/jimmunol.173.1.579; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Segawa Y, 2001, BIOL PHARM BULL, V24, P425, DOI 10.1248/bpb.24.425; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; Spencer J, 2010, J MOL BIOL, V396, P908, DOI 10.1016/j.jmb.2009.12.021; Sugai M, 1997, J BACTERIOL, V179, P1193, DOI 10.1128/jb.179.4.1193-1202.1997; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Vessillier S, 2001, EUR J BIOCHEM, V268, P1049, DOI 10.1046/j.1432-1327.2001.01967.x; Wang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026845; Xiang Y, 2008, P NATL ACAD SCI USA, V105, P9552, DOI 10.1073/pnas.0803787105; Yamagoe S, 1998, BBA-GENE STRUCT EXPR, V1396, P105, DOI 10.1016/S0167-4781(97)00181-4; Yamagoe S, 1996, IMMUNOL LETT, V52, P9, DOI 10.1016/0165-2478(96)02572-2; Zheng H, 2013, ACTA CRYSTALLOGR F, V69, P316, DOI 10.1107/S1744309113003758; Zheng H, 2013, PROTEIN EXPRES PURIF, V88, P221, DOI 10.1016/j.pep.2013.01.008	51	12	14	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17133	17142		10.1074/jbc.M116.720375	http://dx.doi.org/10.1074/jbc.M116.720375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27334921	Green Published, hybrid			2022-12-28	WOS:000382643800019
J	Zogzas, CE; Aschner, M; Mukhopadhyay, S				Zogzas, Charles E.; Aschner, Michael; Mukhopadhyay, Somshuvra			Structural Elements in the Transmembrane and Cytoplasmic Domains of the Metal Transporter SLC30A10 Are Required for Its Manganese Efflux Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAILEY-HAILEY-DISEASE; ESCHERICHIA-COLI; SECRETORY PATHWAY; INTRACELLULAR TRAFFICKING; SUBSTRATE-SPECIFICITY; INDUCED PARKINSONISM; ZINC TRANSPORTERS; HEPATIC CIRRHOSIS; OXIDATIVE DAMAGE; YIIP	Homozygous mutations in SLC30A10 lead to the development of familial manganese-induced parkinsonism. We previously demonstrated that SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its trafficking and efflux activity. Interestingly, other transporters in the SLC30 family mediate zinc efflux. Determining the mechanisms that allow SLC30A10 to transport manganese, which are unclear, is essential to understand its role in parkinsonism. Here, we generated a predicted structure of SLC30A10, based on the structure of the bacterial zinc transporter YiiP, and performed functional studies. In YiiP, side chains of residues Asp-45 and Asp-49 in the second and His-153 and Asp-157 in the fifth transmembrane segments coordinate zinc and are required for transport. In SLC30A10, the corresponding residues are Asn-43 and Asp-47 in the second and His-244 and Asp-248 in the fifth transmembrane segments. Surprisingly, although alanine substitution of Asp-248 abolished manganese efflux, that of Asn-43 and Asp-47 did not. Instead, side chains of charged or polar residues adjacent to Asp-248 in the first (Glu-25) or fourth (Asn-127) transmembrane segments were required. Further analyses revealed that residues His-333 and His-350 in the cytoplasmic C-terminal domain were required for full activity. However, the C-terminal domain failed to transfer manganese transport capability to a related zinc transporter. Overall, our results indicate that residues in the transmembrane and C-terminal domains together confer optimal manganese transport capability to SLC30A10 and suggest that the mechanism of ion coordination in the transmembrane domain of SLC30A10 may be substantially different from that in YiiP/other SLC30 proteins.	[Zogzas, Charles E.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Zogzas, Charles E.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Yeshiva University; Albert Einstein College of Medicine	Mukhopadhyay, S (corresponding author), Albert Einstein Coll Med, Div Pharmacol & Toxicol, 3-510E BME,107 W Dean Keeton, Austin, TX 78712 USA.	som@austin.utexas.edu		zogzas, charles/0000-0003-0092-6316; Mukhopadhyay, Somshuvra/0000-0002-3420-7830	National Institutes of Health from NIEHS [R00-ES020844, R01-ES024812]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024812, R00ES020844] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R00-ES020844 and R01-ES024812 from NIEHS (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anton A, 2004, J BACTERIOL, V186, P7499, DOI 10.1128/JB.186.22.7499-7507.2004; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Butterworth RF, 2013, METAB BRAIN DIS, V28, P261, DOI 10.1007/s11011-012-9341-7; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fujimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077445; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolaj-Robin O, 2015, FEBS LETT, V589, P1283, DOI 10.1016/j.febslet.2015.04.007; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lin HL, 2008, J BIOL CHEM, V283, P33865, DOI 10.1074/jbc.M804377200; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Martin JE, 2016, J BACTERIOL, V198, P1066, DOI 10.1128/JB.00975-15; Masuda M, 2013, SYNAPSE, V67, P205, DOI 10.1002/syn.21632; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Missiaen L, 2004, BIOCHEM BIOPH RES CO, V322, P1204, DOI 10.1016/j.bbrc.2004.07.128; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Ramos-Castaneda J, 2005, J BIOL CHEM, V280, P9467, DOI 10.1074/jbc.M413243200; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Shusterman E, 2014, METALLOMICS, V6, P1656, DOI 10.1039/c4mt00108g; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wahlberg K, 2016, TOXICOL SCI, V149, P473, DOI 10.1093/toxsci/kfv252; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200	50	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15940	15957		10.1074/jbc.M116.726935	http://dx.doi.org/10.1074/jbc.M116.726935			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27307044	Green Published, hybrid			2022-12-28	WOS:000380585400003
J	Martinez-Redondo, V; Jannig, PR; Correia, JC; Ferreira, DMS; Cervenka, I; Lindvall, JM; Sinha, I; Izadi, M; Pettersson-Klein, AT; Agudelo, LZ; Gimenez-Cassina, A; Brum, PC; Dahlman-Wright, K; Ruas, JL				Martinez-Redondo, Vicente; Jannig, Paulo R.; Correia, Jorge C.; Ferreira, Duarte M. S.; Cervenka, Igor; Lindvall, Jessica M.; Sinha, Indranil; Izadi, Manizheh; Pettersson-Klein, Amanda T.; Agudelo, Leandro Z.; Gimenez-Cassina, Alfredo; Brum, Patricia C.; Dahlman-Wright, Karin; Ruas, Jorge L.			Peroxisome Proliferator-activated Receptor gamma Coactivator-1 alpha Isoforms Selectively Regulate Multiple Splicing Events on Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR; PGC-1-ALPHA; PROTEIN; EXPRESSION; ANGIOGENESIS; INHIBITION; COMPLEX; GROWTH; NDRG4	Endurance and resistance exercise training induces specific and profound changes in the skeletal muscle transcriptome. Peroxisome proliferator-activated receptor gamma coactivator-1 a (PGC-1 alpha) coactivators are not only among the genes differentially induced by distinct training methods, but they also participate in the ensuing signaling cascades that allow skeletal muscle to adapt to each type of exercise. Although endurance training preferentially induces PGC-lal expression, resistance exercise activates the expression of PGC-1 alpha 2, -alpha 3, and -alpha 4. These three alternative PGC-la isoforms lack the arginine/serine-rich (RS) and RNA recognition motifs characteristic of PGC-lal. Discrete functions for PGC-lal and -alpha 4 have been described, but the biological role of PGC-1 alpha 2 and -a3 remains elusive. Here we show that different PGC-1 alpha variants can affect target gene splicing through diverse mechanisms, including alternative promoter usage. By analyzing the exon structure of the target transcripts for each PGC-la isoform, we were able to identify a large number of previously unknown PGC-1 alpha 2 and -a3 target genes and pathways in skeletal muscle. In particular, PGC-1a2 seems to mediate a decrease in the levels of cholesterol synthesis genes. Our results suggest that the conservation of the N-terminal activation and repression domains (and not the RS/RNA recognition motif) is what determines the gene programs and splicing options modulated by each PGC-la isoform. By using skeletal muscle-specific transgenic mice for PGC-lal and -alpha 4, we could validate, in vivo, splicing events observed in in vitro studies. These results show that alternative PGC-la variants can affect target gene expression both quantitatively and qualitatively and identify novel biological pathways under the control of this system of coactivators.	[Martinez-Redondo, Vicente; Jannig, Paulo R.; Correia, Jorge C.; Ferreira, Duarte M. S.; Cervenka, Igor; Izadi, Manizheh; Pettersson-Klein, Amanda T.; Agudelo, Leandro Z.; Ruas, Jorge L.] Karolinska Inst, Dept Physiol & Pharmacol, Mol & Cellular Exercise Physiol Unit, SE-17177 Stockholm, Sweden; [Gimenez-Cassina, Alfredo] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Jannig, Paulo R.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, BR-05508030 Sao Paulo, Brazil; [Lindvall, Jessica M.; Sinha, Indranil; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Novum, SE-14183 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Universidade de Sao Paulo; Karolinska Institutet	Ruas, JL (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Mol & Cellular Exercise Physiol Unit, SE-17177 Stockholm, Sweden.	Jorge.Ruas@ki.se	Gimenez-Cassina, Alfredo/AAA-6550-2019; Jannig, Paulo Roberto/E-9482-2013; Brum, Patricia C/E-6605-2011; Ferreira, Duarte M Sacramento/E-4270-2012; Ruas, Jorge/AAE-6094-2019	Jannig, Paulo Roberto/0000-0002-2569-4091; Brum, Patricia C/0000-0002-4750-6506; Ferreira, Duarte M Sacramento/0000-0001-5940-7102; Ruas, Jorge/0000-0002-1110-2606; Correia, Jorge/0000-0002-6377-9053; Sinha, Indranil/0000-0002-2513-5927; Klein, Amanda/0000-0003-3998-920X; Lindvall, Jessica/0000-0002-5042-8481; Gimenez-Cassina, Alfredo/0000-0002-2768-2350	Swedish Research Council; Strategic Research Programme in Diabetes at Karolinska Institutet; Novo Nordisk Foundation (Denmark); Swedish Diabetes Foundation; Malin and Lennart Phiipson Foundation; Wenner-Gren Foundations (Sweden); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil); Svenska Sallskapet for Medicinsk Forskning (Sweden); Novo Nordisk Fonden [NNF12OC1016062] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Programme in Diabetes at Karolinska Institutet; Novo Nordisk Foundation (Denmark)(Novo Nordisk Foundation); Swedish Diabetes Foundation; Malin and Lennart Phiipson Foundation; Wenner-Gren Foundations (Sweden); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Svenska Sallskapet for Medicinsk Forskning (Sweden); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the Swedish Research Council, the Strategic Research Programme in Diabetes at Karolinska Institutet, the Novo Nordisk Foundation (Denmark), the Swedish Diabetes Foundation, and the Malin and Lennart Phiipson Foundation (to J. L. R). The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by a postdoctoral fellowship from the Wenner-Gren Foundations (Sweden).r Recipient of a Fundacao de Amparo a Pesquisa do Estado de Sao Paulo fellowship (Brazil).r Supported in part by Svenska Sallskapet for Medicinsk Forskning (Sweden).	Auboeuf D, 2004, P NATL ACAD SCI USA, V101, P2270, DOI 10.1073/pnas.0308133100; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Chang JS, 2012, J BIOL CHEM, V287, P9100, DOI 10.1074/jbc.M111.320200; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cohen TV, 2015, J PHYSIOL-LONDON, V593, P2479, DOI 10.1113/JP270201; Correia JC, 2015, TRENDS ENDOCRIN MET, V26, P305, DOI 10.1016/j.tem.2015.03.010; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Du C, 2014, J LIPID RES, V55, P1886, DOI 10.1194/jlr.M047555; Du L, 1997, J CELL BIOL, V136, P5, DOI 10.1083/jcb.136.1.5; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Gellert P, 2009, BIOINFORMATICS, V25, P3323, DOI 10.1093/bioinformatics/btp577; Guo YH, 2013, J BIOL CHEM, V288, P4625, DOI 10.1074/jbc.M112.407452; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Johansson M, 2003, MOL BIOL CELL, V14, P903, DOI 10.1091/mbc.E02-08-0459; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kotipatruni RP, 2012, INTEGR BIOL-UK, V4, P1185, DOI 10.1039/c2ib20168b; Lee S, 2012, EXP CELL RES, V318, P2128, DOI 10.1016/j.yexcr.2012.06.012; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; Martinez-Redondo V, 2015, DIABETOLOGIA, V58, P1969, DOI 10.1007/s00125-015-3671-z; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Minsky N, 2015, P NATL ACAD SCI USA, V112, pE5669, DOI 10.1073/pnas.1516219112; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Muscat GEO, 2002, J BIOL CHEM, V277, P40722, DOI 10.1074/jbc.M206681200; Nader GA, 2014, J APPL PHYSIOL, V116, P693, DOI 10.1152/japplphysiol.01366.2013; Nakada N, 2002, DEV BRAIN RES, V135, P45, DOI 10.1016/S0165-3806(02)00303-6; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Roberts TC, 2015, HUM MOL GENET, V24, P6756, DOI 10.1093/hmg/ddv381; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Ryu S, 2006, CELL CYCLE, V5, P1140, DOI 10.4161/cc.5.11.2779; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Silvennoinen M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12563; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Thijssen-Timmer DC, 2006, J MOL ENDOCRINOL, V37, P251, DOI 10.1677/jme.1.01914; Thom R, 2014, J BIOL CHEM, V289, P8810, DOI 10.1074/jbc.M114.554394; Tian LJ, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0210-z; Trapani L, 2012, J CELL BIOCHEM, V113, P2057, DOI 10.1002/jcb.24077; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Trausch-Azar JS, 2015, J CELL PHYSIOL, V230, P842, DOI 10.1002/jcp.24812; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wen XY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/402175; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	47	48	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15169	15184		10.1074/jbc.M115.705822	http://dx.doi.org/10.1074/jbc.M115.705822			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27231350	hybrid, Green Published			2022-12-28	WOS:000380583200026
J	Khelashvili, G; Schmidt, SG; Shi, L; Javitch, JA; Gether, U; Loland, CJ; Weinstein, H				Khelashvili, George; Schmidt, Solveig Gaarde; Shi, Lei; Javitch, Jonathan A.; Gether, Ulrik; Loland, Claus J.; Weinstein, Harel			Conformational Dynamics on the Extracellular Side of LeuT Controlled by Na+ and K+ Ions and the Protonation State of Glu(290)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; membrane protein; molecular dynamics; monoamine transporter; neurotransmitter transport	NEUROTRANSMITTER SODIUM SYMPORTERS; X-RAY STRUCTURES; DOPAMINE TRANSPORTER; BINDING-SITE; MOLECULAR-DYNAMICS; BACTERIAL HOMOLOG; LEUCINE TRANSPORTER; MEMBRANE-TRANSPORT; SUBSTRATE-BINDING; OCCLUDED STATE	Ions play key mechanistic roles in the gating dynamics of neurotransmitter:sodium symporters (NSSs). In recent microsecond scale molecular dynamics simulations of a complete model of the dopamine transporter, a NSS protein, we observed a partitioning of K+ ions from the intracellular side toward the unoccupied Na2 site of dopamine transporter following the release of the Na2-bound Na+. Here we evaluate with computational simulations and experimental measurements of ion affinities under corresponding conditions, the consequences of K+ binding in the Na2 site of LeuT, a bacterial homolog of NSS, when both Na+ ions and substrate have left, and the transporter prepares for a new cycle. We compare the results with the consequences of binding Na+ in the same apo system. Analysis of >50-s atomistic molecular dynamics and enhanced sampling trajectories of constructs with Glu(290), either charged or neutral, point to the Glu(290) protonation state as a main determinant in the structural reconfiguration of the extracellular vestibule of LeuT in which a water gate opens through coordinated motions of residues Leu(25), Tyr(108), and Phe(253). The resulting water channel enables the binding/dissociation of the Na+ and K+ ions that are prevalent, respectively, in the extracellular and intracellular environments.	[Khelashvili, George; Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Schmidt, Solveig Gaarde; Gether, Ulrik; Loland, Claus J.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Shi, Lei] NIDA, Computat Chem & Mol Biophys Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA; [Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Weinstein, Harel] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10065 USA	Cornell University; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Columbia University; Columbia University; New York State Psychiatry Institute; Cornell University	Khelashvili, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, 1300 York Ave,Rm LC 501A, New York, NY 10065 USA.	gek2009@med.cornell.edu	WEINSTEIN, HAREL/O-8245-2019; Shi, Lei/AAV-1321-2020; Loland, Claus/E-5975-2014	WEINSTEIN, HAREL/0000-0003-3473-9818; Shi, Lei/0000-0002-4137-096X; Javitch, Jonathan/0000-0001-7395-2967; Loland, Claus/0000-0002-1773-1446; Gether, Ulrik/0000-0002-0020-3807	Texas Advanced Computing Center at the University of Texas at Austin [TG-MCB120008]; Office of Science of the U.S. Department of Energy [DE-AC05-00OR22725, PSCA14026P]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017293, ZIADA000606, P01DA012408, K05DA022413] Funding Source: NIH RePORTER	Texas Advanced Computing Center at the University of Texas at Austin; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The following computational resources are gratefully acknowledged: an XSEDE allocation at the Texas Advanced Computing Center at the University of Texas at Austin (Stampede supercomputer, project TG-MCB120008, used for initial studies); resources of the Oak Ridge Leadership Computing Facility (ALCC allocation BIP109) at the Oak Ridge National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under Contract DE-AC05-00OR22725; an allocation on the Anton supercomputer (Grant PSCA14026P); and the computational resources of the David A. Cofrin Center for Biomedical Information in the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine at Weill Cornell Medical College. His-tagged LeuT construct inserted in pET16b was a generous gift from Dr. Eric Gouaux (Vollum Institute, Oregon Health Science University).	Abel S, 2011, J PHYS CHEM B, V115, P487, DOI 10.1021/jp109545v; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Billesbolle CB, 2015, J BIOL CHEM, V290, P26725, DOI 10.1074/jbc.M115.677658; Borre L, 2014, J BIOL CHEM, V289, P25764, DOI 10.1074/jbc.M114.574269; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Cheng MH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003879; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Kazmier K, 2014, P NATL ACAD SCI USA, V111, P14752, DOI 10.1073/pnas.1410431111; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khelashvili G, 2015, PROTEINS, V83, P952, DOI 10.1002/prot.24792; Khelashvili G, 2013, J AM CHEM SOC, V135, P14266, DOI 10.1021/ja405984v; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Koldso H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063635; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; LeVine MV, 2016, CHEM REV, V116, P6552, DOI 10.1021/acs.chemrev.5b00627; LeVine MV, 2016, BIOCHEMISTRY-US, V55, P850, DOI 10.1021/acs.biochem.5b01268; LeVine MV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003603; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; Mondal S, 2013, CHEM PHYS LIPIDS, V169, P27, DOI 10.1016/j.chemphyslip.2013.01.006; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2014, J PHYSIOL-LONDON, V592, P863, DOI 10.1113/jphysiol.2013.259051; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sora I, 2009, INT REV NEUROBIOL, V85, P29, DOI 10.1016/S0074-7742(09)85003-4; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Stolzenberg S, 2016, BBA-BIOMEMBRANES, V1858, P1652, DOI 10.1016/j.bbamem.2016.01.010; Stolzenberg S, 2015, J BIOL CHEM, V290, P13992, DOI 10.1074/jbc.M114.625343; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Venable RM, 2013, J PHYS CHEM B, V117, P10183, DOI 10.1021/jp401512z; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang Z, 2015, P NATL ACAD SCI USA, V112, P5219, DOI 10.1073/pnas.1417838112; Zhao CF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003296; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133; Zomot E, 2015, J BIOL CHEM, V290, P544, DOI 10.1074/jbc.M114.617555	73	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19786	19799		10.1074/jbc.M116.731455	http://dx.doi.org/10.1074/jbc.M116.731455			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27474737	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000383243100006
J	Oliver, KH; Duvernay, MT; Hamm, HE; Carneiro, AMD				Oliver, Kendra H.; Duvernay, Matthew T.; Hamm, Heidi E.; Carneiro, Ana M. D.			Loss of Serotonin Transporter Function Alters ADP-mediated Glycoprotein alpha II beta 3 Activation through Dysregulation of the 5-HT2A Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; platelet; receptor regulation; selective serotonin reuptake inhibitor (SSRI); serotonin; serotonin transporter; bleeding	EXTRACELLULAR-REGULATED KINASE; C6 GLIOMA-CELLS; PLATELET-AGGREGATION; PERIPHERAL SEROTONIN; REUPTAKE INHIBITOR; IN-VIVO; PLASMA SEROTONIN; 2A RECEPTOR; PC12 CELLS; ADULT RATS	Reduced platelet aggregation and a mild bleeding phenotype have been observed in patients chronically taking selective serotonin reuptake inhibitors (SSRIs). However, it remains unclear how SSRIs, which inhibit the plasma membrane serotonin transporter (SERT), modulate hemostasis. Here, we examine how sustained inhibition of SERT activity alters serotonergic signaling and influences platelet activation and hemostasis. Pharmaceutical blockade (citalopram dosing) or genetic ablation (SERT-/-) of SERT function in vivo led to reduced serotonin (5-hydroxytryptamine (5-HT)) blood levels that paralleled a mild bleeding phenotype in mice. Transfusion of wild-type platelets to SERT-/- mice normalized bleeding times to wild-type levels, suggesting that loss of SERTs causes a deficiency in platelet activation. Although SERT-/- platelets displayed no difference in P-selectin or IIb3 activation upon stimulation with thrombin, ADP-mediated IIb3 activation is reduced in SERT-/- platelets. Additionally, synergistic potentiation of IIb3 activation by ADP and 5-HT is lost in SERT-/- platelets. Acute treatment of wild-type platelets with 5-HT2A receptor (5-HT2AR) antagonists or SSRIs revealed that functional 5-HT(2A)Rs, not SERTs, are necessary for the synergistic activation of IIb3 by dual 5-HT/ADP stimulation. Pharmacological studies using radiolabeled guanosine 5-3-O-([S-35]thio)triphosphate and [H-3]ketanserin revealed that platelets isolated from SERT-/- or citalopram-treated mice have reduced activation of G-proteins coupled to 5-HT(2A)Rs and receptor surface expression. Taken together, these data demonstrate that sustained SERT loss of function reduces 5-HT2AR surface expression that is critical for the synergistic activation of IIb3 by 5-HT and ADP. These results highlight an antiplatelet strategy centered on blocking or desensitizing 5-HT2AR to attenuate ADP-mediated IIb3 activation.	[Oliver, Kendra H.; Duvernay, Matthew T.; Hamm, Heidi E.; Carneiro, Ana M. D.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Ctr, 442 Robinson Res Bldg,23rd Ave South Pierce, Nashville, TN 37232 USA.; Carneiro, AMD (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Ctr, 461 Preston Res Bldg,23rd Ave South Pierce, Nashville, TN 37232 USA.	heidi.hamm@vanderbilt.edu; ana.carneiro@vanderbilt.edu		Oliver, Kendra/0000-0003-3142-5186; Marin Dias Carneiro, Ana/0000-0002-1204-9202; MD Carneiro, Ana/0000-0002-7470-7047	National Institutes of Health [MH090256]; Clinical and Translational Science Awards [UL1TR000445, KL2TR000446, TL1TR000447]; Molecular Libraries Probe Production Centers Network Grant [U54MH084659]; American Heart Association Predoctoral Fellowship Award [14PRE19640007]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000446, UL1TR000445, TL1TR000447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090256, U54MH084659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Libraries Probe Production Centers Network Grant; American Heart Association Predoctoral Fellowship Award(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant MH090256 (to A. M. D. C.); Clinical and Translational Science Awards UL1TR000445, KL2TR000446, and TL1TR000447 (to Vanderbilt); and Molecular Libraries Probe Production Centers Network Grant U54MH084659 (to H. E. H.) and by American Heart Association Predoctoral Fellowship Award 14PRE19640007 (to K. H. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmalik N, 2008, J THROMB HAEMOST, V6, P2168, DOI 10.1111/j.1538-7836.2008.03196.x; Adams JW, 2009, J PHARMACOL EXP THER, V331, P96, DOI 10.1124/jpet.109.153189; Ahmed BA, 2008, J BIOL CHEM, V283, P9388, DOI 10.1074/jbc.M706367200; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Anderson GM, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0086-8; Anderson GM, 2005, PSYCHOPHARMACOLOGY, V178, P339, DOI 10.1007/s00213-004-2011-7; Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Beikmann BS, 2013, ACS CHEM NEUROSCI, V4, P161, DOI 10.1021/cn300146w; Berger JS, 2013, THROMB HAEMOSTASIS, V109, P85, DOI 10.1160/TH12-03-0202; Bismuth-Evenzal Y, 2012, J AFFECT DISORDERS, V136, P99, DOI 10.1016/j.jad.2011.08.013; Blazevic S, 2015, J PHYSIOL PHARMACOL, V66, P529; Bohn LM, 2010, CRIT REV BIOCHEM MOL, V45, P555, DOI 10.3109/10409238.2010.516741; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Carneiro AMD, 2008, J CLIN INVEST, V118, P1544, DOI 10.1172/JCI33374; CERRITO F, 1993, LIFE SCI, V53, P209; GARTSIDE SE, 1995, BRIT J PHARMACOL, V115, P1064, DOI 10.1111/j.1476-5381.1995.tb15919.x; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Hirsh-Rokach B, 2015, PHARMACOTHERAPY, V35, P140, DOI 10.1002/phar.1542; Hranilovic D, 2011, NEUROCHEM INT, V59, P202, DOI 10.1016/j.neuint.2011.05.003; Hummerich R, 2010, NEUROCHEM INT, V57, P67, DOI 10.1016/j.neuint.2010.04.020; Jernej B, 2002, HEADACHE, V42, P588, DOI 10.1046/j.1526-4610.2002.02145.x; Jirouskova M, 2007, J THROMB HAEMOST, V5, P661, DOI 10.1111/j.1538-7836.2007.02407.x; Johnson-Farley NN, 2005, J NEUROCHEM, V92, P72, DOI 10.1111/j.1471-4159.2004.02832.x; Lau WKW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031617; Li N, 1997, BLOOD COAGUL FIBRIN, V8, P517, DOI 10.1097/00001721-199711000-00006; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; MALYSZKO J, 1994, THROMB RES, V75, P569, DOI 10.1016/0049-3848(94)90231-3; Matondo RB, 2009, AM J PHYSIOL-GASTR L, V296, pG963, DOI 10.1152/ajpgi.90709.2008; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mercado CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02795; Miller KJ, 1997, LIFE SCI, V61, P1819, DOI 10.1016/S0024-3205(97)00806-0; MOORE TC, 1966, SURGERY, V59, P765; Namkung J, 2015, MOL CELLS, V38, P1023, DOI 10.14348/molcells.2015.0258; Oliver KH, 2014, MOL PHARMACOL, V85, P921, DOI 10.1124/mol.114.091736; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; Quinn JC, 2002, J PHARMACOL EXP THER, V303, P746, DOI 10.1124/jpet.102.038083; Schaff M, 2012, THROMB HAEMOSTASIS, V107, P735, DOI 10.1160/TH11-06-0430; Schmid CL, 2008, P NATL ACAD SCI USA, V105, P1079, DOI 10.1073/pnas.0708862105; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Singh Preeti, 2013, Health (Irvine Calif), V5, P31; Stahl EL, 2015, MOL PHARMACOL, V87, P866, DOI 10.1124/mol.114.096503; THOMPSON NT, 1986, EUR J BIOCHEM, V161, P399, DOI 10.1111/j.1432-1033.1986.tb10459.x; Tseng YL, 2010, THROMB RES, V126, P517, DOI 10.1016/j.thromres.2010.09.017; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Yamauchi M, 2006, BRAIN RES, V1067, P164, DOI 10.1016/j.brainres.2005.10.075	48	17	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20210	20219		10.1074/jbc.M116.736983	http://dx.doi.org/10.1074/jbc.M116.736983			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27422820	Green Published, hybrid			2022-12-28	WOS:000383243100040
J	Tsai, WT; Lo, YC; Wu, MS; Li, CY; Kuo, YP; Lai, YH; Tsai, Y; Chen, KC; Chuang, TH; Yao, CH; Lee, JC; Hsu, LC; Hsu, JTA; Yu, GY				Tsai, Wan-Ting; Lo, Yin-Chiu; Wu, Ming-Sian; Li, Chia-Yang; Kuo, Yi-Ping; Lai, Yi-Hui; Tsai, Yu; Chen, Kai-Chieh; Chuang, Tsung-Hsien; Yao, Chun-Hsu; Lee, Jinq-Chyi; Hsu, Li-Chung; Hsu, John T. -A.; Yu, Guann-Yi			Mycotoxin Patulin Suppresses Innate Immune Responses by Mitochondrial Dysfunction and p62/Sequestosome-1-dependent Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; mitophagy; mycotoxin; p62 (sequestosome 1(SQSTM1)); RIG-I-like receptor (RLR); toll-like receptor (TLR); immunomodulation; patulin	TOLL-LIKE RECEPTORS; NF-KAPPA-B; PROTEIN-SYNTHESIS; INDUCED APOPTOSIS; OXIDATIVE STRESS; CPG-DNA; CELLS; RECOGNITION; EXPRESSION; CANCER	Innate immune responses are important for pathogen elimination and adaptive immune response activation. However, excess inflammation may contribute to immunopathology and disease progression (e.g. inflammation-associated hepatocellular carcinoma). Immune modulation resulting from pattern recognition receptor-induced responses is a potential strategy for controlling immunopathology and related diseases. This study demonstrates that the mycotoxin patulin suppresses Toll-like receptor- and RIG-I/MAVS-dependent cytokine production through GSH depletion, mitochondrial dysfunction, the activation of p62-associated mitophagy, and p62-TRAF6 interaction. Blockade of autophagy restored the immunosuppressive activity of patulin, and pharmacological activation of p62-dependent mitophagy directly reduced RIG-I-like receptor-dependent inflammatory cytokine production. These results demonstrated that p62-dependent mitophagy has an immunosuppressive role to innate immune response and might serve as a potential immunomodulatory target for inflammation-associated diseases.	[Tsai, Wan-Ting; Lo, Yin-Chiu; Wu, Ming-Sian; Li, Chia-Yang; Kuo, Yi-Ping; Tsai, Yu; Chen, Kai-Chieh; Yu, Guann-Yi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, R1-8024,35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan; [Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan Town 35053, Miaoli County, Taiwan; [Yao, Chun-Hsu; Lee, Jinq-Chyi; Hsu, John T. -A.] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Town 35053, Miaoli County, Taiwan; [Li, Chia-Yang] Kaohsiung Med Univ, Coll Med, Dept Genome Med, Kaohsiung 80708, Taiwan; [Li, Chia-Yang] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung 80708, Taiwan; [Lai, Yi-Hui; Hsu, Li-Chung] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10002, Taiwan; [Yu, Guann-Yi] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; National Taiwan University; National Cheng Kung University	Yu, GY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, R1-8024,35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	guannyiy@nhri.org.tw	Chuang, Tsung-Hsien/F-9679-2010; Yu, Guann-Yi/O-5139-2019	Yu, Guann-Yi/0000-0002-0580-8282; Hsu, Li-Chung/0000-0001-7206-5231; LI, CHIA-YANG/0000-0001-5689-9850	National Health Research Institutes (NHRI) [IV-103-pp-21]; National Science Council from Taiwan [NSC 100-2320-B-400-006-MY3]	National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan); National Science Council from Taiwan	This study was supported by National Health Research Institutes (NHRI) Grant IV-103-pp-21 and National Science Council Grant NSC 100-2320-B-400-006-MY3 from Taiwan (to G. Y. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; ARAFAT W, 1995, RES COMMUN MOL PATH, V87, P177; Barhoumi R, 1996, FUND APPL TOXICOL, V30, P290, DOI 10.1006/faat.1996.0067; Boussabbeh M, 2015, TOXICOL SCI, V144, P328, DOI 10.1093/toxsci/kfu319; Boyd E M, 1944, Can Med Assoc J, V50, P159; BREITBART H, 1981, BIOCHIM BIOPHYS ACTA, V656, P160, DOI 10.1016/0005-2787(81)90082-4; BURGHARDT RC, 1992, TOXICOL APPL PHARM, V112, P235, DOI 10.1016/0041-008X(92)90193-V; Capone F, 2010, EUR CYTOKINE NETW, V21, P99, DOI 10.1684/ecn.2010.0192; Castello G, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-109; Castello G, 2010, CLIN IMMUNOL, V134, P237, DOI 10.1016/j.clim.2009.10.007; Chuang TH, 2002, J LEUKOCYTE BIOL, V71, P538; Doi K, 2014, J TOXICOL PATHOL, V27, P1, DOI 10.1293/tox.2013-0062; East DA, 2014, CHEM BIOL, V21, P1585, DOI 10.1016/j.chembiol.2014.09.019; Fliege R, 2000, CHEM RES TOXICOL, V13, P373, DOI 10.1021/tx9901480; Fribley AM, 2011, J BIOMOL SCREEN, V16, P825, DOI 10.1177/1087057111414893; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; HATEY F, 1979, TOXICOLOGY, V13, P223; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Kwon O, 2012, CELL SIGNAL, V24, P943, DOI 10.1016/j.cellsig.2011.12.017; Lee JY, 2010, NUTR REV, V68, P38, DOI 10.1111/j.1753-4887.2009.00259.x; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Luft P, 2008, ENVIRON TOXICOL, V23, P84, DOI 10.1002/tox.20309; Marin ML, 1996, J TOXICOL ENV HEALTH, V48, P379, DOI 10.1080/009841096161267; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; OTERO MJ, 1984, MOL CELL BIOCHEM, V61, P183; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Randow F, 2014, CELL HOST MICROBE, V15, P404, DOI 10.1016/j.chom.2014.03.012; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang JQ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00367; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wu TS, 2008, TOXICOL LETT, V183, P105, DOI 10.1016/j.toxlet.2008.09.018; Yu GY, 2012, MOL CELL, V48, P313, DOI 10.1016/j.molcel.2012.07.032; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zhang BG, 2015, TOXICON, V94, P1, DOI 10.1016/j.toxicon.2014.12.002; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	55	28	28	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19299	19311		10.1074/jbc.M115.686683	http://dx.doi.org/10.1074/jbc.M115.686683			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27458013	Green Published, hybrid			2022-12-28	WOS:000383242800011
J	Abert, C; Kontaxis, G; Martens, S				Abert, Christine; Kontaxis, Georg; Martens, Sascha			Accessory Interaction Motifs in the Atg19 Cargo Receptor Enable Strong Binding to the Clustered Ubiquitin-related Atg8 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; SELECTIVE AUTOPHAGY; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; LIR MOTIF; CYTOPLASM; YEAST; MECHANISM; FORM	Selective autophagy contributes to cellular homeostasis by delivering harmful material into the lysosomal system for degradation via vesicular intermediates referred to as autophagosomes. The cytoplasm-to-vacuole targeting pathway is a variant of selective autophagy in Saccharomyces cerevisiae during which hydrolases such as prApel are transported into the vacuole. In general, selectivity is achieved by autophagic cargo receptors that link the cargo to autophagosomal membranes because of their ability to simultaneously interact with the cargo and Atg8 proteins that coat the membrane. The Atg19 receptor contains multiple Atg8 interaction sites in its C terminus in addition to a canonical Atg8-interacting LC3-interacting region (LIR, with LC3 being a homolog of Atg8) motif, but their mode of interaction with Atg8 is unclear. Here we show, using a combination of NMR, microscopy-based interaction assays, and prApel processing experiments, that two additional sites interact with Atg8 in a LIR-like and thus mutually exclusive manner. We term these motifs accessory LIR motifs because their affinities are lower than that of the canonical LIR motif. Thus, one Atg19 molecule has the ability to interact with multiple Atg8 proteins simultaneously, resulting in a high-avidity interaction that may confer specific binding to the Atg8-coated autophagosomal membrane on which Atg8 is concentrated.	[Abert, Christine; Martens, Sascha] Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Biochem & Cell Biol, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria; [Kontaxis, Georg] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, Campus Vienna Bioctr 5-1, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Martens, S (corresponding author), Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	sascha.martens@univie.ac.at		Martens, Sascha/0000-0003-3786-8199	ERC [260304, 646653]; FWF [P25546-B20]; EMBO; DOC fellowship of the Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 25546] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); FWF(Austrian Science Fund (FWF)); EMBO(European Molecular Biology Organization (EMBO)); DOC fellowship of the Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by ERC Grants 260304 and 646653, by FWF Grant P25546-B20), by the EMBO Young Investigator Program, and by a DOC fellowship of the Austrian Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Ho KH, 2009, AUTOPHAGY, V5, P461, DOI 10.4161/auto.5.4.7696; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kumeta H, 2010, J BIOMOL NMR, V47, P237, DOI 10.1007/s10858-010-9420-1; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Randow F, 2014, CELL HOST MICROBE, V15, P404, DOI 10.1016/j.chom.2014.03.012; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rozenknop A, 2011, J MOL BIOL, V410, P477, DOI 10.1016/j.jmb.2011.05.003; Sawa-Makarska J, 2014, NAT CELL BIOL, V16, P425, DOI 10.1038/ncb2935; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Wurzer B, 2015, ELIFE, V4, DOI 10.7554/eLife.08941; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004	26	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18799	18808		10.1074/jbc.M116.736892	http://dx.doi.org/10.1074/jbc.M116.736892			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402840	hybrid, Green Published			2022-12-28	WOS:000383242300017
J	Mollet, IG; Malm, HA; Wendt, A; Orho-Melander, M; Eliasson, L				Mollet, Ines Guerra; Malm, Helena Anna; Wendt, Anna; Orho-Melander, Marju; Eliasson, Lena			Integrator of Stress Responses Calmodulin Binding Transcription Activator 1 (Camta1) Regulates miR-212/miR-132 Expression and Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); cyclic AMP (cAMP); insulin secretion; microRNA (miRNA); pancreatic islet; transcription coactivator; transcription promoter; type 2 diabetes; calmodulin binding transcription activator 1 (Camta1); NK2 homeobox 2 (Nkx2-2)	PANCREATIC BETA-CELLS; B-CELLS; MICE LACKING; RISK LOCI; ISLET; NKX2.2; GENE; EXOCYTOSIS; PROTEINS; FAMILY	Altered microRNA profiles have been demonstrated in experimental models of type 2 diabetes, including in islets of the diabetic Goto-Kakizaki (GK) rat. Our bioinformatic analysis of conserved sequences in promoters of microRNAs, previously observed to be up-regulated in GK rat islets, revealed putative CGCG-core motifs on the promoter of the miR-212/miR-132 cluster, overexpression of which has been shown to increase insulin secretion. These motifs are possible targets of calmodulin binding transcription activators Camta1 and Camta2 that have been recognized as integrators of stress responses. We also identified putative NKE elements, possible targets of NK2 homeobox proteins like the essential islet transcription factor Nkx2-2. As Camtas can function as co-activators with NK2 proteins in other tissues, we explored the role of Camta1, Camta2, and Nkx2-2 in the regulation of the miR-212/miR-132 cluster and insulin secretion. We demonstrate that exposure of control Wistar or GK rat islets to 16.7 mm glucose increases miR-212/miR-132 expression but significantly less so in the GK rat. In addition, Camta1, Camta2, and Nkx2-2 were down-regulated in GK rat islets, and knockdown of Camta1 reduced miR-212/miR-132 promoter activity and miR-212/miR-132 expression, even under cAMP elevation. Knockdown of Camta1 decreased insulin secretion in INS-1 832/13 cells and Wistar rat islets but increased insulin content. Furthermore, knockdown of Camta1 reduced K+-induced insulin secretion and voltage-dependent Ca2+ currents. We also demonstrate Camta1 and Nkx2-2 protein interaction. These results indicate that Camta1 is required not only for expression of the miR-212/miR-132 cluster but at multiple levels for regulating beta cell insulin content and secretion.	[Mollet, Ines Guerra; Malm, Helena Anna; Wendt, Anna; Orho-Melander, Marju; Eliasson, Lena] Lund Univ, Dept Clin Sci, Clin Res Ctr, Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden	Lund University	Mollet, IG (corresponding author), Lund Univ, Dept Clin Sci, Clin Res Ctr, Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden.	inesmollet@gmail.com	Eliasson, Lena/E-9294-2012; Mollet, Ines Guerra/H-8526-2019	Eliasson, Lena/0000-0002-6467-5029; Mollet, Ines Guerra/0000-0002-1422-1336; Wendt, Anna/0000-0001-8807-5979	Vetenskapsradet Project Grant [2012-13147]; Linneus Grant [2006-237]; Strategic Research Grant [2009-1039]; Regional Support through ALF-Skane [ALFSKANE-450661]; Diabetesfonden Grant [DIA 2013-055]; Albert Pahlsson Foundation	Vetenskapsradet Project Grant; Linneus Grant; Strategic Research Grant; Regional Support through ALF-Skane; Diabetesfonden Grant; Albert Pahlsson Foundation	This work was supported by Vetenskapsradet Project Grant 2012-13147 (to L. E.), Linneus Grant 2006-237 (to Lund University Diabetes Centre), Strategic Research Grant 2009-1039 (to SFO-EXODIAB), Regional Support through ALF-Skane ALFSKANE-450661, Diabetesfonden Grant DIA 2013-055, and the Albert Pahlsson Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Aziz H, 2005, PLANTA MED, V71, P609, DOI 10.1055/s-2005-871265; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Anderson KR, 2009, J BIOL CHEM, V284, P31236, DOI 10.1074/jbc.M109.048694; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; Choi MS, 2005, J BIOL CHEM, V280, P40820, DOI 10.1074/jbc.M504616200; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Doyle MJ, 2007, DEVELOPMENT, V134, P515, DOI 10.1242/dev.02763; Doyle MJ, 2007, DIABETES, V56, P1999, DOI 10.2337/db06-1766; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Eckardt NA, 2009, PLANT CELL, V21, P697, DOI 10.1105/tpc.109.210310; Eliasson L, 1997, J PHYSIOL-LONDON, V503, P399, DOI 10.1111/j.1469-7793.1997.399bh.x; Esguerra JLS, 2014, GENES-BASEL, V5, P1018, DOI 10.3390/genes5041018; Esguerra JLS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018613; Finkler A, 2007, FEBS LETT, V581, P3893, DOI 10.1016/j.febslet.2007.07.051; GARCIAFERNANDEZ J, 1991, P NATL ACAD SCI USA, V88, P7338, DOI 10.1073/pnas.88.16.7338; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; Hao MM, 2005, J CELL SCI, V118, P5873, DOI 10.1242/jcs.02684; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huentelman MJ, 2007, HUM MOL GENET, V16, P1469, DOI 10.1093/hmg/ddm097; Jacovetti C, 2012, J CLIN INVEST, V122, P3541, DOI 10.1172/JCI64151; Keller DM, 2012, MOL ENDOCRINOL, V26, P989, DOI 10.1210/me.2011-1205; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Long CZ, 2014, P NATL ACAD SCI USA, V111, P11521, DOI 10.1073/pnas.1411251111; MacDonald PE, 2006, CELL METAB, V4, P283, DOI 10.1016/j.cmet.2006.08.011; Malm HA, 2016, MOL CELL ENDOCRINOL, V424, P23, DOI 10.1016/j.mce.2016.01.010; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miller LA, 2011, PSYCHOGERIATRICS, V11, P135, DOI 10.1111/j.1479-8301.2011.00357.x; Mitsuda N, 2003, PLANT CELL PHYSIOL, V44, P975, DOI 10.1093/pcp/pcg137; Muller-Borer B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038454; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; PRICE M, 1993, J NEUROBIOL, V24, P1385, DOI 10.1002/neu.480241010; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Shang J, 2015, MOL ENDOCRINOL, V29, P1243, DOI 10.1210/me.2014-1335; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Sussel L, 1998, DEVELOPMENT, V125, P2213; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200	55	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18440	18452		10.1074/jbc.M116.716860	http://dx.doi.org/10.1074/jbc.M116.716860			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402838	Green Published, hybrid			2022-12-28	WOS:000383241800034
J	Venetz, D; Koovely, D; Weder, B; Neri, D				Venetz, Dario; Koovely, Danil; Weder, Bruce; Neri, Dario			Targeted Reconstitution of Cytokine Activity upon Antigen Binding using Split Cytokine Antibody Fusion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; cancer; cytokine; immunotherapy; pharmacology; activity-on-demand; tumor targeting; split protein; activity reconstitution; interleukin-12	INTERLEUKIN-12 IL-12 P40; MONOCLONAL-ANTIBODY; IN-VIVO; COMPLEMENTATION ASSAYS; ANTITUMOR-ACTIVITY; CHOP CHEMOTHERAPY; ARMED ANTIBODIES; BREAST-CANCER; CELL LYMPHOMA; DELIVERY	The targeted assembly of antibody products upon antigen binding represents a novel strategy for the reconstitution of potent therapeutic activity at the site of disease, sparing healthy tissues. We demonstrate that interleukin-12, a heterodimeric pro-inflammatory cytokine consisting of the disulfide-linked p40 and p35 subunits, can be reconstituted by sequential reassembly of fusion proteins based on antibody fragments and interleukin-12 subunit mutants. Analysis of the immunostimulatory properties of interleukin-12 and its derivatives surprisingly revealed that the mutated p35 subunit partially retained the activity of the parental cytokine, whereas the p40 subunit alone was not able to stimulate T cells or natural killer cells. The concept of stepwise antibody-based reassembly of split cytokines could be useful for the development of other anticancer therapeutics with improved safety and tolerability.	[Venetz, Dario; Koovely, Danil; Weder, Bruce; Neri, Dario] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Venetz, D; Neri, D (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland.	dario.venetz@pharma.ethz.ch; dario.neri@pharma.ethz.ch	Neri, Dario/P-4368-2016	Neri, Dario/0000-0001-5234-7370; Weder, Bruce/0000-0001-5961-2544	ETH Zurich; Swiss National Science Foundation [310030B_163479/1]; Commission for Technology and Innovation [17072.1]; European Research Council [670603]	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission for Technology and Innovation; European Research Council(European Research Council (ERC)European Commission)	This research was supported by the ETH Zurich, the Swiss National Science Foundation (Project 310030B_163479/1), the Commission for Technology and Innovation (Project 17072.1), and the European Research Council (Project 670603). The authors declare that they have no conflicts of interest with the contents of this article.	Banaszek A, 2013, THESIS; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Carnemolla B, 2002, BLOOD, V99, P1659, DOI 10.1182/blood.V99.5.1659; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Desnoyers LR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006682; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; Eigentler TK, 2011, CLIN CANCER RES, V17, P7732, DOI 10.1158/1078-0432.CCR-11-1203; Gafner V, 2006, INT J CANCER, V119, P2205, DOI 10.1002/ijc.22101; Gallamini A, 2007, BLOOD, V110, P2316, DOI 10.1182/blood-2007-02-074641; Garcin G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4016; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Gillies SD, 2013, PROTEIN ENG DES SEL, V26, P561, DOI 10.1093/protein/gzt045; Gollob JA, 2000, CLIN CANCER RES, V6, P1678; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Halin C, 2002, NAT BIOTECHNOL, V20, P264, DOI 10.1038/nbt0302-264; Heinzel FP, 1997, J IMMUNOL, V158, P4381; Hess C, 2014, MEDCHEMCOMM, V5, P408, DOI 10.1039/c3md00360d; HOSTOMSKY Z, 1991, P NATL ACAD SCI USA, V88, P1148, DOI 10.1073/pnas.88.4.1148; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Lauwerys BR, 2002, LUPUS, V11, P384, DOI 10.1191/0961203302lu213oa; Leonard JP, 1997, BLOOD, V90, P2541; Li J, 2008, ANAL BIOCHEM, V373, P389, DOI 10.1016/j.ab.2007.10.034; Lieschke GJ, 1997, NAT BIOTECHNOL, V15, P35, DOI 10.1038/nbt0197-35; LING P, 1995, J IMMUNOL, V154, P116; Morell M, 2009, FEBS LETT, V583, P1684, DOI 10.1016/j.febslet.2009.03.002; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Neri D, 2016, CURR OPIN IMMUNOL, V40, P96, DOI 10.1016/j.coi.2016.03.006; Pasche N, 2012, CLIN CANCER RES, V18, P4092, DOI 10.1158/1078-0432.CCR-12-0282; Pasche N, 2012, DRUG DISCOV TODAY, V17, P583, DOI 10.1016/j.drudis.2012.01.007; Pietras RJ, 1998, ONCOGENE, V17, P2235, DOI 10.1038/sj.onc.1202132; Remy I, 2007, BIOTECHNIQUES, V42, P137, DOI 10.2144/000112396; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Shigehara K, 2003, CLIN EXP IMMUNOL, V132, P152, DOI 10.1046/j.1365-2249.2003.02105.x; Sommavilla R, 2010, PROTEIN ENG DES SEL, V23, P653, DOI 10.1093/protein/gzq038; Tassev DV, 2009, EXPERT OPIN BIOL TH, V9, P341, DOI 10.1517/14712590802715764 ; Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247; VADHANRAJ S, 1987, NEW ENGL J MED, V317, P1545, DOI 10.1056/NEJM198712173172501; Venetz D, 2015, P NATL ACAD SCI USA, V112, P2000, DOI 10.1073/pnas.1416694112; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Versteegen RM, 2013, ANGEW CHEM INT EDIT, V52, P14112, DOI 10.1002/anie.201305969; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530; Zhang Z, 2003, CANCER RES, V63, P6453	50	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18139	18147		10.1074/jbc.M116.737734	http://dx.doi.org/10.1074/jbc.M116.737734			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402834	Green Published, hybrid			2022-12-28	WOS:000383241800008
J	Di Sebastiano, AR; Fahim, S; Dunn, HA; Walther, C; Ribeiro, FM; Cregan, SP; Angers, S; Schmid, S; Ferguson, SSG				Di Sebastiano, Andrea R.; Fahim, Sandra; Dunn, Henry A.; Walther, Cornelia; Ribeiro, Fabiola M.; Cregan, Sean P.; Angers, Stephane; Schmid, Susanne; Ferguson, Stephen S. G.			Role of Spinophilin in Group I Metabotropic Glutamate Receptor Endocytosis, Signaling, and Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; endocytosis; extracellular-signal-regulated kinase (ERK); glutamate receptor; receptor regulation	PHOSPHORYLATION-INDEPENDENT REGULATION; LONG-TERM DEPRESSION; BETA-GAMMA-SUBUNITS; PROTEIN PHOSPHATASE-1; CELL-SURFACE; DESENSITIZATION; BINDING; VITRO; INTERNALIZATION; INTERACTS	Activation of Group I metabotropic glutamate receptors (mGluRs) activates signaling cascades, resulting in calcium release from intracellular stores, ERK1/2 activation, and long term changes in synaptic activity that are implicated in learning, memory, and neurodegenerative diseases. As such, elucidating the molecular mechanisms underlying Group I mGluR signaling is important for understanding physiological responses initiated by the activation of these receptors. In the current study, we identify the multifunctional scaffolding protein spinophilin as a novel Group I mGluR-interacting protein. We demonstrate that spinophilin interacts with the C-terminal tail and second intracellular loop of Group I mGluRs. Furthermore, we show that interaction of spinophilin with Group I mGluRs attenuates receptor endocytosis and phosphorylation of ERK1/2, an effect that is dependent upon the interaction of spinophilin with the C-terminal PDZ binding motif encoded by Group I mGluRs. Spinophilin knock-out results in enhanced mGluR5 endocytosis as well as increased ERK1/2, AKT, and Ca2+ signaling in primary cortical neurons. In addition, the loss of spinophilin expression results in impaired mGluR5-stimulated LTD. Our results indicate that spinophilin plays an important role in regulating the activity of Group I mGluRs as well as their influence on synaptic activity.	[Di Sebastiano, Andrea R.; Fahim, Sandra; Walther, Cornelia; Cregan, Sean P.] Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, London, ON N6A 3K7, Canada; [Ribeiro, Fabiola M.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, ICB, BR-31270901 Belo Horizonte, MG, Brazil; [Angers, Stephane] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada; [Angers, Stephane] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 3M2, Canada; [Schmid, Susanne; Ferguson, Stephen S. G.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 3K7, Canada; [Dunn, Henry A.] Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Dr, Ottawa, ON K1H 8M5, Canada; [Ferguson, Stephen S. G.] Heart & Stroke Fdn Ontario, Ottawa, ON, Canada; [Ferguson, Stephen S. G.] Tier 1 Canada Res Chair Brain & Mind, Ottawa, ON, Canada	Western University (University of Western Ontario); Universidade Federal de Minas Gerais; University of Toronto; University of Toronto; Western University (University of Western Ontario); University of Ottawa	Ferguson, SSG (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Dr, Ottawa, ON K1H 8M5, Canada.	sferguso@uottawa.ca	Schmid, Susanne/J-3201-2012; Angers, Stephane/E-1432-2014; Ribeiro, Fabiola/E-8831-2013	Schmid, Susanne/0000-0001-5366-8061; Angers, Stephane/0000-0001-7241-9044; Ribeiro, Fabiola/0000-0001-7042-9433; Dunn, Henry A./0000-0002-2543-4740	Canadian Institutes of Health Research Grant [MOP-119437]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-119437 (to S. S. G. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed SM, 2010, J BIOL CHEM, V285, P6538, DOI 10.1074/jbc.M109.069948; Allen PB, 2006, NEUROSCIENCE, V140, P897, DOI 10.1016/j.neuroscience.2006.02.067; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Bhattacharya M, 2004, J NEUROSCI, V24, P8752, DOI 10.1523/JNEUROSCI.3155-04.2004; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Charlton JJ, 2008, NEURON, V58, P238, DOI 10.1016/j.neuron.2008.02.006; Cheng S, 2010, J NEUROCHEM, V112, P588, DOI 10.1111/j.1471-4159.2009.06454.x; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Croci C, 2003, J BIOL CHEM, V278, P50682, DOI 10.1074/jbc.M305764200; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; de Azua IR, 2012, FASEB J, V26, P4275, DOI 10.1096/fj.12-204644; Dhami GK, 2005, J BIOL CHEM, V280, P24420, DOI 10.1074/jbc.M501650200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dingledine R, 1999, PHARMACOL REV, V51, P7; Esseltine JL, 2013, MOL PHARMACOL, V83, P770, DOI 10.1124/mol.112.081695; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Ferguson Stephen S. G., 2003, V237, P121; Fourla DD, 2012, CELL SIGNAL, V24, P2315, DOI 10.1016/j.cellsig.2012.08.002; Hamilton A, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0107-0; Hamilton A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-40; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mao LM, 2008, NEUROPHARMACOLOGY, V55, P403, DOI 10.1016/j.neuropharm.2008.05.034; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; PICKERING DS, 1993, J NEUROCHEM, V61, P85, DOI 10.1111/j.1471-4159.1993.tb03540.x; Pignatelli M, 2014, J NEUROSCI, V34, P4558, DOI 10.1523/JNEUROSCI.1846-13.2014; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; Raka F, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0111-4; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wang X, 2007, EMBO J, V26, P2768, DOI 10.1038/sj.emboj.7601701; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	46	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17602	17615		10.1074/jbc.M116.722355	http://dx.doi.org/10.1074/jbc.M116.722355			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358397	Green Published, hybrid			2022-12-28	WOS:000383241300012
J	Millena, AC; Vo, BT; Khan, SA				Millena, Ana Cecilia; Vo, BaoHan T.; Khan, Shafiq A.			JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor- (TGF-)-induced Inhibition of Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP-1 transcription factor (AP-1); cell proliferation; prostate cancer; protein degradation; transforming growth factor beta (TGF-B)	NF-KAPPA-B; BETA SIGNALING PATHWAY; TRANSCRIPTION FACTOR AP-1; RECEPTOR-TYPE-II; TGF-BETA; C-JUN; ACTIVATOR PROTEIN-1; ANDROGEN RECEPTOR; INTERLEUKIN-6 EXPRESSION; MALIGNANT PROSTATE	TGF- inhibits proliferation of prostate epithelial cells. However, prostate cancer cells in advanced stages become resistant to inhibitory effects of TGF-. The intracellular signaling mechanisms involved in differential effects of TGF- during different stages are largely unknown. Using cell line models, we have shown that TGF- inhibits proliferation in normal (RWPE-1) and prostate cancer (DU145) cells but does not have any effect on proliferation of prostate cancer (PC3) cells. We have investigated the role of Jun family proteins (c-Jun, JunB, and JunD) in TGF- effects on cell proliferation. Jun family members were expressed at different levels and responded differentially to TGF- treatment. TGF- effects on JunD protein levels, but not mRNA levels, correlated with its effects on cell proliferation. TGF- induced significant reduction in JunD protein in RWPE-1 and DU145 cells but not in PC3 cells. Selective knockdown of JunD expression using siRNA in DU145 and PC3 cells resulted in significant reduction in cell proliferation, and forced overexpression of JunD increased the proliferation rate. On the other hand, knockdown of c-Jun or JunB had little, if any, effect on cell proliferation; overexpression of c-Jun and JunB decreased the proliferation rate in DU145 cells. Further studies showed that down-regulation of JunD in response to TGF- treatment is mediated via the proteasomal degradation pathway. In conclusion, we show that specific Jun family members exert differential effects on proliferation in prostate cancer cells in response to TGF-, and inhibition of cell proliferation by TGF- requires degradation of JunD protein.	[Millena, Ana Cecilia; Vo, BaoHan T.; Khan, Shafiq A.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA; [Vo, BaoHan T.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	Clark Atlanta University; St Jude Children's Research Hospital	Khan, SA (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, 223 James P Brawley Dr SW, Atlanta, GA 30314 USA.	skhan@cau.edu			NIMHD, National Institutes of Health [G12MD007590, 5P20MD002285]; National Institute on Minority Health and Health Disparities [G12MD007590, P20MD002285] Funding Source: NIH RePORTER	NIMHD, National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIMHD, National Institutes of Health, Grants G12MD007590 and 5P20MD002285. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Axmann A, 1998, BIOCHEM BIOPH RES CO, V249, P456, DOI 10.1006/bbrc.1998.9188; Barrack ER, 1997, PROSTATE, V31, P61; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; Chakrabarti L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083521; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Church DR, 2005, PROSTATE, V63, P155, DOI 10.1002/pros.20172; De Boeck M, 2012, UPSALA J MED SCI, V117, P153, DOI 10.3109/03009734.2012.654858; Desruisseau S, 1996, INT J CANCER, V66, P796, DOI 10.1002/(SICI)1097-0215(19960611)66:6<796::AID-IJC15>3.0.CO;2-1; Deziel BA, 2010, J CELL BIOCHEM, V111, P742, DOI 10.1002/jcb.22761; Djonov V, 1997, INT J ONCOL, V11, P1185; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Feng ZW, 1998, ONCOGENE, V17, P2593, DOI 10.1038/sj.onc.1202195; Fitzgerald KA, 2014, EXPERT OPIN THER TAR, V18, P633, DOI 10.1517/14728222.2014.896904; FitzGerald UF, 2000, MOL CELL NEUROSCI, V16, P453, DOI 10.1006/mcne.2000.0886; Gohla G, 2008, J CELL BIOCHEM, V104, P850, DOI 10.1002/jcb.21669; Gunthert AR, 2002, BIOCHEM BIOPH RES CO, V294, P11, DOI 10.1016/S0006-291X(02)00427-8; Han SH, 1998, J PHARMACOL EXP THER, V287, P1105; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hirota Y, 2000, OSTEOARTHR CARTILAGE, V8, P241, DOI 10.1053/joca.1999.0297; Hogan KA, 2013, CYTOKINE, V64, P652, DOI 10.1016/j.cyto.2013.09.004; Hung SH, 2009, J AGR FOOD CHEM, V57, P1291, DOI 10.1021/jf8032683; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jacobs-Helber SM, 1998, MOL CELL BIOL, V18, P3699, DOI 10.1128/MCB.18.7.3699; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Johnson Aaron N., 2002, TheScientificWorldJOURNAL, V2, P892; Kajanne R, 2009, INT J ONCOL, V35, P1175, DOI 10.3892/ijo_00000434; Kang DC, 1998, INT J ONCOL, V13, P1117; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim IY, 1998, CLIN CANCER RES, V4, P1625; Kizu R, 2003, ARCH TOXICOL, V77, P335, DOI 10.1007/s00204-003-0454-y; Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120; Krosl J, 2000, ONCOGENE, V19, P5134, DOI 10.1038/sj.onc.1203897; Kumano M, 2008, BRIT J CANCER, V98, P356, DOI 10.1038/sj.bjc.6604169; Kwon GT, 2009, J NUTR BIOCHEM, V20, P663, DOI 10.1016/j.jnutbio.2008.06.005; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lee C, 1999, PROSTATE, V39, P285; Letamendia A, 2001, J BONE JOINT SURG AM, V83A, pS31; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; LOKESHWAR BL, 1992, CANCER RES, V52, P5821; Mashimo T, 2000, BIOCHEM BIOPH RES CO, V274, P370, DOI 10.1006/bbrc.2000.3139; McDonald CA, 2006, MOL ENDOCRINOL, V20, P608, DOI 10.1210/me.2005-0245; Meggiato T, 2003, PANCREAS, V26, P65, DOI 10.1097/00006676-200301000-00011; Mehraein-Ghomi F, 2008, PROSTATE, V68, P924, DOI 10.1002/pros.20737; Mehraein-Ghomi F, 2010, CANCER RES, V70, P4560, DOI 10.1158/0008-5472.CAN-09-3596; Moreno CS, 2010, AM J PATHOL, V176, P518, DOI 10.2353/ajpath.2010.090657; Nyhan KC, 2010, BBA-MOL CELL RES, V1803, P1386, DOI 10.1016/j.bbamcr.2010.09.001; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Parra E, 2011, INT J MOL MED, V28, P847, DOI 10.3892/ijmm.2011.745; Polytarchou C, 2005, J BIOL CHEM, V280, P40428, DOI 10.1074/jbc.M505120200; Qu X, 2014, J INVEST DERMATOL, V134, P159, DOI 10.1038/jid.2013.281; SEGARINI PR, 1991, CIBA F SYMP, V157, P29; Selvaraj N, 2015, MOL CELL BIOL, V35, P88, DOI 10.1128/MCB.00982-14; Seystahl K, 2015, NEURO-ONCOLOGY, V17, P254, DOI 10.1093/neuonc/nou218; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shimada K, 2003, CARCINOGENESIS, V24, P1067, DOI 10.1093/carcin/bgg058; Song K, 2006, J BIOL CHEM, V281, P7765, DOI 10.1074/jbc.M511781200; Strong N, 2013, PROSTATE, V73, P624, DOI 10.1002/pros.22603; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Uzzo RG, 2006, CARCINOGENESIS, V27, P1980, DOI 10.1093/carcin/bgl034; Vanhara P, 2007, BIOCHEM BIOPH RES CO, V353, P92, DOI 10.1016/j.bbrc.2006.11.124; Verrecchia F, 2001, ONCOGENE, V20, P2205, DOI 10.1038/sj.onc.1204347; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Vo BT, 2012, CARCINOGENESIS, V33, P2054, DOI 10.1093/carcin/bgs252; Vo BT, 2011, PROSTATE, V71, P1084, DOI 10.1002/pros.21326; Walker L, 2013, CLIN EXP METASTAS, V30, P13, DOI 10.1007/s10585-012-9494-0; WARE JL, 1993, CANCER METAST REV, V12, P287, DOI 10.1007/BF00665959; Wicks SJ, 2006, BIOCHEM SOC T, V34, P761, DOI 10.1042/BST0340761; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wikstrom P, 1999, UROL RES, V27, P185, DOI 10.1007/s002400050108; Williams RH, 1996, CLIN CANCER RES, V2, P635; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yamada D, 2013, EUR J CANCER, V49, P1725, DOI 10.1016/j.ejca.2012.12.002; Yamaguchi Y, 1992, Nihon Rinsho, V50, P1932; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Zerbini LF, 2003, CANCER RES, V63, P2206; Zerbini LF, 2011, CELL CYCLE, V10, P2583, DOI 10.4161/cc.10.15.16057; Zhang F, 2003, EXP CELL RES, V291, P275, DOI 10.1016/j.yexcr.2003.07.007; Zhou W, 2003, ENDOCRINOLOGY, V144, P4280, DOI 10.1210/en.2003-0554; Zhou W, 2002, LIFE SCI, V72, P11, DOI 10.1016/S0024-3205(02)02183-5	88	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17964	17976		10.1074/jbc.M116.714899	http://dx.doi.org/10.1074/jbc.M116.714899			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358408	Green Published, hybrid			2022-12-28	WOS:000383241300039
J	Miner, GE; Starr, ML; Hurst, LR; Sparks, RP; Padolina, M; Fratti, RA				Miner, Gregory E.; Starr, Matthew L.; Hurst, Logan R.; Sparks, Robert P.; Padolina, Mark; Fratti, Rutilio A.			The Central Polybasic Region of the Soluble SNARE (Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor) Vam7 Affects Binding to Phosphatidylinositol 3-Phosphate by the PX (Phox Homology) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium transport; diacylglycerol; membrane fusion; phosphatidic acid; phosphatidylinositol; SNARE proteins; HOPS; ycf1	HOMOTYPIC VACUOLE FUSION; VERTEX RING DOMAIN; MEMBRANE-FUSION; YEAST VACUOLE; SACCHAROMYCES-CEREVISIAE; REGULATORY LIPIDS; COMPLEX; DOCKING; HOPS; HEMIFUSION	The yeast vacuole requires four SNAREs to trigger membrane fusion including the soluble Qc-SNARE Vam7. The N-terminal PX domain of Vam7 binds to the lipid phosphatidylinositol 3-phosphate (PI3P) and the tethering complex HOPS (homotypic fusion and vacuole protein sorting complex), whereas the C-terminal SNARE motif forms SNARE complexes. Vam7 also contains an uncharacterized middle domain that is predicted to be a coiled-coil domain with multiple helices. One helix contains a polybasic region (PBR) composed of Arg-164, Arg-168, Lys-172, Lys-175, Arg-179, and Lys-186. Polybasic regions are often associated with nonspecific binding to acidic phospholipids including phosphoinositides. Although the PX (phox homology) domain alone binds PI3P, we theorized that the Vam7 PBR could bind to additional acidic phospholipids enriched at fusion sites. Mutating each of the basic residues in the PBR to an alanine (Vam7-6A) led to attenuated vacuole fusion. The defective fusion of Vam7-6A was due in part to inefficient association with its cognate SNAREs and HOPS, yet the overall vacuole association of Vam7-6A was similar to wild type. Experiments testing the binding of Vam7 to specific signaling lipids showed that mutating the PBR to alanines augmented binding to PI3P. The increased binding to PI3P by Vam7-6A likely contributed to the observed wild type levels of vacuole association, whereas protein-protein interactions were diminished. PI3P binding was inhibited when the PX domain mutant Y42A was introduced into Vam7-6A to make Vam7-7A. Thus the Vam7 PBR affects PI3P binding by the PX domain and in turn affects binding to SNAREs and HOPS to support efficient fusion.	[Miner, Gregory E.; Starr, Matthew L.; Hurst, Logan R.; Sparks, Robert P.; Padolina, Mark; Fratti, Rutilio A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Fratti, RA (corresponding author), Univ Illinois, Dept Biochem, Roger Adams Lab 419, B-4,600 S Mathews Ave, Urbana, IL 61801 USA.	rfratti@illinois.edu		Sparks, Robert/0000-0002-0485-8317; Miner, Gregory/0000-0002-1124-4217	National Institutes of Health [GM101132]; NIGMS, National Institutes of Health Chemistry-Biology Interface Training Grant [5T32-GM070421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421, R01GM101132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health Chemistry-Biology Interface Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM101132 (to R. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIGMS, National Institutes of Health Chemistry-Biology Interface Training Grant 5T32-GM070421.	Boal F, 2015, J CELL SCI, V128, P815, DOI 10.1242/jcs.166314; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Fang J, 2007, BIOPHYS J, V93, P1809, DOI 10.1529/biophysj.106.100834; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hawkins PT, 2016, BIOCHEM SOC T, V44, P307, DOI 10.1042/BST20150248; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Jun Y, 2007, P NATL ACAD SCI USA, V104, P13010, DOI 10.1073/pnas.0700970104; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; Karunakaran S, 2013, TRAFFIC, V14, P650, DOI 10.1111/tra.12064; Karunakaran S, 2012, J CELL SCI, V125, P1683, DOI 10.1242/jcs.091900; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lawrence G, 2014, MOL BIOL CELL, V25, P1608, DOI 10.1091/mbc.E13-08-0460; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Matsuoka K, 1998, MOL CELL, V2, P703, DOI 10.1016/S1097-2765(00)80168-9; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nigorikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111698; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Reese C, 2005, J CELL BIOL, V171, P981, DOI 10.1083/jcb.200510018; Roberts RL, 1999, J CELL SCI, V112, P3667; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sasser TL, 2013, J BIOL CHEM, V288, P18300, DOI 10.1074/jbc.M112.441089; Sasser TL, 2012, BIOCHEM J, V448, P365, DOI 10.1042/BJ20120847; Slusarewicz P, 1997, P NATL ACAD SCI USA, V94, P5582, DOI 10.1073/pnas.94.11.5582; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Xu H, 2012, P NATL ACAD SCI USA, V109, P17936, DOI 10.1073/pnas.1216201109	50	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17651	17663		10.1074/jbc.M116.725366	http://dx.doi.org/10.1074/jbc.M116.725366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365394	hybrid, Green Published			2022-12-28	WOS:000383241300016
J	Savas, S; Wei, SZ; Hsu, MH; Falck, JR; Guengerich, FP; Capdevila, JH; Johnson, EF				Savas, Szen; Wei, Shouzou; Hsu, Mei-Hui; Falck, John R.; Guengerich, F. Peter; Capdevila, Jorge H.; Johnson, Eric F.			20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; SALT-SENSITIVE HYPERTENSION; ANDROGEN-INDUCED HYPERTENSION; NA+-CL-COTRANSPORTER; T8590C POLYMORPHISM; OMEGA-HYDROXYLASE; ARACHIDONIC-ACID; CYP4A11 GENE; FUNCTIONAL POLYMORPHISM; CHLORIDE COTRANSPORTER	Male and female homozygous 129/Sv mice carrying four copies of the human cytochrome P450 4A11 gene (CYP4A11) under control of its native promoter (B-129/ Sv-4A11(+/+)) develop hypertension (142 +/- 8 versus 113 +/- 7 mm Hg systolic blood pressure (BP)), and exhibit increased 20-hydroxyeicosatetraenoic acid (20-HETE) in kidney and urine. The hypertension is reversible by a low-sodium diet and by the CYP4A inhibitor HET0016. B-129/ Sv-4A11(+/+) mice display an 18% increase of plasma potassium (p < 0.02), but plasma aldosterone, angiotensin II (ANGII), and renin activities are unchanged. This phenotype resembles human genetic disorders with elevated activity of the sodium chloride co-transporter (NCC) and, accordingly, NCC abundance is increased by 50% in transgenic mice, and NCC levels are normalized by HET0016. ANGII is known to increase NCC abundance, and renal mRNA levels of its precursor angiotensinogen are increased 2-fold in B-129/ Sv-4A11 (+/+), and blockade of the ANGII receptor type 1 with losartan normalizes BP. A pro-hypertensive role for 20-HETE was implicated by normalization of BP and reversal of renal angiotensin mRNA increases by administration of the 20-HETE antagonists 2-((6Z, 15Z)-20-hydroxyicosa- 6,15-dienamido) acetate or (S)-2-((6Z, 15Z)-20hydroxyicosa- 6,15-dienamido) succinate. SGK1 expression is also increased in B-129/ Sv-4A11(+/+) mice and paralleled increases seen for NCC. Losartan, HET0016, and 20-HETE antagonists each normalized SGK1 mRNA expression. These results point to a potential 20-HETE dependence of intrarenal angiotensinogen production and ANGII receptor type 1 activation that are associated with increases in NCC and SGK1 and identify elevated P450 4A11 activity and 20-HETE as potential risk factors for salt-sensitive human hypertension by perturbation of the renal renin-angiotensin axis.	[Savas, Szen; Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Wei, Shouzou; Capdevila, Jorge H.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Falck, John R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Scripps Research Institute; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Johnson, EF (corresponding author), MEM 255,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	johnson@scripps.edu			United States Public Health Service [R01 HD004445, P01 DK038226]; Welch Foundation [I-0011]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD004445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service Grants R01 HD004445 (to E. F. J.) and P01 DK038226 (to J. H. C., J. R. F., and F. P. G.) and The Welch Foundation Grant I-0011 (to J. R. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acres OW, 2011, HYPERTENSION, V57, P608, DOI 10.1161/HYPERTENSIONAHA.110.165464; Alonso-Galicia M, 1999, AM J PHYSIOL-RENAL, V277, pF790, DOI 10.1152/ajprenal.1999.277.5.F790; Baskin R, 2012, CELL SIGNAL, V24, P435, DOI 10.1016/j.cellsig.2011.09.016; BRASIER AR, 1994, KIDNEY INT, V46, P1564, DOI 10.1038/ki.1994.447; CAPDEVILA JH, 1990, METHOD ENZYMOL, V187, P385; Capdevila JH, 2015, PROSTAG OTH LIPID M, V120, P40, DOI 10.1016/j.prostaglandins.2015.05.004; Capdevila JH, 2014, J BIOL CHEM, V289, P4377, DOI 10.1074/jbc.M113.508416; Cheng J, 2012, ARTERIOSCL THROM VAS, V32, P1917, DOI 10.1161/ATVBAHA.112.248344; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Craigie E, 2012, HYPERTENSION, V60, P684, DOI 10.1161/HYPERTENSIONAHA.112.196410; Edson KZ, 2013, BIOCHEMISTRY-US, V52, P8276, DOI 10.1021/bi401208m; Edson KZ, 2013, CURR TOP MED CHEM, V13, P1429; Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088; Fan XQ, 2014, MOL MED REP, V10, P2483, DOI 10.3892/mmr.2014.2492; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; Gainer JV, 2008, J AM SOC NEPHROL, V19, P1606, DOI 10.1681/ASN.2008010063; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Garcia V, 2016, J PHARMACOL EXP THER, V356, P525, DOI 10.1124/jpet.115.229377; Garcia V, 2015, PROSTAG OTH LIPID M, V116, P124, DOI 10.1016/j.prostaglandins.2014.12.001; Ge Y, 2013, PROSTAG OTH LIPID M, V102, P42, DOI 10.1016/j.prostaglandins.2013.03.001; Glover M, 2009, J AM SOC NEPHROL, V20, P1314, DOI 10.1681/ASN.2008050542; Hermann M, 2009, ATHEROSCLEROSIS, V207, P476, DOI 10.1016/j.atherosclerosis.2009.06.009; Holla VR, 2001, P NATL ACAD SCI USA, V98, P5211, DOI 10.1073/pnas.081627898; Hussain A, 2008, KIDNEY BLOOD PRESS R, V31, P80, DOI 10.1159/000119703; Ito O, 2006, MOL CELL BIOCHEM, V284, P141, DOI 10.1007/s11010-005-9038-x; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Laffer CL, 2008, HYPERTENSION, V51, P767, DOI 10.1161/HYPERTENSIONAHA.107.102921; Laffer CL, 2014, J AM SOC HYPERTENS, V8, P475, DOI 10.1016/j.jash.2014.04.011; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; Liu H, 2008, J AM SOC NEPHROL, V19, P714, DOI 10.1681/ASN.2007060713; Liu XL, 2012, GENE, V505, P352, DOI 10.1016/j.gene.2012.02.029; Liu XL, 2009, KIDNEY INT, V75, P1288, DOI 10.1038/ki.2009.67; Mayer B, 2005, HYPERTENSION, V46, P766, DOI 10.1161/01.HYP.0000182658.04299.15; Mayer B, 2006, J HYPERTENS, V24, P1965, DOI 10.1097/01.hjh.0000244944.34546.8e; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Navar LG, 2013, KIDNEY INT SUPPL, V3, P321, DOI 10.1038/kisup.2013.67; O'Shaughnessy KM, 2015, PEDIATR NEPHROL, V30, P1903, DOI 10.1007/s00467-014-2956-7; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Powell PK, 1996, ARCH BIOCHEM BIOPHYS, V335, P219, DOI 10.1006/abbi.1996.0501; Powell PK, 1998, J PHARMACOL EXP THER, V285, P1327; PRAKASH C, 1992, BIOCHEM BIOPH RES CO, V185, P728, DOI 10.1016/0006-291X(92)91686-K; Quigley R, 2009, NEPHRON PHYSIOL, V113, pP23, DOI 10.1159/000235774; Rohrwasser A, 1999, HYPERTENSION, V34, P1265, DOI 10.1161/01.HYP.34.6.1265; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Sandberg MB, 2007, AM J PHYSIOL-RENAL, V293, pF662, DOI 10.1152/ajprenal.00064.2007; Savas U, 2009, J BIOL CHEM, V284, P16541, DOI 10.1074/jbc.M902074200; Sodhi K, 2010, HYPERTENSION, V56, P871, DOI 10.1161/HYPERTENSIONAHA.110.154559; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Sparks MA, 2014, COMPR PHYSIOL, V4, P1201, DOI 10.1002/cphy.c130040; Stec DE, 2007, PHYSIOL GENOMICS, V30, P74, DOI 10.1152/physiolgenomics.00003.2007; Stevens VA, 2008, NEPHROL DIAL TRANSPL, V23, P1834, DOI 10.1093/ndt/gfm923; Sugimoto K, 2008, HYPERTENSION, V52, P1142, DOI 10.1161/HYPERTENSIONAHA.108.114082; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van der Lubbe N, 2013, CURR OPIN NEPHROL HY, V22, P120, DOI 10.1097/MNH.0b013e32835b6551; van der Lubbe N, 2011, KIDNEY INT, V79, P66, DOI 10.1038/ki.2010.290; Ward NC, 2008, HYPERTENSION, V51, P1393, DOI 10.1161/HYPERTENSIONAHA.107.104463; Williams JS, 2011, J HYPERTENS, V29, P1913, DOI 10.1097/HJH.0b013e32834aa786; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Wu CC, 2013, J AM SOC NEPHROL, V24, P1288, DOI 10.1681/ASN.2012070714; Wu JJ, 2013, HUM GENET, V132, P179, DOI 10.1007/s00439-012-1238-3; Yang H, 2014, CLIN EXP HYPERTENS, V36, P398, DOI 10.3109/10641963.2013.846353; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Ying J, 2012, AM J HYPERTENS, V25, P684, DOI 10.1038/ajh.2012.16; Zhang C, 2013, GENET TEST MOL BIOMA, V17, P736, DOI 10.1089/gtmb.2013.0080; Zhang R, 2011, HYPERTENS RES, V34, P645, DOI 10.1038/hr.2011.8; ZOU AP, 1994, AM J PHYSIOL, V266, pF934, DOI 10.1152/ajprenal.1994.266.6.F934	69	25	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16904	16919		10.1074/jbc.M116.732297	http://dx.doi.org/10.1074/jbc.M116.732297			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27298316	Green Published, hybrid			2022-12-28	WOS:000380826700046
J	Wang, L; Zhu, SL; Xu, G; Feng, J; Han, T; Zhao, FP; She, YL; Liu, S; Ye, LB; Zhu, Y				Wang, Li; Zhu, Shengli; Xu, Gang; Feng, Jian; Han, Tao; Zhao, Fanpeng; She, Ying-Long; Liu, Shi; Ye, Linbai; Zhu, Ying			Gene Expression and Antiviral Activity of Interleukin-35 in Response to Influenza A Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; REGULATORY T-CELLS; INNATE IMMUNE-RESPONSE; HEPATITIS-B; PERIPHERAL-BLOOD; INTERFERON-GAMMA; VIRAL REPLICATION; CYTOKINE IL-35; MESSENGER-RNA; IFN-GAMMA	Interleukin-35 (IL-35) is a newly described member of the IL-12 family. It has been reported to inhibit inflammation and autoimmune inflammatory disease and can increase apoptotic sensitivity. Little is known about the role of IL-35 during viral infection. Herein, high levels of IL-35 were found in peripheral blood mononuclear cells and throat swabs from patients with seasonal influenza A virus (IAV) relative to healthy individuals. IAV infection of human lung epithelial and primary cells increased levels of IL-35 mRNA and protein. Further studies demonstrated that IAV-induced IL-35 transcription is regulated by NF-kappa B. IL-35 expression was significantly suppressed by selective inhibitors of cyclooxygenase-2 (COX-2) and inducible nitric-oxide synthase, indicating their involvement in IL-35 expression. Interestingly, IL-35 production may have suppressed IAV RNA replication and viral protein synthesis via induction of type I and III interferons (IFN), leading to activation of downstream IFN effectors, including double-stranded RNA-dependent protein kinase, 2',5'-oligoadenylate synthetase, and myxovirus resistance protein. IL-35 exhibited extensive antiviral activity against the hepatitis B virus, enterovirus 71, and vesicular stomatitis virus. Our results demonstrate that IL-35 is a novel IAV-inducible cytokine, and its production elicits antiviral activity.	[Wang, Li; Zhu, Shengli; Xu, Gang; Feng, Jian; Han, Tao; Zhao, Fanpeng; She, Ying-Long; Liu, Shi; Ye, Linbai; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Zhu, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	yingzhu@whu.edu.cn	Zhu, Shengli/D-5281-2009; Zhao, Fanpeng/X-9816-2019	Zhu, Shengli/0000-0002-0190-2626; 	Major State Basic Research Development Program of China [2013CB911102]; National Natural Science Foundation of China [81461130019, 81271821, 31500149, 31570870]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Major State Basic Research Development Program of China (2013CB911102) and National Natural Science Foundation of China (81461130019, 81271821, 31500149, and 31570870). The authors declare that they have no conflicts of interest with the contents of this article.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Bettini M, 2012, DIABETES, V61, P1519, DOI 10.2337/db11-0784; Choi HJ, 2001, J INFECT DIS, V184, P560, DOI 10.1086/322805; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Huang CH, 2011, J IMMUNOL, V187, P462, DOI 10.4049/jimmunol.1100259; Imanishi N, 2005, MICROBIOL IMMUNOL, V49, P41, DOI 10.1111/j.1348-0421.2005.tb03638.x; Jafarzadeh A, 2015, J MOL NEUROSCI, V55, P891, DOI 10.1007/s12031-014-0443-z; Kalburgi NB, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/489648; Kriegel MA, 2006, IMMUNOLOGY, V119, P43, DOI 10.1111/j.1365-2567.2006.02404.x; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li W, 2010, J IMMUNOL, V185, P5056, DOI 10.4049/jimmunol.0902667; Li W, 2009, EUR J IMMUNOL, V39, P1019, DOI 10.1002/eji.200838885; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Li XF, 2015, CLIN SCI, V129, P395, DOI 10.1042/CS20140511; Li YK, 2013, J BIOL CHEM, V288, P20927, DOI 10.1074/jbc.M112.440115; Liu F, 2011, CLIN IMMUNOL, V139, P1, DOI 10.1016/j.clim.2010.12.012; Liu JQ, 2012, J IMMUNOL, V188, P3099, DOI 10.4049/jimmunol.1100106; Liu L, 2012, J BIOL CHEM, V287, P11899, DOI 10.1074/jbc.M111.308064; Liu L, 2011, CLIN CHIM ACTA, V412, P1081, DOI 10.1016/j.cca.2011.02.028; Londrigan SL, 2012, J LEUKOCYTE BIOL, V92, P97, DOI 10.1189/jlb.1011492; Long J, 2013, BIOCHEM BIOPH RES CO, V430, P364, DOI 10.1016/j.bbrc.2012.11.004; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Mohammed NA, 2004, J CLIN PATHOL, V57, P350, DOI 10.1136/jcp.2003.012120; Mukhtar MM, 2009, INT J BIOCHEM CELL B, V41, P554, DOI 10.1016/j.biocel.2008.07.001; Nakamura R, 2010, J VIROL, V84, P5574, DOI 10.1128/JVI.02030-09; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Paich HA, 2013, OBESITY, V21, P2377, DOI 10.1002/oby.20383; Pan Y, 2007, BIOCHEM BIOPH RES CO, V359, P70, DOI 10.1016/j.bbrc.2007.05.052; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075368; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pirbonen J, 2002, J IMMUNOL, V169, P5673, DOI 10.4049/jimmunol.169.10.5673; Poleganov MA, 2008, MOL IMMUNOL, V45, P2869, DOI 10.1016/j.molimm.2008.01.021; Prescott J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011159; Rasool ST, 2008, IMMUNOL LETT, V117, P161, DOI 10.1016/j.imlet.2008.01.007; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; RONNI T, 1995, J IMMUNOL, V154, P2764; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; SHAW MW, 1992, CLIN MICROBIOL REV, V5, P74, DOI 10.1128/CMR.5.1.74-92.1992; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Shi YY, 2015, VIRAL IMMUNOL, V28, P93, DOI 10.1089/vim.2014.0058; Short KR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00653; Tripathi S, 2015, INNATE IMMUN-LONDON, V21, P73, DOI 10.1177/1753425913508992; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087787; Wang Q, 2013, J VIROL, V87, P11244, DOI 10.1128/JVI.01248-13; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Wong CK, 2015, INFLAMMATION, V38, P348, DOI 10.1007/s10753-014-0038-4; Xiang XG, 2015, J DIGEST DIS, V16, P1, DOI 10.1111/1751-2980.12218; Yan XH, 2006, INT J BIOCHEM CELL B, V38, P1417, DOI 10.1016/j.biocel.2006.02.003; Yang JF, 2008, EUR J IMMUNOL, V38, P1204, DOI 10.1002/eji.200838145; Yue X, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-118; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zeng JC, 2013, INT J CLIN EXP PATHO, V6, P1806; Zhou YL, 2015, CYTOKINE, V73, P169, DOI 10.1016/j.cyto.2015.02.003; Zou F, 2007, BIOCHEM BIOPH RES CO, V355, P494, DOI 10.1016/j.bbrc.2007.01.178	70	11	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16863	16876		10.1074/jbc.M115.693101	http://dx.doi.org/10.1074/jbc.M115.693101			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27307042	Green Published, hybrid			2022-12-28	WOS:000380826700041
J	Kim, HJ; Jeong, MY; Parnell, TJ; Babst, M; Phillips, JD; Winge, DR				Kim, Hyung J.; Jeong, Mi-Young; Parnell, Timothy J.; Babst, Markus; Phillips, John D.; Winge, Dennis R.			The Plasma Membrane Protein Nce102 Implicated in Eisosome Formation Rescues a Heme Defect in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; heme; membrane transport; mitochondria; mitochondrial metabolism; Nce102; eisosomes; ferrochelatase	SACCHAROMYCES-CEREVISIAE; FERRICHROME TRANSPORTER; YEAST; PATHWAY; GENE; BIOSYNTHESIS; MACROPHAGES; ENDOCYTOSIS; ACTIVATION; DEFICIENT	The cellular transport of the cofactor heme and its biosynthetic intermediates such as protoporphyrin IX is a complex and highly coordinated process. To investigate the molecular details of this trafficking pathway, we created a synthetic lesion in the heme biosynthetic pathway by deleting the gene HEM15 encoding the enzyme ferrochelatase in S. cerevisiae and performed a genetic suppressor screen. Cells lacking Hem15 are respiratory-defective because of an inefficient heme delivery to the mitochondria. Thus, the biogenesis of mitochondrial cytochromes is negatively affected. The suppressor screen resulted in the isolation of respiratory-competent colonies containing two distinct missense mutations in Nce102, a protein that localizes to plasma membrane invaginations designated as eisosomes. The presence of the Nce102 mutant alleles enabled formation of the mitochondrial respiratory complexes and respiratory growth in hem15 cells cultured in supplemental hemin. Respiratory function in hem15 cells can also be restored by the presence of a heterologous plasma membrane heme permease (HRG-4), but the mode of suppression mediated by the Nce102 mutant is more efficient. Attenuation of the endocytic pathway through deletion of the gene END3 impaired the Nce102-mediated rescue, suggesting that the Nce102 mutants lead to suppression through the yeast endocytic pathway.	[Kim, Hyung J.; Jeong, Mi-Young; Phillips, John D.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Kim, Hyung J.; Jeong, Mi-Young; Phillips, John D.; Winge, Dennis R.] Univ Utah, Dept Biochem, Hlth Sci Ctr, Salt Lake City, UT 84132 USA; [Parnell, Timothy J.] Huntsman Canc Inst, Bioinformat Shared Resources, Salt Lake City, UT 84132 USA; [Babst, Markus] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Babst, Markus] Univ Utah, Ctr Cell & Genom Sci, Salt Lake City, UT 84112 USA; [Kim, Hyung J.] Univ Washington, Div Phys Sci, Bothell, WA 98011 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Bothell	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.; Winge, DR (corresponding author), Univ Utah, Dept Biochem, Hlth Sci Ctr, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu		Parnell, Timothy/0000-0002-3632-3691	National Institutes of Health [GM110755]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090257, U54DK110858, R01DK020503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM110755 (to D. R. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Desmyter L, 2007, BIOGERONTOLOGY, V8, P527, DOI 10.1007/s10522-007-9095-5; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Douglas LM, 2013, MBIO, V4, DOI 10.1128/mBio.00723-13; Douglas LM, 2011, MEMBRANES, V1, P394, DOI 10.3390/membranes1040394; Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Keener JM, 2013, TRAFFIC, V14, P412, DOI 10.1111/tra.12039; Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579; Kim Y, 2002, EMBO J, V21, P3632, DOI 10.1093/emboj/cdf382; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; Storbeck S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/175050; THORSNESS M, 1989, MOL CELL BIOL, V9, P5702, DOI 10.1128/MCB.9.12.5702; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Xu HB, 2014, CELL PHYSIOL BIOCHEM, V34, P1835, DOI 10.1159/000366383; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	39	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17417	17426		10.1074/jbc.M116.727743	http://dx.doi.org/10.1074/jbc.M116.727743			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27317660	Green Published, hybrid			2022-12-28	WOS:000382643800040
J	Yu, M; Jiang, MX; Chen, YL; Zhang, S; Zhang, WW; Yang, XX; Li, XJ; Li, Y; Duan, SZ; Han, JH; Duan, YJ				Yu, Miao; Jiang, Meixiu; Chen, Yuanli; Zhang, Shuang; Zhang, Wenwen; Yang, Xiaoxiao; Li, Xiaoju; Li, Yan; Duan, Shengzhong; Han, Jihong; Duan, Yajun			Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; cholesterol; lipoprotein metabolism; lipoprotein receptor; macrophage; CD36; ERK1; 2; PPAR; tamoxifen	B SCAVENGER RECEPTOR; INTIMA-MEDIA THICKNESS; REGULATES EXPRESSION; ENDOTHELIAL FUNCTION; INSULIN-RESISTANCE; LESION DEVELOPMENT; ATHEROSCLEROSIS; GAMMA; THERAPY; LIGAND	Macrophage CD36 binds and internalizes oxidized low density lipoprotein (oxLDL) to facilitate foam cell formation. CD36 expression is activated by peroxisome proliferator-activated receptor (PPAR). Tamoxifen, an anti-breast cancer medicine, has demonstrated pleiotropic functions including cardioprotection with unfully elucidated mechanisms. In this study, we determined that treatment of ApoE-deficient mice with tamoxifen reduced atherosclerosis, which was associated with decreased CD36 and PPAR expression in lesion areas. At the cellular level, we observed that tamoxifen inhibited CD36 protein expression in human THP-1 monocytes, THP-1/PMA macrophages, and human blood monocyte-derived macrophages. Associated with decreased CD36 protein expression, tamoxifen reduced cellular oxLDL accumulation in a CD36-dependent manner. At the transcriptional level, tamoxifen decreased CD36 mRNA expression, promoter activity, and the binding of the PPAR response element in CD36 promoter to PPAR protein. Tamoxifen blocked ligand-induced PPAR nuclear translocation and CD36 expression, but it increased PPAR phosphorylation, which was due to that tamoxifen-activated ERK1/2. Furthermore, deficiency of PPAR expression in macrophages abolished the inhibitory effect of tamoxifen on CD36 expression or cellular oxLDL accumulation both in vitro and in vivo. Taken together, our study demonstrates that tamoxifen inhibits CD36 expression and cellular oxLDL accumulation by inactivating the PPAR signaling pathway, and the inhibition of macrophage CD36 expression can be attributed to the anti-atherogenic properties of tamoxifen.	[Yu, Miao; Zhang, Shuang; Zhang, Wenwen; Yang, Xiaoxiao; Li, Xiaoju; Li, Yan; Han, Jihong; Duan, Yajun] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Coll Life Sci, Tianjin 300071, Peoples R China; [Chen, Yuanli] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Sch Med, Tianjin 300071, Peoples R China; [Han, Jihong; Duan, Yajun] Nankai Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Jiang, Meixiu] Nanchang Univ, Inst Translat Med, Nanchang 330000, Peoples R China; [Chen, Yuanli; Han, Jihong; Duan, Yajun] Hefei Univ Technol, Coll Biomed Engn, Hefei 230009, Peoples R China; [Duan, Shengzhong] Chinese Acad Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	Nankai University; Nankai University; Nankai University; Nanchang University; Hefei University of Technology; Chinese Academy of Sciences	Duan, YJ (corresponding author), Nankai Univ, Collaborat Innovat Ctr Biotherapy, Coll Life Sci, Tianjin 300071, Peoples R China.; Duan, YJ (corresponding author), Nankai Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Duan, YJ (corresponding author), Hefei Univ Technol, Coll Biomed Engn, Hefei 230009, Peoples R China.; Han, JH (corresponding author), Hefei Univ Technol, Coll Biomed Engn, 193 Tongxi Rd, Hefei 230000, Peoples R China.	hanjihong2015@hfut.edu.cn; yduan@hfut.edu.cn			National Science Foundation of China [81473204, 81573427, 31400694]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13023]; 111 Project [B08011]; International Science & Technology Cooperation Program of China [2015DFA30430]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project); International Science & Technology Cooperation Program of China	This work was supported in part by National Science Foundation of China Grants 81473204 (to J.H.), 81573427 (to Y.D.), and 31400694 (to Y.C.), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13023) and 111 Project Grant B08011 (to J.H.), and the International Science & Technology Cooperation Program of China Grant 2015DFA30430 (to J.H., Y.D., and Y.C.). The authors declare no conflicts of interest with the contents of this article.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen YL, 2015, ARTERIOSCL THROM VAS, V35, P948, DOI 10.1161/ATVBAHA.114.305116; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Clarke SC, 2001, CIRCULATION, V103, P1497; Dong PZ, 2011, ATHEROSCLEROSIS, V218, P435, DOI 10.1016/j.atherosclerosis.2011.06.048; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GRAINGER DJ, 1995, NAT MED, V1, P1067, DOI 10.1038/nm1095-1067; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Han JH, 1999, J LIPID RES, V40, P830; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang MX, 2013, BIOCHEM J, V454, P467, DOI 10.1042/BJ20130580; Jordan VC, 2007, STEROIDS, V72, P7, DOI 10.1016/j.steroids.2006.10.009; Jordan VC, 2014, ENDOCR-RELAT CANCER, V21, pR235, DOI 10.1530/ERC-14-0092; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin SX, 2010, NAT REV ENDOCRINOL, V6, P485, DOI 10.1038/nrendo.2010.92; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nicholson AC, 2001, ANN NY ACAD SCI, V947, P224; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Reckless J, 1997, CIRCULATION, V95, P1542; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Simon T, 2002, CIRCULATION, V106, P2925, DOI 10.1161/01.CIR.0000041044.93571.CA; Stamatelopoulos KS, 2004, AM HEART J, V147, P1093, DOI 10.1016/j.ahj.2003.12.029; Suarez Y, 2004, CARDIOVASC RES, V64, P346, DOI 10.1016/j.cardiores.2004.06.024; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103071; Wang C, 2014, BIOCHEM BIOPH RES CO, V447, P57, DOI 10.1016/j.bbrc.2014.03.103; Wasan KM, 1997, J PHARM SCI, V86, P876, DOI 10.1021/js970097w; Williams JK, 1997, ARTERIOSCL THROM VAS, V17, P403, DOI 10.1161/01.ATV.17.2.403; Yang XX, 2015, J BIOL CHEM, V290, P21788, DOI 10.1074/jbc.M115.654582	46	34	37	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16977	16989		10.1074/jbc.M116.740092	http://dx.doi.org/10.1074/jbc.M116.740092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27358406	hybrid, Green Published			2022-12-28	WOS:000382643800005
J	Hu, HQ; Gourguechon, S; Wang, CC; Li, ZY				Hu, Huiqing; Gourguechon, Stephane; Wang, Ching C.; Li, Ziyin			The G(1) Cyclin-dependent Kinase CRK1 in Trypanosoma brucei Regulates Anterograde Protein Transport by Phosphorylating the COPII Subunit Sec31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; GTP-BINDING; VESICLE; COAT; ER; FISSION; MITOSIS; SITES	Transport of secretory proteins from the endoplasmic reticulum to the Golgi is mediated by the coat protein II (COPII) complex comprising a Sec23-Sec24 heterodimer and a Sec13-Sec31 heterotetramer. The mechanisms underlying COPII-mediated protein trafficking have been well defined, but the extent of regulation of this secretory machinery by cellular signaling pathways remains poorly understood. Here, we report that CRK1, a G(1) cyclin-dependent kinase in Trypanosoma brucei, regulates anterograde protein trafficking by phosphorylating Sec31. Depletion of CRK1 abolished anterograde transport of the secretory protein and disrupted the localization of multiple Golgi proteins, reminiscent of Sec31 depletion. CRK1 phosphorylates Sec31 at multiple serine/threonine sites, and mutation of these phosphosites to alanine recapitulates the protein trafficking defects caused by Sec31 depletion. Mutation of these CRK1 phosphosites to aspartate restored Sec31 function. Taken together, these results uncover a novel function of CRK1 in anterograde protein trafficking and elucidate the mechanistic role of CRK1 in protein trafficking through regulation of the COPII subunit Sec31.	[Hu, Huiqing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Gourguechon, Stephane; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Francisco	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	ziyin.li@uth.tmc.edu		Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [R01 AI118736, AI101437, R01 AI21786]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101437, R01AI118736, R01AI021786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI118736 and AI101437 (to Z. L.) and Grant R01 AI21786 (to C. C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Demmel L, 2011, TRAFFIC, V12, P1575, DOI 10.1111/j.1600-0854.2011.01257.x; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Hertz Nicholas T, 2010, Curr Protoc Chem Biol, V2, P15, DOI 10.1002/9780470559277.ch090201; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kano F, 2004, MOL BIOL CELL, V15, P4289, DOI 10.1091/mbc.E03-11-0822; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Liu Y, 2013, MOL MICROBIOL, V90, P130, DOI 10.1111/mmi.12352; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matynia A, 2002, J CELL SCI, V115, P421; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; Sharpe LJ, 2011, TRAFFIC, V12, P19, DOI 10.1111/j.1600-0854.2010.01133.x; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Silverman JS, 2012, CURR OPIN MICROBIOL, V15, P463, DOI 10.1016/j.mib.2012.03.002; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2014, INT REV CEL MOL BIO, V308, P127, DOI 10.1016/B978-0-12-800097-7.00004-X	46	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15527	15539		10.1074/jbc.M116.715185	http://dx.doi.org/10.1074/jbc.M116.715185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27252375	Green Published, hybrid			2022-12-28	WOS:000380584200010
J	Li, HJ; Spagnol, G; Zheng, L; Stauch, KL; Sorgen, PL				Li, Hanjun; Spagnol, Gaelle; Zheng, Li; Stauch, Kelly L.; Sorgen, Paul L.			Regulation of Connexin43 Function and Expression by Tyrosine Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; RENIN-ANGIOTENSIN SYSTEM; JAK-STAT PATHWAY; V-SRC; PHOSPHORYLATION SITES; CARBOXYL-TERMINUS; JAK/STAT PATHWAY; DOWN-REGULATION; PHORBOL-ESTER; E-CADHERIN	Connexin43 (Cx43) assembly and degradation, the regulation of electrical and metabolic coupling, as well as modulating the interaction with other proteins, involve phosphorylation. Here, we identified and characterized the biological significance of a novel tyrosine kinase that phosphorylates Cx43, tyrosine kinase 2 (Tyk2). Activation of Tyk2 led to a decrease in Cx43 gap junction communication by increasing the turnover rate of Cx43 from the plasma membrane. Tyk2 directly phosphorylated Cx43 residues Tyr-247 and Tyr-265, leading to indirect phosphorylation on residues Ser-279/Ser-282 (MAPK) and Ser-368 (PKC). Although this phosphorylation pattern is similar to what has been observed following Src activation, the response caused by Tyk2 occurred when Src was inactive in NRK cells. Knockdown of Tyk2 at the permissive temperature (active v-Src) in LA-25 cells decreased Cx43 phosphorylation, indicating that although activation of Tyk2 and v-Src leads to phosphorylation of the same Cx43CT residues, they are not identical in level at each site. Additionally, angiotensin II activation of Tyk2 increased the intracellular protein level of Cx43 via STAT3. These findings indicate that, like Src, Tyk2 can also inhibit gap junction communication by phosphorylating Cx43.	[Li, Hanjun; Spagnol, Gaelle; Zheng, Li; Stauch, Kelly L.; Sorgen, Paul L.] Univ Nebraska Med Ctr, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Medical Center	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health [GM072631, HL131712]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM072631 and HL131712. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akar FG, 2004, CIRC RES, V95, P717, DOI 10.1161/01.RES.0000144125.61927.1c; Alberts B., 2008, MOL BIOL CEL, V5th ed.; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; ATKINSON MM, 1981, J CELL BIOL, V91, P573, DOI 10.1083/jcb.91.2.573; Axelsen LN, 2006, J MOL CELL CARDIOL, V40, P790, DOI 10.1016/j.yjmcc.2006.03.005; Axelsen LN, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00130; AZARNIA R, 1988, SCIENCE, V239, P398, DOI 10.1126/science.2447651; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Breitkopf Susanne B, 2012, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1819s98; Brikci-Nigassa AS, 2012, BIOCHEMISTRY-US, V51, P4331, DOI 10.1021/bi201806j; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Cooper CD, 2000, METHODS, V20, P196, DOI 10.1006/meth.1999.0937; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Delmar M, 2012, CURR OPIN CARDIOL, V27, P236, DOI 10.1097/HCO.0b013e328352220e; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Emdad L, 2001, J MOL CELL CARDIOL, V33, P219, DOI 10.1006/jmcc.2000.1293; FILSON AJ, 1990, CELL GROWTH DIFFER, V1, P661; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; Fischer R, 2007, AM J PHYSIOL-HEART C, V293, pH1242, DOI 10.1152/ajpheart.01400.2006; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Govindarajan R, 2010, MOL BIOL CELL, V21, P4089, DOI 10.1091/mbc.E10-05-0403; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Huang QY, 2012, AM J FOREN MED PATH, V33, P215, DOI 10.1097/PAF.0b013e31823f04eb; Hussain W, 2010, J CARDIOVASC ELECTR, V21, P1276, DOI 10.1111/j.1540-8167.2010.01802.x; Johnson KE, 2013, MOL BIOL CELL, V24, P715, DOI 10.1091/mbc.E12-07-0537; Kanemitsu MY, 1997, J BIOL CHEM, V272, P22824, DOI 10.1074/jbc.272.36.22824; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kasi VS, 2007, AM J PHYSIOL-HEART C, V293, pH182, DOI 10.1152/ajpheart.00684.2006; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; Kodama H, 1998, CIRC RES, V82, P244; Kostin S, 2004, CARDIOVASC RES, V62, P426, DOI 10.1016/j.cardiores.2003.12.010; KURATA WE, 1994, ONCOGENE, V9, P329; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Lin R, 2001, CELL COMMUN ADHES, V8, P265, DOI 10.3109/15419060109080735; LONN EM, 1994, CIRCULATION, V90, P2056, DOI 10.1161/01.CIR.90.4.2056; LOO LWM, 1995, J BIOL CHEM, V270, P12751, DOI 10.1074/jbc.270.21.12751; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; MARRERO MB, 1995, CARDIOVASC RES, V30, P530, DOI 10.1016/0008-6363(95)00094-1; MATESIC DF, 1994, MOL CARCINOGEN, V10, P226, DOI 10.1002/mc.2940100407; MEHTA PP, 1991, J MEMBRANE BIOL, V124, P207, DOI 10.1007/BF01994355; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Mitra S, 2006, MOL BIOL CELL, V17, P5400, DOI 10.1091/mbc.E06-04-0280; Mitra SS, 2012, J MEMBRANE BIOL, V245, P495, DOI 10.1007/s00232-012-9500-0; Murakami Y, 1998, J CELL PHYSIOL, V175, P220, DOI 10.1002/(SICI)1097-4652(199805)175:2<220::AID-JCP12>3.0.CO;2-C; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Ozog MA, 2004, MOL BIOL CELL, V15, P4761, DOI 10.1091/mbc.E04-03-0271; Pagliaro P, 2005, CARDIOVASC DRUG THER, V19, P77, DOI 10.1007/s10557-005-6900-8; Palatinus JA, 2012, BBA-BIOMEMBRANES, V1818, P1831, DOI 10.1016/j.bbamem.2011.08.006; Pan J, 1999, CIRC RES, V84, P1127, DOI 10.1161/01.RES.84.10.1127; Pan J, 1997, CIRC RES, V81, P611, DOI 10.1161/01.RES.81.4.611; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Saez JC, 1997, J MOL CELL CARDIOL, V29, P2131, DOI 10.1006/jmcc.1997.0447; Sato K, 2009, J CLIN IMMUNOL, V29, P815, DOI 10.1007/s10875-009-9320-x; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sirnes S, 2008, BIOCHEM BIOPH RES CO, V373, P597, DOI 10.1016/j.bbrc.2008.06.095; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2008, CELL COMMUN ADHES, V15, P75, DOI 10.1080/15419060802014016; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Spagnol G, 2016, J BIOL CHEM, V291, P7637, DOI 10.1074/jbc.M115.701417; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stein M, 2009, CARDIOVASC RES, V83, P52, DOI 10.1093/cvr/cvp124; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; SWENSON KI, 1990, CELL REGUL, V1, P989, DOI 10.1091/mbc.1.13.989; Tan L. L., 2013, SICHUAN DA XUE XUE B, V44, P549; Tan Li-Li, 2013, Sichuan Da Xue Xue Bao Yi Xue Ban, V44, P531; Ubel C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05865; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Wan J, 2010, J NEUROSCI, V30, P6873, DOI 10.1523/JNEUROSCI.0519-10.2010; Wang RZ, 2014, ADSORPTION REFRIGERATION TECHNOLOGY: THEORY AND APPLICATION, P1; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yang K, 2012, EMBO J, V31, P805, DOI 10.1038/emboj.2011.453; Yoon N, 2013, EXP THER MED, V5, P1009, DOI 10.3892/etm.2013.920; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zhou L, 1999, J CELL BIOL, V144, P1033, DOI 10.1083/jcb.144.5.1033	91	14	14	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15867	15880		10.1074/jbc.M116.727008	http://dx.doi.org/10.1074/jbc.M116.727008			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27235399	Green Published, hybrid			2022-12-28	WOS:000380584200038
J	Rhein, VF; Carroll, J; Ding, SJ; Fearnley, IM; Walker, JE				Rhein, Virginie F.; Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.			NDUFAF5 Hydroxylates NDUFS7 at an Early Stage in the Assembly of Human Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; Complex I; electron transport; hydroxylase; mitochondria; assembly; methyltransferase; protein hydroxylation	ADENOSYL-L-METHIONINE; BOVINE HEART-MITOCHONDRIA; CRYSTAL-STRUCTURE; ANTHRACYCLINE BIOSYNTHESIS; STREPTOMYCES-PURPURASCENS; NADH DEHYDROGENASE; ENCODED SUBUNITS; METHYLTRANSFERASE; UBIQUINONE; MUTATIONS	Complex I (NADH ubiquinone oxidoreductase) in mammalian mitochondria is an L-shaped assembly of 45 proteins. One arm lies in the inner membrane, and the other extends about 100 into the matrix of the organelle. The extrinsic arm contains binding sites for NADH, the primary electron acceptor FMN, and seven iron-sulfur clusters that form a pathway for electrons linking FMN to the terminal electron acceptor, ubiquinone, which is bound in a tunnel in the region of the junction between the arms. The membrane arm contains four antiporter-like domains, energetically coupled to the quinone site and involved in pumping protons from the matrix into the intermembrane space contributing to the proton motive force. Seven of the subunits, forming the core of the membrane arm, are translated from mitochondrial genes, and the remaining subunits, the products of nuclear genes, are imported from the cytosol. Their assembly is coordinated by at least thirteen extrinsic assembly factor proteins that are not part of the fully assembled complex. They assist in insertion of co-factors and in building up the complex from smaller sub-assemblies. One such factor, NDUFAF5, belongs to the family of seven--strand S-adenosylmethionine-dependent methyltransferases. However, similar to another family member, RdmB, it catalyzes the introduction of a hydroxyl group, in the case of NDUFAF5, into Arg-73 in the NDUFS7 subunit of human complex I. This modification occurs early in the pathway of assembly of complex I, before the formation of the juncture between peripheral and membrane arms.	[Rhein, Virginie F.; Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.] MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 0XY, England		Walker, JE (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk		Walker, John/0000-0001-7929-2162	Medical Research Council [U105663150, MR/M009858/1]; Medical Research Council [MC_EX_MR/M009858/1] Funding Source: researchfish; MRC [MC_EX_MR/M009858/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council via Intramural Program U105663150 and Program Grant MR/M009858/1 (to J. E. W.). The authors declare that they have no conflicts of interest with the contents of this publication.	Andrews B, 2013, P NATL ACAD SCI USA, V110, P18934, DOI 10.1073/pnas.1319247110; Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Carilla-Latorre S, 2013, MOL BIOL CELL, V24, P1519, DOI 10.1091/mbc.E12-11-0796; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Gerards M, 2010, J MED GENET, V47, P507, DOI 10.1136/jmg.2009.067553; Grocholski T, 2015, P NATL ACAD SCI USA, V112, P9866, DOI 10.1073/pnas.1501765112; Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Jansson A, 2005, J BIOL CHEM, V280, P3636, DOI 10.1074/jbc.M412095200; Jansson A, 2004, J BIOL CHEM, V279, P41149, DOI 10.1074/jbc.M407081200; Jansson A, 2003, J MOL BIOL, V334, P269, DOI 10.1016/j.jmb.2003.09.061; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Markolovic S, 2015, J BIOL CHEM, V290, P20712, DOI 10.1074/jbc.R115.662627; McKenzie M, 2011, J MOL BIOL, V414, P413, DOI 10.1016/j.jmb.2011.10.012; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Ploumakis A, 2015, MOL CELL, V58, P729, DOI 10.1016/j.molcel.2015.05.026; Rendon OZ, 2014, HUM MOL GENET, V23, P5159, DOI 10.1093/hmg/ddu239; Rendon OZ, 2012, HUM MOL GENET, V21, P3815, DOI 10.1093/hmg/dds209; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Saada A, 2012, J INHERIT METAB DIS, V35, P125, DOI 10.1007/s10545-011-9348-y; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wang YL, 2000, BBA-PROTEIN STRUCT M, V1480, P191, DOI 10.1016/S0167-4838(00)00089-3; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zhu JP, 2015, P NATL ACAD SCI USA, V112, P12087, DOI 10.1073/pnas.1510577112; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	55	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2016	291	28					14851	14860		10.1074/jbc.M116.734970	http://dx.doi.org/10.1074/jbc.M116.734970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS1OV	27226634	Green Published, hybrid			2022-12-28	WOS:000380366700036
J	Chen, H; You, HQ; Wang, LF; Zhang, X; Zhang, JM; He, W				Chen, Hui; You, Hongqin; Wang, Lifang; Zhang, Xuan; Zhang, Jianmin; He, Wei			Chaperonin-containing T-complex Protein 1 Subunit Serves as an Autoantigen Recognized by Human V delta 2 gamma delta T Cells in Autoimmune Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen; autoimmune disease; cellular immune response; immunology; T cell receptor (TCR); chaperonin-containing T-complex protein 1 subunit zeta; autoantigen; complementarity-determining region 3 delta; gamma delta T cells; autoimmune diseases; CDR3; CCT6A	MUTS HOMOLOG 2; CYTOSOLIC CHAPERONIN; TUMOR-CELLS; EXPRESSION; CCT; LIGAND; INVOLVEMENT; CARCINOMA; REGION; GROEL	Human T cells recognize conserved endogenous and stress-induced antigens typically associated with autoimmune diseases. However, the role of T cells in autoimmune diseases is not clear. Few autoimmune disease-related antigens recognized by T cell receptor (TCR) have been defined. In this study, we compared V2 TCR complementarity-determining region 3 (CDR3) between systemic lupus erythematosus (SLE) patients and healthy donors. Results show that CDR3 length distribution differed significantly and displayed oligoclonal characteristics in SLE patients when compared with healthy donors. We found no difference in the frequency of J gene fragment usage between these two groups. According to the dominant CDR3 sequences in SLE patients, synthesized SL2 peptides specifically bound to human renal proximal tubular epithelial cell line HK-2; SL2-Vm, a mutant V sequence of SL2, did not bind. We identified the putative protein ligand chaperonin-containing T-complex protein 1 subunit (CCT6A) using SL2 as a probe in HK-2 cell protein extracts by affinity chromatography and liquid chromatography-electrospray ionization-tandem mass spectrometry analysis. We found CCT6A expression on the surface of HK-2 cells. Cytotoxicity of only V2 T cells to HK-2 cells was blocked by anti-CCT6A antibody. Finally, we note that CCT6A concentration was significantly increased in plasma of SLE and rheumatoid arthritis patients. These data suggest that CCT6A is a novel autoantigen recognized by V2 T cells, which deepens our understanding of mechanisms in autoimmune diseases.	[Chen, Hui; You, Hongqin; Wang, Lifang; Zhang, Jianmin; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Chen, Hui; You, Hongqin; Wang, Lifang; Zhang, Jianmin; He, Wei] Peking Union Med Coll, State Key Lab Med Mol Biol, Sch Basic Med, Beijing 100005, Peoples R China; [Zhang, Xuan] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Zhang, JM; He, W (corresponding author), PUMC, State Key Lab Med Mol Biol, CAMS Sch Basic Med, Dept Immunol,Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	jzhang42@163.com; hewei@ngd.org.cn	zhang, xuan/GQO-8953-2022; zhang, xuan/AAN-9914-2020; zhang, xu/GRX-9733-2022	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; 	National Program for Key Basic Research Projects [2013CB530503]; National Natural Science Foundation of China [81471574, 31500725]; Mega-Projects of National Science Research for the 12th Five-Year Plan [2012ZX10001006]; Ministry of Health [201302018, 201302017]; Peking Union Medical College (PUMC) Youth Fund [3332015111]; PUMC Scholarship	National Program for Key Basic Research Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega-Projects of National Science Research for the 12th Five-Year Plan; Ministry of Health; Peking Union Medical College (PUMC) Youth Fund; PUMC Scholarship	This work was supported by the National Program for Key Basic Research Projects (Grant 2013CB530503), the National Natural Science Foundation of China (Grants 81471574 and 31500725), the Mega-Projects of National Science Research for the 12th Five-Year Plan (Grant 2012ZX10001006), the Programs of Ministry of Health (Grants 201302018 and 201302017), and the Peking Union Medical College (PUMC) Youth Fund (Grant 3332015111). This work was also supported by a PUMC Scholarship (to J. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Born WK, 2013, CELL MOL IMMUNOL, V10, P13, DOI 10.1038/cmi.2012.45; Boudiaf-Benmammar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060895; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; Dai YM, 2012, J BIOL CHEM, V287, P16812, DOI 10.1074/jbc.M111.327650; Fontanella B, 2010, INT J BIOCHEM CELL B, V42, P641, DOI 10.1016/j.biocel.2009.12.008; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Khabirova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102985; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Kotsiopriftis M, 2005, J VIROL, V79, P7255, DOI 10.1128/JVI.79.11.7255-7261.2005; Li XY, 2011, J IMMUNOL, V186, P6693, DOI 10.4049/jimmunol.1002776; Mo C, 2012, J BIOL CHEM, V287, P19242, DOI 10.1074/jbc.M112.349936; Niklas N, 2014, CELL IMMUNOL, V288, P31, DOI 10.1016/j.cellimm.2014.02.001; Odyniec A, 2004, J IMMUNOL, V173, P682, DOI 10.4049/jimmunol.173.1.682; Ponomarev ED, 2005, J IMMUNOL, V174, P4678, DOI 10.4049/jimmunol.174.8.4678; Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Su DL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/985753; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tracy CM, 2014, J BIOL CHEM, V289, P4490, DOI 10.1074/jbc.M113.542159; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wang Z, 2008, CANCER LETT, V272, P242, DOI 10.1016/j.canlet.2008.07.015; Wrobel P, 2007, SCAND J IMMUNOL, V66, P320, DOI 10.1111/j.1365-3083.2007.01963.x; Xu CP, 2007, MOL IMMUNOL, V44, P302, DOI 10.1016/j.molimm.2006.03.010; Yokota S, 2000, CELL STRESS CHAPERON, V5, P337, DOI 10.1379/1466-1268(2000)005<0337:AACCIH>2.0.CO;2; Yokota S, 2001, CELL STRESS CHAPERON, V6, P345, DOI 10.1379/1466-1268(2001)006<0345:IEOCCC>2.0.CO;2; Zhang HY, 2005, IMMUNOL INVEST, V34, P453, DOI 10.1080/08820130500265349; Zhao H, 2012, CELL MOL IMMUNOL, V9, P147, DOI 10.1038/cmi.2011.28; Zhao JP, 2006, BIOCHEM BIOPH RES CO, V339, P232, DOI 10.1016/j.bbrc.2005.10.198	31	9	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19985	19993		10.1074/jbc.M115.700070	http://dx.doi.org/10.1074/jbc.M115.700070			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27489109	Green Published, hybrid			2022-12-28	WOS:000383243100022
J	Bender, G; Schexnaydre, EE; Murphy, RC; Uhlson, C; Newcomer, ME				Bender, Gunes; Schexnaydre, Erin E.; Murphy, Robert C.; Uhlson, Charis; Newcomer, Marcia E.			Membrane-dependent Activities of Human 15-LOX-2 and Its Murine Counterpart IMPLICATIONS FOR MURINE MODELS OF ATHEROSCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); eicosanoid; lipid signaling; lipoxygenase pathway; phospholipid	CYTOSOLIC PHOSPHOLIPASE A(2); 5-LIPOXYGENASE-ACTIVATING PROTEIN; INTERFACIAL CATALYSIS; SUBSTRATE-INHIBITION; CRYSTAL-STRUCTURE; NUCLEAR-MEMBRANE; ARACHIDONIC-ACID; 15-LIPOXYGENASE; LIPOXYGENASE; DOMAIN	The enzyme encoded by the ALOX15B gene has been linked to the development of atherosclerotic plaques in humans and in a mouse model of hypercholesterolemia. In vitro, these enzymes, which share 78% sequence identity, generate distinct products from their substrate arachidonic acid: the human enzyme, a 15-S-hydroperoxy product; and the murine enzyme, an 8-S-product. We probed the activities of these enzymes with nanodiscs as membrane mimics to determine whether they can access substrate esterified in a bilayer and characterized their activities at the membrane interface. We observed that both enzymes transform phospholipid-esterified arachidonic acid to a 15-S-product. Moreover, when expressed in transfected HEK cells, both enzymes result in significant increases in the amounts of 15-hydroxyderivatives of eicosanoids detected. In addition, we show that 15-LOX-2 is distributed at the plasma membrane when the HEK293 cells are stimulated by the addition Ca2+ ionophore and that cellular localization is dependent upon the presence of a putative membrane insertion loop. We also report that sequence differences between the human and mouse enzymes in this loop appear to confer distinct mechanisms of enzyme-membrane interaction for the homologues.	[Bender, Gunes; Schexnaydre, Erin E.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Murphy, Robert C.; Uhlson, Charis] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	Louisiana State University System; Louisiana State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu	Murphy, Robert/AAO-5349-2020; Schexnaydre, Erin/X-3790-2019	Murphy, Robert/0000-0002-9430-6515; Schexnaydre, Erin/0000-0002-2993-8647	National Institutes of Health [HL107887, HL117798]; American Heart Association [16GRNT31000010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887, U54HL117798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by National Institutes of Health Grants HL107887 (to M. E. N.) and HL117798 (to R. C. M.) and American Heart Association Grant 16GRNT31000010 (to M. E. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bocan TMA, 1998, ATHEROSCLEROSIS, V136, P203, DOI 10.1016/S0021-9150(97)00204-9; Boldog T, 2007, METHOD ENZYMOL, V423, P317, DOI 10.1016/S0076-6879(07)23014-9; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; BRASH AR, 1987, BIOCHEMISTRY-US, V26, P5465, DOI 10.1021/bi00391a038; Brinckmann R, 1998, BLOOD, V91, P64, DOI 10.1182/blood.V91.1.64.64_64_74; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Demetz E, 2014, CELL METAB, V20, P787, DOI 10.1016/j.cmet.2014.09.004; Dewal MB, 2013, BIOCHEMISTRY-US, V52, P6559, DOI 10.1021/bi400444y; Garreta A, 2013, FASEB J, V27, P4811, DOI 10.1096/fj.13-235952; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; Gerstmeier J, 2014, BBA-GEN SUBJECTS, V1840, P2961, DOI 10.1016/j.bbagen.2014.05.016; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Hauser H., 2004, LIPID STRUCTURE STRU, P1; HAVIV F, 1987, J MED CHEM, V30, P254, DOI 10.1021/jm00385a005; Hutchins PM, 2012, J LIPID RES, V53, P1588, DOI 10.1194/jlr.M026799; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7330, DOI 10.1021/bi00243a038; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; JAIN MK, 1991, METHOD ENZYMOL, V197, P112; Jisaka M, 1997, J BIOL CHEM, V272, P24410, DOI 10.1074/jbc.272.39.24410; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kawajiri H, 2005, BIOCHEM BIOPH RES CO, V338, P144, DOI 10.1016/j.bbrc.2005.08.099; Kilty I, 1999, EUR J BIOCHEM, V266, P83, DOI 10.1046/j.1432-1327.1999.00818.x; Kobe MJ, 2014, J BIOL CHEM, V289, P8562, DOI 10.1074/jbc.M113.543777; Kotla S, 2014, FREE RADICAL BIO MED, V76, P147, DOI 10.1016/j.freeradbiomed.2014.08.007; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; LiCata VJ, 1997, BIOPHYS CHEM, V64, P225, DOI 10.1016/S0301-4622(96)02204-1; LUDWIG P, 1987, EUR J BIOCHEM, V168, P325, DOI 10.1111/j.1432-1033.1987.tb13424.x; Magnusson LU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043142; Neau DB, 2014, J BIOL CHEM, V289, P31905, DOI 10.1074/jbc.M114.599662; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; Noguchi N, 2002, BIOL CHEM, V383, P619, DOI 10.1515/BC.2002.064; Petrich K, 1996, BIOCHEM J, V314, P911, DOI 10.1042/bj3140911; Pouliot M, 1996, EUR J BIOCHEM, V238, P250, DOI 10.1111/j.1432-1033.1996.0250q.x; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; RAMIS I, 1989, J CHROMATOGR-BIOMED, V496, P416, DOI 10.1016/S0378-4347(00)82589-X; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428; Willemoes M, 2003, ARCH BIOCHEM BIOPHYS, V413, P17, DOI 10.1016/S0003-9861(03)00085-7; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003	53	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19413	19424		10.1074/jbc.M116.741454	http://dx.doi.org/10.1074/jbc.M116.741454			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27435673	hybrid, Green Published			2022-12-28	WOS:000383242800020
J	Peshenko, IV; Olshevskaya, EV; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.			Functional Study and Mapping Sites for Interaction with the Target Enzyme in Retinal Degeneration 3 (RD3) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanylate cyclase (guanylyl cyclase); photoreceptor; phototransduction; retina; signal transduction; calcium-binding proteins; eye; cyclic GMP (cGMP); neurobiology	PHOTORECEPTOR GUANYLYL CYCLASE; LEBER CONGENITAL AMAUROSIS; CONE-ROD DYSTROPHY; ACTIVATING PROTEINS; DIMERIZATION DOMAIN; MOUSE MODEL; 1 RETGC1; GENE; BINDING; GCAPS	Retinal degeneration 3 (RD3) protein, essential for normal expression of retinal membrane guanylyl cyclase (RetGC) in photoreceptor cells, blocks RetGC catalytic activity and stimulation by guanylyl cyclase-activating proteins (GCAPs). In a mouse retina, RD3 inhibited both RetGC1 and RetGC2 isozymes. Photoreceptors in the rd3/rd3 mouse retinas lacking functional RD3 degenerated more severely than in the retinas lacking both RetGC isozymes, consistent with a hypothesis that the inhibitory activity of RD3 has a functional role in photoreceptors. To map the potential target-binding site(s) on RD3, short evolutionary conserved regions of its primary structure were scrambled and the mutations were tested for the RD3 ability to inhibit RetGC1 and co-localize with the cyclase in co-transfected cells. Substitutions in 4 out of 22 tested regions, (KIHP90)-K-87, (93)CGPAI(97), (99)RFRQ(102), and (RSVL122)-R-119, reduced the RD3 apparent affinity for the cyclase 180-700-fold. Changes of amino acid sequences outside the Lys(87)-Leu(122) central portion of the molecule either failed to prevent RD3 binding to the cyclase or had a much smaller effect. Mutations in the (93)CGPAI(97) portion of a predicted central -helix most drastically suppressed the inhibitory activity of RD3 and disrupted RD3 co-localization with RetGC1 in HEK293 cells. Different side chains replacing Cys(93) profoundly reduced RD3 affinity for the cyclase, irrespective of their relative helix propensities. We conclude that the main RetGC-binding interface on RD3 required for the negative regulation of the cyclase localizes to the Lys(87)-Leu(122) region.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Res, Penn Coll Optometry, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Res S416, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from the NEI [EY11522]; Pennsylvania Department of Health CURE Formula grant; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; Pennsylvania Department of Health CURE Formula grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY11522 from the NEI and a Pennsylvania Department of Health CURE Formula grant. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2015, J BIOL CHEM, V290, P19584, DOI 10.1074/jbc.M115.661371; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zinchuk V., 2008, CURR PROTOC CELL BIO, V39; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	46	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19713	19723		10.1074/jbc.M116.742288	http://dx.doi.org/10.1074/jbc.M116.742288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27471269	Green Published, hybrid			2022-12-28	WOS:000383242800043
J	Crepin, A; Santabarbara, S; Caffarri, S				Crepin, Aurelie; Santabarbara, Stefano; Caffarri, Stefano			Biochemical and Spectroscopic Characterization of Highly Stable Photosystem II Supercomplexes from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; OXYGEN-EVOLVING COMPLEX; SUPRAMOLECULAR ORGANIZATION; CRYSTAL-STRUCTURE; EXTRINSIC PROTEINS; THYLAKOID MEMBRANE; ANTENNA COMPLEX; BINDING-SITE; SPINACH; LHCII	Photosystem II (PSII) is a large membrane supercomplex involved in the first step of oxygenic photosynthesis. It is organized as a dimer, with each monomer consisting of more than 20 subunits as well as several cofactors, including chlorophyll and carotenoid pigments, lipids, and ions. The isolation of stable and homogeneous PSII supercomplexes from plants has been a hindrance for their deep structural and functional characterization. In recent years, purification of complexes with different antenna sizes was achieved with mild detergent solubilization of photosynthetic membranes and fractionation on a sucrose gradient, but these preparations were only stable in the cold for a few hours. In this work, we present an improved protocol to obtain plant PSII supercomplexes that are stable for several hours/days at a wide range of temperatures and can be concentrated without degradation. Biochemical and spectroscopic properties of the purified PSII are presented, as well as a study of the complex solubility in the presence of salts. We also tested the impact of a large panel of detergents on PSII stability and found that very few are able to maintain the integrity of PSII. Such new PSII preparation opens the possibility of performing experiments that require room temperature conditions and/or high protein concentrations, and thus it will allow more detailed investigations into the structure and molecular mechanisms that underlie plant PSII function.	[Crepin, Aurelie; Caffarri, Stefano] Aix Marseille Univ, CNRS, CEA, Lab Genet & Biophys Plantes,BIAM, F-13009 Marseille, France; [Santabarbara, Stefano] CNR, Ist Biofis, I-20133 Milan, Italy	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Caffarri, S (corresponding author), Aix Marseille Univ, CNRS, CEA, Lab Genet & Biophys Plantes,BIAM, F-13009 Marseille, France.	stefano.caffarri@univ-amu.fr	Crepin, Aurélie/AAB-2789-2022; Caffarri, Stefano/AAX-8913-2021	Crepin, Aurélie/0000-0002-4754-6823; Caffarri, Stefano/0000-0002-4729-7679; Santabarbara, Stefano/0000-0002-7993-2614	French National Research Agency through the "Investments for the Future" program (France-BioImaging) [ANR-10-INSB-04]	French National Research Agency through the "Investments for the Future" program (France-BioImaging)(French National Research Agency (ANR))	We thank Fabrice Richard and Aicha Aouane (Institut de Biologie du Developpement de Marseille (IBDM)) for technical help with electron microscopy. Pascal Arnoux (Laboratoire de Bioeneretique Cellulaire (LBC)) is thanked for providing the detergent kit. Ben Field (Laboratoire de Genetique et Biophysique des Plantes) is thanked for manuscript revision. Electron microscopy work was supported by the French National Research Agency through the "Investments for the Future" program (France-BioImaging, ANR-10-INSB-04) and was performed at the PiCSL-FBI core facility (Institut de Biologie du Developpement de Marseille, AMU-Marseille UMR 7288).	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Allahverdiyeva Y, 2013, PLANT J, V75, P671, DOI 10.1111/tpj.12230; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Barera S, 2012, PHILOS T R SOC B, V367, P3389, DOI 10.1098/rstb.2012.0056; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Broess K, 2008, BBA-BIOENERGETICS, V1777, P404, DOI 10.1016/j.bbabio.2008.02.003; Buchel C, 2005, PHOTOSYNTH RES, V85, P3, DOI 10.1007/s11120-004-3195-8; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Caffarri S, 2014, CURR PROTEIN PEPT SC, V15, P296, DOI 10.2174/1389203715666140327102218; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Campoli C, 2009, PLANT MOL BIOL, V71, P173, DOI 10.1007/s11103-009-9516-8; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; DAINESE P, 1991, J BIOL CHEM, V266, P8136; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; ENAMI I, 1989, BIOCHIM BIOPHYS ACTA, V977, P33, DOI 10.1016/S0005-2728(89)80006-4; Engelmann ECM, 2005, BBA-BIOENERGETICS, V1706, P276, DOI 10.1016/j.bbabio.2004.11.009; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; Galka P, 2012, PLANT CELL, V24, P2963, DOI 10.1105/tpc.112.100339; Garcia-Cerdan JG, 2011, PLANT J, V65, P368, DOI 10.1111/j.1365-313X.2010.04429.x; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; HOMANN PH, 1988, BIOCHIM BIOPHYS ACTA, V934, P1, DOI 10.1016/0005-2728(88)90113-2; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Ifuku K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00084; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; KUWABARA T, 1982, PLANT CELL PHYSIOL, V23, P533, DOI 10.1093/oxfordjournals.pcp.a076378; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MILLER M, 1985, FEBS LETT, V189, P355, DOI 10.1016/0014-5793(85)81055-3; Nield J, 2002, J BIOL CHEM, V277, P15006, DOI 10.1074/jbc.M110549200; Nogales E, 2016, NAT METHODS, V13, P24, DOI 10.1038/nmeth.3694; Pagliano C, 2014, BBA-BIOENERGETICS, V1837, P1454, DOI 10.1016/j.bbabio.2013.11.004; PAPAGEORGIOU GC, 1995, PHOTOSYNTH RES, V44, P243, DOI 10.1007/BF00048597; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; PETER GF, 1991, J BIOL CHEM, V266, P16745; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2016, PLANTA, V243, P889, DOI 10.1007/s00425-015-2462-6; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmidt-Krey I, 2007, METHODS, V41, P417, DOI 10.1016/j.ymeth.2006.07.011; SHEN JR, 1988, BIOCHIM BIOPHYS ACTA, V936, P386, DOI 10.1016/0005-2728(88)90015-1; Shi LX, 2004, BBA-BIOENERGETICS, V1608, P75, DOI 10.1016/j.bbabio.2003.12.004; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tibiletti T., 2016, PLANT PHYSIOL, DOI [10.1104/pp.16.00572, DOI 10.1104/PP.16.00572]; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Tumino G, 2008, BIOCHEMISTRY-US, V47, P10449, DOI 10.1021/bi800831j; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vinothkumar KR, 2011, J MOL BIOL, V407, P232, DOI 10.1016/j.jmb.2011.01.029; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x	60	14	14	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19157	19171		10.1074/jbc.M116.738054	http://dx.doi.org/10.1074/jbc.M116.738054			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432883	Green Published, hybrid			2022-12-28	WOS:000383242300047
J	Grumet, L; Eichmann, TO; Taschler, U; Zierler, KA; Leopold, C; Moustafa, T; Radovic, B; Romauch, M; Yan, C; Du, H; Haemmerle, G; Zechner, R; Fickert, P; Kratky, D; Zimmermann, R; Lass, A				Grumet, Lukas; Eichmann, Thomas O.; Taschler, Ulrike; Zierler, Kathrin A.; Leopold, Christina; Moustafa, Tarek; Radovic, Branislav; Romauch, Matthias; Yan, Cong; Du, Hong; Haemmerle, Guenter; Zechner, Rudolf; Fickert, Peter; Kratky, Dagmar; Zimmermann, Robert; Lass, Achim			Lysosomal Acid Lipase Hydrolyzes Retinyl Ester and Affects Retinoid Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrolase; lipase; retinoid; retinol; vitamin A; knockout mouse; lysosomal acid lipase; retinyl ester	CHOLESTERYL ESTER; RAT-LIVER; DEFICIENT; MICE; ABSORPTION; ENDOSOMES; TRANSPORT; CELLS; SITE	Lysosomal acid lipase (LAL) is essential for the clearance of endocytosed cholesteryl ester and triglyceride-rich chylomicron remnants. Humans and mice with defective or absent LAL activity accumulate large amounts of cholesteryl esters and triglycerides in multiple tissues. Although chylomicrons also contain retinyl esters (REs), a role of LAL in the clearance of endocytosed REs has not been reported. In this study, we found that murine LAL exhibits RE hydrolase activity. Pharmacological inhibition of LAL in the human hepatocyte cell line HepG2, incubated with chylomicrons, led to increased accumulation of REs in endosomal/lysosomal fractions. Furthermore, pharmacological inhibition or genetic ablation of LAL in murine liver largely reduced in vitro acid RE hydrolase activity. Interestingly, LAL-deficient mice exhibited increased RE content in the duodenum and jejunum but decreased RE content in the liver. Furthermore, LAL-deficient mice challenged with RE gavage exhibited largely reduced post-prandial circulating RE content, indicating that LAL is required for efficient nutritional vitamin A availability. In summary, our results indicate that LAL is the major acid RE hydrolase and required for functional retinoid homeostasis.	[Grumet, Lukas; Eichmann, Thomas O.; Taschler, Ulrike; Zierler, Kathrin A.; Romauch, Matthias; Haemmerle, Guenter; Zechner, Rudolf; Zimmermann, Robert; Lass, Achim] Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria; [Leopold, Christina; Radovic, Branislav; Kratky, Dagmar] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Moustafa, Tarek; Fickert, Peter] Med Univ Graz, Lab Expt & Mol Hepatol, Div Gastroenterol & Hepatol, Dept Internal Med, A-8010 Graz, Austria; [Yan, Cong; Du, Hong] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Yan, Cong; Du, Hong] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA; [Lass, Achim] BioTechMed, A-8010 Graz, Austria	University of Graz; Medical University of Graz; Medical University of Graz; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lass, A (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria.	achim.lass@uni-graz.at	Moustafa, Tarek/P-9509-2016; Kratky, Dagmar/ABF-5699-2021; Lass, Achim/C-3332-2008	Moustafa, Tarek/0000-0002-6755-4687; Lass, Achim/0000-0002-8190-7151; Kratky, Dagmar/0000-0003-1357-7573; Zechner, Rudolf/0000-0001-5483-1182; Haemmerle, Guenter/0000-0001-9900-5896; Zimmermann, Robert/0000-0002-7354-870X; Du, Hong/0000-0001-6652-4702; Taschler, Ulrike/0000-0001-9000-1602; Eichmann, Thomas O./0000-0002-8521-2795	DK Molecular Enzymology [W901]; DK Metabolic and Cardiovascular Disease [W1226]; F30 SFB Lipotox; Austrian Science Fund (FWF);  [P25193];  [P21296];  [P27070]; Austrian Science Fund (FWF) [P 27070, P 25193, F 3004, F 3002, P 24944, W 901] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA152099] Funding Source: NIH RePORTER	DK Molecular Enzymology(Austrian Science Fund (FWF)); DK Metabolic and Cardiovascular Disease; F30 SFB Lipotox; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ; ; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants P25193 (to A. L.), P21296 (to R. Zimmermann), P27070 (to D. K.), DK Molecular Enzymology W901 (to R. Zimmermann and R. Zechner), DK Metabolic and Cardiovascular Disease W1226 (to D. K.), and F30 SFB Lipotox (to R. Zechner), funded by the Austrian Science Fund (FWF). The authors declare that they have no conflicts of interest with the contents of this article.	Aqul A, 2014, AM J PHYSIOL-GASTR L, V307, pG836, DOI 10.1152/ajpgi.00243.2014; BLOMHOFF R, 1985, J BIOL CHEM, V260, P3566; Burton BK, 2015, J PEDIATR GASTR NUTR, V61, P619, DOI 10.1097/MPG.0000000000000935; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2001, J LIPID RES, V42, P489; Eichmann TO, 2015, J LIPID RES, V56, P1972, DOI 10.1194/jlr.M062372; Fouchier SW, 2013, CURR OPIN LIPIDOL, V24, P332, DOI 10.1097/MOL.0b013e328361f6c6; Hagen E, 1999, J LIPID RES, V40, P309; Hamilton J, 2012, CLIN CHIM ACTA, V413, P1207, DOI 10.1016/j.cca.2012.03.019; HARRISON EH, 1993, BIOCHIM BIOPHYS ACTA, V1170, P99, DOI 10.1016/0005-2760(93)90058-H; HARRISON EH, 1995, J LIPID RES, V36, P1498; HOEG JM, 1984, AM J HUM GENET, V36, P1190; IMANAKA T, 1984, J BIOCHEM, V96, P1089, DOI 10.1093/oxfordjournals.jbchem.a134926; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; JOUTTI A, 1981, CHEM PHYS LIPIDS, V29, P235, DOI 10.1016/0009-3084(81)90054-2; Lopez AM, 2014, BIOCHEM BIOPH RES CO, V454, P162, DOI 10.1016/j.bbrc.2014.10.063; MERCIER M, 1994, BBA-LIPID LIPID MET, V1212, P176, DOI 10.1016/0005-2760(94)90251-8; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pollak NM, 2013, J LIPID RES, V54, P1092, DOI 10.1194/jlr.M034710; Porto AF, 2014, PEDIATR ENDOCR REV P, V12, P125; Reboul E, 2013, NUTRIENTS, V5, P3563, DOI 10.3390/nu5093563; SHERIFF S, 1995, J BIOL CHEM, V270, P27766, DOI 10.1074/jbc.270.46.27766; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Weng W, 1999, BIOCHEMISTRY-US, V38, P4143, DOI 10.1021/bi981679a	24	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17977	17987		10.1074/jbc.M116.724054	http://dx.doi.org/10.1074/jbc.M116.724054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27354281	Green Published, hybrid			2022-12-28	WOS:000383241300040
J	Nguyen, T; Shively, JE				Nguyen, Tung; Shively, John E.			Induction of Lumen Formation in a Three-dimensional Model of Mammary Morphogenesis by Transcriptional Regulator ID4 ROLE OF CaMK2D IN THE EPIGENETIC REGULATION OF ID4 GENE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ADHESION MOLECULE; DIFFERENTIATION 4 ID4; BILIARY GLYCOPROTEIN CD66A; BREAST-CANCER CELLS; NF-KAPPA-B; PROSTATE-CANCER; CYTOPLASMIC DOMAIN; DOWN-REGULATION; HISTONE DEACETYLASE-4; MALIGNANT BREAST	Concomitant loss of lumen formation and cell adhesion protein-CEACAM1 is a hallmark feature of breast cancer. In a three-dimensional culture model, transfection of CEACAM1 into MCF7 breast cells can restore lumen formation by an unknown mechanism. ID4, a transcriptional regulator lacking a DNA binding domain, is highly up-regulated in CEACAM1-transfected MCF7 cells, and when down-regulated with RNAi, abrogates lumen formation. Conversely, when MCF7 cells, which fail to form lumena in a three-dimensional culture, are transfected with ID4, lumen formation is restored, demonstrating that ID4 may substitute for CEACAM1. After showing the ID4 promoter is hypermethylated in MCF7 cells but hypomethylated in MCF/CEACAM1 cells, ID4 expression was induced in MCF7 cells by agents affecting chromatin remodeling and methylation. Mechanistically, CaMK2D was up-regulated in CEACAM1-transfected cells, effecting phosphorylation of HDAC4 and its sequestration in the cytoplasm by the adaptor protein 14-3-3. CaMK2D also phosphorylates CEACAM1 on its cytoplasmic domain and mutation of these phosphorylation sites abrogates lumen formation. Thus, CEACAM1 is able to maintain the active transcription of ID4 by an epigenetic mechanism involving HDAC4 and CaMK2D, and the same kinase enables lumen formation by CEACAM1. Because ID4 can replace CEACAM1 in parental MCF7 cells, it must act downstream from CEACAM1 by inhibiting the activity of other transcription factors that would otherwise prevent lumen formation. This overall mechanism may be operative in other cancers, such as colon and prostate, where the down-regulation of CEACAM1 is observed.	[Nguyen, Tung; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), 1450 E Duarte Rd, Duarte, CA 91010 USA.	jshively@coh.org			National Institutes of Health [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA84202. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson ME, 2009, J CLIN INVEST, V119, P1082, DOI 10.1172/JCI39262; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2010, EXP CELL RES, V316, P638, DOI 10.1016/j.yexcr.2009.11.001; Chinaranagari S, 2014, ONCOTARGET, V5, P7172, DOI 10.18632/oncotarget.2262; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Federman N, 2014, J PHYSIOL-PARIS, V108, P278, DOI 10.1016/j.jphysparis.2014.06.003; Gray CBB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00015; Hartman J, 2004, ONCOGENE, V23, P8826, DOI 10.1038/sj.onc.1208139; Hoffman L, 2013, BIOCHEMISTRY-US, V52, P1198, DOI 10.1021/bi3016586; Huang J, 1998, ANTICANCER RES, V18, P3203; Huang J, 1999, J CELL SCI, V112, P4193; Itahana Y, 2003, CANCER RES, V63, P7098; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Jin L, 2008, EXP BIOL MED, V233, P849, DOI 10.3181/0712-RM-352; Junankar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7548; Killoran RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123934; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Kirshner J, 2004, J MOL HISTOL, V35, P287, DOI 10.1023/B:HIJO.0000032360.01976.81; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kuzontkoski PM, 2010, ONCOGENE, V29, P3793, DOI 10.1038/onc.2010.147; Li CL, 2011, BIOCHEM BIOPH RES CO, V409, P125, DOI 10.1016/j.bbrc.2011.04.128; Li Y, 2013, EXP CELL RES, V319, P1061, DOI 10.1016/j.yexcr.2013.02.020; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Liu QA, 2011, ANN DIAGN PATHOL, V15, P30, DOI 10.1016/j.anndiagpath.2010.07.010; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; Marley PD, 1996, BIOCHEM BIOPH RES CO, V221, P15, DOI 10.1006/bbrc.1996.0536; Muller P, 2002, J BIOL CHEM, V277, P28376, DOI 10.1074/jbc.C200340200; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Patel D, 2015, BBA-REV CANCER, V1855, P92, DOI 10.1016/j.bbcan.2014.12.002; Patel D, 2014, MOL ENDOCRINOL, V28, P1239, DOI 10.1210/me.2014-1100; Pradeep CR, 2012, ONCOGENE, V31, P907, DOI 10.1038/onc.2011.279; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Sharma P, 2015, BIOCHIMIE, V112, P139, DOI 10.1016/j.biochi.2015.03.006; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Nguyen T, 2014, J BIOL CHEM, V289, P2934, DOI 10.1074/jbc.M113.496992; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Wang JL, 2011, CHINESE J PHYSIOL, V54, P332, DOI 10.4077/CJP.2011.AMM087; Weng CY, 2016, J BIOL CHEM, V291, P16777, DOI 10.1074/jbc.M115.710152; Woodcock JM, 2015, ONCOTARGET, V6, P14522, DOI 10.18632/oncotarget.3995; Yang CC, 2015, ACTA BIOCH BIOPH SIN, V47, P788, DOI 10.1093/abbs/gmv075; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhao H, 2010, PROSTATE CANCER P D, V13, P252, DOI 10.1038/pcan.2010.9	50	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16766	16776		10.1074/jbc.M115.710160	http://dx.doi.org/10.1074/jbc.M115.710160			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27302061	hybrid, Green Published			2022-12-28	WOS:000380826700033
J	Wang, L; Gonzalez, S; Dai, W; Deng, S; Lu, L				Wang, Ling; Gonzalez, Sheyla; Dai, Wei; Deng, Sophie; Lu, Luo			Effect of Hypoxia-regulated Polo-like Kinase 3 (Plk3) on Human Limbal Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL EPITHELIAL-CELLS; C-JUN; SERINE/THREONINE KINASE; STEM/PROGENITOR CELLS; IN-VITRO; KAPPA-B; EXPRESSION; ACTIVATION; APOPTOSIS; NEOVASCULARIZATION	Hypoxic conditions in the cornea affect epithelial function by activating Polo-like kinase 3 (Plk3) signaling and the c-Jun.AP-1 transcription complex, resulting in apoptosis of corneal epithelial cells. Hypoxic stress in the culture conditions also regulates limbal stem cell growth and fate. In this study, we demonstrate that there is a differential response of Plk3 in hypoxic stress-induced primary human limbal stem (HLS) and corneal epithelial (HCE) cells, resulting in different pathways of cell fate. We found that hypoxic stress induced HLS cell differentiation by down-regulating Plk3 activity at the transcription level, which was opposite to the effect of hypoxic stress on Plk3 activation to elicit HCE cell apoptosis, detected by DNA fragmentation and TUNEL assays. Hypoxic stress-induced increases in c-Jun phosphorylation/activation were not observed in HLS cells because Plk3 expression and activity were suppressed in hypoxia-induced HLS cells. Instead, hypoxic stress-induced HLS cell differentiation was monitored by cell cycle analysis and measured by the decrease and increase in p63 and keratin 12 expression, respectively. Hypoxic stress-induced Plk3 signaling to regulate c-Jun activity, resulting in limbal stem cell differentiation and center epithelial apoptosis, was also found in the corneas of wild-type and Plk3(-/-)-deficient mice. Our results, for the first time, reveal the differential effects of hypoxic stress on Plk3 activity in HLS and HCE cells. Instead of apoptosis, hypoxic stress suppresses Plk3 activity to protect limbal stem cells from death and to allow the process of HLS cell differentiation.	[Wang, Ling; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA; [Gonzalez, Sheyla; Deng, Sophie] Univ Calif Los Angeles, David Geffen Sch Med, Julie Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 91020 USA; [Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	National Institutes of Health [EY022364, EY EY021797, CA 090658]; NATIONAL CANCER INSTITUTE [R01CA090658] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022364, R01EY021797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health Grants EY022364 (to L. L.), EY EY021797 (to S. D.), and CA 090658 (to W. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arpitha P, 2005, INVEST OPHTH VIS SCI, V46, P3631, DOI 10.1167/iovs.05-0343; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; Conn CW, 2000, CANCER RES, V60, P6826; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; Laderoute KR, 2004, MOL CELL BIOL, V24, P4128, DOI 10.1128/MCB.24.10.4128-4137.2004; Laderoute KR, 2002, MOL CELL BIOL, V22, P2515, DOI 10.1128/MCB.22.8.2515-2523.2002; Lee JH, 2008, INVEST OPHTH VIS SCI, V49, P1827, DOI 10.1167/iovs.07-1142; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Liu HT, 2004, J IMMUNOL, V172, P1907, DOI 10.4049/jimmunol.172.3.1907; Lu JW, 2010, INVEST OPHTH VIS SCI, V51, P5034, DOI 10.1167/iovs.10-5501; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; Miyashita H, 2007, INVEST OPHTH VIS SCI, V48, P3586, DOI 10.1167/iovs.07-0077; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Nishi H, 2002, CANCER RES, V62, P827; Nishida K, 1996, INVEST OPHTH VIS SCI, V37, P1800; O'Callaghan AR, 2011, CURR EYE RES, V36, P691, DOI 10.3109/02713683.2011.556302; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Singh N, 2005, INVEST OPHTH VIS SCI, V46, P1647, DOI 10.1167/iovs.04-1172; Singh N, 2006, INVEST OPHTH VIS SCI, V47, P4787, DOI 10.1167/iovs.06-0419; Tanifuji-Terai N, 2006, INVEST OPHTH VIS SCI, V47, P545, DOI 10.1167/iovs.05-1182; Truong TT, 2011, INVEST OPHTH VIS SCI, V52, P6315, DOI 10.1167/iovs.11-7518; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Wang L, 2005, ONCOGENE, V24, P3020, DOI 10.1038/sj.onc.1208547; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Wang L, 2007, J BIOL CHEM, V282, P32121, DOI 10.1074/jbc.M702791200; Wang L, 2011, J BIOL CHEM, V286, P1951, DOI 10.1074/jbc.M110.166009; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Xu DZ, 2010, J BIOL CHEM, V285, P38944, DOI 10.1074/jbc.M110.160325; Xu KP, 2000, TOXICOL SCI, V58, P306, DOI 10.1093/toxsci/58.2.306; Zhang MC, 2006, OCUL IMMUNOL INFLAMM, V14, P359, DOI 10.1080/09273940601001322	41	10	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16519	16529		10.1074/jbc.M116.725747	http://dx.doi.org/10.1074/jbc.M116.725747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27281822	Green Published, hybrid			2022-12-28	WOS:000380826700012
J	Zanetti, SR; Ziblat, A; Torres, NI; Zwirner, NW; Bouzat, C				Zanetti, Samanta R.; Ziblat, Andrea; Torres, Nicolas I.; Zwirner, Norberto W.; Bouzat, Cecilia			Expression and Functional Role of alpha 7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTORS; DENDRITIC CELLS; IMMUNE FUNCTION; CHOLINERGIC SYSTEM; T-CELLS; ALLOSTERIC MODULATION; EFFECTOR FUNCTIONS; ACTIVATION; LIGANDS; NACHRS	The homomeric alpha 7 nicotinic receptor (nAChR) is one of the most abundant nAChRs in the central nervous system where it contributes to cognition, attention, and working memory. alpha 7 nAChR is also present in lymphocytes, dendritic cells (DCs), and macrophages and it is emerging as an important drug target for intervention in inflammation and sepsis. Natural killer (NK) cells display cytotoxic activity against susceptible target cells and modulate innate and adaptive immune responses through their interaction with DCs. We here show that human NK cells also express alpha 7 nAChR. alpha 7 nAChR mRNA is detected by RTPCR and cell surface expression of alpha 7 nAChR is detected by confocal microscopy and flow cytometry using alpha-bungarotoxin, a specific antagonist. Both mRNA and protein levels increase during NK stimulation with cytokines (IL-12, IL-18, and IL-15). Exposure of cytokine-stimulated NK cells to PNU-282987, a specific alpha 7 nAChR agonist, increases intracellular calcium concentration ([Ca2+](i)) mainly released from intracellular stores, indicating that alpha 7 nAChR is functional. Moreover, its activation by PNU-282987 plus a specific positive allosteric modulator greatly enhances the Ca2+ responses in NK cells. Stimulation of NK cells with cytokines and PNU-282987 decreases NF-kappa B levels and nuclear mobilization, down-regulates NKG2D receptors, and decreases NKG2D-dependent cell-mediated cytotoxicity and IFN-gamma production. Also, such NK cells are less efficient to trigger DC maturation. Thus, our results demonstrate the anti-inflammatory role of alpha 7 nAChR in NK cells and suggest that modulation of its activity in these cells may constitute a novel target for regulation of the immune response.	[Zanetti, Samanta R.; Bouzat, Cecilia] Univ Nacl Sur, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Bioquim INIBIBB, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Ziblat, Andrea; Torres, Nicolas I.; Zwirner, Norberto W.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, C1428ADN, Buenos Aires, DF, Argentina; [Zwirner, Norberto W.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, C1428ADN, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Bouzat, C (corresponding author), Univ Nacl Sur, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Bioquim INIBIBB, RA-8000 Bahia Blanca, Buenos Aires, Argentina.; Zwirner, NW (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, C1428ADN, Buenos Aires, DF, Argentina.; Zwirner, NW (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, C1428ADN, Buenos Aires, DF, Argentina.	norzwi@gmail.com; inbouzat@criba.edu.ar	Zwirner, Norberto/AAI-8961-2020; torres, nicolas/AAE-4849-2019	Zwirner, Norberto/0000-0001-7098-359X; Torres, Nicolas/0000-0001-6501-185X; Ziblat, Andrea/0000-0003-1469-8836	Fundacion Rene Baron; Fundacion Williams	Fundacion Rene Baron; Fundacion Williams	We thank the staff of Hemotherapy Service, Hospital Interzonal Dr. Jose Penna, Bahia Blanca, Buenos Aires, Argentina, for their valuable assistance. We thank the people of the Blood Bank of the "Carlos Durand" Hospital and of the "Complejo Medico Churruca-Visca" for providing the buffy coats. We thank Fundacion Rene Baron and Fundacion Williams for additional support, Prof. Dr. Gabriela Salvador for providing anti-p65 NF-kappa B mAb, Dr. Veronica Gonzalez-Pardo for providing BAPTA-AM, and Alessandra Zingoni and Angela Santoni from the Laboratory of Molecular Immunology and Immunopathology, Department of Molecular Medicine, Sapienza University of Rome, Italy, for providing the retroviral vectors for the transduction experiments.	Adamczyk M, 2006, CLIN CHEM, V52, P2123, DOI 10.1373/clinchem.2006.074369; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Bouzat C, 2012, J PHYSIOL-PARIS, V106, P23, DOI 10.1016/j.jphysparis.2011.09.012; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chatzidaki A, 2015, BIOCHEM PHARMACOL, V97, P408, DOI 10.1016/j.bcp.2015.07.028; Chernyavsky AI, 2009, INT J IMMUNOPATH PH, V22, P461, DOI 10.1177/039463200902200223; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Chijioke O, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00365; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Corradi J, 2016, MOL PHARMACOL, V90, P288, DOI 10.1124/mol.116.104240; da Silva RB, 2011, CELL MOL LIFE SCI, V68, P3505, DOI 10.1007/s00018-011-0801-8; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Egea J, 2015, BIOCHEM PHARMACOL, V97, P463, DOI 10.1016/j.bcp.2015.07.032; Fasoli F, 2015, CURR TOP BEHAV NEURO, V23, P1, DOI 10.1007/978-3-319-13665-3_1; Ferlazzo G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00159; Ferlazzo G, 2009, J CLIN IMMUNOL, V29, P265, DOI 10.1007/s10875-009-9283-y; Filippini P, 2012, CURR DRUG TARGETS, V13, P644, DOI 10.2174/138945012800399008; Fogel LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4232; Hao JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057495; Hao JW, 2011, EXP NEUROL, V227, P110, DOI 10.1016/j.expneurol.2010.09.020; Hoogduijn MJ, 2009, STEM CELLS DEV, V18, P103, DOI 10.1089/scd.2008.0032; Hsueh CM, 2002, J NEUROIMMUNOL, V123, P102, DOI 10.1016/S0165-5728(01)00488-X; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Domaica CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051677; Weinstein LI, 2015, ANN NY ACAD SCI, V1351, P39, DOI 10.1111/nyas.12792; De Rosa MJ, 2009, LIFE SCI, V85, P444, DOI 10.1016/j.lfs.2009.07.010; Kalkman HO, 2016, CELL MOL LIFE SCI, V73, P2511, DOI 10.1007/s00018-016-2175-4; Kawashima K, 2004, FRONT BIOSCI-LANDMRK, V9, P2063, DOI 10.2741/1390; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kawashima K, 2015, INT IMMUNOPHARMACOL, V29, P127, DOI 10.1016/j.intimp.2015.04.015; Kawashima K, 2012, LIFE SCI, V91, P1027, DOI 10.1016/j.lfs.2012.05.006; Kawashima K, 2012, ANN NY ACAD SCI, V1261, P7, DOI 10.1111/j.1749-6632.2012.06516.x; King JR, 2016, J NEUROCHEM, V138, P532, DOI 10.1111/jnc.13660; King JR, 2015, J BIOL CHEM, V290, P20060, DOI 10.1074/jbc.M115.647040; Lam RA, 2013, ANN MED, V45, P384, DOI 10.3109/07853890.2013.792495; Landais Emilie, 2010, Front Biosci (Elite Ed), V2, P928; Lueders C, 2007, LABMEDICINE, V38, P726, DOI 10.1309/1N2NAYWQ53QVR6FX; Mandal Arundhati, 2015, Hematol Oncol Stem Cell Ther, V8, P47, DOI 10.1016/j.hemonc.2014.11.006; Mignini F., 2003, Autonomic & Autacoid Pharmacology, V23, P1, DOI 10.1046/j.1474-8673.2003.00280.x; Mistry AR, 2007, IMMUNOLOGY, V121, P439, DOI 10.1111/j.1365-2567.2007.02652.x; Nizri E, 2013, AMINO ACIDS, V45, P73, DOI 10.1007/s00726-011-1192-8; Pacheco Rodrigo, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P65; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Poggi A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00027; Pohanka M, 2012, INT J MOL SCI, V13, P2219, DOI 10.3390/ijms13022219; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; Qiu YH, 2004, LYMPHOLOGY, V37, P31; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Romee R, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/205796; Rossi LE, 2012, J LEUKOCYTE BIOL, V91, P321, DOI 10.1189/jlb.0711339; Schedel A, 2011, ARTERIOSCL THROM VAS, V31, P928, DOI 10.1161/ATVBAHA.110.218297; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Simard AR, 2013, IMMUNOL CELL BIOL, V91, P195, DOI 10.1038/icb.2013.1; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Tian ZG, 2012, J AUTOIMMUN, V39, P206, DOI 10.1016/j.jaut.2012.05.006; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Wu JCF, 2009, J CELL BIOCHEM, V108, P433, DOI 10.1002/jcb.22270; Zdanowski R, 2015, CENT EUR J IMMUNOL, V40, P373, DOI 10.5114/ceji.2015.54602; Ziblat A, 2015, EUR J IMMUNOL, V45, P192, DOI 10.1002/eji.201444699; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	77	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16541	16552		10.1074/jbc.M115.710574	http://dx.doi.org/10.1074/jbc.M115.710574			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27284006	Green Published, hybrid			2022-12-28	WOS:000380826700014
J	Basudhar, D; Madrona, Y; Yukl, ET; Sivaramakrishnan, S; Nishida, CR; Moenne-Loccoz, P; de Montellano, PRO				Basudhar, Debashree; Madrona, Yarrow; Yukl, Erik T.; Sivaramakrishnan, Santhosh; Nishida, Clinton R.; Moenne-Loccoz, Pierre; de Montellano, Paul R. Ortiz			Distal Hydrogen-bonding Interactions in Ligand Sensing and Signaling by Mycobacterium tuberculosis DosS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONREPLICATING PERSISTENCE; MOLECULAR-DYNAMICS; GAF DOMAIN; HEME; DEVS; SENSOR; PROTEIN; DORMANCY; MACROPHAGES; KINASES	Mycobacterium tuberculosis DosS is critical for the induction of M. tuberculosis dormancy genes in response to nitric oxide (NO), carbon monoxide (CO), or hypoxia. These environmental stimuli, which are sensed by the DosS heme group, result in autophosphorylation of a DosS His residue, followed by phosphotransfer to an Asp residue of the response regulator DosR. To clarify the mechanism of gaseous ligand recognition and signaling, we investigated the hydrogen-bonding interactions of the iron-bound CO and NO ligands by site-directed mutagenesis of Glu-87 and His-89. Autophosphorylation assays and molecular dynamics simulations suggest that Glu-87 has an important role in ligand recognition, whereas His-89 is essential for signal transduction to the kinase domain, a process for which Arg-204 is important. Mutation of Glu-87 to Ala or Gly rendered the protein constitutively active as a kinase, but with lower autophosphorylation activity than the wild-type in the Fe(II) and the Fe(II)-CO states, whereas the E87D mutant had little kinase activity except for the Fe(II)-NO complex. The H89R mutant exhibited attenuated autophosphorylation activity, although the H89A and R204A mutants were inactive as kinases, emphasizing the importance of these residues in communication to the kinase core. Resonance Raman spectroscopy of the wild-type and H89A mutant indicates the mutation does not alter the heme coordination number, spin state, or porphyrin deformation state, but it suggests that interdomain interactions are disrupted by the mutation. Overall, these results confirm the importance of the distal hydrogen-bonding network in ligand recognition and communication to the kinase domain and reveal the sensitivity of the system to subtle differences in the binding of gaseous ligands.	[Basudhar, Debashree; Madrona, Yarrow; Sivaramakrishnan, Santhosh; Nishida, Clinton R.; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Yukl, Erik T.; Moenne-Loccoz, Pierre] Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Portland, OR 97239 USA; [Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	University of California System; University of California San Francisco; Oregon Health & Science University; New Mexico State University	de Montellano, PRO (corresponding author), Univ Calif San Francisco, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu		MOENNE-LOCCOZ, PIERRE/0000-0002-7684-7617	National Institutes of Health [AI074824, GM74785]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI074824 (to P. R. O. M.) and GM74785 (P. M.-L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Cho HY, 2011, FEBS LETT, V585, P1873, DOI 10.1016/j.febslet.2011.04.050; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Dick T, 2001, J ANTIMICROB CHEMOTH, V47, P117, DOI 10.1093/jac/47.1.117; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Gautam US, 2015, AM J RESP CELL MOL, V52, P708, DOI 10.1165/rcmb.2014-0230OC; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Ioanoviciu A, 2009, BIOCHEMISTRY-US, V48, P5839, DOI 10.1021/bi802309y; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Regev D, 2012, LAB INVEST, V92, P1541, DOI 10.1038/labinvest.2012.125; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Silva-Gomes S, 2013, INFECT IMMUN, V81, P2536, DOI 10.1128/IAI.00251-13; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne L G, 2001, Methods Mol Med, V54, P247, DOI 10.1385/1-59259-147-7:247; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w; Yukl ET, 2007, BIOCHEMISTRY-US, V46, P9728, DOI 10.1021/bi7008695	30	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16100	16111		10.1074/jbc.M116.724815	http://dx.doi.org/10.1074/jbc.M116.724815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27235395	Green Published, hybrid			2022-12-28	WOS:000380585400016
J	Harvey, BM; Rana, NA; Moss, H; Leonardi, J; Jafar-Nejad, H; Haltiwanger, RS				Harvey, Beth M.; Rana, Nadia A.; Moss, Hillary; Leonardi, Jessica; Jafar-Nejad, Hamed; Haltiwanger, Robert S.			Mapping Sites of O-Glycosylation and Fringe Elongation on Drosophila Notch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED-N-ACETYLGLUCOSAMINE; LIGAND-BINDING; MOLECULAR-CLONING; PROTEIN O-FUCOSYL-TRANSFERASE-1; EXTRACELLULAR DOMAIN; ALAGILLE-SYNDROME; HUMAN JAGGED1; EGF REPEATS; MUTATIONS; GENE	Glycosylation of the Notch receptor is essential for its activity and serves as an important modulator of signaling. Three major forms of O-glycosylation are predicted to occur at consensus sites within the epidermal growth factor-like repeats in the extracellular domain of the receptor: O-fucosylation, O-glucosylation, and O-GlcNAcylation. We have performed comprehensive mass spectral analyses of these three types of O-glycosylation on Drosophila Notch produced in S2 cells and identified peptides containing all 22 predicted O-fucose sites, all 18 predicted O-glucose sites, and all 18 putative O-GlcNAc sites. Using semiquantitative mass spectral methods, we have evaluated the occupancy and relative amounts of glycans at each site. The majority of the O-fucose sites were modified to high stoichiometries. Upon expression of the beta 3-N-acetylglucosaminyltransferase Fringe with Notch, we observed varying degrees of elongation beyond O-fucose monosaccharide, indicating that Fringe preferentially modifies certain sites more than others. Rumi modified O-glucose sites to high stoichiometries, although elongation of the O-glucose was site-specific. Although the current putative consensus sequence for O-GlcNAcylation predicts 18 O-GlcNAc sites on Notch, we only observed apparent O-GlcNAc modification at five sites. In addition, we performed mass spectral analysis on endogenous Notch purified from Drosophila embryos and found that the glycosylation states were similar to those found on Notch from S2 cells. These data provide foundational information for future studies investigating the mechanisms of how O-glycosylation regulates Notch activity.	[Harvey, Beth M.; Rana, Nadia A.; Moss, Hillary; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Leonardi, Jessica; Jafar-Nejad, Hamed] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Jafar-Nejad, Hamed] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor College of Medicine; Baylor College of Medicine	Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	rhalti@uga.edu	Moss, Hillary/AAV-4895-2021	Harvey, Beth/0000-0002-9291-5640	Bloomington Drosophila Stock Center (National Institutes of Health Grant) [P40OD018537]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084135, R01GM061126, T32GM008468] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Bloomington Drosophila Stock Center (National Institutes of Health Grant); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Rodrigo Fernandez-Valdivia and Yi-Dong Li for discussions and technical assistance with generation of the Notch<SUP>gt-FH</SUP> transgene. We thank the Bloomington Drosophila Stock Center (National Institutes of Health Grant P40OD018537) for fly stocks. We also thank Spyros Artavanis-Tsakonas and Kazuya Hori for sharing unpublished data indicating that the insertion of epitope tags between EGF repeats and LNR repeats does not disrupt the function of the Drosophila Notch in vivo. We thank the Haltiwanger laboratory for comments on the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Aminkeng F, 2015, CLIN GENET, V88, P532, DOI 10.1111/cge.12681; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1983, P NATL ACAD SCI-BIOL, V80, P1977, DOI 10.1073/pnas.80.7.1977; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cohen I, 2014, EUR J HUM GENET, V22, P374, DOI 10.1038/ejhg.2013.159; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dexter JS, 1914, AM NAT, V48, P712, DOI 10.1086/279446; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kakuda S, 2014, METHODS MOL BIOL, V1187, P209, DOI 10.1007/978-1-4939-1139-4_16; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; LeBon L, 2014, ELIFE, V3, DOI 10.7554/eLife.02950; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Leonardi J, 2014, METHODS MOL BIOL, V1187, P29, DOI 10.1007/978-1-4939-1139-4_3; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Meester JAN, 2015, AM J HUM GENET, V97, P475, DOI 10.1016/j.ajhg.2015.07.015; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062835; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ogawa M, 2015, J BIOL CHEM, V290, P2137, DOI 10.1074/jbc.M114.598821; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Perdigoto CN, 2011, DEVELOPMENT, V138, P4585, DOI 10.1242/dev.065292; Ramkumar N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005551; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sethi MK, 2012, J BIOL CHEM, V287, P2739, DOI 10.1074/jbc.M111.302406; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Southgate L, 2015, CIRC-CARDIOVASC GENE, V8, P572, DOI 10.1161/CIRCGENETICS.115.001086; Stittrich AB, 2014, AM J HUM GENET, V95, P275, DOI 10.1016/j.ajhg.2014.07.011; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Thakurdas SM, 2016, HEPATOLOGY, V63, P550, DOI 10.1002/hep.28024; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; WELSHONS WJ, 1971, GENETICS, V68, P259; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745	65	46	47	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16348	16360		10.1074/jbc.M116.732537	http://dx.doi.org/10.1074/jbc.M116.732537			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27268051	Green Published, hybrid			2022-12-28	WOS:000380585400038
J	Tossavainen, H; Aitio, O; Hellman, M; Saksela, K; Permi, P				Tossavainen, Helena; Aitio, Olli; Hellman, Maarit; Saksela, Kalle; Permi, Perttu			Structural Basis of the High Affinity Interaction between the Alphavirus Nonstructural Protein-3 (nsP3) and the SH3 Domain of Amphiphysin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C VIRUS NS5A; SIGNAL-TRANSDUCTION; LINEAR MOTIFS; BINDING; RECOGNITION; BIN1; REPLICATION; SPECIFICITY; MEMBRANE; ACTIN	We show that a peptide from Chikungunya virus nsP3 protein spanning residues 1728-1744 binds the amphiphysin-2 (BIN1) Src homology-3 (SH3) domain with an unusually high affinity (K-d 24 nM). Our NMR solution complex structure together with isothermal titration calorimetry data on several related viral and cellular peptide ligands reveal that this exceptional affinity originates from interactions between multiple basic residues in the target peptide and the extensive negatively charged binding surface of amphiphysin-2 SH3. Remarkably, these arginines show no fixed conformation in the complex structure, indicating that a transient or fluctuating polyelectrostatic interaction accounts for this affinity. Thus, via optimization of such dynamic electrostatic forces, viral peptides have evolved a superior binding affinity for amphiphysin-2 SH3 compared with typical cellular ligands, such as dynamin, thereby enabling hijacking of amphiphysin-2 SH3-regulated host cell processes by these viruses. Moreover, our data show that the previously described consensus sequence PXRPXR for amphiphysin SH3 ligands is inaccurate and instead define it as an extended Class II binding motif PXXPXRpXR, where additional positive charges between the two constant arginine residues can give rise to extraordinary high SH3 binding affinity.	[Tossavainen, Helena; Aitio, Olli; Hellman, Maarit; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FI-00014 Helsinki, Finland; [Saksela, Kalle] Univ Helsinki, Dept Virol, FI-00014 Helsinki, Finland; [Saksela, Kalle] Helsinki Univ Hosp, FI-00014 Helsinki, Finland; [Permi, Perttu] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Hellman, Maarit; Permi, Perttu] Univ Jyvaskyla, Nanosci Ctr, Dept Chem, FI-40014 Jyvaskyla, Finland; [Tossavainen, Helena; Aitio, Olli; Hellman, Maarit] Glykos Finland Ltd, FI-00790 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Jyvaskyla; University of Jyvaskyla	Permi, P (corresponding author), Univ Jyvaskyla, POB 35, FI-40014 Jyvaskyla, Finland.	perttu.permi@jyu.fi		Saksela, Kalle/0000-0003-0827-122X				Aitio O, 2012, STRUCTURE, V20, P1692, DOI 10.1016/j.str.2012.07.015; Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Aladag A, 2014, J PEPT SCI, V20, P334, DOI 10.1002/psc.2618; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Borg M, 2007, P NATL ACAD SCI USA, V104, P9650, DOI 10.1073/pnas.0702580104; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kim S, 2013, J BIOMOL NMR, V55, P249, DOI 10.1007/s10858-013-9706-1; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Neuvonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002383; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Park E, 2009, VIROLOGY, V388, P305, DOI 10.1016/j.virol.2009.03.031; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pineda-Lucena A, 2005, J MOL BIOL, V351, P182, DOI 10.1016/j.jmb.2005.05.046; Prokic I, 2014, J MOL MED, V92, P453, DOI 10.1007/s00109-014-1138-1; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Rouka E, 2015, J BIOL CHEM, V290, P25275, DOI 10.1074/jbc.M115.637207; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; Tuittila M, 2003, J GEN VIROL, V84, P1525, DOI 10.1099/vir.0.18936-0; Via A, 2015, TRENDS BIOCHEM SCI, V40, P36, DOI 10.1016/j.tibs.2014.11.001; Yoshikawa M, 2008, BIOCHEM BIOPH RES CO, V372, P168, DOI 10.1016/j.bbrc.2008.05.027; Zech B, 2003, J GEN VIROL, V84, P555, DOI 10.1099/vir.0.18801-0	39	26	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16307	16317		10.1074/jbc.M116.732412	http://dx.doi.org/10.1074/jbc.M116.732412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27268056	Green Published, hybrid			2022-12-28	WOS:000380585400034
J	Fukui, K; Ferris, HA; Kahn, CR				Fukui, Kenji; Ferris, Heather A.; Kahn, C. Ronald			Effect of cholesterol reduction on receptor signaling in neurons (vol 290, pg 26383, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NIDDK NIH HHS [T32 DK007260] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007260] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Fukui K, 2015, J BIOL CHEM, V290, P26383, DOI 10.1074/jbc.M115.664367	1	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15910	15910		10.1074/jbc.A115.664367	http://dx.doi.org/10.1074/jbc.A115.664367			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27451432	hybrid, Green Published			2022-12-28	WOS:000380584200043
J	Funmilayo, E; Yeates, A; Tesco, G				Funmilayo, Eniola; Yeates, Aduke; Tesco, Giuseppina			The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; EPIDERMAL-GROWTH-FACTOR; ALPHA-SECRETASE CLEAVAGE; RECEPTOR DOWN-REGULATION; BETA-SECRETASE; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; GAMMA-SECRETASE; EGFR DEGRADATION; TRAFFICKING	The beta-site amyloid precursor protein-cleaving enzyme (BACE1) is the rate-limiting enzyme in the production of amyloid-beta, the toxic peptide that accumulates in the brain of subjects affected by Alzheimer disease. Our previous studies have shown that BACE1 is degraded via the lysosomal pathway and that that depletion of the trafficking molecule Golgi-localized gamma-ear-containing ARF-binding protein 3 (GGA3) results in increased BACE1 levels and activity because of impaired lysosomal degradation. We also determined that GGA3 regulation of BACE1 levels requires its ability to bind ubiquitin. Accordingly, we reported that BACE1 is ubiquitinated at lysine 501 and that lack of ubiquitination at lysine 501 produces BACE1 stabilization. Ubiquitin conjugation is a reversible process mediated by deubiquitinating enzymes. The ubiquitin-specific peptidase 8 (USP8), an endosome-associated deubiquitinating enzyme, regulates the ubiquitination, trafficking, and lysosomal degradation of several plasma membrane proteins. Here, we report that RNAi-mediated depletion of USP8 reduced levels of both ectopically expressed and endogenous BACE1 in H4 human neuroglioma cells. Moreover, USP8 depletion increased BACE1 ubiquitination, promoted BACE1 accumulation in the early endosomes and late endosomes/lysosomes, and decreased levels of BACE1 in the recycling endosomes. We also found that decreased BACE1 protein levels were accompanied by a decrease in BACE1-mediated amyloid precursor protein cleavage and amyloid-beta levels. Our findings demonstrate that USP8 plays a key role in the trafficking and degradation of BACE1 by deubiquitinating lysine 501. These studies suggest that therapies able to accelerate BACE1 degradation (e.g. by increasing BACE1 ubiquitination) may represent a potential treatment for Alzheimer disease.	[Funmilayo, Eniola; Yeates, Aduke; Tesco, Giuseppina] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Tufts University	Tesco, G (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Alzheimers Dis Res Lab, 136 Harrison Ave,Ste 328A, Boston, MA 02111 USA.	giuseppina.tesco@Tufts.edu			National Institutes of Health [NS047243]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092497, P30NS047243, T32NS061764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Dan Cox for assisting with statistical analysis and Dr. Lai Ding for designing the ImageJ macro used for image analysis. We thank Dr. Alenka Lovy-Wheeler for assistance with confocal microscopy at the Tufts Center for Neuroscience Research (supported by National Institutes of Health Grant NS047243).	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Arnst JL, 2013, ANAL BIOCHEM, V440, P71, DOI 10.1016/j.ab.2013.05.017; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Bruzzone F, 2008, BRAIN RES, V1195, P56, DOI 10.1016/j.brainres.2007.12.014; Buggia-Prevot V, 2013, CELL REP, V5, P1552, DOI 10.1016/j.celrep.2013.12.006; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Ceriani M, 2015, EXP CELL RES, V333, P49, DOI 10.1016/j.yexcr.2015.01.019; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Das U, 2016, NAT NEUROSCI, V19, P55, DOI 10.1038/nn.4188; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; De Strooper B, 2000, NATURE, V405, P627, DOI 10.1038/35015193; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Guglielmotto M, 2012, AGING CELL, V11, P834, DOI 10.1111/j.1474-9726.2012.00854.x; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Kang EL, 2012, J BIOL CHEM, V287, P42867, DOI 10.1074/jbc.M112.407072; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kawasaki M, 2005, GENES CELLS, V10, P639, DOI 10.1111/j.1365-2443.2005.00865.x; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lee EJ, 2009, EXP MOL MED, V41, P555, DOI 10.3858/emm.2009.41.8.061; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Matz A, 2015, CELL DEATH DIFFER, V22, P626, DOI 10.1038/cdd.2014.163; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Oh YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04980; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Scudder SL, 2014, J NEUROSCI, V34, P16637, DOI 10.1523/JNEUROSCI.2452-14.2014; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sirisaengtaksin N, 2014, J BIOL CHEM, V289, P3026, DOI 10.1074/jbc.M113.495671; Slomnicki LP, 2008, ACTA NEUROBIOL EXP, V68, P219; Smith GA, 2016, TRAFFIC, V17, P53, DOI 10.1111/tra.12341; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vingtdeux V, 2007, NEUROBIOL DIS, V25, P686, DOI 10.1016/j.nbd.2006.09.019; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Weinstock J, 2012, ACS MED CHEM LETT, V3, P789, DOI 10.1021/ml200276j; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang MM, 2012, J NEUROCHEM, V120, P1129, DOI 10.1111/j.1471-4159.2011.07644.x	71	44	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15753	15766		10.1074/jbc.M116.718023	http://dx.doi.org/10.1074/jbc.M116.718023			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27302062	hybrid, Green Published			2022-12-28	WOS:000380584200028
J	Ha, R; Frirdich, E; Sychantha, D; Biboy, J; Taveirne, ME; Johnson, JG; DiRita, VJ; Vollmer, W; Clarke, AJ; Gaynor, EC				Ha, Reuben; Frirdich, Emilisa; Sychantha, David; Biboy, Jacob; Taveirne, Michael E.; Johnson, Jeremiah G.; DiRita, Victor J.; Vollmer, Waldemar; Clarke, Anthony J.; Gaynor, Erin C.			Accumulation of Peptidoglycan O-Acetylation Leads to Altered Cell Wall Biochemistry and Negatively Impacts Pathogenesis Factors of Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; bacterial pathogenesis; cell wall; gram-negative bacteria; peptidoglycan; Campylobacter jejuni; O-Acetylation; O-Acetylesterase	BACTERIAL FLAGELLAR MOTOR; GUILLAIN-BARRE-SYNDROME; ACETYLPEPTIDOGLYCAN ESTERASE; ESCHERICHIA-COLI; NEISSERIA-GONORRHOEAE; GONOCOCCAL PEPTIDOGLYCAN; LYTIC TRANSGLYCOSYLASE; SURFACE HYDROPHOBICITY; ANTIBACTERIAL TARGET; PROTEUS-MIRABILIS	Campylobacter jejuni is a leading cause of bacterial gastroenteritis in the developed world. Despite its prevalence, its mechanisms of pathogenesis are poorly understood. Peptidoglycan (PG) is important for helical shape, colonization, and host-pathogen interactions in C. jejuni. Therefore, changes in PG greatly impact the physiology of this organism. O-acetylation of peptidoglycan (OAP) is a bacterial phenomenon proposed to be important for proper cell growth, characterized by acetylation of the C6 hydroxyl group of N-acetylmuramic acid in the PG glycan backbone. The OAP gene cluster consists of a PG O-acetyltransferase A (patA) for translocation of acetate into the periplasm, a PG O-acetyltransferase B (patB) for O-acetylation, and an O-acetylpeptidoglycan esterase (ape1) for de-O-acetylation. In this study, reduced OAP in patA and patB had minimal impact on C. jejuni growth and fitness under the conditions tested. However, accumulation of OAP in ape1 resulted in marked differences in PG biochemistry, including O-acetylation, anhydromuropeptide levels, and changes not expected to result directly from Ape1 activity. This suggests that OAP may be a form of substrate level regulation in PG biosynthesis. Ape1 acetylesterase activity was confirmed in vitro using p-nitrophenyl acetate and O-acetylated PG as substrates. In addition, ape1 exhibited defects in pathogenesis-associated phenotypes, including cell shape, motility, biofilm formation, cell surface hydrophobicity, and sodium deoxycholate sensitivity. ape1 was also impaired for chick colonization and adhesion, invasion, intracellular survival, and induction of IL-8 production in INT407 cells in vitro. The importance of Ape1 in C. jejuni biology makes it a good candidate as an antimicrobial target.	[Ha, Reuben; Frirdich, Emilisa; Gaynor, Erin C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Sychantha, David; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Biboy, Jacob; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Taveirne, Michael E.; Johnson, Jeremiah G.; DiRita, Victor J.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [DiRita, Victor J.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	University of British Columbia; University of Guelph; Newcastle University - UK; University of Michigan System; University of Michigan; Michigan State University	Gaynor, EC (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	egaynor@mail.ubc.ca	Johnson, Jeremiah/AFL-6049-2022	Johnson, Jeremiah/0000-0001-5302-3247; Biboy, jacob/0000-0002-1286-6851	Canadian Institutes of Health Research [MOP-68981, TGC-114045]; Wellcome Trust [101824/Z/13/Z]; National Institutes of Health NIAID [AI069383]; Natural Sciences and Engineering Research Council Canada Graduate Scholarship; United States Department of Agriculture NIFA Grant [2012-67012-19704]; National Center for Advancing Translational Sciences Grant [UL1TR000433]; National Institutes of Health Molecular Mechanisms of Microbial Pathogenesis Training Program Grant [T32 AI007528]; United States Department of Agriculture; National Institute for Food and Agriculture [2010-65201-20594, 2013-67012-21136]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069383, T32AI007528] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Sciences and Engineering Research Council Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States Department of Agriculture NIFA Grant; National Center for Advancing Translational Sciences Grant; National Institutes of Health Molecular Mechanisms of Microbial Pathogenesis Training Program Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institute for Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Canadian Institutes of Health Research Grants MOP-68981 (to E. C. G.) and TGC-114045 (to A. J. C.), Wellcome Trust Grant 101824/Z/13/Z (to W. V.), and National Institutes of Health NIAID Grant AI069383 (to V. J. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a Natural Sciences and Engineering Research Council Canada Graduate Scholarship.r Supported in part with federal funds from the United States Department of Agriculture NIFA Grant 2012-67012-19704 and National Center for Advancing Translational Sciences Grant UL1TR000433. Present address: Dept. of Biological Sciences, North Carolina State University, Raleigh, NC 27695.r Supported by National Institutes of Health Molecular Mechanisms of Microbial Pathogenesis Training Program Grant T32 AI007528 and United States Department of Agriculture, National Institute for Food and Agriculture, Grants 2010-65201-20594 and 2013-67012-21136. Present address: Dept. of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824.	Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; Ben Abdallah F, 2014, IRAN J PUBLIC HEALTH, V43, P423; Bera A, 2006, INFECT IMMUN, V74, P4598, DOI 10.1128/IAI.00301-06; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Buswell CM, 1998, APPL ENVIRON MICROB, V64, P733; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; DUPONT C, 1991, EUR J BIOCHEM, V195, P763, DOI 10.1111/j.1432-1033.1991.tb15764.x; Dworkin J, 2010, MOL MICROBIOL, V78, P792, DOI 10.1111/j.1365-2958.2010.07387.x; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; EVEREST PH, 1992, J MED MICROBIOL, V37, P319, DOI 10.1099/00222615-37-5-319; FLEMING TJ, 1986, INFECT IMMUN, V52, P600, DOI 10.1128/IAI.52.2.600-608.1986; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Frirdich E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002602; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Godlewska R, 2009, FEMS MICROBIOL LETT, V298, P1, DOI 10.1111/j.1574-6968.2009.01659.x; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Hancock R.E.W., 1999, HANCOCK LAB METHODS; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Hizukuri Y, 2008, MICROBIOL-SGM, V154, P810, DOI 10.1099/mic.0.2007/013854-0; Hizukuri Y, 2009, J BIOCHEM, V146, P219, DOI 10.1093/jb/mvp061; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; JONES CJ, 1989, J BACTERIOL, V171, P3890, DOI 10.1128/jb.171.7.3890-3900.1989; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kanungpean D, 2011, J VET MED SCI, V73, P389, DOI 10.1292/jvms.10-0396; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Lin MF, 2013, INFORM SYST RES, V24, P906, DOI 10.1287/isre.2013.0480; Louwen RPL, 2006, J CLIN MICROBIOL, V44, P1867, DOI 10.1128/JCM.44.5.1867-1868.2006; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; McGee DJ, 2005, INFECT IMMUN, V73, P1820, DOI 10.1128/IAI.73.3.1820-1827.2005; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; MENARD R, 1993, J BACTERIOL, V175, P5899; Morimoto YV, 2013, J BACTERIOL, V195, P474, DOI 10.1128/JB.01971-12; Moynihan PJ, 2014, BIOORG CHEM, V54, P44, DOI 10.1016/j.bioorg.2014.03.010; Moynihan PJ, 2014, J BIOL CHEM, V289, P16748, DOI 10.1074/jbc.M114.567388; Moynihan PJ, 2013, ANAL BIOCHEM, V439, P73, DOI 10.1016/j.ab.2013.04.022; Moynihan PJ, 2011, INT J BIOCHEM CELL B, V43, P1655, DOI 10.1016/j.biocel.2011.08.007; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Pfeffer JM, 2012, CHEMBIOCHEM, V13, P722, DOI 10.1002/cbic.201100744; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Pryjma M, 2012, J BACTERIOL, V194, P3803, DOI 10.1128/JB.06665-11; ROMAN SJ, 1992, J BACTERIOL, V174, P6247, DOI 10.1128/JB.174.19.6247-6255.1992; ROMEIS T, 1994, J BIOL CHEM, V269, P21603; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; ROSENTHAL RS, 1982, INFECT IMMUN, V37, P826, DOI 10.1128/IAI.37.2.826-829.1982; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Roure S, 2012, MOL MICROBIOL, V86, P845, DOI 10.1111/mmi.12019; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Schoonmaker MK, 2014, J BACTERIOL, V196, P1394, DOI 10.1128/JB.01396-13; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Strating H, 2012, CAN J MICROBIOL, V58, P1183, DOI 10.1139/w2012-102; Svensson SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106063; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Szymanski CM, 2012, GUT MICROBES, V3, P135, DOI 10.4161/gmic.19488; Tracz DM, 2005, EMERG INFECT DIS, V11, P838; Veyrier FJ, 2013, MOL MICROBIOL, V87, P1100, DOI 10.1111/mmi.12153; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang G, 2012, MBIO, V3, DOI 10.1128/mBio.00409-12; Weadge JT, 2007, BIOCHEMISTRY-US, V46, P4932, DOI 10.1021/bi700254m; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s; Williams AH, 2014, ACTA CRYSTALLOGR D, V70, P2631, DOI 10.1107/S1399004714016770; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525	88	17	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22686	22702		10.1074/jbc.M116.746404	http://dx.doi.org/10.1074/jbc.M116.746404			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27474744	Green Published, hybrid			2022-12-28	WOS:000386760600028
J	Harrington, KM; Clevenger, CV				Harrington, Katherine M.; Clevenger, Charles V.			Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; extracellular-signal-regulated kinase (ERK); focal adhesion; prolactin; serine; threonine protein kinase; NEK3; threonine phosphorylation	ACTIVATED PROTEIN-KINASE; HUMAN PROLACTIN RECEPTOR; POTENTIAL HUMAN HOMOLOG; MAP KINASE; ASPERGILLUS-NIDULANS; NIMA-FAMILY; SUBSTRATE-SPECIFICITY; INTEGRIN ENGAGEMENT; SIGNAL-TRANSDUCTION; MAMMARY-CARCINOMA	Accumulating evidence supports a role for prolactin (PRL) in the development and progression of human breast cancer. Although PRL is an established chemoattractant for breast cancer cells, the precise molecular mechanisms of how PRL regulates breast cancer cell motility and invasion are not fully understood. PRL activates the serine/threonine kinase NEK3, which was reported to enhance breast cancer cell migration, invasion, and the actin cytoskeletal reorganization necessary for these processes. However, the specific mechanisms of NEK3 activation in response to PRL signaling have not been defined. In this report, a novel PRL-inducible regulatory phosphorylation site within the activation segment of NEK3, threonine 165 (Thr-165), was identified. Phosphorylation at NEK3 Thr-165 was found to be dependent on activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway using both pharmacological inhibition and siRNA-mediated knockdown approaches. Strikingly, inhibition of phosphorylation at NEK3 Thr-165 by expression of a phospho-deficient mutant (NEK3-T165V) resulted in increased focal adhesion size, formation of zyxin-positive focal adhesions, and reorganization of the actin cytoskeleton into stress fibers. Concordantly, NEK3-T165V cells exhibited migratory defects. Together, these data support a modulatory role for phosphorylation at NEK3 Thr-165 in focal adhesion maturation and/or turnover to promote breast cancer cell migration.	[Harrington, Katherine M.] Northwestern Univ, Dept Pathol, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Clevenger, Charles V.] Virginia Commonwealth Univ, Dept Pathol, 1101 E Marshall St,4 Sanger,POB 980662, Richmond, VA 23298 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Virginia Commonwealth University	Clevenger, CV (corresponding author), Virginia Commonwealth Univ, Dept Pathol, 1101 E Marshall St,4 Sanger,POB 980662, Richmond, VA 23298 USA.	charles.clevenger@vcuhealth.org			National Institutes of Health from NCI [CCSG P30 CA06553]; NATIONAL CANCER INSTITUTE [R01CA092265] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Suzanne Schauwecker from the Clevenger laboratory for insightful discussions of the manuscript. Imaging work was performed at the Northwestern University Center for Advanced Microscopy generously supported by National Institutes of Health Grant CCSG P30 CA06553 from NCI awarded to the Robert H. Lurie Comprehensive Cancer Center.	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bayliss R, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120136; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; BHATAVDEKAR JM, 1990, CANCER, V65, P2028, DOI 10.1002/1097-0142(19900501)65:9&lt;2028::AID-CNCR2820650924&gt;3.0.CO;2-9; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BRUNET A, 1994, ONCOGENE, V9, P3379; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chang JF, 2009, J CELL SCI, V122, P2274, DOI 10.1242/jcs.048975; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Costa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074659; Das R, 1996, BREAST CANCER RES TR, V40, P141, DOI 10.1007/BF01806209; Das R, 1996, ONCOGENE, V13, P1139; DASILVA L, 1994, J BIOL CHEM, V269, P18267; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Fagerholm SC, 2004, TRENDS BIOCHEM SCI, V29, P504, DOI 10.1016/j.tibs.2004.07.005; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Galbaugh T, 2010, MOL CANCER RES, V8, P1413, DOI 10.1158/1541-7786.MCR-10-0130; Gill S, 2001, J CLIN PATHOL, V54, P956, DOI 10.1136/jcp.54.12.956; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Gutzman JH, 2004, MOL ENDOCRINOL, V18, P3064, DOI 10.1210/me.2004-0187; Hashimoto Y, 2002, BIOCHEM BIOPH RES CO, V293, P753, DOI 10.1016/S0006-291X(02)00297-8; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lester RD, 2005, J BIOL CHEM, V280, P39273, DOI 10.1074/jbc.M509446200; Li ZL, 2010, J BIOL CHEM, V285, P23699, DOI 10.1074/jbc.M110.123497; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; Llovera M, 2000, ONCOGENE, V19, P4695, DOI 10.1038/sj.onc.1203846; LU KP, 1994, J BIOL CHEM, V269, P6603; Maus MV, 1999, ENDOCRINOLOGY, V140, P5447, DOI 10.1210/en.140.11.5447; Meng JP, 2004, CANCER RES, V64, P5677, DOI 10.1158/0008-5472.CAN-04-1019; Miller SL, 2007, ONCOGENE, V26, P4668, DOI 10.1038/sj.onc.1210264; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Mujagic Z, 2004, CROAT MED J, V45, P176; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ono H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096060; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Piazza TM, 2009, MOL ENDOCRINOL, V23, P202, DOI 10.1210/me.2008-0341; Pullikuth AK, 2010, MOL CELL BIOL, V30, P3233, DOI 10.1128/MCB.01178-09; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Reynolds C, 1997, ENDOCRINOLOGY, V138, P5555, DOI 10.1210/en.138.12.5555; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Roig J, 2005, MOL BIOL CELL, V16, P4827, DOI 10.1091/mbc.E05-04-0315; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; SCHULTZ SJ, 1993, CELL GROWTH DIFFER, V4, P821; SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P625; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Tanaka K, 1999, J BIOL CHEM, V274, P13491, DOI 10.1074/jbc.274.19.13491; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Tong JF, 2013, MOL CELL BIOL, V33, P4538, DOI 10.1128/MCB.00822-13; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; Tworoger SS, 2013, CANCER RES, V73, P4810, DOI 10.1158/0008-5472.CAN-13-0665; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yonezawa T, 2015, CANCER LETT, V366, P84, DOI 10.1016/j.canlet.2015.06.010; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544	77	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21388	21406		10.1074/jbc.M116.726190	http://dx.doi.org/10.1074/jbc.M116.726190			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27489110	Green Published, hybrid			2022-12-28	WOS:000385999200005
J	Muszynski, A; Heiss, C; Hjuler, CT; Sullivan, JT; Kelly, SJ; Thygesen, MB; Stougaard, J; Azadi, P; Carlson, RW; Ronson, CW				Muszynski, Artur; Heiss, Christian; Hjuler, Christian T.; Sullivan, John T.; Kelly, Simon J.; Thygesen, Mikkel B.; Stougaard, Jens; Azadi, Parastoo; Carlson, Russell W.; Ronson, Clive W.			Structures of Exopolysaccharides Involved in Receptor-mediated Perception of Mesorhizobium loti by Lotus japonicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMBIOTICALLY IMPORTANT EXOPOLYSACCHARIDE; MOLECULAR-WEIGHT SUCCINOGLYCAN; HOST-SYMBIONT INTERACTIONS; RHIZOBIUM-MELILOTI RM1021; SP STRAIN NGR234; SINORHIZOBIUM-MELILOTI; NODULE INVASION; MEDICAGO-SATIVA; GROUP MIGRATION; CAPILLARY GLC	In the symbiosis formed between Mesorhizobium loti strain R7A and Lotus japonicus Gifu, rhizobial exopolysaccharide (EPS) plays an important role in infection thread formation. Mutants of strain R7A affected in early exopolysaccharide biosynthetic steps form nitrogen-fixing nodules on L. japonicus Gifu after a delay, whereas mutants affected in mid or late biosynthetic steps induce uninfected nodule primordia. Recently, it was shown that a plant receptor-like kinase, EPR3, binds low molecular mass exopolysaccharide from strain R7A to regulate bacterial passage through the plant's epidermal cell layer (Kawaharada, Y., Kelly, S., Nielsen, M. W., Hjuler, C. T., Gysel, K., Muszyn ' ski, A., Carlson, R. W., Thygesen, M. B., Sandal, N., Asmussen, M. H., Vinther, M., Andersen, S. U., Krusell, L., Thirup, S., Jensen, K. J., et al. (2015) Nature 523, 308-312). In this work, we define the structure of both high and low molecular mass exopolysaccharide from R7A. The low molecular mass exopolysaccharide produced by R7A is a monomer unit of the acetylated octasaccharide with the structure (2,3/3-OAc)beta-D-RibfA-(1 -> 4)-alpha-D-GlcpA-(1 -> 4)-alpha-D-Glcp-(1 -> 6)-(3OAc)beta-D-Glcp-(1 -> 6)-*[(2OAc)beta-D-Glcp-(1 -> 4)-(2/3OAc)beta-D-Glcp(1 -> 4)-beta-D-Glcp-(1 -> 3)-beta-D-Galp]. We propose it is a biosynthetic constituent of high molecular mass EPS polymer. Every new repeating unit is attached via its reducing-end beta-D-Galp to C-4 of the fourth glucose (asterisked above) of the octasaccharide, forming a branch. TheO-acetylation occurs on the four glycosyl residues in a non-stoichiometric ratio, and each octasaccharide subunit is on average substituted with three O-acetyl groups. The availability of these structures will facilitate studies of EPR3 receptor binding of symbiotically compatible and incompatible EPS and the positive or negative consequences on infection by the M. loti exo mutants synthesizing such EPS variants.	[Muszynski, Artur; Heiss, Christian; Azadi, Parastoo; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA; [Sullivan, John T.; Kelly, Simon J.; Ronson, Clive W.] Univ Otago, Dept Microbiol & Immunol, 720 Cumberland St, Dunedin 9016, New Zealand; [Kelly, Simon J.; Stougaard, Jens] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Hjuler, Christian T.; Thygesen, Mikkel B.] Univ Copenhagen, Dept Chem, DK-1871 Frederiksberg C, Denmark	University System of Georgia; University of Georgia; University of Otago; Aarhus University; University of Copenhagen	Muszynski, A (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.; Ronson, CW (corresponding author), Univ Otago, Dept Microbiol & Immunol, 720 Cumberland St, Dunedin 9016, New Zealand.	muszynski@ccrc.uga.edu; Clive.Ronson@otago.ac.nz	Heiss, Christian/GPX-7678-2022; Thygesen, Mikkel B./F-4418-2014	Heiss, Christian/0000-0003-1118-8953; Thygesen, Mikkel B./0000-0002-0158-2802; Toftegaard Hjuler, Christian/0000-0001-6055-6391; Stougaard, Jens/0000-0002-9312-2685; Muszynski, Artur/0000-0003-3497-9977; Kelly, Simon/0000-0003-4243-300X; Azadi, Parastoo/0000-0002-6166-9432; Ronson, Clive/0000-0002-2217-9676	Chemical Sciences Geosciences and Biosciences Division, Office of Basic Energy Sciences, United States Department of Energy [DE-FG02-93ER20097]; Danish National Research Foundation [DNFR79]	Chemical Sciences Geosciences and Biosciences Division, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by Chemical Sciences Geosciences and Biosciences Division, Office of Basic Energy Sciences, United States Department of Energy Grant DE-FG02-93ER20097 to the Department of Energy-Center for Plant and Microbial Complex Carbohydrates at the Complex Carbohydrate Research Center (to A. M., C. H., R. W. C., and P. A.), and the Danish National Research Foundation Grant DNFR79 (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	AMAN P, 1981, CARBOHYD RES, V95, P263, DOI 10.1016/S0008-6215(00)85582-2; AMEMURA A, 1981, CARBOHYD RES, V91, P59, DOI 10.1016/S0008-6215(00)80991-X; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; BATTISTI L, 1992, P NATL ACAD SCI USA, V89, P5625, DOI 10.1073/pnas.89.12.5625; BENESI AJ, 1994, CARBOHYD RES, V258, P27, DOI 10.1016/0008-6215(94)84072-5; Brecker L, 2009, MAGN RESON CHEM, V47, P328, DOI 10.1002/mrc.2395; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Chouly C, 1995, INT J BIOL MACROMOL, V17, P357, DOI 10.1016/0141-8130(96)81846-0; Desbrosses GJ, 2011, CELL HOST MICROBE, V10, P348, DOI 10.1016/j.chom.2011.09.005; DJORDJEVIC SP, 1986, CARBOHYD RES, V148, P87, DOI 10.1016/0008-6215(86)80039-8; DJORDJEVIC SP, 1987, J BACTERIOL, V169, P53, DOI 10.1128/jb.169.1.53-60.1987; Fournier J, 2015, PLANT PHYSIOL, V167, P1233, DOI 10.1104/pp.114.253302; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; GERWIG GJ, 1978, CARBOHYD RES, V62, P349, DOI 10.1016/S0008-6215(00)80881-2; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; GILSERRANO A, 1990, CARBOHYD RES, V204, P103, DOI 10.1016/0008-6215(90)84025-P; Gonzalez JE, 1998, P NATL ACAD SCI USA, V95, P13477, DOI 10.1073/pnas.95.23.13477; Gonzalez JE, 1996, P NATL ACAD SCI USA, V93, P8636, DOI 10.1073/pnas.93.16.8636; Hanniffy OM, 1999, CARBOHYD RES, V319, P124, DOI 10.1016/S0008-6215(99)00129-9; HER GR, 1990, CARBOHYD RES, V198, P305, DOI 10.1016/0008-6215(90)84300-J; Janczarek M, 2015, APPL SOIL ECOL, V85, P94, DOI 10.1016/j.apsoil.2014.08.010; JANSSON PE, 1987, J CHEM SOC PERK T 1, P377, DOI 10.1039/p19870000377; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Kelly SJ, 2013, MOL PLANT MICROBE IN, V26, P319, DOI 10.1094/MPMI-09-12-0227-R; Laus MC, 2005, MOL PLANT MICROBE IN, V18, P533, DOI 10.1094/MPMI-18-0533; Lehman AP, 2013, J BACTERIOL, V195, P5362, DOI 10.1128/JB.00681-13; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Mendis HC, 2016, MBIO, V7, DOI 10.1128/mBio.00606-16; Mendis HC, 2013, MOL PLANT MICROBE IN, V26, P1089, DOI 10.1094/MPMI-03-13-0087-R; ONEILL MA, 1991, J BIOL CHEM, V266, P9549; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; PHILIPHOLLINGSWORTH S, 1989, J BIOL CHEM, V264, P5710; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; REINHOLD BB, 1994, J BACTERIOL, V176, P1997, DOI 10.1128/jb.176.7.1997-2002.1994; REUBER TL, 1993, CELL, V74, P269, DOI 10.1016/0092-8674(93)90418-P; REUBER TL, 1993, J BACTERIOL, V175, P3653, DOI 10.1128/jb.175.11.3653-3655.1993; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rodpothong P, 2009, MOL PLANT MICROBE IN, V22, P1546, DOI 10.1094/MPMI-22-12-1546; Rodriguez-Navarro DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115391; Roslund MU, 2008, J AM CHEM SOC, V130, P8769, DOI 10.1021/ja801177s; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Staehelin C, 2006, J BACTERIOL, V188, P6168, DOI 10.1128/JB.00365-06; Sutherland IW, 2001, INT DAIRY J, V11, P663, DOI 10.1016/S0958-6946(01)00112-1; Tielen P, 2005, MICROBIOL RES, V160, P165, DOI 10.1016/j.micres.2004.11.003; URZAINQUI A, 1992, J BACTERIOL, V174, P3403, DOI 10.1128/jb.174.10.3403-3406.1992; Wang LX, 1999, J BACTERIOL, V181, P6788, DOI 10.1128/JB.181.21.6788-6796.1999; WU J, 1991, CARBOHYD RES, V210, P51, DOI 10.1016/0008-6215(91)80112-Z; Xie F, 2012, P NATL ACAD SCI USA, V109, P633, DOI 10.1073/pnas.1113992109; York GM, 1997, MOL MICROBIOL, V25, P117, DOI 10.1046/j.1365-2958.1997.4481804.x; York GM, 1998, J BACTERIOL, V180, P4184, DOI 10.1128/JB.180.16.4184-4191.1998; YORK WS, 1986, METHOD ENZYMOL, V118, P3; ZEVENHUIZEN LPTM, 1983, CARBOHYD RES, V118, P127, DOI 10.1016/0008-6215(83)88041-0	58	27	29	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20946	+		10.1074/jbc.M116.743856	http://dx.doi.org/10.1074/jbc.M116.743856			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27502279	Green Published, hybrid			2022-12-28	WOS:000385406200013
J	Lamothe, SM; Guo, J; Li, WT; Yang, TH; Zhang, ST				Lamothe, Shawn M.; Guo, Jun; Li, Wentao; Yang, Tonghua; Zhang, Shetuan			The Human Ether-a-go-go-related Gene (hERG) Potassium Channel Represents an Unusual Target for Protease-mediated Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface protein; electrophysiology; hERG; ion channel; patch clamp; potassium channel; protease	LONG QT SYNDROME; ISCHEMIA-REPERFUSION INJURY; HUMAN VENTRICULAR MYOCYTES; CORONARY-ARTERY-DISEASE; I-KR; CARDIAC-ARRHYTHMIA; MYOCARDIAL-INFARCTION; MATRIX METALLOPROTEINASE-2; INTERVAL PROLONGATION; SERINE PROTEASES	The human ether-a-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier potassium channel (I-Kr), which is important for cardiac repolarization. Dysfunction of hERG causes long QT syndrome and sudden death, which occur in patients with cardiac ischemia. Cardiac ischemia is also associated with activation, up-regulation, and secretion of various proteolytic enzymes. Here, using whole-cell patch clamp and Western blotting analysis, we demonstrate that the hERG/I-Kr channel was selectively cleaved by the serine protease, proteinase K (PK). Using molecular biology techniques including making a chimeric channel between protease-sensitive hERG and insensitive human ether-a-go-go (hEAG), as well as application of the scorpion toxin BeKm-1, we identified that the S5-pore linker of hERG is the target domain for proteinase K cleavage. To investigate the physiological relevance of the unique susceptibility of hERG to proteases, we show that cardiac ischemia in a rabbit model was associated with a reduction in mature ERG expression and an increase in the expression of several proteases, including calpain. Using cell biology approaches, we found that calpain-1 was actively released into the extracellular milieu and cleaved hERG at the S5-pore linker. Using protease cleavage-predicting software and site-directed mutagenesis, we identified that calpain-1 cleaves hERG at position Gly-603 in the S5-pore linker of hERG. Clarification of protease-mediated damage of hERG extends our understanding of hERG regulation. Damage of hERG mediated by proteases such as calpain may contribute to ischemia-associated QT prolongation and sudden cardiac death.	[Lamothe, Shawn M.; Guo, Jun; Li, Wentao; Yang, Tonghua; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193; Lamothe, Shawn/0000-0001-8722-2631	Canadian Institutes of Health Research [MOP 72911]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP 72911 (to S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Chen J, 2015, J BIOL CHEM, V290, P21101, DOI 10.1074/jbc.M115.636324; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; Chohan PK, 2006, CARDIOVASC RES, V69, P152, DOI 10.1016/j.cardiores.2005.07.016; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Gadaleta FL, 2003, AM J CARDIOL, V92, P203, DOI 10.1016/S0002-9149(03)00539-3; Gerlach AC, 2010, MOL PHARMACOL, V77, P58, DOI 10.1124/mol.109.059543; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hogan-Cann A, 2016, BBA-BIOMEMBRANES, V1858, P1082, DOI 10.1016/j.bbamem.2016.02.012; Jiang M, 2005, J PHYSIOL-LONDON, V569, P75, DOI 10.1113/jphysiol.2005.093682; Jin DN, 2004, J PHARMACOL EXP THER, V309, P490, DOI 10.1124/jpet.103.061465; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Kang YD, 2015, BIOCHEM J, V472, P71, DOI 10.1042/BJ20141282; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035; KONARZEWSKA H, 1995, CIRCULATION, V92, P1179, DOI 10.1161/01.CIR.92.5.1179; Korolkova YV, 2002, J BIOL CHEM, V277, P43104, DOI 10.1074/jbc.M204083200; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Letavernier B, 2012, ARTERIOSCL THROM VAS, V32, P335, DOI 10.1161/ATVBAHA.111.240242; Letavernier E, 2012, CARDIOVASC RES, V96, P38, DOI 10.1093/cvr/cvs099; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Maurer E, 2012, BIOL CHEM, V393, P535, DOI 10.1515/hsz-2011-0221; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Mehta D, 1997, CIRCULATION, V96, P3215, DOI 10.1161/01.CIR.96.9.3215; Muller AL, 2013, INT J CARDIOL, V164, P39, DOI 10.1016/j.ijcard.2012.01.103; Neuhof C, 2008, BIOL CHEM, V389, P1505, DOI 10.1515/BC.2008.172; PEETERS GA, 1995, AM J PHYSIOL-HEART C, V268, pH1757, DOI 10.1152/ajpheart.1995.268.4.H1757; Perez J, 2016, J IMMUNOL, V196, P168, DOI 10.4049/jimmunol.1500749; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schaffer P, 1999, CARDIOVASC RES, V43, P332, DOI 10.1016/S0008-6363(99)00118-2; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; SHAWL FA, 1990, J AM COLL CARDIOL, V16, P325, DOI 10.1016/0735-1097(90)90581-9; SHEETS MF, 1983, CIRC RES, V53, P544, DOI 10.1161/01.RES.53.4.544; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; Torres AM, 2003, J BIOL CHEM, V278, P42136, DOI 10.1074/jbc.M212824200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; VAHOUNY GV, 1970, SCIENCE, V167, P1616, DOI 10.1126/science.167.3925.1616; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Zhang M, 2003, BIOPHYS J, V84, P3022, DOI 10.1016/S0006-3495(03)70028-9; Zhao Y, 2016, HEART RHYTHM, V13, P2004, DOI 10.1016/j.hrthm.2016.06.019; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	57	25	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20387	20401		10.1074/jbc.M116.743138	http://dx.doi.org/10.1074/jbc.M116.743138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27502273	Green Published, hybrid			2022-12-28	WOS:000384574800009
J	Sautron, E; Giustini, C; Dang, T; Moyet, L; Salvi, D; Crouzy, S; Rolland, N; Catty, P; Seigneurin-Berny, D				Sautron, Emeline; Giustini, Cecile; ThuyVan Dang; Moyet, Lucas; Salvi, Daniel; Crouzy, Serge; Rolland, Norbert; Catty, Patrice; Seigneurin-Berny, Daphne			Identification of Two Conserved Residues Involved in Copper Release from Chloroplast PIB-1-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; ATPase; chloroplast; copper transport; plant biochemistry; copper release site; PIB-1-ATPases	P-TYPE ATPASE; SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; CU+ CHAPERONES; TRANSPORT; ARABIDOPSIS; MECHANISM; ENVELOPE; ATP7A; COMPARTMENTS	Copper is an essential transition metal for living organisms. In the plant model Arabidopsis thaliana, half of the copper content is localized in the chloroplast, and as a cofactor of plastocyanin, copper is essential for photosynthesis. Within the chloroplast, copper delivery to plastocyanin involves two transporters of the PIB-1-ATPases subfamily: HMA6 at the chloroplast envelope and HMA8 in the thylakoid membranes. Both proteins are high affinity copper transporters but share distinct enzymatic properties. In the present work, the comparison of 140 sequences of PIB-1-ATPases revealed a conserved region unusually rich in histidine and cysteine residues in the TMA-L1 region of eukaryotic chloroplast copper ATPases. To evaluate the role of these residues, we mutated them in HMA6 and HMA8. Mutants of interest were selected from phenotypic tests in yeast and produced in Lactococcus lactis for further biochemical characterizations using phosphorylation assays from ATP and P-i. Combining functional and structural data, we highlight the importance of the cysteine and the first histidine of the CX3HX2H motif in the process of copper release from HMA6 and HMA8 and propose a copper pathway through the membrane domain of these transporters. Finally, our work suggests a more general role of the histidine residue in the transport of copper by PIB-1-ATPases.	[Sautron, Emeline; Giustini, Cecile; ThuyVan Dang; Moyet, Lucas; Salvi, Daniel; Rolland, Norbert; Seigneurin-Berny, Daphne] CNRS, Lab Physiol Cellulaire & Vegetale, UMR 5168, F-38054 Grenoble, France; [Sautron, Emeline; Giustini, Cecile; ThuyVan Dang; Moyet, Lucas; Salvi, Daniel; Crouzy, Serge; Rolland, Norbert; Catty, Patrice; Seigneurin-Berny, Daphne] Univ Grenoble Alpes, F-38054 Grenoble, France; [Sautron, Emeline; Giustini, Cecile; ThuyVan Dang; Moyet, Lucas; Salvi, Daniel; Crouzy, Serge; Rolland, Norbert; Catty, Patrice; Seigneurin-Berny, Daphne] CEA, DSV, BIG, F-38054 Grenoble, France; [Sautron, Emeline; Giustini, Cecile; ThuyVan Dang; Moyet, Lucas; Salvi, Daniel; Rolland, Norbert; Seigneurin-Berny, Daphne] INRA, LPCV, UMR 1417, F-38054 Grenoble, France; [Crouzy, Serge; Catty, Patrice] CNRS, Lab Chim & Biol Met, UMR 5249, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Catty, P (corresponding author), CEA Grenoble, LCBM, BIG, 17 Rue Martyrs, F-38054 Grenoble 9, France.; Seigneurin-Berny, D (corresponding author), CEA Grenoble, LPCV, BIG, 17 Rue Martyrs, F-38054 Grenoble 9, France.	patrice.catty@cea.fr; daphne.berny@univ-grenoble-alpes.fr	ROLLAND, Norbert/B-4405-2012; SEIGNEURIN-BERNY, Daphne/C-8412-2017	ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885	Commissariat a l'Energie Atomique et aux Energies Alternatives; Centre National de la Recherche Scientifique; French National Institute for Agricultural Research; University of Grenoble Alpes; GRAL Labex [ANR-10-LABX-49-01]; CEA	Commissariat a l'Energie Atomique et aux Energies Alternatives; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French National Institute for Agricultural Research; University of Grenoble Alpes; GRAL Labex; CEA(French Atomic Energy Commission)	This work was supported by the Commissariat a l'Energie Atomique et aux Energies Alternatives, the Centre National de la Recherche Scientifique, the French National Institute for Agricultural Research, and the University of Grenoble Alpes. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a joint grant from the GRAL Labex (ANR-10-LABX-49-01) and the CEA.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Barry AN, 2011, J BIOL CHEM, V286, P26585, DOI 10.1074/jbc.M111.229039; Blaby-Haas CE, 2014, P NATL ACAD SCI USA, V111, pE5480, DOI 10.1073/pnas.1421545111; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Catty P, 2011, J BIOL CHEM, V286, P36188, DOI 10.1074/jbc.M111.241034; Chu CC, 2005, PLANT PHYSIOL, V139, P425, DOI 10.1104/pp.105.065284; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; Cohu CM, 2009, MOL PLANT, V2, P1336, DOI 10.1093/mp/ssp084; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Ferro M, 2003, MOL CELL PROTEOMICS, V2, P325, DOI 10.1074/mcp.M300030-MCP200; Frelet-Barrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008746; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gourdon P, 2012, BIOL CHEM, V393, P205, DOI 10.1515/hsz-2011-0249; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Hanikenne M, 2014, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00388, 10.3389/fpls.2013.00544]; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Huang CH, 2012, PLANT PHYSIOL, V158, P737, DOI 10.1104/pp.111.190223; Hung YH, 2007, BIOCHEM J, V401, P569, DOI 10.1042/BJ20060924; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; KUO CL, 1983, MOL CELL BIOL, V3, P1730, DOI 10.1128/MCB.3.10.1730; LI HM, 1990, P NATL ACAD SCI USA, V87, P6748, DOI 10.1073/pnas.87.17.6748; Mattle D, 2015, EMBO REP, V16, P728, DOI 10.15252/embr.201439927; Otoikhian A, 2012, J AM CHEM SOC, V134, P10458, DOI 10.1021/ja301221s; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Ravet K, 2013, ANTIOXID REDOX SIGN, V19, P919, DOI 10.1089/ars.2012.5084; Rubino JT, 2011, METALLOMICS, V3, P61, DOI 10.1039/c0mt00044b; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sautron E, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150065; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Sitsel O, 2015, BIOCHEMISTRY-US, V54, P5673, DOI 10.1021/acs.biochem.5b00512; Smith AT, 2014, J BIOL INORG CHEM, V19, P947, DOI 10.1007/s00775-014-1129-2; Tomizioli M, 2014, MOL CELL PROTEOMICS, V13, P2147, DOI 10.1074/mcp.M114.040923; VOLLAND C, 1994, FOLIA MICROBIOL, V39, P554, DOI 10.1007/BF02814106; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200	40	4	4	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20136	20148		10.1074/jbc.M115.706978	http://dx.doi.org/10.1074/jbc.M115.706978			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27493208	Green Published, hybrid			2022-12-28	WOS:000383243100034
J	Maldonado, EN; DeHart, DN; Patnaik, J; Klatt, SC; Gooz, MB; Lemasters, JJ				Maldonado, Eduardo N.; DeHart, David N.; Patnaik, Jyoti; Klatt, Sandra C.; Gooz, Monika Beck; Lemasters, John J.			ATP/ADP Turnover and Import of Glycolytic ATP into Mitochondria in Cancer Cells Is Independent of the Adenine Nucleotide Translocator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; glycolysis; mitochondria; voltage-dependent anion channel (VDAC); Warburg effect; ANT; ATP; ADP turnover; bongkrekic acid; carboxyatractyloside	DEPENDENT ANION CHANNELS; PERMEABILITY TRANSITION; ADP/ATP CARRIER; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; RAT HEPATOCYTES; METABOLISM; IDENTIFICATION; BINDING; GROWTH	Non-proliferating cells oxidize respiratory substrates in mitochondria to generate a protonmotive force (p) that drives ATP synthesis. The mitochondrial membrane potential (), a component of p, drives release of mitochondrial ATP(4-) in exchange for cytosolic ADP(3-) via the electrogenic adenine nucleotide translocator (ANT) located in the mitochondrial inner membrane, which leads to a high cytosolic ATP/ADP ratio up to >100-fold greater than matrix ATP/ADP. In rat hepatocytes, ANT inhibitors, bongkrekic acid (BA), and carboxyatractyloside (CAT), and the F1FO-ATP synthase inhibitor, oligomycin (OLIG), inhibited ureagenesis-induced respiration. However, in several cancer cell lines, OLIG but not BA and CAT inhibited respiration. In hepatocytes, respiratory inhibition did not collapse until OLIG, BA, or CAT was added. Similarly, in cancer cells OLIG and 2-deoxyglucose, a glycolytic inhibitor, depolarized mitochondria after respiratory inhibition, which showed that mitochondrial hydrolysis of glycolytic ATP maintained in the absence of respiration in all cell types studied. However in cancer cells, BA, CAT, and knockdown of the major ANT isoforms, ANT2 and ANT3, did not collapse after respiratory inhibition. These findings indicated that ANT did mediate mitochondrial ATP/ADP exchange in cancer cells. We propose that suppression of ANT contributes to low cytosolic ATP/ADP, activation of glycolysis, and a Warburg metabolic phenotype in proliferating cells.	[Maldonado, Eduardo N.; Lemasters, John J.] Med Univ South Carolina, Ctr Cell Death Injury & Regenerat, DD504 Drug Discovery Bld,70 President St,MSC 140, Charleston, SC 29425 USA; [Maldonado, Eduardo N.; DeHart, David N.; Patnaik, Jyoti; Klatt, Sandra C.; Gooz, Monika Beck; Lemasters, John J.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Lemasters, John J.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142290, Russia	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Lemasters, JJ (corresponding author), Med Univ South Carolina, Ctr Cell Death Injury & Regenerat, DD504 Drug Discovery Bld,70 President St,MSC 140, Charleston, SC 29425 USA.	JJLemasters@musc.edu	RAHI, DEEPALI/GMW-8189-2022; Maldonado, Eduardo/AAN-3907-2020	RAHI, DEEPALI/0000-0002-4818-5572; Maldonado, Eduardo/0000-0002-5285-3027	NIH [P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA184456, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037034, R01DK037034, R01DK073336, R37DK037034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021191] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Dr. Craig C. Beeson for advice on Seahorse experiments and to Gregory L. Lovelace for technical assistance. Imaging facilities were supported, in part, by NIH Grant P30 CA138313.	Barath P, 1999, EXP CELL RES, V248, P583, DOI 10.1006/excr.1999.4432; BATTINI R, 1987, J BIOL CHEM, V262, P4355; Brown J, 1997, J CELL BIOCHEM, V66, P245, DOI 10.1002/(SICI)1097-4644(19970801)66:2<245::AID-JCB11>3.0.CO;2-G; Chevrollier A, 2005, J BIOENERG BIOMEMBR, V37, P307, DOI 10.1007/s10863-005-8642-5; Clemencon B, 2013, MOL ASPECTS MED, V34, P485, DOI 10.1016/j.mam.2012.05.006; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; del Arco A, 2004, J BIOL CHEM, V279, P24701, DOI 10.1074/jbc.M401417200; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; DRGON T, 1991, FEBS LETT, V289, P159, DOI 10.1016/0014-5793(91)81059-H; FARKAS DL, 1989, BIOPHYS J, V56, P1053, DOI 10.1016/S0006-3495(89)82754-7; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Giraud S, 1998, J MOL BIOL, V281, P409, DOI 10.1006/jmbi.1998.1955; Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HELDT HW, 1972, EUR J BIOCHEM, V30, P434, DOI 10.1111/j.1432-1033.1972.tb02115.x; Holmuhamedov EL, 2012, J BIOL CHEM, V287, P7692, DOI 10.1074/jbc.M111.293399; JOYAL JL, 1992, J BIOL CHEM, V267, P19198; KLINGENBERG M, 1983, EUR J BIOCHEM, V131, P647, DOI 10.1111/j.1432-1033.1983.tb07312.x; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; LAWSON JE, 1988, J BIOL CHEM, V263, P14812; Le Bras M, 2006, CANCER RES, V66, P9143, DOI 10.1158/0008-5472.CAN-05-4407; Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Moreno-Sanchez R, 2014, INT J BIOCHEM CELL B, V50, P10, DOI 10.1016/j.biocel.2014.01.025; NAKASHIMA RA, 1984, CANCER RES, V44, P5702; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; PFAFF E, 1969, EUR J BIOCHEM, V10, P484, DOI 10.1111/j.1432-1033.1969.tb00715.x; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Singleterry J, 2014, MITOCHONDRION, V17, P50, DOI 10.1016/j.mito.2014.05.010; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; ZAHREBELSKI G, 1995, HEPATOLOGY, V21, P1361, DOI 10.1002/hep.1840210521; Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011	46	33	34	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19642	19650		10.1074/jbc.M116.734814	http://dx.doi.org/10.1074/jbc.M116.734814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27458020	Green Published, hybrid			2022-12-28	WOS:000383242800037
J	Feng, X; Liu, P; Zhou, X; Li, MT; Li, FL; Wang, Z; Meng, ZP; Sun, YP; Yu, Y; Xiong, Y; Yuan, HX; Guan, KL				Feng, Xu; Liu, Peng; Zhou, Xin; Li, Meng-Tian; Li, Fu-Long; Wang, Zhen; Meng, Zhipeng; Sun, Yi-Ping; Yu, Ying; Xiong, Yue; Yuan, Hai-Xin; Guan, Kun-Liang			Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO PATHWAY; CORONARY ANGIOPLASTY; TISSUE-GROWTH; NEOINTIMAL HYPERPLASIA; RECEPTOR ANTAGONIST; HYPERTENSIVE RATS; BALLOON INJURY; SIZE-CONTROL; F-ACTIN; A(2)	The thromboxane A2 receptor (TP) has been implicated in restenosis after vascular injury, which induces vascular smooth muscle cell (VSMC) migration and proliferation. However, the mechanism for this process is largely unknown. In this study, we report that TP signaling induces VSMC migration and proliferation through activating YAP/TAZ, two major downstream effectors of the Hippo signaling pathway. The TP-specific agonists [1S-[1 alpha,2 alpha(Z),3 beta(1E,3S*),4 alpha]]-7-[3-[3-hydroxy-4-(4-odophenoxy)-1-butenyl]-7-oxabicyclo[2.2.1]hept-2-yll-5-hep-tenoic acid (1-BOP) and 9,11-dideoxy-9 alpha,11 alpha-methanoepoxyprosta-5Z,13E-dien-l-oic acid (U-46619) induce YAP/TAZ activation in multiple cell lines, including VSMCs. YAP/TAZ activation induced by I-BOP is blocked by knockout of the receptor TP or knockdown of the downstream G proteins G alpha(12/13). Moreover, Rho inhibition or actin cytoskeleton disruption prevents I-BOP-induced YAP/TAZ activation. Importantly, TP activation promotes DNA synthesis and cell migration in VSMCs in a manner dependent on YAP/TAZ. Taken together, thromboxane A2 signaling activates YAP/TAZ to promote VSMC migration and proliferation, indicating YAP/TAZ as potential therapeutic targets for cardiovascular diseases.	[Feng, Xu; Liu, Peng; Zhou, Xin; Li, Meng-Tian; Li, Fu-Long; Wang, Zhen; Sun, Yi-Ping; Xiong, Yue; Yuan, Hai-Xin; Guan, Kun-Liang] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200032, Peoples R China; [Feng, Xu; Liu, Peng; Zhou, Xin; Li, Meng-Tian; Li, Fu-Long; Wang, Zhen; Sun, Yi-Ping; Xiong, Yue; Yuan, Hai-Xin; Guan, Kun-Liang] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Meng, Zhipeng; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA; [Meng, Zhipeng; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92130 USA; [Yu, Ying] Chinese Acad Sci, Key Lab Food Safety Res, Ctr Excellence Mol Cell Sci, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill	Xiong, Y; Yuan, HX; Guan, KL (corresponding author), Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200032, Peoples R China.; Xiong, Y; Yuan, HX; Guan, KL (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA.; Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92130 USA.; Xiong, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yxiong@email.unc.edu; yuanhaixin@fudan.edu.cn; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Zhou, Xin/AAD-6937-2019		National Natural Science Foundation of China [31570784]; National Institutes of Health [RO1GM067113, RO1CA068377, RO1CA163834, R35CA196878, RO1GM51586, RO1EY022611]; NATIONAL CANCER INSTITUTE [R35CA196878] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Natural Science Foundation of China Grant 31570784 (to H. X. Y.). K. L G. is a cofounder of Vivace Therapeutics Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants RO1GM067113, RO1CA068377, and RO1CA163834. To whom correspondence may be addressed: E-mail: yxiong@email.unc.edu.; Supported by National Institutes of Health Grants R35CA196878, RO1GM51586, and RO1EY022611. To whom correspondence may be addressed. E-mail: kuguan@ucsd.edu.	Audoly LP, 2000, CIRCULATION, V101, P2833, DOI 10.1161/01.CIR.101.24.2833; Bauer J, 2014, BRIT J PHARMACOL, V171, P3115, DOI 10.1111/bph.12677; Belton O, 2000, CIRCULATION, V102, P840; Belton OA, 2003, CIRCULATION, V108, P3017, DOI 10.1161/01.CIR.0000104565.78013.AD; BRADEN GA, 1991, CIRCULATION, V84, P679, DOI 10.1161/01.CIR.84.2.679; Byrne A, 1997, ARTERIOSCL THROM VAS, V17, P3224, DOI 10.1161/01.ATV.17.11.3224; Cayatte AJ, 2000, ARTERIOSCL THROM VAS, V20, P1724, DOI 10.1161/01.ATV.20.7.1724; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Egan KM, 2005, CIRCULATION, V111, P334, DOI 10.1161/01.CIR.0000153386.95356.78; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Fetalvero KM, 2006, AM J PHYSIOL-HEART C, V290, pH1337, DOI 10.1152/ajpheart.00936.2005; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; HANASAKI K, 1990, BIOCHEM PHARMACOL, V40, P2535, DOI 10.1016/0006-2952(90)90096-4; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; ISHIMITSU T, 1988, HYPERTENSION, V12, P46, DOI 10.1161/01.HYP.12.1.46; ISHIMITSU T, 1988, AM J HYPERTENS, V1, pS38, DOI 10.1093/ajh/1.3.38S; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lv XB, 2015, EMBO REP, V16, P975, DOI 10.15252/embr.201439951; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; Matsumae H, 2008, ARTERIOSCL THROM VAS, V28, P1077, DOI 10.1161/ATVBAHA.108.162362; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Michels S, 2001, Semin Ophthalmol, V16, P201, DOI 10.1076/soph.16.4.201.10298; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pakala R, 1997, CIRCULATION, V96, P2280; Pakala Rajbabu, 2004, Cardiovasc Radiat Med, V5, P20, DOI 10.1016/j.carrad.2003.12.002; PETERSON MB, 1986, AM HEART J, V111, P1, DOI 10.1016/0002-8703(86)90544-2; Pratico D, 2000, BLOOD, V96, P3823, DOI 10.1182/blood.V96.12.3823.h8003823_3823_3826; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Ting HJ, 2012, J CARDIOVASC PHARM T, V17, P248, DOI 10.1177/1074248411424145; Wang XB, 2012, ARTERIOSCL THROM VAS, V32, P2662, DOI 10.1161/ATVBAHA.112.254730; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Xie CQ, 2012, J BIOL CHEM, V287, P14598, DOI 10.1074/jbc.M111.329268; Yamagami S, 1999, JPN HEART J, V40, P791, DOI 10.1536/jhj.40.791; Yokota T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094895; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhou X, 2015, J CLIN INVEST, V125, P2123, DOI 10.1172/JCI79573	59	67	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18947	18958		10.1074/jbc.M116.739722	http://dx.doi.org/10.1074/jbc.M116.739722			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27382053	Green Published, hybrid			2022-12-28	WOS:000383242300030
J	Grzegorzewicz, AE; de Sousa-d'Auria, C; McNeil, MR; Huc-Claustre, E; Jones, V; Petit, C; Angala, SK; Zemanova, J; Wang, QL; Belardinelli, JM; Gao, Q; Ishizaki, Y; Mikusova, K; Brennan, PJ; Ronning, DR; Chami, M; Houssin, C; Jackson, M				Grzegorzewicz, Anna E.; de Sousa-d'Auria, Celia; McNeil, Michael R.; Huc-Claustre, Emilie; Jones, Victoria; Petit, Cecile; Angala, Shiva Kumar; Zemanova, Julia; Wang, Qinglan; Belardinelli, Juan Manuel; Gao, Qian; Ishizaki, Yoshimasa; Mikusova, Katarina; Brennan, Patrick J.; Ronning, Donald R.; Chami, Mohamed; Houssin, Christine; Jackson, Mary			Assembling of the Mycobacterium tuberculosis Cell Wall Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPSA-PSR FAMILY; CORYNEBACTERIUM-GLUTAMICUM; CAPSULAR POLYSACCHARIDE; STAPHYLOCOCCUS-AUREUS; OUTER-MEMBRANE; FUNCTIONAL-ANALYSIS; ARABINOGALACTAN; STREPTOCOCCUS; BIOSYNTHESIS; PROTEIN	The unique cell wall of mycobacteria is essential to their viability and the target of many clinically used anti-tuberculosis drugs and inhibitors under development. Despite intensive efforts to identify the ligase(s) responsible for the covalent attachment of the two major heteropolysaccharides of the mycobacterial cell wall, arabinogalactan (AG) and peptidoglycan (PG), the enzyme or enzymes responsible have remained elusive. We here report on the identification of the two enzymes of Mycobacterium tuberculosis, CpsA1 (Rv3267) and CpsA2 (Rv3484), responsible for this function. CpsAl and CpsA2 belong to the widespread LytR-Cps2A-Psr (LCP) family of enzymes that has been shown to catalyze a variety of glycopolymer transfer reactions in Gram-positive bacteria, including the attachment of wall teichoic acids to PG. Although individual cpsA1 and cpsA2 knock-outs of M. tuberculosis were readily obtained, the combined inactivation of both genes appears to be lethal. In the closely related microorganism Corynebacterium glutamicum, the ortholog of cpsA1 is the only gene involved in this function, and its conditional knockdown leads to dramatic changes in the cell wall composition and morphology of the bacteria due to extensive shedding of cell wall material in the cut ture medium as a result of defective attachment of AG to PG. This work marks an important step in our understanding of the biogenesis of the unique cell envelope of mycobacteria and opens new opportunities for drug development.	[Grzegorzewicz, Anna E.; McNeil, Michael R.; Huc-Claustre, Emilie; Jones, Victoria; Angala, Shiva Kumar; Wang, Qinglan; Belardinelli, Juan Manuel; Ishizaki, Yoshimasa; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [de Sousa-d'Auria, Celia; Houssin, Christine] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell, F-91198 Gif Sur Yvette, France; [Petit, Cecile] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA; [Zemanova, Julia; Mikusova, Katarina] Comenius Univ, Fac Nat Sci, Dept Biochem, Mlynska Dolina CH 1, Bratislava 84215, Slovakia; [Wang, Qinglan; Gao, Qian] Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Shanghai Med Coll,Key Lab Med Mol Virol MOE & MOH, Shanghai 200032, Peoples R China; [Wang, Qinglan; Gao, Qian] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Inst Med Microbiol, Shanghai 200032, Peoples R China; [Ishizaki, Yoshimasa] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo 31423, Japan; [Chami, Mohamed] Univ Basel, Biozentrum, C CINA Ctr Imaging & NanoAnalyt, Mattenstr 26, CH-4058 Basel, Switzerland	Colorado State University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University System of Ohio; University of Toledo; Comenius University Bratislava; Fudan University; Fudan University; University of Basel	Houssin, C (corresponding author), Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell, F-91198 Gif Sur Yvette, France.; Jackson, M (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	christine.houssin@u-psud.fr; Mary.Jackson@colostate.edu	McNeil, Michael/G-3325-2019; Jackson, Mary/D-5345-2017; Mikusova, Katarina/I-3622-2014; Claustre, Emilie Huc/M-6693-2016; Belardinelli, Juan Manuel/N-7335-2019; Wang, Qinglan/AAM-3023-2020; Brennan, Patrick J/G-6896-2017	Jackson, Mary/0000-0002-9212-0258; Claustre, Emilie Huc/0000-0002-8856-207X; Belardinelli, Juan Manuel/0000-0003-1336-9141; Sousa, Celia R/0000-0001-8988-3724; Wang, Qinglan/0000-0002-7629-5058; Mikusova, Katarina/0000-0002-0100-4877; Ronning, Donald/0000-0003-2583-8849; Houssin, christine/0000-0003-4319-1313	NIAID, National Institutes of Health [AI119670]; College of Veterinary Medicine and Biomedical Sciences Research Council (Colorado State University); Swiss National Science Foundation (SystemsX.ch RTD CINA); Swiss National Science Foundation (NCCR TransCure); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119670, R01AI105084] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); College of Veterinary Medicine and Biomedical Sciences Research Council (Colorado State University); Swiss National Science Foundation (SystemsX.ch RTD CINA)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (NCCR TransCure)(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health, Grant AI119670 and the College of Veterinary Medicine and Biomedical Sciences Research Council (Colorado State University). The electron microscopy work at C-CINA (Biozentrum) was supported in part by the Swiss National Science Foundation (SystemsX.ch RTD CINA and NCCR TransCure). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, GLYCOBIOLOGY, V16, P1073, DOI 10.1093/glycob/cwl030; Angala SK, 2014, CRIT REV BIOCHEM MOL, V49, P361, DOI 10.3109/10409238.2014.925420; Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Belardinelli JM, 2014, J BIOL CHEM, V289, P27952, DOI 10.1074/jbc.M114.581199; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Bhamidi S, 2012, ANAL BIOCHEM, V421, P240, DOI 10.1016/j.ab.2011.10.046; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; Chan YGY, 2014, J BIOL CHEM, V289, P15680, DOI 10.1074/jbc.M114.567669; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Hancock IC, 2002, MICROBIOL-SGM, V148, P3059, DOI 10.1099/00221287-148-10-3059; Hanson BR, 2012, J BACTERIOL, V194, P1668, DOI 10.1128/JB.06373-11; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Hubscher J, 2009, FEMS MICROBIOL LETT, V295, P251, DOI 10.1111/j.1574-6968.2009.01603.x; Ishizaki Y, 2013, J BIOL CHEM, V288, P30309, DOI 10.1074/jbc.M113.492173; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; Pavelka MS, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0034-2013; PEYRET JL, 1993, MOL MICROBIOL, V9, P97, DOI 10.1111/j.1365-2958.1993.tb01672.x; Raad RB, 2010, J BACTERIOL, V192, P2691, DOI 10.1128/JB.00009-10; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Wang QL, 2015, INFECT IMMUN, V83, P2844, DOI 10.1128/IAI.03081-14; Wu CG, 2014, MOL MICROBIOL, V94, P1227, DOI 10.1111/mmi.12780; Yagi T, 2003, J BIOL CHEM, V278, P26497, DOI 10.1074/jbc.M302216200; Zilla ML, 2015, J BACTERIOL, V197, P3731, DOI 10.1128/JB.00656-15; Zilla ML, 2015, J BACTERIOL, V197, P343, DOI 10.1128/JB.02364-14; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	44	30	31	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18867	18879		10.1074/jbc.M116.739227	http://dx.doi.org/10.1074/jbc.M116.739227			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27417139	Green Published, hybrid			2022-12-28	WOS:000383242300025
J	Jin, ES; Sherry, AD; Malloy, CR				Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.			An Oral Load of [C-13(3)]Glycerol and Blood NMR Analysis Detect Fatty Acid Esterification, Pentose Phosphate Pathway, and Glycerol Metabolism through the Tricarboxylic Acid Cycle in Human Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO LIPOGENESIS; GLUCOSE-PRODUCTION; GLUCONEOGENESIS; IMPROVES; FLUXES	Drugs and other interventions for high impact hepatic diseases often target biochemical pathways such as gluconeogenesis, lipogenesis, or the metabolic response to oxidative stress. However, traditional liver function tests do not provide quantitative data about these pathways. In this study, we developed a simple method to evaluate these processes by NMR analysis of plasma metabolites. Healthy subjects ingested [U-C-13(3)]glycerol, and blood was drawn at multiple times. Each subject completed three visits under differing nutritional states. High resolution C-13 NMR spectra of plasma triacylglycerols and glucose provided new insights into a number of hepatic processes including fatty acid esterification, the pentose phosphate pathway, and gluconeogenesis through the tricarboxylic acid cycle. Fasting stimulated pentose phosphate pathway activity and metabolism of [U-C-13(3)]glycerol in the tricarboxylic acid cycle prior to gluconeogenesis or glyceroneogenesis. Fatty acid esterification was transient in the fasted state but continuous under fed conditions. We conclude that a simple NMR analysis of blood metabolites provides an important biomarker of pentose phosphate pathway activity, triacylglycerol synthesis, and flux through anaplerotic pathways in mitochondria of human liver.	[Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Jin, Eunsook S.; Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sherry, A. Dean; Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75080 USA; [Malloy, Craig R.] VA North Texas Hlth Care Syst, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Jin, ES (corresponding author), Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eunsook.jin@utsouthwestern.edu	Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Malloy, Craig/0000-0001-5077-0642	National Institutes of Health [DK099289, DK058398, EB015908, HL34557]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034557, R01HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, R01DK099289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK099289 (to E. S. J.), DK058398 and EB015908 (to C. R. M.), and HL34557 (to A. D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; Auger C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00040; Bock G, 2008, DIABETES, V57, P50, DOI 10.2337/db07-0694; Browning JD, 2008, HEPATOLOGY, V48, P1487, DOI 10.1002/hep.22504; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Federico A, 2014, WORLD J GASTROENTERO, V20, P16841, DOI 10.3748/wjg.v20.i45.16841; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Goulet Eric D. B., 2008, Journal of Physiological Anthropology, V27, P263, DOI 10.2114/jpa2.27.263; Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jin ES, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.577692; Jin ES, 2015, J CLIN ENDOCR METAB, V100, P235, DOI 10.1210/jc.2014-2404; Jin ES, 2013, J BIOL CHEM, V288, P14488, DOI 10.1074/jbc.M113.461947; Lee WS, 2007, SEMIN LIVER DIS, V27, P259, DOI 10.1055/s-2007-985071; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; MAGNUSSON I, 1988, P NATL ACAD SCI USA, V85, P4682, DOI 10.1073/pnas.85.13.4682; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Massicotte D, 2006, EUR J APPL PHYSIOL, V96, P322, DOI 10.1007/s00421-005-0058-8; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Pawlyk AC, 2014, DIABETES, V63, P2590, DOI 10.2337/db13-1367; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Sumida Y, 2014, WORLD J GASTROENTERO, V20, P475, DOI 10.3748/wjg.v20.i2.475; Takahashi Y, 2015, WORLD J GASTROENTERO, V21, P3777, DOI 10.3748/wjg.v21.i13.3777; Ugochukwu NH, 2007, CHEM-BIOL INTERACT, V165, P45, DOI 10.1016/j.cbi.2006.10.008; Van Rosendal SP, 2012, MED SCI SPORT EXER, V44, P1780, DOI 10.1249/MSS.0b013e31825420f4	27	13	15	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19031	19041		10.1074/jbc.M116.742262	http://dx.doi.org/10.1074/jbc.M116.742262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432878	hybrid, Green Published			2022-12-28	WOS:000383242300037
J	Chang, I; Wang, CY				Chang, Insoon; Wang, Cun-Yu			Inhibition of HDAC6 Protein Enhances Bortezomib-induced Apoptosis in Head and Neck Squamous Cell Carcinoma (HNSCC) by Reducing Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; autophagy; head and neck squamous cell carcinoma (HNSCC); proteasome; protein aggregation; signal transduction; signaling	ENDOPLASMIC-RETICULUM STRESS; BREAST-CANCER CELLS; PROTEASOME INHIBITOR; HISTONE DEACETYLASES; AGGRESOME FORMATION; PS-341; RESISTANCE; ULK1; PHOSPHORYLATION; MECHANISMS	Chemoresistance is a major barrier to effective chemotherapy of solid tumors, including head and neck squamous cell carcinoma (HNSCC). Recently, autophagy, a highly conservative intracellular recycling system, has shown to be associated with chemoresistance in cancer cells. However, little is known about how autophagy plays a role in the development of chemoresistance in HNSCC and how autophagy is initiated when HNSCC cells undergo cytotoxic stress. Here, we report that autophagy was activated when HNSCC cells are treated with the proteasome inhibitor bortezomib, proposed as an alternative chemotherapeutic agent for both primary and cisplatin-resistant HNSCC cells. Ablation of histone deacetylase 6 (HDAC6) expression and its activity in HNSCC cells significantly inhibited autophagy induction by altering the phosphorylation status of mammalian target of rapamycin and enhanced the bortezomib cytotoxicity. Similarly, a combination regimen of bortezomib and the histone deacetylase inhibitor trichostatin A abolished HDAC6 activity and decreased autophagy induction while significantly enhancing bortezomib-induced apoptosis in HNSCC cells. These data uncover a novel molecular mechanism indicating that HDAC6 may serve as a critical causal link between autophagy, apoptosis, and the cell survival response in HNSCC. A combination regimen resulting in regression of autophagy improves chemotherapeutic efficacy, thereby providing a new strategy to overcome chemoresistance and to improve the treatment and survival of HNSCC patients.	[Chang, Insoon; Wang, Cun-Yu] Univ Calif Los Angeles, Div Oral Biol & Med, Sch Dent, CHS 33-030,10833 Le Conte Ave, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, CY (corresponding author), Univ Calif Los Angeles, Div Oral Biol & Med, Sch Dent, CHS 33-030,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	cwang@dentistry.ucla.edu			National Institutes of Health Shared Resources from NCRR [CJX1-443835-WS-29646]; National Science Foundation Major Research Instrumentation Grant [CHE-0722519]; National Institutes of Health [P30 CA016042, 5P30AI028697]; Jonsson Comprehensive Cancer Center; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; UCLA Chancellor's Office; UCLA Vice Chancellor's Office of Research; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013848, R01DE023874, F30DE025159, R01DE015964] Funding Source: NIH RePORTER	National Institutes of Health Shared Resources from NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Major Research Instrumentation Grant(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonsson Comprehensive Cancer Center; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); UCLA Chancellor's Office; UCLA Vice Chancellor's Office of Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Confocal laser scanning microscopy was performed at the California NanoSystems Institute's Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA, supported with funding by National Institutes of Health Shared Resources Grant CJX1-443835-WS-29646 from NCRR and National Science Foundation Major Research Instrumentation Grant CHE-0722519. Flow cytometry was performed at UCLA and Center for AIDS Research Flow Cytometry Core Facility, supported by National Institutes of Health Awards P30 CA016042 and 5P30AI028697, and by the Jonsson Comprehensive Cancer Center, the UCLA AIDS Institute, the David Geffen School of Medicine at UCLA, the UCLA Chancellor's Office, and the UCLA Vice Chancellor's Office of Research.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Caravita T, 2006, NAT CLIN PRACT ONCOL, V3, P374, DOI 10.1038/ncponc0555; Chung CH, 2010, ANN ONCOL, V21, P864, DOI 10.1093/annonc/mdp390; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Gilbert J, 2013, HEAD NECK-J SCI SPEC, V35, P942, DOI 10.1002/hed.23046; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim J, 2010, MOL CANCER THER, V9, P1977, DOI 10.1158/1535-7163.MCT-10-0141; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kramer OH, 2014, TRENDS PHARMACOL SCI, V35, P501, DOI 10.1016/j.tips.2014.08.001; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li CY, 2012, CANCER LETT, V314, P102, DOI 10.1016/j.canlet.2011.09.020; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moriya S, 2015, INT J ONCOL, V46, P474, DOI 10.3892/ijo.2014.2773; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; Pulte D, 2010, ONCOLOGIST, V15, P994, DOI 10.1634/theoncologist.2009-0289; Rikiishi Hidemi, 2010, Cancers (Basel), V2, P2026, DOI 10.3390/cancers2042026; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sakuma T, 2006, INT J ONCOL, V29, P117; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Selimovic D, 2013, CELL SIGNAL, V25, P308, DOI 10.1016/j.cellsig.2012.10.004; Shvets E, 2009, METHOD ENZYMOL, V452, P131, DOI 10.1016/S0076-6879(08)03609-4; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Sun WL, 2011, AUTOPHAGY, V7, P1035, DOI 10.4161/auto.7.9.16521; Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Verfaillie Tom, 2010, Int J Cell Biol, V2010, P930509, DOI 10.1155/2010/930509; Vincenz L, 2013, MOL CANCER THER, V12, P831, DOI 10.1158/1535-7163.MCT-12-0782; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Yan MM, 2015, ONCOL LETT, V10, P1959, DOI 10.3892/ol.2015.3508; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031601; Yao YL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/146493; Zhu Keyi, 2009, Proceedings of the American Association for Cancer Research Annual Meeting, V50, P451, DOI 10.1038/onc.2009.343; Zhu T, 2016, NEUROBIOL AGING, V37, P91, DOI 10.1016/j.neurobiolaging.2015.09.021	53	24	25	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18199	18209		10.1074/jbc.M116.717793	http://dx.doi.org/10.1074/jbc.M116.717793			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27369083	Green Published, hybrid			2022-12-28	WOS:000383241800013
J	Grabinska, KA; Park, EJ; Sessa, WC				Grabinska, Kariona A.; Park, Eon Joo; Sessa, William C.			cis-Prenyltransferase: New Insights into Protein Glycosylation, Rubber Synthesis, and Human Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						enzyme; genetic disease; glycosylation; glycosylphosphatidylinositol (GPI anchor); lipid; dolichol; polyprenol; cis-prenyltransferase; polyprenol synthesis; NgBR; hCIT; NUS1; RER2; DHDDS	NOGO-B RECEPTOR; UNDECAPRENYL-PYROPHOSPHATE SYNTHASE; YEAST SACCHAROMYCES-CEREVISIAE; CHAIN-LENGTH DETERMINATION; DIPHOSPHATE SYNTHASE; DOLICHOL BIOSYNTHESIS; MICROCOCCUS-LUTEUS; LINKED OLIGOSACCHARIDES; DETERMINATION MECHANISM; PRODUCT SPECIFICITY	cis-Prenyltransferases (cis-PTs) constitute a large family of enzymes conserved during evolution and present in all domains of life. cis-PTs catalyze consecutive condensation reactions of allylic diphosphate acceptor with isopentenyl diphosphate (IPP) in the cis (Z) configuration to generate linear polyprenyl diphosphate. The chain lengths of isoprenoid carbon skeletons vary widely from neryl pyrophosphate (C-10) to natural rubber (C->10,C-000). The homo-dimeric bacterial enzyme, undecaprenyl diphosphate synthase (UPPS), has been structurally and mechanistically characterized in great detail and serves as a model for understanding the mode of action of eukaryotic cis-PTs. However, recent experiments have revealed that mammals, fungal, and long-chain plant cis-PTs are heteromeric enzymes composed of two distantly related subunits. In this review, the classification, function, and evolution of cis-PTs will be discussed with a special emphasis on the role of the newly described NgBR/Nus1 subunit and its plants' orthologs as essential, structural components of the cis-PTs activity.	Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA; Yale Univ, Sch Med, Vasc Biol & Therapeut Program VBT, 333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University	Sessa, WC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, Vasc Biol & Therapeut Program, Amistad Res Bldg,10 Amistad St, New Haven, CT 06520 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938; Grabinska, Kariona A./0000-0002-1232-2555	National Institutes of Health [R01 HL64793, R01 HL61371, R01 HL081190, RO1 HL133018]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064793, R01HL133018, R01HL081190, R01HL061371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL64793, R01 HL61371, R01 HL081190, and RO1 HL133018 (to W. C. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; ADAIR WL, 1987, ARCH BIOCHEM BIOPHYS, V259, P589; ADAIR WL, 1984, J BIOL CHEM, V259, P4441; Akhtar TA, 2013, PLANT J, V73, P640, DOI 10.1111/tpj.12063; ALLEN CM, 1976, ARCH BIOCHEM BIOPHYS, V175, P236, DOI 10.1016/0003-9861(76)90504-X; Ambo T, 2008, BIOCHEM BIOPH RES CO, V375, P536, DOI 10.1016/j.bbrc.2008.08.057; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Apfel CM, 1999, J BACTERIOL, V181, P483, DOI 10.1128/JB.181.2.483-492.1999; BABA T, 1980, ARCH BIOCHEM BIOPHYS, V200, P474, DOI 10.1016/0003-9861(80)90379-3; Barba C, 2016, DEV MED CHILD NEUROL, V58, P1085, DOI 10.1111/dmcn.13141; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Brasher MI, 2015, PLANT J, V82, P903, DOI 10.1111/tpj.12859; Chan HC, 2014, J AM CHEM SOC, V136, P2892, DOI 10.1021/ja413127v; Chang SY, 2004, PROTEIN SCI, V13, P971, DOI 10.1110/ps.03519904; Chang SY, 2003, J BIOL CHEM, V278, P29298, DOI 10.1074/jbc.M302687200; Chen YH, 2002, J BIOL CHEM, V277, P7369, DOI 10.1074/jbc.M110014200; CHRISTENSON JG, 1969, J BIOL CHEM, V244, P5436; Demissie ZA, 2013, J BIOL CHEM, V288, P6333, DOI 10.1074/jbc.M112.431171; Epping J, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.48; ERICSSON J, 1991, EUR J BIOCHEM, V202, P789, DOI 10.1111/j.1432-1033.1991.tb16434.x; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grabinska K, 2005, ACTA BIOCHIM POL, V52, P221; Grabinska KA, 2010, GLYCOBIOLOGY, V20, P824, DOI 10.1093/glycob/cwq036; Grabowska D, 1998, FEBS LETT, V434, P406, DOI 10.1016/S0014-5793(98)01019-9; Haeuptle MA, 2011, J BIOL CHEM, V286, P6085, DOI 10.1074/jbc.M110.165795; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Harrison KD, 2009, CELL METAB, V10, P208, DOI 10.1016/j.cmet.2009.07.003; Hemmi H, 2001, J BACTERIOL, V183, P401, DOI 10.1128/JB.183.1.401-404.2001; HIGASHI Y, 1967, P NATL ACAD SCI USA, V57, P1878, DOI 10.1073/pnas.57.6.1878; Jones J, 2005, BIOCHEM BIOPH RES CO, V331, P379, DOI 10.1016/j.bbrc.2005.03.181; Jozsef L, 2014, J BIOL CHEM, V289, P9380, DOI 10.1074/jbc.M114.548602; Kang JH, 2014, PLANT PHYSIOL, V164, P80, DOI 10.1104/pp.113.230466; Karnkowska A, 2016, CURR BIOL, V26, P1274, DOI 10.1016/j.cub.2016.03.053; Kato JI, 1999, J BACTERIOL, V181, P2733, DOI 10.1128/JB.181.9.2733-2738.1999; Kaur D, 2004, J BACTERIOL, V186, P7564, DOI 10.1128/JB.186.22.7564-7570.2004; Kera K, 2012, FEBS J, V279, P3813, DOI 10.1111/j.1742-4658.2012.08742.x; Kharel Y, 2006, FEBS J, V273, P647, DOI 10.1111/j.1742-4658.2005.05097.x; Kharel Y, 2001, J BIOL CHEM, V276, P28459, DOI 10.1074/jbc.M102057200; Ko TP, 2001, J BIOL CHEM, V276, P47474, DOI 10.1074/jbc.M106747200; Konrad M, 1996, BIOCHEM J, V316, P575, DOI 10.1042/bj3160575; KOYAMA T, 1988, J BIOCHEM-TOKYO, V103, P867, DOI 10.1093/oxfordjournals.jbchem.a122363; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwon M, 2016, METHOD ENZYMOL, V576, P121, DOI 10.1016/bs.mie.2016.02.026; LENNON K, 1995, GLYCOBIOLOGY, V5, P633, DOI 10.1093/glycob/5.6.633; Liu MX, 2016, ANGEW CHEM INT EDIT, V55, P4721, DOI 10.1002/anie.201600656; Magnelli P, 2008, J BIOL CHEM, V283, P18355, DOI 10.1074/jbc.M800725200; Martinez JA, 2000, ADV EXP MED BIOL, V476, P197; MATSUOKA S, 1991, J BIOL CHEM, V266, P3464; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Milani D, 2016, CONGENIT ANOM, V56, P187, DOI 10.1111/cga.12164; Mori T, 2013, BIOCHEM BIOPH RES CO, V436, P230, DOI 10.1016/j.bbrc.2013.05.081; Noike M, 2008, BIOCHEM BIOPH RES CO, V377, P17, DOI 10.1016/j.bbrc.2008.09.014; Ogawa T, 2016, FEBS J, V283, P2369, DOI 10.1111/febs.13749; Park EJ, 2016, EMBO REP, V17, P167, DOI 10.15252/embr.201540789; Park EJ, 2014, CELL METAB, V20, P448, DOI 10.1016/j.cmet.2014.06.016; Perlinska-Lenart U, 2006, FUNGAL GENET BIOL, V43, P422, DOI 10.1016/j.fgb.2006.01.009; Pilsyk S, 2014, GENE, V544, P114, DOI 10.1016/j.gene.2014.04.073; Poznanski J, 2007, BIOPOLYMERS, V86, P155, DOI 10.1002/bip.20715; Pula B, 2014, ANTICANCER RES, V34, P4059; Qu Y, 2015, J BIOL CHEM, V290, P1898, DOI 10.1074/jbc.M114.616920; Rohmer Michel, 2004, Curr Opin Investig Drugs, V5, P154; Sato M, 2001, GENES CELLS, V6, P495, DOI 10.1046/j.1365-2443.2001.00438.x; Sato M, 1999, MOL CELL BIOL, V19, P471; Schenk B, 2001, GLYCOBIOLOGY, V11, P89, DOI 10.1093/glycob/11.1.89; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Schulbach MC, 2000, J BIOL CHEM, V275, P22876, DOI 10.1074/jbc.M003194200; Shimizu N, 1998, J BIOL CHEM, V273, P19476, DOI 10.1074/jbc.273.31.19476; Shridas P, 2003, BIOCHEM BIOPH RES CO, V312, P1349, DOI 10.1016/j.bbrc.2003.11.065; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Surmacz L, 2015, BBA-MOL CELL BIOL L, V1851, P1296, DOI 10.1016/j.bbalip.2015.06.006; Surmacz L, 2014, BBA-MOL CELL BIOL L, V1841, P240, DOI 10.1016/j.bbalip.2013.11.011; Szafranski P, 2015, EUR J HUM GENET, V23, P173, DOI 10.1038/ejhg.2014.75; Szkopinska A, 1997, J LIPID RES, V38, P962; Taguchi Y, 2016, J BIOL CHEM, V291, P11042, DOI 10.1074/jbc.M115.713156; TAKAHASHI I, 1982, J BIOCHEM-TOKYO, V92, P1527, DOI 10.1093/oxfordjournals.jbchem.a134077; Takahashi S, 2006, CHEM REC, V6, P194, DOI 10.1002/tcr.20083; Teng KH, 2012, BIOORG CHEM, V43, P51, DOI 10.1016/j.bioorg.2011.09.004; Troutman JM, 2015, BIOCHEMISTRY-US, V54, P2817, DOI 10.1021/acs.biochem.5b00310; Wallrapp FH, 2013, P NATL ACAD SCI USA, V110, pE1196, DOI 10.1073/pnas.1300632110; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078083; Wang W, 2008, J MOL BIOL, V381, P129, DOI 10.1016/j.jmb.2008.05.060; Wen R, 2013, J LIPID RES, V54, P3516, DOI 10.1194/jlr.M043232; WRIGHT A, 1967, P NATL ACAD SCI USA, V57, P1798, DOI 10.1073/pnas.57.6.1798; Yamada Y, 2009, J BIOTECHNOL, V143, P151, DOI 10.1016/j.jbiotec.2009.06.026; Yu L, 2006, MOL BIOL CELL, V17, P4736, DOI 10.1091/mbc.E06-04-0368; Zelinger L, 2011, AM J HUM GENET, V88, P207, DOI 10.1016/j.ajhg.2011.01.002; Zhang HR, 2008, PLANT CELL, V20, P1879, DOI 10.1105/tpc.108.061150; Zhu W, 2013, P NATL ACAD SCI USA, V110, P123, DOI 10.1073/pnas.1219899110; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	90	47	48	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18582	18590		10.1074/jbc.R116.739490	http://dx.doi.org/10.1074/jbc.R116.739490			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402831	Green Published, hybrid			2022-12-28	WOS:000383241800046
J	Wessel, SR; Cornilescu, CC; Cornilescu, G; Metz, A; Leroux, M; Hu, KF; Sandler, SJ; Markley, JL; Keck, JL				Wessel, Sarah R.; Cornilescu, Claudia C.; Cornilescu, Gabriel; Metz, Alice; Leroux, Maxime; Hu, Kaifeng; Sandler, Steven J.; Markley, John L.; Keck, James L.			Structure and Function of the PriC DNA Replication Restart Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA replication; DNA-protein interaction; nuclear magnetic resonance (NMR); protein-protein interaction; DNA replication restart; DnaB helicase; PriC; single-stranded DNA-binding protein	N-TERMINAL DOMAIN; ESCHERICHIA-COLI; BINDING PROTEIN; PRIMOSOME FACTOR; FORKS; INITIATION; COMPLEX; POLYMERASE; HELICASE; DYNAMICS	Collisions between DNA replication complexes (replisomes) and barriers such as damaged DNA or tightly bound protein complexes can dissociate replisomes from chromosomes prematurely. Replisomes must be reloaded under these circumstances to avoid incomplete replication and cell death. Bacteria have evolved multiple pathways that initiate DNA replication restart by recognizing and remodeling abandoned replication forks and reloading the replicative helicase. In vitro, the simplest of these pathways is mediated by the single-domain PriC protein, which, along with the DnaC helicase loader, can load the DnaB replicative helicase onto DNA bound by the single-stranded DNA (ssDNA)-binding protein (SSB). Previous biochemical studies have identified PriC residues that mediate interactions with ssDNA and SSB. However, the mechanisms by which PriC drives DNA replication restart have remained poorly defined due to the limited structural information available for PriC. Here, we report the NMR structure of full-length PriC from Cronobacter sakazakii. PriC forms a compact bundle of -helices that brings together residues involved in ssDNA and SSB binding at adjacent sites on the protein surface. Disruption of these interaction sites and of other conserved residues leads to decreased DnaB helicase loading onto SSB-bound DNA. We also demonstrate that PriC can directly interact with DnaB and the DnaB<bold>DnaC complex</bold>. These data lead to a model in which PriC acts as a scaffold for recruiting DnaB<bold>DnaC to SSB</bold>/ssDNA sites present at stalled replication forks.	[Wessel, Sarah R.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA; [Cornilescu, Claudia C.; Cornilescu, Gabriel; Hu, Kaifeng; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Cornilescu, Claudia C.; Cornilescu, Gabriel; Hu, Kaifeng; Markley, John L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Metz, Alice; Leroux, Maxime; Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Hu, Kaifeng] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Grp Liquid State NMR, Kunming 650201, Yunnan, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA.	jlkeck@wisc.edu	Cornilescu, Gabriel/H-3113-2011; Cornilescu, Claudia/K-1981-2015	Cornilescu, Gabriel/0000-0002-1204-8904; Cornilescu, Claudia/0000-0002-2401-7806; Keck, James/0000-0002-5961-0220	NIGMS, National Institutes of Health [P41GM103399]; University of Wisconsin-Madison; National Institutes of Health [P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR008438, S10RR002781, P41RR002301, S10RR029220, S10RR023438, S10RR025062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098885, T32GM007215, P41GM103399] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin-Madison; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ken Satyshur for assistance with binding pocket volume analysis, Tricia Windgassen for assistance with two-hybrid experiments, and members of the Keck laboratory for critical reading of the manuscript. This study made use of the National Magnetic Resonance Facility at Madison, which is supported by NIGMS, National Institutes of Health, Grant P41GM103399 (old number: P41RR002301). Equipment was purchased with funds from the University of Wisconsin-Madison; National Institutes of Health Grants P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, and S10RR029220; National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394; and the United States Department of Agriculture.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aramaki T, 2015, J BIOCHEM, V157, P529, DOI 10.1093/jb/mvv014; Aramaki T, 2013, PROTEIN SCI, V22, P1279, DOI 10.1002/pro.2314; Aramaki T, 2013, GENES CELLS, V18, P723, DOI 10.1111/gtc.12069; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Grimwade JE, 2007, MOL MICROBIOL, V66, P428, DOI 10.1111/j.1365-2958.2007.05930.x; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YH, 2013, PROTEIN J, V32, P477, DOI 10.1007/s10930-013-9509-y; James P, 1996, GENETICS, V144, P1425; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kim S, 1996, J BIOL CHEM, V271, P4315; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kohlbacher O, 2000, BIOINFORMATICS, V16, P815, DOI 10.1093/bioinformatics/16.9.815; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Petzold C, 2015, J BIOL CHEM, V290, P14626, DOI 10.1074/jbc.M115.655134; Sandler SJ, 2000, GENETICS, V155, P487; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Tian Y, 2014, J MAGN RESON, V243, P54, DOI 10.1016/j.jmr.2014.03.011; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WAHLE E, 1989, J BIOL CHEM, V264, P2463; Wessel SR, 2013, J BIOL CHEM, V288, P17569, DOI 10.1074/jbc.M113.478156; Wuthrich K., 1986, NMR PROTEINS NUCL AC, V36, P180	44	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18384	18396		10.1074/jbc.M116.738781	http://dx.doi.org/10.1074/jbc.M116.738781			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382050	Green Published, hybrid			2022-12-28	WOS:000383241800029
J	Sun, T; Yi, HQ; Yang, CY; Kishnani, PS; Sun, BD				Sun, Tao; Yi, Haiqing; Yang, Chunyu; Kishnani, Priya S.; Sun, Baodong			Starch Binding Domain-containing Protein 1 Plays a Dominant Role in Glycogen Transport to Lysosomes in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE TYPE-II; POMPE-DISEASE; ADENOASSOCIATED VIRUS; SKELETAL-MUSCLE; NERVOUS-SYSTEM; GENE-THERAPY; METABOLISM; EXPRESSION; GABARAPL1; MODEL	A small portion of cellular glycogen is transported to and degraded in lysosomes by acid alpha-glucosidase (GAA) in mammals, but it is unclear why and how glycogen is transported to the lysosomes. Stbd1 has recently been proposed to participate in glycogen trafficking to lysosomes. However, our previous study demonstrated that knockdown of Stbd1 in GAA knockout mice did not alter lysosomal glycogen storage in skeletal muscles. To further determine whether Stbd1 participates in glycogen transport to lysosomes, we generated GAA/Stbd1 double knock-out mice. In fasted double knock-out mice, glycogen accumulation in skeletal and cardiac muscles was not affected, but glycogen content in liver was reduced by nearly 73% at 3 months of age and by 60% at 13 months as compared with GAA knock-out mice, indicating that the transport of glycogen to lysosomes was suppressed in liver by the loss of Stbd1. Exogenous expression of human Stbd1 in double knock-out mice restored the liver lysosomal glycogen content to the level of GAA knock-out mice, as did a mutant lacking the Atg8 family interacting motif (AIM) and another mutant that contains only the N-terminal 24 hydrophobic segment and the C-terminal starch binding domain (CBM20) interlinked by an HA tag. Our results demonstrate that Stbd1 plays a dominant role in glycogen transport to lysosomes in liver and that the N-terminal transmembrane region and the C-terminal CBM20 domain are critical for this function.	[Sun, Tao; Yi, Haiqing; Yang, Chunyu; Kishnani, Priya S.; Sun, Baodong] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, 905 LaSalle St,GSRB1 Bldg,Rm 4044,DUMC Box 103856, Durham, NC 27710 USA	Duke University	Sun, BD (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, 905 LaSalle St,GSRB1 Bldg,Rm 4044,DUMC Box 103856, Durham, NC 27710 USA.	baodong.sun@duke.edu	Liu, Wenjun/L-5256-2016	Liu, Wenjun/0000-0001-9380-2990; Yi, Haiqing/0000-0003-2254-6226	Alice and YT Chen Pediatrics Genetics; Genomics Research Center	Alice and YT Chen Pediatrics Genetics; Genomics Research Center	This work was supported by the Alice and YT Chen Pediatrics Genetics and Genomics Research Center. The authors declare that they have no conflicts of interest with the contents of this article.	Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; Bouju S, 1998, BIOCHEM J, V335, P549, DOI 10.1042/bj3350549; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; Chakrapani A, 2010, J INHERIT METAB DIS, V33, P747, DOI 10.1007/s10545-010-9206-3; de Vries JM, 2010, MOL GENET METAB, V101, P338, DOI 10.1016/j.ymgme.2010.08.009; GEDDES R, 1977, BIOCHEM J, V163, P193, DOI 10.1042/bj1630193; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Kishnani P. S., 2009, ONLINE METABOLIC MOL; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Kishnani PS, 2004, J PEDIATR-US, V144, pS35, DOI 10.1016/j.jpeds.2004.01.053; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Le Grand JN, 2011, AUTOPHAGY, V7, P1098, DOI 10.4161/auto.7.10.15904; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Melvin JJ, 2000, ARCH NEUROL-CHICAGO, V57, P134, DOI 10.1001/archneur.57.1.134; Nemos C, 2003, MOL BRAIN RES, V119, P216, DOI 10.1016/j.molbrainres.2003.09.011; Patel TT, 2012, MOL GENET METAB, V106, P301, DOI 10.1016/j.ymgme.2012.04.027; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben N, 2010, AUTOPHAGY, V6, P1078, DOI 10.4161/auto.6.8.13378; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Sun BD, 2008, MOL THER, V16, P1366, DOI 10.1038/mt.2008.133; Xu F, 2004, GENE THER, V11, P1590, DOI 10.1038/sj.gt.3302314; Yi HQ, 2013, MOL GENET METAB, V109, P312, DOI 10.1016/j.ymgme.2013.05.004; Yi HQ, 2012, DIS MODEL MECH, V5, P804, DOI 10.1242/dmm.009712; Zhu YQ, 2014, BIOSCIENCE REP, V34, P311, DOI 10.1042/BSR20140053	27	25	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16479	16484		10.1074/jbc.C116.741397	http://dx.doi.org/10.1074/jbc.C116.741397			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27358407	Green Published, hybrid			2022-12-28	WOS:000380826700008
J	Sung, B; Ravindran, J; Prasad, S; Pandey, MK; Aggarwal, BB				Sung, Bokyung; Ravindran, Jayaraj; Prasad, Sahdeo; Pandey, Manoj K.; Aggarwal, Bharat B.			RETRACTION: Gossypol induces death receptor-5 through activation of ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL (Retraction of vol 285, pg 35418, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767	1	7	8	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16923	16923		10.1074/jbc.A110.172767	http://dx.doi.org/10.1074/jbc.A110.172767			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27496964	Green Published, hybrid			2022-12-28	WOS:000380826700050
J	Hodge, K; Tunghirun, C; Kamkaew, M; Limjindaporn, T; Yenchitsomanus, PT; Chimnaronk, S				Hodge, Kenneth; Tunghirun, Chairat; Kamkaew, Maliwan; Limjindaporn, Thawornchai; Yenchitsomanus, Pa-thai; Chimnaronk, Sarin			Identification of a Conserved RNA-dependent RNA Polymerase (RdRp)-RNA Interface Required for Flaviviral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dengue virus (DENV); viral polymerase; viral protein; viral replication; virology; RNA-dependent RNA polymerase (RdRp); untranslated region (UTR); viral non-structural protein (NS) 5; yeast three-hybrid (Y3H)	YEAST 3-HYBRID SYSTEM; 3'-TERMINAL STEM-LOOP; 3 UNTRANSLATED REGION; C VIRUS POLYMERASE; DENGUE VIRUS; VIRAL-RNA; PROTEIN INTERACTIONS; CYCLIZATION SEQUENCES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE	Dengue virus, an approximate to 10.7-kb positive-sense RNA virus, is the most common arthropod-communicated pathogen in the world. Despite dengue's clear epidemiological importance, mechanisms for its replication remain elusive. Here, we probed the entire dengue genome for interactions with viral RNA-dependent RNA polymerase (RdRp), and we identified the dominant interaction as a loop-forming ACAG motif in the 3 positive-stranded terminus, complicating the prevailing model of replication. A subset of interactions coincides with known flaviviral recombination sites inside the viral protein-coding region. Specific recognition of the RNA element occurs via an arginine patch in the C-terminal thumb domain of RdRp. We also show that the highly conserved nature of the consensus RNA motif may relate to its tolerance to various mutations in the interacting region of RdRp. Disruption of the interaction resulted in loss of viral replication ability in cells. This unique RdRp-RNA interface is found throughout flaviviruses, implying possibilities for broad disease interventions.	[Hodge, Kenneth; Tunghirun, Chairat; Kamkaew, Maliwan; Chimnaronk, Sarin] Mahidol Univ, Inst Mol Biosci, Lab RNA Biol, Salaya Campus, Phutthamonthon 73170, Nakhon Pathom, Thailand; [Limjindaporn, Thawornchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok 10700, Thailand; [Yenchitsomanus, Pa-thai] Mahidol Univ, Siriraj Hosp, Fac Med, Div Mol Med,Dept Res & Dev, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University	Chimnaronk, S (corresponding author), Mahidol Univ, Inst Mol Biosci, Lab RNA Biol, Salaya Campus, Phutthamonthon 73170, Nakhon Pathom, Thailand.	sarin.chi@mahidol.ac.th			Mahidol University, Thailand; Thailand Research Fund [RSA5680054]	Mahidol University, Thailand; Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by grants-in-aid for scientific research from Mahidol University, Thailand (to S. C. and P. Y.), a senior research scholar grant from the Thailand Research Fund (to P. Y.), and Mid-Career Grant RSA5680054 from Thailand Research Fund (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Bernstein DS, 2002, METHODS, V26, P123, DOI 10.1016/S1046-2023(02)00015-4; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Chen SP, 2008, ARCH VIROL, V153, P1175, DOI 10.1007/s00705-008-0090-1; Cheng JC, 1999, J VIROL, V73, P7044, DOI 10.1128/JVI.73.8.7044-7049.1999; Choi KH, 2006, STRUCTURE, V14, P1107, DOI 10.1016/j.str.2006.05.020; Choksupmanee O, 2012, BIOCHEMISTRY-US, V51, P2840, DOI 10.1021/bi2018267; Chuang CK, 2009, VIROLOGY, V394, P286, DOI 10.1016/j.virol.2009.08.030; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; CUI T, 1995, NUCLEIC ACIDS RES, V23, P377, DOI 10.1093/nar/23.3.377; D'Agostino VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072426; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; DREHER TW, 1988, J MOL BIOL, V201, P31, DOI 10.1016/0022-2836(88)90436-6; Dyson MR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn151; Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hook B, 2005, RNA, V11, P227, DOI 10.1261/rna.7202705; Kamkaew M, 2015, PROTEIN EXPRES PURIF, V112, P43, DOI 10.1016/j.pep.2015.04.008; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; Karpala AJ, 2005, IMMUNOL CELL BIOL, V83, P211, DOI 10.1111/j.1440-1711.2005.01331.x; Khromykh AA, 2003, J VIROL, V77, P10623, DOI 10.1128/JVI.77.19.10623-10629.2003; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019447; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13; Oh JW, 2000, J BIOL CHEM, V275, P17710, DOI 10.1074/jbc.M908781199; Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Siegel RW, 1997, P NATL ACAD SCI USA, V94, P11238, DOI 10.1073/pnas.94.21.11238; SONG CZ, 1995, J MOL BIOL, V254, P6, DOI 10.1006/jmbi.1995.0594; Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203; Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022; Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410; Wurster SE, 2010, RNA, V16, P253, DOI 10.1261/rna.1880410; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	27	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17437	17449		10.1074/jbc.M116.724013	http://dx.doi.org/10.1074/jbc.M116.724013			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27334920	Green Published, hybrid			2022-12-28	WOS:000382643800042
J	Huang, SS; Su, WP; Lin, HP; Kuo, HL; Wei, HL; Chang, NS				Huang, Shenq-Shyang; Su, Wan-Pei; Lin, Hsin-Pin; Kuo, Hsiang-Ling; Wei, Hsiao-Ling; Chang, Nan-Shan			Role of WW Domain-containing Oxidoreductase WWOX in Driving T Cell Acute Lymphoblastic Leukemia Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; extracellular-signal-regulated kinase (ERK); lymphocyte; phorbol ester; phosphorylation; tumor suppressor gene	NF-KAPPA-B; TUMOR-SUPPRESSOR WWOX; TIAF1 SELF-AGGREGATION; POTENTIAL ROLE; PHORBOL ESTER; IN-VITRO; THYMOCYTE DEVELOPMENT; PHYSICALLY INTERACTS; POSITIVE SELECTION; ALZHEIMERS-DISEASE	Whether tumor suppressor WWOX (WW domain-containing oxidoreductase) stimulates immune cell maturation is largely unknown. Here, we determined that Tyr-33-phosphorylated WWOX physically binds non-phosphorylated ERK and I kappa B alpha in immature acute lymphoblastic leukemia MOLT-4 T cells and in the naive mouse spleen. The I kappa B alpha center dot ERK center dot WWOX complex was shown to localize, in part, in the mitochondria. WWOX prevents I kappa B alpha from proteasomal degradation. Upon stimulating MOLT-4 with ionophore A23187/phorbol myristate acetate, endogenous I kappa B alpha and ERK undergo rapid phosphorylation in < 5 min, and subsequently WWOX is Tyr-33 and Tyr-287 de-phosphorylated and Ser-14 phosphorylated. Three hours later, I kappa B alpha starts to degrade, and ERK returns to basal or non-phosphorylation, and this lasts for the next 12 h. Finally, expression of CD3 and CD8 occurs in MOLT-4 along with reappearance of the I kappa B alpha center dot ERK center dot WWOX complex near 24 h. Inhibition of ERK phosphorylation by U0126 or I kappa B alpha degradation by MG132 prevents MOLT-4 maturation. By time-lapse FRET microscopy, I kappa B alpha center dot ERK center dot WWOX complex exhibits an increased binding strength by 1-2-fold after exposure to ionophore A23187/phorbol myristate acetate for 15-24 h. Meanwhile, a portion of ERK and WWOX relocates to the nucleus, suggesting their role in the induction of CD3 and CD8 expression in MOLT-4.	[Huang, Shenq-Shyang; Su, Wan-Pei; Lin, Hsin-Pin; Kuo, Hsiang-Ling; Wei, Hsiao-Ling; Chang, Nan-Shan] Natl Cheng Kung Univ, Inst Mol Med, Tainan 70101, Taiwan; [Chang, Nan-Shan] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chang, Nan-Shan] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Tainan 70101, Taiwan; [Chang, Nan-Shan] New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA; [Chang, Nan-Shan] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Chang, Nan-Shan] China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung 40402, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Institute for Basic Research in Developmental Disabilities; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; China Medical University Taiwan	Chang, NS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Lab Mol Immunol, Tainan, Taiwan.	nschang13827@gmail.com		Huang, Shenq-Shyang/0000-0001-8476-3141	United States Department of Defense [W81XWH-08-1-0682]; Ministry of Science and Education, Taiwan, ROC [NSC99-2320-B-006-012-MY3, 102-2320-B-006-018-, 102-2320-B-006-030-, 102-3011-P-006-005-]; National Health Research Institute, Taiwan, ROC [NHRI-EX99-9704BI]	United States Department of Defense(United States Department of Defense); Ministry of Science and Education, Taiwan, ROC; National Health Research Institute, Taiwan, ROC(National Health Research Institutes - Taiwan)	This work was supported by the United States Department of Defense (W81XWH-08-1-0682), the Ministry of Science and Education, Taiwan, ROC (NSC99-2320-B-006-012-MY3, 102-2320-B-006-018-, 102-2320-B-006-030-, and 102-3011-P-006-005-), and the National Health Research Institute, Taiwan, ROC (NHRI-EX99-9704BI) (to N.-S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Remaileh M, 2015, J BIOL CHEM, V290, P30728, DOI 10.1074/jbc.R115.676346; Abu-Remaileh M, 2015, EXP BIOL MED, V240, P345, DOI 10.1177/1535370214561956; Anderson G, 2014, CURR TOP MICROBIOL, V373, P19, DOI 10.1007/82_2013_320; Bakker TR, 1999, J IMMUNOL, V162, P3456; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Chang HT, 2014, ONCOTARGET, V5, P11792, DOI 10.18632/oncotarget.2961; Chang JY, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.3; Chang JY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.36; Chang JY, 2010, EXP BIOL MED, V235, P796, DOI 10.1258/ebm.2010.009351; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 2015, EXP BIOL MED, V240, P281, DOI 10.1177/1535370215574226; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2005, ONCOGENE, V24, P714, DOI 10.1038/sj.onc.1208124; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; Chang NS, 2002, J BIOL CHEM, V277, P10323, DOI 10.1074/jbc.M106607200; Chang NS, 2002, INT J MOL MED, V9, P19; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chang Y, 2015, EXP BIOL MED, V240, P329, DOI 10.1177/1535370214561957; Chen SJ, 2015, ONCOTARGET, V6, P8007, DOI 10.18632/oncotarget.3153; Chen Szu-Jung, 2013, Transl Respir Med, V1, P15, DOI 10.1186/2213-0802-1-15; Choo A, 2015, GENE CHROMOSOME CANC, V54, P745, DOI 10.1002/gcc.22286; Dodson EJ, 2015, EXP BIOL MED, V240, P351, DOI 10.1177/1535370214566558; Ferguson BW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-593; Gibbings DJ, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-12; He HC, 1999, CELL GROWTH DIFFER, V10, P307; Hettmann T, 2000, J IMMUNOL, V165, P5004, DOI 10.4049/jimmunol.165.9.5004; Hong QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005755; Hsu LJ, 2008, CELL SIGNAL, V20, P1303, DOI 10.1016/j.cellsig.2008.02.018; Hsu LJ, 2009, J BIOL CHEM, V284, P16049, DOI 10.1074/jbc.M806688200; Iessi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126526; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Lai FJ, 2005, CLIN CANCER RES, V11, P5769, DOI 10.1158/1078-0432.CCR-04-2274; Lee MH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.83; Li MY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007820; Lin Hsin-Ping, 2011, Genes Cancer, V2, P550, DOI 10.1177/1947601911418498; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Martin-Blanco NM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.438; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Reuven N, 2015, EXP BIOL MED, V240, P375, DOI 10.1177/1535370214565991; Schrock MS, 2015, EXP BIOL MED, V240, P296, DOI 10.1177/1535370214561590; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sze CI, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.251; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Takahama Y, 1996, J IMMUNOL, V157, P1508; Tanahashi M, 2001, HUM IMMUNOL, V62, P771, DOI 10.1016/S0198-8859(01)00276-2; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; VANDONGEN JJM, 1988, BLOOD, V71, P603; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Zhu MX, 2015, EXP CELL RES, V331, P387, DOI 10.1016/j.yexcr.2014.12.012; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4	54	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17319	17331		10.1074/jbc.M116.716167	http://dx.doi.org/10.1074/jbc.M116.716167			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339895	Green Published, hybrid			2022-12-28	WOS:000382643800032
J	Campbell, SJ; Stern, DB				Campbell, Stephen J.; Stern, David B.			Activation of an Endoribonuclease by Non-intein Protein Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSBA MESSENGER-RNA; CHLAMYDOMONAS-REINHARDTII; POLY(A)-BINDING PROTEIN; CHLOROPLAST; TRANSLATION; GENES; DEGRADATION; EXPRESSION; RB47	The Chlamydomonas reinhardtii chloroplast-localized poly(A)-binding protein RB47 is predicted to contain a non-conserved linker (NCL) sequence flanked by highly conserved N-and C-terminal sequences, based on the corresponding cDNA. RB47 was purified from chloroplasts in association with an endoribonuclease activity; however, protein sequencing failed to detect the NCL. Furthermore, while recombinant RB47 including the NCL did not display endoribonuclease activity in vitro, versions lacking the NCL displayed strong activity. Both full-length and shorter forms of RB47 could be detected in chloroplasts, with conversion to the shorter form occurring in chloroplasts isolated from cells grown in the light. This conversion could be replicated in vitro in chloroplast extracts in a light-dependent manner, where epitope tags and protein sequencing showed that the NCL was excised from a full-length recombinant substrate, together with splicing of the flanking sequences. The requirement for endogenous factors and light differentiates this protein splicing from autocatalytic inteins, and may allow the chloroplast to regulate the activation of RB47 endoribonuclease activity. We speculate that this protein splicing activity arose to post-translationally repair proteins that had been inactivated by deleterious insertions or extensions.	[Campbell, Stephen J.; Stern, David B.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research	Stern, DB (corresponding author), Boyce Thompson Inst Plant Res, 533 Tower Rd, Ithaca, NY 14853 USA.	ds28@cornell.edu	Stern, David B/H-7852-2012	Stern, David/0000-0002-0653-6602	National Science Foundation [MCB-1244106]; Direct For Biological Sciences [1244106] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation award MCB-1244106. The authors declare that they have no conflicts of interest with the contents of this article.	Alergand T, 2006, PLANT CELL PHYSIOL, V47, P540, DOI 10.1093/pcp/pcj023; Barkan A, 2011, PLANT PHYSIOL, V155, P1520, DOI 10.1104/pp.110.171231; Bouabe H., 2008, J PROTEOM BIOINFORM, V1, P336; Bruick RK, 1998, J CELL BIOL, V143, P1145, DOI 10.1083/jcb.143.5.1145; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; DANON A, 1994, EMBO J, V13, P2227, DOI 10.1002/j.1460-2075.1994.tb06500.x; DANON A, 1991, EMBO J, V10, P3993, DOI 10.1002/j.1460-2075.1991.tb04974.x; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; Derrien B, 2009, J BIOL CHEM, V284, P15408, DOI 10.1074/jbc.M109.002733; FONG SE, 1992, CURR GENET, V21, P485, DOI 10.1007/BF00351659; FONG SE, 1992, CURR GENET, V21, P527, DOI 10.1007/BF00351664; Germain A, 2013, WIRES RNA, V4, P295, DOI 10.1002/wrna.1161; Hicks A, 2002, J BIOL CHEM, V277, P3325, DOI 10.1074/jbc.M108979200; KLEIN U, 1983, PLANT PHYSIOL, V72, P481, DOI 10.1104/pp.72.2.481; Lange H, 2009, TRENDS PLANT SCI, V14, P497, DOI 10.1016/j.tplants.2009.06.007; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Mason CB, 2006, NAT PROTOC, V1, P2227, DOI 10.1038/nprot.2006.348; Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Smith RWP, 2010, BIOCHEM J, V426, P1, DOI 10.1042/BJ20091571; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; STERN DB, 1993, MOL CELL BIOL, V13, P2277, DOI 10.1128/MCB.13.4.2277; Stoppel R, 2012, J EXP BOT, V63, P1663, DOI 10.1093/jxb/err401; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; Yohn CB, 1998, J CELL BIOL, V142, P435, DOI 10.1083/jcb.142.2.435; Yohn CB, 1996, MOL CELL BIOL, V16, P3560; Yohn CB, 1998, P NATL ACAD SCI USA, V95, P2238, DOI 10.1073/pnas.95.5.2238	30	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15911	15922		10.1074/jbc.M116.727768	http://dx.doi.org/10.1074/jbc.M116.727768			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27311716	Green Published, hybrid			2022-12-28	WOS:000380585400001
J	Chan, MC; Ilott, NE; Schodel, J; Sims, D; Tumber, A; Lippl, K; Mole, DR; Pugh, CW; Ratcliffe, PJ; Ponting, CP; Schofield, CJ				Chan, Mun Chiang; Ilott, Nicholas E.; Schoedel, Johannes; Sims, David; Tumber, Anthony; Lippl, Kerstin; Mole, David R.; Pugh, Christopher W.; Ratcliffe, Peter J.; Ponting, Chris P.; Schofield, Christopher J.			Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythropoiesis; hydroxylase; hypoxia; hypoxia-inducible factor (HIF); inhibitor; 2-oxoglutarate and ferrous iron dioxygenase; anaemia; metallo-enzyme inhibitor; oxygen sensing; transcriptional regulation	STRUCTURAL BASIS; HISTONE DEMETHYLASES; FACTOR (HIF)-1-ALPHA; FACTOR-ALPHA; TRANSACTIVATION DOMAIN; ROXADUSTAT FG-4592; GENE-EXPRESSION; OXYGEN SENSOR; BINDING SITES; TARGET GENES	The hypoxia-inducible factor (HIF) system orchestrates cellular responses to hypoxia in animals. HIF is an /-heterodimeric transcription factor that regulates the expression of hundreds of genes in a tissue context-dependent manner. The major hypoxia-sensing component of the HIF system involves oxygen-dependent catalysis by the HIF hydroxylases; in humans there are three HIF prolyl hydroxylases (PHD1-3) and an asparaginyl hydroxylase (factor-inhibiting HIF (FIH)). PHD catalysis regulates HIF levels, and FIH catalysis regulates HIF activity. How differences in HIF hydroxylation status relate to variations in the induction of specific HIF target gene transcription is unknown. We report studies using small molecule HIF hydroxylase inhibitors that investigate the extent to which HIF target gene expression is induced by PHD or FIH inhibition. The results reveal substantial differences in the role of prolyl and asparaginyl hydroxylation in regulating hypoxia-responsive genes in cells. PHD inhibitors with different structural scaffolds behave similarly. Under the tested conditions, a broad-spectrum 2-oxoglutarate dioxygenase inhibitor is a better mimic of the overall transcriptional response to hypoxia than the selective PHD inhibitors, consistent with an important role for FIH in the hypoxic transcriptional response. Indeed, combined application of selective PHD and FIH inhibitors resulted in the transcriptional induction of a subset of genes not fully responsive to PHD inhibition alone. Thus, for the therapeutic regulation of HIF target genes, it is important to consider both PHD and FIH activity, and in the case of some sets of target genes, simultaneous inhibition of the PHDs and FIH catalysis may be preferable.	[Chan, Mun Chiang; Lippl, Kerstin; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Chan, Mun Chiang; Schoedel, Johannes; Mole, David R.; Pugh, Christopher W.; Ratcliffe, Peter J.] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford OX3 7BN, England; [Ilott, Nicholas E.; Sims, David; Ponting, Chris P.] Univ Oxford, MRC Funct Genom Unit, Dept Physiol Anat & Genet, Computat Genom Anal & Training Programme, South Parks Rd, Oxford OX1 3PT, England; [Tumber, Anthony] Univ Oxford, Target Discovery Inst, Oxford OX3 7FZ, England; [Ilott, Nicholas E.] Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Headington OX3 7FY, England; [Schoedel, Johannes] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Ulmenweg 18, D-91054 Erlangen, Germany; [Ponting, Chris P.] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Erlangen Nuremberg; University of Edinburgh	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk	Chan, Mun Chiang/T-4867-2019; Ponting, Chris/AAV-2621-2021	Chan, Mun Chiang/0000-0002-3162-6036; Schodel, Johannes/0000-0002-3587-8839; Ilott, Nicholas/0000-0002-8432-8622; Pugh, Chris/0000-0002-5170-1662; Mole, David/0000-0002-0984-300X; Schofield, Christopher/0000-0002-0290-6565; Ratcliffe, Peter/0000-0002-2853-806X	Wellcome Trust [090532/Z/09/Z]; MRC Hub Grant [G0900747 91070]; BBSRC [BB/J003018/1, BB/D011523/1] Funding Source: UKRI; MRC [MC_EX_UU_G1000902, MC_UU_12021/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011523/1, BB/J003018/1] Funding Source: researchfish; British Heart Foundation [RG/11/1/28684, PG/12/33/29546] Funding Source: researchfish; Cancer Research UK [16466, 16016, 18245] Funding Source: researchfish; Medical Research Council [MC_UU_12021/1, MC_EX_UU_G1000902] Funding Source: researchfish; National Institute for Health Research [RP-2015-06-004] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Hub Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust Grant 090532/Z/09/Z and MRC Hub Grant G0900747 91070) for the generation of the Gene Expression and sequencing data.	Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bagnall J, 2014, J BIOL CHEM, V289, P5549, DOI 10.1074/jbc.M113.500405; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Besarab A, 2016, J AM SOC NEPHROL, V27, P1225, DOI 10.1681/ASN.2015030241; Besarab A, 2015, NEPHROL DIAL TRANSPL, V30, P1665, DOI 10.1093/ndt/gfv302; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Chan MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132004; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Holdstock L, 2016, J AM SOC NEPHROL, V27, P1234, DOI 10.1681/ASN.2014111139; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rose NR, 2012, J MED CHEM, V55, P6639, DOI 10.1021/jm300677j; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Ruas JL, 2010, J BIOL CHEM, V285, P2601, DOI 10.1074/jbc.M109.021824; Sanchez-Fernandez EM, 2013, BIOCHEM J, V449, P491, DOI 10.1042/BJ20121155; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sims D, 2014, BIOINFORMATICS, V30, P1290, DOI 10.1093/bioinformatics/btt756; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; Tegley CM, 2008, BIOORG MED CHEM LETT, V18, P3925, DOI 10.1016/j.bmcl.2008.06.031; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Williams ST, 2014, EPIGENETICS-US, V9, P1596, DOI 10.4161/15592294.2014.983381; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106	63	64	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20661	20673		10.1074/jbc.M116.749291	http://dx.doi.org/10.1074/jbc.M116.749291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27502280	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000384574800029
J	Lee, JH; Han, JS; Kong, J; Ji, Y; Lv, XC; Lee, J; Li, P; Kim, JB				Lee, Jung Hyun; Han, Ji Seul; Kong, Jinuk; Ji, Yul; Lv, Xuchao; Lee, Junho; Li, Peng; Kim, Jae Bum			Protein Kinase A Subunit Balance Regulates Lipid Metabolism in Caenorhabditis elegans and Mammalian Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose triglyceride lipase (ATGL); lipid droplet; lipolysis; protein kinase A (PKA); stoichiometry	ADIPOSE TRIGLYCERIDE LIPASE; NF-KAPPA-B; RII-BETA-SUBUNIT; INSULIN-INDUCED PHOSPHORYLATION; CYCLIC ADENINE RIBONUCLEOTIDE; CHANARIN-DORFMAN-SYNDROME; FAT-SPECIFIC PROTEIN-27; CATALYTIC SUBUNIT; C. ELEGANS; 3T3-L1 ADIPOCYTES	Protein kinase A (PKA) is a cyclic AMP (cAMP)-dependent protein kinase composed of catalytic and regulatory subunits and involved in various physiological phenomena, including lipid metabolism. Here we demonstrated that the stoichiometric balance between catalytic and regulatory subunits is crucial for maintaining basal PKA activity and lipid homeostasis. To uncover the potential roles of each PKA subunit, Caenorhabditis elegans was used to investigate the effects of PKA subunit deficiency. In worms, suppression of PKA via RNAi resulted in severe phenotypes, including shortened life span, decreased egg laying, reduced locomotion, and altered lipid distribution. Similarly, in mammalian adipocytes, suppression of PKA regulatory subunits RI and RII via siRNAs potently stimulated PKA activity, leading to potentiated lipolysis without increasing cAMP levels. Nevertheless, insulin exerted anti-lipolytic effects and restored lipid droplet integrity by antagonizing PKA action. Together, these data implicate the importance of subunit stoichiometry as another regulatory mechanism of PKA activity and lipid metabolism.	[Lee, Jung Hyun; Han, Ji Seul; Kong, Jinuk; Ji, Yul; Lee, Junho; Kim, Jae Bum] Seoul Natl Univ, Inst Mol Biol & Genet, Dept Biol Sci, 1 Gwanak Ro, Seoul 08862, South Korea; [Lv, Xuchao; Li, Peng] Tsinghua Univ, MOE Key Lab Bioinformat, Sch Life Sci, Beijing 100084, Peoples R China; [Lv, Xuchao; Li, Peng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Lee, Junho] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 08862, South Korea	Seoul National University (SNU); Tsinghua University; Tsinghua University; Seoul National University (SNU)	Kim, JB (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, Dept Biol Sci, 1 Gwanak Ro, Seoul 08862, South Korea.	jaebkim@snu.ac.kr	Lee, Junho/AAO-4706-2021; Song, Minsun/I-5701-2015	KIM, Jae Bum/0000-0003-2337-6935	National Research Foundation of Korea - South Korean government [MSIP 2011-0018312]	National Research Foundation of Korea - South Korean government	This work was supported by National Research Foundation of Korea Grant MSIP 2011-0018312 funded by the South Korean government. The authors declare that they have no conflicts of interest with the contents of this article.	Ackerman D, 2012, BIOESSAYS, V34, P466, DOI 10.1002/bies.201100189; Almahariq M, 2014, TRENDS ENDOCRIN MET, V25, P60, DOI 10.1016/j.tem.2013.10.004; Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; BERTHET J, 1957, J BIOL CHEM, V229, P351; BROSTROM CO, 1971, P NATL ACAD SCI USA, V68, P2444, DOI 10.1073/pnas.68.10.2444; BUILDER SE, 1980, J BIOL CHEM, V255, P3514; C. elegans Deletion Mutant Consortium, 2012, LARG SCAL SCREEN TAR, VG3, P1415; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DiPilato LM, 2015, MOL CELL BIOL, V35, P2752, DOI 10.1128/MCB.00422-15; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Elle IC, 2010, FEBS LETT, V584, P2183, DOI 10.1016/j.febslet.2010.03.046; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Gao XJ, 2008, GENOMICS, V92, P457, DOI 10.1016/j.ygeno.2008.08.013; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GRANOT J, 1980, J BIOL CHEM, V255, P4569; GRANOT J, 1980, ARCH BIOCHEM BIOPHYS, V205, P1, DOI 10.1016/0003-9861(80)90078-8; GROSS RE, 1990, J BIOL CHEM, V265, P6896; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; HOFMANN F, 1980, J BIOL CHEM, V255, P1559; HOFMANN F, 1977, J BIOL CHEM, V252, P1441; JIANG H, 1992, BIOCHEM CELL BIOL, V70, P1283, DOI 10.1139/o92-175; Jo H, 2009, CELL METAB, V9, P440, DOI 10.1016/j.cmet.2009.04.004; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kim S, 2012, GENETICS, V192, P905, DOI 10.1534/genetics.112.143271; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; KREBS EG, 1959, J BIOL CHEM, V234, P2867; KUMON A, 1970, BIOCHEM BIOPH RES CO, V41, P1290, DOI 10.1016/0006-291X(70)90228-7; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee JH, 2014, MOL CELL BIOL, V34, P4165, DOI 10.1128/MCB.00722-14; LONDOS C, 1985, J BIOL CHEM, V260, P5139; LU XY, 1990, J BIOL CHEM, V265, P3293; Mantovani G, 2009, DIABETES, V58, P620, DOI 10.2337/db08-0585; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Nian ZQ, 2010, J BIOL CHEM, V285, P9604, DOI 10.1074/jbc.M109.043786; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Planas JV, 1999, J BIOL CHEM, V274, P36281, DOI 10.1074/jbc.274.51.36281; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; RALL TW, 1958, J BIOL CHEM, V232, P1065; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; REIMANN EM, 1971, BIOCHEM BIOPH RES CO, V42, P187, DOI 10.1016/0006-291X(71)90086-6; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Soberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060935; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Steinbaugh MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07836; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; TAO M, 1970, P NATL ACAD SCI USA, V67, P408, DOI 10.1073/pnas.67.1.408; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vrablik TL, 2013, MOL REPROD DEV, V80, P244, DOI 10.1002/mrd.22167; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wijkander J, 1998, ENDOCRINOLOGY, V139, P219, DOI 10.1210/en.139.1.219; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zmuda-Trzebiatowska E, 2006, CELL SIGNAL, V18, P382, DOI 10.1016/j.cellsig.2005.05.007; Zmuda-Trzebiatowska E, 2007, CELL SIGNAL, V19, P81, DOI 10.1016/j.cellsig.2006.05.024	91	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20315	20328		10.1074/jbc.M116.740464	http://dx.doi.org/10.1074/jbc.M116.740464			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27496951	hybrid, Green Published			2022-12-28	WOS:000384574800004
J	McCormick, SM; Gowda, N; Fang, JX; Heller, NM				McCormick, Sarah M.; Gowda, Nagaraj; Fang, Jessie X.; Heller, Nicola M.			Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergy; asthma; macrophage; monocyte; phosphotyrosine signaling; signal transduction; insulin receptor substrate 2; interleukin-4; suppressor of cytokine signaling 1; ubiquination	TARGET GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; SOCS BOX; ALVEOLAR MACROPHAGES; ADIPOSE-TISSUE; SH2 DOMAINS; IN-VITRO; ACTIVATION; INHIBITION; PROTEINS	Allergic asthma is a chronic lung disease initiated and driven by Th2 cytokines IL-4/-13. In macrophages, IL-4/-13 bind IL-4 receptors, which signal through insulin receptor substrate (IRS)-2, inducing M2 macrophage differentiation. M2 macrophages correlate with disease severity and poor lung function, although the mechanisms that regulate M2 polarization are not understood. Following IL-4 exposure, suppressor of cytokine signaling (SOCS)1 is highly induced in human monocytes. We found that siRNA knockdown of SOCS1 prolonged IRS-2 tyrosine phosphorylation and enhanced M2 differentiation, although siRNA knockdown of SOCS3 did not affect either. By co-immunoprecipitation, we found that SOCS1 complexes with IRS-2 at baseline, and this association increased after IL-4 stimulation. Because SOCS1 is an E3 ubiquitin ligase, we examined the effect of proteasome inhibitors on IL-4-induced IRS-2 phosphorylation. Proteasomal inhibition prolonged IRS-2 tyrosine phosphorylation, increased ubiquitination of IRS-2, and enhanced M2 gene expression. siRNA knockdown of SOCS1 inhibited ubiquitin accumulation on IRS-2, although siRNA knockdown of SOCS3 had no effect on ubiquitination of IRS-2. Monocytes from healthy and allergic individuals revealed that SOCS1 is induced by IL-4 in healthy monocytes but not allergic cells, whereas SOCS3 is highly induced in allergic monocytes. Healthy monocytes displayed greater ubiquitination of IRS-2 and lower M2 polarization than allergic monocytes in response to IL-4 stimulation. Here, we identify SOCS1 as a key negative regulator of IL-4-induced IRS-2 signaling and M2 differentiation. Our findings provide novel insight into how dysregulated expression of SOCS increases IL-4 responses in allergic monocytes, and this may represent a new therapeutic avenue for managing allergic disease.	[McCormick, Sarah M.; Gowda, Nagaraj; Fang, Jessie X.; Heller, Nicola M.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Ross 367,720 Rutland Ave, Baltimore, MD 21205 USA; [Heller, Nicola M.] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Heller, NM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Ross 367,720 Rutland Ave, Baltimore, MD 21205 USA.	nheller@jhmi.edu			National Institutes of Health [K99/R00 HL096897]; Canadian Institute of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL096897, K99HL096897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant K99/R00 HL096897. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a fellowship award from the Canadian Institute of Health Research.	Arnold CE, 2014, IMMUNOLOGY, V141, P96, DOI 10.1111/imm.12173; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Bruun C, 2009, MOL CELL ENDOCRINOL, V311, P32, DOI 10.1016/j.mce.2009.07.019; Chung CS, 2007, APOPTOSIS, V12, P1143, DOI 10.1007/s10495-007-0059-7; Cuesta N, 2003, J IMMUNOL, V170, P5739, DOI 10.4049/jimmunol.170.11.5739; DAVID M, 1993, MOL CELL BIOL, V13, P7515, DOI 10.1128/MCB.13.12.7515; De Boever EH, 2014, J ALLERGY CLIN IMMUN, V133, P989, DOI 10.1016/j.jaci.2014.01.002; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Doran E, 2016, EUR RESPIR J, V48, P715, DOI 10.1183/13993003.00400-2015; Draijer C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/632049; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Ford AQ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-6; Fujimoto M, 2004, INT IMMUNOL, V16, P303, DOI 10.1093/intimm/dxh030; Fukushima T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7780; Fukuyama S, 2009, AM J RESP CRIT CARE, V179, P992, DOI 10.1164/rccm.200806-992OC; Gielen V, 2015, J ALLERGY CLIN IMMUN, V136, P177, DOI 10.1016/j.jaci.2014.11.039; Gordon P, 2016, J LEUKOCYTE BIOL, V100, P771, DOI 10.1189/jlb.3A1215-554RR; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; Haffner MC, 2008, J BIOL CHEM, V283, P22089, DOI 10.1074/jbc.M801041200; Hambly N, 2014, CURR OPIN PULM MED, V20, P87, DOI 10.1097/MCP.0000000000000007; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Harada M, 2007, AM J RESP CELL MOL, V36, P491, DOI 10.1165/rcmb.2006-0090OC; Heller N, 2012, J IMMUNOL, V188; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Holt PG, 1999, NATURE, V402, pB12; Horiuchi Y, 2006, ARCH DERMATOL RES, V298, P163, DOI 10.1007/s00403-006-0674-0; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Jager LD, 2011, J NEUROIMMUNOL, V232, P108, DOI 10.1016/j.jneuroim.2010.10.018; Jiang YD, 2014, MOL VIS, V20, P1463; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Kau AL, 2014, CURR OPIN ALLERGY CL, V14, P570, DOI 10.1097/ACI.0000000000000108; Kelly EAB, 2003, J ALLERGY CLIN IMMUN, V111, P79, DOI 10.1067/mai.2003.28; Kelly-Welch AE, 2004, J IMMUNOL, V172, P4545, DOI 10.4049/jimmunol.172.7.4545; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kim TH, 2012, INT ARCH ALLERGY IMM, V158, P387, DOI 10.1159/000333103; Knosp CA, 2012, IMMUNOLOGY, V135, P101, DOI 10.1111/j.1365-2567.2011.03520.x; Kubo M, 2013, EUR J IMMUNOL, V43, P1702, DOI 10.1002/eji.201343748; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Leikfoss IS, 2013, GENES IMMUN, V14, P62, DOI 10.1038/gene.2012.52; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liang Y, 2014, EUR J IMMUNOL, V44, P1265, DOI 10.1002/eji.201344369; Linossi EM, 2013, CYTOKINE GROWTH F R, V24, P241, DOI 10.1016/j.cytogfr.2013.03.005; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu Y, 2008, J IMMUNOL, V180, P6270, DOI 10.4049/jimmunol.180.9.6270; Lopez E, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/917015; Madonna S, 2010, J IMMUNOL, V185, P2467, DOI 10.4049/jimmunol.1001426; McCormick SM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00549; Melgert BN, 2011, J ALLERGY CLIN IMMUN, V127, P831, DOI 10.1016/j.jaci.2010.10.045; Mostecki J, 2011, J IMMUNOL, V187, P2794, DOI 10.4049/jimmunol.0902569; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Recio C, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-014-0458-1; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Sedeno-Monge V, 2014, J NEUROIMMUNOL, V273, P117, DOI 10.1016/j.jneuroim.2014.05.013; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Sheikh F, 2015, J INNATE IMMUN, V7, P494, DOI 10.1159/000376579; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Stark JL, 2006, INT IMMUNOL, V18, P347, DOI 10.1093/intimm/dxh373; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Tsao JT, 2008, CLIN EXP MED, V8, P179, DOI 10.1007/s10238-008-0006-0; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Vandenbroeck K, 2012, GENES IMMUN, V13, P21, DOI 10.1038/gene.2011.44; Venieratos PD, 2010, CELL SIGNAL, V22, P791, DOI 10.1016/j.cellsig.2010.01.003; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Viksman MY, 2002, CLIN IMMUNOL, V104, P77, DOI 10.1006/clim.2002.5233; Wakioka T, 1999, LEUKEMIA, V13, P760, DOI 10.1038/sj.leu.2401397; Walsh GM, 2013, IMMUNOTHERAPY-UK, V5, P1255, DOI [10.2217/IMT.13.118, 10.2217/imt.13.118]; Watanabe H, 2006, J IMMUNOL, V177, P8650, DOI 10.4049/jimmunol.177.12.8650; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Wilson HM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00357; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163; Zhang J., 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1109/ICNP.2013.6733609; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhou H, 2007, CLIN CANCER RES, V13, P2344, DOI 10.1158/1078-0432.CCR-06-2303; Zhu JG, 2013, MOL CELL BIOCHEM, V381, P51, DOI 10.1007/s11010-013-1687-6	101	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20574	20587		10.1074/jbc.M116.746164	http://dx.doi.org/10.1074/jbc.M116.746164			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27507812	Green Published, hybrid			2022-12-28	WOS:000384574800023
J	Adachi, N; Hess, DT; McLaughlin, P; Stamler, JS				Adachi, Naoko; Hess, Douglas T.; McLaughlin, Precious; Stamler, Jonathan S.			S-Palmitoylation of a Novel Site in the beta(2)-Adrenergic Receptor Associated with a Novel Intracellular Itinerary	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adrenergic receptor; G protein-coupled receptor (GPCR); membrane trafficking; protein palmitoylation; receptor desensitization	ACYL-PROTEIN THIOESTERASE; BETA-2-ADRENERGIC RECEPTOR; PHOSPHORYLATION SITES; AGONIST STIMULATION; MOLECULAR-CLONING; MEMBRANE DOMAINS; ALPHA-SUBUNITS; NITROSYLATION; ACTIVATION; PALMITATE	We report here that a population of human (2)-adrenergic receptors ((2)AR), a canonical G protein-coupled receptor, traffics along a previously undescribed intracellular itinerary via the Golgi complex that is associated with the sequential S-palmitoylation and depalmitoylation of a previously undescribed site of modification, Cys-265 within the third intracellular loop. Basal S-palmitoylation of Cys-265 is negligible, but agonist-induced (2)AR activation results in enhanced S-palmitoylation, which requires phosphorylation by the cAMP-dependent protein kinase of Ser-261/Ser-262. Agonist-induced turnover of palmitate occurs predominantly on Cys-265. Cys-265 S-palmitoylation is mediated by the Golgi-resident palmitoyl transferases zDHHC9/14/18 and is followed by depalmitoylation by the plasma membrane-localized acyl-protein thioesterase APT1. Inhibition of depalmitoylation reveals that S-palmitoylation of Cys-265 may stabilize the receptor at the plasma membrane. In addition, (2)AR S-palmitoylated at Cys-265 are selectively preserved under a sustained adrenergic stimulation, which results in the down-regulation and degradation of AR. Cys-265 is not conserved in (1)AR, and S-palmitoylation of Cys-265 may thus be associated with functional differences between (2)AR and (1)AR, including relative resistance of (2)AR to down-regulation in multiple pathophysiologies. Trafficking via the Golgi complex may underlie new roles in G protein-coupled receptor biology.	[Adachi, Naoko; Hess, Douglas T.; McLaughlin, Precious; Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Adachi, Naoko; Hess, Douglas T.; McLaughlin, Precious; Stamler, Jonathan S.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Adachi, Naoko; Hess, Douglas T.; McLaughlin, Precious; Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Univ Hosp Case Med Ctr, Harrington Discovery Inst, Cleveland, OH 44106 USA; [Adachi, Naoko] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Kobe University	Stamler, JS (corresponding author), Case Western Reserve Univ, Inst Transformat Mol Med, 10900 Euclid Ave,Locat Code 7294, Cleveland, OH 44106 USA.	jonathan.stamler@case.edu		Adachi, Naoko/0000-0002-8797-0717; Stamler, Jonathan/0000-0002-6866-1572	National Institutes of Health [P01HL075443]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant P01HL075443. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Davda D, 2014, MEDCHEMCOMM, V5, P268, DOI 10.1039/c3md00333g; Devic E, 2001, MOL PHARMACOL, V60, P577; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Galbiati F, 1999, J BIOL CHEM, V274, P5843, DOI 10.1074/jbc.274.9.5843; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Liu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042658; Loisel TP, 1996, BIOCHEMISTRY-US, V35, P15923, DOI 10.1021/bi9611321; Lorent JH, 2015, CHEM PHYS LIPIDS, V192, P23, DOI 10.1016/j.chemphyslip.2015.07.022; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Moffett S, 1996, J BIOL CHEM, V271, P21490, DOI 10.1074/jbc.271.35.21490; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; MUNTZ KH, 1994, CIRC RES, V74, P369, DOI 10.1161/01.RES.74.3.369; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; OBRIEN PJ, 1984, J BIOL CHEM, V259, P5054; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2008, MOL PHARMACOL, V73, P1333, DOI 10.1124/mol.108.045849; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; WILMORE DW, 1974, ANN SURG, V180, P653, DOI 10.1097/00000658-197410000-00031; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zuckerman DM, 2011, J BIOL CHEM, V286, P19014, DOI 10.1074/jbc.M110.189977	49	31	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20232	20246		10.1074/jbc.M116.725762	http://dx.doi.org/10.1074/jbc.M116.725762			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27481942	Green Published, hybrid			2022-12-28	WOS:000383243100042
J	Erb, SJ; Schappi, JM; Rasenick, MM				Erb, Samuel J.; Schappi, Jeffrey M.; Rasenick, Mark M.			Antidepressants Accumulate in Lipid Rafts Independent of Monoamine Transporters to Modulate Redistribution of the G Protein, G alpha(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP (cAMP); depression; drug action; G protein; gas chromatography-mass spectrometry (GC-MS); glial cell; intracellular trafficking; lipid raft; monoamine transporter; selective serotonin reuptake inhibitor (SSRI); G protein-coupled receptor (GPCR); glia; heterotrimeric G protein; lipid; mass spectrometry (MS); membrane trafficking; plasma membrane; protein-drug interaction; protein translocation; protein-lipid interaction; serotonin; serotonin transporter	C6 GLIOMA-CELLS; MAJOR DEPRESSIVE DISORDER; BETA-ADRENERGIC-RECEPTOR; ADENYLYL-CYCLASE; PLASMA-MEMBRANE; GLIAL-CELLS; MICROTUBULE DYNAMICS; DRUGS INCREASES; DOMAINS; ALPHA	Depression is a significant public health problem for which currently available medications, if effective, require weeks to months of treatment before patients respond. Previous studies have shown that the G protein responsible for increasing cAMP (G(s)) is increasingly localized to lipid rafts in depressed subjects and that chronic antidepressant treatment translocates G(s) from lipid rafts. Translocation of G(s), which shows delayed onset after chronic antidepressant treatment of rats or of C6 glioma cells, tracks with the delayed onset of therapeutic action of antidepressants. Because antidepressants appear to specifically modify G(s) localized to lipid rafts, we sought to determine whether structurally diverse antidepressants accumulate in lipid rafts. Sustained treatment of C6 glioma cells, which lack 5-hydroxytryptamine transporters, showed marked concentration of several antidepressants in raft fractions, as revealed by increased absorbance and by mass fingerprint. Closely related molecules without antidepressant activity did not concentrate in raft fractions. Thus, at least two classes of antidepressants accumulate in lipid rafts and effect translocation of G(s) to the non-raft membrane fraction, where it activates the cAMP-signaling cascade. Analysis of the structural determinants of raft localization may both help to explain the hysteresis of antidepressant action and lead to design and development of novel substrates for depression therapeutics.	[Erb, Samuel J.; Rasenick, Mark M.] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA; [Schappi, Jeffrey M.; Rasenick, Mark M.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Rasenick, Mark M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Rasenick, Mark M.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rasenick, MM (corresponding author), Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA.; Rasenick, MM (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA.; Rasenick, MM (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.; Rasenick, MM (corresponding author), Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA.	raz@uic.edu			Veterans Administration Merit Award [BX001149]; National Institutes of Health [R01AT009169, T32 MH067631]; Eli Lilly; Lundbeck, Inc.; National Center for Complementary & Integrative Health [R01AT009169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067631] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001149] Funding Source: NIH RePORTER	Veterans Administration Merit Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly(Eli Lilly); Lundbeck, Inc.(Lundbeck Corporation); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Administration Merit Award BX001149 and National Institutes of Health Grants R01AT009169 and T32 MH067631. M. M. R. has received research support from Eli Lilly and Lundbeck, Inc. and is a consultant to Otsuka Pharmaceuticals. He also has ownership in Pax Neuroscience. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chen GA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001754; CHEN JA, 1995, J NEUROCHEM, V64, P724; CHIOU CT, 1981, J PHARM SCI, V70, P1176, DOI 10.1002/jps.2600701027; Czysz AH, 2015, NEUROPSYCHOPHARMACOL, V40, P766, DOI 10.1038/npp.2014.256; Di Benedetto B, 2013, CURR DRUG TARGETS, V14, P1329; Donati RJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1238, DOI 10.1038/sj.npp.1300697; Donati RJ, 2001, MOL PHARMACOL, V59, P1426, DOI 10.1124/mol.59.6.1426; Donati RJ, 2008, J NEUROSCI, V28, P3042, DOI 10.1523/JNEUROSCI.5713-07.2008; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Eisensamer B, 2005, J NEUROSCI, V25, P10198, DOI 10.1523/JNEUROSCI.2460-05.2005; Eshleman AJ, 1997, J NEUROCHEM, V69, P1459; Fujita M, 2012, BIOL PSYCHIAT, V72, P548, DOI 10.1016/j.biopsych.2012.04.030; Golan M, 2011, INT J NEUROPSYCHOPH, V14, P1289, DOI 10.1017/S1461145710001550; Hisaoka K, 2008, BRAIN RES, V1196, P53, DOI 10.1016/j.brainres.2007.12.019; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Insel PA, 2005, BIOCHEM SOC T, V33, P1131, DOI 10.1042/BST0331131; Kalinowska M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121464; Kasahara K, 2000, GLYCOCONJUGATE J, V17, P153, DOI 10.1023/A:1026576804247; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; MENKES DB, 1983, SCIENCE, V219, P65, DOI 10.1126/science.6849117; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; OZAWA H, 1991, J NEUROCHEM, V56, P330, DOI 10.1111/j.1471-4159.1991.tb02599.x; Rothschild AJ, 1999, J CLIN PSYCHIAT, V60, P116, DOI 10.4088/JCP.v60n0208; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Sarma T, 2015, J BIOL CHEM, V290, P10045, DOI 10.1074/jbc.M114.630632; Toki S, 1999, J NEUROCHEM, V73, P1114, DOI 10.1046/j.1471-4159.1999.0731114.x; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; VETULANI J, 1975, NATURE, V257, P495, DOI 10.1038/257495a0; Wenig P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-405; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winecker RE, 2010, METHODS MOL BIOL, V603, P45, DOI 10.1007/978-1-60761-459-3_5; Yan K, 2001, J NEUROCHEM, V76, P182, DOI 10.1046/j.1471-4159.2001.00013.x; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zhang LQ, 2010, J PHARMACOL EXP THER, V332, P977, DOI 10.1124/jpet.109.162644	42	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19725	19733		10.1074/jbc.M116.727263	http://dx.doi.org/10.1074/jbc.M116.727263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27432886	Green Published, hybrid			2022-12-28	WOS:000383243100001
J	Oh, CK; Park, SH; Kim, J; Moon, Y				Oh, Chang-Kyu; Park, Seong-Hwan; Kim, Juil; Moon, Yuseok			Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation EVIDENCE FOR ENVIRONMENTAL HEMOCHROMATOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intestine; iron metabolism; NF-B transcription factor; nuclear factor 2 (erythroid-derived 2-like factor; NFE2L2; Nrf2); p38 MAPK; ribosomal inactivation	INTESTINAL EPITHELIAL-CELLS; RIBOTOXIC STRESS-RESPONSE; NF-KAPPA-B; IRON-METABOLISM; T-2 TOXIN; OXIDATIVE STRESS; GENE-EXPRESSION; CACO-2 CELLS; HEREDITARY HEMOCHROMATOSIS; CAENORHABDITIS-ELEGANS	Iron transfer across the basolateral membrane of an enterocyte into the circulation is the rate-limiting step in iron absorption and is regulated by various pathophysiological factors. Ferroportin (FPN), the only known mammalian iron exporter, transports iron from the basolateral surface of enterocytes, macrophages, and hepatocytes into the blood. Patients with genetic mutations in FPN or repeated blood transfusion develop hemochromatosis. In this study, non-mutagenic ribosomal inactivation was assessed as an etiological factor of FPN-associated hemochromatosis in enterocytes. Non-mutagenic chemical ribosomal inactivation disrupted iron homeostasis by regulating expression of the iron exporter FPN-1, leading to intracellular accumulation in enterocytes. Mechanistically, a xenobiotic insult stimulated the intracellular sentinel p38 MAPK signaling pathway, which was positively involved in FPN-1 suppression by ribosomal dysfunction. Moreover, ribosomal inactivation-induced iron accumulation in Caenorhabditis elegans as a simplified in vivo model for gut nutrition uptake was dependent on SEK-1, a p38 kinase activator, leading to suppression of FPN-1.1 expression and iron accumulation. In terms of gene regulation, ribosomal stress-activated p38 signaling down-regulated NRF2 and NF-B, both of which were positive transcriptional regulators of FPN-1 transcription. This study provides molecular evidence for the modulation of iron bioavailability by ribosomal dysfunction as a potent etiological factor of non-mutagenic environmental hemochromatosis in the gut-to-blood axis.	[Oh, Chang-Kyu; Park, Seong-Hwan; Kim, Juil; Moon, Yuseok] Pusan Natl Univ, Sch Med, Dept Biomed Sci, Lab Mucosal Exposome & Biomodulat, Yangsan 50612, South Korea; [Moon, Yuseok] Pusan Natl Univ, Med Res Inst, Busan 46241, South Korea	Pusan National University; Pusan National University	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Biomed Sci, Yangsan 50612, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020	MOON, YUSEOK/0000-0001-8686-8166	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2015R1A2A1A15056056]; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [HI13C0259]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning Grant NRF-2015R1A2A1A15056056 and Grant HI13C0259 from the Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Anderson CP, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00113; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; Awad WA, 2007, POULTRY SCI, V86, P15, DOI 10.1093/ps/86.1.15; Baldwin GS, 2009, METALLOMICS, V1, P370, DOI 10.1039/b909112m; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Calvert TW, 2005, MYCOPATHOLOGIA, V159, P413, DOI 10.1007/s11046-005-0254-4; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chen HH, 2015, CHEM RES TOXICOL, V28, P1681, DOI 10.1021/acs.chemrestox.5b00085; Chong WS, 2005, HUM REPROD, V20, P3532, DOI 10.1093/humrep/dei246; Collins JE, 2008, J NUTR, V138, P2284, DOI 10.3945/jn.108.096347; Cowan MJ, 2006, J APPL PHYSIOL, V101, P1127, DOI 10.1152/japplphysiol.01287.2005; Davies PS, 2004, J BIOL CHEM, V279, P25085, DOI 10.1074/jbc.M400537200; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Del Regno M, 2015, TOXICOL APPL PHARM, V285, P118, DOI 10.1016/j.taap.2015.04.002; Do KH, 2012, BIOCHEM PHARMACOL, V84, P513, DOI 10.1016/j.bcp.2012.05.015; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Espinoza A, 2012, BIOL TRACE ELEM RES, V146, P281, DOI 10.1007/s12011-011-9243-2; FAIFER GC, 1992, TOXICOLOGY, V75, P169, DOI 10.1016/0300-483X(92)90155-8; FAIFER GC, 1991, TOXICOLOGY, V70, P133, DOI 10.1016/0300-483X(91)90040-8; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Gowrinathan Y, 2011, FOOD ADDIT CONTAM A, V28, P1235, DOI 10.1080/19440049.2011.587836; Griffiths WJH, 2010, HEPATOLOGY, V51, P788, DOI 10.1002/hep.23377; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HAN O, 1995, J NUTR, V125, P1291; Harada N, 2011, ARCH BIOCHEM BIOPHYS, V508, P101, DOI 10.1016/j.abb.2011.02.001; Harada S, 2015, J PHARMACOL EXP THER, V355, P353, DOI 10.1124/jpet.115.226431; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; HUNDER G, 1991, FOOD CHEM TOXICOL, V29, P809, DOI 10.1016/0278-6915(91)90107-I; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598; Kaye P, 2008, HISTOPATHOLOGY, V53, P311, DOI 10.1111/j.1365-2559.2008.03081.x; Kuwano T, 2015, J AGR FOOD CHEM, V63, P7937, DOI 10.1021/acs.jafc.5b01992; Laskin JD, 2002, TOXICOL SCI, V69, P289, DOI 10.1093/toxsci/69.2.289; Lee P, 2004, P NATL ACAD SCI USA, V101, P9263, DOI 10.1073/pnas.0403108101; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Maresca M, 2010, TOXICON, V56, P282, DOI 10.1016/j.toxicon.2010.04.016; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Messner Donald J, 2010, Hepatology, V51, P705, DOI 10.1002/hep.23507; Mishra S, 2014, FOOD CHEM TOXICOL, V72, P20, DOI 10.1016/j.fct.2014.06.027; Moon Y, 2008, TOXICOL APPL PHARM, V231, P94, DOI 10.1016/j.taap.2008.03.016; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Noiri E, 1996, AM J PHYSIOL-CELL PH, V270, pC794, DOI 10.1152/ajpcell.1996.270.3.C794; Outten FW, 2009, ANTIOXID REDOX SIGN, V11, P1029, DOI [10.1089/ars.2008.2296, 10.1089/ARS.2008.2296]; Park SH, 2013, J IMMUNOL, V191, P5170, DOI 10.4049/jimmunol.1301145; Persichini T, 2010, NEUROSCI LETT, V484, P133, DOI 10.1016/j.neulet.2010.08.034; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Ren ZH, 2015, ENVIRON TOXICOL PHAR, V39, P339, DOI 10.1016/j.etap.2014.11.028; Reuther JY, 1999, J BIOL CHEM, V274, P20664, DOI 10.1074/jbc.274.29.20664; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Shifrin VI, 1999, J BIOL CHEM, V274, P13985, DOI 10.1074/jbc.274.20.13985; Slocum SL, 2011, ARCH TOXICOL, V85, P273, DOI 10.1007/s00204-011-0675-4; Smith WE, 2003, INFECT IMMUN, V71, P1497, DOI 10.1128/IAI.71.3.1497-1504.2003; Steele TM, 2005, IUBMB LIFE, V57, P499, DOI 10.1080/15216540500149904; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tallkvist J, 2003, PHARMACOL TOXICOL, V92, P121, DOI 10.1034/j.1600-0773.2003.920303.x; Thorpe CM, 2001, INFECT IMMUN, V69, P6140, DOI 10.1128/IAI.69.10.6140-6147.2001; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Velazco V, 1996, FOOD CHEM TOXICOL, V34, P371, DOI 10.1016/0278-6915(96)00118-4; Verma AK, 2015, REDOX BIOL, V6, P80, DOI 10.1016/j.redox.2015.06.020; Yamaji S, 2004, BLOOD, V104, P2178, DOI 10.1182/blood-2004-03-0829; Yang H, 2008, TOXICOLOGY, V243, P145, DOI 10.1016/j.tox.2007.10.002; Yeh KY, 2011, GASTROENTEROLOGY, V141, P292, DOI 10.1053/j.gastro.2011.03.059; Yoder JM, 2007, INFECT IMMUN, V75, P1745, DOI 10.1128/IAI.01528-06; Yu R, 2000, J BIOL CHEM, V275, P2322, DOI 10.1074/jbc.275.4.2322; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006; Zheng G, 2012, TOXICOL APPL PHARM, V260, P285, DOI 10.1016/j.taap.2012.03.006; Zhou WX, 2014, J CLIN GASTROENTEROL, V48, P336, DOI 10.1097/MCG.0b013e3182a9be10	82	3	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19858	19872		10.1074/jbc.M116.722520	http://dx.doi.org/10.1074/jbc.M116.722520			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27445333	Green Published, hybrid			2022-12-28	WOS:000383243100012
J	Wirth, N; Gross, J; Roth, HM; Buechner, CN; Kisker, C; Tessmer, I				Wirth, Nicolas; Gross, Jonas; Roth, Heide M.; Buechner, Claudia N.; Kisker, Caroline; Tessmer, Ingrid			Conservation and Divergence in Nucleotide Excision Repair Lesion Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; UVRAB PROTEIN COMPLEX; GROUP D HELICASE; DNA-REPAIR; DAMAGE RECOGNITION; GENERAL TRANSCRIPTION; STRUCTURAL INSIGHTS; PREINCISION COMPLEX; CRYSTAL-STRUCTURE; ATPASE ACTIVITY	Nucleotide excision repair is an important and highly conserved DNA repair mechanism with an exceptionally large range of chemically and structurally unrelated targets. Lesion verification is believed to be achieved by the helicases UvrB and XPD in the prokaryotic and eukaryotic processes, respectively. Using single molecule atomic force microscopy analyses, we demonstrate that UvrB and XPD are able to load onto DNA and pursue lesion verification in the absence of the initial lesion detection proteins. Interestingly, our studies show different lesion recognition strategies for the two functionally homologous helicases, as apparent from their distinct DNA strand preferences, which can be rationalized from the different structural features and interactions with other nucleotide excision repair protein factors of the two enzymes.	[Wirth, Nicolas; Gross, Jonas; Roth, Heide M.; Buechner, Claudia N.; Kisker, Caroline; Tessmer, Ingrid] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Roth, Heide M.] NanoTemper Technol, Floessergasse 4, Wurzburg, Germany	University of Wurzburg	Tessmer, I (corresponding author), Rudolf Virchow Ctr Expt Biomed, Struct Biol, Josef Schneider Str 2 D15-00-015, D-97080 Wurzburg, Germany.	ingrid.tessmer@virchow.uni-wuerzburg.de	Kisker, Caroline/T-1724-2019; Tessmer, Ingrid/O-2810-2013	Resch, Heide Marie/0000-0001-9635-6340; Kisker, Caroline/0000-0002-0216-6026; Tessmer, Ingrid/0000-0002-8353-6315; Wirth, Nicolas Thilo/0000-0003-0799-1321	Deutsche Forschungsgemeinschaft (DFG) [KI-562/7-1, Forschungszentrurn FZ82, TE-671/4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants KI-562/7-1, Forschungszentrurn FZ82, and TE-671/4 (to C. K. and I. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Bessho T, 1997, MOL CELL BIOL, V17, P6822, DOI 10.1128/MCB.17.12.6822; Buechner CN, 2014, J BIOL CHEM, V289, P3613, DOI 10.1074/jbc.M113.523001; Buechner CN, 2013, J MOL RECOGNIT, V26, P605, DOI 10.1002/jmr.2311; CARON PR, 1988, NUCLEIC ACIDS RES, V16, P10891, DOI 10.1093/nar/16.22.10891; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; de Jesus BMB, 2008, MOL CELL BIOL, V28, P7225, DOI 10.1128/MCB.00781-08; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Gordienko I, 1997, EMBO J, V16, P889, DOI 10.1093/emboj/16.4.889; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hou EW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm639; Hughes CD, 2013, NUCLEIC ACIDS RES, V41, P4901, DOI 10.1093/nar/gkt177; Jaciuk M, 2011, NAT STRUCT MOL BIOL, V18, P191, DOI 10.1038/nsmb.1973; Jia L, 2009, BIOCHEMISTRY-US, V48, P8948, DOI 10.1021/bi9010072; Jiang GH, 2006, BIOCHEMISTRY-US, V45, P7834, DOI 10.1021/bi052515e; Koch SC, 2015, P NATL ACAD SCI USA, V112, P8272, DOI 10.1073/pnas.1508509112; Kuper J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001954; Kuper J, 2012, CURR OPIN STRUC BIOL, V22, P88, DOI 10.1016/j.sbi.2011.12.002; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Li CL, 2015, MOL CELL, V59, P1025, DOI 10.1016/j.molcel.2015.08.012; Li XM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000876; Liu Y, 2011, DNA REPAIR, V10, P684, DOI 10.1016/j.dnarep.2011.04.020; Luo J, 2015, MOL CELL, V59, P794, DOI 10.1016/j.molcel.2015.07.016; Maillard O, 2008, MUTAT RES-REV MUTAT, V658, P271, DOI 10.1016/j.mrrev.2008.01.007; Mathieu N, 2013, CURR BIOL, V23, P204, DOI 10.1016/j.cub.2012.12.032; Mathieu N, 2010, P NATL ACAD SCI USA, V107, P17545, DOI 10.1073/pnas.1004339107; Moolenaar GF, 1998, J BIOL CHEM, V273, P34896, DOI 10.1074/jbc.273.52.34896; Moolenaar GF, 2000, J BIOL CHEM, V275, P8038, DOI 10.1074/jbc.275.11.8038; Moolenaar GF, 1997, MUTAT RES-DNA REPAIR, V385, P195, DOI 10.1016/S0921-8777(97)00042-6; Moolenaar GF, 1995, J BIOL CHEM, V270, P30508, DOI 10.1074/jbc.270.51.30508; Moolenaar GF, 2001, EMBO J, V20, P6140, DOI 10.1093/emboj/20.21.6140; OH EY, 1989, J BIOL CHEM, V264, P1336; Oksenych V, 2009, EMBO J, V28, P2971, DOI 10.1038/emboj.2009.230; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Roth HM, 2012, DNA REPAIR, V11, P286, DOI 10.1016/j.dnarep.2011.12.002; Rudolf J, 2010, NUCLEIC ACIDS RES, V38, P931, DOI 10.1093/nar/gkp1058; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SCHENDEL PF, 1982, J BACTERIOL, V150, P676, DOI 10.1128/JB.150.2.676-685.1982; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sohi M, 2000, FEBS LETT, V465, P161, DOI 10.1016/S0014-5793(99)01690-7; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Sugasawa K, 2009, MOL CELL, V36, P642, DOI 10.1016/j.molcel.2009.09.035; Tessmer I, 2012, NUCLEIC ACIDS RES, V40, P8296, DOI 10.1093/nar/gks574; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Theis K, 2000, MUTAT RES-DNA REPAIR, V460, P277, DOI 10.1016/S0921-8777(00)00032-X; Truglio JJ, 2006, NAT STRUCT MOL BIOL, V13, P360, DOI 10.1038/nsmb1072; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Truglio JJ, 2005, EMBO J, V24, P885, DOI 10.1038/sj.emboj.7600568; Verhoeven EEA, 2002, EMBO J, V21, P4196, DOI 10.1093/emboj/cdf396; Verhoeven EEA, 2001, EMBO J, V20, P601, DOI 10.1093/emboj/20.3.601; Wang H, 2008, NANO LETT, V8, P1631, DOI 10.1021/nl080316l; Wang H, 2006, J BIOL CHEM, V281, P15227, DOI 10.1074/jbc.M601476200; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Zou Y, 1999, EMBO J, V18, P4889, DOI 10.1093/emboj/18.17.4889; Zou Y, 1997, J BIOL CHEM, V272, P4820, DOI 10.1074/jbc.272.8.4820; Zou Y, 2004, BIOCHEMISTRY-US, V43, P4196, DOI 10.1021/bi035992a	63	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18932	18946		10.1074/jbc.M116.739425	http://dx.doi.org/10.1074/jbc.M116.739425			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27405761	hybrid, Green Published			2022-12-28	WOS:000383242300029
J	Pozzi, N; Bystranowska, D; Zuo, XB; Di Cera, E				Pozzi, Nicola; Bystranowska, Dominika; Zuo, Xiaobing; Di Cera, Enrico			Structural Architecture of Prothrombin in Solution Revealed by Single Molecule Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; prothrombin; single-molecule biophysics; structure-function; thrombin	ALTERNATING-LASER EXCITATION; TRYPSIN-LIKE PROTEASES; RAY CRYSTAL-STRUCTURE; BLOOD-COAGULATION; CONFORMATIONAL SELECTION; SOLUTION SCATTERING; FRET; ACTIVATION; EVOLUTION; THROMBIN	The coagulation factor prothrombin has a complex spatial organization of its modular assembly that comprises the N-terminal Gla domain, kringle-1, kringle-2, and the C-terminal protease domain connected by three intervening linkers. Here we use single molecule Forster resonance energy transfer to access the conformational landscape of prothrombin in solution and uncover structural features of functional significance that extend recent x-ray crystallographic analysis. Prothrombin exists in equilibrium between two alternative conformations, open and closed. The closed conformation predominates (70%) and features an unanticipated intramolecular collapse of Tyr(93) in kringle-1 onto Trp(547) in the protease domain that obliterates access to the active site and protects the zymogen from autoproteolytic conversion to thrombin. The open conformation (30%) is more susceptible to chymotrypsin digestion and autoactivation, and features a shape consistent with recent x-ray crystal structures. Small angle x-ray scattering measurements of prothrombin wild type stabilized 70% in the closed conformation and of the mutant Y93A stabilized 80% in the open conformation directly document two envelopes that differ 50 in length. These findings reveal important new details on the conformational plasticity of prothrombin in solution and the drastic structural difference between its alternative conformations. Prothrombin uses the intramolecular collapse of kringle-1 onto the active site in the closed form to prevent autoactivation. The open-closed equilibrium also defines a new structural framework for the mechanism of activation of prothrombin by prothrombinase.	[Pozzi, Nicola; Bystranowska, Dominika; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Zuo, Xiaobing] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Bystranowska, Dominika] Wroclaw Univ Technol, Dept Biochem, PL-50370 Wroclaw, Poland	Saint Louis University; United States Department of Energy (DOE); Argonne National Laboratory; Wroclaw University of Science & Technology	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Pozzi, Nicola/AAE-4910-2020; Pozzi, Nicola/AAV-4876-2021	Pozzi, Nicola/0000-0003-2309-7100; Bystranowska, Dominika/0000-0002-6745-5355; Zuo, Xiaobing/0000-0002-0134-4804	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112303, R01HL073813, R29HL049413, R01HL049413] Funding Source: NIH RePORTER	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge Dr. David Gohara and Zhiwei Chen for their assistance with the model of the closed conformation of prothrombin, Daniel Shropshire and Leslie Pelc for expression and labeling of several constructs for smFRET measurements, and Dr. Tomasz Heyduk and Rachel Hickey for providing double-stranded DNA constructs used for calibration of the Micro-Time instrument and control experiments. This research used resources of the Advanced Photon Source, a U. S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Barranco-Medina S, 2013, J BIOL CHEM, V288, P35749, DOI 10.1074/jbc.M113.509786; BODE W, 1992, PROTEIN SCI, V1, P426; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; Chung HS, 2013, CHEM PHYS, V422, P229, DOI 10.1016/j.chemphys.2012.08.005; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; Flick MJ, 2011, BLOOD, V117, P6326, DOI 10.1182/blood-2010-08-304915; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Gould TJ, 2015, J THROMB HAEMOST, V13, pS82, DOI 10.1111/jth.12977; Huang YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015809; Juette MF, 2014, CURR OPIN CHEM BIOL, V20, P103, DOI 10.1016/j.cbpa.2014.05.010; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; Kudryavtsev V, 2012, CHEMPHYSCHEM, V13, P1060, DOI 10.1002/cphc.201100822; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Muia J, 2014, P NATL ACAD SCI USA, V111, P18584, DOI 10.1073/pnas.1413282112; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; PATTHY L, 1985, CELL, V41, P657, DOI 10.1016/S0092-8674(85)80046-5; Pozzi N, 2016, J BIOL CHEM, V291, P6071, DOI 10.1074/jbc.M115.700401; Pozzi N, 2014, P NATL ACAD SCI USA, V111, P7630, DOI 10.1073/pnas.1403779111; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; ROSING J, 1980, J BIOL CHEM, V255, P274; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tomescu AI, 2014, P NATL ACAD SCI USA, V111, pE3335, DOI 10.1073/pnas.1406056111; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wang SZ, 2016, NAT STRUCT MOL BIOL, V23, P31, DOI 10.1038/nsmb.3138; Xue JC, 1998, P NATL ACAD SCI USA, V95, P7603, DOI 10.1073/pnas.95.13.7603	49	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18107	18116		10.1074/jbc.M116.738310	http://dx.doi.org/10.1074/jbc.M116.738310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27435675	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000383241800005
J	Stein, R; Kapplusch, F; Heymann, MC; Russ, S; Staroske, W; Hedrich, CM; Rosen-Wolff, A; Hofmann, SR				Stein, Robert; Kapplusch, Franz; Heymann, Michael Christian; Russ, Susanne; Staroske, Wolfgang; Hedrich, Christian Michael; Roesen-Wolff, Angela; Hofmann, Sigrun Ruth			Enzymatically Inactive Procaspase 1 stabilizes the ASC Pyroptosome and Supports Pyroptosome Spreading during Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caspase 1 (CASP1); imaging; inflammasome; IL-1; NLRP3; ASC; IL-1; apoptosis-associated speck-like protein containing a CARD; interleukin 1-converting enzyme; pyroptosome	NF-KAPPA-B; NLRP3 INFLAMMASOME ACTIVATION; CONTAINING APAF1-LIKE PROTEIN; REGULATES ACTIVATION; MURINE MACROPHAGES; CONVERTING-ENZYME; CUTTING EDGE; ADAPTER ASC; CASPASE-1; DEATH	Caspase-1 is a key player during the initiation of pro-inflammatory innate immune responses, activating pro-IL-1 in so-called inflammasomes. A subset of patients with recurrent febrile episodes and systemic inflammation of unknown origin harbor mutations in CASP1 encoding caspase-1. CASP1 variants result in reduced enzymatic activity of caspase-1 and impaired IL-1 secretion. The apparent paradox of reduced IL-1 secretion but systemic inflammation led to the hypothesis that CASP1 mutations may result in variable protein interaction clusters, thus activating alternative signaling pathways. To test this hypothesis, we established and characterized an in vitro system of transduced immortalized murine macrophages expressing either WT or enzymatically inactive (p.C284A) procaspase-1 fusion reporter proteins. Macrophages with variant p.C284A caspase-1 did not secrete IL-1 and exhibited reduced inflammatory cell death, referred to as pyroptosis. Caspase-1 and apoptosis-associated speck-like protein containing a CARD (ASC) formed cytosolic macromolecular complexes (so-called pyroptosomes) that were significantly increased in number and size in cells carrying the p.C284A caspase-1 variant compared with WT caspase-1. Furthermore, enzymatically inactive caspase-1 interacted with ASC longer and with increased intensity compared with WT caspase-1. Applying live cell imaging, we documented for the first time that pyroptosomes containing enzymatically inactive variant p.C284A caspase-1 spread during cell division. In conclusion, variant p.C284A caspase-1 stabilizes pyroptosome formation, potentially enhancing inflammation by two IL-1-independent mechanisms: pyroptosomes convey an enhanced inflammatory stimulus through the recruitment of additional proteins (such as RIP2, receptor interacting protein kinase 2), which is further amplified through pyroptosome and cell division.	[Stein, Robert; Kapplusch, Franz; Heymann, Michael Christian; Russ, Susanne; Hedrich, Christian Michael; Roesen-Wolff, Angela; Hofmann, Sigrun Ruth] Tech Univ Dresden, Med Fak Carl Gustav Carus, Dept Pediat, D-01307 Dresden, Germany; [Staroske, Wolfgang] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Hofmann, SR (corresponding author), Univ Hosp Carl Gustav Carus, Dept Pediat, Fetscherstr 74, D-01307 Dresden, Germany.	sigrun.hofmann@uniklinikum-dresden.de	Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020	Stein, Robert/0000-0003-0896-9943; Hedrich, Christian/0000-0002-1295-6179	German Research Foundation (DFG) [KFO249, HO4510/1-2, RO/471-11]; Else Kroner Fresenius Stiftung (Else-Kroner-Promotionskolleg); Else Kroner Fresenius Stiftung (EKFS Foundation)	German Research Foundation (DFG)(German Research Foundation (DFG)); Else Kroner Fresenius Stiftung (Else-Kroner-Promotionskolleg); Else Kroner Fresenius Stiftung (EKFS Foundation)	This work was supported by German Research Foundation (DFG) Grants KFO249, TP2, HO4510/1-2 (to S. R. H.) and TP1 and RO/471-11 (to A. R. W.) and the Else Kroner Fresenius Stiftung (Else-Kroner-Promotionskolleg, EKFS Foundation) (to R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aachoui Y, 2013, CURR OPIN MICROBIOL, V16, P319, DOI 10.1016/j.mib.2013.04.004; Abdelaziz DHA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00018; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; BLASI E, 1987, EUR J IMMUNOL, V17, P1491, DOI 10.1002/eji.1830171016; Broz P, 2016, CELL RES, V26, P859, DOI 10.1038/cr.2016.67; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Broz P, 2015, NATURE, V526, P642, DOI 10.1038/nature15632; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Dick MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11929; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandez DJ, 2015, BIOL CHEM, V396, P193, DOI 10.1515/hsz-2014-0253; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Hauenstein AV, 2015, CURR OPIN STRUC BIOL, V31, P75, DOI 10.1016/j.sbi.2015.03.014; Heymann M. C., 2011, J GENET SYNDR GENE S, V3, P1; Heymann MC, 2015, CLIN IMMUNOL, V160, P172, DOI 10.1016/j.clim.2015.05.011; Heymann MC, 2014, J IMMUNOL, V192, P4379, DOI 10.4049/jimmunol.1203524; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kayalar C, 1996, P NATL ACAD SCI USA, V93, P2234, DOI 10.1073/pnas.93.5.2234; Kersse K, 2011, J BIOL CHEM, V286, P35874, DOI 10.1074/jbc.M111.242321; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Lakowicz J. R., 2010, PRINCIPLES FLUORESCE, P367; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Luksch H, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0520-5; Luksch H, 2013, HUM MUTAT, V34, P122, DOI 10.1002/humu.22169; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martin BN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5977; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Stoffels M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00054; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Zhang L, 2014, HEPATOB PANCREAT DIS, V13, P138, DOI 10.1016/S1499-3872(14)60024-2	54	9	9	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18419	18429		10.1074/jbc.M116.718668	http://dx.doi.org/10.1074/jbc.M116.718668			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402835	Green Published, hybrid			2022-12-28	WOS:000383241800032
J	Kilgore, MB; Holland, CK; Jez, JM; Kutchan, TM				Kilgore, Matthew B.; Holland, Cynthia K.; Jez, Joseph M.; Kutchan, Toni M.			Identification of a Noroxomaritidine Reductase with Amaryllidaceae Alkaloid Biosynthesis Related Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRININE-TYPE ALKALOIDS; CRYSTAL-STRUCTURE; STRICTOSIDINE SYNTHASE; SUBSTRATE-BINDING; CHAIN; 5-BETA-REDUCTASE; NORBELLADINE; CATALYSIS; LYCORINE; ENZYME	Amaryllidaceae alkaloids are a large group of plant natural products with over 300 documented structures and diverse biological activities. Several groups of Amaryllidaceae alkaloids including the hemanthamine- and crinine-type alkaloids show promise as anticancer agents. Two reduction reactions are required for the production of these compounds: the reduction of norcraugsodine to norbelladine and the reduction of noroxomaritidine to normaritidine, with the enantiomer of noroxomaritidine dictating whether the derivatives will be the crinine-type or hemanthamine-type. It is also possible for the carbon-carbon double bond of noroxomaritidine to be reduced, forming the precursor for maritinamine or elwesine depending on the enantiomer reduced to an oxomaritinamine product. In this study, a short chain alcohol dehydrogenase/reductase that co-expresses with the previously discovered norbelladine 4'-O-methyltransferase from Narcissus sp. and Galanthus spp. was cloned and expressed in Escherichia coli. Biochemical analyses and x-ray crystallography indicates that this protein functions as a noroxomaritidine reductase that forms oxomaritinamine from noroxomaritidine through a carbon-carbon double bond reduction. The enzyme also reduces norcraugsodine to norbelladine with a 400-fold lower specific activity. These studies identify a missing step in the biosynthesis of this pharmacologically important class of plant natural products.	[Kilgore, Matthew B.; Kutchan, Toni M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Kilgore, Matthew B.; Holland, Cynthia K.; Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Donald Danforth Plant Science Center; Washington University (WUSTL)	Kutchan, TM (corresponding author), 975 N Warson Rd, St Louis, MO 63132 USA.	tmkutchan@danforthcenter.org	Kutchan, Toni/L-4625-2013	Holland, Cynthia/0000-0001-6099-7998	Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092561] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research under Grant DE-AC02-06CH11357.	Abdel-Halim OB, 2004, J NAT PROD, V67, P1119, DOI 10.1021/np030529k; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banfi L., 2001, ENCY REAGENTS ORGANI; BATTERSBY A, 1961, J AM CHEM SOC, V83, P4098, DOI 10.1021/ja01480a037; BATTERSBY A, 1961, P CHEM SOC LONDON, P243; BOIT HG, 1961, NATURWISSENSCHAFTEN, V48, P406, DOI 10.1007/BF00609105; Brock A, 2008, PLANT J, V54, P388, DOI 10.1111/j.1365-313X.2008.03422.x; Deacon AM, 2000, STRUCT FOLD DES, V8, P453, DOI 10.1016/S0969-2126(00)00128-3; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evidente A, 2009, PHYTOCHEM REV, V8, P449, DOI 10.1007/s11101-008-9119-z; FEINSTEIN AI, 1976, J ORG CHEM, V41, P2447, DOI 10.1021/jo00876a020; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; FUGANTI C, 1973, GAZZ CHIM ITAL, V103, P1255; Fuganti C., 1972, J CHEM SOC CHEM COMM, V1972, P237; Gallage NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5037; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HAMPP N, 1988, PHYTOCHEMISTRY, V27, P3811, DOI 10.1016/0031-9422(88)83023-1; Havelek R, 2014, PHYTOMEDICINE, V21, P479, DOI 10.1016/j.phymed.2013.09.005; He MM, 2015, RSC ADV, V5, P16562, DOI 10.1039/c4ra14666b; Jez JM, 1998, BIOCHEMISTRY-US, V37, P9695, DOI 10.1021/bi980294p; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kilgore M. B., 2015, U. S. patent, Patent No. [WO/2015/196100, 2015196100]; Kilgore MB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00225; Kilgore MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103223; Kries H, 2016, NAT CHEM BIOL, V12, P6, DOI 10.1038/nchembio.1955; KUTCHAN TM, 1994, PHYTOCHEMISTRY, V35, P353, DOI 10.1016/S0031-9422(00)94763-0; Lamoral-Theys D, 2009, J MED CHEM, V52, P6244, DOI 10.1021/jm901031h; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moummou H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-219; PABUCCUOGLU V, 1989, J NAT PROD, V52, P785, DOI 10.1021/np50064a020; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Reinhardt N, 2014, BIOORG CHEM, V53, P37, DOI 10.1016/j.bioorg.2014.01.004; Samanani N, 2002, J BIOL CHEM, V277, P33878, DOI 10.1074/jbc.M203051200; Stavrinides A, 2015, CHEM BIOL, V22, P336, DOI 10.1016/j.chembiol.2015.02.006; SUHADOLNIK RJ, 1963, BIOCHEM BIOPH RES CO, V11, P208, DOI 10.1016/0006-291X(63)90335-8; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Widhalm JR, 2015, MOL PLANT, V8, P83, DOI 10.1016/j.molp.2014.12.001; Wilcock G, 2003, DRUG AGING, V20, P777, DOI 10.2165/00002512-200320100-00006; WILDMAN WC, 1962, P CHEM SOC LONDON, P180; Yamashita A, 1999, BIOCHEMISTRY-US, V38, P7630, DOI 10.1021/bi9825044; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x	44	31	34	4	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16740	16752		10.1074/jbc.M116.717827	http://dx.doi.org/10.1074/jbc.M116.717827			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27252378	Green Published, hybrid			2022-12-28	WOS:000380826700031
J	Niu, XH; He, WY; Song, B; Ou, ZH; Fan, D; Chen, YC; Fan, Y; Sun, XF				Niu, Xiaohua; He, Wenyin; Song, Bing; Ou, Zhanhui; Fan, Di; Chen, Yuchang; Fan, Yong; Sun, Xiaofang			Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in beta-Thalassemia-induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; IPS CELLS; RECENT TRENDS; THERAPY; GENERATION; DISEASE; PATIENT; ANEMIA; NUCLEASES; TALENS	beta-Thalassemia (beta-Thal) is one of the most common genetic diseases in the world. The generation of patient-specific beta-Thal-induced pluripotent stem cells (iPSCs), correction of the disease-causing mutations in those cells, and then differentiation into hematopoietic stem cells offers a new therapeutic strategy for this disease. Here, we designed a CRISPR/Cas9 to specifically target the Homo sapiens hemoglobin beta (HBB) gene CD41/42(-CTTT) mutation. We demonstrated that the combination of single strand oligodeoxynucleotides with CRISPR/Cas9 was capable of correcting the HBB gene CD41/42 mutation in beta-Thal iPSCs. After applying a correction-specific PCR assay to purify the corrected clones followed by sequencing to confirm mutation correction, we verified that the purified clones retained full pluripotency and exhibited normal karyotyping. Additionally, whole-exome sequencing showed that the mutation load to the exomes was minimal after CRISPR/Cas9 targeting. Furthermore, the corrected iPSCs were selected for erythroblast differentiation and restored the expression of HBB protein compared with the parental iPSCs. This method provides an efficient and safe strategy to correct the HBB gene mutation in beta-Thal iPSCs.	[Niu, Xiaohua; He, Wenyin; Song, Bing; Ou, Zhanhui; Fan, Di; Chen, Yuchang; Fan, Yong; Sun, Xiaofang] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Reprod & Genet Guangdong Higher Educ Inst, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou 510150, Guangdong, Peoples R China	Guangzhou Medical University	Sun, XF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Reprod & Genet Guangdong Higher Educ Inst, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou 510150, Guangdong, Peoples R China.	xiaofangsun@gzhmu.edu.cn			National Natural Science Foundation of China [31171229, U1132005, 81301184, 81502445]; Natural Science Foundation of Guangdong Province [2014A030312012]; International Cooperation Project of Science and Technology Planning Project of Guangdong Province [2013B51000087]; Science and Information Technology of Guangzhou [201508020258, 201400000003-4, 201400000004-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); International Cooperation Project of Science and Technology Planning Project of Guangdong Province; Science and Information Technology of Guangzhou	This work was supported by National Natural Science Foundation of China Grants 31171229, U1132005, 81301184 and 81502445; Natural Science Foundation of Guangdong Province Grant 2014A030312012; International Cooperation Project of Science and Technology Planning Project of Guangdong Province Grant 2013B51000087; and Science and Information Technology of Guangzhou Key Project Grants 201508020258, 201400000003-4, and 201400000004-4. The authors declare that they have no conflicts of interest with the contents of this article.	Bialk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129308; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Chang JC, 2006, P NATL ACAD SCI USA, V103, P1036, DOI 10.1073/pnas.0510177103; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Finotti A, 2015, J BLOOD MED, V6, P69, DOI 10.2147/JBM.S46256; Finotti A, 2014, EXPERT OPIN BIOL TH, V14, P1443, DOI 10.1517/14712598.2014.927434; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Leavitt AD, 2011, CTS-CLIN TRANSL SCI, V4, P298, DOI 10.1111/j.1752-8062.2011.00281.x; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Papapetrou EP, 2005, GENE THER, V12, pS118, DOI 10.1038/sj.gt.3302626; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Ramalingam S, 2014, CURR GENE THER, V14, P461, DOI 10.2174/1566523214666140918101725; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Sun N, 2014, BIOTECHNOL BIOENG, V111, P1048, DOI 10.1002/bit.25018; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093575; Wang YX, 2012, CELL RES, V22, P637, DOI 10.1038/cr.2012.23; Wang YX, 2009, CELL RES, V19, P1120, DOI 10.1038/cr.2009.100; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12065; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456; Yang YY, 2016, STEM CELL TRANSL MED, V5, P267, DOI 10.5966/sctm.2015-0157erratum; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	34	60	65	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16576	16585		10.1074/jbc.M116.719237	http://dx.doi.org/10.1074/jbc.M116.719237			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288406	hybrid, Green Published			2022-12-28	WOS:000380826700017
J	Prasad, S; Yadav, VR; Kannappan, R; Aggarwal, BB				Prasad, Sahdeo; Yadav, Vivek R.; Kannappan, Ramaswamy; Aggarwal, Bharat B.			RETRACTION: Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors (Retraction of vol 286, pg 5546, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		PRASAD S, 2011, EVIDENCE FOR THE REA, V286, P5546	1	5	5	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16924	16924		10.1074/jbc.A110.183699	http://dx.doi.org/10.1074/jbc.A110.183699			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27496965	hybrid, Green Published			2022-12-28	WOS:000380826700051
J	Weng, CY; Nguyen, T; Shively, JE				Weng, Chunyue; Nguyen, Tung; Shively, John E.			miRNA-342 Regulates CEACAM1-induced Lumen Formation in a Three-dimensional Model of Mammary Gland Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ADHESION MOLECULE; BILIARY GLYCOPROTEIN CD66A; BREAST EPITHELIAL-CELLS; DNA METHYLTRANSFERASE 1; LOOP-HELIX PROTEIN; CYTOPLASMIC DOMAIN; MUTATIONAL ANALYSIS; COLORECTAL-CANCER; MALIGNANT BREAST; LEUKEMIA-CELLS	Lumen formation of breast epithelium is rapidly lost during tumorigenesis along with expression of cell adhesion molecule CEACAM1. CEACAM1 induces lumena in a three-dimensional culture of MCF7/CEACAM1 cells that otherwise fail to form lumena. We hypothesized miRNAs may be involved because >400 genes were up-or down-regulated in MCF7/CEACAM1 cells and miRNAs may modify global expression patterns. Comparative analysis of miRNA expression in MCF7 versus MCF7/ CEACAM1 cells revealed two miRNAs significantly down-regulated (hsa-miR-30a-3p by 6.73-fold and hsa-miR-342-5p by 5.68-fold). Location of miR-342 within an intron of the EVL gene, hypermethylated and involved in tumorigenesis, suggested that miR-342 overexpression may block lumen formation. In fact, overexpression of miR-342 in MCF7/CEACAM1 cells significantly blocked lumen formation (p < 0.001). ID4, a dominant-negative inhibitor of basic helix-loop-helix transcription factors, up-regulated in MCF7/CEACAM1 cells, down-regulated in breast cancer, and containing a miR-342 binding site, was tested as a potential target of miR-342. The ratio of ID4 to miR-342 increased from 1: 2 in MCF7 cells to 30: 1 in MCF7/ CEACAM1 cells and a miR-342 inhibitor was able to induce 3'-UTR ID4 reporter activity in MCF7 cells. Because 5-methylcytosine methyltransferase DNMT1 is also a potential target of miR-342, we inhibited miR-342 in MCF7 cells and found DNMT1 was up-regulated with no change in EVL expression, suggesting that miR-342 regulates DNMT1 expression but DNMT1 does not affect the EVL expression in these cells. We conclude that the regulation of lumen formation by miR-342 involves at least two of its known targets, namely ID4 and DNMT1.	[Weng, Chunyue] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Weng, Chunyue; Nguyen, Tung; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), 1450 E Duarte Rd, Duarte, CA 91010 USA.	jshively@coh.org			National Institutes of Health [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA84202. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2010, EXP CELL RES, V316, P638, DOI 10.1016/j.yexcr.2009.11.001; Chinaranagari S, 2014, ONCOTARGET, V5, P7172, DOI 10.18632/oncotarget.2262; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Crippa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087039; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Dery KJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-64; Ferrari N, 2013, J CELL PHYSIOL, V228, P1137, DOI 10.1002/jcp.24285; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang J, 1998, ANTICANCER RES, V18, P3203; Huang J, 1999, J CELL SCI, V112, P4193; Kirshner J, 2004, J MOL HISTOL, V35, P287, DOI 10.1023/B:HIJO.0000032360.01976.81; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Li CX, 2009, EXP CELL RES, V315, P1225, DOI 10.1016/j.yexcr.2008.12.015; Li XR, 2014, FEBS LETT, V588, P3298, DOI 10.1016/j.febslet.2014.07.020; Lu RZ, 2012, CANCER RES, V72, P2239, DOI 10.1158/0008-5472.CAN-11-3016; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; MCCUAIG K, 1993, GENE, V127, P173, DOI 10.1016/0378-1119(93)90716-G; Mohan KN, 2013, INT REV CEL MOL BIO, V306, P1, DOI 10.1016/B978-0-12-407694-5.00001-8; Nagaoka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065127; Nguyen T, 2016, J BIOL CHEM, V291, P16766, DOI 10.1074/jbc.M115.710160; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; Ozeki M, 2008, J LEUKOCYTE BIOL, V84, P769, DOI 10.1189/jlb.1207817; Pan H, 2010, IMMUNITY, V33, P620, DOI 10.1016/j.immuni.2010.10.009; Patel D, 2015, BBA-REV CANCER, V1855, P92, DOI 10.1016/j.bbcan.2014.12.002; Piao HL, 2012, J MAMMARY GLAND BIOL, V17, P33, DOI 10.1007/s10911-012-9245-5; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; RIECHMANN V, 1994, NUCLEIC ACIDS RES, V22, P749, DOI 10.1093/nar/22.5.749; Ronchetti D, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-37; Rotter B, 2005, BIOCHEM J, V388, P631, DOI 10.1042/BJ20041502; Sutherland KD, 2007, CELL CYCLE, V6, P799, DOI 10.4161/cc.6.7.4037; Tandon M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3611; Tao K, 2014, AM J TRANSL RES, V6, P391; Nguyen T, 2014, J BIOL CHEM, V289, P2934, DOI 10.1074/jbc.M113.496992; Umetani N, 2004, CLIN CANCER RES, V10, P7475, DOI 10.1158/1078-0432.CCR-04-0689; Umetani N, 2005, ONCOGENE, V24, P4721, DOI 10.1038/sj.onc.1208538; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wang LL, 2012, ANTIVIR RES, V93, P270, DOI 10.1016/j.antiviral.2011.12.004; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Xie X, 2015, TUMOR BIOL, V36, P5031, DOI 10.1007/s13277-015-3154-3; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053359; Zhao L, 2015, BIOCHEM BIOPH RES CO, V457, P370, DOI 10.1016/j.bbrc.2014.12.119	52	12	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16777	16786		10.1074/jbc.M115.710152	http://dx.doi.org/10.1074/jbc.M115.710152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27302063	Green Published, hybrid			2022-12-28	WOS:000380826700034
J	Sinha, D; Srivastava, S; D'Silva, P				Sinha, Devanjan; Srivastava, Shubhi; D'Silva, Patrick			Functional Diversity of Human Mitochondrial J-proteins Is Independent of Their Association with the Inner Membrane Presequence Translocase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); chaperone DnaJ (DnaJ); mitochondria; mitochondrial transport; molecular chaperone; protein folding; J-protiens; import motor; mtHsp70	TIM23 PREPROTEIN TRANSLOCASE; IMPORT MOTOR; PRECURSOR PROTEINS; OVARIAN-CANCER; MCJ GENE; J-DOMAIN; HSP70; YEAST; METHYLATION; CHAPERONES	Mitochondrial J-proteins play a critical role in governing Hsp70 activity and, hence, are essential for organellar protein translocation and folding. In contrast to yeast, which has a single J-protein Pam18, humans involve two J-proteins, DnaJC15 and DnaJC19, associated with contrasting cellular phenotype, to transport proteins into the mitochondria. Mutation in DnaJC19 results in dilated cardiomyopathy and ataxia syndrome, whereas expression of DnaJC15 regulates the response of cancer cells to chemotherapy. In the present study we have comparatively assessed the biochemical properties of the J-protein paralogs in relation to their association with the import channel. Both DnaJC15 and DnaJC19 formed two distinct subcomplexes with Magmas at the import channel. Knockdown analysis suggested an essential role for Magmas and DnaJC19 in organellar protein translocation and mitochondria biogenesis, whereas DnaJC15 had dispensable supportive function. The J-proteins were found to have equal affinity for Magmas and could stimulate mitochondrial Hsp70 ATPase activity by equivalent levels. Interestingly, we observed that DnaJC15 exhibits bifunctional properties. At the translocation channel, it involves conserved interactions and mechanism to translocate the precursors into mitochondria. In addition to protein transport, DnaJC15 also showed a dual role in yeast where its expression elicited enhanced sensitivity of cells to cisplatin that required the presence of a functional J-domain. The amount of DnaJC15 expressed in the cell was directly proportional to the sensitivity of cells. Our analysis indicates that the differential cellular phenotype displayed by human mitochondrial J-proteins is independent of their activity and association with Magmas at the translocation channel.	[Sinha, Devanjan; Srivastava, Shubhi; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India; [Sinha, Devanjan] Banaras Hindu Univ, Dept Zool, Inst Sci, Varanasi 221005, Uttar Pradesh, India	Indian Institute of Science (IISC) - Bangalore; Banaras Hindu University (BHU)	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	D'Silva, Patrick/L-6653-2019; Sinha, Devanjan/A-3953-2017	Sinha, Devanjan/0000-0001-5060-2075	Swarnajayanti Fellowship, Department of Science and Technology (DST), India; Council of Scientific and Industrial Research Fellowship; Department of Science and Technology INSPIRE Fellowship	Swarnajayanti Fellowship, Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research Fellowship(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology INSPIRE Fellowship(Department of Science & Technology (India))	This work was supported by Swarnajayanti Fellowship, Department of Science and Technology (DST), India (to P. D. S), Council of Scientific and Industrial Research Fellowship (to D. S), and Department of Science and Technology INSPIRE Fellowship (to S. S). The authors declare that they have no conflicts of interest with the contents of this article.	Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Hatle KM, 2007, MOL CELL BIOL, V27, P2952, DOI 10.1128/MCB.01804-06; Hatle KM, 2013, MOL CELL BIOL, V33, P2302, DOI 10.1128/MCB.00189-13; Kamenskii P A, 2007, Mol Biol (Mosk), V41, P216; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lindsey JC, 2006, INT J CANCER, V118, P346, DOI 10.1002/ijc.21353; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Mokranjac D, 2005, J BIOL CHEM, V280, P31608, DOI 10.1074/jbc.M502397200; Mokranjac D, 2007, J BIOL CHEM, V282, P18037, DOI 10.1074/jbc.M701895200; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ojala T, 2012, PEDIATR RES, V72, P432, DOI 10.1038/pr.2012.92; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Schusdziarra C, 2013, HUM MOL GENET, V22, P1348, DOI 10.1093/hmg/dds541; Shridhar V, 2001, CANCER RES, V61, P4258; Sinha D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.72; Sinha D, 2014, MOL CELL BIOL, V34, P1757, DOI 10.1128/MCB.01527-13; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Srivastava S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.355; Strathdee G, 2005, GYNECOL ONCOL, V97, P898, DOI 10.1016/j.ygyno.2005.03.023; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0	43	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17345	17359		10.1074/jbc.M116.738146	http://dx.doi.org/10.1074/jbc.M116.738146			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27330077	hybrid, Green Published			2022-12-28	WOS:000382643800034
J	Bang, YJ; Lee, ZW; Kim, D; Jo, I; Ha, NC; Choi, SH				Bang, Ye-Ji; Lee, Zee-Won; Kim, Dukyun; Jo, Inseong; Ha, Nam-Chul; Choi, Sang Ho			OxyR2 Functions as a Three-state Redox Switch to Tightly Regulate Production of Prx2, a Peroxiredoxin of Vibrio vulnificus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTINCT CHARACTERISTICS; OXIDATIVE STRESS; EXPRESSION; PEROXIDE; ACTIVATION; MECHANISMS; PROTEIN	The bacterial transcriptional regulator OxyR is known to function as a two-state redox switch. OxyR senses cellular levels of H2O2 via a "sensing cysteine" that switches from the reduced to a disulfide state upon H2O2 exposure, inducing the expression of antioxidant genes. The reduced and disulfide states of OxyR, respectively, bind to extended and compact regions of DNA, where the reduced state blocks and the oxidized state allows transcription and further induces target gene expression by interacting with RNA polymerase. Vibrio vulnificus OxyR2 senses H2O2 with high sensitivity and induces the gene encoding the antioxidant Prx2. In this study, we used mass spectrometry to identify a third redox state of OxyR2, in which the sensing cysteine was overoxidized to S-sulfonated cysteine (Cys-SO3H) by high H2O2 in vitro and in vivo, where the modification deterred the transcription of prx2. The DNA binding preferences of OxyR2(5CA)-C206D, which mimics overoxidized OxyR2, suggested that overoxidized OxyR2 binds to the extended DNA site, masking the -35 region of the prx2 promoter. These combined results demonstrate that OxyR2 functions as a three-state redox switch to tightly regulate the expression of prx2, preventing futile production of Prx2 in cells exposed to high levels of H2O2 sufficient to inactivate Prx2. We further provide evidence that another OxyR homolog, OxyR1, displays similar three-state behavior, inviting further exploration of this phenomenon as a potentially general regulatory mechanism.	[Bang, Ye-Ji; Lee, Zee-Won; Kim, Dukyun; Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 08826, South Korea; [Bang, Ye-Ji; Lee, Zee-Won; Kim, Dukyun; Jo, Inseong; Ha, Nam-Chul; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea; [Bang, Ye-Ji; Lee, Zee-Won; Kim, Dukyun; Jo, Inseong; Ha, Nam-Chul; Choi, Sang Ho] Seoul Natl Univ, Ctr Food Safety & Toxicol, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 08826, South Korea.; Ha, NC; Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea.; Ha, NC; Choi, SH (corresponding author), Seoul Natl Univ, Ctr Food Safety & Toxicol, Seoul 08826, South Korea.	hanc210@snu.ac.kr; choish@snu.ac.kr	Jo, Inseong/AGY-9957-2022	Choi, Sang Ho/0000-0003-3865-1039; Jo, Inseong/0000-0002-7964-4751; Lee, Zee-Won/0000-0003-0376-1860; Bang, Ye-Ji/0000-0003-4009-0824	Mid-career Researcher Program Grant through the National Research Foundation [2015R1A2A1A13001654]; Ministry of Science, ICT, and Future Planning; RAMP;D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	Mid-career Researcher Program Grant through the National Research Foundation; Ministry of Science, ICT, and Future Planning; RAMP;D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	This work was supported by Mid-career Researcher Program Grant 2015R1A2A1A13001654 through the National Research Foundation, funded by the Ministry of Science, ICT, and Future Planning (to S. H. C.) and the R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs (to S. H. C. and N.-C. H.), Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Bang YJ, 2012, J BIOL CHEM, V287, P42516, DOI 10.1074/jbc.M112.421214; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Dong Tao, 2008, P313, DOI 10.1007/978-3-540-74921-9_11; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Groitl B, 2014, BBA-PROTEINS PROTEOM, V1844, P1335, DOI 10.1016/j.bbapap.2014.03.007; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; Janek K, 2001, RAPID COMMUN MASS SP, V15, P1593, DOI 10.1002/rcm.417; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Klauck E, 2012, BACTERIAL REGULATORY NETWORKS, P1; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Lim JG, 2014, J BIOL CHEM, V289, P36263, DOI 10.1074/jbc.M114.611020; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Seo SW, 2015, CELL REP, V12, P1289, DOI 10.1016/j.celrep.2015.07.043; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; TAO K, 1993, MOL MICROBIOL, V7, P859, DOI 10.1111/j.1365-2958.1993.tb01176.x; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tseng HJ, 2003, INFECT IMMUN, V71, P550, DOI 10.1128/IAI.71.1.550-556.2003; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	26	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16038	16047		10.1074/jbc.M115.710343	http://dx.doi.org/10.1074/jbc.M115.710343			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27268058	hybrid, Green Published			2022-12-28	WOS:000380585400010
J	Rezaei-Ghaleh, N; Kumar, S; Walter, J; Zweckstetter, M				Rezaei-Ghaleh, Nasrollah; Kumar, Sathish; Walter, Jochen; Zweckstetter, Markus			Phosphorylation Interferes with Maturation of Amyloid-beta Fibrillar Structure in the N Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; ALPHA-SYNUCLEIN CLEARANCE; ALZHEIMERS-DISEASE; A-BETA; POSTTRANSLATIONAL MODIFICATIONS; PEPTIDE; PROTEIN; AGGREGATION; TOXICITY; DYNAMICS	Neurodegeneration is characterized by the ubiquitous presence of modifications in protein deposits. Despite their potential significance in the initiation and progression of neurodegenerative diseases, the effects of posttranslational modifications on the molecular properties of protein aggregates are largely unknown. Here, we study the Alzheimer disease-related amyloid-beta (A beta) peptide and investigate how phosphorylation at serine 8 affects the structure of A beta aggregates. Serine 8 is shown to be located in a region of high conformational flexibility in monomeric A beta, which upon phosphorylation undergoes changes in local conformational dynamics. Using hydrogen-deuterium exchange NMR and fluorescence quenching techniques, we demonstrate that A beta phosphorylation at serine 8 causes structural changes in the N-terminal region of A beta aggregates in favor of less compact conformations. Structural changes induced by serine 8 phosphorylation can provide a mechanistic link between phosphorylation and other biological events that involve the N-terminal region of A beta aggregates. Our data therefore support an important role of posttranslational modifications in the structural polymorphism of amyloid aggregates and their modulatory effect on neurodegeneration.	[Rezaei-Ghaleh, Nasrollah; Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, Von Siebold Str 3a, D-37075 Gottingen, Germany; [Rezaei-Ghaleh, Nasrollah; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany; [Kumar, Sathish; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Zweckstetter, Markus] Univ Gottingen, Univ Med Ctr, Dept Neurol, Waldweg 33, D-37073 Gottingen, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; University of Bonn; University of Gottingen	Rezaei-Ghaleh, N; Zweckstetter, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Von Siebold Str 3a, D-37075 Gottingen, Germany.	nare@nmr.mpibpc.mpg.de; markus.zweckstetter@dzne.de	Wang, Caihong/T-5837-2019; Rezaei-Ghaleh, Nasrollah/B-9443-2008; Walter, Jochen/B-3677-2014; Kumar, Sathish/L-1367-2019	Wang, Caihong/0000-0002-6808-3709; Rezaei-Ghaleh, Nasrollah/0000-0001-6935-6564; Walter, Jochen/0000-0002-4678-2912; Kumar, Sathish/0000-0002-2792-7047; Zweckstetter, Markus/0000-0002-2536-6581				Abelein A, 2014, J BIOL INORG CHEM, V19, P623, DOI 10.1007/s00775-014-1131-8; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Das AK, 2015, ACS CHEM NEUROSCI, V6, P1290, DOI 10.1021/acschemneuro.5b00074; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Fandrich M., 2011, TRENDS BIOCHEM SCI, V36, P338; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Goddard T. D, 2007, SPARKY 3; Goncalves S, 2013, MOL NEUROBIOL, V47, P1081, DOI 10.1007/s12035-013-8406-x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haupt C, 2012, ANGEW CHEM INT EDIT, V51, P1576, DOI 10.1002/anie.201105638; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Hoyer W, 2008, J MOL BIOL, V378, P398, DOI 10.1016/j.jmb.2008.02.040; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Kumar S, 2016, ACTA NEUROPATHOL, V131, P525, DOI 10.1007/s00401-016-1546-0; Kumar S, 2012, J BIOL CHEM, V287, P8641, DOI 10.1074/jbc.M111.279133; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lim KH, 2007, CHEMBIOCHEM, V8, P1251, DOI 10.1002/cbic.200700194; Mahul-Mellier AL, 2014, HUM MOL GENET, V23, P2858, DOI 10.1093/hmg/ddt674; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Morgado I, 2015, ADV EXP MED BIOL, V855, P67, DOI 10.1007/978-3-319-17344-3_3; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Parthasarathy S, 2011, J AM CHEM SOC, V133, P3390, DOI 10.1021/ja1072178; Qiang W, 2014, BIOCHEMISTRY-US, V53, P7503, DOI 10.1021/bi501003n; Rezaei-Ghaleh N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11359; Rezaei-Ghaleh N, 2014, J AM CHEM SOC, V136, P4913, DOI 10.1021/ja411707y; Rezaei-Ghaleh N, 2011, BIOPHYS J, V101, P1202, DOI 10.1016/j.bpj.2011.06.062; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Russell CL, 2014, J ALZHEIMERS DIS, V41, P345, DOI 10.3233/JAD-132312; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schmid AW, 2013, MOL CELL PROTEOMICS, V12, P3543, DOI 10.1074/mcp.R113.032730; Shao HY, 1999, J MOL BIOL, V285, P755, DOI 10.1006/jmbi.1998.2348; Tenreiro S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00042; Tenreiro S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004302; Thal DR, 2015, ACTA NEUROPATHOL, V129, P167, DOI 10.1007/s00401-014-1375-y; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Upadhaya AR, 2014, BRAIN, V137, P887, DOI 10.1093/brain/awt362; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293	50	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16059	16067		10.1074/jbc.M116.728956	http://dx.doi.org/10.1074/jbc.M116.728956			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27252381	Green Published, hybrid			2022-12-28	WOS:000380585400012
J	Hudson, CD; Morris, PJ; Latchman, DS; Budhram-Mahadeo, VS				Hudson, Chantelle D.; Morris, Peter J.; Latchman, David S.; Budhram-Mahadeo, Vishwanie S.			Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate (vol 280, pg 11851, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Hudson CD, 2005, J BIOL CHEM, V280, P11851, DOI 10.1074/jbc.M408679200	1	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15909	15909		10.1074/jbc.A116.408679	http://dx.doi.org/10.1074/jbc.A116.408679			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27451431	Green Published, hybrid			2022-12-28	WOS:000380584200042
J	LaMattina, JW; Keul, ND; Reitzer, P; Kapoor, S; Galzerani, F; Koch, DJ; Gouvea, IE; Lanzilotta, WN				LaMattina, Joseph W.; Keul, Nicholas D.; Reitzer, Pierre; Kapoor, Suraj; Galzerani, Felipe; Koch, Daniel J.; Gouvea, Iuri E.; Lanzilotta, William N.			1,2-Propanediol Dehydration in Roseburia inulinivorans STRUCTURAL BASIS FOR SUBSTRATE AND ENANTIOMER SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE FORMATE-LYASE; ESCHERICHIA-COLI PYRUVATE; BENZYLSUCCINATE SYNTHASE; RIBONUCLEOTIDE REDUCTASE; ACTIVATING ENZYME; CRYSTAL-STRUCTURE; MECHANISM; GLYCEROL; 1,3-PROPANEDIOL; CHOLINE	Glycyl radical enzymes (GREs) represent a diverse superfamily of enzymes that utilize a radical mechanism to catalyze difficult, but often essential, chemical reactions. In this work we present the first biochemical and structural data for a GRE-type diol dehydratase from the organism Roseburia inulinivorans (RiDD). Despite high sequence (48% identity) and structural similarity to the GRE-type glycerol dehydratase from Clostridium butyricum, we demonstrate that the RiDD is in fact a diol dehydratase. In addition, the RiDD will utilize both (S)-1,2-propanediol and (R)-1,2-propanediol as a substrate, with an observed preference for the S enantiomer. Based on the new structural information we developed and successfully tested a hypothesis that explains the functional differences we observe.	[LaMattina, Joseph W.; Keul, Nicholas D.; Reitzer, Pierre; Kapoor, Suraj; Lanzilotta, William N.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Galzerani, Felipe; Koch, Daniel J.; Gouvea, Iuri E.] BRASKEM SA, Rua Lemos Moonteiro, BR-05501050 Sao Paulo, SP, Brazil	University System of Georgia; University of Georgia; Braskem	Lanzilotta, WN (corresponding author), Univ Georgia, Dept Biochem, A220B Davison Life Sci Bldg,Green St, Athens, GA 30602 USA.	wlanzilo@bmb.uga.edu		Keul, Nicholas/0000-0002-5302-006X				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Bharadwaj VS, 2013, J AM CHEM SOC, V135, P12279, DOI 10.1021/ja404842r; Bruender NA, 2015, BIOCHEMISTRY-US, V54, P2903, DOI 10.1021/acs.biochem.5b00210; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHROMY V, 1974, CLIN CHEM, V20, P1362; Craciun S, 2014, ACS CHEM BIOL, V9, P1408, DOI 10.1021/cb500113p; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Crain AV, 2014, J BIOL CHEM, V289, P5723, DOI 10.1074/jbc.M113.496877; DANIEL R, 1995, J BACTERIOL, V177, P2151, DOI 10.1128/jb.177.8.2151-2156.1995; Demick JM, 2011, BIOCHEMISTRY-US, V50, P440, DOI 10.1021/bi101255e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feliks M, 2013, J AM CHEM SOC, V135, P14574, DOI 10.1021/ja402379q; Feliks M, 2012, J PHYS CHEM B, V116, P7076, DOI 10.1021/jp301165b; FREY M, 1994, J BIOL CHEM, V269, P12432; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; Funk MA, 2014, P NATL ACAD SCI USA, V111, P10161, DOI 10.1073/pnas.1405983111; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Henshaw TF, 2000, J AM CHEM SOC, V122, P8331, DOI 10.1021/ja002012q; Hioe J, 2011, CHEM-EUR J, V17, P3781, DOI 10.1002/chem.201002620; Jarboe LR, 2011, APPL MICROBIOL BIOT, V89, P249, DOI 10.1007/s00253-010-2912-9; Kalnins G, 2015, J BIOL CHEM, V290, P21732, DOI 10.1074/jbc.M115.670471; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1111/j.1574-6968.1990.tb04108.x; KNAPPE J, 1995, METHOD ENZYMOL, V258, P343; KNAPPE J, 1993, BIOCHEM SOC T, V21, P731, DOI 10.1042/bst0210731; Krieger CJ, 2001, J BIOL CHEM, V276, P12924, DOI 10.1074/jbc.M009453200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; LAUE TM, 1986, BIOPHYS J, V49, pA274; Lehtio L, 2002, ACTA CRYSTALLOGR D, V58, P2209, DOI 10.1107/S0907444902016402; Leppanen VM, 1999, ACTA CRYSTALLOGR D, V55, P531, DOI 10.1107/S0907444998011056; Leppanen VM, 1999, STRUCT FOLD DES, V7, P733, DOI 10.1016/S0969-2126(99)80098-7; Li L, 2009, BIOCHEMISTRY-US, V48, P1284, DOI 10.1021/bi801766g; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Martins BM, 2011, J AM CHEM SOC, V133, P14666, DOI 10.1021/ja203344x; Nnyepi MR, 2007, ARCH BIOCHEM BIOPHYS, V459, P1, DOI 10.1016/j.abb.2006.12.024; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Ofer A, 2011, J BACTERIOL, V193, P2931, DOI 10.1128/JB.01405-10; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Peng Y, 2010, J BIOL CHEM, V285, P27224, DOI 10.1074/jbc.M109.096875; Pontes H, 2009, J CHROMATOGR SCI, V47, P272, DOI 10.1093/chromsci/47.4.272; Raynaud C, 2003, P NATL ACAD SCI USA, V100, P5010, DOI 10.1073/pnas.0734105100; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Selmer T, 2005, BIOL CHEM, V386, P981, DOI 10.1515/BC.2005.114; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Shibata N, 2003, J BIOL CHEM, V278, P22717, DOI 10.1074/jbc.M301513200; Shisler KA, 2014, ARCH BIOCHEM BIOPHYS, V546, P64, DOI 10.1016/j.abb.2014.01.020; SOTTOCAS.GL, 1971, EXPERIENTIA, V27, P1247, DOI 10.1007/BF02286956; Sulzenbacher G, 2004, J MOL BIOL, V342, P489, DOI 10.1016/j.jmb.2004.07.034; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; SUN XY, 1995, J BIOL CHEM, V270, P2443, DOI 10.1074/jbc.270.6.2443; Toraya T, 2002, CHEM REC, V2, P352, DOI 10.1002/tcr.10035; Toraya T, 2002, SEIKAGAKU, V74, P87; Trivic S, 1998, J ENZYM INHIB, V13, P57, DOI 10.3109/14756369809035827; Yamanishi M, 2012, FEBS J, V279, P793, DOI 10.1111/j.1742-4658.2012.08470.x; Zhuge B, 2010, APPL MICROBIOL BIOT, V87, P2177, DOI 10.1007/s00253-010-2678-0	57	22	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15515	15526		10.1074/jbc.M116.721142	http://dx.doi.org/10.1074/jbc.M116.721142			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27252380	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000380584200009
J	Wei, QE; Ran, TT; Ma, CC; He, JH; Xu, DQ; Wang, WW				Wei, Qiaoe; Ran, Tingting; Ma, Chencui; He, Jianhua; Xu, Dongqing; Wang, Weiwu			Crystal Structure and Function of PqqF Protein in the Pyrroloquinoline Quinone Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-DEGRADING ENZYME; MITOCHONDRIAL PROCESSING PEPTIDASE; GLUCOSE-DEHYDROGENASE; SERRATIA-MARCESCENS; ACINETOBACTER-CALCOACETICUS; METHANOL DEHYDROGENASE; PRODIGIOSIN PRODUCTION; KLEBSIELLA-PNEUMONIAE; RESPIRATORY-CHAIN; MASS-SPECTROMETRY	Pyrroloquinoline quinone (PQQ) has received considerable attention due to its numerous important physiological functions. PqqA is a precursor peptide of PQQ with two conserved residues: glutamate and tyrosine. After linkage of the C gamma of glutamate and C epsilon of tyrosine by PqqE, these two residues are hypothesized to be cleaved from PqqA by PqqF. The linked glutamate and tyrosine residues are then used to synthesize PQQ. Here, we demonstrated that the pqqF gene is essential for PQQ biosynthesis as deletion of it eliminated the inhibition of prodigiosin production by glucose. We further determined the crystal structure of PqqF, which has a closed clamshell-like shape. The PqqF consists of two halves composed of an N-and a C-terminal lobe. The PqqF-N and PqqF-C lobes form a chamber with the volume of the cavity of similar to 9400 angstrom(3). The PqqF structure conforms to the general structure of inverzincins. Compared with the most thoroughly characterized inverzincin insulin-degrading enzyme, the size of PqqF chamber is markedly smaller, which may define the specificity for its substrate PqqA. Furthermore, the 14-amino acid-residue-long tag formed by the N-terminal tag from expression vector precisely protrudes into the counterpart active site; this N-terminal tag occupies the active site and stabilizes the closed, inactive conformation. His-48, His-52, Glu-129 and His-14 from the N-terminal tag coordinate with the zinc ion. Glu-51 acts as a base catalyst. The observed histidine residue-mediated inhibition may be applicable for the design of a peptide for the inhibition of M16 metalloproteases.	[Wei, Qiaoe; Ran, Tingting; Ma, Chencui; Xu, Dongqing; Wang, Weiwu] Nanjing Agr Univ, Dept Microbiol, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China; [He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China	Nanjing Agricultural University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Xu, DQ; Wang, WW (corresponding author), Nanjing Agr Univ, Dept Microbiol, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.	dqxu@njau.edu.cn; wwwang@njau.edu.cn	wang, weiwu/AAD-1490-2022	, Tingting/0000-0002-5541-3553; , weiwu/0000-0001-6922-9207; Xu, Dongqing/0000-0002-8388-2330	National Natural Science Foundation of Chain [31100028, 31170686, 31400055]; Natural Science Foundation of Jiangsu Province [BK20140690]; Youth Science and Technology Innovation Fund from Nanjing Agricultural University [KJ2013027]	National Natural Science Foundation of Chain(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Youth Science and Technology Innovation Fund from Nanjing Agricultural University	This work was supported by National Natural Science Foundation of Chain Grants 31100028, 31170686, and 31400055, Natural Science Foundation of Jiangsu Province Grant BK20140690, and a grant from the Youth Science and Technology Innovation Fund from Nanjing Agricultural University (KJ2013027). The authors declare that they have no conflicts of interest associated with the contents of this manuscript.	AIZENMAN E, 1992, J NEUROSCI, V12, P2362; Aleshin AE, 2009, STRUCTURE, V17, P1465, DOI 10.1016/j.str.2009.09.009; Anthony C, 2004, ARCH BIOCHEM BIOPHYS, V428, P2, DOI 10.1016/j.abb.2004.03.038; Bennett RG, 1997, DIABETES, V46, P197, DOI 10.2337/diabetes.46.2.197; BUNTING MI, 1949, J BACTERIOL, V58, P114, DOI 10.1128/JB.58.1.114-115.1949; Charton J, 2015, EUR J MED CHEM, V90, P547, DOI 10.1016/j.ejmech.2014.12.005; Charton J, 2014, EUR J MED CHEM, V79, P184, DOI 10.1016/j.ejmech.2014.04.009; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; DeLano W.L, PYMOL MOL GRAPHICS S; DEMAIN AL, 1995, SYMP SOC GEN MICROBI, V53, P205; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; Duine JA, 2001, CHEM REC, V1, P74; DUINE JA, 1980, EUR J BIOCHEM, V108, P187, DOI 10.1111/j.1432-1033.1980.tb04711.x; Durham TB, 2015, J BIOL CHEM, V290, P20044, DOI 10.1074/jbc.M115.638205; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fender JE, 2012, APPL ENVIRON MICROB, V78, P6225, DOI 10.1128/AEM.01778-12; GERBER N N, 1975, Critical Reviews in Microbiology, V3, P469, DOI 10.3109/10408417509108758; GOOSEN N, 1989, A VAN LEEUW J MICROB, V56, P85, DOI 10.1007/BF00822588; GROEN BW, 1990, METHOD ENZYMOL, V188, P33; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Hao GF, 2012, J AM CHEM SOC, V134, P11168, DOI 10.1021/ja3001908; He K, 2003, BIOCHEM PHARMACOL, V65, P67, DOI 10.1016/S0006-2952(02)01453-3; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Johnson KA, 2006, EMBO J, V25, P1977, DOI 10.1038/sj.emboj.7601080; Krishnaraj PU, 2001, FEMS MICROBIOL LETT, V205, P215, DOI 10.1111/j.1574-6968.2001.tb10950.x; Latham JA, 2015, J BIOL CHEM, V290, P12908, DOI 10.1074/jbc.M115.646521; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Magnusson OT, 2004, J AM CHEM SOC, V126, P5342, DOI 10.1021/ja0493852; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104851; MATSUSHITA K, 1987, J BACTERIOL, V169, P205, DOI 10.1128/jb.169.1.205-209.1987; McCord LA, 2013, P NATL ACAD SCI USA, V110, P13827, DOI 10.1073/pnas.1304575110; Metlitzky M, 2012, JBPC, V3, P206, DOI DOI 10.4236/JBPC.2012.32023; MEULENBERG JJM, 1990, FEMS MICROBIOL LETT, V71, P337, DOI 10.1016/0378-1097(90)90244-K; MEULENBERG JJM, 1992, MOL GEN GENET, V232, P284, DOI 10.1007/BF00280008; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Muhl D, 2014, METHODS MOL BIOL, V1149, P521, DOI 10.1007/978-1-4939-0473-0_40; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagao Y, 2000, J BIOL CHEM, V275, P34552, DOI 10.1074/jbc.M003110200; Nakano M, 2015, J NUTR SCI VITAMINOL, V61, P241, DOI 10.3177/jnsv.61.241; Noji N, 2007, J AGR FOOD CHEM, V55, P7258, DOI 10.1021/jf070483r; Ohtsuka J, 2009, PROTEINS, V75, P774, DOI 10.1002/prot.22365; Puehringer Sandra, 2008, BMC Biochemistry, V9, P8, DOI 10.1186/1471-2091-9-8; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Sarker MR, 1997, MOL MICROBIOL, V23, P410, DOI 10.1046/j.1365-2958.1997.t01-1-00190.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarzenbacher R, 2004, PROTEINS, V56, P401, DOI 10.1002/prot.20085; Shen YQ, 2012, BIOCHEMISTRY-US, V51, P2265, DOI 10.1021/bi201763d; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sole M, 1997, LETT APPL MICROBIOL, V25, P81, DOI 10.1046/j.1472-765X.1997.00171.x; Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205; Takeda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115722; Tao R, 2015, INFLAMMATION, V38, P1546, DOI 10.1007/s10753-015-0129-x; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Toyama H, 1997, MICROBIOL-SGM, V143, P595, DOI 10.1099/00221287-143-2-595; Tsai TY, 2009, PROTEINS, V76, P1042, DOI 10.1002/prot.22461; Umezawa K, 2015, J BACTERIOL, V197, P1322, DOI 10.1128/JB.02376-14; VANKLEEF MAG, 1988, ARCH MICROBIOL, V150, P32, DOI 10.1007/BF00409714; VANKLEEF MAG, 1988, FEBS LETT, V237, P91, DOI 10.1016/0014-5793(88)80178-9; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; WESTERLING J, 1979, BIOCHEM BIOPH RES CO, V87, P719, DOI 10.1016/0006-291X(79)92018-7; Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Zhang CL, 2015, MOL MED REP, V12, P4382, DOI 10.3892/mmr.2015.3990	70	15	16	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15575	15587		10.1074/jbc.M115.711226	http://dx.doi.org/10.1074/jbc.M115.711226			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231346	hybrid, Green Published			2022-12-28	WOS:000380584200014
J	Gohara, DW; Di Cera, E				Gohara, David W.; Di Cera, Enrico			Molecular Mechanisms of Enzyme Activation by Monovalent Cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ALPHA-KETOACID DEHYDROGENASE; MUSCLE PYRUVATE-KINASE; CRYSTAL-STRUCTURE; NA+ BINDING; ACTIVE-SITE; 3-DIMENSIONAL STRUCTURE; ALLOSTERIC REGULATION; METAL-IONS; BETA-GALACTOSIDASE; CATALYTIC-ACTIVITY	Regulation of enzymes through metal ion complexation is widespread in biology and underscores a physiological need for stability and high catalytic activity that likely predated proteins in the RNA world. In addition to divalent metals such as Ca2+, Mg2+, and Zn2+, monovalent cations often function as efficient and selective promoters of catalysis. Advances in structural biology unravel a rich repertoire of molecular mechanisms for enzyme activation by Na+ and K+. Strategies range from short-range effects mediated by direct participation in substrate binding, to more distributed effects that propagate long-range to catalytic residues. This review addresses general considerations and examples.	[Gohara, David W.; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu		Gohara, David/0000-0001-8799-9125	National Institutes of Health Research [HL049413, HL073813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049413, U54HL112303, R01HL073813, R01HL049413] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health Research Grants HL049413, HL073813, and HL112303 (to E. D. C.). This is the first article in the Thematic Minireview series "Metals in Biology 2016: Molecular Basis of Selection of Metals by Enzymes." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AEvarsson A, 2000, STRUCTURE, V8, P277, DOI 10.1016/S0969-2126(00)00105-2; Andersson CE, 2002, J MOL BIOL, V315, P409, DOI 10.1006/jmbi.2001.5248; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Boyer Paul D., 1942, JOUR BIOL CHEM, V146, P673; Bush LA, 2006, J BIOL CHEM, V281, P7183, DOI 10.1074/jbc.M512082200; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; De Filippis V, 2005, BIOCHEM J, V390, P485, DOI 10.1042/BJ20050252; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; Dierkers AT, 2009, BIOCHEMISTRY-US, V48, P10997, DOI 10.1021/bi9008374; Dunn MF, 2012, ARCH BIOCHEM BIOPHYS, V519, P154, DOI 10.1016/j.abb.2012.01.016; EVANS HJ, 1966, ANN REV PLANT PHYSIO, V17, P47, DOI 10.1146/annurev.pp.17.060166.000403; Fedor MJ, 2002, CURR OPIN STRUC BIOL, V12, P289, DOI 10.1016/S0959-440X(02)00324-X; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gallagher DT, 2004, J MOL BIOL, V342, P119, DOI 10.1016/j.jmb.2004.06.090; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gonzalez B, 2000, J MOL BIOL, V300, P363, DOI 10.1006/jmbi.2000.3858; Goswami T, 2002, BIOCHEM CELL BIOL, V80, P679, DOI 10.1139/O02-159; Hall DR, 1999, J MOL BIOL, V287, P383, DOI 10.1006/jmbi.1999.2609; Hall DR, 2002, J BIOL CHEM, V277, P22018, DOI 10.1074/jbc.M202464200; Hayashi J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11674; Hedstrom L, 2012, CRIT REV BIOCH; Hiller DA, 2011, PHILOS T R SOC B, V366, P2929, DOI 10.1098/rstb.2011.0143; HOHENESTER E, 1994, BIOCHEMISTRY-US, V33, P13561, DOI 10.1021/bi00250a008; Horovitz A, 2001, J STRUCT BIOL, V135, P104, DOI 10.1006/jsbi.2001.4377; Hu XJ, 2003, FEBS LETT, V544, P268, DOI 10.1016/S0014-5793(03)00519-2; Isupov MN, 1998, J MOL BIOL, V276, P603, DOI 10.1006/jmbi.1997.1561; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Juers DH, 2001, BIOCHEMISTRY-US, V40, P14781, DOI 10.1021/bi011727i; Juers DH, 2000, PROTEIN SCI, V9, P1685, DOI 10.1110/ps.9.9.1685; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KACHMAR JF, 1953, J BIOL CHEM, V200, P669; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Komoto J, 2004, BIOCHEMISTRY-US, V43, P1821, DOI 10.1021/bi035611t; LaineCessac P, 1996, ENZYME PROTEIN, V49, P291, DOI 10.1159/000468639; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Li MH, 2002, J BIOL CHEM, V277, P46385, DOI 10.1074/jbc.M208600200; Liang XM, 2016, CURR OPIN CHEM BIOL, V31, P120, DOI 10.1016/j.cbpa.2016.02.008; Liao DI, 2003, J INORG BIOCHEM, V93, P84, DOI 10.1016/S0162-0134(02)00523-8; Lilley DMJ, 2011, BIOCHEM SOC T, V39, P641, DOI 10.1042/BST0390641; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; MACHIUS M, 1995, J MOL BIOL, V246, P545, DOI 10.1006/jmbi.1994.0106; Machius M, 1998, STRUCTURE, V6, P281, DOI 10.1016/S0969-2126(98)00032-X; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Mamat B, 2002, PROTEIN SCI, V11, P2168, DOI 10.1110/ps.0211002; MARCUS F, 1980, J BIOL CHEM, V255, P2481; MUDD SH, 1958, J BIOL CHEM, V231, P481; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Niu WL, 2009, J BIOL CHEM, V284, P36175, DOI 10.1074/jbc.M109.069500; Nonaka T, 2003, J BIOL CHEM, V278, P24818, DOI 10.1074/jbc.M212763200; O'Rear JL, 2001, RNA, V7, P537, DOI 10.1017/S1355838201002461; OBRIEN MC, 1995, J BIOL CHEM, V270, P2247, DOI 10.1074/jbc.270.5.2247; Ogawa H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9004; ORTHNER CL, 1978, ARCH BIOCHEM BIOPHYS, V185, P400, DOI 10.1016/0003-9861(78)90182-0; ORTHNER CL, 1980, ARCH BIOCHEM BIOPHYS, V202, P63, DOI 10.1016/0003-9861(80)90406-3; Page MJ, 2008, J MOL BIOL, V378, P666, DOI 10.1016/j.jmb.2008.03.003; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Paul R, 2015, ADV EXP MED BIOL, V842, P293, DOI 10.1007/978-3-319-11280-0_19; Pelc LA, 2015, BIOCHEMISTRY-US, V54, P1457, DOI 10.1021/acs.biochem.5b00014; PERACCHI A, 1995, BIOCHEMISTRY-US, V34, P9459, DOI 10.1021/bi00029a022; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Prasad S, 2003, P NATL ACAD SCI USA, V100, P13785, DOI 10.1073/pnas.2333109100; Premikumar L, 2005, P NATL ACAD SCI USA, V102, P7493, DOI 10.1073/pnas.0502829102; Rana S, 2011, P NATL ACAD SCI USA, V108, P5221, DOI 10.1073/pnas.1018860108; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Rhee S, 1996, BIOCHEMISTRY-US, V35, P4211, DOI 10.1021/bi952506d; Shibata N, 1999, STRUCTURE, V7, P997, DOI 10.1016/S0969-2126(99)80126-9; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; STEINER SA, 1980, BIOCHEM BIOPH RES CO, V94, P340, DOI 10.1016/S0006-291X(80)80226-9; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; Sundararaju B, 1997, BIOCHEMISTRY-US, V36, P6502, DOI 10.1021/bi962917+; TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040; TONEY MD, 1995, J MOL BIOL, V245, P151, DOI 10.1006/jmbi.1994.0014; TORAYA T, 1971, BIOCHEMISTRY-US, V10, P3475, DOI 10.1021/bi00794a025; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P8916, DOI 10.1073/pnas.92.19.8916; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; Vogt AD, 2010, J PHYS CHEM B, V114, P16125, DOI 10.1021/jp105502c; Weyand M, 1999, BIOCHEMISTRY-US, V38, P16469, DOI 10.1021/bi9920533; Wheatley RW, 2015, PHYS CHEM CHEM PHYS, V17, P10899, DOI 10.1039/c4cp04952g; WILBANKS SM, 1995, J BIOL CHEM, V270, P2251, DOI 10.1074/jbc.270.5.2251; WOEHL EU, 1995, BIOCHEMISTRY-US, V34, P9466, DOI 10.1021/bi00029a023; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; Xu J, 2004, BIOCHEM CELL BIOL, V82, P275, DOI 10.1139/o04-004; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p; Yamanishi M, 2002, EUR J BIOCHEM, V269, P4484, DOI 10.1046/j.1432-1033.2002.03151.x; Yannone SM, 2012, CURR OPIN BIOTECH, V23, P89, DOI 10.1016/j.copbio.2011.11.005; Zhang Y, 2004, STRUCTURE, V12, P1809, DOI 10.1016/j.str.2004.07.020	100	43	45	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20840	20848		10.1074/jbc.R116.737833	http://dx.doi.org/10.1074/jbc.R116.737833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27462078	hybrid, Green Published			2022-12-28	WOS:000385406200003
J	Merino-Gracia, J; Zamora-Carreras, H; Bruix, M; Rodriguez-Crespo, I				Merino-Gracia, Javier; Zamora-Carreras, Hector; Bruix, Marta; Rodriguez-Crespo, Ignacio			Molecular Basis for the Protein Recognition Specificity of the Dynein Light Chain DYNLT1/Tctex1 CHARACTERIZATION OF THE INTERACTION WITH ACTIVIN RECEPTOR IIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; MECHANISTIC INSIGHT; PEPSCAN TECHNIQUE; STRUCTURAL BASIS; TCTEX-1; SUBUNIT; COMPLEX; DOMAIN	It has been suggested that DYNLT1, a dynein light chain known to bind to various cellular and viral proteins, can function both as a molecular clamp and as a microtubule-cargo adapter. Recent data have shown that the DYNLT1 homodimer binds to two dynein intermediate chains to subsequently link cargo proteins such as the guanine nucleotide exchange factor Lfc or the small GTPases RagA and Rab3D. Although over 20 DYNLT1-interacting proteins have been reported, the exact sequence requirements that enable their association to the canonical binding groove or to the secondary site within the DYNLT1 surface are unknown. We describe herein the sequence recognition properties of the hydrophobic groove of DYNLT1 known to accommodate dynein intermediate chain. Using a pepscan approach, we have substituted each amino acid within the interacting peptide for all 20 natural amino acids and identified novel binding sequences. Our data led us to propose activin receptor IIB as a novel DYNLT1 ligand and suggest that DYNLT1 functions as a molecular dimerization engine bringing together two receptor monomers in the cytoplasmic side of the membrane. In addition, we provide evidence regarding a dual binding mode adopted by certain interacting partners such as Lfc or the parathyroid hormone receptor. Finally, we have used NMR spectroscopy to obtain the solution structure of human DYNLT1 forming a complex with dynein intermediate chain of similar to 74 kDa; it is the first mammalian structure available.	[Merino-Gracia, Javier; Rodriguez-Crespo, Ignacio] Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain; [Zamora-Carreras, Hector; Bruix, Marta] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Serrano 119, E-28006 Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Rodriguez-Crespo, I (corresponding author), Univ Complutense, Fac Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain.	nacho@bbm1.ucm.es	Bruix, Marta/H-4161-2011; Zamora-Carreras, Héctor/AAC-2287-2020; Rodriguez-Crespo, J. Ignacio/M-1966-2018	Bruix, Marta/0000-0002-0096-3558; Zamora-Carreras, Héctor/0000-0002-9141-2750; Rodriguez-Crespo, J. Ignacio/0000-0002-2582-129X; Merino Gracia, Javier/0000-0003-3397-8171	Spanish Ministerio of Economia y Competitividad [BFU2012-37934, CTQ2014-252633-P]; Comunidad de Madrid [S2010/BMD-2305]; Ministerio de Ciencia e Innovacion; Ministerio de Economia y Competitividad	Spanish Ministerio of Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government)	This work was supported in part by Spanish Ministerio of Economia y Competitividad Grants BFU2012-37934 (to I. R.-C.) and CTQ2014-252633-P (to M. B.) as well as Comunidad de Madrid Grant S2010/BMD-2305 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Formacion de Personal Investigador (FPI) fellowship from the Ministerio de Ciencia e Innovacion.; Recipient of an FPI fellowship from the Ministerio de Economia y Competitividad.	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Angulo I, 2011, GLYCOBIOLOGY, V21, P1349, DOI 10.1093/glycob/cwr074; Balan M., 2013, THESIS; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Bauch A, 1998, EUR J IMMUNOL, V28, P2167, DOI 10.1002/(SICI)1521-4141(199807)28:07<2167::AID-IMMU2167>3.0.CO;2-L; Cao JJ, 2015, J VIROL, V89, P2777, DOI 10.1128/JVI.03117-14; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Garcia-Mayoral MF, 2011, FEBS LETT, V585, P53, DOI 10.1016/j.febslet.2010.11.027; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Garcia-Mayoral MF, 2010, FEBS J, V277, P2340, DOI 10.1111/j.1742-4658.2010.07649.x; Goddard T. D., 2005, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Martinez-Moreno M, 2003, FEBS LETT, V544, P262, DOI 10.1016/S0014-5793(03)00516-7; Meiri D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5857; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Merino-Gracia J, 2016, J BIOL CHEM, V291, P11581, DOI 10.1074/jbc.M116.724427; Merino-Gracia J, 2015, FEBS J, V282, P3945, DOI 10.1111/febs.13388; Merino-Gracia J, 2011, FEBS J, V278, P2997, DOI 10.1111/j.1742-4658.2011.08252.x; Mital J, 2015, BIOCHEM BIOPH RES CO, V462, P165, DOI 10.1016/j.bbrc.2015.04.116; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Mueller S, 2002, J BIOL CHEM, V277, P7897, DOI 10.1074/jbc.M111937200; Nagano F, 1998, J BIOL CHEM, V273, P30065, DOI 10.1074/jbc.273.46.30065; Navarro-Lerida I, 2006, J CELL SCI, V119, P1558, DOI 10.1242/jcs.02878; Navarro-Lerida I, 2007, MOL BIOL CELL, V18, P2768, DOI 10.1091/mbc.E06-12-1102; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Pavlos NJ, 2011, MOL CELL BIOL, V31, P1551, DOI 10.1128/MCB.00834-10; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1996, MOL BIOL CELL, V7, P331, DOI 10.1091/mbc.7.2.331; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Sanchez-Ruiloba L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095191; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sugai M, 2003, BIOCHEM BIOPH RES CO, V311, P24, DOI 10.1016/j.bbrc.2003.09.157; Tai AW, 1998, J BIOL CHEM, V273, P19639, DOI 10.1074/jbc.273.31.19639; Whitehead B, 1997, Methods Mol Biol, V60, P29; Williams JC, 2005, J BIOL CHEM, V280, P21981, DOI 10.1074/jbc.M414643200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Williams JC, 2012, DYNEINS: STRUCTURE, BIOLOGY AND DISEASE, P157, DOI 10.1016/B978-0-12-382004-4.10005-6; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu HW, 2000, NAT STRUCT BIOL, V7, P575; Wu HW, 2005, STRUCTURE, V13, P213, DOI 10.1016/j.str.2004.11.013; Yoshimura Y, 2011, BIOCHEM BIOPH RES CO, V408, P322, DOI 10.1016/j.bbrc.2011.04.032	53	8	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20962	20975		10.1074/jbc.M116.736884	http://dx.doi.org/10.1074/jbc.M116.736884			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27502274	hybrid, Green Published			2022-12-28	WOS:000385406200014
J	Mould, AP; Askari, JA; Byron, A; Takada, Y; Jowitt, TA; Humphries, MJ				Mould, A. Paul; Askari, Janet A.; Byron, Adam; Takada, Yoshikazu; Jowitt, Thomas A.; Humphries, Martin J.			Ligand-induced Epitope Masking DISSOCIATION OF INTEGRIN alpha 5 beta 1-FIBRONECTIN COMPLEXES ONLY BY MONOCLONAL ANTIBODIES WITH AN ALLOSTERIC MODE OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; ALPHA 4 SUBUNIT; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; A-DOMAIN; CONFORMATIONAL-CHANGES; EXTRACELLULAR SEGMENT; FIBRINOGEN BINDING; FIBRONECTIN	We previously demonstrated that Arg-Gly-Asp (RGD)-containing ligand-mimetic inhibitors of integrins are unable to dissociate pre-formed integrin-fibronectin complexes (IFCs). These observations suggested that amino acid residues involved in integrin-fibronectin binding become obscured in the ligand-occupied state. Because the epitopes of some function-blocking anti-integrin monoclonal antibodies (mAbs) lie near the ligand-binding pocket, it follows that the epitopes of these mAbs may become shielded in the ligand-occupied state. Here, we tested whether function-blocking mAbs directed against alpha 5 beta 1 can interact with the integrin after it forms a complex with an RGD-containing fragment of fibronectin. We showed that the anti-alpha 5 subunit mAbs JBS5, SNAKA52, 16, and P1D6 failed to disrupt IFCs and hence appeared unable to bind to the ligand-occupied state. In contrast, the allosteric anti-beta 1 subunit mAbs 13, 4B4, and AIIB2 could dissociate IFCs and therefore were able to interact with the ligand-bound state. However, another class of function-blocking anti-beta 1 mAbs, exemplified by Lia1/2, could not disrupt IFCs. This second class of mAbs was also distinguished from 13, 4B4, and AIIB2 by their ability to induce homotypic cell aggregation. Although the epitope of Lia1/2 was closely overlapping with those of 13, 4B4, and AIIB2, it appeared to lie closer to the ligand-binding pocket. A new model of the alpha 5 beta 1-fibronectin complex supports our hypothesis that the epitopes of mAbs that fail to bind to the ligand-occupied state lie within, or very close to, the integrin-fibronectin interface. Importantly, our findings imply that the efficacy of some therapeutic anti-integrin mAbs could be limited by epitope masking.	[Mould, A. Paul; Jowitt, Thomas A.] Univ Manchester, Fac Life Sci, Biomol Anal Core Facil, Manchester M13 9PT, Lancs, England; [Askari, Janet A.; Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Byron, Adam] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Takada, Yoshikazu] Scripps Res Inst, Dept Vasc Biol, VB-1, La Jolla, CA 92037 USA; [Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol Biochem & Mol Med, Sacramento, CA 95817 USA; [Takada, Yoshikazu] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei 11031, Taiwan	University of Manchester; University of Manchester; University of Edinburgh; Scripps Research Institute; University of California System; University of California Davis; Taipei Medical University	Humphries, MJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	martin.humphries@manchester.ac.uk	Byron, Adam/AID-5111-2022; Byron, Adam/C-4871-2008	Byron, Adam/0000-0002-5939-9883; Humphries, Martin/0000-0002-4331-6967; Mould, Paul/0000-0003-0076-6228; Jowitt, Thomas/0000-0002-4045-0933	University of Manchester Intellectual Property Impact Scheme from the Wellcome Trust [092015, 105610/Z/14/Z]	University of Manchester Intellectual Property Impact Scheme from the Wellcome Trust	This work was supported in part by an award from University of Manchester Intellectual Property Impact Scheme (to A. P. M. and T. A. J.) and Grants 092015 (to M. J. H.) and 105610/Z/14/Z (to M. J. H., A. P. M., and T. A. J.) from the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.	AOTA S, 1994, J BIOL CHEM, V269, P24756; Askari J. A, 2006, THESIS; Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Barton SJ, 2004, BIOCHEM J, V380, P401, DOI 10.1042/BJ20031973; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Blandin AF, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00279; Burrows L, 1999, BIOCHEM J, V344, P527, DOI 10.1042/0264-6021:3440527; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; CAIXIA S, 1991, CELL IMMUNOL, V138, P216, DOI 10.1016/0008-8749(91)90146-3; CAMPANERO MR, 1992, EUR J IMMUNOL, V22, P3111, DOI 10.1002/eji.1830221213; CAMPANERO MR, 1990, J CELL BIOL, V110, P2157, DOI 10.1083/jcb.110.6.2157; Cherry LN, 2015, THER ADV CHRONIC DIS, V6, P224, DOI 10.1177/2040622315586970; Cho JY, 2001, BLOOD, V98, P374, DOI 10.1182/blood.V98.2.374; Clark K, 2005, J CELL SCI, V118, P291, DOI 10.1242/jcs.01623; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Copie V, 1998, J MOL BIOL, V277, P663; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Dickreuter E, 2016, ONCOGENE, V35, P1353, DOI 10.1038/onc.2015.212; Giordano A, 2016, CURR DRUG METAB, V17, P194, DOI 10.2174/1389200217666151211121112; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Heidenreich A, 2013, ANN ONCOL, V24, P329, DOI 10.1093/annonc/mds505; Hersey P, 2010, CANCER-AM CANCER SOC, V116, P1526, DOI 10.1002/cncr.24821; Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Irie A, 1997, P NATL ACAD SCI USA, V94, P7198, DOI 10.1073/pnas.94.14.7198; Kamata T, 2001, J BIOL CHEM, V276, P44275, DOI 10.1074/jbc.M107021200; Kasirer-Friede A, 2014, BLOOD, V123, P3156, DOI 10.1182/blood-2013-08-520627; Kimura H, 2012, INT J CANCER, V131, P2027, DOI 10.1002/ijc.27475; Lee YG, 2010, IMMUNOBIOLOGY, V215, P294, DOI 10.1016/j.imbio.2009.05.009; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mahalingam B, 2014, J BIOL CHEM, V289, P13801, DOI 10.1074/jbc.M113.546929; Mason WP, 2015, NEURO-ONCOLOGY, V17, P634, DOI 10.1093/neuonc/nov018; Mateo J, 2014, CANCER CHEMOTH PHARM, V74, P1039, DOI 10.1007/s00280-014-2576-8; Mould AP, 2009, BIOCHEM J, V424, P179, DOI 10.1042/BJ20090992; Mould AP, 1998, J BIOL CHEM, V273, P25664, DOI 10.1074/jbc.273.40.25664; Mould AP, 2005, J BIOL CHEM, V280, P4238, DOI 10.1074/jbc.M412240200; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283; Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; Moule AP, 2014, BIOCHEM J, V464, P301, DOI 10.1042/BJ20141047; MULLER B, 1993, J BIOL CHEM, V268, P6800; Munoz M, 1996, J BIOL CHEM, V271, P2696, DOI 10.1074/jbc.271.5.2696; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Ni HY, 1998, CELL ADHES COMMUN, V5, P257, DOI 10.3109/15419069809040296; Nishimichi N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13756; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; ORLANDO RA, 1991, J BIOL CHEM, V266, P19543; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Peerschke EIB, 1999, J LAB CLIN MED, V134, P398, DOI 10.1016/S0022-2143(99)90155-5; Pike KA, 2011, P NATL ACAD SCI USA, V108, P1116, DOI 10.1073/pnas.1018224108; Reardon David A, 2011, Genes Cancer, V2, P1159, DOI 10.1177/1947601912450586; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Van Agthoven JF, 2014, NAT STRUCT MOL BIOL, V21, P383, DOI 10.1038/nsmb.2797; Wilkins JA, 1996, J BIOL CHEM, V271, P3046, DOI 10.1074/jbc.271.6.3046; Xia W, 2014, P NATL ACAD SCI USA, V111, P17863, DOI 10.1073/pnas.1420645111; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yu YM, 2013, J BIOL CHEM, V288, P32314, DOI 10.1074/jbc.M113.501668; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang CM, 2013, J CELL SCI, V126, P5735, DOI 10.1242/jcs.137828; Zhang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep09275; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	72	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20993	21007		10.1074/jbc.M116.736942	http://dx.doi.org/10.1074/jbc.M116.736942			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27484800	Green Published, hybrid			2022-12-28	WOS:000385406200016
J	Yu, J; Yun, H; Shin, B; Kim, Y; Park, ES; Choi, S; Yu, J; Amarasekara, DS; Kim, S; Inoue, J; Walsh, MC; Choi, Y; Takami, M; Rho, J				Yu, Jiyeon; Yun, Hyeongseok; Shin, Bongjin; Kim, Yongjin; Park, Eui-Soon; Choi, Seunga; Yu, Jungeun; Amarasekara, Dulshara Sachini; Kim, Sumi; Inoue, Jun-ichiro; Walsh, Matthew C.; Choi, Yongwon; Takami, Masamichi; Rho, Jaerang			Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor B (RANK) Signaling Complex Enhances Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitogen-activated protein kinase (MAPK); NFAT transcription factor; osteoclast; osteoporosis; signal transduction	NF-KAPPA-B; DEFECTIVE INTERLEUKIN-1; BONE MASS; TNF-ALPHA; OSTEOIMMUNOLOGY; OSTEOPETROSIS; PROTEINS; IMMUNE; MICE; AUTOUBIQUITINATION	The signaling pathway downstream of stimulation of receptor activator of nuclear factor B (RANK) by RANK ligand is crucial for osteoclastogenesis. RANK recruits TNF receptor-associated factor 6 (TRAF6) to TRAF6-binding sites (T6BSs) in the RANK cytoplasmic tail (RANK(cyto)) to trigger downstream osteoclastogenic signaling cascades. RANK(cyto) harbors an additional highly conserved domain (HCR) that also activates crucial signaling during RANK-mediated osteoclastogenesis. However, the functional cross-talk between T6BSs and the HCR in the RANK signaling complex remains unclear. To characterize the cross-talk between T6BSs and the HCR, we screened TRAF6-interacting proteins using a proteomics approach. We identified Vav3 as a novel TRAF6 binding partner and evaluated the functional importance of the TRAF6-Vav3 interaction in the RANK signaling complex. We demonstrated that the coiled-coil domain of TRAF6 interacts directly with the Dbl homology domain of Vav3 to form the RANK signaling complex independent of the TRAF6 ubiquitination pathway. TRAF6 is recruited to the RANK(cyto) mutant, which lacks T6BSs, via the Vav3 interaction; conversely, Vav3 is recruited to the RANK(cyto) mutant, which lacks the IVVY motif, via the TRAF6 interaction. Finally, we determined that the TRAF6-Vav3 interaction resulting from cross-talk between T6BSs and the IVVY motif in RANK(cyto) enhances downstream NF-B, MAPK, and NFATc1 activation by further strengthening TRAF6 signaling, thereby inducing RANK-mediated osteoclastogenesis. Thus, Vav3 is a novel TRAF6 interaction partner that functions in the activation of cooperative signaling between T6BSs and the IVVY motif in the RANK signaling complex.	[Yu, Jiyeon; Yun, Hyeongseok; Shin, Bongjin; Kim, Yongjin; Park, Eui-Soon; Choi, Seunga; Yu, Jungeun; Amarasekara, Dulshara Sachini; Kim, Sumi; Rho, Jaerang] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Daejeon 305764, South Korea; [Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Cellular & Mol Biol, Tokyo 1088639, Japan; [Walsh, Matthew C.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Takami, Masamichi] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan	Chungnam National University; University of Tokyo; University of Pennsylvania; Showa University	Rho, J (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Daejeon 305764, South Korea.	jrrho@cnu.ac.kr		Takami, Masamichi/0000-0002-4506-3975; Amarasekara, A D D Sachini/0000-0001-7085-0682; Rho, Jaerang/0000-0002-0019-4939	Basic Science Research Program through National Research Foundation of Korea; Ministry of Education [NRF-2014R1A1A2057884]; Chungnam National University; Ministry of National Defense Foundation [ADD14-01-06-06]; National Institutes of Health [AR069546, AR067726]; Grants-in-Aid for Scientific Research [26290036] Funding Source: KAKEN; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067726, R01AR069546] Funding Source: NIH RePORTER	Basic Science Research Program through National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education; Chungnam National University; Ministry of National Defense Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, by Ministry of Education Grant NRF-2014R1A1A2057884, by the research fund of Chungnam National University, by Ministry of National Defense Foundation Grant ADD14-01-06-06, and National Institutes of Health Grants AR069546 and AR067726 (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amarasekara DS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832127; Charvet C, 2005, J BIOL CHEM, V280, P15289, DOI 10.1074/jbc.M500275200; Choi HK, 2013, CELL RES, V23, P524, DOI 10.1038/cr.2013.33; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Gautheron J, 2010, HUM MOL GENET, V19, P3138, DOI 10.1093/hmg/ddq222; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Jules J, 2015, J BIOL CHEM, V290, P23738, DOI 10.1074/jbc.M115.667535; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Kadono Y, 2005, EMBO REP, V6, P171, DOI 10.1038/sj.embor.7400345; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Ma T, 2004, CYTOKINE, V26, P138, DOI 10.1016/j.cyto.2004.02.001; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Park ES, 2015, J BIOL CHEM, V290, P9660, DOI 10.1074/jbc.M114.609685; Rauner M, 2007, INT ARCH ALLERGY IMM, V143, P31, DOI 10.1159/000098223; Rho J, 2004, MOL CELLS, V17, P1; Shin B, 2014, J BIOL CHEM, V289, P35868, DOI 10.1074/jbc.M114.589614; Taguchi Y, 2012, J BONE MINER METAB, V30, P543, DOI 10.1007/s00774-012-0353-5; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Yang K, 2004, BIOCHEM BIOPH RES CO, V324, P432, DOI 10.1016/j.bbrc.2004.09.070; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yu Jing-Hua, 2012, Bulletin of Botanical Research, V32, P1	41	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20643	20660		10.1074/jbc.M116.728303	http://dx.doi.org/10.1074/jbc.M116.728303			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27507811	Green Published, hybrid			2022-12-28	WOS:000384574800028
J	Cui, SK; Hayashi, Y; Otomo, M; Mano, S; Oikawa, K; Hayashi, M; Nishimura, M				Cui, Songkui; Hayashi, Yasuko; Otomo, Masayoshi; Mano, Shoji; Oikawa, Kazusato; Hayashi, Makoto; Nishimura, Mikio			Sucrose Production Mediated by Lipid Metabolism Suppresses the Physical Interaction of Peroxisomes and Oil Bodies during Germination of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; lipid droplet; lipolysis; membrane; organelle; peroxisome; oil body; sucrose production	BINDING CASSETTE TRANSPORTER; TRIACYLGLYCEROL LIPASE; BETA-OXIDATION; PROTEINS; GENE; VISUALIZATION; MOBILIZATION; EXPRESSION; CELLS; GFP	Physical interaction between organelles is a flexible event and essential for cells to adapt rapidly to environmental stimuli. Germinating plants utilize oil bodies and peroxisomes to mobilize storage lipids for the generation of sucrose as the main energy source. Although membrane interaction between oil bodies and peroxisomes has been widely observed, its underlying molecular mechanism is largely unknown. Here we present genetic evidence for control of the physical interaction between oil bodies and peroxisomes. We identified alleles of the sdp1 mutant altered in oil body morphology. This mutant accumulates bigger and more oil body aggregates compared with the wild type and showed defects in lipid mobilization during germination. SUGAR DEPENDENT 1 (SDP1) encodes major triacylglycerol lipase in Arabidopsis. Interestingly, sdp1 seedlings show enhanced physical interaction between oil bodies and peroxisomes compared with the wild type, whereas exogenous sucrose supplementation greatly suppresses the interaction. The same phenomenon occurs in the peroxisomal defective 1 (ped1) mutant, defective in lipid mobilization because of impaired peroxisomal -oxidation, indicating that sucrose production is a key factor for oil body-peroxisomal dissociation. Peroxisomal dissociation and subsequent release from oil bodies is dependent on actin filaments. We also show that a peroxisomal ATP binding cassette transporter, PED3, is the potential anchor protein to the membranes of these organelles. Our results provide novel components linking lipid metabolism and oil body-peroxisome interaction whereby sucrose may act as a negative signal for the interaction of oil bodies and peroxisomes to fine-tune lipolysis.	[Cui, Songkui; Mano, Shoji; Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Myodaiji Cho, Okazaki, Aichi 4448585, Japan; [Cui, Songkui; Mano, Shoji] SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Myodaiji Cho, Okazaki, Aichi 4448585, Japan; [Cui, Songkui] RIKEN, RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Hayashi, Yasuko; Otomo, Masayoshi] Niigata Univ, Grad Sch Sci & Technol, 8050 Ikarashi, Niigata 9502181, Japan; [Oikawa, Kazusato] Niigata Univ, Fac Agr, Dept Appl Biol Chem, Niigata 9502181, Japan; [Hayashi, Makoto] Nagahama Inst Biosci & Technol, Dept Biosci, 1266 Tamura Cho, Nagahama 5260829, Japan; [Cui, Songkui] Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan; [Mano, Shoji] Natl Inst Basic Biol, Dept Evolutionary Biol & Biodivers, Lab Biol Divers, Myodaiji Cho, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; RIKEN; Niigata University; Niigata University; Nara Institute of Science & Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Nishimura, M (corresponding author), Natl Inst Basic Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	mikosome@nibb.ac.jp	Cui, Songkui/ABF-4552-2021	Cui, Songkui/0000-0001-7777-6681; Mano, Shoji/0000-0003-1323-3308; Oikawa, Kazusato/0000-0002-1033-9089; Nishimura, Mikio/0000-0001-7960-9721	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25891029, 22120007]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 25891029 to S. C. and 22120007 to M. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Ayre BG, 2003, PLANT PHYSIOL, V131, P1518, DOI 10.1104/pp.012054; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Brown LA, 2013, NEW PHYTOL, V200, P641, DOI 10.1111/nph.12467; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Cui S, 2013, J BIOL CHEM, V288, P6014, DOI 10.1074/jbc.M112.438143; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Eastmond PJ, 2007, PLANT CELL, V19, P1376, DOI 10.1105/tpc.106.043992; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Fan JL, 2014, PLANT CELL, V26, P4119, DOI 10.1105/tpc.114.130377; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Germain V, 2001, PLANT J, V28, P1, DOI 10.1046/j.1365-313X.2001.01095.x; Gibson SI, 2001, BIOCHEM BIOPH RES CO, V280, P196, DOI 10.1006/bbrc.2000.4062; Gidda SK, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.27141; Hayashi H, 2002, PLANT PHYSIOL, V130, P2019, DOI 10.1104/pp.012955; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; Hayashi M, 2000, EMBO J, V19, P5701, DOI 10.1093/emboj/19.21.5701; Hayashi M, 2012, PLANT CELL PHYSIOL, V53, P1310, DOI 10.1093/pcp/pcs078; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hayashi Y, 2001, PROTOPLASMA, V218, P83, DOI 10.1007/BF01288364; Horn PJ, 2013, PLANT PHYSIOL, V162, P1926, DOI 10.1104/pp.113.222455; Jedd G, 2002, PLANT CELL PHYSIOL, V43, P384, DOI 10.1093/pcp/pcf045; Kato A, 1996, PLANT MOL BIOL, V31, P843, DOI 10.1007/BF00019471; Knoblach B, 2013, EMBO J, V32, P2439, DOI 10.1038/emboj.2013.170; Krahmer N, 2013, MOL CELL PROTEOMICS, V12, P1115, DOI 10.1074/mcp.M112.020230; Lehner A, 2006, PLANT CELL PHYSIOL, V47, P818, DOI 10.1093/pcp/pcj053; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Hernandez ML, 2012, PLANT PHYSIOL, V160, P215, DOI 10.1104/pp.112.201541; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; MANSFIELD SG, 1992, CAN J BOT, V70, P151, DOI 10.1139/b92-021; Mitsuhashi N, 2000, PLANT CELL PHYSIOL, V41, P993, DOI 10.1093/pcp/pcd040; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Mullen RT, 2001, PLANTA, V213, P849, DOI 10.1007/s004250100579; NISHIMURA M, 1986, PLANT PHYSIOL, V81, P313, DOI 10.1104/pp.81.1.313; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Oikawa K, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.35, 10.1038/nplants.2015.35]; Peng CC, 2003, BIOTECHNOL PROGR, V19, P1623, DOI 10.1021/bp034129z; Rapp S, 1996, J CELL SCI, V109, P837; Reumann S, 2004, PLANT PHYSIOL, V135, P783, DOI 10.1104/pp.103.035584; Rognoni S, 2007, PLANT GROWTH REGUL, V52, P217, DOI 10.1007/s10725-007-9193-z; Rylott EL, 2001, BIOCHEM SOC T, V29, P283, DOI 10.1042/BST0290283; Schrader M, 2001, J HISTOCHEM CYTOCHEM, V49, P1421, DOI 10.1177/002215540104901110; Shimada TL, 2008, PLANT J, V55, P798, DOI 10.1111/j.1365-313X.2008.03553.x; Shimada TL, 2014, PLANT PHYSIOL, V164, P105, DOI 10.1104/pp.113.230185; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; THOMAS BR, 1994, PLANT PHYSIOL, V106, P1235, DOI 10.1104/pp.106.4.1235; To Jennifer P C, 2002, BMC Plant Biol, V2, P4, DOI 10.1186/1471-2229-2-4; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; Tzen JTC, 1997, J BIOCHEM-TOKYO, V121, P762, DOI 10.1093/oxfordjournals.jbchem.a021651; Tzen JTC., 2012, ISRN BOT, V2012, P173954; YAMAGUCHI K, 1995, PLANT CELL PHYSIOL, V36, P1157, DOI 10.1093/oxfordjournals.pcp.a078862; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	59	45	45	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19734	19745		10.1074/jbc.M116.748814	http://dx.doi.org/10.1074/jbc.M116.748814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27466365	Green Published, hybrid			2022-12-28	WOS:000383243100002
J	Holdfeldt, A; Skovbakke, SL; Winther, M; Gabl, M; Nielsen, C; Perez-Gassol, I; Larsen, CJ; Wang, JM; Karlsson, A; Dahlgren, C; Forsman, H; Franzyk, H				Holdfeldt, Andre; Skovbakke, Sarah Line; Winther, Malene; Gabl, Michael; Nielsen, Christina; Perez-Gassol, Iris; Larsen, Camilla Josephine; Wang, Ji Ming; Karlsson, Anna; Dahlgren, Claes; Forsman, Huamei; Franzyk, Henrik			The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-Nphe)(6)-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein-coupled receptor (GPCR); inflammation; NADPH oxidase; neutrophil; receptor structure-function; structure-function	RESPIRATORY BURST PRODUCTS; N-FORMYLPEPTIDE RECEPTOR; CHEMOATTRACTANT RECEPTORS; HOST-DEFENSE; PROFESSIONAL PHAGOCYTES; LISTERIA-MONOCYTOGENES; ANTIMICROBIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; GRANULE MOBILIZATION; MURINE NEUTROPHILS	Neutrophils expressing formyl peptide receptor 2 (FPR2) play key roles in host defense, immune regulation, and resolution of inflammation. Consequently, the search for FPR2-specific modulators has attracted much attention due to its therapeutic potential. Earlier described agonists for this receptor display potent activity for the human receptor (FPR2) but low activity for the mouse receptor orthologue (Fpr2), rendering them inapplicable in murine models of human disease. Here we describe a novel FPR2 agonist, the proteolytically stable -peptide/-peptoid hybrid Lau-((S)-Aoc)-(Lys-Nphe)(6)-NH2 (F2M2), showing comparable potency in activating human and mouse neutrophils by inducing a rise in intracellular Ca2+ concentration and assembly of the superoxide-generating NADPH oxidase. This FPR2/Fpr2 agonist contains a headgroup consisting of a 2-aminooctanoic acid (Aoc) residue acylated with lauric acid (C-12 fatty acid), which is linked to a peptide/peptoid repeat ((Lys-Nphe)(6)-NH2). Both the fatty acid moiety and the (S)-Aoc residue were required for FPR2/Fpr2 activation. This type of proteolytically stable FPR2-specific peptidomimetics may serve as valuable tools for future analysis of FPR2 signaling as well as for development of prophylactic immunomodulatory therapy. This novel class of cross-species FPR2/Fpr2 agonists should enable translation of results obtained with mouse neutrophils (and disease models) into enhanced understanding of human inflammatory and immune diseases.	[Holdfeldt, Andre; Winther, Malene; Gabl, Michael; Karlsson, Anna; Dahlgren, Claes; Forsman, Huamei] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Box 480, S-40530 Gothenburg, Sweden; [Skovbakke, Sarah Line; Nielsen, Christina; Perez-Gassol, Iris; Larsen, Camilla Josephine; Franzyk, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Wang, Ji Ming] NCI Frederick, Canc & Inflammat Program, NIH, Frederick, MD 21702 USA	University of Gothenburg; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Forsman, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Box 480, S-40530 Gothenburg, Sweden.	Huamei.forsman@rheuma.gu.se		Franzyk, Henrik/0000-0002-2822-1927; de Winther, Menno/0000-0002-4038-6636; Skovbakke, Sarah Line/0000-0002-4673-4419; Karlsson, Anna/0000-0001-6796-1154	Swedish Research Council; King Gustaf V 80-Year Foundation; IngaBritt and Arne Lundbergs foundation; Sahlgrenska University Hospital through the national ALF agreement; Department of Drug Design and Pharmacology (Faculty of Health and Medical Sciences, University of Copenhagen); Aase and Ejnar Danielsens Foundation; King Christian 10th Foundation; NATIONAL CANCER INSTITUTE [ZIABC010725] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V 80-Year Foundation; IngaBritt and Arne Lundbergs foundation; Sahlgrenska University Hospital through the national ALF agreement; Department of Drug Design and Pharmacology (Faculty of Health and Medical Sciences, University of Copenhagen); Aase and Ejnar Danielsens Foundation; King Christian 10th Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Swedish research group was supported by grants from the Swedish Research Council, the King Gustaf V 80-Year Foundation, the IngaBritt and Arne Lundbergs foundation, and the Sahlgrenska University Hospital through the national ALF agreement. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by grants from the Department of Drug Design and Pharmacology (Faculty of Health and Medical Sciences, University of Copenhagen), Aase and Ejnar Danielsens Foundation, and King Christian 10th Foundation.	Almkvist J, 2002, J IMMUNOL, V168, P4034, DOI 10.4049/jimmunol.168.8.4034; Bonke G, 2008, SYNTHESIS-STUTTGART, P2381, DOI 10.1055/s-2008-1067171; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J, 2002, INFECT IMMUN, V70, P2908, DOI 10.1128/IAI.70.6.2908-2914.2002; Bylund J, 2003, J BIOL CHEM, V278, P30578, DOI 10.1074/jbc.M209202200; Bylund J, 2003, EXP CELL RES, V282, P70, DOI 10.1016/S0014-4827(02)00010-1; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Dahlgren Claes, 2007, V412, P349, DOI 10.1007/978-1-59745-467-4_23; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Forsman H, 2013, BBA-MOL CELL RES, V1833, P1914, DOI 10.1016/j.bbamcr.2013.03.026; Forsman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060169; Forsman H, 2012, J IMMUNOL, V189, P629, DOI 10.4049/jimmunol.1101616; Fu HM, 2004, IMMUNOLOGY, V112, P201, DOI 10.1111/j.1365-2567.2004.01884.x; Fu HM, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-50; Gabl M, 2016, BBA-MOL CELL RES, V1863, P1228, DOI 10.1016/j.bbamcr.2016.03.014; Gabl M, 2015, EXP CELL RES, V336, P242, DOI 10.1016/j.yexcr.2015.07.014; Gabl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109516; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; He R, 2000, J IMMUNOL, V165, P4598, DOI 10.4049/jimmunol.165.8.4598; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Jahnsen RD, 2013, CHEM BIOL, V20, P1286, DOI 10.1016/j.chembiol.2013.09.007; Jahnsen RD, 2012, J MED CHEM, V55, P7253, DOI 10.1021/jm300820a; Karlsson J, 2010, J IMMUNOL METHODS, V352, P45, DOI 10.1016/j.jim.2009.10.011; Karlsson J, 2009, CELL CALCIUM, V45, P431, DOI 10.1016/j.ceca.2009.02.002; KLOTZ KN, 1994, BIOESSAYS, V16, P193, DOI 10.1002/bies.950160310; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Li LZ, 2016, J LEUKOCYTE BIOL, V99, P425, DOI 10.1189/jlb.2RI0815-354RR; Liu Y, 2013, INT J ANTIMICROB AG, V41, P20, DOI 10.1016/j.ijantimicag.2012.09.014; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Olsen CA, 2010, CHEMBIOCHEM, V11, P1356, DOI 10.1002/cbic.201000232; Onnheim K, 2008, IMMUNOLOGY, V125, P591, DOI 10.1111/j.1365-2567.2008.02873.x; Onnheim K, 2014, EXP CELL RES, V323, P209, DOI 10.1016/j.yexcr.2014.01.023; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Riesselman M, 2007, J IMMUNOL, V179, P2520, DOI 10.4049/jimmunol.179.4.2520; Skovbakke SL, 2015, J MED CHEM, V58, P801, DOI 10.1021/jm501341h; Skovbakke SL, 2015, BIOCHEM PHARMACOL, V93, P182, DOI 10.1016/j.bcp.2014.11.004; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Winther M, 2015, FEBS LETT, V589, P1832, DOI 10.1016/j.febslet.2015.05.050; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang P, 2015, METHODS MOL BIOL, V1324, P191, DOI 10.1007/978-1-4939-2806-4_13	51	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19888	19899		10.1074/jbc.M116.736850	http://dx.doi.org/10.1074/jbc.M116.736850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27422818	Green Published, hybrid			2022-12-28	WOS:000383243100014
J	Atkison, JH; Parnham, S; Marcotte, WR; Olsen, SK				Atkison, James H.; Parnham, Stuart; Marcotte, William R., Jr.; Olsen, Shaun K.			Crystal Structure of the Nephila clavipes Major Ampullate Spidroin 1 A N-terminal Domain Reveals Plasticity at the Dimer Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PH-DEPENDENT DIMERIZATION; SPIDER SILK PROTEINS; MECHANISM	Spider dragline silk is a natural polymer harboring unique physical and biochemical properties that make it an ideal biomaterial. Artificial silk production requires an understanding of the in vivo mechanisms spiders use to convert soluble proteins, called spidroins, into insoluble fibers. Controlled dimerization of the spidroin N-terminal domain (NTD) is crucial to this process. Here, we report the crystal structure of the Nephila clavipes major ampullate spidroin NTD dimer. Comparison of our N. clavipes NTD structure with previously determined Euprosthenops australis NTD structures reveals subtle conformational alterations that lead to differences in how the subunits are arranged at the dimer interface. We observe a subset of contacts that are specific to each ortholog, as well as a substantial increase in asymmetry in the interactions observed at the N. clavipes NTD dimer interface. These asymmetric interactions include novel intermolecular salt bridges that provide new insights into the mechanism of NTD dimerization. We also observe a unique intramolecular "handshake" interaction between two conserved acidic residues that our data suggest adds an additional layer of complexity to the pH-sensitive relay mechanism for NTD dimerization. The results of a panel of tryptophan fluorescence dimerization assays probing the importance of these interactions support our structural observations. Based on our findings, we propose that conformational selectivity and plasticity at the NTD dimer interface play a role in the pH-dependent transition of the NTD from monomer to stably associated dimer as the spidroin progresses through the silk extrusion duct.	[Atkison, James H.; Parnham, Stuart; Olsen, Shaun K.] Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,MSC 509,Rm 501, Charleston, SC 29425 USA; [Marcotte, William R., Jr.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA	Medical University of South Carolina; Clemson University	Olsen, SK (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,MSC 509,Rm 501, Charleston, SC 29425 USA.	olsensk@musc.edu	Marcotte, William/AAD-8354-2019	Marcotte, William/0000-0003-4580-1939; Olsen, Shaun/0000-0002-1265-7101	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-ENG-38]; NIGMS from National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Programs High End Instrumentation grant [S10 RR029205]; DOE Office of Science by the Argonne National Laboratory [DE-AC02-06CH11357]; Office of the Vice President for Research at the Medical University of South Carolina; National Institutes of Health Shared Instrumentation Award [S10 RR027139-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027139, S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIGMS from National Institutes of Health; National Institutes of Health Office of Research Infrastructure Programs High End Instrumentation grant; DOE Office of Science by the Argonne National Laboratory(United States Department of Energy (DOE)); Office of the Vice President for Research at the Medical University of South Carolina; National Institutes of Health Shared Instrumentation Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-ENG-38. Data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory, This work is also based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the NIGMS from the National Institutes of Health (Grant P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by an National Institutes of Health Office of Research Infrastructure Programs High End Instrumentation grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. DOE Office of Science User Facility operated for the DOE Office of Science by the Argonne National Laboratory under Contract DE-AC02-06CH11357. The x-ray crystallography facility used for this work is supported by the Office of the Vice President for Research at the Medical University of South Carolina. The crystallization robotics instrument used in this study was purchased via a National Institutes of Health Shared Instrumentation Award (S10 RR027139-01), We thank Dr. Mirko Hennig and Dr. Daniella Ishimaru for providing insights and advice at early stages of the project, We also thank Katelyn Williams, Dr, Zongyang Lyu, Dr. Lingmin Yuan, and Dr, Christopher Davies for critically reviewing this manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adrianos SL, 2013, BIOMACROMOLECULES, V14, P1751, DOI 10.1021/bm400125w; Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6; Hagn F, 2011, ANGEW CHEM INT EDIT, V50, P310, DOI 10.1002/anie.201003795; Jaudzems K, 2012, J MOL BIOL, V422, P477, DOI 10.1016/j.jmb.2012.06.004; Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220; Kronqvist N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4254; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otikovs M, 2015, CHEMBIOCHEM, V16, P1720, DOI 10.1002/cbic.201500263; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ries J, 2014, J AM CHEM SOC, V136, P17136, DOI 10.1021/ja508760a; Schwarze S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3815; Vollrath F, 2000, J Biotechnol, V74, P67; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wallace JA, 2012, J PHYS CHEM LETT, V3, P658, DOI 10.1021/jz2016846; Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	26	13	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19006	19017		10.1074/jbc.M116.736710	http://dx.doi.org/10.1074/jbc.M116.736710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27445329	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000383242300035
J	Summers, JA; Harper, AR; Feasley, CL; Van-Der-Wel, H; Byrum, JN; Hermann, M; West, CM				Summers, Jody A.; Harper, Angelica R.; Feasley, Christa L.; Van-Der-Wel, Hanke; Byrum, Jennifer N.; Hermann, Marcela; West, Christopher M.			Identification of Apolipoprotein A-I as a Retinoic Acid-binding Protein in the Eye	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORM DEPRIVATION MYOPIA; HUMAN SERUM-ALBUMIN; VITAMIN-A; CHOLESTEROL TRANSPORT; CELLULAR CHOLESTEROL; MASS-SPECTROMETRY; HUMAN-PLASMA; QUANTIFICATION; CHICKEN; RAT	All-trans-retinoic acid may be an important molecular signal in the postnatal control of eye size. The goal of this study was to identify retinoic acid-binding proteins secreted by the choroid and sclera during visually guided ocular growth. Following photoaffinity labeling with all-trans-[11,12-H-3]retinoic acid, the most abundant labeled protein detected in the conditioned medium of choroid or sclera had an apparent M-r of 27,000 Da. Following purification and mass spectrometry, the M-r 27,000 band was identified as apolipoprotein A-I. Affinity capture of the radioactive M-r 27,000 band by anti-chick apolipoprotein A-I antibodies confirmed its identity as apolipoprotein A-I. Photoaffinity labeling and fluorescence quenching experiments demonstrated that binding of retinoic acid to apolipoprotein A-I is 1) concentration-dependent, 2) selective for all-trans-retinoic acid, and 3) requires the presence of apolipoprotein A-I-associated lipids for retinoid binding. Expression of apolipoprotein A-I mRNA and protein synthesis were markedly up regulated in choroids of chick eyes during the recovery from induced myopia, and apolipoprotein A-I mRNA was significantly increased in choroids following retinoic acid treatment. Together, these data suggest that apolipoprotein A-I may participate in a regulatory feedback mechanism with retinoic acid to control the action of retinoic acid on ocular targets during postnatal ocular growth.	[Summers, Jody A.; Harper, Angelica R.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St, Oklahoma City, OK 73104 USA; [Feasley, Christa L.; Van-Der-Wel, Hanke; Byrum, Jennifer N.; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Feasley, Christa L.] Thermo Fisher Sci, W Palm Beach, FL 33407 USA; [Van-Der-Wel, Hanke; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Hermann, Marcela] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Thermo Fisher Scientific; University System of Georgia; University of Georgia; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Summers, JA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St, Oklahoma City, OK 73104 USA.	Jody-summers@ouhsc.edu		Hermann, Marcela/0000-0003-2298-4269	National Institutes of Health [EY09391, GM037539]; University of Oklahoma Health Sciences Center (OUHSC); OUHSC Department of Biochemistry and Molecular Biology; OUHSC Vice President's Office for Research; Herzfelder'sche Familienstiftung; NATIONAL EYE INSTITUTE [R01EY009391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Oklahoma Health Sciences Center (OUHSC); OUHSC Department of Biochemistry and Molecular Biology; OUHSC Vice President's Office for Research; Herzfelder'sche Familienstiftung; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants EY09391 (to J. A. S.) and GM037539 (to C. M. W.); the University of Oklahoma Health Sciences Center (OUHSC), which funded the Oklahoma Center for Medical Glycobiology (to C. M. W.) in association with the OUHSC Department of Biochemistry and Molecular Biology and the OUHSC Vice President's Office for Research; and the Herzfelder'sche Familienstiftung (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arbuckle JL, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-23; BAILEY JS, 1988, J BIOL CHEM, V263, P9326; Bay?n A., 2007, OPHTHALMOLOGY, V17, P1; Belgacem O, 2007, BIOLOGICALS, V35, P43, DOI 10.1016/j.biologicals.2006.01.004; BERNSTEIN PS, 1995, P NATL ACAD SCI USA, V92, P654, DOI 10.1073/pnas.92.3.654; Bertrand E, 2006, MOL CELL PROTEOMICS, V5, P2158, DOI 10.1074/mcp.M600073-MCP200; Chen Y, 1996, J BIOL CHEM, V271, P20507, DOI 10.1074/jbc.271.34.20507; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Dolgin E, 2015, NATURE, V519, P276, DOI 10.1038/519276a; During A, 2007, J LIPID RES, V48, P2283, DOI 10.1194/jlr.M700263-JLR200; Eckhoff C., 1990, J LIPID RES, V31, P1445; FIELDING CJ, 1995, J LIPID RES, V36, P211; FIORELLA PD, 1991, J BIOL CHEM, V266, P16572; FOGH K, 1993, ARCH BIOCHEM BIOPHYS, V300, P751, DOI 10.1006/abbi.1993.1104; Fox G., 1978, BIOCHIM BIOPHYS ACTA, V537, P358; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; HARA H, 1991, J BIOL CHEM, V266, P3080; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Heroux M. S., 2014, PHYSIOL GENOMICS, V46, P467; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kaptein A, 1997, J LIPID RES, V38, P2273; Karnaukhova E, 2007, BIOCHEM PHARMACOL, V73, P901, DOI 10.1016/j.bcp.2006.11.023; KELLEY JL, 1980, COMP BIOCHEM PHYS B, V65, P239, DOI 10.1016/0305-0491(80)90008-5; KEMMINK J, 1995, BIOCHEMISTRY-US, V34, P12630, DOI 10.1021/bi00039a019; Kiss RS, 1999, BIOCHEMISTRY-US, V38, P4327, DOI 10.1021/bi982597p; KISS RS, 1993, BIOCHEMISTRY-US, V32, P7872, DOI 10.1021/bi00082a006; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; N'soukpoe-Kossi CN, 2007, INT J BIOL MACROMOL, V40, P484, DOI 10.1016/j.ijbiomac.2006.11.005; NAPOLI JL, 1986, J BIOL CHEM, V261, P3592; NAPOLI JL, 1985, J LIPID RES, V26, P387; Neele DM, 1999, BIOCHEM PHARMACOL, V58, P263, DOI 10.1016/S0006-2952(99)00105-7; NIMPF J, 1988, J LIPID RES, V29, P657; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; NORTON TT, 1995, VISION RES, V35, P1271, DOI 10.1016/0042-6989(94)00243-F; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; NOY N, 1992, BIOCHIM BIOPHYS ACTA, V1106, P159, DOI 10.1016/0005-2736(92)90234-D; Ong DE, 2000, BBA-PROTEIN STRUCT M, V1482, P209, DOI 10.1016/S0167-4838(00)00156-4; Oram J. F., 2000, J BIOL CHEM, V275, P34508; PETERSON PA, 1971, J BIOL CHEM, V246, P7544; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; RADA JA, 1991, DEV BIOL, V147, P303, DOI 10.1016/0012-1606(91)90288-E; Rada JA, 2001, CURR EYE RES, V22, P121, DOI 10.1076/ceyr.22.2.121.5525; Rada JAS, 2012, INVEST OPHTH VIS SCI, V53, P1649, DOI 10.1167/iovs.11-8444; Rengarajan K, 2001, BIOCHEM BIOPH RES CO, V284, P268, DOI 10.1006/bbrc.2001.4960; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; ROSS AC, 1980, J LIPID RES, V21, P100; Seko Y, 1998, OPHTHALMIC RES, V30, P361, DOI 10.1159/000055496; SHACKELFORD JE, 1983, J BIOL CHEM, V258, P7175; Siegwart JT, 2011, OPTOMETRY VISION SCI, V88, pE365, DOI 10.1097/OPX.0b013e31820b053d; Smith EL, 2011, OPTOMETRY VISION SCI, V88, P1029, DOI 10.1097/OPX.0b013e3182279cfa; Summers JA, 2015, INVEST OPHTH VIS SCI, V56; Sun H, 2012, BBA-MOL CELL BIOL L, V1821, P99, DOI 10.1016/j.bbalip.2011.06.010; Sundaram M, 1998, BIOCHEM J, V334, P155, DOI 10.1042/bj3340155; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Troilo D, 2006, INVEST OPHTH VIS SCI, V47, P1768, DOI 10.1167/iovs.05-0298; Vachali PP, 2013, ARCH BIOCHEM BIOPHYS, V539, P181, DOI 10.1016/j.abb.2013.07.008; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021; ZOLFAGHARI R, 1994, J LIPID RES, V35, P1985	67	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18991	19005		10.1074/jbc.M116.725523	http://dx.doi.org/10.1074/jbc.M116.725523			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402828	hybrid, Green Published			2022-12-28	WOS:000383242300034
J	Ng, CA; Gravel, AE; Perry, MD; Arnold, AA; Marcotte, I; Vandenberg, JI				Ng, Chai-Ann; Gravel, Andree E.; Perry, Matthew D.; Arnold, Alexandre A.; Marcotte, Isabelle; Vandenberg, Jamie I.			Tyrosine Residues from the S4-S5 Linker of Kv11.1 Channels Are Critical for Slow Deactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; gating; hERG; ion channel; nuclear magnetic resonance (NMR); potassium channel; site-directed mutagenesis; Kv11; 1; S4S5 linker; lipid membrane	BURIED SALT BRIDGES; CRYSTAL-STRUCTURE; SWISS-MODEL; AROMATIC INTERACTIONS; PROTEIN STABILITY; ACTIVATION GATE; HERG; ENVIRONMENT; MUTATIONS; FAMILY	Slow deactivation of Kv11.1 channels is critical for its function in the heart. The S4-S5 linker, which joins the voltage sensor and pore domains, plays a critical role in this slow deactivation gating. Here, we use NMR spectroscopy to identify the membrane-bound surface of the S4S5 linker, and we show that two highly conserved tyrosine residues within the KCNH subfamily of channels are membrane-associated. Site-directed mutagenesis and electrophysiological analysis indicates that Tyr-542 interacts with both the pore domain and voltage sensor residues to stabilize activated conformations of the channel, whereas Tyr-545 contributes to the slow kinetics of deactivation by primarily stabilizing the transition state between the activated and closed states. Thus, the two tyrosine residues in the Kv11.1 S4S5 linker play critical but distinct roles in the slow deactivation phenotype, which is a hallmark of Kv11.1 channels.	[Ng, Chai-Ann; Perry, Matthew D.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, 405 Liverpool St, Darlinghurst, NSW, Australia; [Ng, Chai-Ann; Perry, Matthew D.; Vandenberg, Jamie I.] Univ New South Wales, St Vincents Clin Sch, Victoria St, Darlinghurst, NSW 2010, Australia; [Gravel, Andree E.; Arnold, Alexandre A.; Marcotte, Isabelle] Univ Quebec, Dept Chem, Montreal, PQ H3C 3P8, Canada; [Marcotte, Isabelle] Ctr Quebecois Mat Fonctionnels, Quebec City, PQ, Canada; [Marcotte, Isabelle] GRASP, Montreal, PQ, Canada	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Quebec; University of Quebec Montreal	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, 405 Liverpool St, Darlinghurst, NSW, Australia.; Marcotte, I (corresponding author), Univ Quebec, Dept Chim, Downtown Stn, POB 8888, Montreal, PQ H3C 3P8, Canada.; Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Programme Cardiac Electro, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	marcotte.isabelle@uqam.ca; j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Ng, Chai Ann/0000-0002-3120-5450; Arnold, Alexandre/0000-0001-9624-6416	National Health and Medical Research Council of Australia [App1074386, 1019693]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research training program; Groupe de Recherche Axesur la Structure des Proteines (GRASP)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research training program(Canadian Institutes of Health Research (CIHR)); Groupe de Recherche Axesur la Structure des Proteines (GRASP)	This work was supported in part by National Health and Medical Research Council of Australia Program Grant App1074386 and Fellowship 1019693 (to J. I. V.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes of Health Research training program, and the Groupe de Recherche Axesur la Structure des Proteines (GRASP).	Alonso-Ron C, 2008, BIOPHYS J, V94, P3893, DOI 10.1529/biophysj.107.116731; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Ng CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031640; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Grant AO, 2009, CIRC-ARRHYTHMIA ELEC, V2, P185, DOI 10.1161/CIRCEP.108.789081; Gravel AE, 2013, BBA-BIOMEMBRANES, V1828, P1494, DOI 10.1016/j.bbamem.2013.02.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Klabunde R. E., 2012, CARDIOVASCULAR PHYSL, P9; Liu SG, 1996, BIOPHYS J, V70, P2704, DOI 10.1016/S0006-3495(96)79840-5; Lorinczi E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7672; LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; MARQUSEE S, 1994, PROTEIN SCI, V3, P2217, DOI 10.1002/pro.5560031207; Ng CA, 2014, J BIOL CHEM, V289, P25822, DOI 10.1074/jbc.M114.558379; Ng CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077032; Nolandt OV, 2012, BBA-BIOMEMBRANES, V1818, P1142, DOI 10.1016/j.bbamem.2012.01.007; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Perry MD, 2016, J PHYSIOL-LONDON, V594, P4031, DOI 10.1113/JP271805; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; SEELIG J, 1980, Q REV BIOPHYS, V13, P19, DOI 10.1017/S0033583500000305; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Smith PL, 2002, J GEN PHYSIOL, V119, P275, DOI 10.1085/jgp.119.3.275; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	46	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17293	17302		10.1074/jbc.M116.729392	http://dx.doi.org/10.1074/jbc.M116.729392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27317659	Green Published, hybrid			2022-12-28	WOS:000382643800030
J	Prysyazhna, O; Burgoyne, JR; Scotcher, J; Grover, S; Kass, D; Eaton, P				Prysyazhna, Oleksandra; Burgoyne, Joseph Robert; Scotcher, Jenna; Grover, Steven; Kass, David; Eaton, Philip			Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G I Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cardiomyopathy; heart failure; oxidative stress; phosphodiesterases; protein kinase G (PKG)	LEFT-VENTRICULAR DYSFUNCTION; OXIDANT-INDUCED ACTIVATION; NITRIC-OXIDE; CYCLIC-GMP; BLOOD-PRESSURE; INDUCED CARDIOMYOPATHY; PDE5 INHIBITION; CGMP; APOPTOSIS; ALPHA	Phosphodiesterase 5 (PDE5) inhibitors limit myocardial injury caused by stresses, including doxorubicin chemotherapy. cGMP binding to PKG I attenuates oxidant-induced disulfide formation. Because PDE5 inhibition elevates cGMP and protects from doxorubicin-induced injury, we reasoned that this may be because it limits PKG I disulfide formation. To investigate the role of PKG I disulfide dimerization in the development of apoptosis, doxorubicin-induced cardiomyopathy was compared in male wild type (WT) or disulfide-resistant C42S PKG I knock-in (KI) mice. Echocardiography showed that doxorubicin treatment caused loss of myocardial tissue and depressed left ventricular function in WT mice. Doxorubicin also reduced pro-survival signaling and increased apoptosis in WT hearts. In contrast, KI mice were markedly resistant to the dysfunction induced by doxorubicin in WTs. In follow-on experiments the influence of the PDE5 inhibitor tadalafil on the development of doxorubicin-induced cardiomyopathy in WT and KI mice was investigated. In WT mice, co-administration of tadalafil with doxorubicin reduced PKG I oxidation caused by doxorubicin and also protected against cardiac injury and loss of function. KI mice were again innately resistant to doxorubicin-induced cardiotoxicity, and therefore tadalafil afforded no additional protection. Doxorubicin decreased phosphorylation of RhoA (Ser-188), stimulating its GTPase activity to activate Rho-associated protein kinase (ROCK) in WTs. These pro-apoptotic events were absent in KI mice and were attenuated in WTs co-administered tadalafil. PKG I disulfide formation triggers cardiac injury, and this initiation of maladaptive signaling can be blocked by pharmacological therapies that elevate cGMP, which binds kinase to limit its oxidation.	[Prysyazhna, Oleksandra; Burgoyne, Joseph Robert; Scotcher, Jenna; Eaton, Philip] Kings Coll London, Rayne Inst, British Heart Fdn Ctr Excellence, St Thomas Hosp,Cardiovasc Div, London SE1 7EH, England; [Grover, Steven] Kings Coll London, Acad Dept Surg, British Heart Fdn Ctr Excellence, St Thomas Hosp,Cardiovasc Div, London SE1 7EH, England; [Kass, David] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Johns Hopkins University; Johns Hopkins Medicine	Eaton, P (corresponding author), Kings Coll London, Div Cardiovasc, Rayne Inst, St Thomas Hosp, London SE1 7EH, England.	philip.eaton@kcl.ac.uk	; Eaton, Philip/I-5444-2015	Grover, Steven/0000-0001-8709-8394; Burgoyne, Joseph/0000-0001-7325-7382; Prysyazhna, Oleksandra/0000-0002-0394-7000; Eaton, Philip/0000-0003-0748-2367	European Research Council (Advanced Award); British Heart Foundation; Medical Research Council; Fondation Leducq; Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre; MRC [MR/L009684/1, G1000458, G0700320, G0600785, MR/K003232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503646/1] Funding Source: researchfish; British Heart Foundation [FS/14/1/30551, FS/11/45/28859, RG/12/12/29872, PG/15/26/31373, PG/13/13/30018, PG/10/98/28655] Funding Source: researchfish; Medical Research Council [G0700320, MR/K003232/1, G1000458, 998501, MR/L009684/1, G0600785] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119012] Funding Source: NIH RePORTER	European Research Council (Advanced Award)(European Research Council (ERC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondation Leducq(Leducq Foundation); Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the European Research Council (Advanced Award), the British Heart Foundation, the Medical Research Council and Fondation Leducq, and the Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's & St Thomas' National Health Service Foundation Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; BAIM DS, 1983, NEW ENGL J MED, V309, P748, DOI 10.1056/NEJM198309293091302; Blanton RM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003731; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Burgoyne JR, 2012, HYPERTENSION, V60, P1301, DOI 10.1161/HYPERTENSIONAHA.112.198754; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; da Silva FH, 2013, INT J IMPOT RES, V25, P69, DOI 10.1038/ijir.2012.35; Das A, 2010, P NATL ACAD SCI USA, V107, P18202, DOI 10.1073/pnas.1006965107; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Fiscus RR, 2002, J CARDIAC SURG, V17, P336; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jin Z, 2013, J CARDIOL, V62, P110, DOI 10.1016/j.jjcc.2013.03.018; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Kim YM, 1999, CIRC RES, V84, P253, DOI 10.1161/01.RES.84.3.253; Koka S, 2010, J PHARMACOL EXP THER, V334, P1023, DOI 10.1124/jpet.110.170191; Lauriol J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005262; Lee DI, 2015, NATURE, V519, P472, DOI 10.1038/nature14332; Li F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.243; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Muller PM, 2012, FREE RADICAL BIO MED, V53, P1574, DOI 10.1016/j.freeradbiomed.2012.08.011; Nagayama T, 2009, J AM COLL CARDIOL, V53, P207, DOI 10.1016/j.jacc.2008.08.069; Nakamura T, 2015, J CLIN INVEST, V125, P2468, DOI 10.1172/JCI80275; Prysyazhna O, 2012, NAT MED, V18, P286, DOI 10.1038/nm.2603; Rudyk O, 2013, P NATL ACAD SCI USA, V110, P9909, DOI 10.1073/pnas.1301026110; Rudyk O, 2012, CIRCULATION, V126, P287, DOI 10.1161/CIRCULATIONAHA.112.101287; Shi Y, 2011, HERZ, V36, P296, DOI 10.1007/s00059-011-3470-3; Stubbert D, 2014, HYPERTENSION, V64, P1344, DOI 10.1161/HYPERTENSIONAHA.114.04281; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; van der Staay FJ, 2008, NEUROPHARMACOLOGY, V55, P908, DOI 10.1016/j.neuropharm.2008.07.005; Wunder F, 2005, MOL PHARMACOL, V68, P1775, DOI 10.1124/mol.105.017608; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7	40	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17427	17436		10.1074/jbc.M116.724070	http://dx.doi.org/10.1074/jbc.M116.724070			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27342776	Green Published, hybrid			2022-12-28	WOS:000382643800041
J	Wang, ZX; Dang, TT; Liu, TT; Chen, S; Li, L; Huang, S; Fang, M				Wang, Zixi; Dang, Tingting; Liu, Tingting; Chen, She; Li, Lin; Huang, Song; Fang, Min			NEDD4L Protein Catalyzes Ubiquitination of PIK3CA Protein and Regulates PI3K-AKT Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; E3 ubiquitin ligase; phosphatidylinositide 3-kinase (PI 3-kinase); proteasome; protein degradation; ubiquitylation (ubiquitination); NEDD4L; PIK3CA	C2 DOMAIN; CBL-B; CANCER; LIGASE; EXPRESSION; DEGRADATION; PROGRESSION; MUTATIONS; PROGNOSIS; 3-KINASE	Oncogenic PIK3CA (p110), the catalytic subunit of class IA PI3K, plays a major role in PI3K-related cancer progression. The mechanisms underlying the dynamic regulation of PIK3CA protein levels remain unknown. Here we demonstrated that PIK3CA is regulated by polyubiquitination. We identified NEDD4L as the E3 ligase that catalyzes PIK3CA polyubiquitination, leading to its proteasome-dependent degradation. NEDD4L ubiquitinates both the free and regulatory subunit-bound PIK3CA but does not ubiquitinate the regulatory subunit of PI3K. Overexpression of NEDD4L accelerates the turnover rate of PIK3CA, whereas suppression of NEDD4L results in not only the accumulation of PIK3CA but also a paradoxical decrease of AKT activation. Thus, we propose that NEDD4L negatively regulates PIK3CA protein levels via ubiquitination and is required for the maintenance of PI3K-AKT signaling pathway.	[Wang, Zixi; Dang, Tingting; Liu, Tingting; Fang, Min] Peking Univ, Div Cell Biol, Coll Life Sci, Yiheyuan Rd 5, Beijing 100871, Peoples R China; [Wang, Zixi; Dang, Tingting; Liu, Tingting; Fang, Min] Peking Univ, Joint Ctr Life Sci, Yiheyuan Rd 5, Beijing 100871, Peoples R China; [Chen, She; Li, Lin; Huang, Song] Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China	Peking University; Peking University; National Institute of Biological Sciences, Beijing	Fang, M (corresponding author), Peking Univ, Div Cell Biol, Coll Life Sci, Yiheyuan Rd 5, Beijing 100871, Peoples R China.	min.fang@pku.edu.cn	liu, ting/GZM-3326-2022	Wang, Zixi/0000-0002-9354-1206	National Basic Program of China 973 Program [2013CB910104]; National Natural Science Foundation of China [31271524]; start-up foundation from the Joint Center for Life Sciences at Peking University; post-doctoral fellowship from Joint Center for Life Sciences at Peking University	National Basic Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); start-up foundation from the Joint Center for Life Sciences at Peking University; post-doctoral fellowship from Joint Center for Life Sciences at Peking University	This work was supported by the National Basic Program of China 973 Program (2013CB910104), National Natural Science Foundation of China (31271524), and the start-up foundation from the Joint Center for Life Sciences at Peking University. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the post-doctoral fellowship from Joint Center for Life Sciences at Peking University.	Brognard J, 2001, CANCER RES, V61, P3986; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Gao CC, 2012, MED ONCOL, V29, P1733, DOI 10.1007/s12032-011-0061-3; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; He SM, 2012, JPN J CLIN ONCOL, V42, P196, DOI 10.1093/jjco/hyr195; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hellwinkel OJC, 2011, PROSTATE CANCER P D, V14, P38, DOI 10.1038/pcan.2010.48; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu XY, 2009, EJSO-EUR J SURG ONC, V35, P527, DOI 10.1016/j.ejso.2008.09.015; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Kito Y, 2014, INT J EXP PATHOL, V95, P24, DOI 10.1111/iep.12051; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Kuchay S, 2013, NAT CELL BIOL, V15, P472, DOI 10.1038/ncb2731; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sakashita H, 2013, ANN SURG ONCOL, V20, pS590, DOI 10.1245/s10434-013-3059-6; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Tanksley JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081514; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Woenckhaus J, 2002, J PATHOL, V198, P335, DOI 10.1002/path.1207; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Yuan TL, 2011, CURR BIOL, V21, P173, DOI 10.1016/j.cub.2010.12.047	34	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17467	17477		10.1074/jbc.M116.726083	http://dx.doi.org/10.1074/jbc.M116.726083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339899	hybrid, Green Published			2022-12-28	WOS:000382643800044
J	Low, JKK; Webb, SR; Silva, APG; Saathoff, H; Ryan, DP; Torrado, M; Brofelth, M; Parker, BL; Shepherd, NE; Mackay, JP				Low, Jason K. K.; Webb, Sarah R.; Silva, Ana P. G.; Saathoff, Hinnerk; Ryan, Daniel P.; Torrado, Mario; Brofelth, Mattias; Parker, Benjamin L.; Shepherd, Nicholas E.; Mackay, Joel P.			CHD4 Is a Peripheral Component of the Nucleosome Remodeling and Deacetylase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NURD COMPLEX; CHROMATIN REMODELER; STRUCTURAL-ANALYSIS; MI-2/NURD COMPLEX; SOMATIC-CELLS; STEM-CELLS; ARCHITECTURE; BINDING; MBD3/NURD; INSIGHTS	Chromatin remodeling enzymes act to dynamically regulate gene accessibility. In many cases, these enzymes function as large multicomponent complexes that in general comprise a central ATP-dependent Snf2 family helicase that is decorated with a variable number of regulatory subunits. The nucleosome remodeling and deacetylase (NuRD) complex, which is essential for normal development in higher organisms, is one such macromolecular machine. The NuRD complex comprises similar to 10 subunits, including the histone deacetylases 1 and 2 (HDAC1 and HDAC2), and is defined by the presence of a CHD family remodeling enzyme, most commonly CHD4 (chromodomain helicase DNA-binding protein 4). The existing paradigm holds that CHD4 acts as the central hub upon which the complex is built. We show here that this paradigm does not, in fact, hold and that CHD4 is a peripheral component of the NuRD complex. A complex lacking CHD4 that has HDAC activity can exist as a stable species. The addition of recombinant CHD4 to this nucleosome deacetylase complex reconstitutes a NuRD complex with nucleosome remodeling activity. These data contribute to our understanding of the architecture of the NuRD complex.	[Low, Jason K. K.; Webb, Sarah R.; Silva, Ana P. G.; Saathoff, Hinnerk; Torrado, Mario; Brofelth, Mattias; Parker, Benjamin L.; Shepherd, Nicholas E.; Mackay, Joel P.] Univ Sydney, Sch Life & Environm Sci, Bldg G08, Sydney, NSW 2006, Australia; [Ryan, Daniel P.] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Acton, ACT 2601, Australia; [Webb, Sarah R.] Francis Crick Inst, Mill Hill Lab, Mill Hill, London, England	University of Sydney; Australian National University; John Curtin School of Medical Research	Mackay, JP (corresponding author), Univ Sydney, Sch Life & Environm Sci, Bldg G08, Sydney, NSW 2006, Australia.; Shepherd, NE (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	n.shepherd@imb.uq.edu.au; joel.mackay@sydney.edu.au	Mackay, Joel P/D-6834-2011	Mackay, Joel P/0000-0001-7508-8033; Low, Jason/0000-0003-0862-0012; Brofelth, Mattias/0000-0003-1187-4005; Ryan, Daniel/0000-0001-9842-2620	Australian Research Council [DE120102857]; National Health and Medical Research Council [APP1012161, 1063301, 571099]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant DE120102857 and National Health and Medical Research Council Grants APP1012161, 1063301, and 571099. The authors declare that they have no conflicts of interest with the contents of this article.	Alkhatib SG, 2011, FEBS LETT, V585, P3197, DOI 10.1016/j.febslet.2011.09.003; Alqarni SSM, 2014, J BIOL CHEM, V289, P21844, DOI 10.1074/jbc.M114.558940; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Brownlee PM, 2012, BIOCHEM SOC T, V40, P364, DOI 10.1042/BST20110754; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Desai MA, 2015, NUCLEIC ACIDS RES, V43, P3100, DOI 10.1093/nar/gkv168; dos Santos RL, 2014, CELL STEM CELL, V15, P102, DOI 10.1016/j.stem.2014.04.019; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Kloet SL, 2015, FEBS J, V282, P1774, DOI 10.1111/febs.12972; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lazarev AV, 2009, ELECTROPHORESIS, V30, P966, DOI 10.1002/elps.200800474; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Leschziner AE, 2005, STRUCTURE, V13, P267, DOI 10.1016/j.str.2004.12.008; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P1026, DOI 10.1038/nsmb.2648; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nguyen VQ, 2013, CELL, V154, P1220, DOI 10.1016/j.cell.2013.08.018; O'Shaughnessy A, 2013, BIOCHEM SOC T, V41, P777, DOI 10.1042/BST20130027; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Saathoff H, 2015, BIOORGAN MED CHEM, V23, P960, DOI 10.1016/j.bmc.2015.01.023; Silva APG, 2016, J BIOL CHEM, V291, P924, DOI 10.1074/jbc.M115.683227; Sims JK, 2011, CELL, V144, P626, DOI 10.1016/j.cell.2011.02.019; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Sparmann A, 2013, EMBO J, V32, P1598, DOI 10.1038/emboj.2013.93; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun YE, 2014, DEV CELL, V30, P9, DOI 10.1016/j.devcel.2014.06.028; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Torchy MP, 2015, CELL MOL LIFE SCI, V72, P2491, DOI 10.1007/s00018-015-1880-8; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yadon AN, 2011, CELL, V144, P454, DOI 10.1016/j.cell.2011.01.019; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808	56	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15853	15866		10.1074/jbc.M115.707018	http://dx.doi.org/10.1074/jbc.M115.707018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27235397	hybrid, Green Published			2022-12-28	WOS:000380584200037
J	Bonala, S; Lokireddy, S; Arigela, H; Teng, S; Wahli, W; Sharma, M; McFarlane, C; Kambadur, R				Bonala, Sabeera; Lokireddy, Sudarsanareddy; Arigela, Harikumar; Teng, Serena; Wahli, Walter; Sharma, Mridula; McFarlane, Craig; Kambadur, Ravi			RETRACTION: Peroxisome proliferator-activated receptor beta/delta induces myogenesis by modulating myostatin activity (Retraction of vol 287, pg 12935, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Wahli, Walter/I-3194-2019; Wahli, Walter/B-1398-2009; ARIGELA, HARIKUMAR/J-9872-2019	Wahli, Walter/0000-0002-5966-9089; ARIGELA, HARIKUMAR/0000-0003-3293-7618				Bonala S, 2012, J BIOL CHEM, V287, P12935, DOI 10.1074/jbc.M111.319145	1	0	0	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14391	14391		10.1074/jbc.A111.319145	http://dx.doi.org/10.1074/jbc.A111.319145			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371567	Green Published, hybrid			2022-12-28	WOS:000379975100045
J	Bonala, S; Lokireddy, S; McFarlane, C; Patnam, S; Sharma, M; Kambadur, R				Bonala, Sabeera; Lokireddy, Sudarsanareddy; McFarlane, Craig; Patnam, Sreekanth; Sharma, Mridula; Kambadur, Ravi			RETRACTION: Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) in response to high calorie diet intake (Retraction of vol 289, pg 7654, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Bonala S, 2014, J BIOL CHEM, V289, P7654, DOI 10.1074/jbc.M113.529925	1	2	2	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14392	14392		10.1074/jbc.A113.529925	http://dx.doi.org/10.1074/jbc.A113.529925			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371568	hybrid, Green Published			2022-12-28	WOS:000379975100046
J	Sonobe, Y; Takeuchi, H; Kataoka, K; Li, H; Jin, SJ; Mimuro, M; Hashizume, Y; Sano, Y; Kanda, T; Mizuno, T; Suzumura, A				Sonobe, Yoshifumi; Takeuchi, Hideyuki; Kataoka, Kunio; Li, Hua; Jin, Shijie; Mimuro, Maya; Hashizume, Yoshio; Sano, Yasuteru; Kanda, Takashi; Mizuno, Tetsuya; Suzumura, Akio			Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase C epsilon-dependent manner (vol 284, pg 31834, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940	1	3	4	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12573	12573		10.1074/jbc.A109.025940	http://dx.doi.org/10.1074/jbc.A109.025940			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27288521	Green Published, hybrid			2022-12-28	WOS:000378119900013
J	Phillips, RK; Peter, LG; Gilbert, SP; Rayment, I				Phillips, Rebecca K.; Peter, Logan G.; Gilbert, Susan P.; Rayment, Ivan			Family-specific Kinesin Structures Reveal Neck-linker Length Based on Initiation of the Coiled-coil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kinesin; microtubule; molecular motor; protein structure; x-ray crystallography; coiled-coil; kinesin neck-linker	CRYSTAL-STRUCTURE; DIMERIC KINESIN; PROCESSIVE RUN; FRONT HEAD; CENP-E; MOTOR; DOMAIN; PROTEIN; DYNAMICS; DETERMINES	Kinesin-1, -2, -5, and -7 generate processive hand-over-hand 8-nm steps to transport intracellular cargoes toward the microtubule plus end. This processive motility requires gating mechanisms to coordinate the mechanochemical cycles of the two motor heads to sustain the processive run. A key structural element believed to regulate the degree of processivity is the neck-linker, a short peptide of 12-18 residues, which connects the motor domain to its coiled-coil stalk. Although a shorter neck-linker has been correlated with longer run lengths, the structural data to support this hypothesis have been lacking. To test this hypothesis, seven kinesin structures were determined by x-ray crystallography. Each included the neck-linker motif, followed by helix 7 that constitutes the start of the coiled-coil stalk. In the majority of the structures, the neck-linker length differed from predictions because helix 7, which initiates the coiled-coil, started earlier in the sequence than predicted. A further examination of structures in the Protein Data Bank reveals that there is a great disparity between the predicted and observed starting residues. This suggests that an accurate prediction of the start of a coiled-coil is currently difficult to achieve. These results are significant because they now exclude simple comparisons between members of the kinesin superfamily and add a further layer of complexity when interpreting the results of mutagenesis or protein fusion. They also re-emphasize the need to consider factors beyond the kinesin neck-linker motif when attempting to understand how inter-head communication is tuned to achieve the degree of processivity required for cellular function.	[Phillips, Rebecca K.; Peter, Logan G.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA; [Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA	University of Wisconsin System; University of Wisconsin Madison; Rensselaer Polytechnic Institute	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	United States Department of Energy, Office of Energy Research [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141] Funding Source: NIH RePORTER	United States Department of Energy, Office of Energy Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Structural Biology ID19 and BM19 beamlines, Argonne National Laboratory Advanced Photon Source, was supported by the United States Department of Energy, Office of Energy Research, under Contract No. W-31-109-ENG-38. We also thank Dr. Alessandro Senes (University of Wisconsin-Madison) for enthusiastic and helpful discussions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Arpag G, 2014, BIOPHYS J, V107, P1896, DOI 10.1016/j.bpj.2014.09.009; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Bartoli L, 2009, BIOINFORMATICS, V25, P2757, DOI 10.1093/bioinformatics/btp539; Bigalke JM, 2011, J MOL BIOL, V414, P639, DOI 10.1016/j.jmb.2011.10.022; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Carpenter BS, 2015, J CELL SCI, V128, P1034, DOI 10.1242/jcs.162552; Chang JF, 2003, STRUCTURE, V11, P637, DOI 10.1016/S0969-2126(03)00093-5; Chen GY, 2015, J BIOL CHEM, V290, P10274, DOI 10.1074/jbc.M114.628032; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; Chen YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9160; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Cottee MA, 2015, ELIFE, V4, DOI 10.7554/eLife.07236; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Day CL, 2000, J MOL BIOL, V301, P147, DOI 10.1006/jmbi.2000.3895; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dogan MY, 2015, CELL REP, V10, P1967, DOI 10.1016/j.celrep.2015.02.061; Duselder A, 2012, J MOL BIOL, V423, P159, DOI 10.1016/j.jmb.2012.06.043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endow SA, 2010, J CELL SCI, V123, P3420, DOI 10.1242/jcs.064113; Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Gudimchuk N, 2013, NAT CELL BIOL, V15, P1079, DOI 10.1038/ncb2831; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoenger A, 1998, J CELL BIOL, V141, P419, DOI 10.1083/jcb.141.2.419; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P17382, DOI 10.1073/pnas.0708828104; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P2175, DOI 10.1073/pnas.0610939104; Isojima H, 2016, NAT CHEM BIOL, V12, P290, DOI [10.1038/NCHEMBIO.2028, 10.1038/nchembio.2028]; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Klenchin VA, 2011, J BIOL CHEM, V286, P18240, DOI 10.1074/jbc.M111.227371; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Korkmaz EN, 2016, PROTEINS, V84, P172, DOI 10.1002/prot.24964; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li C, 2016, BRIEF BIOINFORM, V17, P270, DOI 10.1093/bib/bbv047; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mickolajczyk KJ, 2015, P NATL ACAD SCI USA, V112, pE7186, DOI 10.1073/pnas.1517638112; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Muretta JM, 2015, P NATL ACAD SCI USA, V112, pE6606, DOI 10.1073/pnas.1512305112; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Rackham OJL, 2010, J MOL BIOL, V403, P480, DOI 10.1016/j.jmb.2010.08.032; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; Sardar HS, 2010, CURR BIOL, V20, P1648, DOI 10.1016/j.cub.2010.08.001; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Scholey JE, 2014, ELIFE, V3, DOI 10.7554/eLife.02217; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; Taylor KC, 2015, P NATL ACAD SCI USA, V112, pE3806, DOI 10.1073/pnas.1505813112; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Trigg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023519; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; van Breugel M, 2014, ELIFE, V3, DOI 10.7554/eLife.01812; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Zhang PW, 2016, J BIOL CHEM, V291, P4407, DOI 10.1074/jbc.M115.705970	87	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20372	20386		10.1074/jbc.M116.737577	http://dx.doi.org/10.1074/jbc.M116.737577			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27462072	Green Published, hybrid			2022-12-28	WOS:000384574800008
J	Oroz, J; Barrera-Vilarmau, S; Alfonso, C; Rivas, G; de Alba, E				Oroz, Javier; Barrera-Vilarmau, Susana; Alfonso, Carlos; Rivas, German; de Alba, Eva			ASC Pyrin Domain Self-associates and Binds NLRP3 Protein Using Equivalent Binding Interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; inflammasome; inflammation; NLRP3; nuclear magnetic resonance (NMR); ASC; pyrin	CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; PROVIDES INSIGHTS; NMR-SPECTROSCOPY; INFLAMMASOME; DEATH; APOPTOSIS; MECHANISM; REVEALS; COMPLEX	Death domain superfamily members typically act as adaptors mediating in the assembly of supramolecular complexes with critical apoptosis and inflammation functions. These modular proteins consist of death domains, death effector domains, caspase recruitment domains, and pyrin domains (PYD). Despite the high structural similarity among them, only homotypic interactions participate in complex formation, suggesting that subtle factors differentiate each interaction type. It is thus critical to identify these factors as an essential step toward the understanding of the molecular basis of apoptosis and inflammation. The proteins apoptosis-associated speck-like protein containing a CARD (ASC) and NLRP3 play key roles in the regulation of apoptosis and inflammation through self-association and protein-protein interactions mediated by their PYDs. To better understand the molecular basis of their function, we have characterized ASC and NLRP3 PYD self-association and their intermolecular interaction by solution NMR spectroscopy and analytical ultracentrifugation. We found that ASC self-associates and binds NLRP3 PYD through equivalent protein regions, with higher binding affinity for the latter. These regions are located at opposite sides of the protein allowing multimeric complex formation previously shown in ASC PYD fibril assemblies. We show that NLRP3 PYD coexists in solution as a monomer and highly populated large-order oligomerized species. Despite this, we determined its monomeric three-dimensional solution structure by NMR and characterized its binding to ASC PYD. Using our novel structural data, we propose molecular models of ASCASC and ASCNLRP3 PYD early supramolecular complexes, providing new insights into the molecular mechanisms of inflammasome and apoptosis signaling.	[Oroz, Javier; Barrera-Vilarmau, Susana] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Ramiro de Maeztu 9, Madrid 28040, Spain; [Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Ramiro de Maeztu 9, Madrid 28040, Spain; [de Alba, Eva] CSIC, Ctr Nacl Biotecnol, Madrid 28040, Spain; [Oroz, Javier] Max Planck Inst Biophys Chem, German Ctr Neurodegenerat Dis DZNE, Fassberg 11, D-37077 Gottingen, Germany; [de Alba, Eva] Univ Calif Merced, Hlth Sci Res Inst, 5200 North Lake Rd, Merced, CA 95343 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; University of California System; University of California Merced	Oroz, J (corresponding author), Max Planck Inst Biophys Chem, German Ctr Neurodegenerat Dis DZNE, Fassberg 11, D-37077 Gottingen, Germany.; de Alba, E (corresponding author), Univ Calif Merced, Hlth Sci Res Inst, 5200 North Lake Rd, Merced, CA 95343 USA.	jaor@nmr.mpibpc.mpg.de; edealbabastarrechea@ucmerced.edu	Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Oroz, Javier/J-3297-2015; Barrera-Vilarmau, Susana/ABD-1039-2020	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Oroz, Javier/0000-0003-2687-3013; Barrera-Vilarmau, Susana/0000-0003-4868-6593	Spanish Ministry of Science and Innovation Plan Nacional I+D+i Program [BFU2008-03278, BFU2011-23797]; Programa Ingenio-CONSOLIDER Grant [CSD2009-00088]; Marie Curie Intra-European Fellowship Project [626526]	Spanish Ministry of Science and Innovation Plan Nacional I+D+i Program(Ministry of Science and Innovation, Spain (MICINN)); Programa Ingenio-CONSOLIDER Grant; Marie Curie Intra-European Fellowship Project(European Commission)	This work was supported in part by Spanish Ministry of Science and Innovation Plan Nacional I+D+i Program, Grants BFU2008-03278 and BFU2011-23797, and Programa Ingenio-2010-CONSOLIDER Grant CSD2009-00088 (to E. dA.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Marie Curie Intra-European Fellowship Project 626526. To whom correspondence may be addressed: German Center for Neurodegenerative Diseases (DZNE) %Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, Gottingen-37077, Germany. E-mail: jaor@nmr.mpibpc.mpg.de.	Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CHATELIER RC, 1987, BIOPOLYMERS, V26, P507, DOI 10.1002/bip.360260405; Chu LH, 2015, APOPTOSIS, V20, P157, DOI 10.1007/s10495-014-1065-1; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cook GP, 2010, EUR J IMMUNOL, V40, P631, DOI 10.1002/eji.200940162; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Alba E., 2014, INFLAMMASOME, V1, P44; de Alba E, 2007, BIOMOL NMR ASSIGM, V1, P135, DOI 10.1007/s12104-007-9036-x; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2014, PYMOL MOL GRAPH SYST; Eibl C, 2012, BIOCHEMISTRY-US, V51, P7330, DOI 10.1021/bi3007059; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goddard TD, 2004, SPARKY; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hull KM, 2003, CURR OPIN RHEUMATOL, V15, P61, DOI 10.1097/00002281-200301000-00011; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kubota T, 2010, MOD RHEUMATOL, V20, P213, DOI 10.1007/s10165-009-0271-0; Kwon D, 2012, NUCLEIC ACIDS RES, V40, pD331, DOI 10.1093/nar/gkr1149; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Muramatsu N, 1989, J Mol Recognit, V1, P166, DOI 10.1002/jmr.300010404; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2012, APOPTOSIS, V17, P1247, DOI 10.1007/s10495-012-0775-5; Pinheiro AS, 2011, J MOL BIOL, V413, P790, DOI 10.1016/j.jmb.2011.09.024; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sborgi L, 2015, P NATL ACAD SCI USA, V112, P13237, DOI 10.1073/pnas.1507579112; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Stehlik C, 2003, J BIOL CHEM, V278, P31941, DOI 10.1074/jbc.M300009200; Su MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067843; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Touitou I, 2004, HUM MUTAT, V24, P194, DOI 10.1002/humu.20080; Vajjhala PR, 2014, J BIOL CHEM, V289, P23504, DOI 10.1074/jbc.M114.553305; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; van Holde K. E., 1986, PHYSICAL BIOCH, P110; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024	73	46	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19487	19501		10.1074/jbc.M116.741082	http://dx.doi.org/10.1074/jbc.M116.741082			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27432880	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000383242800026
J	Xie, JD; Chen, SR; Chen, H; Zeng, WA; Pan, HL				Xie, Jing-Dun; Chen, Shao-Rui; Chen, Hong; Zeng, Wei-An; Pan, Hui-Lin			Presynaptic N-Methyl-d-aspartate (NMDA) Receptor Activity Is Increased Through Protein Kinase C in Paclitaxel-induced Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; ion channel; neuron; pain; synaptic plasticity; toxicity	CORD DORSAL-HORN; RAT SPINAL-CORD; GLUTAMATE RELEASE; PERIPHERAL NEUROPATHY; NEUROTRANSMITTER RELEASE; CHLORIDE HOMEOSTASIS; PRIMARY AFFERENTS; ROOT GANGLION; NR1 SUBUNIT; NEURONS	Painful peripheral neuropathy is a severe adverse effect of chemotherapeutic drugs such as paclitaxel (Taxol). The glutamate N-methyl-d-aspartate receptors (NMDARs) are critically involved in the synaptic plasticity associated with neuropathic pain. However, paclitaxel treatment does not alter the postsynaptic NMDAR activity of spinal dorsal horn neurons. In this study, we determined whether paclitaxel affects presynaptic NMDAR activity by recording excitatory postsynaptic currents (EPSCs) of dorsal horn neurons in spinal cord slices. In paclitaxel-treated rats, the baseline frequency of miniature EPSCs (mEPSCs) was significantly increased; the NMDAR antagonist 2-amino-5-phosphonopentanoic acid (AP5) completely normalized this frequency. Also, AP5 significantly reduced the amplitude of monosynaptic EPSCs evoked by dorsal root stimulation and reversed the reduction in the paired-pulse ratio of evoked EPSCs in paclitaxel-treated rats. Blocking GluN2A-containing, but not GluN2B-containing, NMDARs largely decreased the frequency of mEPSCs and the amplitude of evoked EPSCs of dorsal horn neurons in paclitaxel-treated rats. Furthermore, inhibition of protein kinase C fully reversed the increased frequency of mEPSCs and the amplitude of evoked EPSCs in paclitaxel-treated rats. Paclitaxel treatment significantly increased the protein level of GluN2A and phosphorylated GluN1 in the dorsal root ganglion. In addition, intrathecal injection of AP5 or systemic administration of memantine profoundly attenuated pain hypersensitivity induced by paclitaxel. Our findings indicate that paclitaxel treatment induces tonic activation of presynaptic NMDARs in the spinal cord through protein kinase C to potentiate nociceptive input from primary afferent nerves. Targeting presynaptic NMDARs at the spinal cord level may be an effective strategy for treating chemotherapy-induced neuropathic pain.	[Xie, Jing-Dun; Chen, Shao-Rui; Chen, Hong; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA; [Xie, Jing-Dun; Zeng, Wei-An] Sun Yat Sen Univ, Dept Anesthesiol, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University	Chen, SR; Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110,1515 Holcombe Blvd, Houston, TX 77030 USA.	schen@mdanderson.org; huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [DE022015, NS073935]; N.G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N.G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grants DE022015 and NS073935 from the National Institutes of Health and by the N.G. and Helen T. Hawkins Endowment (to H.-L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bardoni R, 2004, J NEUROSCI, V24, P2774, DOI 10.1523/JNEUROSCI.4637-03.2004; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bouvier G, 2015, NEUROSCIENCE, V311, P322, DOI 10.1016/j.neuroscience.2015.10.033; Brasier DJ, 2008, J NEUROSCI, V28, P2199, DOI 10.1523/JNEUROSCI.3915-07.2008; Brenner GJ, 2004, EUR J NEUROSCI, V20, P375, DOI 10.1111/j.1460-9568.2004.03506.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; Chen SR, 2014, J BIOL CHEM, V289, P31111, DOI 10.1074/jbc.M114.600320; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2014, J PHYSIOL-LONDON, V592, P215, DOI 10.1113/jphysiol.2013.263814; Chen SR, 2011, J PHARMACOL EXP THER, V337, P285, DOI 10.1124/jpet.110.176586; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; Edman S, 2012, NEUROPHARMACOLOGY, V63, P441, DOI 10.1016/j.neuropharm.2012.04.027; Farlow MR, 2007, AM J MED, V120, P388, DOI 10.1016/j.amjmed.2006.08.036; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Glitsch M, 1999, J NEUROSCI, V19, P511; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Hansen KB, 2012, J NEUROSCI, V32, P6197, DOI 10.1523/JNEUROSCI.5757-11.2012; Hara T, 2013, PAIN, V154, P882, DOI 10.1016/j.pain.2013.02.023; He Y, 2015, J NEUROSCI, V35, P4614, DOI 10.1523/JNEUROSCI.1580-14.2015; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Kunz PA, 2013, J NEUROSCI, V33, P7762, DOI 10.1523/JNEUROSCI.2482-12.2013; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Li LY, 2016, CELL REP, V15, P1376, DOI 10.1016/j.celrep.2016.04.039; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; Matsumoto M, 2006, J PHARMACOL EXP THER, V318, P735, DOI 10.1124/jpet.106.103614; Momiyama A, 2000, J PHYSIOL-LONDON, V523, P621, DOI 10.1111/j.1469-7793.2000.t01-1-00621.x; Nagy GG, 2004, EUR J NEUROSCI, V20, P3301, DOI 10.1111/j.1460-9568.2004.03798.x; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; Schwartzman RJ, 2009, PAIN, V147, P107, DOI 10.1016/j.pain.2009.08.015; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Scuteri A, 2006, ANTICANCER RES, V26, P1065; Sigtermans MJ, 2009, PAIN, V145, P304, DOI 10.1016/j.pain.2009.06.023; Sinis N, 2007, CLIN J PAIN, V23, P237, DOI 10.1097/AJP.0b013e31802f67a7; Sisignano M, 2014, NAT REV NEUROL, V10, P694, DOI 10.1038/nrneurol.2014.211; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Woodhall G, 2001, J NEUROPHYSIOL, V86, P1644, DOI 10.1152/jn.2001.86.4.1644; YAMAMOTO T, 1992, PAIN, V49, P121, DOI 10.1016/0304-3959(92)90198-K; Yan XS, 2013, J PHYSIOL-LONDON, V591, P2001, DOI 10.1113/jphysiol.2012.250522; Zhao YL, 2012, J BIOL CHEM, V287, P25073, DOI 10.1074/jbc.M112.378737; Zhou HY, 2008, J PHARMACOL EXP THER, V327, P375, DOI 10.1124/jpet.108.141226; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	49	37	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19364	19373		10.1074/jbc.M116.732347	http://dx.doi.org/10.1074/jbc.M116.732347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27458019	Green Published, hybrid			2022-12-28	WOS:000383242800016
J	Zanphorlin, LM; Lima, TB; Wong, MJ; Balbuena, TS; Minetti, CASA; Remeta, DP; Young, JC; Barbosa, LRS; Gozzo, FC; Ramos, CHI				Zanphorlin, Leticia M.; Lima, Tatiani B.; Wong, Michael J.; Balbuena, Tiago S.; Minetti, Conceicao A. S. A.; Remeta, David P.; Young, Jason C.; Barbosa, Leandro R. S.; Gozzo, Fabio C.; Ramos, Carlos H. I.			Heat Shock Protein 90 kDa (Hsp90) Has a Second Functional Interaction Site with the Mitochondrial Import Receptor Tom70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE-SCATTERING; SPECTROMETRY; CHAPERONES; RESOLUTION; COMPLEXES; BINDING; LIGAND; HSP70	To accomplish its crucial role, mitochondria require proteins that are produced in the cytosol, delivered by cytosolic Hsp90, and translocated to its interior by the translocase outer membrane (TOM) complex. Hsp90 is a dimeric molecular chaperone and its function is modulated by its interaction with a large variety of co-chaperones expressed within the cell. An important family of co-chaperones is characterized by the presence of one TPR (tetratricopeptide repeat) domain, which binds to the C-terminal MEEVD motif of Hsp90. These include Tom70, an important component of the TOM complex. Despite a wealth of studies conducted on the relevance of Tom 70 center dot Hsp90 complex formation, there is a dearth of information regarding the exact molecular mode of interaction. To help fill this void, we have employed a combined experimental strategy consisting of cross-linking/mass spectrometry to investigate binding of the C-terminal Hsp90 domain to the cytosolic domain of Tom70. This approach has identified a novel region of contact between C-Hsp90 and Tom70, a finding that is confirmed by probing the corresponding peptides derived from cross-linking experiments via isothermal titration calorimetry and mitochondrial import assays. The data generated in this study are combined to input constraints for a molecular model of the Hsp90/Tom70 interaction, which has been validated by small angle x-ray scattering, hydrogen/deuterium exchange, and mass spectrometry. The resultant model suggests that only one of the MEEVD motifs within dimeric Hsp90 contacts Tom70. Collectively, our findings provide significant insight on the mechanisms by which preproteins interact with Hsp90 and are translocated via Tom70 to the mitochondria.	[Zanphorlin, Leticia M.; Lima, Tatiani B.; Gozzo, Fabio C.; Ramos, Carlos H. I.] Univ Campinas UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil; [Wong, Michael J.; Young, Jason C.] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Balbuena, Tiago S.] State Univ Sao Paulo, Coll Agr & Vet Sci, BR-14884900 Sao Paulo, Brazil; [Minetti, Conceicao A. S. A.; Remeta, David P.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Barbosa, Leandro R. S.] Univ Sao Paulo, Inst Fis, BR-05508090 Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; McGill University; Universidade Estadual Paulista; Rutgers State University New Brunswick; Universidade de Sao Paulo	Ramos, CHI (corresponding author), Univ Campinas UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil.	cramos@iqm.unicamp.br	Minetti, Conceicao/AGD-6419-2022; Balbuena, Tiago Santana/B-7971-2012; Minetti, Conceicao/B-5077-2009; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Barbosa, Tiago M./ABE-6789-2020; Lima, Tatiani Brenelli/A-3454-2017; Barbosa, Leandro Ramos Souza/E-6577-2012; Ramos, CH/C-1571-2012; Barbosa, L. R. S./AAN-7787-2020	Minetti, Conceicao/0000-0002-9682-2898; Minetti, Conceicao/0000-0002-9682-2898; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Barbosa, Tiago M./0000-0001-7071-2116; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Ramos, CH/0000-0002-7246-9081; Lima, Tatiani Brenelli de/0000-0003-4869-0592; Balbuena, Tiago/0000-0002-1053-0254; Remeta, David/0000-0002-4142-0904	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant FAPESP [2012/50161-8]; Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq); FAPESP; Canadian Institutes of Health Research [MOP-130332]; INBEB (Instituto Nacional de Biologia Estrutural e Bioimagem)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); INBEB (Instituto Nacional de Biologia Estrutural e Bioimagem)	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant FAPESP 2012/50161-8, Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq), and fellowships from FAPESP and the Canadian Institutes of Health Research (MOP-130332). The authors declare they have no conflict of interest with the contents of this article.; Supported by INBEB (Instituto Nacional de Biologia Estrutural e Bioimagem).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BARBOSA LRS, 2013, PROTEINS SOLUTION IN, P49; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; da Sava V. C., 2012, J PROTEOMICS, V75, P2790; da Silva VCH, 2013, PLANT PHYSIOL BIOCH, V68, P16, DOI 10.1016/j.plaphy.2013.03.015; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Engen JR, 2003, ANALYST, V128, P623, DOI 10.1039/b212800b; Fan ACY, 2011, J BIOL CHEM, V286, P32208, DOI 10.1074/jbc.M111.280446; Fan ACY, 2011, PROTEIN PEPTIDE LETT, V18, P122; Fan ACY, 2010, BIOCHEM J, V429, P553, DOI 10.1042/BJ20091855; Gava LM, 2011, ARCH BIOCHEM BIOPHYS, V513, P119, DOI 10.1016/j.abb.2011.06.015; Graf Christian, 2014, Front Mol Biosci, V1, P4, DOI 10.3389/fmolb.2014.00004; Guinier A., 1955, SMALL ANGLE SCATTERI; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Kahraman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073411; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li JZ, 2010, ACTA CRYSTALLOGR F, V66, P985, DOI 10.1107/S1744309110025522; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Lima DB, 2015, J PROTEOMICS, V129, P51, DOI 10.1016/j.jprot.2015.01.013; Makhnevych T., 2012, CELL RES, V1823, P674; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; Melin J, 2015, BBA-MOL CELL RES, V1853, P1850, DOI 10.1016/j.bbamcr.2015.04.021; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Rhangoo M. K, 2007, BIOL CELL, V18, P3414; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; Tiroli-Cepeda AO, 2014, J PROTEOMICS, V104, P48, DOI 10.1016/j.jprot.2014.02.004; Tsutakawa SE, 2007, J STRUCT BIOL, V158, P214, DOI 10.1016/j.jsb.2006.09.008; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wales TE, 2006, J MOL BIOL, V357, P1592, DOI 10.1016/j.jmb.2006.01.075; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zanphorlin LM, 2014, BBA-GEN SUBJECTS, V1840, P3145, DOI 10.1016/j.bbagen.2014.06.008; Zhang YL, 1998, ANAL BIOCHEM, V261, P139, DOI 10.1006/abio.1998.2738	40	24	24	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18620	18631		10.1074/jbc.M115.710137	http://dx.doi.org/10.1074/jbc.M115.710137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402847	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000383242300003
J	Berthoud, VM; Minogue, PJ; Lambert, PA; Snabb, JI; Beyer, EC				Berthoud, Viviana M.; Minogue, Peter J.; Lambert, Paul A.; Snabb, Joseph I.; Beyer, Eric C.			The Cataract-linked Mutant Connexin50D47A Causes Endoplasmic Reticulum Stress in Mouse Lenses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; cataract; cell death; connexin; endoplasmic reticulum stress (ER stress); gap junction; unfolded protein response (UPR)	UNFOLDED PROTEIN RESPONSE; ALPHA-B-CRYSTALLIN; ER STRESS; CELL-DEATH; PULVERULENT CATARACTS; EYE LENS; MUTATION; MICE; MICROPHTHALMIA; DEGRADATION	Mice expressing connexin50D47A (Cx50D47A) exhibit nuclear cataracts and impaired differentiation. Cx50D47A does not traffic properly, and homozygous mutant lenses show increased levels of the stress-responsive B-crystallins. Therefore, we assessed whether expression of Cx50D47A led to endoplasmic reticulum (ER) stress in the lens in vivo. Although pharmacologic induction of ER stress can be transduced by three different pathways, we found no evidence for activation of the IRE1 or ATF6 pathways in Cx50D47A-expressing lenses. In contrast, heterozygous and homozygous Cx50D47A lenses showed an increase in phosphorylated PERK immunoreactivity and in the ratio of phosphorylated to total EIF2 (2.4- and 3.3-fold, respectively) compared with wild type. Levels of ATF4 were similar in wild type and heterozygous lenses but elevated in homozygotes (391%). In both heterozygotes and homozygotes, levels of calreticulin protein were increased (184 and 262%, respectively), as was Chop mRNA (1.9- and 12.4-fold, respectively). CHOP protein was increased in homozygotes (384%). TUNEL staining was increased in Cx50D47A lenses, especially in homozygous mice. Levels of two factors that may be pro-survival, Irs2 and Trib3, were greatly increased in homozygous lenses. These results suggest that expression of Cx50D47A induces ER stress, triggering activation of the PERK-ATF4 pathway, which potentially contributes to the lens pathology and leads to increased expression of anti-apoptotic factors, allowing cell survival.	[Berthoud, Viviana M.; Minogue, Peter J.; Snabb, Joseph I.; Beyer, Eric C.] Univ Chicago, Dept Pediat, KCBD-5,900 E 57th St, Chicago, IL 60637 USA; [Lambert, Paul A.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Berthoud, VM (corresponding author), Univ Chicago, Dept Pediat, KCBD-5,900 E 57th St, Chicago, IL 60637 USA.	vberthou@peds.bsd.uchicago.edu	Beyer, Eric/V-1317-2019	Beyer, Eric/0000-0001-8044-1356	National Institutes of Health [RO1EY08368]; NIDDK [2T35DK062719]; NATIONAL EYE INSTITUTE [R01EY008368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK062719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1EY08368 (to E. C. B.) and NIDDK Grant 2T35DK062719 (to P. A. L. as a trainee). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Alapure BV, 2012, EXP EYE RES, V102, P28, DOI 10.1016/j.exer.2012.06.004; Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; Arora A, 2008, J MED GENET, V45, P155, DOI 10.1136/jmg.2007.051029; Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; Berthoud VM, 2013, INVEST OPHTH VIS SCI, V54, P7614, DOI 10.1167/iovs.13-13188; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; FAVOR J, 1983, MUTAT RES, V110, P367, DOI 10.1016/0027-5107(83)90153-7; Firtina Z, 2011, GENE EXPR PATTERNS, V11, P135, DOI 10.1016/j.gep.2010.10.005; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Klooster R, 2009, J IMMUNOL METHODS, V342, P1, DOI 10.1016/j.jim.2008.10.009; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Mulhern ML, 2006, INVEST OPHTH VIS SCI, V47, P3951, DOI 10.1167/iovs.06-0193; Ng CL, 2010, EXP CELL RES, V316, P2113, DOI 10.1016/j.yexcr.2010.04.010; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Rong P, 2002, DEVELOPMENT, V129, P167; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sellitto C, 2004, INVEST OPHTH VIS SCI, V45, P3196, DOI 10.1167/iovs.04-0194; Steele EC, 1998, CURR EYE RES, V17, P883, DOI 10.1076/ceyr.17.9.883.5144; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Tattersall D, 2009, HUM MOL GENET, V18, P4734, DOI 10.1093/hmg/ddp436; Watson GW, 2010, BIOCHEM BIOPH RES CO, V401, P192, DOI 10.1016/j.bbrc.2010.09.023; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7	36	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17569	17578		10.1074/jbc.M115.707950	http://dx.doi.org/10.1074/jbc.M115.707950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27317663	Green Published, hybrid			2022-12-28	WOS:000383241300009
J	Meyer, MB; Benkusky, NA; Sen, B; Rubin, J; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Sen, Buer; Rubin, Janet; Pike, J. Wesley			Epigenetic Plasticity Drives Adipogenic and Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; cell differentiation; ChIP-sequencing (ChIP-seq); histone modification; mesenchymal stem cells (MSCs); osteoblast	VITAMIN-D-RECEPTOR; TRANSCRIPTION FACTOR-BINDING; BONE-MARROW; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; PPAR-GAMMA; SIGNALING PATHWAY; FAT ACCUMULATION; CIRCADIAN CLOCK; ADIPOSE-TISSUE	Terminal differentiation of multipotent stem cells is achieved through a coordinated cascade of activated transcription factors and epigenetic modifications that drive gene transcription responsible for unique cell fate. Within the mesenchymal lineage, factors such as RUNX2 and PPAR are indispensable for osteogenesis and adipogenesis, respectively. We therefore investigated genomic binding of transcription factors and accompanying epigenetic modifications that occur during osteogenic and adipogenic differentiation of mouse bone marrow-derived mesenchymal stem cells (MSCs). As assessed by ChIP-sequencing and RNA-sequencing analyses, we found that genes vital for osteogenic identity were linked to RUNX2, C/EBP, retinoid X receptor, and vitamin D receptor binding sites, whereas adipocyte differentiation favored PPAR, retinoid X receptor, C/EBP, and C/EBP binding sites. Epigenetic marks were clear predictors of active differentiation loci as well as enhancer activities and selective gene expression. These marrow-derived MSCs displayed an epigenetic pattern that suggested a default preference for the osteogenic pathway; however, these patterns were rapidly altered near the Adipoq, Cidec, Fabp4, Lipe, Plin1, Pparg, and Cebpa genes during adipogenic differentiation. Surprisingly, we found that these cells also exhibited an epigenetic plasticity that enabled them to trans-differentiate from adipocytes to osteoblasts (and vice versa) after commitment, as assessed by staining, gene expression, and ChIP-quantitative PCR analysis. The osteogenic default pathway may be subverted during pathological conditions, leading to skeletal fragility and increased marrow adiposity during aging, estrogen deficiency, and skeletal unloading. Taken together, our data provide an increased mechanistic understanding of the epigenetic programs necessary for multipotent differentiation of MSCs that may prove beneficial in the development of therapeutic strategies.	[Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Sen, Buer; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27514 USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Biochem Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health [DK-072281, AR-066616]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK-072281 (to J. W. P.) and AR-066616 (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARBOUR NC, 1993, MOL ENDOCRINOL, V7, P1307, DOI 10.1210/me.7.10.1307; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bieszczad KM, 2015, J NEUROSCI, V35, P13124, DOI 10.1523/JNEUROSCI.0914-15.2015; Boonyatecha N, 2012, MOL IMMUNOL, V51, P255, DOI 10.1016/j.molimm.2012.03.017; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Case N, 2013, BONE, V52, P454, DOI 10.1016/j.bone.2012.08.122; Case N, 2010, J ORTHOP RES, V28, P1531, DOI 10.1002/jor.21156; Case N, 2010, J CELL BIOCHEM, V110, P545, DOI 10.1002/jcb.22574; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhanasekaran M, 2013, CELL BIOCHEM FUNCT, V31, P612, DOI 10.1002/cbf.2948; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Kaneko I, 2015, FASEB J, V29, P4023, DOI 10.1096/fj.14-269811; Kim S, 2007, J STEROID BIOCHEM, V103, P430, DOI 10.1016/j.jsbmb.2006.12.020; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Kondo M, 2015, ARTHRITIS RHEUMATOL, V67, P1250, DOI 10.1002/art.39036; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Lin CS, 2013, HISTOL HISTOPATHOL, V28, P1109, DOI 10.14670/HH-28.1109; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Madsen MS, 2014, MOL CELL BIOL, V34, P939, DOI 10.1128/MCB.01344-13; Masri S, 2012, ANN NY ACAD SCI, V1264, P103, DOI 10.1111/j.1749-6632.2012.06649.x; Matthews D. G., 2015, J STEROID BIOCHEM, DOI [10.1016/j.jsbmb.2015.1009.1035, DOI 10.1016/J.JSBMB.2015.1009.1035]; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Meyer M. B., 2015, J STEROID BIOCHEM, DOI [10.1016/j.jsbmb.2015.1009.1001, DOI 10.1016/J.JSBMB.2015.1009.1001]; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Meyer MB, 2015, J BIOL CHEM, V290, P11093, DOI 10.1074/jbc.M115.648394; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nielsen R, 2014, METHOD ENZYMOL, V537, P261, DOI 10.1016/B978-0-12-411619-1.00014-8; Ortiz-Gonzalez XR, 2004, CURR NEUROVASC RES, V1, P207, DOI 10.2174/1567202043362342; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peng T, 2015, CLIN LAB, V61, P1171, DOI 10.7754/Clin.Lab.2015.150217; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rojas A, 2015, J BIOL CHEM, V290, P28329, DOI 10.1074/jbc.M115.657825; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; SATO M, 1988, J CELL PHYSIOL, V135, P545, DOI 10.1002/jcp.1041350326; Schwartz AV, 2013, J CLIN ENDOCR METAB, V98, P2294, DOI 10.1210/jc.2012-3949; Sen B, 2015, STEM CELLS, V33, P3065, DOI 10.1002/stem.2090; Siersbaek R, 2014, CELL REP, V7, P1434, DOI 10.1016/j.celrep.2014.04.043; St John HC, 2015, BONE, V72, P81, DOI 10.1016/j.bone.2014.11.010; St John HC, 2014, MOL ENDOCRINOL, V28, P1150, DOI 10.1210/me.2014-1091; Styner M, 2014, BONE, V64, P39, DOI 10.1016/j.bone.2014.03.044; Styner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051613; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Thompson B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148619; Thompson WR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11049; Tong J, 2011, MECH AGEING DEV, V132, P552, DOI 10.1016/j.mad.2011.09.004; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trudel G, 2009, J APPL PHYSIOL, V107, P540, DOI 10.1152/japplphysiol.91530.2008; Visweswaran M, 2015, INT J BIOCHEM CELL B, V68, P139, DOI 10.1016/j.biocel.2015.09.008; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140	73	102	105	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17829	17847		10.1074/jbc.M116.736538	http://dx.doi.org/10.1074/jbc.M116.736538			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27402842	hybrid, Green Published			2022-12-28	WOS:000383241300029
J	Fekry, B; Jeffries, KA; Esmaeilniakooshkghazi, A; Ogretmen, B; Krupenko, SA; Krupenko, NI				Fekry, Baharan; Jeffries, Kristen A.; Esmaeilniakooshkghazi, Amin; Ogretmen, Besim; Krupenko, Sergey A.; Krupenko, Natalia I.			CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; CERAMIDE SYNTHASES; 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; P53-INDUCIBLE REGULATOR; BIOPHYSICAL PROPERTIES; METABOLIC-REGULATION; GLUCOSE-METABOLISM; FOLATE-DEPLETION; UP-REGULATION; EXPRESSION	Our previous study suggested that ceramide synthase 6 (CerS6), an enzyme in sphingolipid biosynthesis, is regulated by p53: CerS6 was elevated in several cell lines in response to transient expression of p53 or in response to folate stress, which is known to activate p53. It was not clear, however, whether CerS6 gene is a direct transcriptional target of p53 or whether this was an indirect effect through additional regulatory factors. In the present study, we have shown that the CerS6 promoter is activated by p53 in luciferase assays, whereas transcriptionally inactive R175H p53 mutant failed to induce the luciferase expression from this promoter. In vitro immunoprecipitation assays and gel shift analyses have further demonstrated that purified p53 binds within the CerS6 promoter sequence spanning 91 bp upstream and 60 bp downstream of the transcription start site. The Promo 3.0.2 online tool for the prediction of transcription factor binding sites indicated the presence of numerous putative non-canonical p53 binding motifs in the CerS6 promoter. Luciferase assays and gel shift analysis have identified a single motif upstream of the transcription start as a key p53 response element. Treatment of cells with Nutlin-3 or low concentrations of actinomycin D resulted in a strong elevation of CerS6 mRNA and protein, thus demonstrating that CerS6 is a component of the non-genotoxic p53-dependent cellular stress response. This study has shown that by direct transcriptional activation of CerS6, p53 can regulate specific ceramide biosynthesis, which contributes to the pro-apoptotic cellular response.	[Fekry, Baharan; Jeffries, Kristen A.; Esmaeilniakooshkghazi, Amin; Krupenko, Sergey A.; Krupenko, Natalia I.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA; [Ogretmen, Besim] Med Univ South Carolina, Dept Biochem, Charleston, SC 29425 USA; [Ogretmen, Besim] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Krupenko, Sergey A.; Krupenko, Natalia I.] Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Medical University of South Carolina; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Krupenko, NI (corresponding author), Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA.; Krupenko, NI (corresponding author), Univ N Carolina, Dept Nutr, Kannapolis, NC 28081 USA.	Natalia_krupenko@unc.edu	Fekry, Baharan/GLT-6510-2022	Fekry, Baharan/0000-0003-1218-4161	National Institutes of Health [CA193782, CA88932, CA97165, DE16572, DK54388]; NATIONAL CANCER INSTITUTE [R01CA193782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA193782 (to N. I. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the National Institutes of Health Grants CA88932, CA97165, and DE16572.r Supported by the National Institutes of Health Grant DK54388.	Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Choong ML, 2009, CELL CYCLE, V8, P2810, DOI 10.4161/cc.8.17.9503; Colombini Marco, 2013, Handb Exp Pharmacol, P109, DOI 10.1007/978-3-7091-1368-4_6; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; Crott JW, 2007, MUTAT RES-GEN TOX EN, V626, P171, DOI 10.1016/j.mrgentox.2006.10.001; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fekry B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146618; Fischer M, 2014, CELL CYCLE, V13, P3037, DOI 10.4161/15384101.2014.949083; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Goldstein I, 2012, TRENDS ENDOCRIN MET, V23, P567, DOI 10.1016/j.tem.2012.06.007; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heffernan-Stroud LA, 2011, ADV ENZYME REGUL, V51, P219, DOI 10.1016/j.advenzreg.2010.10.003; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hoeferlin LA, 2013, J BIOL CHEM, V288, P12880, DOI 10.1074/jbc.M113.461798; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; KRUPENKO SA, 1995, PROTEIN EXPRES PURIF, V6, P457, DOI 10.1006/prep.1995.1061; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mathupala SP, 1997, J BIOL CHEM, V272, P22776, DOI 10.1074/jbc.272.36.22776; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Menendez D, 2006, P NATL ACAD SCI USA, V103, P1406, DOI 10.1073/pnas.0508103103; Menendez D, 2010, DISCOV MED, V10, P94; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Meyers-Needham M, 2012, EMBO MOL MED, V4, P78, DOI 10.1002/emmm.201100189; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Oleinik Natalia V, 2011, Genes Cancer, V2, P130, DOI 10.1177/1947601911405841; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Ou Y, 2015, J BIOL CHEM, V290, P457, DOI 10.1074/jbc.M114.616359; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinn JL, 2011, TRENDS CELL BIOL, V21, P344, DOI 10.1016/j.tcb.2011.04.002; Saddoughi SA, 2013, ADV CANCER RES, V117, P37, DOI 10.1016/B978-0-12-394274-6.00002-9; Sanchez-Macedo N, 2013, CELL DEATH DIFFER, V20, P659, DOI 10.1038/cdd.2012.168; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Sinha AU, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-88; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Suzuki M, 2016, J CLIN INVEST, V126, P254, DOI 10.1172/JCI79775; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; TISHLER RB, 1993, CANCER RES, V53, P2212; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang SJ, 2014, CURR OPIN ONCOL, V26, P78, DOI 10.1097/CCO.0000000000000024; Wang SJ, 2013, CELL CYCLE, V12, P753, DOI 10.4161/cc.23597; Wegner MS, 2014, BIOCHEM PHARMACOL, V92, P577, DOI 10.1016/j.bcp.2014.10.007; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhang X, 2015, MOL CELL, V59, P243, DOI 10.1016/j.molcel.2015.05.036	59	30	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16586	16596		10.1074/jbc.M116.716902	http://dx.doi.org/10.1074/jbc.M116.716902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27302066	hybrid, Green Published			2022-12-28	WOS:000380826700018
J	Hicks, KC; Patel, TB				Hicks, Kristin C.; Patel, Tarun B.			Sprouty2 Protein Regulates Hypoxia-inducible Factor-alpha (HIF alpha) Protein Levels and Transcription of HIF alpha-responsive Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HUMAN ERYTHROPOIETIN GENE; FACTOR-I; HEPATOCELLULAR-CARCINOMA; KINASE PATHWAY; FACTOR 1-ALPHA; PROSTATE-CANCER; DOWN-REGULATION; ERK ACTIVATION; UP-REGULATION	The alpha-subunits of hypoxia-inducible factors (HIF1 alpha and HIF2 alpha) promote transcription of genes that regulate glycolysis and cell survival and growth. Sprouty2 (Spry2) is a modulator of receptor tyrosine kinase signaling and inhibits cell proliferation by a number of different mechanisms. Because of the seemingly opposite actions of HIF alpha subunits and Spry2 on cellular processes, we investigated whether Spry2 regulates the levels of HIF1 alpha and HIF2 alpha proteins. In cell lines from different types of tumors in which the decreased protein levels of Spry2 have been associated with poor prognosis, silencing of Spry2 elevated HIF1 alpha protein levels. Increases in HIF1 alpha and HIF2 alpha protein levels due to silencing of Spry2 also up-regulated HIF alpha target genes. Using HIF1 alpha as a prototype, we show that Spry2 decreases HIF1 alpha stability and enhances the ubiquitylation of HIF1 alpha by a von Hippel-Lindau protein (pVHL)-dependent mechanism. Spry2 also exists in a complex with HIF1 alpha. Because Spry2 can also associate with pVHL, using a mutant form of Spry2 (3P/3A-Spry2) that binds HIF1 alpha, but not pVHL, we show that WT-Spry2, but not the 3P/3A-Spry2 decreases HIF1 alpha protein levels. In accordance, expression of WT-Spry2, but not 3P/3A-Spry2 results in a decrease in HIF1 alpha-sensitive glucose uptake. Together our data suggest that Spry2 acts as a scaffold to bring more pVHL/associated E3 ligase in proximity of HIF1 alpha and increase its ubiquitylation and degradation. This represents a novel action for Spry2 in modulating biological processes regulated by HIF alpha subunits.	[Hicks, Kristin C.] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Patel, Tarun B.] Albany Coll Pharm & Hlth Sci, OBrien Bldg,Ste 104G,106 New Scotland Ave, Albany, NY 12208 USA	Loyola University Chicago; Albany College of Pharmacy & Health Sciences	Patel, TB (corresponding author), Albany Coll Pharm & Hlth Sci, OBrien Bldg,Ste 104G,106 New Scotland Ave, Albany, NY 12208 USA.	tarun.patel@acphs.edu		Hicks, Kristin/0000-0001-9192-875X	Schmitt fellowship; Veterans Affairs Merit Review Award [5IBX002355]; Veterans Affairs [I01BX002355] Funding Source: NIH RePORTER	Schmitt fellowship; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Schmitt fellowship (to K. H.) and Veterans Affairs Merit Review Award 5IBX002355 (to T. B. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baumann MU, 2007, AM J PHYSIOL-CELL PH, V293, pC477, DOI 10.1152/ajpcell.00075.2007; Bemis L, 2004, GENE DEV, V18, P739, DOI 10.1101/gad.1180104; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Faratian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023772; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190; Gao ML, 2012, EMBO MOL MED, V4, P776, DOI 10.1002/emmm.201100944; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hopfer U, 2006, J BIOL CHEM, V281, P8645, DOI 10.1074/jbc.M513751200; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim BY, 2008, EXP MOL MED, V40, P71, DOI 10.3858/emm.2008.40.1.71; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lee SA, 2010, HEPATOLOGY, V52, P506, DOI 10.1002/hep.23681; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu X., 2014, ELECTRON J DIFFER EQ, V2014, P1, DOI DOI 10.1007/S11033-014-3506-X; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Macia A, 2012, ONCOGENE, V31, P3961, DOI 10.1038/onc.2011.556; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Mastrogiannaki M, 2012, HAEMATOL-HEMATOL J, V97, P827, DOI 10.3324/haematol.2011.056119; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McKie AB, 2005, ONCOGENE, V24, P2166, DOI 10.1038/sj.onc.1208371; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Ozaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1084, DOI 10.1006/bbrc.2001.5295; Ozaki K, 2005, J CELL SCI, V118, P5861, DOI 10.1242/jcs.02711; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Perl AKT, 2003, DEV BIOL, V258, P154, DOI 10.1016/S0012-1606(03)00106-4; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ravi R, 2000, GENE DEV, V14, P34; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sirivatanauksorn Y, 2012, J SURG ONCOL, V105, P273, DOI 10.1002/jso.22095; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song K, 2012, HEPATOB PANCREAT DIS, V11, P177, DOI 10.1016/S1499-3872(12)60145-3; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Taniguchi K, 2009, CANCER SCI, V100, P1648, DOI 10.1111/j.1349-7006.2009.01214.x; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Wang CM, 2012, J HEPATOL, V57, P577, DOI 10.1016/j.jhep.2012.04.026; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3; Zhong H, 2000, CANCER RES, V60, P1541; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51	94	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16787	16801		10.1074/jbc.M116.714139	http://dx.doi.org/10.1074/jbc.M116.714139			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27281823	Green Published, hybrid			2022-12-28	WOS:000380826700035
J	Pakchuen, S; Ishibashi, M; Takakusagi, E; Shirahige, K; Sutani, T				Pakchuen, Sujiraporn; Ishibashi, Mai; Takakusagi, Emi; Shirahige, Katsuhiko; Sutani, Takashi			Physical Association of Saccharomyces cerevisiae Polo-like Kinase Cdc5 with Chromosomal Cohesin Facilitates DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ChIP-sequencing (ChIP-seq); chromosomes; DNA damage response; Saccharomyces cerevisiae; serine; threonine protein kinase; polo-like kinase; cohesin; priming phosphorylation	SISTER-CHROMATID SEPARATION; DOUBLE-STRAND BREAKS; ANAPHASE TRANSITION; CUT2 PROTEOLYSIS; FISSION YEAST; SUBUNIT SCC1; PLK1 DOCKING; BOX DOMAIN; PHOSPHORYLATION; REPLICATION	At the onset of anaphase, a protease called separase breaks the link between sister chromatids by cleaving the cohesin subunit Scc1. This irreversible step in the cell cycle is promoted by degradation of the separase inhibitor, securin, and polo-like kinase (Plk) 1-dependent phosphorylation of the Scc1 subunit. Plk could recognize substrates through interaction between its phosphopeptide interaction domain, the polo-box domain, and a phosphorylated priming site in the substrate, which has been generated by a priming kinase beforehand. However, the physiological relevance of this targeting mechanism remains to be addressed for many of the Plk1 substrates. Here, we show that budding yeast Plk1, Cdc5, is pre-deposited onto cohesin engaged in cohesion on chromosome arms in G(2)/M phase cells. The Cdc5-cohesin association is mediated by direct interaction between the polo-box domain of Cdc5 and Scc1 phosphorylated at multiple sites in its middle region. Alanine substitutions of the possible priming phosphorylation sites (scc1-15A) impair Cdc5 association with chromosomal cohesin, but they make only a moderate impact on mitotic cell growth even in securin-deleted cells (pds1), where Scc1 phosphorylation by Cdc5 is indispensable. The same scc1-15A pds1 double mutant, however, exhibits marked sensitivity to the DNA-damaging agent phleomycin, suggesting that the priming phosphorylation of Scc1 poses an additional layer of regulation that enables yeast cells to adapt to genotoxic environments.	[Pakchuen, Sujiraporn; Ishibashi, Mai; Shirahige, Katsuhiko; Sutani, Takashi] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan; [Pakchuen, Sujiraporn; Takakusagi, Emi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan	University of Tokyo; Tokyo Institute of Technology	Sutani, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan.	tsutani@iam.u-tokyo.ac.jp		Pakchuen, Sujiraporn/0000-0003-1107-098X; Shirahige, Katsuhiko/0000-0002-7862-1144; Sutani, Takashi/0000-0002-9959-9513	Chromosome Orchestration System; Japan Society for the Promotion of Science	Chromosome Orchestration System; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grant-in-aid for scientific Research on innovative areas (Chromosome Orchestration System) (to K.S.) and grants-in-aid for scientific research (A) (to K.S. and T.S.) from Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi Y, 2008, CELL CYCLE, V7, P765, DOI 10.4161/cc.7.6.5530; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Attner MA, 2013, P NATL ACAD SCI USA, V110, P14278, DOI 10.1073/pnas.1311845110; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Blancher C, 2001, Methods Mol Med, V57, P145, DOI 10.1385/1-59259-136-1:145; Brar GA, 2006, NATURE, V441, P532, DOI 10.1038/nature04794; Burke D, 2000, METHODS YEAST GENETI, P155; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Jeppsson K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004680; Kaina B, 2004, CYTOGENET GENOME RES, V104, P77, DOI 10.1159/000077469; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Merrill BJ, 1999, GENETICS, V153, P595; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; MOORE CW, 1988, CANCER RES, V48, P6837; Nakato R, 2013, GENES CELLS, V18, P589, DOI 10.1111/gtc.12058; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; Oppermann FS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.012351; POVIRK LF, 1977, NUCLEIC ACIDS RES, V4, P3573, DOI 10.1093/nar/4.10.3573; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Ratsima H, 2011, P NATL ACAD SCI USA, V108, pE914, DOI 10.1073/pnas.1106448108; Rossio V, 2010, J CELL BIOL, V191, P981, DOI 10.1083/jcb.201007025; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Sutani T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8815; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2001, EMBO REP, V2, P487, DOI 10.1093/embo-reports/kve113; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Valk E, 2014, MOL BIOL CELL, V25, P3456, DOI 10.1091/mbc.E14-02-0774; WRIGHT APH, 1989, YEAST, V5, P51, DOI 10.1002/yea.320050107; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	65	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17228	17246		10.1074/jbc.M116.727438	http://dx.doi.org/10.1074/jbc.M116.727438			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325700	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000382643800025
J	Zhu, XQ; Dahlmans, V; Thali, R; Preisinger, C; Viollet, B; Voncken, JW; Neumann, D				Zhu, Xiaoqing; Dahlmans, Vivian; Thali, Ramon; Preisinger, Christian; Viollet, Benoit; Voncken, J. Willem; Neumann, Dietbert			AMP-activated Protein Kinase Up-regulates Mitogen-activated Protein (MAP) Kinase-interacting Serine/Threonine Kinase 1a-dependent Phosphorylation of Eukaryotic Translation Initiation Factor 4E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); eukaryotic translation initiation factor 4E (eIF4E); mitogen-activated protein kinase (MAPK); post-translational modification (PTM); protein phosphorylation; translation; MAP kinase-interacting serine; threonine protein kinase 1a (MNK1a)	CELL-GROWTH; CANCER; IDENTIFICATION; EIF4E; MNK1; COMPLEX; SUBSTRATE; PATHWAYS; VECTORS; TARGETS	AMP-activated protein kinase (AMPK) is a molecular energy sensor that acts to sustain cellular energy balance. Although AMPK is implicated in the regulation of a multitude of ATP-dependent cellular processes, exactly how these processes are controlled by AMPK as well as the identity of AMPK targets and pathways continues to evolve. Here we identify MAP kinase-interacting serine/threonine protein kinase 1a (MNK1a) as a novel AMPK target. Specifically, we show AMPK-dependent Ser(353) phosphorylation of the human MNK1a isoform in cell-free and cellular systems. We show that AMPK and MNK1a physically interact and that in vivo MNK1a-Ser(353) phosphorylation requires T-loop phosphorylation, in good agreement with a recently proposed structural regulatory model of MNK1a. Our data suggest a physiological role for MNK1a-Ser(353) phosphorylation in regulation of the MNK1a kinase, which correlates with increased eIF4E phosphorylation in vitro and in vivo.	[Zhu, Xiaoqing; Neumann, Dietbert] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Dahlmans, Vivian; Voncken, J. Willem] Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Thali, Ramon; Neumann, Dietbert] Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Preisinger, Christian] RWTH Univ Hosp Aachen, Interdisciplinary Ctr Clin Res IZKF, Prote Facil, D-52074 Aachen, Germany; [Viollet, Benoit] Inst Cochin, Dept Endocrinol Metab & Diabet, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit] CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France	Maastricht University; Maastricht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; RWTH Aachen University; RWTH Aachen University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Neumann, D (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.	d.neumann@maastrichtuniversity.nl	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Neumann, Dietbert/0000-0002-4316-684X	IZKF Aachen	IZKF Aachen	We thank R. Stead (Southampton, UK) and members of the Molecular Genetics Department (Maastricht University) for helpful comments and support. The Proteomics Facility is funded by the IZKF Aachen.	Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dasgupta B, 2016, TRENDS PHARMACOL SCI, V37, P192, DOI 10.1016/j.tips.2015.11.007; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Goto S, 2009, BIOCHEM J, V423, P279, DOI 10.1042/BJ20090228; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hou JQ, 2012, ONCOTARGET, V3, P118; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Joshi Sonali, 2014, World J Biol Chem, V5, P321, DOI 10.4331/wjbc.v5.i3.321; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Klaus A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062497; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Lu CW, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2015.20; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mok J, 2009, NAT PROTOC, V4, P1820, DOI 10.1038/nprot.2009.194; Moreno D, 2009, INT J BIOCHEM CELL B, V41, P2431, DOI 10.1016/j.biocel.2009.07.002; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; Oligschlaeger Y, 2015, J BIOL CHEM, V290, P11715, DOI 10.1074/jbc.M114.633271; Proud CG, 2015, BBA-GENE REGUL MECH, V1849, P766, DOI 10.1016/j.bbagrm.2014.10.003; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thali R. F., 2010, THESIS, P84; Thali RF, 2010, BIOCHEM BIOPH RES CO, V398, P296, DOI 10.1016/j.bbrc.2010.06.084; Tuerk RD, 2007, J PROTEOME RES, V6, P3266, DOI 10.1021/pr070160a; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Viollet B, 2014, CHEM BIOL, V21, P567, DOI 10.1016/j.chembiol.2014.05.003; von Kriegsheim A, 2008, METHODS MOL BIOL, V484, P177, DOI 10.1007/978-1-59745-398-1_12; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200	43	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17020	17027		10.1074/jbc.C116.740498	http://dx.doi.org/10.1074/jbc.C116.740498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27413184	hybrid, Green Published			2022-12-28	WOS:000382643800009
J	Ali, I; Ramage, H; Boehm, D; Dirk, LMA; Sakane, N; Hanada, K; Pagans, S; Kaehlcke, K; Aull, K; Weinberger, L; Trievel, R; Schnoelzer, M; Kamada, M; Houtz, R; Ott, M				Ali, Ibraheem; Ramage, Holly; Boehm, Daniela; Dirk, Lynnette M. A.; Sakane, Naoki; Hanada, Kazuki; Pagans, Sara; Kaehlcke, Katrin; Aull, Katherine; Weinberger, Leor; Trievel, Raymond; Schnoelzer, Martina; Kamada, Masafumi; Houtz, Robert; Ott, Melanie			The HIV-1 Tat Protein Is Monomethylated at Lysine 71 by the Lysine Methyltransferase KMT7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CYCLIN T1; TRANSCRIPTIONAL ACTIVITY; STRUCTURAL BASIS; IN-VITRO; METHYLATION; TRANSACTIVATION; RNA; REGION; LATENCY; CURE	The HIV-1 transactivator protein Tat is a critical regulator of HIV transcription primarily enabling efficient elongation of viral transcripts. Its interactions with RNA and various host factors are regulated by ordered, transient post-translational modifications. Here, we report a novel Tat modification, monomethylationatlysine-71 (K71). We found that Lys-71 monomethylation (K71me) is catalyzed by KMT7, a methyltransferase that also targets lysine 51 (K51) in Tat. Using mass spectrometry, in vitro enzymology, and modification-specific antibodies, we found that KMT7 monomethylates both Lys-71 and Lys-51 in Tat. K71me is important for full Tat transactivation, as KMT7 knockdown impaired the transcriptional activity of wild type (WT) Tat but not a Tat K71R mutant. These findings underscore the role of KMT7 as an important monomethyltransferase regulating HIV transcription through Tat.	[Ali, Ibraheem; Ramage, Holly; Boehm, Daniela; Sakane, Naoki; Pagans, Sara; Kaehlcke, Katrin; Aull, Katherine; Weinberger, Leor; Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Ali, Ibraheem; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Aull, Katherine; Weinberger, Leor] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Dirk, Lynnette M. A.; Houtz, Robert] Univ Kentucky, Dept Hort, Lexington, KY 40508 USA; [Sakane, Naoki; Hanada, Kazuki; Kamada, Masafumi] JT Inc, Pharmaceut Frontier Res Lab, Yokohama, Kanagawa 2360004, Japan; [Trievel, Raymond] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Schnoelzer, Martina] German Canc Res Ctr, D-69121 Heidelberg, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Kentucky; University of Michigan System; University of Michigan; Helmholtz Association; German Cancer Research Center (DKFZ)	Ott, M (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.; Ott, M (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Pagans, Sara/G-3407-2015	Pagans, Sara/0000-0003-0772-6982; Hanada, Kazuki/0000-0001-7554-107X; Aull, Katherine/0000-0003-4289-1342; Ali, Ibraheem/0000-0003-3945-2701; Ramage, Holly/0000-0002-0390-6786	University of California San Francisco; Gladstone Institute of Virology and Immunology Center for AIDS Research; JT Pharma, Gladstone Institutes, CA AIDS Research Program; National Institutes of Health [R01AI083139, U19AI096113, T32IA7334-26, P30AI027763]; California HIV/AIDS Research Program (CHRP) [ID F13-GI-316]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109593, T32AI060537, P30AI027763, U19AI096113, R01AI083139, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER	University of California San Francisco(University of California System); Gladstone Institute of Virology and Immunology Center for AIDS Research; JT Pharma, Gladstone Institutes, CA AIDS Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV/AIDS Research Program (CHRP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of California San Francisco, Gladstone Institute of Virology and Immunology Center for AIDS Research, a collaboration with JT Pharma, Gladstone Institutes, CA AIDS Research Program, and Grants R01AI083139, U19AI096113, T32IA7334-26, and P30AI027763 from the National Institutes of Health, and Grant ID F13-GI-316 from the California HIV/AIDS Research Program (CHRP). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Bruner KM, 2015, TRENDS MICROBIOL, V23, P192, DOI 10.1016/j.tim.2015.01.013; Campbell GR, 2004, J BIOL CHEM, V279, P48197, DOI 10.1074/jbc.M406195200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Dahabieh MS, 2015, ANNU REV MED, V66, P407, DOI 10.1146/annurev-med-092112-152941; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Endo-Munoz L, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-17; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; GARCIA JA, 1989, EMBO J, V8, P765, DOI 10.1002/j.1460-2075.1989.tb03437.x; HOUTZ RL, 1991, PLANT PHYSIOL, V97, P913, DOI 10.1104/pp.97.3.913; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; LORET EP, 1992, P NATL ACAD SCI USA, V89, P9734, DOI 10.1073/pnas.89.20.9734; Masatsugu T, 2009, BIOCHEM BIOPH RES CO, V381, P22, DOI 10.1016/j.bbrc.2009.01.185; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pagans S, 2011, METHODS, V53, P91, DOI 10.1016/j.ymeth.2010.07.001; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Rambaut A., 2015, HIV SEQUENCE COMPEND; Razooky BS, 2015, CELL, V160, P990, DOI 10.1016/j.cell.2015.02.009; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; SELBY MJ, 1989, GENE DEV, V3, P547, DOI 10.1101/gad.3.4.547; Singh A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.38; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Taube R, 2000, J VIROL, V74, P892, DOI 10.1128/JVI.74.2.892-898.2000; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	40	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16240	16248		10.1074/jbc.M116.735415	http://dx.doi.org/10.1074/jbc.M116.735415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27235396	Green Published, hybrid			2022-12-28	WOS:000380585400028
J	Wickline, ED; Dale, IW; Merkel, CD; Heier, JA; Stolz, DB; Kwiatkowski, AV				Wickline, Emily D.; Dale, Ian W.; Merkel, Chelsea D.; Heier, Jonathon A.; Stolz, Donna B.; Kwiatkowski, Adam V.			alpha T-Catenin Is a Constitutive Actin-binding alpha-Catenin That Directly Couples the Cadherin center dot Catenin Complex to Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; BETA-CATENIN; AREA COMPOSITA; IN-VITRO; F-ACTIN; PROTEIN; VINCULIN; JUNCTIONS; TENSION; MECHANOTRANSDUCTION	alpha-Catenin is the primary link between the cadherin center dot catenin complex and the actin cytoskeleton. Mammalian alpha E-catenin is allosterically regulated: the monomer binds the beta-catenin center dot cadherin complex, whereas the homodimer does not bind beta-catenin but interacts with F-actin. As part of the cadherin center dot catenin complex, alpha E-catenin requires force to bind F-actin strongly. It is not known whether these properties are conserved across the mammalian alpha-catenin family. Here we show that alpha T (testes)-catenin, a protein unique to amniotes that is expressed predominantly in the heart, is a constitutive actin-binding alpha-catenin. We demonstrate that alpha T-catenin is primarily a monomer in solution and that alpha T-catenin monomer binds F-actin in cosedimentation assays as strongly as alpha E-catenin homodimer. The beta-catenin center dot alpha T-catenin heterocomplex also binds F-actin with high affinity unlike the beta-catenin center dot alpha E-catenin complex, indicating that alpha T-catenin can directly link the cadherin center dot catenin complex to the actin cytoskeleton. Finally, we show that a mutation in alpha T-catenin linked to arrhythmogenic right ventricular cardiomyopathy, V94D, promotes homodimerization, blocks beta-catenin binding, and in cardiomyocytes disrupts localization at cell-cell contacts. Together, our data demonstrate that alpha T-catenin is a constitutively active actin-binding protein that can physically couple the cadherin center dot catenin complex to F-actin in the absence of tension. We speculate that these properties are optimized to meet the demands of cardiomyocyte adhesion.	[Wickline, Emily D.; Dale, Ian W.; Merkel, Chelsea D.; Heier, Jonathon A.; Stolz, Donna B.; Kwiatkowski, Adam V.] Univ Pittsburgh, Sch Med, Dept Cell Biol, S324 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kwiatkowski, AV (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, S324 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15261 USA.	adamkwi@pitt.edu		Kwiatkowski, Adam/0000-0003-3997-7057	March of Dimes Basil O'Connor Starter Scholar Award; American Heart Association; National Institutes of Health [HL127711]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127711] Funding Source: NIH RePORTER	March of Dimes Basil O'Connor Starter Scholar Award(March of Dimes); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a March of Dimes Basil O'Connor Starter Scholar Award (to A. V. K.), an American Heart Association Grant-in-Aid (to A. V. K.), and National Institutes of Health Grant HL127711 (to A. V. K.). The authors declare they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bianchini JM, 2015, J CELL BIOL, V210, P1065, DOI 10.1083/jcb.201411080; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Collinet C, 2013, PROG MOL BIOL TRANSL, V116, P25, DOI 10.1016/B978-0-12-394311-8.00002-9; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Ehler E, 2013, JOVE-J VIS EXP, DOI 10.3791/50154; Folmsbee SS, 2015, AM J PHYSIOL-LUNG C, V308, pL253, DOI 10.1152/ajplung.00331.2014; FOWLER VM, 1987, J BIOL CHEM, V262, P12792; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Goossens S, 2007, J CELL SCI, V120, P2126, DOI 10.1242/jcs.004713; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Janssens B, 2001, J CELL SCI, V114, P3177; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; Li JF, 2015, CIRC RES, V116, P70, DOI 10.1161/CIRCRESAHA.116.304472; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Li J, 2015, J BIOL CHEM, V290, P18890, DOI 10.1074/jbc.M115.647941; Lyon RC, 2015, CIRC RES, V116, P1462, DOI 10.1161/CIRCRESAHA.116.304937; Maki K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24878; Miller PW, 2013, J BIOL CHEM, V288, P22324, DOI 10.1074/jbc.M113.458406; Needham PG, 2006, YEAST, V23, P1151, DOI 10.1002/yea.1429; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nieset JE, 1997, J CELL SCI, V110, P1013; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; van Hengel J, 2013, EUR HEART J, V34, P201, DOI 10.1093/eurheartj/ehs373; Vile A., 2014, CELL COMMUN ADHES, V21, P169; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	46	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15687	15699		10.1074/jbc.M116.735423	http://dx.doi.org/10.1074/jbc.M116.735423			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231342	Green Published, hybrid			2022-12-28	WOS:000380584200023
J	Leighton, TL; Yong, DH; Howell, PL; Burrows, LL				Leighton, Tiffany L.; Yong, Daniel H.; Howell, P. Lynne; Burrows, Lori L.			Type IV Pilus Alignment Subcomplex Proteins PilN and PilO Form Homo- and Heterodimers in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; protein-protein interaction; Pseudomonas aeruginosa (P; aeruginosa); type II secretion system (T2SS); type IV pili; twitching motility	II SECRETION SYSTEM; INNER MEMBRANE PLATFORM; TRANSMISSION ELECTRON-MICROSCOPY; PSEUDOMONAS-AERUGINOSA; TWITCHING MOTILITY; VIBRIO-CHOLERAE; NEISSERIA-MENINGITIDIS; MYXOCOCCUS-XANTHUS; BIOGENESIS; EPSL	Pseudomonas aeruginosa is a leading cause of hospital-acquired infections and is resistant to many antibiotics. Type IV pili (T4P) are among the key virulence factors used by P. aeruginosa for host cell attachment, biofilm formation, and twitching motility, making this system a promising target for novel therapeutics. Point mutations in the conserved PilMNOP alignment subcomplex were previously shown to have distinct effects on assembly and disassembly of T4P, suggesting that it may function in a dynamic manner. We introduced mutations encoding Cys substitutions into pilN and/or pilO on the chromosome to maintain normal stoichiometry and expression levels and captured covalent PilNO heterodimers, as well as PilN and PilO homodimers, in vivo. Most covalent PilN or PilO homodimers had minimal functional impact in P. aeruginosa, suggesting that homodimers are a physiologically relevant state. However, certain covalent homo- or heterodimers eliminated twitching motility, suggesting that specific PilNO configurations are essential for T4P function. These data were verified using soluble N-terminal truncated fragments of PilN and PilO Cys mutants, which purified as a mixture of homo- and heterodimers at volumes consistent with a tetramer. Deletion of genes encoding alignment subcomplex components, PilM or PilP, but not other T4P components, including the motor ATPases PilB or PilT, blocked in vivo formation of disulfide-bonded PilNO heterodimers, suggesting that both PilM and PilP influence the heterodimer interface. Combined, our data suggest that T4P function depends on rearrangements at PilN and PilO interfaces.	[Leighton, Tiffany L.; Yong, Daniel H.; Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Leighton, Tiffany L.; Yong, Daniel H.; Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [Howell, P. Lynne] Univ Toronto, Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5G 0A4, Canada	McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Howell, PL (corresponding author), 20 9 715 Peter Giligan Ctr Res & Learning, 686 Bay St, Toronto, ON M5G 0A4, Canada.; Burrows, LL (corresponding author), 4H18 Hlth Sci Ctr, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	howell@sickkids.ca; burrowl@mcmaster.ca			Canadian Institutes of Health Research [MOP-93585]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Operating Grant MOP-93585 from the Canadian Institutes of Health Research (to L. L. B. and P. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Abendroth J, 2004, J MOL BIOL, V338, P585, DOI 10.1016/j.jmb.2004.01.064; Abendroth J, 2009, J STRUCT BIOL, V168, P313, DOI 10.1016/j.jsb.2009.07.022; Arts J, 2007, MICROBIOL-SGM, V153, P1582, DOI 10.1099/mic.0.2006/002840-0; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; Bischof LF, 2016, J BIOL CHEM, V291, P6946, DOI 10.1074/jbc.M115.701284; Bose N, 2002, J BACTERIOL, V184, P2305, DOI 10.1128/JB.184.8.2305-2309.2002; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Chang YW, 2016, SCIENCE, V351, DOI 10.1126/science.aad2001; Chiang P, 2005, J BACTERIOL, V187, P829, DOI 10.1128/JB.187.3.829-839.2005; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Friedrich C, 2014, J BACTERIOL, V196, P378, DOI 10.1128/JB.01094-13; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Harvey H, 2009, J BACTERIOL, V191, P6513, DOI 10.1128/JB.00943-09; Karuppiah V, 2013, P NATL ACAD SCI USA, V110, pE4638, DOI 10.1073/pnas.1312313110; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Koo J, 2013, BIOCHEMISTRY-US, V52, P2914, DOI 10.1021/bi3015345; Koo J, 2012, FEMS MICROBIOL LETT, V328, P1, DOI 10.1111/j.1574-6968.2011.02464.x; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; Lallemand M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079562; Leighton TL, 2015, ENVIRON MICROBIOL, V17, P4148, DOI 10.1111/1462-2920.12849; Leighton TL, 2015, J BACTERIOL, V197, P2229, DOI 10.1128/JB.00220-15; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; McCallum M, 2016, J BIOL CHEM, V291, P11003, DOI 10.1074/jbc.M116.718353; Nguyen Y, 2010, J MOL BIOL, V395, P491, DOI 10.1016/j.jmb.2009.10.070; NUNN D, 1990, J BACTERIOL, V172, P2911, DOI 10.1128/jb.172.6.2911-2919.1990; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Py B, 1999, J MOL BIOL, V289, P659, DOI 10.1006/jmbi.1999.2803; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robert V, 2002, J BACTERIOL, V184, P1779, DOI 10.1128/JB.184.6.1779-1782.2002; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Sandkvist M, 1999, J BACTERIOL, V181, P3129, DOI 10.1128/JB.181.10.3129-3135.1999; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; SIMON V, 1987, APPL ENVIRON MICROB, V53, P1649, DOI 10.1128/AEM.53.7.1649-1654.1987; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; Tammam S, 2013, J BACTERIOL, V195, P2126, DOI 10.1128/JB.00032-13; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338; WHITCHURCH CB, 1994, MOL MICROBIOL, V13, P1079, DOI 10.1111/j.1365-2958.1994.tb00499.x; WHITCHURCH CB, 1991, GENE, V101, P33, DOI 10.1016/0378-1119(91)90221-V; Winston SE, 2005, BIOCHEMISTRY-US, V44, P12655, DOI 10.1021/bi0507884; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Yamagata A, 2012, J MOL BIOL, V419, P110, DOI 10.1016/j.jmb.2012.02.041; Nguyen Y, 2015, J BIOL CHEM, V290, P601, DOI 10.1074/jbc.M114.616904	62	12	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19923	19938		10.1074/jbc.M116.738377	http://dx.doi.org/10.1074/jbc.M116.738377			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27474743	Green Published, hybrid			2022-12-28	WOS:000383243100017
J	Lunetti, P; Damiano, F; De Benedetto, G; Siculella, L; Pennetta, A; Muto, L; Paradies, E; Marobbio, CMT; Dolce, V; Capobianco, L				Lunetti, Paola; Damiano, Fabrizio; De Benedetto, Giuseppe; Siculella, Luisa; Pennetta, Antonio; Muto, Luigina; Paradies, Eleonora; Marobbio, Carlo Marya Thomas; Dolce, Vincenza; Capobianco, Loredana			Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; heme; mitochondrial respiratory chain complex; mitochondrial transport; yeast metabolism; HEM25; SLC25A38; heme synthesis; mitochondrial glycine carrier; sideroblastic anemia	CYTOCHROME BC(1) COMPLEX; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; BACTERIAL EXPRESSION; SIDEROBLASTIC ANEMIA; CITRATE CARRIER; KEY ENZYME; IDENTIFICATION; RECONSTITUTION; GENE	Heme is an essential molecule in many biological processes, such as transport and storage of oxygen and electron transfer as well as a structural component of hemoproteins. Defects of heme biosynthesis in developing erythroblasts have profound medical implications, as represented by sideroblastic anemia. The synthesis of heme requires the uptake of glycine into the mitochondrial matrix where glycine is condensed with succinyl coenzyme A to yield -aminolevulinic acid. Herein we describe the biochemical and molecular characterization of yeast Hem25p and human SLC25A38, providing evidence that they are mitochondrial carriers for glycine. In particular, the hem25 mutant manifests a defect in the biosynthesis of -aminolevulinic acid and displays reduced levels of downstream heme and mitochondrial cytochromes. The observed defects are rescued by complementation with yeast HEM25 or human SLC25A38 genes. Our results identify new proteins in the heme biosynthetic pathway and demonstrate that Hem25p and its human orthologue SLC25A38 are the main mitochondrial glycine transporters required for heme synthesis, providing definitive evidence of their previously proposed glycine transport function. Furthermore, our work may suggest new therapeutic approaches for the treatment of congenital sideroblastic anemia.	[Lunetti, Paola; Damiano, Fabrizio; Siculella, Luisa; Capobianco, Loredana] Univ Salento, Dept Biol & Environm Sci & Technol, I-73100 Lecce, Italy; [De Benedetto, Giuseppe; Pennetta, Antonio] Univ Salento, Dept Cultural Heritage, Lab Analyt & Isotop Mass Spectrometry, I-73100 Lecce, Italy; [Muto, Luigina; Dolce, Vincenza] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Cosenza, Italy; [Paradies, Eleonora] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy; [Marobbio, Carlo Marya Thomas] Univ Bari, Dept Biosci Biotechnol & Pharmacol Sci, I-70125 Bari, Italy	University of Salento; University of Salento; University of Calabria; Consiglio Nazionale delle Ricerche (CNR); Universita degli Studi di Bari Aldo Moro	Capobianco, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, I-73100 Lecce, Italy.; Dolce, V (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Cosenza, Italy.		Damiano, Fabrizio/AAF-9594-2020; De Benedetto, Giuseppe Egidio/G-9470-2012; CAPOBIANCO, LOREDANA/L-9047-2015; Lunetti, Paola/AAL-7582-2020; Paradies, Eleonora/K-4606-2014	Damiano, Fabrizio/0000-0001-7828-9519; De Benedetto, Giuseppe Egidio/0000-0002-0832-5470; capobianco, loredana/0000-0002-9058-7743; Paradies, Eleonora/0000-0002-1668-7148; LUNETTI, Paola/0000-0001-7118-1994; Pennetta, Antonio/0000-0002-6760-9393	Italian Ministry of Education, Universities, and Research (MIUR)	Italian Ministry of Education, Universities, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	3 This work was supported by grants from the Italian Ministry of Education, Universities, and Research (MIUR) (SIR 2015, molecular and pathogenetic mechanism of congenital sideroblastic anemia associated with the SLC25A38 gene deficiency). The authors declare that they have no conflicts of interest with the contents of this article.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; BENAVIDES J, 1980, BIOCHIM BIOPHYS ACTA, V598, P588, DOI 10.1016/0005-2736(80)90038-3; Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244; BOTTOMLEY SS, 1995, J BIOENERG BIOMEMBR, V27, P161, DOI 10.1007/BF02110031; Brachmann CB, 1998, YEAST, V14, P115; Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001; Cappello AR, 2012, ENDOCRINOLOGY, V153, P1743, DOI 10.1210/en.2011-1562; Carrisi C, 2008, J BIOCHEM, V144, P389, DOI 10.1093/jb/mvn076; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; Chiabrando D, 2014, HAEMATOLOGICA, V99, P973, DOI 10.3324/haematol.2013.091991; Conte A, 2015, BBA-MOL CELL RES, V1853, P987, DOI 10.1016/j.bbamcr.2015.02.006; COX TC, 1994, NEW ENGL J MED, V330, P675, DOI 10.1056/NEJM199403103301004; Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581; Damiano F, 2010, BIOCHEM J, V429, P603, DOI 10.1042/BJ20091827; DAUM G, 1982, J BIOL CHEM, V257, P3028; De Benedetto GE, 2013, J RAMAN SPECTROSC, V44, P899, DOI 10.1002/jrs.4298; De Benedetto GE, 2009, ELECTROPHORESIS, V30, P1798, DOI 10.1002/elps.200800379; De Caroli M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00660; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Dolce V, 2014, IUBMB LIFE, V66, P462, DOI 10.1002/iub.1290; Ducamp S, 2013, HUM MOL GENET, V22, P1280, DOI 10.1093/hmg/dds531; Fernandez-Murray JP, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005783; Ferramosca A, 2013, BBA-MOL CELL RES, V1833, P494, DOI 10.1016/j.bbamcr.2012.11.014; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Fleming MD, 2011, HEMATOL-AM SOC HEMAT, P525, DOI 10.1182/asheducation-2011.1.525; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Harigae H, 2010, INT J HEMATOL, V92, P425, DOI 10.1007/s12185-010-0688-4; Iacopetta D, 2011, BBA-BIOENERGETICS, V1807, P251, DOI 10.1016/j.bbabio.2010.11.013; Iacopetta D, 2010, BREAST CANCER RES TR, V122, P755, DOI 10.1007/s10549-009-0620-x; Iacopetta D, 2010, FEBS J, V277, P1172, DOI 10.1111/j.1742-4658.2009.07550.x; Kannengiesser C, 2011, HAEMATOL-HEMATOL J, V96, P808, DOI 10.3324/haematol.2010.039164; Kardon JR, 2015, CELL, V161, P858, DOI 10.1016/j.cell.2015.04.017; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; Kranen RW, 1999, POULTRY SCI, V78, P467, DOI 10.1093/ps/78.3.467; Lee Johnny C-Y, 2013, FEMS Yeast Res, V13, P618, DOI 10.1111/1567-1364.12063; Lombardi A, 2002, FEBS LETT, V532, P12, DOI 10.1016/S0014-5793(02)03690-6; Lunetti P, 2013, BBA-BIOENERGETICS, V1827, P1245, DOI 10.1016/j.bbabio.2013.07.002; Madeo M, 2009, J BIOENERG BIOMEMBR, V41, P289, DOI 10.1007/s10863-009-9226-6; Materazzi S, 2014, INT J MASS SPECTROM, V365, P372, DOI 10.1016/j.ijms.2014.03.013; Monschau N, 1997, FEMS MICROBIOL LETT, V150, P55, DOI 10.1016/S0378-1097(97)00096-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2016, BBA-MOL CELL RES, V1863, P2362, DOI 10.1016/j.bbamcr.2016.03.007; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri L, 1999, MOL MICROBIOL, V31, P569, DOI 10.1046/j.1365-2958.1999.01197.x; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; PASTERNACK LB, 1992, BIOCHEMISTRY-US, V31, P8713, DOI 10.1021/bi00152a005; Ponka P., 2010, WILLIAMS HEMATOLOGY, P865; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Rigiracciolo DC, 2015, ONCOTARGET, V6, P34158, DOI 10.18632/oncotarget.5779; Schlosser T, 2004, YEAST, V21, P63, DOI 10.1002/yea.1058; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sinclair P R, 2001, Curr Protoc Toxicol, VChapter 8, DOI 10.1002/0471140856.tx0803s00; Smith PM, 2012, BBA-BIOENERGETICS, V1817, P276, DOI 10.1016/j.bbabio.2011.11.009; Stendardi A, 2011, INT J ANDROL, V34, P247, DOI 10.1111/j.1365-2605.2010.01078.x; Subramanian M, 2005, MOL MICROBIOL, V57, P53, DOI 10.1111/j.1365-2958.2005.04663.x; Trotter PJ, 2005, ARCH BIOCHEM BIOPHYS, V442, P21, DOI 10.1016/j.abb.2005.07.016; Tunali NE, 2014, MOL GENET METAB, V112, P25, DOI 10.1016/j.ymgme.2014.03.002; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; WILLIAMS DM, 1983, SEMIN HEMATOL, V20, P118; Zara V, 2007, FEBS J, V274, P4526, DOI 10.1111/j.1742-4658.2007.05982.x; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011	64	43	45	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19746	19759		10.1074/jbc.M116.736876	http://dx.doi.org/10.1074/jbc.M116.736876			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27476175	Green Published, hybrid			2022-12-28	WOS:000383243100003
J	Sharma, S; Xing, F; Liu, Y; Wu, KR; Said, N; Pochampally, R; Shiozawa, Y; Lin, HK; Balaji, KC; Watabe, K				Sharma, Sambad; Xing, Fei; Liu, Yin; Wu, Kerui; Said, Neveen; Pochampally, Radhika; Shiozawa, Yusuke; Lin, Hui-Kuan; Balaji, K. C.; Watabe, Kounosuke			Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA demethylation; prostate cancer; stromal cell; tumor cell biology; tumor microenvironment; BMP7; bone metastasis; dormancy; SPARC	BREAST-CANCER; TUMOR-GROWTH; MORPHOGENETIC PROTEIN-7; RADICAL PROSTATECTOMY; PROGNOSTIC VALUE; DEFICIENT MICE; CELL DORMANCY; IN-VITRO; EXPRESSION; PROGRESSION	Prostate cancer is known to frequently recur in bone; however, how dormant cells switch its phenotype leading to recurrent tumor remains poorly understood. We have isolated two syngeneic cell lines (indolent and aggressive) through in vivo selection by implanting PC3mm stem-like cells into tibial bones. We found that indolent cells retained the dormant phenotype, whereas aggressive cells grew rapidly in bone in vivo, and the growth rates of both cells in culture were similar, suggesting a role of the tumor microenvironment in the regulation of dormancy and recurrence. Indolent cells were found to secrete a high level of secreted protein acidic and rich in cysteine (SPARC), which significantly stimulated the expression of BMP7 in bone marrow stromal cells. The secreted BMP7 then kept cancer cells in a dormant state by inducing senescence, reducing stemness, and activating dormancy-associated p38 MAPK signaling and p21 expression in cancer cells. Importantly, we found that SPARC was epigenetically silenced in aggressive cells by promoter methylation, but 5-azacytidine treatment reactivated the expression. Furthermore, high SPARC promoter methylation negatively correlated with disease-free survival of prostate cancer patients. We also found that the COX2 inhibitor NS398 down-regulated DNMTs and increased expression of SPARC, which led to tumor growth suppression in bone in vivo. These findings suggest that SPARC plays a key role in maintaining the dormancy of prostate cancer cells in the bone microenvironment.	[Sharma, Sambad; Xing, Fei; Liu, Yin; Wu, Kerui; Shiozawa, Yusuke; Lin, Hui-Kuan; Watabe, Kounosuke] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA; [Said, Neveen] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA; [Balaji, K. C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA; [Pochampally, Radhika] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Pochampally, Radhika] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Watabe, K (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	kwatabe@wakehealth.edu	Said, Neveen/K-1563-2019		Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health [P30CA012197]; NATIONAL CANCER INSTITUTE [R01CA185650, R01CA193437, P30CA012197, R01CA173499] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001421] Funding Source: NIH RePORTER	Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Dr. Aya Kobayashi for help with the initial work of isolation and characterization of the clones. The Flow Cytometry Shared Resources, Cell and Viral Vector Core Lab are supported by the Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health Grant (P30CA012197).	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Chen C, 2012, J CELL BIOCHEM, V113, P3672, DOI 10.1002/jcb.24240; Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330; Chery L, 2014, ONCOTARGET, V5, P9939, DOI 10.18632/oncotarget.2480; Chlenski A, 2006, INT J CANCER, V118, P310, DOI 10.1002/ijc.21357; De S, 2003, J BIOL CHEM, V278, P39044, DOI 10.1074/jbc.M304494200; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; DeRosa CA, 2012, PROSTATE CANCER P D, V15, P150, DOI 10.1038/pcan.2011.61; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ferrario A, 2005, CANCER RES, V65, P9473, DOI 10.1158/0008-5472.CAN-05-1659; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Golembieski WA, 2008, GLIA, V56, P1061, DOI 10.1002/glia.20679; Hiraga T, 2006, CANCER RES, V66, P2067, DOI 10.1158/0008-5472.CAN-05-2012; Horwich A, 2013, ANN ONCOL, V24, P106, DOI 10.1093/annonc/mdt208; Jacob K, 1999, CANCER RES, V59, P4453; Jones MK, 1999, NAT MED, V5, P1418; Kapinas K, 2012, MATRIX BIOL, V31, P299, DOI 10.1016/j.matbio.2012.03.002; Kim IY, 2004, CANCER RES, V64, P7355, DOI 10.1158/0008-5472.CAN-04-0154; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; Kodach LL, 2008, GASTROENTEROLOGY, V134, P1332, DOI 10.1053/j.gastro.2008.02.059; Kwabi-Addo B, 2010, CLIN CANCER RES, V16, P3539, DOI 10.1158/1078-0432.CCR-09-3342; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Leyton PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076947; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McCabe NP, 2011, NEOPLASIA, V13, P31, DOI 10.1593/neo.10998; Mohler JL, 2013, J NATL COMPR CANC NE, V11, P1471, DOI 10.6004/jnccn.2013.0174; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; MORRIS VL, 1993, CLIN EXP METASTAS, V11, P103, DOI 10.1007/BF00880071; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Nagaraju GP, 2014, CARCINOGENESIS, V35, P967, DOI 10.1093/carcin/bgu072; Nishikawa M, 2004, J AM COLL SURGEONS, V199, P428, DOI 10.1016/j.jamcollsurg.2004.05.265; OSSOWSKI L, 1987, J CELL PHYSIOL, V133, P288, DOI 10.1002/jcp.1041330212; Pan MR, 2008, EXP BIOL MED, V233, P456, DOI 10.3181/0709-RM-257; Podgorski I, 2009, AM J PATHOL, V175, P1255, DOI 10.2353/ajpath.2009.080906; Podhajcer OL, 2008, CANCER METAST REV, V27, P523, DOI 10.1007/s10555-008-9135-x; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Said N, 2009, ONCOGENE, V28, P3487, DOI 10.1038/onc.2009.205; Said N, 2013, J CLIN INVEST, V123, P751, DOI 10.1172/JCI64782; Said NA, 2008, NEOPLASIA, V10, P1092, DOI 10.1593/neo.08672; Schulz WA, 2002, GENE CHROMOSOME CANC, V35, P58, DOI 10.1002/gcc.10092; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; Sosa MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7170; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Weckermann D, 2001, J UROLOGY, V166, P699, DOI 10.1016/S0022-5347(05)66046-6; Welsh JB, 2001, CANCER RES, V61, P5974; Wong SY, 2008, CLIN EXP METASTAS, V25, P109, DOI 10.1007/s10585-007-9126-2; Wong SY, 2007, P NATL ACAD SCI USA, V104, P12784, DOI 10.1073/pnas.0705499104; Ye L, 2007, J UROLOGY, V178, P1086, DOI 10.1016/j.juro.2007.05.003; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang JL, 2014, ONCOL REP, V31, P2312, DOI 10.3892/or.2014.3118; Zietman AL, 2010, J CLIN ONCOL, V28, P1106, DOI 10.1200/JCO.2009.25.8475	68	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19351	19363		10.1074/jbc.M116.737379	http://dx.doi.org/10.1074/jbc.M116.737379			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27422817	hybrid, Green Published			2022-12-28	WOS:000383242800015
J	Costabile, BK; Kim, YK; Iqbal, J; Zuccaro, MV; Wassef, L; Narayanasamy, S; Curley, RW; Harrison, EH; Hussain, MM; Quadro, L				Costabile, Brianna K.; Kim, Youn-Kyung; Iqbal, Jahangir; Zuccaro, Michael V.; Wassef, Lesley; Narayanasamy, Sureshbabu; Curley, Robert W., Jr.; Harrison, Earl H.; Hussain, M. Mahmood; Quadro, Loredana			beta-Apo-10 '-carotenoids Modulate Placental Microsomal Triglyceride Transfer Protein Expression and Function to Optimize Transport of Intact beta-Carotene to the Embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carotenoid; metabolism; placenta; retinoid; vitamin A; apocarotenoid	RETINOIC ACID RECEPTORS; VITAMIN-A; LIPID-METABOLISM; GENE-EXPRESSION; X-RECEPTOR; P19 CELLS; APO-B; TRANSCRIPTION; PROVITAMIN; CLEAVAGE	beta-Carotene is an important source of vitamin A for the mammalian embryo, which depends on its adequate supply to achieve proper organogenesis. In mammalian tissues, beta-carotene 15,15-oxygenase (BCO1) converts beta-carotene to retinaldehyde, which is then oxidized to retinoic acid, the biologically active form of vitamin A that acts as a transcription factor ligand to regulate gene expression. beta-Carotene can also be cleaved by beta-carotene 9,10-oxygenase (BCO2) to form beta-apo-10-carotenal, a precursor of retinoic acid and a transcriptional regulator per se. The mammalian embryo obtains beta-carotene from the maternal circulation. However, the molecular mechanisms that enable its transfer across the maternal-fetal barrier are not understood. Given that beta-carotene is transported in the adult bloodstream by lipoproteins and that the placenta acquires, assembles, and secretes lipoproteins, we hypothesized that the aforementioned process requires placental lipoprotein biosynthesis. Here we show that beta-carotene availability regulates transcription and activity of placental microsomal triglyceride transfer protein as well as expression of placental apolipoprotein B, two key players in lipoprotein biosynthesis. We also show that beta-apo-10-carotenal mediates the transcriptional regulation of microsomal triglyceride transfer protein via hepatic nuclear factor 4 and chicken ovalbumin upstream promoter transcription factor I/II. Our data provide the first in vivo evidence of the transcriptional regulatory activity of beta-apocarotenoids and identify microsomal triglyceride transfer protein and its transcription factors as the targets of their action. This study demonstrates that beta-carotene induces a feed-forward mechanism in the placenta to enhance the assimilation of beta-carotene for proper embryogenesis.	[Costabile, Brianna K.; Kim, Youn-Kyung; Zuccaro, Michael V.; Wassef, Lesley; Quadro, Loredana] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Costabile, Brianna K.; Kim, Youn-Kyung; Zuccaro, Michael V.; Wassef, Lesley; Quadro, Loredana] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Costabile, Brianna K.; Kim, Youn-Kyung; Zuccaro, Michael V.; Wassef, Lesley; Quadro, Loredana] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Narayanasamy, Sureshbabu; Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, 500 W 12th Ave, Columbus, OH 43210 USA; [Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Quadro, L (corresponding author), Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.; Quadro, L (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA.; Quadro, L (corresponding author), Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA.; Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.; Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA.	mahmood.hussain@downstate.edu; quadro@aesop.rutgers.edu	NARAYANASAMY, SURESHBABU/AAN-6604-2021; Iqbal, Jahangir/B-3903-2014; Zuccaro, Michael/HGC-5116-2022; Harrison, Earl H/AAN-5378-2021; Zuccaro, Michael/HDN-0529-2022	Iqbal, Jahangir/0000-0002-9021-2271; Narayanasamy, Sureshbabu/0000-0002-5846-3230	National Institutes of Health [R01HD057493, R01HD057493-02S1, R01HD057493-05S1, R01HD833331, R01HL95924, R01DK81879, R01HL049879]; Veterans Affairs Merit Award [BX001728]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057493, R01HD083331] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879, R01HL095924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081879, R01DK101251] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants R01HD057493, R01HD057493-02S1, R01HD057493-05S1, and R01HD833331 (to L. Q.); R01HL95924 and R01DK81879 (to M. M. H.); and R01HL049879 (to E. H. H. and R. W. C.) and by Veterans Affairs Merit Award BX001728 (to M. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bakillah A, 2000, BIOCHEMISTRY-US, V39, P4892, DOI 10.1021/bi9924009; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Dai K, 2012, J LIPID RES, V53, P901, DOI 10.1194/jlr.M025130; Dai KZ, 2010, ARTERIOSCL THROM VAS, V30, P568, DOI 10.1161/ATVBAHA.109.198135; dela Sena C, 2014, J BIOL CHEM, V289, P13661, DOI 10.1074/jbc.M114.557710; Dimenstein R, 1996, BIOL NEONATE, V69, P230, DOI 10.1159/000244315; Dolle P., 2015, RETINOIDS BIOL BIOCH, P309; ERDMAN JW, 1993, ANN NY ACAD SCI, V691, P76, DOI 10.1111/j.1749-6632.1993.tb26159.x; Eroglu A, 2013, J LIPID RES, V54, P1719, DOI 10.1194/jlr.R039537; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; Fisher EA, 2012, BBA-MOL CELL BIOL L, V1821, P778, DOI 10.1016/j.bbalip.2012.02.001; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; Ginsberg HN, 1998, ENDOCRIN METAB CLIN, V27, P503, DOI 10.1016/S0889-8529(05)70023-2; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Kamper M, 2015, BIOCHIMIE, V112, P121, DOI 10.1016/j.biochi.2015.03.002; Kim YK, 2011, FASEB J, V25, P1641, DOI 10.1096/fj.10-175448; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lee SA, 2014, AM J PHYSIOL-HEART C, V307, pH1675, DOI 10.1152/ajpheart.00548.2014; Li R, 2011, BIOCHEM BIOPH RES CO, V406, P268, DOI 10.1016/j.bbrc.2011.02.031; Lobo GP, 2012, BBA-MOL CELL BIOL L, V1821, P78, DOI 10.1016/j.bbalip.2011.04.010; Madsen EM, 2004, J BIOL CHEM, V279, P55271, DOI 10.1074/jbc.M411404200; Marceau G, 2007, VITAM HORM, V75, P97, DOI 10.1016/S0083-6729(06)75004-X; Nadeau V, 2014, DEVELOPMENT, V141, P2825, DOI 10.1242/dev.107409; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Panariello L, 1996, J BIOL CHEM, V271, P25524, DOI 10.1074/jbc.271.41.25524; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Pickens BS, 2013, J CELL PHYSIOL, V228, P791, DOI 10.1002/jcp.24228; Qian A, 2000, BIOCHEM BIOPH RES CO, V276, P837, DOI 10.1006/bbrc.2000.3549; Rava P, 2005, J LIPID RES, V46, P1779, DOI 10.1194/jlr.D400043-JLR200; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Roder K, 2007, BIOCHEM SOC T, V35, P1211, DOI 10.1042/BST0351211; Simmons DG, 2008, DEVELOPMENT, V135, P2083, DOI 10.1242/dev.020099; Spiegler E, 2012, BBA-MOL CELL BIOL L, V1821, P88, DOI 10.1016/j.bbalip.2011.05.003; Sun J, 2014, J BIOL CHEM, V289, P33118, DOI 10.1074/jbc.M114.610501; Topletz AR, 2015, MOL PHARMACOL, V87, P430, DOI 10.1124/mol.114.096784; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Wang CX, 2015, ARCH BIOCHEM BIOPHYS, V572, P2, DOI 10.1016/j.abb.2015.01.009; Wassef L, 2013, ARCH BIOCHEM BIOPHYS, V539, P223, DOI 10.1016/j.abb.2013.07.004; Wassef L, 2015, J NUTR, V145, P1408, DOI 10.3945/jn.114.207043; Wassef L, 2012, J NUTR, V142, P1456, DOI 10.3945/jn.112.162677; Wassef L, 2011, J BIOL CHEM, V286, P32198, DOI 10.1074/jbc.M111.253070; WITTMAACK FM, 1995, ENDOCRINOLOGY, V136, P340, DOI 10.1210/en.136.1.340; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	55	26	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18525	18535		10.1074/jbc.M116.738336	http://dx.doi.org/10.1074/jbc.M116.738336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402843	Green Published, hybrid			2022-12-28	WOS:000383241800042
J	Wang, J; Sinnett-Smith, J; Stevens, JV; Young, SH; Rozengurt, E				Wang, Jia; Sinnett-Smith, James; Stevens, Jan V.; Young, Steven H.; Rozengurt, Enrique			Biphasic Regulation of Yes-associated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelial Cells: A NOVEL ROLE FOR PROTEIN KINASE D (PKD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II; G protein-coupled receptor (GPCR); protein kinase C (PKC); protein kinase D (PKD); yes-associated protein (YAP)	ACTIVATION LOOP SER(744); NUCLEAR EXPORT SIGNALS; HIPPO PATHWAY; IN-VIVO; DNA-SYNTHESIS; ANG-II; G(Q)-COUPLED RECEPTORS; LYSOPHOSPHATIDIC ACID; ANTITUMOR-ACTIVITY; PHORBOL ESTERS	We examined the regulation of Yes-associated protein (YAP) localization, phosphorylation, and transcriptional activity in intestinal epithelial cells. Our results show that stimulation of intestinal epithelial IEC-18 cells with the G protein-coupled receptor (GPCR) agonist angiotensin II, a potent mitogen for these cells, induced rapid translocation of YAP from the nucleus to the cytoplasm (within 15 min) and a concomitant increase in YAP phosphorylation at Ser(127) and Ser(397). Angiotensin II elicited YAP phosphorylation and cytoplasmic accumulation in a dose-dependent manner (ED50 = 0.3 nm). Similar YAP responses were provoked by stimulation with vasopressin or serum. Treatment of the cells with the protein kinase D (PKD) family inhibitors CRT0066101 and kb NB 142-70 prevented the increase in YAP phosphorylation on Ser(127) and Ser(397) via Lats2, YAP cytoplasmic accumulation, and increase in the mRNA levels of YAP/TEAD-regulated genes (Ctgf and Areg). Furthermore, siRNA-mediated knockdown of PKD1, PKD2, and PKD3 markedly attenuated YAP nuclear-cytoplasmic shuttling, phosphorylation at Ser(127), and induction of Ctgf and Areg expression in response to GPCR activation. These results identify a novel role for the PKD family in the control of biphasic localization, phosphorylation, and transcriptional activity of YAP in intestinal epithelial cells. In turn, YAP and TAZ are necessary for the stimulation of the proliferative response of intestinal epithelial cells to GPCR agonists that act via PKD. The discovery of interaction between YAP and PKD pathways identifies a novel cross-talk in signal transduction and demonstrates, for the first time, that the PKDs feed into the YAP pathway.	[Wang, Jia; Sinnett-Smith, James; Stevens, Jan V.; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Dept Med, Los Angeles, CA 90095 USA; [Sinnett-Smith, James; Rozengurt, Enrique] Univ Calif Los Angeles, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Rozengurt, Enrique] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sinnett-Smith, James; Young, Steven H.; Rozengurt, Enrique] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Dept Med, Sch Med, 900 Vet Ave,Warren Hall Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			National Institutes of Health [R01DK100405, P30DK41301, P01CA163200]; Department of Veterans Affair Grant [1I01BX001473]; Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK100405] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affair Grant; Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01DK100405, P30DK41301, and P01CA163200, by Department of Veterans Affair Grant 1I01BX001473 (to E.R.), and by the Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research (to E.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Blake JF, 2012, J MED CHEM, V55, P8110, DOI 10.1021/jm301024w; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; Chiu T, 2003, AM J PHYSIOL-GASTR L, V285, pG1, DOI 10.1152/ajpgi.00419.2002; Chiu T, 2002, AM J PHYSIOL-CELL PH, V282, pC434, DOI 10.1152/ajpcell.00240.2001; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Collak FK, 2012, J BIOL CHEM, V287, P23698, DOI 10.1074/jbc.M112.358713; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gong R, 2015, CELL RES, V25, P985, DOI 10.1038/cr.2015.88; Guha S, 2002, CANCER RES, V62, P1632; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Kim D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009616; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lee KW, 2015, CLIN CANCER RES, V21, P357, DOI 10.1158/1078-0432.CCR-14-1374; Lee SJ, 2013, MOL CELL BIOL, V33, P2016, DOI 10.1128/MCB.00038-13; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Ni Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073149; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Pusapati GV, 2012, J BIOL CHEM, V287, P9473, DOI 10.1074/jbc.M112.339564; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Quaroni A, 1980, Methods Cell Biol, V21B, P403; Raufman JP, 2008, CANCER RES, V68, P3573, DOI 10.1158/0008-5472.CAN-07-6810; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Rey O, 2003, J CELL PHYSIOL, V196, P483, DOI 10.1002/jcp.10323; Rey O, 2012, J BIOL CHEM, V287, P1158, DOI 10.1074/jbc.M111.274589; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2001, ANNU REV PHYSIOL, V63, P49, DOI 10.1146/annurev.physiol.63.1.49; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Scholz RP, 2011, EXP CELL RES, V317, P496, DOI 10.1016/j.yexcr.2010.11.003; Shang X, 2013, P NATL ACAD SCI USA, V110, P3155, DOI 10.1073/pnas.1212324110; Shanzer M, 2015, ONCOGENE, V34, P4190, DOI 10.1038/onc.2014.347; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2014, AM J PHYSIOL-CELL PH, V306, pC961, DOI 10.1152/ajpcell.00048.2014; Sinnett-Smith J, 2011, J BIOL CHEM, V286, P511, DOI 10.1074/jbc.M110.167528; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Slice LW, 2005, J BIOL CHEM, V280, P1582, DOI 10.1074/jbc.M408172200; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Suh E, 1996, MOL CELL BIOL, V16, P619; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Waldron RT, 2012, CELL SIGNAL, V24, P914, DOI 10.1016/j.cellsig.2011.12.014; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Wu SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1432, DOI 10.1152/ajpcell.00323.2001; Young SH, 2006, AM J PHYSIOL-CELL PH, V290, pC728, DOI 10.1152/ajpcell.00310.2005; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001; Young SH, 2012, AM J PHYSIOL-GASTR L, V303, pG356, DOI 10.1152/ajpgi.00025.2012; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhang L, 2015, CURR BIOL, V25, P296, DOI 10.1016/j.cub.2014.11.054; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014	75	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17988	18005		10.1074/jbc.M115.711275	http://dx.doi.org/10.1074/jbc.M115.711275			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27369082	Green Published, hybrid			2022-12-28	WOS:000383241300041
J	Wittmann, A; Lamprinaki, D; Bowles, KM; Katzenellenbogen, E; Knirel, YA; Whitfield, C; Nishimura, T; Matsumoto, N; Yamamoto, K; Iwakura, Y; Saijo, S; Kawasaki, N				Wittmann, Alexandra; Lamprinaki, Dimitra; Bowles, Kristian M.; Katzenellenbogen, Ewa; Knirel, Yuriy A.; Whitfield, Chris; Nishimura, Takashi; Matsumoto, Naoki; Yamamoto, Kazuo; Iwakura, Yoichiro; Saijo, Shinobu; Kawasaki, Norihito			Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; lectin; lipopolysaccharide (LPS); polysaccharide; Toll-like receptor 4 (TLR4)	C-TYPE LECTIN; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; DENDRITIC CELLS; SERRATIA-MARCESCENS; STRUCTURAL-ANALYSIS; PRESENTING CELLS; RECEPTOR; POLYSACCHARIDE; IDENTIFICATION	LPS consists of a relatively conserved region of lipid A and core oligosaccharide and a highly variable region of O-antigen polysaccharide. Whereas lipid A is known to bind to the Toll-like receptor 4 (TLR4)-myeloid differentiation factor 2 (MD2) complex, the role of the O-antigen remains unclear. Here we report a novel molecular interaction between dendritic cell-associated C-type lectin-2 (Dectin-2) and mannosylated O-antigen found in a human opportunistic pathogen, Hafnia alvei PCM 1223, which has a repeating unit of [-Man-1,3-Man-1,2-Man-1,2-Man-1,2-Man-1,3-]. H. alvei LPS induced higher levels of TNF and IL-10 from mouse bone marrow-derived dendritic cells (BM-DCs), when compared with Salmonella enterica O66 LPS, which has a repeat of [-Gal-1,6-Gal-1,4-[Glc-1,3]GalNAc-1,3-GalNAc-1,3-]. In a cell-based reporter assay, Dectin-2 was shown to recognize H. alvei LPS. This binding was inhibited by mannosidase treatment of H. alvei LPS and by mutations in the carbohydrate-binding domain of Dectin-2, demonstrating that H. alvei LPS is a novel glycan ligand of Dectin-2. The enhanced cytokine production by H. alvei LPS was Dectin-2-dependent, because Dectin-2 knock-out BM-DCs failed to do so. This receptor cross-talk between Dectin-2 and TLR4 involved events including spleen tyrosine kinase (Syk) activation and receptor juxtaposition. Furthermore, another mannosylated LPS from Escherichia coli O9a also bound to Dectin-2 and augmented TLR4 activation of BM-DCs. Taken together, these data indicate that mannosylated O-antigens from several Gram-negative bacteria augment TLR4 responses through interaction with Dectin-2.	[Wittmann, Alexandra; Lamprinaki, Dimitra; Kawasaki, Norihito] Inst Food Res, Food & Hlth Inst Strateg Programme, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England; [Bowles, Kristian M.] Univ East Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Katzenellenbogen, Ewa] Ludwik Hirszfeld Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Knirel, Yuriy A.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; [Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Nishimura, Takashi; Matsumoto, Naoki; Yamamoto, Kazuo; Kawasaki, Norihito] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Ctr Anim Dis Models, Chiba 2780022, Japan; [Saijo, Shinobu] Chiba Univ, Dept Mol Immunol, Med Mycol Res Ctr, Chiba 2608673, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of East Anglia; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; University of Guelph; University of Tokyo; Tokyo University of Science; Chiba University	Kawasaki, N (corresponding author), Inst Food Res, Food & Hlth Inst Strateg Programme, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	norihito.kawasaki@ifr.ac.uk	Saijo, Shinobu/I-1501-2017; Knirel, Yuriy A/E-2058-2014; Iwakura, Yoichiro/E-5457-2011	Saijo, Shinobu/0000-0002-3802-8821; Iwakura, Yoichiro/0000-0002-9934-5775; Lamprinaki, Dimitra/0000-0001-6959-4917; Bowles, Kristian/0000-0003-1334-4526	BBSRC [BBS/E/F/00044486]; Big C cancer research grant; European Union; BBSRC [BBS/E/F/00042723] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044486, BBS/E/F/00042723] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Big C cancer research grant; European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC strategic core Grant BBS/E/F/00044486 (to the Institute of Food Research) and a Big C cancer research grant (to N. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Marie-Curie International Incoming Fellowship from the European Union 7th Framework Programme.	Akatsuka A, 2010, INT IMMUNOL, V22, P783, DOI 10.1093/intimm/dxq430; Aucken HM, 1996, FEMS MICROBIOL LETT, V138, P77; Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Blasius AL, 2006, TRENDS IMMUNOL, V27, P255, DOI 10.1016/j.it.2006.04.005; Cardile AP, 2011, TRANSPL INFECT DIS, V13, P407, DOI 10.1111/j.1399-3062.2011.00600.x; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Carter RW, 2006, CELL IMMUNOL, V239, P87, DOI 10.1016/j.cellimm.2006.05.001; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dodgson C, 1996, J BACTERIOL, V178, P1895, DOI 10.1128/jb.178.7.1895-1902.1996; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Eder K, 2009, BIOCHEM BIOPH RES CO, V389, P46, DOI 10.1016/j.bbrc.2009.08.082; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garcia-Vallejo JJ, 2014, J EXP MED, V211, P1457, DOI 10.1084/jem.20122192; Gavino ACP, 2005, EXP DERMATOL, V14, P281, DOI 10.1111/j.0906-6705.2005.00312.x; GORDEUK VR, 1992, BLOOD, V79, P1855; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Herget S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-35; Inagaki M, 2003, FEMS MICROBIOL LETT, V226, P221, DOI 10.1016/S0378-1097(03)00601-3; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; Jiang LY, 2014, CARBOHYD RES, V397, P27, DOI 10.1016/j.carres.2014.07.022; Kanazawa N, 2004, J INVEST DERMATOL, V122, P1522, DOI 10.1111/j.0022-202X.2004.22602.x; Katzenellenbogen E, 2001, FEMS IMMUNOL MED MIC, V30, P223; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki N, 2014, J IMMUNOL, V193, P1560, DOI 10.4049/jimmunol.1303278; Kawasaki N, 2011, J INNATE IMMUN, V3, P411, DOI 10.1159/000322375; Khanna A, 2013, J CLIN DIAGN RES, V7, P243, DOI 10.7860/JCDR/2013/5010.2737; Kocharova NA, 2001, CARBOHYD RES, V333, P335, DOI 10.1016/S0008-6215(01)00158-6; Kubler-Kielb J, 2012, CARBOHYD RES, V347, P186, DOI 10.1016/j.carres.2011.11.019; Lai CC, 2010, J HOSP INFECT, V76, P332, DOI 10.1016/j.jhin.2010.06.006; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Liu B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034; Liu B, 2010, MICROBIOL-SGM, V156, P1642, DOI 10.1099/mic.0.037325-0; Lugowski Czeslaw, 1995, Acta Biochimica Polonica, V42, P51; Lukasiewicz J, 2010, J LIPID RES, V51, P564, DOI 10.1194/jlr.M001362; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Macauley MS, 2013, J CLIN INVEST, V123, P3074, DOI 10.1172/JCI69187; Mann E, 2016, J BIOL CHEM, V291, P9748, DOI 10.1074/jbc.M116.719344; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mesci A, 2007, J IMMUNOL METHODS, V323, P78, DOI 10.1016/j.jim.2007.02.007; Michalski M, 2015, IMMUNOBIOLOGY, V220, P117, DOI 10.1016/j.imbio.2014.08.012; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Nagaoka K, 2005, INT IMMUNOL, V17, P827, DOI 10.1093/intimm/dxh264; Nagarjuna D., 2015, New Microbes and New Infections, V7, P57, DOI 10.1016/j.nmni.2015.05.006; Norimoto A, 2014, AM J RESP CELL MOL, V51, P201, DOI 10.1165/rcmb.2013-0522OC; Olsthoorn MMA, 1998, J BIOL CHEM, V273, P3817, DOI 10.1074/jbc.273.7.3817; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Parsons MW, 2014, J IMMUNOL, V192, P1361, DOI 10.4049/jimmunol.1301809; Pfrengle F, 2013, J IMMUNOL, V191, P1724, DOI 10.4049/jimmunol.1300921; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; PREHM P, 1976, EUR J BIOCHEM, V67, P53, DOI 10.1111/j.1432-1033.1976.tb10631.x; RICK PD, 1994, J BACTERIOL, V176, P2877, DOI 10.1128/JB.176.10.2877-2884.1994; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rudick CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041273; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Swierzko A, 2012, GLYCOBIOLOGY, V22, P267, DOI 10.1093/glycob/cwr119; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Tichaczek-Goska D, 2012, ADV CLIN EXP MED, V21, P289; Tsolis RM, 2008, NAT REV MICROBIOL, V6, P883, DOI 10.1038/nrmicro2012; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200; Zhao LJ, 2002, BLOOD, V100, P3233, DOI 10.1182/blood-2002-01-0252	71	25	26	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17629	17638		10.1074/jbc.M116.741256	http://dx.doi.org/10.1074/jbc.M116.741256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358401	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000383241300014
J	Walinda, E; Morimoto, D; Sugase, K; Shirakawa, M				Walinda, Erik; Morimoto, Daichi; Sugase, Kenji; Shirakawa, Masahiro			Dual Function of Phosphoubiquitin in E3 Activation of Parkin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE GENE-PRODUCT; UBIQUITIN LIGASE; CONFORMATIONAL ENTROPY; PINK1-DEPENDENT PHOSPHORYLATION; MOLECULAR RECOGNITION; AUTOINHIBITED STATE; DYNAMIC ACTIVATION; NMR-SPECTROSCOPY; RING DOMAIN; PROTEIN	Mutations in the gene encoding parkin, an auto-inhibited E3 ubiquitin ligase that functions in the clearance of damaged mitochondria, are the most common cause of autosomal recessive juvenile Parkinsonism. The mechanism regulating parkin activation remains poorly understood. Here we show, by using isothermal titration calorimetry, solution NMR, and fluorescence spectroscopy, that parkin can bind ubiquitin and phosphomimetic ubiquitin by recognizing the canonical hydrophobic patch and C terminus of ubiquitin. The affinity of parkin for both phosphomimetic and unmodified ubiquitin is markedly enhanced upon removal of the ubiquitin-like (UBL) domain of parkin. This suggests that the agonistic binding of ubiquitin to parkin in trans is counterbalanced by the antagonistic activity of the parkin UBL domain in cis. Intriguingly, UBL binding is enthalpy-driven, whereas ubiquitin binding is driven by an increase in the total entropy of the system. These thermodynamic differences are explained by different chemistry in the ubiquitin-and UBL-binding pockets of parkin and, as shown by molecular dynamics simulations, are not a consequence of changes in protein conformational entropy. Indeed, comparison of conformational fluctuations reveals that the RING1-IBR element becomes considerably more rigid upon complex formation. A model of parkin activation is proposed in which E2 similar to Ub binding triggers large scale diffusional motion of the RING2 domain toward the ubiquitin-stabilized RING1-IBR assembly to complete formation of the active parkin-E2 similar to Ub transfer complex. Thus, ubiquitin plays a dual role in parkin activation by competing with the inhibitory UBL domain and stabilizing the active form of parkin.	[Walinda, Erik] Kyoto Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Kyoto 6068501, Japan; [Morimoto, Daichi; Sugase, Kenji; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan	Kyoto University; Kyoto University	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan.	shirakawa@moleng.kyoto-u.ac.jp	Sugase, Kenji/S-3132-2016; Sugase, Kenji/AAF-4552-2021	Sugase, Kenji/0000-0001-8623-7743; Sugase, Kenji/0000-0001-8623-7743; Morimoto, Daichi/0000-0002-7672-2136	Japan Society for the Promotion of Science KAKENHI Grant [15H04342]; Grants-in-Aid for Scientific Research [15H04342, 16K18503] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 15H04342. The authors declare that they have no conflicts of interest with the contents of this article.	Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Craft JW, 2005, J BIOMOL NMR, V33, P15, DOI 10.1007/s10858-005-1199-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Hedrich K, 2002, NEUROLOGY, V58, P1239, DOI 10.1212/WNL.58.8.1239; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kazlauskaite A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130213; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Macedo MG, 2009, MOVEMENT DISORD, V24, P196, DOI 10.1002/mds.22287; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Munoz E, 2002, J NEUROL NEUROSUR PS, V73, P582, DOI 10.1136/jnnp.73.5.582; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050; Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Periquet M, 2001, AM J HUM GENET, V68, P617, DOI 10.1086/318791; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Sauve V, 2015, EMBO J, V34, P2492, DOI 10.15252/embj.201592237; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; TORDA AE, 1989, CHEM PHYS LETT, V157, P289, DOI 10.1016/0009-2614(89)87249-5; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; TROPP J, 1980, J CHEM PHYS, V72, P6035, DOI 10.1063/1.439059; Tzeng SR, 2013, NAT CHEM BIOL, V9, P462, DOI [10.1038/NCHEMBIO.1250, 10.1038/nchembio.1250]; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966	64	10	10	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16879	16891		10.1074/jbc.M116.728600	http://dx.doi.org/10.1074/jbc.M116.728600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27284007	hybrid, Green Published			2022-12-28	WOS:000380826700044
J	Guthrie, LN; Abiraman, K; Plyler, ES; Sprenkle, NT; Gibson, SA; McFarland, BC; Rajbhandari, R; Rowse, AL; Benveniste, EN; Meares, GP				Guthrie, Lauren N.; Abiraman, Kavitha; Plyler, Emily S.; Sprenkle, Neil T.; Gibson, Sara A.; McFarland, Braden C.; Rajbhandari, Rajani; Rowse, Amber L.; Benveniste, Etty N.; Meares, Gordon P.			Attenuation of PKR-like ER Kinase (PERK) Signaling Selectively Controls Endoplasmic Reticulum Stress-induced Inflammation Without Compromising Immunological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; NEURODEGENERATIVE DISEASES; INNATE IMMUNITY; CELLS; ACTIVATION; ASTROCYTES; EXPRESSION; SYSTEM; GROWTH; DAMAGE	Inflammation and endoplasmic reticulum (ER) stress are associated with many neurological diseases. ER stress is brought on by the accumulation of misfolded proteins in the ER, which leads to activation of the unfolded protein response (UPR), a conserved pathway that transmits signals to restore homeostasis or eliminate the irreparably damaged cell. We provide evidence that inhibition or genetic haploinsufficiency of protein kinase R-like endoplasmic reticulum kinase (PERK) can selectively control inflammation brought on by ER stress without impinging on UPR-dependent survival and adaptive responses or normal immune responses. Using astrocytes lacking one or both alleles of PERK or the PERK inhibitor GSK2606414, we demonstrate that PERK haploinsufficiency or partial inhibition led to reduced ER stress-induced inflammation (IL-6, CCL2, and CCL20 expression) without compromising prosurvival responses. In contrast, complete loss of PERK blocked canonical PERK-dependent UPR genes and promoted apoptosis. Reversal of eIF2 alpha-mediated translational repression using ISRIB potently suppressed PERK-dependent inflammatory gene expression, indicating that the selective modulation of inflammatory gene expression by PERK inhibition may be linked to attenuation of eIF2 alpha phosphorylation and reveals a previously unknown link between translational repression and transcription of inflammatory genes. Additionally, ER-stressed astrocytes can drive an inflammatory M1-like phenotype in microglia, and this can be attenuated with inhibition of PERK. Importantly, targeting PERK neither disrupted normal cytokine signaling in astrocytes or microglia nor impaired macrophage phagocytosis or T cell polarization. Collectively, this work suggests that targeting PERK may provide a means for selective immunoregulation in the context of ER stress without disrupting normal immune function.	[Guthrie, Lauren N.; Plyler, Emily S.; Sprenkle, Neil T.; Meares, Gordon P.] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, 1 Med Ctr Dr,BMRC 311, Morgantown, WV 26505 USA; [Abiraman, Kavitha; Gibson, Sara A.; McFarland, Braden C.; Rajbhandari, Rajani; Rowse, Amber L.; Benveniste, Etty N.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	West Virginia University; University of Alabama System; University of Alabama Birmingham	Meares, GP (corresponding author), West Virginia Univ, Dept Microbiol Immunol & Cell Biol, 1 Med Ctr Dr,BMRC 311, Morgantown, WV 26505 USA.	gpmeares@hsc.wvu.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155; McFarland, Braden C./0000-0002-7517-9688	National Multiple Sclerosis Society [TA3050-A-1, CA-1059-A-13]; National Institutes of Health [NS57563, CA158534]; West Virginia Clinical and Translational Science Institute; NIGMS, National Institutes of Health [U54GM104942]; NATIONAL CANCER INSTITUTE [R01CA158534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057563] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia Clinical and Translational Science Institute; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Multiple Sclerosis Society Career Transition Award TA3050-A-1 (to G. P. M.), National Multiple Sclerosis Society Collaborative Award CA-1059-A-13 (to E. N. B.), and National Institutes of Health Grants NS57563 and CA158534 (to E. N. B.). Support was also provided by the West Virginia Clinical and Translational Science Institute and NIGMS, National Institutes of Health Grant U54GM104942. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; Halliday M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.49; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14; Meares GP, 2013, J IMMUNOL, V190, P372, DOI 10.4049/jimmunol.1202390; Meares GP, 2004, FEBS LETT, V574, P181, DOI 10.1016/j.febslet.2004.08.026; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Verkhratsky A, 2014, BIOCHEM SOC T, V42, P1291, DOI 10.1042/BST20140107; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	41	58	58	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15830	15840		10.1074/jbc.M116.738021	http://dx.doi.org/10.1074/jbc.M116.738021			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226638	hybrid, Green Published			2022-12-28	WOS:000380584200035
J	Sankari, S; O'Brian, MR				Sankari, Siva; O'Brian, Mark R.			The Bradyrhizobium japonicum Ferrous Iron Transporter FeoAB Is Required for Ferric Iron Utilization in Free Living Aerobic Cells and for Symbiosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOYBEAN ROOT-NODULES; RESPONSE REGULATOR IRR; SIDEROPHORE-UPTAKE; RHIZOBIUM-LEGUMINOSARUM; UPTAKE SYSTEM; MAJOR ROLE; HEME; BACTERIA; PROTEIN; ACQUISITION	The bacterium Bradyrhizobium japonicum USDA110 does not synthesize siderophores for iron utilization in aerobic environments, and the mechanism of iron uptake within symbiotic soybean root nodules is unknown. An mbfA bfr double mutant defective in iron export and storage activities cannot grow aerobically in very high iron medium. Here, we found that this phenotype was suppressed by loss of function mutations in the feoAB operon encoding ferrous (Fe2+) iron uptake proteins. Expression of the feoAB operon genes was elevated under iron limitation, but mutants defective in either gene were unable to grow aerobically over a wide external ferric (Fe3+) iron (FeCl3) concentration range. Thus, FeoAB accommodates iron acquisition under iron limited and iron replete conditions. Incorporation of radiolabel from either Fe-55(2+) or Fe-59(3+) into cells was severely defective in the feoA and feoB strains, suggesting Fe3+ reduction to Fe2+ prior to traversal across the cytoplasmic membrane by FeoAB. The feoA or feoB deletion strains elicited small, ineffective nodules on soybean roots, containing few bacteria and lacking nitrogen fixation activity. A feoA(E40K) mutant contained partial iron uptake activity in culture that supported normal growth and established an effective symbiosis. The feoA(E40K) strain had partial iron uptake activity in situ within nodules and in isolated cells, indicating that FeoAB is the iron transporter in symbiosis. We conclude that FeoAB supports iron acquisition under limited conditions of soil and in the iron-rich environment of a symbiotic nodule.	[Sankari, Siva; O'Brian, Mark R.] SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY USA.	mrobrian@buffalo.edu	sankaran, Siva Sankari iyer mani/AAB-5222-2020		National Institutes of Health [R01 GM099667]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM099667 (to M. R. O.) The authors declare that they have no conflicts of interest with the contents of this article.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Benson HP, 2005, MOL PLANT MICROBE IN, V18, P950, DOI 10.1094/MPMI-18-0950; Brear EM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00359; Brickman TJ, 2012, MOL MICROBIOL, V86, P580, DOI 10.1111/mmi.12003; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Elhassanny AEM, 2013, MOL MICROBIOL, V88, P1070, DOI 10.1111/mmi.12242; Escamilla-Hernandez R, 2012, J BACTERIOL, V194, P3137, DOI 10.1128/JB.00071-12; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; GUERINOT ML, 1990, J BACTERIOL, V172, P3298, DOI 10.1128/jb.172.6.3298-3303.1990; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Jaggavarapu S, 2014, MOL MICROBIOL, V92, P609, DOI 10.1111/mmi.12584; Kaiser BN, 2003, PLANT J, V35, P295, DOI 10.1046/j.1365-313X.2003.01802.x; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; LeVier K, 1996, PLANT PHYSIOL, V111, P893, DOI 10.1104/pp.111.3.893; Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001; Mathew A, 2014, MOL MICROBIOL, V91, P805, DOI 10.1111/mmi.12499; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Nienaber A, 2001, MOL MICROBIOL, V41, P787, DOI 10.1046/j.1365-2958.2001.02555.x; Noya F, 1997, J BACTERIOL, V179, P3076, DOI 10.1128/jb.179.9.3076-3078.1997; OBRIAN MR, 1987, J BACTERIOL, V169, P1089, DOI 10.1128/jb.169.3.1089-1094.1987; PERSMARK M, 1993, J AM CHEM SOC, V115, P3950, DOI 10.1021/ja00063a014; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; PLESSNER O, 1993, APPL ENVIRON MICROB, V59, P1688, DOI 10.1128/AEM.59.5.1688-1690.1993; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; REGENSBURGER B, 1986, ARCH MICROBIOL, V144, P355, DOI 10.1007/BF00409885; Robey M, 2002, INFECT IMMUN, V70, P5659, DOI 10.1128/IAI.70.10.5659-5669.2002; Sankari S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157250; Sankari S, 2014, J BIOL CHEM, V289, P16498, DOI 10.1074/jbc.M114.571562; Small SK, 2011, J BACTERIOL, V193, P4088, DOI 10.1128/JB.05064-11; Small SK, 2009, J BACTERIOL, V191, P1361, DOI 10.1128/JB.01571-08; SO JS, 1987, MOL GEN GENET, V207, P15, DOI 10.1007/BF00331485; Stevens JB, 1999, MICROBIOL-UK, V145, P593, DOI 10.1099/13500872-145-3-593; Su YC, 2010, ACTA CRYSTALLOGR F, V66, P636, DOI 10.1107/S1744309110013941; Thomas-Charles CA, 2013, INFECT IMMUN, V81, P2828, DOI 10.1128/IAI.00170-13; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wittenberg JB, 1996, PLANT SOIL, V178, P161, DOI 10.1007/BF00011579; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Yeoman KH, 2000, MICROBIOL-SGM, V146, P829, DOI 10.1099/00221287-146-4-829	42	15	16	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15653	15662		10.1074/jbc.M116.734129	http://dx.doi.org/10.1074/jbc.M116.734129			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27288412	hybrid, Green Published			2022-12-28	WOS:000380584200020
J	[Anonymous]				[Anonymous]			Solving the Riddle of the Role of Sphingolipids in Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material																			0	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11460	11461		10.1074/jbc.O116.000003	http://dx.doi.org/10.1074/jbc.O116.000003			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27226641	Green Published, hybrid			2022-12-28	WOS:000377042100042
J	Qin, DZ; Wang, XH; Li, YT; Yang, LW; Wang, RT; Peng, JT; Essandoh, K; Mu, XJ; Peng, TQ; Han, QH; Yu, KJ; Fan, GC				Qin, Dongze; Wang, Xiaohong; Li, Yutian; Yang, Liwang; Wang, Ruitao; Peng, Jiangtong; Essandoh, Kobina; Mu, Xingjiang; Peng, Tianqing; Han, Qinghua; Yu, Kai-Jiang; Fan, Guo-Chang			MicroRNA-223-5p and-3p Cooperatively Suppress Necroptosis in Ischemic/Reperfused Hearts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; ischemia; microRNA (miRNA); myocardial infarction; necrosis (necrotic death)	ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; FACTOR-KAPPA-B; NLRP3 INFLAMMASOME; CELL-DEATH; IN-VIVO; NECROSIS; RECEPTOR; INHIBITION; PROTECTS	Recent studies have shown that myocardial ischemia/reperfusion (I/R)-induced necrosis can be controlled by multiple genes. In this study, we observed that both strands (5p and 3p) of miR-223 were remarkably dysregulated in mouse hearts upon I/R. Precursor miR-223 (pre-miR-223) transgenic mouse hearts exhibited better recovery of contractile performance over reperfusion period and lesser degree of myocardial necrosis than wild type hearts upon ex vivo and in vivo myocardial ischemia. Conversely, pre-miR-223 knock-out (KO) mouse hearts displayed opposite effects. Furthermore, we found that the RIP1/RIP3/MLKL necroptotic pathway and inflammatory response were suppressed in transgenic hearts, whereas they were activated in pre-miR-223 KO hearts upon I/R compared with wild type controls. Accordingly, treatment of pre-miR-223 KO mice with necrostatin-1s, a potent necroptosis inhibitor, significantly decreased I/R-triggered cardiac necroptosis, infarction size, and dysfunction. Mechanistically, we identified two critical cell death receptors, TNFR1 and DR6, as direct targets of miR-223-5p, whereas miR-223-3p directly suppressed the expression of NLRP3 and IB kinase , two important mediators known to be involved in I/R-induced inflammation and cell necroptosis. Our findings indicate that miR-223-5p/-3p duplex works together and cooperatively inhibits I/R-induced cardiac necroptosis at multiple layers. Thus, pre-miR-223 may constitute a new therapeutic agent for the treatment of ischemic heart disease.	[Qin, Dongze; Han, Qinghua] Shanxi Med Univ, Dept Cardiol, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China; [Qin, Dongze; Wang, Xiaohong; Li, Yutian; Yang, Liwang; Peng, Jiangtong; Essandoh, Kobina; Mu, Xingjiang; Fan, Guo-Chang] Univ Cincinnati, Dept Pharmacol & Cell Biophys, Coll Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Wang, Ruitao; Yu, Kai-Jiang] Harbin Med Univ, Dept Intens Care Unit, Affiliated Hosp 3, Harbin 150081, Heilongjiang, Peoples R China; [Peng, Tianqing] Lawson Hlth Res Inst, Crit Illness Res, London, ON N6A 4G5, Canada	Shanxi Medical University; University System of Ohio; University of Cincinnati; Harbin Medical University; Western University (University of Western Ontario)	Fan, GC (corresponding author), Univ Cincinnati, Dept Pharmacol & Cell Biophys, Coll Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	fangg@ucmail.uc.edu	Fan, Guo-Chang/E-1153-2012; Peng, Tianqing/G-3340-2011	Fan, Guo-Chang/0000-0002-0439-8277; Han, Qinghua/0000-0002-9099-2327; Li, Yutian/0000-0002-5118-0916	National Institutes of Health [HL-087861, GM-112930]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL-087861 and GM-112930 (to G.-C. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Benschop R, 2009, ADV EXP MED BIOL, V647, P186, DOI 10.1007/978-0-387-89520-8_13; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Dmitriev YV, 2013, B EXP BIOL MED+, V155, P245; Essandoh K, 2016, SHOCK, V46, P122, DOI 10.1097/SHK.0000000000000604; Flaherty MP, 2008, J MOL CELL CARDIOL, V45, P735, DOI 10.1016/j.yjmcc.2008.08.014; Frohlich GM, 2013, EUR HEART J, V34, P1714, DOI 10.1093/eurheartj/eht090; Gershlick AH, 2013, LANCET, V382, P624, DOI 10.1016/S0140-6736(13)61454-3; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hu R, 2014, FEBS LETT, V588, P401, DOI 10.1016/j.febslet.2013.12.010; Kang TB, 2014, METHOD ENZYMOL, V545, P67, DOI 10.1016/B978-0-12-801430-1.00003-2; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Koshinuma S, 2014, J ANESTH, V28, P235, DOI 10.1007/s00540-013-1716-3; Koudstaal S, 2015, EUR J CLIN INVEST, V45, P150, DOI 10.1111/eci.12391; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Makarov Roman, 2013, Methods Mol Biol, V961, P201, DOI 10.1007/978-1-62703-227-8_12; Malik S, 2011, J CARDIOVASC PHARM, V58, P199, DOI 10.1097/FJC.0b013e31822002a6; Marchetti C, 2015, J CARDIOVASC PHARM, V66, P1, DOI 10.1097/FJC.0000000000000247; Oerlemans MIFJ, 2013, INT J CARDIOL, V165, P410, DOI 10.1016/j.ijcard.2012.03.055; Oerlemans MIFJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0270-8; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P1001, DOI 10.1016/j.bbadis.2014.03.005; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Vilahur G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00496; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang JX, 2015, CIRC RES, V117, P352, DOI 10.1161/CIRCRESAHA.117.305781; Wang K, 2015, CELL DEATH DIFFER, V22, P743, DOI 10.1038/cdd.2014.165; Wang XH, 2014, BBA-MOL BASIS DIS, V1842, P701, DOI 10.1016/j.bbadis.2014.01.012; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Yang LW, 2016, J BIOL CHEM, V291, P15700, DOI 10.1074/jbc.M116.715805; Ye YM, 2010, CARDIOVASC RES, V87, P535, DOI 10.1093/cvr/cvq053; Zhang AB, 2014, TRANSPL INT, V27, P1077, DOI 10.1111/tri.12349; Zhang T, 2016, NAT MED, V22, P175, DOI 10.1038/nm.4017; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291; Zingarelli B, 2002, SHOCK, V17, P127, DOI 10.1097/00024382-200202000-00008	43	93	95	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20247	20259		10.1074/jbc.M116.732735	http://dx.doi.org/10.1074/jbc.M116.732735			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27502281	hybrid, Green Published			2022-12-28	WOS:000383243100043
J	Langelaan, DN; Liburd, J; Yang, Y; Miller, E; Chitayat, S; Crawley, SW; Cote, GP; Smith, SP				Langelaan, David N.; Liburd, Janine; Yang, Yidai; Miller, Emily; Chitayat, Seth; Crawley, Scott W.; Cote, Graham P.; Smith, Steven P.			Structure of the Single-lobe Myosin Light Chain C in Complex with the Light Chain-binding Domains of Myosin-1C Provides Insights into Divergent IQ Motif Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; nuclear magnetic resonance (NMR); protein motif; protein structure; protein-protein interaction; structural biology; x-ray crystallography; EF-hand; IQ motif; light chain	DICTYOSTELIUM-DISCOIDEUM; CRYSTAL-STRUCTURE; ARP2/3 COMPLEX; PROTEIN; MUTANTS; TAIL; ACANTHAMOEBA; QUALITY; SYSTEM; MOTOR	Myosin light chains are key regulators of class 1 myosins and typically comprise two domains, with calmodulin being the archetypal example. They bind IQ motifs within the myosin neck region and amplify conformational changes in the motor domain. A single lobe light chain, myosin light chain C (MlcC), was recently identified and shown to specifically bind to two sequentially divergent IQ motifs of the Dictyostelium myosin-1C. To provide a molecular basis of this interaction, the structures of apo-MlcC and a 2:1 MlcCmyosin-1C neck complex were determined. The two non-functional EF-hand motifs of MlcC pack together to form a globular four-helix bundle that opens up to expose a central hydrophobic groove, which interacts with the N-terminal portion of the divergent IQ1 and IQ2 motifs. The N- and C-terminal regions of MlcC make critical contacts that contribute to its specific interactions with the myosin-1C divergent IQ motifs, which are contacts that deviate from the traditional mode of calmodulin-IQ recognition.	[Langelaan, David N.; Liburd, Janine; Yang, Yidai; Miller, Emily; Chitayat, Seth; Crawley, Scott W.; Cote, Graham P.; Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Cote, GP; Smith, SP (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	coteg@queensu.ca; steven.smith@queensu.ca	Langelaan, David/AET-9707-2022	Langelaan, David/0000-0001-9592-3075; Smith, Steven/0000-0003-2710-4400	Natural Science and Engineering Research Council of Canada [RGPIN-391522, RGPIN-298508]; Canadian Institutes for Health Research; Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Natural Science and Engineering Research Council of Canada Discovery Grants RGPIN-391522 (to G. P. C.) and RGPIN-298508 (to S. P. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canadian Institutes for Health Research Postdoctoral Fellowship.; Supported by a Natural Science and Engineering Research Council of Canada PGS-D doctoral award.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADAMS RJ, 1986, NATURE, V322, P754, DOI 10.1038/322754a0; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Chen CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002446; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crawley SW, 2011, BIOCHEMISTRY-US, V50, P6579, DOI 10.1021/bi2007178; Crawley SW, 2006, J BIOL CHEM, V281, P6307, DOI 10.1074/jbc.M508670200; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; Dai JW, 1999, BIOPHYS J, V77, P1168, DOI 10.1016/S0006-3495(99)76968-7; De La Roche MA, 2003, BIOCHEM J, V374, P697, DOI 10.1042/BJ20030656; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Greenberg MJ, 2013, TRENDS CELL BIOL, V23, P81, DOI 10.1016/j.tcb.2012.10.008; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1994, FEBS LETT, V342, P197, DOI 10.1016/0014-5793(94)80500-8; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kollmar M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-183; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Liburd J, 2014, J BIOL CHEM, V289, P17030, DOI 10.1074/jbc.M113.536532; Lu Q, 2015, NAT STRUCT MOL BIOL, V22, P81, DOI 10.1038/nsmb.2923; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; Munnich S, 2014, J MOL BIOL, V426, P2070, DOI 10.1016/j.jmb.2014.03.004; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Osherov N, 2000, CELL MOTIL CYTOSKEL, V47, P163, DOI 10.1002/1097-0169(200011)47:3<163::AID-CM1>3.0.CO;2-U; PETERSON MD, 1995, J CELL SCI, V108, P1093; Rump A, 2011, J CELL SCI, V124, P2521, DOI 10.1242/jcs.084335; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Shuman H, 2014, P NATL ACAD SCI USA, V111, P2116, DOI 10.1073/pnas.1321022111; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; Terrak M, 2002, ACTA CRYSTALLOGR D, V58, P1882, DOI 10.1107/S0907444902013951; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406	50	5	5	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19607	19617		10.1074/jbc.M116.746313	http://dx.doi.org/10.1074/jbc.M116.746313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27466369	Green Published, hybrid			2022-12-28	WOS:000383242800034
J	Meyer, M; Leptihn, S; Welz, M; Schaller, A				Meyer, Michael; Leptihn, Sebastian; Welz, Max; Schaller, Andreas			Functional Characterization of Propeptides in Plant Subtilases as Intramolecular Chaperones and Inhibitors of the Mature Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pH regulation; protease inhibitor; protein folding; protein processing; serine protease; intramolecular chaperone; prodomain; subtilase; zymogen	SUBTILISIN BPN; PRO-SEQUENCE; PEPTIDE LIBRARIES; CRYSTAL-STRUCTURE; FOLDING REACTION; CLEAVAGE SITE; ACTIVE-SITE; PATHWAY; ACTIVATION; DOMAIN	Subtilisin-like serine proteases (SBTs) are extracellular proteases that depend on their propeptides for zymogen maturation and activation. The function of propeptides in plant SBTs is poorly understood and was analyzed here for the propeptide of tomato subtilase 3 (SBT3PP). SBT3PP was found to be required as an intramolecular chaperone for zymogen maturation and secretion of SBT3 in vivo. Secretion was impaired in a propeptide-deletion mutant but could be restored by co-expression of the propeptide in trans. SBT3 was inhibited by SBT3PP with a K-d of 74 nm for the enzyme-inhibitor complex. With a melting point of 87 degrees C, thermal stability of the complex was substantially increased as compared with the free protease suggesting that propeptide binding stabilizes the structure of SBT3. Even closely related propeptides from other plant SBTs could not substitute for SBT3PP as a folding assistant or autoinhibitor, revealing high specificity for the SBT3-SBT3PP interaction. Separation of the chaperone and inhibitor functions of SBT3PP in a domain-swap experiment indicated that they are mediated by different regions of the propeptide and, hence, different modes of interaction with SBT3. Release of active SBT3 from the autoinhibited complex relied on a pH-dependent cleavage of the propeptide at Asn-38 and Asp-54. The remarkable stability of the autoinhibited complex and pH dependence of the secondary cleavage provide means for stringent control of SBT3 activity, to ensure that the active enzyme is not released before it reaches the acidic environment of the trans-Golgi network or its final destination in the cell wall.	[Meyer, Michael; Welz, Max; Schaller, Andreas] Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany; [Leptihn, Sebastian] Univ Hohenheim, Dept Microbiol, D-70593 Stuttgart, Germany	University Hohenheim; University Hohenheim	Schaller, A (corresponding author), Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany.	andreas.schaller@uni-hohenheim.de	Leptihn, Sebastian/H-3677-2019; Schaller, Andreas/AAC-1940-2020	Leptihn, Sebastian/0000-0002-4847-4622; Schaller, Andreas/0000-0001-6872-9576	German Research Foundation (DFG) [SCHA 591/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation (DFG) Grant SCHA 591/4-1 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander PA, 2001, BIOCHEMISTRY-US, V40, P10634, DOI 10.1021/bi010797m; Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Buevich AV, 2001, J BIOMOL NMR, V20, P233, DOI 10.1023/A:1011243116136; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dillon SL, 2012, J MOL BIOL, V423, P47, DOI 10.1016/j.jmb.2012.06.023; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; EDER J, 1993, BIOCHEMISTRY-US, V32, P18, DOI 10.1021/bi00052a004; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; Effenberger I, 2015, ANGEW CHEM INT EDIT, V54, P14660, DOI 10.1002/anie.201507543; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Huang HW, 1997, PROTEIN ENG, V10, P1227, DOI 10.1093/protein/10.10.1227; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; LI YY, 1994, J BIOL CHEM, V269, P4169; Luo Y, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.94, 10.1038/nplants.2015.94]; Marie-Claire C, 2001, J MOL BIOL, V305, P151, DOI 10.1006/jmbi.2000.4233; Marino G, 2014, BIOCHEM J, V457, P335, DOI 10.1042/BJ20130196; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Murayama K, 2012, J MOL BIOL, V423, P386, DOI 10.1016/j.jmb.2012.07.013; Nakagawa M, 2010, J BIOL CHEM, V285, P29797, DOI 10.1074/jbc.M109.083162; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RATHMELL WG, 1974, PLANT PHYSIOL, V53, P317, DOI 10.1104/pp.53.2.317; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rawlings N.D., 2010, NUCLEIC ACIDS RES S1, V38, P227, DOI [10.1093/nar/gkp971, DOI 10.1093/NAR/GKP971]; Rose R, 2010, PLANT SIGNAL BEHAV, V5, P180, DOI 10.4161/psb.5.2.11069; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schaller A, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3247, DOI 10.1016/B978-0-12-382219-2.00717-1; Schaller A, 2012, PHYSIOL PLANTARUM, V145, P52, DOI 10.1111/j.1399-3054.2011.01529.x; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2011, BIOL CHEM, V392, P1031, DOI 10.1515/BC.2011.158; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; SHINDE U, 1994, J BIOCHEM, V115, P629, DOI 10.1093/oxfordjournals.jbchem.a124386; SHINDE U, 1995, J MOL BIOL, V252, P25, DOI 10.1006/jmbi.1995.0472; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Shukla D, 2011, J PHYS CHEM B, V115, P11831, DOI 10.1021/jp204462t; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SILEN JL, 1989, NATURE, V341, P462, DOI 10.1038/341462a0; SMITH EL, 1966, J BIOL CHEM, V241, P5974; SMITH SM, 1989, J BIOL CHEM, V264, P20487; STRAUSBERG S, 1993, BIOCHEMISTRY-US, V32, P8112, DOI 10.1021/bi00083a009; Subbian E, 2005, J MOL BIOL, V347, P367, DOI 10.1016/j.jmb.2005.01.028; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Tangrea MA, 2001, BIOCHEMISTRY-US, V40, P5488, DOI 10.1021/bi0026472; VANDENHAZEL HB, 1993, J BIOL CHEM, V268, P18002; WONG SL, 1986, J BIOL CHEM, V261, P176; Yabuta Y, 2003, J BIOL CHEM, V278, P15246, DOI 10.1074/jbc.M212003200; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	64	22	24	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19449	19461		10.1074/jbc.M116.744151	http://dx.doi.org/10.1074/jbc.M116.744151			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27451395	hybrid, Green Published			2022-12-28	WOS:000383242800023
J	Damaraju, VL; Weber, D; Kuzma, M; Cass, CE; Sawyer, MB				Damaraju, Vijaya L.; Weber, Dwayne; Kuzma, Michelle; Cass, Carol E.; Sawyer, Michael B.			Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE; IMATINIB MESYLATE; CELLULAR UPTAKE; PHARMACOLOGICAL-PROPERTIES; SACCHAROMYCES-CEREVISIAE; PHILADELPHIA-CHROMOSOME; COMBINATION THERAPY; DRUG-RESISTANCE	Human nucleoside transporters (hNTs) mediate cellular influx of anticancer nucleoside drugs, including cytarabine, cladribine, and fludarabine. BCR-ABL tyrosine kinase inhibitors (TKIs) imatinib and dasatinib inhibit fludarabine and cytarabine uptake. We assessed interactions of bosutinib, dasatinib, imatinib, nilotinib, and ponatinib with recombinant hNTs (hENT1, 2; hCNT1, -2, and-3) produced individually in yeast Saccharomyces cerevisiae. Nilotinib inhibited hENT1-mediated uridine transport most potently (IC50 value, 0.7 mu m) followed by ponatinib > bosutinib > dasatinib > imatinib. Imatinib inhibited hCNI2 with an IC50 value of 2.3 mu m. Ponatinib inhibited all five hNTs with the greatest effect seen for hENT1 (IC50 value, 9 gm). TKIs inhibited [H-3]uridine uptake in a competitive manner. Studies in yeast with mutants at two amino acid residues of hENT1 (L4421, L442T, M33A, M33A/L442I) previously shown to be involved in uridine and dipyridamole binding, suggested that BCR-ABL TKIs interacted with Met(33) (TM1) and Leu(442) (TM11) residues of hENT1. In cultured human CEM lymphoblastoid cells, which possess a single hNT type (hENT1), accumulation of [H-3]cytarabine, [H-3]cladribine, or [H-3]fludarabine was reduced by each of the five TKIs, and also caused a reduction in cell surface expression of hENT1 protein. In conclusion, BCR-ABL TKIs variously inhibit five different hNTs, cause a decrease in cell surface hENT1 expression, and decrease uridine accumulation when presented together with uridine or when given before uridine. In experiments with mutant hENT1, we showed for the first time interaction of Met(33) (involved in dipyridamole binding) with BCR-ABI, inhibitors and reduced interaction with M33A mutant hENT1.	Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Sawyer, MB (corresponding author), 11560 Univ Ave NW, Edmonton, AB T6G 1Z2, Canada.	michael.sawyer@albertahealthservices.ca			Alberta Cancer Foundation; Alberta Innovates Health Solutions	Alberta Cancer Foundation; Alberta Innovates Health Solutions	This work was supported by grants from the Alberta Cancer Foundation and Alberta Innovates Health Solutions (to M. B. S.). V. L D. and M. B. S. are listed on a patent "Combination treatments for cancer" held by Alberta Health Services.	Asaki T, 2006, BIOORG MED CHEM LETT, V16, P1421, DOI 10.1016/j.bmcl.2005.11.042; Breccia M, 2010, LEUKEMIA RES, V34, P129, DOI 10.1016/j.leukres.2009.08.031; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; CRAWFORD CR, 1990, BIOCHIM BIOPHYS ACTA, V1024, P289, DOI 10.1016/0005-2736(90)90357-T; Damaraju VL, 2015, CANCER CHEMOTH PHARM, V76, P1093, DOI 10.1007/s00280-015-2859-8; Damaraju VL, 2015, MOL CANCER THER, V14, P236, DOI 10.1158/1535-7163.MCT-14-0337; Damaraju VL, 2014, CLIN CANCER RES, V20, P176, DOI 10.1158/1078-0432.CCR-13-2293; Damaraju VL, 2009, NUCLEOS NUCLEOT NUCL, V28, P450, DOI 10.1080/15257770903044499; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Eck MJ, 2009, CURR OPIN CELL BIOL, V21, P288, DOI 10.1016/j.ceb.2009.01.014; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Hegedus C, 2009, BRIT J PHARMACOL, V158, P1153, DOI 10.1111/j.1476-5381.2009.00383.x; Hiwase DK, 2008, CLIN CANCER RES, V14, P3881, DOI 10.1158/1078-0432.CCR-07-5095; Huang M, 2002, J BIOL CHEM, V277, P28364, DOI 10.1074/jbc.C200321200; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Jabbour E, 2011, HEMATOL ONCOL CLIN N, V25, P981, DOI 10.1016/j.hoc.2011.09.004; JARVIS SM, 1982, J PHYSIOL-LONDON, V324, P31, DOI 10.1113/jphysiol.1982.sp014099; JARVIS SM, 1986, MOL PHARMACOL, V30, P659; Leisewitz AV, 2008, NUCLEOS NUCLEOT NUCL, V27, P779, DOI 10.1080/15257770802145892; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Manley PW, 2005, BBA-PROTEINS PROTEOM, V1754, P3, DOI 10.1016/j.bbapap.2005.07.040; Naud JS, 2012, LEUKEMIA RES, V36, P1311, DOI 10.1016/j.leukres.2012.06.012; Ohanian M, 2012, EXPERT OPIN PHARMACO, V13, P927, DOI 10.1517/14656566.2012.672974; Paproski RJ, 2008, BIOCHEM J, V414, P291, DOI 10.1042/BJ20080074; PATERSON ARP, 1980, MOL PHARMACOL, V18, P40; Ravandi F, 2011, CL LYMPH MYELOM LEUK, V11, P198, DOI 10.1016/j.clml.2011.03.002; Robak P, 2013, CANCER TREAT REV, V39, P851, DOI 10.1016/j.ctrv.2013.03.006; Robins MJ, 2010, J MED CHEM, V53, P6040, DOI 10.1021/jm100432w; Segel I.H., 1975, ENZYME KINETICS; Sen R, 2012, MOL CANCER THER, V11, P2033, DOI 10.1158/1535-7163.MCT-12-0302; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Thielen N, 2013, ANN HEMATOL, V92, P1049, DOI 10.1007/s00277-013-1730-4; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Vickers MF, 2002, BIOCHEM CELL BIOL, V80, P639, DOI 10.1139/O02-148; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687; Woodahl EL, 2008, CANCER CHEMOTH PHARM, V62, P735, DOI 10.1007/s00280-007-0629-y; Yamakawa Y, 2011, CLIN PHARMACOL THER, V90, P157, DOI 10.1038/clpt.2011.102; Yamakawa Y, 2014, BIOL PHARM BULL, V37, P1330, DOI 10.1248/bpb.b14-00254; Yang K, 2015, CRIT REV ONCOL HEMAT, V93, P277, DOI 10.1016/j.critrevonc.2014.11.001; Zhang J, 2003, MOL PHARMACOL, V64, P1512, DOI 10.1124/mol.64.6.1512; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	46	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18809	18817		10.1074/jbc.M116.741074	http://dx.doi.org/10.1074/jbc.M116.741074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432881	Green Published, hybrid			2022-12-28	WOS:000383242300018
J	Deligny, A; Dierker, T; Dagalv, A; Lundequist, A; Eriksson, I; Nairn, AV; Moremen, KW; Merry, CLR; Kjellen, L				Deligny, Audrey; Dierker, Tabea; Dagalv, Anders; Lundequist, Anders; Eriksson, Inger; Nairn, Alison V.; Moremen, Kelley W.; Merry, Catherine L. R.; Kjellen, Lena			NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEACETYLASE/N-SULFOTRANSFERASE 1; EMBRYONIC STEM-CELLS; MICE DEFICIENT; N-SULFATION; BIOSYNTHESIS; MOUSE; PROTEOGLYCANS; EXPRESSION; GLYCOSAMINOGLYCAN; DIFFERENTIATION	Analysis of heparan sulfate synthesized by HEK 293 cells overexpressing murine NDST1 and/or NDST2 demonstrated that the amount of heparan sulfate was increased in NDST2-but not in NDST1-overexpressing cells. Altered transcript expression of genes encoding other biosynthetic enzymes or proteoglycan core proteins could not account for the observed changes. However, the role of NDST2 in regulating the amount of heparan sulfate synthesized was confirmed by analyzing heparan sulfate content in tissues isolated from Ndst2(-/-) mice, which contained reduced levels of the polysaccharide. Detailed disaccharide composition analysis showed no major structural difference between heparan sulfate from control and Ndst2(-/-) tissues, with the exception of heparan sulfate from spleen where the relative amount of trisulfated disaccharides was lowered in the absence of NDST2. In vivo transcript expression levels of the heparan sulfate-polymerizing enzymes Ext1 and Ext2 were also largely unaffected by NDST2 levels, pointing to a mode of regulation other than increased gene transcription. Size estimation of heparan sulfate polysaccharide chains indicated that increased chain lengths in NDST2-overexpressing cells alone could explain the increased heparan sulfate content. A model is discussed where NDST2-specific substrate modification stimulates elongation resulting in increased heparan sulfate chain length.	[Deligny, Audrey; Dierker, Tabea; Dagalv, Anders; Lundequist, Anders; Eriksson, Inger; Merry, Catherine L. R.; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, SE-75123 Uppsala, Sweden; [Nairn, Alison V.; Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Merry, Catherine L. R.] Univ Nottingham, Ctr Biomol Sci, Wolfson Ctr Stem Cells Tissue Engn & Modelling, Nottingham NG7 2RD, England	Uppsala University; University System of Georgia; University of Georgia; University of Nottingham	Kjellen, L (corresponding author), Biomed Ctr, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	lena.kjellen@imbim.uu.se	Moremen, Kelley/AAD-4661-2019	merry, catherine/0000-0002-3490-2809; Nairn, Alison/0000-0002-4453-7593	Swedish Research Council; Swedish Cancer Society; Stiftelsen for Proteoglykanforskning; DAAD, German Academic Exchange Service; International Academic Fellowship from Leverhulme Trust; National Institutes of Health [GM103490]; EPSRC [EP/J013854/1] Funding Source: UKRI; MRC [G0701165, G0902170] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [978724] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1169153, EP/J013854/1] Funding Source: researchfish; Medical Research Council [G0701165, G0902170] Funding Source: researchfish; National Centre for the Replacement [NC/N001583/1] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Stiftelsen for Proteoglykanforskning; DAAD, German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); International Academic Fellowship from Leverhulme Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	This work was supported by grants from the Swedish Research Council (to L.K.), the Swedish Cancer Society (to L.K.), Stiftelsen for Proteoglykanforskning (to L.K.), and DAAD, German Academic Exchange Service (to T. D.), an International Academic Fellowship from the Leverhulme Trust (to C. L. R. M.), and National Institutes of Health Grant GM103490 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Barkefors I, 2011, J BIOL CHEM, V286, P24189, DOI 10.1074/jbc.M110.212209; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Carlsson Pernilla, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-23056-1_2; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; Dagalv A, 2015, METHODS MOL BIOL, V1229, P189, DOI 10.1007/978-1-4939-1714-3_17; Dagalv A, 2011, J BIOL CHEM, V286, P44433, DOI 10.1074/jbc.M111.303891; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Foley EM, 2010, PROG MOL BIOL TRANSL, V93, P213, DOI 10.1016/S1877-1173(10)93010-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Forsberg M, 2012, J BIOL CHEM, V287, P10853, DOI 10.1074/jbc.M111.337030; Gasimli L, 2014, BBA-GEN SUBJECTS, V1840, P1993, DOI 10.1016/j.bbagen.2014.01.007; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Li BYZ, 2011, METHODS MOL BIOL, V690, P285, DOI 10.1007/978-1-60761-962-8_19; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; LIDHOLT K, 1992, BIOCHEM J, V287, P21, DOI 10.1042/bj2870021; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Petersen F, 1999, J BIOL CHEM, V274, P12376, DOI 10.1074/jbc.274.18.12376; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pikas DS, 2000, BIOCHEMISTRY-US, V39, P4552, DOI 10.1021/bi992524l; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Ringvall M, 2010, PROG MOL BIOL TRANSL, V93, P35, DOI 10.1016/S1877-1173(10)93003-2; ROBINSON HC, 1978, J BIOL CHEM, V253, P6687; Ronnberg E, 2012, METHODS MOL BIOL, V836, P201, DOI 10.1007/978-1-61779-498-8_14; Roy A, 2014, J BIOL CHEM, V289, P237, DOI 10.1074/jbc.M112.435156; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Vives RR, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00331; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314	45	23	23	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18600	18607		10.1074/jbc.M116.744433	http://dx.doi.org/10.1074/jbc.M116.744433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27387504	Green Published, hybrid			2022-12-28	WOS:000383242300001
J	Hershey, DM; Browne, PJ; Iavarone, AT; Teyra, J; Lee, EH; Sidhu, SS; Komeili, A				Hershey, David M.; Browne, Patrick J.; Iavarone, Anthony T.; Teyra, Joan; Lee, Eun H.; Sidhu, Sachdev S.; Komeili, Arash			Magnetite Biomineralization in Magnetospirillum magneticum Is Regulated by a Switch-like Behavior in the HtrA Protease MamE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; biomineralization; iron; metal; serine protease; HtrA protease; MamE; magnetite; magnetosome; magnetotactic bacteria	PDZ DOMAINS; SUBSTRATE-SPECIFICITY; FUNCTIONAL-ANALYSIS; GENETIC DISSECTION; CRYSTAL-STRUCTURE; STRESS SENSOR; DEGS; REVEALS; MAGNETOCHROME; PROTEOLYSIS	Magnetotactic bacteria are aquatic organisms that produce subcellular magnetic particles in order to orient in the earth's geomagnetic field. MamE, a predicted HtrA protease required to produce magnetite crystals in the magnetotactic bacterium Magnetospirillum magneticum AMB-1, was recently shown to promote the proteolytic processing of itself and two other biomineralization factors in vivo. Here, we have analyzed the in vivo processing patterns of three proteolytic targets and used this information to reconstitute proteolysis with a purified form of MamE. MamE cleaves a custom peptide substrate with positive cooperativity, and its autoproteolysis can be stimulated with exogenous substrates or peptides that bind to either of its PDZ domains. A misregulated form of the protease that circumvents specific genetic requirements for proteolysis causes biomineralization defects, showing that proper regulation of its activity is required during magnetite biosynthesis in vivo. Our results represent the first reconstitution of the proteolytic activity of MamE and show that its behavior is consistent with the previously proposed checkpoint model for biomineralization.	[Hershey, David M.; Browne, Patrick J.; Komeili, Arash] Univ Calif Berkeley, Dept Plant & Microbial Biol, 261 Koshland Hall, Berkeley, CA 94720 USA; [Lee, Eun H.; Komeili, Arash] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Iavarone, Anthony T.; Komeili, Arash] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Chem Mass Spectrometry Facil QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; [Teyra, Joan; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Terrance Donnelly Ctr Cellular & Biomed Res, Toronto, ON M5S 3E1, Canada	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Toronto	Komeili, A (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 261 Koshland Hall, Berkeley, CA 94720 USA.	komeili@berkeley.edu	Hamid Reza, Komeili/A-7818-2017	Hamid Reza, Komeili/0000-0002-6665-6462	National Institutes of Health [1S10OD020062-01]; Direct For Mathematical & Physical Scien [1504681] Funding Source: National Science Foundation; Division Of Physics [1504610] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084122] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The QB3/Chemistry Mass Spectrometry Facility at the University of California (Berkeley, CA) is supported by National Institutes of Health Grant 1S10OD020062-01.	Arita Y, 2016, BIOCHEM BIOPH RES CO, V473, P370, DOI 10.1016/j.bbrc.2016.01.050; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; BALKWILL DL, 1980, J BACTERIOL, V141, P1399, DOI 10.1128/JB.141.3.1399-1408.1980; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Cornejo E, 2016, MBIO, V7, DOI 10.1128/mBio.01898-15; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Held HA, 2004, J MOL BIOL, V340, P587, DOI 10.1016/j.jmb.2004.04.060; Hershey DM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002402; Ivarsson Y, 2014, P NATL ACAD SCI USA, V111, P2542, DOI 10.1073/pnas.1312296111; Jones SR, 2015, P NATL ACAD SCI USA, V112, P3904, DOI 10.1073/pnas.1417614112; Kashyap S, 2014, ACS NANO, V8, P9097, DOI 10.1021/nn502551y; Kim S, 2014, GENE DEV, V28, P902, DOI 10.1101/gad.238394.114; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Kley J, 2011, NAT STRUCT MOL BIOL, V18, P728, DOI 10.1038/nsmb.2055; Kolinko I, 2014, NAT NANOTECHNOL, V9, P193, DOI [10.1038/nnano.2014.13, 10.1038/NNANO.2014.13]; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Lohse I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021486; Lohsse A, 2014, J BACTERIOL, V196, P2658, DOI 10.1128/JB.01716-14; Londer YY, 2006, PROTEIN EXPRES PURIF, V47, P241, DOI 10.1016/j.pep.2005.11.017; Mauldin RV, 2013, NAT CHEM BIOL, V9, P90, DOI [10.1038/nchembio.1135, 10.1038/NCHEMBIO.1135]; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Quinlan A, 2011, MOL MICROBIOL, V80, P1075, DOI 10.1111/j.1365-2958.2011.07631.x; Rahn-Lee L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004811; Rawlings AE, 2014, P NATL ACAD SCI USA, V111, P16094, DOI 10.1073/pnas.1409256111; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Siponen MI, 2013, NATURE, V502, P681, DOI 10.1038/nature12573; Siponen MI, 2012, BIOCHEM SOC T, V40, P1319, DOI 10.1042/BST20120104; Small JL, 2013, J BIOL CHEM, V288, P12489, DOI 10.1074/jbc.M113.456541; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2010, J BIOL CHEM, V285, P34039, DOI 10.1074/jbc.M110.135541; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wolff A, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1161-5; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108; Yang W, 2010, RES MICROBIOL, V161, P701, DOI [10.1016/J.resmic.2010.07.002, 10.1016/j.resmic.2010.07.002]; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207	49	13	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17941	17952		10.1074/jbc.M116.731000	http://dx.doi.org/10.1074/jbc.M116.731000			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27302060	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000383241300037
J	Khosravi, F; Michel, V; Galuska, CE; Bhushan, S; Christian, P; Schuppe, HC; Pilatz, A; Galuska, SP; Meinhardt, A				Khosravi, Farhad; Michel, Vera; Galuska, Christina E.; Bhushan, Sudhanshu; Christian, Philipp; Schuppe, Hans-Christian; Pilatz, Adrian; Galuska, Sebastian P.; Meinhardt, Andreas			Desialylation of Spermatozoa and Epithelial Cell Glycocalyx Is a Consequence of Bacterial Infection of the Epididymis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; glycosylation; glycosylation inhibitor; reproduction; sialic acid; sialidase; sperm; spermatozoa	PERFORMANCE LIQUID-CHROMATOGRAPHY; MAMMALIAN SPERM; SIALIC ACIDS; ACROSOME REACTION; POLYSIALIC ACIDS; NEURAMINIDASE; SIALYLATION; CAPACITATION; PERSPECTIVE; SIALIDASES	Urinary tract infections caused by uropathogenic Escherichia coli (UPEC) pathovars belong to the most frequent infections in humans. In men, pathogens can also spread to the genital tract via the continuous ductal system, eliciting bacterial prostatitis and/or epididymo-orchitis. Antibiotic treatment usually clears pathogens in acute epididymitis; however, the fertility of patients can be permanently impaired. Because a premature acrosome reaction was observed in an UPEC epididymitis mouse model, and sialidases on the sperm surface are considered to be activated via proteases of the acrosome, we aimed to investigate whether alterations of the sialome of epididymal spermatozoa and surrounding epithelial cells occur during UPEC infection. In UPEC-elicited acute epididymitis in mice, a substantial loss of N-acetylneuraminic acid residues was detected in epididymal spermatozoa and epithelial cells using combined laser microdissection/HPLC-ESI-MS analysis. In support, a substantial reduction of sialic acid residues bound to the surface of spermatozoa was documented in men with a recent history of E. coli-associated epididymitis. In vitro, such an UPEC induced N-acetylneuraminic acid release from human spermatozoa was effectively counteracted by a sialidase inhibitor. These findings strongly suggest a substantial remodeling of the glycocalyx of spermatozoa and epididymal epithelial cells by endogenous sialidases after a premature acrosome reaction during acute epididymitis.	[Khosravi, Farhad; Michel, Vera; Bhushan, Sudhanshu; Meinhardt, Andreas] Univ Giessen, Inst Anat & Cell Biol, Fac Med, D-35392 Giessen, Germany; [Khosravi, Farhad; Galuska, Christina E.; Christian, Philipp; Galuska, Sebastian P.] Univ Giessen, Inst Biochem, Fac Med, D-35392 Giessen, Germany; [Schuppe, Hans-Christian; Pilatz, Adrian] Univ Giessen, Dept Urol Pediat Urol & Androl, Fac Med, D-35392 Giessen, Germany; [Galuska, Sebastian P.] Leibniz Inst Farm Anim Biol, Dept Reprod Biol, D-18196 Dummerstorf, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Forschungsinstitut fur Nutztierbiologie (FBN)	Meinhardt, A (corresponding author), Univ Giessen, Inst Anat & Cell Biol, Fac Med, D-35392 Giessen, Germany.; Galuska, SP (corresponding author), Leibniz Inst Farm Anim Biol, Dept Reprod Biol, D-18196 Dummerstorf, Germany.	galuska.sebastian@fbn-dummerstorf.de; andreas.meinhardt@anatomie.med.uni-giessen.de	郑, 丽丽/HGE-2239-2022	Khosravi, Farhad/0000-0003-0730-2266	Deutsche Forschungsgemeinschaft [GA 1755/1-2, GRK 1871/1]; von Behring-Roentgen-Stiftung; Faculty of Medicine of the Justus Liebig University of Giessen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von Behring-Roentgen-Stiftung; Faculty of Medicine of the Justus Liebig University of Giessen	This work was supported by Deutsche Forschungsgemeinschaft Grants GA 1755/1-2 (to S. P. G.) GRK 1871/1 (to A. M.), the von Behring-Roentgen-Stiftung, and the Faculty of Medicine of the Justus Liebig University of Giessen. The authors declare that they have no conflicts of interest with the contents of this article.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bartel J, 2014, ANAL CHEM, V86, P2326, DOI 10.1021/ac403966h; Bayer NB, 2013, MOLECULES, V18, P2571, DOI 10.3390/molecules18032571; BERGER RE, 1987, J INFECT DIS, V155, P1341, DOI 10.1093/infdis/155.6.1341; Bhushan S, 2008, J IMMUNOL, V180, P5537, DOI 10.4049/jimmunol.180.8.5537; Bhushan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028452; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Cairo CW, 2014, MEDCHEMCOMM, V5, P1067, DOI 10.1039/c4md00089g; Chen GY, 2011, NAT BIOTECHNOL, V29, P428, DOI 10.1038/nbt.1846; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Galuska SP, 2013, SIALOBIOLOGY: BIOSYNTHESIS, STRUCTURE AND FUNCTION: SIALIC ACID GLYCOCONJUGATES IN HEALTH AND DISEASE, P448; Galuska SP, 2012, J PROTEOMICS, V75, P5266, DOI 10.1016/j.jprot.2012.06.011; Galuska SP, 2010, ANAL CHEM, V82, P4591, DOI 10.1021/ac100627e; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; JANTOS C, 1992, INFECT IMMUN, V60, P2324, DOI 10.1128/IAI.60.6.2324-2328.1992; Kang Taek Won, 2007, J Infect, V54, pe69, DOI 10.1016/j.jinf.2006.04.005; Kim S, 2011, APPL MICROBIOL BIOT, V91, P1, DOI 10.1007/s00253-011-3307-2; Lang TL, 2014, INFECT IMMUN, V82, P1104, DOI 10.1128/IAI.01373-13; Lang TL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110379; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Ma F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380584; Ma X, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137810; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Michel V., 2016, J PATHOL; Michel V, 2015, ASIAN J ANDROL, V17, P756, DOI 10.4103/1008-682X.155770; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Paulson JC, 2011, NAT BIOTECHNOL, V29, P406, DOI 10.1038/nbt.1859; Pilatz A, 2015, EUR UROL, V68, P428, DOI 10.1016/j.eururo.2014.12.005; Rusz A, 2012, WORLD J UROL, V30, P23, DOI 10.1007/s00345-011-0726-8; Sajo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146398; Sakarya S, 2003, FEMS IMMUNOL MED MIC, V39, P45, DOI 10.1016/S0928-8244(03)00185-8; Sakaue T, 2010, J BIOL CHEM, V285, P2184, DOI 10.1074/jbc.M109.063495; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Shahraz A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16800; Simon P, 2013, J BIOL CHEM, V288, P18825, DOI 10.1074/jbc.M113.451112; SRIVASTAVA PN, 1988, J EXP ZOOL, V245, P106, DOI 10.1002/jez.1402450116; SRIVASTAVA PN, 1970, BIOCHEM BIOPH RES CO, V39, P575, DOI 10.1016/0006-291X(70)90242-1; SRIVASTAVA PN, 1977, BIOCHEM J, V161, P193, DOI 10.1042/bj1610193; Stammler A, 2015, HUM REPROD, V30, P1557, DOI 10.1093/humrep/dev112; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; TALBOT P, 1974, J REPROD FERTIL, V39, P429, DOI 10.1530/jrf.0.0390429; Tambe A S, 2001, Indian J Med Sci, V55, P125; Tecle E, 2015, MOL REPROD DEV, V82, P635, DOI 10.1002/mrd.22500; TOSHIMORI K, 1991, ARCH ANDROLOGY, V27, P79, DOI 10.3109/01485019108987656; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Younglai EV, 2001, HUM REPROD, V16, P1950, DOI 10.1093/humrep/16.9.1950	54	8	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17717	17726		10.1074/jbc.M116.718072	http://dx.doi.org/10.1074/jbc.M116.718072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27339898	Green Published, hybrid			2022-12-28	WOS:000383241300021
J	Semack, A; Sandhu, M; Malik, RU; Vaidehi, N; Sivaramakrishnan, S				Semack, Ansley; Sandhu, Manbir; Malik, Rabia U.; Vaidehi, Nagarajan; Sivaramakrishnan, Sivaraj			Structural Elements in the G(s) and G(q) C Termini That Mediate Selective G Protein-coupled Receptor (GPCR) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; fluorescence resonance energy transfer (FRET); G protein; G protein-coupled receptor (GPCR); molecular dynamics; Receptor Conformation	HETEROTRIMERIC G-PROTEIN; BETA(2) ADRENERGIC-RECEPTOR; ALPHA-HELICAL DOMAIN; MOLECULAR-DYNAMICS; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; VASOPRESSIN RECEPTOR; SYNTHETIC PEPTIDES; BINDING-SITE	Although the importance of the C terminus of the subunit of the heterotrimeric G protein in G protein-coupled receptor (GPCR)-G protein pairing is well established, the structural basis of selective interactions remains unknown. Here, we combine live cell FRET-based measurements and molecular dynamics simulations of the interaction between the GPCR and a peptide derived from the C terminus of the G subunit (G peptide) to dissect the molecular mechanisms of G protein selectivity. We observe a direct link between G peptide binding and stabilization of the GPCR conformational ensemble. We find that cognate and non-cognate G peptides show deep and shallow binding, respectively, and in distinct orientations within the GPCR. Binding of the cognate G peptide stabilizes the agonist-bound GPCR conformational ensemble resulting in favorable binding energy and lower flexibility of the agonist-GPCR pair. We identify three hot spot residues (G(s)/G(q)-Gln-384/Leu-349, Gln-390/Glu-355, and Glu-392/Asn-357) that contribute to selective interactions between the 2-adrenergic receptor (2-AR)-G(s) and V-1A receptor (V1AR)-G(q). The G(s) and G(q) peptides adopt different orientations in 2-AR and V1AR, respectively. The 2-AR/G(s) peptide interface is dominated by electrostatic interactions, whereas the V1AR/G(q) peptide interactions are predominantly hydrophobic. Interestingly, our study reveals a role for both favorable and unfavorable interactions in G protein selection. Residue Glu-355 in G(q) prevents this peptide from interacting strongly with 2-AR. Mutagenesis to the G(s) counterpart (E355Q) imparts a cognate-like interaction. Overall, our study highlights the synergy in molecular dynamics and FRET-based approaches to dissect the structural basis of selective G protein interactions.	[Semack, Ansley; Malik, Rabia U.; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Sandhu, Manbir; Vaidehi, Nagarajan] Beckman Res Inst City Hope, Dept Mol Immunol, Duarte, CA 91010 USA; [Malik, Rabia U.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Minnesota System; University of Minnesota Twin Cities; City of Hope; Beckman Research Institute of City of Hope; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 4-130 MCB,420 Washington Ave SE, Twin Cities Minneapolis, MN 55455 USA.	sivaraj@umn.edu	Sandhu, Manbir/AAI-2124-2019	Sandhu, Manbir/0000-0003-1182-7268	American Heart Association Scientist Development Grant [13SDG14270009]; National Institutes of Health [1DP2 CA186752-01, 1-R01-GM-105646-01-A1, R01 GM097261-04]; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097261, R01GM105646] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Scientist Development Grant 13SDG14270009 and National Institutes of Health Grants 1DP2 CA186752-01 and 1-R01-GM-105646-01-A1 (to S. S.) and R01 GM097261-04 (to N.V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya S, 2008, BIOPHYS J, V94, P2027, DOI 10.1529/biophysj.107.117648; Cheng LL, 2004, J MED CHEM, V47, P2375, DOI 10.1021/jm030611c; CHINI B, 1995, EMBO J, V14, P2176, DOI 10.1002/j.1460-2075.1995.tb07211.x; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Cotte N, 2000, EUR J BIOCHEM, V267, P4253, DOI 10.1046/j.1432-1033.2000.01472.x; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HAMM HE, 1994, METHOD ENZYMOL, V237, P423; Hermans E, 2009, Bull Mem Acad R Med Belg, V164, P255; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibrahim BS, 2005, J MOL BIOL, V348, P1191, DOI 10.1016/j.jmb.2005.03.034; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kostenis E, 1997, J BIOL CHEM, V272, P19107, DOI 10.1074/jbc.272.31.19107; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lubecka EA, 2015, EUR BIOPHYS J BIOPHY, V44, P727, DOI 10.1007/s00249-015-1071-4; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; MOUILLAC B, 1995, J BIOL CHEM, V270, P25771, DOI 10.1074/jbc.270.43.25771; Niesen MJM, 2011, J AM CHEM SOC, V133, P13197, DOI 10.1021/ja205313h; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rodrigo J, 2007, MOL ENDOCRINOL, V21, P512, DOI 10.1210/me.2006-0202; Sapay N, 2009, SOFT MATTER, V5, P3295, DOI 10.1039/b902376c; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Slessareva JE, 2003, J BIOL CHEM, V278, P50530, DOI 10.1074/jbc.M304417200; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Yang CS, 1999, J BIOL CHEM, V274, P2379, DOI 10.1074/jbc.274.4.2379; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	54	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17929	17940		10.1074/jbc.M116.735720	http://dx.doi.org/10.1074/jbc.M116.735720			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27330078	Green Published, hybrid			2022-12-28	WOS:000383241300036
J	Basagiannis, D; Christoforidis, S				Basagiannis, Dimitris; Christoforidis, Savvas			Constitutive Endocytosis of VEGFR2 Protects the Receptor against Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR-2; AMYLOID-BETA-PROTEIN; MEDIATED ENDOCYTOSIS; ENDOTHELIAL-CELLS; VASCULAR FUNCTION; EPSIN DEFICIENCY; TUMOR-GROWTH; DYNAMIN; ANGIOGENESIS; TRAFFICKING	VEGFR2 plays a fundamental role in blood vessel formation and in life threatening diseases, such as cancer angiogenesis and cardiovascular disorders. Although inactive growth factor receptors are mainly localized at the plasma membrane, VEGFR2 undergoes constitutive endocytosis (in the absence of ligand) and recycling. Intriguingly, the significance of these futile transport cycles of VEGFR2 remains unclear. Here we found that, unexpectedly, the function of constitutive endocytosis of VEGFR2 is to protect the receptor against plasma membrane cleavage (shedding), thereby preserving the functional state of the receptor until the time of activation by VEGF. Inhibition of constitutive endocytosis of VEGFR2, by interference with the function of clathrin, dynamin, or Rab5, increases dramatically the cleavage/shedding of VEGFR2. Shedding of VEGFR2 produces an N-terminal soluble fragment (100 kDa, s100), which is released in the extracellular space, and a residual C-terminal part (130 kDa, p130) that remains integrated at the plasma membrane. The released soluble fragment (s100) co-immunoprecipitates with VEGF, in line with the topology of the VEGF-binding domain at the N terminus of VEGFR2. Increased shedding of VEGFR2 (via inhibition of constitutive endocytosis) results in reduced response to VEGF, consistently with the loss of the VEGF-binding domain from the membrane remnant of VEGFR2. These data suggest that constitutive internalization of VEGFR2 protects the receptor against shedding and provides evidence for an unprecedented mechanism via which endocytosis can regulate the fate and activity of growth factor receptors.	[Basagiannis, Dimitris; Christoforidis, Savvas] Fdn Res & Technol, Inst Mol Biol & Biotechnol Biomed Res, Ioannina 45110, Greece; [Basagiannis, Dimitris; Christoforidis, Savvas] Univ Ioannina, Sch Hlth Sci, Biol Chem Lab, Dept Med, GR-45110 Ioannina, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Ioannina	Christoforidis, S (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol Biomed Res, Ioannina 45110, Greece.	savvas_christoforidis@imbb.forth.gr		Basagiannis, Dimitris/0000-0002-3932-5051; Christoforidis, Savvas/0000-0002-0210-0713	EMBO Young Investigator Program; Integrated Project "PULMOTENSION" (EU, FP6); Integrated Project "ENDOTRACK" (EU, FP6); European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning"	EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Integrated Project "PULMOTENSION" (EU, FP6); Integrated Project "ENDOTRACK" (EU, FP6); European Union (European Social Fund)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning"	This work was supported by the EMBO Young Investigator Program and the Integrated Projects "PULMOTENSION" and "ENDOTRACK" (EU, FP6), grants "ARISTEIA II" (SecrEndo), Heracleitus II, Synergasia (NOISEPLUS), and KRIPIS, co-funded by the European Union (European Social Fund), and Greek national funds through the Operational Program "Education and Lifelong Learning" (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Bruns AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048539; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Buchanan SM, 2010, P NATL ACAD SCI USA, V107, P17774, DOI 10.1073/pnas.1013105107; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; Domigan CK, 2014, CELL, V159, P473, DOI 10.1016/j.cell.2014.10.008; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Ebos JML, 2004, MOL CANCER RES, V2, P315; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fukuda S, 2012, BIOCHEM BIOPH RES CO, V420, P315, DOI 10.1016/j.bbrc.2012.02.156; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Gonzalez-Jamett Arlek M, 2013, Front Endocrinol (Lausanne), V4, P126, DOI 10.3389/fendo.2013.00126; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; HOPKINS CR, 1985, J CELL SCI, P173; Huang YW, 2009, J BIOL CHEM, V284, P29644, DOI 10.1074/jbc.M109.045682; Hunker CM, 2006, ARCH BIOCHEM BIOPHYS, V449, P130, DOI 10.1016/j.abb.2006.01.020; Ivanov AI, 2014, METHODS MOL BIOL, V1174, P3, DOI 10.1007/978-1-4939-0944-5_1; Ivanov Andrei I, 2008, Methods Mol Biol, V440, pv; Jin YX, 2013, MOL CELL BIOL, V33, P4181, DOI 10.1128/MCB.00650-13; Jopling HM, 2011, BIOCHEM BIOPH RES CO, V410, P170, DOI 10.1016/j.bbrc.2011.04.093; Koch S, 2014, DEV CELL, V28, P633, DOI 10.1016/j.devcel.2014.02.010; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lee MY, 2014, DEVELOPMENT, V141, P1465, DOI 10.1242/dev.104539; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Numrich J, 2014, BIOL CHEM, V395, P327, DOI 10.1515/hsz-2013-0258; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Papanikolaou A, 2011, TRAFFIC, V12, P1148, DOI 10.1111/j.1600-0854.2011.01224.x; Park SY, 2013, ARTERIOSCL THROM VAS, V33, P737, DOI 10.1161/ATVBAHA.112.300386; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pasula S, 2012, J CLIN INVEST, V122, P4424, DOI 10.1172/JCI64537; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Robinson DG, 2014, TRENDS PLANT SCI, V19, P134, DOI 10.1016/j.tplants.2013.10.008; Rodman JS, 2000, J CELL SCI, V113, P183; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Smith GA, 2016, TRAFFIC, V17, P53, DOI 10.1111/tra.12341; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Tessneer KL, 2014, ARTERIOSCL THROM VAS, V34, P331, DOI 10.1161/ATVBAHA.113.302586; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Zografou S, 2012, J CELL SCI, V125, P4780, DOI 10.1242/jcs.104174	70	37	38	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16892	16903		10.1074/jbc.M116.730309	http://dx.doi.org/10.1074/jbc.M116.730309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27298320	hybrid, Green Published			2022-12-28	WOS:000380826700045
J	Hall, G; Cullen, E; Sawmynaden, K; Arnold, J; Fox, S; Cowan, R; Muskett, FW; Matthews, D; Merritt, A; Kettleborough, C; Cruikshank, W; Taylor, D; Bayliss, R; Carr, MD				Hall, Gareth; Cullen, Eilish; Sawmynaden, Kovilen; Arnold, Joanne; Fox, Simon; Cowan, Richard; Muskett, Frederick W.; Matthews, David; Merritt, Andrew; Kettleborough, Catherine; Cruikshank, William; Taylor, Debra; Bayliss, Richard; Carr, Mark D.			Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16) MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE CHEMOATTRACTANT FACTOR; PDZ DOMAIN; BINDING; RECOGNITION; MIGRATION; CELLS; IDENTIFICATION; TRANSFORMATION; ASSOCIATION; ACTIVATION	Interleukin-16 (IL-16) is reported to be a chemoattractant cytokine and modulator of T-cell activation, and has been proposed as a ligand for the co-receptor CD4. The secreted active form of IL-16 has been detected at sites of T(H)1-mediated inflammation, such as those seen in autoimmune diseases, ischemic reperfusion injury (IRI), and tissue transplant rejection. Neutralization of IL-16 recruitment to its receptor, using an anti-IL16 antibody, has been shown to significantly attenuate inflammation and disease pathology in IRI, as well as in some autoimmune diseases. The 14.1 antibody is a monoclonal anti-IL-16 antibody, which when incubated with CD4(+) cells is reported to cause a reduction in the T(H)1-type inflammatory response. Secreted IL-16 contains a characteristic PDZ domain. PDZ domains are typically characterized by a defined globular structure, along with a peptide-binding site located in a groove between the alpha B and beta B structural elements and a highly conserved carboxylate-binding loop. In contrast to other reported PDZ domains, the solution structure previously reported for IL-16 reveals a tryptophan residue obscuring the recognition groove. We have solved the structure of the 14.1Fab fragment in complex with IL-16, revealing that binding of the antibody requires a conformational change in the IL-16 PDZ domain. This involves the rotation of the alpha B-helix, accompanied movement of the peptide groove obscuring tryptophan residue, and consequent opening up of the binding site for interaction. Our study reveals a surprising mechanism of action for the antibody and identifies new opportunities for the development of IL-16-targeted therapeutics, including small molecules that mimic the interaction of the antibody.	[Hall, Gareth; Cowan, Richard; Muskett, Frederick W.; Bayliss, Richard; Carr, Mark D.] Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England; [Cullen, Eilish; Sawmynaden, Kovilen; Arnold, Joanne; Fox, Simon; Matthews, David; Merritt, Andrew; Kettleborough, Catherine; Taylor, Debra] Ctr Therapeut Discovery, MRC Technol, 1-3 Burtonhole Lane,Mill Hill, London NW7 1AD, England; [Cruikshank, William] Boston Univ, Sch Med, Boston, MA 02118 USA	University of Leicester; Boston University	Hall, G; Carr, MD (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.; Matthews, D (corresponding author), Ctr Therapeut Discovery, MRC Technol, 1-3 Burtonhole Lane,Mill Hill, London NW7 1AD, England.	gh126@le.ac.uk; david.matthews@tech.mrc.ac.uk; mdc12@le.ac.uk		Cowan, Richard/0000-0003-0311-9739; Bayliss, Richard/0000-0003-0604-2773; Carr, Mark/0000-0002-3939-0996	MRC [MC_G1000806] Funding Source: UKRI; Medical Research Council [MC_G1000806] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Addis PW, 2014, J BIOL CHEM, V289, P7200, DOI 10.1074/jbc.M113.492215; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; Center DM, 1996, IMMUNOL TODAY, V17, P476, DOI 10.1016/0167-5699(96)10052-I; Conti P, 2002, ALLERGY ASTHMA PROC, V23, P103; CRUIKSHANK W, 1982, J IMMUNOL, V128, P2569; Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467; CRUIKSHANK WW, 1994, P NATL ACAD SCI USA, V91, P5109, DOI 10.1073/pnas.91.11.5109; CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glass WG, 2006, J INTERF CYTOK RES, V26, P511, DOI 10.1089/jir.2006.26.511; Harris BZ, 2001, J CELL SCI, V114, P3219; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Ivanova ME, 2015, ACTA CRYSTALLOGR D, V71, P555, DOI 10.1107/S139900471402776X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Keane J, 1998, J IMMUNOL, V160, P5945; LABERGE S, 1995, J IMMUNOL, V155, P2902; Larsen NA, 2001, J MOL BIOL, V311, P9, DOI 10.1006/jmbi.2001.4839; Lawson ADG, 2012, NAT REV DRUG DISCOV, V11, P519, DOI 10.1038/nrd3756; Lim KG, 1996, J IMMUNOL, V156, P2566; Little FF, 2004, EXPERT OPIN BIOL TH, V4, P837, DOI 10.1517/14712598.4.6.837; Liu Y, 1999, J BIOL CHEM, V274, P23387, DOI 10.1074/jbc.274.33.23387; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lynch EA, 2003, J IMMUNOL, V171, P4965, DOI 10.4049/jimmunol.171.10.4965; Ma JC, 2012, J BIOL CHEM, V287, P33123, DOI 10.1074/jbc.M112.381756; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muhlhahn P, 1998, NAT STRUCT BIOL, V5, P682, DOI 10.1038/1376; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicoll J, 1999, J IMMUNOL, V163, P1827; Richmond J, 2014, J CELL PHYSIOL, V229, P139, DOI 10.1002/jcp.24441; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rumsaeng V, 1997, J IMMUNOL, V159, P2904; Santamaria P, 2003, ADV EXP MED BIOL, V520, P1; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Stoitzner P, 2001, J INVEST DERMATOL, V116, P641, DOI 10.1046/j.1523-1747.2001.01328.x; Wang S, 2008, KIDNEY INT, V73, P318, DOI 10.1038/sj.ki.5002692; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Wilson KC, 2002, BIOCHEMISTRY-US, V41, P14306, DOI 10.1021/bi020163v; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144	46	4	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16840	16848		10.1074/jbc.M115.709303	http://dx.doi.org/10.1074/jbc.M115.709303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27231345	Green Published, hybrid			2022-12-28	WOS:000380826700039
J	Bate, C; Nolan, W; McHale-Owen, H; Williams, A				Bate, Clive; Nolan, William; McHale-Owen, Harriet; Williams, Alun			Sialic Acid within the Glycosylphosphatidylinositol Anchor Targets the Cellular Prion Protein to Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; glycosylphosphatidylinositol (GPI anchor); prion; sialic acid; synapse	LIPID RAFTS; MEMBRANE DOMAINS; (GPI)-ANCHORED PROTEINS; PLASMA-MEMBRANE; SCRAPIE; CELLS; GANGLIOSIDES; CHOLESTEROL; SURFACE; BRAIN	Although the cellular prion protein (PrPC) is concentrated at synapses, the factors that target PrPC to synapses are not understood. Here we demonstrate that exogenous PrPC was rapidly targeted to synapses in recipient neurons derived from Prnp knock-out((0/0)) mice. The targeting of PrPC to synapses was dependent upon both neuronal cholesterol concentrations and the lipid and glycan composition of its glycosylphosphatidylinositol (GPI) anchor. Thus, the removal of either an acyl chain or sialic acid from the GPI anchor reduced the targeting of PrPC to synapses. Isolated GPIs (derived from PrPC) were also targeted to synapses, as was IgG conjugated to these GPIs. The removal of sialic acid from GPIs prevented the targeting of either the isolated GPIs or the IgG-GPI conjugate to synapses. Competition studies showed that pretreatment with sialylated GPIs prevented the targeting of PrPC to synapses. These results are consistent with the hypothesis that the sialylated GPI anchor attached to PrPC acts as a synapse homing signal.	[Bate, Clive; Nolan, William; McHale-Owen, Harriet] Royal Vet Coll, Dept Pathol & Pathogen Biol, Hawkshead Lane, N Mymms AL9 7TA, Herts, England; [Williams, Alun] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 OES, England	University of London; University of London Royal Veterinary College; University of Cambridge	Williams, A (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 OES, England.	aw510@cam.ac.uk			European Commission FP6 "Neuroprion," Network of Excellence	European Commission FP6 "Neuroprion," Network of Excellence	This work was supported by the European Commission FP6 "Neuroprion," Network of Excellence. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Bate C, 2012, J BIOL CHEM, V287, P7935, DOI 10.1074/jbc.M111.275743; Bate C, 2011, J BIOL CHEM, V286, P8752, DOI 10.1074/jbc.M110.186833; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Cancellotti E, 2005, J BIOL CHEM, V280, P42909, DOI 10.1074/jbc.M509557200; Cantu L, 2011, CHEM PHYS LIPIDS, V164, P796, DOI 10.1016/j.chemphyslip.2011.09.005; Chen R, 1998, P NATL ACAD SCI USA, V95, P9512, DOI 10.1073/pnas.95.16.9512; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; CRICK DC, 1995, J NEUROCHEM, V65, P1365; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Galvan C, 2005, MOL CELL NEUROSCI, V30, P304, DOI 10.1016/j.mcn.2005.07.003; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Hering H, 2003, J NEUROSCI, V23, P3262; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Ingham V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-115; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Li RL, 2003, BIOCHEM BIOPH RES CO, V303, P446, DOI 10.1016/S0006-291X(03)00354-1; Lipton AM, 2001, ARCH NEUROL-CHICAGO, V58, P1233, DOI 10.1001/archneur.58.8.1233; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Maglio LE, 2006, BRAIN RES, V1097, P11, DOI 10.1016/j.brainres.2006.04.056; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Ohmi Y, 2012, NEUROCHEM RES, V37, P1185, DOI 10.1007/s11064-012-0764-7; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Premkumar DRD, 2001, J CELL BIOCHEM, V82, P234, DOI 10.1002/jcb.1154; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024624; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Simons M, 1999, MOL BIOL CELL, V10, P3187, DOI 10.1091/mbc.10.10.3187; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	50	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17093	17101		10.1074/jbc.M116.731117	http://dx.doi.org/10.1074/jbc.M116.731117			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325697	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000382643800015
J	Herrendorff, R; Faleschini, MT; Stiefvater, A; Erne, B; Wiktorowicz, T; Kern, F; Hamburger, M; Potterat, O; Kinter, J; Sinnreich, M				Herrendorff, Ruben; Faleschini, Maria Teresa; Stiefvater, Adeline; Erne, Beat; Wiktorowicz, Tatiana; Kern, Frances; Hamburger, Matthias; Potterat, Olivier; Kinter, Jochen; Sinnreich, Michael			Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myotonic dystrophy; natural product; RNA splicing; RNA-protein interaction; trinucleotide repeat disease; MBNL1; alkaloids; non-coding RNA	3 UNTRANSLATED REGION; TRIPLET REPEAT RNA; PRE-MESSENGER-RNA; SMALL MOLECULES; CUG REPEATS; TRINUCLEOTIDE REPEAT; MUSCLEBLIND PROTEINS; CHLORIDE CHANNEL; NATURAL-PRODUCTS; PATHOGENIC RNAS	Myotonic dystrophy type I (DM1) is a disabling neuromuscular disease with no causal treatment available. This disease is caused by expanded CTG trinucleotide repeats in the 3 UTR of the dystrophia myotonica protein kinase gene. On the RNA level, expanded (CUG)(n) repeats form hairpin structures that sequester splicing factors such as muscleblind-like 1 (MBNL1). Lack of available MBNL1 leads to misregulated alternative splicing of many target pre-mRNAs, leading to the multisystemic symptoms in DM1. Many studies aiming to identify small molecules that target the (CUG)(n)-MBNL1 complex focused on synthetic molecules. In an effort to identify new small molecules that liberate sequestered MBNL1 from (CUG)(n) RNA, we focused specifically on small molecules of natural origin. Natural products remain an important source for drugs and play a significant role in providing novel leads and pharmacophores for medicinal chemistry. In a new DM1 mechanism-based biochemical assay, we screened a collection of isolated natural compounds and a library of over 2100 extracts from plants and fungal strains. HPLC-based activity profiling in combination with spectroscopic methods were used to identify the active principles in the extracts. The bioactivity of the identified compounds was investigated in a human cell model and in a mouse model of DM1. We identified several alkaloids, including the -carboline harmine and the isoquinoline berberine, that ameliorated certain aspects of the DM1 pathology in these models. Alkaloids as a compound class may have potential for drug discovery in other RNA-mediated diseases.	[Herrendorff, Ruben; Stiefvater, Adeline; Erne, Beat; Wiktorowicz, Tatiana; Kern, Frances; Kinter, Jochen; Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Res Grp, Dept Neurol, Klingelbergstr 50, CH-4056 Basel, Switzerland; [Herrendorff, Ruben; Stiefvater, Adeline; Erne, Beat; Wiktorowicz, Tatiana; Kern, Frances; Kinter, Jochen; Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Res Grp, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland; [Faleschini, Maria Teresa; Hamburger, Matthias; Potterat, Olivier] Univ Basel, Dept Pharmaceut Sci, Div Pharmaceut Biol, Klingelbergstr 50, CH-4056 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Kinter, J; Sinnreich, M (corresponding author), Univ Basel Hosp, Neuromuscular Res Grp, Dept Neurol, Klingelbergstr 50, CH-4056 Basel, Switzerland.; Kinter, J; Sinnreich, M (corresponding author), Univ Basel Hosp, Neuromuscular Res Grp, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland.	j.kinter@unibas.ch; michael.sinnreich@unibas.ch		Sinnreich, Michael/0000-0002-9835-1276	Neuromuscular Research Association Basel; Swiss National Science Foundation; Myosuisse	Neuromuscular Research Association Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Myosuisse	This work was funded by the Neuromuscular Research Association Basel, Swiss National Science Foundation, and by Myosuisse. The authors declare that they have no conflicts of interest with the contents of this article.	Arambula JF, 2009, P NATL ACAD SCI USA, V106, P16068, DOI 10.1073/pnas.0901824106; Berg J, 2004, NEUROLOGY, V63, P2371, DOI 10.1212/01.WNL.0000148482.40683.88; BROOK, 1992, CELL, V69, P385; Cetinkol OP, 2009, NUCLEIC ACIDS RES, V37, P611, DOI 10.1093/nar/gkn977; Chaouch S, 2009, HUM GENE THER, V20, P784, DOI 10.1089/hum.2008.163; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen CZ, 2012, ANAL BIOANAL CHEM, V402, P1889, DOI 10.1007/s00216-011-5604-0; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P856, DOI 10.1021/cb200408a; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Gareiss PC, 2008, J AM CHEM SOC, V130, P16254, DOI 10.1021/ja804398y; Guan YB, 2001, J TOXICOL ENV HEAL A, V64, P645, DOI 10.1080/152873901753246241; Herraiz T, 2010, FOOD CHEM TOXICOL, V48, P839, DOI 10.1016/j.fct.2009.12.019; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hoskins JW, 2014, NUCLEIC ACIDS RES, V42, P6591, DOI 10.1093/nar/gku275; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Jiang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054234; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Krzyzosiak WJ, 2012, NUCLEIC ACIDS RES, V40, P11, DOI 10.1093/nar/gkr729; Kumar GS, 2012, J BIOSCIENCES, V37, P539, DOI 10.1007/s12038-012-9217-3; Lee JE, 2012, P NATL ACAD SCI USA, V109, P4221, DOI 10.1073/pnas.1117019109; Lee SS, 1999, MED SCI RES, V27, P749; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Nafisi S, 2010, DNA CELL BIOL, V29, P753, DOI 10.1089/dna.2010.1087; Ofori LO, 2012, NUCLEIC ACIDS RES, V40, P6380, DOI 10.1093/nar/gks298; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Potterat O, 2014, PLANTA MED, V80, P1171, DOI 10.1055/s-0034-1382900; Pushechnikov A, 2009, J AM CHEM SOC, V131, P9767, DOI 10.1021/ja9020149; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	45	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17165	17177		10.1074/jbc.M115.710616	http://dx.doi.org/10.1074/jbc.M115.710616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27298317	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000382643800021
J	Liu, HJ; Ooms, LM; Srijakotre, N; Man, J; Vieusseux, J; Waters, JE; Feng, Y; Bailey, CG; Rasko, JEJ; Price, JT; Mitchell, CA				Liu, Heng-Jia; Ooms, Lisa M.; Srijakotre, Nuthasuda; Man, Joey; Vieusseux, Jessica; Waters, JoAnne E.; Feng, Yue; Bailey, Charles G.; Rasko, John E. J.; Price, John T.; Mitchell, Christina A.			PtdIns(3,4,5)P-3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cell migration; cell proliferation; cell signaling; ERK; guanine nucleotide exchange factor (GEF)	CYCLIN D1; FACTOR RECEPTOR; PROTEIN-KINASE; RHO GTPASES; P-REX1; PATHWAY; METASTASIS; INHIBITOR; MIGRATION; IDENTIFICATION	PtdIns(3,4,5)P-3-dependent Rac exchanger 1 (PREX1) is a Rac-guanine nucleotide exchange factor (GEF) overexpressed in a significant proportion of human breast cancers that integrates signals from upstream ErbB2/3 and CXCR4 membrane surface receptors. However, the PREX1 domains that facilitate its oncogenic activity and downstream signaling are not completely understood. We identify that ERK1/2 MAPK acts downstream of PREX1 and contributes to PREX1-mediated anchorage-independent cell growth. PREX1 overexpression increased but its shRNA knockdown decreased ERK1/2 phosphorylation in response to EGF/IGF-1 stimulation, resulting in induction of the cell cycle regulators cyclin D1 and p21(WAF1/CIP1). PREX1-mediated ERK1/2 phosphorylation, anchorage-independent cell growth, and cell migration were suppressed by inhibition of MEK1/2/ERK1/2 signaling. PREX1 overexpression reduced staurosporine-induced apoptosis whereas its shRNA knockdown promoted apoptosis in response to staurosporine or the anti-estrogen drug tamoxifen. Expression of wild-type but not GEF-inactive PREX1 increased anchorage-independent cell growth. In addition, mouse xenograft studies revealed that expression of wild-type but not GEF-dead PREX1 resulted in the formation of larger tumors that displayed increased phosphorylation of ERK1/2 but not AKT. The impaired anchorage-independent cell growth, apoptosis, and ERK1/2 signaling observed in stable PREX1 knockdown cells was restored by expression of wild-type but not GEF-dead-PREX1. Therefore, PREX1-Rac-GEF activity is critical for PREX1-dependent anchorage-independent cell growth and xenograft tumor growth and may represent a possible therapeutic target for breast cancers that exhibit PREX1 overexpression.	[Liu, Heng-Jia; Ooms, Lisa M.; Srijakotre, Nuthasuda; Man, Joey; Vieusseux, Jessica; Waters, JoAnne E.; Rasko, John E. J.; Price, John T.; Mitchell, Christina A.] Monash Univ, Canc Program, Monash Biomed Discovery Inst, 23 Innovat Walk, Clayton, Vic 3800, Australia; [Liu, Heng-Jia; Ooms, Lisa M.; Srijakotre, Nuthasuda; Man, Joey; Vieusseux, Jessica; Waters, JoAnne E.; Rasko, John E. J.; Price, John T.; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, 23 Innovat Walk, Clayton, Vic 3800, Australia; [Feng, Yue; Bailey, Charles G.] Centenary Inst Canc Med & Cell Biol, Camperdown, NSW 2050, Australia; [Bailey, Charles G.; Rasko, John E. J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Rasko, John E. J.] Royal Prince Alfred Hosp, Cell & Mol Therapies, Camperdown, NSW 2050, Australia; [Price, John T.] Victoria Univ, Ctr Chron Dis, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia	Monash University; Monash University; University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Victoria University	Mitchell, CA (corresponding author), Monash Univ, Canc Program, Monash Biomed Discovery Inst, 23 Innovat Walk, Clayton, Vic 3800, Australia.; Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, 23 Innovat Walk, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Ooms, Lisa/AGZ-7420-2022	Mitchell, Christina A/0000-0001-9372-3192; Price, John/0000-0002-8244-1023; Ooms, Lisa Michelle/0000-0002-8918-9932; rasko, John/0000-0003-2975-807X; Bailey, Charles/0000-0002-4725-7829	National Health and Medical Research Council [APP1044737]; Tour de Cure	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Tour de Cure	This work was supported by a grant from the National Health and Medical Research Council (APP1044737) and a fellowship and research grant from Tour de Cure (to C. G. B. and J. E. J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Ajabnoor GMA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.139; Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Asimakopoulos FA, 1996, BRIT J HAEMATOL, V95, P219; Barrio-Real L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003543; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; Campbell AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053982; Dillon LM, 2015, ONCOGENE, V34, P3968, DOI 10.1038/onc.2014.328; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Larramendy ML, 2000, CANCER GENET CYTOGEN, V119, P132, DOI 10.1016/S0165-4608(99)00226-5; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lawson CD, 2011, J IMMUNOL, V186, P1467, DOI 10.4049/jimmunol.1002738; Lewis-Saravalli S, 2013, CELL SIGNAL, V25, P1813, DOI 10.1016/j.cellsig.2013.05.011; Lindsay CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1560; Liu Y, 1996, CANCER RES, V56, P31; Lucato CM, 2015, J BIOL CHEM, V290, P20827, DOI 10.1074/jbc.M115.660456; Manns J, 2011, FASEB J, V25, P3250, DOI 10.1096/fj.10-177527; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Morimura S., 2011, INT J CELL BIOL, V2011; Ooms LM, 2015, CANCER CELL, V28, P155, DOI 10.1016/j.ccell.2015.07.003; Orgaz Jose L, 2014, Small GTPases, V5, pe29019, DOI 10.4161/sgtp.29019; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rynkiewicz Natalie K, 2012, Adv Biol Regul, V52, P265; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Stumpf E, 2000, GENE CHROMOSOME CANC, V29, P83, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1011>3.0.CO;2-Z; Thompson DS, 2009, J CLIN ONCOL, V27; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang C, 2008, BIOCHEM J, V410, P167, DOI 10.1042/BJ20070781; Zezula J, 1997, J BIOL CHEM, V272, P29967, DOI 10.1074/jbc.272.47.29967	51	14	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17258	17270		10.1074/jbc.M116.743401	http://dx.doi.org/10.1074/jbc.M116.743401			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27358402	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000382643800027
J	Abe, M; Hasegawa, Y; Oku, M; Sawada, Y; Tanaka, E; Sakai, Y; Miyoshi, H				Abe, Masato; Hasegawa, Yui; Oku, Masahide; Sawada, Yoshiki; Tanaka, Eriko; Sakai, Yasuyoshi; Miyoshi, Hideto			Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BARTH-SYNDROME; CYTOCHROME-C; YEAST; GENE; TRANSACYLATION; PHOSPHOLIPIDS; PHOSPHATASE; MEMBRANES; SYNTHASE	Remodeling of the acyl chains of cardiolipin (CL) is responsible for final molecular composition of mature CL after de novo CL synthesis in mitochondria. Yeast Saccharomyces cerevisiae undergoes tafazzin-mediated CL remodeling, in which tafazzin serves as a transacylase from phospholipids to monolyso-CL (MLCL). In light of the diversity of the acyl compositions of mature CL between different organisms, the mechanism underlying tafazzin-mediated transacylation remains to be elucidated. We investigated the mechanism responsible for transacylation using purified S. cerevisiae tafazzin with liposomes composed of various sets of acyl donors and acceptors. The results revealed that tafazzin efficiently catalyzes transacylation in liposomal membranes with highly ordered lipid bilayer structure. Tafazzin elicited unique acyl chain specificity against phosphatidylcholine (PC) as follows: linoleoyl (18:2) > oleoyl (18:1) = palmitoleoyl (16:1) >> palmitoyl (16:0). In these reactions, tafazzin selectively removed the sn-2 acyl chain of PC and transferred it into the sn-1 and sn-2 positions of MLCL isomers at equivalent rates. We demonstrated for the first time that MLCL and dilyso-CL have inherent abilities to function as an acyl donor to monolyso-PC and acyl acceptor from PC, respectively. Furthermore, a Barth syndrome-associated tafazzin mutant (H77Q) was shown to completely lack the catalytic activity in our assay. It is difficult to reconcile the present results with the so-called thermodynamic remodeling hypothesis, which premises that tafazzin reacylates MLCL by unsaturated acyl chains only in disordered non-bilayer lipid domain. The acyl specificity of tafazzin may be one of the factors that determine the acyl composition of mature CLin S. cerevisiae mitochondria.	[Abe, Masato; Hasegawa, Yui; Oku, Masahide; Sawada, Yoshiki; Tanaka, Eriko; Sakai, Yasuyoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Miyoshi, H (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	miyoshi@kais.kyoto-u.ac.jp	Oku, Masahide/AAW-4752-2021; Oku, Masahide/R-9389-2019	Oku, Masahide/0000-0001-5991-6281; Oku, Masahide/0000-0001-5991-6281	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [16K07689] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Kyoto University Nano Technology Hub in the "Nanotechnology Platform Project," which is sponsored by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, for allowing us access to the dynamic light scattering particle-size analyzer (ELSZ-2Plus, Otsuka Electronic).	Abe M, 2015, TETRAHEDRON LETT, V56, P2258, DOI 10.1016/j.tetlet.2015.03.056; Abe M, 2011, BIOCHEMISTRY-US, V50, P8383, DOI 10.1021/bi2010202; Abe M, 2010, TETRAHEDRON LETT, V51, P2071, DOI 10.1016/j.tetlet.2010.02.071; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Butterworth PJ, 2012, CARBOHYD POLYM, V87, P2189, DOI 10.1016/j.carbpol.2011.10.048; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Epand RM, 2015, BBA-BIOMEMBRANES, V1848, P220, DOI 10.1016/j.bbamem.2014.05.004; Gallet PF, 1997, BIOCHEM J, V324, P627, DOI 10.1042/bj3240627; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Hatch GM, 2004, BIOCHEM CELL BIOL, V82, P99, DOI 10.1139/o03-074; Jiang GW, 2006, J ORG CHEM, V71, P934, DOI 10.1021/jo051894e; KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Lu YW, 2016, HUM MOL GENET, V25, P1754, DOI 10.1093/hmg/ddw046; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; Minkler PE, 2010, J LIPID RES, V51, P856, DOI 10.1194/jlr.D002857; Nakano M, 2009, J PHYS CHEM B, V113, P6745, DOI 10.1021/jp900913w; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Oswald M, 2016, INT J PHARMACEUT, V497, P293, DOI 10.1016/j.ijpharm.2015.11.014; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Rosseto R, 2007, J ORG CHEM, V72, P1691, DOI 10.1021/jo062352f; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shintou K, 2007, BIOPHYS J, V93, P3900, DOI 10.1529/biophysj.107.108399; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yamashita S, 2014, LIPIDS, V49, P1261, DOI 10.1007/s11745-014-3957-9; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	50	23	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15491	15502		10.1074/jbc.M116.718510	http://dx.doi.org/10.1074/jbc.M116.718510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27268057	Green Published, hybrid			2022-12-28	WOS:000380584200007
J	Abeykoon, AH; Noinaj, N; Choi, BE; Wise, L; He, Y; Chao, CC; Wang, GH; Gucek, M; Ching, WM; Chock, PB; Buchanan, SK; Yang, DCH				Abeykoon, Amila H.; Noinaj, Nicholas; Choi, Bok-Eum; Wise, Lindsay; He, Yi; Chao, Chien-Chung; Wang, Guanghui; Gucek, Marjan; Ching, Wei-Mei; Chock, P. Boon; Buchanan, Susan K.; Yang, David C. H.			Structural Insights into Substrate Recognition and Catalysis in Outer Membrane Protein B (OmpB) by Protein-lysine Methyltransferases from Rickettsia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; cell surface protein; enzyme catalysis; enzyme structure; protein methylation; virulence factor	HISTONE METHYLTRANSFERASE; PRODUCT SPECIFICITY; FUNCTIONAL-ANALYSIS; PROWAZEKII STRAINS; CHAPERONE DNAK; METHYLATION; DOMAIN; ROMPB; TYPHI; VIRULENCE	Rickettsia belong to a family of Gram-negative obligate intracellular infectious bacteria that are the causative agents of typhus and spotted fever. Outer membrane protein B (OmpB) occurs in all rickettsial species, serves as a protective envelope, mediates host cell adhesion and invasion, and is a major immunodominant antigen. OmpBs from virulent strains contain multiple trimethylated lysine residues, whereas the avirulent strain contains mainly monomethyllysine. Two protein-lysine methyltransferases (PKMTs) that catalyze methylation of recombinant OmpB at multiple sites with varying sequences have been identified and overexpressed. PKMT1 catalyzes predominantly monomethylation, whereas PKMT2 catalyzes mainly trimethylation. Rickettsial PKMT1 and PKMT2 are unusual in that their primary substrate appears to be limited to OmpB, and both are capable of methylating multiple lysyl residues with broad sequence specificity. Here we report the crystal structures of PKMT1 from Rickettsia prowazekii and PKMT2 from Rickettsia typhi, both the apo form and in complex with its cofactor S-adenosylmethionine or S-adenosylhomocysteine. The structure of PKMT1 in complex with S-adenosylhomocysteine is solved to a resolution of 1.9 . Both enzymes are dimeric with each monomer containing an S-adenosylmethionine binding domain with a core Rossmann fold, a dimerization domain, a middle domain, a C-terminal domain, and a centrally located open cavity. Based on the crystal structures, residues involved in catalysis, cofactor binding, and substrate interactions were examined using site-directed mutagenesis followed by steady state kinetic analysis to ascertain their catalytic functions in solution. Together, our data reveal new structural and mechanistic insights into how rickettsial methyltransferases catalyze OmpB methylation.	[Abeykoon, Amila H.; Choi, Bok-Eum; Wise, Lindsay; Yang, David C. H.] Georgetown Univ, Dept Chem, Washington, DC 20057 USA; [Noinaj, Nicholas] Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA; [Wang, Guanghui; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA; [Buchanan, Susan K.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Chao, Chien-Chung; Ching, Wei-Mei] Naval Med Res Ctr, Infect Dis Directorate, Viral & Rickettsial Dis Dept, Silver Spring, MD 20910 USA	Georgetown University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Naval Medical Research Center (NMRC)	Yang, DCH (corresponding author), Georgetown Univ, Dept Chem, Washington, DC 20057 USA.; Noinaj, N (corresponding author), Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.	nnoinaj@purdue.edu; yangdc@georgetown.edu	He, Yi/AAL-5658-2020		United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005903, ZIAHL000202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI113078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK011011] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) beamline 22-ID and the General Medicine Sciences and National Cancer Institute Collaborative Access Team (GM/CA-CAT) beamline 23-ID at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567; Abeykoon AH, 2012, J BACTERIOL, V194, P6410, DOI 10.1128/JB.01379-12; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AMBLER RP, 1959, NATURE, V184, P56, DOI 10.1038/184056b0; An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Cardwell MM, 2009, INFECT IMMUN, V77, P5272, DOI 10.1128/IAI.00201-09; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chao CC, 2008, CLIN VACCINE IMMUNOL, V15, P684, DOI 10.1128/CVI.00281-07; Chao CC, 2007, BBA-PROTEINS PROTEOM, V1774, P373, DOI 10.1016/j.bbapap.2007.01.001; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Ching W.M., 1993, TECHNIQUES PROTEIN C, P307; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; DASCH GA, 1981, J CLIN MICROBIOL, V14, P333, DOI 10.1128/JCM.14.3.333-341.1981; DASCH GA, 1981, INFECT IMMUN, V31, P276, DOI 10.1128/IAI.31.1.276-288.1981; Demirci H, 2007, EMBO J, V26, P567, DOI 10.1038/sj.emboj.7601508; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GILMORE RD, 1991, MOL MICROBIOL, V5, P2361, DOI 10.1111/j.1365-2958.1991.tb02082.x; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Jiang YY, 2014, J MOL BIOL, V426, P3413, DOI 10.1016/j.jmb.2014.02.019; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Niu YL, 2013, J BIOL CHEM, V288, P13728, DOI 10.1074/jbc.M113.452979; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROBERTS DM, 1986, J BIOL CHEM, V261, P1491; RODIONOV AV, 1991, ACTA VIROL, V35, P557; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; TURCO J, 1994, INFECT IMMUN, V62, P3172, DOI 10.1128/IAI.62.8.3172-3177.1994; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu WY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2304; Zahn M, 2013, J MOL BIOL, V425, P2463, DOI 10.1016/j.jmb.2013.03.041; Zhang JZ, 2006, VACCINE, V24, P2317, DOI 10.1016/j.vaccine.2005.11.044; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	49	10	10	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19962	19974		10.1074/jbc.M116.723460	http://dx.doi.org/10.1074/jbc.M116.723460			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27474738	Green Published, hybrid			2022-12-28	WOS:000383243100020
J	Koh, HB; Scruggs, AM; Huang, SK				Koh, Hailey B.; Scruggs, Anne M.; Huang, Steven K.			Transforming Growth Factor-1 Increases DNA Methyltransferase 1 and 3a Expression through Distinct Post-transcriptional Mechanisms in Lung Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; DNA methylation; DNA methyltransferase; fibroblast; glycogen synthase kinase 3 (GSK-3); mammalian target of rapamycin (mTOR); transforming growth factor beta (TGF-B); ubiquitylation (ubiquitination); DNMT1; DNMT3a	INDUCED PULMONARY-FIBROSIS; FOCAL ADHESION KINASE; ZINC-FINGER PROTEINS; BETA TGF-BETA; PROSTAGLANDIN E-2; MYOFIBROBLAST DIFFERENTIATION; TUMOR-SUPPRESSOR; DNMT1 STABILITY; BREAST-CANCER; T-CELLS	DNA methylation is a fundamental epigenetic mark that plays a critical role in differentiation and is mediated by the actions of DNA methyltransferases (DNMTs). TGF-1 is one of the most potent inducers of fibroblast differentiation, and although many of its actions on fibroblasts are well described, the ability of TGF-1 to modulate DNA methylation in mesenchymal cells is less clear. Here, we examine the ability of TGF-1 to modulate the expression of various DNMTs in primary lung fibroblasts (CCL210). TGF-1 increased the protein expression, but not RNA levels, of both DNMT1 and DNMT3a. The increases in DNMT1 and DNMT3a were dependent on TGF-1 activation of focal adhesion kinase and PI3K/Akt. Activation of mammalian target of rapamycin complex 1 by Akt resulted in increased protein translation of DNMT3a. In contrast, the increase in DNMT1 by TGF-1 was not dependent on new protein synthesis and instead was due to decreased protein degradation. TGF-1 treatment led to the phosphorylation and inactivation of glycogen synthase kinase-3, which resulted in inhibition of DNMT1 ubiquitination and proteosomal degradation. The phosphorylation and inactivation of glycogen synthase kinase-3 was dependent on mammalian target of rapamycin complex 1. These results demonstrate that TGF-1 increases expression of DNMT1 and DNMT3a through different post-transcriptional mechanisms. Because DNA methylation is critical to many processes including development and differentiation, for which TGF-1 is known to be crucial, the ability of TGF-1 to increase expression of both DNMT1 and DNMT3a demonstrates a novel means by which TGF-1 may regulate DNA methylation in these cells.	[Koh, Hailey B.; Scruggs, Anne M.; Huang, Steven K.] Univ Michigan, Div Pulm & Crit Care Med, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Huang, SK (corresponding author), 6301 MSRB IIII,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	stehuang@umich.edu			NHLBI, National Institutes of Health [HL119289, HL127203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127203, R56HL119289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by Grants HL119289 and HL127203 from the NHLBI, National Institutes of Health (to S. K. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agoston AT, 2005, J BIOL CHEM, V280, P18302, DOI 10.1074/jbc.M501675200; Aschner Y, 2016, AM J RESP CELL MOL, V54, P647, DOI 10.1165/rcmb.2015-0391TR; Azizi M, 2014, CANCER BIOL THER, V15, P419, DOI 10.4161/cbt.27630; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Chen TL, 2013, INHAL TOXICOL, V25, P525, DOI 10.3109/08958378.2013.809393; De Marzo AM, 1999, CANCER RES, V59, P3855; Diaz A, 1998, EXP CELL RES, V241, P222, DOI 10.1006/excr.1998.4050; Domingo-Gonzalez R, 2015, AM J PHYSIOL-LUNG C, V308, pL86, DOI 10.1152/ajplung.00283.2014; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Garrison G, 2013, AM J RESP CELL MOL, V48, P550, DOI 10.1165/rcmb.2012-0262OC; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Harding P, 2006, KIDNEY INT, V69, P1578, DOI 10.1038/sj.ki.5000323; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107055; Huang SK, 2012, FASEB J, V26, P3703, DOI 10.1096/fj.11-203323; Huang SK, 2010, AM J PATHOL, V177, P2245, DOI 10.2353/ajpath.2010.100446; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Jinawath A, 2005, BIOCHEM J, V385, P557, DOI 10.1042/BJ20040684; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Kimura H, 2003, NUCLEIC ACIDS RES, V31, P3101, DOI 10.1093/nar/gkg406; Kishikawa S, 2002, EUR J BIOCHEM, V269, P2961, DOI 10.1046/j.1432-1033.2002.02972.x; Lang UE, 2013, ONCOGENE, V32, P4557, DOI 10.1038/onc.2012.457; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li CR, 2013, J BIOL CHEM, V288, P19127, DOI 10.1074/jbc.M113.453357; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li M, 2011, J CLIN INVEST, V121, P277, DOI 10.1172/JCI42090; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li YP, 2010, EXP GERONTOL, V45, P312, DOI 10.1016/j.exger.2009.12.008; Lin RK, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-46; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Martin M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-435; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Neveu WA, 2015, AM J PHYSIOL-CELL PH, V309, pC616, DOI 10.1152/ajpcell.00086.2015; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pathania R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7910; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Shamma A, 2013, MOL CELL BIOL, V33, P3113, DOI 10.1128/MCB.01597-12; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soltani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039736; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; SZYF M, 1991, J BIOL CHEM, V266, P10027; Tabish AM, 2015, METHODS MOL BIOL, V1315, P201, DOI 10.1007/978-1-4939-2715-9_15; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Wettlaufer SH, 2016, AM J RESP CELL MOL, V54, P114, DOI 10.1165/rcmb.2014-0468OC; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Zhang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025168; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330	70	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19287	19298		10.1074/jbc.M116.723080	http://dx.doi.org/10.1074/jbc.M116.723080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27405758	Green Published, hybrid			2022-12-28	WOS:000383242800010
J	Yigit, S; Yu, HT; An, B; Hamaia, S; Farndale, RW; Kaplan, DL; Lin, YS; Brodsky, B				Yigit, Sezin; Yu, Hongtao; An, Bo; Hamaia, Samir; Farndale, Richard W.; Kaplan, David L.; Lin, Yu-Shan; Brodsky, Barbara			Mapping the Effect of Gly Mutations in Collagen on alpha 2 beta 1 Integrin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENESIS IMPERFECTA; TRIPLE-HELIX; PRO-ALPHA-1(I) CHAIN; MOLECULAR-STRUCTURE; I COLLAGEN; SUBSTITUTION; RECOGNITION; DOMAINS; SITES; MODEL	The replacement of one Gly in the essential repeating tripeptide sequence of the type I collagen triple helix results in the dominant hereditary bone disorder osteogenesis imperfecta. The mechanism leading to pathology likely involves misfolding and autophagy, although it has been hypothesized that some mutations interfere with known collagen interactions. Here, the effect of Gly replacements within and nearby the integrin binding GFPGER sequence was investigated using a recombinant bacterial collagen system. When a six-triplet human type I collagen sequence containing GFPGER was introduced into a bacterial collagen-like protein, this chimeric protein bound to integrin. Constructs with Gly to Ser substitutions within and nearby the inserted human sequence still formed a trypsin-resistant triple helix, suggesting a small local conformational perturbation. Gly to Ser mutations within the two Gly residues in the essential GFPGER sequence prevented integrin binding and cell attachment as predicted from molecular dynamics studies of the complex. Replacement of Gly residues C-terminal to GFPGER did not affect integrin binding. In contrast, Gly replacements N-terminal to the GFPGER sequence, up to four triplets away, decreased integrin binding and cell adhesion. This pattern suggests either an involvement of the triplets N-terminal to GFPGER in initial binding or a propagation of the perturbation of the triple helix C-terminal to a mutation site. The asymmetry in biological consequences relative to the mutation site may relate to the observed pattern of osteogenesis imperfecta mutations near the integrin binding site.	[Yigit, Sezin; Yu, Hongtao; An, Bo; Kaplan, David L.; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Yigit, Sezin; Yu, Hongtao; Lin, Yu-Shan] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Hamaia, Samir; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England	Tufts University; Tufts University; University of Cambridge	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.; Lin, YS (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	Yu-Shan.Lin@tufts.edu; Barbara.Brodsky@tufts.edu	Lin, Yu-Shan/E-2198-2013; Yu, Hongtao/D-2277-2014	Lin, Yu-Shan/0000-0001-6460-2877; Yu, Hongtao/0000-0003-4818-872X	National Institutes of Health [EB011620, GM60048]; British Heart Foundation [RG/15/4/31268, PG/10/011/28199]; Tufts start-up fund; Knez Family Faculty Investment Fund; MRC [G0500707] Funding Source: UKRI; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0500707] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Tufts start-up fund; Knez Family Faculty Investment Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants EB011620 (to B.B. and D.L.K.) and GM60048 (to B.B.), by British Heart Foundation Grants RG/15/4/31268 and PG/10/011/28199 (to R. W. F. and S. H.), and by a Tufts start-up fund and the Knez Family Faculty Investment Fund (to Y.-S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen M. P., 1989, COMPUTER SIMULATION, P64; An B, 2016, J BIOL CHEM, V291, P4343, DOI 10.1074/jbc.M115.674507; An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808; An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Carafoli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069833; Chan SWP, 2010, BIOMACROMOLECULES, V11, P1460, DOI 10.1021/bm100052y; Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Hamaia S, 2014, ADV EXP MED BIOL, V819, P127, DOI 10.1007/978-94-017-9153-3_9; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Li YJ, 2009, J BIOL CHEM, V284, P20660, DOI 10.1074/jbc.M109.018077; LIGHTFOOT SJ, 1994, J BIOL CHEM, V269, P30352; LIGHTFOOT SJ, 1992, J BIOL CHEM, V267, P25521; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mirigian LS, 2016, J BONE MINER RES, V31, P1608, DOI 10.1002/jbmr.2824; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Peng YY, 2014, J BIOMED MATER RES A, V102, P2189, DOI 10.1002/jbm.a.34898; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Que RA, 2015, BIOMATERIALS, V53, P309, DOI 10.1016/j.biomaterials.2015.02.074; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; Rainey JK, 2004, BIOINFORMATICS, V20, P2458, DOI 10.1093/bioinformatics/bth247; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; STOSS H, 1993, AM J MED GENET, V45, P257, DOI 10.1002/ajmg.1320450220; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; TANGEMANN K, 1995, FEBS LETT, V358, P179, DOI 10.1016/0014-5793(94)01411-S; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979	52	17	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19196	19207		10.1074/jbc.M116.726182	http://dx.doi.org/10.1074/jbc.M116.726182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432884	hybrid, Green Published			2022-12-28	WOS:000383242300050
J	Kuboyama, K; Fujikawa, A; Suzuki, R; Tanga, N; Noda, M				Kuboyama, Kazuya; Fujikawa, Akihiro; Suzuki, Ryoko; Tanga, Naomi; Noda, Masaharu			Role of Chondroitin Sulfate ( CS) Modification in the Regulation of Protein-tyrosine Phosphatase Receptor Type Z (PTPRZ) Activity PLEIOTROPHIN-PTPRZ-A SIGNALING IS INVOLVED IN OLIGODENDROCYTE DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondroitin sulfate; oligodendrocyte; phosphotyrosine signaling; pleiotrophin; proteoglycan	BINDING GROWTH-FACTOR; MYELIN BASIC-PROTEIN; SUBSTRATE-TRAPPING SYSTEM; CENTRAL-NERVOUS-SYSTEM; ZETA RPTP-BETA; ZETA/RPTP-BETA; 6B4 PROTEOGLYCAN/PHOSPHACAN; DEVELOPMENTAL EXPRESSION; EXTRACELLULAR VARIANT; MULTIPLE-SCLEROSIS	Protein-tyrosine phosphatase receptor type Z (PTPRZ) is predominantly expressed in the developing brain as a CS proteoglycan. PTPRZ has long (PTPRZ-A) and short type (PTPRZ-B) receptor forms by alternative splicing. The extracellular CS moiety of PTPRZ is required for high-affinity binding to inhibitory ligands, such as pleiotrophin (PTN), midkine, and interleukin-34; however, its functional significance in regulating PTPRZ activity remains obscure. We herein found that protein expression of CS-modified PTPRZ-A began earlier, peaking at approximately postnatal days 5-10 (P5-P10), and then that of PTN peaked at P10 at the developmental stage corresponding to myelination onset in the mouse brain. Ptn-deficient mice consistently showed a later onset of the expression of myelin basic protein, a major component of the myelin sheath, than wild-type mice. Upon ligand application, PTPRZ-A/B in cultured oligodendrocyte precursor cells exhibited punctate localization on the cell surface instead of diffuse distribution, causing the inactivation of PTPRZ and oligodendrocyte differentiation. The same effect was observed with the removal of CS chains with chondroitinase ABC but not polyclonal antibodies against the extracellular domain of PTPRZ. These results indicate that the negatively charged CS moiety prevents PTPRZ from spontaneously clustering and that the positively charged ligand PTN induces PTPRZ clustering, potentially by neutralizing electrostatic repulsion between CS chains. Taken altogether, these data indicate that PTN-PTPRZ-A signaling controls the timing of oligodendrocyte precursor cell differentiation in vivo, in which the CS moiety of PTPRZ receptors maintains them in a monomeric active state until its ligand binding.	[Kuboyama, Kazuya; Fujikawa, Akihiro; Suzuki, Ryoko; Tanga, Naomi; Noda, Masaharu] NIBB, Div Mol Neurobiol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Tanga, Naomi; Noda, Masaharu] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), NIBB, Div Mol Neurobiol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp		Kuboyama, Kazuya/0000-0002-9878-1209	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP26830050]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [JP26110722]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Young Scientists (B) (Japan Society for the Promotion of Science (JSPS) KAKENHI Grant JP26830050 (to K. K.)) and for Scientific Research on Innovative Areas (Grant JP26110722 (to A. F.)) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). The authors declare that they have no conflicts of interest with the contents of this article.	Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Buffo A, 2013, PROG NEUROBIOL, V109, P42, DOI 10.1016/j.pneurobio.2013.08.001; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Chow JPH, 2008, NEUROSCI LETT, V442, P208, DOI 10.1016/j.neulet.2008.07.028; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fox IJ, 2004, DEV BRAIN RES, V153, P121, DOI 10.1016/j.devbrainres.2004.07.011; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fujikawa A, 2016, NEURAL REGEN RES, V11, P549, DOI 10.4103/1673-5374.180761; Fujikawa A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20473; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Gottle P, 2015, INT J MOL SCI, V16, P15057, DOI 10.3390/ijms160715057; Iwasaki W, 1997, EMBO J, V16, P6936, DOI 10.1093/emboj/16.23.6936; Karus M, 2016, GLIA, V64, P270, DOI 10.1002/glia.22928; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; Kuboyama K, 2015, J NEUROSCI, V35, P12162, DOI 10.1523/JNEUROSCI.2127-15.2015; Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lau LW, 2012, ANN NEUROL, V72, P419, DOI 10.1002/ana.23599; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Muramatsu H, 2006, GENES CELLS, V11, P1405, DOI 10.1111/j.1365-2443.2006.01028.x; Murasugi A, 2003, BIOSCI BIOTECH BIOCH, V67, P2288, DOI 10.1271/bbb.67.2288; Nandi S, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.442731; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; Ranjan M, 1996, MOL CELL NEUROSCI, V7, P404, DOI 10.1006/mcne.1996.0029; Ryan E, 2016, FEBS J, V283, P1488, DOI 10.1111/febs.13686; Sattelle BM, 2015, BIOMACROMOLECULES, V16, P951, DOI 10.1021/bm5018386; Seiwa C, 2000, NEUROSCI RES, V37, P21, DOI 10.1016/S0168-0102(00)00100-0; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Sim FJ, 2006, ANN NEUROL, V59, P990, DOI 10.1002/ana.20907; Solera C, 2016, CHEM-EUR J, V22, P2356, DOI 10.1002/chem.201504440; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Umemori H, 1999, J NEUROSCI, V19, P1393; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; WANAKA A, 1993, DEV BRAIN RES, V72, P133, DOI 10.1016/0165-3806(93)90166-8; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Xu CY, 2014, BIOL PHARM BULL, V37, P511, DOI 10.1248/bpb.b13-00845	56	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18117	18128		10.1074/jbc.M116.742536	http://dx.doi.org/10.1074/jbc.M116.742536			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27445335	hybrid, Green Published			2022-12-28	WOS:000383241800006
J	Li, K; Xiao, YZ; Yu, JJ; Xia, TT; Liu, B; Guo, YJ; Deng, JL; Chen, SH; Wang, CX; Guo, FF				Li, Kai; Xiao, Yuzhong; Yu, Junjie; Xia, Tingting; Liu, Bin; Guo, Yajie; Deng, Jiali; Chen, Shanghai; Wang, Chunxia; Guo, Feifan			Liver-specific Gene Inactivation of the Transcription Factor ATF4 Alleviates Alcoholic Liver Steatosis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); fatty acid synthase (FAS); lipid; liver injury; liver metabolism; ATF4; Alcoholic liver steatosis; CPT1; TRB3	ACTIVATED PROTEIN-KINASE; HEPATIC INSULIN-RESISTANCE; FATTY LIVER; DEFICIENCY PROTECTS; SIGNALING PATHWAY; OXIDATIVE STRESS; TRIBBLES HOMOLOG; ETHANOL; TRB3; BINDING	Although numerous biological functions of the activating transcription factor 4 (ATF4) have been identified, a direct effect of ATF4 on alcoholic liver steatosis has not been described previously. The aim of our current study is to investigate the role of ATF4 in alcoholic liver steatosis and elucidate the underlying mechanisms. Here, we showed that the expression of ATF4 is induced by ethanol in hepatocytes in vitro and in vivo, and liver-specific ATF4 knock-out mice are resistant to ethanol-induced liver steatosis, associated with stimulated hepatic AMP-activated protein kinase (AMPK) activity. Furthermore, adenovirus-mediated AMPK knockdown significantly reversed the suppressive effects of ATF4 deficiency on ethanol-induced liver steatosis in mice. In addition, ethanol-fed ATF4 knock-out mice exhibit AMPK-dependent inhibition of fatty acid synthase and stimulation of carnitine palmitoyltransferase 1 (CPT1) in the liver. Moreover, hepatic Tribbles homolog 3 (TRB3) expression was stimulated by ethanol in an ATF4-dependent manner, and adenovirus-mediated TRB3 knockdown blocked ATF4-dependent ethanol-induced AMPK inhibition and triglyceride accumulation in AML-12 cells. Finally, TRB3 directly interacted with AMPK to suppress its phosphorylation. Taken together, these results identify the ATF4-TRB3-AMPK axis as a novel pathway responsible for ethanol-induced liver steatosis.	[Li, Kai; Xiao, Yuzhong; Yu, Junjie; Xia, Tingting; Liu, Bin; Guo, Yajie; Deng, Jiali; Chen, Shanghai; Wang, Chunxia; Guo, Feifan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Key Lab Nutr & Metab,Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, CX; Guo, FF (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Key Lab Nutr & Metab,Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	wangcx@sibs.ac.cn; ffguo@sibs.ac.cn		Li, Kai/0000-0002-4040-8604	National Natural Science Foundation [81130076, 81325005, 31271269, 81100615, 81390350, 81300659, 81471076]; Basic Research Project of Shanghai Science and Technology Commission [13JC1409000]; International S&T Cooperation Program of China (Singapore) [2014DFG32470]; CAS/SAFEA international partnership program for creative research teams; One Hundred Talents Program of the Chinese Academy of Sciences	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; International S&T Cooperation Program of China (Singapore); CAS/SAFEA international partnership program for creative research teams(Chinese Academy of Sciences); One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation Grants 81130076, 81325005, 31271269, 81100615, 81390350, 81300659, and 81471076; Basic Research Project of Shanghai Science and Technology Commission Grant 13JC1409000; International S&T Cooperation Program of China (Singapore Grant 2014DFG32470); and the CAS/SAFEA international partnership program for creative research teams. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the One Hundred Talents Program of the Chinese Academy of Sciences. To whom correspondence may be addressed. Tel.: 86-21-54920945; Fax: 86-21-54920291; E-mail: ffguo@sibs.ac.cn.	Bergheim I, 2006, GASTROENTEROLOGY, V130, P2099, DOI 10.1053/j.gastro.2006.03.020; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bi LJ, 2015, ALCOHOL ALCOHOLISM, V50, P146, DOI 10.1093/alcalc/agu102; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Chen G, 2008, J NEUROSCI RES, V86, P937, DOI 10.1002/jnr.21540; Chen YP, 2013, CELL PHYSIOL BIOCHEM, V32, P743, DOI 10.1159/000354476; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Villafranca J, 2008, BIOCHIMIE, V90, P460, DOI 10.1016/j.biochi.2007.09.019; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708; Ji C, 2014, INT J HEPATOL, V2014, DOI 10.1155/2014/513787; Jiang ZA, 2015, ALCOHOL CLIN EXP RES, V39, P424, DOI 10.1111/acer.12641; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Li HK, 2011, BIOCHEM J, V438, P283, DOI 10.1042/BJ20110263; Li K, 2015, J BIOL CHEM, V290, P8185, DOI 10.1074/jbc.M114.633990; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V370, P44, DOI 10.1016/j.bbrc.2008.03.005; Magne L, 2011, J HEPATOL, V54, P729, DOI 10.1016/j.jhep.2010.07.023; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Rasineni K, 2012, INDIAN J PHARMACOL, V44, P299, DOI 10.4103/0253-7613.96297; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Sun Q, 2015, AM J PHYSIOL-GASTR L, V308, pG757, DOI 10.1152/ajpgi.00442.2014; Tomita K, 2005, ALCOHOL CLIN EXP RES, V29, p240S, DOI 10.1097/01.alc.0000191126.11479.69; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Wang CX, 2014, J CELL MOL MED, V18, P80, DOI 10.1111/jcmm.12166; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao GZ, 2013, J BIOL CHEM, V288, P25350, DOI 10.1074/jbc.M113.470526; Xiao YZ, 2016, DIABETES, V65, P393, DOI 10.2337/db15-1024; Xu F, 2014, BIOCHEM J, V458, P159, DOI 10.1042/BJ20130986; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yao XH, 2008, AM J PHYSIOL-REG I, V294, pR1797, DOI 10.1152/ajpregu.00804.2007; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Yu JJ, 2015, DIABETES, V64, P1591, DOI 10.2337/db14-1368; Zhang Q, 2013, DIABETES, V62, P2230, DOI 10.2337/db12-1050; Zhu SL, 2014, ACTA BIOCH BIOPH SIN, V46, P1041, DOI 10.1093/abbs/gmu097	52	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18536	18546		10.1074/jbc.M116.726836	http://dx.doi.org/10.1074/jbc.M116.726836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405764	hybrid, Green Published			2022-12-28	WOS:000383241800043
J	Thomas, JC; Cooper, JM; Clayton, NS; Wang, CS; White, MA; Abell, C; Owen, D; Mott, HR				Thomas, Jemima C.; Cooper, Jonathan M.; Clayton, Natasha S.; Wang, Chensu; White, Michael A.; Abell, Chris; Owen, Darerca; Mott, Helen R.			Inhibition of Ral GTPases Using a Stapled Peptide Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; cell signaling; peptide chemical synthesis; peptides; protein-protein interaction; small GTPase; Ral; Ras; stapled peptides; therapeutics	PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; CANCER; COMPLEX; ACTIVATION; EXOCYST; PHOSPHORYLATION; AUTOPHAGY; AFFINITY; MEDIATE	Aberrant Ras signaling drives numerous cancers, and drugs to inhibit this are urgently required. This compelling clinical need combined with recent innovations in drug discovery including the advent of biologic therapeutic agents, has propelled Ras back to the forefront of targeting efforts. Activated Ras has proved extremely difficult to target directly, and the focus has moved to the main downstream Ras-signaling pathways. In particular, the Ras-Raf and Ras-PI3K pathways have provided conspicuous enzyme therapeutic targets that were more accessible to conventional drug-discovery strategies. The Ras-RalGEF-Ral pathway is a more difficult challenge for traditional medicinal development, and there have, therefore, been few inhibitors reported that disrupt this axis. We have used our structure of a Ral-effector complex as a basis for the design and characterization of -helical-stapled peptides that bind selectively to active, GTP-bound Ral proteins and that compete with downstream effector proteins. The peptides have been thoroughly characterized biophysically. Crucially, the lead peptide enters cells and is biologically active, inhibiting isoform-specific RalB-driven cellular processes. This, therefore, provides a starting point for therapeutic inhibition of the Ras-RalGEF-Ral pathway.	[Thomas, Jemima C.; Clayton, Natasha S.; Owen, Darerca; Mott, Helen R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Thomas, Jemima C.; Abell, Chris] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Cooper, Jonathan M.; Wang, Chensu; White, Michael A.] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; [Thomas, Jemima C.] Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England	University of Cambridge; University of Cambridge; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; Institute of Cancer Research - UK	Owen, D; Mott, HR (corresponding author), Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do202@cam.ac.uk; hrm28@cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Cooper, Jonathan/0000-0002-7468-2062	Cambridge Cancer Centre Pump Priming award; BBSRC (Biotechnology and Biological Sciences Research Council); National Institutes of Health [CA71443]; Welch Foundation [I- 1414]; MRC [MR/J007803/1, MC_PC_14116] Funding Source: UKRI; Medical Research Council [MR/J007803/1, MC_PC_14116] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA071443] Funding Source: NIH RePORTER	Cambridge Cancer Centre Pump Priming award; BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Cambridge Cancer Centre Pump Priming award (to C. A., D. O., and H. R. M.), a BBSRC (Biotechnology and Biological Sciences Research Council) studentship (to N. S. C.), National Institutes of Health Grant CA71443, and Welch Foundation Grant I- 1414 (to M. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Campbell LJ, 2015, BIOCHEMISTRY-US, V54, P1380, DOI 10.1021/bi501530u; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chu Q, 2015, MEDCHEMCOMM, V6, P111, DOI 10.1039/c4md00131a; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Fenwick RB, 2010, STRUCTURE, V18, P985, DOI 10.1016/j.str.2010.05.013; Fiordalisi JJ, 2003, J BIOL CHEM, V278, P41718, DOI 10.1074/jbc.M305733200; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Grossmann TN, 2012, P NATL ACAD SCI USA, V109, P17942, DOI 10.1073/pnas.1208396109; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kauffman WB, 2015, TRENDS BIOCHEM SCI, V40, P749, DOI 10.1016/j.tibs.2015.10.004; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Leshchiner ES, 2015, P NATL ACAD SCI USA, V112, P1761, DOI 10.1073/pnas.1413185112; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Martin Timothy D, 2012, Small GTPases, V3, P126, DOI 10.4161/sgtp.19571; Martin TD, 2012, J BIOL CHEM, V287, P14827, DOI 10.1074/jbc.M112.344986; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Neyraud V, 2012, J BIOL CHEM, V287, P29397, DOI 10.1074/jbc.M112.357764; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Popovic M, 2016, J STRUCT BIOL, V193, P106, DOI 10.1016/j.jsb.2015.12.006; Prasannan S, 2007, BIOMOL NMR ASSIGN, V1, P147, DOI 10.1007/s12104-007-9040-1; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Saito R, 2013, ONCOGENE, V32, P894, DOI 10.1038/onc.2012.101; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Spiegel J, 2014, ANGEW CHEM INT EDIT, V53, P2498, DOI 10.1002/anie.201308568; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Wang H, 2010, CANCER RES, V70, P8760, DOI 10.1158/0008-5472.CAN-10-0952; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wittrup K Dane, 2012, Methods Enzymol, V502, pxiii, DOI [10.1016/B978-0-12-396962-0.00013-6, 10.1016/B978-0-12-416039-2.00031-8]; Yan C, 2014, NATURE, V515, P443, DOI 10.1038/nature13713; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047	55	15	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18310	18325		10.1074/jbc.M116.720243	http://dx.doi.org/10.1074/jbc.M116.720243			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27334922	Green Published, hybrid			2022-12-28	WOS:000383241800024
J	Bullard, SA; Seo, S; Schilling, B; Dyle, MC; Dierdorff, JM; Ebert, SM; DeLau, AD; Gibson, BW; Adams, CM				Bullard, Steven A.; Seo, Seongjin; Schilling, Birgit; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Gibson, Bradford W.; Adams, Christopher M.			Gadd45a Protein Promotes Skeletal Muscle Atrophy by Forming a Complex with the Protein Kinase MEKK4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; mass spectrometry (MS); muscle; muscle atrophy; skeletal muscle; skeletal muscle metabolism; Gadd45a; MEKK4	GENE-EXPRESSION PROFILE; ACTIVATION; MTK1/MEKK4; MASS; PROTEOMICS; QUANTITATION; RESPONSES; NETWORK; PATHWAY; SKYLINE	Skeletal muscle atrophy is a serious and highly prevalent condition that remains poorly understood at the molecular level. Previous work found that skeletal muscle atrophy involves an increase in skeletal muscle Gadd45a expression, which is necessary and sufficient for skeletal muscle fiber atrophy. However, the direct mechanism by which Gadd45a promotes skeletal muscle atrophy was unknown. To address this question, we biochemically isolated skeletal muscle proteins that associate with Gadd45a as it induces atrophy in mouse skeletal muscle fibers in vivo. We found that Gadd45a interacts with multiple proteins in skeletal muscle fibers, including, most prominently, MEKK4, a mitogen-activated protein kinase kinase kinase that was not previously known to play a role in skeletal muscle atrophy. Furthermore, we found that, by forming a complex with MEKK4 in skeletal muscle fibers, Gadd45a increases MEKK4 protein kinase activity, which is both sufficient to induce skeletal muscle fiber atrophy and required for Gadd45a-mediated skeletal muscle fiber atrophy. Together, these results identify a direct biochemical mechanism by which Gadd45a induces skeletal muscle atrophy and provide new insight into the way that skeletal muscle atrophy occurs at the molecular level.	[Bullard, Steven A.; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bullard, Steven A.; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Adams, Christopher M.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Bullard, Steven A.; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Adams, Christopher M.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Seo, Seongjin] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Bullard, Steven A.; Dyle, Michael C.; Dierdorff, Jason M.; Ebert, Scott M.; DeLau, Austin D.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Dyle, Michael C.; Ebert, Scott M.; Adams, Christopher M.] Emmyon Inc, Coralville, IA 52241 USA; [Schilling, Birgit; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Buck Institute for Research on Aging; University of California System; University of California San Francisco	Adams, CM (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu		Adams, Christopher/0000-0002-5795-7212; Seo, Seongjin/0000-0002-7908-3210	National Institutes of Health [R01AR059115, R01EY022616]; United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant [IBX000976A]; United States Department of Veterans Affairs Rehabilitation and Research Development Service Grant [1I01RX001477]; Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; National Institutes of Health Shared Instrumentation Grant [1S10 OD016281]; NATIONAL EYE INSTITUTE [R01EY022616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016281] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976, I01RX001477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant; United States Department of Veterans Affairs Rehabilitation and Research Development Service Grant; Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01AR059115 and R01EY022616, United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant IBX000976A, the United States Department of Veterans Affairs Rehabilitation and Research Development Service Grant 1I01RX001477, the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa, and National Institutes of Health Shared Instrumentation Grant 1S10 OD016281 for the TripleTOF mass spectrometric system at the Buck Institute (to B. W. G.). C. M. A., S. M. E., and M. C. D. hold equity in Emmyon, Inc. C. M. A. is a founder and officer of Emmyon, Inc. S. M. E. and M. C. D. are employees of Emmyon, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banduseela VC, 2009, PHYSIOL GENOMICS, V39, P141, DOI 10.1152/physiolgenomics.00026.2009; Bettinger BT, 2007, J CELL BIOCHEM, V101, P34, DOI 10.1002/jcb.21289; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Deshmukh AS, 2015, MOL CELL PROTEOMICS, V14, P841, DOI 10.1074/mcp.M114.044222; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Llano-Diez M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-602; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Mizote I, 2010, J MOL CELL CARDIOL, V48, P302, DOI 10.1016/j.yjmcc.2009.10.010; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Sanchez R, 2010, J BIOL CHEM, V285, P22196, DOI 10.1074/jbc.M109.069344; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Sharma V, 2014, J PROTEOME RES, V13, P4205, DOI 10.1021/pr5006636; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Zeman RJ, 2009, PFLUG ARCH EUR J PHY, V458, P525, DOI 10.1007/s00424-009-0643-5	40	30	31	9	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17496	17509		10.1074/jbc.M116.740308	http://dx.doi.org/10.1074/jbc.M116.740308			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358404	Green Published, hybrid			2022-12-28	WOS:000383241300002
J	Romek, KM; Remaud, GS; Silvestre, V; Paneth, P; Robins, RJ				Romek, Katarzyna M.; Remaud, Gerald S.; Silvestre, Virginie; Paneth, Piotr; Robins, Richard J.			Non-statistical C-13 Fractionation Distinguishes Co-incident and Divergent Steps in the Biosynthesis of the Alkaloids Nicotine and Tropine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ISOTOPE FRACTIONATION; DATURA-STRAMONIUM; NATURAL-ABUNDANCE; ACID; OXIDASE; ASPARTATE; SYNTHASE; REVEALS; PATHWAY	During the biosynthesis of natural products, isotopic fractionation occurs due to the selectivity of enzymes for the heavier or lighter isotopomers. As only some of the positions in the molecule are implicated in a given reaction mechanism, position-specific fractionation occurs, leading to a non-statistical distribution of isotopes. This can be accessed by isotope ratio monitoring C-13 NMR spectrometry. The solanaceous alkaloids S-(-)-nicotine and hyoscyamine (atropine) are related in having a common intermediate, but downstream enzymatic steps diverge, providing a relevant test case to: (a) elucidate the isotopic affiliation between carbon atoms in the alkaloids and those in the precursors; (b) obtain information about the kinetic isotope effects of as yet undescribed enzymes, thus to make predictions as to their possible mechanism(s). We show that the position-specific C-13/C-12 ratios in the different moieties of these compounds can satisfactorily be related to their known precursors and to the known kinetic isotope effects of enzymes involved in their biosynthesis, or to similar reaction mechanisms. Thus, the pathway to the common intermediate, N-methyl-Delta(1)-pyrrolinium, is seen to introduce similar isotope distribution patterns in the two alkaloids independent of plant species, whereas the remaining atoms of each target compound, which are of different origins, reflect their specific metabolic ancestry. We further demonstrate that the measured 13C distribution pattern can be used to deduce aspects of the reaction mechanism of enzymes still to be identified.	[Romek, Katarzyna M.; Remaud, Gerald S.; Silvestre, Virginie; Robins, Richard J.] Univ Nantes, CNRS,UMR6230, Elucidat Biosynth Isotop Spectrometry Grp, Interdisciplinary Chem Synth,Anal,Modeling, F-44322 Nantes, France; [Romek, Katarzyna M.; Paneth, Piotr] Lodz Univ Technol, Fac Chem, Inst Appl Radiat Chem, Ul Stefana Zeromskiego 116, PL-90924 Lodz, Poland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite; Lodz University of Technology	Robins, RJ (corresponding author), Univ Nantes, CNRS, Elucidat Biosynth Isotop Spectrometry Grp, CEISAM,UMR6230, 2 Rue Houssiniere, F-44322 Nantes, France.	richard.robins@univ-nantes.fr		Robins, Richard/0000-0002-5325-8983; Paneth, Piotr/0000-0002-3091-8387	French Research Ministry; CNRS	French Research Ministry(Ministry of Research, France); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the French Research Ministry (to K. M. R.) and the CNRS (to R. J. R.). The authors declare that they have no conflicts of interest within the contents of this article.	BALDWIN IT, 1988, OECOLOGIA, V77, P378, DOI 10.1007/BF00378046; Bayle K, 2015, J BIOL CHEM, V290, P4118, DOI 10.1074/jbc.M114.621441; Bayle K, 2014, ANAL CHIM ACTA, V846, P1, DOI 10.1016/j.aca.2014.07.018; Biastoff S, 2009, PHYTOCHEMISTRY, V70, P1708, DOI 10.1016/j.phytochem.2009.06.012; Botosoa EP, 2009, ANAL BIOCHEM, V393, P182, DOI 10.1016/j.ab.2009.06.031; Chaintreau A, 2013, ANAL CHIM ACTA, V788, P108, DOI 10.1016/j.aca.2013.06.004; Cherrier MV, 2014, J AM CHEM SOC, V136, P5253, DOI 10.1021/ja501431b; CHESTERS NCJE, 1994, J CHEM SOC PERK T 1, P1159, DOI 10.1039/p19940001159; Dalton HL, 2016, J EXP BOT, V67, P3367, DOI 10.1093/jxb/erw166; Dewey RE, 2013, PHYTOCHEMISTRY, V94, P10, DOI 10.1016/j.phytochem.2013.06.002; Diomande DG, 2015, ANAL CHEM, V87, P6600, DOI 10.1021/acs.analchem.5b00559; Drager B, 2006, PHYTOCHEMISTRY, V67, P327, DOI 10.1016/j.phytochem.2005.12.001; FRIESEN JB, 1990, TETRAHEDRON LETT, V31, P6295; Gilbert A, 2011, PLANT CELL ENVIRON, V34, P1104, DOI 10.1111/j.1365-3040.2011.02308.x; Greule M, 2011, ISOT ENVIRON HEALT S, V47, P470, DOI 10.1080/10256016.2011.616270; JACKANICZ TM, 1966, J BIOL CHEM, V241, P1296; Katoh A, 2006, PLANT PHYSIOL, V141, P851, DOI 10.1104/pp.106.081091; KIM JM, 1993, J AM CHEM SOC, V115, P10591, DOI 10.1021/ja00076a017; LEETE E, 1967, J AM CHEM SOC, V89, P7081, DOI 10.1021/ja01002a042; Lewis RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117273; Li R, 2006, CHEM BIOL, V13, P513, DOI 10.1016/j.chembiol.2006.03.005; Melander L., 1980, REACTION RATES ISOTO; MELZER E, 1988, BIOCHEM J, V252, P913, DOI 10.1042/bj2520913; MONSON KD, 1982, J BIOL CHEM, V257, P5568; Naconsie M, 2014, PLANT CELL PHYSIOL, V55, P436, DOI 10.1093/pcp/pct179; O'Hagan D, 1998, CHEM SOC REV, V27, P207, DOI 10.1039/a827207z; ROBINS RJ, 1994, RECENT ADV PHYTOCHEM, V28, P1; Robins RJ, 1997, J AM CHEM SOC, V119, P10929, DOI 10.1021/ja964461p; ROBINS RJ, 1994, J CHEM SOC PERK T 1, P615, DOI 10.1039/p19940000615; Robins RJ, 1993, ALKALOIDS, V44, P115; Romek KM, 2015, P NATL ACAD SCI USA, V112, P8296, DOI 10.1073/pnas.1506011112; Schmidt H, 1998, STABLE ISOTOPES INTE, P13; Schmidt HL, 2015, ISOT ENVIRON HEALT S, V51, P155, DOI 10.1080/10256016.2015.1014355; Schmidt HL, 2003, NATURWISSENSCHAFTEN, V90, P537, DOI 10.1007/s00114-003-0485-5; SCHMIDT HL, 1995, SYNTHESIS AND APPLICATIONS OF ISOTOPICALLY LABELLED COMPOUNDS 1994, P869; Schultes R.E., 1992, PLANTS GODS THEIR SA; Shoji T, 2015, PHYTOCHEMISTRY, V113, P41, DOI 10.1016/j.phytochem.2014.05.017; Silvestre V, 2009, J PHARMACEUT BIOMED, V50, P336, DOI 10.1016/j.jpba.2009.04.030; Tenailleau E, 2007, J MAGN RESON, V185, P50, DOI 10.1016/j.jmr.2006.11.007; Waldhauser SSM, 1997, PHYTOCHEMISTRY, V44, P853, DOI 10.1016/S0031-9422(96)00662-0; Weilacher T, 1996, PHYTOCHEMISTRY, V41, P1073, DOI 10.1016/0031-9422(95)00757-1; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258	42	11	11	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16620	16629		10.1074/jbc.M116.734087	http://dx.doi.org/10.1074/jbc.M116.734087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288405	Green Published, hybrid			2022-12-28	WOS:000380826700021
J	Tagami, T; Miyano, E; Sadahiro, J; Okuyama, M; Iwasaki, T; Kimura, A				Tagami, Takayoshi; Miyano, Eri; Sadahiro, Juri; Okuyama, Masayuki; Iwasaki, Tomohito; Kimura, Atsuo			Two Novel Glycoside Hydrolases Responsible for the Catabolism of Cyclobis-(1 -> 6)-alpha-nigerosyl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRASACCHARIDE-SYNTHESIZING ENZYMES; BACILLUS-GLOBISPORUS C-11; LONG-CHAIN SUBSTRATE; SP NRRL B-21195; CYCLIC TETRASACCHARIDE; ALPHA-GLUCOSIDASE; GLUCOAMYLASE; GLUCOSYLTRANSFERASE; OLIGOSACCHARIDES; CYCLOALTERNAN	The actinobacterium Kribbella flavida NBRC 14399(T) produces cyclobis-(1 -> 6)-alpha-nigerosyl (CNN), a cyclic glucotetraose with alternate alpha-(1 -> 6)- and alpha-(1 -> 3)-glucosidic linkages, from starch in the culture medium. We identified gene clusters associated with the production and intracellular catabolism of CNN in the K. flavida genome. One cluster encodes 6-alpha-glucosyl-transferase and 3-alpha-isomaltosyltransferase, which are known to coproduce CNN from starch. The other cluster contains four genes annotated as a transcriptional regulator, sugar transporter, glycoside hydrolase family (GH) 31 protein (Kfla1895), and GH15 protein (Kfla1896). Kfla1895 hydrolyzed the alpha-(1 -> 3)-glucosidic linkages of CNN and produced isomaltose via a possible linear tetrasaccharide. The initial rate of hydrolysis of CNN (11.6 s(-1)) was much higher than that of panose (0.242 s(-1)), and hydrolysis of isomaltotriose and nigerose was extremely low. Because Kfla1895 has a strong preference for the alpha-(1 -> 3)-isomaltosyl moiety and effectively hydrolyzes the alpha-(1 -> 3)-glucosidic linkage, it should be termed 1,3-alpha-isomaltosidase. Kfla1896 effectively hydrolyzed isomaltose with liberation of beta-glucose, but displayed low or no activity toward CNN and the general GH15 enzyme substrates such as maltose, soluble starch, or dextran. The k(cat)/K-m for isomaltose (4.81 +/- 0.18 s(-1) mM(-1)) was 6.9- and 19-fold higher than those for panose and isomaltotriose, respectively. These results indicate that Kfla1896 is a new GH15 enzyme with high substrate specificity for isomaltose, suggesting the enzyme should be designated an isomaltose glucohydrolase. This is the first report to identify a starch-utilization pathway that proceeds via CNN.	[Tagami, Takayoshi; Iwasaki, Tomohito] Rakuno Gakuen Univ, Coll Agr Food & Environm Sci, Ebetsu, Hokkaido 0698501, Japan; [Miyano, Eri; Sadahiro, Juri; Okuyama, Masayuki; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Rakuno Gakuen University; Hokkaido University	Tagami, T (corresponding author), Rakuno Gakuen Univ, 582 Bunkyodai Midorimachi, Ebetsu, Hokkaido 0698501, Japan.; Kimura, A (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.	t-tagami@rakuno.ac.jp; kimura@abs.agr.hokudai.ac.jp	Tagami, Takayoshi/Q-3953-2019; Okuyama, Masayuki/D-8739-2012	Okuyama, Masayuki/0000-0001-7013-6032; Tagami, Takayoshi/0000-0002-4004-1558	Northern Advancement Center for Science AMP; Technology of Hokkaido Japan	Northern Advancement Center for Science AMP; Technology of Hokkaido Japan	This work was supported in part by Grants-in-Aid for Regional R&D Proposal-based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Aga H, 2003, J BIOSCI BIOENG, V95, P215, DOI 10.1263/jbb.95.215; Aga H, 2002, BIOSCI BIOTECH BIOCH, V66, P1057, DOI 10.1271/bbb.66.1057; COTE GL, 1994, EUR J BIOCHEM, V226, P641, DOI 10.1111/j.1432-1033.1994.tb20091.x; Cote GL, 2001, CARBOHYD RES, V332, P373, DOI 10.1016/S0008-6215(01)00106-9; COUTINHO PM, 1994, PROTEIN ENG, V7, P393, DOI 10.1093/protein/7.3.393; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; Hodge JE, 1962, METHODS CARBOHYDRATE, DOI DOI 10.1371/JOURNAL.PONE.0065418; Kazanov MD, 2013, NUCLEIC ACIDS RES, V41, P790, DOI 10.1093/nar/gks1184; Kim YK, 2004, CARBOHYD RES, V339, P1179, DOI 10.1016/j.carres.2004.02.008; Kim YK, 2003, CARBOHYD RES, V338, P2213, DOI 10.1016/S0008-6215(03)00375-6; Kitamura M, 2008, J BIOL CHEM, V283, P36328, DOI 10.1074/jbc.M806115200; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P1267, DOI 10.1007/s00253-010-3034-0; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; MCFEETERS RF, 1980, ANAL BIOCHEM, V103, P302, DOI 10.1016/0003-2697(80)90614-4; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Miyazaki T, 2015, BIOCHEM J, V469, P145, DOI 10.1042/BJ20150261; Mizuno M, 2004, J BIOL CHEM, V279, P10575, DOI 10.1074/jbc.M310771200; Mukai K, 2004, BIOSCI BIOTECH BIOCH, V68, P2529, DOI 10.1271/bbb.68.2529; Nishimoto T, 2002, BIOSCI BIOTECH BIOCH, V66, P1806, DOI 10.1271/bbb.66.1806; Okuyama M, 2004, PROTEIN EXPRES PURIF, V37, P170, DOI 10.1016/j.pep.2004.05.008; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pukall R, 2010, STAND GENOMIC SCI, V2, P186, DOI 10.4056/sigs.731321; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saburi W, 2006, BBA-PROTEINS PROTEOM, V1764, P688, DOI 10.1016/j.bbapap.2006.01.012; Sakaguchi M, 2015, APPL ENVIRON MICROB, V81, P4920, DOI 10.1128/AEM.00956-15; Sauer J, 2000, BBA-PROTEIN STRUCT M, V1543, P275, DOI 10.1016/S0167-4838(00)00232-6; Tagami T, 2015, J BIOL CHEM, V290, P1796, DOI 10.1074/jbc.M114.606939; Uotsu-Tomita R, 2001, APPL MICROBIOL BIOT, V56, P465, DOI 10.1007/s002530100609	33	8	11	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16438	16447		10.1074/jbc.M116.727305	http://dx.doi.org/10.1074/jbc.M116.727305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27302067	hybrid, Green Published			2022-12-28	WOS:000380826700003
J	Henriques, ST; Deplazes, E; Lawrence, N; Cheneval, O; Chaousis, S; Inserra, M; Thongyoo, P; King, GF; Mark, AE; Vetter, I; Craik, DJ; Schroeder, CI				Henriques, Sonia Troeira; Deplazes, Evelyne; Lawrence, Nicole; Cheneval, Olivier; Chaousis, Stephanie; Inserra, Marco; Thongyoo, Panumart; King, Glenn F.; Mark, Alan E.; Vetter, Irina; Craik, David J.; Schroeder, Christina I.			Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel Na(V)1.7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane bilayer; peptides; sodium channel; toxin; transmembrane domain; NaV1; 7; analgesic; gating modifier toxin; peptide-lipid interactions; voltage-gated ion channel	CYCLOTIDE KALATA B1; SEA-ANEMONE TOXIN; AUTOIMMUNE-DISEASES; POTASSIUM CHANNEL; FORCE-FIELD; THERAPEUTIC TARGETS; GATING MODIFIERS; SENSOR TOXIN; SPIDER-VENOM; ION CHANNELS	ProTx-II is a disulfide-rich peptide toxin from tarantula venom able to inhibit the human voltage-gated sodium channel 1.7 (hNa(V)1.7), a channel reported to be involved in nociception, and thus it might have potential as a pain therapeutic. ProTx-II acts by binding to the membrane-embedded voltage sensor domain of hNa(V)1.7, but the precise peptide channel-binding site and the importance of membrane binding on the inhibitory activity of ProTx-II remain unknown. In this study, we examined the structure and membrane-binding properties of ProTx-II and several analogues using NMR spectroscopy, surface plasmon resonance, fluorescence spectroscopy, and molecular dynamics simulations. Our results show a direct correlation between ProTx-II membrane binding affinity and its potency as an hNa(V)1.7 channel inhibitor. The data support a model whereby a hydrophobic patch on the ProTx-II surface anchors the molecule at the cell surface in a position that optimizes interaction of the peptide with the binding site on the voltage sensor domain. This is the first study to demonstrate that binding of ProTx-II to the lipid membrane is directly linked to its potency as an hNa(V)1.7 channel inhibitor.	[Henriques, Sonia Troeira; Deplazes, Evelyne; Lawrence, Nicole; Cheneval, Olivier; Chaousis, Stephanie; Inserra, Marco; Thongyoo, Panumart; King, Glenn F.; Mark, Alan E.; Vetter, Irina; Craik, David J.; Schroeder, Christina I.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Deplazes, Evelyne; Mark, Alan E.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Vetter, Irina] Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia; [Thongyoo, Panumart] Thammasat Univ, Fac Sci & Technol, Dept Chem, Med Chem Res Unit, Bangkok 12121, Thailand	University of Queensland; University of Queensland; University of Queensland; Thammasat University	Henriques, ST; Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	s.henriques@uq.edu.au; c.schroeder@imb.uq.edu.au	Lawrence, Nicole/A-5573-2017; Craik, David/B-1695-2010; Cheneval, Olivier/O-1384-2017; Deplazes, Evelyne/F-4618-2012; Vetter, Irina/A-6035-2010; Schroeder, Cristina I./K-2042-2014; Deplazes, Evelyne/P-7573-2019; Mark, Alan E/A-8799-2011; King, Glenn F/J-5059-2012; Henriques, Sonia Troeira/J-3500-2016	Lawrence, Nicole/0000-0002-9013-1770; Craik, David/0000-0003-0007-6796; Cheneval, Olivier/0000-0003-0109-7767; Deplazes, Evelyne/0000-0003-2052-5536; Vetter, Irina/0000-0002-3594-9588; Schroeder, Cristina I./0000-0002-6737-6374; Deplazes, Evelyne/0000-0003-2052-5536; Mark, Alan E/0000-0001-5880-4798; King, Glenn F/0000-0002-2308-2200; Henriques, Sonia Troeira/0000-0001-9564-9651; Thongyoo, Panumart/0000-0001-9918-8805	Australian National Health and Medical Research Center [APP1080405, APP1071293, APP1044414, APP1072113]; Australian Research Council in the form of an Australian Research Council Discovery Outstanding Researcher Grant [DP130102153, FT130101215]; Australian Research Council Australian Laureate Fellowship [FL150100146]; Institute for Molecular Bioscience Industry Fellowship	Australian National Health and Medical Research Center; Australian Research Council in the form of an Australian Research Council Discovery Outstanding Researcher Grant(Australian Research Council); Australian Research Council Australian Laureate Fellowship(Australian Research Council); Institute for Molecular Bioscience Industry Fellowship	This work was supported in part by Australian National Health and Medical Research Center Project Grant APP1080405 (to C. I. S. and S. T. H.), Early Career Fellowship APP1071293 (to E. D.), Principal Research Fellowship APP1044414 and Program Grant APP1072113 (to G. F. K.), Australian Research Council in the form of an Australian Research Council Discovery Outstanding Researcher Grant DP130102153 (to A. E. M.), Future Fellowship FT130101215 (to I. V.), Australian Research Council Australian Laureate Fellowship FL150100146 (to D. J. C.), and an Institute for Molecular Bioscience Industry Fellowship (to C. I. S.). This research was undertaken with the assistance of resources provided at the NCI National Facility systems at the Australian National University through the National Computational Merit Allocation Scheme supported by the Australian Government. The authors declare that they have no conflicts of interest with the contents of this article.	Amand HL, 2012, BBA-BIOMEMBRANES, V1818, P2669, DOI 10.1016/j.bbamem.2012.06.006; Bae C, 2016, ELIFE, V5, DOI 10.7554/eLife.11273; Bagal S, 2013, J MED CHEM, V56, P593, DOI 10.1021/jm3011433; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Deplazes E, 2016, BBA-BIOMEMBRANES, V1858, P872, DOI 10.1016/j.bbamem.2016.02.002; Dilly S, 2011, CHEMBIOCHEM, V12, P1808, DOI 10.1002/cbic.201100236; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gupta K, 2015, ELIFE, V4, DOI 10.7554/eLife.06774; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2015, CHEM BIOL, V22, P1087, DOI 10.1016/j.chembiol.2015.07.012; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Henriques ST, 2005, FEBS LETT, V579, P4498, DOI 10.1016/j.febslet.2005.06.085; Henriques ST, 2005, BBA-BIOMEMBRANES, V1669, P75, DOI 10.1016/j.bbamem.2004.11.017; Herzig V, 2015, TOXINS, V7, P4366, DOI 10.3390/toxins7104366; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Jung HH, 2010, BIOPHYS J, V99, P638, DOI 10.1016/j.bpj.2010.04.061; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Knapp O, 2012, TOXINS, V4, P1236, DOI 10.3390/toxins4111236; Koziara KB, 2014, J COMPUT AID MOL DES, V28, P221, DOI 10.1007/s10822-014-9713-7; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Maier O, 2002, CHEM PHYS LIPIDS, V116, P3, DOI 10.1016/S0009-3084(02)00017-8; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; McGivern JG, 2007, EXPERT OPIN THER TAR, V11, P265, DOI 10.1517/14728222.11.3.265; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Mihailescu M, 2014, P NATL ACAD SCI USA, V111, pE5463, DOI 10.1073/pnas.1415324111; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Moran Y, 2009, TOXICON, V54, P1089, DOI 10.1016/j.toxicon.2009.02.028; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pan M, 2014, CHEM COMMUN, V50, P5837, DOI 10.1039/c4cc00779d; Park JH, 2014, J MED CHEM, V57, P6623, DOI 10.1021/jm500687u; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Poger D, 2012, J CHEM THEORY COMPUT, V8, P4807, DOI 10.1021/ct300675z; Poger D, 2010, J COMPUT CHEM, V31, P1117, DOI 10.1002/jcc.21396; Pokorny A, 2006, BIOPHYS J, V91, P2184, DOI 10.1529/biophysj.106.085027; Posokhov YO, 2007, BIOPHYS J, V93, pL20, DOI 10.1529/biophysj.107.112375; Prevette LE, 2015, BIOPHYS CHEM, V207, P40, DOI 10.1016/j.bpc.2015.08.003; Priest BT, 2007, TOXICON, V49, P194, DOI 10.1016/j.toxicon.2006.09.014; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Stock RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036003; Tang M, 2007, J AM CHEM SOC, V129, P11438, DOI 10.1021/ja072511s; Tikhonov DB, 2011, J BIOL CHEM, V286, P2998, DOI 10.1074/jbc.M110.175406; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vetter I, 2012, BIOCHEM PHARMACOL, V83, P1562, DOI 10.1016/j.bcp.2012.02.022; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; Yang ST, 2003, FEBS LETT, V540, P229, DOI 10.1016/S0014-5793(03)00266-7; Zager RA, 2000, J AM SOC NEPHROL, V11, P894, DOI 10.1681/ASN.V115894	74	55	56	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17049	17065		10.1074/jbc.M116.729095	http://dx.doi.org/10.1074/jbc.M116.729095			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27311819	Green Published, hybrid			2022-12-28	WOS:000382643800012
J	Bock, A; Bermudez, M; Krebs, F; Matera, C; Chirinda, B; Sydow, D; Dallanoce, C; Holzgrabe, U; De Amici, M; Lohse, MJ; Wolber, G; Mohr, K				Bock, Andreas; Bermudez, Marcel; Krebs, Fabian; Matera, Carlo; Chirinda, Brian; Sydow, Dominique; Dallanoce, Clelia; Holzgrabe, Ulrike; De Amici, Marco; Lohse, Martin J.; Wolber, Gerhard; Mohr, Klaus			Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSIGHTS; ALLOSTERIC LIGANDS; CONFORMATIONAL DYNAMICS; AMINO-ACIDS; SITE; MODULATION; AFFINITY	G protein-coupled receptors constitute the largest family of membrane receptors and modulate almost every physiological process in humans. Binding of agonists to G protein-coupled receptors induces a shift from inactive to active receptor conformations. Biophysical studies of the dynamic equilibrium of receptors suggest that a portion of receptors can remain in inactive states even in the presence of saturating concentrations of agonist and G protein mimetic. However, the molecular details of agonist-bound inactive receptors are poorly understood. Here we use the model of bitopic orthosteric/allosteric (i.e. dualsteric) agonists for muscarinic M-2 receptors to demonstrate the existence and function of such inactive agonist.receptor complexes on a molecular level. Using all-atom molecular dynamics simulations, dynophores (i.e. a combination of static three-dimensional pharmacophores and molecular dynamics-based conformational sampling), ligand design, and receptor mutagenesis, we show that inactive agonist.receptor complexes can result from agonist binding to the allosteric vestibule alone, whereas the dualsteric binding mode produces active receptors. Each agonist forms a distinct ligand binding ensemble, and different agonist efficacies depend on the fraction of purely allosteric (i.e. inactive) versus dualsteric (i.e. active) binding modes. We propose that this concept may explain why agonist.receptor complexes can be inactive and that adopting multiple binding modes may be generalized also to small agonists where binding modes will be only subtly different and confined to only one binding site.	[Bock, Andreas; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany; [Bermudez, Marcel; Sydow, Dominique; Wolber, Gerhard] Free Univ Berlin, Inst Pharm, Konigin Luise Str 2 & 4, D-14195 Berlin, Germany; [Krebs, Fabian; Chirinda, Brian; Mohr, Klaus] Univ Bonn, Inst Pharm, Pharmacol & Toxicol Sect, Gerhard Domagk Str 3, D-53121 Bonn, Germany; [Matera, Carlo; Dallanoce, Clelia; De Amici, Marco] Univ Milan, Dipartimento Sci Farmaceut, Sez Chim Farmaceut Pietro Pratesi, Via Mangiagalli 25, I-20133 Milan, Italy; [Holzgrabe, Ulrike] Univ Wurzburg, Inst Pharm, D-97074 Wurzburg, Germany; [Krebs, Fabian] Univ Bonn, Res Training Grp GRK 1873, Bonn, Germany	University of Wurzburg; Free University of Berlin; University of Bonn; University of Milan; University of Wurzburg; University of Bonn	Bock, A (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.; Bermudez, M (corresponding author), Free Univ Berlin, Inst Pharm, Konigin Luise Str 2 & 4, D-14195 Berlin, Germany.; Mohr, K (corresponding author), Univ Bonn, Inst Pharm, Pharmacol & Toxicol Sect, Gerhard Domagk Str 3, D-53121 Bonn, Germany.	andreas.bock@uni-wuerzburg.de; m.bermudez@fu-berlin.de	Matera, Carlo/G-3808-2015; Lohse, Martin J/A-7160-2012; Wolber, Gerhard/C-7133-2008; Bermudez, Marcel/D-5449-2015; Wolber, Gerhard/ABD-4955-2020; De Amici, Marco/F-9684-2015	Matera, Carlo/0000-0001-6939-3859; Lohse, Martin J/0000-0002-0599-3510; Wolber, Gerhard/0000-0002-5344-0048; Bermudez, Marcel/0000-0002-7421-3282; Wolber, Gerhard/0000-0002-5344-0048; De Amici, Marco/0000-0002-0236-0662; Holzgrabe, Ulrike/0000-0002-0364-7278; Bock, Andreas/0000-0002-6344-6494; Sydow, Dominique/0000-0003-4205-8705	international doctoral program (Elite Network of Bavaria) "Receptor Dynamics: Emerging Paradigms for Novel Drugs"	international doctoral program (Elite Network of Bavaria) "Receptor Dynamics: Emerging Paradigms for Novel Drugs"	Supported by the international doctoral program (Elite Network of Bavaria) "Receptor Dynamics: Emerging Paradigms for Novel Drugs."	Anami Y, 2014, J MED CHEM, V57, P4351, DOI 10.1021/jm500392t; [Anonymous], 2010, Drug Discov Today Technol, V7, pe203, DOI 10.1016/j.ddtec.2010.11.004; Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Bermudez M, 2015, MOL INFORM, V34, P526, DOI 10.1002/minf.201500025; Bermudez M, 2015, BIOORGAN MED CHEM, V23, P3907, DOI 10.1016/j.bmc.2015.03.026; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bock A, 2014, TRENDS PHARMACOL SCI, V35, P630, DOI 10.1016/j.tips.2014.10.002; Bock A, 2014, NAT CHEM BIOL, V10, P18, DOI 10.1038/nchembio.1384; Bock Andreas, 2013, Drug Discov Today Technol, V10, pe245, DOI 10.1016/j.ddtec.2012.12.003; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI 10.1038/NCHEMBIO.451; Burgmer U, 1998, N-S ARCH PHARMACOL, V357, P363, DOI 10.1007/PL00005180; Chen X, 2015, J MED CHEM, V58, P560, DOI 10.1021/jm500860w; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christopoulos A, 2014, PHARMACOL REV, V66, P918, DOI 10.1124/pr.114.008862; Dallanoce C, 1999, BIOORGAN MED CHEM, V7, P1539, DOI 10.1016/S0968-0896(99)00107-8; Disingrini T, 2006, J MED CHEM, V49, P366, DOI 10.1021/jm050769s; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kaur D, 2011, COMPUT THEOR CHEM, V963, P71, DOI 10.1016/j.comptc.2010.09.011; Kenakin T, 2002, TRENDS PHARMACOL SCI, V23, P275, DOI 10.1016/S0165-6147(02)02036-9; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kloeckner J, 2010, TETRAHEDRON LETT, V51, P3470, DOI 10.1016/j.tetlet.2010.04.130; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mohr K, 2013, ANGEW CHEM INT EDIT, V52, P508, DOI 10.1002/anie.201205315; Mortier J, 2015, DRUG DISCOV TODAY, V20, P686, DOI 10.1016/j.drudis.2015.01.003; Muth M, 2003, J MED CHEM, V46, P1031, DOI 10.1021/jm021017q; Nwachukwu JC, 2014, ELIFE, V3, DOI 10.7554/eLife.02057; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Olofsson L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6206; Onaran HO, 1997, ANN NY ACAD SCI, V812, P98, DOI 10.1111/j.1749-6632.1997.tb48150.x; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PAGE KM, 1995, EUR J PHARM-MOLEC PH, V289, P429, DOI 10.1016/0922-4106(95)90151-5; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rakers C, 2016, J BIOL CHEM, V291, P58, DOI 10.1074/jbc.M115.685610; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schmitz J, 2014, J MED CHEM, V57, P6739, DOI 10.1021/jm500790x; Sounier R, 2015, NATURE, V524, P375, DOI 10.1038/nature14680; Srinivasan S, 2013, NAT CHEM BIOL, V9, P326, DOI [10.1038/NCHEMBIO.1214, 10.1038/nchembio.1214]; Vafabakhsh R, 2015, NATURE, V524, P497, DOI 10.1038/nature14679; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Werner C, 2007, CHEM-EUR J, V13, P9462, DOI 10.1002/chem.200700827; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Wolber G, 2006, J COMPUT AID MOL DES, V20, P773, DOI 10.1007/s10822-006-9078-7	73	53	53	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16375	16389		10.1074/jbc.M116.735431	http://dx.doi.org/10.1074/jbc.M116.735431			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27298318	Green Published, hybrid			2022-12-28	WOS:000380585400040
J	Gopalakrishna, KN; Boyd, K; Yadav, RP; Artemyev, NO				Gopalakrishna, Kota N.; Boyd, Kimberly; Yadav, Ravi P.; Artemyev, Nikolai O.			Aryl Hydrocarbon Receptor-interacting Protein-like 1 Is an Obligate Chaperone of Phosphodiesterase 6 and Is Assisted by the gamma-Subunit of Its Client	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; CYCLIC-GMP PHOSPHODIESTERASE; ROD CGMP-PHOSPHODIESTERASE; BETA-SUBUNIT; RETINAL DEGENERATION; NONSENSE MUTATION; AIPL1; GENE; MOUSE; DOMAIN	Phosphodiesterase 6 (PDE6) is the effector enzyme in the phototransduction cascade and is critical for the health of both rod and cone photoreceptors. Its dysfunction, caused by mutations in either the enzyme itself or AIPL1 (aryl hydrocarbon receptor-interacting protein-like 1), leads to retinal diseases culminating in blindness. Progress in research on PDE6 and AIPL1 has been severely hampered by failure to express functional PDE6 in a heterologous expression system. Here, we demonstrated that AIPL1 is an obligate chaperone of PDE6 and that it enables low yield functional folding of cone PDE6C in cultured cells. We further show that the AIPL1-mediated production of folded PDE6C is markedly elevated in the presence of the inhibitory P gamma-subunit of PDE6. As illustrated in this study, a simple and sensitive system in which AIPL1 and P gamma are co-expressed with PDE6 represents an effective tool for probing structure-function relationships of AIPL1 and reliably establishing the pathogenicity of its variants.	[Gopalakrishna, Kota N.; Boyd, Kimberly; Yadav, Ravi P.; Artemyev, Nikolai O.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Artemyev, Nikolai O.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Artemyev, NO (corresponding author), Dept Mol Physiol & Biophys, 5-532 Bowen Sci Bldg,51 Newton Rd, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu		Artemyev, Nikolai/0000-0002-5266-6854; Yadav, Ravi Prakash/0000-0002-6243-8388	National Institutes of Health [EY-10843]; NATIONAL EYE INSTITUTE [R01EY010843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY-10843 (to N. O. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ANANT JS, 1992, J BIOL CHEM, V267, P687; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Bellingham J, 2015, INVEST OPHTH VIS SCI, V56, P7784, DOI 10.1167/iovs.15-18092; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Cahill KB, 2012, J BIOL CHEM, V287, P41406, DOI 10.1074/jbc.M112.389189; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Cheguru P, 2015, MOL CELL NEUROSCI, V64, P1, DOI 10.1016/j.mcn.2014.10.007; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dhamaraj S, 2004, ARCH OPHTHALMOL-CHIC, V122, P1029, DOI 10.1001/archopht.122.7.1029; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; Dvir L, 2010, AM J HUM GENET, V87, P258, DOI 10.1016/j.ajhg.2010.06.016; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Galvin JA, 2005, RETINA-J RET VIT DIS, V25, P919, DOI 10.1097/00006982-200510000-00016; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Granovsky AE, 1998, J BIOL CHEM, V273, P24485, DOI 10.1074/jbc.273.38.24485; Grau T, 2011, HUM MOL GENET, V20, P719, DOI 10.1093/hmg/ddq517; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Kirschman LT, 2010, HUM MOL GENET, V19, P1076, DOI 10.1093/hmg/ddp571; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Kohl S, 2012, AM J HUM GENET, V91, P527, DOI 10.1016/j.ajhg.2012.07.006; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Majumder A, 2015, J NEUROSCI, V35, P9225, DOI 10.1523/JNEUROSCI.3563-14.2015; Majumder A, 2013, J BIOL CHEM, V288, P21320, DOI 10.1074/jbc.M113.476242; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Morgan RML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053339; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2009, J BIOL CHEM, V284, P32662, DOI 10.1074/jbc.M109.049916; OYCHINNIKOV YA, 1986, FEBS LETT, V204, P288; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; QIN N, 1994, J BIOL CHEM, V269, P3265; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Schwartz ML, 2006, ADV EXP MED BIOL, V572, P89; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tan MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032330; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; van der Spuy J, 2006, ADV EXP MED BIOL, V572, P471; Yadav RP, 2015, J NEUROCHEM, V135, P165, DOI 10.1111/jnc.13223; Zeng-Elmore X, 2014, J MOL BIOL, V426, P3713, DOI 10.1016/j.jmb.2014.07.033; Zhang ZX, 2015, J BIOL CHEM, V290, P12833, DOI 10.1074/jbc.M115.647636	57	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16282	16291		10.1074/jbc.M116.737593	http://dx.doi.org/10.1074/jbc.M116.737593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27268253	Green Published, hybrid			2022-12-28	WOS:000380585400032
J	Peck, BCE; Sincavage, J; Feinstein, S; Mah, AT; Simmons, JG; Lund, PK; Sethupathy, P				Peck, Bailey C. E.; Sincavage, John; Feinstein, Sydney; Mah, Amanda T.; Simmons, James G.; Lund, P. Kay; Sethupathy, Praveen			miR-30 Family Controls Proliferation and Differentiation of Intestinal Epithelial Cell Models by Directing a Broad Gene Expression Program That Includes SOX9 and the Ubiquitin Ligase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TRANSCRIPTION FACTOR; SUCRASE-ISOMALTASE; CACO-2; MICRORNAS; TARGETS; POPULATIONS; SUPPRESSES; REGULATORS; INHIBITION	Proliferation and differentiation of intestinal epithelial cells (IECs) occur in part through precise regulation of key transcription factors, such as SOX9. MicroRNAs (miRNAs) have emerged as prominent fine-tuners of transcription factor expression and activity. We hypothesized that miRNAs, in part through the regulation of SOX9, may mediate IEC homeostasis. Bioinformatic analyses of the SOX9 3'-UTR revealed highly conserved target sites for nine different miRNAs. Of these, only the miR-30 family members were both robustly and variably expressed across functionally distinct cell types of the murine jejunal epithelium. Inhibition of miR-30 using complementary locked nucleic acids (LNA30bcd) in both human IECs and human colorectal adenocarcinoma-derived Caco-2 cells resulted in significant up-regulation of SOX9 mRNA but, interestingly, significant down-regulation of SOX9 protein. To gain mechanistic insight into this non-intuitive finding, we performed RNA sequencing on LNA30bcd-treated human IECs and found 2440 significantly increased genes and 2651 significantly decreased genes across three time points. The up-regulated genes are highly enriched for both predicted miR-30 targets, as well as genes in the ubiquitin-proteasome pathway. Chemical suppression of the proteasome rescued the effect of LNA30bcd on SOX9 protein levels, indicating that the regulation of SOX9 protein by miR-30 is largely indirect through the proteasome pathway. Inhibition of the miR-30 family led to significantly reduced IEC proliferation and a dramatic increase in markers of enterocyte differentiation. This in-depth analysis of a complexm iRNA regulatory program in intestinal epithelial cell models provides novel evidence that the miR-30 family likely plays an important role in IEC homeostasis.	[Peck, Bailey C. E.; Lund, P. Kay; Sethupathy, Praveen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Sincavage, John; Feinstein, Sydney; Sethupathy, Praveen] Univ N Carolina, Dept Genet, 5091 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Mah, Amanda T.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Mah, Amanda T.; Simmons, James G.; Lund, P. Kay] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Sethupathy, Praveen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sethupathy, P (corresponding author), Univ N Carolina, Dept Genet, 5091 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	praveen_sethupathy@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022	Peck, Bailey/0000-0002-4316-0966	University of North Carolina Genetics and Molecular Biology Training Grant through the NIGMS, National Institutes of Health [T32GM007092]; University of North Carolina Initiative to Maximize Student Diversity (IMSD) Diversity Fellowship Award through NIGMS, National Institutes of Health Grant [5R25GM55336]; NIDDK/National Institutes of Health Grants [F31DK105747, 5R00DK091318, P30DK056350]; American Diabetes Association [1-16-ACE-47]; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK091318, P30DK056350, F31DK105747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055336, T32GM007092] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	University of North Carolina Genetics and Molecular Biology Training Grant through the NIGMS, National Institutes of Health; University of North Carolina Initiative to Maximize Student Diversity (IMSD) Diversity Fellowship Award through NIGMS, National Institutes of Health Grant; NIDDK/National Institutes of Health Grants; American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by University of North Carolina Genetics and Molecular Biology Training Grant T32GM007092 (to B. C. E. P.) through the NIGMS, National Institutes of Health; by the University of North Carolina Initiative to Maximize Student Diversity (IMSD) Diversity Fellowship Award (to B. C. E. P.) through NIGMS, National Institutes of Health Grant 5R25GM55336; NIDDK/National Institutes of Health Grants F31DK105747 (to B. C. E. P.), 5R00DK091318 (to P. S.), and P30DK056350 (to P. S.); and American Diabetes Association Grant 1-16-ACE-47 (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Andres SF, 2013, J CELL SCI, V126, P5645, DOI 10.1242/jcs.132985; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baran-Gale J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073240; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Belo J, 2013, STEM CELLS DEV, V22, P2935, DOI 10.1089/scd.2013.0106; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248; Chang TJ, 2016, CELL PROLIFERAT, V49, P207, DOI 10.1111/cpr.12246; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Dynoodt P, 2013, INT J ONCOL, V42, P1443, DOI 10.3892/ijo.2013.1823; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gil-Zamorano J, 2014, J NUTR, V144, P575, DOI 10.3945/jn.113.189050; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229; Hattori T, 2013, J BIOL CHEM, V288, P35138, DOI 10.1074/jbc.M113.486795; He P, 2015, INT J CLIN EXP MED, V8, P6510; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kanai Y, 2005, J BIOCHEM, V138, P13, DOI 10.1093/jb/mvi098; Kurtz CL, 2014, DIABETES, V63, P3141, DOI 10.2337/db13-1015; Lee S, 2014, STEM CELLS DEV, V23, P1798, DOI 10.1089/scd.2013.0609; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu SR, 2016, CELL HOST MICROBE, V19, P32, DOI 10.1016/j.chom.2015.12.005; Mah AT, 2014, ENDOCRINOLOGY, V155, P3302, DOI 10.1210/en.2014-1112; Martinez-Sanchez A, 2012, J BIOL CHEM, V287, P916, DOI 10.1074/jbc.M111.302430; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Nunn A.C, 2012, THESIS U COLL LONDON, P1; Peck BCE, 2015, INFLAMM BOWEL DIS, V21, P2178, DOI 10.1097/MIB.0000000000000478; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roche KC, 2015, GASTROENTEROLOGY, V149, P1553, DOI 10.1053/j.gastro.2015.07.004; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; She ZY, 2015, EUR J CELL BIOL, V94, P547, DOI 10.1016/j.ejcb.2015.08.002; Shi ZC, 2013, AM J PHYSIOL-GASTR L, V305, pG74, DOI 10.1152/ajpgi.00086.2013; Su WL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.23; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; VANBEERS EH, 1995, BIOCHEM J, V308, P769, DOI 10.1042/bj3080769; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005; Yu CC, 2013, CANCER RES, V73, P3425, DOI 10.1158/0008-5472.CAN-12-3840; Zhang YQ, 2012, FEBS LETT, V586, P4362, DOI 10.1016/j.febslet.2012.10.053; ZWEIBAUM A, 1983, INT J CANCER, V32, P407, DOI 10.1002/ijc.2910320403	60	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15975	15984		10.1074/jbc.M116.733733	http://dx.doi.org/10.1074/jbc.M116.733733			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27261459	Green Published, hybrid			2022-12-28	WOS:000380585400005
J	Xiong, YQ; Lee, HJ; Mariko, B; Lu, YC; Dannenberg, AJ; Haka, AS; Maxfield, FR; Camerer, E; Proia, RL; Hla, T				Xiong, Yuquan; Lee, Hyuek Jong; Mariko, Boubacar; Lu, Yi-Chien; Dannenberg, Andrew J.; Haka, Abigail S.; Maxfield, Frederick R.; Camerer, Eric; Proia, Richard L.; Hla, Timothy			Sphingosine kinases are not required for inflammatory responses in macrophages (vol 288, pg 32563, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Lee, Hyuek Jong/AAP-9190-2021; Hla, Timothy/G-5873-2012	Camerer, Eric/0000-0002-6271-7125; Proia, Richard/0000-0003-0456-1270; Hla, Timothy/0000-0001-8355-4065	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Xiong YQ, 2013, J BIOL CHEM, V288, P32563, DOI 10.1074/jbc.M113.483750	1	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11465	11465		10.1074/jbc.A113.483750	http://dx.doi.org/10.1074/jbc.A113.483750			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27226645	Green Published, hybrid			2022-12-28	WOS:000377042100046
J	Koo, J; Shiigi, S; Rohovie, M; Mehta, K; Swartz, JR				Koo, Jamin; Shiigi, Stacey; Rohovie, Marcus; Mehta, Kunal; Swartz, James R.			Characterization of [FeFe] Hydrogenase O-2 Sensitivity Using a New, Physiological Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme inactivation; enzyme kinetics; fusion protein; hydrogenase; metalloprotein	OXIDATIVE INACTIVATION; OXYGEN-TOLERANT; H-CLUSTER; CELL; GENERATION	[FeFe] hydrogenases catalyze rapid H-2 production but are highly O-2-sensitive. Developing O-2-tolerant enzymes is needed for sustainable H-2 production technologies, but the lack of a quantitative and predictive assay for O-2 tolerance has impeded progress. We describe a new approach to provide quantitative assessment of O-2 sensitivity by using an assay employing ferredoxin NADP(+) reductase (FNR) to transfer electrons from NADPH to hydrogenase via ferredoxins (Fd). Hydrogenase inactivation is measured during H-2 production in an O-2-containing environment. An alternative assay uses dithionite (DTH) to provide reduced Fd. This second assay measures the remaining hydrogenase activity in periodic samples taken from the NADPH-driven reaction solutions. The second assay validates the more convenient NADPH-driven assay, which better mimics physiological conditions. During development of the NADPH-driven assay and while characterizing the Clostridium pasteurianum (Cp) [FeFe] hydrogenase, CpI, we detected significant rates of direct electron loss from reduced Fd to O-2. However, this loss does not interfere with measurement of first order hydrogenase inactivation, providing rate constants insensitive to initial hydrogenase concentration. We show increased activity and O-2 tolerance for a protein fusion between Cp ferredoxin (CpFd) and CpI mediated by a 15-amino acid linker but not for a longer linker. We suggest that this precise, solution phase assay for [FeFe] hydrogenase O-2 sensitivity and the insights we provide constitute an important advance toward the discovery of the O-2-tolerant [FeFe] hydrogenases required for photosynthetic, biological H-2 production.	[Koo, Jamin; Rohovie, Marcus; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Shiigi, Stacey; Mehta, Kunal; Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Swartz, JR (corresponding author), Stanford Univ, Dept Chem Engn & Bioengn, 443 Via Ortega, Stanford, CA 94305 USA.	jswartz@stanford.edu			Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U. S. Department of Energy [DE-FG02-09ER46632]; Samsung Scholarship Foundation; Stanford Bio-X program; National Science Foundation (NSF) [1264289]; Div Of Chem, Bioeng, Env, & Transp Sys [1264289] Funding Source: National Science Foundation	Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U. S. Department of Energy(United States Department of Energy (DOE)); Samsung Scholarship Foundation(Samsung); Stanford Bio-X program; National Science Foundation (NSF)(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by grants from the Division of Material Sciences and Engineering (Award DE-FG02-09ER46632) of the Office of Basic Energy Sciences of the U. S. Department of Energy (to J. R. S. and J. K.). This work was also supported by the Samsung Scholarship Foundation (to J. K.), the Stanford Bio-X program (to K. M.), and National Science Foundation (NSF) Award Number 1264289 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abou Hamdan A, 2013, NAT CHEM BIOL, V9, P15, DOI [10.1038/nchembio.1110, 10.1038/NCHEMBIO.1110]; Agapakis Christina M, 2010, J Biol Eng, V4, P3, DOI 10.1186/1754-1611-4-3; Bingham AS, 2012, INT J HYDROGEN ENERG, V37, P2965, DOI 10.1016/j.ijhydene.2011.02.048; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Cohen J, 2005, STRUCTURE, V13, P1321, DOI 10.1016/j.str.2005.05.013; Demuez M, 2007, FEMS MICROBIOL LETT, V275, P113, DOI 10.1111/j.1574-6968.2007.00868.x; Fourmond V, 2014, NAT CHEM, V6, P336, DOI [10.1038/NCHEM.1892, 10.1038/nchem.1892]; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Gulaboski R, 2012, J SOLID STATE ELECTR, V16, P2315, DOI 10.1007/s10008-011-1397-5; Hallenbeck PC, 2012, BIORESOURCE TECHNOL, V110, P1, DOI 10.1016/j.biortech.2012.01.103; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; Heidary N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143101; Kim DH, 2011, BIORESOURCE TECHNOL, V102, P8423, DOI 10.1016/j.biortech.2011.02.113; Knorzer P, 2012, J BIOL CHEM, V287, P1489, DOI 10.1074/jbc.M111.305797; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Lu F, 2015, INT J HYDROGEN ENERG, V40, P9113, DOI 10.1016/j.ijhydene.2015.05.121; Lukey MJ, 2011, J AM CHEM SOC, V133, P16881, DOI 10.1021/ja205393w; MISRA HP, 1971, J BIOL CHEM, V246, P6886; Reisner E, 2009, J AM CHEM SOC, V131, P18457, DOI 10.1021/ja907923r; Shiigi S, 2016, THESIS STANFORD U; Smith PR, 2012, INT J HYDROGEN ENERG, V37, P2977, DOI 10.1016/j.ijhydene.2011.03.172; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Swanson KD, 2015, J AM CHEM SOC, V137, P1809, DOI 10.1021/ja510169s; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Wulff P, 2014, P NATL ACAD SCI USA, V111, P6606, DOI 10.1073/pnas.1322393111; Yacoby I, 2011, P NATL ACAD SCI USA, V108, P9396, DOI 10.1073/pnas.1103659108	26	13	13	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21563	21570		10.1074/jbc.M116.737122	http://dx.doi.org/10.1074/jbc.M116.737122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27435671	hybrid, Green Published			2022-12-28	WOS:000385999200023
J	Choi, SG; Wang, Q; Jia, JJ; Chikina, M; Pincas, H; Dolios, G; Sasaki, K; Wang, R; Minamino, N; Salton, SRJ; Sealfon, SC				Choi, Soon Gang; Wang, Qian; Jia, Jingjing; Chikina, Maria; Pincas, Hanna; Dolios, Georgia; Sasaki, Kazuki; Wang, Rong; Minamino, Naoto; Salton, Stephen R. J.; Sealfon, Stuart C.			Characterization of Gonadotrope Secretoproteome Identifies Neurosecretory Protein VGF-derived Peptide Suppression of Follicle-stimulating Hormone Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; NEUROENDOCRINE REGULATORY PEPTIDE-1; GNRH PULSE FREQUENCY; BETA-SUBUNIT TRANSCRIPTION; PITUITARY-CELL-CULTURES; EARLY BREAST-CANCER; IN-VIVO; DIFFERENTIAL REGULATION; L-BETA-T2 CELLS; MALE RATS	Reproductive function is controlled by the pulsatile release of hypothalamic gonadotropin-releasing hormone (GnRH), which regulates the expression of the gonadotropins luteinizing hormone and FSH in pituitary gonadotropes. Paradoxically, Fshb gene expression is maximally induced at lower frequency GnRH pulses, which provide a very low average concentration of GnRH stimulation. We studied the role of secreted factors in modulating gonadotropin gene expression. Inhibition of secretion specifically disrupted gonadotropin subunit gene regulation but left early gene induction intact. We characterized the gonadotrope secretoproteome and global mRNA expression at baseline and after G alpha(s) knockdown, which has been found to increase Fshb gene expression (1). We identified 1077 secreted proteins or peptides, 19 of which showed mRNA regulation by GnRH or/and G alpha(s) knockdown. Among several novel secreted factors implicated in Fshb gene regulation, we focused on the neurosecretory protein VGF. Vgf mRNA, whose gene has been implicated in fertility (2), exhibited high induction by GnRH and depended on G alpha(s). In contrast with Fshb induction, Vgf induction occurred preferentially at high GnRH pulse frequency. We hypothesized that a VGF-derived peptide might regulate Fshb gene induction. siRNA knockdown or extracellular immunoneutralization of VGF augmented Fshb mRNA induction by GnRH. GnRH stimulated the secretion of the VGF-derived peptide NERP1. NERP1 caused a concentration-dependent decrease in Fshb gene induction. These findings implicate a VGF-derived peptide in selective regulation of the Fshb gene. Our results support the concept that signaling specificity from the cell membrane GnRH receptor to the nuclear Fshb gene involves integration of intracellular signaling and exosignaling regulatory motifs.	[Choi, Soon Gang; Wang, Qian; Jia, Jingjing; Chikina, Maria; Pincas, Hanna; Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Dolios, Georgia; Wang, Rong] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Sealfon, Stuart C.] Icahn Sch Med Mt Sinai, Ctr Adv Res Diagnost Assays, New York, NY 10029 USA; [Salton, Stephen R. J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Sasaki, Kazuki; Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Mol Pharmacol, Osaka 5658565, Japan; [Choi, Soon Gang] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Cerebral & Cardiovascular Center - Japan; Harvard University; Dana-Farber Cancer Institute	Sealfon, SC (corresponding author), Icahn Sch Med Mt Sinai, Annenberg 14-44,Box 1137,One Gustave L Levy Pl, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	choi, soon gang/AAE-3187-2019; Wang, Qian/AAJ-6823-2021	choi, soon gang/0000-0003-0314-3958; Wang, Qian/0000-0001-5504-0008; SEALFON, Stuart/0000-0001-5791-1217; Salton, Stephen/0000-0003-4087-8427	National Institutes of Health [DK46943, R21/R33 MH083496, RO1 DE021996, RO1 MH086499, P30 NS061777, S10 RR022415]; Diabetes Action and Education Foundation; Hope for Depression Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046943, R01DK046943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086499, R33MH083496, R21MH083496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Action and Education Foundation; Hope for Depression Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants DK46943, R21/R33 MH083496, RO1 DE021996, RO1 MH086499, P30 NS061777, and S10 RR022415; the Diabetes Action and Education Foundation; and the Hope for Depression Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar E, 2013, NEUROENDOCRINOLOGY, V98, P38, DOI 10.1159/000350323; Alarid ET, 1996, DEVELOPMENT, V122, P3319; An BS, 2009, BIOL REPROD, V81, P243, DOI 10.1095/biolreprod.109.076216; Bar-Lev TH, 2015, MOL CELL ENDOCRINOL, V415, P12, DOI 10.1016/j.mce.2015.07.029; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Boerboom D, 2015, ENDOCRINOLOGY, V156, P323, DOI 10.1210/en.2014-1296; Choi SG, 2014, J BIOL CHEM, V289, P16164, DOI 10.1074/jbc.M113.537696; Choi SG, 2011, MOL ENDOCRINOL, V25, P1027, DOI 10.1210/me.2010-0387; Choi SG, 2012, J BIOL CHEM, V287, P21550, DOI 10.1074/jbc.M112.348607; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; Coss D, 2007, MOL ENDOCRINOL, V21, P3071, DOI 10.1210/me.2007-0247; D'Amato F, 2012, J CHEM NEUROANAT, V44, P57, DOI 10.1016/j.jchemneu.2012.05.001; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; Del Mastro L, 2011, CANCER TREAT REV, V37, P208, DOI 10.1016/j.ctrv.2010.07.007; Ely HA, 2011, MOL ENDOCRINOL, V25, P669, DOI 10.1210/me.2010-0437; Fargali S, 2012, J ENDOCRINOL, V215, P313, DOI 10.1530/JOE-12-0172; Faure MO, 2005, J ENDOCRINOL, V186, P109, DOI 10.1677/joe.1.05988; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; FERRI GL, 1995, ENDOCRINOLOGY, V136, P2244, DOI 10.1210/en.136.5.2244; Fortin J, 2014, FASEB J, V28, P3396, DOI 10.1096/fj.14-249532; Fortin J, 2014, FASEB J, V28, P1474, DOI 10.1096/fj.13-237818; Fortin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059058; Fujii Y, 2002, MOL CELL ENDOCRINOL, V192, P55, DOI 10.1016/S0303-7207(02)00109-0; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Hackshaw A, 2009, JNCI-J NATL CANCER I, V101, P341, DOI 10.1093/jnci/djn498; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Haisenleder DJ, 2008, ENDOCRINOLOGY, V149, P139, DOI 10.1210/en.2007-1113; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Ho CC, 2009, BIOL REPROD, V81, P133, DOI 10.1095/biolreprod.108.074211; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2275, DOI 10.1210/en.142.6.2275; Humaidan P, 2012, REPROD BIOMED ONLINE, V24, P134, DOI 10.1016/j.rbmo.2011.11.001; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Kanasaki H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105601; Kanasaki H, 2009, BIOL REPROD, V81, P465, DOI 10.1095/biolreprod.108.074765; Kim DK, 2009, CANCER RES, V69, P923, DOI 10.1158/0008-5472.CAN-08-2115; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lee KB, 2007, J MOL ENDOCRINOL, V38, P315, DOI 10.1677/jme.1.02196; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Liu FJ, 2002, J BIOL CHEM, V277, P32099, DOI 10.1074/jbc.M203639200; Liu FJ, 2002, MOL ENDOCRINOL, V16, P419, DOI 10.1210/me.16.3.419; MARSHALL JC, 1986, NEW ENGL J MED, V315, P1459; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; McNeilly AS, 2003, REPRODUCTION, P463; Melis MR, 2012, REGUL PEPTIDES, V177, P46, DOI 10.1016/j.regpep.2012.04.007; Mishiro-Sato E, 2010, J NEUROCHEM, V114, P1097, DOI 10.1111/j.1471-4159.2010.06827.x; Mistry DS, 2011, MOL ENDOCRINOL, V25, P1387, DOI 10.1210/me.2011-0032; Naidich M, 2010, ENDOCRINOLOGY, V151, P2700, DOI 10.1210/en.2009-1335; NAOR Z, 1986, J BIOL CHEM, V261, P2506; Naor Z, 2007, MOL ENDOCRINOL, V21, P524, DOI 10.1210/me.2006-0253; Nicol L, 2008, J ENDOCRINOL, V196, P497, DOI 10.1677/jOE-07-0542; Noel SD, 2011, MOL CELL ENDOCRINOL, V346, P91, DOI 10.1016/j.mce.2011.06.022; Noli B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108456; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Otsuka F, 2002, ENDOCRINOLOGY, V143, P4938, DOI 10.1210/en.2002-220929; Petrella C, 2012, PEPTIDES, V36, P133, DOI 10.1016/j.peptides.2012.03.035; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Pincas H, 2014, MOL CELL ENDOCRINOL, V385, P56, DOI 10.1016/j.mce.2013.08.015; Pinilla L, 2011, AM J PHYSIOL-ENDOC M, V300, pE837, DOI 10.1152/ajpendo.00598.2010; Rindi G, 2007, J CLIN ENDOCR METAB, V92, P2811, DOI 10.1210/jc.2007-0035; Sadahiro M, 2015, ENDOCRINOLOGY, V156, P1724, DOI 10.1210/en.2014-1826; Sasaki K, 2013, MOL CELL PROTEOMICS, V12, P700, DOI 10.1074/mcp.M112.017400; Sasaki K, 2010, J PROTEOME RES, V9, P5047, DOI 10.1021/pr1003455; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Severini C, 2009, BRIT J PHARMACOL, V157, P984, DOI 10.1111/j.1476-5381.2009.00192.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Succu S, 2004, EUR J NEUROSCI, V20, P3035, DOI 10.1111/j.1460-9568.2004.03781.x; Suszko MI, 2005, MOL ENDOCRINOL, V19, P1849, DOI 10.1210/me.2004-0475; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Thompson IR, 2014, MOL CELL ENDOCRINOL, V385, P28, DOI 10.1016/j.mce.2013.09.012; Thompson IR, 2013, MOL ENDOCRINOL, V27, P606, DOI 10.1210/me.2012-1281; TSUJII T, 1995, MOL CELL ENDOCRINOL, V113, P123, DOI 10.1016/0303-7207(95)03613-C; Tsutsumi R, 2010, J BIOL CHEM, V285, P20262, DOI 10.1074/jbc.M110.132662; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Van Poppel H, 2012, INT J UROL, V19, P594, DOI 10.1111/j.1442-2042.2012.02997.x; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang Y, 2014, ENDOCRINOLOGY, V155, P1970, DOI 10.1210/en.2013-1741; Winters SJ, 2011, BIOL REPROD, V84, P844, DOI 10.1095/biolreprod.110.087593; Xie HM, 2015, MOL ENDOCRINOL, V29, P842, DOI 10.1210/me.2014-1279; Yamaguchi H, 2007, J BIOL CHEM, V282, P26354, DOI 10.1074/jbc.M701665200; Young JM, 2008, J ENDOCRINOL, V196, P251, DOI 10.1677/JOE-07-0148	85	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21322	+		10.1074/jbc.M116.740365	http://dx.doi.org/10.1074/jbc.M116.740365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27466366	Green Published, hybrid			2022-12-28	WOS:000385406200042
J	Mourino, S; Giardina, BJ; Reyes-Caballero, H; Wilks, A				Mourino, Susana; Giardina, Bennett J.; Reyes-Caballero, Hermes; Wilks, Angela			Metabolite-driven Regulation of Heme Uptake by the Biliverdin IX/-Selective Heme Oxygenase (HemO) of Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial genetics; heme; heme oxygenase; mass spectrometry (MS); Pseudomonas aeruginosa (P; aeruginosa); signaling; biliverdin	GRAM-NEGATIVE BACTERIA; BINDING PROTEIN PHUS; ACQUISITION; SYSTEM; RECOMBINATION; DEGRADATION; EXPRESSION; CLEAVAGE; PRODUCT; GENE	Pseudomonas aeruginosa acquires extracellular heme via the Phu (Pseudomonasheme uptake) and Has (heme assimilation system) systems. We have previously shown the catalytic actions of heme oxygenase (HemO) along with the cytoplasmic heme transport protein PhuS control heme flux into the cell. To further investigate the role of the PhuS-HemO couple in modulating heme uptake, we have characterized two HemO variants, one that is catalytically inactive (HemO H26A/K34A/K132A or HemO(in)) and one that has altered regioselectivity (HemO N19K/K34A/F117Y/K132A or HemO), producing biliverdin IX (BVIX). HemO similar to wild type was able to interact and acquire heme from holo-PhuS. In contrast, the HemO(in) variant did not interact with holo-PhuS and showed no enzymatic activity. Complementation of a hemO deletion strain with the hemO(in) or hemO variants in combination with [C-13]heme isotopic labeling experiments revealed that the absence of BVIX and BVIX leads to a decrease in extracellular levels of hemophore HasA. We propose BVIX and/or BVIX transcriptionally or post-transcriptionally regulates HasA. Thus, coupling the PhuS-dependent flux of heme through HemO to feedback regulation of the cell surface signaling system through HasA allows P. aeruginosa to rapidly respond to fluctuating extracellular heme levels independent of the iron status of the cell.	[Mourino, Susana; Giardina, Bennett J.; Reyes-Caballero, Hermes; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, HSF 2,20 Penn St, Baltimore, MD 21201 USA; [Reyes-Caballero, Hermes] Johns Hopkins Univ, Dept Environm Hlth Sci, Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Wilks, A (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, HSF 2,20 Penn St, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu	Mouriño, Susana/K-3785-2019		National Institutes of Health [AI102883]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI102883 (to A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barker KD, 2012, J BIOL CHEM, V287, P18342, DOI 10.1074/jbc.M112.359265; Biville F, 2004, MOL MICROBIOL, V53, P1267, DOI 10.1111/j.1365-2958.2004.04207.x; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Cornelis P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00075; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Letoffe S, 1996, EMBO J, V15, P5804, DOI 10.1002/j.1460-2075.1996.tb00967.x; Letoffe S, 2004, J BACTERIOL, V186, P4067, DOI 10.1128/JB.186.13.4067-4074.2004; O'Neill MJ, 2013, ACS CHEM BIOL, V8, P1794, DOI 10.1021/cb400165b; O'Neill MJ, 2012, P NATL ACAD SCI USA, V109, P5639, DOI 10.1073/pnas.1121549109; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; Smith AD, 2015, J BIOL CHEM, V290, P7756, DOI 10.1074/jbc.M114.633495; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wilks A, 2011, HANDB PORPHYR SCI, V15, P357; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	28	27	27	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20503	20515		10.1074/jbc.M116.728527	http://dx.doi.org/10.1074/jbc.M116.728527			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27493207	hybrid, Green Published			2022-12-28	WOS:000384574800017
J	Fuller, JJ; Ropke, R; Krausze, J; Rennhack, KE; Daniel, NP; Blankenfeldt, W; Schulz, S; Jahn, D; Moser, J				Fueller, Janis J.; Roepke, Rene; Krausze, Joern; Rennhack, Kim E.; Daniel, Nils P.; Blankenfeldt, Wulf; Schulz, Stefan; Jahn, Dieter; Moser, Juergen			Biosynthesis of Violacein, Structure and Function of l-Tryptophan Oxidase VioA from Chromobacterium violaceum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mechanism; flavoprotein; site-directed mutagenesis; substrate specificity; L-tryptophan oxidase; enzyme-inhibitor complex; redox chemistry; violacein	AMINO-ACID OXIDASE; CHROMOPYRROLIC ACID; CRYSTAL-STRUCTURE; HIGH-RESOLUTION; GENE-CLUSTER; REBECCAMYCIN; INDOLOCARBAZOLE; SUBSTRATE; GENERATION; ANTITUMOR	Violacein is a natural purple pigment of Chromobacterium violaceum with potential medical applications as antimicrobial, antiviral, and anticancer drugs. The initial step of violacein biosynthesis is the oxidative conversion of L-tryptophan into the corresponding alpha-imine catalyzed by the flavoenzyme L-tryptophan oxidase (VioA). A substrate-related (3-(1H-indol-3-yl)-2-methylpropanoic acid) and a product-related (2-(1H-indol- 3-ylmethyl)prop-2-enoic acid) competitive VioA inhibitor was synthesized for subsequent kinetic and x-ray crystallographic investigations. Structures of the binary VioA.FADH(2) and of the ternary VioA.FADH(2).2-(1H-indol-3-ylmethyl)prop-2-enoic acid complex were resolved. VioA forms a "loosely associated" homodimer as indicated by small-angle x-ray scattering experiments. VioA belongs to the glutathione reductase family 2 of FAD-dependent oxidoreductases according to the structurally conserved cofactor binding domain. The substrate-binding domain of VioA is mainly responsible for the specific recognition of L-tryptophan. Other canonical amino acids were efficiently discriminated with a minor conversion of L-phenylalanine. Furthermore, 7-aza-tryptophan, 1-methyl-tryptophan, 5-methyl-tryptophan, and 5-fluoro-tryptophan were efficient substrates of VioA. The ternary product-related VioA structure indicated involvement of protein domain movement during enzyme catalysis. Extensive structure-based mutagenesis in combination with enzyme kinetics (using L-tryptophan and substrate analogs) identified Arg(64), Lys(269), and Tyr(309) as key catalytic residues of VioA. An increased enzyme activity of protein variant H163A in the presence of L-phenylalanine indicated a functional role of His(163) in substrate binding. The combined structural and mutational analyses lead to the detailed understanding of VioA substrate recognition. Related strategies for the in vivo synthesis of novel violacein derivatives are discussed.	[Fueller, Janis J.; Rennhack, Kim E.; Daniel, Nils P.; Jahn, Dieter; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany; [Blankenfeldt, Wulf] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Spielmannstr 7, D-38106 Braunschweig, Germany; [Roepke, Rene; Schulz, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, Hagenring 30, D-38106 Braunschweig, Germany; [Krausze, Joern; Blankenfeldt, Wulf] Helmholtz Ctr Infect Res, Struct & Funct Prot, Inhoffenstr 7, D-38124 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Jahn, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	d.jahn@tu-bs.de	Blankenfeldt, Wulf/F-8877-2010	Blankenfeldt, Wulf/0000-0001-9886-9668; Jahn, Dieter/0000-0002-4064-9205; Schulz, Stefan/0000-0002-4810-324X	Government of Niedersachsen, Graduate School MINAS Microbial Natural Products	Government of Niedersachsen, Graduate School MINAS Microbial Natural Products	This work was supported by the Government of Niedersachsen, Graduate School MINAS Microbial Natural Products. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anizon F, 1997, J MED CHEM, V40, P3456, DOI 10.1021/jm9702084; Antonio Regina Vasconcellos, 2004, Genet Mol Res, V3, P85; Asamizu S, 2006, TETRAHEDRON LETT, V47, P473, DOI 10.1016/j.tetlet.2005.11.061; Asamizu S, 2012, CHEMBIOCHEM, V13, P2495, DOI 10.1002/cbic.201200535; August PR, 2000, J MOL MICROB BIOTECH, V2, P513; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Baskaran K, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0022-0; Blanchard M, 1944, J BIOL CHEM, V155, P421; Borrell JI, 1998, J MED CHEM, V41, P3539, DOI 10.1021/jm9801298; Burkhardt A, 2016, EUR PHYS J PLUS, V131, P1, DOI 10.1140/epjp/i2016-16056-0; Chen HS, 2012, BIOCHIMIE, V94, P335, DOI 10.1016/j.biochi.2011.07.022; Cuenca-Lopez MD, 2015, ONCOTARGET, V6, P27923, DOI 10.18632/oncotarget.4736; Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747; Duran N, 2007, BIOTECHNOL APPL BIOC, V48, P127, DOI 10.1042/BA20070115; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faust A, 2007, J MOL BIOL, V367, P234, DOI 10.1016/j.jmb.2006.11.071; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Geueke B, 2002, ENZYME MICROB TECH, V31, P77, DOI 10.1016/S0141-0229(02)00072-8; Hirano S, 2008, J BIOL CHEM, V283, P6459, DOI 10.1074/jbc.M708109200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLZAPFEL CW, 1994, SYNTHETIC COMMUN, V24, P3197, DOI 10.1080/00397919408010241; Howard-Jones AR, 2005, BIOCHEMISTRY-US, V44, P15652, DOI 10.1021/bi051706e; Ida K, 2008, J BIOL CHEM, V283, P16584, DOI 10.1074/jbc.M800366200; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kachalova G, 2011, P NATL ACAD SCI USA, V108, P4800, DOI 10.1073/pnas.1016684108; Kameya M, 2013, ANAL BIOCHEM, V438, P124, DOI 10.1016/j.ab.2013.03.024; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kwon Youn I., 1986, TETRAHEDRON LETT, V27, P2409; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Macheroux P, 1999, METH MOL B, V131, P1; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORI K, 1986, TETRAHEDRON, V42, P5281, DOI 10.1016/S0040-4020(01)82077-9; Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032; MUELLER U, 2015, EPJ PLUS, V130, P1; Niall H D, 1973, Methods Enzymol, V27, P942; Nishizawa T, 2005, J BACTERIOL, V187, P2084, DOI 10.1128/JB.187.6.2084-2092.2005; Onaka H, 2003, BIOSCI BIOTECH BIOCH, V67, P127, DOI 10.1271/bbb.67.127; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Pierce LT, 2011, TETRAHEDRON, V67, P4601, DOI 10.1016/j.tet.2011.04.077; Pozzi MH, 2010, ARCH BIOCHEM BIOPHYS, V498, P83, DOI 10.1016/j.abb.2010.04.015; Sanchez C, 2002, CHEM BIOL, V9, P519, DOI 10.1016/S1074-5521(02)00126-6; Sanchez C, 2006, CHEMBIOCHEM, V7, P1231, DOI 10.1002/cbic.200600029; Sanchez C, 2009, CHEM COMMUN, P4118, DOI 10.1039/b905068j; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shinoda K, 2007, CHEM COMMUN, P4140, DOI 10.1039/b705358d; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spolitak T, 2015, ARCH BIOCHEM BIOPHYS, V573, P111, DOI 10.1016/j.abb.2015.03.020; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tilocca A, 2002, BIOCHEMISTRY-US, V41, P14111, DOI 10.1021/bi020309q; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wartmann T, 2013, EUR J ORG CHEM, V2013, P1649, DOI 10.1002/ejoc.201201726; WELLNER D, 1961, J BIOL CHEM, V236, P2357; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yu CZ, 2001, J ORG CHEM, V66, P5413, DOI 10.1021/jo015628m	67	29	31	3	47	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20068	20084		10.1074/jbc.M116.741561	http://dx.doi.org/10.1074/jbc.M116.741561			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27466367	hybrid, Green Published			2022-12-28	WOS:000383243100029
J	Liao, Y; Chu, HP; Hu, ZX; Merkin, JJ; Chen, JM; Liu, ZG; Degenhardt, K; White, E; Ryazanov, AG				Liao, Yi; Chu, Hsueh-Ping; Hu, Zhixian; Merkin, Jason J.; Chen, Jianmin; Liu, Zuguo; Degenhardt, Kurt; White, Eileen; Ryazanov, Alexey G.			Paradoxical Roles of Elongation Factor-2 Kinase in Stem Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell cycle; cell death; radiation biology; stem cells; eukaryotic elongation factor-2 kinase (eEF2K); mitotic catastrophe	INDUCED GASTROINTESTINAL SYNDROME; DNA-DAMAGE CHECKPOINTS; MITOTIC CATASTROPHE; IONIZING-RADIATION; EEF2 KINASE; MOLECULAR-MECHANISMS; PROTEIN-SYNTHESIS; APOPTOSIS; MICE; PHOSPHORYLATION	Protein synthesis inhibition is an immediate response during stress to switch the composition of protein pool in order to adapt to the new environment. It was reported that this response could be either protective or deleterious. However, how cells choose to live or die upon protein synthesis inhibition is largely unknown. Previously, we have shown that elongation factor-2 kinase (eEF2K), a protein kinase that suppresses protein synthesis during elongation phase, is a positive regulator of apoptosis both in vivo and in vitro. Consistently, here we report that knock-out of eEF2K protects mice from a lethal dose of whole-body ionizing radiation at 8 Gy by reducing apoptosis levels in both bone marrow and gastrointestinal tracts. Surprisingly, similar to the loss of p53, eEF2K deficiency results in more severe damage to the gastrointestinal tract at 20 Gy with the increased mitotic cell death in small intestinal stem cells. Furthermore, using epithelial cell lines, we showed that eEF2K is required for G(2)/M arrest induced by radiation to prevent mitotic catastrophe in a p53-independent manner. Specifically, we observed the elevation of Akt/ERK activity as well as the reduction of p21 expression in Eef2k(-/-) cells. Therefore, eEF2K also provides a protective strategy to maintain genomic integrity by arresting cell cycle in response to stress. Our results suggest that protective versus pro-apoptotic roles of eEF2K depend on the type of cells: eEF2K is protective in highly proliferative cells, such as small intestinal stem cells and cancer cells, which are more susceptible to mitotic catastrophe.	[Liao, Yi; Liu, Zuguo] Xiamen Univ, Inst Eye, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen 361102, Fujian, Peoples R China; [Liao, Yi; Chu, Hsueh-Ping; Hu, Zhixian; Merkin, Jason J.; Ryazanov, Alexey G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Chen, Jianmin] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Liu, Zuguo] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen 361102, Fujian, Peoples R China; [Degenhardt, Kurt; White, Eileen] Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Chu, Hsueh-Ping] Harvard Med Sch, Dept Genet, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Xiamen University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Xiamen University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Harvard University; Harvard Medical School; Massachusetts General Hospital	Ryazanov, AG (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	ryazanag@rwjms.rutgers.edu	White, Eileen/ABD-6745-2021; ryazanov, alexey/J-8081-2017	White, Eileen/0000-0003-2961-3065; 	National Institutes of Health [R01GM57300, R01CA81102, R01AG19890, RC1AI078513, R03TW008217, R21AG042870]; Ministry of Education of the People's Republic of China; FOGARTY INTERNATIONAL CENTER [R03TW008217] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA081102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI078513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019890, R21AG042870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education of the People's Republic of China(Ministry of Education, China); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01GM57300, R01CA81102, R01AG19890, RC1AI078513, R03TW008217, and R21AG042870 and the Ministry of Education of the People's Republic of China. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chu HP, 2014, DEV CELL, V28, P561, DOI 10.1016/j.devcel.2014.01.027; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Cohen-Jonathan E, 1999, CURR OPIN CHEM BIOL, V3, P77, DOI 10.1016/S1367-5931(99)80014-3; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Degenhardt K, 2006, CLIN CANCER RES, V12, P5298, DOI 10.1158/1078-0432.CCR-06-0439; Dorovkov MV, 2002, BIOCHEMISTRY-US, V41, P13444, DOI 10.1021/bi026494p; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Galluzzi L, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00005; Gudkov AV, 2010, J CLIN INVEST, V120, P2270, DOI 10.1172/JCI43794; Hizli AA, 2013, MOL CELL BIOL, V33, P596, DOI 10.1128/MCB.01270-12; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; Leibowitz BJ, 2011, MOL CANCER RES, V9, P616, DOI 10.1158/1541-7786.MCR-11-0052; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; Neta R, 1995, ANN NY ACAD SCI, V762, P274; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Portugal J, 2010, CURR PHARM DESIGN, V16, P69, DOI 10.2174/138161210789941801; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanli T, 2014, CANCER BIOL THER, V15, P156, DOI 10.4161/cbt.26726; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; Sullivan JM, 2012, RADIAT RES, V177, P307, DOI 10.1667/RR2545.1; Tao WK, 2005, CELL CYCLE, V4, P1495, DOI 10.4161/cc.4.11.2130; van Vugt MATM, 2010, CELL CYCLE, V9, P2097, DOI 10.4161/cc.9.11.11840; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; White-Gilbertson S, 2009, MOL ONCOL, V3, P402, DOI 10.1016/j.molonc.2009.05.003	46	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19545	19557		10.1074/jbc.M116.724856	http://dx.doi.org/10.1074/jbc.M116.724856			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27466362	Green Published, hybrid			2022-12-28	WOS:000383242800030
J	Schmidt, T; Ye, F; Situ, AJ; An, W; Ginsberg, MH; Ulmer, TS				Schmidt, Thomas; Ye, Feng; Situ, Alan J.; An, Woojin; Ginsberg, Mark H.; Ulmer, Tobias S.			A Conserved Ectodomain-Transmembrane Domain Linker Motif Tunes the Allosteric Regulation of Cell Surface Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cytokine; integrin; isothermal titration calorimetry (ITC); nuclear magnetic resonance (NMR); protein dynamics; receptor signaling; transmembrane cell surface receptors	GROWTH-FACTOR RECEPTOR; INTEGRIN ACTIVATION; DIPOLAR COUPLINGS; PROTEIN STRUCTURES; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; CHEMICAL-SHIFTS; ALPHA-SUBUNIT; COMPLEX	In many families of cell surface receptors, a single transmembrane (TM) -helix separates ecto- and cytosolic domains. A defined coupling of ecto- and TM domains must be essential to allosteric receptor regulation but remains little understood. Here, we characterize the linker structure, dynamics, and resulting ecto-TM domain coupling of integrin IIb in model constructs and relate it to other integrin subunits by mutagenesis. Cellular integrin activation assays subsequently validate the findings in intact receptors. Our results indicate a flexible yet carefully tuned ecto-TM coupling that modulates the signaling threshold of integrin receptors. Interestingly, a proline at the N-terminal TM helix border, termed NBP, is critical to linker flexibility in integrins. NBP is further predicted in 21% of human single-pass TM proteins and validated in cytokine receptors by the TM domain structure of the cytokine receptor common subunit and its P441A-substituted variant. Thus, NBP is a conserved uncoupling motif of the ecto-TM domain transition and the degree of ecto-TM domain coupling represents an important parameter in the allosteric regulation of diverse cell surface receptors.	[Schmidt, Thomas; Situ, Alan J.; Ulmer, Tobias S.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Schmidt, Thomas; Situ, Alan J.; Ulmer, Tobias S.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [An, Woojin] Univ Southern Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [An, Woojin] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Schmidt, Thomas] NIDDK, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA	University of Southern California; University of Southern California; University of California System; University of California San Diego; University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ulmer, TS (corresponding author), 1501 San Pablo St,ZNI 111, Los Angeles, CA 90033 USA.	tulmer@usc.edu			American Heart Association [15GRNT23200010]; National Institutes of Health [HL31950, HL078784, HL117807]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117807, P01HL031950, P01HL078784] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 15GRNT23200010 (to T. S. U.) and National Institutes of Health Grants HL31950, HL078784, and HL117807 (to M. H. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bessman NJ, 2014, CURR OPIN STRUC BIOL, V29, P95, DOI 10.1016/j.sbi.2014.10.002; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Dai A, 2015, J BIOL CHEM, V290, P27168, DOI 10.1074/jbc.M115.682377; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong XC, 2012, BIOCHEMISTRY-US, V51, P8814, DOI 10.1021/bi300734n; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; Grigoryan G, 2011, ANNU REV BIOCHEM, V80, P211, DOI 10.1146/annurev-biochem-091008-152423; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hercus TR, 2013, CYTOKINE GROWTH F R, V24, P189, DOI 10.1016/j.cytogfr.2013.03.002; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Jaroniec CP, 2004, J BIOMOL NMR, V30, P181, DOI 10.1023/B:JNMR.0000048946.71249.2f; Kalli AC, 2010, STRUCTURE, V18, P1280, DOI 10.1016/j.str.2010.07.012; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; KAMATH U, 1989, J BIOL CHEM, V264, P5586; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li RH, 2002, BIOCHEMISTRY-US, V41, P15618, DOI 10.1021/bi026822l; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Maruyama IN, 2015, BIOESSAYS, V37, P959, DOI 10.1002/bies.201500041; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Scheck RA, 2012, ACS CHEM BIOL, V7, P1367, DOI 10.1021/cb300216f; SCHIMMEL PR, 1968, J MOL BIOL, V34, P105, DOI 10.1016/0022-2836(68)90237-4; Schlessinger J, 2014, COLD SPRING HARBOR P, V6; Schmidt T, 2015, J BIOL CHEM, V290, P8283, DOI 10.1074/jbc.M114.623504; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHATTIL SJ, 1987, BLOOD, V70, P307; Shelar A, 2014, PROTEINS, V82, P3420, DOI 10.1002/prot.24696; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Situ AJ, 2014, J MOL BIOL, V426, P3670, DOI 10.1016/j.jmb.2014.08.020; Suk JE, 2012, J AM CHEM SOC, V134, P9030, DOI 10.1021/ja304247f; Surya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074281; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Wang W, 2010, BIOCHEMISTRY-US, V49, P10158, DOI 10.1021/bi101462h; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	60	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17536	17546		10.1074/jbc.M116.733683	http://dx.doi.org/10.1074/jbc.M116.733683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365391	hybrid, Green Published			2022-12-28	WOS:000383241300006
J	Wang, Y; Wang, R; Jin, F; Liu, Y; Yu, JY; Fu, XM; Chang, ZY				Wang, Yan; Wang, Rui; Jin, Feng; Liu, Yang; Yu, Jiayu; Fu, Xinmiao; Chang, Zengyi			A Supercomplex Spanning the Inner and Outer Membranes Mediates the Biogenesis of beta-Barrel Outer Membrane Proteins in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; IN-VIVO; CHAPERONE; COMPLEX; SURA; SHOCK; BAMA; TRANSLOCON; RELEASE; ACID	beta-barrel outer membrane proteins (OMPs) are ubiquitously present in Gram-negative bacteria, mitochondria and chloroplasts, and function in a variety of biological processes. The mechanism by which the hydrophobic nascent beta-barrel OMPs are transported through the hydrophilic periplasmic space in bacterial cells remains elusive. Here, mainly via unnatural amino acid-mediated in vivo photo-crosslinking studies, we revealed that the primary periplasmic chaperone SurA interacts with nascent beta-barrel OMPs largely via its N-domain but with beta-barrel assembly machine protein BamA mainly via its satellite P2 domain, and that the nascent beta-barrel OMPs interact with SurA via their N- and C-terminal regions. Additionally, via dual in vivo photo-crosslinking, we demonstrated the formation of a ternary complex involving beta-barrel OMP, SurA, and BamA in cells. More importantly, we found that a supercomplex spanning the inner and outer membranes and involving the BamA, BamB, SurA, PpiD, SecY, SecE, and SecA proteins appears to exist in living cells, as revealed by a combined analyses of sucrose-gradient ultra-centrifugation, Blue native PAGE and mass spectrometry. We propose that this supercomplex integrates the translocation, transportation, and membrane insertion events for beta-barrel OMP biogenesis.	[Wang, Yan; Wang, Rui; Jin, Feng; Liu, Yang; Yu, Jiayu; Fu, Xinmiao; Chang, Zengyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Fu, Xinmiao; Chang, Zengyi] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China; [Jin, Feng] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Fu, XM; Chang, ZY (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Fu, XM; Chang, ZY (corresponding author), Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China.	fuxinmiao@pku.edu.cn; changzy@pku.edu.cn	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904	National Basic Research Program of China (973 Program) [2012CB917300]; National Natural Science Foundation of China [31470766, 31270804, 31570778]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Research Grant 2012CB917300 (to Z. Y. C. and X. M. F.) from the National Basic Research Program of China (973 Program) and Research Grants 31470766 (to Z. Y. C.) and 31270804 and 31570778 (to X. M. F.) from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Chen YC, 2005, J CHIN INST CHEM ENG, V36, P527; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Fu XM, 2013, J BIOL CHEM, V288, P11897, DOI 10.1074/jbc.M113.450437; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Ge X, 2014, FEBS J, V281, P1226, DOI 10.1111/febs.12701; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W; Kim KH, 2012, PROTEIN SCI, V21, P751, DOI 10.1002/pro.2069; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; McMorran LM, 2014, ARCH BIOCHEM BIOPHYS, V564, P265, DOI 10.1016/j.abb.2014.02.011; NEU HC, 1965, J BIOL CHEM, V240, P3685; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Sachelaru I, 2014, J BIOL CHEM, V289, P21706, DOI 10.1074/jbc.M114.577916; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sinnige T, 2014, J MOL BIOL, V426, P2009, DOI 10.1016/j.jmb.2014.02.007; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	32	37	38	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16720	16729		10.1074/jbc.M115.710715	http://dx.doi.org/10.1074/jbc.M115.710715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27298319	hybrid, Green Published			2022-12-28	WOS:000380826700029
J	Zhang, TZ; Sell, P; Braun, U; Leitges, M				Zhang, Tianzhou; Sell, Philipp; Braun, Ursula; Leitges, Michael			PKD1 protein is involved in reactive oxygen species-mediated mitochondrial depolarization in cooperation with protein kinase C delta (PKC delta) (vol 290, pg 10472, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995				Zhang TZ, 2015, J BIOL CHEM, V290, P10472, DOI 10.1074/jbc.M114.619148	1	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16877	16877		10.1074/jbc.A114.619148	http://dx.doi.org/10.1074/jbc.A114.619148			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27496959	Green Published, hybrid			2022-12-28	WOS:000380826700042
J	Offermann, LR; Schlachter, CR; Perdue, ML; Majorek, KA; He, JZ; Booth, WT; Garrett, J; Kowal, K; Chruszcz, M				Offermann, Lesa R.; Schlachter, Caleb R.; Perdue, Makenzie L.; Majorek, Karolina A.; He, John Z.; Booth, William T.; Garrett, Jessica; Kowal, Krzysztof; Chruszcz, Maksymilian			Structural, Functional, and Immunological Characterization of Profilin Panallergens Amb a 8, Art v 4, and Bet v 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CROSS-REACTIVITY; PROTEIN FAMILIES; ALLERGENIC REACTIVITY; IMMUNOGLOBULIN-E; MAJOR ALLERGEN; IGE EPITOPES; POLLEN; SENSITIZATION; IDENTIFICATION	Ragweed allergens affect several million people in the United States and Canada. To date, only two ragweed allergens, Ambt 5 and Amb a 11, have their structures determined and deposited to the Protein Data Bank. Here, we present structures of methylated ragweed allergen Amb a 8, Amb a 8 in the presence of poly(L-proline), and Art v 4 (mugwort allergen). Amb a 8 and Art v 4 are panallergens belonging to the profilin family of proteins. They share significant sequence and structural similarities, which results in cross-recognition by IgE antibodies. Molecular and immunological properties of Amb a 8 and Art v 4 are compared with those of Bet v 2 (birch pollen allergen) as well as with other allergenic profilins. We purified recombinant allergens that are recognized by patient IgE and are highly cross-reactive. It was determined that the analyzed allergens are relatively unstable. Structures of Amb a 8 in complex with poly(L-proline) 10 or poly(L-proline) 14 are the first structures of the plant profilin in complex with proline-rich peptides. Amb a 8 binds the poly(L-proline) in a mode similar to that observed in human, mouse, and P. falciparum profilin.peptide complexes. However, only some of the residues that form the peptide binding site are conserved.	[Offermann, Lesa R.; Schlachter, Caleb R.; Perdue, Makenzie L.; He, John Z.; Booth, William T.; Garrett, Jessica; Chruszcz, Maksymilian] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Offermann, Lesa R.] Davidson Coll, Dept Chem, Davidson, NC 28035 USA; [Majorek, Karolina A.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Kowal, Krzysztof] Med Univ Bialystok, Dept Allergol & Internal Med, PL-15276 Bialystok, Poland; [Kowal, Krzysztof] Med Univ Bialystok, Dept Expt Allergol & Immunol, PL-15276 Bialystok, Poland	University of South Carolina System; University of South Carolina Columbia; Davidson College; University of Virginia; Medical University of Bialystok; Medical University of Bialystok	Chruszcz, M (corresponding author), Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.	chruszcz@mailbox.sc.edu	Chruszcz, Maksymilian/E-6407-2011	Chruszcz, Maksymilian/0000-0001-7521-5485; Offermann, Lesa/0000-0002-0365-7978; /0000-0002-0910-1292	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The structural results shown here are derived from work performed at Argonne National Laboratory, at the Southeast Regional Collaborative Access Team (SER-CAT) and the Life Sciences Collaborative Access Team (LS-CAT) of the Advanced Photon Source. Supporting institutions for SER-CAT may be found on the SER-CAT website. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado MI, 2014, ALLERGY, V69, P1610, DOI 10.1111/all.12509; Asero R, 2008, CLIN EXP ALLERGY, V38, P1033, DOI 10.1111/j.1365-2222.2008.02980.x; Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x; Asero R, 2003, J ALLERGY CLIN IMMUN, V112, P427, DOI 10.1067/mai.2003.1611; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Asturias JA, 2002, INT IMMUNOL, V14, P993, DOI 10.1093/intimm/dxf070; Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Barderas R, 2004, J ALLERGY CLIN IMMUN, V113, P1192, DOI 10.1016/j.jaci.2003.12.587; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Behnen M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-34; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Bonura A, 2014, MOL IMMUNOL, V57, P220, DOI 10.1016/j.molimm.2013.09.004; Boopathy S, 2015, P NATL ACAD SCI USA, V112, P7984, DOI 10.1073/pnas.1424108112; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Cases B, 2010, INT ARCH ALLERGY IMM, V153, P215, DOI 10.1159/000314361; Crespo JF, 2006, MOL NUTR FOOD RES, V50, P282, DOI 10.1002/mnfr.200500200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gadermaier G, 2004, CURR ALLERGY ASTHM R, V4, P391, DOI 10.1007/s11882-004-0090-5; Gadermaier G, 2014, METHODS, V66, P55, DOI 10.1016/j.ymeth.2013.06.014; Ganglberger E, 2001, INT ARCH ALLERGY IMM, V125, P216, DOI 10.1159/000053819; Ghosh D, 2014, J BIOL CHEM, V289, P21374, DOI 10.1074/jbc.M114.559971; HANSSON A, 1988, BIOCHEM BIOPH RES CO, V150, P526, DOI 10.1016/0006-291X(88)90425-1; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; LINDBERG U, 1988, BIOCHIM BIOPHYS ACTA, V967, P391, DOI 10.1016/0304-4165(88)90102-X; Lopez-Torrejon G, 2005, ALLERGY, V60, P1424, DOI 10.1111/j.1398-9995.2005.00903.x; Lopez-Torrejon G, 2005, CLIN EXP ALLERGY, V35, P1065, DOI 10.1111/j.1365-2222.2005.02303.x; Lopez-Torrejon G, 2007, J ALLERGY CLIN IMMUN, V119, P1481, DOI 10.1016/j.jaci.2007.02.004; MACHESKY LM, 1990, CELL REGUL, V1, P937, DOI 10.1091/mbc.1.12.937; Mari A, 2001, INT ARCH ALLERGY IMM, V125, P57, DOI 10.1159/000053797; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mondal AK, 1998, ANN AGR ENV MED, V5, P17; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oberhuber C, 2008, INT ARCH ALLERGY IMM, V145, P94, DOI 10.1159/000108134; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polet D, 2007, FEBS LETT, V581, P211, DOI 10.1016/j.febslet.2006.12.013; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Rossi RE, 1996, ALLERGY, V51, P940; Scheurer S, 2001, J CHROMATOGR B, V756, P315, DOI 10.1016/S0378-4347(01)00090-1; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; Tawde P, 2006, J ALLERGY CLIN IMMUN, V118, P915, DOI 10.1016/j.jaci.2006.05.028; Tinghino R, 2002, J ALLERGY CLIN IMMUN, V109, P314, DOI 10.1067/mai.2002.121528; Tordesillas L, 2010, CLIN EXP ALLERGY, V40, P174, DOI 10.1111/j.1365-2222.2009.03401.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Vallverdu A, 1998, J ALLERGY CLIN IMMUN, V101, P363, DOI 10.1016/S0091-6749(98)70249-0; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Villalta D, 2010, J INVEST ALLERG CLIN, V20, P591; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Westphal S, 2004, ALLERGY, V59, P526, DOI 10.1046/j.1398-9995.2003.00413.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wopfner N, 2008, ALLERGY, V63, P872, DOI 10.1111/j.1398-9995.2008.01635.x; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419	74	25	27	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15447	15459		10.1074/jbc.M116.733659	http://dx.doi.org/10.1074/jbc.M116.733659			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231348	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000380584200003
J	Wang, H; Lu, B; Castillo, J; Zhang, Y; Yang, ZE; McAllister, G; Lindeman, A; Reece-Hoyes, J; Tallarico, J; Russ, C; Hoffman, G; Xu, WQ; Schirle, M; Cong, F				Wang, Hui; Lu, Bo; Castillo, Johnny; Zhang, Yue; Yang, Zinger; McAllister, Gregory; Lindeman, Alicia; Reece-Hoyes, John; Tallarico, John; Russ, Carsten; Hoffman, Greg; Xu, Wenqing; Schirle, Markus; Cong, Feng			Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO PATHWAY; TISSUE HOMEOSTASIS; TUMOR-SUPPRESSOR; ADP-RIBOSYLATION; FAMILY PROTEINS; BREAST-CANCER; DEGRADATION; TARGET; KRAS; AXIN	YAP signaling pathway plays critical roles in tissue homeostasis, and aberrant activation of YAP signaling has been implicated in cancers. To identify tractable targets of YAP pathway, we have performed a pathway-based pooled CRISPR screen and identified tankyrase and its associated E3 ligase RNF146 as positive regulators of YAP signaling. Genetic ablation or pharmacological inhibition of tankyrase prominently suppresses YAP activity and YAP target gene expression. Using a proteomic approach, we have identified angiomotin family proteins, which are known negative regulators of YAP signaling, as novel tankyrase substrates. Inhibition of tankyrase or depletion of RNF146 stabilizes angiomotins. Angiomotins physically interact with tankyrase through a highly conserved motif at their N terminus, and mutation of this motif leads to their stabilization. Tankyrase inhibitor -induced stabilization of angiomotins reduces YAP nuclear translocation and decreases downstream YAP signaling. We have further shown that knock -out of YAP sensitizes non-small cell lung cancer to EGER inhibitor Erlotinib. Tankyrase inhibitor, but not porcupine inhibitor, which blocks Wnt secretion, enhances growth inhibitory activity of Erlotinib. This activity is mediated by YAP inhibition and not Wnt/O-catenin inhibition. Our data suggest that tankyrase inhibition could serve as a novel strategy to suppress YAP signaling for combinatorial targeted therapy.	[Wang, Hui; Lu, Bo; Castillo, Johnny; Zhang, Yue; Yang, Zinger; McAllister, Gregory; Lindeman, Alicia; Reece-Hoyes, John; Tallarico, John; Russ, Carsten; Hoffman, Greg; Schirle, Markus; Cong, Feng] Novartis Inst Biomed Res, Dept Dev & Mol Pathways, Cambridge, MA 02139 USA; [Xu, Wenqing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Novartis; University of Washington; University of Washington Seattle	Cong, F (corresponding author), Novartis Inst Biomed Res, Dev & Mol Pathways, Cambridge, MA 02139 USA.	feng.cong@novartis.com		Castillo, Johnny/0000-0003-2009-7519; Reece-Hoyes, John/0000-0001-5251-5813; Yang Loureiro, Zinger/0000-0001-8543-4841				Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; DaRosa PA, 2015, NATURE, V517, P223, DOI 10.1038/nature13826; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Irvine KD, 2012, SEMIN CELL DEV BIOL, V23, P812, DOI 10.1016/j.semcdb.2012.04.006; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lehtio L, 2013, FEBS J, V280, P3576, DOI 10.1111/febs.12320; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Li N, 2015, GENE DEV, V29, P157, DOI 10.1101/gad.251785.114; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Nishimura M, 2002, J BIOL CHEM, V277, P5583, DOI 10.1074/jbc.M110154200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Patrie KM, 2005, BBA-MOL CELL RES, V1745, P131, DOI 10.1016/j.bbamcr.2005.05.011; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Schoumacher M, 2014, CANCER RES, V74, P3294, DOI 10.1158/0008-5472.CAN-14-0138-T; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; Shultz MD, 2013, J MED CHEM, V56, P6495, DOI 10.1021/jm400807n; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Touil Y, 2014, CLIN CANCER RES, V20, P837, DOI 10.1158/1078-0432.CCR-13-1854; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wang WQ, 2015, CELL REP, V13, P524, DOI 10.1016/j.celrep.2015.09.014; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhou X, 2015, J CLIN INVEST, V125, P2123, DOI 10.1172/JCI79573; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	51	52	52	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15256	15266		10.1074/jbc.M116.722967	http://dx.doi.org/10.1074/jbc.M116.722967			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27231341	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000380583200032
J	Cascella, R; Capitini, C; Fani, G; Dobson, CM; Cecchi, C; Chiti, F				Cascella, Roberta; Capitini, Claudia; Fani, Giulia; Dobson, Christopher M.; Cecchi, Cristina; Chiti, Fabrizio			Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); neurodegeneration; neurodegenerative disease; protein aggregation; protein misfolding; TAR DNA-binding protein 43 (TDP-43) (TARDBP); Frontotemporal Dementia; Frontotemporal lobar degeneration; motor neuron disease	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; TRANSGENIC MICE; AGGREGATE FORMATION; MOTOR DEFICITS; GENE-MUTATIONS; CELL-DEATH; IN-VITRO; ALS; NEURONS	Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin positive inclusions (FTLD-U) are two clinically distinct neurodegenerative conditions sharing a similar histopathology characterized by the nuclear clearance of TDP-43 and its associated deposition into cytoplasmic inclusions in different areas of the central nervous system. Given the concomitant occurrence of TDP-43 nuclear depletion and cytoplasmic accumulation, it has been proposed that TDP-43 proteinopathies originate from either a loss-of-function (LOF) mechanism, a gain-of-function (GOF) process, or both. We have addressed this issue by transfecting murine NSC34 and N2a cells with siRNA for endogenous murine TDP-43 and with human recombinant TDP-43 inclusion bodies (IBs). These two strategies allowed the depletion of nuclear TDP-43 and the accumulation of cytoplasmic TDP-43 aggregates to occur separately and independently. Endogenous and exogenous TDP-43 were monitored and quantified using both immunofluorescence and Western blotting analysis, and nuclear functional TDP-43 was measured by monitoring the sortilin 1 mRNA splicing activity. Various degrees of TDP-43 cytoplasmic accumulation and nuclear TDP-43 depletion were achieved and the resulting cellular viability was evaluated, leading to a quantitative global analysis on the relative effects of LOF and GOF on the overall cytotoxicity. These were found to be approximate to 55% and 45%, respectively, in both cell lines and using both readouts of cell toxicity, showing that these two mechanisms are likely to contribute apparently equally to the pathologies of ALS and FTLD-U.	[Cascella, Roberta; Capitini, Claudia; Fani, Giulia; Cecchi, Cristina; Chiti, Fabrizio] Univ Florence, Biochem Sect, Dept Expt & Clin Biomed Sci, Vle GB Morgagni 50, I-50134 Florence, Italy; [Dobson, Christopher M.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England	University of Florence; University of Cambridge	Chiti, F (corresponding author), Univ Florence, Biochem Sect, Dept Expt & Clin Biomed Sci, Vle GB Morgagni 50, I-50134 Florence, Italy.	fabrizio.chiti@unifi.it		Capitini, Claudia/0000-0003-2834-1424; Cecchi, Cristina/0000-0001-8387-7737	Fondazione Cassa di Risparmio di Pistoia e Pescia [2014.0251]	Fondazione Cassa di Risparmio di Pistoia e Pescia	This work was supported by the Fondazione Cassa di Risparmio di Pistoia e Pescia (Project no. 2014.0251). The authors declare that they have no conflicts of interest with the contents of this article.	Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Cannon A, 2012, ACTA NEUROPATHOL, V123, P807, DOI 10.1007/s00401-012-0979-3; Capitini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086720; Cappelli S, 2016, BIOL CHEM, V397, P401, DOI 10.1515/hsz-2015-0250; Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P2302, DOI 10.1016/j.bbadis.2013.09.011; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Diehl-Schmid J, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0489-x; Evangelisti E, 2013, CURR ALZHEIMER RES, V10, P143, DOI 10.2174/1567205011310020004; Halliday G, 2012, ACTA NEUROPATHOL, V124, P373, DOI 10.1007/s00401-012-1030-4; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Liu YJ, 2015, HUM MOL GENET, V24, P787, DOI 10.1093/hmg/ddu497; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Prudencio M, 2012, P NATL ACAD SCI USA, V109, P21510, DOI 10.1073/pnas.1211577110; Rasband W., 2006, IMAGEJ; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Suzuki H, 2011, J BIOL CHEM, V286, P13171, DOI 10.1074/jbc.M110.197483; Tian TA, 2011, INT J BIOL SCI, V7, P234, DOI 10.7150/ijbs.7.234; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Wu LS, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-33; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Xu ZS, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-27; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	53	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19437	19448		10.1074/jbc.M116.737726	http://dx.doi.org/10.1074/jbc.M116.737726			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27445339	Green Published, hybrid			2022-12-28	WOS:000383242800022
J	Dema, A; Schroter, MF; Perets, E; Skroblin, P; Moutty, MC; Deak, VA; Birchmeier, W; Klussmann, E				Dema, Alessandro; Schroeter, Micha Friedemann; Perets, Ekaterina; Skroblin, Philipp; Moutty, Marie Christine; Deak, Veronika Anita; Birchmeier, Walter; Klussmann, Enno			The A-Kinase Anchoring Protein (AKAP) Glycogen Synthase Kinase 3 Interaction Protein (GSKIP) Regulates -Catenin through Its Interactions with Both Protein Kinase A (PKA) and GSK3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase anchoring protein (AKAP); beta-catenin (-catenin); cell compartmentalization; glycogen synthase kinase 3 (GSK-3); Wnt signaling; GSKIP; glycogen synthase kinase 3 interaction protein; protein kinase	BETA-CATENIN; AQUAPORIN-2 SHUTTLE; RECEPTOR ACTIVATION; NEGATIVE REGULATOR; PRINCIPAL CELLS; CANONICAL WNT; PHOSPHORYLATION; PATHWAY; COMPLEX; 3-BETA	The A-kinase anchoring protein (AKAP) GSK3 interaction protein (GSKIP) is a cytosolic scaffolding protein binding protein kinase A (PKA) and glycogen synthase kinase 3 (GSK3). Here we show that both the AKAP function of GSKIP, i.e. its direct interaction with PKA, and its direct interaction with GSK3 are required for the regulation of -catenin and thus Wnt signaling. A cytoplasmic destruction complex targets -catenin for degradation and thus prevents Wnt signaling. Wnt signals cause -catenin accumulation and translocation into the nucleus, where it induces Wnt target gene expression. GSKIP facilitates control of the -catenin stabilizing phosphorylation at Ser-675 by PKA. Its interaction with GSK3 facilitates control of the destabilizing phosphorylation of -catenin at Ser-33/Ser-37/Thr-41. The influence of GSKIP on -catenin is explained by its scavenger function; it recruits the kinases away from the destruction complex without forming a complex with -catenin. The regulation of -catenin by GSKIP is specific for this AKAP as AKAP220, which also binds PKA and GSK3, did not affect Wnt signaling. We find that the binding domain of AKAP220 for GSK3 is a conserved GSK3 interaction domain (GID), which is also present in GSKIP. Our findings highlight an essential compartmentalization of both PKA and GSK3 by GSKIP, and ascribe a function to a cytosolic AKAP-PKA interaction as a regulatory factor in the control of canonical Wnt signaling. Wnt signaling controls different biological processes, including embryonic development, cell cycle progression, glycogen metabolism, and immune regulation; deregulation is associated with diseases such as cancer, type 2 diabetes, inflammatory, and Alzheimer's and Parkinson's diseases.	[Dema, Alessandro; Schroeter, Micha Friedemann; Perets, Ekaterina; Skroblin, Philipp; Moutty, Marie Christine; Deak, Veronika Anita; Birchmeier, Walter; Klussmann, Enno] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Klussmann, Enno] Partner Site Berlin, DZHK German Ctr Cardiovasc Res, Oudenarder Str 16, D-13347 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research	Klussmann, E (corresponding author), Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.; Klussmann, E (corresponding author), Partner Site Berlin, DZHK German Ctr Cardiovasc Res, Oudenarder Str 16, D-13347 Berlin, Germany.	enno.klussmann@mdc-berlin.de		Skroblin, Philipp/0000-0003-0321-3493	Else Kroner-Fresenius-Stiftung [2013_A145]; German-Israeli Foundation (G.I.F.) [I-1210-286.13/2012]; German Centre for Cardiovascular Research (DZHK) [81X210012]	Else Kroner-Fresenius-Stiftung; German-Israeli Foundation (G.I.F.)(German-Israeli Foundation for Scientific Research and Development); German Centre for Cardiovascular Research (DZHK)	This work was supported by grants from the Else Kroner-Fresenius-Stiftung (2013_A145), the German-Israeli Foundation (G.I.F. I-1210-286.13/2012), and the German Centre for Cardiovascular Research (DZHK 81X210012) (to E.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Chou HY, 2006, BIOCHEMISTRY-US, V45, P11379, DOI 10.1021/bi061147r; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Deak VA, 2016, CURR DRUG TARGETS, V17, P1147, DOI 10.2174/1389450116666150416114247; Deak VA, 2016, J BIOL CHEM, V291, P681, DOI 10.1074/jbc.M115.701177; Dema A, 2015, CELL SIGNAL, V27, P2474, DOI 10.1016/j.cellsig.2015.09.008; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Esseltine JL, 2013, TRENDS PHARMACOL SCI, V34, P648, DOI 10.1016/j.tips.2013.10.005; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Flynn MP, 2008, MOL ENDOCRINOL, V22, P1695, DOI 10.1210/me.2007-0457; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Horner A, 2012, J BIOL CHEM, V287, P42495, DOI 10.1074/jbc.M112.414946; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; Howng SL, 2010, MOL CELL BIOCHEM, V339, P23, DOI 10.1007/s11010-009-0366-0; Hundsrucker C, 2010, J BIOL CHEM, V285, P5507, DOI 10.1074/jbc.M109.047944; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klussmann E, 2016, CELL SIGNAL, V28, P713, DOI 10.1016/j.cellsig.2015.10.005; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lin CC, 2009, J CELL BIOCHEM, V108, P1325, DOI 10.1002/jcb.22362; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; Logue JS, 2011, J BIOL CHEM, V286, P39269, DOI 10.1074/jbc.M111.277756; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maass PG, 2015, NAT GENET, V47, P647, DOI 10.1038/ng.3302; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McSorley T, 2006, EUR J CELL BIOL, V85, P673, DOI 10.1016/j.ejcb.2006.01.005; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Radeva MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106733; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Sadot E, 2002, J CELL SCI, V115, P2771; Saliba J, 2015, NAT GENET, V47, P1131, DOI 10.1038/ng.3380; Schott MB, 2013, CELL SIGNAL, V25, P2125, DOI 10.1016/j.cellsig.2013.07.004; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Szaszak M, 2008, CELL SIGNAL, V20, P590, DOI 10.1016/j.cellsig.2007.10.020; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Troger J, 2012, BRIT J PHARMACOL, V166, P420, DOI 10.1111/j.1476-5381.2011.01796.x; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Whiting JL, 2015, J BIOL CHEM, V290, P19445, DOI 10.1074/jbc.M115.654822; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zhang Y, 2014, CELL TISSUE RES, V358, P633, DOI 10.1007/s00441-014-2010-x	65	27	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19618	19630		10.1074/jbc.M116.738047	http://dx.doi.org/10.1074/jbc.M116.738047			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27484798	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000383242800035
J	Kim, J; Lee, HY; Ahn, J; Hyun, M; Lee, I; Min, KJ; You, YJ				Kim, Jeongho; Lee, Hye-Yeon; Ahn, Jheesoo; Hyun, Moonjung; Lee, Inhwan; Min, Kyung-Jin; You, Young-Jai			NHX-5, an Endosomal Na+/H+ Exchanger, Is Associated with Metformin Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; Caenorhabditis elegans (C; elegans); drug action; endosome; metformin; sodium-proton exchange; Type 2 diabetes; sodium-proton exchange	CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; C. ELEGANS; AUTOPHAGY; COMPLEX; APOPTOSIS; AMPK; DYSFUNCTION; MECHANISMS; SURVIVAL	Diabetes is one of the most impactful diseases worldwide. The most commonly prescribed anti-diabetic drug is metformin. In this study, we identified an endosomal Na+/H+ exchanger (NHE) as a new potential target of metformin from an unbiased screen in Caenorhabditis elegans. The same NHE homolog also exists in flies, where it too mediates the effects of metformin. Our results suggest that endosomal NHEs could be a metformin target and provide an insight into a novel mechanism of action of metformin on regulating the endocytic cycle.	[Kim, Jeongho; Lee, Hye-Yeon; Min, Kyung-Jin] Inha Univ, Dept Biol Sci, Inchon 22212, South Korea; [Ahn, Jheesoo; Hyun, Moonjung; Lee, Inhwan; You, Young-Jai] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [You, Young-Jai] Nagoya Univ, Grad Sch Sci, Nagoya Res Ctr Brain & Neural Circuits, Nagoya, Aichi 4648602, Japan	Inha University; Virginia Commonwealth University; Nagoya University	You, YJ (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.; You, YJ (corresponding author), Nagoya Univ, Grad Sch Sci, Nagoya Res Ctr Brain & Neural Circuits, Nagoya, Aichi 4648602, Japan.	yjyou@bio.nagoya-u.ac.jp	Min, Kyung-Jin/AAG-5774-2020	Min, Kyung-Jin/0000-0001-5829-6842; you, young/0000-0002-5716-5418	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Bloomington Drosophila Stock Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; Bloomington Drosophila Stock Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. L. Avery for reviewing the manuscript and Dr. K.-C. Kim for helping with WGS analysis. Some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by National Institutes of Health Office of Research Infrastructure Programs (Grant P40 OD010440) and the Bloomington Drosophila Stock Center.	AVERY L, 1993, GENETICS, V133, P897; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Djeddi A, 2012, J CELL SCI, V125, P685, DOI 10.1242/jcs.091702; DOMS RW, 1985, J BIOL CHEM, V260, P2973; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lee I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044720; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee SY, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0136385, 10.1371/journal.pone.0128448]; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Ohgaki R, 2011, BIOCHEMISTRY-US, V50, P443, DOI 10.1021/bi101082e; Ouyang Q, 2013, NEURON, V80, P97, DOI 10.1016/j.neuron.2013.07.043; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Park DB, 2015, DIABETES METAB J, V39, P518, DOI 10.4093/dmj.2015.39.6.518; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; Stromme P, 2011, BRAIN, V134, P3369, DOI 10.1093/brain/awr250; Sulston J., 1988, NEMATODE CAENORHABDI, P594; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wilson CM, 2014, CNS NEUROL DISORD-DR, V13, P226, DOI 10.2174/18715273113126660146; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	47	15	15	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18591	18599		10.1074/jbc.C116.744037	http://dx.doi.org/10.1074/jbc.C116.744037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27435670	Green Published, hybrid			2022-12-28	WOS:000383241800047
J	Pietrocola, G; Nobile, G; Gianotti, V; Zapotoczna, M; Foster, TJ; Geoghegan, JA; Speziale, P				Pietrocola, Giampiero; Nobile, Giulia; Gianotti, Valentina; Zapotoczna, Marta; Foster, Timothy J.; Geoghegan, Joan A.; Speziale, Pietro			Molecular Interactions of Human Plasminogen with Fibronectin-binding Protein B (FnBPB), a Fibrinogen/Fibronectin-binding Protein from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; cell surface protein; fibrinogen; plasminogen; Staphylococcus aureus (S; aureus); tissue plasminogen activator (tPA)	STREPTOCOCCUS-PNEUMONIAE; SURFACE PROTEIN; AFFINITY-CHROMATOGRAPHY; BORRELIA-BURGDORFERI; CRYSTAL-STRUCTURE; BIOFILM FORMATION; CLUMPING FACTOR; HUMAN PLASMA; A-DOMAIN; FIBRINOGEN	Staphylococcus aureus is a commensal bacterium that has the ability to cause superficial and deep-seated infections. Like several other invasive pathogens, S. aureus can capture plasminogen from the human host where it can be converted to plasmin by host plasminogen activators or by endogenously expressed staphylokinase. This study demonstrates that sortase-anchored cell wall-associated proteins are responsible for capturing the bulk of bound plasminogen. Two cell wall-associated proteins, the fibrinogen- and fibronectin-binding proteins A and B, were found to bind plasminogen, and one of them, FnBPB, was studied in detail. Plasminogen captured on the surface of S. aureus- or Lactococcus lactis-expressing FnBPB could be activated to the potent serine protease plasmin by staphylokinase and tissue plasminogen activator. Plasminogen bound to recombinant FnBPB with a K-D of 0.532 m as determined by surface plasmon resonance. Plasminogen binding did not to occur by the same mechanism through which FnBPB binds to fibrinogen. Indeed, FnBPB could bind both ligands simultaneously indicating that their binding sites do not overlap. The N3 subdomain of FnBPB contains the full plasminogen-binding site, and this includes, at least in part, two conserved patches of surface-located lysine residues that were recognized by kringle 4 of the host protein.	[Pietrocola, Giampiero; Nobile, Giulia; Gianotti, Valentina; Speziale, Pietro] Univ Pavia, Dept Mol Med, Biochem Unit, Viale Taramelli 3-B, I-27100 Pavia, Italy; [Zapotoczna, Marta; Foster, Timothy J.; Geoghegan, Joan A.] Univ Dublin, Trinity Coll, Sch Genet & Microbiol, Dept Microbiol,Moyne Inst Prevent Med, Dublin 2, Ireland	University of Pavia; Trinity College Dublin	Speziale, P (corresponding author), Univ Pavia, Dept Mol Med, Biochem Unit, Viale Taramelli 3-B, I-27100 Pavia, Italy.; Geoghegan, JA (corresponding author), Univ Dublin, Trinity Coll Dublin, Sch Microbiol & Genet, Dept Microbiol,Moyne Inst Prevent Med, Dublin 2, Ireland.	geoghegj@tcd.ie; pspeziale@unipv.it	Zapotoczna, M./E-6874-2015	Zapotoczna, M./0000-0001-5971-1163; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155	Fondazione CARIPLO Grant [2009-3546]; European Union [634588]	Fondazione CARIPLO Grant(Fondazione Cariplo); European Union(European Commission)	This work was supported by Fondazione CARIPLO Grant Vaccines 2009-3546 (to P. S.) and European Union's Horizon 2020 Research and Innovation Program Grant 634588. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; BREMELL T, 1990, ARTHRITIS RHEUM, V33, P1739, DOI 10.1002/art.1780331120; Burke FM, 2011, FEBS J, V278, P2359, DOI 10.1111/j.1742-4658.2011.08159.x; Burke FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-160; Buscetta M, 2016, MOL MICROBIOL, V101, P27, DOI 10.1111/mmi.13357; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Chavakis T, 2005, BLOOD, V105, P1036, DOI 10.1182/blood-2004-01-0166; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Duboscq C, 1997, THROMB RES, V86, P505, DOI 10.1016/S0049-3848(97)00099-6; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Fulde M, 2011, BIOCHEM J, V434, P523, DOI 10.1042/BJ20101121; Furuya H, 2011, MICROBIOL IMMUNOL, V55, P855, DOI 10.1111/j.1348-0421.2011.00392.x; Geoghegan JA, 2013, J BACTERIOL, V195, P2675, DOI 10.1128/JB.02128-12; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Koch TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047638; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Loof TG, 2015, MICROBIOL-SGM, V161, P621, DOI 10.1099/mic.0.000019; Loughman A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-74; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCourt J, 2014, FEMS MICROBIOL LETT, V353, P157, DOI 10.1111/1574-6968.12424; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Palmqvist N, 2005, J INFECT DIS, V191, P791, DOI 10.1086/427663; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Peetermans M., 2015, CRIT REV MICROBIOL, V2015, P1; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Salazar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112730; Sambrook J., 1989, MOL CLONING LAB MANU, P175; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; SHERERTZ RJ, 1993, J INFECT DIS, V167, P98, DOI 10.1093/infdis/167.1.98; Six A, 2015, MOL MICROBIOL, V97, P1209, DOI 10.1111/mmi.13097; Speziale P, 2008, NAT PROTOC, V3, P525, DOI 10.1038/nprot.2008.12; VALI Z, 1982, J BIOL CHEM, V257, P2104; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Wang XX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060872, 10.1371/currents.flu.3679b56a3a5313dc7c043fb944c6f138]; Wiles KG, 2010, J BIOL CHEM, V285, P21153, DOI 10.1074/jbc.M110.107730	59	34	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18148	18162		10.1074/jbc.M116.731125	http://dx.doi.org/10.1074/jbc.M116.731125			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387503	Green Published, hybrid			2022-12-28	WOS:000383241800009
J	Tillman, TS; Alvarez, FJD; Reinert, NJ; Liu, C; Wang, DW; Xu, Y; Xiao, KH; Zhang, PJ; Tang, P				Tillman, Tommy S.; Alvarez, Frances J. D.; Reinert, Nathan J.; Liu, Chuang; Wang, Dawei; Xu, Yan; Xiao, Kunhong; Zhang, Peijun; Tang, Pei			Functional Human 7 Nicotinic Acetylcholine Receptor (nAChR) Generated from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys-loop receptor; electron microscopy (EM); ion channel; nicotinic acetylcholine receptors (nAChR); recombinant protein expression; 7nAChR; 7 nAChR; pLGICs; pentameric ligand-gated ion channels	GATED ION-CHANNEL; ALPHA-BUNGAROTOXIN RECEPTORS; X-RAY-STRUCTURE; THERAPEUTIC TARGET; ALLOSTERIC MODULATION; RECOMBINANT PROTEINS; 5-HT3 RECEPTOR; EXPRESSION; CELLS; MEMBRANE	Human Cys-loop receptors are important therapeutic targets. High-resolution structures are essential for rational drug design, but only a few are available due to difficulties in obtaining sufficient quantities of protein suitable for structural studies. Although expression of proteins in E. coli offers advantages of high yield, low cost, and fast turnover, this approach has not been thoroughly explored for full-length human Cys-loop receptors because of the conventional wisdom that E. coli lacks the specific chaperones and post-translational modifications potentially required for expression of human Cys-loop receptors. Here we report the successful production of full-length wild type human 7nAChR from E. coli. Chemically induced chaperones promote high expression levels of well-folded proteins. The choice of detergents, lipids, and ligands during purification determines the final protein quality. The purified 7nAChR not only forms pentamers as imaged by negative-stain electron microscopy, but also retains pharmacological characteristics of native 7nAChR, including binding to bungarotoxin and positive allosteric modulators specific to 7nAChR. Moreover, the purified 7nAChR injected into Xenopus oocytes can be activated by acetylcholine, choline, and nicotine, inhibited by the channel blockers QX-222 and phencyclidine, and potentiated by the 7nAChR specific modulators PNU-120596 and TQS. The successful generation of functional human 7nAChR from E. coli opens a new avenue for producing mammalian Cys-loop receptors to facilitate structure-based rational drug design.	[Tillman, Tommy S.; Reinert, Nathan J.; Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Alvarez, Frances J. D.; Liu, Chuang; Xu, Yan; Zhang, Peijun] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Wang, Dawei; Xu, Yan; Xiao, Kunhong; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Tang, Pei] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tang, P (corresponding author), Univ Pittsburgh, 2049 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	ptang@pitt.edu	Xiao, Kunhong/AAG-4275-2020	Xiao, Kunhong/0000-0002-1069-1226; Reinert, Nathan/0000-0001-6764-5522; Tang, Pei/0000-0002-2869-2737	National Institutes of Health [R01GM66358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049202, R01GM066358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM66358 (to P. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; Aztiria EM, 2000, NEUROCHEM RES, V25, P171, DOI 10.1023/A:1007512121082; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2014, BBA-BIOMEMBRANES, V1838, P1389, DOI 10.1016/j.bbamem.2013.12.018; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Cheng H, 2015, ACTA PHARMACOL SIN, V36, P1013, DOI 10.1038/aps.2015.34; CONNOLLY J, 1992, BRIT J PHARMACOL, V105, P657, DOI 10.1111/j.1476-5381.1992.tb09035.x; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Csardi G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005206; CUEVAS J, 1994, BRIT J PHARMACOL, V111, P663, DOI 10.1111/j.1476-5381.1994.tb14789.x; Dascal N., 2001, CURR PROTOC NEUROSCI; de Marco A, 2005, CELL STRESS CHAPERON, V10, P329, DOI 10.1379/CSC-139R.1; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Dineley KT, 2000, J BIOL CHEM, V275, P13974, DOI 10.1074/jbc.275.18.13974; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Fryer JD, 1999, J PHARMACOL EXP THER, V288, P88; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Kahsai AW, 2014, NAT PROTOC, V9, P1301, DOI 10.1038/nprot.2014.075; Labriola JM, 2013, J BIOL CHEM, V288, P11294, DOI 10.1074/jbc.M113.458133; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Lynch JW, 2006, CURR OPIN INVEST DR, V7, P48; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Miledi Ricardo, 2006, V322, P347; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Molinari EJ, 1998, EUR J PHARMACOL, V347, P131, DOI 10.1016/S0014-2999(98)00084-3; Moraga-Cid G, 2015, P NATL ACAD SCI USA, V112, P2865, DOI 10.1073/pnas.1417864112; MORALES A, 1995, P NATL ACAD SCI USA, V92, P8468, DOI 10.1073/pnas.92.18.8468; Mowrey DD, 2013, J BIOL CHEM, V288, P35793, DOI 10.1074/jbc.M113.508333; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Peng JH, 2005, J PHARMACOL EXP THER, V313, P24, DOI 10.1124/jpet.104.079004; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; Rakhilin S, 1999, J CELL BIOL, V146, P203; Rangwala F, 1997, J NEUROSCI, V17, P8201; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Tillman TS, 2014, J BIOL CHEM, V289, P13851, DOI 10.1074/jbc.M113.524611; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wu J, 2016, TRENDS PHARMACOL SCI, V37, P562, DOI 10.1016/j.tips.2016.03.005; Zdanowski R, 2015, CENT EUR J IMMUNOL, V40, P373, DOI 10.5114/ceji.2015.54602	56	5	5	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18276	18282		10.1074/jbc.M116.729970	http://dx.doi.org/10.1074/jbc.M116.729970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27385587	hybrid, Green Published			2022-12-28	WOS:000383241800020
J	Anand, S; Madhubala, R				Anand, Sneha; Madhubala, Rentala			Twin Attributes of Tyrosyl-tRNA Synthetase of Leishmania donovani: A HOUSEKEEPING PROTEIN TRANSLATION ENZYME AND A MIMIC OF HOST CHEMOKINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; chemokine; cytokine; drug action; Leishmania; ELR peptide motif; fisetin; moonlighting	NEUTROPHIL GRANULOCYTES; IMMUNE EVASION; TNF-ALPHA; RECRUITMENT; SECRETION; INTERLEUKIN-8; INFLAMMATION; GENERATION; INHIBITION; RECEPTOR	Aminoacyl-tRNA synthetases (aaRSs) are housekeeping enzymes essential for protein synthesis. Apart from their parent aminoacylation activity, several aaRSs perform non-canonical functions in diverse biological processes. The present study explores the twin attributes of Leishmania tyrosyl-tRNA synthetase (LdTyrRS) namely, aminoacylation, and as a mimic of host CXC chemokine. Leishmania donovani is a protozoan parasite. Its genome encodes a single copy of tyrosyl-tRNA synthetase. We first tested the canonical aminoacylation role of LdTyrRS. The recombinant protein was expressed, and its kinetic parameters were determined by aminoacylation assay. To study the physiological role of LdTyrRS in Leishmania, gene deletion mutations were attempted via targeted gene replacement. The heterozygous mutants showed slower growth kinetics and exhibited attenuated virulence. LdTyrRS appears to be an essential gene as the chromosomal null mutants did not survive. Our data also highlights the non-canonical function of L. donovani tyrosyl-tRNA synthetase. We show that LdTyrRS protein is present in the cytoplasm and exits from the parasite cytoplasm into the extracellular medium. The released LdTyrRS functions as a neutrophil chemoattractant. We further show that LdTyrRS specifically binds to host macrophages with its ELR (Glu-Leu-Arg) peptide motif. The ELR-CXCR2 receptor interaction mediates this binding. This interaction triggers enhanced secretion of the proinflammatory cytokines TNF- and IL-6 by host macrophages. Our data indicates a possible immunomodulating role of LdTyrRS in Leishmania infection. This study provides a platform to explore LdTyrRS as a potential target for drug development	[Anand, Sneha; Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Madhubala, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rentala@outlook.com		madhubala, rentala/0000-0002-0034-399X; Anand, Sneha/0000-0002-6461-9174	Department of Biotechnology, Government of India [102/IFD/SAN/3321/2014-15]; University Grants Commission, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission, India(University Grants Commission, India)	This work was supported in part by Department of Biotechnology, Government of India Grant 102/IFD/SAN/3321/2014-15 (to R. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of funding from the University Grants Commission, India.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Arena A, 1997, MICROBIOLOGICA, V20, P233; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Bhatt TK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1522; Brown MV, 2010, VASC PHARMACOL, V52, P21, DOI 10.1016/j.vph.2009.11.009; de Moura MC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001398; Cecilio P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00480; Cestari I, 2013, MOL CELL BIOL, V33, P4872, DOI 10.1128/MCB.00711-13; Cestari I, 2013, J BIOMOL SCREEN, V18, P490, DOI 10.1177/1087057112465980; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Darveau A., 1995, METH NEUROSCI, V26, P77, DOI DOI 10.1016/S1043-9471(06)80084-4; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Duque GA, 2014, J IMMUNOL, V193, P2363, DOI 10.4049/jimmunol.1303043; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Gadelha FR, 2013, EXP PARASITOL, V133, P287, DOI 10.1016/j.exppara.2012.12.007; Gowri VS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-621; GRAVES DT, 1995, CRIT REV ORAL BIOL M, V6, P109, DOI 10.1177/10454411950060020101; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Gupta G, 2013, ADV APPL MICROBIOL, V82, P155, DOI 10.1016/B978-0-12-407679-2.00005-3; Gupta G, 2009, J INFECT DIS, V200, P1300, DOI 10.1086/605895; Hurrell BP, 2016, TRENDS PARASITOL, V32, P392, DOI 10.1016/j.pt.2016.02.003; Hurrell BP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004929; Jia H, 2003, PROTEIN EXPRES PURIF, V27, P104, DOI 10.1016/S1046-5928(02)00576-4; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kansal S, 2012, J ANTIMICROB CHEMOTH, V67, P2650, DOI 10.1093/jac/dks286; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Karam MC, 2006, EXP PARASITOL, V113, P168, DOI 10.1016/j.exppara.2006.01.003; Kawa S, 1997, FEBS LETT, V420, P196, DOI 10.1016/S0014-5793(97)01516-0; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; KIJIMA S, 1968, J BIOCHEM-TOKYO, V63, P434, DOI 10.1093/oxfordjournals.jbchem.a128795; Krobitsch S, 1998, J BIOL CHEM, V273, P6488, DOI 10.1074/jbc.273.11.6488; Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326; Larson ET, 2011, J MOL BIOL, V409, P159, DOI 10.1016/j.jmb.2011.03.026; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; Laufs H, 2002, INFECT IMMUN, V70, P826, DOI 10.1128/IAI.70.2.826-835.2002; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; McCall LI, 2010, MOL MICROBIOL, V77, P518, DOI 10.1111/j.1365-2958.2010.07229.x; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Ribeiro-Gomes FL, 2014, INFECT IMMUN, V82, P2713, DOI 10.1128/IAI.01600-13; Ribeiro-Gomes FL, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00059; Rolao N, 2004, ACTA TROP, V90, P123, DOI 10.1016/j.actatropica.2003.09.010; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Taylor SC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/361590; Thalhofer CJ, 2011, INFECT IMMUN, V79, P108, DOI 10.1128/IAI.00338-10; van Zandbergen G, 2002, INFECT IMMUN, V70, P4177, DOI 10.1128/IAI.70.8.4177-4184.2002; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wenzel UA, 2012, FASEB J, V26, P29, DOI 10.1096/fj.11-184895	63	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17754	17771		10.1074/jbc.M116.727107	http://dx.doi.org/10.1074/jbc.M116.727107			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27382051	Green Published, hybrid			2022-12-28	WOS:000383241300024
J	Li, Y; Wong, YL; Ng, FM; Liu, BP; Wong, YX; Poh, ZY; Liu, S; Then, SW; Lee, MY; Ng, HQ; Huang, QW; Hung, AW; Cherian, J; Hill, J; Keller, TH; Kang, CB				Li, Yan; Wong, Ying Lei; Ng, Fui Mee; Liu, Boping; Wong, Yun Xuan; Poh, Zhi Ying; Liu, Shuang; Then, Siew Wen; Lee, Michelle Yueqi; Ng, Hui Qi; Huang, Qiwei; Hung, Alvin W.; Cherian, Joseph; Hill, Jeffrey; Keller, Thomas H.; Kang, CongBao			Escherichia coli Topoisomerase IV E Subunit and an Inhibitor Binding Mode Revealed by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; DNA gyrase; DNA topoisomerase; drug discovery; NMR	DNA GYRASE INHIBITORS; F-19 NMR; ANTIBACTERIAL AGENTS; CRYSTAL-STRUCTURE; LIGAND COMPLEXES; PARE SUBUNIT; DISCOVERY; FRAGMENT; PROTEIN; SUBSTANTIATE	Bacterial topoisomerases are attractive antibacterial drug targets because of their importance in bacterial growth and low homology with other human topoisomerases. Structure-based drug design has been a proven approach of efficiently developing new antibiotics against these targets. Past studies have focused on developing lead compounds against the ATP binding pockets of both DNA gyrase and topoisomerase IV. A detailed understanding of the interactions between ligand and target in a solution state will provide valuable information for further developing drugs against topoisomerase IV targets. Here we describe a detailed characterization of a known potent inhibitor containing a 9H-pyrimido[4,5-b]indole scaffold against the N-terminal domain of the topoisomerase IV E subunit from Escherichia coli (eParE). Using a series of biophysical and biochemical experiments, it has been demonstrated that this inhibitor forms a tight complex with eParE. NMR studies revealed the exact protein residues responsible for inhibitor binding. Through comparative studies of two inhibitors of markedly varied potencies, it is hypothesized that gaining molecular interactions with residues in the 4 and residues close to the loop of 1-2 and residues in the loop of 3-4 might improve the inhibitor potency.	[Li, Yan; Wong, Ying Lei; Ng, Fui Mee; Liu, Boping; Wong, Yun Xuan; Poh, Zhi Ying; Liu, Shuang; Then, Siew Wen; Lee, Michelle Yueqi; Ng, Hui Qi; Huang, Qiwei; Hung, Alvin W.; Cherian, Joseph; Hill, Jeffrey; Keller, Thomas H.; Kang, CongBao] ASTAR, Ctr Expt Therapeut, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre	Kang, CB (corresponding author), 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.	cbkang@etc.a-star.edu.sg	Liu, Bo/HCG-9782-2022; Li, Yan/G-4642-2013; LI, feng/HIR-1703-2022; Kang, Congbao/AAP-7572-2020	Liu, Bo/0000-0003-1685-7968; Li, Yan/0000-0003-1963-839X; Kang, Congbao/0000-0002-9886-9374; Liu, Shuang/0000-0003-3287-2404; Keller, Thomas/0000-0002-7553-6235	A*STAR JCO Grants [1331A028, 1231B015]	A*STAR JCO Grants	This work was supported by A*STAR JCO Grants 1331A028 and 1231B015. The authors declare that they have no conflicts of interest with the contents of this article.	Basarab GS, 2013, J MED CHEM, V56, P8712, DOI 10.1021/jm401208b; Bellon S, 2004, ANTIMICROB AGENTS CH, V48, P1856, DOI 10.1128/AAC.48.5.1856-1864.2004; Brvar M, 2012, J MED CHEM, V55, P6413, DOI 10.1021/jm300395d; Campos-Olivas R, 2011, CURR TOP MED CHEM, V11, P43, DOI 10.2174/156802611793611887; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen GY, 2015, CHEMPLUSCHEM, V80, P1250, DOI 10.1002/cplu.201500197; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dias DM, 2016, BIOCHEM J, V473, P335, DOI 10.1042/BJ20141555; Didenko T, 2013, CURR OPIN STRUC BIOL, V23, P740, DOI 10.1016/j.sbi.2013.07.011; Entress RMH, 1998, CHEM BIOL, V5, P329, DOI 10.1016/S1074-5521(98)90171-5; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gayen S, 2011, PROTEINS, V79, P2557, DOI 10.1002/prot.23089; Grossman TH, 2007, ANTIMICROB AGENTS CH, V51, P657, DOI 10.1128/AAC.00596-06; Hughes TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4571; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kang CB, 2015, BIOPHYS J, V109, P1969, DOI 10.1016/j.bpj.2015.10.001; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Li Y, 2016, BIOMOL NMR ASSIGN, V10, P135, DOI 10.1007/s12104-015-9652-9; Li Y, 2015, BIOCHEM BIOPH RES CO, V467, P961, DOI 10.1016/j.bbrc.2015.10.036; Li Y, 2015, FEBS LETT, V589, P2683, DOI 10.1016/j.febslet.2015.07.044; Lubbers T, 2000, BIOORG MED CHEM LETT, V10, P821, DOI 10.1016/S0960-894X(00)00109-8; Manchester JI, 2012, BIOORG MED CHEM LETT, V22, P5150, DOI 10.1016/j.bmcl.2012.05.128; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Miller JR, 2010, EXPERT OPIN DRUG DIS, V5, P145, DOI 10.1517/17460440903493449; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147; Saito H, 2010, PROG NUCL MAG RES SP, V57, P181, DOI 10.1016/j.pnmrs.2010.04.005; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Skedelj V, 2011, J MED CHEM, V54, P915, DOI 10.1021/jm101121s; Stanger FV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107289; Suzuki Y, 2013, BIOCHEMISTRY-US, V52, P1903, DOI 10.1021/bi400027y; Suzuki Y, 2012, BIOCHEMISTRY-US, V51, P8154, DOI 10.1021/bi3012548; Tari LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084409; Tsai FTF, 1997, PROTEINS, V28, P41; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vulpetti A, 2010, J FLUORINE CHEM, V131, P570, DOI 10.1016/j.jfluchem.2009.12.024; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001	42	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17743	17753		10.1074/jbc.M116.737429	http://dx.doi.org/10.1074/jbc.M116.737429			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365392	Green Published, hybrid			2022-12-28	WOS:000383241300023
J	Shao, W; Zumer, K; Fujinaga, K; Peterlin, BM				Shao, Wei; Zumer, Kristina; Fujinaga, Koh; Peterlin, B. Matija			FBXO3 Protein Promotes Ubiquitylation and Transcriptional Activity of AIRE (Autoimmune Regulator)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmunity; gene regulation; protein phosphorylation; transcription factor; ubiquitylation (ubiquitination); AIRE; FBXO3; P-TEFb	THYMIC EPITHELIAL-CELLS; P-TEFB; GENE-EXPRESSION; IMMUNOLOGICAL-TOLERANCE; TARGET GENES; INTERACTING PROTEIN; UBIQUITIN LIGASE; HISTONE H3K4; PHD FINGER; ELONGATION	The autoimmune regulator (AIRE) is a transcription factor which is expressed in medullary thymic epithelial cells. It directs the expression of otherwise tissue-specific antigens, which leads to the elimination of autoreactive T cells during development. AIRE is modified post-translationally by phosphorylation and ubiquitylation. In this report we connected these modifications. AIRE, which is phosphorylated on two specific residues near its N terminus, then binds to the F-box protein 3 (FBXO3) E3 ubiquitin ligase. In turn, this SCFFBXO3 (SKP1-CUL1-F box) complex ubiquitylates AIRE, increases its binding to the positive transcription elongation factor b (P-TEFb), and potentiates its transcriptional activity. Because P-TEFb is required for the transition from initiation to elongation of transcription, this interaction ensures proper expression of AIRE-responsive tissue-specific antigens in the thymus.	[Shao, Wei; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Shao, Wei; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Shao, Wei; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; [Zumer, Kristina] Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Max Planck Society	Peterlin, BM (corresponding author), Rm U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu			Nora Eccles Treadwell Foundation	Nora Eccles Treadwell Foundation	This work was supported by a grant from the Nora Eccles Treadwell Foundation. The authors declare that they have no conflict of interest with the contents of this article.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen ZW, 2014, NUCLEIC ACIDS RES, V42, P11560, DOI 10.1093/nar/gku876; Chuprin A, 2015, NAT IMMUNOL, V16, P737, DOI 10.1038/ni.3194; Eifler TT, 2015, MOL CELL BIOL, V35, P468, DOI 10.1128/MCB.01157-14; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Girauda M, 2014, P NATL ACAD SCI USA, V111, P1491, DOI 10.1073/pnas.1323535111; Kainulainen M, 2014, J VIROL, V88, P3464, DOI 10.1128/JVI.02914-13; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Laan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00326; Lee M, 2014, J CELL SCI, V127, P4037, DOI 10.1242/jcs.151944; Li DN, 2015, BIOCHEM BIOPH RES CO, V458, P941, DOI 10.1016/j.bbrc.2015.02.089; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Mallampalli RK, 2013, J IMMUNOL, V191, P5247, DOI 10.4049/jimmunol.1300456; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Meloni A, 2010, J BIOL CHEM, V285, P13012, DOI 10.1074/jbc.M109.037747; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Org T, 2009, HUM MOL GENET, V18, P4699, DOI 10.1093/hmg/ddp433; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rattay K, 2015, J IMMUNOL, V194, P921, DOI 10.4049/jimmunol.1402694; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Seiden-Long IM, 2006, ONCOGENE, V25, P91, DOI 10.1038/sj.onc.1209005; Shima Y, 2008, MOL CELL BIOL, V28, P7126, DOI 10.1128/MCB.00897-08; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Unanue ER, 2014, ANNU REV IMMUNOL, V32, P579, DOI 10.1146/annurev-immunol-032712-095941; Waterfield M, 2014, NAT IMMUNOL, V15, P258, DOI 10.1038/ni.2820; Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112; Zumer K, 2013, J IMMUNOL, V190, P2479, DOI 10.4049/jimmunol.1203210; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11; Zumer K, 2011, NUCLEIC ACIDS RES, V39, P7908, DOI 10.1093/nar/gkr527	47	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17953	17963		10.1074/jbc.M116.724401	http://dx.doi.org/10.1074/jbc.M116.724401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365398	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000383241300038
J	Hresko, RC; Kraft, TE; Quigley, A; Carpenter, EP; Hruz, PW				Hresko, Richard C.; Kraft, Thomas E.; Quigley, Andrew; Carpenter, Elisabeth P.; Hruz, Paul W.			Mammalian Glucose Transporter Activity Is Dependent upon Anionic and Conical Phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transport; glucose transporter type 4 (GLUT4); liposome; membrane transporter reconstitution; phospholipid; phospholipid vesicle; protein-lipid interaction; glucose transport kinetics; glucose transporter type 3 (GLUT3)	FUNCTIONAL-CHARACTERIZATION; LIPID-COMPOSITION; MEMBRANE-LIPIDS; PHOSPHATIDYLETHANOLAMINE; BINDING; MECHANISM; EXPRESSION; CURVATURE; LIPOSOMES; CARNITINE	The regulated movement of glucose across mammalian cell membranes is mediated by facilitative glucose transporters (GLUTs) embedded in lipid bilayers. Despite the known importance of phospholipids in regulating protein structure and activity, the lipid-induced effects on the GLUTs remain poorly understood. We systematically examined the effects of physiologically relevant phospholipids on glucose transport in liposomes containing purified GLUT4 and GLUT3. The anionic phospholipids, phosphatidic acid, phosphatidylserine, phosphatidylglycerol, and phosphatidylinositol, were found to be essential for transporter function by activating it and stabilizing its structure. Conical lipids, phosphatidylethanolamine and diacylglycerol, enhanced transporter activity up to 3-fold in the presence of anionic phospholipids but did not stabilize protein structure. Kinetic analyses revealed that both lipids increase the k(cat) of transport without changing the K-m values. These results allowed us to elucidate the activation of GLUT by plasma membrane phospholipids and to extend the field of membrane protein-lipid interactions to the family of structurally and functionally related human solute carriers.	[Hresko, Richard C.; Kraft, Thomas E.; Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Quigley, Andrew; Carpenter, Elisabeth P.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	Washington University (WUSTL); Washington University (WUSTL); University of Oxford	Kraft, TE (corresponding author), Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev, Penzberg, Germany.; Hruz, PW (corresponding author), Washington Univ, Sch Med, 660 South Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.	thomas_kraft@gmx.net; hruz_p@kids.wustl.edu		Quigley, Andrew/0000-0002-5022-9845; Carpenter, Liz/0000-0001-9138-2937; Kraft, Thomas/0000-0002-5528-3197; Hruz, Paul/0000-0002-1478-3355	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; American Heart Association; Structural Genomics Consortium from AbbVie [1097737]; Bayer; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z, 106169]	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; American Heart Association(American Heart Association); Structural Genomics Consortium from AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by the Children's Discovery Institute of Washington University and St. Louis Children's Hospital. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Predoctoral Fellowship from the American Heart Association. To whom correspondence may be addressed: Roche Pharma Research and Early Development, Roche Innovation Center Munich, Nonnenwald, Penzberg, Germany. E-mail: thomas_kraft@gmx.net.; Supported by the Structural Genomics Consortium, which is a registered charity (number 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust Grant 092809/Z/10/Z.; Supported by Wellcome Trust Grant 106169.	Ansell G.V., 1973, FORM FUNCTION PHOSPH; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Barnes K, 2004, BIOCHEM J, V378, P343, DOI 10.1042/BJ20031186; Bechara C, 2015, NAT CHEM, V7, P255, DOI [10.1038/NCHEM.2172, 10.1038/nchem.2172]; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Brown MF, 2012, BIOCHEMISTRY-US, V51, P9782, DOI 10.1021/bi301332v; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; Dawaliby R, 2016, J BIOL CHEM, V291, P3658, DOI 10.1074/jbc.M115.706523; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Escriba PV, 2015, PROG LIPID RES, V59, P38, DOI 10.1016/j.plipres.2015.04.003; FIELD CJ, 1990, J BIOL CHEM, V265, P11143; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; Kim KH, 2003, BIOCHEMISTRY-US, V42, P15377, DOI 10.1021/bi035280k; Kobayashi D, 2005, REPRODUCTION, V130, P931, DOI 10.1530/rep.1.00737; Kraft TE, 2015, PROTEIN SCI, V24, P2008, DOI 10.1002/pro.2812; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lee S.-J., 2013, NAT COMMUN, V4, P1; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Neale C, 2015, BIOPHYS J, V109, P1652, DOI 10.1016/j.bpj.2015.08.028; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; Nowis D, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000017; Oppedisano F, 2007, BBA-BIOMEMBRANES, V1768, P291, DOI 10.1016/j.bbamem.2006.09.002; Parrish CC, 1997, BBA-BIOMEMBRANES, V1323, P253, DOI 10.1016/S0005-2736(96)00192-7; Pliotas C, 2015, NAT STRUCT MOL BIOL, V22, P991, DOI 10.1038/nsmb.3120; Pochini L, 2004, BBA-BIOMEMBRANES, V1661, P78, DOI 10.1016/j.bbamem.2003.12.001; RAY TK, 1969, J BIOL CHEM, V244, P5528; Rog T, 2014, CHEM PHYS LIPIDS, V184, P82, DOI 10.1016/j.chemphyslip.2014.10.004; Rosenhouse-Dantsker A, 2012, COMPR PHYSIOL, V2, P31, DOI 10.1002/cphy.c110001; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; TEFFT RE, 1986, BIOCHEMISTRY-US, V25, P3709, DOI 10.1021/bi00360a035; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vitrac H, 2013, J BIOL CHEM, V288, P5873, DOI 10.1074/jbc.M112.442988; Weijers RNM, 2012, CURR DIABETES REV, V8, P390, DOI 10.2174/157339912802083531; Wieczorke R, 2003, CELL PHYSIOL BIOCHEM, V13, P123, DOI 10.1159/000071863; Yeagle PL, 2014, BBA-BIOMEMBRANES, V1838, P1548, DOI 10.1016/j.bbamem.2013.11.009	52	40	41	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17271	17282		10.1074/jbc.M116.730168	http://dx.doi.org/10.1074/jbc.M116.730168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27302065	Green Published, hybrid			2022-12-28	WOS:000382643800028
J	Aly, HH; Suzuki, J; Watashi, K; Chayama, K; Hoshino, S; Hijikata, M; Kato, T; Wakita, T				Aly, Hussein H.; Suzuki, Junya; Watashi, Koichi; Chayama, Kazuaki; Hoshino, Shin-ichi; Hijikata, Makoto; Kato, Takanobu; Wakita, Takaji			RNA Exosome Complex Regulates Stability of the Hepatitis B Virus X-mRNA Transcript in a Non-stop-mediated (NSD) RNA Quality Control Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C VIRUS; GENOME REPLICATION; ANTIVIRAL FACTOR; LIVER-DISEASE; VIRAL GENOME; HBX PROTEIN; CELL-LINE; EXPRESSION; INFECTION; HELICASE	Hepatitis B virus (HBV) is a stealth virus, minimally inducing the interferon system required for efficient induction of both innate and adaptive immune responses. However, 90% of acutely infected adults can clear the virus, suggesting the presence of other, interferon-independent pathways leading to viral clearance. Given the known ability of helicases to bind viral nucleic acids, we performed a functional screening assay to identify helicases that regulate HBV replication. We identified the superkiller viralicidic activity 2-like (SKIV2L) RNA helicase (a homolog of the Saccharomyces cerevisiae Ski2 protein) on the basis of its direct and preferential interaction with HBV X-mRNA. This interaction was essential for HBVX-mRNA degradation at the RNA exosome. The degradation of HBV X-mRNA at the RNA exosome was also mediated by HBS1L (HBS1-like translational GTPase) protein, a known component of the host RNA quality control system. We found that the redundant HBV-precore translation initiation site present at the 3'-end of HBV X-mRNA (3'precore) is translationally active. The initiation of translation from this site without a proper stop codon was identified by the non-stop-mediated RNA decay mechanism leading to its degradation. Although 3'-precore is present in the five main HBV-RNA transcripts, only X-mRNA lacks the presence of an upstream start codons for large, middle, and small (L, M, and S) HBV surface proteins. These upstream codons are in-frame with 3'-precore translation initiation site, blocking its translation from the other HBV-mRNA transcripts. To our knowledge, this is the first demonstration of the anti-viral function of the non-stop-mediated RNA decay mechanism.	[Aly, Hussein H.; Suzuki, Junya; Watashi, Koichi; Kato, Takanobu; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Watashi, Koichi] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Watashi, Koichi] Japan Sci & Technol Agcy JST, CREST, Saitama 3320012, Japan; [Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan; [Hoshino, Shin-ichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Nagoya, Aichi 4678603, Japan; [Hijikata, Makoto] Kyoto Univ, Inst Virus Res, Lab Human Tumor Viruses, Kyoto 6068507, Japan	National Institute of Infectious Diseases (NIID); Tokyo University of Science; Japan Science & Technology Agency (JST); Hiroshima University; Nagoya City University; Kyoto University	Aly, HH; Wakita, T (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan.	ahussein@nih.go.jp; wakita@nih.go.jp	Aly, Hussein Hassan/GWV-0669-2022	Aly, Hussein H/0000-0002-2455-0694; Chayama, Kazuaki/0000-0002-5530-5341; Hoshino, Shinichi/0000-0001-6135-7896	Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED) Japan; Miyakawa memorial research fund	Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED) Japan(Japan Agency for Medical Research and Development (AMED)); Miyakawa memorial research fund	This study was supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and development (AMED) Japan and the Miyakawa memorial research fund. The authors declare that they have no conflicts of interest with the contents of this article.	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Cullen BR, 2014, J VIROL, V88, P12934, DOI 10.1128/JVI.01179-14; DANGEL AW, 1995, NUCLEIC ACIDS RES, V23, P2120, DOI 10.1093/nar/23.12.2120; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Garcia D, 2014, CELL HOST MICROBE, V16, P391, DOI 10.1016/j.chom.2014.08.001; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Leupin O, 2005, J VIROL, V79, P4238, DOI 10.1128/JVI.79.7.4238-4245.2005; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Michitaka K, 2010, J GASTROENTEROL, V45, P86, DOI 10.1007/s00535-009-0128-5; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Murata T, 2005, VIROLOGY, V331, P407, DOI 10.1016/j.virol.2004.10.036; NAOUMOV NV, 1992, GASTROENTEROLOGY, V102, P538, DOI 10.1016/0016-5085(92)90101-4; Ogura N, 2014, BIOCHEM BIOPH RES CO, V452, P315, DOI 10.1016/j.bbrc.2014.08.029; Orzalli MH, 2014, ANNU REV MICROBIOL, V68, P477, DOI 10.1146/annurev-micro-091313-103409; PUGH JC, 1988, J VIROL, V62, P3513, DOI 10.1128/JVI.62.9.3513-3516.1988; Rigby RE, 2015, TRENDS IMMUNOL, V36, P179, DOI 10.1016/j.it.2015.02.001; Saito S, 2013, J BIOL CHEM, V288, P17832, DOI 10.1074/jbc.M112.448977; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; Shin JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003411; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Tang H, 2005, J VIROL, V79, P5548, DOI 10.1128/JVI.79.9.5548-5556.2005; Tsuge M, 2010, J GEN VIROL, V91, P1854, DOI 10.1099/vir.0.019224-0; Tsukuda S, 2015, J BIOL CHEM, V290, P5673, DOI 10.1074/jbc.M114.602540; ULRICH PP, 1990, J MED VIROL, V32, P109, DOI 10.1002/jmv.1890320208; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang HF, 2009, J VIROL, V83, P5815, DOI 10.1128/JVI.00011-09; Watashi K, 2007, J BIOL CHEM, V282, P32765, DOI 10.1074/jbc.M704418200; Watashi Koichi, 2013, J Biol Chem, V288, P31715, DOI 10.1074/jbc.M113.501122; WIDNER WR, 1993, MOL CELL BIOL, V13, P4331, DOI 10.1128/MCB.13.7.4331; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yokosuka O, 2011, HEPATOL RES, V41, P1, DOI 10.1111/j.1872-034X.2010.00739.x; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhang ZS, 2004, J VIROL, V78, P4566, DOI 10.1128/JVI.78.9.4566-4572.2004; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	46	18	18	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15958	15974		10.1074/jbc.M116.724641	http://dx.doi.org/10.1074/jbc.M116.724641			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27281821	Green Published, hybrid			2022-12-28	WOS:000380585400004
J	Barcomb, K; Hell, JW; Benke, TA; Bayer, KU				Barcomb, Kelsey; Hell, Johannes W.; Benke, Tim A.; Bayer, K. Ulrich			The CaMKII/GluN2B Protein Interaction Maintains Synaptic Strength	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; KINASE-II; CAMKII INHIBITOR; DUPLICATE GENES; NR2B SUBUNIT; PKM-ZETA; LTP; PLASTICITY; MECHANISM	Learning, memory, and cognition are thought to require normal long-term potentiation (LTP) of synaptic strength, which in turn requires binding of the Ca2+/calmodulin-dependent protein kinase II (CaMKII) to the NMDA-type glutamate receptor (NMDAR) subunit GluN2B. For LTP induction, many additional required players are known. Here we tested the hypothesis that CaMKII/GluN2B binding also mediates the more elusive maintenance of synaptic strength. Intriguingly, the CaMKII inhibitor tatCN21 reduces synaptic strength only at high concentrations necessary for CaMKII/NMDAR disruption (20 mu M) but not at lower concentrations sufficient for kinase inhibition (5 mu M). However, increased concentration also causes unrelated effects. Thus, to distinguish between correlation and causality, we used a pharmacogenetic approach. In a mouse with a mutant NMDARGluN2B subunit that is CaMKII binding-incompetent, any tatCN21 effects that are specific to the CaMKII/GluN2B interaction should be abolished, and any remaining tatCN21 effects have to be nonspecific (i.e. mediated by other targets). The results showed that the persistent reduction of synaptic strength by transient application of 20 mu M tatCN21 had a non-specific presynaptic component (on fiber volley amplitude) that was unrelated to the CaMKII/GluN2B interaction or CaMKII activity. However, the remaining component of the persistent tatCN21 effect was almost completely abolished in the GluN2B mutant mouse. These results highlight the requirement for stringent pharmacogenetic approaches to separate specific on-target effects from nonspecific off-target effects. Importantly, they also demonstrate that the CaMKII/GluN2B interaction is required not only for normal LTP induction but also for the maintenance of synaptic strength.	[Barcomb, Kelsey; Bayer, K. Ulrich] Univ Colorado Denver, Sch Med, Neurol Sect, Dept Pharmacol, Aurora, CO 80045 USA; [Benke, Tim A.] Univ Colorado Denver, Sch Med, Neurol Sect, Dept Pediat, Aurora, CO 80045 USA; [Hell, Johannes W.] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA; [Barcomb, Kelsey] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Davis; Brown University	Bayer, KU (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Mail Stop 8303,RC1-North,12800 E 19th Ave, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu	Hell, Johannes W./P-5085-2019	Barcomb, Kelsey/0000-0002-4050-0566	National Institute of Health [F31NS083298, P30NS048154, R01NS078792, R01NS076577, R21DA036300, R01NS081248]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS083298, R01NS081248, R01NS076577, P30NS048154, R01NS080851, R01NS078792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA036300] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health Grants F31NS083298 (to K. B.), P30NS048154 (University of Colorado Center grant), R01NS078792 (to J. W. H.), R01NS076577 (to T. A. B.), and R21DA036300 and R01NS081248 (to K. U. B.). The University of Colorado holds the patent rights for tatCN21, its derivatives, and its uses (PCT/US08/077934 ''Compositions and Methods for Improved CaMKII Inhibitors and Uses Thereof"). K. U. B. is the owner of Neurexus Therapeutics, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bogard AS, 2015, MOL PHARMACOL, V88, P728, DOI 10.1124/mol.115.099457; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Kim S, 2015, P NATL ACAD SCI USA, V112, P3122, DOI 10.1073/pnas.1417498112; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shonesy BC, 2014, PROG MOL BIOL TRANSL, V122, P61, DOI 10.1016/B978-0-12-420170-5.00003-9; Stein Ivar S, 2014, F1000Res, V3, P193, DOI 10.12688/f1000research.4660.1; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tao-Cheng JH, 2013, NEUROSCIENCE, V244, P188, DOI 10.1016/j.neuroscience.2013.03.063; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	32	45	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16082	16089		10.1074/jbc.M116.734822	http://dx.doi.org/10.1074/jbc.M116.734822			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246855	Green Published, hybrid			2022-12-28	WOS:000380585400014
J	Bhardwaj, A; Srivastava, SK; Singh, S; Tyagi, N; Arora, S; Carter, JE; Khushman, M; Singh, AP				Bhardwaj, Arun; Srivastava, Sanjeev K.; Singh, Seema; Tyagi, Nikhil; Arora, Sumit; Carter, James E.; Khushman, Moh'd; Singh, Ajay P.			MYB Promotes Desmoplasia in Pancreatic Cancer through Direct Transcriptional Up-regulation and Cooperative Action of Sonic Hedgehog and Adrenomedullin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYB; MESENCHYMAL TRANSITION; INDUCE FIBROSIS; TUMOR-GROWTH; CELLS; ACTIVATION; EXPRESSION; HYPOXIA; DIFFERENTIATION; PROLIFERATION	Extensive desmoplasia is a prominent pathological characteristic of pancreatic cancer (PC) that not only impacts tumor development, but therapeutic outcome as well. Recently, we demonstrated a novel role of MYB, an oncogenic transcription factor, in PC growth and metastasis. Here we studied its effect on pancreatic tumor histopathology and associated molecular and biological mechanisms. Tumor-xenografts derived from orthotopic-inoculation of MYB-overexpressing PC cells exhibited far-greater desmoplasia in histological analyses compared with those derived from MYB-silenced PC cells. These findings were further confirmed by immunostaining of tumor-xenograft sections with collagen-I, fibronectin (major extracellular-matrix proteins), and alpha-SMA (well-characterized marker of myofibroblasts or activated pancreatic stellate cells (PSCs)). Likewise, MYB-overexpressing PC cells provided significantly greater growth benefit to PSCs in a co-culture system as compared with the MYB-silenced cells. Interrogation of deep-sequencing data from MYB-overexpressing versus-silenced PC cells identified Sonic-hedgehog (SHH) and Adrenomedullin (ADM) as two differentially-expressed genes among others, which encode for secretory ligands involved in tumor-stromal cross-talk. In-silico analyses predicted putative MYB-binding sites in SHH and ADM promoters, which was later confirmed by chromatin-immunoprecipitation. A cooperative role of SHH and ADM in growth promotion of PSCs was confirmed in co-culture by using their specific-inhibitors and exogenous recombinant-proteins. Importantly, while SHH acted exclusively in a paracrine fashion on PSCs and influenced the growth of PC cells only indirectly, ADM could directly impact the growth of both PC cells and PSCs. In summary, we identified MYB as novel regulator of pancreatic tumor desmoplasia, which is suggestive of its diverse roles in PC pathobiology.	[Bhardwaj, Arun; Srivastava, Sanjeev K.; Singh, Seema; Tyagi, Nikhil; Arora, Sumit; Singh, Ajay P.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA; [Khushman, Moh'd] Univ S Alabama, Mitchell Canc Inst, Dept Interdisciplinary Clin Oncol, Mobile, AL 36604 USA; [Singh, Seema; Singh, Ajay P.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Carter, James E.] Univ S Alabama, Coll Med, Dept Pathol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Singh, AP (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA.	asingh@health.southalabama.edu	Singh, Ajay/AAF-4414-2020	Singh, Ajay/0000-0003-3492-6330	National Institutes of Health/NCI [CA167137, CA175772, CA185490]; USAMCI; NATIONAL CANCER INSTITUTE [R21CA167137, R01CA175772, U01CA185490] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USAMCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from National Institutes of Health/NCI Grants CA167137, CA175772, and CA185490 (to A. P. S.) and the USAMCI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggarwal G, 2012, GASTROENTEROLOGY, V143, P1510, DOI 10.1053/j.gastro.2012.08.044; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bhardwaj A, 2014, BRIT J CANCER, V110, P2000, DOI 10.1038/bjc.2014.141; Bhardwaj A, 2014, ONCOTARGET, V5, P11490, DOI 10.18632/oncotarget.2571; Biroccio A, 2001, AM J PATHOL, V158, P1289, DOI 10.1016/S0002-9440(10)64080-1; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Duan WX, 2014, CURR CANCER DRUG TAR, V14, P446, DOI 10.2174/1568009614666140402105101; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; Greco C, 2001, ANTICANCER RES, V21, P3185; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jagadeeshan S, 2015, ONCOGENE, V34, P455, DOI 10.1038/onc.2013.576; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Kumar S, 2015, ONCOGENE, V34, P2052, DOI 10.1038/onc.2014.154; Larrayoz IM, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0339-2; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Masamune A, 2008, AM J PHYSIOL-GASTR L, V295, pG709, DOI 10.1152/ajpgi.90356.2008; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; Ramachandran V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007502; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Sakurai T, 2011, PANCREATOLOGY, V11, P7, DOI 10.1159/000323478; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Spivak-Kroizman TR, 2013, CANCER RES, V73, P3235, DOI 10.1158/0008-5472.CAN-11-1433; Srivastava SK, 2015, BRIT J CANCER, V113, P1694, DOI 10.1038/bjc.2015.400; Srivastava SK, 2012, CARCINOGENESIS, V33, P1149, DOI 10.1093/carcin/bgs134; Wallrapp C, 1997, CANCER RES, V57, P3135	38	14	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16263	16270		10.1074/jbc.M116.732651	http://dx.doi.org/10.1074/jbc.M116.732651			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246849	Green Published, hybrid			2022-12-28	WOS:000380585400030
J	Ball, J; Salvi, F; Gadda, G				Ball, Jacob; Salvi, Francesca; Gadda, Giovanni			Functional Annotation of a Presumed Nitronate Monoxygenase Reveals a New Class of NADH:Quinone Reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLD YELLOW ENZYME; FATTY-ACID OXIDATION; QUINONE REDUCTASE; DT-DIAPHORASE; 2-NITROPROPANE DIOXYGENASE; 2-ELECTRON REDUCTION; CRYSTAL-STRUCTURE; 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE CB-1954; NAD(P)H-QUINONE REDUCTASE; SACCHAROMYCES-CEREVISIAE	The protein PA1024 from Pseudomonas aeruginosa PAO1 is currently classified as 2-nitropropane dioxygenase, the previous name for nitronate monooxygenase in the GenBank (TM) and PDB databases, but the enzyme was not kinetically characterized. In this study, PA1024 was purified to high levels, and the enzymatic activity was investigated by spectroscopic and polarographic techniques. Purified PA1024 did not exhibit nitronate monooxygenase activity; however, it displayed NADH: quinone reductase and a small NADH: oxidase activity. The enzyme preferred NADH to NADPH as a reducing substrate. PA1024 could reduce a broad spectrum of quinone substrates via a Ping Pong Bi Bi steady-state kinetic mechanism, generating the corresponding hydroquinones. The reductive half-reaction with NADH showed a k(red) value of 24 s(-1) and an apparent K-d value estimated in the low micromolar range. The enzyme was not able to reduce the azo dye methyl red, routinely used in the kinetic characterization of azoreductases. Finally, we revisited and modified the existing six conserved motifs of PA1024, which define a new class of NADH:quinone reductases and are present in more than	[Ball, Jacob; Salvi, Francesca; Gadda, Giovanni] Georgia State Univ, Dept Chem, POB 3965, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Gadda, G (corresponding author), Georgia State Univ, Dept Chem, POB 3965, Atlanta, GA 30302 USA.	ggadda@gsu.edu	Gadda, Giovanni/M-2354-2016	Gadda, Giovanni/0000-0002-7508-4195; Ball, Jacob/0000-0002-5176-0048; Salvi, Francesca/0000-0001-5294-1310	National Science Foundation [CHE-1506518]; Georgia State University	National Science Foundation(National Science Foundation (NSF)); Georgia State University	This work was supported in part by National Science Foundation Grant CHE-1506518 (to G. G.), and a Molecular Basis of Disease Fellowship from Georgia State University (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anton BP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001638; Anusevicius Z, 2005, ARCH BIOCHEM BIOPHYS, V437, P144, DOI 10.1016/j.abb.2005.03.015; Bin Y, 2004, FEMS MICROBIOL LETT, V236, P129, DOI 10.1016/j.femsle.2004.05.034; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen HZ, 2004, PROTEIN EXPRES PURIF, V34, P302, DOI 10.1016/j.pep.2003.12.016; CHESIS PL, 1984, P NATL ACAD SCI-BIOL, V81, P1696, DOI 10.1073/pnas.81.6.1696; Deller S, 2008, CELL MOL LIFE SCI, V65, P141, DOI 10.1007/s00018-007-7300-y; Foster CE, 1999, BIOCHEMISTRY-US, V38, P9881, DOI 10.1021/bi990799v; Francis K, 2005, J BIOL CHEM, V280, P5195, DOI 10.1074/jbc.M411249200; Francis K, 2013, IUBMB LIFE, V65, P759, DOI 10.1002/iub.1195; Francis K, 2009, BIOORG CHEM, V37, P167, DOI 10.1016/j.bioorg.2009.07.005; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Green LK, 2014, J MICROBIOL, V52, P771, DOI 10.1007/s12275-014-4208-8; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; IYANAGI T, 1990, FREE RADICAL RES COM, V8, P259, DOI 10.3109/10715769009053359; Jadhav SB, 2013, ENVIRON SCI POLLUT R, V20, P2854, DOI 10.1007/s11356-012-1155-y; Jordan BJ, 2007, CHEM COMMUN, P1248, DOI 10.1039/b616159f; Kabra AN, 2013, WATER RES, V47, P1035, DOI 10.1016/j.watres.2012.11.007; Karplus PA, 1995, FASEB J, V9, P1518, DOI 10.1096/fasebj.9.15.8529830; KIMURA RE, 1988, PEDIATR RES, V23, P262, DOI 10.1203/00006450-198803000-00006; Knox RJ, 2000, CANCER RES, V60, P4179; KNOX RJ, 1988, BIOCHEM PHARMACOL, V37, P4661, DOI 10.1016/0006-2952(88)90335-8; KNOX RJ, 1988, BIOCHEM PHARMACOL, V37, P4671, DOI 10.1016/0006-2952(88)90336-X; Laskowski MJ, 2002, PLANT PHYSIOL, V128, P578, DOI 10.1104/pp.010581; LEQUOC D, 1989, ARCH BIOCHEM BIOPHYS, V273, P466, DOI 10.1016/0003-9861(89)90506-7; Leskovac V, 2005, INT J BIOCHEM CELL B, V37, P731, DOI 10.1016/j.biocel.2004.10.014; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; MATTHEWS RG, 1986, METHOD ENZYMOL, V122, P372; MCCOMB RB, 1976, CLIN CHEM, V22, P141; Mijatovic S, 2008, ARCH BIOCHEM BIOPHYS, V473, P61, DOI 10.1016/j.abb.2008.02.029; Muller N, 2009, J BACTERIOL, V191, P6167, DOI 10.1128/JB.01605-08; Munday R, 2000, FREE RADICAL RES, V32, P245, DOI 10.1080/10715760000300251; Nakanishi M, 2001, J BIOL CHEM, V276, P46394, DOI 10.1074/jbc.M104483200; Nam S, 2000, CHEMOSPHERE, V40, P351, DOI 10.1016/S0045-6535(99)00226-X; NIINO YS, 1995, J BIOL CHEM, V270, P1983, DOI 10.1074/jbc.270.5.1983; NISHIMOTO K, 1978, BIOCHIM BIOPHYS ACTA, V526, P34, DOI 10.1016/0005-2744(78)90287-5; Nivinskas H, 2002, ARCH BIOCHEM BIOPHYS, V403, P249, DOI 10.1016/S0003-9861(02)00228-X; Opperman DJ, 2008, J BACTERIOL, V190, P3076, DOI 10.1128/JB.01766-07; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Pintea AM, 2008, CHEM FUNCT PROP FOOD, P101; Punj S, 2009, CURR ISSUES MOL BIOL, V11, P59; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; ROSS D, 1993, CANCER METAST REV, V12, P83, DOI 10.1007/BF00689803; Ryan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098551; Ryan A, 2010, PROTEIN CELL, V1, P780, DOI 10.1007/s13238-010-0090-2; Salvi F, 2014, J BIOL CHEM, V289, P23764, DOI 10.1074/jbc.M114.577791; Sedlacek V, 2009, ARCH BIOCHEM BIOPHYS, V483, P29, DOI 10.1016/j.abb.2008.12.016; Siegel David, 2008, P169, DOI 10.1007/978-0-387-77300-1_7; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Skelly JV, 1999, J MED CHEM, V42, P4325, DOI 10.1021/jm991060m; Smitherman C, 2013, BIOCHEMISTRY-US, V52, P2694, DOI 10.1021/bi400030d; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Sparla F, 1999, FEBS LETT, V463, P382, DOI 10.1016/S0014-5793(99)01625-7; Suzuki Y, 2001, J BIOL CHEM, V276, P9059, DOI 10.1074/jbc.M008083200; TEDESCHI G, 1995, J BIOL CHEM, V270, P1198, DOI 10.1074/jbc.270.3.1198; THOMSON RH, 1991, PHARM WEEKBLAD, V13, P70, DOI 10.1007/BF01974983; Ullmann E, 2014, BIOSCIENCE REP, V34, P893, DOI 10.1042/BSR20140143; WAKIL SJ, 1954, J BIOL CHEM, V207, P631; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; Zhao M, 2014, ENVIRON SCI POLLUT R, V21, P6136, DOI 10.1007/s11356-014-2579-3	67	15	15	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21160	+		10.1074/jbc.M116.739151	http://dx.doi.org/10.1074/jbc.M116.739151			32	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27502282	hybrid, Green Published			2022-12-28	WOS:000385406200030
J	Guengerich, FP				Guengerich, F. Peter			Metals in Biology 2016: Molecular Basis of Selection of Metals by Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MINIREVIEW SERIES METALS; FIDELITY	This ninth Metals in Biology Thematic Series deals with the fundamental issue of why certain enzymes prefer individual metals. Why do some prefer sodium and some prefer potassium? Is it just the size? Why does calcium have so many regulatory functions? Why do some proteins have an affinity for zinc? Howis the homeostasis of calcium and zinc achieved? How do enzymes discriminate between the similar metals magnesium and manganese? Four Minireviews address these and related questions about metal ion preferences in biological systems.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			NIEHS NIH HHS [R01 ES010546] Funding Source: Medline; NIGMS NIH HHS [R01 GM103937, R01 GM118122] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122, R01GM103937] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Capdevila DA, 2016, J BIOL CHEM, V291, P20858, DOI 10.1074/jbc.R116.742023; Carafoli E, 2016, J BIOL CHEM, V291, P20849, DOI 10.1074/jbc.R116.735894; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Gohara DW, 2016, J BIOL CHEM, V291, P20840, DOI 10.1074/jbc.R116.737833; Guengerich FP, 2015, J BIOL CHEM, V290, P20700, DOI 10.1074/jbc.R115.675652; Guengerich FP, 2015, J BIOL CHEM, V290, P18943, DOI 10.1074/jbc.R115.670265; Guengerich FP, 2014, J BIOL CHEM, V289, P28094, DOI 10.1074/jbc.R114.607093; Guengerich FP, 2013, J BIOL CHEM, V288, P13164, DOI 10.1074/jbc.R113.467712; Guengerich FP, 2012, J BIOL CHEM, V287, P13508, DOI 10.1074/jbc.R112.355933; Guengerich FP, 2010, J BIOL CHEM, V285, P26727, DOI 10.1074/jbc.R110.150870; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Vashishtha AK, 2016, J BIOL CHEM, V291, P20869, DOI 10.1074/jbc.R116.742494; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300	15	5	5	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20838	20839		10.1074/jbc.R116.749259	http://dx.doi.org/10.1074/jbc.R116.749259			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27462079	Green Published, hybrid			2022-12-28	WOS:000385406200002
J	Swaminathan, A; Delage, H; Chatterjee, S; Belgarbi-Dutron, L; Cassel, R; Martinez, N; Cosquer, B; Kumari, S; Mongelard, F; Lannes, B; Cassel, JC; Boutillier, AL; Bouvet, P; Kundu, TK				Swaminathan, Amrutha; Delage, Helene; Chatterjee, Snehajyoti; Belgarbi-Dutron, Laurence; Cassel, Raphaelle; Martinez, Nicole; Cosquer, Brigitte; Kumari, Sujata; Mongelard, Fabien; Lannes, Beatrice; Cassel, Jean-Christophe; Boutillier, Anne-Laurence; Bouvet, Philippe; Kundu, Tapas K.			Transcriptional Coactivator and Chromatin Protein PC4 Is Involved in Hippocampal Neurogenesis and Spatial Memory Extinction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin structure; gene expression; hypoxia; neurogenesis; transgenic mice; Knockout; Spatial memory	FEAR EXTINCTION; NERVOUS-SYSTEM; VEGF-C; GENE; CONSOLIDATION; ACTIVATION; EXPRESSION; NEURONS; CAMKII; MICE	Although the elaborate combination of histone and non-histone protein complexes defines chromatin organization and hence regulates numerous nuclear processes, the role of chromatin organizing proteins remains unexplored at the organismal level. The highly abundant, multifunctional, chromatin-associated protein and transcriptional coactivator positive coactivator 4 (PC4/Sub1) is absolutely critical for life, because its absence leads to embryonic lethality. Here, we report results obtained with conditional PC4 knock-out (PC4(f/f) Nestin-Cre) mice where PC4 is knocked out specifically in the brain. Compared with the control (PC4(+/+) Nestin-Cre) mice, PC4(f/f) Nestin-Cre mice are smaller with decreased nocturnal activity but are fertile and show no motor dysfunction. Neurons in different areas of the brains of these mice show sensitivity to hypoxia/anoxia, and decreased adult neurogenesis was observed in the dentate gyrus. Interestingly, PC4(f/f) Nestin-Cre mice exhibit a severe deficit in spatial memory extinction, whereas acquisition and long term retention were unaffected. Gene expression analysis of the dorsal hippocampus of PC4(f/f) Nestin-Cre mice revealed dysregulated expression of several neural function-associated genes, and PC4 was consistently found to localize on the promoters of these genes, indicating that PC4 regulates their expression. These observations indicate that non-histone chromatin-associated proteins like PC4 play a significant role in neuronal plasticity.	[Swaminathan, Amrutha; Kumari, Sujata; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bangalore 560064, Karnataka, India; [Delage, Helene; Martinez, Nicole; Mongelard, Fabien; Bouvet, Philippe] Univ Lyon, Ctr Rech Cancerol Lyon, Ecole Normale Super Lyon,Cter Leon Berard, Canc Cell Plast Dept,UMR INSERM CNRS 5286 1052, Lyon, France; [Belgarbi-Dutron, Laurence] Univ Lyon, Dept Biol, Ecole Normale Super Lyon, Lyon, France; [Chatterjee, Snehajyoti; Cassel, Raphaelle; Cosquer, Brigitte; Cassel, Jean-Christophe; Boutillier, Anne-Laurence] Univ Strasbourg, Lab Neurosci Cognit & Adaptat, UMR7364, F-67000 Strasbourg, France; [Chatterjee, Snehajyoti; Cassel, Raphaelle; Cassel, Jean-Christophe; Boutillier, Anne-Laurence] CNRS, Lab Neurosci Cognit & Adaptat, UMR 7364, F-67000 Strasbourg, France; [Lannes, Beatrice] Univ Strasbourg, Dept Pathol, Hop Hautepierre, F-67081 Strasbourg, France	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bouvet, P (corresponding author), Univ Lyon, Ctr Rech Cancerol Lyon, Ecole Normale Super Lyon,Cter Leon Berard, Canc Cell Plast Dept,UMR INSERM CNRS 5286 1052, Lyon, France.; Boutillier, AL; Kundu, TK (corresponding author), Univ Strasbourg, Lab Neurosci Cognit & Adaptat, UMR7364, F-67000 Strasbourg, France.; Boutillier, AL (corresponding author), CNRS, Lab Neurosci Cognit & Adaptat, UMR 7364, F-67000 Strasbourg, France.; Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.; Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Neurosci Unit, Bangalore 560064, Karnataka, India.	laurette@unistra.fr; philippe.bouvet@ens-lyon.fr; tapas@jncasr.ac.in	Chatterjee, Snehajyoti/AAV-3919-2021; Swaminathan, Amrutha/F-8409-2016; , Bouvet/AAC-8779-2020	Chatterjee, Snehajyoti/0000-0002-4873-9416; Swaminathan, Amrutha/0000-0002-0177-3756; Boutillier, Anne-Laurence/0000-0002-2317-9280; Kundu, Tapas/0000-0001-7790-214X; Mongelard, Fabien/0000-0002-5929-6120; CASSEL, Raphaelle/0000-0002-3157-3798; Bouvet, Philippe/0000-0003-4524-2233	Charpak fellowship from the French Embassy in India, Region Rhone-Alpes COOPERA [12 004948 01]; Department of Science and Technology, Government of India through a Sir J. C. Bose Fellowship; Council of Scientific and Industrial Research; Department of Biotechnology [BT/01/CEIB/10/III/01]; CNRS-International Programs for Scientific Cooperation Grant [6449]; CNRS, Universite de Strasbourg [ANR-12-MALZ-0002-01]; IFCPAR Grant [4803-3]; Alsace Alzheimer 67 Association	Charpak fellowship from the French Embassy in India, Region Rhone-Alpes COOPERA(Region Auvergne-Rhone-Alpes); Department of Science and Technology, Government of India through a Sir J. C. Bose Fellowship(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; CNRS-International Programs for Scientific Cooperation Grant; CNRS, Universite de Strasbourg(Centre National de la Recherche Scientifique (CNRS)); IFCPAR Grant; Alsace Alzheimer 67 Association	This work was supported by the Charpak fellowship from the French Embassy in India, Region Rhone-Alpes COOPERA 2012 Grant 12 004948 01, the Department of Science and Technology, Government of India through a Sir J. C. Bose Fellowship (to T. K. K.), Council of Scientific and Industrial Research Senior Research Fellow funding (to A. S.), Department of Biotechnology Grant BT/01/CEIB/10/III/01 (to T. K. K.), and CNRS-International Programs for Scientific Cooperation Grant 6449 (to P. B.). Work performed in the laboratory of A.-L. B. was supported by CNRS, Universite de Strasbourg, Grant ANR-12-MALZ-0002-01, IFCPAR Grant 4803-3, and funds from the Alsace Alzheimer 67 Association. The authors declare that they have no conflicts of interest with the contents of this article.	Auer R. N., 2002, GREENFIELDS NEUROPAT; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Bhuiyan MIH, 2015, NEUROSCIENCE, V290, P90, DOI 10.1016/j.neuroscience.2015.01.025; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Carey MF, 2009, COLD SPRING HARB PRO, V2009; Cestari V, 2014, BRAIN RES BULL, V105, P8, DOI 10.1016/j.brainresbull.2013.09.007; Chatterjee S, 2013, J NEUROSCI, V33, P10698, DOI 10.1523/JNEUROSCI.5772-12.2013; Chatzi C, 2015, ELIFE, V4, DOI 10.7554/eLife.08722; Conde E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033258; Conesa C, 2010, RNA BIOL, V7, P287, DOI 10.4161/rna.7.3.11491; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kimura R, 2008, LEARN MEMORY, V15, P837, DOI 10.1101/lm.1049608; Kirby ED, 2015, P NATL ACAD SCI USA, V112, P4128, DOI 10.1073/pnas.1422448112; Kondo M, 2014, LEARN MEMORY, V21, P1, DOI 10.1101/lm.032193.113; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; Marek R, 2013, J PHYSIOL-LONDON, V591, P2381, DOI 10.1113/jphysiol.2012.248575; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Pang KCH, 2011, HIPPOCAMPUS, V21, P835, DOI 10.1002/hipo.20799; Park SM, 2012, REV NEUROSCIENCE, V23, P555, DOI 10.1515/revneuro-2012-0052; Powell JD, 2002, BIOL REPROD, V67, P995, DOI 10.1095/biolreprod.101.002576; Probst B, 2007, DEV BIOL, V312, P461, DOI 10.1016/j.ydbio.2007.09.054; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Selvi BR, 2015, MOL BIOL CELL, V26, P316, DOI 10.1091/mbc.E14-01-0019; Singh P B, 2010, Genetika, V46, P1424; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang JF, 2004, J BIOL CHEM, V279, P27088, DOI 10.1074/jbc.M314015200; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509	41	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20303	20314		10.1074/jbc.M116.744169	http://dx.doi.org/10.1074/jbc.M116.744169			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27471272	Green Published, hybrid			2022-12-28	WOS:000384574800003
J	Lai, LH; Azzam, KM; Lin, WC; Rai, P; Lowe, JM; Gabor, KA; Madenspacher, JH; Aloor, JJ; Parks, JS; Naar, AM; Fessler, MB				Lai, Lihua; Azzam, Kathleen M.; Lin, Wan-Chi; Rai, Prashant; Lowe, Julie M.; Gabor, Kristin A.; Madenspacher, Jennifer H.; Aloor, Jim J.; Parks, John S.; Naar, Anders M.; Fessler, Michael B.			MicroRNA-33 Regulates the Innate Immune Response via ATP Binding Cassette Transporter-mediated Remodeling of Membrane Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; cholesterol; lipid raft; macrophage; microRNA (miRNA); toll-like receptor (TLR)	REVERSE CHOLESTEROL TRANSPORT; HIGH-DENSITY-LIPOPROTEIN; INFLAMMATORY RESPONSE; HOST-DEFENSE; LIPID RAFTS; ADAPTIVE IMMUNITY; DENDRITIC CELLS; X RECEPTOR; MACROPHAGES; EXPRESSION	MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression by promoting degradation and/or repressing translation of specific target mRNAs. Several miRNAs have been identified that regulate the amplitude of the innate immune response by directly targeting Toll-like receptor (TLR) pathway members and/or cytokines. miR-33a and miR-33b (the latter present in primates but absent in rodents and lower species) are located in introns of the sterol regulatory element-binding protein (SREBP)-encoding genes and control cholesterol/lipid homeostasis in concert with their host gene products. These miRNAs regulate macrophage cholesterol by targeting the lipid efflux transporters ATP binding cassette (ABC)A1 and ABCG1. We and others have previously reported that Abca1(-/-) and Abcg1(-/-) macrophages have increased TLR proinflammatory responses due to augmented lipid raft cholesterol. Given this, we hypothesized that miR-33 would augment TLR signaling in macrophages via a raft cholesterol-dependent mechanism. Herein, we report that multiple TLR ligands down-regulate miR-33 in murine macrophages. In the case of lipopolysaccharide, this is a delayed, Toll/interleukin-1 receptor (TIR) domain-containing adapter-inducing interferon--dependent response that also down-regulates Srebf-2, the host gene for miR-33. miR-33 augments macrophage lipid rafts and enhances proinflammatory cytokine induction and NF-B activation by LPS. This occurs through an ABCA1- and ABCG1-dependent mechanism and is reversible by interventions upon raft cholesterol and by ABC transporter-inducing liver X receptor agonists. Taken together, these findings extend the purview of miR-33, identifying it as an indirect regulator of innate immunity that mediates bidirectional cross-talk between lipid homeostasis and inflammation.	[Lai, Lihua; Azzam, Kathleen M.; Lin, Wan-Chi; Rai, Prashant; Lowe, Julie M.; Gabor, Kristin A.; Madenspacher, Jennifer H.; Aloor, Jim J.; Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Parks, John S.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Naar, Anders M.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Naar, Anders M.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Wake Forest University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Fessler, MB (corresponding author), NIEHS, 111 TW Alexander Dr,POB 12233,D2-01, Res Triangle Pk, NC 27709 USA.	fesslerm@niehs.nih.gov	Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613	Intramural Research Program, NIEHS, National Institutes of Health Grant [Z01 ES102005]; China Scholarship Council; National Natural Science Foundation of China [81401283]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102005, ZICES102546, Z01ES102005] Funding Source: NIH RePORTER	Intramural Research Program, NIEHS, National Institutes of Health Grant; China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by Intramural Research Program, NIEHS, National Institutes of Health Grant Z01 ES102005. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the China Scholarship Council and National Natural Science Foundation of China Grant 81401283. Present address: Inst. of Immunology, Zhejiang University School of Medicine, Hangzhou 310058, China.	Allen RM, 2012, EMBO MOL MED, V4, P882, DOI 10.1002/emmm.201201228; Azzam KM, 2012, TRENDS ENDOCRIN MET, V23, P169, DOI 10.1016/j.tem.2012.02.001; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Distel E, 2014, CIRC RES, V115, P759, DOI 10.1161/CIRCRESAHA.115.304164; Doan JES, 2004, J IMMUNOL, V172, P7654, DOI 10.4049/jimmunol.172.12.7654; Draper DW, 2012, J IMMUNOL, V188, P5327, DOI 10.4049/jimmunol.1101605; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fu YH, 2014, BIOCHEM PHARMACOL, V90, P126, DOI 10.1016/j.bcp.2014.05.004; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Herrera-Merchan A, 2010, CELL CYCLE, V9, P3277, DOI 10.4161/cc.9.16.12598; Ho PC, 2011, FASEB J, V25, P1758, DOI 10.1096/fj.10-179267; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kim J, 2012, EXP NEUROL, V235, P476, DOI 10.1016/j.expneurol.2011.11.010; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li LC, 2013, AM J PHYSIOL-HEART C, V304, pH874, DOI 10.1152/ajpheart.00096.2012; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Ma L, 2012, J BIOL CHEM, V287, P40502, DOI 10.1074/jbc.M112.413245; Madenspacher JH, 2013, J EXP MED, V210, P891, DOI 10.1084/jem.20121674; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Nilsen NJ, 2015, J BIOL CHEM, V290, P3209, DOI 10.1074/jbc.M114.593426; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ouimet M, 2015, J CLIN INVEST, V125, P4334, DOI 10.1172/JCI81676; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Park Y, 2012, INFLAMM RES, V61, P465, DOI 10.1007/s00011-011-0433-3; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Ramirez CM, 2013, CIRC RES, V112, P1592, DOI 10.1161/CIRCRESAHA.112.300626; Ramirez CM, 2011, ARTERIOSCL THROM VAS, V31, P2707, DOI 10.1161/ATVBAHA.111.232066; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Smoak KA, 2010, CELL METAB, V11, P493, DOI 10.1016/j.cmet.2010.04.006; Sun DS, 2012, FEBS LETT, V586, P1472, DOI 10.1016/j.febslet.2012.03.068; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Triantafilou M, 2002, J CELL SCI, V115, P2603; Vallim TQD, 2013, CIRC RES, V112, P1602, DOI 10.1161/CIRCRESAHA.112.300648; Wang DL, 2012, CIRC RES, V111, P967, DOI [10.1161/circresaha.112.266502, 10.1161/CIRCRESAHA.112.266502]; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhang N, 2015, EXP CELL RES, V336, P33, DOI 10.1016/j.yexcr.2015.05.023; Zhao GJ, 2014, INT J CARDIOL, V171, pE93, DOI 10.1016/j.ijcard.2013.11.093; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	59	45	51	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19651	19660		10.1074/jbc.M116.723056	http://dx.doi.org/10.1074/jbc.M116.723056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27471270	Green Published, hybrid			2022-12-28	WOS:000383242800038
J	Liu, HC; Jamshidi, N; Chen, YC; Eraly, SA; Cho, SY; Bhatnagar, V; Wu, W; Bush, KT; Abagyan, R; Palsson, BO; Nigam, SK				Liu, Henry C.; Jamshidi, Neema; Chen, Yuchen; Eraly, Satish A.; Cho, Sai Yee; Bhatnagar, Vibha; Wu, Wei; Bush, Kevin T.; Abagyan, Ruben; Palsson, Bernhard O.; Nigam, Sanjay K.			An Organic Anion Transporter 1 (OAT1)-centered Metabolic Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; diabetes; kidney; microbiome; systems biology; Recon; SLC transporter; chronic kidney disease; genome-scale metabolic reconstruction; pharmacophore	REVERSE-TRANSCRIPTASE INHIBITORS; GENOME-SCALE RECONSTRUCTION; FLUX BALANCE ANALYSIS; UREMIC TOXINS; DRUG TRANSPORTERS; ANTIRETROVIRAL THERAPY; KIDNEY-DISEASE; OAT FAMILY; URIC-ACID; IN-VITRO	There has been a recent interest in the broader physiological importance of multispecific drug transporters of the SLC and ABC transporter families. Here, a novel multi-tiered systems biology approach was used to predict metabolites and signaling molecules potentially affected by the in vivo deletion of organic anion transporter 1 (Oat1, Slc22a6, originally NKT), a major kidney-expressed drug transporter. Validation of some predictions in wet-lab assays, together with re-evaluation of existing transport and knock-out metabolomics data, generated an experimentally validated, confidence ranked set of OAT1-interacting endogenous compounds enabling construction of an OAT1-centered metabolic interaction network. Pathway and enrichment analysis indicated an important role for OAT1 in metabolism involving: the TCA cycle, tryptophan and other amino acids, fatty acids, prostaglandins, cyclic nucleotides, odorants, polyamines, and vitamins. The partly validated reconstructed network is also consistent with a major role for OAT1 in modulating metabolic and signaling pathways involving uric acid, gut microbiome products, and so-called uremic toxins accumulating in chronic kidney disease. Together, the findings are compatible with the hypothesized role of drug transporters in remote inter-organ and inter-organismal communication: The Remote Sensing and Signaling Hypothesis (Nigam, S. K. (2015) Nat. Rev. Drug Disc. 14, 29). The fact that OAT1 can affect many systemic biological pathways suggests that drug-metabolite interactions need to be considered beyond simple competition for the drug transporter itself and may explain aspects of drug-induced metabolic syndrome. Our approach should provide novel mechanistic insights into the role of OAT1 and other drug transporters implicated in metabolic diseases like gout, diabetes, and chronic kidney disease.	[Liu, Henry C.; Jamshidi, Neema; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Eraly, Satish A.; Wu, Wei; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Cho, Sai Yee] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Bhatnagar, Vibha] Univ Calif San Diego, Dept Family & Preventat Med, La Jolla, CA 92093 USA; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chen, Yuchen] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,MC0693, La Jolla, CA 92093 USA.	snigam@ucsd.edu		Jamshidi, Neema/0000-0003-3857-9735	National Institutes of Health [R01-GM098449, RO1GM104098, U54-HD07160]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098449, R01GM104098, R01GM071872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM098449, RO1GM104098, and U54-HD07160. R. Abagyan has a significant financial interest in Molsoft or its products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SY, 2011, J BIOL CHEM, V286, P31522, DOI 10.1074/jbc.M111.272534; Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Anderson PL, 2004, CLIN INFECT DIS, V38, P743, DOI 10.1086/381678; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Bordbar A, 2012, J INTERN MED, V271, P131, DOI 10.1111/j.1365-2796.2011.02494.x; Burckhardt G, 2011, HANDB EXP PHARMACOL, V201, P29, DOI 10.1007/978-3-642-14541-4_2; Buscemi S, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-80; Bush KT, 2014, WILEY SER DRUG DISC, P25; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Chen YC, 2014, FUTURE MED CHEM, V6, P1741, DOI [10.4155/fmc.14.113, 10.4155/FMC.14.113]; Duan P, 2012, MOL PHARMACEUT, V9, P3340, DOI 10.1021/mp300365t; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; ELION GB, 1989, BIOSCIENCE REP, V9, P509, DOI 10.1007/BF01119794; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2003, CURR OPIN NEPHROL HY, V12, P551, DOI 10.1097/00041552-200309000-00011; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gupta S, 2007, MOL DIVERS, V11, P23, DOI 10.1007/s11030-006-9054-0; Hester EK, 2012, NUTR CLIN PRACT, V27, P51, DOI 10.1177/0884533611431985; HITCHINGS GH, 1989, IN VITRO CELL DEV B, V25, P303; Hodson L, 2013, CURR OPIN CLIN NUTR, V16, P225, DOI 10.1097/MCO.0b013e32835d2edf; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Karakoc E, 2006, J CHEM INF MODEL, V46, P2167, DOI 10.1021/ci0601517; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Khanna V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S10; Knies D, 2015, METABOLITES, V5, P659, DOI 10.3390/metabo5040659; Kouznetsova VL, 2011, BIOORGAN MED CHEM, V19, P3320, DOI 10.1016/j.bmc.2011.04.045; Lee SC, 2014, WILEY SER DRUG DISC, P473; Lewis W, 2003, PROG CARDIOVASC DIS, V45, P305, DOI 10.1053/pcad.2003.3b; Liu H. C., 2016, J PHARMACOL EXP THER; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; LopezNieto CE, 1996, J AM SOC NEPHROL, V7, pA0277; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mitrea C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00278; MOLLER JV, 1982, PHARMACOL REV, V34, P315; Monier PL, 2004, AM J MED SCI, V328, P48, DOI 10.1097/00000441-200407000-00007; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam SK, 2015, CLIN J AM SOC NEPHRO, V10, P2039, DOI 10.2215/CJN.02440314; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; O'Hagan S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00105; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; PRITCHARD JB, 1995, J PHARMACOL EXP THER, V274, P1278; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Schuetz JD, 2014, DRUG METAB DISPOS, V42, P541, DOI 10.1124/dmd.114.057539; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Sinxadi PZ, 2013, AIDS RES HUM RETROV, V29, P1031, DOI [10.1089/aid.2012.0373, 10.1089/AID.2012.0373]; Sweeney DE, 2011, MOL PHARMACOL, V80, P147, DOI 10.1124/mol.110.070680; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Totrov M, 2008, CHEM BIOL DRUG DES, V71, P15, DOI 10.1111/j.1747-0285.2007.00605.x; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wang RS, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105014; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wolman AT, 2013, DRUG METAB DISPOS, V41, P791, DOI 10.1124/dmd.112.049569; Wu W, 2015, DRUG METAB DISPOS, V43, P1855, DOI 10.1124/dmd.115.065250; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zhang YP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03426; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	75	34	34	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19474	19486		10.1074/jbc.M116.745216	http://dx.doi.org/10.1074/jbc.M116.745216			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27440044	Green Published, hybrid			2022-12-28	WOS:000383242800025
J	Sun, RL; Huang, CX; Bao, JL; Jiang, JY; Zhang, B; Zhou, SX; Cai, WB; Wang, H; Wang, JF; Zhang, YL				Sun, Run-Lu; Huang, Can-Xia; Bao, Jin-Lan; Jiang, Jie-Yu; Zhang, Bo; Zhou, Shu-Xian; Cai, Wei-Bin; Wang, Hong; Wang, Jing-Feng; Zhang, Yu-Ling			CC-Chemokine Ligand 2 (CCL2) Suppresses High Density Lipoprotein (HDL) Internalization and Cholesterol Efflux via CC-Chemokine Receptor 2 (CCR2) Induction and p42/44 Mitogen-activated Protein Kinase (MAPK) Activation in Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; cholesterol metabolism; endothelial cell; high-density lipoprotein (HDL); mitogen-activated protein kinase (MAPK); CC-chemokine ligand 2 (CCL2)	MONOCYTE CHEMOATTRACTANT PROTEIN-1; VASCULAR SMOOTH-MUSCLE; ACUTE CORONARY SYNDROMES; SR-BI; INFLAMMATORY CYTOKINES; SURFACE EXPRESSION; HUMAN MACROPHAGES; DEFICIENT MICE; PLASMA-LEVELS; ATHEROSCLEROSIS	High density lipoprotein (HDL) has been proposed to be internalized and to promote reverse cholesterol transport in endothelial cells (ECs). However, the mechanism underlying these processes has not been studied. In this study, we aim to characterize HDL internalization and cholesterol efflux in ECs and regulatory mechanisms. We found mature HDL particles were reduced in patients with coronary artery disease (CAD), which was associated with an increase in CC-chemokine ligand 2 (CCL2). In cultured primary human coronary artery endothelial cells and human umbilical vein endothelial cells, we determined that CCL2 suppressed the binding (4 degrees C) and association (37 degrees C) of HDL to/with ECs and HDL cellular internalization. Furthermore, CCL2 inhibited [H-3]cholesterol efflux to HDL/apoA1 in ECs. We further found that CCL2 induced CC-chemokine receptor 2 (CCR2) expression and siRNA-CCR2 reversed CCL2 suppression on HDL binding, association, internalization, and on cholesterol efflux in ECs. Moreover, CCL2 induced p42/44 mitogen-activated protein kinase (MAPK) phosphorylation via CCR2, and p42/44 MAPK inhibition reversed the suppression of CCL2 on HDL metabolism in ECs. Our study suggests that CCL2 was elevated in CAD patients. CCL2 suppressed HDL internalization and cholesterol efflux via CCR2 induction and p42/44 MAPK activation in ECs. CCL2 induction may contribute to impair HDL function and form atherosclerosis in CAD.	[Sun, Run-Lu; Zhang, Bo; Zhou, Shu-Xian; Wang, Jing-Feng; Zhang, Yu-Ling] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Cardiovasc Med Dept, 107 West Yanjiang Rd, Guangzhou 510120, Guangdong, Peoples R China; [Huang, Can-Xia] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Intens Care Unit, Guangzhou 510120, Guangdong, Peoples R China; [Bao, Jin-Lan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Comprehens Dept, Guangzhou 510120, Guangdong, Peoples R China; [Jiang, Jie-Yu] Sun Yat Sen Univ, Affiliated Hosp 6, Graceland Med Ctr, Guangzhou 510655, Guangdong, Peoples R China; [Zhou, Shu-Xian; Wang, Jing-Feng; Zhang, Yu-Ling] Guangdong Prov Key Lab Arrhythmia & Electrophysio, Guangzhou 51020, Guangdong, Peoples R China; [Cai, Wei-Bin] Sun Yat Sen Univ, Zhongshan Med Sch, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Hong] Temple Univ, Dept Pharmacol, Ctr Metab Res, Philadelphia, PA 19140 USA; [Wang, Hong] Temple Univ, Dept Pharmacol, Ctr Cardiovasc Res, Philadelphia, PA 19140 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wang, JF; Zhang, YL (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Cardiovasc Med Dept, 107 West Yanjiang Rd, Guangzhou 510120, Guangdong, Peoples R China.	dr_wjf@hotmail.com; zzhangyuling@126.com	wang, jing/GRS-7509-2022		Natural Science Foundation of China [81070182]; Natural Science Foundation of Guangdong Province [2014A030313712]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in whole or part by Natural Science Foundation of China Grant 81070182 and Natural Science Foundation of Guangdong Province Grant 2014A030313712. The authors declare that they have no conflicts of interest with the contents of this article.	Awan Z, 2008, CAN J CARDIOL, V24, p27C, DOI 10.1016/S0828-282X(08)71035-3; Barlic J, 2009, J IMMUNOL, V182, P7928, DOI 10.4049/jimmunol.0804112; Berger O, 1999, MOL MED, V5, P795, DOI 10.1007/BF03401992; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Chen YL, 2015, ARTERIOSCL THROM VAS, V35, P948, DOI 10.1161/ATVBAHA.114.305116; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; de Lemos JA, 2007, J AM COLL CARDIOL, V50, P2117, DOI 10.1016/j.jacc.2007.06.057; Deo R, 2004, J AM COLL CARDIOL, V44, P1812, DOI 10.1016/j.jacc.2004.07.047; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Feingold KR, 2010, J LIPID RES, V51, P682, DOI 10.1194/jlr.E005454; Frisdal E, 2011, J BIOL CHEM, V286, P30926, DOI 10.1074/jbc.M111.264325; Fruhwurth Stefanie, 2013, World J Biol Chem, V4, P131, DOI 10.4331/wjbc.v4.i4.131; Gawaz M, 1998, CIRCULATION, V98, P1164, DOI 10.1161/01.CIR.98.12.1164; Gerhardt S, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0094-z; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Huang CX, 2013, J LIPID RES, V54, P1231, DOI 10.1194/jlr.M032482; Javadov S, 2014, PHARMACOL THERAPEUT, V144, P202, DOI 10.1016/j.pharmthera.2014.05.013; Kanzler I, 2012, CURR PHARM BIOTECHNO, V13, P37, DOI 10.2174/138920112798868557; Karabacak M, 2015, SCAND J CLIN LAB INV, V75, P327, DOI 10.3109/00365513.2014.1003595; Khovidhunkit W, 2001, J LIPID RES, V42, P967; Liu Q, 2015, VASC PHARMACOL, V67-69, P59, DOI 10.1016/j.vph.2015.03.015; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nomiyama H, 2011, DEV COMP IMMUNOL, V35, P705, DOI 10.1016/j.dci.2011.01.019; O'Connell BJ, 2004, CIRCULATION, V110, P2881, DOI 10.1161/01.CIR.0000146333.20727.2B; O'Connor T, 2015, ENDOCR METAB IMMUNE, V15, P105, DOI 10.2174/1871530315666150316120920; Ohashi R, 2005, QJM-INT J MED, V98, P845, DOI 10.1093/qjmed/hci136; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; Pagler TA, 2007, J LIPID RES, V48, P2141, DOI 10.1194/jlr.M700056-JLR200; Parissis JT, 2002, J INTERF CYTOK RES, V22, P223, DOI 10.1089/107999002753536194; Potteaux S, 2006, ARTERIOSCL THROM VAS, V26, P1858, DOI 10.1161/01.ATV.0000231527.22762.71; Prosser HC, 2012, CURR OPIN LIPIDOL, V23, P182, DOI 10.1097/MOL.0b013e328352c4dd; Qiu HN, 2016, MOL CELL BIOCHEM, V411, P1, DOI 10.1007/s11010-015-2563-3; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Robert J, 2013, ARTERIOSCL THROM VAS, V33, P2699, DOI 10.1161/ATVBAHA.113.301363; Rohrer L, 2009, CIRC RES, V104, P1142, DOI 10.1161/CIRCRESAHA.108.190587; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297; SAVION N, 1989, EUR J BIOCHEM, V183, P363, DOI 10.1111/j.1432-1033.1989.tb14937.x; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Sviridov D, 1997, INT J BIOCHEM CELL B, V29, P583, DOI 10.1016/S1357-2725(96)00174-4; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tehrani DM, 2013, ATHEROSCLEROSIS, V231, P246, DOI 10.1016/j.atherosclerosis.2013.08.036; Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]; Veillard NR, 2005, CIRCULATION, V112, P870, DOI 10.1161/CIRCULATIONAHA.104.520718; Wang H, 2011, AM J PHYSIOL-ENDOC M, V300, pE134, DOI 10.1152/ajpendo.00498.2010; Wood P, 2011, J BIOL CHEM, V286, P23077, DOI 10.1074/jbc.M111.236398; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Zhang X, 2011, ACTA BIOCH BIOPH SIN, V43, P787, DOI 10.1093/abbs/gmr072; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601	56	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19532	19544		10.1074/jbc.M116.714279	http://dx.doi.org/10.1074/jbc.M116.714279			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27458015	hybrid, Green Published			2022-12-28	WOS:000383242800029
J	Assentoft, M; Kaptan, S; Schneider, HP; Deitmer, JW; de Groot, BL; MacAulay, N				Assentoft, Mette; Kaptan, Shreyas; Schneider, Hans-Peter; Deitmer, Joachim W.; de Groot, Bert L.; MacAulay, Nanna			Aquaporin 4 as a NH3 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELATIVE CO2/NH3 SELECTIVITIES; XENOPUS-LAEVIS OOCYTES; THICK ASCENDING LIMB; AMMONIUM TRANSPORT; POTASSIUM CHANNELS; NH4+ CONDUCTANCE; INTRACELLULAR PH; WATER TRANSPORT; GLIAL-CELLS; PERMEABILITY	Ammonia is a biologically potent molecule, and the regulation of ammonia levels in the mammalian body is, therefore, strictly controlled. The molecular paths of ammonia permeation across plasma membranes remain ill-defined, but the structural similarity of water and NH3 has pointed to the aquaporins as putative NH3-permeable pores. Accordingly, a range of aquaporins from mammals, plants, fungi, and protozoans demonstrates ammonia permeability. Aquaporin 4 (AQP4) is highly expressed at perivascular glia end-feet in the mammalian brain and may, with this prominent localization at the bloodbrain- interface, participate in the exchange of ammonia, which is required to sustain the glutamate-glutamine cycle. Here we observe that AQP4-expressing Xenopus oocytes display a reflection coefficient <1 for NH4Cl at pH 8.0, at which pH an increased amount of the ammonia occurs in the form of NH3. Taken together with an NH4Cl-mediated intracellular alkalization (or lesser acidification) of AQP4-expressing oocytes, these data suggest that NH3 is able to permeate the pore of AQP4. Exposure to NH4Cl increased the membrane currents to a similar extent in uninjected oocytes and in oocytes expressing AQP4, indicating that the ionic NH4+ did not permeate AQP4. Molecular dynamics simulations revealed partial pore permeation events of NH3 but not of NH4+ and a reduced energy barrier for NH3 permeation through AQP4 compared with that of a cholesterol-containing lipid bilayer, suggesting AQP4 as a favored transmembrane route for NH3. Our data propose that AQP4 belongs to the growing list of NH3-permeable water channels.	[Assentoft, Mette; MacAulay, Nanna] Univ Copenhagen, Dept Neurosci & Pharmacol, Blegdamsvej 3,Bldg 22-3, DK-2200 Copenhagen N, Denmark; [Kaptan, Shreyas; de Groot, Bert L.] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany; [Schneider, Hans-Peter; Deitmer, Joachim W.] Univ Kaiserslautern, Dept Biol, Div Gen Zool, D-67653 Kaiserslautern, Germany	University of Copenhagen; Max Planck Society; University of Kaiserslautern	MacAulay, N (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Blegdamsvej 3,Bldg 22-3, DK-2200 Copenhagen N, Denmark.	macaulay@sund.ku.dk	MacAulay, Nanna/AER-7709-2022	MacAulay, Nanna/0000-0002-7800-6600; Kaptan, Shreyas/0000-0003-1265-4557	Danish Medical Research Council; Max Planck Society; German Research Foundation [SFB 803]; Deutsche Forschungsgemeinschaft [DE 231/24-2]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Danish Medical Research Council.; Supported by the Max Planck Society and the German Research Foundation via the SFB 803 (Project A03).; Supported by the Deutsche Forschungsgemeinschaft (DE 231/24-2).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adeva MM, 2012, METABOLISM, V61, P1495, DOI 10.1016/j.metabol.2012.07.007; Bachmann O, 2003, J PHYSIOL-LONDON, V549, P525, DOI 10.1113/jphysiol.2002.030205; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Benga O, 2012, MOL ASPECTS MED, V33, P562, DOI 10.1016/j.mam.2012.03.008; Bergeron MJ, 2003, AM J PHYSIOL-RENAL, V285, pF68, DOI 10.1152/ajprenal.00032.2003; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; BLATZ AL, 1984, J GEN PHYSIOL, V84, P1, DOI 10.1085/jgp.84.1.1; Bodega G, 2012, NEUROCHEM INT, V61, P1314, DOI 10.1016/j.neuint.2012.09.008; Boldt M, 2003, PFLUG ARCH EUR J PHY, V446, P652, DOI 10.1007/s00424-003-1122-z; BORON WF, 1994, J EXP BIOL, V196, P347; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; BURCKHARDT BC, 1992, PFLUG ARCH EUR J PHY, V420, P83, DOI 10.1007/BF00378645; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; BUTTERWORTH RF, 1987, NEUROCHEM PATHOL, V6, P1, DOI 10.1007/BF02833598; Butterworth RF, 2002, METAB BRAIN DIS, V17, P221, DOI 10.1023/A:1021989230535; Caner T, 2015, AM J PHYSIOL-CELL PH, V309, pC747, DOI 10.1152/ajpcell.00085.2015; CHEPILKO S, 1995, AM J PHYSIOL-CELL PH, V268, pC389, DOI 10.1152/ajpcell.1995.268.2.C389; Choe H, 2000, J GEN PHYSIOL, V115, P391, DOI 10.1085/jgp.115.4.391; Cohn RM, 2004, CLIN PEDIATR, V43, P683, DOI 10.1177/000992280404300801; Cougnon M, 1996, PFLUG ARCH EUR J PHY, V431, P658, DOI 10.1007/BF02191917; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Dynowski M, 2008, FEBS LETT, V582, P2458, DOI 10.1016/j.febslet.2008.06.012; Edvinsson JM, 2011, CHANNELS, V5, P269, DOI 10.4161/chan.5.3.15827; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Flub J. S., 2010, J AM CHEM SOC, V132, P13251; Geyer RR, 2013, AM J PHYSIOL-CELL PH, V304, pC985, DOI 10.1152/ajpcell.00033.2013; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; HAMM LL, 1985, J CLIN INVEST, V75, P478, DOI 10.1172/JCI111723; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Hub JS, 2010, BIOPHYS J, V99, pL97, DOI 10.1016/j.bpj.2010.11.003; Hwang JH, 2010, FEBS LETT, V584, P4339, DOI 10.1016/j.febslet.2010.09.033; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KINNE R, 1986, J MEMBRANE BIOL, V94, P279, DOI 10.1007/BF01869723; Kirscht A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002411; KURTZ I, 1986, AM J PHYSIOL, V250, pF497, DOI 10.1152/ajprenal.1986.250.3.F497; LAURSEN H, 1980, ACTA NEUROPATHOL, V51, P65, DOI 10.1007/BF00688851; Liu K, 2006, BIOL CELL, V98, P153, DOI 10.1042/BC20050026; LOCKWOOD AH, 1993, HEPATOLOGY, V18, P1061; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF255, DOI 10.1152/ajprenal.2001.281.2.F255; Nielsen S, 1997, J NEUROSCI, V17, P171; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; OCARROLL RE, 1991, LANCET, V337, P1250, DOI 10.1016/0140-6736(91)92920-W; Rao KVR, 2003, NEUROREPORT, V14, P2379, DOI 10.1097/01.wnr.0000099610.19426.a6; Rose C, 2006, J NEUROCHEM, V97, P11, DOI 10.1111/j.1471-4159.2006.03796.x; Rose C, 2005, J BIOL CHEM, V280, P20937, DOI 10.1074/jbc.M412448200; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; SASAKI S, 1992, BIOCHIM BIOPHYS ACTA, V1137, P45, DOI 10.1016/0167-4889(92)90098-V; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sogaard R, 2012, AM J PHYSIOL-CELL PH, V302, pC880, DOI 10.1152/ajpcell.00238.2011; SWAIN M, 1992, HEPATOLOGY, V15, P449, DOI 10.1002/hep.1840150316; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vilas GL, 2013, HUM MOL GENET, V22, P4579, DOI 10.1093/hmg/ddt307; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WATTS BA, 1994, J GEN PHYSIOL, V103, P917, DOI 10.1085/jgp.103.5.917; WOLBURG H, 1995, J BRAIN RES, V36, P239; YIP KP, 1995, AM J PHYSIOL-RENAL, V269, pF545, DOI 10.1152/ajprenal.1995.269.4.F545; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65; Zeuthen T, 2006, J PHYSIOL-LONDON, V570, P485, DOI 10.1113/jphysiol.2005.100933; Zeuthen T, 2006, MOL MICROBIOL, V61, P1598, DOI 10.1111/j.1365-2958.2006.05325.x; Zhang W, 2015, INT J ANTENN PROPAG, V2015, P1, DOI DOI 10.1145/2820783.2820823.10; ZHOU H, 1994, AM J PHYSIOL, V266, pC809, DOI 10.1152/ajpcell.1994.266.3.C809	74	20	20	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19184	19195		10.1074/jbc.M116.740217	http://dx.doi.org/10.1074/jbc.M116.740217			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27435677	Green Published, hybrid			2022-12-28	WOS:000383242300049
J	Rong, ZY; Ouyang, ZQ; Magin, RS; Marnnorstein, R; Yu, HT				Rong, Ziye; Ouyang, Zhuqing; Magin, Robert S.; Marnnorstein, Ronen; Yu, Hongtao			Opposing Functions of the N-terminal Acetyltransferases Naa50 and NatA in Sister-chromatid Cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; CHROMOSOME SEGREGATION; SMC3 ACETYLATION; DNA-REPLICATION; MOLECULAR-BASIS; COMPLEX; WAPL; SORORIN; CENTROMERES; BINDING	During the cell cycle, sister-chromatid cohesion tethers sister chromatids together from S phase to the metaphase-anaphase transition and ensures accurate segregation of chromatids into daughter cells. N-terminal acetylation is one of the most prevalent protein covalent modifications in eukaryotes and is mediated by a family of N-terminal acetyltransferases (NAT). Naa50 (also called San) has previously been shown to play a role in sister-chromatid cohesion in metazoans. The mechanism by which Naa50 contributes to cohesion is not understood however. Here, we show that depletion of Naa50 in HeLa cells weakens the interaction between cohesin and its positive regulator sororin and causes cohesion defects in S phase, consistent with a role of Naa50 in cohesion establishment. Strikingly, co-depletion of NatA, a heterodimeric NAT complex that physically interacts with Naa50, rescues the sister-chromatid cohesion defects and the resulting mitotic arrest caused by Naa50 depletion, indicating that NatA and Naa50 play antagonistic roles in cohesion. Purified recombinant NatA and Naa50 do not affect each other's NAT activity in vitro. Because NatA and Naa50 exhibit distinct substrate specificity, we propose that they modify different effectors and regulate sister-chromatid cohesion in opposing ways.	[Rong, Ziye; Ouyang, Zhuqing; Yu, Hongtao] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Magin, Robert S.; Marnnorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine	Yu, HT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu	ouyang, zhuqing/HHC-3950-2022	Magin, Robert/0000-0002-8480-8511	Welch Foundation [I-1441]; Cancer Prevention and Research Institute of Texas [RP110465-P3, RP120717-P2]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071339, R35GM118090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Welch Foundation (I-1441; to H.Y.) and the Cancer Prevention and Research Institute of Texas (RP110465-P3 and RP120717-P2; to H.Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Chu CW, 2011, MOL BIOL CELL, V22, P448, DOI 10.1091/mbc.E10-03-0203; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hara K, 2014, NAT STRUCT MOL BIOL, V21, P864, DOI 10.1038/nsmb.2880; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Ladurner R, 2014, CURR BIOL, V24, P2228, DOI 10.1016/j.cub.2014.08.011; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Liu H, 2015, MOL CELL, V59, P426, DOI 10.1016/j.molcel.2015.06.018; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Liu H, 2013, NAT CELL BIOL, V15, P40, DOI 10.1038/ncb2637; Magin RS, 2016, J BIOL CHEM, V291, P5270, DOI 10.1074/jbc.M115.709428; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nishiyama T, 2013, P NATL ACAD SCI USA, V110, P13404, DOI 10.1073/pnas.1305020110; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Ouyang ZQ, 2016, MOL CELL, V62, P248, DOI 10.1016/j.molcel.2016.02.033; Ouyang ZQ, 2013, P NATL ACAD SCI USA, V110, P11355, DOI 10.1073/pnas.1304594110; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Van Damme P, 2015, PROTEOMICS, V15, P2436, DOI 10.1002/pmic.201400575; Van Damme P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004580; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	49	8	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19079	19091		10.1074/jbc.M116.737585	http://dx.doi.org/10.1074/jbc.M116.737585			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27422821	Green Published, hybrid			2022-12-28	WOS:000383242300041
J	Theparambil, SM; Weber, T; Schmalzle, J; Ruminot, I; Deitmer, JW				Theparambil, Shefeeq M.; Weber, Tobias; Schmalzle, Jana; Ruminot, Ivan; Deitmer, Joachim W.			Proton Fall or Bicarbonate Rise GLYCOLYTIC RATE IN MOUSE ASTROCYTES IS PAVED BY INTRACELLULAR ALKALINIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; CORTICAL ASTROCYTES; ENERGY-METABOLISM; NEURONAL-ACTIVITY; SNAIL NEURONS; PH TRANSIENTS; FROG-MUSCLE; GLIAL-CELLS; LACTATE; BRAIN	Glycolysis is the primary step for major energy production in the cell. There is strong evidence suggesting that glucose consumption and rate of glycolysis are highly modulated by cytosolic pH/[H+], but those can also be stimulated by an increase in the intracellular [HCO3-]. Because proton and bicarbonate shift concomitantly, it remained unclear whether enhanced glucose consumption and glycolytic rate were mediated by the changes in intracellular [H+] or[HCO3-]. We have asked whether glucose metabolism is enhanced by either a fall in intracellular [H+] or a rise in intracellular [HCO3-], or by both, in mammalian astrocytes. We have recorded intracellular glucose in mouse astrocytes using a FRET-based nanosensor, while imposing different intracellular [H+] and [CO2]/[HCO3-]. Glucose consumption and glycolytic rate were augmented by a fall in intracellular [H+], irrespective of a concomitant rise or fall in intracellular [HCO3-]. Transport of HCO3- into and out of astrocytes by the electrogenic sodium bicarbonate cotransporter (NBCe1) played a crucial role in causing changes in intracellular pH and [HCO3-], but was not obligatory for the pH-dependent changes in glucose metabolism. Our results clearly show that it is the cytosolic pH that modulates glucose metabolism in cortical astrocytes, and possibly also in other cell types.	[Theparambil, Shefeeq M.; Weber, Tobias; Schmalzle, Jana; Ruminot, Ivan; Deitmer, Joachim W.] Univ Kaiserlautern, FB Biol, Abt Allgemeine Zool, PB 3049, D-67653 Kaiserslautern, Germany; [Ruminot, Ivan] Ctr Estudios Cient, Valdivia 5110466, Chile		Theparambil, SM; Deitmer, JW (corresponding author), Univ Kaiserlautern, FB Biol, Abt Allgemeine Zool, PB 3049, D-67653 Kaiserslautern, Germany.	theparambil@biologie.uni-kl.de; deitmer@biologie.uni-kl.de		Ruminot Moraga, Ivan/0000-0002-3985-384X	Deutsche Forschungsgemeinschaft [DE 231/24-1,2]; Priority Group of the Land Rheinland-Pfalz 'Bio-Comp' at the University of Kaiserslautern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Priority Group of the Land Rheinland-Pfalz 'Bio-Comp' at the University of Kaiserslautern	This work was supported by the Deutsche Forschungsgemeinschaft (Grant DE 231/24-1,2) and by the Priority Group of the Land Rheinland-Pfalz 'Bio-Comp' at the University of Kaiserslautern (to J. W. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Baeza Y., 2014, NEUROPHOTON, V1; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; Bittner CX, 2011, J NEUROSCI, V31, P4709, DOI 10.1523/JNEUROSCI.5311-10.2011; Brookes N, 1997, GLIA, V21, P64; Buck J, 2011, SENSORS-BASEL, V11, P2112, DOI 10.3390/s110202112; CARPENTER JF, 1986, ARCH BIOCHEM BIOPHYS, V248, P1, DOI 10.1016/0003-9861(86)90394-2; Chang JC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00042; CHESLER M, 1987, AM J PHYSIOL, V253, pR666, DOI 10.1152/ajpregu.1987.253.4.R666; CHESLER M, 1989, J NEUROSCI, V9, P2011; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Deitmer JW, 2001, RESP PHYSIOL, V129, P71, DOI 10.1016/S0034-5687(01)00283-3; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; ERECINSKA M, 1995, J NEUROCHEM, V65, P2765; FOLBERGROVA J, 1972, J NEUROCHEM, V19, P2507, DOI 10.1111/j.1471-4159.1972.tb01310.x; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; HASSEL B, 1995, NEUROCHEM RES, V20, P413, DOI 10.1007/BF00973096; Jakoby P, 2014, CEREB CORTEX, V24, P222, DOI 10.1093/cercor/bhs309; Karagiannis A, 2016, J CEREBR BLOOD F MET, V36, P1202, DOI 10.1177/0271678X15611912; Kerly M, 1933, J BIOL CHEM, V103, P161; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; PENG L, 1994, BRAIN RES, V663, P168, DOI 10.1016/0006-8993(94)90475-8; ROSE CR, 1994, J PHYSIOL-LONDON, V481, P1, DOI 10.1113/jphysiol.1994.sp020413; Ruminot I, 2011, J NEUROSCI, V31, P14264, DOI 10.1523/JNEUROSCI.2310-11.2011; San Martin A, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011004; Schneider J, 2015, J NEUROSCI RES, V93, P1067, DOI 10.1002/jnr.23590; Schrodl-Haussel M, 2015, GLIA, V63, P1226, DOI 10.1002/glia.22814; Sotelo-Hitschfeld T, 2015, J NEUROSCI, V35, P4168, DOI 10.1523/JNEUROSCI.5036-14.2015; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Theparambil SM, 2015, J PHYSIOL-LONDON, V593, P3533, DOI 10.1113/JP270086; Theparambil SM, 2015, GLIA, V63, P1581, DOI 10.1002/glia.22829; Theparambil SM, 2014, J NEUROSCI, V34, P1148, DOI 10.1523/JNEUROSCI.2377-13.2014; THOMAS RC, 1976, J PHYSIOL-LONDON, V255, P715, DOI 10.1113/jphysiol.1976.sp011305; THOMAS RC, 1974, J PHYSIOL-LONDON, V238, P159, DOI 10.1113/jphysiol.1974.sp010516; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; Valdebenito R, 2016, J CEREBR BLOOD F MET, V36, P1813, DOI 10.1177/0271678X15613955; Wuttke M S, 2001, JOP, V2, P154; Zippin JH, 2013, J BIOL CHEM, V288, P33283, DOI 10.1074/jbc.M113.510073	43	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19108	19117		10.1074/jbc.M116.730143	http://dx.doi.org/10.1074/jbc.M116.730143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27422823	hybrid, Green Published			2022-12-28	WOS:000383242300043
J	Tong, SL; Lin, YB; Lu, S; Wang, MT; Bogdanov, M; Zheng, L				Tong, Shuilong; Lin, Yibin; Lu, Shuo; Wang, Meitian; Bogdanov, Mikhail; Zheng, Lei			Structural Insight into Substrate Selection and Catalysis of Lipid Phosphate Phosphatase PgpB in the Cell Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; phosphatidylglycerol; phospholipid metabolism; protein-lipid interaction; X-ray crystallography; lipid phosphate dephosphorylation; substrate selectivity	ESCHERICHIA-COLI PGPB; X-RAY-STRUCTURE; AUTOINDUCTION; ACTIVATION; PROTEINS; SYSTEM; GENE	PgpB belongs to the lipid phosphate phosphatase protein family and is one of three bacterial integral membrane phosphatases catalyzing dephosphorylation of phosphatidylglycerol phosphate (PGP) to generate phosphatidylglycerol. Although the structure of its apo form became recently available, the mechanisms of PgpB substrate binding and catalysis are still unclear. We found that PgpB was inhibited by phosphatidylethanolamine (PE) in a competitive mode in vitro. Here we report the crystal structure of the lipid-bound form of PgpB. The structure shows that a PE molecule is stabilized in a membrane-embedded tunnel formed by TM3 and the PSGH fingerprint peptide near the catalytic site, providing structural insight into PgpB substrate binding mechanism. Noteworthy, in silico docking of varied lipid phosphates exhibited similar substrate binding modes to that of PE, and the residues in the lipid tunnel appear to be important for PgpB catalysis. The catalytic triad in the active site is essential for dephosphorylating substrates lysophosphatidic acid, phosphatidic acid, or sphingosine-1-phosphate but surprisingly not for the native substrate PGP. Remarkably, residue His-207 alone is sufficient to hydrolyze PGP, indicating a specific catalytic mechanism for PgpB in PG biosynthesis. We also identified two novel sensor residues, Lys-93 and Lys-97, on TM3. Our data show that Lys-97 is essential for the recognition of lyso-form substrates. Modification at the Lys-93 position may alter substrate specificity of lipid phosphate phosphatase proteins in prokaryotes versus eukaryotes. These studies reveal new mechanisms of lipid substrate selection and catalysis by PgpB and suggest that the enzyme rests in a PE-stabilized state in the bilayer.	[Tong, Shuilong; Lin, Yibin; Lu, Shuo; Bogdanov, Mikhail; Zheng, Lei] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA; [Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Zheng, L (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	lei.zheng@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017; Lin, B.Y./AAA-7774-2020; Crystal, Boy/Q-3005-2019	Crystal, Boy/0000-0003-0608-7875; Wang, Meitian/0000-0002-5340-3036	National Institute of General Medical Sciences [R01GM098572, R01GM097290]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097290, R01GM098572] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences Grants R01GM098572 and R01GM097290 (to L. Z.). This work was also supported by American Heart Association postdoctoral fellowships (to S. T.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Fan JP, 2014, P NATL ACAD SCI USA, V111, P7636, DOI 10.1073/pnas.1403097111; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; Makde RD, 2007, BIOCHEMISTRY-US, V46, P2079, DOI 10.1021/bi062180g; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Meijberg W, 2002, J MOL BIOL, V319, P839, DOI 10.1016/S0022-2836(02)00342-X; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; MOZHAROV AD, 1985, FEBS LETT, V186, P103, DOI 10.1016/0014-5793(85)81348-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Pierrugues O, 2001, J BIOL CHEM, V276, P20300, DOI 10.1074/jbc.M009726200; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Stukey J, 1997, PROTEIN SCI, V6, P469; Tanyi JL, 2003, CLIN CANCER RES, V9, P3534; Touze T, 2008, J BIOL CHEM, V283, P16573, DOI 10.1074/jbc.M800394200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Weyand M, 1999, J MOL BIOL, V293, P595, DOI 10.1006/jmbi.1999.3179; WINN SI, 1981, PHILOS T ROY SOC B, V293, P121, DOI 10.1098/rstb.1981.0066	35	19	19	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18342	18352		10.1074/jbc.M116.737874	http://dx.doi.org/10.1074/jbc.M116.737874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405756	Green Published, hybrid			2022-12-28	WOS:000383241800026
J	Yadav, PK; Rajasekharan, R				Yadav, Pradeep Kumar; Rajasekharan, Ram			Misregulation of a DDHD Domain-containing Lipase Causes Mitochondrial Dysfunction in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; gene regulation; metabolism; mitochondria; phospholipid; AFT1; 2 transcription factors; Barth syndrome; DDHD domain; YOR022C; hereditary spastic paraplegia	HEREDITARY SPASTIC PARAPLEGIA; SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; PHOSPHOLIPASE A(1); LIPID-METABOLISM; CARDIOLIPIN; MEMBRANE; PROTEIN; MUTANT; PHOSPHATIDYLGLYCEROL	The DDHD domain-containing proteins, which belong to the intracellular phospholipase A(1) (iPLA(1)) family, have been predicted to be involved in phospholipid metabolism, lipid trafficking, membrane turnover, and signaling. Defective cardiolipin (CL), phosphatidylethanolamine, and phosphatidylglycerol remodeling cause Barth syndrome and mitochondrial dysfunction. Here, we report that Yor022c is a Ddl1 (DDHD domain-containing lipase 1) that hydrolyzes CL, phosphatidylethanolamine, and phosphatidylglycerol. Ddl1 has been implicated in the remodeling of mitochondrial phospholipids and CL degradation. Our data also suggested that the accumulation of monolysocardiolipin is deleterious to the cells. We show that Aft1 and Aft2 transcription factors antagonistically regulate the DDL1 gene. This study reveals that the misregulation of DDL1 by Aft1/2 transcription factors alters CL metabolism and causes mitochondrial dysfunction in the cells. In humans, mutations in the DDHD1 and DDHD2 genes cause specific types of hereditary spastic paraplegia (SPG28 and SPG54, respectively), and the yeast DDL1-defective strain produces similar phenotypes of hereditary spastic paraplegia (mitochondrial dysfunction and defects in lipid metabolism). Therefore, the DDL1-defective strain could be a good model system for understanding hereditary spastic paraplegia.	Cent Food Technol Res Inst, CSIR, Dept Lipid Sci, Lipid Ctr, Mysore 570020, Karnataka, India; Cent Food Technol Res Inst, CSIR, Acad Sci & Innovat Res, Mysore 570020, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Rajasekharan, R (corresponding author), Cent Food Technol Res Inst, CSIR, Mysore 570020, Karnataka, India.	ram@cftri.com	Rajasekharan, Ram/R-2257-2019; Yadav, Pradeep Kumar/GZA-4317-2022	Rajasekharan, Ram/0000-0002-2124-6013; Yadav, Pradeep/0000-0002-4777-4914; Ram, Rajasekharan/0000-0002-4114-0654	Council of Scientific and Industrial Research (CSIR), New Delhi, India; CSIR, New Delhi; J. C. Bose National Fellowship	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); J. C. Bose National Fellowship	This study was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India under the 12th 5-year plan project (LIPIC). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from CSIR, New Delhi.; Recipient of the J. C. Bose National Fellowship. To whom correspondence should be addressed: Central Food Technological Research Institute, Council of Scientific and Industrial Research, Mysore 570020, Karnataka, India. Tel.: 91-821-2517760; Fax: 91-821-2516308; E-mail: ram@cftri.com.	Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Berthelet S, 2010, GENETICS, V185, P1111, DOI 10.1534/genetics.110.117531; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Dimmer KS, 2006, PHYSIOLOGY, V21, P233, DOI 10.1152/physiol.00010.2006; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalez M, 2013, EUR J HUM GENET, V21, P1214, DOI 10.1038/ejhg.2013.29; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; Huang H, 2015, REDOX BIOL, V5, P169, DOI 10.1016/j.redox.2015.04.011; Inloes JM, 2014, P NATL ACAD SCI USA, V111, P14924, DOI 10.1073/pnas.1413706111; Inoue H, 2012, BBA-MOL CELL RES, V1823, P930, DOI 10.1016/j.bbamcr.2012.02.002; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Laha S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-83; Lev S, 2004, EXP CELL RES, V297, P1, DOI 10.1016/j.yexcr.2004.02.033; Lewandowska A, 2006, BBA-MOL CELL RES, V1763, P141, DOI 10.1016/j.bbamcr.2006.01.007; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Nie J, 2010, BBA-MOL CELL BIOL L, V1801, P438, DOI 10.1016/j.bbalip.2009.12.002; Oganesyan N, 2007, PROTEIN EXPRES PURIF, V52, P280, DOI 10.1016/j.pep.2006.09.015; Pokorna L, 2016, BBA-BIOENERGETICS, V1857, P34, DOI 10.1016/j.bbabio.2015.10.004; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; ROSE M, 1983, METHOD ENZYMOL, V101, P167; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; Simons B, 2012, METABOLITES, V2, P195, DOI 10.3390/metabo2010195; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tani Katsuko, 2012, Biomol Concepts, V3, P471, DOI 10.1515/bmc-2012-0014; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vijayakumar A, 2016, PLANT PHYSIOL, V170, P180, DOI 10.1104/pp.15.01615; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Yadav KK, 2015, MOL MICROBIOL, V98, P456, DOI 10.1111/mmi.13133; Yamashita A, 2010, BBA-MOL CELL BIOL L, V1801, P711, DOI 10.1016/j.bbalip.2010.03.012; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487	44	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18562	18581		10.1074/jbc.M116.733378	http://dx.doi.org/10.1074/jbc.M116.733378			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402848	Green Published, hybrid			2022-12-28	WOS:000383241800045
J	Sheng, R; Jung, DJ; Silkov, A; Kim, H; Singaram, I; Wang, ZG; Xin, Y; Kim, E; Park, MJ; Thiagarajan-Rosenkranz, P; Smrt, S; Honig, B; Baek, K; Ryu, S; Lorieau, J; Kim, YM; Cho, W				Sheng, Ren; Jung, Da-Jung; Silkov, Antonina; Kim, Hyunjin; Singaram, Indira; Wang, Zhi-Gang; Xin, Yao; Kim, Eui; Park, Mi-Jeong; Thiagarajan-Rosenkranz, Pallavi; Smrt, Sean; Honig, Barry; Baek, Kwanghee; Ryu, Sungho; Lorieau, Justin; Kim, You-Me; Cho, Wonhwa			Lipids Regulate Lck Protein Activity through Their Interactions with the Lck Src Homology 2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; phosphoinositide; plasma membrane; Src homology 2 domain (SH2 domain); T-cell receptor (TCR); Lck	T-CELL-ACTIVATION; MEMBRANE-BINDING; FAMILY KINASES; SIGNALING PATHWAYS; LIVING CELLS; SH2 DOMAINS; C2 DOMAINS; DOCKING; SURFACE; SYSTEM	Lymphocyte-specific protein-tyrosine kinase (Lck) plays an essential role in T cell receptor (TCR) signaling and T cell development, but its activation mechanism is not fully understood. To explore the possibility that plasma membrane (PM) lipids control TCR signaling activities of Lck, we measured the membrane binding properties of its regulatory Src homology 2 (SH2) and Src homology 3 domains. The Lck SH2 domain binds anionic PM lipids with high affinity but with low specificity. Electrostatic potential calculation, NMR analysis, and mutational studies identified the lipid-binding site of the Lck SH2 domain that includes surface-exposed basic, aromatic, and hydrophobic residues but not the phospho-Tyr binding pocket. Mutation of lipid binding residues greatly reduced the interaction of Lck with the chain in the activated TCR signaling complex and its overall TCR signaling activities. These results suggest that PM lipids, including phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate, modulate interaction of Lck with its binding partners in the TCR signaling complex and its TCR signaling activities in a spatiotemporally specific manner via its SH2 domain.	[Sheng, Ren; Kim, Hyunjin; Singaram, Indira; Wang, Zhi-Gang; Xin, Yao; Thiagarajan-Rosenkranz, Pallavi; Smrt, Sean; Lorieau, Justin; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Jung, Da-Jung; Kim, Eui; Park, Mi-Jeong; Kim, You-Me] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Ryu, Sungho; Kim, You-Me] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Silkov, Antonina; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 11032 USA; [Baek, Kwanghee; Cho, Wonhwa] Kyung Hee Univ, Dept Genet Engn, Yongin 446701, South Korea	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Columbia University; Howard Hughes Medical Institute; Kyung Hee University	Cho, W (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.; Kim, YM (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.; Cho, W (corresponding author), Kyung Hee Univ, Dept Genet Engn, Yongin 446701, South Korea.	youmekim@postech.ac.kr; wcho@uic.edu	Lorieau, Justin/GXV-8916-2022; Baek, Kwanghee/N-2760-2018; Kim, You-Me/I-5553-2013; Xin, Yao/L-6259-2019; Singaram, Indira/AAB-8321-2021	Baek, Kwanghee/0000-0002-1364-1355; Kim, You-Me/0000-0001-8780-704X; Singaram, Indira/0000-0001-7508-7997; Park, Mi-Jeong/0000-0002-9592-4972; Jung, Da-Jung/0000-0003-4399-8029; Honig, Barry/0000-0002-1835-1031; Ryu, Sung Ho/0000-0003-0913-3048	National Institutes of Health [GM68849, GM110128, GM030518, GM094597, CA121852]; National Research Foundation of Korea [NRF-2013R1A1A2074573]; World Class University Program by the Korean Government [R31-2008-000-10105-0]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, R01GM068849, R01GM110128, R01GM030518, R37GM030518] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012351, S10OD021764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); World Class University Program by the Korean Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants GM68849 and GM110128 (to W. C.) and GM030518, GM094597, and CA121852 (to B. H.), National Research Foundation of Korea Grant NRF-2013R1A1A2074573, and World Class University Program R31-2008-000-10105-0 by the Korean Government. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho Wonhwa, 2006, Sci STKE, V2006, ppe7, DOI 10.1126/stke.3212006pe7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Gamper CJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00312; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Hong Yoojin, 2009, J Proteomics Bioinform, V2, P139; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Kim H, 2013, J LIPID RES, V54, P3531, DOI 10.1194/jlr.D041376; Kim J, 2013, J IMMUNOL, V190, P5287, DOI 10.4049/jimmunol.1202767; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Lo Surdo P, 1999, J BIOL CHEM, V274, P15678, DOI 10.1074/jbc.274.22.15678; Lorber DM, 1998, PROTEIN SCI, V7, P938; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park MJ, 2016, MOL CELL, V62, P7, DOI 10.1016/j.molcel.2016.01.027; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Scott MP, 2000, BIOCHEMISTRY-US, V39, P14531, DOI 10.1021/bi001850u; Sheng R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5393; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Silkov A, 2011, J BIOL CHEM, V286, P34155, DOI 10.1074/jbc.M111.265611; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Stephen TL, 2012, P NATL ACAD SCI USA, V109, P7415, DOI 10.1073/pnas.1119272109; Stirnweiss A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003607; Tokonzaba E, 2006, CHEM BIOL DRUG DES, V67, P230, DOI 10.1111/j.1747-0285.2006.00361.x; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yoon Y, 2011, NAT CHEM, V3, P868, DOI [10.1038/NCHEM.1163, 10.1038/nchem.1163]	57	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17639	17650		10.1074/jbc.M116.720284	http://dx.doi.org/10.1074/jbc.M116.720284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27334919	Green Published, hybrid			2022-12-28	WOS:000383241300015
J	Beck, D; Zobel, J; Barber, R; Evans, S; Lezina, L; Allchin, RL; Blades, M; Elliott, R; Lord, CJ; Ashworth, A; Porter, ACG; Wagner, SD				Beck, Daniel; Zobel, Jenny; Barber, Ruth; Evans, Sian; Lezina, Larissa; Allchin, Rebecca L.; Blades, Matthew; Elliott, Richard; Lord, Christopher J.; Ashworth, Alan; Porter, Andrew C. G.; Wagner, Simon D.			Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL-CENTER FORMATION; NEGATIVE AUTOREGULATION; TRANSCRIPTION FACTOR; SIGNAL TRANSDUCER; DOWN-REGULATION; IN-VITRO; BCL6; DIFFERENTIATION; REPRESSION; EXPRESSION	We demonstrate the usefulness of synthetic lethal screening of a conditionally BCL6-deficient Burkitt lymphoma cell line, DG75-AB7, with a library of small molecules to determine survival pathways suppressed by BCL6 and suggest mechanism-based treatments for lymphoma. Lestaurtinib, a JAK2 inhibitor and one of the hits from the screen, repressed survival of BCL6-deficient cells in vitro and reduced growth and proliferation of xenografts in vivo. BCL6 deficiency in DG75-AB7 induced JAK2 mRNA and protein expression and STAT3 phosphorylation. Surface IL10RA was elevated by BCL6 deficiency, and blockade of IL10RA repressed STAT3 phosphorylation. Therefore, we define an IL10RA/JAK2/STAT3 pathway each component of which is repressed by BCL6. We also show for the first time that JAK2 is a direct BCL6 target gene; BCL6 bound to the JAK2 promoter in vitro and was enriched by ChIP-seq. The place of JAK2 inhibitors in the treatment of diffuse large B-cell lymphoma has not been defined; we suggest that JAK2 inhibitors might be most effective in poor prognosis ABC-DLBCL, which shows higher levels of IL10RA, JAK2, and STAT3 but lower levels of BCL6 than GC-DLBCL and might be usefully combined with novel approaches such as inhibition of IL10RA.	[Beck, Daniel; Barber, Ruth; Evans, Sian; Lezina, Larissa; Allchin, Rebecca L.; Wagner, Simon D.] Univ Leicester, Ernest & Helen Scott Haematol Res Inst, Dept Canc Studies, Lancaster Rd, Lancaster LE1 7HB, England; [Barber, Ruth] Univ Leicester, Leicester Diagnost & Drug Dev Ctr LD3, Lancaster Rd, Lancaster LE1 7HB, England; [Zobel, Jenny; Porter, Andrew C. G.] Imperial Coll London, Dept Haematol, Hammersmith Campus,Du Cane Rd, London W12 0NN, England; [Blades, Matthew] Univ Leicester, Bioinformat & Biostat Anal Support Hub B BASH, Leicester LE1 9HN, Leics, England; [Elliott, Richard; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England	University of Leicester; University of Leicester; Imperial College London; University of Leicester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Wagner, SD (corresponding author), Univ Leicester, Dept Canc Studies, Rm 104,Hodgkin Bldg,Lancaster Rd, Leicester LE1 7HB, Leics, England.	sw227@le.ac.uk	Lord, Christopher/AAX-7130-2021; Lezina, Larissa/AAO-3574-2020; Allchin, Rebecca/HDO-5629-2022; Lord, Christopher/B-3295-2012	Lord, Christopher/0000-0002-3226-0515	Leukemia and Lymphoma Research; Gordon Piller Leukaemia and Lymphoma Research PhD Studentship; University of Leicester; Ernest and Helen Scott Hematology Research Institute; Cancer Research UK [14276] Funding Source: researchfish; Medical Research Council [MC_PC_14117] Funding Source: researchfish; MRC [MC_PC_14117] Funding Source: UKRI	Leukemia and Lymphoma Research; Gordon Piller Leukaemia and Lymphoma Research PhD Studentship; University of Leicester; Ernest and Helen Scott Hematology Research Institute; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from Leukemia and Lymphoma Research (to S. D. W.). The authors declare that they have no conflicts of interest with the contents of this article.r A Gordon Piller Leukaemia and Lymphoma Research PhD Studentship to S. D. W. and A. C. G. P. supported J. Z.r Supported by a University of Leicester Ph.D. Studentship.r Supported by a Clinical Research Fellowship from the Ernest and Helen Scott Hematology Research Institute.	Beguelin W, 2015, LEUKEMIA, V29, P1684, DOI 10.1038/leu.2015.57; Cerchietti LC, 2010, J CLIN INVEST, V120, P4569, DOI 10.1172/JCI42869; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Derenzini E, 2013, EXPERT OPIN INV DRUG, V22, P775, DOI 10.1517/13543784.2013.775244; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Gupta M, 2012, BLOOD, V119, P2844, DOI 10.1182/blood-2011-10-388538; HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li ZP, 2005, J IMMUNOL, V174, P205, DOI 10.4049/jimmunol.174.1.205; Maier S, 2005, J VIROL, V79, P8784, DOI 10.1128/JVI.79.14.8784-8792.2005; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; OFFIT K, 1994, NEW ENGL J MED, V331, P74, DOI 10.1056/NEJM199407143310202; Papadopoulou V, 2010, BIOCHEM J, V427, P541, DOI 10.1042/BJ20091578; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Witzig TE, 2013, LEUKEMIA LYMPHOMA, V54, P397, DOI 10.3109/10428194.2012.708931; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Younes A, 2012, J CLIN ONCOL, V30, P4161, DOI 10.1200/JCO.2012.42.5223; Yu RYL, 2005, BLOOD, V105, P1777, DOI 10.1182/blood-2004-08-3171; Zhou T, 2014, LEUKEMIA, V28, P471, DOI 10.1038/leu.2013.299	50	8	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16686	16698		10.1074/jbc.M116.736868	http://dx.doi.org/10.1074/jbc.M116.736868			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27268052	hybrid, Green Published			2022-12-28	WOS:000380826700026
J	Bal, NC; Maurya, SK; Singh, S; Wehrens, XHT; Periasamy, M				Bal, Naresh C.; Maurya, Santosh K.; Singh, Sushant; Wehrens, Xander H. T.; Periasamy, Muthu			Increased Reliance on Muscle-based Thermogenesis upon Acute Minimization of Brown Adipose Tissue Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium transport; mitochondria; mitochondrial metabolism; sarcoplasmic reticulum (SR); skeletal muscle; cold adaptation; core body temperature; mitochondrial dynamics; brown adipose tissue	ADAPTIVE NONSHIVERING THERMOGENESIS; COLD-ACCLIMATED DUCKLINGS; SKELETAL-MUSCLE; RYANODINE RECEPTOR; CA2+ TRANSPORT; CALCIUM-UPTAKE; SARCOLIPIN; MITOCHONDRIAL; MICE; PROTEIN	Skeletal muscle has been suggested as a site of nonshivering thermogenesis (NST) besides brown adipose tissue (BAT). Studies in birds, which do not contain BAT, have demonstrated the importance of skeletal muscle-based NST. However, muscle-based NST in mammals remains poorly characterized. We recently reported that sarco/endoplasmic reticulum Ca2+ cycling and that its regulation by SLN can be the basis for muscle NST. Because of the dominant role of BAT-mediated thermogenesis in rodents, the role of muscle-based NST is less obvious. In this study, we investigated whether muscle will become an important site of NST when BAT function is conditionally minimized in mice. We surgically removed interscapular BAT (iBAT, which constitutes approximate to 70% of total BAT) and exposed the mice to prolonged cold (4 degrees C) for 9 days. The iBAT-ablated mice were able to maintain optimal body temperature (approximate to 35-37 degrees C) during the entire period of cold exposure. After 4 days in the cold, both sham controls and iBAT-ablated mice stopped shivering and resumed routine physical activity, indicating that they are cold-adapted. The iBAT-ablated mice showed higher oxygen consumption and decreased body weight and fat mass, suggesting an increased energy cost of cold adaptation. The skeletal muscles in these mice underwent extensive remodeling of both the sarcoplasmic reticulum and mitochondria, including alteration in the expression of key components of Ca2+ handling and mitochondrial metabolism. These changes, along with increased sarcolipin expression, provide evidence for the recruitment of NST in skeletal muscle. These studies collectively suggest that skeletal muscle becomes the major site of NST when BAT activity is minimized.	[Bal, Naresh C.; Maurya, Santosh K.; Singh, Sushant; Periasamy, Muthu] Sanford Burnham Prebys Med Discovery Inst Lake No, Orlando, FL 32827 USA; [Bal, Naresh C.; Maurya, Santosh K.; Singh, Sushant; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bal, Naresh C.] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Odisha, India; [Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Cardiovasc Res Inst, Houston, TX 77030 USA; [Wehrens, Xander H. T.] Baylor Coll Med, Dept Med, Cardiovasc Res Inst, Houston, TX 77030 USA; [Wehrens, Xander H. T.] Baylor Coll Med, Dept Pediat, Cardiovasc Res Inst, Houston, TX 77030 USA	Sanford Burnham Prebys Medical Discovery Institute; University System of Ohio; Ohio State University; Kalinga Institute of Industrial Technology (KIIT); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bal, NC (corresponding author), Sanford Burnham Preby Med Discovery Inst, 6400 Sanger Rd, Orlando, FL 32827 USA.	nbal@sbpdiscovery.org	Maurya, Santosh/O-9066-2017; Singh, Sushant/AAQ-7930-2021; Wehrens, Xander/AAQ-9574-2020; Singh, Sushant/AAP-3860-2020	Maurya, Santosh/0000-0002-7610-2463; Singh, Sushant/0000-0002-0858-4405; Wehrens, Xander/0000-0001-5044-672X; 	National Institutes of Health [R01-HL 088555, R01 DK098240-01, R01-HL089598, R01-HL091947, R01-HL117641]; NIDDK, National Institutes of Health [DK102772]; American Heart Association [13EIA14560061]; Department of Biotechnology, India; American Physiological Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555, R01HL089598, R01HL117641, R01HL091947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098240, K01DK102772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); Department of Biotechnology, India(Department of Biotechnology (DBT) India); American Physiological Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01-HL 088555 and R01 DK098240-01 (to M. P.) and R01-HL089598, R01-HL091947, and R01-HL117641 (to X. H. T. W.). The research reported in this publication was supported in part by the NIDDK, National Institutes of Health under Award DK102772 (to N. C. B.) and by American Heart Association Grant 13EIA14560061 (to X. H. T. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a Ramalingaswamy Re-entry Fellowship from the Department of Biotechnology, India. Supported by a postdoctoral fellowship in physiological genomics from the American Physiological Society. To whom correspondence should be addressed: 6400 Sanger Rd., Sanford Burnham Preby Medical Discovery Institute, Lake Nona, Orlando, FL 32827. Fax: 407-745-2001. E-mail: nbal@sbpdiscovery.org or naresh.bal@kiitbiotech.ac.in.	Ainbinder A, 2015, CELL CALCIUM, V57, P14, DOI 10.1016/j.ceca.2014.11.002; Arruda AP, 2008, ENDOCRINOLOGY, V149, P6262, DOI 10.1210/en.2008-0564; Aydin J, 2008, FASEB J, V22, P3919, DOI 10.1096/fj.08-113712; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Blondin DP, 2015, J PHYSIOL-LONDON, V593, P701, DOI 10.1113/jphysiol.2014.283598; Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIS TRA, 1967, AM J PHYSIOL, V213, P1423, DOI 10.1152/ajplegacy.1967.213.6.1423; DUCHAMP C, 1991, AM J PHYSIOL, V261, pR1438, DOI 10.1152/ajpregu.1991.261.6.R1438; DUCHAMP C, 1993, AM J PHYSIOL, V265, pR1076, DOI 10.1152/ajpregu.1993.265.5.R1076; DUMONTEIL E, 1993, AM J PHYSIOL, V265, pC507, DOI 10.1152/ajpcell.1993.265.2.C507; DUMONTEIL E, 1995, AM J PHYSIOL-CELL PH, V269, pC955, DOI 10.1152/ajpcell.1995.269.4.C955; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Gamu D, 2014, EXERC SPORT SCI REV, V42, P136, DOI 10.1249/JES.0000000000000016; Garcia-Perez C, 2011, AM J PHYSIOL-HEART C, V301, pH1907, DOI 10.1152/ajpheart.00397.2011; Gehlert S, 2015, INT J MOL SCI, V16, P1066, DOI 10.3390/ijms16011066; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; GRAV HJ, 1979, SCIENCE, V204, P87, DOI 10.1126/science.219477; GRAV HJ, 1988, J COMP PHYSIOL B, V158, P513, DOI 10.1007/BF00692558; GREENWAY DC, 1978, AM J PHYSIOL, V234, pC7, DOI 10.1152/ajpcell.1978.234.1.C7; HELDMAIER G, 1985, J COMP PHYSIOL B, V156, P237, DOI 10.1007/BF00695778; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; JANSKY L, 1973, BIOL REV, V48, P85; JANSKY L, 1973, PHYSIOL BOHEMOSLOV, V22, P125; Louzada RA, 2014, AM J PHYSIOL-ENDOC M, V307, pE1020, DOI 10.1152/ajpendo.00637.2013; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; Maurya SK, 2015, PHARMACOL RES, V102, P270, DOI 10.1016/j.phrs.2015.10.020; McKay WP, 2013, APPL PHYSIOL NUTR ME, V38, P227, DOI 10.1139/apnm-2011-0358; MILNER RE, 1989, AM J PHYSIOL, V256, pR42, DOI 10.1152/ajpregu.1989.256.1.R42; Mineo PM, 2012, COMP BIOCHEM PHYS A, V161, P395, DOI 10.1016/j.cbpa.2011.12.012; NEDERGAARD J, 1984, AM J PHYSIOL, V247, pR506, DOI 10.1152/ajpregu.1984.247.3.R506; Nedergaard J, 2001, BIOCHEM SOC T, V29, P756; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; Pant M, 2015, J EXP BIOL, V218, P2321, DOI 10.1242/jeb.119164; Paran CW, 2015, OBESITY, V23, P1440, DOI 10.1002/oby.21123; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Rowland LA, 2015, BIOL REV, V90, P1279, DOI 10.1111/brv.12157; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Sahoo SK, 2015, J BIOL CHEM, V290, P14057, DOI 10.1074/jbc.M115.636738; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Shaikh SA, 2016, J MOL CELL CARDIOL, V91, P81, DOI 10.1016/j.yjmcc.2015.12.030; Shum A Y, 1991, Chin J Physiol, V34, P427; Song MS, 2015, CELL METAB, V21, P195, DOI 10.1016/j.cmet.2014.12.019; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Teets NM, 2013, P NATL ACAD SCI USA, V110, P9154, DOI 10.1073/pnas.1306705110; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2	53	52	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17247	17257		10.1074/jbc.M116.728188	http://dx.doi.org/10.1074/jbc.M116.728188			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27298322	Green Published, hybrid			2022-12-28	WOS:000382643800026
J	Li, XQ; Liu, P; Gan, SZ; Zhang, CM; Zheng, YL; Jiang, YQ; Yuan, Y				Li, Xueqin; Liu, Peng; Gan, Shuzhen; Zhang, Chunmao; Zheng, Yuling; Jiang, Yongqiang; Yuan, Yuan			Mechanisms of Host-Pathogen Protein Complex Formation and Bacterial Immune Evasion of Streptococcus suis Protein Fhb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complement; host defense; infection; secretion; Streptococcus; Streptococcus suis; Fhb; Factor H; complement 3; immune evasion; streptococcus; streptococcus suis	H-BINDING-PROTEIN; INNATE IMMUNITY; SURFACE PROTEIN; INHIBITION; INFECTION; VIRULENCE; REGION; SERIES	Streptococcus suis serotype 2 (S. suis 2)-induced sepsis and meningitis are often accompanied by bacteremia. The evasion of polymorphonuclear leukocyte-mediated phagocytic clearance is central to the establishment of bacteremia caused by S. suis 2 and is facilitated by the ability of factor H (FH)-binding protein (Fhb) to bind FH on the bacterial surface, thereby impeding alternative pathway complement activation and phagocytic clearance. Here, C3b/C3d was found to bind to Fhb, along with FH, forming a large immune complex. The formation of this immune complex was mediated by domain II of Fhb via electrostatic and hydrophobic interactions, which, to our knowledge, is a new type of interaction. Interestingly, Fhb was found to be associated with the cell envelope and also present in the culture supernatant, where secreted Fhb inhibited complement activation via interactions with domain II, thereby enhancing antiphagocytic clearance by polymorphonuclear leukocytes. Thus, Fhb is a multifunctional bacterial protein, which binds host complement component C3 as well as FH and interferes with innate immune recognition in a secret protein manner. S. suis 2 therefore appears to have developed a new strategy to combat host innate immunity and enhance survival in host blood.	[Li, Xueqin; Liu, Peng; Gan, Shuzhen; Zhang, Chunmao; Zheng, Yuling; Jiang, Yongqiang; Yuan, Yuan] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Li, Xueqin] Wannan Med Coll, Yijishan Hosp, Cent Lab, Wuhu 241001, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Wannan Medical College	Jiang, YQ; Yuan, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	jiangyq@nic.bmi.ac.cn; miniminiyuan@163.com	Liu, Peng/V-9305-2019		National Basic Research Program (973) of China [2012CB518804]; National Natural Science Foundation [81171528, 81371766]; State Key Laboratory of Pathogen and Biosecurity Foundation (Academy of Military Medical Science) [SKLPBS1414]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pathogen and Biosecurity Foundation (Academy of Military Medical Science)	This work was supported by National Basic Research Program (973) of China Grant 2012CB518804 (to Y. J.), National Natural Science Foundation Grants 81171528 and 81371766 (to Y. J.), and State Key Laboratory of Pathogen and Biosecurity Foundation (Academy of Military Medical Science) Grant SKLPBS1414 (to Y. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Amdahl H, 2013, J IMMUNOL, V191, P1775, DOI 10.4049/jimmunol.1300638; Areschoug T, 2002, J BACTERIOL, V184, P6376, DOI 10.1128/JB.184.22.6376-6393.2002; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Durdagi S, 2012, J MED CHEM, V55, P5529, DOI 10.1021/jm3004587; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Johnsson E, 1998, J IMMUNOL, V161, P4894; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Liu P, 2014, J INFECT DIS, V210, P35, DOI 10.1093/infdis/jiu050; Miller DP, 2012, J BIOL CHEM, V287, P12715, DOI 10.1074/jbc.M112.339721; Pian YY, 2012, INFECT IMMUN, V80, P2402, DOI 10.1128/IAI.06294-11; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Sharma AK, 1997, INFECT IMMUN, V65, P484, DOI 10.1128/IAI.65.2.484-487.1997; Sharp JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038407; Sriskandan S, 2006, PLOS MED, V3, P595, DOI 10.1371/journal.pmed.0030187; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Huong VTL, 2014, EMERG INFECT DIS, V20, P1105, DOI 10.3201/eid2007.131594; Wangkaew S, 2006, J INFECTION, V52, P455, DOI 10.1016/j.jinf.2005.02.012; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Yuan ZZ, 2013, J BIOL CHEM, V288, P956, DOI 10.1074/jbc.M112.388686; Zhang CM, 2015, BIOCHEM BIOPH RES CO, V466, P413, DOI 10.1016/j.bbrc.2015.09.040; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	31	12	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17122	17132		10.1074/jbc.M116.719443	http://dx.doi.org/10.1074/jbc.M116.719443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27342778	Green Published, hybrid			2022-12-28	WOS:000382643800018
J	Akabane, S; Matsuzaki, K; Yamashita, S; Arai, K; Okatsu, K; Kanki, T; Matsuda, N; Oka, T				Akabane, Shiori; Matsuzaki, Kohei; Yamashita, Shun-ichi; Arai, Kana; Okatsu, Kei; Kanki, Tomotake; Matsuda, Noriyuki; Oka, Toshihiko			Constitutive Activation of PINK1 Protein Leads to Proteasome-mediated and Non-apoptotic Cell Death Independently of Mitochondrial Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 LIGASE PARKIN; MEMBRANE PERMEABILIZATION; DAMAGED MITOCHONDRIA; OXIDATIVE STRESS; OUTER-MEMBRANE; CYTOCHROME-C; RECRUITMENT; IDENTIFICATION; DEGRADATION; MITOPHAGY	Phosphatase and tensin homolog-induced putative kinase 1 (PINK1), a Ser/Thr kinase, and PARKIN, a ubiquitin ligase, are causal genes for autosomal recessive early-onset parkinsonism. Multiple lines of evidence indicate that PINK1 and PARKIN cooperatively control the quality of the mitochondrial population via selective degradation of damaged mitochondria by autophagy. Here, we report that PINK1 and PARKIN induce cell death with a 12-h delay after mitochondrial depolarization, which differs from the time profile of selective autophagy of mitochondria. This type of cell death exhibited definite morphologic features such as plasma membrane rupture, was insensitive to a pan-caspase inhibitor, and did not involve mitochondrial permeability transition. Expression of a constitutively active form of PINK1 caused cell death in the presence of a pan-caspase inhibitor, irrespective of the mitochondrial membrane potential. PINK1-mediated cell death depended on the activities of PARKIN and proteasomes, but it was not affected by disruption of the genes required for autophagy. Furthermore, fluorescence and electron microscopic analyses revealed that mitochondria were still retained in the dead cells, indicating that PINK1-mediated cell death is not caused by mitochondrial loss. Our findings suggest that PINK1 and PARKIN play critical roles in selective cell death in which damaged mitochondria are retained, independent of mitochondrial autophagy.	[Akabane, Shiori; Matsuzaki, Kohei; Arai, Kana; Oka, Toshihiko] Rikkyo Univ, Dept Life Sci, Toshima Ku, 34-1 Nishi Ikebukuro, Tokyo 1718501, Japan; [Yamashita, Shun-ichi; Kanki, Tomotake] Niigata Univ, Inst Nephrol, Dept Cellular Physiol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Okatsu, Kei; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Ubiquitin Project, Tokyo 1568506, Japan; [Okatsu, Kei] Univ Tokyo, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan	Rikkyo University; Niigata University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo	Oka, T (corresponding author), Rikkyo Univ, Dept Life Sci, Toshima Ku, 34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	toka@rikkyo.ac.jp	Matsuda, Noriyuki/AAI-3156-2020; Kanki, Tomotake/H-7250-2012	Matsuda, Noriyuki/0000-0001-8199-952X; Kanki, Tomotake/0000-0001-9646-5379; Okatsu, Kei/0000-0001-8949-3750	Japan Society for the Promotion of Science; CREST grant from the Japan Science and Technology Corp.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST grant from the Japan Science and Technology Corp.	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and a CREST grant from the Japan Science and Technology Corp. (to T. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Aki T, 2015, TOXICOLOGY, V333, P118, DOI 10.1016/j.tox.2015.04.003; Carroll RG, 2014, CELL REP, V9, P1538, DOI 10.1016/j.celrep.2014.10.046; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hirota Y, 2015, AUTOPHAGY, V11, P332, DOI 10.1080/15548627.2015.1023047; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kazlauskaite A, 2015, FEBS J, V282, P215, DOI 10.1111/febs.13127; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Muller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Okatsu K, 2015, J CELL SCI, V128, P964, DOI 10.1242/jcs.161000; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Simbula G, 1997, AM J PHYSIOL-CELL PH, V273, pC479, DOI 10.1152/ajpcell.1997.273.2.C479; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014; Zhu H, 2007, BBA-MOL CELL RES, V1773, P593, DOI 10.1016/j.bbamcr.2007.01.008	45	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16162	16174		10.1074/jbc.M116.714923	http://dx.doi.org/10.1074/jbc.M116.714923			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27302064	Green Published, hybrid			2022-12-28	WOS:000380585400021
J	Gartung, A; Zhao, JW; Chen, S; Mottillo, E; VanHecke, GC; Ahn, YH; Maddipati, KR; Sorokin, A; Granneman, J; Lee, MJ				Gartung, Allison; Zhao, Jiawei; Chen, Simon; Mottillo, Emilio; VanHecke, Garrett C.; Ahn, Young-Hoon; Maddipati, Krishna Rao; Sorokin, Andrey; Granneman, James; Lee, Menq-Jer			Characterization of Eicosanoids Produced by Adipocyte Lipolysis IMPLICATION OF CYCLOOXYGENASE-2 IN ADIPOSE INFLAMMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; HORMONE-SENSITIVE LIPASE; ADIPOSE-TISSUE; FATTY-ACIDS; OBESITY; INFLAMMATION; EXPRESSION; CYCLOOXYGENASE-2; PATHWAY; AXIS	Excessive adipocyte lipolysis generates lipid mediators and triggers inflammation in adipose tissue. However, the specific roles of lipolysis-generated mediators in adipose inflammation remain to be elucidated. In the present study, cultured 3T3-L1 adipocytes were treated with isoproterenol to activate lipolysis and the fatty acyl lipidome of released lipids was determined by using LC-MS/MS. We observed that beta-adrenergic activation elevated levels of approximately fifty lipid species, including metabolites of cyclooxygenases, lipoxygenases, epoxygenases, and other sources. Moreover, we found that beta-adrenergic activation induced cyclooxygenase 2 (COX-2), not COX-1, expression in a manner that depended on activation of hormone-sensitive lipase (HSL) in cultured adipocytes and in the epididymal white adipose tissue (EWAT) of C57BL/6 mice. We found that lipolysis activates the JNK/NF kappa B signaling pathway and inhibition of the JNK/NF kappa B axis abrogated the lipolysis-stimulated COX-2 expression. In addition, pharmacological inhibition of COX-2 activity diminished levels of COX-2 metabolites during lipolytic activation. Inhibition of COX-2 abrogated the induction of CCL2/MCP-1 expression by beta-adrenergic activation and prevented recruitment of macrophage/monocyte to adipose tissue. Collectively, our data indicate that excessive adipocyte lipolysis activates the JNK/NF-kappa B pathway leading to the up-regulation of COX-2 expression and recruitment of inflammatory macrophages.	[Gartung, Allison; Zhao, Jiawei; Chen, Simon; Maddipati, Krishna Rao; Lee, Menq-Jer] Wayne State Univ, Bioact Lipid Res Program, Detroit, MI 48202 USA; [Gartung, Allison; Zhao, Jiawei; Chen, Simon; Mottillo, Emilio; Maddipati, Krishna Rao; Lee, Menq-Jer] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [VanHecke, Garrett C.; Ahn, Young-Hoon] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Granneman, James] Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Detroit, MI 48202 USA; [Granneman, James] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Lee, Menq-Jer] Wayne State Univ, Cardiovasc Res Inst, Detroit, MI 48202 USA; [Lee, Menq-Jer] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA; [Sorokin, Andrey] Med Coll Wisconsin, Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Medical College of Wisconsin	Lee, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 541 East Canfield Ave,Scott Hall 9215, Detroit, MI 48201 USA.	menqjer.lee@wayne.edu	Maddipati, Krishna Rao/H-3569-2019; Maddipati, Krishna Rao/G-1859-2011	Maddipati, Krishna Rao/0000-0003-1445-791X; Maddipati, Krishna Rao/0000-0003-1445-791X; Sorokin, Andrey/0000-0002-5660-0190	Department of Defense Grant [W81XWH-14-1-0346]; Wayne State University; National Institutes of Health [DK-076229, DK-062292, CA-182114]; NATIONAL CANCER INSTITUTE [R03CA182114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R56DK062292, R01DK062292] Funding Source: NIH RePORTER	Department of Defense Grant(United States Department of Defense); Wayne State University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Department of Defense Grant W81XWH-14-1-0346, a funding support of Wayne State University (to M. L.), and National Institutes of Health Grants DK-076229, DK-062292 (to J. G. G.) and CA-182114 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Ahn G, 2013, BBA-GEN SUBJECTS, V1830, P2820, DOI 10.1016/j.bbagen.2012.12.008; Al-Shabrawey M, 2011, DIABETES, V60, P614, DOI 10.2337/db10-0008; Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Claus TH, 2005, J PHARMACOL EXP THER, V315, P1396, DOI 10.1124/jpet.105.086926; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Das Arghya, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P23; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Fain JN, 2000, PROSTAG OTH LIPID M, V62, P343, DOI 10.1016/S0090-6980(00)00088-5; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Garcia-Alonso V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153751; Gomez I, 2013, PROSTAG LEUKOTR ESS, V89, P55, DOI 10.1016/j.plefa.2013.04.004; Hellmann J, 2013, J IMMUNOL, V191, P1383, DOI 10.4049/jimmunol.1203369; Henrichot E, 2005, ARTERIOSCL THROM VAS, V25, P2594, DOI 10.1161/01.ATV.0000188508.40052.35; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; HO MK, 1982, J IMMUNOL, V128, P1221; Hsieh PS, 2010, EUR J CLIN INVEST, V40, P164, DOI 10.1111/j.1365-2362.2009.02239.x; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; Kawahara K., 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI [10.1016/j.bbalip.2014.07.008, DOI 10.1016/J.BBALIP.2014.07.008]; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Krishnamoorthy S, 2010, EXP CELL RES, V316, P1706, DOI 10.1016/j.yexcr.2010.03.005; Kuo WW, 2013, INT J CARDIOL, V168, P270, DOI 10.1016/j.ijcard.2012.09.080; Largo R, 2004, ANN RHEUM DIS, V63, P1197, DOI 10.1136/ard.2003.011163; Lee YH, 2014, BBA-MOL BASIS DIS, V1842, P358, DOI 10.1016/j.bbadis.2013.05.011; Lim JW, 2001, LAB INVEST, V81, P349, DOI 10.1038/labinvest.3780243; Lowe DB, 2004, BIOORG MED CHEM LETT, V14, P3155, DOI 10.1016/j.bmcl.2004.04.015; Maddipati KR, 2014, FASEB J, V28, P4835, DOI 10.1096/fj.14-254383; Maddipati KR, 2011, PROSTAG OTH LIPID M, V94, P59, DOI 10.1016/j.prostaglandins.2011.01.003; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shantsila E, 2009, ARTERIOSCL THROM VAS, V29, P1433, DOI 10.1161/ATVBAHA.108.180513; Torres R, 2015, MOL IMMUNOL, V63, P61, DOI 10.1016/j.molimm.2014.03.007; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Vona-Davis L, 2013, J MAMMARY GLAND BIOL, V18, P291, DOI 10.1007/s10911-013-9299-z; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Zahner G, 2009, BIOCHEM J, V422, P563, DOI 10.1042/BJ20090420; Zhang WL, 2014, J BIOL CHEM, V289, P32178, DOI 10.1074/jbc.M114.601096; Zhang WL, 2013, J BIOL CHEM, V288, P32126, DOI 10.1074/jbc.M113.495218; Zhou H, 2015, MOL MED REP, V11, P4327, DOI 10.3892/mmr.2015.3289	50	27	28	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16001	16010		10.1074/jbc.M116.725937	http://dx.doi.org/10.1074/jbc.M116.725937			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246851	hybrid, Green Published			2022-12-28	WOS:000380585400007
J	Llopis-Torregrosa, V; Ferri-Blazquez, A; Adam-Artigues, A; Deffontaines, E; van Heusden, GPH; Yenush, L				Llopis-Torregrosa, Vicent; Ferri-Blazquez, Alba; Adam-Artigues, Anna; Deffontaines, Emilie; van Heusden, G. Paul H.; Yenush, Lynne			Regulation of the Yeast Hxt6 Hexose Transporter by the Rod1 alpha-Arrestin, the Snf1 Protein Kinase, and the Bmh2 14-3-3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN-LIGASE; MULTIVESICULAR BODY; PHEROMONE RESPONSE; CELL-SURFACE; COMPLEX; ENDOCYTOSIS; TRAFFICKING; PERMEASE; SWITCH	Cell viability requires adaptation to changing environmental conditions. Ubiquitin-mediated endocytosis plays a crucial role in this process, because it provides a mechanism to remove transport proteins from the membrane. Arrestin-related trafficking proteins are important regulators of the endocytic pathway in yeast, facilitating selective ubiquitylation of target proteins by the E3 ubiquitin ligase, Rsp5. Specifically, Rodl (Art4) has been reported to regulate the endocytosis of both the Hxtl, Hxt3, and Hxt6 glucose transporters and the Jen1 lactate transporter. Also, the AMP kinase homologue, Snfl, and 14-3-3 proteins have been shown to regulate Jenl via Rodl. Here, we further characterized the role of Rodl, Snfl, and 14-3-3 in the signal transduction route involved in the endocytic regulation of the Hxt6 high affinity glucose transporter by showing that Sal interacts specifically with Rodl and Rog3 (Art7), that the interaction between the Bmh2 and several arrestin-related trafficking proteins may be modulated by carbon source, and that both the 14-3-3 protein Bmh2 and the Snfl regulatory domain interact with the arrestin-like domain containing the N -terminal half of Rodl (amino acids 1-395). Finally, using both co-immunoprecipitation and bimolecular fluorescence complementation, we demonstrated the interaction of Rodl with Hxt6 and showed that the localization of the Rodl-Hxt6 complex at the plasma membrane is affected by carbon source and is reduced upon overexpression of SNF1 and BMH2.	[Llopis-Torregrosa, Vicent; Ferri-Blazquez, Alba; Adam-Artigues, Anna; Deffontaines, Emilie; Yenush, Lynne] Univ Politecn Valencia, IBMCP, CSIC, E-46022 Valencia, Spain; [van Heusden, G. Paul H.] Leiden Univ, Inst Biol, Sect Mol & Dev Genet, Sylviusweg 72, NL-2333 BE Leiden, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Leiden University; Leiden University - Excl LUMC	Yenush, L (corresponding author), Univ Politecn Valencia, IBMCP, CSIC, E-46022 Valencia, Spain.; Yenush, L (corresponding author), Inst Biol Mol & Celular Plantas, C Vera S-N, Valencia 46022, Spain.	lynne@ibmcp.upv.es	Yenush, Lynne/J-8815-2014; van Heusden, Paul/S-3495-2017; Llopis, Vicent/AAW-2467-2021	Yenush, Lynne/0000-0001-8589-7002; van Heusden, Paul/0000-0002-6422-8034; Llopis, Vicent/0000-0003-1041-9676; ADAM-ARTIGUES, ANNA/0000-0002-4257-8535; Ferri-Blazquez, Alba/0000-0002-4533-5117	Ministerio de Economia y Competitividad (Madrid, Spain) [BFU2011-30197-C03-03]; Netherlands Organization for Scientific Research-Earth and Life Sciences [826.09.006]; Polytechnic University of Valencia	Ministerio de Economia y Competitividad (Madrid, Spain); Netherlands Organization for Scientific Research-Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Polytechnic University of Valencia	This work was supported by Grant BFU2011-30197-C03-03 from the Ministerio de Economia y Competitividad (Madrid, Spain) and in part by Netherlands Organization for Scientific Research-Earth and Life Sciences Grant 826.09.006. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a predoctoral fellowship from the Polytechnic University of Valencia.	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Alvaro CG, 2016, GENETICS, V203, P299, DOI 10.1534/genetics.115.186122; Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; Andres AM, 2011, FEBS LETT, V585, P1223, DOI 10.1016/j.febslet.2011.03.042; Aubry L, 2013, PROG MOL BIOL TRANSL, V118, P21, DOI 10.1016/B978-0-12-394440-5.00002-4; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; GAXIOLA R, 1992, EMBO J, V11, P3157, DOI 10.1002/j.1460-2075.1992.tb05392.x; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mayordomo I, 2003, FEBS LETT, V544, P160, DOI 10.1016/S0014-5793(03)00498-8; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Mulet JM, 2013, CURR GENET, V59, P207, DOI 10.1007/s00294-013-0401-2; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; O'Donnell AF, 2015, MOL CELL BIOL, V35, P939, DOI 10.1128/MCB.01183-14; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Sanz P, 2000, GENETICS, V154, P99; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Shinoda J, 2007, BIOCHEM BIOPH RES CO, V364, P258, DOI 10.1016/j.bbrc.2007.09.134; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; ZONNEVELD BJM, 1986, J MICROBIOL METH, V4, P287, DOI 10.1016/0167-7012(86)90040-0	42	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14973	14985		10.1074/jbc.M116.733923	http://dx.doi.org/10.1074/jbc.M116.733923			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27261460	Green Published, hybrid			2022-12-28	WOS:000380583200010
J	Oikawa, T; Nonaka, T; Terada, M; Tamaoka, A; Hisanaga, S; Hasegawa, M				Oikawa, Takayuki; Nonaka, Takashi; Terada, Makoto; Tamaoka, Akira; Hisanaga, Shin-ichi; Hasegawa, Masato			alpha-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SYSTEM ATROPHY; LEWY BODY DISEASE; NEURODEGENERATIVE-DISEASES; PARKINSONS-DISEASE; AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; IN-VITRO; FILAMENTS; PROTEIN; MUTATION	alpha-synuclein is the major component of Lewy bodies and Lewy neurites in Parkinson disease and dementia with Lewy bodies and of glial cytoplasmic inclusions in multiple system atrophy. It has been suggested that alpha-synuclein fibrils or intermediate protofibrils in the process of fibril formation may have a toxic effect on neuronal cells. In this study, we investigated the ability of soluble monomeric alpha-synuclein to promote microtubule assembly and the effects of conformational changes of alpha-synuclein on Tau -promoted microtubule assembly. In marked contrast to previous findings, monomeric alpha-synuclein had no effect on microtubule polymerization. However, both alpha-synuclein fibrils and protofibrils inhibited Tau-promoted micro tubule assembly. The inhibitory effect of alpha-synuclein fibrils was greater than that of the protofibrils. Dot blot overlay assay and spin -down techniques revealed that alpha-synuclein fibrils bind to Tau and inhibit microtubule assembly by depleting the Tau available for microtubule polymerization. Using various deletion mutants of a.-synuclein and Tau, the acidic C-terminal region of alpha-synuclein and the basic central region of Tau were identified as regions involved in the binding. Furthermore, introduction of alpha-synuclein fibrils into cultured cells overexpressing Tau protein induced Tau aggregation. These results raise the possibility that alpha-synuclein fibrils interact with Tau, inhibit its function to stabilize microtubules, and also promote Tau aggregation, leading to dysfunction of neuronal cells.	[Oikawa, Takayuki; Nonaka, Takashi; Terada, Makoto; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 1568506, Japan; [Oikawa, Takayuki; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; [Terada, Makoto; Tamaoka, Akira] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Neurol, Tsukuba, Ibaraki 3058576, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University; University of Tsukuba	Hasegawa, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan.	hasegawa-ms@igakuken.or.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403	Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grants [26117005, 15H02356, 26111730]; Japan Society for the Promotion of Science KAKENHI Grant [23228004]; Ministry of Health, Labor, and Welfare of Japan [13800916]; Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED	Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grants; Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grants 26117005 and 15H02356 (to M. H.) and 26111730 (to T. N.),Japan Society for the Promotion of Science KAKENHI Grant 23228004 (to M. H.), Ministry of Health, Labor, and Welfare of Japan Grant 13800916 (to M. H.), grant-in-aid for research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis,and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development, AMED (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Castillo P. E., 2000, NEURON, V25, P239; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Colom-Cadena M, 2013, J NEUROPATH EXP NEUR, V72, P1203, DOI 10.1097/NEN.0000000000000018; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Feany MB, 2003, NEURON, V40, P1, DOI 10.1016/S0896-6273(03)00600-7; Fujishiro H, 2008, ACTA NEUROPATHOL, V116, P17, DOI 10.1007/s00401-008-0383-1; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hinckelmann MV, 2013, TRENDS CELL BIOL, V23, P634, DOI 10.1016/j.tcb.2013.08.007; Jensen PH, 2000, J BIOL CHEM, V275, P21500, DOI 10.1074/jbc.M000099200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lindersson EK, 2004, NEUROREPORT, V15, P2735; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Masuda M, 2009, FEBS LETT, V583, P787, DOI 10.1016/j.febslet.2009.01.037; Masuda-Suzukake M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0088-8; Merrick SE, 1997, J NEUROSCI, V17, P5726; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WEISENBERG RC, 1984, J CELL BIOL, V99, P1527, DOI 10.1083/jcb.99.4.1527; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	58	48	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15046	15056		10.1074/jbc.M116.736355	http://dx.doi.org/10.1074/jbc.M116.736355			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226637	Green Published, hybrid			2022-12-28	WOS:000380583200016
J	Wu, P; Yan, Y; Ma, LL; Hou, BY; He, YY; Zhang, L; Niu, ZR; Song, JK; Pang, XC; Yang, XY; Du, GH				Wu, Ping; Yan, Yu; Ma, Lin-lin; Hou, Bi-yu; He, Yang-yang; Zhang, Li; Niu, Zi-ran; Song, Jun-ke; Pang, Xiao-cong; Yang, Xiu-ying; Du, Guan-hua			Effects of the Nrf2 Protein Modulator Salvianolic Acid A Alone or Combined with Metformin on Diabetes-associated Macrovascular and Renal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; diabetic nephropathy; metformin; Nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); oxidative stress; diabetic macrovascular injury; salvianolic acid A	CHRONIC KIDNEY-DISEASE; ANTIOXIDANT GENE-EXPRESSION; INDUCED OXIDATIVE STRESS; APOE-DEFICIENT MICE; BARDOXOLONE METHYL; HIGH-GLUCOSE; MESANGIAL CELLS; ENDOTHELIAL DYSFUNCTION; VASCULAR INFLAMMATION; NADPH OXIDASE	Nuclear factor E2-related factor 2 (Nrf2) is considered a promising target against diabetic complications such as cardiovascular diseases and diabetic nephropathy. Herein, we investigated the effects of a potential Nrf2 modulator, salvianolic acid A (SAA), which is a natural polyphenol, on diabetes-associated macrovascular and renal injuries in streptozotocin-induced diabetic mice. Given that lowering glucose is the first objective of diabetic patients, we also examined the effects of SAA combined with metformin (MET) on both complications. Our results showed that SAA significantly increased the macrovascular relaxation response to acetylcholine and sodium nitroprusside in diabetic mice. Interestingly, treatment with SAA alone only provided minor protection against renal injury, as reflected by minor improvements in impaired renal function and structure, despite significantly reduced oxidative stress observed in the diabetic kidney. We demonstrated that decreased oxidative stress and NF-B p65 expression were associated with SAA-induced expression of Nrf2-responsive antioxidant enzymes heme oxygenase-1 (HO-1), NAD(P)H dehydrogenase (quinone) 1 (NQO-1), and glutathione peroxidase-1 (GPx-1) in vivo or in vitro, which suggested that SAA was a potential Nrf2 modulator. More significantly, compared with treatment with either SAA or MET alone, we found that their combination provided further protection against the macrovascular and renal injury, which was at least partly due to therapeutic activation of both MET-mediated AMP-activated protein kinase and SAA-mediated Nrf2/antioxidant-response element pathways. These findings suggested that polyphenol Nrf2 modulators, especially combined with drugs activating AMP-activated protein kinase, including hypoglycemic drugs, are worthy of further investigation to combat diabetic complications.	[Wu, Ping; Yan, Yu; Hou, Bi-yu; He, Yang-yang; Zhang, Li; Niu, Zi-ran; Song, Jun-ke; Pang, Xiao-cong; Yang, Xiu-ying; Du, Guan-hua] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; [Ma, Lin-lin] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; Peking Union Med Coll, Beijing 100050, Peoples R China; [He, Yang-yang] Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Du, GH (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China.	dugh@imm.ac.cn	Song, Junke/AGG-9922-2022	Song, Junke/0000-0002-4379-0909	National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2013ZX09508104, 2013ZX09402203]; Doctoral Innovation Fund of Peking Union Medical College Grant [10023-1007-1020]; National Natural Science Foundation of China [81470159]	National Science and Technology Major Projects for "Major New Drugs Innovation and Development"; Doctoral Innovation Fund of Peking Union Medical College Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grants 2013ZX09508104 and 2013ZX09402203 (to G. D.), Doctoral Innovation Fund of Peking Union Medical College Grant 10023-1007-1020 (to P. W.), and National Natural Science Foundation of China Grant 81470159 (to X. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Cheng JT, 2006, DIABETES, V55, P819, DOI 10.2337/diabetes.55.03.06.db05-0934; Chin M, 2013, AM J PHYSIOL-RENAL, V304, pF1438, DOI 10.1152/ajprenal.00387.2012; Csiszar A., 2011, FASEB J, V25, P1093; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Detaille D, 2005, DIABETES, V54, P2179, DOI 10.2337/diabetes.54.7.2179; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Erejuwa OO, 2011, INT J BIOL SCI, V7, P244, DOI 10.7150/ijbs.7.244; Fan HY, 2010, THROMB RES, V126, pE17, DOI 10.1016/j.thromres.2010.04.006; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Guo R, 2014, DIABETES VASC DIS RE, V11, P92, DOI 10.1177/1479164113520332; Hamilton J, 2003, DIABETES CARE, V26, P138, DOI 10.2337/diacare.26.1.138; Hasko G, 2010, AM J PHYSIOL-HEART C, V299, pH10, DOI 10.1152/ajpheart.00436.2010; Huang J, 2013, CELL PROLIFERAT, V46, P595, DOI 10.1111/cpr.12056; Huang ZS, 2010, J THROMB HAEMOST, V8, P1383, DOI 10.1111/j.1538-7836.2010.03859.x; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Kim JH, 2012, FREE RADICAL BIO MED, V53, P629, DOI 10.1016/j.freeradbiomed.2012.04.019; Kinaan M, 2015, MED PRIN PRACT, V24, P401, DOI 10.1159/000381643; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kumar H, 2014, NAT PROD REP, V31, P109, DOI 10.1039/c3np70065h; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Li H, 2011, CELL SIGNAL, V23, P1625, DOI 10.1016/j.cellsig.2011.05.016; Lin CC, 2009, J CHIN MED ASSOC, V72, P109, DOI 10.1016/S1726-4901(09)70035-8; Lin JT, 2014, EXPERT OPIN INV DRUG, V23, P1253, DOI 10.1517/13543784.2014.922951; Lin TJ, 1996, BIOCHEM PHARMACOL, V51, P1237, DOI 10.1016/0006-2952(96)00067-6; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Oelze M, 2006, HYPERTENSION, V48, P677, DOI 10.1161/01.HYP.0000239207.82326.29; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pergola PE, 2011, AM J NEPHROL, V33, P469, DOI 10.1159/000327599; Pilmore HL, 2010, NEPHROLOGY, V15, P412, DOI 10.1111/j.1440-1797.2010.01328.x; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Taguchi K, 2014, BIOL PHARM BULL, V37, P1056, DOI 10.1248/bpb.b14-00157; Tan SM, 2014, DIABETES, V63, P3091, DOI 10.2337/db13-1743; Tan SM, 2013, INVEST OPHTH VIS SCI, V54, P555, DOI 10.1167/iovs.12-10685; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Vaziri ND, 2015, FREE RADICAL BIO MED, V86, P374, DOI 10.1016/j.freeradbiomed.2015.04.022; Vikram A, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/679754; Wang SB, 2009, LIFE SCI, V85, P499, DOI 10.1016/j.lfs.2009.07.018; Xu H, 2014, DRUG METAB DISPOS, V42, P274, DOI 10.1124/dmd.113.053694; Yao F, 2016, ACTA PHARM SIN B, V6, P20, DOI 10.1016/j.apsb.2015.07.009; Zhang HA, 2012, BIOCHEM BIOPH RES CO, V421, P479, DOI 10.1016/j.bbrc.2012.04.021; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zhang M, 2009, DIABETES, V58, pA190; Zhang XC, 2014, J CARDIOVASC PHARM, V64, P318, DOI 10.1097/FJC.0000000000000117; Zhao JH, 2015, AM J PHYSIOL-RENAL, V308, pF1167, DOI 10.1152/ajprenal.00234.2014; Zhao QF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/231351; Zheng Z, 2012, DIABETES, V61, P217, DOI 10.2337/db11-0416; Zoja C, 2013, AM J PHYSIOL-RENAL, V304, pF808, DOI 10.1152/ajprenal.00376.2012	60	34	38	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22288	22301		10.1074/jbc.M115.712703	http://dx.doi.org/10.1074/jbc.M115.712703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27417135	Green Published, hybrid			2022-12-28	WOS:000386332600039
J	Wang, YF; Rahman, D; Mistry, M; Lehner, T				Wang, Yufei; Rahman, Durdana; Mistry, Mukesh; Lehner, Thomas			The Effect of Cellular Stress on T and B Cell Memory Pathways in Immunized and Unimmunized BALB/c Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular immune response; heat shock protein (HSP); inflammasome; interleukin 1 (IL-1); oxidative stress; stress response; AID; IL-15; T and B memory cells	CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; ACTIVATION; EXPRESSION; PHENOTYPE; RECEPTOR; BIOLOGY; NAIVE; AID	Immunological memory is a fundamental function of vaccination. The antigenic breakdown products of the vaccine may not persist, and undefined tonic stimulation has been proposed to maintain the specific memory. We have suggested that cellular stress agents to which the immune cells are constantly exposed may be responsible for tonic stimulation. Here we have studied four stress agents: sodium arsenite, an oxidative agent; Gramicidin, eliciting K+ efflux and calcium influx; dithiocarbamate, a metal ionophore; and aluminum hydroxide (alum), an immunological adjuvant. The aims of this study are to extend these investigations to T and B cell responses of unimmunized and ovalbumin (OVA)-immunized BALB/c mice, and furthermore, to ascertain whether stress is involved in optimal expression of memory B cells, as demonstrated in CD4(+) T cells. Examination of the homeostatic pathway defined by IL-15/IL-15R (IL-15 receptor) interaction and the inflammasome pathway defined by the IL-1-IL-1R interaction between dendritic cells (DC) and CD4(+) T cells suggests that both pathways are involved in the development of optimal expression of CD4(+)CD45RO(+) memory T cells in unimmunized and OVA-immunized BALB/c mice. Furthermore, significant direct correlation was found between CD4(+)CD44(+) memory T cells and both IL-15 of the homeostatic and IL-1 of the inflammasome pathways. However, CD19(+)CD27(+) memory B cells in vivo seem to utilize only the IL-15/IL-15R homeostatic pathway, although the proliferative responses are enhanced by the stress agents. Altogether, stress agents may up-regulate unimmunized and OVA-immunized CD4(+)CD44(+) memory T cells by the homeostatic and inflammasome pathways. However, the CD19(+)CD27(+) memory B cells utilize only the homeostatic pathway.	[Wang, Yufei; Rahman, Durdana; Mistry, Mukesh; Lehner, Thomas] Kings Coll London, Guys Hosp, Mucosal Immunol Unit, London SE1 1UT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lehner, T (corresponding author), Kings Coll London, Guys Hosp, Mucosal Immunol Unit, London SE1 1UT, England.	Thomas.lehner@kcl.ac.uk			European Union [280873]; King's Health Partner's Research and Challenge Fund; King's College London	European Union(European Commission); King's Health Partner's Research and Challenge Fund; King's College London	This work was supported by the European Union 'Advanced Immunization Technology Grant 280873' and the King's Health Partner's Research and Challenge Fund. Open access for this article was funded by King's College London. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; BOURINBAIAR AS, 1994, LIFE SCI, V54, pPL5, DOI 10.1016/0024-3205(94)00579-6; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Intlekofer AM, 2006, IMMUNOL REV, V211, P203, DOI 10.1111/j.0105-2896.2006.00396.x; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P2011, DOI 10.1016/j.bbamem.2007.05.011; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tomlin C., 1994, PESTICIDE MANUAL WOR, V10th ed.; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang YF, 2015, J BIOL CHEM, V290, P15595, DOI 10.1074/jbc.M115.645754; Wang YF, 2012, J BIOL CHEM, V287, P17152, DOI 10.1074/jbc.M112.347179; Wang YF, 2010, EUR J IMMUNOL, V40, P1628, DOI 10.1002/eji.200940251; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	25	1	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20707	20717		10.1074/jbc.M116.746057	http://dx.doi.org/10.1074/jbc.M116.746057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27502276	Green Published, hybrid			2022-12-28	WOS:000384574800032
J	Banday, S; Farooq, Z; Rashid, R; Abdullah, E; Altaf, M				Banday, Shahid; Farooq, Zeenat; Rashid, Romana; Abdullah, Ehsaan; Altaf, Mohammad			Role of Inner Nuclear Membrane Protein Complex Lem2-Nur1 in Heterochromatic Gene Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; gene silencing; heterochromatin; histone modification; nuclear envelope; chromatin; gene silencing	FISSION YEAST; LYSINE-9 METHYLATION; LAMINA INTERACTIONS; HISTONE H3; CHROMATIN; DOMAIN; GENOME; TRANSCRIPTION; LOCALIZATION; ORGANIZATION	Heterochromatin in the fission yeast Schizosaccharomyces pombe is clustered at the nuclear periphery and interacts with a number of nuclear membrane proteins. However, the significance and the factors that sequester heterochromatin at the nuclear periphery are not fully known. Here, we report that an inner nuclear membrane protein complex Lem2-Nur1 is essential for heterochromatin-mediated gene silencing. We found that Lem2 is physically associated with another inner nuclear membrane protein, Nur1, and deletion of either lem2 or nur1 causes silencing defect at centromeres, telomeres, and rDNA loci. We analyzed the genome-wide association of Lem2 using ChIP sequencing and we found that it binds to the central core region of centromeres, in striking contrast to Chp1, a component of pericentromeric heterochromatin, which binds H3K9me-rich chromatin in neighboring sequences. The recruitment of Lem2 and Nur1 to silent regions of the genome is dependent on H3K9 methyltransferase, Clr4. Finally, we show that the Lem2-Nur1 complex regulates the local balance between the underln]Snf2/HDAC-containing repressor complex (SHREC) histone deacetylase complex and the anti-silencing protein Epe1. These findings uncover a novel role for Lem2-Nur1 as a key functional link between localization at the nuclear periphery and heterochromatin-mediated gene silencing.	[Banday, Shahid; Farooq, Zeenat; Rashid, Romana; Abdullah, Ehsaan; Altaf, Mohammad] Univ Kashmir, Dept Biotechnol, Chromatin & Epigenet Lab, Srinagar 190006, Jammu & Kashmir, India	University of Kashmir	Altaf, M (corresponding author), Univ Kashmir, Dept Biotechnol, Srinagar 190006, Jammu & Kashmir, India.	altafbhat@uok.edu.in			National Institutes of Health [R01 GM072805]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to Prof. Danesh Moazed of Harvard University for his support (under National Institutes of Health Grant R01 GM072805), suggestions, and critical reading of the manuscript. We are grateful to Dr. Ajazul Hamid Wani for valuable suggestions. We also thank Gloria Jih for help in analysis of the ChIP-seq data.	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Allshire RC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018770; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Altaf M, 2007, MUTAT RES-FUND MOL M, V618, P81, DOI 10.1016/j.mrfmmm.2006.09.009; Amendola M, 2014, CURR OPIN CELL BIOL, V28, P61, DOI 10.1016/j.ceb.2014.03.003; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barrales RR, 2016, GENE DEV, V30, P133, DOI 10.1101/gad.271288.115; Barton LJ, 2015, CURR OPIN CELL BIOL, V34, P1, DOI 10.1016/j.ceb.2015.03.005; Bloom KS, 2014, ANNU REV GENET, V48, P457, DOI 10.1146/annurev-genet-120213-092033; Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Gonzalez Y, 2012, NUCLEUS-PHILA, V3, P60, DOI 10.4161/nucl.18824; Gonzalez-Sandoval A, 2015, CELL, V163, P1333, DOI 10.1016/j.cell.2015.10.066; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Hubner B, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0038-0; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mans BJ, 2004, CELL CYCLE, V3, P1612; Martienssen R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019323; Mattout A, 2011, CURR BIOL, V21, P1603, DOI 10.1016/j.cub.2011.08.030; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Mizuguchi T, 2015, FEBS LETT, V589, P2975, DOI 10.1016/j.febslet.2015.06.008; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Suganuma T, 2013, CURR OPIN CELL BIOL, V25, P322, DOI 10.1016/j.ceb.2013.02.016; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Towbin BD, 2013, TRENDS BIOCHEM SCI, V38, P356, DOI 10.1016/j.tibs.2013.04.004; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WALKER CL, 1991, P NATL ACAD SCI USA, V88, P6191, DOI 10.1073/pnas.88.14.6191; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	46	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20021	20029		10.1074/jbc.M116.743211	http://dx.doi.org/10.1074/jbc.M116.743211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27451393	Green Published, hybrid			2022-12-28	WOS:000383243100025
J	Valinsky, WC; Jolly, A; Miquel, P; Touyz, RM; Shrier, A				Valinsky, William C.; Jolly, Anna; Miquel, Perrine; Touyz, Rhian M.; Shrier, Alvin			Aldosterone Upregulates Transient Receptor Potential Melastatin 7 (TRPM7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aldosterone; electrophysiology; mineralocorticoid receptor; plasma membrane; transient receptor potential channels (TRP channels); SGK1; -kinase	RENAL COLLECTING DUCT; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-D; FUNCTIONAL-CHARACTERIZATION; MINERALOCORTICOID RECEPTOR; MG2+ TRANSPORTER; NA+/H+ EXCHANGE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; SODIUM-TRANSPORT; PHOSPHOLIPASE-C	Transient receptor potential melastatin 7 (TRPM7) is a ubiquitously expressed Mg2+-permeable ion channel fused to a C-terminal -kinase domain. Recently, aldosterone was shown to increase intracellular Mg2+ levels and alter inflammatory signaling in TRPM7-expressing HEK293 cells. This study was undertaken to assess whether these effects were related to an aldosterone-mediated increase of TRPM7 current and/or plasma membrane localization. Using HEK293 cells stably expressing WT-TRPM7, we found that 18-h application of aldosterone significantly increased TRPM7 current and TRPM7 plasma membrane protein expression by 48% and 34%, respectively. The aldosterone-mediated increase of TRPM7 current was inhibited by eplerenone, a mineralocorticoid receptor (MR) blocker, and GSK-650394, an inhibitor of the serum- and glucocorticoid-regulated kinase 1 (SGK1). SGK1 blockade also prevented the aldosterone-induced increase of TRPM7 plasma membrane protein. It was further determined that K1648R-TRPM7, the phosphotransferase-inactive TRPM7 mutant, was unresponsive to aldosterone. Therefore, chronic aldosterone treatment increases the plasma membrane expression of TRPM7, which is associated with an increase of TRPM7 current. This process occurs via an MR-dependent, genomic signaling cascade involving SGK1 and a functioning TRPM7 -kinase domain. We suggest that this mechanism may be of general relevance when interpreting the effects of aldosterone because the MR receptor is found in multiple tissues, and TRPM7 and SGK1 are ubiquitously expressed.	[Valinsky, William C.; Jolly, Anna; Miquel, Perrine; Shrier, Alvin] McGill Univ, Dept Physiol, Bellini Bldg,Rm 165, Montreal, PQ H3G 0B1, Canada; [Touyz, Rhian M.] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF GCRC, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland	McGill University; University of Glasgow	Shrier, A (corresponding author), McGill Univ, Dept Physiol, Bellini Bldg,Rm 165, Montreal, PQ H3G 0B1, Canada.	alvin.shrier@mcgill.ca	Touyz, Rhian/AAM-3564-2020	Touyz, Rhian/0000-0003-0670-0887; Valinsky, Corey/0000-0001-7736-9146; Shrier, Alvin/0000-0002-6133-4931	Canadian Institute of Health Research (CIHR) [MOP57786]; Canada Research Chair/Canadian Foundation for Innovation; British Heart Foundation Chair [29762]; British Heart Foundation [RG/13/7/30099] Funding Source: researchfish	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair/Canadian Foundation for Innovation(Canada Foundation for InnovationCanada Research Chairs); British Heart Foundation Chair(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This study was funded by grants from the Canadian Institute of Health Research (CIHR, MOP57786) (to R. M. T. and A. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported through a Canada Research Chair/Canadian Foundation for Innovation award and British Heart Foundation Chair (29762).	ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Asher C, 1996, AM J PHYSIOL-CELL PH, V271, pC605, DOI 10.1152/ajpcell.1996.271.2.C605; BAULIEU EE, 1959, J CLIN ENDOCR METAB, V19, P1081, DOI 10.1210/jcem-19-9-1081; Bessac BF, 2007, J PHYSIOL-LONDON, V582, P1073, DOI 10.1113/jphysiol.2007.130534; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; BIGLIERI EG, 1961, JAMA-J AM MED ASSOC, V178, P19, DOI 10.1001/jama.1961.03040400021004; Boehmer C, 2007, FEBS LETT, V581, P5586, DOI 10.1016/j.febslet.2007.11.006; Bostonjoglo M, 1998, J AM SOC NEPHROL, V9, P1347; Braun S, 2004, FEBS LETT, V570, P69, DOI 10.1016/j.febslet.2004.06.031; Brennan FE, 2000, MOL CELL ENDOCRINOL, V166, P129, DOI 10.1016/S0303-7207(00)00274-4; Brown NJ, 2003, CIRCULATION, V107, P2512, DOI 10.1161/01.CIR.0000071081.35693.9A; Campean V, 2001, AM J PHYSIOL-RENAL, V281, pF1028, DOI 10.1152/ajprenal.0148.2001; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Christ M, 1999, CIRCULATION, V99, P1485, DOI 10.1161/01.CIR.99.11.1485; CHRIST M, 1995, BIOCHEM BIOPH RES CO, V213, P123, DOI 10.1006/bbrc.1995.2106; CHRIST M, 1995, HYPERTENSION, V25, P117, DOI 10.1161/01.HYP.25.1.117; CHRIST M, 1993, J CLIN ENDOCR METAB, V77, P1452, DOI 10.1210/jc.77.6.1452; Dai LJ, 1997, AM J PHYSIOL-RENAL, V272, pF249, DOI 10.1152/ajprenal.1997.272.2.F249; Deason-Towne F, 2011, FEBS LETT, V585, P2275, DOI 10.1016/j.febslet.2011.05.052; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; DEGASPARO M, 1987, J PHARMACOL EXP THER, V240, P650; Embark HM, 2004, KIDNEY INT, V66, P1918, DOI 10.1111/j.1523-1755.2004.00966.x; GANONG WF, 1958, AM J PHYSIOL, V195, P337, DOI 10.1152/ajplegacy.1958.195.2.337; Gekle M, 1996, P NATL ACAD SCI USA, V93, P10500, DOI 10.1073/pnas.93.19.10500; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037; Goytain A, 2008, AM J PHYSIOL-CELL PH, V295, pC944, DOI 10.1152/ajpcell.00091.2008; Goytain A, 2008, AM J PHYSIOL-CELL PH, V294, pC495, DOI 10.1152/ajpcell.00238.2007; Goytain A, 2007, J BIOL CHEM, V282, P8060, DOI 10.1074/jbc.M610314200; Goytain A, 2008, J BIOL CHEM, V283, P33365, DOI 10.1074/jbc.M801469200; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; HORTON R, 1962, J CLIN ENDOCR METAB, V22, P1187, DOI 10.1210/jcem-22-12-1187; Jeong Y, 2009, P NATL ACAD SCI USA, V106, P3782, DOI 10.1073/pnas.0804037106; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Kaitsuka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05718; KEMENDY AE, 1992, AM J PHYSIOL, V263, pC825, DOI 10.1152/ajpcell.1992.263.4.C825; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; KORNEL L, 1994, AM J HYPERTENS, V7, P100, DOI 10.1093/ajh/7.1.100; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Le Moellic C, 2004, J AM SOC NEPHROL, V15, P1145; Leroy V, 2009, J AM SOC NEPHROL, V20, P131, DOI 10.1681/ASN.2008020232; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; LOMBES M, 1992, CIRC RES, V71, P503, DOI 10.1161/01.RES.71.3.503; Martin-Fernandez B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145946; May A, 1997, J AM SOC NEPHROL, V8, P1813; McEneaney V, 2008, MOL ENDOCRINOL, V22, P881, DOI 10.1210/me.2007-0225; McEneaney V, 2007, J STEROID BIOCHEM, V107, P180, DOI 10.1016/j.jsbmb.2007.03.043; MEYER WJ, 1981, J STEROID BIOCHEM, V14, P1157, DOI 10.1016/0022-4731(81)90046-7; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; NEHER E, 1992, METHOD ENZYMOL, V207, P123; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; Palmada M, 2005, CELL PHYSIOL BIOCHEM, V15, P175, DOI 10.1159/000083650; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Queisser N, 2014, ANTIOXID REDOX SIGN, V21, P2126, DOI 10.1089/ars.2013.5565; ROUSSEAU G, 1972, J STEROID BIOCHEMIST, V3, P219, DOI 10.1016/0022-4731(72)90053-2; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova L. V., 2001, Molekulyarnaya Biologiya (Moscow), V35, P321; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Shin SH, 2012, CELL SIGNAL, V24, P641, DOI 10.1016/j.cellsig.2011.11.002; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Soundararajan R, 2012, MOL CELL ENDOCRINOL, V350, P242, DOI 10.1016/j.mce.2011.11.003; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; TAKEDA Y, 1995, HYPERTENSION, V25, P170, DOI 10.1161/01.HYP.25.2.170; Thomas SV, 2011, J BIOL CHEM, V286, P32074, DOI 10.1074/jbc.M111.278283; THORN GW, 1955, ANN NY ACAD SCI, V61, P609, DOI 10.1111/j.1749-6632.1955.tb42514.x; Tsybouleva N, 2004, CIRCULATION, V109, P1284, DOI 10.1161/01.CIR.0000121426.43044.2B; UHLICH E, 1969, PFLUG ARCH EUR J PHY, V308, P111, DOI 10.1007/BF00587019; VANDER AJ, 1958, P SOC EXP BIOL MED, V99, P323; VILELLA S, 1992, PFLUG ARCH EUR J PHY, V422, P9, DOI 10.1007/BF00381507; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yogi A, 2013, CELL SIGNAL, V25, P2163, DOI 10.1016/j.cellsig.2013.07.002; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Yu L, 2013, AM J PHYSIOL-RENAL, V305, pF31, DOI 10.1152/ajprenal.00652.2012; Yun CC, 2002, J AM SOC NEPHROL, V13, P2823, DOI 10.1097/01.ASN.0000035085.54451.81; YUNIS SL, 1964, J CLIN INVEST, V43, P1668, DOI 10.1172/JCI105042; Zaun HC, 2008, J BIOL CHEM, V283, P12456, DOI 10.1074/jbc.M800267200; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	89	16	16	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20163	20172		10.1074/jbc.M116.735175	http://dx.doi.org/10.1074/jbc.M116.735175			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27466368	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000383243100036
J	Zhang, Y; Muhlen, S; Oates, CV; Pearson, JS; Hartland, EL				Zhang, Ying; Muehlen, Sabrina; Oates, Clare V.; Pearson, Jaclyn S.; Hartland, Elizabeth L.			Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); infection; inflammation; NF-B (NF-B); substrate specificity	NF-KAPPA-B; ENTEROPATHOGENIC ESCHERICHIA-COLI; IMMUNE-RESPONSES; ACTIVATION; INFECTION; PROTEIN	The type III secretion system effector protein NleE from enteropathogenic Escherichia coli plays a key role in the inhibition of NF-B activation during infection. NleE inactivates the ubiquitin chain binding activity of host proteins TAK1-binding proteins 2 and 3 (TAB2 and TAB3) by modifying the Npl4 zinc finger domain through S-adenosyl methionine-dependent cysteine methylation. Using yeast two-hybrid protein interaction studies, we found that a conserved region between amino acids 34 and 52 of NleE, in particular the motif (49)GITR(52), was critical for TAB2 and TAB3 binding. NleE mutants lacking (49)GITR(52) were unable to methylate TAB3, and wild type NleE but not NleE(49AAAA52) where each of GITR was replaced with alanine restored the ability of an nleE mutant to inhibit IL-8 production during infection. Another NleE target, ZRANB3, also associated with NleE through the (49)GITR(52) motif. Ectopic expression of an N-terminal fragment of NleE (NleE(34-52)) in HeLa cells showed competitive inhibition of wild type NleE in the suppression of IL-8 secretion during enteropathogenic E. coli infection. Similar results were observed for the NleE homologue OspZ from Shigella flexneri 6 that also bound TAB3 through the (49)GITR(52) motif and decreased IL-8 transcription through modification of TAB3. In summary, we have identified a unique substrate-binding motif in NleE and OspZ that is required for the ability to inhibit the host inflammatory response.	[Zhang, Ying; Muehlen, Sabrina; Oates, Clare V.; Pearson, Jaclyn S.; Hartland, Elizabeth L.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3000, Australia; [Muehlen, Sabrina] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, D-38124 Braunschweig, Germany	University of Melbourne; Helmholtz Association; Helmholtz-Center for Infection Research	Hartland, EL (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3000, Australia.	hartland@unimelb.edu.au	; Hartland, Elizabeth/O-2569-2014	Pearson, Jaclyn/0000-0002-7358-4479; Muehlen, Sabrina/0000-0001-7474-705X; Hartland, Elizabeth/0000-0003-4254-2863; Oates, Clare/0000-0002-3858-019X	Australian National Health and Medical Research Council [APP606788]; University of Melbourne International Research Scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne International Research Scholarship(University of Melbourne)	This work was supported in part by Australian National Health and Medical Research Council Grant APP606788 (to E. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a University of Melbourne International Research Scholarship.	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Dutta U, 2000, AM J GASTROENTEROL, V95, P784, DOI 10.1111/j.1572-0241.2000.01860.x; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Giogha C, 2015, CELL MICROBIOL, V17, P1766, DOI 10.1111/cmi.12469; LEVINE MM, 1978, LANCET, V1, P1119; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Machado AMD, 2010, BBA-REV CANCER, V1806, P58, DOI 10.1016/j.bbcan.2010.01.007; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Royan SV, 2010, MOL MICROBIOL, V78, P1232, DOI 10.1111/j.1365-2958.2010.07400.x; Ruchaud-Sparagano MH, 2007, CELL MICROBIOL, V9, P1909, DOI 10.1111/j.1462-5822.2007.00923.x; Ruchaud-Sparagano MH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002414; Sham HP, 2011, INFECT IMMUN, V79, P3552, DOI 10.1128/IAI.05033-11; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Wickham ME, 2007, MICROBES INFECT, V9, P400, DOI 10.1016/j.micinf.2006.12.016; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yao Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004522; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zeman MK, 2012, MOL CELL, V47, P333, DOI 10.1016/j.molcel.2012.07.024; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zurawski DV, 2008, INFECT IMMUN, V76, P369, DOI 10.1128/IAI.00684-07	26	15	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20149	20162		10.1074/jbc.M116.734079	http://dx.doi.org/10.1074/jbc.M116.734079			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27445336	Green Published, hybrid			2022-12-28	WOS:000383243100035
J	Alferink, J; Specht, S; Arends, H; Schumak, B; Schmidt, K; Ruland, C; Lundt, R; Kemter, A; Dlugos, A; Kuepper, JM; Poppensieker, K; Findeiss, M; Albayram, O; Otte, DM; Marazzi, J; Gertsch, J; Forster, I; Maier, W; Scheu, S; Hoerauf, A; Zimmer, A				Alferink, Judith; Specht, Sabine; Arends, Hannah; Schumak, Beatrix; Schmidt, Kim; Ruland, Christina; Lundt, Ramona; Kemter, Andrea; Dlugos, Andrea; Kuepper, Janina M.; Poppensieker, Karola; Findeiss, Matthias; Albayram, Oender; Otte, David-M.; Marazzi, Janine; Gertsch, Juerg; Foerster, Irmgard; Maier, Wolfgang; Scheu, Stefanie; Hoerauf, Achim; Zimmer, Andreas			Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; endocannabinoid; macrophage; malaria; neuroinflammation	DENDRITIC CELLS; T-CELLS; CB2 RECEPTOR; PLASMODIUM-FALCIPARUM; SUPPRESSOR-CELLS; ALTERNATIVE ACTIVATION; NEUROPATHIC PAIN; IMMUNE-RESPONSE; IFN-GAMMA; BRAIN	Cerebral malaria is a severe and often fatal complication of Plasmodium falciparum infection. It is characterized by parasite sequestration, a breakdown of the blood-brain barrier, and a strong inflammation in the brain. We investigated the role of the cannabinoid receptor 2 (CB2), an important modulator of neuroinflammatory responses, in experimental cerebral malaria (ECM). Strikingly, mice with a deletion of the CB2-encoding gene (Cnr2(-/-)) inoculated with Plasmodium berghei ANKA erythrocytes exhibited enhanced survival and a diminished blood-brain barrier disruption. Therapeutic application of a specific CB2 antagonist also conferred increased ECM resistance in wild type mice. Hematopoietic derived immune cells were responsible for the enhanced protection in bone marrow (BM) chimeric Cnr2(-/-) mice. Mixed BM chimeras further revealed that CB2-expressing cells contributed to ECM development. A heterogeneous CD11b(+) cell population, containing macrophages and neutrophils, expanded in the Cnr2(-/-) spleen after infection and expressed macrophage mannose receptors, arginase-1 activity, and IL-10. Also in the Cnr2(-/-) brain, CD11b(+) cells that expressed selected anti-inflammatory markers accumulated, and expression of inflammatory mediators IFN- and TNF- was reduced. Finally, the M2 macrophage chemokine CCL17 was identified as an essential factor for enhanced survival in the absence of CB2, because CCL17 x Cnr2 double-deficient mice were fully susceptible to ECM. Thus, targeting CB2 may be promising for the development of alternative treatment regimes of ECM.	[Alferink, Judith; Arends, Hannah; Lundt, Ramona; Kemter, Andrea; Poppensieker, Karola; Findeiss, Matthias; Albayram, Oender; Otte, David-M.; Zimmer, Andreas] Univ Bonn, Fac Med, Inst Mol Psychiat, D-53127 Bonn, Germany; [Foerster, Irmgard] Univ Bonn, Dept Immunol & Environm, Life & Med Sci Inst LIMES, D-53127 Bonn, Germany; [Alferink, Judith; Ruland, Christina; Dlugos, Andrea] Univ Munster, Dept Psychiat, Albert Schweitzer Campus 1, D-48149 Munster, Germany; [Alferink, Judith] Cluster Excellence EXC 1003, Cells Motion, D-48149 Munster, Germany; [Specht, Sabine; Schumak, Beatrix; Schmidt, Kim; Kuepper, Janina M.; Hoerauf, Achim] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany; [Maier, Wolfgang] Univ Hosp Bonn, Dept Psychiat, D-53105 Bonn, Germany; [Marazzi, Janine; Gertsch, Juerg] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Scheu, Stefanie] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Specht, Sabine] Univ Zurich, Vetsuisse Fac, Inst Lab Anim Sci, CH-8952 Schlieren, Switzerland; [Hoerauf, Achim; Zimmer, Andreas] DFG EXC 1023, Cluster Excellence ImmunoSensat EXC 1023, Munster, Germany	University of Bonn; University of Bonn; University of Munster; University of Bonn; University of Bonn; University of Bern; Heinrich Heine University Dusseldorf	Alferink, J (corresponding author), Univ Munster, Dept Psychiat, Albert Schweitzer Campus 1, D-48149 Munster, Germany.; Zimmer, A (corresponding author), Univ Bonn, Inst Mol Psychiat, Sigmund Freud Str 25, D-53127 Bonn, Germany.	Judith.alferink@ukmuenster.de; neuro@uni-bonn.de	Scheu, Stefanie/H-3670-2019; Förster, Irmgard/P-8545-2016; Zimmer, Andreas/B-8357-2009	Scheu, Stefanie/0000-0002-9707-8191; Förster, Irmgard/0000-0002-7644-5642; Kuehlwein, Janina M./0000-0003-3648-2649; Gertsch, Jurg/0000-0003-0978-1555; alferink, judith/0000-0002-3251-6584	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [FOR926]; DFG, Cells in Motion Cluster of Excellence, Munster, Germany [EXC 1003, FF-2014-01]; DFG [SCHE692/3-1, SCHE692/4-1, SFB 704]; Strategic Research Fund of Heinrich Heine University Dusseldorf; Medical Faculty, Bonn University [2012-1-22, 2013-1-29]; intramural Munster IMF funding Grant [I-DL121204, I-ST111423]	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); DFG, Cells in Motion Cluster of Excellence, Munster, Germany(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Strategic Research Fund of Heinrich Heine University Dusseldorf; Medical Faculty, Bonn University; intramural Munster IMF funding Grant	This study was supported by German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) Grant FOR926 (to J. A. and A. Z.); DFG EXC 1003, Grant FF-2014-01 Cells in Motion Cluster of Excellence, Munster, Germany (to J. A.); DFG Grants SCHE692/3-1 and SCHE692/4-1 (to S. Scheu); Strategic Research Fund of Heinrich Heine University Dusseldorf (to S. Scheu); DFG Grant SFB 704 (to I. F.); BONFOR intramural funding scheme of the Medical Faculty, Bonn University, Grants 2012-1-22 and 2013-1-29 (to J. K. and B. S.); intramural Munster IMF funding Grant I-DL121204 (to J. A. and A. D.); and intramural Munster IMF funding Grant I-ST111423 (to J. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Alferink J, 2003, J EXP MED, V197, P585, DOI 10.1084/jem.20021859; Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Ashton JC, 2007, NEUROSCI LETT, V412, P114, DOI 10.1016/j.neulet.2006.10.053; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Ayi K, 2005, INFECT IMMUN, V73, P2559, DOI 10.1128/IAI.73.4.2559-2563.2005; Backer R, 2010, P NATL ACAD SCI USA, V107, P216, DOI 10.1073/pnas.0909541107; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Besnard AG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004607; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Bose TO, 2013, INFECT IMMUN, V81, P1140, DOI 10.1128/IAI.00749-12; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Capasso R, 2001, BRIT J PHARMACOL, V134, P945, DOI 10.1038/sj.bjp.0704339; Centonze D, 2007, INT REV NEUROBIOL, V82, P171, DOI 10.1016/S0074-7742(07)8209-5; Chuchawankul S, 2004, INT IMMUNOPHARMACOL, V4, P265, DOI 10.1016/j.intimp.2003.12.011; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Hey YY, 2012, J CELL MOL MED, V16, P2611, DOI 10.1111/j.1582-4934.2012.01608.x; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Jorda MA, 2002, BLOOD, V99, P2786; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kogan Natalya M, 2007, Dialogues Clin Neurosci, V9, P413; Kossodo S, 1997, IMMUNOLOGY, V91, P536, DOI 10.1046/j.1365-2567.1997.00290.x; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Medana IM, 1997, GLIA, V19, P91, DOI 10.1002/(SICI)1098-1136(199702)19:2<91::AID-GLIA1>3.0.CO;2-C; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Montecucco F, 2009, ATHEROSCLEROSIS, V205, P433, DOI 10.1016/j.atherosclerosis.2008.12.040; Mukhopadhyay S, 2009, ADV EXP MED BIOL, V653, P1, DOI 10.1109/TENCON.2009.5396176; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; Poppensieker K, 2012, P NATL ACAD SCI USA, V109, P3897, DOI 10.1073/pnas.1114153109; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Racz I, 2008, J NEUROSCI, V28, P12136, DOI 10.1523/JNEUROSCI.3402-08.2008; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; Riley EM, 2010, TRENDS PARASITOL, V26, P277, DOI 10.1016/j.pt.2010.03.002; Ross RA, 2000, EUR J PHARMACOL, V401, P121, DOI 10.1016/S0014-2999(00)00437-4; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Sigel E, 2011, P NATL ACAD SCI USA, V108, P18150, DOI 10.1073/pnas.1113444108; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Specht S, 2006, MICROBES INFECT, V8, P694, DOI 10.1016/j.micinf.2005.09.006; Specht S, 2011, J IMMUNOL, V186, P4845, DOI 10.4049/jimmunol.1000612; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Van Ginderachter JA, 2010, EUR J IMMUNOL, V40, P2976, DOI 10.1002/eji.201040911; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Wolf SA, 2008, J NEUROENDOCRINOL, V20, P15, DOI 10.1111/j.1365-2826.2008.01672.x; Wu XZ, 2015, J BIOL CHEM, V290, P23135, DOI 10.1074/jbc.M115.671065; Yanez DM, 1996, J IMMUNOL, V157, P1620; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044	69	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19517	19531		10.1074/jbc.M116.746594	http://dx.doi.org/10.1074/jbc.M116.746594			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27474745	hybrid, Green Published			2022-12-28	WOS:000383242800028
J	Gujjula, R; Veeraiah, S; Kumar, K; Thakur, SS; Mishra, K; Kaur, R				Gujjula, Rahul; Veeraiah, Sangeetha; Kumar, Kundan; Thakur, Suman S.; Mishra, Krishnaveni; Kaur, Rupinder			Identification of Components of the SUMOylation Machinery in Candida glabrata: ROLE OF THE DESUMOYLATION PEPTIDASE CgUlp2 IN VIRULENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; biofilm; microbial pathogenesis; small ubiquitin-like modifier (SUMO); sumoylation; C; glabrata; Epa adhesins; SUMO peptidase; fungal pathogenesis; SUMO ligase	PROTEIN SUMOYLATION; CONJUGATING ENZYME; SUMO ISOPEPTIDASE; TELOMERE LENGTH; ADHESINS; LIGASE; EPIDEMIOLOGY; ULL1/SIZ1; VIRULENCE; ADHERENCE	Regulation of protein function by reversible post-translational modification, SUMOylation, is widely conserved in the eukaryotic kingdom. SUMOylation is essential for cell growth, division, and adaptation to stress in most organisms, including fungi. As these are key factors in determination of fungal virulence, in this study, we have investigated the importance of SUMOylation in the human pathogen, Candida glabrata. We identified the enzymes involved in small ubiquitin-like modifier conjugation and show that there is strong conservation between Saccharomyces cerevisiae and C. glabrata. We demonstrate that SUMOylation is an essential process and that adaptation to stress involves changes in global SUMOylation in C. glabrata. Importantly, loss of the deSUMOylating enzyme CgUlp2 leads to highly reduced small ubiquitin-like modifier protein levels, and impaired growth, sensitivity to multiple stress conditions, reduced adherence to epithelial cells, and poor colonization of specific tissues in mice. Our study thus demonstrates a key role for protein SUMOylation in the life cycle and pathobiology of C. glabrata.	[Kaur, Rupinder] Ctr DNA Fingerprinting & Diagnost, Bldg 7,Gruhakalpa 5-4-399-B, Hyderabad 500001, Andhra Pradesh, India; [Veeraiah, Sangeetha; Mishra, Krishnaveni] Univ Hyderabad, Sch Life Sci, Dept Biochem, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India; [Kumar, Kundan] Manipal Univ, Grad Studies Program, Manipal 576104, Karnataka, India; [Thakur, Suman S.] Habsiguda, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Gujjula, Rahul] Auroras Degree & PG Coll, Dept Biochem, Hyderabad 500020, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Hyderabad; Manipal Academy of Higher Education (MAHE); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Kaur, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Bldg 7,Gruhakalpa 5-4-399-B, Hyderabad 500001, Andhra Pradesh, India.; Mishra, K (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India.	krishnaveni.mishra@gmail.com; rkaur@cdfd.org.in		Thakur, Suman/0000-0001-5928-8836; Kumar, Kundan/0000-0002-5467-9384	Department of Biotechnology, Government of India [BT/PR7388/MED/29/650/2012, BT/PR7123/BRB/10/1149/ 2012, BT/PR11752/BRB/10/685/2009, BT/PR5145/MED/29/470/2012]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India, Grants BT/PR7388/MED/29/650/2012 and BT/PR7123/BRB/10/1149/ 2012 (to R. K.), BT/PR11752/BRB/10/685/2009 (to K. M.), and BT/PR5145/MED/29/470/2012 (to R. K., K. M., and S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu Irqeba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087306; Ben-Ami R, 2011, J INFECT DIS, V204, P626, DOI 10.1093/infdis/jir351; Borah S, 2014, ANTIMICROB AGENTS CH, V58, P5976, DOI 10.1128/AAC.02786-14; Borah S, 2011, J BIOL CHEM, V286, P34311, DOI 10.1074/jbc.M111.264671; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Castano I, 2005, MOL MICROBIOL, V55, P1246, DOI 10.1111/j.1365-2958.2004.04465.x; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; Cormack BP, 1999, GENETICS, V151, P979; D'Ambrosio LM, 2014, CURR BIOL, V24, P361, DOI 10.1016/j.cub.2013.12.038; Darst RP, 2008, MOL CELL BIOL, V28, P1361, DOI 10.1128/MCB.01291-07; de Groot PWJ, 2013, EUKARYOT CELL, V12, P470, DOI 10.1128/EC.00364-12; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hannan A, 2015, NUCLEIC ACIDS RES, V43, P10213, DOI 10.1093/nar/gkv842; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Harting R, 2013, MOL MICROBIOL, V90, P1125, DOI 10.1111/mmi.12421; Iraqui I, 2005, MOL MICROBIOL, V55, P1259, DOI 10.1111/j.1365-2958.2004.04475.x; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Klevay MJ, 2008, DIAGN MICR INFEC DIS, V60, P273, DOI 10.1016/j.diagmicrobio.2007.10.001; Leach MD, 2011, MOL BIOL CELL, V22, P687, DOI 10.1091/mbc.E10-07-0632; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Montagna MT, 2014, EUR REV MED PHARMACO, V18, P661; Moran C, 2010, AM J INFECT CONTROL, V38, P78, DOI 10.1016/j.ajic.2009.06.014; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Pasupala N, 2012, EUKARYOT CELL, V11, P452, DOI 10.1128/EC.05243-11; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3; Sydorskyy Y, 2010, MOL CELL BIOL, V30, P4452, DOI 10.1128/MCB.00335-10; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Takahashi Y, 2008, CELL CYCLE, V7, P1738, DOI 10.4161/cc.7.12.6156; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	58	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19573	19589		10.1074/jbc.M115.706044	http://dx.doi.org/10.1074/jbc.M115.706044			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27382059	Green Published, hybrid			2022-12-28	WOS:000383242800032
J	Fresco, VM; Kern, CB; Mohammadi, M; Twal, WO				Fresco, Victor M.; Kern, Christine B.; Mohammadi, Moosa; Twal, Waleed O.			Fibulin-1 Binds to Fibroblast Growth Factor 8 with High Affinity EFFECTS ON EMBRYO SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL NEURAL CREST; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; CELL-MIGRATION; FGF8; FIBRONECTIN; MORPHOGENESIS; EXPRESSION; DELETION; SITES	Fibulin-1 (FBLN1) is a member of a growing family of extracellular matrix glycoproteins that includes eight members and is involved in cellular functions such as adhesion, migration, and differentiation. FBLN1 has also been implicated in embryonic heart and valve development and in the formation of neural crest derived structures, including aortic arch, thymus, and cranial nerves. Fibroblast growth factor 8 (FGF8) is a member of a large family of growth factors, and its functions include neural crest cell (NCC) maintenance, specifically NCC migration as well as patterning of structures formed from NCC such as outflow tract and cranial nerves. In this report, we sought to investigate whether FBLN1 and FGF8 have cooperative roles in vivo given their influence on the development of the same NCC-derived structures. Surface plasmon resonance binding data showed that FBLN1 binds tightly to FGF8 and prevents its enzymatic degradation by ADAM17. Moreover, overexpression of FBLN1 up-regulates FGF8 gene expression, and down-regulation of FBLN1 by siRNA inhibits FGF8 expression. The generation of a double mutant Fbln1 and mice (Fbln1(-/-) and Fgf8(-/-)) showed that haplo-insufficiency (Fbln1(+/-) and Ffg8(+/-)) resulted in increased embryonic mortality compared with single heterozygote crosses. The mortality of the FGF8/Fbln1 double heterozygote embryos occurred between 14.5 and 16.5 days post-coitus. In conclusion, FBLN1/FGF8 interaction plays a role in survival of vertebrate embryos, and reduced levels of both proteins resulted in added mortality in utero. The FBLN1/FGF8 interaction may also be involved in the survival of neural crest cell population during development.	[Twal, Waleed O.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave,MSC 508, Charleston, SC 29425 USA; [Mohammadi, Moosa] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	Medical University of South Carolina; New York University	Twal, WO (corresponding author), Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave,MSC 508, Charleston, SC 29425 USA.	twalwo@musc.edu	kasaei, fahime/T-7197-2018	Twal, Waleed/0000-0002-2888-4544; Kern, Christine/0000-0001-7955-8979; Mohammadi, Moosa/0000-0003-2434-9437	National Institutes of Health from NHLBI [R01 HL09506, P01 HL52813]; NIGMS [P30 GM103342]; National Institutes of Health [HL121382]; NIDCR [R01 DE-13686]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121382, F32HL009506, P01HL052813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 HL09506 and P01 HL52813 from NHLBI and Grant P30 GM103342 from NIGMS (to South Carolina COBRE for Developmentally Based Cardiovascular Diseases). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant HL121382.r Supported by NIDCR Grant R01 DE-13686.	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155; BALBONA K, 1992, J BIOL CHEM, V267, P20120; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; BOCKMAN DE, 1989, ANAT RECORD, V225, P209, DOI 10.1002/ar.1092250306; Castoldi M, 2002, BIOCHEM J, V362, P41, DOI 10.1042/0264-6021:3620041; Cooley MA, 2008, DEV BIOL, V319, P336, DOI 10.1016/j.ydbio.2008.04.029; Cooley MA, 2011, BIOL EXTRACELL MATR, P337, DOI 10.1007/978-3-642-16555-9_10; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Farley AM, 2013, DEVELOPMENT, V140, P2015, DOI 10.1242/dev.087320; Frank DU, 2002, DEVELOPMENT, V129, P4591; Ghosh AK, 1996, CELL GROWTH DIFFER, V7, P1425; Goh KL, 1997, DEVELOPMENT, V124, P4309; GREENBERG JH, 1981, DEV BIOL, V87, P259, DOI 10.1016/0012-1606(81)90149-4; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kubota Y, 2004, CURR BIOL, V14, P2011, DOI 10.1016/j.cub.2004.10.047; Lee NV, 2005, J BIOL CHEM, V280, P34796, DOI 10.1074/jbc.M506980200; LORENZI MV, 1995, ONCOGENE, V10, P2051; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Mittal A, 2013, DEV BIOL, V381, P73, DOI 10.1016/j.ydbio.2013.06.010; Moon AM, 2006, DEV CELL, V10, P71, DOI 10.1016/j.devcel.2005.12.003; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Pan Y, 2014, MATRIX BIOL, V35, P253, DOI 10.1016/j.matbio.2013.10.013; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Pietri T, 2004, DEVELOPMENT, V131, P3871, DOI 10.1242/dev.01264; ROVASIO RA, 1983, J CELL BIOL, V96, P462, DOI 10.1083/jcb.96.2.462; Sato A, 2011, DEV BIOL, V354, P18, DOI 10.1016/j.ydbio.2011.03.010; SPENCE SG, 1992, DEV BIOL, V151, P473, DOI 10.1016/0012-1606(92)90186-K; Tran H, 1997, MATRIX BIOL, V15, P479, DOI 10.1016/S0945-053X(97)90021-4; Tran H, 1997, J BIOL CHEM, V272, P22600, DOI 10.1074/jbc.272.36.22600; Twal WO, 2015, MATRIX BIOL, V43, P97, DOI 10.1016/j.matbio.2015.01.021; Twal WO, 2001, J CELL SCI, V114, P4587; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852; ZHANG HY, 1993, DIFFERENTIATION, V52, P211, DOI 10.1111/j.1432-0436.1993.tb00633.x; Zhang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136518; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	40	7	7	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18730	18739		10.1074/jbc.M115.702761	http://dx.doi.org/10.1074/jbc.M115.702761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402846	Green Published, hybrid			2022-12-28	WOS:000383242300011
J	Sullivan, LC; Berry, R; Sosnin, N; Widjaja, JML; Deuss, FA; Balaji, GR; LaGruta, NL; Mirams, M; Trapani, JA; Rossjohn, J; Brooks, AG; Andrews, DM				Sullivan, Lucy C.; Berry, Richard; Sosnin, Natasha; Widjaja, Jacqueline M. L.; Deuss, Felix A.; Balaji, Gautham R.; LaGruta, Nicole L.; Mirams, Michiko; Trapani, Joseph A.; Rossjohn, Jamie; Brooks, Andrew G.; Andrews, Daniel M.			Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; HLA-G; CRYSTAL-STRUCTURE; ANTIGEN PRESENTATION; NK CELLS; PEPTIDE CONFORMATION; STRUCTURAL BASIS; BINDING; EXPRESSION; CIS	Murine natural killer (NK) cells are regulated by the interaction of Ly49 receptors with major histocompatibility complex class I molecules (MHC-I). Although the ligands for inhibitory Ly49 were considered to be restricted to classical MHC (MHC-La), we have shown that the non-classical MHC molecule (MHC-Ib) H2-M3 was a ligand for the inhibitory Ly49A. Here we establish that another MHC-Ib, H2-Q10, is a bona fide ligand for the inhibitory Ly49C receptor. H2-Q10 bound to Ly49C with a marginally lower affinity (similar to-5 mu m) than that observed between Ly49C and MHC-Ia (H-2K(b)/H-2D(d), both similar to 1 mu m), and this recognition could be prevented by cis interactions with H-2K in situ. To understand the molecular details underpinning Ly49. MHC-Ib recognition, we determined the crystal structures of H2-Q10 and Ly49C bound H2-Q10. Unliganded H2-Q10 adopted a classical MHC-I fold and possessed a peptide-binding groove that exhibited features similar to those found in MHC-Ia, explaining the diverse peptide binding repertoire of H2-Q10. Ly49C bound to H2-Q10 underneath the peptide binding platform to a region that encompassed residues from the alpha 1, alpha 2, and alpha 3 domains, as well as the associated beta 2-microglobulin subunit. This docking mode was conserved with that previously observed for Ly490H-2K(b). Indeed, structure-guided mutation of Ly49C indicated that Ly49C center dot H2-Q10 and Ly49C center dot H-2K(b) possess similar energetic footprints focused around residues located within the Ly49C beta 4-stand and L5 loop, which contact the underside of the peptide-binding platform floor. Our data provide a structural basis for Ly49 center dot MHC-Ib recognition and demonstrate that MHC-Ib represent an extended family of ligands for Ly49 molecules.	[Sullivan, Lucy C.; Widjaja, Jacqueline M. L.; LaGruta, Nicole L.; Mirams, Michiko; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Berry, Richard; Deuss, Felix A.; Balaji, Gautham R.; LaGruta, Nicole L.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Berry, Richard; Deuss, Felix A.; Balaji, Gautham R.; LaGruta, Nicole L.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Berry, Richard; Deuss, Felix A.; Balaji, Gautham R.; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Sosnin, Natasha; Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Cell Death Lab, East Melbourne, Vic 3000, Australia; [Trapani, Joseph A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Andrews, Daniel M.] Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic 3004, Australia	University of Melbourne; Monash University; Monash University; Monash University; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Cardiff University; Monash University	Brooks, AG (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Andrews, DM (corresponding author), Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Burnet Inst, Level 6,89 Commercial Rd, Melbourne, Vic 3004, Australia.	jamie.rossjohn@monash.edu; agbrooks@unimelb.edu.au; dan.andrews@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Trapani, Joseph/0000-0003-0983-1532; Sosnin, Natasha/0000-0003-0481-3386; Deuss, Felix/0000-0002-0386-4336; Balaji, Gautham/0000-0002-7436-4689; Sullivan, Lucy/0000-0003-2907-4989; Brooks, Andrew/0000-0002-4085-9683; Andrews, Dan/0000-0002-5896-7885; berry, richard/0000-0001-7043-0469; La Gruta, Nicole/0000-0001-5358-9363	National Health and Medical Research Council (NHMRC); Sylvia and Charles Viertel Charitable Foundation; NHMRC Australia	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Charitable Foundation; NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) Career Development Awards (to L. C. S., R. B, and D. M. A.), the Sylvia and Charles Viertel Charitable Foundation (to N. L L), and by an NHMRC Australia Fellowship (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews DM, 2012, NAT IMMUNOL, V13, P1171, DOI 10.1038/ni.2468; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; Bessoles S, 2013, J IMMUNOL, V191, P5044, DOI 10.4049/jimmunol.1301971; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; COSMAN D, 1982, P NATL ACAD SCI-BIOL, V79, P4947, DOI 10.1073/pnas.79.16.4947; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Dimasi N, 2005, IMMUNOL CELL BIOL, V83, P1, DOI 10.1111/j.1440-1711.2005.01301.x; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; He XL, 2001, STRUCTURE, V9, P1213, DOI 10.1016/S0969-2126(01)00689-X; Hoare HL, 2008, J MOL BIOL, V377, P1297, DOI 10.1016/j.jmb.2008.01.098; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Ishitani A, 2003, J IMMUNOL, V171, P1376, DOI 10.4049/jimmunol.171.3.1376; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KIM S., 2008, P WORLD C ENG 2008 W, V1, P1, DOI DOI 10.1109/IEDM.2008.4796617; Kowiel M, 2014, ACTA CRYSTALLOGR D, V70, P3290, DOI 10.1107/S1399004714024572; KRESS M, 1983, CELL, V34, P189, DOI 10.1016/0092-8674(83)90149-6; LEE N, 1995, IMMUNITY, V3, P591, DOI 10.1016/1074-7613(95)90130-2; LeMaoult J, 2003, TISSUE ANTIGENS, V62, P273, DOI 10.1034/j.1399-0039.2003.00143.x; LEW AM, 1986, J IMMUNOL, V136, P254; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Morandi F, 2011, BLOOD, V118, P5840, DOI 10.1182/blood-2011-05-352393; Morandi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011763; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Rajagopalan S, 2014, CELL MOL IMMUNOL, V11, P460, DOI 10.1038/cmi.2014.53; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Takada T, 2003, GENOME RES, V13, P589, DOI 10.1101/gr.975303; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Zappacosta F, 2000, J IMMUNOL, V164, P1906, DOI 10.4049/jimmunol.164.4.1906	42	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18740	18752		10.1074/jbc.M116.737130	http://dx.doi.org/10.1074/jbc.M116.737130			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27385590	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000383242300012
J	Li, MH; Leng, TD; Feng, XC; Yang, T; Simon, RP; Xiong, ZG				Li, Ming-Hua; Leng, Tian-Dong; Feng, Xue-Chao; Yang, Tao; Simon, Roger P.; Xiong, Zhi-Gang			Modulation of Acid-sensing Ion Channel 1a by Intracellular pH and Its Role in Ischemic Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acid sensing ion channel (ASIC); brain; electrophysiology; ischemia; patch clamp	FOCAL CEREBRAL-ISCHEMIA; HIPPOCAMPAL-NEURONS; THERAPEUTIC TARGETS; CATION CHANNELS; ACTIVATED CURRENTS; TRANSIENT ISCHEMIA; EXTRACELLULAR PH; NERVOUS-SYSTEM; BRAIN-INJURY; RAT-BRAIN	An important contributor to brain ischemia is known to be extracellular acidosis, which activates acid-sensing ion channels (ASICs), a family of proton-gated sodium channels. Lines of evidence suggest that targeting ASICs may lead to novel therapeutic strategies for stroke. Investigations of the role of ASICs in ischemic brain injury have naturally focused on the role of extracellular pH in ASIC activation. By contrast, intracellular pH (pH(i)) has received little attention. This is a significant gap in our understanding because the ASIC response to extracellular pH is modulated by pH(i), and activation of ASICs by extracellular protons is paradoxically enhanced by intracellular alkalosis. Our previous studies show that acidosis-induced cell injury in in vitro models is attenuated by intracellular acidification. However, whether pH(i) affects ischemic brain injury in vivo is completely unknown. Furthermore, whereas ASICs in native neurons are composed of different subunits characterized by distinct electrophysiological/pharmacological properties, the subunit-dependent modulation of ASIC activity by pH(i) has not been investigated. Using a combination of in vitro and in vivo ischemic brain injury models, electrophysiological, biochemical, and molecular biological approaches, we show that the intracellular alkalizing agent quinine potentiates, whereas the intracellular acidifying agent propionate inhibits, oxygen-glucose deprivation-induced cell injury in vitro and brain ischemia-induced infarct volume in vivo. Moreover, we find that the potentiation of ASICs by quinine depends on the presence of the ASIC1a, ASIC2a subunits, but not ASIC1b, ASIC3 subunits. Furthermore, we have determined the amino acids in ASIC1a that are involved in the modulation of ASICs by pH(i).	[Li, Ming-Hua] Oregon Hlth & Sci Univ, Dept Neurol Surg, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Leng, Tian-Dong; Yang, Tao; Simon, Roger P.; Xiong, Zhi-Gang] Morehouse Sch Med, Dept Neurobiol, Inst Neurosci, Atlanta, GA 30310 USA; [Feng, Xue-Chao] Northeast Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun 130000, Peoples R China	Oregon Health & Science University; Morehouse School of Medicine; Northeast Normal University - China	Li, MH (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol Surg, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Xiong, ZG (corresponding author), Morehouse Sch Med, Dept Neurobiol, 720 Westview Dr SW, Atlanta, GA 30310 USA.	limin@ohsu.edu; zxiong@msm.edu		feng, xuechao/0000-0003-2444-3757	American Heart Association [13SDG14590005]; National Institutes of Health [R01NS066027, U54NS08932]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS083932, R01NS066027] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association Grant 13SDG14590005 (to M. H. L.) and National Institutes of Health Grants R01NS066027 and U54NS08932 (to Z. G. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.3.CO;2-#; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Benveniste M, 2005, NEW ENGL J MED, V352, P85, DOI 10.1056/NEJMcibr045010; BLOMQVIST P, 1982, ACTA PHYSIOL SCAND, V116, P103, DOI 10.1111/j.1748-1716.1982.tb10606.x; Bonnet U, 2000, NEUROPHARMACOLOGY, V39, P2067, DOI 10.1016/S0028-3908(00)00033-2; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; BUSA WB, 1984, AM J PHYSIOL, V246, pR409, DOI 10.1152/ajpregu.1984.246.4.R409; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHESLER M, 1990, PROG NEUROBIOL, V34, P401, DOI 10.1016/0301-0082(90)90034-E; CHOPP M, 1990, J CEREBR BLOOD F MET, V10, P860, DOI 10.1038/jcbfm.1990.142; Chu XP, 2012, CURR DRUG TARGETS, V13, P263, DOI 10.2174/138945012799201685; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Chu XP, 2003, J PHYSIOL-LONDON, V550, P385, DOI 10.1113/jphysiol.2003.043091; Collins A, 2005, J CELL PHYSIOL, V202, P76, DOI 10.1002/jcp.20093; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; DEITMER JW, 1980, J PHYSIOL-LONDON, V304, P471, DOI 10.1113/jphysiol.1980.sp013337; Dixon DB, 1996, VISION RES, V36, P3925, DOI 10.1016/S0042-6989(96)00129-0; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Joeres N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27647; Johnson MB, 2001, J CEREBR BLOOD F MET, V21, P734, DOI 10.1097/00004647-200106000-00011; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; KATSURA K, 1991, J CEREBR BLOOD F MET, V11, P597, DOI 10.1038/jcbfm.1991.109; KATSURA K, 1992, EUR J NEUROSCI, V4, P166, DOI 10.1111/j.1460-9568.1992.tb00863.x; Krauson AJ, 2016, J BIOL CHEM, V291, P11407, DOI 10.1074/jbc.M115.702316; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Krishtal O, 2015, NEUROPHARMACOLOGY, V94, P4, DOI 10.1016/j.neuropharm.2014.12.014; Kweon HJ, 2013, BMB REP, V46, P295, DOI 10.5483/BMBRep.2013.46.6.121; LAMANNA JC, 1992, CAN J PHYSIOL PHARM, V70, pS269, DOI 10.1139/y92-272; Leng TD, 2014, PROG NEUROBIOL, V115, P189, DOI 10.1016/j.pneurobio.2013.12.008; Li MH, 2015, J PHYSIOL-LONDON, V593, P217, DOI 10.1113/jphysiol.2014.275701; Li MH, 2010, J PHYSIOL-LONDON, V588, P3883, DOI 10.1113/jphysiol.2010.192922; MABE H, 1983, J CEREBR BLOOD F MET, V3, P109, DOI 10.1038/jcbfm.1983.13; MacLean DM, 2016, J PHYSIOL-LONDON, V594, P2629, DOI 10.1113/JP271915; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; Svichar N, 2011, J NEUROSCI, V31, P6997, DOI 10.1523/JNEUROSCI.6088-10.2011; TOMBAUGH GC, 1990, J CEREBR BLOOD F MET, V10, P527, DOI 10.1038/jcbfm.1990.94; Ugawa S, 2003, J NEUROSCI, V23, P3616; VONHANWEHR R, 1986, J NEUROCHEM, V46, P331; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Xiong ZG, 2007, FRONT BIOSCI-LANDMRK, V12, P1376, DOI 10.2741/2154; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	69	27	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18370	18383		10.1074/jbc.M115.713636	http://dx.doi.org/10.1074/jbc.M115.713636			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402850	hybrid, Green Published			2022-12-28	WOS:000383241800028
J	Morozova, K; Clement, CC; Kaushik, S; Stiller, B; Arias, E; Ahmad, A; Rauch, JN; Chatterjee, V; Melis, C; Scharf, B; Gestwicki, JE; Cuervo, AM; Zuiderweg, ERP; Santambrogio, L				Morozova, Kateryna; Clement, Cristina C.; Kaushik, Susmita; Stiller, Barbara; Arias, Esperanza; Ahmad, Atta; Rauch, Jennifer N.; Chatterjee, Victor; Melis, Chiara; Scharf, Brian; Gestwicki, Jason E.; Cuervo, Ana-Maria; Zuiderweg, Erik R. P.; Santambrogio, Laura			Structural and Biological Interaction of hsc-70 Protein with Phosphatidylserine in Endosomal Microautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); autophagy; chaperone; endosome; phosphatidylserine	MOLECULAR CHAPERONE DNAK; E3 UBIQUITIN LIGASE; HEAT-SHOCK-PROTEIN-70 HSP70; SUBSTRATE-BINDING; HSC70; COMPLEX; ATP; DOMAIN; MEMBRANES; BILAYERS	hsc-70 (HSPA8) is a cytosolic molecular chaperone, which plays a central role in cellular proteostasis, including quality control during protein refolding and regulation of protein degradation. hsc-70 is pivotal to the process of macroautophagy, chaperone-mediated autophagy, and endosomal microautophagy. The latter requires hsc-70 interaction with negatively charged phosphatidylserine (PS) at the endosomal limiting membrane. Herein, by combining plasmon resonance, NMR spectroscopy, and amino acid mutagenesis, we mapped the C terminus of the hsc-70 LID domain as the structural interface interacting with endosomal PS, and we estimated an hsc-70/PS equilibrium dissociation constant of 4.7 +/- 0.1 m. This interaction is specific and involves a total of 4-5 lysine residues. Plasmon resonance and NMR results were further experimentally validated by hsc-70 endosomal binding experiments and endosomal microautophagy assays. The discovery of this previously unknown contact surface for hsc-70 in this work elucidates the mechanism of hsc-70 PS/membrane interaction for cytosolic cargo internalization into endosomes.	[Morozova, Kateryna; Clement, Cristina C.; Chatterjee, Victor; Melis, Chiara; Scharf, Brian; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Kaushik, Susmita; Stiller, Barbara; Arias, Esperanza; Cuervo, Ana-Maria] Albert Einstein Coll Med, Dept Dev Mol Biol, New York, NY 10461 USA; [Ahmad, Atta; Zuiderweg, Erik R. P.] Univ Michigan, Dept Biol Chem, Sch Med, 1500 Med Ctr Dr, Ann Arbor, MI 48105 USA; [Rauch, Jennifer N.; Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Santambrogio, L (corresponding author), Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Zuiderweg, ERP (corresponding author), Univ Michigan, Dept Biol Chem, Sch Med, 1500 Med Ctr Dr, Ann Arbor, MI 48105 USA.	zuiderwe@umich.edu; laura.santambrogio@einstein.yu.edu	Kaushik, Susmita/GVS-3186-2022; Clement, Cristina/ABG-4525-2021; Rauch, Jennifer/AGI-2683-2022	Kaushik, Susmita/0000-0002-6096-5387; Clement, Cristina/0000-0003-1464-407X; Rauch, Jennifer/0000-0001-6853-5915; Cuervo, Ana Maria/0000-0002-0771-700X; Arias, Esperanza/0000-0002-7836-5072	National Institutes of Health [AG045223, AG031782, NS059690]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045223, P30AG038072, P01AG031782, R37AG021904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG045223 (to L. S.), AG031782 (to A. M. C. and L. S.), NS059690 (to E. R. P. Z. and J. E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Arispe N, 2000, J BIOL CHEM, V275, P30839, DOI 10.1074/jbc.M005226200; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; BenTal N, 1996, BIOPHYS J, V70, P1803, DOI 10.1016/S0006-3495(96)79744-8; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Garimella R, 2006, BIOCHEMISTRY-US, V45, P6917, DOI 10.1021/bi060411d; Guan JY, 2014, CHEMBIOCHEM, V15, P556, DOI 10.1002/cbic.201300623; Heimburg T, 1996, BIOPHYS J, V70, P84, DOI 10.1016/S0006-3495(96)79551-6; Horobin RW, 2002, BIOTECH HISTOCHEM, V77, P3; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Mahalka AK, 2014, BBA-BIOMEMBRANES, V1838, P1344, DOI 10.1016/j.bbamem.2014.01.022; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; MORSHAUSER RC, 1995, BIOCHEMISTRY-US, V34, P6261, DOI 10.1021/bi00019a001; Mukherjee A., 2016, AUTOPHAGY; Orenstein SJ, 2010, SEMIN CELL DEV BIOL, V21, P719, DOI 10.1016/j.semcdb.2010.02.005; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Uytterhoeven V, 2015, NEURON, V88, P735, DOI 10.1016/j.neuron.2015.10.012; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	39	37	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18096	18106		10.1074/jbc.M116.736744	http://dx.doi.org/10.1074/jbc.M116.736744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405763	Green Published, hybrid			2022-12-28	WOS:000383241800004
J	Silversmith, RE; Wang, BY; Fulcher, NB; Wolfgang, MC; Bourret, RB				Silversmith, Ruth E.; Wang, Boya; Fulcher, Nanette B.; Wolfgang, Matthew C.; Bourret, Robert B.			Phosphoryl Group Flow within the Pseudomonas aeruginosa Pil-Chp Chemosensory System: DIFFERENTIAL FUNCTION OF THE EIGHT PHOSPHOTRANSFERASE AND THREE RECEIVER DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; chemotaxis; histidine kinase; phosphoryl transfer; Pseudomonas aeruginosa (P; aeruginosa); type IV pili	SIGNAL-TRANSDUCTION SYSTEM; TWITCHING MOTILITY; RESPONSE REGULATOR; IV PILI; CRYSTAL-STRUCTURE; HISTIDINE; CHEMOTAXIS; CHEA; PATHWAYS; CYCLASE	Bacterial chemosensory signal transduction systems that regulate motility by type IV pili (T4P) can be markedly more complex than related flagellum-based chemotaxis systems. In T4P-based systems, the CheA kinase often contains numerous potential sites of phosphorylation, but the signaling mechanisms of these systems are unknown. In Pseudomonas aeruginosa, the Pil-Chp system regulates T4P-mediated twitching motility and cAMP levels, both of which play roles in pathogenesis. The Pil-Chp histidine kinase (ChpA) has eight Xpt domains; six are canonical histidine-containing phosphotransfer (Hpt) domains and two have a threonine (Tpt) or serine (Spt) in place of the histidine. Additionally, there are two stand-alone receiver domains (PilG and PilH) and a ChpA C-terminal receiver domain (ChpArec). Here, we demonstrate that the ChpA Xpts are functionally divided into three categories as follows: (i) those phosphorylated with ATP (Hpt4-6); (ii) those reversibly phosphorylated by ChpArec (Hpt2-6), and (iii) those with no detectable phosphorylation (Hpt1, Spt, and Tpt). There was rapid phosphotransfer from Hpt2-6 to ChpArec and from Hpt3 to PilH, whereas transfer to PilG was slower. ChpArec also had a rapid rate of autodephosphorylation. The biochemical results together with in vivo cAMP and twitching phenotypes of key ChpA phosphorylation site point mutants supported a scheme whereby ChpArec functions both as a phosphate sink and a phosphotransfer element linking Hpt4-6 to Hpt2-3. Hpt2 and Hpt3 are likely the dominant sources of phosphoryl groups for PilG and PilH, respectively. The data are synthesized in a signaling circuit that contains fundamental features of two-component phosphorelays.	[Silversmith, Ruth E.; Wolfgang, Matthew C.; Bourret, Robert B.] Univ N Carolina, Dept Microbiol & Immunol, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Wang, Boya; Fulcher, Nanette B.; Wolfgang, Matthew C.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Silversmith, RE (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA.	silversr@med.unc.edu	Bourret, Robert/X-3606-2019	Bourret, Robert/0000-0002-6666-9220	National Institutes of Health [R01GM050860, AI069116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM050860 (to R. B. B.) and AI069116 (to M. C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansaldi M, 2001, J BACTERIOL, V183, P2691, DOI 10.1128/JB.183.8.2691-2695.2001; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000306; Bertrand JJ, 2010, J BACTERIOL, V192, P994, DOI 10.1128/JB.01390-09; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P113, DOI 10.1016/j.mib.2010.02.003; Bourret RB, 2010, METHOD ENZYMOL, V471, P89, DOI 10.1016/S0076-6879(10)71006-5; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Csikasz-Nagy A, 2011, J R SOC INTERFACE, V8, P480, DOI 10.1098/rsif.2010.0336; DARZINS A, 1994, MOL MICROBIOL, V11, P137, DOI 10.1111/j.1365-2958.1994.tb00296.x; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Fassler JS, 2013, EUKARYOT CELL, V12, P1052, DOI 10.1128/EC.00083-13; Fulcher NB, 2010, MOL MICROBIOL, V76, P889, DOI 10.1111/j.1365-2958.2010.07135.x; Garzon A, 1996, J BACTERIOL, V178, P6752, DOI 10.1128/jb.178.23.6752-6758.1996; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; Hahn HP, 1997, GENE, V192, P99, DOI 10.1016/S0378-1119(97)00116-9; Inclan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015867; Janiak-Spens F, 2000, MOL MICROBIOL, V37, P136, DOI 10.1046/j.1365-2958.2000.01973.x; Jimenez-Pearson MA, 2005, MICROBIOL-SGM, V151, P3299, DOI 10.1099/mic.0.28217-0; Jin F, 2011, P NATL ACAD SCI USA, V108, P12617, DOI 10.1073/pnas.1105073108; Kim JR, 2006, COMPUT BIOL CHEM, V30, P438, DOI 10.1016/j.compbiolchem.2006.09.004; Kirby JR, 2009, ANNU REV MICROBIOL, V63, P45, DOI 10.1146/annurev.micro.091208.073221; Knudsen M, 2012, J THEOR BIOL, V300, P7, DOI 10.1016/j.jtbi.2012.01.007; Kothamachu VB, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0234; Kothamachu VB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003322; Laub MT, 2007, METHOD ENZYMOL, V423, P531, DOI 10.1016/S0076-6879(07)23026-5; Leech AJ, 2006, J BACTERIOL, V188, P8479, DOI 10.1128/JB.00157-06; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mourey L, 2001, J BIOL CHEM, V276, P31074, DOI 10.1074/jbc.M101943200; Nishiyama S, 2014, J BACTERIOL, V196, P257, DOI 10.1128/JB.01167-13; Parkinson JS, 2015, TRENDS MICROBIOL, V23, P257, DOI 10.1016/j.tim.2015.03.003; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Quezada CM, 2005, J BIOL CHEM, V280, P30581, DOI 10.1074/jbc.M505316200; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Stewart RC, 2000, BIOCHEMISTRY-US, V39, P13157, DOI 10.1021/bi001100k; Topal H, 2012, J MOL BIOL, V416, P271, DOI 10.1016/j.jmb.2011.12.045; Varughese KI, 1998, MOL CELL, V2, P485, DOI 10.1016/S1097-2765(00)80148-3; Whitchurch CB, 2004, MOL MICROBIOL, V52, P873, DOI 10.1111/j.1365-2958.2004.04026.x; WHITCHURCH CB, 1991, GENE, V101, P33, DOI 10.1016/0378-1119(91)90221-V; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Xu QP, 1999, J MOL BIOL, V292, P1039, DOI 10.1006/jmbi.1999.3143; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	54	10	10	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17677	17691		10.1074/jbc.M116.737528	http://dx.doi.org/10.1074/jbc.M116.737528			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27354279	Green Published, hybrid			2022-12-28	WOS:000383241300018
J	Chang, CY; Chien, CI; Chang, CP; Lin, BC; Wang, CC				Chang, Chih-Yao; Chien, Chin-, I; Chang, Chia-Pei; Lin, Bo-Chun; Wang, Chien-Chia			A WHEP Domain Regulates the Dynamic Structure and Activity of Caenorhabditis elegans Glycyl-tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; THERMUS-THERMOPHILUS; GENE ENCODES; MITOCHONDRIAL; MUTATIONS; PROTEIN; TRANSLATION; DUPLICATION; DIVERGENCE; EXPRESSION	WHEP domains exist in certain eukaryotic aminoacyl-tRNA synthetases and play roles in tRNA or protein binding. We present evidence herein that cytoplasmic and mitochondrial forms of Caenorhabditis elegans glycyl-tRNA synthetase (CeGlyRS) are encoded by the same gene (CeGRS1) through alternative initiation of translation. The cytoplasmic form possessed an N-terminal WHEP domain, whereas its mitochondrial isoform possessed an extra N-terminal sequence consisting of an mitochondrial targeting signal and an appended domain. Cross-species complementation assays showed that CeGRS1 effectively rescued the cytoplasmic and mitochondrial defects of a yeast GRS1 knock-out strain. Although both forms of CeGlyRS efficiently charged the cytoplasmic tRNAs(Gly) of C. elegans, the mitochondrial form was much more efficient than its cytoplasmic counterpart in charging the mitochondrial tRNA(Gly) isoacceptor, which carries a defective T psi C hairpin. Despite the WHEP domain per se lacking tRNA binding activity, deletion of this domain reduced the catalytic efficiency of the enzyme. Most interestingly, the deletion mutant possessed a higher thermal stability and a somewhat lower structural flexibility. Our study suggests a role for the WHEP domain as a regulator of the dynamic structure and activity of the enzyme.	[Chang, Chih-Yao; Chien, Chin-, I; Chang, Chia-Pei; Lin, Bo-Chun; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Taoyuan 32001, Taiwan	National Central University	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan 32001, Taiwan.	dukewang@cc.ncu.edu.tw		Wang, Chien-Chia/0000-0002-7104-1307	Ministry of Science and Technology [MOST 103-2311-B-008-003-MY3, MOST 103-2923-B-008-001-MY3, NSC 102-2311-B-008-004-MY3]; National Central University; Landseed Hospital Joint Research Program Grant [NCU-LSH-103-A-003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Central University; Landseed Hospital Joint Research Program Grant	This work was supported by Ministry of Science and Technology Grants MOST 103-2311-B-008-003-MY3, MOST 103-2923-B-008-001-MY3, and NSC 102-2311-B-008-004-MY3 (to C.-C. W.) and National Central University and Landseed Hospital Joint Research Program Grant NCU-LSH-103-A-003 (to C.-C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang CP, 2015, MOL CELL BIOL, V35, P2242, DOI 10.1128/MCB.00018-15; Chang CP, 2012, NUCLEIC ACIDS RES, V40, P314, DOI 10.1093/nar/gkr724; Chang Chia-Pei, 2008, J Biol Chem, V283, P30699, DOI 10.1074/jbc.M805339200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Chien CI, 2015, FUNGAL GENET BIOL, V76, P47, DOI 10.1016/j.fgb.2015.02.004; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Giege R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187; Grice SJ, 2015, HUM MOL GENET, V24, P4397, DOI 10.1093/hmg/ddv176; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108; Huang HY, 2006, MOL MICROBIOL, V60, P189, DOI 10.1111/j.1365-2958.2006.05083.x; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Krajewski KM, 2000, BRAIN, V123, P1516, DOI 10.1093/brain/123.7.1516; Ladror US, 1998, PROTEIN SCI, V7, P2595, DOI 10.1002/pro.5560071213; Liao CC, 2012, NUCLEIC ACIDS RES, V40, P9171, DOI 10.1093/nar/gks689; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; Mazauric MH, 1998, EUR J BIOCHEM, V251, P744, DOI 10.1046/j.1432-1327.1998.2510744.x; Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001; NADA S, 1993, J BIOL CHEM, V268, P7660; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; OSTREM DL, 1970, P NATL ACAD SCI USA, V67, P1967, DOI 10.1073/pnas.67.4.1967; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Sakurai M, 2005, NUCLEIC ACIDS RES, V33, P1653, DOI 10.1093/nar/gki309; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Turner RJ, 2000, J BIOL CHEM, V275, P27681	35	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16567	16575		10.1074/jbc.M116.730812	http://dx.doi.org/10.1074/jbc.M116.730812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27298321	Green Published, hybrid			2022-12-28	WOS:000380826700016
J	Katorcha, E; Srivastava, S; Klimova, N; Baskakov, IV				Katorcha, Elizaveta; Srivastava, Saurabh; Klimova, Nina; Baskakov, Ilia V.			Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain; glycosylphosphatidylinositol (GPI anchor); prion; prion disease; sialic acid; myotube; sialylation; spleen	TRANSMISSIBLE MINK ENCEPHALOPATHY; FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; SIALYLTRANSFERASE ACTIVITY; SIALIC-ACID; ECTO-SIALYLTRANSFERASE; INTERCELLULAR TRANSFER; MASS-SPECTROMETRY; LYMPHOID-TISSUES; PROTEIN	Prions or PrPSc are proteinaceous infectious agents that consist of misfolded, self-replicating states of the prion protein or PrPC. PrPC is posttranslationally modified with N-linked glycans and a sialylated glycosylphosphatidylinositol (GPI) anchor. Conformational conversion of PrPC gives rise to glycosylated and GPI-anchored PrPSc. The question of the sialylation status of GPIs within PrPSc has been controversial. Previous studies that examined scrapie brains reported that both sialo- and asialo-GPIs were present in PrPSc, with the majority being asialo-GPIs. In contrast, recent work that employed cultured cells claimed that only PrPC with sialylo-GPIs could be recruited into PrPSc, whereas PrPC with asialo-GPIs inhibited conversion. To resolve this controversy, we analyzed the sialylation status of GPIs within PrPSc generated in the brain, spleen, or cultured N2a or C2C12 myotube cells. We found that recruiting PrPC with both sialo- and asialo-GPIs is a common feature of PrPSc. The mixtures of sialo- and asialo-GPIs were observed in PrPSc universally regardless of prion strain as well as host, tissue, or type of cells that produced PrPSc. Remarkably, the proportion of sialo- versus asialo-GPIs was found to be controlled by host, tissue, and cell type but not prion strain. In summary, this study found no strain-specific preferences for selecting PrPC with sialo- versus asialo-GPIs. Instead, this work suggests that the sialylation status of GPIs within PrPSc is regulated in a cell-, tissue-, or host-specific manner and is likely to be determined by the specifics of GPI biosynthesis.	[Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, 111 S Penn St, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, 111 S Penn St, Baltimore, MD 21201 USA.	baskakov@umaryland.edu	Srivastava, Saurabh/L-1188-2017	Srivastava, Saurabh/0000-0003-3159-7826	National Institutes of Health [R01 NS045585, R01 NS074998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074998, R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS045585 and R01 NS074998 (to I.V.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Baldwin MA, 2005, METHOD ENZYMOL, V405, P172, DOI 10.1016/S0076-6879(05)05008-1; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Bate C, 2012, J BIOL CHEM, V287, P7935, DOI 10.1074/jbc.M111.275743; Bate C, 2010, BIOCHEM J, V428, P95, DOI 10.1042/BJ20091469; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Breydo L, 2007, BIOCHEMISTRY-US, V46, P852, DOI 10.1021/bi061923v; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Crespo HJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00491; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Ferguson MAJ, 2009, ESSENTIALS GLYCOBIOL, V2nd, P143; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Gross HJ, 1996, BLOOD, V87, P5113, DOI 10.1182/blood.V87.12.5113.bloodjournal87125113; Cabral MG, 2010, IMMUNOL LETT, V131, P89, DOI 10.1016/j.imlet.2010.02.009; Guillerme-Bosselut F, 2009, GLYCOBIOLOGY, V19, P879, DOI 10.1093/glycob/cwp062; Guo BB, 2016, J BIOL CHEM, V291, P5128, DOI 10.1074/jbc.M115.684258; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Herbst A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003755; Jeffrey M, 2014, NEUROPATH APPL NEURO, V40, P296, DOI 10.1111/nan.12053; Katorcha E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143218; Katorcha E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16912; Katorcha E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004366; Kaufmann M, 1999, INT IMMUNOL, V11, P731, DOI 10.1093/intimm/11.5.731; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Klimova N, 2015, VIRUS RES, V207, P113, DOI 10.1016/j.virusres.2014.10.002; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Makarava N, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0248-5; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; McCulloch L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002402; Monaco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032382; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Morales R, 2016, SCI REP-UK, V6, DOI 10.1038/srep20526; Nasirikenari M, 2014, J BIOL CHEM, V289, P7178, DOI 10.1074/jbc.M113.508457; Noble GP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005017; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Pan T, 2001, J BIOL CHEM, V276, P37284, DOI 10.1074/jbc.M107358200; Patil SA, 2012, ANAL BIOCHEM, V425, P135, DOI 10.1016/j.ab.2012.03.009; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B, 2014, PRION, V8, P11, DOI 10.4161/pri.27892; Rifat S, 2008, J LEUKOCYTE BIOL, V84, P1075, DOI 10.1189/jlb.0706462; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Schwartz-Albiez R, 2004, GLYCOCONJUGATE J, V21, P451, DOI 10.1007/s10719-004-5535-5; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Srivastava S, 2015, P NATL ACAD SCI USA, V112, pE6654, DOI 10.1073/pnas.1517993112; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	77	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17009	17019		10.1074/jbc.M116.732040	http://dx.doi.org/10.1074/jbc.M116.732040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27317661	Green Published, hybrid			2022-12-28	WOS:000382643800008
J	Zhao, G; Liu, LP; Peek, RM; Hao, XS; Polk, DB; Li, H; Yan, F				Zhao, Gang; Liu, Liping; Peek, Richard M., Jr.; Hao, Xishan; Polk, D. Brent; Li, Hui; Yan, Fang			Activation of Epidermal Growth Factor Receptor in Macrophages Mediates Feedback Inhibition of M2 Polarization and Gastrointestinal Tumor Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor receptor (EGFR); epithelial-mesenchymal transition (EMT); gastric cancer; macrophage; tumor microenvironment; HB-EGF; M2 polarization; STAT6; colonic tumor	EGFR; PROMOTE; CANCER; COLON; ESTABLISHMENT; RESISTANCE; RESPONSES; ADENOMAS; INVASION; MUTATION	EGF receptor (EGFR) in tumor cells serves as a tumor promoter. However, information about EGFR activation in macrophages in regulating M2 polarization and tumor development is limited. This study aimed to investigate the effects of EGFR activation in macrophages on M2 polarization and development of gastrointestinal tumors. IL-4, a cytokine to elicit M2 polarization, stimulated release of an EGFR ligand, HB-EGF, and transactivation and down-regulation of EGFR in Raw 264.7 cells and peritoneal macrophages from WT mice. Knockdown of HB-EGF in macrophages inhibited EGFR transactivation by IL-4. IL-4-stimulated STAT6 activation, Arg1 and YM1 gene expression, and HB-EGF production were further enhanced by inhibition of EGFR activity in Raw 264.7 cells using an EGFR kinase inhibitor and in peritoneal macrophages from Egfr(wa5) mice with kinase inactive EGFR and by knockdown of EGFR in peritoneal macrophages from Egfr(fl/fl) LysM-Cre mice with myeloid cell-specific EGFR deletion. Chitin induced a higher level of M2 polarization in peritoneal macrophages in Egfr(fl/fl) LysM-Cre mice than that in Egfr(fl/fl) mice. Accordingly, IL-4-conditioned medium stimulated growth and epithelial-to-mesenchymal transition in gastric epithelial and colonic tumor cells, which were suppressed by that from Raw 264.7 cells with HB-EGF knockdown but promoted by that from Egfr(wa5) and Egfr(fl/fl) LysM-Cre peritoneal macrophages. Clinical assessment revealed that the number of macrophages with EGFR expression became less, indicating decreased inhibitory effects on M2 polarization, in late stage of human gastric cancers. Thus, IL-4-stimulated HB-EGF-dependent transactivation of EGFR in macrophages may mediate inhibitory feedback for M2 polarization and HB-EGF production, thereby inhibiting gastrointestinal tumor growth.	[Zhao, Gang; Liu, Liping; Yan, Fang] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA; [Zhao, Gang; Hao, Xishan; Li, Hui] Tianjin Canc Inst, Dept Gastrointestinal Canc Biol, Natl Clin Canc Res Ctr, Tianjin 300060, Peoples R China; [Zhao, Gang; Hao, Xishan; Li, Hui] Tianjin Med Univ, Canc Inst & Hosp, Huanhuxi Rd, Tianjin 300060, Peoples R China; [Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37232 USA; [Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Div Gastroenterol, Nashville, TN 37232 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Dept Biochem & Mol Biol, Los Angeles, CA 90027 USA; [Polk, D. Brent] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90027 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA	Vanderbilt University; Tianjin Medical University; Tianjin Medical University; Vanderbilt University; Vanderbilt University; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles	Li, H (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Huanhuxi Rd, Tianjin 300060, Peoples R China.; Polk, DB (corresponding author), Childrens Hosp Los Angeles, 4650 Sunset Blvd MS 126, Los Angeles, CA 90027 USA.; Yan, F (corresponding author), Vanderbilt Univ, Med Ctr, 2215 Garland Ave,MRB 4,Rm 1035, Nashville, TN 37232 USA.	dbpolk@chla.usc.edu; lihui@tjmuch.com; fang.yan@vanderbilt.edu	liu, li/HGC-0900-2022		National Institutes of Health [R01DK081134, R01DK56008, R01DK54993, P30DK058404]; National Natural Science Foundation of China [31471341]; NATIONAL CANCER INSTITUTE [R01CA077955, P01CA116087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054993, P30DK058404, R01DK081134, R01DK056008, R01DK058587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK081134 (to F. Y.) and R01DK56008 and R01DK54993 (to D. B. P.), and core services were performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404. This work was also supported by National Natural Science Foundation of China Grant 31471341 (to H. L.) The authors declare no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Alferez D, 2008, MOL CANCER THER, V7, P590, DOI 10.1158/1535-7163.MCT-07-0433; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bucci M, 2000, BRIT J PHARMACOL, V131, P13, DOI 10.1038/sj.bjp.0703549; Burova E, 2007, FEBS LETT, V581, P1475, DOI 10.1016/j.febslet.2007.03.002; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gao P, 2013, CARDIOVASC RES, V97, P533, DOI 10.1093/cvr/cvs369; Goel GA, 2011, AM J GASTROENTEROL, V106, P719, DOI 10.1038/ajg.2011.51; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Kawahara A, 2010, ONCOL REP, V24, P405, DOI 10.3892/or_00000873; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lu N, 2014, J IMMUNOL, V192, P1013, DOI 10.4049/jimmunol.1300133; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pander J, 2011, CLIN CANCER RES, V17, P5668, DOI 10.1158/1078-0432.CCR-11-0239; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rigo A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-273; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yamashita M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002581; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	46	18	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20462	20472		10.1074/jbc.M116.750182	http://dx.doi.org/10.1074/jbc.M116.750182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27507810	hybrid, Green Published			2022-12-28	WOS:000384574800014
J	Andrew, RJ; Kellett, KAB; Thinakaran, G; Hooper, NM				Andrew, Robert J.; Kellett, Katherine A. B.; Thinakaran, Gopal; Hooper, Nigel M.			A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						ADAM; Alzheimer disease; amyloid; amyloid precursor protein (APP); amyloid-beta (AB); beta-secretase 1 (BACE1); cathepsin B (CTSB); presenilin; protease; proteolysis; secretase; ADAM10	METALLOPROTEASE MEPRIN BETA; APP INTRACELLULAR DOMAIN; CLEAVING ENZYME 1(BACE1); RECEPTOR-RELATED PROTEIN; DISEASE MOUSE MODEL; A-BETA; GAMMA-SECRETASE; ALPHA-SECRETASE; TERMINAL FRAGMENT; CATHEPSIN-B	Proteolysis of the amyloid precursor protein (APP) liberates various fragments including the proposed initiator of Alzheimer disease-associated dysfunctions, amyloid-. However, recent evidence suggests that the accepted view of APP proteolysis by the canonical -, -, and -secretases is simplistic, with the discovery of a number of novel APP secretases (including - and -secretases, alternative -secretases) and additional metabolites, some of which may also cause synaptic dysfunction. Furthermore, various proteins have been identified that interact with APP and modulate its cleavage by the secretases. Here, we give an overview of the increasingly complex picture of APP proteolysis.	[Andrew, Robert J.; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Andrew, Robert J.; Thinakaran, Gopal] Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Andrew, Robert J.; Thinakaran, Gopal] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kellett, Katherine A. B.; Hooper, Nigel M.] Univ Manchester, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol, Manchester M13 9PT, Lancs, England	University of Chicago; University of Chicago; University of Chicago; University of Manchester	Andrew, RJ (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.; Andrew, RJ (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Andrew, RJ (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Hooper, NM (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol, Manchester M13 9PT, Lancs, England.	rjandrew@uchicago.edu; nigel.hooper@manchester.ac.uk		Hooper, Nigel/0000-0002-5811-3484; Kellett, Katherine/0000-0002-2802-0615	Alzheimer's Research UK [PhD2012-5]; Dr Donald Dean Fund in Dementia Research; University of Manchester; National Institutes of Health [AG019070, AG051230]; MRC [MR/L023784/1, MR/L023784/2] Funding Source: UKRI; Alzheimers Research UK [ART-PhD2009-1, ARUK-PhD2012-5] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R21AG051230, R01AG019070] Funding Source: NIH RePORTER	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Dr Donald Dean Fund in Dementia Research; University of Manchester; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Alzheimer's Research UK (PhD2012-5), the Dr Donald Dean Fund in Dementia Research, and the University of Manchester (to N. M. H.). This work was also supported by National Institutes of Health Grants AG019070 and AG051230 (to G. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Baranger K, 2016, CELL MOL LIFE SCI, V73, P217, DOI 10.1007/s00018-015-1992-1; Bayer TA, 2014, ACTA NEUROPATHOL, V127, P787, DOI 10.1007/s00401-014-1287-x; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Ben Halima S, 2016, CELL REP, V14, P2127, DOI 10.1016/j.celrep.2016.01.076; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Bittner T, 2009, J NEUROSCI, V29, P10405, DOI 10.1523/JNEUROSCI.2288-09.2009; Brodeur J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-31; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Chen AC, 2015, J CELL BIOL, V211, P1157, DOI 10.1083/jcb.201502001; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Cottrell BA, 2005, ANN NEUROL, V58, P277, DOI 10.1002/ana.20554; Dawkins E, 2014, J NEUROSCI RES, V92, P1478, DOI 10.1002/jnr.23422; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Deng Y, 2013, EUR J NEUROSCI, V37, P1962, DOI 10.1111/ejn.12235; Dobrowolska JA, 2014, J NEUROSCI, V34, P8336, DOI 10.1523/JNEUROSCI.0540-14.2014; Dulin F, 2008, FEBS LETT, V582, P1865, DOI 10.1016/j.febslet.2008.05.002; Endres K, 2014, NEUROLOGY, V83, P1930, DOI 10.1212/WNL.0000000000001017; Fol R, 2016, ACTA NEUROPATHOL, V131, P247, DOI 10.1007/s00401-015-1498-9; Fragkouli A, 2014, NEUROBIOL DIS, V70, P179, DOI 10.1016/j.nbd.2014.06.021; Freude KK, 2011, J BIOL CHEM, V286, P24264, DOI 10.1074/jbc.M111.227421; Frost JL, 2015, NEUROBIOL AGING, V36, P3187, DOI 10.1016/j.neurobiolaging.2015.08.021; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gautam V, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0028-5; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Giliberto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011609; GOWING E, 1994, J BIOL CHEM, V269, P10987; Gowrishankar S, 2015, P NATL ACAD SCI USA, V112, pE3699, DOI 10.1073/pnas.1510329112; Grimm MOW, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00077; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hernandez-Guillamon M, 2015, J BIOL CHEM, V290, P15078, DOI 10.1074/jbc.M114.610931; Hick M, 2015, ACTA NEUROPATHOL, V129, P21, DOI 10.1007/s00401-014-1368-x; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; Hook G, 2014, J ALZHEIMERS DIS, V41, P129, DOI 10.3233/JAD-131370; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Hosp F, 2015, CELL REP, V11, P1134, DOI 10.1016/j.celrep.2015.04.030; Inoue M, 2015, FEBS J, V282, P2587, DOI 10.1111/febs.13303; Jackle F, 2015, BIOCHEM J, V470, P91, DOI 10.1042/BJ20141417; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Kuan YH, 2006, J BIOL CHEM, V281, P40114, DOI 10.1074/jbc.M605407200; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2011, J ALZHEIMERS DIS, V27, P385, DOI 10.3233/JAD-2011-110785; Matsuda S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-41; Matsuda S, 2009, J BIOL CHEM, V284, P15815, DOI 10.1074/jbc.M109.006403; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Mecozzi VJ, 2014, NAT CHEM BIOL, V10, P443, DOI [10.1038/NCHEMBIO.1508, 10.1038/nchembio.1508]; Milosch N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.352; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Multhaup G, 2015, J BIOL CHEM, V290, P23515, DOI 10.1074/jbc.R115.677211; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nhan HS, 2015, ACTA NEUROPATHOL, V129, P1, DOI 10.1007/s00401-014-1347-2; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Olsen O, 2014, J NEUROSCI, V34, P6438, DOI 10.1523/JNEUROSCI.3522-13.2014; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Pasciuto E, 2015, NEURON, V87, P382, DOI 10.1016/j.neuron.2015.06.032; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Portelius E, 2015, NEURODEGENER DIS, V15, P50, DOI 10.1159/000369465; Portelius E, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0075-0; Portelius E, 2011, CURR PHARM DESIGN, V17, P2594, DOI 10.2174/138161211797416039; Portelius E, 2010, EXP NEUROL, V223, P351, DOI 10.1016/j.expneurol.2009.06.011; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Reitz C, 2011, ANN NEUROL, V69, P47, DOI 10.1002/ana.22308; Rice HC, 2013, BIOCHEMISTRY-US, V52, P3264, DOI 10.1021/bi400165f; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Simons M, 1996, J NEUROSCI, V16, P899; So Pauline Pl, 2012, Am J Neurodegener Dis, V1, P75; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tian YA, 2010, J BIOL CHEM, V285, P32549, DOI 10.1074/jbc.M110.128439; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Vella LJ, 2012, FASEB J, V26, P2930, DOI 10.1096/fj.11-200295; Wang JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9876; Welzel AT, 2014, BIOCHEMISTRY-US, V53, P3908, DOI 10.1021/bi5003053; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Zhang ZT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9762; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700; Zhou XD, 2011, FASEB J, V25, P3146, DOI 10.1096/fj.11-184325	100	114	116	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19235	19244		10.1074/jbc.R116.746032	http://dx.doi.org/10.1074/jbc.R116.746032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27474742	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000383242800003
J	Osman, D; Piergentili, C; Chen, JJ; Sayer, LN; Uson, I; Huggins, TG; Robinson, NJ; Pohl, E				Osman, Deenah; Piergentili, Cecilia; Chen, Junjun; Sayer, Lucy N.; Uson, Isabel; Huggins, Thomas G.; Robinson, Nigel J.; Pohl, Ehmke			The Effectors and Sensory Sites of Formaldehyde-responsive Regulator FrmR and Metal-sensing Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; Escherichia coli (E; coli); metal; Salmonella enterica; zinc; RcnR; CsoR; cobalt; formaldehyde; glutathione	S-FORMYLGLUTATHIONE HYDROLASE; ESCHERICHIA-COLI; MACROMOLECULAR CRYSTALLOGRAPHY; PARACOCCUS-DENITRIFICANS; DEHYDROGENASE-ACTIVITY; CRYSTAL-STRUCTURE; PROTEIN; SYSTEM; FAMILY; COPPER	The DUF156 family of DNA-binding transcriptional regulators includes metal sensors that respond to cobalt and/or nickel (RcnR, InrS) or copper (CsoR) plus CstR, which responds to persulfide, and formaldehyde-responsive FrmR. Unexpectedly, the allosteric mechanism of FrmR from Salmonella enterica serovar Typhimurium is triggered by metals in vitro, and variant FrmR(E64H) gains responsiveness to Zn(II) and cobalt in vivo. Here we establish that the allosteric mechanism of FrmR is triggered directly by formaldehyde in vitro. Sensitivity to formaldehyde requires a cysteine (Cys(35) in FrmR) conserved in all DUF156 proteins. A crystal structure of metal- and formaldehyde-sensing FrmR(E64H) reveals that an FrmR-specific amino-terminal Pro(2) is proximal to Cys(35), and these residues form the deduced formaldehyde-sensing site. Evidence is presented that implies that residues spatially close to the conserved cysteine tune the sensitivities of DUF156 proteins above or below critical thresholds for different effectors, generating the semblance of specificity within cells. Relative to FrmR, RcnR is less responsive to formaldehyde in vitro, and RcnR does not sense formaldehyde in vivo, but reciprocal mutations FrmR(P2S) and RcnR(S2P), respectively, impair and enhance formaldehyde reactivity in vitro. Formaldehyde detoxification by FrmA requires S-(hydroxymethyl)glutathione, yet glutathione inhibits formaldehyde detection by FrmR in vivo and in vitro. Quantifying the number of FrmR molecules per cell and modeling formaldehyde modification as a function of [formaldehyde] demonstrates that FrmR reactivity is optimized such that FrmR is modified and frmRA is derepressed at lower [formaldehyde] than required to generate S-(hydroxymethyl)glutathione. Expression of FrmA is thereby coordinated with the accumulation of its substrate.	[Osman, Deenah; Piergentili, Cecilia; Sayer, Lucy N.; Robinson, Nigel J.; Pohl, Ehmke] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Osman, Deenah; Piergentili, Cecilia; Robinson, Nigel J.; Pohl, Ehmke] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Chen, Junjun; Huggins, Thomas G.] Procter & Gamble, Mason Business Ctr, Cincinnati, OH 45040 USA; [Uson, Isabel] CSIC, IBMB, Barcelona Sci Pk, E-08028 Barcelona, Spain; [Uson, Isabel] ICREA, Pg Lluis Companys 23, Barcelona 08010, Spain	Durham University; Durham University; Procter & Gamble; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA	Robinson, NJ (corresponding author), Univ Durham, Dept Chem, Durham DH1 3LE, England.; Robinson, NJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	nigel.robinson@durham.ac.uk	Pohl, Ehmke/I-2408-2012; Osman, Deenah/AAB-4516-2020; Robinson, Nigel J/J-6363-2012	Pohl, Ehmke/0000-0002-9949-4471; Osman, Deenah/0000-0002-0251-9231; Robinson, Nigel J/0000-0001-5586-1092	Biotechnology and Biological Sciences Research Council [BB/J017787/1]; Procter and Gamble; ICREA Funding Source: Custom; BBSRC [BB/L013711/1, BB/J017787/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L013711/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Procter and Gamble(Procter & Gamble); ICREA(ICREA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council Industrial Partnership Award BB/J017787/1. This work received support from Procter and Gamble.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; BOLT HM, 1987, J CANCER RES CLIN, V113, P305, DOI 10.1007/BF00397713; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Brotzel F, 2007, ORG BIOMOL CHEM, V5, P3814, DOI 10.1039/b713778h; Brotzel F, 2007, J ORG CHEM, V72, P3679, DOI 10.1021/jo062586z; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Chang FMJ, 2014, J BIOL CHEM, V289, P19204, DOI 10.1074/jbc.M114.556704; Chen NH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00257; Chen NH, 2013, ANTIOXID REDOX SIGN, V18, P743, DOI 10.1089/ars.2012.4749; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Conaway CC, 1996, PHARMACOL THERAPEUT, V71, P29, DOI 10.1016/0163-7258(96)00061-7; Coyne HJ, 2013, BIOMOL NMR ASSIGN, V7, P279, DOI 10.1007/s12104-012-9428-4; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denby KJ, 2015, ENVIRON MICROBIOL, V17, P2477, DOI 10.1111/1462-2920.12726; Dwarakanath S, 2012, J BIOL CHEM, V287, P17833, DOI 10.1074/jbc.M112.352740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; FERENCI T, 1974, BIOCHEM J, V144, P477, DOI 10.1042/bj1440477; FERNANDEZ MR, 1993, FEBS LETT, V328, P235, DOI 10.1016/0014-5793(93)80934-M; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Foster AW, 2014, MOL MICROBIOL, V92, P797, DOI 10.1111/mmi.12594; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Goenrich M, 2002, J BIOL CHEM, V277, P3069, DOI 10.1074/jbc.C100579200; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Grossoehme Nicholas E, 2012, Methods Mol Biol, V875, P165, DOI 10.1007/978-1-61779-806-1_8; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; Gutheil WG, 1997, BIOCHEM BIOPH RES CO, V238, P693, DOI 10.1016/S0006-291X(00)90000-7; GUTHEIL WG, 1992, BIOCHEMISTRY-US, V31, P475, DOI 10.1021/bi00117a025; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Henard CA, 2010, J BIOL CHEM, V285, P36785, DOI 10.1074/jbc.M110.160960; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; Higgins KA, 2014, CHEM LETT, V43, P20, DOI 10.1246/cl.130965; Higgins KA, 2012, J AM CHEM SOC, V134, P7081, DOI 10.1021/ja300834b; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Iwig JS, 2009, J MOL BIOL, V393, P514, DOI 10.1016/j.jmb.2009.08.038; KAULFERS PM, 1991, FEMS MICROBIOL LETT, V79, P335, DOI 10.1016/0378-1097(91)90108-M; Kidd SP, 2005, MOL MICROBIOL, V57, P1676, DOI 10.1111/j.1365-2958.2005.04773.x; Kidd SP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-159; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Liu T, 2008, BIOCHEMISTRY-US, V47, P10564, DOI 10.1021/bi801313y; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luebke JL, 2013, METALLOMICS, V5, P335, DOI 10.1039/c3mt20205d; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MA TH, 1988, MUTAT RES, V196, P37, DOI 10.1016/0165-1110(88)90027-9; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Marx CJ, 2004, J BACTERIOL, V186, P2173, DOI 10.1128/JB.186.7.2173-2178.2004; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; MASON RP, 1986, BIOCHEMISTRY-US, V25, P4504, DOI 10.1021/bi00364a008; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; McClelland M, 2000, NUCLEIC ACIDS RES, V28, P4974, DOI 10.1093/nar/28.24.4974; McEwan AG, 2011, ADV MICROB PHYSIOL, V58, P1, DOI 10.1016/B978-0-12-381043-4.00001-5; Millan C, 2015, IUCRJ, V2, P95, DOI 10.1107/S2052252514024117; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nobre LS, 2009, MICROBIOL-SGM, V155, P813, DOI 10.1099/mic.0.023911-0; Osman D, 2015, J BIOL CHEM, V290, P19806, DOI 10.1074/jbc.M115.663427; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Osman D, 2010, NAT PROD REP, V27, P668, DOI 10.1039/b906682a; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powell HR, 2013, ACTA CRYSTALLOGR D, V69, P1195, DOI 10.1107/S0907444912048524; Propper K, 2014, ACTA CRYSTALLOGR D, V70, P1743, DOI 10.1107/S1399004714007603; Rubio-Sanz L, 2013, APPL ENVIRON MICROB, V79, P6414, DOI 10.1128/AEM.01954-13; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Sambrook J., 2001, MOL CLONING LAB MANU; SANDERSON KE, 1976, ANNU REV MICROBIOL, V30, P327, DOI 10.1146/annurev.mi.30.100176.001551; Sanghani PC, 2000, BIOCHEMISTRY-US, V39, P10720, DOI 10.1021/bi9929711; SHARP PM, 1991, J MOL EVOL, V33, P23, DOI 10.1007/BF02100192; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Song M, 2013, MOL MICROBIOL, V87, P609, DOI 10.1111/mmi.12119; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Streit BR, 2016, J BIOL CHEM, V291, P862, DOI 10.1074/jbc.M115.666560; Stroeher UH, 2007, J INFECT DIS, V196, P1820, DOI 10.1086/523107; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; THORNALLEY P, 1984, BIOCHIM BIOPHYS ACTA, V797, P276, DOI 10.1016/0304-4165(84)90131-4; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Travers A. A., 2000, DNA PROTEIN INTERACT, P141; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; UOTILA L, 1974, J BIOL CHEM, V249, P7653; UOTILA L, 1974, J BIOL CHEM, V249, P7664; Uson I, 1999, STRUCT FOLD DES, V7, P55, DOI 10.1016/S0969-2126(99)80009-4; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Wilson SM, 2008, MICROBIOL-SGM, V154, P296, DOI 10.1099/mic.0.2007/011346-0; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yurimoto H, 2005, CHEM REC, V5, P367, DOI 10.1002/tcr.20056; Yurimoto H, 2005, MOL MICROBIOL, V57, P511, DOI 10.1111/j.1365-2958.2005.04702.x	103	20	21	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19502	19516		10.1074/jbc.M116.745174	http://dx.doi.org/10.1074/jbc.M116.745174			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27474740	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000383242800027
J	Sayedyahossein, S; Li, ZG; Hedman, AC; Morgan, CJ; Sacks, DB				Sayedyahossein, Samar; Li, Zhigang; Hedman, Andrew C.; Morgan, Chase J.; Sacks, David B.			IQGAP1 Binds to Yes-associated Protein (YAP) and Modulates Its Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; Hippo pathway; protein complex; transcription factor; yes-associated protein (YAP); IQGAP1	HIPPO PATHWAY; HEPATOCELLULAR-CARCINOMA; NEURITE OUTGROWTH; GROWTH-CONTROL; BETA-CATENIN; IQ MOTIFS; TAZ; CALMODULIN; COMPLEX; CANCER	During development, the Hippo signaling pathway regulates key physiological processes, such as control of organ size, regeneration, and stem cell biology. Yes-associated protein (YAP) is a major transcriptional co-activator of the Hippo pathway. The scaffold protein IQGAP1 interacts with more than 100 binding partners to integrate diverse signaling pathways. In this study, we report that IQGAP1 binds to YAP and modulates its activity. IQGAP1 and YAP co-immunoprecipitated from cells. In vitro analysis with pure proteins demonstrated a direct interaction between IQGAP1 and YAP. Analysis with multiple fragments of each protein showed that the interaction occurs via the IQ domain of IQGAP1 and the TEAD-binding domain of YAP. The interaction between IQGAP1 and YAP has functional effects. Knock-out of endogenous IQGAP1 significantly increased the formation of nuclear YAP-TEAD complexes. Transcription assays were performed with IQGAP1-null mouse embryonic fibroblasts and HEK293 cells with IQGAP1 knockdown by CRISPR/Cas9. Quantification demonstrated that YAP-TEAD-mediated transcription in cells lacking IQGAP1 was significantly greater than in control cells. These data reveal that IQGAP1 binds to YAP and modulates its co-transcriptional function, suggesting that IQGAP1 participates in Hippo signaling.	[Sayedyahossein, Samar; Li, Zhigang; Hedman, Andrew C.; Morgan, Chase J.; Sacks, David B.] NIH, Dept Lab Med, 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Sacks, DB (corresponding author), NIH, Dept Lab Med, 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735; Sayedyahossein, Samar/0000-0003-1773-4740	National Institutes of Health Intramural Research Program; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported by the National Institutes of Health Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brill S, 1996, MOL CELL BIOL, V16, P4869; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Erdemir HH, 2014, J BIOL CHEM, V289, P9100, DOI 10.1074/jbc.M114.553511; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Goto T, 2013, J BIOL CHEM, V288, P36351, DOI 10.1074/jbc.M113.520528; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Johnson M, 2011, INT J BIOCHEM CELL B, V43, P65, DOI 10.1016/j.biocel.2010.09.014; Kim JH, 2013, ANTIOXID REDOX SIGN, V19, P89, DOI 10.1089/ars.2012.4586; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Liu CS, 2013, J CLIN INVEST, V123, P1138, DOI 10.1172/JCI63836; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nishio M, 2012, J CLIN INVEST, V122, P4505, DOI 10.1172/JCI63735; Oh H, 2009, DEV BIOL, V335, P188, DOI 10.1016/j.ydbio.2009.08.026; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Sansores-Garcia L, 2013, CURR BIOL, V23, P229, DOI 10.1016/j.cub.2012.12.033; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Tan GS, 2015, ONCOTARGET, V6, P8676, DOI 10.18632/oncotarget.3254; Terrak M, 2003, EMBO J, V22, P362, DOI 10.1093/emboj/cdg058; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; White CD, 2011, J BIOL CHEM, V286, P29734, DOI 10.1074/jbc.M111.220939; White CD, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-125; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	47	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19261	19273		10.1074/jbc.M116.732529	http://dx.doi.org/10.1074/jbc.M116.732529			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27440047	Green Published, hybrid			2022-12-28	WOS:000383242800008
J	MacDiarmid, CW; Taggart, J; Jeong, J; Kerdsomboon, K; Eide, DJ				MacDiarmid, Colin W.; Taggart, Janet; Jeong, Jeeyon; Kerdsomboon, Kittikhun; Eide, David J.			Activation of the Yeast UBI4 Polyubiquitin Gene by Zap1 Transcription Factor via an Intragenic Promoter Is Critical for Zinc-deficient Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; ALCOHOL-DEHYDROGENASE; QUALITY-CONTROL; PHOSPHOLIPID-SYNTHESIS; UBIQUITIN LIGASE; PROTEASE COMPLEX; STRUCTURAL ZINC; GENOME-WIDE; EXPRESSION	Stability of many proteins requires zinc. Zinc deficiency disrupts their folding, and the ubiquitin-proteasome system may help manage this stress. In Saccharomyces cerevisiae, UBI4 encodes five tandem ubiquitin monomers and is essential for growth in zinc-deficient conditions. Although UBI4 is only one of four ubiquitin-encoding genes in the genome, a dramatic decrease in ubiquitin was observed in zinc-deficient ubi4 Delta cells. The three other ubiquitin genes were strongly repressed under these conditions, contributing to the decline in ubiquitin. In a screen for ubi4 Delta suppressors, a hypomorphic allele of the RPT2 proteasome regulatory subunit gene (rpt2(E301K)) suppressed the ubi4 Delta growth defect. The rpt2(E301K) mutation also increased ubiquitin accumulation in zinc-deficient cells, and by using a ubiquitin-independent proteasome substrate we found that proteasome activity was reduced. These results suggested that increased ubiquitin supply in suppressed ubi4 Delta cells was a consequence of more efficient ubiquitin release and recycling during proteasome degradation. Degradation of a ubiquitin-de pendent substrate was restored by the rpt2(E301K) mutation, indicating that ubiquitination is rate-limiting in this process. The UBI4 gene was induced similar to 5-fold in low zinc and is regulated by the zinc-responsive Zap 1 transcription factor. Surprisingly, Zap1 controls UBI4 by inducing transcription from an intragenic promoter, and the resulting truncated mRNA encodes only two of the five ubiquitin repeats. Expression of a short transcript alone complemented the ubi4 Delta mutation, indicating that it is efficiently translated. Loss of Zap1-dependent UBI4 expression caused a growth defect in zinc-deficient conditions. Thus, the intragenic UBI4 promoter is critical to preventing ubiquitin deficiency in zinc-deficient cells.	[MacDiarmid, Colin W.; Taggart, Janet; Kerdsomboon, Kittikhun; Eide, David J.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Jeong, Jeeyon] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	University of Wisconsin System; University of Wisconsin Madison; Amherst College	Eide, DJ (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	eide@nutrisci.wisc.edu	MacDiarmid, Colin/AAV-5920-2021; Jeong, Jeeyon/U-9617-2019	Jeong, Jeeyon/0000-0002-5826-2682; MacDiarmid, Colin/0000-0001-8578-5756	National Institutes of Health [GM056285]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM056285. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2009, BIOINFORMATICS, V25, P2088, DOI 10.1093/bioinformatics/btp256; Arribere JA, 2013, GENOME RES, V23, P977, DOI 10.1101/gr.150342.112; Bagola K, 2008, CURR BIOL, V18, pR1019, DOI 10.1016/j.cub.2008.09.036; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bilsland E, 2007, DNA REPAIR, V6, P1471, DOI 10.1016/j.dnarep.2007.04.010; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Birkeland SR, 2010, GENETICS, V186, P1127, DOI 10.1534/genetics.110.123232; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; DeGennaro CM, 2013, MOL CELL BIOL, V33, P4779, DOI 10.1128/MCB.01068-13; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; ENGELS WR, 1993, TRENDS BIOCHEM SCI, V18, P448, DOI 10.1016/0968-0004(93)90148-G; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Frey AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022535; Frey AG, 2011, J BIOL CHEM, V286, P6844, DOI 10.1074/jbc.M110.203927; Gammie AE, 1999, MOL CELL BIOL, V19, P817; GANZHORN AJ, 1988, J BIOL CHEM, V263, P5446; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gauci VJ, 2009, FEMS YEAST RES, V9, P1187, DOI 10.1111/j.1567-1364.2009.00557.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Isasa M, 2015, J PROTEOME RES, V14, P5306, DOI 10.1021/acs.jproteome.5b00802; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; JELOKOVA J, 1994, EUR J BIOCHEM, V225, P1015, DOI 10.1111/j.1432-1033.1994.1015b.x; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kato H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02186; Lee YJ, 2013, MOL CELL, V51, P105, DOI 10.1016/j.molcel.2013.05.005; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2013, J BIOL CHEM, V288, P31313, DOI 10.1074/jbc.M113.512384; MAGONET E, 1992, BIOCHEM J, V287, P361, DOI 10.1042/bj2870361; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; North M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002699; Nostramo R, 2016, MOL CELL BIOL, V36, P173, DOI 10.1128/MCB.00609-15; O'Donnell AF, 2012, MOL CELL BIOL, V32, P4506, DOI 10.1128/MCB.01176-12; Olivarius S, 2009, BIOTECHNIQUES, V46, P130, DOI 10.2144/000113066; Ossareh-Nazari B, 2014, J CELL BIOL, V204, P909, DOI 10.1083/jcb.201308139; Poulsen JW, 2012, J PROTEOMICS, V75, P3886, DOI 10.1016/j.jprot.2012.04.055; RIVETT AJ, 1995, MOL BIOL REP, V21, P35, DOI 10.1007/BF00990968; SCHNALL R, 1994, YEAST, V10, P1141, DOI 10.1002/yea.320100903; Simon JR, 1999, MOL MICROBIOL, V31, P823, DOI 10.1046/j.1365-2958.1999.01220.x; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Winston F., 2008, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB1303BS82; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; WU M, 1987, J BIOL CHEM, V262, P12275; Yashiroda H, 1996, MOL CELL BIOL, V16, P3255; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	66	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18880	18896		10.1074/jbc.M116.743120	http://dx.doi.org/10.1074/jbc.M116.743120			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432887	Green Published, hybrid			2022-12-28	WOS:000383242300026
J	Mi, Y; Coonce, M; Fiete, D; Steirer, L; Dveksler, G; Townsend, RR; Baenziger, JU				Mi, Yiling; Coonce, Marcy; Fiete, Dorothy; Steirer, Lindsay; Dveksler, Gabriela; Townsend, R. Reid; Baenziger, Jacques U.			Functional Consequences of Mannose and Asialoglycoprotein Receptor Ablation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; PERFORMANCE LIQUID-CHROMATOGRAPHY; GLYCANASE-RELEASED OLIGOSACCHARIDES; PITUITARY GLYCOPROTEIN HORMONES; VON-WILLEBRAND-FACTOR; CYSTEINE-RICH DOMAIN; ACTIVATED PROTEIN-C; BETA 1,4GLCNAC BETA; FACTOR-V-LEIDEN; MICE LACKING	The mannose receptor (ManR, Mrc1) and asialoglycoprotein receptor (ASGR, Asgr1 and Asgr2) are highly abundant endocytic receptors expressed by sinusoidal endothelial cells and parenchymal cells in the liver, respectively. We genetically manipulated either receptor individually or in combination, revealing phenotypic changes in female and male mice associated with changes in circulating levels of many glycoproteins. Both receptors rise and fall in response to progesterone during pregnancy. Thirty percent of Asgr2(-/-) and 65% of Mrc1(-/-) Asgr2(-/-) mice are unable to initiate parturition at the end of pregnancy, whereas Mrcl(-/-) mice initiate normally. Twenty five percent of Mrcl(-/-) Asgr2(-/-) male mice develop priapism when mating due to thrombosis of the penile vein, but neither Mrc1(-/-) nor Asgr2(-/-) mice do so. The half-life for luteinizing hormone (LH) clearance increases in Mrc1(-/-) and Mrc1(-/-) Asgr2(-/-) mice but not in Asgr2(-/-) mice; however, LH and testosterone are elevated in all three knockouts. The ManR clears I,H thus regulating testosterone production, whereas the ASGR appears to mediate clearance of an unidentified glycoprotein that increases LH levels. More than 40 circulating glycoproteins are elevated >3.0-fold in pregnant Mrc1(-/-) Asgr2(-/-) mice. Pregnancy-specific glycoprotein 23, undetectable in WT mice (<50 ng/ml plasma), reaches levels of 1-10 mg/ml in the plasma of Mrc1(-/-) Asgr2(-/-) and Asgr2(-/-) mice, indicating it is cleared by the ASGR. Elevation of multiple coagulation factors in Mrc1(-/-)Asgr2(-/-) mice may account for priapism seen in males. These male and female phenotypic changes underscore the key roles of the ManR and ASGR in controlling circulating levels of numerous glycoproteins critical for regulating reproductive hormones and blood coagulation.	[Mi, Yiling; Coonce, Marcy; Fiete, Dorothy; Steirer, Lindsay; Dveksler, Gabriela; Townsend, R. Reid; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 South Euclid Ave, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 South Euclid Ave, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health [R01-CA21923, R01-HD058474]; Washington University Institute of Clinical and Translational Sciences Grant from National Center for Advancing Translational Sciences [UL1 TR000448]; National Institutes of Health from NIGMS [P41 GM103422-35]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA021923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Institute of Clinical and Translational Sciences Grant from National Center for Advancing Translational Sciences; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-CA21923 and R01-HD058474 (to J. U. B), Washington University Institute of Clinical and Translational Sciences Grant UL1 TR000448 from the National Center for Advancing Translational Sciences, and National Institutes of Health Grant P41 GM103422-35 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1988, BIOCHIM BIOPHYS ACTA, V947, P287, DOI 10.1016/0304-4157(88)90012-3; BAENZIGER JU, 1980, CELL, V22, P611, DOI 10.1016/0092-8674(80)90371-2; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BERTINA RM, 1995, THROMB HAEMOSTASIS, V74, P449; Braun JR, 1996, J BIOL CHEM, V271, P21160, DOI 10.1074/jbc.271.35.21160; Collier TS, 2011, RAPID COMMUN MASS SP, V25, P2524, DOI 10.1002/rcm.5151; Collier TS, 2010, ANAL CHEM, V82, P8696, DOI 10.1021/ac101978b; Coombs PJ, 2006, GLYCOBIOLOGY, V16, p1C, DOI 10.1093/glycob/cwj126; Dobrkovska A, 1998, HAEMOPHILIA, V4, P33; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Fisher R. A., 1938, STAT TABLES BIOL AGR, P1; GREEN ED, 1985, J BIOL CHEM, V260, P5623; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; GREEN ED, 1987, ANAL BIOCHEM, V167, P62, DOI 10.1016/0003-2697(87)90134-5; GREEN ED, 1987, J BIOL CHEM, V262, P12030; GREEN ED, 1989, TRENDS BIOCHEM SCI, V14, P168, DOI 10.1016/0968-0004(89)90267-3; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Ha CT, 2008, AM J REPROD IMMUNOL, V59, P251, DOI 10.1111/j.1600-0897.2007.00573.x; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; HUDGIN RL, 1974, J BIOL CHEM, V249, P5536; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Kang HG, 2001, J BIOL CHEM, V276, P10861, DOI 10.1074/jbc.M011560200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim HJ, 2009, BLOOD, V114, P5206, DOI 10.1182/blood-2009-03-212415; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Lemmerhirt HL, 2006, BLOOD, V108, P3061, DOI 10.1182/blood-2006-04-014688; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Mandalasi M, 2013, GLYCOBIOLOGY, V23, P877, DOI 10.1093/glycob/cwt025; MAYNARD Y, 1981, J BIOL CHEM, V256, P8063; McLellan AS, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-39; McLellan AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-4; Menache D, 1996, BRIT J HAEMATOL, V94, P740, DOI 10.1046/j.1365-2141.1996.d01-1860.x; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; MERKLE RK, 1987, METHOD ENZYMOL, V138, P232; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Mi YL, 2014, J BIOL CHEM, V289, P12157, DOI 10.1074/jbc.M113.544973; Mohlke KL, 1996, P NATL ACAD SCI USA, V93, P15352, DOI 10.1073/pnas.93.26.15352; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Park EI, 2004, J BIOL CHEM, V279, P40954, DOI 10.1074/jbc.M406647200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piekorz RP, 2005, MOL ENDOCRINOL, V19, P431, DOI 10.1210/me.2004-0302; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Roseman DS, 2001, J BIOL CHEM, V276, P17052, DOI 10.1074/jbc.M101027200; Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030; Shanley DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057491; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; STAHL P, 1976, P NATL ACAD SCI USA, V73, P4045, DOI 10.1073/pnas.73.11.4045; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wu JA, 2008, BIOL REPROD, V79, P1054, DOI 10.1095/biolreprod.108.070268; Xia GQ, 2000, J BIOL CHEM, V275, P38402, DOI 10.1074/jbc.M007821200; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	71	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18700	18717		10.1074/jbc.M116.738948	http://dx.doi.org/10.1074/jbc.M116.738948			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27405760	Green Published, hybrid			2022-12-28	WOS:000383242300009
J	Follett, J; Bugarcic, A; Yang, Z; Ariotti, N; Norwood, SJ; Collins, BM; Parton, RG; Teasdale, RD				Follett, Jordan; Bugarcic, Andrea; Yang, Zhe; Ariotti, Nicholas; Norwood, Suzanne J.; Collins, Brett M.; Parton, Robert G.; Teasdale, Rohan D.			Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal Association of Retromer and Induces -Synuclein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; intracellular trafficking; membrane transport; Parkinson disease; protein sorting; retromer	CHAPERONE-MEDIATED AUTOPHAGY; ALPHA-SYNUCLEIN; WASH COMPLEX; MAMMALIAN RETROMER; DROSOPHILA MODEL; CATHEPSIN-D; CARGO; DEGRADATION; RECRUITMENT; CELLS	Endosomal sorting is a highly orchestrated cellular process. Retromer is a heterotrimeric complex that associates with endosomal membranes and facilitates the retrograde sorting of multiple receptors, including the cation-independent mannose 6-phosphate receptor for lysosomal enzymes. The cycling of retromer on and off the endosomal membrane is regulated by a network of retromer-interacting proteins. Here, we find that Parkinson disease-associated Vps35 variant, R524W, but not P316S, is a loss-of-function mutation as marked by a reduced association with this regulatory network and dysregulation of endosomal receptor sorting. Expression of Vps35 R524W-containing retromer results in the accumulation of intracellular -synuclein-positive aggregates, a hallmark of Parkinson disease. Overall, the Vps35 R524W-containing retromer has a decreased endosomal association, which can be partially rescued by R55, a small molecule previously shown to stabilize the retromer complex, supporting the potential for future targeting of the retromer complex in the treatment of Parkinson disease.	[Follett, Jordan; Bugarcic, Andrea; Yang, Zhe; Ariotti, Nicholas; Norwood, Suzanne J.; Collins, Brett M.; Parton, Robert G.; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Teasdale, RD (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	r.teasdale@uq.edu.au	Teasdale, Rohan D/B-2538-2009; Bugarcic, Andrea/AAN-8952-2021; Teasdale, Rohan/AAD-6698-2019; Ariotti, Nicholas/GXH-4833-2022; Yang, Zhe/O-3489-2019; Collins, Brett/J-1563-2014; Parton, Robert/C-5673-2009	Teasdale, Rohan D/0000-0001-7455-5269; Teasdale, Rohan/0000-0001-7455-5269; Yang, Zhe/0000-0002-7987-0855; Collins, Brett/0000-0002-6070-3774; Ariotti, Nicholas/0000-0003-3901-0831; Parton, Robert/0000-0002-7494-5248; Bugarcic, Andrea/0000-0003-2525-2450	National Health and Medical Research Council (NHMRC) of Australia [APP1025538, APP1037320, APP1042082, APP1045092, APP1058734]; Australian Research Council [DP120103930]; Centre of Excellence in Convergent Bio-Nano Science and Technology; ANZ Trustees National Medical Program Grant from Judith Jane Mason and Harold Stannett Williams Memorial Foundation; NHMRC [APP1061574, APP1058565, APP1041929]; ARC Future Fellowship [FT100100027]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Centre of Excellence in Convergent Bio-Nano Science and Technology; ANZ Trustees National Medical Program Grant from Judith Jane Mason and Harold Stannett Williams Memorial Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Grants APP1025538, APP1037320, APP1042082, APP1045092, and APP1058734; Australian Research Council Project Grant DP120103930 and Centre of Excellence in Convergent Bio-Nano Science and Technology; and an ANZ Trustees National Medical Program Grant from the Judith Jane Mason and Harold Stannett Williams Memorial Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NHMRC Career Development Fellowship APP1061574 and ARC Future Fellowship FT100100027.; Supported by NHMRC Senior Principal Research Fellowship APP1058565.; Supported by NHMRC Senior Research Fellowship APP1041929. To whom correspondence should be addressed. Tel.: 61-3202-9143; E-mail: r.teasdale@uq.edu.au.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bugarcic A, 2011, TRAFFIC, V12, P1759, DOI 10.1111/j.1600-0854.2011.01284.x; Chi RJ, 2015, CELL MOL LIFE SCI, V72, P3441, DOI 10.1007/s00018-015-1935-x; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Follett J, 2017, CURR PROTEIN PEPT SC, V18, P687, DOI 10.2174/1389203717666160311121246; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Follett J, 2013, NEUROTOX RES, V23, P378, DOI 10.1007/s12640-012-9366-z; Furlong RA, 2000, BIOCHEM J, V346, P577, DOI 10.1042/0264-6021:3460577; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Harrison MS, 2014, P NATL ACAD SCI USA, V111, P267, DOI 10.1073/pnas.1316482111; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Hossain S, 2001, J ALZHEIMERS DIS, V3, P577, DOI 10.3233/JAD-2001-3608; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jia D, 2012, MOL BIOL CELL, V23, P2352, DOI 10.1091/mbc.E11-12-1059; Kerr MC, 2005, TRAFFIC, V6, P991, DOI 10.1111/j.1600-0854.2005.00328.x; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Konno M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-38; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Lesage S, 2012, NEUROLOGY, V78, P1449, DOI 10.1212/WNL.0b013e318253d5f2; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; McGough IJ, 2014, CURR BIOL, V24, P1670, DOI 10.1016/j.cub.2014.06.024; Mecozzi VJ, 2014, NAT CHEM BIOL, V10, P443, DOI [10.1038/NCHEMBIO.1508, 10.1038/nchembio.1508]; Miura E, 2014, NEUROBIOL DIS, V71, P1, DOI 10.1016/j.nbd.2014.07.014; Munsie LN, 2015, HUM MOL GENET, V24, P1691, DOI 10.1093/hmg/ddu582; Norwood SJ, 2011, TRAFFIC, V12, P56, DOI 10.1111/j.1600-0854.2010.01124.x; Popovic D, 2014, EMBO REP, V15, P392, DOI 10.1002/embr.201337995; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Priya A, 2015, TRAFFIC, V16, P68, DOI 10.1111/tra.12237; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zavodszky E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4828; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	54	53	53	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18283	18298		10.1074/jbc.M115.703157	http://dx.doi.org/10.1074/jbc.M115.703157			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27385586	Green Published, hybrid			2022-12-28	WOS:000383241800021
J	Saffert, P; Adamla, F; Schieweck, R; Atkins, JF; Ignatova, Z				Saffert, Paul; Adamla, Frauke; Schieweck, Rico; Atkins, John F.; Ignatova, Zoya			An Expanded CAG Repeat in Huntingtin Causes+1 Frameshifting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; Huntington disease; translation; translation regulation; trinucleotide repeat disease; frameshifting; seeding	INTRANUCLEAR INCLUSIONS; MOLECULAR ARCHITECTURE; CONTAINING PROTEINS; RAN TRANSLATION; DISORDERS; DISEASE; YEAST; TRANSLOCATION; TRANSCRIPTS; POLYALANINE	Maintenance of triplet decoding is crucial for the expression of functional protein because deviations either into the -1 or +1 reading frames are often non-functional. We report here that expression of huntingtin (Htt) exon 1 with expanded CAG repeats, implicated in Huntington pathology, undergoes a sporadic +1 frameshift to generate from the CAG repeat a trans-frame AGC repeat-encoded product. This +1 recoding is exclusively detected in pathological Htt variants, i.e. those with expanded repeats with more than 35 consecutive CAG codons. An atypical +1 shift site, UUC C at the 5 end of CAG repeats, which has some resemblance to the influenza A virus shift site, triggers the +1 frameshifting and is enhanced by the increased propensity of the expanded CAG repeats to form a stem-loop structure. The +1 trans-frame-encoded product can directly influence the aggregation of the parental Htt exon 1.	[Saffert, Paul; Schieweck, Rico; Ignatova, Zoya] Univ Potsdam, Inst Biochem, D-14467 Potsdam, Germany; [Adamla, Frauke; Ignatova, Zoya] Univ Hamburg, Dept Chem, Biochem & Mol Biol, D-20146 Hamburg, Germany; [Atkins, John F.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	University of Potsdam; University of Hamburg; University College Cork; Utah System of Higher Education; University of Utah	Ignatova, Z (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Martin Luther King Pl 6, D-20146 Hamburg, Germany.	zoya.ignatova@uni-hamburg.de		Ignatova, Zoya/0000-0002-9478-8825; Atkins, John/0000-0001-7933-0165	Deutsche Forschungsgemeinschaft [FOR 1805, SFB 740]; Science Foundation Ireland	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR 1805 and SFB 740 (to Z. I.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Science Foundation Ireland.	Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Atkinson J, 1997, MOL MICROBIOL, V26, P747, DOI 10.1046/j.1365-2958.1997.6101959.x; Brierley I, 2008, BIOCHEM SOC T, V36, P684, DOI 10.1042/BST0360684; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Chen J, 2014, NATURE, V512, P328, DOI 10.1038/nature13428; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; Davies JE, 2006, J MED GENET, V43, P893, DOI 10.1136/jmg.2006.044222; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; FARABAUGH PJ, 1993, CELL, V74, P93, DOI 10.1016/0092-8674(93)90297-4; Firth AE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120109; Gaspar C, 2000, HUM MOL GENET, V9, P1957, DOI 10.1093/hmg/9.13.1957; Girstmair H, 2013, CELL REP, V3, P148, DOI 10.1016/j.celrep.2012.12.019; Griffiths A, 2006, J VIROL, V80, P6568, DOI 10.1128/JVI.00155-06; Gurvich OL, 2005, J BACTERIOL, V187, P4023, DOI 10.1128/JB.187.12.4023-4032.2005; Herr AJ, 2004, J BIOL CHEM, V279, P11081, DOI 10.1074/jbc.M311491200; Hinz J, 2012, J BIOL CHEM, V287, P2068, DOI 10.1074/jbc.M111.318915; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kwun HJ, 2014, P NATL ACAD SCI USA, V111, pE4342, DOI 10.1073/pnas.1416122111; Lehmann J, 2008, RNA, V14, P1264, DOI 10.1261/rna.1029808; Liao PY, 2008, NUCLEIC ACIDS RES, V36, P2619, DOI 10.1093/nar/gkn100; Licznar P, 2003, EMBO J, V22, P4770, DOI 10.1093/emboj/cdg465; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Oma Y, 2004, J BIOL CHEM, V279, P21217, DOI 10.1074/jbc.M309887200; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; de Pouplana LR, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI 10.1016/j.tibs.2014.06.002; Satpati P, 2014, NUCLEIC ACIDS RES, V42, P12876, DOI 10.1093/nar/gku1044; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Stochmanski SJ, 2012, HUM MOL GENET, V21, P2211, DOI 10.1093/hmg/dds036; Taliaferro D, 2007, RNA, V13, P606, DOI 10.1261/rna.412707; Tamm T, 2009, VIRUS RES, V146, P73, DOI 10.1016/j.virusres.2009.09.002; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Toulouse A, 2005, HUM MOL GENET, V14, P2649, DOI 10.1093/hmg/ddi299; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; West JP, 2014, SCIENCE, V345, P1118, DOI 10.1126/science.1259461; Wojciechowska M, 2014, NUCLEIC ACIDS RES, V42, P11849, DOI 10.1093/nar/gku794; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yan SN, 2015, CELL, V160, P870, DOI 10.1016/j.cell.2015.02.003; Zhang G, 2010, NUCLEIC ACIDS RES, V38, P4778, DOI 10.1093/nar/gkq196	45	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18505	18513		10.1074/jbc.M116.744326	http://dx.doi.org/10.1074/jbc.M116.744326			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382061	hybrid, Green Published			2022-12-28	WOS:000383241800040
J	Vugmeyster, L; Clark, MA; Falconer, IB; Ostrovsky, D; Gantz, D; Qiang, W; Hoatson, GL				Vugmeyster, Liliya; Clark, Matthew A.; Falconer, Isaac B.; Ostrovsky, Dmitry; Gantz, Donald; Qiang, Wei; Hoatson, Gina L.			Flexibility and Solvation of Amyloid- Hydrophobic Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid; amyloid- (AB); protein dynamic; solid state NMR; solvation	BETA-SHEET; FIBRIL STRUCTURE; A-BETA(1-42) PEPTIDES; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; HEAT-CAPACITY; FAST DYNAMICS; SIDE-CHAINS; THERMODYNAMICS; ARCHITECTURE	Amyloid fibril deposits found in Alzheimer disease patients are composed of amyloid- (A) protein forming a number of hydrophobic interfaces that are believed to be mostly rigid. We have investigated the s-ms time-scale dynamics of the intra-strand hydrophobic core and interfaces of the fibrils composed of A(1-40) protein. Using solid-state H-2 NMR line shape experiments performed on selectively deuterated methyl groups, we probed the 3-fold symmetric and 2-fold symmetric polymorphs of native A as well as the protofibrils of D23N Iowa mutant, associated with an early onset of Alzheimer disease. The dynamics of the hydrophobic regions probed at Leu-17, Leu-34, Val-36, and Met-35 side chains were found to be very pronounced at all sites and in all polymorphs of A, with methyl axis motions persisting down to 230-200 K for most of the sites. The dominant mode of motions is the rotameric side chain jumps, with the Met-35 displaying the most complex multi-modal behavior. There are distinct differences in the dynamics among the three protein variants, with the Val-36 site displaying the most variability. Solvation of the fibrils does not affect methyl group motions within the hydrophobic core of individual cross- subunits but has a clear effect on the motions at the hydrophobic interface between the cross- subunits, which is defined by Met-35 contacts. In particular, hydration activates transitions between additional rotameric states that are not sampled in the dry protein. Thus, these results support the existence of water-accessible cavity recently predicted by molecular dynamics simulations and suggested by cryo-EM studies.	[Vugmeyster, Liliya; Falconer, Isaac B.; Ostrovsky, Dmitry] Univ Colorado, Denver, CO 80204 USA; [Clark, Matthew A.] Univ Alaska Anchorage, Anchorage, AK 99508 USA; [Gantz, Donald] Boston Univ, Sch Med, Boston, MA 02118 USA; [Qiang, Wei] SUNY Binghamton, Binghamton, NY 13902 USA; [Hoatson, Gina L.] Coll William & Mary, Williamsburg, VA 23187 USA	University of Colorado System; University of Colorado Denver; University of Alaska System; University of Alaska Anchorage; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; William & Mary	Vugmeyster, L (corresponding author), Univ Colorado, Denver, CO 80204 USA.	liliya.vugmeyster@ucdenver.edu			National Institutes of Health (NIH) [1R15 GM111681-02]; Institutional Development Award (IDeA) under NIH [P20GM103395]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103395, R15GM111681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award (IDeA) under NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant (NIH) 1R15 GM111681-02 (to L. V.) as well as by an Institutional Development Award (IDeA) under NIH Grant P20GM103395. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler J, 2014, PHYS CHEM CHEM PHYS, V16, P7461, DOI 10.1039/c3cp54501f; Ahmed AB, 2013, FEBS LETT, V587, P1089, DOI 10.1016/j.febslet.2012.12.006; Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; BATCHELDER LS, 1982, P NATL ACAD SCI-BIOL, V79, P386, DOI 10.1073/pnas.79.2.386; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Chimon S, 2007, BIOPHYS J, p195A; Dubochet J, 1982, ADV OPTICAL ELECT MI, P107; Fawzi NL, 2014, ANGEW CHEM INT EDIT, V53, P10345, DOI 10.1002/anie.201405180; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Harris Jonathan Gil, 1994, ELECT MICROSCOPY BIO, P203; Hong L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238102; Hou LM, 2013, J ALZHEIMERS DIS, V37, P9, DOI 10.3233/JAD-122389; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Hubin E, 2014, CELL MOL LIFE SCI, V71, P3507, DOI 10.1007/s00018-014-1634-z; Igumenova TI, 2006, CHEM REV, V106, P1672, DOI 10.1021/cr040422h; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Krushelnitsky A, 2009, J PHYS CHEM B, V113, P10022, DOI 10.1021/jp900337x; Lee AL, 2001, NATURE, V411, P501, DOI 10.1038/35078119; Lewandowski JR, 2011, J AM CHEM SOC, V133, P14686, DOI 10.1021/ja203736z; Linser R, 2014, J BIOMOL NMR, V59, P1, DOI 10.1007/s10858-014-9822-6; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; McDonald M, 2012, J MOL BIOL, V423, P454, DOI 10.1016/j.jmb.2012.08.004; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pinotsi D, 2013, CHEMBIOCHEM, V14, P846, DOI 10.1002/cbic.201300103; Popova LA, 2010, J AM CHEM SOC, V132, P6324, DOI 10.1021/ja909074j; Prade E, 2016, BIOCHEMISTRY-US, V55, P1839, DOI 10.1021/acs.biochem.5b01272; Prade E, 2015, J BIOL CHEM, V290, P28737, DOI 10.1074/jbc.M115.675215; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Sabo TM, 2012, PROTEIN SCI, V21, P562, DOI 10.1002/pro.2045; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Sgourakis NG, 2015, STRUCTURE, V23, P216, DOI 10.1016/j.str.2014.10.022; Song XJ, 2007, BIOPHYS J, V92, pL43, DOI 10.1529/biophysj.106.102160; Tamura A, 1996, PROTEIN SCI, V5, P127; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; van der Kamp MW, 2010, STRUCTURE, V18, P423, DOI 10.1016/j.str.2010.01.012; Vold R. R., 1991, ADV MAGN OPT RESON, V16, P85; Vugmeyster L, 2011, BIOCHEMISTRY-US, V50, P10637, DOI 10.1021/bi201515b; Vugmeyster L, 2009, J AM CHEM SOC, V131, P13651, DOI 10.1021/ja902977u; Wang SSS, 2003, BIOCHEMISTRY-US, V42, P9507, DOI 10.1021/bi0342766; Weidner T, 2010, P NATL ACAD SCI USA, V107, P13288, DOI 10.1073/pnas.1003832107; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P567, DOI 10.1021/ar0681934; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	70	29	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18484	18495		10.1074/jbc.M116.740530	http://dx.doi.org/10.1074/jbc.M116.740530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402826	Green Published, hybrid			2022-12-28	WOS:000383241800038
J	Kim, D; Pauer, SH; Yong, HM; An, SS; Liggett, SB				Kim, Donghwa; Pauer, Susan H.; Yong, Hwan M.; An, Steven S.; Liggett, Stephen B.			beta(2)-Adrenergic Receptors Chaperone Trapped Bitter Taste Receptor 14 to the Cell Surface as a Heterodimer and Exert Unidirectional Desensitization of Taste Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; chronic obstructive pulmonary disease (COPD); cyclic AMP (cAMP); dimerization; G protein; receptor internalization; smooth muscle; bitter taste receptor	AIRWAY SMOOTH-MUSCLE; PROTEIN-COUPLED RECEPTORS; BETA-2-ADRENERGIC RECEPTORS; MAMMALIAN TASTE; PHOSPHORYLATION; EXPRESSION; LACKING; GRK	Bitter taste receptors (TAS2Rs) are G-protein-coupled receptors now recognized to be expressed on extraoral cells, including airway smooth muscle (ASM) where they evoke relaxation. TAS2Rs are difficult to express in heterologous systems, with most receptors being trapped intracellularly. We find, however, that co-expression of (2)-adrenergic receptors ((2)AR) in HEK-293T routes TAS2R14 to the cell surface by forming receptor heterodimers. Cell surface TAS2R14 expression was increased by approximate to 5-fold when (2)AR was co-expressed. Heterodimer formation was shown by co-immunoprecipitation with tagged receptors, biomolecular fluorescence complementation, and merged confocal images. The dynamic nature of this interaction was shown by: a gene-dose relationship between transfected (2)AR and TAS2R14 expression, enhanced (up to 3-fold) TAS2R14 agonist stimulation of [Ca2+](i) with (2)AR co-transfection, approximate to 53% decrease in [Ca2+](i) signaling with shRNA knockdown of (2)AR in H292 cells, and approximate to 60% loss of [Ca2+](i) responsiveness in AR knock-out mouse ASM. Once expressed on the surface, we detected unidirectional, conformation-dependent, interaction within the heterodimer, with (2)AR activation rapidly uncoupling TAS2R14 function (approximate to 65% desensitization). Cross-talk was independent of (2)AR internalization and cAMP/PKA, and not accompanied by TAS2R14 internalization. With prolonged -agonist exposure, TAS2R14 internalized, consistent with slow recycling of naked TAS2R14 in the absence of the heterodimeric milieu. In studies of ASM mechanics, rapid cross-talk was confirmed at the physiologic level, where relaxation from TAS2R14 agonist was decreased by approximate to 50% with -agonist co-treatment. Thus the (2)AR acts as a double-edged sword: increasing TAS2R14 cell surface expression, but when activated by -agonist, partially offsetting the expression phenotype by direct receptor:receptor desensitization of TAS2R14 function.	[Kim, Donghwa; Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Dept Med, Tampa, FL 33612 USA; [Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Kim, Donghwa; Pauer, Susan H.; Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Ctr Personalized Med & Genom, Tampa, FL 33612 USA; [Yong, Hwan M.; An, Steven S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Liggett, SB (corresponding author), 12901 Bruce B Downs Blvd,MDC02, Tampa, FL 33612 USA.	sliggett@health.usf.edu	Kim, Donghwa/AAJ-8148-2021; An, Steven/AAM-3848-2020	Kim, Donghwa/0000-0002-8994-8513; An, Steven/0000-0003-4723-1888; Liggett, Stephen B./0000-0002-0128-3669	National Institutes of Health [HL114471, HL045967, HL107361]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045967, R01HL107361, R56HL045967, R37HL045967, P01HL114471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL114471, HL045967, and HL107361. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001; An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; An SS, 2016, J ALLERGY CLIN IMMUN, V138, P294, DOI 10.1016/j.jaci.2015.12.1315; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Billington CK, 2003, RESP RES, V4; Camoretti-Mercado B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131582; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Krzywinski M, 2014, NAT METHODS, V11, P977, DOI 10.1038/nmeth.3137; LIGGETT SB, 1989, MOL PHARMACOL, V36, P641; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; McGraw DW, 1999, J BIOL CHEM, V274, P32241, DOI 10.1074/jbc.274.45.32241; McGraw DW, 2006, J CLIN INVEST, V116, P1400, DOI 10.1172/JCI25840; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Robinett KS, 2011, AM J RESP CELL MOL, V45, P1069, DOI 10.1165/rcmb.2011-0061OC; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Small KM, 2006, BIOCHEMISTRY-US, V45, P4760, DOI 10.1021/bi052074z; Swift SM, 2007, AM J RESP CELL MOL, V36, P236, DOI 10.1165/rcmb.2006-0257OC; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	27	17	17	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17616	17628		10.1074/jbc.M116.722736	http://dx.doi.org/10.1074/jbc.M116.722736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27342779	hybrid, Green Published			2022-12-28	WOS:000383241300013
J	Leiting, S; Seidl, S; Martinez-Palacian, A; Muhl, L; Kanse, SM				Leiting, Silke; Seidl, Sebastian; Martinez-Palacian, Adoracion; Muhl, Lars; Kanse, Sandip M.			Transforming Growth Factor-beta (TGF-beta) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED TRANSCRIPTION FACTORS; HYALURONAN-BINDING PROTEIN; HEPATIC STELLATE CELLS; LIVER FIBROSIS; ANTIGEN LEVELS; GENE; PLASMA; CANCER; HABP2; PROMOTER	Deletion of the Habp2 gene encoding Factor VII-activating protease (FSAP) increases liver fibrosis in mice. A single nucleotide polymorphism (G534E) in HABP2 leads to lower enzymatic activity and is associated with enhanced liver fibrosis in humans. Liver fibrosis is associated with a decrease in FSAP expression but, to date, nothing is known about how this might be regulated. Primary mouse hepatocytes or the hepatocyte cell line, AML12, were treated with different factors, and expression of FSAP was determined. Of the various regulatory factors tested, only transforming growth factor-beta (TGF-beta) demonstrated a concentration-and time-dependent inhibition of FSAP expression at the mRNA and protein level. The TGF-beta Type I receptor (ALK-5) antagonist SB431542 and Smad2 siRNA, but neither SIS3, which inhibits SMAD3, nor siRNA against Smad3 could block this effect. Various regions of the HABP2 promoter region were cloned into reporter constructs, and the promoter activity was determined. Accordingly, the promoter activity, which could phenocopy changes in Habp2 mRNA in response to TGF-beta, was found to be located in the 177-bp region upstream of the transcription start site, and this region did not contain any SMAD binding sites. Mutation analysis of the promoter and chromatin immunoprecipitation assays were performed to identify an important role for the ATF3 binding element. Thus, TGF-beta is the most likely mediator responsible for the decrease in FSAP expression in liver fibrosis.	[Leiting, Silke; Kanse, Sandip M.] Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; [Seidl, Sebastian; Kanse, Sandip M.] Univ Oslo, Oslo Univ Hosp, N-0372 Oslo, Norway; [Martinez-Palacian, Adoracion; Kanse, Sandip M.] Univ Oslo, Inst Basic Med Sci, N-0372 Oslo, Norway; [Muhl, Lars] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Justus Liebig University Giessen; University of Oslo; University of Oslo; Karolinska Institutet	Kanse, SM (corresponding author), Univ Oslo, Inst Basic Med Sci, N-0372 Oslo, Norway.	Sandip.Kanse@medisin.uio.no		Kanse, Sandip/0000-0003-0782-9957	Deutsche Forschungsgemeinschaft (Bonn, Germany) [KA 1468/4-1]; Kreftforeningen [3365379]	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Kreftforeningen	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (Bonn, Germany) (KA 1468/4-1) as well as Kreftforeningen (Project 3365379). The authors declare that they have no conflicts of interest with the contents of this article.	Borkham-Kamphorst E, 2013, J HEPATOL, V58, P104, DOI 10.1016/j.jhep.2012.09.007; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Cheng YC, 2016, STROKE, V47, P307, DOI 10.1161/STROKEAHA.115.011328; Choi-Miura NH, 2001, BIOL PHARM BULL, V24, P892, DOI 10.1248/bpb.24.892; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Gara SK, 2015, NEW ENGL J MED, V373, P448, DOI 10.1056/NEJMoa1502449; Hall AJ, 2006, BRIT J HAEMATOL, V135, P538, DOI 10.1111/j.1365-2141.2006.06327.x; Hanson E, 2012, J THROMB HAEMOST, V10, P848, DOI 10.1111/j.1538-7836.2012.04692.x; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Lund E, 2013, GENOME RES, V23, P1580, DOI 10.1101/gr.159400.113; Martinez-Palacian A, 2014, PROTEOM CLIN APPL, V8, P438, DOI 10.1002/prca.201300078; Mirzapoiazova T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00164; Muhl L, 2007, BIOCHEM J, V404, P191, DOI 10.1042/BJ20061630; Neef M, 2006, J HEPATOL, V44, P167, DOI 10.1016/j.jhep.2005.06.015; Parahuleva MS, 2012, CIRC J, V76, P2653, DOI 10.1253/circj.CJ-11-1502; Parahuleva MS, 2010, THROMB RES, V126, pE36, DOI 10.1016/j.thromres.2010.03.003; Roderfeld M, 2009, LIVER INT, V29, P686, DOI 10.1111/j.1478-3231.2008.01897.x; Romisch J, 2002, BIOL CHEM, V383, P1119, DOI 10.1515/BC.2002.121; Romisch J, 2001, BLOOD COAGUL FIBRIN, V12, P375, DOI 10.1097/00001721-200107000-00007; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Sedding D, 2006, J EXP MED, V203, P2801, DOI 10.1084/jem.20052546; Stephan F, 2011, CRIT CARE, V15, DOI 10.1186/cc10131; Stephan S, 2008, CLIN CHEM LAB MED, V46, P1109, DOI 10.1515/CCLM.2008.218; Sumiya J, 1997, J BIOCHEM-TOKYO, V122, P983; Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/egh.11.92, 10.1586/EGH.11.92]; Tatsumi K, 2011, THROMB RES, V128, P54, DOI 10.1016/j.thromres.2011.01.008; Wasmuth HE, 2009, HEPATOLOGY, V49, P775, DOI 10.1002/hep.22707; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Yamazaki K, 2011, DIGEST DIS, V29, P284, DOI 10.1159/000327560; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	37	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21020	+		10.1074/jbc.M116.744631	http://dx.doi.org/10.1074/jbc.M116.744631			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27462075	hybrid, Green Published			2022-12-28	WOS:000385406200018
J	Sosa-Costa, A; de Val, SI; Sevilla-Movilla, S; Borgman, KJE; Manzo, C; Teixido, J; Garcia-Parajo, MF				Sosa-Costa, Alberto; Isern de Val, Sol; Sevilla-Movilla, Silvia; Borgman, Kyra J. E.; Manzo, Carlo; Teixido, Joaquin; Garcia-Parajo, Maria F.			Lateral Mobility and Nanoscale Spatial Arrangement of Chemokine-activated alpha 4 beta 1 Integrins on T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE ADHESION; LYMPHOCYTE ARREST; LFA-1; AFFINITY; INFLAMMATION; INDUCTION; MIGRATION; MEMBRANE; KINDLINS; BINDING	Chemokine stimulation of integrin alpha 4 beta 1-dependent T lymphocyte adhesion is a key step during lymphocyte trafficking. A central question regarding alpha 4 beta 1 function is how its lateral mobility and organization influence its affinity and avidity following cell stimulation with chemokines and/or ligands. Using single particle tracking and superresolution imaging approaches, we explored the lateral mobility and spatial arrangement of individual alpha 4 beta 1 integrins on T cells exposed to different activating stimuli. We show that CXCL12 stimulation leads to rapid and transient alpha 4 beta 1 activation, measured by induction of the activation epitope recognized by the HUTS21 anti-beta 1antibody and by increased talin-beta 1 association. CXCL12-dependent alpha 4 beta 1 activation directly correlated with restricted lateral diffusion and integrin immobilization. Moreover, co-stimulation by CXCL12 together with soluble VCAM-1 potentiated integrin immobilization with a 5-fold increase in immobile integrins compared with unstimulated conditions. Our data indicate that docking by talin of the chemokine-activated alpha 4 beta 1 to the actin cytoskeleton favors integrin immobilization, which likely facilitates ligand interaction and increased adhesiveness. Superresolution imaging showed that the nanoscale organization of high-affinity alpha 4 beta 1 remains unaffected following chemokine and/or ligand addition. Instead, newly activated alpha 4 beta 1 integrins organize on the cell membrane as independent units without joining pre-established integrin sites to contribute to cluster formation. Altogether, our results provide a rationale to understand how the spatiotemporal organization of activated alpha 4 beta 1 integrins regulates T lymphocyte adhesion.	[Sosa-Costa, Alberto; Borgman, Kyra J. E.; Manzo, Carlo; Garcia-Parajo, Maria F.] Barcelona Inst Sci & Technol, Inst Ciencies Foton, Barcelona 08860, Spain; [Isern de Val, Sol; Sevilla-Movilla, Silvia; Teixido, Joaquin] Ctr Invest Biol, Dept Cellular & Mol Med, Madrid 28040, Spain; [Garcia-Parajo, Maria F.] ICREA, Pg Lluis Companys 23, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); ICREA	Garcia-Parajo, MF (corresponding author), Barcelona Inst Sci & Technol, Inst Ciencies Foton, Barcelona 08860, Spain.; Garcia-Parajo, MF (corresponding author), ICREA, Pg Lluis Companys 23, Barcelona 08010, Spain.	maria.garcia-parajo@icfo.es	Manzo, Carlo/B-9745-2012; Garcia-Parajo, Maria F./I-4610-2015	Manzo, Carlo/0000-0002-8625-0996; Garcia-Parajo, Maria F./0000-0001-6618-3944; Isern de Val, Maria Soledad/0000-0002-1303-706X	Erasmus Mundus Doctorate Program Europhotonics Grant [159224-1-2009-1-FR-ERA MUNDUS-EMJD]; Spanish Ministry of Economy and Competitiveness "Severo Ochoa" Programme for Centres of Excellence in RD Grants [SEV-2015-0522, FIS2014-5617-R, SAF2014-53059-R, RD12/0036/0061]; Fundacio Privada CELLEX (Barcelona); HFSP Grant [GA RGP0027/2012]; LaserLab Europe 4 Grant [GA 654148]; ICREA Funding Source: Custom	Erasmus Mundus Doctorate Program Europhotonics Grant; Spanish Ministry of Economy and Competitiveness "Severo Ochoa" Programme for Centres of Excellence in RD Grants; Fundacio Privada CELLEX (Barcelona)(Foundation CELLEX); HFSP Grant; LaserLab Europe 4 Grant; ICREA(ICREA)	This work was supported by Erasmus Mundus Doctorate Program Europhotonics Grant 159224-1-2009-1-FR-ERA MUNDUS-EMJD), Spanish Ministry of Economy and Competitiveness "Severo Ochoa" Programme for Centres of Excellence in R&D Grants SEV-2015-0522, FIS2014-5617-R, SAF2014-53059-R, and RD12/0036/0061; Fundacio Privada CELLEX (Barcelona); HFSP Grant GA RGP0027/2012; and LaserLab Europe 4 Grant GA 654148. The authors declare that they have no conflicts of interest with the contents of this article.	Alon R, 2012, CURR OPIN CELL BIOL, V24, P670, DOI 10.1016/j.ceb.2012.06.001; Borgman KJE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099589; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Chen HF, 2007, BIOPHYS J, V92, P1399, DOI 10.1529/biophysj.106.094896; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Garcia-Bernal D, 2009, IMMUNITY, V31, P953, DOI 10.1016/j.immuni.2009.09.021; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Bakker GJ, 2012, P NATL ACAD SCI USA, V109, P4869, DOI 10.1073/pnas.1116425109; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mainali D, 2013, EUR BIOPHYS J BIOPHY, V42, P281, DOI 10.1007/s00249-012-0873-x; Manevich E, 2007, J BIOL CHEM, V282, P25338, DOI 10.1074/jbc.M700089200; Manzo C, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/12/124601; Manzo C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04354; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Sanz-Rodriguez F, 2001, BLOOD, V97, P346, DOI 10.1182/blood.V97.2.346; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Ticchioni M, 2002, BLOOD, V99, P3111, DOI 10.1182/blood.V99.9.3111; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012	38	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21053	+		10.1074/jbc.M116.733709	http://dx.doi.org/10.1074/jbc.M116.733709			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27481944	Green Published, hybrid			2022-12-28	WOS:000385406200021
J	Lu, MD; Xu, W; Gao, B; Xiong, SD				Lu, Mudan; Xu, Wei; Gao, Bo; Xiong, Sidong			Blunting Autoantigen-induced FOXO3a Protein Phosphorylation and Degradation Is a Novel Pathway of Glucocorticoids for the Treatment of Systemic Lupus Erythematosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; FOXO; glucocorticoid; NF-kappa B (NF-KB); phosphorylation	NF-KAPPA-B; FORKHEAD TRANSCRIPTION FACTORS; TRIPARTITE MOTIF 22; NUCLEAR EXCLUSION; ACTIVATION; PATHOGENESIS; DISEASE; DNA; CLASSIFICATION; INHIBITION	Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease affecting multiple organs. Glucocorticoids (GCs), the potent anti-inflammatory drugs, remain as a cornerstone in the treatment for SLE; nevertheless, their clinical efficacy is compromised by the side effects of long term treatment and resistance. To improve the therapeutic efficacy of GCs in SLE, it is important to further decipher the molecular mechanisms of how GCs exert their anti-inflammatory effects. In this investigation, FOXO3a was identified as a molecule that was down-regulated in the course of SLE. Of interest, GC treatment was found to rescue FOXO3a expression both in SLE mice and in SLE patients. Gain- and loss-of-function studies demonstrated that FOXO3a played a crucial role in GC treatment of SLE via inhibiting inflammatory responses. Further studies showed that the up-regulation of FOXO3a by GCs relied on the suppression of pI3K/AKT-mediated FOXO3a phosphorylation and the arrest of FOXO3a in the nucleus. Finally, our data revealed that FOXO3a was critical for GC-mediated inhibition of NF-B activity, which might involve its interaction with NF-B p65 protein. Collectively, these data indicated that FOXO3a played an important role in GC treatment of SLE by suppressing pro-inflammatory response, and targeting FOXO3a might provide a novel therapeutic strategy against SLE.	[Lu, Mudan; Gao, Bo; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Dept Immunol, Inst Immunobiol, Shanghai 200032, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215006, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215006, Peoples R China	Fudan University; Soochow University - China; Soochow University - China	Gao, B (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Immunol, 138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.; Xiong, SD (corresponding author), Soochow Univ, Inst Biol Sci, 199 Ren Ai Rd, Suzhou 215006, Peoples R China.; Xiong, SD (corresponding author), Soochow Univ, Inst Med Sci, 199 Ren Ai Rd, Suzhou 215006, Peoples R China.	gaobo@fudan.edu.cn; sdxiongfd@126.com			Major State Basic Research Development Program of China [2013CB530501]; National Natural Science Foundation of China [81273300, 21334001]; Jiangsu Provincial Innovative Team; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT-IRT1075]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Innovative Team; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by Major State Basic Research Development Program of China Grant 2013CB530501, National Natural Science Foundation of China Grants 81273300 and 21334001, Jiangsu Provincial Innovative Team, Priority Academic Program Development of Jiangsu Higher Education Institutions, and Program for Changjiang Scholars and Innovative Research Team in University Grant PCSIRT-IRT1075. The authors declare that they have no conflicts of interest with the contents of this article.	Al Gadban MM, 2015, CLIN IMMUNOL, V157, P133, DOI 10.1016/j.clim.2015.01.008; Almawi WY, 2002, J MOL ENDOCRINOL, V28, P69, DOI 10.1677/jme.0.0280069; Ambatkar N, 2015, MOL BIOL INT, V2015; Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Benedek TG, 2011, CLIN EXP RHEUMATOL, V29, pS5; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cameron JS, 1999, J AM SOC NEPHROL, V10, P413; Chen M, 2011, MOL IMMUNOL, V48, P1532, DOI 10.1016/j.molimm.2011.04.016; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065542; Consolaro F, 2015, MOL CANCER RES, V13, P1578, DOI 10.1158/1541-7786.MCR-15-0127; Dejean AS, 2011, ANTIOXID REDOX SIGN, V14, P663, DOI 10.1089/ars.2010.3414; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Gao B, 2013, J IMMUNOL, V191, P464, DOI 10.4049/jimmunol.1203533; Gao B, 2010, J IMMUNOL, V185, P2314, DOI 10.4049/jimmunol.1001053; Gui J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046515; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6; Kim DH, 2012, J NUTR BIOCHEM, V23, P1277, DOI 10.1016/j.jnutbio.2011.07.008; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Li F, 2016, CELL PHYSIOL BIOCHEM, V38, P330, DOI 10.1159/000438633; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lu MD, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/946748; Luijten RKMAC, 2013, AUTOIMMUN REV, V12, P617, DOI 10.1016/j.autrev.2012.12.001; Ma JX, 2008, BIOCHEM BIOPH RES CO, V377, P894, DOI 10.1016/j.bbrc.2008.10.097; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Mao XL, 2014, CLIN RHEUMATOL, V33, P1585, DOI 10.1007/s10067-014-2717-9; Miao HM, 2012, MOL ENDOCRINOL, V26, P423, DOI 10.1210/me.2011-1233; Min M, 2014, INFLAMM BOWEL DIS, V20, P652, DOI 10.1097/MIB.0000000000000009; Mohan C, 2015, NAT REV NEPHROL, V11, P329, DOI 10.1038/nrneph.2015.33; Morris BJ, 2015, GERONTOLOGY, V61, P515, DOI 10.1159/000375235; Qiao B, 2005, RHEUMATOLOGY, V44, P1108, DOI 10.1093/rheumatology/keh656; Rekvig OP, 2014, SEMIN IMMUNOPATHOL, V36, P301, DOI 10.1007/s00281-014-0428-6; Reyes-Thomas J, 2011, CLIN REV ALLERG IMMU, V40, P138, DOI 10.1007/s12016-010-8197-z; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ruiz-Irastorza G, 2012, RHEUMATOLOGY, V51, P1145, DOI 10.1093/rheumatology/ker410; Snoeks L, 2009, LAB INVEST, V89, P1053, DOI 10.1038/labinvest.2009.66; Stahn C, 2008, NAT CLIN PRACT RHEUM, V4, P525, DOI 10.1038/ncprheum0898; Stanbury RM, 1998, BRIT J OPHTHALMOL, V82, P704, DOI 10.1136/bjo.82.6.704; Suarez-Fueyo A, 2014, J IMMUNOL, V193, P544, DOI 10.4049/jimmunol.1400350; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Wen ZK, 2007, RHEUMATOLOGY, V46, P1796, DOI 10.1093/rheumatology/kem275; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124; Zhang WJ, 2013, J BIOL CHEM, V288, P13534, DOI 10.1074/jbc.M113.457218; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhou W, 2009, GASTROENTEROLOGY, V137, P1403, DOI 10.1053/j.gastro.2009.06.049	56	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19900	19912		10.1074/jbc.M116.728840	http://dx.doi.org/10.1074/jbc.M116.728840			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27481940	hybrid, Green Published			2022-12-28	WOS:000383243100015
J	Ronchi, JA; Francisco, A; Passos, LAC; Figueira, TR; Castilho, RF				Ronchi, Juliana Aparecida; Francisco, Annelise; Correa Passos, Luiz Augusto; Figueira, Tiago Rezende; Castilho, Roger Frigerio			The Contribution of Nicotinamide Nucleotide Transhydrogenase to Peroxide Detoxification Is Dependent on the Respiratory State and Counterbalanced by Other Sources of NADPH in Liver Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; mitochondria; oxidation-reduction (redox); peroxidase; respiratory chain; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); c57bl; 6j; NADPH; transhydrogenase	FAMILIAL GLUCOCORTICOID DEFICIENCY; TERT-BUTYL HYDROPEROXIDE; RAT-LIVER; C57BL/6J MICE; PERMEABILITY TRANSITION; GLUTAMATE-DEHYDROGENASE; MALIC ENZYMES; GLUCOSE; METABOLISM; SUBSTRAINS	The forward reaction of nicotinamide nucleotide transhydrogenase (NNT) reduces NADP(+) at the expense of NADH oxidation and H+ movement down the electrochemical potential across the inner mitochondrial membrane, establishing an NADPH/NADP(+) ratio severalfold higher than the NADH/NAD(+) ratio in the matrix. In turn, NADPH drives processes, such as peroxide detoxification and reductive biosynthesis. In this study, we generated a congenic mouse model carrying a mutated Nnt(C57BL/6J) allele from the C57BL/6J substrain. Suspensions of isolated mitochondria from Nnt(+/+), Nnt(+/-), and Nnt(-/-) mouse liver were biochemically evaluated and challenged with exogenous peroxide under different respiratory states. The respiratory substrates were also varied, and the participation of concurrent NADPH sources (i.e. isocitrate dehydrogenase-2, malic enzymes, and glutamate dehydrogenase) was assessed. The principal findings include the following: Nnt(+/-) and Nnt(-/-) exhibit approximate to 50% and absent NNT activity, respectively, but the activities of concurrent NADPH sources are unchanged. The lack of NNT activity in Nnt(-/-) mice impairs peroxide metabolism in intact mitochondria. The contribution of NNT to peroxide metabolism is decreased during ADP phosphorylation compared with the non-phosphorylating state; however, it is accompanied by increased contributions of concurrent NADPH sources, especially glutamate dehydrogenase. NNT makes a major contribution to peroxide metabolism during the blockage of mitochondrial electron transport. Interestingly, peroxide metabolism in the Nnt(+/-) mitochondria matched that in the Nnt(+/+) mitochondria. Overall, this study demonstrates that the respiratory state and/or substrates that sustain energy metabolism markedly influence the relative contribution of NNT (i.e. varies between nearly 0 and 100%) to NADPH-dependent mitochondrial peroxide metabolism.	[Ronchi, Juliana Aparecida; Francisco, Annelise; Figueira, Tiago Rezende; Castilho, Roger Frigerio] Univ Estadual Campinas, Fac Med Sci, Dept Clin Pathol, BR-13083877 Campinas, SP, Brazil; [Correa Passos, Luiz Augusto] Univ Estadual Campinas, Multidisciplinary Ctr Biol Invest Lab Anim Sci, BR-13083877 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Castilho, RF (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Clin Pathol, BR-13083877 Campinas, SP, Brazil.; Figueira, TR (corresponding author), Univ Campinas UNICAMP, Dept Clin Pathol, Fac Med Sci, BR-13083887 Campinas, SP, Brazil.	figueirat@yahoo.com.br; roger@fcm.unicamp.br	Castilho, Roger F/G-3906-2012; Francisco, Annelise/AAQ-8826-2021; Figueira, Tiago Rezende/G-3251-2014	Figueira, Tiago Rezende/0000-0003-2228-2646; Francisco, Annelise/0000-0001-6729-8807; Castilho, Roger/0000-0003-2338-8717	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/50400-0, 2015/22063-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Postdoctoral Fellowship [403733/2014-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Postdoctoral Fellowship	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 2011/50400-0 (to R. F. C.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Scholarship Grant 2015/22063-0 (to A. F.), and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Postdoctoral Fellowship Grant 403733/2014-6 (to T. R. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Agledal L, 2010, REDOX REP, V15, P2, DOI 10.1179/174329210X12650506623122; Arkblad EL, 2005, FREE RADICAL BIO MED, V38, P1518, DOI 10.1016/j.freeradbiomed.2005.02.012; Bizouarn T, 1996, BBA-BIOENERGETICS, V1273, P4, DOI 10.1016/0005-2728(95)00125-5; Bourdi M, 2011, CHEM RES TOXICOL, V24, P794, DOI 10.1021/tx200143x; Cervinkova Z, 2008, PHYSIOL RES, V57, P133, DOI 10.33549/physiolres.931198; Chandel NS, 1997, J BIOL CHEM, V272, P18808, DOI 10.1074/jbc.272.30.18808; Chen Y, 2006, FEBS LETT, V580, P6596, DOI 10.1016/j.febslet.2006.11.007; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chweih H, 2015, EXP PHYSIOL, V100, P1073, DOI 10.1113/EP085248; Conner D.A., 2002, CURRENT PROTOCOLS MO; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; Davisson MT, 2005, ILAR J, V46, P338, DOI 10.1093/ilar.46.4.338; Drahota Z, 2005, PHYSIOL RES, V54, P67, DOI 10.33549/physiolres.930578; ESTABROOK RW, 1962, ANAL BIOCHEM, V4, P231, DOI 10.1016/0003-2697(62)90006-4; Fergusson G, 2014, MOL METAB, V3, P848, DOI 10.1016/j.molmet.2014.09.006; Figueira TR, 2013, EXP PHYSIOL, V98, P1643, DOI 10.1113/expphysiol.2013.074682; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Figueira TR, 2011, MOL GENET METAB, V104, P521, DOI 10.1016/j.ymgme.2011.08.031; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Flohe L, 2011, ANTIOXID REDOX SIGN, V15, P763, DOI 10.1089/ars.2010.3397; Fontaine DA, 2016, DIABETES, V65, P25, DOI 10.2337/db15-0982; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Fujisawa Y, 2015, BBA CLIN, V3, P70, DOI 10.1016/j.bbacli.2014.12.003; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; GEER BW, 1980, COMP BIOCHEM PHYS B, V65, P25, DOI 10.1016/0305-0491(80)90109-1; GODINOT C, 1971, FEBS LETT, V13, P235, DOI 10.1016/0014-5793(71)80543-4; HOEK JB, 1988, BIOCHEM J, V254, P1; Hsieh JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025312; Kraev A, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-18; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; LEHNINGER AL, 1978, P NATL ACAD SCI USA, V75, P1690, DOI 10.1073/pnas.75.4.1690; LENARTOWICZ E, 1988, ARCH BIOCHEM BIOPHYS, V260, P309, DOI 10.1016/0003-9861(88)90455-9; Leung JH, 2015, SCIENCE, V347, P178, DOI 10.1126/science.1260451; LIN RC, 1974, J BIOL CHEM, V249, P3867; Liu H, 1996, FREE RADICAL BIO MED, V20, P433, DOI 10.1016/0891-5849(95)02093-4; Lopert P, 2014, J BIOL CHEM, V289, P15611, DOI 10.1074/jbc.M113.533653; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; NICHOLLS DG, 1969, BIOCHEM J, V114, P215, DOI 10.1042/bj1140215; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; REINHART PH, 1982, BIOCHEM J, V204, P731, DOI 10.1042/bj2040731; Ripoll VM, 2012, FASEB J, V26, P3550, DOI 10.1096/fj.11-199935; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; VERCESI AE, 1987, ARCH BIOCHEM BIOPHYS, V252, P171, DOI 10.1016/0003-9861(87)90021-X; Vogel R, 1999, NEUROSCI LETT, V275, P97, DOI 10.1016/S0304-3940(99)00748-X; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004; Zhang X, 2004, J BIOL CHEM, V279, P43035, DOI 10.1074/jbc.M402759200	50	66	66	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20173	20187		10.1074/jbc.M116.730473	http://dx.doi.org/10.1074/jbc.M116.730473			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27474736	hybrid, Green Published			2022-12-28	WOS:000383243100037
J	Xu, B; O'Donnell, M; O'Donnell, J; Yu, JC; Zhang, YX; Sartor, MA; Koenig, RJ				Xu, Bin; O'Donnell, Michael; O'Donnell, Jeffrey; Yu, Jingcheng; Zhang, Yanxiao; Sartor, Maureen A.; Koenig, Ronald J.			Adipogenic Differentiation of Thyroid Cancer Cells Through the Pax8-PPAR Fusion Protein Is Regulated by Thyroid Transcription Factor 1 (TTF-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; differentiation; fusion protein; gene expression; thyroid	GENE-EXPRESSION; LUNG ADENOCARCINOMA; FACTOR PAX8; PPAR-GAMMA; CARCINOMA; PROGRESSION; ONCOGENE; SURVIVAL; ENHANCER	A subset of thyroid carcinomas contains a t(2;3)(q13;p25) chromosomal translocation that fuses paired box gene 8 (PAX8) with the peroxisome proliferator-activated receptor gene (PPARG), resulting in expression of a PAX8-PPAR fusion protein, PPFP. We previously generated a transgenic mouse model of PPFP thyroid carcinoma and showed that feeding the PPAR agonist pioglitazone greatly decreased the size of the primary tumor and prevented metastatic disease in vivo. The antitumor effect correlates with the fact that pioglitazone turns PPFP into a strongly PPAR-like molecule, resulting in trans-differentiation of the thyroid cancer cells into adipocyte-like cells that lose malignant character as they become more differentiated. To further study this process, we performed cell culture experiments with thyrocytes from the PPFP mouse thyroid cancers. Our data show that pioglitazone induced cellular lipid accumulation and the expression of adipocyte marker genes in the cultured cells, and shRNA knockdown of PPFP eliminated this pioglitazone effect. In addition, we found that PPFP and thyroid transcription factor 1 (TTF-1) physically interact, and that these transcription factors bind near each other on numerous target genes. TTF-1 knockdown and overexpression studies showed that TTF-1 inhibits PPFP target gene expression and impairs adipogenic trans-differentiation. Surprisingly, pioglitazone repressed TTF-1 expression in PPFP-expressing thyrocytes. Our data indicate that TTF-1 interacts with PPFP to inhibit the pro-adipogenic response to pioglitazone, and that the ability of pioglitazone to decrease TTF-1 expression contributes to its pro-adipogenic action.	[Xu, Bin; O'Donnell, Michael; O'Donnell, Jeffrey; Yu, Jingcheng; Koenig, Ronald J.] Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Zhang, Yanxiao; Sartor, Maureen A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, B (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	bxu@umich.edu	Zhang, Yanxiao/Q-8263-2019; Sartor, Maureen/L-2902-2019	Zhang, Yanxiao/0000-0001-9618-637X	National Institutes of Health (NIH) [R01CA151842, R01CA166033]; NATIONAL CANCER INSTITUTE [R01CA166033, R01CA151842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants R01CA151842 and R01CA166033. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Vu-Phan D, 2013, ENDOCR-RELAT CANCER, V20, P725, DOI 10.1530/ERC-13-0058; Di Palma T, 2003, J BIOL CHEM, V278, P3395, DOI 10.1074/jbc.M205977200; Dobson ME, 2011, ENDOCRINOLOGY, V152, P4455, DOI 10.1210/en.2011-1178; Endo T, 2013, ENDOCR-RELAT CANCER, V20, P767, DOI 10.1530/ERC-13-0310; Esposito C, 1998, BIOCHEM J, V331, P37, DOI 10.1042/bj3310037; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fabbro D, 1998, J MOL ENDOCRINOL, V21, P347, DOI 10.1677/jme.0.0210347; Giordano TJ, 2006, CLIN CANCER RES, V12, P1983, DOI 10.1158/1078-0432.CCR-05-2039; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Miccadei S, 2002, MOL ENDOCRINOL, V16, P837, DOI 10.1210/me.16.4.837; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Ngan ESW, 2009, JNCI-J NATL CANCER I, V101, P162, DOI 10.1093/jnci/djn471; Ohno M, 1999, MOL CELL BIOL, V19, P2051; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stanfel MN, 2005, CELL MOL BIOL, V51, pOL785, DOI 10.1170/92; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Zhang YX, 2015, ONCOTARGET, V6, P40418, DOI 10.18632/oncotarget.6340	27	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19274	19286		10.1074/jbc.M116.740324	http://dx.doi.org/10.1074/jbc.M116.740324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27435678	Green Published, hybrid			2022-12-28	WOS:000383242800009
J	Dang, FW; Chen, L; Madura, K				Dang, Francis Wang; Chen, Li; Madura, Kiran			Catalytically Active Proteasomes Function Predominantly in the Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY CONTROL DEGRADATION; NUCLEOTIDE EXCISION-REPAIR; 26S PROTEASOME; SACCHAROMYCES-CEREVISIAE; 20S PROTEASOME; SUBCELLULAR-LOCALIZATION; NUCLEAR PROTEINS; GENE-EXPRESSION; HO ENDONUCLEASE; YEAST-CELLS	The ubiquitin/proteasome pathway is a well characterized system for degrading intracellular proteins, although many aspects remain poorly understood. There is, for instance, a conspicuous lack of understanding of the site(s) where nuclear proteins are degraded because the subcellular distribution of peptidase activity has not been investigated systematically. Although nuclear proteins could be degraded by importing proteasomes into the nucleus, it is also evident that some nuclear proteins are degraded only after export to cytosolic proteasomes. Proteasomes and substrates are mobile, and consequently, the sites of degradation might not be static. We sought to identify the location of proteasomes to provide more conclusive evidence on the sites of protein degradation. We report that catalytically active proteasomes exist almost exclusively in the cytosol. The resulting lack of nuclear peptidase activity suggests that little, if any, degradation occurs in the nucleus. These and other studies suggest that the export of proteolytic substrates could define an important regulatory step in the degradation of nuclear proteins by cytosolic proteasomes.	[Dang, Francis Wang; Chen, Li; Madura, Kiran] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, SPH 383,683 Hoes Lane, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Madura, K (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, SPH 383,683 Hoes Lane, Piscataway, NJ 08854 USA.	maduraki@rwjms.rutgers.edu			National Institutes of Health [GM104968]; National Cancer Institute [CA083875]; NATIONAL CANCER INSTITUTE [R01CA083875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM104968 and Grant CA083875 from National Cancer Institute (to K. M.). K. M. is a founder of CellXplore LLC whose objectives are unrelated to the content of this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Apcher GS, 2004, FEBS LETT, V569, P211, DOI 10.1016/j.febslet.2004.05.067; Bakhrat A, 2008, CURR GENET, V54, P271, DOI 10.1007/s00294-008-0216-8; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chandra A, 2010, J BIOL CHEM, V285, P8330, DOI 10.1074/jbc.M109.076786; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chen L, 2008, MOL CELL BIOL, V28, P1829, DOI 10.1128/MCB.01256-07; Chen L, 2014, J BIOL CHEM, V289, P32339, DOI 10.1074/jbc.M114.582023; Chen L, 2014, GENETICS, V197, P193, DOI 10.1534/genetics.114.163824; Chen L, 2011, J BIOL CHEM, V286, P3104, DOI 10.1074/jbc.M110.135863; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Dieppois G, 2010, J CELL SCI, V123, P1989, DOI 10.1242/jcs.053694; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hedhli N, 2008, CARDIOVASC RES, V77, P497, DOI 10.1093/cvr/cvm054; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kulichkova VA, 2015, MOL BIOTECHNOL, V57, P36, DOI 10.1007/s12033-014-9799-0; Lahaye F, 2010, NUCLEIC ACIDS RES, V38, P3655, DOI 10.1093/nar/gkq098; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Livinskaya VA, 2014, PROTEIN EXPRES PURIF, V97, P37, DOI 10.1016/j.pep.2014.02.011; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Niepel M, 2013, MOL BIOL CELL, V24, P3920, DOI 10.1091/mbc.E13-07-0412; Pack CG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4396; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Sanchez Leticia, 2005, J Biomol Tech, V16, P235; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Tsuchiya H, 2013, BIOCHEM BIOPH RES CO, V436, P372, DOI 10.1016/j.bbrc.2013.05.105; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Wiehens N, 2001, CURR BIOL, V11, P18; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zang ZJ, 2009, CELL SIGNAL, V21, P34, DOI 10.1016/j.cellsig.2008.09.018	50	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18765	18777		10.1074/jbc.M115.712406	http://dx.doi.org/10.1074/jbc.M115.712406			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27417138	Green Published, hybrid			2022-12-28	WOS:000383242300014
J	Jimenez-Canino, R; Fernandes, MX; de la Rosa, DA				Jimenez-Canino, Ruben; Fernandes, Miguel X.; Alvarez de la Rosa, Diego			Phosphorylation of Mineralocorticoid Receptor Ligand Binding Domain Impairs Receptor Activation and Has a Dominant Negative Effect over Non-phosphorylated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; GLUCOCORTICOID-RECEPTORS; TRANSCRIPTIONAL ACTIVITY; ALDOSTERONE; HETERODIMERIZATION; IDENTIFICATION; COACTIVATOR; MECHANISMS; EXPRESSION; GENE	Post-translational modification of steroid receptors allows fine-tuning different properties of this family of proteins, including stability, activation, or interaction with co-regulators. Recently, a novel effect of phosphorylation on steroid receptor biology was described. Phosphorylation of human mineralocorticoid receptor (MR) on Ser-843, a residue placed on the ligand binding domain, lowers affinity for agonists, producing inhibition of gene transactivation. We now show that MR inhibition by phosphorylation occurs even at high agonist concentration, suggesting that phosphorylation may also impair coupling between ligand binding and receptor activation. Our results demonstrate that agonists are able to induce partial nuclear translocation of MR but fail to produce transactivation due at least in part to impaired co-activator recruitment. The inhibitory effect of phosphorylation on MR acts in a dominant-negative manner, effectively amplifying its functional effect on gene transactivation.	[Alvarez de la Rosa, Diego] Univ La Laguna, Inst Tecnol Biomed, Dept Ciencias Med Basicas, Tenerife 38071, Spain; Univ La Laguna, Ctr Invest Biomed Canarias CIBICAN, Tenerife 38071, Spain	Universidad de la Laguna; Universidad de la Laguna	de la Rosa, DA (corresponding author), Univ La Laguna, Inst Tecnol Biomed, Dept Ciencias Med Basicas, Tenerife 38071, Spain.	diego.alvarez@ull.edu.es	Fernandes, Miguel Xavier/AAP-6504-2020; Alvarez de la Rosa, Diego/H-8500-2015	Fernandes, Miguel Xavier/0000-0002-1840-616X; Alvarez de la Rosa, Diego/0000-0002-4324-2793	Ministerio de Economia y Competitividad (Spain) [BFU2013-47089-R]; European Cooperation on Science and Technology (COST) network ADMIRE [BM1301]; European Union [FP7-REGPOT-2012-CT2012-31637-IMBRAIN]; Cajacanarias (Spain); Formacion de Profesorado Universitario (FPU) Program (Ministerio de Educacion, Spain)	Ministerio de Economia y Competitividad (Spain); European Cooperation on Science and Technology (COST) network ADMIRE; European Union(European Commission); Cajacanarias (Spain); Formacion de Profesorado Universitario (FPU) Program (Ministerio de Educacion, Spain)(German Research Foundation (DFG))	This work was supported by Ministerio de Economia y Competitividad (Spain) Grant BFU2013-47089-R, European Cooperation on Science and Technology (COST) network ADMIRE BM1301, and the European Union Seventh Framework Program "Capacities" (FP7-REGPOT-2012-CT2012-31637-IMBRAIN). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by predoctoral fellowships from Cajacanarias (Spain) and Formacion de Profesorado Universitario (FPU) Program (Ministerio de Educacion, Spain).	Aguilar-Sanchez C, 2012, ENDOCRINOLOGY, V153, P3517, DOI 10.1210/en.2012-1210; Amazit L, 2015, J BIOL CHEM, V290, P21876, DOI 10.1074/jbc.M115.657957; Anbalagan Muralidharan, 2012, Nucl Recept Signal, V10, pe001, DOI 10.1621/nrs.10001; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Funder JW, 2013, CELL METAB, V18, P609, DOI 10.1016/j.cmet.2013.10.010; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Gravez B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073737; Hasui T, 2011, J MED CHEM, V54, P8616, DOI 10.1021/jm2011645; Hellal-Levy C, 1999, FEBS LETT, V464, P9, DOI 10.1016/S0014-5793(99)01667-1; Hellal-Levy C, 2000, KIDNEY INT, V57, P1250, DOI 10.1046/j.1523-1755.2000.00958.x; Hernandez-Diaz I, 2010, ENDOCRINOLOGY, V151, P3888, DOI 10.1210/en.2010-0099; Hultman ML, 2005, MOL ENDOCRINOL, V19, P1460, DOI 10.1210/me.2004-0537; Jimenez-Canino R, 2016, ENDOCRINOLOGY, V157, P2515, DOI 10.1210/en.2015-2055; Kino T, 2010, MOL ENDOCRINOL, V24, P941, DOI 10.1210/me.2009-0395; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; LOMBES M, 1994, ENDOCRINOLOGY, V135, P834, DOI 10.1210/en.135.3.834; Mani O, 2016, J STEROID BIOCHEM, V159, P31, DOI 10.1016/j.jsbmb.2016.02.017; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Refolio E, 2011, J CELL SCI, V124, P2488, DOI 10.1242/jcs.081711; Sever R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016709; Shibata S, 2013, CELL METAB, V18, P660, DOI 10.1016/j.cmet.2013.10.005; Walther RF, 2005, J BIOL CHEM, V280, P17549, DOI 10.1074/jbc.M501548200	26	8	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19068	19078		10.1074/jbc.M116.718395	http://dx.doi.org/10.1074/jbc.M116.718395			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27422824	Green Published, hybrid			2022-12-28	WOS:000383242300040
J	Babbitt, SE; Hsu, J; Kranz, RG				Babbitt, Shalon E.; Hsu, Jennifer; Kranz, Robert G.			Molecular Basis Behind Inability of Mitochondrial Holocytochrome c Synthase to Mature Bacterial Cytochromes: DEFINING A CRITICAL ROLE FOR CYTOCHROME c alpha HELIX-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c; heme; post-translational modification (PTM); protein structure; substrate specificity; system III; thioether	BIOGENESIS SYSTEM-I; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; HEME LYASE; SUBSTRATE SPECIFICITIES; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; PEP-FOLD; MECHANISMS; RESOLUTION	Mitochondrial holocytochrome c synthase (HCCS) is required for cytochrome c (cyt c) maturation and therefore respiration. HCCS efficiently attaches heme via two thioethers to CXXCH of mitochondrial but not bacterial cyt c even though they are functionally conserved. This inability is due to residues in the bacterial cyt c N terminus, but the molecular basis is unknown. Human cyts c with deletions of single residues in helix-1, which mimic bacterial cyt c, are poorly matured by human HCCS. Focusing on M13 cyt c, we co-purified this variant with HCCS, demonstrating that HCCS recognizes the bacterial-like cytochrome. Although an HCCS-WT cyt c complex contains two covalent links, HCCS-M13 cyt c contains only one thioether attachment. Using multiple approaches, we show that the single attachment is to the second thiol of C(15)SQC(18)H, indicating that helix-1 is required for positioning the first cysteine for covalent attachment, whereas the histidine of CXXCH positions the second cysteine. Modeling of the N-terminal structure suggested that the serine residue (of CSQCH) would be anchored where the first cysteine should be in M13 cyt c. An engineered cyt c with a CQCH motif in the M13 background is matured at higher levels (2-3-fold), providing further evidence for helix-1 positioning the first cysteine. Bacterial cyt c biogenesis pathways (Systems I and II) appear to recognize simply the CXXCH motif, not requiring helix-1. Results here explain mechanistically how HCCS (System III) requires an extended region adjacent to CXXCH for maturation.	[Babbitt, Shalon E.; Hsu, Jennifer; Kranz, Robert G.] Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA	Washington University (WUSTL)	Kranz, RG (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	kranz@biology.wustl.edu			National Institutes of Health [R01 GM47909, F32 GM108278]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108278, R01GM047909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM47909 (to R. G. K.) and F32 GM108278 (to S. E. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JWA, 2011, FEBS J, V278, P4198, DOI 10.1111/j.1742-4658.2011.08231.x; Allen JWA, 2009, BIOCHEM J, V419, P177, DOI 10.1042/BJ20081999; AXELROD HL, 1994, ACTA CRYSTALLOGR D, V50, P596, DOI 10.1107/S0907444994001319; Babbitt SE, 2015, TRENDS BIOCHEM SCI, V40, P446, DOI 10.1016/j.tibs.2015.05.006; Babbitt SE, 2014, J BIOL CHEM, V289, P28795, DOI 10.1074/jbc.M114.593509; Babbitt SE, 2014, BIOCHEMISTRY-US, V53, P5261, DOI 10.1021/bi500704p; BANCI L, 2001, HDB METALLOPROTEINS, V1, P33; Beckett CS, 2000, MOL MICROBIOL, V38, P465, DOI 10.1046/j.1365-2958.2000.02174.x; Bernard DG, 2003, J BIOL CHEM, V278, P49732, DOI 10.1074/jbc.M308881200; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Braun M, 2004, P NATL ACAD SCI USA, V101, P12830, DOI 10.1073/pnas.0402435101; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Clarke TA, 2011, P NATL ACAD SCI USA, V108, P9384, DOI 10.1073/pnas.1017200108; Corvest V, 2010, GENETICS, V186, P561, DOI 10.1534/genetics.110.120022; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Elias DA, 2005, PROTEOMICS, V5, P3120, DOI 10.1002/pmic.200401140; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Feissner RE, 2006, MOL MICROBIOL, V60, P563, DOI 10.1111/j.1365-2958.2006.05132.x; Giege P, 2008, MITOCHONDRION, V8, P61, DOI 10.1016/j.mito.2007.10.001; Goddard AD, 2010, FEBS J, V277, P726, DOI 10.1111/j.1742-4658.2009.07517.x; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; Herbaud ML, 2000, BBA-PROTEIN STRUCT M, V1481, P18, DOI 10.1016/S0167-4838(00)00117-5; Kadziola A, 1997, STRUCTURE, V5, P203, DOI 10.1016/S0969-2126(97)00179-2; Kleingardner JG, 2011, METALLOMICS, V3, P396, DOI 10.1039/c0mt00086h; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; LOUIE GV, 1990, J MOL BIOL, V214, P527, DOI 10.1016/0022-2836(90)90197-T; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moore G. R., 1990, CYTOCHROMES C EVOLUT, P115; Pattarkine MV, 2006, J MOL BIOL, V358, P1314, DOI 10.1016/j.jmb.2006.03.010; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; PETTIGREW GW, 1975, BIOCHEM J, V147, P291, DOI 10.1042/bj1470291; PRIEST JW, 1992, J BIOL CHEM, V267, P20188; Rajagopal BS, 2013, BIOCHEM J, V456, P441, DOI 10.1042/BJ20130758; Richard-Fogal CL, 2012, BBA-BIOENERGETICS, V1817, P911, DOI 10.1016/j.bbabio.2011.09.008; Romine MF, 2004, OMICS, V8, P239, DOI 10.1089/omi.2004.8.239; Rosell FI, 2002, BIOCHEMISTRY-US, V41, P7811, DOI 10.1021/bi016060e; San Francisco B, 2013, P NATL ACAD SCI USA, V110, P3221, DOI 10.1073/pnas.1213897109; Sanders C, 2000, BBA-BIOENERGETICS, V1459, P131, DOI 10.1016/S0005-2728(00)00122-5; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Santos-Silva T, 2007, J MOL BIOL, V370, P659, DOI 10.1016/j.jmb.2007.04.055; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Simon J, 2011, FEBS J, V278, P4179, DOI 10.1111/j.1742-4658.2011.08374.x; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Stevens JM, 2011, FEBS LETT, V585, P1891, DOI 10.1016/j.febslet.2011.04.058; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; VELOSO D, 1984, J BIOL CHEM, V259, P6067; Verissimo AF, 2012, BIOCHEM BIOPH RES CO, V424, P130, DOI 10.1016/j.bbrc.2012.06.088; Xie ZY, 1998, BBA-BIOENERGETICS, V1365, P309, DOI 10.1016/S0005-2728(98)00085-1; Xie ZY, 1996, J BIOL CHEM, V271, P4632; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1; Zhang YL, 2014, FEBS LETT, V588, P3367, DOI 10.1016/j.febslet.2014.07.026; ZOLLNER A, 1992, EUR J BIOCHEM, V207, P1093, DOI 10.1111/j.1432-1033.1992.tb17146.x	53	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17523	17534		10.1074/jbc.M116.741231	http://dx.doi.org/10.1074/jbc.M116.741231			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27387500	hybrid, Green Published			2022-12-28	WOS:000383241300004
J	Fleet, A; Lee, JPY; Tamachi, A; Javeed, I; Hamel, PA				Fleet, Andrew; Lee, Jennifer P. Y.; Tamachi, Aaliya; Javeed, Imaan; Hamel, Paul A.			Activities of the Cytoplasmic Domains of Patched-1 Modulate but Are Not Essential for the Regulation of Canonical Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cilia; Hedgehog signaling pathway; oligomerization; sonic hedgehog (SHH); Patched-1; Smoothened	CELL-CYCLE PROGRESSION; TUMOR-SUPPRESSOR GENE; SONIC HEDGEHOG; MESENCHYMAL DYSPLASIA; DROSOPHILA SEGMENT; PRIMARY CILIUM; MAMMARY-GLAND; HUMAN HOMOLOG; RECEPTOR; PROTEIN	The Hedgehog (Hh) pathway is a highly conserved signaling cascade crucial for cell fate determination during embryogenesis. Response to the Hh ligands is mediated by the receptor Patched-1 (Ptch1), a 12-pass transmembrane glycoprotein. Despite its essential role in Hh signaling and its activity as a tumor suppressor, Ptch1 remains largely uncharacterized. We demonstrate here that Ptch1 binds to itself to form oligomeric structures. Oligomerization is mediated by two distinct, structurally disordered, intracellular domains spanning amino acids 584-734 (middle loop) and 1162-1432 (C terminus). However, oligomerization is not required for Ptch1-dependent regulation of the canonical Hh pathway operating through Smo. Expression of a mutant protein that deletes both regions represses the Hh pathway and responds to the addition of Hh ligand independent of its inability to bind other factors such as Smurf2. Additionally, deletion of the cytoplasmic middle loop domain generates a Ptch1 mutant that, despite binding to Hh ligand, constitutively suppresses Hh signaling and increases the length of primary cilia. Constitutive activity because of deletion of this region is reversed by further deletion of specific sequences in the cytoplasmic C-terminal domain. These data reveal an interaction between the cytoplasmic domains of Ptch1 and that these domains modulate Ptch1 activity but are not essential for regulation of the Hh pathway.	[Fleet, Andrew; Lee, Jennifer P. Y.; Tamachi, Aaliya; Javeed, Imaan; Hamel, Paul A.] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, 1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada	University of Toronto	Hamel, PA (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, 1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada.	paul.hamel@utoronto.ca			Canadian Institutes of Health Research [MOP-97929]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-97929 (to P. A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Adolphe C, 2014, J INVEST DERMATOL, V134, P1981, DOI 10.1038/jid.2014.63; Alfaro AC, 2014, DEVELOPMENT, V141, P3331, DOI 10.1242/dev.110056; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Braun S, 2012, CANCER BIOL THER, V13, P487, DOI 10.4161/cbt.19591; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chang H, 2012, DEV BIOL, V370, P187, DOI 10.1016/j.ydbio.2012.07.027; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Chen XLL, 2014, MOL CELL BIOL, V34, P3855, DOI 10.1128/MCB.00960-14; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Harvey MC, 2014, J BIOL CHEM, V289, P10939, DOI 10.1074/jbc.M113.514844; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; HIDALGO A, 1990, DEVELOPMENT, V110, P291; Holtz AM, 2013, DEVELOPMENT, V140, P3423, DOI 10.1242/dev.095083; Huang SJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001721; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kim J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5622; Li Z, 2008, INT J BIOL SCI, V4, P29; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Makino S, 2001, DEV BIOL, V239, P95, DOI 10.1006/dbio.2001.0419; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/ng0298-104; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Nieuwenhuis E, 2007, DEV BIOL, V308, P547, DOI 10.1016/j.ydbio.2007.06.016; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Okolowsky N, 2014, DEV BIOL, V391, P219, DOI 10.1016/j.ydbio.2014.04.007; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Sweet HO, 1996, J HERED, V87, P87, DOI 10.1093/oxfordjournals.jhered.a022981; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Wilson CW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-102; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Wolter M, 1997, CANCER RES, V57, P2581; Yue S, 2014, ELIFE, V3, DOI 10.7554/eLife.02555; Zaphiropoulos PG, 1999, CANCER RES, V59, P787; Zhulyn O, 2015, DEV BIOL, V397, P191, DOI 10.1016/j.ydbio.2014.10.023	48	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17557	17568		10.1074/jbc.M116.731745	http://dx.doi.org/10.1074/jbc.M116.731745			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27325696	hybrid, Green Published			2022-12-28	WOS:000383241300008
J	Nguyen, HA; Su, Y; Lavie, A				Hien Anh Nguyen; Su, Ying; Lavie, Arnon			Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; enzyme kinetics; enzyme mutation; leukemia; structural biology; structure-function; substrate specificity	VIBRIO-SUCCINOGENES; ESCHERICHIA-COLI; DEPLETION; ENZYME; MECHANISM; CHILDREN; LEUKEMIA; THERAPY; INSIGHT; ASSAY	Current FDA-approved l-asparaginases also possess significant l-glutaminase activity, which correlates with many of the toxic side effects of these drugs. Therefore, l-asparaginases with reduced l-glutaminase activity are predicted to be safer. We exploited our recently described structures of the Erwinia chrysanthemil-asparaginase (ErA) to inform the design of mutants with diminished ability to hydrolyze l-glutamine. Structural analysis of these variants provides insight into the molecular basis for the increased l-asparagine specificity. A primary role is attributed to the E63Q mutation that acts to hinder the correct positioning of l-glutamine but not l-asparagine. The substitution of Ser-254 with either an asparagine or a glutamine increases the l-asparagine specificity but only when combined with the E63Q mutation. The A31I mutation reduces the substrate K-m value; this is a key property to allow the required therapeutic l-asparagine depletion. Significantly, an ultra-low l-glutaminase ErA variant maintained its cell killing ability. By diminishing the l-glutaminase activity of these highly active l-asparaginases, our engineered ErA variants hold promise as l-asparaginases with fewer side effects.	[Hien Anh Nguyen; Su, Ying; Lavie, Arnon] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Hien Anh Nguyen; Su, Ying; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lavie, A (corresponding author), 900 South Ashland Ave,MBRB Rm 1108, Chicago, IL 60607 USA.	Lavie@uic.edu		Lavie, Arnon/0000-0001-5591-8722	DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013685] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001919] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Veterans Affairs(US Department of Veterans Affairs)	We appreciate the technical support of the staff at LS-CAT during data collection. We also thank Dr. Schalk for review of the manuscript. This research used the resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Aldoss I, 2016, EUR J HAEMATOL, V96, P375, DOI 10.1111/ejh.12600; Alsaid Y, 2013, CASE REP HEMATOL, V2013, DOI 10.1155/2013/841057; Alvarez OA, 2000, MED PEDIATR ONCOL, V34, P200, DOI 10.1002/(SICI)1096-911X(200003)34:3<200::AID-MPO7>3.0.CO;2-T; BERENBAUM MC, 1970, NATURE, V225, P550, DOI 10.1038/225550a0; Bhojwani D, 2014, EUR J CANCER, V50, P2685, DOI 10.1016/j.ejca.2014.06.023; Bushman JE, 2000, LEUKEMIA RES, V24, P559, DOI 10.1016/S0145-2126(00)00017-5; Cappelletti D, 2008, BIOCHEM BIOPH RES CO, V377, P1222, DOI 10.1016/j.bbrc.2008.10.118; Chan WK, 2014, BLOOD, V123, P3596, DOI 10.1182/blood-2013-10-535112; Derst C, 2000, PROTEIN SCI, V9, P2009, DOI 10.1110/ps.9.10.2009; DISTASIO JA, 1982, INT J CANCER, V30, P343, DOI 10.1002/ijc.2910300314; DISTASIO JA, 1977, P SOC EXP BIOL MED, V155, P528; DURDEN DL, 1981, INT J CANCER, V27, P59, DOI 10.1002/ijc.2910270110; DURDEN DL, 1983, CANCER RES, V43, P1602; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez CA, 2013, INT J CLIN EXP MED, V6, P478; GELLA FJ, 1982, ANAL BIOCHEM, V127, P322; Hernandez-Espinosa D, 2006, AM J PATHOL, V169, P142, DOI 10.2353/ajpath.2006.051238; Nguyen HA, 2016, BIOCHEMISTRY-US, V55, P1246, DOI 10.1021/acs.biochem.5b01351; HOROWITZ B, 1968, SCIENCE, V160, P533, DOI 10.1126/science.160.3827.533; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; KAFKEWITZ D, 1983, AM J CLIN NUTR, V37, P1025; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; OLLENSCHLAGER G, 1988, EUR J CLIN INVEST, V18, P512, DOI 10.1111/j.1365-2362.1988.tb01049.x; Parmentier JH, 2015, LEUKEMIA RES, V39, P757, DOI 10.1016/j.leukres.2015.04.008; Payne JH, 2007, BRIT J HAEMATOL, V138, P430, DOI 10.1111/j.1365-2141.2007.06677.x; Raja RA, 2014, BRIT J HAEMATOL, V165, P126, DOI 10.1111/bjh.12733; Ramya LN, 2012, APPL BIOCHEM BIOTECH, V167, P2144, DOI 10.1007/s12010-012-9755-z; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Rizzari C, 2013, CURR OPIN ONCOL, V25, pS1, DOI 10.1097/CCO.0b013e32835d7d85; Salzer WL, 2014, ANN NY ACAD SCI, V1329, P81, DOI 10.1111/nyas.12496; Schalk AM, 2016, J BIOL CHEM, V291, P5088, DOI 10.1074/jbc.M115.699884; Schalk AM, 2014, J BIOL CHEM, V289, P33175, DOI 10.1074/jbc.M114.609552; Truelove E, 2013, LEUKEMIA, V27, P553, DOI 10.1038/leu.2012.290; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	35	41	46	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17664	17676		10.1074/jbc.M116.728485	http://dx.doi.org/10.1074/jbc.M116.728485			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27354283	hybrid, Green Published			2022-12-28	WOS:000383241300017
J	Junkunlo, K; Soderhall, K; Soderhall, I; Noonin, C				Junkunlo, Kingkamon; Soderhall, Kenneth; Soderhall, Irene; Noonin, Chadanat			Reactive Oxygen Species Affect Transglutaminase Activity and Regulate Hematopoiesis in a Crustacean	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; hematopoiesis; invertebrate; reactive oxygen species (ROS); transglutaminase	STEM-CELL FUNCTION; TISSUE TRANSGLUTAMINASE; INVERTEBRATE HEMATOPOIESIS; EXTRACELLULAR-MATRIX; DROSOPHILA LARVAE; OXIDATIVE STRESS; GROWTH-FACTORS; DIFFERENTIATION; PROGENITORS; PROLIFERATION	Reactive oxygen species (ROS) serve as a prime signal in the commitment to hematopoiesis in both mammals and Drosophila. In this study, the potential function of ROS during hematopoiesis in the crayfish Pacifastacus leniusculus was examined. The antioxidant N-acetylcysteine (NAC) was used to decrease ROS in both in vivo and in vitro experiments. An increase in ROS was observed in the anterior proliferation center (APC) after LPS injection. In the absence of NAC, the LPS-induced increase in ROS levels resulted in the rapid restoration of the circulating hemocyte number. In the presence of NAC, a delay in the recovery rate of the hemocyte number was observed. NAC treatment also blocked the spread of APC and other hematopoietic tissue (HPT) cells, maintaining these cells at an undifferentiated stage. Extracellular transglutaminase (TGase) has been shown previously to play a role in maintaining HPT cells in an undifferentiated form. In this study, we show that extracellular TGase activity increased when the ROS level in HPT or APC cells was reduced after NAC treatment. In addition, collagen, a major component of the extracellular matrix and a TGase substrate were co-localized on the HPT cell surface. Taken together, the results of this study show that ROS are involved in crayfish hematopoiesis, in which a low ROS level is required to maintain hematopoietic progenitor cells in the tissue and to reduce hemocyte release. The potential roles of TGase in this process are investigated and discussed.	[Junkunlo, Kingkamon; Soderhall, Kenneth; Soderhall, Irene; Noonin, Chadanat] Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden	Uppsala University	Noonin, C (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	chadanat.noonin@ebc.uu.se	Soderhall, Irene/AAS-5433-2020; Noonin, Chadanat/AAD-6269-2022		Swedish Science Research Council [VR 20114797, VR 621-2012-2418]	Swedish Science Research Council	This work was supported by Swedish Science Research Council, VR 20114797 (to I. S.) and VR 621-2012-2418 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; Chaga Oleg, 1995, Animal Biology, V4, P59; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Dieterich W, 2006, GUT, V55, P478, DOI 10.1136/gut.2005.069385; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gao HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107768; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Gold KS, 2014, EXP HEMATOL, V42, P717, DOI 10.1016/j.exphem.2014.06.002; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Grigorian M, 2013, DEV BIOL, V384, P301, DOI 10.1016/j.ydbio.2013.03.007; Grigorian M, 2013, DEV GENES EVOL, V223, P103, DOI 10.1007/s00427-012-0428-2; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lin XH, 2010, J BIOL CHEM, V285, P28577, DOI 10.1074/jbc.M110.138560; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Lindner JR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-121; Liu HP, 2007, DEV COMP IMMUNOL, V31, P340, DOI 10.1016/j.dci.2006.07.007; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Monnier J, 2010, CANCER LETT, V296, P144, DOI 10.1016/j.canlet.2010.06.011; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Negri L, 2009, INT REV NEUROBIOL, V85, P145, DOI 10.1016/S0074-7742(09)85011-3; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Noonin C, 2012, STEM CELLS DEV, V21, P3173, DOI 10.1089/scd.2012.0077; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Piercy-Kotb SA, 2012, J CELL PHYSIOL, V227, P2936, DOI 10.1002/jcp.23040; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Small C, 2014, GENETICS, V197, P471, DOI 10.1534/genetics.113.159210; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2016, DEV COMP IMMUNOL, V58, P129, DOI 10.1016/j.dci.2015.12.009; Song SW, 2009, STEM CELLS, V27, P1358, DOI 10.1002/stem.47; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Wang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.318; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5	41	26	27	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17593	17601		10.1074/jbc.M116.741348	http://dx.doi.org/10.1074/jbc.M116.741348			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27339892	hybrid, Green Published			2022-12-28	WOS:000383241300011
J	Parra, LA; Baust, TB; Smith, AD; Jaumotte, JD; Zigmond, MJ; Torres, S; Leak, RK; Pino, JA; Torres, GE				Parra, Leonardo A.; Baust, Tracy B.; Smith, Amanda D.; Jaumotte, Juliann D.; Zigmond, Michael J.; Torres, Soledad; Leak, Rehana K.; Pino, Jose A.; Torres, Gonzalo E.			The Molecular Chaperone Hsc70 Interacts with Tyrosine Hydroxylase to Regulate Enzyme Activity and Synaptic Vesicle Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complex; dopamine; enzyme; protein targeting; synapse; Hsc70	VESICULAR MONOAMINE TRANSPORTER-2; ALPHA-SYNUCLEIN; GTP CYCLOHYDROLASE; DOPAMINE SYNTHESIS; FUNCTIONAL INTERACTION; PARKINSONS-DISEASE; CYTOSOLIC DOPAMINE; SUBSTANTIA-NIGRA; PROTEIN; BIOSYNTHESIS	We previously reported that the vesicular monoamine transporter 2 (VMAT2) is physically and functionally coupled with Hsc70 as well as with the dopamine synthesis enzymes tyrosine hydroxylase (TH) and aromatic amino acid decarboxylase, providing a novel mechanism for dopamine homeostasis regulation. Here we expand those findings to demonstrate that Hsc70 physically and functionally interacts with TH to regulate the enzyme activity and synaptic vesicle targeting. Co-immunoprecipitation assays performed in brain tissue and heterologous cells demonstrated that Hsc70 interacts with TH and aromatic amino acid decarboxylase. Furthermore, in vitro binding assays showed that TH directly binds the substrate binding and carboxyl-terminal domains of Hsc70. Immunocytochemical studies indicated that Hsc70 and TH co-localize in midbrain dopaminergic neurons. The functional significance of the Hsc70-TH interaction was then investigated using TH activity assays. In both dopaminergic MN9D cells and mouse brain synaptic vesicles, purified Hsc70 facilitated an increase in TH activity. Neither the closely related protein Hsp70 nor the unrelated Hsp60 altered TH activity, confirming the specificity of the Hsc70 effect. Overexpression of Hsc70 in dopaminergic MN9D cells consistently resulted in increased TH activity whereas knockdown of Hsc70 by short hairpin RNA resulted in decreased TH activity and dopamine levels. Finally, in cells with reduced levels of Hsc70, the amount of TH associated with synaptic vesicles was decreased. This effect was rescued by addition of purified Hsc70. Together, these data demonstrate a novel interaction between Hsc70 and TH that regulates the activity and localization of the enzyme to synaptic vesicles, suggesting an important role for Hsc70 in dopamine homeostasis.	[Parra, Leonardo A.; Baust, Tracy B.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; [Smith, Amanda D.; Jaumotte, Juliann D.; Zigmond, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Torres, Soledad] Univ Valparaiso, Ctr Invest & Modelamiento Fenomenos Aleatorios Va, Fac Engn, Valparaiso 2362905, Chile; [Leak, Rehana K.] Duquesne Univ, Div Pharmaceut Sci, Pittsburgh, PA 15282 USA; [Pino, Jose A.; Torres, Gonzalo E.] Univ Florida, Dept Pharmacol & Therapeut, Coll Med, 1200 Newell Dr,ARB R5-252,POB 100267, Gainesville, FL 32610 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidad de Valparaiso; Duquesne University; State University System of Florida; University of Florida	Torres, GE (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Coll Med, 1200 Newell Dr,ARB R5-252,POB 100267, Gainesville, FL 32610 USA.	gonzalotorres@ufl.edu	Pino, José/AAF-4359-2021; Leak, Rehana K./I-2607-2019	Pino, José/0000-0002-1542-0660; Leak, Rehana K./0000-0003-2817-7417; Parra Rivas, Leonardo/0000-0002-6707-1255	National Institutes of Health [DA038598]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grant DA038598 (to G. E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adinoff B, 2004, HARVARD REV PSYCHIAT, V12, P305, DOI 10.1080/10673220490910844; Arias-Carrion O, 2007, ACTA NEUROBIOL EXP, V67, P481; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bowling KM, 2008, J BIOL CHEM, V283, P31449, DOI 10.1074/jbc.M802552200; Carlsson A, 1987, Adv Neurol, V45, P513; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; Chen R, 2003, J BIOMED SCI, V10, P774, DOI 10.1159/000073965; CHRISTENSON JG, 1972, P NATL ACAD SCI USA, V69, P343, DOI 10.1073/pnas.69.2.343; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fon EA, 2001, MUSCLE NERVE, V24, P581, DOI 10.1002/mus.1044; Funderburk CD, 2006, J BIOL CHEM, V281, P33302, DOI 10.1074/jbc.M602196200; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Greengard P, 2001, BIOSCIENCE REP, V21, P247, DOI 10.1023/A:1013205230142; Guo JT, 2008, CELL MOL NEUROBIOL, V28, P35, DOI 10.1007/s10571-007-9227-0; Hastings TG, 1996, ADV EXP MED BIOL, V387, P97; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; HAYCOCK JW, 1991, J BIOL CHEM, V266, P5650; Hinzpeter A, 2006, AM J PHYSIOL-CELL PH, V290, pC45, DOI 10.1152/ajpcell.00209.2005; Hsu CC, 2000, J BIOL CHEM, V275, P20822, DOI 10.1074/jbc.M001403200; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; KOPIN IJ, 1985, PHARMACOL REV, V37, P333; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Meimaridou E, 2011, MOL ENDOCRINOL, V25, P1650, DOI 10.1210/me.2011-1020; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Parra LA, 2008, MOL PHARMACOL, V74, P1521, DOI 10.1124/mol.108.050005; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; Requena DF, 2009, J NEUROCHEM, V110, P581, DOI 10.1111/j.1471-4159.2009.06135.x; Roth Robert H., 1995, P227; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; SKAGERBERG G, 1984, BRAIN RES, V307, P99, DOI 10.1016/0006-8993(84)90465-7; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Swick L, 2006, J NEUROCHEM, V97, P1447, DOI 10.1111/j.1471-4159.2006.03836.x; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Ungewickell E, 1997, J BIOL CHEM, V272, P19594, DOI 10.1074/jbc.272.31.19594; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wang Z, 2011, J NEUROCHEM, V119, P1294, DOI 10.1111/j.1471-4159.2011.07517.x; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215; Zinsmaier KE, 2001, BIOCHEM PHARMACOL, V62, P1, DOI 10.1016/S0006-2952(01)00648-7	50	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17510	17522		10.1074/jbc.M116.728782	http://dx.doi.org/10.1074/jbc.M116.728782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27365397	Green Published, hybrid			2022-12-28	WOS:000383241300003
J	Gupta, SC; Reuter, S; Phromnoi, K; Park, B; Hema, PS; Nair, M; Aggarwal, BB				Gupta, Subash C.; Reuter, Simone; Phromnoi, Kanokkarn; Park, Byoungduck; Hema, Padmanabhan S.; Nair, Mangalam; Aggarwal, Bharat B.			RETRACTION: Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species-and ERK-dependent up-regulation of death receptors, p53, and Bax (Retraction of vol 286, pg 1134, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction														Phromnoi, Kanokkarn/0000-0002-8003-6112				Gupta SC, 2011, J BIOL CHEM, V286, P1134, DOI 10.1074/jbc.M110.191379	1	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16925	16925		10.1074/jbc.A110.191379	http://dx.doi.org/10.1074/jbc.A110.191379			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27496966	hybrid, Green Published			2022-12-28	WOS:000380826700052
J	Kralova, J; Fabisik, M; Pokorna, J; Skopcova, T; Malissen, B; Brdicka, T				Kralova, Jarmila; Fabisik, Matej; Pokorna, Jana; Skopcova, Tereza; Malissen, Bernard; Brdicka, Tomas			The Transmembrane Adaptor Protein SCIMP Facilitates Sustained Dectin-1 Signaling in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECEPTOR; C-TYPE LECTIN; TOLL-LIKE RECEPTORS; FUNGAL-INFECTIONS; ANTIFUNGAL IMMUNITY; PATTERN-RECOGNITION; CANDIDA-ALBICANS; ERK ACTIVATION; MICE; INNATE	Transmembrane adaptor proteins are molecules specialized in recruiting cytoplasmic proteins to the proximity of the cell membrane as part of the signal transduction process. A member of this family, SLP65/SLP76, Csk-interacting membrane protein (SCIMP), recruits a complex of SLP65/SLP76 and Grb2 adaptor proteins, known to be involved in the activation of PLC gamma 1/2, Ras, and other pathways. SCIMP expression is restricted to antigen-presenting cells. In a previous cell line-based study, it was shown that, in B cells, SCIMP contributes to the reverse signaling in the immunological synapse, downstream of MHCII glycoproteins. There it mainly facilitates the activation of ERK MAP kinases. However, its importance for MHCII glycoprotein-dependent ERK signaling in primary B cells has not been analyzed. Moreover, its role in macrophages and dendritic cells has remained largely unknown. Here we present the results of our analysis of SCIMP-deficient mice. In these mice, we did not observe any defects in B cell signaling and B cell-dependent responses. On the other hand, we found that, in dendritic cells and macrophages, SCIMP expression is up-regulated after exposure to GM-CSF or the Dectin-1 agonist zymosan. Moreover, we found that SCIMP is strongly phosphorylated after Dectin-1 stimulation and that it participates in signal transduction downstream of this important pattern recognition receptor. Our analysis of SCIMP-deficient dendritic cells revealed that SCIMP specifically contributes to sustaining long-term MAP kinase signaling and cytokine production downstream of Dectin-1 because of an increased expression and sustained phosphorylation lasting at least 24 h after signal initiation.	[Kralova, Jarmila; Fabisik, Matej; Skopcova, Tereza; Brdicka, Tomas] Acad Sci Czech Republ, Lab Leukocyte Signaling, Inst Mol Genet, Videnska 1083, Prague 14220, Czech Republic; [Pokorna, Jana] Acad Sci Czech Republ, Lab Mol Immunol, Inst Mol Genet, Prague 14220, Czech Republic; [Malissen, Bernard] Aix Marseille Univ UM2, INSERM US012, CNRS UMS3367, Ctr Immunophenom,PHENOMIN CIPHE, F-13288 Marseille, France	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Brdicka, T (corresponding author), Acad Sci Czech Republ, Lab Leukocyte Signaling, Inst Mol Genet, Videnska 1083, Prague 14220, Czech Republic.	tomas.brdicka@img.cas.cz	Brdicka, Tomas/G-6205-2014; Fabisik, Matej/V-7224-2017; Kralova, Jarmila/G-3834-2014; Malissen, Bernard/AAK-4659-2020	Brdicka, Tomas/0000-0002-1560-4398; Fabisik, Matej/0000-0003-2347-245X; Kralova, Jarmila/0000-0003-3017-2666; Kralova, Jarmila/0000-0002-4735-8857; Malissen, Bernard/0000-0003-1340-9342	Czech Science Foundation (GACR) [P302/12/1712]; IMG ASCR [RVO 68378050]; Faculty of Science, Charles University, Prague; PHENOMIN CIPHE	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); IMG ASCR; Faculty of Science, Charles University, Prague; PHENOMIN CIPHE	This work was supported by Czech Science Foundation (GACR, Project P302/12/1712) and received institutional funding from IMG ASCR (RVO 68378050). The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by the Faculty of Science, Charles University, Prague.r Supported by PHENOMIN CIPHE.	Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; ANDRE P, 1994, J EXP MED, V179, P763, DOI 10.1084/jem.179.2.763; Barreto-Bergter E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00145; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cenci E, 2001, J INFECT DIS, V184, P610, DOI 10.1086/322793; Chatterjee P, 2012, J IMMUNOL, V188, P2695, DOI 10.4049/jimmunol.1101527; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Draber P, 2011, MOL CELL BIOL, V31, P4550, DOI 10.1128/MCB.05817-11; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Filler SG, 2005, CLIN INFECT DIS, V41, pS208, DOI 10.1086/430000; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jia XM, 2014, J EXP MED, V211, P2307, DOI 10.1084/jem.20132349; Jun JE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00239; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Meyer-Wentrup F, 2007, J IMMUNOL, V178, P154, DOI 10.4049/jimmunol.178.1.154; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Seo Beom-Seok, 2013, Immune Netw, V13, P205, DOI 10.4110/in.2013.13.5.205; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Stepanek O, 2014, CELL SIGNAL, V26, P895, DOI 10.1016/j.cellsig.2014.01.007; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vallabhaneni S, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0572-1; Van Enckevort FHJ, 1999, MED MYCOL, V37, P419, DOI 10.1046/j.1365-280X.1999.00247.x; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Wu YJ, 2015, J IMMUNOL, V195, P2612, DOI 10.4049/jimmunol.1402944; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Zhu W, 2000, J IMMUNOL, V164, P6349, DOI 10.4049/jimmunol.164.12.6349	47	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16530	16540		10.1074/jbc.M116.717157	http://dx.doi.org/10.1074/jbc.M116.717157			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288407	Green Published, hybrid			2022-12-28	WOS:000380826700013
J	Rajpurohit, YS; Bihani, SC; Waldor, MK; Misra, HS				Rajpurohit, Yogendra S.; Bihani, Subhash C.; Waldor, Matthew K.; Misra, Hari S.			Phosphorylation of Deinococcus radiodurans RecA Regulates Its Activity and May Contribute to Radioresistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-STRAND EXCHANGE; EXTREME RADIORESISTANCE; PROTEIN-KINASE; IONIZING-RADIATION; RESISTANCE; BINDING; REPAIR; ATP; DAMAGE; RECOMBINATION	Deinococcus radiodurans has a remarkable capacity to survive exposure to extreme levels of radiation that cause hundreds of DNA double strand breaks (DSBs). DSB repair in this bacterium depends on its recombinase A protein (DrRecA). DrRecA plays a pivotal role in both extended synthesis-dependent strand annealing and slow crossover events of DSB repair during the organism's recovery from DNA damage. The mechanisms that control DrRecA activity during the D. radiodurans response to gamma radiation exposure are unknown. Here, we show that DrRecA undergoes phosphorylation at Tyr-77 and Thr-318 by a DNA damage-responsive serine threonine/tyrosine protein kinase (RqkA). Phosphorylation modifies the activity of DrRecA in several ways, including increasing its affinity for dsDNA and its preference for dATP over ATP. Strand exchange reactions catalyzed by phosphorylated versus unphosphorylated DrRecA also differ. In silico analysis of DrRecA structure support the idea that phosphorylation can modulate crucial functions of this protein. Collectively, our findings suggest that phosphorylation of DrRecA enables the recombinase to selectively use abundant dsDNA substrate present during post-irradiation recovery for efficient DSB repair, thereby promoting the extraordinary radioresistance of D. radiodurans.	[Rajpurohit, Yogendra S.; Misra, Hari S.] Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India; [Bihani, Subhash C.] Bhabha Atom Res Ctr, Div Solid State Phys, Bombay 400085, Maharashtra, India; [Waldor, Matthew K.] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Waldor, Matthew K.] Harvard Med Sch, Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Misra, HS (corresponding author), Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India.	hsmisra@barc.gov.in	Bihani, Subhash Chandra/G-1255-2010	Bihani, Subhash Chandra/0000-0002-0724-4919; Misra, Hari/0000-0002-9349-1229; Waldor, Matthew/0000-0003-1843-7000	Fulbright-Nehru senior research fellowship grant from United States-India Education Foundation (USIEF); J. William Fulbright foreign scholarship Board	Fulbright-Nehru senior research fellowship grant from United States-India Education Foundation (USIEF); J. William Fulbright foreign scholarship Board	Recipient of a Fulbright-Nehru senior research fellowship grant from the United States-India Education Foundation (USIEF) and the J. William Fulbright foreign scholarship Board. To whom correspondence should be addressed: Molecular Biology Division, Bhabha Atomic Research Centre, Mumbai-400 085, India. Tel.: 91-22-25595417; Fax: 91-22-25505151; E-mail: hsmisra@barc.gov.in.	Aihara H, 1997, J MOL BIOL, V274, P213, DOI 10.1006/jmbi.1997.1403; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; Bidnenko V, 2013, MOL MICROBIOL, V88, P921, DOI 10.1111/mmi.12233; Buxbaum E, 1999, EUR J BIOCHEM, V265, P64, DOI 10.1046/j.1432-1327.1999.00644.x; Charaka VK, 2012, J BACTERIOL, V194, P5739, DOI 10.1128/JB.00610-12; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Das AD, 2011, MICROBIOL-SGM, V157, P2196, DOI 10.1099/mic.0.040436-0; Datta S, 2003, PROTEINS, V50, P474, DOI 10.1002/prot.10315; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; Flott S, 2011, EMBO REP, V12, P833, DOI 10.1038/embor.2011.127; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; GUTMAN PD, 1994, GENE, V141, P31, DOI 10.1016/0378-1119(94)90124-4; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jers C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014653; Kamble VA, 2010, DNA REPAIR, V9, P488, DOI 10.1016/j.dnarep.2010.01.012; KIM JI, 1992, J BIOL CHEM, V267, P16444; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; Kim JI, 2002, J BACTERIOL, V184, P1649, DOI 10.1128/JB.184.6.1649-1660.2002; Kim SH, 2014, J AM CHEM SOC, V136, P14796, DOI 10.1021/ja506363y; Kota S, 2010, BIOCHEM J, V431, P149, DOI 10.1042/BJ20100446; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Mazin AV, 1998, EMBO J, V17, P1161, DOI 10.1093/emboj/17.4.1161; Mijakovic I, 2006, NUCLEIC ACIDS RES, V34, P1588, DOI 10.1093/nar/gkj514; Misra HS, 2013, CURR SCI INDIA, V104, P194; Misra HS, 2006, MOL MICROBIOL, V59, P1308, DOI 10.1111/j.1365-2958.2005.05005.x; Narumi I, 2001, J BACTERIOL, V183, P6951, DOI 10.1128/JB.183.23.6951-6956.2001; Nayak S, 1999, J BIOL CHEM, V274, P25979, DOI 10.1074/jbc.274.37.25979; Nishi H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00270; Rajan R, 2004, J MOL BIOL, V344, P951, DOI 10.1016/j.jmb.2004.09.087; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Rajpurohit YS, 2010, MOL MICROBIOL, V77, P1470, DOI 10.1111/j.1365-2958.2010.07301.x; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Schafer M, 2000, PHOTOCHEM PHOTOBIOL, V71, P514, DOI 10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shi L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00538; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	46	23	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16672	16685		10.1074/jbc.M116.736389	http://dx.doi.org/10.1074/jbc.M116.736389			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27255712	Green Published, hybrid			2022-12-28	WOS:000380826700025
J	Alvarez-Zaldiernas, C; Lu, J; Zheng, YJ; Yang, HQ; Blasi, J; Solsona, C; Holmgren, A				Alvarez-Zaldiernas, Cristina; Lu, Jun; Zheng, Yujuan; Yang, Hongqian; Blasi, Juan; Solsona, Carles; Holmgren, Arne			Cellular Redox Systems Impact the Aggregation of Cu,Zn Superoxide Dismutase Linked to Familial Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ALS (Lou Gehrig disease); reduction-oxidation (redox); oxidative stress; protein aggregation; thiol; thioredoxin; cysteine 111; SOD1; glutaredoxin; glutathione	MUTANT CU,ZN-SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE 1; MOTOR-NEURON INJURY; DISULFIDE BOND; TRANSGENIC MICE; MOUSE MODEL; WILD-TYPE; KEY ROLE; SOD1; ALS	Protein misfolding is implicated in neurodegenerative diseases such as ALS, where mutations of superoxide dismutase 1 (SOD1) account for about 20% of the inherited mutations. Human SOD1 (hSOD1) contains four cysteines, including Cys(57) and Cys(146), which have been linked to protein stability and folding via forming a disulfide bond, and Cys(6) and Cys(111) as free thiols. But the roles of the cellular oxidation-reduction (redox) environment in SOD1 folding and aggregation are not well understood. Here we explore the effects of cellular redox systems on the aggregation of hSOD1 proteins. We found that the known hSOD1 mutations G93A and A4V increased the capability of the thioredoxin and glutaredoxin systems to reduce hSOD1 compared with wild-type hSOD1. Treatment with inhibitors of these redox systems resulted in an increase of hSOD1 aggregates in the cytoplasm of cells transfected with mutants but not in cells transfected with wild-type hSOD1 or those containing a secondary C111G mutation. This aggregation may be coupled to changes in the redox state of the G93A and A4V mutants upon mild oxidative stress. These results strongly suggest that the thioredoxin and glutaredoxin systems are the key regulators for hSOD1 aggregation and may play critical roles in the pathogenesis of ALS.	[Alvarez-Zaldiernas, Cristina; Lu, Jun; Zheng, Yujuan; Yang, Hongqian; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Alvarez-Zaldiernas, Cristina; Blasi, Juan; Solsona, Carles] Univ Barcelona, Fac Med, Dept Pathol & Expt Therapeut, Campus Bellvitge,Feixa Llarga S-N, Barcelona 08907, Spain; [Alvarez-Zaldiernas, Cristina; Blasi, Juan; Solsona, Carles] Bellvitge Biomed Res Inst, Gran Via Hospitalet 199-203, Barcelona 08908, Spain	Karolinska Institutet; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Solsona, C (corresponding author), Univ Barcelona, Fac Med, Dept Pathol & Expt Therapeut, Campus Bellvitge,Feixa Llarga S-N, Barcelona 08907, Spain.; Lu, J (corresponding author), Southwest Univ, Sch Pharmaceut Sci, Chongqing 400715, Peoples R China.; Holmgren, A (corresponding author), Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	junlu@swu.edu.cn; solsona@ub.edu; arne.holmgren@ki.se	Lu, Jun/E-9701-2017	Lu, Jun/0000-0002-1699-8835	Swedish Cancer Society [961]; Swedish Research Council Medicine [13X-3529]; K&A Wallenberg Foundation; Karolinska Institutet and Boehringer Ingelheim Fonds; Spanish Ministry of Economy and Competitiveness [SAF2014-56811R]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council Medicine(Swedish Research Council); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet and Boehringer Ingelheim Fonds; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Swedish Cancer Society (961), the Swedish Research Council Medicine (13X-3529), the K&A Wallenberg Foundation, grants from Karolinska Institutet and Boehringer Ingelheim Fonds, and Grant SAF2014-56811R from the Spanish Ministry of Economy and Competitiveness. The authors declare that they have no conflicts of interest with the contents of this article.	Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bouldin SD, 2012, BIOCHEM J, V446, P59, DOI 10.1042/BJ20120075; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; CATZ SD, 1995, FREE RADICAL BIO MED, V19, P741, DOI 10.1016/0891-5849(95)00065-6; Chattopadhyay M, 2015, J BIOL CHEM, V290, P30624, DOI 10.1074/jbc.M115.666503; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferri A, 2010, HUM MOL GENET, V19, P4529, DOI 10.1093/hmg/ddq383; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Goodall Emily F., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010854; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Kato S, 2004, ACTA NEUROPATHOL, V107, P149, DOI 10.1007/s00401-003-0791-1; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Lee JK, 2013, P NATL ACAD SCI USA, V110, P12066, DOI 10.1073/pnas.1300894110; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; Lu J, 2014, ANTIOXID REDOX SIGN, V21, P457, DOI 10.1089/ars.2014.5849; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Mitchell J, 2009, FREE RADICAL BIO MED, V46, P202, DOI 10.1016/j.freeradbiomed.2008.09.041; Nagano S, 2015, HUM MOL GENET, V24, P3427, DOI 10.1093/hmg/ddv093; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Ogawa M, 2015, BIOCHEM BIOPH RES CO, V463, P1196, DOI 10.1016/j.bbrc.2015.06.084; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Redler RL, 2011, BIOCHEMISTRY-US, V50, P7057, DOI 10.1021/bi200614y; Roberts BLT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047838; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Solsona C, 2014, J BIOL CHEM, V289, P26722, DOI 10.1074/jbc.M114.565333; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200	57	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17197	17208		10.1074/jbc.M115.708230	http://dx.doi.org/10.1074/jbc.M115.708230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27261461	hybrid, Green Published			2022-12-28	WOS:000382643800023
J	Subbaramaiah, K; Brown, KA; Zahid, H; Balmus, G; Weiss, RS; Herbert, BS; Dannenberg, AJ				Subbaramaiah, Kotha; Brown, Kristy A.; Zahid, Heba; Balmus, Gabriel; Weiss, Robert S.; Herbert, Brittney-Shea; Dannenberg, Andrew J.			RETRACTED: Hsp90 and PKM2 Drive the Expression of Aromatase in Li-Fraumeni Syndrome Breast Adipose Stromal Cells (Retracted article. See vol. 295, pg. 290, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							PYRUVATE-KINASE M2; WILD-TYPE P53; PROSTAGLANDIN E-2; PROMOTER-II; TRANSCRIPTIONAL REGULATION; ALTERNATIVE PROMOTERS; GENE-EXPRESSION; ATPASE ACTIVITY; CANCER-CELLS; CYP19 GENE	Li-Fraumeni syndrome (LFS) patients harbor germ line mutations in the TP53 gene and are at increased risk of hormone receptor-positive breast cancers. Recently, elevated levels of aromatase, the rate-limiting enzyme for estrogen biosynthesis, were found in the breast tissue of LFS patients. Although p53 down-regulates aromatase expression, the underlying mechanisms are incompletely understood. In the present study, we found that LFS stromal cells expressed higher levels of Hsp90 ATPase activity and aromatase compared with wild-type stromal cells. Inhibition of Hsp90 ATPase suppressed aromatase expression. Silencing Aha1 (activator of Hsp90 ATPase 1), a cochaperone of Hsp90 required for its ATPase activity, led to both inhibition of Hsp90 ATPase activity and reduced aromatase expression. In comparison with wild-type stromal cells, increased levels of the Hsp90 client proteins, HIF-1 alpha, and PKM2 were found in LFS stromal cells. A complex comprised of HIF-1 alpha and PKM2 was recruited to the aromatase promoter II in LFS stromal cells. Silencing either HIF-1 alpha or PKM2 suppressed aromatase expression in LFS stromal cells. CP-31398, a p53 rescue compound, suppressed levels of Aha1, Hsp90 ATPase activity, levels of PKM2 and HIF-1 alpha, and aromatase expression in LFS stromal cells. Consistent with these in vitro findings, levels of Hsp90 ATPase activity, Aha1, HIF-1 alpha, PKM2, and aromatase were increased in the mammary glands of p53 null versus wild-type mice. PKM2 and HIF-1 alpha were shown to co-localize in the nucleus of stromal cells of LFS breast tissue. Taken together, our results show that the Aha1-Hsp90-PKM2/HIF-1 alpha axis mediates the induction of aromatase in LFS.	[Subbaramaiah, Kotha; Dannenberg, Andrew J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Brown, Kristy A.; Zahid, Heba] Hudson Inst Med Res, Ctr Canc Res, Metab & Canc Lab, Clayton, Vic 3168, Australia; [Brown, Kristy A.; Zahid, Heba] Monash Univ, Clayton, Vic 3800, Australia; [Zahid, Heba] Taibah Univ, Fac Appl Med Sci, Medina, Saudi Arabia; [Balmus, Gabriel; Weiss, Robert S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Herbert, Brittney-Shea] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Balmus, Gabriel] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	Cornell University; Hudson Institute of Medical Research; Monash University; Taibah University; Cornell University; Indiana University System; Indiana University Bloomington; University of Cambridge	Subbaramaiah, K (corresponding author), Weill Cornell Med Coll, 525 East 68th St,Rm F-203A, New York, NY 10065 USA.	ksubba@med.cornell.edu	Balmus, Gabriel/G-3497-2017; Zahid, Heba/GRX-1975-2022; Balmus, Gabriel/GZM-2145-2022	Balmus, Gabriel/0000-0003-2872-4468; Balmus, Gabriel/0000-0003-2872-4468	Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; National Institutes of Health [R01 CA108773]; National Health and Medical Research Council Career Development Award [GNT1007714]; National Breast Cancer Foundation [NC-14-011, ECF-16-004]; NATIONAL CANCER INSTITUTE [R01CA108773] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Breast Cancer Research Foundation and the Botwinick-Wolfensohn Foundation in memory of Mr. and Mrs. Benjamin Botwinick (to A. J. D.), National Institutes of Health Grant R01 CA108773 (to R. S. W.), and National Health and Medical Research Council Career Development Award GNT1007714 and National Breast Cancer Foundation Grants NC-14-011 and ECF-16-004) (to K. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Brown KA, 2013, MOL CELL ENDOCRINOL, V366, P170, DOI 10.1016/j.mce.2012.06.016; Brown KA, 2010, BREAST CANCER RES TR, V123, P591, DOI 10.1007/s10549-010-0834-y; Brown KA, 2009, CANCER RES, V69, P5392, DOI 10.1158/0008-5472.CAN-09-0108; BULUN SE, 1994, BREAST CANCER RES TR, V30, P19, DOI 10.1007/BF00682738; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen S, 2002, J STEROID BIOCHEM, V83, P93, DOI 10.1016/S0960-0760(02)00276-5; Chen SA, 2010, P NATL ACAD SCI USA, V107, P11032, DOI 10.1073/pnas.1000917107; Choi HK, 2008, ENDOCR-RELAT CANCER, V15, P139, DOI 10.1677/ERC-07-0192; Herbert BS, 2010, ONCOTARGET, V1, P405; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jordan JJ, 2010, MOL CANCER RES, V8, P701, DOI 10.1158/1541-7786.MCR-09-0442; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Kochhar A, 2014, CANCER PREV RES, V7, P596, DOI 10.1158/1940-6207.CAPR-14-0051; Li ZW, 2014, BBA-REV CANCER, V1846, P285, DOI 10.1016/j.bbcan.2014.07.008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu ML, 2006, J CLIN ENDOCR METAB, V91, P4514, DOI 10.1210/jc.2006-1364; Luo WB, 2011, ONCOTARGET, V2, P551; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; MAHENDROO MS, 1993, J BIOL CHEM, V268, P19463; Masciari S, 2012, BREAST CANCER RES TR, V133, P1125, DOI 10.1007/s10549-012-1993-9; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Okayama S, 2014, J BIOL CHEM, V289, P6513, DOI 10.1074/jbc.M113.532523; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Samarajeewa NU, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3410; Samarajeewa NU, 2013, HORM CANCER-US, V4, P233, DOI 10.1007/s12672-013-0142-1; Sasano H, 2003, J STEROID BIOCHEM, V86, P239, DOI 10.1016/S0960-0760(03)00363-7; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Subbaramaiah K, 2008, J BIOL CHEM, V283, P3433, DOI 10.1074/jbc.M705409200; Subbaramaiah K, 2006, CANCER RES, V66, P5504, DOI 10.1158/0008-5472.CAN-05-4076; Subbaramaiah K, 2012, CANCER PREV RES, V5, P1183, DOI 10.1158/1940-6207.CAPR-12-0201; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Subbaramaiah K, 2011, CANCER PREV RES, V4, P194, DOI 10.1158/1940-6207.CAPR-10-0367; Takimoto R, 2002, CANCER BIOL THER, V1, P47, DOI 10.4161/cbt.1.1.41; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wang X, 2015, CANCER RES, V75, P645, DOI 10.1158/0008-5472.CAN-14-2164; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Zhao RB, 2000, GENE DEV, V14, P981; Zhao Y, 1997, J STEROID BIOCHEM, V61, P203, DOI 10.1016/S0960-0760(97)80013-1; Zhao Y, 1996, ENDOCRINOLOGY, V137, P5739, DOI 10.1210/en.137.12.5739	48	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16011	16023		10.1074/jbc.M115.698902	http://dx.doi.org/10.1074/jbc.M115.698902			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27467582	Green Published, hybrid			2022-12-28	WOS:000380585400008
J	Yang, DL; Frego, L; Lasaro, M; Truncali, K; Kroe-Barrett, R; Singh, S				Yang, Danlin; Frego, Lee; Lasaro, Marcio; Truncali, Kristopher; Kroe-Barrett, Rachel; Singh, Sanjaya			Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; HUMAN MONOCLONAL-ANTIBODIES; LINKED-IMMUNOSORBENT-ASSAY; MEMORY B-CELLS; THERAPEUTIC ANTIBODIES; VACCINE DEVELOPMENT; ELISA; IMMUNIZATION; SERUM; STRATEGIES	To determine the effectiveness of immunization strategies used in therapeutic antibody or vaccine development, it is critical to assess the quality of immunization-induced polyclonal antibody responses. Here, we developed a workflow that uses sensitive methods to quantitatively and qualitatively assess immune responses against foreign antigens with regard to antibody binding affinity and epitope diversity. The application of such detailed assessments throughout an immunization campaign can significantly reduce the resources required to generate highly specific antibodies. Our workflow consists of the following two steps: 1) the use of surface plasmon resonance to quantify antigen-specific antibodies and evaluate their apparent binding affinities, and 2) the recovery of serum IgGs using an automated small scale purification system, followed by the determination of their epitope diversity using hydrogen deuterium exchange coupled with mass spectrometry. We showed that these methods were sensitive enough to detect antigen-specific IgGs in the nanogram/mu l range and that they provided information for differentiating the antibody responses of the various immunized animals that could not be obtained by conventional methods. We also showed that this workflow can guide the selection of an animal that produces high affinity antibodies with a desired epitope coverage profile, resulting in the generation of potential therapeutic monoclonal antibody clones with desirable functional profiles. We postulate that this workflow will be an important tool in the development of effective vaccines to combat the highly sophisticated evasion mechanisms of pathogens.	[Yang, Danlin; Frego, Lee; Lasaro, Marcio; Truncali, Kristopher; Kroe-Barrett, Rachel; Singh, Sanjaya] Boehringer Ingelheim Pharmaceut Inc, Dept Biotherapeut Discovery Immune Modulat & Biot, 900 Ridgebury Rd, Ridgefield, CT 06877 USA	Boehringer Ingelheim	Singh, S (corresponding author), Boehringer Ingelheim Pharmaceut Inc, Dept Biotherapeut Discovery Immune Modulat & Biot, 900 Ridgebury Rd, Ridgefield, CT 06877 USA.	sanjaya.singh@boehringer-ingelheim.com		Yang, Danlin/0000-0002-5085-5950; Kroe-Barrett, Rachel/0000-0003-1413-1223; Singh, Sanjaya/0000-0002-9119-7966				AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; An ZQ, 2010, PROTEIN CELL, V1, P319, DOI 10.1007/s13238-010-0052-8; Awasthi S, 2011, J VIROL, V85, P10472, DOI 10.1128/JVI.00849-11; Benjamin, 1996, Methods, V9, P508; Burns Robert, 2009, V508, P27, DOI 10.1007/978-1-59745-062-1_3; Campagnolo C, 2004, J BIOCHEM BIOPH METH, V61, P283, DOI 10.1016/j.jbbm.2004.05.006; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cho HS, 2007, J VET DIAGN INVEST, V19, P414, DOI 10.1177/104063870701900414; Cho HS, 2006, J VET MED SCI, V68, P1327, DOI 10.1292/jvms.68.1327; Deantonio C, 2014, METHODS MOL BIOL, V1060, P277, DOI 10.1007/978-1-62703-586-6_14; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Gan SD, 2013, J INVEST DERMATOL, V133, pE10, DOI 10.1038/jid.2013.287; Hanly W. Carey, 1995, ILAR J, V37, P93; Hauge S, 2007, CLIN VACCINE IMMUNOL, V14, P978, DOI 10.1128/CVI.00033-07; Heinrich L, 2010, J IMMUNOL METHODS, V352, P13, DOI 10.1016/j.jim.2009.10.002; Hoa XD, 2007, BIOSENS BIOELECTRON, V23, P151, DOI 10.1016/j.bios.2007.07.001; Kamata T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066096; Kaufmann SHE, 2014, CURR OPIN IMMUNOL, V28, P18, DOI 10.1016/j.coi.2014.01.009; KOHLER G, 1985, EMBO J, V4, P1359, DOI 10.1002/j.1460-2075.1985.tb03787.x; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Leenaars M, 2005, ILAR J, V46, P269, DOI 10.1093/ilar.46.3.269; Masch A, 2010, METHODS MOL BIOL, V669, P161, DOI 10.1007/978-1-60761-845-4_13; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; MORI H, 1989, INT J IMMUNOPHARMACO, V11, P597, DOI 10.1016/0192-0561(89)90144-6; Moy FJ, 2001, J MOL BIOL, V310, P219, DOI 10.1006/jmbi.2001.4764; NOSSAL GJV, 1992, CELL, V68, P1, DOI 10.1016/0092-8674(92)90198-L; Obungu VH, 2009, BIOCHEMISTRY-US, V48, P7251, DOI 10.1021/bi900296g; Petrakou E, 1998, ANTICANCER RES, V18, P4419; Pirrone GF, 2015, ANAL CHEM, V87, P99, DOI 10.1021/ac5040242; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Wang H, 2000, P NATL ACAD SCI USA, V97, P847, DOI 10.1073/pnas.97.2.847; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744	39	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16361	16374		10.1074/jbc.M116.736660	http://dx.doi.org/10.1074/jbc.M116.736660			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27288409	hybrid, Green Published			2022-12-28	WOS:000380585400039
J	Hayes, JB; Sircy, LM; Heusinkveld, LE; Ding, WD; Leander, RN; McClelland, EE; Nelson, DE				Hayes, James B.; Sircy, Linda M.; Heusinkveld, Lauren E.; Ding, Wandi; Leander, Rachel N.; McClelland, Erin E.; Nelson, David E.			Modulation of Macrophage Inflammatory Nuclear Factor kappa B (NF-kappa B) Signaling by Intracellular Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; DEPENDENT TRANSCRIPTION; PULMONARY INFECTION; INDUCED DEGRADATION; POLYSACCHARIDE; CAPSULE; GLUCURONOXYLOMANNAN; MITOCHONDRIAL	Cryptococcus neoformans (Cn) is a common facultative intracellular pathogen that can cause life-threatening fungal meningitis in immunocompromised individuals. Shortly after infection, Cn is detectable as both extra-and intracellular yeast particles, with Cn being capable of establishing long-lasting latent infections within host macrophages. Although recent studies have shown that shed capsular polysaccharides and intact extracellular Cn can compromise macrophage function through modulation of NF-kappa B signaling, it is currently unclear whether intracellular Cn also affects NF-kappa B signaling. Utilizing live cell imaging and computational modeling, we find that extra-and intracellular Cn support distinct modes of NF-kappa B signaling in cultured murine macrophages. Specifically, in RAW 264.7 murine macrophages treated with extracellular glucuronoxylomannan (GXM), the major Cn capsular polysaccharide, LPS-induced nuclear translocation of p65 is inhibited, whereas in cells with intracellular Cn, LPS-induced nuclear translocation of p65 is both amplified and sustained. Mathematical simulations and quantification of nascent protein expression indicate that this is a possible consequence of Cn-induced "translational interference," impeding I kappa B alpha resynthesis. We also show that long term Cn infection induces stable nuclear localization of p65 and I kappa B alpha proteins in the absence of additional proinflammatory stimuli. In this case, nuclear localization of p65 is not accompanied by TNF alpha or inducible NOS (iNOS) expression. These results demonstrate that capsular polysaccharides and intact intracellular yeast manipulate NF-kappa B via multiple distinct mechanisms and provide new insights into how Cn might modulate cellular signaling at different stages of an infection.	[Hayes, James B.; Sircy, Linda M.; Heusinkveld, Lauren E.; McClelland, Erin E.; Nelson, David E.] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37130 USA; [Ding, Wandi; Leander, Rachel N.] Middle Tennessee State Univ, Dept Math Sci, Murfreesboro, TN 37130 USA	Middle Tennessee State University; Middle Tennessee State University	McClelland, EE; Nelson, DE (corresponding author), Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37130 USA.	erin.mcclelland@mtsu.edu; david.e.nelson@mtsu.edu		Sircy, Linda/0000-0003-3335-9258; Ding, Wandi/0000-0002-2031-9700; Nelson, David/0000-0002-5034-0885	Middle Tennessee State University; Middle Tennessee State University Faculty Research and Creative Committee (FRCAC); Middle Tennessee State University Foundation; Middle Tennessee State University Undergraduate Research Center (URECA); Sigma Xi Grants-in-Aid of Research Program (GIAR)	Middle Tennessee State University; Middle Tennessee State University Faculty Research and Creative Committee (FRCAC); Middle Tennessee State University Foundation; Middle Tennessee State University Undergraduate Research Center (URECA); Sigma Xi Grants-in-Aid of Research Program (GIAR)	This work was supported by start-up funds from Middle Tennessee State University (to D. E. N. and E. E. M.), by Middle Tennessee State University Faculty Research and Creative Committee (FRCAC) and the Middle Tennessee State University Foundation (Special Projects) funds (to D. E. N.), and scholarships from Middle Tennessee State University Undergraduate Research Center (URECA) and Sigma Xi Grants-in-Aid of Research Program (GIAR) (to L. E. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Ben-Abdallah M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002555; Bergqvist S, 2009, P NATL ACAD SCI USA, V106, P19328, DOI 10.1073/pnas.0908797106; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; CHERNIAK R, 1982, CARBOHYD RES, V103, P239, DOI 10.1016/S0008-6215(00)80686-2; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; Coelho C, 2015, J IMMUNOL, V194, P2345, DOI 10.4049/jimmunol.1402350; Coelho C, 2014, ANNU REV PATHOL-MECH, V9, P219, DOI 10.1146/annurev-pathol-012513-104653; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Dalloneau E, 2011, J IMMUNOL, V187, P4826, DOI 10.4049/jimmunol.1101087; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; FROMTLING RA, 1982, MYCOPATHOLOGIA, V79, P23, DOI 10.1007/BF00636177; Ganesh L, 2006, MOL CELL BIOL, V26, P3864, DOI 10.1128/MCB.26.10.3864-3874.2006; Garcia-Rivera J, 2004, EUKARYOT CELL, V3, P385, DOI 10.1128/EC.3.2.385-392.2004; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Monari C, 2005, J INFECT DIS, V191, P127, DOI 10.1086/426511; Moreira D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004684; Morris KR, 2003, INFECT IMMUN, V71, P1442, DOI 10.1128/IAI.71.3.1442-1452.2003; Moyrand F, 2008, EUKARYOT CELL, V7, P2069, DOI 10.1128/EC.00189-08; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Murata T, 2000, J GEN VIROL, V81, P401, DOI 10.1099/0022-1317-81-2-401; Nelson DE, 2004, BIOCHEM SOC T, V32, P1090; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ohshima D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046911; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Piccioni M, 2013, INFECT IMMUN, V81, P90, DOI 10.1128/IAI.00553-12; POWDERLY WG, 1994, CLIN INFECT DIS, V18, P789, DOI 10.1093/clinids/18.5.789; Rajasingham R, 2014, EMERG INFECT DIS, V20, P722, DOI 10.3201/eid2004.131277; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; Sung MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004764; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Vecchiarelli A, 2013, FUTURE MICROBIOL, V8, P1107, DOI 10.2217/fmb.13.84; Villena SN, 2008, CELL MICROBIOL, V10, P1274, DOI 10.1111/j.1462-5822.2008.01125.x; Williams RA, 2014, COMPUTATION, V2, P131, DOI 10.3390/computation2040131; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	59	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15614	15627		10.1074/jbc.M116.738187	http://dx.doi.org/10.1074/jbc.M116.738187			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231343	Green Published, hybrid			2022-12-28	WOS:000380584200017
J	Capdevila, DA; Wang, JF; Giedroc, DP				Capdevila, Daiana A.; Wang, Jiefei; Giedroc, David P.			Bacterial Strategies to Maintain Zinc Metallostasis at the Host-Pathogen Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIFFUSION FACILITATOR FAMILY; INWARD-FACING CONFORMATION; METAL SENSOR PROTEINS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; TRANSCRIPTIONAL REGULATOR; STREPTOCOCCUS-PNEUMONIAE; HUMAN CALPROTECTIN; ABC TRANSPORTER; STRUCTURAL ELEMENTS	Among the biologically required first row, late d-block metals from Mn-II to Zn-II, the catalytic and structural reach of ZnII ensures that this essential micronutrient touches nearly every major metabolic process or pathway in the cell. Zn is also toxic in excess, primarily because it is a highly competitive divalent metal and will displace more weakly bound transition metals in the active sites of metalloenzymes if left unregulated. The vertebrate innate immune system uses several strategies to exploit this "Achilles heel" of microbial physiology, but bacterial evolution has responded in kind. This review highlights recent insights into transcriptional, transport, and trafficking mechanisms that pathogens use to "win the fight" over zinc and thrive in an otherwise hostile environment.	[Capdevila, Daiana A.; Wang, Jiefei; Giedroc, David P.] Indiana Univ, Dept Chem, 800 E Kirkwood Ave, Bloomington, IN 47405 USA; [Wang, Jiefei; Giedroc, David P.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Capdevila, Daiana A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, C1428EHA, Buenos Aires, DF, Argentina	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Buenos Aires	Giedroc, DP (corresponding author), Indiana Univ, Dept Chem, 800 E Kirkwood Ave, Bloomington, IN 47405 USA.	giedroc@indiana.edu	Capdevila, Daiana/AAG-1365-2019; Giedroc, David/A-8608-2018; Wang, Jiefei/AAA-1301-2020	Capdevila, Daiana/0000-0002-0500-1016; Giedroc, David/0000-0002-2342-1620; 	National Institutes of Health [GM042569, GM118157]; Pew Latin American Fellows Program in the Biomedical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118157, R01GM042569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Latin American Fellows Program in the Biomedical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM042569 and GM118157 (to D. P. G.). This work was also supported by the Pew Latin American Fellows Program in the Biomedical Sciences (to D. A. C.). This is the third article in the Thematic Minireview series "Metals in Biology 2016: Molecular Basis of Selection of Metals by Enzymes." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Arunkumar AI, 2009, P NATL ACAD SCI USA, V106, P18177, DOI 10.1073/pnas.0905558106; Begg SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7418; Bersch B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081168; Blaby-Haas CE, 2012, METALLOMICS, V4, P488, DOI 10.1039/c2mt20012k; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; Blindauer CA, 2002, MOL MICROBIOL, V45, P1421, DOI 10.1046/j.1365-2958.2002.03109.x; Blindauer CA, 2015, CHEM COMMUN, V51, P4544, DOI 10.1039/c4cc10174j; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; Calmettes C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8996; Cerasi M, 2014, METALLOMICS, V6, P845, DOI 10.1039/c3mt00352c; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; Cunden LS, 2016, CHEM SCI, V7, P1338, DOI 10.1039/c5sc03655k; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Eicken C, 2003, J MOL BIOL, V333, P683, DOI 10.1016/j.jmb.2003.09.007; Farrugia MA, 2013, J BIOL CHEM, V288, P13178, DOI 10.1074/jbc.R112.446526; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Gabriel SE, 2008, J BACTERIOL, V190, P3482, DOI 10.1128/JB.01978-07; Gabriel SE, 2009, J BACTERIOL, V191, P6116, DOI 10.1128/JB.00802-09; Gagnon DM, 2015, J AM CHEM SOC, V137, P3004, DOI 10.1021/ja512204s; Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Giedroc DP, 2007, DALTON T, P3107, DOI 10.1039/b706769k; Gilston BA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001987; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Grass G, 2001, J BACTERIOL, V183, P4664, DOI 10.1128/JB.183.15.4664-4667.2001; Guan GH, 2015, MOL MICROBIOL, V98, P787, DOI 10.1111/mmi.13158; Guerra AJ, 2011, J AM CHEM SOC, V133, P19614, DOI 10.1021/ja2080532; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; Haley KP, 2015, INFECT IMMUN, V83, P2944, DOI 10.1128/IAI.00544-15; Handali M, 2015, J BIOL CHEM, V290, P29984, DOI 10.1074/jbc.M115.684506; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hood MI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003068; Hou ZJ, 2003, J BIOL CHEM, V278, P28455, DOI 10.1074/jbc.M301415200; Ilari A, 2016, BBA-GEN SUBJECTS, V1860, P534, DOI 10.1016/j.bbagen.2015.12.006; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Jaffe EK, 2003, CHEM BIOL, V10, P25, DOI 10.1016/S1074-5521(02)00296-X; Johnstone TC, 2015, DALTON T, V44, P6320, DOI 10.1039/c4dt03559c; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; Kolaj-Robin O, 2015, FEBS LETT, V589, P1283, DOI 10.1016/j.febslet.2015.04.007; Lacasse MJ, 2016, BIOCHEMISTRY-US, V55, P1689, DOI 10.1021/acs.biochem.5b01328; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Ma Z, 2014, MOL MICROBIOL, V94, P756, DOI 10.1111/mmi.12794; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P9130, DOI 10.1093/nar/gkr625; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Maret W, 2007, MOL MED, V13, P371, DOI 10.2119/2007-00036.Maret; Martin JE, 2016, J BACTERIOL, V198, P1066, DOI 10.1128/JB.00975-15; Mattle D, 2015, EMBO REP, V16, P728, DOI 10.15252/embr.201439927; Murphy JT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002013; Nairn BL, 2016, CELL HOST MICROBE, V19, P826, DOI 10.1016/j.chom.2016.05.007; Nakashige TG, 2015, NAT CHEM BIOL, V11, P765, DOI [10.1038/NCHEMBIO.1891, 10.1038/nchembio.1891]; Nanamiya H, 2004, MOL MICROBIOL, V52, P273, DOI 10.1111/j.1365-2958.2003.03972.x; Napolitano M, 2012, J BACTERIOL, V194, P2426, DOI 10.1128/JB.00090-12; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Neyrolles O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00089; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Ong CLY, 2014, J INFECT DIS, V209, P1500, DOI 10.1093/infdis/jiu053; Osman D, 2015, J BIOL CHEM, V290, P19806, DOI 10.1074/jbc.M115.663427; Osman D, 2011, ADV MICROB PHYSIOL, V58, P175, DOI 10.1016/B978-0-12-381043-4.00005-2; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P11334, DOI 10.1074/jbc.M112.448175; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Pederick VG, 2015, SCI REP-UK, V5, DOI 10.1038/srep13139; Pennella MA, 2003, P NATL ACAD SCI USA, V100, P3713, DOI 10.1073/pnas.0636943100; Philips SJ, 2015, SCIENCE, V349, P877, DOI 10.1126/science.aaa9809; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Raimunda D, 2014, MOL MICROBIOL, V91, P185, DOI 10.1111/mmi.12454; Raimunda D, 2012, BBA-BIOMEMBRANES, V1818, P1374, DOI 10.1016/j.bbamem.2012.02.020; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Sankaran B, 2009, J BACTERIOL, V191, P6936, DOI 10.1128/JB.00287-09; Sanson M, 2015, NUCLEIC ACIDS RES, V43, P418, DOI 10.1093/nar/gku1304; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Sheng Y, 2015, INFECT IMMUN, V83, P3902, DOI 10.1128/IAI.00447-15; Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108; Stephan JR, 2016, CHEM SCI, V7, P1962, DOI 10.1039/c5sc03287c; Stork M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003733; Strausak D, 1997, J BIOL CHEM, V272, P8932; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang KT, 2014, NATURE, V514, P518, DOI 10.1038/nature13618; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	98	87	90	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20858	20868		10.1074/jbc.R116.742023	http://dx.doi.org/10.1074/jbc.R116.742023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27462080	Green Published, hybrid			2022-12-28	WOS:000385406200005
J	Fiebig, D; Schmelz, S; Zindel, S; Ehret, V; Beck, J; Ebenig, A; Ehret, M; Frols, S; Pfeifer, F; Kolmar, H; Fuchsbauer, HL; Scrima, A				Fiebig, David; Schmelz, Stefan; Zindel, Stephan; Ehret, Vera; Beck, Jan; Ebenig, Aileen; Ehret, Marina; Froels, Sabrina; Pfeifer, Felicitas; Kolmar, Harald; Fuchsbauer, Hans-Lothar; Scrima, Andrea			Structure of the Dispase Autolysis-inducing Protein from Streptomyces mobaraensis and Glutamine Cross-linking Sites for Transglutaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; protein chemical modification; protein chemistry; tertiary structure; X-ray crystallography; Dispase autolysis inducing protein; Streptomyces mobaraensis; glutamine cross-linking sites; microbial transglutaminase	MICROBIAL TRANSGLUTAMINASE; SUBSTRATE-SPECIFICITY; PRO-TRANSGLUTAMINASE; PURIFICATION; AMINOPEPTIDASE; HYGROSCOPICUS; MUTAGENESIS; SEQUENCE	Transglutaminase from Streptomyces mobaraensis (MTG) is an important enzyme for cross-linking and modifying proteins. An intrinsic substrate of MTG is the dispase autolysis-inducing protein (DAIP). The amino acid sequence of DAIP contains 5 potential glutamines and 10 lysines for MTG-mediated cross-linking. The aim of the study was to determine the structure and glutamine cross-linking sites of the first physiological MTG substrate. A production procedure was established in Escherichia coli BL21 (DE3) to obtain high yields of recombinant DAIP. DAIP variants were prepared by replacing four of five glutamines for asparagines in various combinations via site-directed mutagenesis. Incorporation of biotin cadaverine revealed a preference of MTG for the DAIP glutamines in the order of Gln-39 >> Gln-298 > Gln-345 approximate to Gln-65 >> Gln-144. In the structure of DAIP the preferred glutamines do cluster at the top of the seven-bladed -propeller. This suggests a targeted cross-linking of DAIP by MTG that may occur after self-assembly in the bacterial cell wall. Based on our biochemical and structural data of the first physiological MTG substrate, we further provide novel insight into determinants of MTG-mediated modification, specificity, and efficiency.	[Schmelz, Stefan; Scrima, Andrea] Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Fiebig, David; Zindel, Stephan; Ehret, Vera; Beck, Jan; Ebenig, Aileen; Ehret, Marina; Fuchsbauer, Hans-Lothar] Univ Appl Sci Darmstadt, Dept Chem Engn & Biotechnol, Schnittspahnstr 12, D-64287 Darmstadt, Germany; [Fiebig, David; Zindel, Stephan; Beck, Jan; Ebenig, Aileen; Kolmar, Harald] Tech Univ Darmstadt, Dept Chem, D-64287 Darmstadt, Germany; [Froels, Sabrina; Pfeifer, Felicitas] Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hochschule Darmstadt; Technical University of Darmstadt; Technical University of Darmstadt	Scrima, A (corresponding author), Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany.; Fuchsbauer, HL (corresponding author), Univ Appl Sci Darmstadt, Dept Chem Engn & Biotechnol, Schnittspahnstr 12, D-64287 Darmstadt, Germany.	hans-lothar.fuchsbauer@h-da.de; andrea.scrima@helmholtz-hzi.de	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993; Pfeifer, Felicitas/0000-0003-1631-1543; Fuchsbauer, Hans-Lothar/0000-0003-4954-5741; Ebenig, Aileen/0000-0001-7066-0184	Centre for R&D (ZFE) at the University of Applied Sciences of Darmstadt; Deutsche Forschungsgemeinschaft [SPP1623]; Helmholtz Association [VH-NG-727]	Centre for R&D (ZFE) at the University of Applied Sciences of Darmstadt; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association)	This work was supported by the Centre for R&D (ZFE) at the University of Applied Sciences of Darmstadt and in part by a grant from the Deutsche Forschungsgemeinschaft in the frame of Priority Program SPP1623 (to H. K.). Work in the group of A. Scrima was partially funded by Helmholtz Association Young Investigator Grant VH-NG-727. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735; Buchert J, 2010, ANNU REV FOOD SCI T, V1, P113, DOI 10.1146/annurev.food.080708.100841; Dennler P, 2014, BIOCONJUGATE CHEM, V25, P569, DOI 10.1021/bc400574z; Du K, 2014, APPL ENVIRON MICROB, V80, P723, DOI 10.1128/AEM.02820-13; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; GERBER U, 1994, BIOCHEM J, V299, P825, DOI 10.1042/bj2990825; Gundersen MT, 2014, APPL MICROBIOL BIOT, V98, P219, DOI 10.1007/s00253-013-4886-x; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P6900, DOI 10.1021/bi00370a025; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiya N, 2011, METHODS MOL BIOL, V751, P81, DOI 10.1007/978-1-61779-151-2_7; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiss RS, 2001, BBA-MOL CELL BIOL L, V1531, P251, DOI 10.1016/S1388-1981(01)00109-3; Lee JH, 2013, BIOTECHNOL BIOENG, V110, P353, DOI 10.1002/bit.24622; Marx CK, 2008, J BIOTECHNOL, V136, P156, DOI 10.1016/j.jbiotec.2008.06.005; Mehta K, 2005, PROG EXP TUMOR RES, V38, P1; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Rachel NM, 2013, BIOMOLECULES, V3, P870, DOI 10.3390/biom3040870; Sarafeddinov A, 2011, J MICROBIOL BIOTECHN, V21, P617, DOI 10.4014/jmb.1012.12004; Sarafeddinov A, 2009, BIOSCI BIOTECH BIOCH, V73, P993, DOI 10.1271/bbb.80769; Schmidt S, 2008, FEBS LETT, V582, P3132, DOI 10.1016/j.febslet.2008.07.049; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Siegmund V, 2015, ANGEW CHEM INT EDIT, V54, P13420, DOI 10.1002/anie.201504851; Sommer C, 2012, AMINO ACIDS, V42, P997, DOI 10.1007/s00726-011-1016-x; Strop P, 2014, BIOCONJUGATE CHEM, V25, P855, DOI 10.1021/bc500099v; Sugimura Y, 2008, ARCH BIOCHEM BIOPHYS, V477, P379, DOI 10.1016/j.abb.2008.06.014; Taguchi S, 2002, J BIOSCI BIOENG, V94, P478, DOI 10.1263/jbb.94.478; Taguchi S, 2000, J BIOCHEM-TOKYO, V128, P415, DOI 10.1093/oxfordjournals.jbchem.a022769; Umezawa Y, 2004, J BIOCHEM, V136, P293, DOI 10.1093/jb/mvh129; Weimer S, 2006, ANAL BIOCHEM, V352, P110, DOI 10.1016/j.ab.2006.02.029; YANG H, 2013, GENOME ANNOUCEMENTS, V0001; Yokoyama K, 2010, APPL MICROBIOL BIOT, V87, P2087, DOI 10.1007/s00253-010-2656-6; Zhang DX, 2008, J AGR FOOD CHEM, V56, P10261, DOI 10.1021/jf8008519; Zindel S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149145; Zotzel J, 2003, EUR J BIOCHEM, V270, P4149, DOI 10.1046/j.1432-1033.2003.03809.x; Zotzel J, 2003, EUR J BIOCHEM, V270, P3214, DOI 10.1046/j.1432-1033.2003.03703.x	40	16	16	5	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20417	20426		10.1074/jbc.M116.731109	http://dx.doi.org/10.1074/jbc.M116.731109			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27493205	Green Published, hybrid			2022-12-28	WOS:000384574800011
J	McCammon, KM; Panda, SP; Xia, CW; Kim, JJP; Moutinho, D; Kranendonk, M; Auchus, RJ; Lafer, EM; Ghosh, D; Martasek, P; Kar, R; Masters, BS; Roman, LJ				McCammon, Karen M.; Panda, Satya P.; Xia, Chuanwu; Kim, Jung-Ja P.; Moutinho, Daniela; Kranendonk, Michel; Auchus, Richard J.; Lafer, Eileen M.; Ghosh, Debashis; Martasek, Pavel; Kar, Rekha; Masters, Bettie Sue; Roman, Linda J.			Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; flavoprotein; membrane protein; protein crystallization; protein stability; reductase; POR deficiency; cytochrome P450 oxidoreductase; diflavin oxidoreductase	P450 OXIDOREDUCTASE DEFICIENCY; CONGENITAL ADRENAL-HYPERPLASIA; HEME OXYGENASE-1 ACTIVITY; ESCHERICHIA-COLI; DISORDERED STEROIDOGENESIS; LIMITED PROTEOLYSIS; STRUCTURAL BASIS; HUMAN AROMATASE; SYSTEM; MUTATIONS	Human NADPH-cytochrome P450 oxidoreductase (POR) gene mutations are associated with severe skeletal deformities and disordered steroidogenesis. The human POR mutation A287P presents with disordered sexual development and skeletal malformations. Difficult recombinant expression and purification of this POR mutant suggested that the protein was less stable than WT. The activities of cytochrome P450 17A1, 19A1, and 21A2, critical in steroidogenesis, were similar using our purified, full-length, unmodified A287P or WT POR, as were those of several xenobiotic-metabolizing cytochromes P450, indicating that the A287P protein is functionally competent in vitro, despite its functionally deficient phenotypic behavior in vivo. Differential scanning calorimetry and limited trypsinolysis studies revealed a relatively unstable A287P compared with WT protein, leading to the hypothesis that the syndrome observed in vivo results from altered POR protein stability. The crystal structures of the soluble domains of WT and A287P reveal only subtle differences between them, but these differences are consistent with the differential scanning calorimetry results as well as the differential susceptibility of A287P and WT observed with trypsinolysis. The relative in vivo stabilities of WT and A287P proteins were also examined in an osteoblast cell line by treatment with cycloheximide, a protein synthesis inhibitor, showing that the level of A287P protein post-inhibition is lower than WT and suggesting that A287P may be degraded at a higher rate. Current studies demonstrate that, unlike previously described mutations, A287P causes POR deficiency disorder due to conformational instability leading to proteolytic susceptibility in vivo, rather than through an inherent flavin-binding defect.	[McCammon, Karen M.; Panda, Satya P.; Lafer, Eileen M.; Kar, Rekha; Masters, Bettie Sue; Roman, Linda J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Xia, Chuanwu; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Moutinho, Daniela; Kranendonk, Michel] Univ Nova Lisboa, NOVA Med Sch FCM, Ctr Toxicogen & Human Hlth Tox Genet Oncol & Huma, Campo Martires Patria 130, P-1169056 Lisbon, Portugal; [Auchus, Richard J.] Univ Michigan, Div Metab Endocrinol & Diabet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ghosh, Debashis] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Martasek, Pavel] Charles Univ Prague, Dept Pediat, Fac Med 1, CR-11636 Prague 1, Czech Republic; [Martasek, Pavel] Gen Univ Hosp, Prague 11636 1, Czech Republic; [Moutinho, Daniela] Univ Santiago de Compostela, CIMUS, Ave Barcelona, Santiago De Compostela 15782, Spain	University of Texas System; University of Texas Health San Antonio; Medical College of Wisconsin; Universidade Nova de Lisboa; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Charles University Prague; General University Hospital Prague; Universidade de Santiago de Compostela	Roman, LJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.; Masters, BS (corresponding author), Duke Univ, Sch Med, Dept Biochem, Box 3711,307 Res Dr, Durham, NC 27710 USA.	bettie.sue.masters@duke.edu; roman@uthscsa.edu	Kranendonk, Michel/AAP-7609-2021; Martásek, Pavel/G-6622-2017; Kranendonk, Michel/H-8176-2013; Moutinho, Daniela/Y-7010-2019	Martásek, Pavel/0000-0001-6165-4444; Kranendonk, Michel/0000-0003-1362-0076; Lafer, Eileen/0000-0002-0493-6522; Moutinho, Daniela/0000-0002-8554-4765	University of Texas Health Science Center at San Antonio Institutional Mass Spectrometry Core Laboratory; Center for Macromolecular Interactions; Cancer Therapy and Research Center, National Institutes of Health, NCI [CA054174]; Texas State funds through University of Texas Health Science Center at San Antonio Office of the Vice President for Research; National Institutes of Health Shared Instrumentation Grant [S10RR025111]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097031, R01GM081568, R01GM086596] Funding Source: NIH RePORTER	University of Texas Health Science Center at San Antonio Institutional Mass Spectrometry Core Laboratory; Center for Macromolecular Interactions; Cancer Therapy and Research Center, National Institutes of Health, NCI; Texas State funds through University of Texas Health Science Center at San Antonio Office of the Vice President for Research; National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source beamlines SBC 19ID for their assistance in data collection and Jessica Lo and Egbuta Chinaza for performing the aromatase assays. We gratefully acknowledge the support of the University of Texas Health Science Center at San Antonio Institutional Mass Spectrometry Core Laboratory and Center for Macromolecular Interactions, both of which are supported in part by the Cancer Therapy and Research Center, National Institutes of Health, NCI P30 Award CA054174, and by Texas State funds provided through the University of Texas Health Science Center at San Antonio Office of the Vice President for Research. The Mass Spectrometry Laboratory is also supported in part by National Institutes of Health Shared Instrumentation Grant S10RR025111 (to S.T. Weintraub), and the expert technical assistance of Sammy Pardo is gratefully acknowledged. We also thank Dr. Verna Frasca of Malvern Instruments for invaluable advice and guidance, and Liping Wang for technical expertise in performing the DSC experiments. Thanks are also due to Dr. Neal C. Robinson for the careful reading and sage advice regarding interpretation of the DSC experiments.	Adachi M, 2006, AM J MED GENET A, V140A, P633, DOI 10.1002/ajmg.a.31112; Adachi M, 2004, AM J MED GENET A, V128A, P333, DOI 10.1002/ajmg.a.30169; Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Arlt W, 2004, LANCET, V363, P2128, DOI 10.1016/S0140-6736(04)16503-3; Arnold U, 2005, BIOCATAL BIOTRANSFOR, V23, P159, DOI 10.1080/10242420500183287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Duarte MP, 2005, MUTAGENESIS, V20, P199, DOI 10.1093/mutage/gei028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHER CW, 1992, FASEB J, V6, P759, DOI 10.1096/fasebj.6.2.1537466; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Fluck CE, 2010, BIOCHEM BIOPH RES CO, V401, P149, DOI 10.1016/j.bbrc.2010.09.035; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fukami M, 2005, J CLIN ENDOCR METAB, V90, P414, DOI 10.1210/jc.2004-0810; Ghosh D, 2010, J STEROID BIOCHEM, V118, P197, DOI 10.1016/j.jsbmb.2009.09.012; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Heiring C, 2001, PROTEIN ENG, V14, P183, DOI 10.1093/protein/14.3.183; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Huber WJ, 2009, DRUG METAB DISPOS, V37, P857, DOI 10.1124/dmd.108.025023; ILAN Z, 1981, J BIOL CHEM, V256, P66; Jin Y, 2015, BIOCHEM J, V468, P25, DOI 10.1042/BJ20141410; KMOCH S, 1995, J INHERIT METAB DIS, V18, P227, DOI 10.1007/BF00711774; Kranendonk M, 1998, MUTAGENESIS, V13, P263, DOI 10.1093/mutage/13.3.263; Kranendonk M, 2008, ARCH BIOCHEM BIOPHYS, V475, P93, DOI 10.1016/j.abb.2008.04.014; Krone N, 2012, J CLIN ENDOCR METAB, V97, pE257, DOI 10.1210/jc.2011-0640; Lala P, 2004, J STEROID BIOCHEM, V88, P235, DOI 10.1016/j.jsbmb.2003.12.010; Makaji E, 2010, TOXICOL SCI, V113, P293, DOI 10.1093/toxsci/kfp255; Marohnic CC, 2006, J BIOL CHEM, V281, P35975, DOI 10.1074/jbc.M607095200; Marohnic CC, 2011, ARCH BIOCHEM BIOPHYS, V513, P42, DOI 10.1016/j.abb.2011.06.008; Marohnic CC, 2010, DRUG METAB DISPOS, V38, P332, DOI 10.1124/dmd.109.030445; McLaughlin LA, 2008, DRUG METAB DISPOS, V36, P1322, DOI 10.1124/dmd.108.021261; McPherson A., 1999, CRYSTALLIZATION BIOL; Moutinho D, 2012, DRUG METAB DISPOS, V40, P754, DOI 10.1124/dmd.111.042820; Mui B., 1993, LIPOSOME TECHNOLOGY, P55; Nicolo C, 2010, MOL CELL ENDOCRINOL, V321, P245, DOI 10.1016/j.mce.2010.02.024; ONO T, 1975, J BIOL CHEM, V250, P1571; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Panda SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075638; Pandey AV, 2013, PHARMACOL THERAPEUT, V138, P229, DOI 10.1016/j.pharmthera.2013.01.010; Pudney CR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001222; Riddick DS, 2013, DRUG METAB DISPOS, V41, P12, DOI 10.1124/dmd.112.048991; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; STURA E A, 1990, Methods (Orlando), V1, P38, DOI 10.1016/S1046-2023(05)80145-8; Tomkova M, 2015, PHARMACOGENOMICS, V16, P205, DOI 10.2217/pgs.14.169; Tomkova M, 2012, PHARMACOGENOMICS, V13, P543, DOI [10.2217/PGS.12.21, 10.2217/pgs.12.21]; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang YH, 2010, ENDOCRINOLOGY, V151, P1677, DOI 10.1210/en.2009-1247; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Yoshimoto FK, 2014, BIOCHEMISTRY-US, V53, P7531, DOI 10.1021/bi5011865; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w	60	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20487	20502		10.1074/jbc.M116.716019	http://dx.doi.org/10.1074/jbc.M116.716019			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27496950	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000384574800016
J	Page, KM; Rothwell, SW; Dolphin, AC				Page, Karen M.; Rothwell, Simon W.; Dolphin, Annette C.			The Ca-V beta Subunit Protects the I-II Loop of the Voltage-gated Calcium Channel Ca(V)2.2 from Proteasomal Degradation but Not Oligoubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; confocal microscopy; protein degradation; trafficking; ubiquitin; ubiquitylation (ubiquitination); Western blot	PLASMA-MEMBRANE; TRAFFICKING; BINDING; LINKER; PALMITOYLATION; G-ALPHA(S); COMPLEX; MOTIF; MODULATION; UBIQUITIN	Ca-V subunits interact with the voltage-gated calcium channel Ca(V)2.2 on a site in the intracellular loop between domains I and II (the I-II loop). This interaction influences the biophysical properties of the channel and leads to an increase in its trafficking to the plasma membrane. We have shown previously that a mutant Ca(V)2.2 channel that is unable to bind Ca-V subunits (Ca(V)2.2 W391A) was rapidly degraded (Waithe, D., Ferron, L., Page, K. M., Chaggar, K., and Dolphin, A. C. (2011) J. Biol. Chem. 286, 9598-9611). Here we show that, in the absence of Ca-V subunits, a construct consisting of the I-II loop of Ca(V)2.2 was directly ubiquitinated and degraded by the proteasome system. Ubiquitination could be prevented by mutation of all 12 lysine residues in the I-II loop to arginines. Including a palmitoylation motif at the N terminus of Ca(V)2.2 I-II loop was insufficient to target it to the plasma membrane in the absence of Ca-V subunits even when proteasomal degradation was inhibited with MG132 or ubiquitination was prevented by the lysine-to-arginine mutations. In the presence of Ca-V subunit, the palmitoylated Ca(V)2.2 I-II loop was protected from degradation, although oligoubiquitination could still occur, and was efficiently trafficked to the plasma membrane. We propose that targeting to the plasma membrane requires a conformational change in the I-II loop that is induced by binding of the Ca-V subunit.	[Page, Karen M.; Rothwell, Simon W.; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England	University of London; University College London	Page, KM; Dolphin, AC (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	k.page@ucl.ac.uk; a.dolphin@ucl.ac.uk			Wellcome Trust [098360/Z/ 12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Investigator Award 098360/Z/ 12/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Cassidy JS, 2014, P NATL ACAD SCI USA, V111, P8979, DOI 10.1073/pnas.1403731111; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Comyn SA, 2014, J PROTEOMICS, V100, P92, DOI 10.1016/j.jprot.2013.08.005; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crouthamel M, 2008, CELL SIGNAL, V20, P1900, DOI 10.1016/j.cellsig.2008.06.019; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; Fang K, 2011, J PHYSIOL-LONDON, V589, P4437, DOI 10.1113/jphysiol.2011.214247; Gebhart M, 2010, MOL CELL NEUROSCI, V44, P246, DOI 10.1016/j.mcn.2010.03.011; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Kaur G, 2015, J BIOL CHEM, V290, P21086, DOI 10.1074/jbc.M115.645671; Kosloff M, 2002, BIOCHEMISTRY-US, V41, P14518, DOI 10.1021/bi026729x; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Meir A, 2000, BIOPHYS J, V79, P731, DOI 10.1016/S0006-3495(00)76331-4; Miranda-Laferte E, 2014, J BIOL CHEM, V289, P10387, DOI 10.1074/jbc.M113.507244; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y; Thiyagarajan MM, 2002, BIOCHEMISTRY-US, V41, P9470, DOI 10.1021/bi025533u; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang Y, 2008, J NEUROSCI, V28, P14176, DOI 10.1523/JNEUROSCI.1350-08.2008	44	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20402	20416		10.1074/jbc.M116.737270	http://dx.doi.org/10.1074/jbc.M116.737270			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27489103	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000384574800010
J	Reddi, R; Saddanapu, V; Chinthapalli, DK; Sankoju, P; Sripadi, P; Addlagatta, A				Reddi, Ravikumar; Saddanapu, Venkateshwarlu; Chinthapalli, Dinesh Kumar; Sankoju, Priyanka; Sripadi, Prabhakar; Addlagatta, Anthony			Human Naa50 Protein Displays Broad Substrate Specificity for Amino-terminal Acetylation: DETAILED STRUCTURAL AND BIOCHEMICAL ANALYSIS USING TETRAPEPTIDE LIBRARY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyltransferase; enzyme kinetics; peptides; protein stability; protein structure	SISTER-CHROMATID COHESION; MOLECULAR-BASIS; ACETYLTRANSFERASE; IDENTIFICATION; NATA; AMINOPEPTIDASE; HNAT5/HSAN; PROTEOMICS; STABILITY; RIBOSOME	Amino-terminal acetylation is a critical co-translational modification of the newly synthesized proteins in a eukaryotic cell carried out by six amino-terminal acetyltransferases (NATs). All NATs contain at least one catalytic subunit, and some contain one or two additional auxiliary subunits. For example, NatE is a complex of Naa10, Naa50, and Naa15 (auxiliary). In the present study, the crystal structure of human Naa50 suggested the presence of CoA and acetylated tetrapeptide (AcMMXX) that have co-purified with the protein. Biochemical and thermal stability studies on the tetrapeptide library with variations in the first and second positions confirm our results from the crystal structure that a peptide with Met-Met in the first two positions is the best substrate for this enzyme. In addition, Naa50 acetylated all MXAA peptides except for MPAA. Transcriptome analysis of 10 genes that make up six NATs in humans from eight different cell lines suggests that components of NatE are transcribed in all cell lines, whereas others are variable. Because Naa10 is reported to acetylate all amino termini that are devoid of methionine and Naa50 acetylates all other peptides that are followed by methionine, we believe that NatE complex can be a major contributor for amino-terminal acetylation at the ribosome exit tunnel.	[Reddi, Ravikumar; Saddanapu, Venkateshwarlu; Sankoju, Priyanka; Addlagatta, Anthony] Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Hyderabad 500607, Telangana, India; [Chinthapalli, Dinesh Kumar; Sripadi, Prabhakar] Indian Inst Chem Technol, CSIR, Natl Ctr Mass Spectrometry, Hyderabad 500607, Telangana, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Addlagatta, A (corresponding author), Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Hyderabad 500607, Telangana, India.	anthony@iict.res.in	Addlagatta, Anthony/AAW-2675-2020; Reddi, Ravikumar/AAM-6814-2021	Reddi, Ravikumar/0000-0002-7657-4727	Council of Scientific and Industrial Research; University Grants Commission, New Delhi, India; Department of Science and Technology [SR/SO/BB-55/2008]; Department of Biotechnology [BT-BRB-TF-2-2011]; Council of Scientific and Industrial Research (SMiLE) New Delhi, India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi, India(University Grants Commission, India); Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council of Scientific and Industrial Research (SMiLE) New Delhi, India	This work was supported by research fellowships from the Council of Scientific and Industrial Research and University Grants Commission, New Delhi, India (to R. R., V. S., and D. K. C.) and by Department of Science and Technology Grant SR/SO/BB-55/2008, Department of Biotechnology Grant BT-BRB-TF-2-2011, and the Council of Scientific and Industrial Research (SMiLE) New Delhi, India (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Addlagatta A, 2001, ACTA CRYSTALLOGR D, V57, P649, DOI 10.1107/S0907444901003468; Arnesen T, 2006, GENE, V371, P291, DOI 10.1016/j.gene.2005.12.008; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Caesar R, 2006, EUKARYOT CELL, V5, P368, DOI 10.1128/EC.5.2.368-378.2006; DeLano W.L, PYMOL MOL GRAPHICS S; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Evjenth RH, 2012, J BIOL CHEM, V287, P10081, DOI 10.1074/jbc.M111.326587; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Giglione C, 2015, BIOCHIMIE, V114, P134, DOI 10.1016/j.biochi.2014.11.008; Gromyko D, 2010, INT J CANCER, V127, P2777, DOI 10.1002/ijc.25275; Gumpena R, 2012, PROTEIN SCI, V21, P727, DOI 10.1002/pro.2060; Hole K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024713; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Magin RS, 2015, STRUCTURE, V23, P332, DOI 10.1016/j.str.2014.10.025; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Simpson R. J., 2010, COLD SPRING HARBOR P; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Damme P, 2015, PROTEOMICS, V15, P2436, DOI 10.1002/pmic.201400575; Van Damme P, 2012, P NATL ACAD SCI USA, V109, P12449, DOI 10.1073/pnas.1210303109; Van Damme P, 2011, FEBS J, V278, P3822, DOI 10.1111/j.1742-4658.2011.08230.x; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Vasudev PG, 2012, PROTEINS, V80, P991, DOI 10.1002/prot.24001; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; WILCOX C, 1987, SCIENCE, V238, P1275, DOI 10.1126/science.3685978; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang XH, 2011, MOL CELL, V44, P39, DOI 10.1016/j.molcel.2011.07.032; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang LH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02992	47	7	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20530	20538		10.1074/jbc.M116.730432	http://dx.doi.org/10.1074/jbc.M116.730432			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27484799	hybrid, Green Published			2022-12-28	WOS:000384574800019
J	Chu, XG; Chen, XY; Wan, QW; Zheng, Z; Du, QS				Chu, Xiaogang; Chen, Xuanyu; Wan, Qingwen; Zheng, Zhen; Du, Quansheng			Nuclear Mitotic Apparatus (NuMA) Interacts with and Regulates Astrin at the Mitotic Spindle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromosomes; microtubule; mitosis; mitotic spindle; protein-protein interaction; Astrin; NuMA	KINETOCHORE-MICROTUBULE INTERACTIONS; CHROMOSOME ALIGNMENT; PLANAR DIVISIONS; PROTEIN ASTRIN; CELL-DIVISION; POLES; COMPLEX; MITOSIS; ORGANIZATION; MECHANISMS	The large nuclear mitotic apparatus (NuMA) protein is an essential player in mitotic spindle assembly and maintenance. We report here the identification of Astrin, a spindle- and kinetochore-associated protein, as a novel interactor of NuMA. We show that the C-terminal tail of NuMA can directly bind to the C terminus of Astrin and that this interaction helps to recruit Astrin to microtubules. Knockdown of NuMA by RNA interference dramatically impaired Astrin recruitment to the mitotic spindle. Overexpression of the N terminus of mammalian homologue of Drosophila Pins (LGN), which blocks the microtubule binding of NuMA and competes with Astrin for NuMA binding, also led to similar results. Furthermore, we found that cytoplasmic dynein is required for the spindle pole accumulation of Astrin, and dynein-mediated transport is important for balanced distribution of Astrin between spindle poles and kinetochores. On the other hand, if Astrin levels are reduced, then NuMA could not efficiently concentrate at the spindle poles. Our findings reveal a direct physical link between two important regulators of mitotic progression and demonstrate the critical role of the NuMA-Astrin interaction for accurate cell division.	[Chu, Xiaogang; Chen, Xuanyu; Wan, Qingwen; Zheng, Zhen; Du, Quansheng] Augusta Univ, Dept Neurosci & Regenerat Med, Med Coll Georgia, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Chu, XG; Du, QS (corresponding author), Augusta Univ, Dept Neurosci & Regenerat Med, Med Coll Georgia, Augusta, GA 30912 USA.	xichu@augusta.edu; qdu@augusta.edu		Du, Quansheng/0000-0003-4079-8662	National Institutes of Health [GM079506, NS093549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS093549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by National Institutes of Health Grants GM079506 and NS093549 (to Q. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ban KH, 2007, DEV CELL, V13, P29, DOI 10.1016/j.devcel.2007.04.017; Ben-Yair R, 2011, DEVELOPMENT, V138, P4155, DOI 10.1242/dev.065169; Cheng TS, 2008, J BIOL CHEM, V283, P2454, DOI 10.1074/jbc.M706794200; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Compton DA, 1998, J CELL SCI, V111, P1477; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2002, CURR BIOL, V12, P1928, DOI 10.1016/S0960-9822(02)01298-8; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Fant X, 2004, INT REV CYTOL, V238, P1, DOI 10.1016/S0074-7696(04)38001-0; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Haren L, 2002, J CELL SCI, V115, P1815; Haren Laurence, 2009, BMC Res Notes, V2, P64, DOI 10.1186/1756-0500-2-64; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Levesque AA, 2003, MOL BIOL CELL, V14, P3541, DOI 10.1091/mbc.E03-02-0082; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Maiato H, 2004, INT REV CYTOL, V241, P53, DOI 10.1016/S0074-7696(04)41002-X; Manning AL, 2008, CELL, V134, P694, DOI 10.1016/j.cell.2008.08.001; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; Saredi A, 1996, J CELL SCI, V109, P619; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Zheng Z, 2014, MOL BIOL CELL, V25, P606, DOI 10.1091/mbc.E13-08-0474; Zheng Z, 2013, MOL BIOL CELL, V24, P901, DOI 10.1091/mbc.E12-06-0458; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011	47	18	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20055	20067		10.1074/jbc.M116.724831	http://dx.doi.org/10.1074/jbc.M116.724831			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27462074	Green Published, hybrid			2022-12-28	WOS:000383243100028
J	Hwang, SK; Koper, K; Satoh, H; Okita, TW				Hwang, Seon-Kap; Koper, Kaan; Satoh, Hikaru; Okita, Thomas W.			Rice Endosperm Starch Phosphorylase (Pho1) Assembles with Disproportionating Enzyme (Dpe1) to Form a Protein Complex That Enhances Synthesis of Malto-oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosyltransferase; metabolism; phosphorylase; protein complex; protein-protein interaction; D-enzyme; disproportionating enzyme; rice endosperm; starch phosphorylase; starch synthesis	ALPHA-GLUCAN PHOSPHORYLASE; SWEET-POTATO ROOTS; BIOSYNTHETIC-ENZYMES; BRANCHING ENZYME; CHLAMYDOMONAS-REINHARDTII; POLYACRYLAMIDE-GEL; MALTOSE METABOLISM; LOW-TEMPERATURE; SPINACH LEAVES; SYNTHASE I	Starch synthesis in cereal grain endosperm is dependent on the concerted actions of many enzymes. The starch plastidial phosphorylase (Pho1) plays an important role in the initiation of starch synthesis and in the maturation of starch granule in developing rice seeds. Prior evidence has suggested that the rice enzyme, OsPho1, may have a physical/functional interaction with other starch biosynthetic enzymes. Pulldown experiments showed that OsPho1 as well as OsPho1 devoid of its L80 region, a peptide unique to higher plant phosphorylases, captures disproportionating enzyme (OsDpe1). Interaction of the latter enzyme form with OsDpe1 indicates that the putative regulatory L80 is not responsible for multienzyme assembly. This heterotypic enzyme complex, determined at a molar ratio of 1:1, was validated by reciprocal co-immunoprecipitation studies of native seed proteins and by co-elution chromatographic and co-migration electrophoretic patterns of these enzymes in rice seed extracts. The OsPho1-OsDpe1 complex utilized a broader range of substrates for enhanced synthesis of larger maltooligosaccharides than each individual enzyme and significantly elevated the substrate affinities of OsPho1 at 30 degrees C. Moreover, the assembly with OsDpe1 enables OsPho1 to utilize products of transglycosylation reactions involving G1 and G3, sugars that it cannot catalyze directly.	[Hwang, Seon-Kap; Koper, Kaan; Okita, Thomas W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Satoh, Hikaru] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan	Washington State University; Kyushu University	Okita, TW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	okita@wsu.edu		Hwang, Paul/0000-0001-9552-5341; Okita, Tom/0000-0002-2246-0599	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-12ER20216]; USDA-NIFA (United States Department of Agriculture National Institute of Food and Agriculture) [WNP00590]; Agricultural Research Center, College of Agricultural, Human, and Natural Resource Sciences, Washington State University	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); USDA-NIFA (United States Department of Agriculture National Institute of Food and Agriculture); Agricultural Research Center, College of Agricultural, Human, and Natural Resource Sciences, Washington State University	This work was supported in part by DE-FG02-12ER20216 from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy (to T. W. O, S.-K. H., and K. K.) and by project WNP00590, USDA-NIFA (United States Department of Agriculture National Institute of Food and Agriculture), and the Agricultural Research Center, College of Agricultural, Human, and Natural Resource Sciences, Washington State University. The authors declare that they have no conflicts of interest with the contents of this article.	Abe N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-80; Ahmed Z, 2015, PLANT SCI, V233, P95, DOI 10.1016/j.plantsci.2014.12.016; Akdogan G., 2011, Journal of Applied Glycoscience, V58, P99, DOI 10.5458/jag.jag.JAG-2010_026; Chen HM, 2002, PHYSIOL PLANTARUM, V114, P506, DOI 10.1034/j.1399-3054.2002.1140402.x; Colleoni C, 1999, PLANT PHYSIOL, V120, P1005, DOI 10.1104/pp.120.4.1005; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Crofts AJ, 2010, PLANTA, V231, P1261, DOI 10.1007/s00425-010-1125-x; Crofts N, 2015, J EXP BOT, V66, P4469, DOI 10.1093/jxb/erv212; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Dong XB, 2015, PLANT PHYSIOL, V169, P2496, DOI 10.1104/pp.15.01411; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Grimaud F, 2008, J EXP BOT, V59, P3395, DOI 10.1093/jxb/ern198; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Hwang SK, 2008, J BIOL CHEM, V283, P6640, DOI 10.1074/jbc.M707447200; Hwang SK, 2007, PHYTOCHEMISTRY, V68, P464, DOI 10.1016/j.phytochem.2006.11.027; Hwang SK, 2016, PLANTA, V243, P999, DOI 10.1007/s00425-015-2461-7; Hwang SK, 2010, ARCH BIOCHEM BIOPHYS, V495, P82, DOI 10.1016/j.abb.2009.12.023; Jiang HW, 2003, PHYTOCHEMISTRY, V63, P53, DOI 10.1016/S0031-9422(03)00005-0; KAKEFUDA G, 1989, PLANT PHYSIOL, V91, P136, DOI 10.1104/pp.91.1.136; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035336; Liu FS, 2012, BIOCHEM J, V448, P373, DOI 10.1042/BJ20120573; Liu FS, 2012, J EXP BOT, V63, P1167, DOI 10.1093/jxb/err341; Liu FS, 2009, J EXP BOT, V60, P4423, DOI 10.1093/jxb/erp297; Lloyd JR, 2004, PLANT PHYSIOL, V134, P1347, DOI 10.1104/pp.103.038026; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Lu Y, 2006, PLANT PHYSIOL, V142, P878, DOI 10.1104/pp.106.086850; Lutken H, 2010, PLANTA, V232, P1127, DOI 10.1007/s00425-010-1245-3; MORI H, 1993, J BIOL CHEM, V268, P5574; Nakamura Y, 2012, PLANT CELL PHYSIOL, V53, P869, DOI 10.1093/pcp/pcs030; NAKANO K, 1986, J BIOL CHEM, V261, P8230; O'Neill EC, 2014, CHEM SCI, V5, P341, DOI 10.1039/c3sc51829a; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; OKITA TW, 1979, PLANT PHYSIOL, V64, P187, DOI 10.1104/pp.64.2.187; OKITA TW, 1980, PLANT PHYSIOL, V66, P870, DOI 10.1104/pp.66.5.870; Satoh H, 2008, PLANT CELL, V20, P1833, DOI 10.1105/tpc.107.054007; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SHIMOMURA S, 1982, J BIOCHEM-TOKYO, V91, P703, DOI 10.1093/oxfordjournals.jbchem.a133743; Sorensen BK, 2002, ANAL BIOCHEM, V304, P33, DOI 10.1006/abio.2001.5604; Subasinghe RM, 2014, PLANT PHYSIOL BIOCH, V83, P168, DOI 10.1016/j.plaphy.2014.07.016; SUGANUMA T, 1991, CARBOHYD RES, V212, P201, DOI 10.1016/0008-6215(91)84057-L; Takaha T, 1996, J BIOL CHEM, V271, P2902, DOI 10.1074/jbc.271.6.2902; Takaha T, 1998, BIOCHEM BIOPH RES CO, V247, P493, DOI 10.1006/bbrc.1998.8817; Takaha T, 1998, PLANTA, V205, P445, DOI 10.1007/s004250050342; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1	48	40	44	4	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19994	20007		10.1074/jbc.M116.735449	http://dx.doi.org/10.1074/jbc.M116.735449			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27502283	Green Published, hybrid			2022-12-28	WOS:000383243100023
J	Kojima, S; Muramoto, K; Kusano, T				Kojima, Seiji; Muramoto, Koji; Kusano, Tomonobu			Outer Membrane Proteins Derived from Non-cyanobacterial Lineage Cover the Peptidoglycan of Cyanophora paradoxa Cyanelles and Serve as a Cyanelle Diffusion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; cyanobacteria; Gram-negative bacteria; outer membrane; peptidoglycan; cyanelle; diffusion channel	SYNECHOCOCCUS PCC 6301; ESCHERICHIA-COLI; CELL-WALL; MUREIN-LIPOPROTEIN; SELENOMONAS-RUMINANTIUM; PSEUDOMONAS-AERUGINOSA; BUDDING BACTERIA; PORIN CHANNELS; ENVELOPE; DIVISION	The cyanelle is a primitive chloroplast that contains a peptidoglycan layer between its inner and outer membranes. Despite the fact that the envelope structure of the cyanelle is reminiscent of Gram-negative bacteria, the Cyanophora paradoxa genome appears to lack genes encoding homologs of putative peptidoglycan-associated outer membrane proteins and outer membrane channels. These are key components of Gram-negative bacterial membranes, maintaining structural stability and regulating permeability of outer membrane, respectively. Here, we discovered and characterized two dominant peptidoglycan-associated outer membrane proteins of the cyanelle (approximate to 2 x 10(6) molecules per cyanelle). We named these proteins CppF and CppS (cyanelle peptidoglycan-associated proteins). They are homologous to each other and function as a diffusion channel that allows the permeation of compounds with M-r <1,000 as revealed by permeability measurements using proteoliposomes reconstituted with purified CppS and CppF. Unexpectedly, amino acid sequence analysis revealed no evolutionary linkage to cyanobacteria, showing only a moderate similarity to cell surface proteins of bacteria belonging to Planctomycetes phylum. Our findings suggest that the C. paradoxa cyanelle adopted non-cyanobacterial lineage proteins as its main outer membrane components, providing a physical link with the underlying peptidoglycan layer and functioning as a diffusion route for various small substances across the outer membrane.	[Kojima, Seiji] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Kojima, Seiji; Muramoto, Koji; Kusano, Tomonobu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan	Tohoku University; Tohoku University	Kojima, S (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	skojima0801@gmail.com	Kojima, Seiji/I-8643-2017	Kojima, Seiji/0000-0002-2184-1592	Japan Society for the Promotion of Science [15K20860]; Agricultural Chemical Research Foundation [1-322]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agricultural Chemical Research Foundation(Agricultural Chemical Research Foundation, Japan)	This work was supported by Japan Society for the Promotion of Science Grant-in-aid for Young Scientist (B) 15K20860 and by Agricultural Chemical Research Foundation Grant 1-322 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	AITKEN A, 1979, J GEN MICROBIOL, V112, P219, DOI 10.1099/00221287-112-2-219; Baumgartner LK, 2009, ENVIRON MICROBIOL, V11, P2710, DOI 10.1111/j.1462-2920.2009.01998.x; Bhattacharya D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2931; Boomer SM, 2009, APPL ENVIRON MICROB, V75, P2464, DOI 10.1128/AEM.01802-08; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Dyson HJ, 2016, BIOPHYS J, V110, P1013, DOI 10.1016/j.bpj.2016.01.030; Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070; Facchinelli F, 2013, PLANTA, V237, P637, DOI 10.1007/s00425-012-1819-3; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; FUNG J, 1978, J BACTERIOL, V133, P1467, DOI 10.1128/JB.133.3.1467-1471.1978; GEHRING KB, 1989, J BIOL CHEM, V264, P2810; HALL WT, 1963, J CELL BIOL, V19, P551, DOI 10.1083/jcb.19.3.551; Hansel A, 1998, CURR MICROBIOL, V36, P321, DOI 10.1007/s002849900316; Hansel A, 1998, BBA-GENE STRUCT EXPR, V1399, P31, DOI 10.1016/S0167-4781(98)00090-6; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Hirano T, 2016, PLANT CELL, V28, P1521, DOI 10.1105/tpc.16.00104; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Huber C, 2005, MOL MICROBIOL, V55, P197, DOI 10.1111/j.1365-2958.2004.04351.x; Iino M, 2003, J PHYCOL, V39, P561, DOI 10.1046/j.1529-8817.2003.02132.x; JURGENS UJ, 1985, ARCH MICROBIOL, V142, P168, DOI 10.1007/BF00447062; Koike H, 2000, PHOTOSYNTH RES, V65, P207, DOI 10.1023/A:1010734912776; Koike H, 2007, PHOTOSYNTH RES, V93, P45, DOI 10.1007/s11120-007-9156-2; Kojima S, 2016, BIOSCI BIOTECH BIOCH, V80, P1954, DOI 10.1080/09168451.2016.1194185; Kojima S, 2011, J BACTERIOL, V193, P2347, DOI 10.1128/JB.00106-11; Kojima S, 2010, J BACTERIOL, V192, P5953, DOI 10.1128/JB.00417-10; KONIG E, 1984, ARCH MICROBIOL, V138, P200, DOI 10.1007/BF00402120; KOSKI P, 1987, ANAL BIOCHEM, V164, P261, DOI 10.1016/0003-2697(87)90395-2; Kowata H, 2016, J ANTIBIOT, V69, P863, DOI 10.1038/ja.2016.50; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; LIESACK W, 1986, ARCH MICROBIOL, V145, P361, DOI 10.1007/BF00470872; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; NIKAIDO H, 1991, J BIOL CHEM, V266, P770; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pfanzagl B, 1996, J BACTERIOL, V178, P332, DOI 10.1128/jb.178.2.332-339.1996; Qiu H, 2013, TRENDS PLANT SCI, V18, P680, DOI 10.1016/j.tplants.2013.09.007; Raven JA, 2003, EUR J PHYCOL, V38, P47, DOI 10.1080/0967026031000096245; Ribeiro ACF, 2006, DEFECT DIFFUS FORUM, V258-260, P305, DOI 10.4028/www.scientific.net/DDF.258-260.305; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; SUZUKI H, 1978, MOL GEN GENET, V167, P1; Takano H, 2010, BBA-GEN SUBJECTS, V1800, P144, DOI 10.1016/j.bbagen.2009.07.020; van Baren MJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2585-6; Voigt B, 2012, PROTEOMICS, V12, P1781, DOI 10.1002/pmic.201100512; WECKESSER J, 1988, METHOD ENZYMOL, V167, P173; YEM DW, 1978, J BACTERIOL, V133, P1419, DOI 10.1128/JB.133.3.1419-1426.1978; YOSHIMURA F, 1983, J BIOL CHEM, V258, P2308; Zhao GS, 2006, APPL MICROBIOL BIOT, V70, P464, DOI 10.1007/s00253-005-0079-6	56	7	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20198	20209		10.1074/jbc.M116.746131	http://dx.doi.org/10.1074/jbc.M116.746131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27502278	Green Published, hybrid			2022-12-28	WOS:000383243100039
J	MacDonald, NJ; Nguyen, V; Shimp, R; Reiter, K; Herrera, R; Burkhardt, M; Muratova, O; Kumar, K; Aebig, J; Rausch, K; Lambert, L; Dawson, N; Sattabongkot, J; Ambroggio, X; Duffy, PE; Wu, YM; Narum, DL				MacDonald, Nicholas J.; Vu Nguyen; Shimp, Richard; Reiter, Karine; Herrera, Raul; Burkhardt, Martin; Muratova, Olga; Kumar, Krishan; Aebig, Joan; Rausch, Kelly; Lambert, Lynn; Dawson, Nikiah; Sattabongkot, Jetsumon; Ambroggio, Xavier; Duffy, Patrick E.; Wu, Yimin; Narum, David L.			Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						malaria; protein structure; recombinant protein expression; vaccine; yeast; Pfs230; Pichia pastoris; transmission blocking	TRANSMISSION-BLOCKING VACCINE; RTS,S/AS01 MALARIA VACCINE; AERUGINOSA EXOPROTEIN-A; SURFACE-ANTIGEN PFS230; ANTIBODY-RESPONSES; ESCHERICHIA-COLI; CANDIDATE; PFS48/45; IMMUNITY; TARGET	Development of a Plasmodium falciparum (Pf) transmission blocking vaccine (TBV) has the potential to significantly impact malaria control. Antibodies elicited against sexual stage proteins in the human bloodstream are taken up with the blood meal of the mosquitoes and inactivate parasite development in the mosquito. In a phase 1 trial, a leading TBV identified as Pfs25-EPA/Alhydrogel (R) appeared safe and immunogenic, however, the level of Pfs25-specific antibodies were likely too low for an effective vaccine. Pfs230, a 230-kDa sexual stage protein expressed in gametocytes is an alternative vaccine candidate. A unique 6-cysteine-rich domain structure within Pfs230 have thwarted its recombinant expression and characterization for clinical evaluation for nearly a quarter of a century. Here, we report on the identification, biochemical, biophysical, and immunological characterization of recombinant Pfs230 domains. Rabbit antibodies generated against recombinant Pfs230 domains blocked mosquito transmission of a laboratory strain and two field isolates using an ex vivo assay. A planned clinical trial of the Pfs230 vaccine is a significant step toward the potential development of a transmission blocking vaccine to eliminate malaria.	[MacDonald, Nicholas J.; Vu Nguyen; Shimp, Richard; Reiter, Karine; Herrera, Raul; Burkhardt, Martin; Muratova, Olga; Kumar, Krishan; Aebig, Joan; Rausch, Kelly; Lambert, Lynn; Dawson, Nikiah; Duffy, Patrick E.; Wu, Yimin; Narum, David L.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Twinbrook 1,Rm 1115, Rockville, MD 20852 USA; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok 10400, Thailand; [Ambroggio, Xavier] Rosetta Design Grp LLC, Burlington, VT 05401 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University	Narum, DL (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Twinbrook 1,Rm 1115, Rockville, MD 20852 USA.	dnarum@niaid.nih.gov	Prachumsri, Jetsumon/AAZ-7732-2021	Narum, David/0000-0003-3041-5402; Sattabongkot, Jetsumon/0000-0002-3938-4588	Wellcome Trust [098051, 090770]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001008, ZIAAI001009, ZIAAI001007] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Buddhadeb Mallik, Dr. Guan-Hong Song, Dr. Yanling Zhang, and Christopher Rowe for technical assistance within the Laboratory of Malaria Immunology and Vaccinology. Dr. Carl Hammer, Mark Garfield, from Research Technologies Branch, NIAID, for analytical support, and Dr. Michael Fay, from Biostatistics Research Branch, NIAID, for statistical support. Dr. Michael Nold from Waters Inc. for assistance with disulfide mapping studies, and Dr. Julian Rayner for the assistance with genotypic analysis of Pfs230 from the Wellcome Trust Sanger Institute. Finally we appreciate Dr. Louis Miller for his support and helpful discussion, This publication uses data from the MalariaGEN Pfalciparum Community Project as described in Ref. 28. Genome sequencing was performed by the Wellcome Trust Sanger Institute and the Community Projects is coordinated by the MalariaGENResource Centre with funding from the Wellcome Trust Grants 098051 and 090770.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Brooks SR, 2000, MOL BIOCHEM PARASIT, V106, P77, DOI 10.1016/S0166-6851(99)00201-7; Bustamante PJ, 2000, PARASITE IMMUNOL, V22, P373, DOI 10.1046/j.1365-3024.2000.00315.x; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; Farrance CE, 2011, CLIN VACCINE IMMUNOL, V18, P1351, DOI 10.1128/CVI.05105-11; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; Herrera R, 2015, INFECT IMMUN, V83, P3771, DOI 10.1128/IAI.02676-14; Jones S, 2015, J INFECTION, V71, P117, DOI 10.1016/j.jinf.2015.03.007; KOCKEN CHM, 1993, MOL BIOCHEM PARASIT, V61, P59, DOI 10.1016/0166-6851(93)90158-T; KUMAR N, 1987, PARASITE IMMUNOL, V9, P321, DOI 10.1111/j.1365-3024.1987.tb00511.x; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057909; Niederwieser Igor, 2001, American Journal of Tropical Medicine and Hygiene, V64, P9; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Parker ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139407; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Qian F, 2008, VACCINE, V26, P2521, DOI 10.1016/j.vaccine.2008.03.005; Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; READ D, 1994, PARASITE IMMUNOL, V16, P511, DOI 10.1111/j.1365-3024.1994.tb00305.x; ROEFFEN W, 1995, EXP PARASITOL, V80, P15, DOI 10.1006/expr.1995.1003; ROEFFEN W, 1995, INFECT IMMUN, V63, P467, DOI 10.1128/IAI.63.2.467-471.1995; Shimp RL, 2013, VACCINE, V31, P2954, DOI 10.1016/j.vaccine.2013.04.034; Simon N, 2016, PARASITOL INT, V65, P27, DOI 10.1016/j.parint.2015.09.007; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Strait RT, 2015, NATURE, V517, P501, DOI 10.1038/nature13868; Tachibana M, 2011, CLIN VACCINE IMMUNOL, V18, P1343, DOI 10.1128/CVI.05104-11; Templeton TJ, 1999, MOL BIOCHEM PARASIT, V101, P223, DOI 10.1016/S0166-6851(99)00066-3; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tonkin ML, 2013, J BIOL CHEM, V288, P12805, DOI 10.1074/jbc.M113.455667; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; Uchime O, 2012, EUKARYOT CELL, V11, P615, DOI 10.1128/EC.00039-12; Vincent AA, 1999, PARASITE IMMUNOL, V21, P573, DOI 10.1046/j.1365-3024.1999.00255.x; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williamson KC, 2003, PARASITE IMMUNOL, V25, P351, DOI 10.1046/j.1365-3024.2003.00643.x; Williamson KC, 1995, MOL BIOCHEM PARASIT, V75, P33, DOI 10.1016/0166-6851(95)02507-3; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Wu Yu-Huan, 2008, P3; Zhu DM, 2005, J IMMUNOL METHODS, V306, P40, DOI 10.1016/j.jim.2005.07.021	45	62	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19913	19922		10.1074/jbc.M116.732305	http://dx.doi.org/10.1074/jbc.M116.732305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27432885	hybrid, Green Published			2022-12-28	WOS:000383243100016
J	Kumar, VA; Goyal, R; Bansal, R; Singh, N; Sevalkar, RR; Kumar, A; Sarkar, D				Kumar, Vijjamarri Anil; Goyal, Rajni; Bansal, Roohi; Singh, Nisha; Sevalkar, Ritesh Rajesh; Kumar, Ashwani; Sarkar, Dibyendu			EspR-dependent ESAT-6 Protein Secretion of Mycobacterium tuberculosis Requires the Presence of Virulence Regulator PhoP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL CONTROL; CALMETTE-GUERIN; ESX-1 SECRETION; DNA TRANSFER; SYSTEM; GENE; RECOGNITION; SEQUENCE; RD1; ESAT-6/CFP-10	Attenuation of Mycobacterium bovis BCG strain is related to the loss of the RD1-encoded ESX-1 secretion system. The ESX-1 system secretes virulence factor ESAT-6 that plays a critical role in modulation of the host immune system, which is essential for establishment of a productive infection. Previous studies suggest that among the reasons for attenuation of Mycobacterium tuberculosis H37Ra is a mutation in the phoP gene that interferes with the ESX-1 secretion system and inhibits secretion of ESAT-6. Here, we identify a totally different and distinct regulatory mechanism involving PhoP and transcription regulator EspR on transcriptional control of the espACD operon, which is required for ESX-1-dependent ESAT-6 secretion. Although both of these regulators are capable of influencing espACD expression, we show that activation of espACD requires direct recruitment of both PhoP and EspR at the espACD promoter. The most fundamental insights are derived from the inhibition of EspR binding at the espACD regulatory region of the phoP mutant strain because of PhoP-EspR protein-protein interactions. Based on these results, a model is proposed suggesting how PhoP and EspR protein-protein interactions contribute to activation of espACD expression and, in turn, control ESAT-6 secretion, an essential pathogenic determinant of M. tuberculosis. Together, these results have significant implications on the mechanism of virulence regulation of M. tuberculosis.	[Kumar, Vijjamarri Anil; Goyal, Rajni; Bansal, Roohi; Singh, Nisha; Sevalkar, Ritesh Rajesh; Kumar, Ashwani; Sarkar, Dibyendu] CSIR, Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India; [Goyal, Rajni] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Michigan State University	Sarkar, D (corresponding author), CSIR, Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India.	dibyendu@imtech.res.in	Kumar, Ashwani/AAU-5045-2020	Kumar, Ashwani/0000-0002-6240-6810; Sevalkar, Ritesh/0000-0002-1694-8854	Supra Institutional Project on Infectious Disease from Council of Scientific and Industrial Research; Department of Science and Technology; Department of Biotechnology, Government of India; CSIR; Indian Council of Medical Research; University Grants Commission, Government of India; National Bioscience Award from Department of Biotechnology, Government of India	Supra Institutional Project on Infectious Disease from Council of Scientific and Industrial Research; Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); University Grants Commission, Government of India(University Grants Commission, India); National Bioscience Award from Department of Biotechnology, Government of India	This work was supported in part by the Supra Institutional Project on Infectious Disease from the Council of Scientific and Industrial Research, research grants (to D. S.) from the Department of Science and Technology, and grants from the Department of Biotechnology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by fellowships from the CSIR.; Supported by the Indian Council of Medical Research. Present address: Dept. of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824.; Supported by the University Grants Commission, Government of India.; Recipient of funding from the National Bioscience Award for career development from the Department of Biotechnology, Government of India. To whom correspondence should be addressed. Tel.: 91-172-6665291; Fax: 91-172-2690585; E-mail: dibyendu@imtech.res.in.	Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Blasco B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002621; Blasco B, 2011, MOL MICROBIOL, V82, P251, DOI 10.1111/j.1365-2958.2011.07813.x; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Broset E, 2015, MBIO, V6, DOI 10.1128/mBio.01289-15; Cao GX, 2015, MICROBIOL-SGM, V161, P477, DOI 10.1099/mic.0.000023; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; De Smet KAL, 1999, MICROBIOL-UK, V145, P3177, DOI 10.1099/00221287-145-11-3177; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Flint JL, 2004, P NATL ACAD SCI USA, V101, P12598, DOI 10.1073/pnas.0404892101; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Garces A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000957; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Goyal R, 2011, J BIOL CHEM, V286, P45197, DOI 10.1074/jbc.M111.307447; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Gupta S, 2009, J BACTERIOL, V191, P7466, DOI 10.1128/JB.00669-09; He XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep24442; He XY, 2014, BIOCHEMISTRY-US, V53, P8008, DOI 10.1021/bi501019u; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Hunt DM, 2012, J BACTERIOL, V194, P2307, DOI 10.1128/JB.00142-12; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Kahramanoglou C, 2014, NUCLEIC ACIDS RES, V42, P8320, DOI 10.1093/nar/gku548; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Majlessi L, 2015, IMMUNOL REV, V264, P25, DOI 10.1111/imr.12251; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Pang XH, 2013, J BACTERIOL, V195, P66, DOI 10.1128/JB.01067-12; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Rosenberg OS, 2011, P NATL ACAD SCI USA, V108, P13450, DOI 10.1073/pnas.1110242108; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Singh R, 2014, MOL MICROBIOL, V94, P450, DOI 10.1111/mmi.12778; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Solans L, 2014, INFECT IMMUN, V82, P3446, DOI 10.1128/IAI.01824-14; Solans L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004183; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x	61	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19018	19030		10.1074/jbc.M116.746289	http://dx.doi.org/10.1074/jbc.M116.746289			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27445330	Green Published, hybrid			2022-12-28	WOS:000383242300036
J	Yugami, M; Odagiri, H; Endo, M; Tsutsuki, H; Fujii, S; Kadomatsu, T; Masuda, T; Miyata, K; Terada, K; Tanoue, H; Ito, H; Morinaga, J; Horiguchi, H; Sugizaki, T; Akaike, T; Gotoh, T; Takai, T; Sawa, T; Mizuta, H; Oike, Y				Yugami, Masaki; Odagiri, Haruki; Endo, Motoyoshi; Tsutsuki, Hiroyasu; Fujii, Shigemoto; Kadomatsu, Tsuyoshi; Masuda, Tetsuro; Miyata, Keishi; Terada, Kazutoyo; Tanoue, Hironori; Ito, Hitoshi; Morinaga, Jun; Horiguchi, Haruki; Sugizaki, Taichi; Akaike, Takaaki; Gotoh, Tomomi; Takai, Toshiyuki; Sawa, Tomohiro; Mizuta, Hiroshi; Oike, Yuichi			Mice Deficient in Angiopoietin-like Protein 2 (Angptl2) Gene Show Increased Susceptibility to Bacterial Infection Due to Attenuated Macrophage Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHESIS; IFN-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; HOST-DEFENSE; IN-VITRO; GM-CSF; INFLAMMATION; SALMONELLA; EXPRESSION	Macrophages play crucial roles in combatting infectious disease by promoting inflammation and phagocytosis. Angiopoiefin-like protein 2 (ANGPTL2) is a secreted factor that induces tissue inflammation by attracting and activating macrophages to produce inflammatory cytokines in chronic inflammation associated diseases such as obesity-associated metabolic syndrome, atherosclerosis, and rheumatoid arthritis. Here, we asked whether and how ANGPTL2 activates macrophages in the innate immune response. ANGPTL2 was predominantly expressed in proinflammatory mouse bone marrow-derived differentiated macrophages (GM-BMMs) following GM-CSF treatment relative to anti-inflammatory cells (M-BMMs) established by M-CSF treatment. Expression of the proinflammatory markers IL-1 beta, IL-12p35, and IL-12p10 significantly decreased in GM-BMMs from Angpt12-deficient compared with wild-type (WT) mice, suggestive of attenuated proinflammatory activity. We also report that ANGPTL2 inflammatory signaling is transduced through integrin alpha 5 beta 1 rather than through paired immunoglobulin-like receptor B. Interestingly, Angpt12-deficient mice were more susceptible to infection with Salmonella enterica serovar Typhimurium than were WT mice, Moreover, nitric oxide (NO) production by Angpt/2-deficient GM-BMMs was significantly lower than in WT GM-BMMs. Collectively, our findings suggest that macrophage-derived ANGPTL2 promotes an innate immune response in those cells by enhancing proinflammatory activity and NO production required to fight infection.	[Yugami, Masaki; Odagiri, Haruki; Endo, Motoyoshi; Kadomatsu, Tsuyoshi; Masuda, Tetsuro; Miyata, Keishi; Terada, Kazutoyo; Tanoue, Hironori; Ito, Hitoshi; Morinaga, Jun; Horiguchi, Haruki; Sugizaki, Taichi; Gotoh, Tomomi; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan; [Yugami, Masaki; Odagiri, Haruki; Masuda, Tetsuro; Tanoue, Hironori; Ito, Hitoshi; Mizuta, Hiroshi] Kumamoto Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kumamoto 8608556, Japan; [Tsutsuki, Hiroyasu; Sawa, Tomohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Fujii, Shigemoto; Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Sendai, Miyagi 9808575, Japan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan; [Oike, Yuichi] Japan Agcy Med Res & Dev AMED, CREST, Tokyo 1020076, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST)	Endo, M; Oike, Y (corresponding author), Kumamoto Univ, Dept Mol Genet, 1-1-1 Honjo, Kumamoto 8608556, Japan.	enmoto@gpo.kurnamoto-u.ac.jp; oike@gpo.kumamoto-u.ac.jp	Miyata, Keishi/HGF-1876-2022; Endo, Motoyoshi/T-5840-2019	Miyata, Keishi/0000-0003-0336-1859; 	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan [15K20008, 25461192, 15H01159]; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency [13417915]; CREST program of the Japan Agency for Medical Research and Development [15gm0610007h0003]; Grants-in-Aid for Scientific Research [15H06508] Funding Source: KAKEN	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); CREST program of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants 15K20008, 25461192, and 15H01159), the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (Grant 13417915), and the CREST program of the Japan Agency for Medical Research and Development (Grant 15gm0610007h0003). The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Beletskii A, 2005, BIOTECHNIQUES, V39, P894, DOI 10.2144/000112001; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Cunnick J, 2006, J IMMUNOL METHODS, V311, P96, DOI 10.1016/j.jim.2006.01.017; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Haverslag RT, 2013, CURR VASC PHARMACOL, V11, P21; Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Igietseme JU, 1998, INFECT IMMUN, V66, P1282, DOI 10.1128/IAI.66.4.1282-1286.1998; JAMES SL, 1995, MICROBIOL REV, V59, P533, DOI 10.1128/MMBR.59.4.533-547.1995; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kubota Y, 2005, GENE EXPR PATTERNS, V5, P679, DOI 10.1016/j.modgep.2005.02.006; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lari R, 2007, BONE, V40, P323, DOI 10.1016/j.bone.2006.09.003; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; Mantovani A, 2008, EUR J IMMUNOL, V38, P3269, DOI 10.1002/eji.200838918; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V44, P367, DOI 10.1002/jlb.44.5.367; Murphy JT, 2006, PHYSIOL GENOMICS, V28, P67, DOI 10.1152/physiolgenomics.00098.2006; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Shimizu T, 2012, MOL MICROBIOL, V85, P492, DOI 10.1111/j.1365-2958.2012.08122.x; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Terzyan SS, 1999, J MOL BIOL, V285, P205, DOI 10.1006/jmbi.1998.2288; Thale C, 2005, IMMUNOBIOLOGY, V210, P673, DOI 10.1016/j.imbio.2005.07.003; Torii I, 2008, J IMMUNOL, V181, P4229, DOI 10.4049/jimmunol.181.6.4229; Tsutsuki H, 2012, INFECT IMMUN, V80, P3939, DOI 10.1128/IAI.00581-12; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Umezawa K, 1997, INFECT IMMUN, V65, P2932, DOI 10.1128/IAI.65.7.2932-2940.1997; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342	46	10	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18843	18852		10.1074/jbc.M116.720870	http://dx.doi.org/10.1074/jbc.M116.720870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402837	hybrid, Green Published			2022-12-28	WOS:000383242300020
J	Zhang, B; Du, YL; Lu, W; Yan, XY; Yang, Q; Yang, W; Luo, JH				Zhang, Bin; Du, Yong-lan; Lu, Wen; Yan, Xun-yi; Yang, Qian; Yang, Wei; Luo, Jian-hong			Increased Activity of Src Homology 2 Domain Containing Phosphotyrosine Phosphatase 2 (Shp2) Regulates Activity-dependent AMPA Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SYNAPTIC NMDA RECEPTORS; LONG-TERM POTENTIATION; NOONAN-SYNDROME; SURFACE EXPRESSION; MEMORY FORMATION; PHOSPHORYLATION; PLASTICITY; SUBUNIT; ACTIVATION	Long term synaptic plasticity, such as long term potentiation (LTP), has been widely accepted as a cellular mechanism underlying memory. Recently, it has been unraveled that Shp2 plays a role in synaptic plasticity and memory in Drosophila and mice, revealing significant and conserved effects of Shp2 in cognitive function. However, the exact mechanism underlying this function of Shp2 in synaptic plasticity and memory still remains elusive. Here, we examine the regulation of Shp2 in hippocampal LTP and contextual tear conditioning. We find that Shp2 is rapidly recruited into spines after LTP induction. Furthermore, the phosphorylation level of Shp2 at Tyr-542 is elevated after LTP stimuli either in cultured hippocampal neurons or acute slices. Notably, contextual fear conditioning also regulates the phosphorylation level of Shp2 at Tyr-542, suggesting fine-tuned regulation of Shp2 in LTP and memory formation. By using a Shp2-specific inhibitor and adeno-associated virus-Cre mediated Shp2 knock-out in cultured neurons, we provide evidence that the phosphatase activity of Shp2 is critical for activity-dependent AMPA receptor surface trafficking. Collectively, our results have revealed a regulatory mechanism of Shp2 underlying LTP and memory, broadening our understanding of Shp2 in cognitive function.	[Zhang, Bin; Du, Yong-lan; Lu, Wen; Yan, Xun-yi; Yang, Qian; Yang, Wei; Luo, Jian-hong] Zhejiang Univ, Key Lab Med Neurobiol, Collaborat Innovat Ctr Brain Sci, Dept Neurobiol,Minist Hlth China,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Luo, JH (corresponding author), 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn	Lu, Wen/AAL-8524-2020; Luo, jian/HGE-7331-2022	Yang, Qian/0000-0001-9861-2790	Natural Science Foundation of China [91232303, 81221003, 81561168022]; National Basic Research Program of China [2014CB910300]; Fundamental Research Funds for the Central Universities of China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by Natural Science Foundation of China Grants 91232303, 81221003, and 81561168022, National Basic Research Program of China Grant 2014CB910300, and the Fundamental Research Funds for the Central Universities of China. The authors declare that they have no conflict of interest with the contents of this article.	Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Barki-Harrington L, 2009, J NEUROSCI, V29, P9219, DOI 10.1523/JNEUROSCI.5667-08.2009; Bates Mark, 2013, Cold Spring Harb Protoc, V2013, P498, DOI 10.1101/pdb.top075143; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Corera AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006021; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Grosskopf S, 2015, CHEMMEDCHEM, V10, P815, DOI 10.1002/cmdc.201500015; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kusakari S, 2015, MOL CELL BIOL, V35, P1557, DOI 10.1128/MCB.01339-14; Lee YS, 2014, NAT NEUROSCI, V17, P1736, DOI 10.1038/nn.3863; Lin SY, 1999, MOL BRAIN RES, V70, P18, DOI 10.1016/S0169-328X(99)00122-9; Lu W, 2015, EXP NEUROL, V271, P251, DOI 10.1016/j.expneurol.2015.06.016; Lu W, 2015, J BIOL CHEM, V290, P22945, DOI 10.1074/jbc.M115.663450; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Peng HY, 2012, PAIN, V153, P1042, DOI 10.1016/j.pain.2012.02.006; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Ressels H. W., 2009, NEURON, V61, P340; Saladin K. D., 2021, ANATOMY PHYSL UNITY, V9th; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Shen HW, 2008, BRAIN STRUCT FUNCT, V213, P149, DOI 10.1007/s00429-008-0184-2; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V211, P950, DOI 10.1006/bbrc.1995.1904; Tang Y, 2015, NEUROSCIENCE, V304, P109, DOI 10.1016/j.neuroscience.2015.07.021; Zhang XM, 2015, CELL RES, V25, P818, DOI 10.1038/cr.2015.75; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	33	13	14	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18856	18866		10.1074/jbc.M116.714501	http://dx.doi.org/10.1074/jbc.M116.714501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27417137	Green Published, hybrid			2022-12-28	WOS:000383242300024
J	Smith, TH; Coronel, LJ; Li, JG; Dores, MR; Nieman, MT; Trejo, J				Smith, Thomas H.; Coronel, Luisa J.; Li, Julia G.; Dores, Michael R.; Nieman, Marvin T.; Trejo, JoAnn			Protease-activated Receptor-4 Signaling and Trafficking Is Regulated by the Clathrin Adaptor Protein Complex-2 Independent of -Arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; clathrin; extracellular-signal-regulated kinase (ERK); G protein-coupled receptor (GPCR); lysosome; thrombin; Akt; adaptor protein complex-2; megakaryocyte	INTRACELLULAR TRAFFICKING; INTERNALIZATION; ENDOCYTOSIS; PAR4; REQUIREMENTS; MECHANISMS; MOTIF; AP-2; PHOSPHORYLATION; HEMOSTASIS	Protease-activated receptor-4 (PAR4) is a G protein-coupled receptor (GPCR) for thrombin and is proteolytically activated, similar to the prototypical PAR1. Due to the irreversible activation of PAR1, receptor trafficking is intimately linked to signal regulation. However, unlike PAR1, the mechanisms that control PAR4 trafficking are not known. Here, we sought to define the mechanisms that control PAR4 trafficking and signaling. In HeLa cells depleted of clathrin by siRNA, activated PAR4 failed to internalize. Consistent with clathrin-mediated endocytosis, expression of a dynamin dominant-negative K44A mutant also blocked activated PAR4 internalization. However, unlike most GPCRs, PAR4 internalization occurred independently of -arrestins and the receptor's C-tail domain. Rather, we discovered a highly conserved tyrosine-based motif in the third intracellular loop of PAR4 and found that the clathrin adaptor protein complex-2 (AP-2) is important for internalization. Depletion of AP-2 inhibited PAR4 internalization induced by agonist. In addition, mutation of the critical residues of the tyrosine-based motif disrupted agonist-induced PAR4 internalization. Using Dami megakaryocytic cells, we confirmed that AP-2 is required for agonist-induced internalization of endogenous PAR4. Moreover, inhibition of activated PAR4 internalization enhanced ERK1/2 signaling, whereas Akt signaling was markedly diminished. These findings indicate that activated PAR4 internalization requires AP-2 and a tyrosine-based motif and occurs independent of -arrestins, unlike most classical GPCRs. Moreover, these findings are the first to show that internalization of activated PAR4 is linked to proper ERK1/2 and Akt activation.	[Smith, Thomas H.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Smith, Thomas H.; Coronel, Luisa J.; Li, Julia G.; Dores, Michael R.; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Dores, Michael R.] Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA; [Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44016 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Hofstra University; Case Western Reserve University	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		Smith, Thomas/0000-0002-8798-7228; Orlando, Luisa/0000-0002-3177-5242	National Institutes of Health (NIGMS) [R01 GM090689]; NHLBI, National Institutes of Health [F31 HL116187]; Initiative for Maximizing Student Development at UCSD; San Diego IRACDA (Institutional Research and Academic Career Development Award) Program NIH [K12 GM06852]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, K12GM068524, R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Initiative for Maximizing Student Development at UCSD; San Diego IRACDA (Institutional Research and Academic Career Development Award) Program NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM090689 (NIGMS; to J. T.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an NHLBI, National Institutes of Health Predoctoral Fellowship F31 HL116187.; Supported by the Initiative for Maximizing Student Development at UCSD.; Supported by the San Diego IRACDA (Institutional Research and Academic Career Development Award) Program NIH K12 GM06852.	Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dores MR, 2012, MOL BIOL CELL, V23, P3612, DOI 10.1091/mbc.E12-03-0251; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Edelstein LC, 2014, BLOOD, V124, P3450, DOI 10.1182/blood-2014-04-572479; Edelstein LC, 2013, NAT MED, V19, P1609, DOI 10.1038/nm.3385; French SL, 2015, BLOOD REV, V29, P179, DOI 10.1016/j.blre.2014.10.006; Gasnereau I, 2011, J BIOL CHEM, V286, P43324, DOI 10.1074/jbc.M111.307231; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grimsey N, 2014, METHOD ENZYMOL, V535, P389, DOI 10.1016/B978-0-12-397925-4.00022-5; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Khan A, 2014, MOL PHARMACOL, V86, P1, DOI 10.1124/mol.114.091595; Khandoga AL, 2011, CARDIOVASC RES, V90, P157, DOI 10.1093/cvr/cvq369; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Magnone M, 2008, J BIOL CHEM, V283, P24460, DOI 10.1074/jbc.M710568200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mumaw MM, 2015, THROMB RES, V135, P1165, DOI 10.1016/j.thromres.2015.03.027; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Rosciglione S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5556; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Tian XF, 2016, J BIOL CHEM, V291, P14510, DOI 10.1074/jbc.M116.716589; Tourdot BE, 2014, ARTERIOSCL THROM VAS, V34, P2644, DOI 10.1161/ATVBAHA.114.304249; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Withey JME, 2005, BRIT J HAEMATOL, V129, P377, DOI 10.1111/j.1365-2141.2005.05468.x; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Woulfe DS, 2005, J THROMB HAEMOST, V3, P2193, DOI 10.1111/j.1538-7836.2005.01338.x; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	53	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18453	18464		10.1074/jbc.M116.729285	http://dx.doi.org/10.1074/jbc.M116.729285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402844	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000383241800035
J	Luo, JH; Warmlander, SKTS; Graslund, A; Abrahams, JP				Luo, Jinghui; Warmlander, Sebastian K. T. S.; Graslund, Astrid; Abrahams, Jan Pieter			Cross-interactions between the Alzheimer Disease Amyloid-beta Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							A-BETA; ALPHA-SYNUCLEIN; CYSTATIN-C; PRION PROTEIN; PRECURSOR PROTEIN; P COMPONENT; MOUSE MODEL; NEURONAL DEFICITS; DIABETES-MELLITUS; BINDING-SITES	Many protein folding diseases are intimately associated with accumulation of amyloid aggregates. The amyloid materials formed by different proteins/peptides share many structural similarities, despite sometimes large amino acid sequence differences. Some amyloid diseases constitute risk factors for others, and the progression of one amyloid disease may affect the progression of another. These connections are arguably related to amyloid aggregates of one protein being able to directly nucleate amyloid formation of another, different protein: the amyloid cross-interaction. Here, we discuss such cross-interactions between the Alzheimer disease amyloid-beta (A beta) peptide and other amyloid proteins in the context of what is known from in vitro and in vivo experiments, and of what might be learned from clinical studies. The aim is to clarify potential molecular associations between different amyloid diseases. We argue that the amyloid cascade hypothesis in Alzheimer disease should be expanded to include cross-interactions between A beta and other amyloid proteins.	[Luo, Jinghui] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Warmlander, Sebastian K. T. S.; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Abrahams, Jan Pieter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Abrahams, Jan Pieter] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland	University of Oxford; Stockholm University; University of Basel; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Luo, JH (corresponding author), Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England.; Abrahams, JP (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.; Abrahams, JP (corresponding author), Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland.	jinghui.luo.86@gmail.com; jan-pieter.abrahams@psi.ch	Abrahams, Jan Pieter/AAE-4319-2020	Abrahams, Jan Pieter/0000-0001-8216-1868; Luo, Jinghui/0000-0002-7014-8153				Abelein A, 2014, J BIOL INORG CHEM, V19, P623, DOI 10.1007/s00775-014-1131-8; Adler-Abramovich L, 2012, NAT CHEM BIOL, V8, P701, DOI [10.1038/NCHEMBIO.1002, 10.1038/nchembio.1002]; Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Boddaert J, 2007, AM J PATHOL, V170, P921, DOI 10.2353/ajpath.2007.060664; Cao P, 2013, FEBS LETT, V587, P1106, DOI 10.1016/j.febslet.2013.01.046; Celsi F, 2004, NEUROCHEM INT, V44, P25, DOI 10.1016/S0197-0186(03)00101-3; Cheng PN, 2012, NAT CHEM, V4, P927, DOI [10.1038/NCHEM.1433, 10.1038/nchem.1433]; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cortes-Canteli M, 2012, J ALZHEIMERS DIS, V32, P599, DOI 10.3233/JAD-2012-120820; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; Du JL, 2012, PROTEIN ENG DES SEL, V25, P337, DOI 10.1093/protein/gzs026; Ettle B, 2014, MOL CELL NEUROSCI, V62, P68, DOI 10.1016/j.mcn.2014.06.012; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Gasparini L, 2002, TRENDS PHARMACOL SCI, V23, P288, DOI 10.1016/S0165-6147(02)02037-0; Gessel MM, 2012, ACS CHEM NEUROSCI, V3, P909, DOI 10.1021/cn300050d; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Gray EH, 2010, J ALZHEIMERS DIS, V21, P1101, DOI 10.3233/JAD-2010-100717; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Hakansson K, 1996, COMP BIOCHEM PHYS B, V114, P303, DOI 10.1016/0305-0491(96)00025-9; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hane F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059005; HANSEN L, 1990, NEUROLOGY, V40, P1; Helmfors L, 2015, NEUROBIOL DIS, V83, P122, DOI 10.1016/j.nbd.2015.08.024; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Huang HC, 2009, J ALZHEIMERS DIS, V16, P15, DOI 10.3233/JAD-2009-0960; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Kaur G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00079; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Kotzbauer PT, 2012, ARCH NEUROL-CHICAGO, V69, P1326, DOI 10.1001/archneurol.2012.1608; Kuo YM, 1999, BIOCHEM BIOPH RES CO, V257, P787, DOI 10.1006/bbrc.1999.0552; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Li XH, 2012, NEUROBIOL AGING, V33, P1400, DOI 10.1016/j.neurobiolaging.2011.02.003; Li XY, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-79; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Luo JH, 2016, ACS CHEM NEUROSCI, V7, P269, DOI 10.1021/acschemneuro.5b00325; Luo JH, 2014, BIOCHEMISTRY-US, V53, P6302, DOI 10.1021/bi5003579; Luo JH, 2014, J BIOL CHEM, V289, P27766, DOI 10.1074/jbc.M114.574947; Luo JH, 2014, BIOMACROMOLECULES, V15, P1985, DOI 10.1021/bm401874j; Luo JH, 2014, NANOSCALE, V6, P6720, DOI 10.1039/c4nr00291a; Luo JH, 2014, CHEM-EUR J, V20, P2410, DOI 10.1002/chem.201304253; Luo JH, 2013, CHEM-EUR J, V19, P17338, DOI 10.1002/chem.201301535; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Luo JH, 2013, ACS CHEM NEUROSCI, V4, P454, DOI 10.1021/cn300170x; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Mehla J, 2014, J ALZHEIMERS DIS, V39, P145, DOI 10.3233/JAD-131238; Mi WQ, 2009, J ALZHEIMERS DIS, V18, P273, DOI 10.3233/JAD-2009-1147; Mold M, 2012, J ALZHEIMERS DIS, V29, P875, DOI 10.3233/JAD-2012-120076; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nicolls MR, 2004, CURR ALZHEIMER RES, V1, P47, DOI 10.2174/1567205043480555; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Porquet D, 2015, AGE, V37, DOI 10.1007/s11357-015-9747-3; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Reardon S, 2015, NATURE, V523, P509, DOI 10.1038/nature.2015.18031; Ribeiro CA, 2014, J ALZHEIMERS DIS, V39, P357, DOI 10.3233/JAD-131355; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Sousa JC, 2007, NEUROBIOL LEARN MEM, V88, P381, DOI 10.1016/j.nlm.2007.07.006; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Tamaki C, 2007, MOL PHARMACOL, V72, P850, DOI 10.1124/mol.107.036913; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Vollbach H, 2005, ANN NEUROL, V58, P436, DOI 10.1002/ana.20593; Wallin C, 2016, J TRACE ELEM MED BIO, V38, P183, DOI 10.1016/j.jtemb.2016.03.009; Wang C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371641; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Warmlander S, 2013, CHEMBIOCHEM, V14, P1692, DOI 10.1002/cbic.201300262; Whitehouse IJ, 2010, J ALZHEIMERS DIS, V22, P1023, DOI 10.3233/JAD-2010-101071; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yan LM, 2013, ANGEW CHEM INT EDIT, V52, P10378, DOI 10.1002/anie.201302840; Yang GZ, 2012, J NEUROCHEM, V122, P1010, DOI 10.1111/j.1471-4159.2012.07845.x; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	100	84	86	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16485	16493		10.1074/jbc.R116.714576	http://dx.doi.org/10.1074/jbc.R116.714576			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27325705	hybrid, Green Published			2022-12-28	WOS:000380826700009
J	Palsgaard, J; Emanuelli, B; Winnay, JN; Sumara, G; Karsenty, G; Kahn, CR				Palsgaard, Jane; Emanuelli, Brice; Winnay, Jonathon N.; Sumara, Grzegorz; Karsenty, Gerard; Kahn, C. Ronald			Cross-talk between Insulin and Wnt Signaling in Preadipocytes ROLE OF WNT CO-RECEPTOR LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5 (LRP5)(vol 287, pg 12016, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Kahn, Ronald/AAY-2435-2021; Emanuelli, Brice/M-2097-2016	Kahn, Ronald/0000-0002-7583-9228; Emanuelli, Brice/0000-0001-5795-5666; Karsenty, Gerard/0000-0002-9253-7627	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R37DK031036, T32DK007260] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK007260, P30 DK036836, R37 DK031036] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		PALSGAARD J, 2012, ROLE WNT CORECEPTER, V287, P12016	1	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16878	16878		10.1074/jbc.A111.337048	http://dx.doi.org/10.1074/jbc.A111.337048			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27496960	Green Published, hybrid			2022-12-28	WOS:000380826700043
J	Vanderperre, B; Cermakova, K; Escoffier, J; Kaba, M; Bender, T; Nef, S; Martinou, JC				Vanderperre, Benoit; Cermakova, Kristina; Escoffier, Jessica; Kaba, Mayis; Bender, Tom; Nef, Serge; Martinou, Jean-Claude			MPC1-like Is a Placental Mammal-specific Mitochondrial Pyruvate Carrier Subunit Expressed in Postmeiotic Male Germ Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLISM; PROTEIN; FUNCTIONALITY; ACETYLATION; GLUCONEOGENESIS; EVOLUTION; TRANSPORT; DEFECTS; LEADS	Selective transport of pyruvate across the inner mitochondrial membrane by the mitochondrial pyruvate carrier (MPC) is a fundamental step that couples cytosolic and mitochondrial metabolism. The recent molecular identification of the MPC complex has revealed two interacting subunits, MPC1 and MPC2. Although in yeast, an additional subunit, MPC3, can functionally replace MPC2, no alternative MPC subunits have been described in higher eukaryotes. Here, we report for the first time the existence of a novel MPC subunit termed MPC1-like (MPC1L), which is present uniquely in placental mammals. MPC1L shares high sequence, structural, and topological homology with MPC1. In addition, we provide several lines of evidence to show that MPC1L is functionally equivalent to MPC1: 1) when co-expressed with MPC2, it rescues pyruvate import in a MPC-deleted yeast strain; 2) in mammalian cells, it can associate with MPC2 to form a functional carrier as assessed by bioluminescence resonance energy transfer; 3) in MPC1 depleted mouse embryonic fibroblasts, MPC1L rescues the loss of pyruvate-driven respiration and stabilizes MPC2 expression; and 4) MPC1- and MPC1L-mediated pyruvate imports show similar efficiency. However, we show that MPC1L has a highly specific expression pattern and is localized almost exclusively in testis and more specifically in postmeiotic spermatids and sperm cells. This is in marked contrast to MPC1/MPC2, which are ubiquitously expressed throughout the organism. To date, the biological importance of this alternative MPC complex during spermatogenesis in placental mammals remains unknown. Nevertheless, these findings open up new avenues for investigating the structure-function relationship within the MPC complex.	[Vanderperre, Benoit; Cermakova, Kristina; Bender, Tom; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Escoffier, Jessica; Kaba, Mayis; Nef, Serge] Univ Geneva, Swiss Ctr Appl Human Toxicol, CH-1211 Geneva 4, Switzerland; [Escoffier, Jessica; Kaba, Mayis; Nef, Serge] Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Martinou, JC (corresponding author), Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland.	jean-claude.martinou@unige.ch	Escoffier, jessica/E-9498-2017; Nef, Serge/AAV-6445-2020; Escoffier, jessica/T-9857-2019	Escoffier, jessica/0000-0001-8166-5845; Nef, Serge/0000-0001-5462-0676; Vanderperre, Benoit/0000-0002-2111-1071; martinou, Jean-claude/0000-0002-9847-2051; Cermakova, Kristina/0000-0002-9143-8766	Swiss National Science Foundation [310030B_160257/1]; Sinergia Grant [CRSII3_147637/1]; IGE3; State of Geneva; Swiss Centre for Applied Human Toxicology; Departement de l'Instruction Publique of the State of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia Grant; IGE3; State of Geneva; Swiss Centre for Applied Human Toxicology; Departement de l'Instruction Publique of the State of Geneva	This work was supported in the Martinou lab by Swiss National Science Foundation Grant 310030B_160257/1, Sinergia Grant CRSII3_147637/1, IGE3, and the State of Geneva, and in the Nef lab by the Swiss Centre for Applied Human Toxicology and by the Departement de l'Instruction Publique of the State of Geneva (to S. N., M. K., and J. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Agathocleous M, 2013, TRENDS CELL BIOL, V23, P484, DOI 10.1016/j.tcb.2013.05.004; Agathocleous M, 2012, NAT CELL BIOL, V14, P859, DOI 10.1038/ncb2531; Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; Bender T, 2015, EMBO J, V34, P911, DOI 10.15252/embj.201490197; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Compan V, 2015, MOL CELL, V59, P491, DOI 10.1016/j.molcel.2015.06.035; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; EBOLI ML, 1977, BIOCHIM BIOPHYS ACTA, V460, P183, DOI 10.1016/0005-2728(77)90166-9; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Galdieri L, 2014, EUKARYOT CELL, V13, P1472, DOI 10.1128/EC.00189-14; Gallon F, 2006, FERTIL STERIL, V86, P1526, DOI 10.1016/j.fertnstert.2006.03.055; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lercher MJ, 2003, MOL BIOL EVOL, V20, P1113, DOI 10.1093/molbev/msg131; Liang L, 2015, BIOCHEM BIOPH RES CO, V468, P807, DOI 10.1016/j.bbrc.2015.11.036; Marchiq I, 2015, CANCER RES, V75, P171, DOI 10.1158/0008-5472.CAN-14-2260; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; PARADIES G, 1983, CANCER RES, V43, P5068; Parra MT, 2003, J CELL SCI, V116, P961, DOI 10.1242/jcs.00330; Patterson JN, 2014, J BIOL CHEM, V289, P13335, DOI 10.1074/jbc.M113.521666; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Rato L, 2012, NAT REV UROL, V9, P330, DOI 10.1038/nrurol.2012.77; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; San Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085780; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Schell JC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-6; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Stouffs K, 2012, BBA-MOL BASIS DIS, V1822, P1864, DOI 10.1016/j.bbadis.2012.05.012; Vanderperre B, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006056; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Wang LM, 2016, ONCOTARGET, V7, P14673, DOI 10.18632/oncotarget.7405; Yannez AJ, 2007, J CELL PHYSIOL, V212, P807, DOI 10.1002/jcp.21077; Yang CD, 2014, J BIOL CHEM, V289, P6212, DOI 10.1074/jbc.M113.543637; Zhong YL, 2015, ONCOTARGET, V6, P37758, DOI 10.18632/oncotarget.5386	47	21	21	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16448	16461		10.1074/jbc.M116.733840	http://dx.doi.org/10.1074/jbc.M116.733840			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27317664	Green Published, hybrid			2022-12-28	WOS:000380826700004
J	Tran, TTT; Postal, BG; Demignot, S; Ribeiro, A; Osinski, C; de Barros, JPP; Blachnio-Zabielska, A; Leturque, A; Rousset, M; Ferre, P; Hajduch, E; Carriere, V				Tran, Thi Thu Trang; Postal, Barbara Graziela; Demignot, Sylvie; Ribeiro, Agnes; Osinski, Celine; de Barros, Jean-Paul Pais; Blachnio-Zabielska, Agnieszka; Leturque, Armelle; Rousset, Monique; Ferre, Pascal; Hajduch, Eric; Carriere, Veronique			Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; APOLIPOPROTEIN B48-CONTAINING LIPOPROTEINS; SKELETAL-MUSCLE CELLS; FREE FATTY-ACIDS; CACO-2 CELLS; SPHINGOLIPID METABOLISM; CHYLOMICRON PRODUCTION; ANIMAL-MODEL; SERINE PALMITOYLTRANSFERASE; NONFASTING TRIGLYCERIDES	The worldwide prevalence of metabolic diseases is increasing, and there are global recommendations to limit consumption of certain nutrients, especially saturated lipids. Insulin resistance, a common trait occurring in obesity and type 2 diabetes, is associated with intestinal lipoprotein overproduction. However, the mechanisms by which the intestine develops insulin resistance in response to lipid overload remain unknown. Here, we show that insulin inhibits triglyceride secretion and intestinal microsomal triglyceride transfer protein expression in vivo in healthy mice force-fed monounsaturated fatty acid-rich olive oil but not in mice force-fed saturated fatty acid-rich palm oil. Moreover, when mouse intestine and human Caco-2/TC7 enterocytes were treated with the saturated fatty acid, palmitic acid, the insulin-signaling pathway was impaired. We show that palmitic acid or palm oil increases ceramide production in intestinal cells and that treatment with a ceramide analogue partially reproduces the effects of palmitic acid on insulin signaling. In Caco-2/TC7 enterocytes, ceramide effects on insulin-dependent AKT phosphorylation are mediated by protein kinase C but not by protein phosphatase 2A. Finally, inhibiting de novo ceramide synthesis improves the response of palmitic acid-treated Caco-2/TC7 enterocytes to insulin. These results demonstrate that a palmitic acid-ceramide pathway accounts for impaired intestinal insulin sensitivity, which occurs within several hours following initial lipid exposure.	[Tran, Thi Thu Trang; Postal, Barbara Graziela; Demignot, Sylvie; Ribeiro, Agnes; Osinski, Celine; Leturque, Armelle; Rousset, Monique; Carriere, Veronique] Univ Paris Diderot, Univ Paris Sci & Lettres,Inst Cardiometab & Nutr, Sorbonne Univ,Univ Paris Descartes,Sorbonne Paris, CNRS,Ctr Rech Cordeliers,UPMC Univ Paris 06,INSER, F-75006 Paris, France; [de Barros, Jean-Paul Pais] Univ Bourgogne, INSERM UMR866, F-21070 Dijon, France; [Blachnio-Zabielska, Agnieszka] Med Univ Bialystok, PL-15089 Bialystok, Poland; [Ferre, Pascal; Hajduch, Eric] Univ Paris Diderot, Univ Paris Descartes,Ctr Rech Cordeliers, Sorbonne Paris Cite,Inst Cardiometab & Nutr ICAN, INSERM UMRS 1138,Sorbonne Univ,UPMC Univ Paris 06, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Universite Paris Cite; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Medical University of Bialystok; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Carriere, V (corresponding author), Ctr Rech Cordeliers, Equipe Armelle Leturque, UMRS U1138, 15 Rue Ecole Med, F-75006 Paris, France.	veronique.carriere@crc.jussieu.fr	Blachnio-Zabielsk, Agnieszka U/A-4879-2018; Leturque, Armelle/Q-9437-2017; Carrière, Véronique/AAQ-5027-2021; Ferré, Pascal/K-1250-2013; Ribeiro, Agnès/Q-9702-2017; Hajduch, Eric/B-7332-2008	Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Leturque, Armelle/0000-0001-6570-6387; Carrière, Véronique/0000-0002-6263-0847; Ferré, Pascal/0000-0003-0115-7045; Ribeiro, Agnès/0000-0003-2063-6084; Hajduch, Eric/0000-0002-0125-7751; PAIS DE BARROS, Jean-Paul/0000-0002-5124-2283; Demignot, Sylvie/0000-0001-7149-1992	Institute of Cardiometabolism and Nutrition; Fondation pour la Recherche Medicale (Equipe FRM) [DEQ20140329504]	Institute of Cardiometabolism and Nutrition; Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale)	This work was supported in part by the Institute of Cardiometabolism and Nutrition and by Fondation pour la Recherche Medicale (Equipe FRM DEQ20140329504). The authors declare that they have no conflicts of interest with the contents of this article.	Adeli K, 2008, CURR OPIN LIPIDOL, V19, P221, DOI 10.1097/MOL.0b013e3282ffaf82; Allister EM, 2005, DIABETES, V54, P1676, DOI 10.2337/diabetes.54.6.1676; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Dash S, 2015, ANNU REV NUTR, V35, P265, DOI 10.1146/annurev-nutr-071714-034338; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Duez H, 2008, ATHEROSCLEROSIS SUPP, V9, P33, DOI 10.1016/j.atherosclerosissup.2008.05.013; Duez H, 2006, ARTERIOSCL THROM VAS, V26, P1357, DOI 10.1161/01.ATV.0000222015.76038.14; Federico LM, 2006, DIABETES, V55, P1316, DOI 10.2337/db04-1084; Frochot V, 2012, AM J PHYSIOL-GASTR L, V302, pG1253, DOI 10.1152/ajpgi.00329.2011; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Haas ME, 2013, TRENDS ENDOCRIN MET, V24, P391, DOI [10.101, 10.1016/j.tem.2013.04.001]; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hassan RH, 2014, WORLD J DIABETES, V5, P244, DOI 10.4239/wjd.v5.i3.244; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hooper AJ, 2015, CIRC RES, V116, P193, DOI 10.1161/CIRCRESAHA.116.304637; Hsieh J, 2008, ATHEROSCLEROSIS SUPP, V9, P7, DOI 10.1016/j.atherosclerosissup.2008.05.011; Huang H, 2011, OBESITY, V19, P2235, DOI 10.1038/oby.2011.107; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Larsen PJ, 2014, MOL METAB, V3, P252, DOI 10.1016/j.molmet.2014.01.011; Leung N, 2004, ATHEROSCLEROSIS, V174, P235, DOI 10.1016/j.atherosclerosis.2004.02.005; Levy E, 1996, FEBS LETT, V393, P253, DOI 10.1016/0014-5793(96)00896-4; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; LOIRDIGHI N, 1992, BIOCHIM BIOPHYS ACTA, V1175, P100, DOI 10.1016/0167-4889(92)90015-4; Marandi S, 2001, AM J PHYSIOL-GASTR L, V280, pG229, DOI 10.1152/ajpgi.2001.280.2.G229; Mathur SN, 1997, J LIPID RES, V38, P61; Nogueira JP, 2012, ARTERIOSCL THROM VAS, V32, P1039, DOI 10.1161/ATVBAHA.111.242073; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Padilla N, 2014, ARTERIOSCL THROM VAS, V34, P2330, DOI 10.1161/ATVBAHA.114.303849; Pauquai T, 2006, BIOCHEM J, V395, P393, DOI 10.1042/BJ20051359; Pavlic M, 2010, DIABETES, V59, P580, DOI 10.2337/db09-1297; Phillips Catherine, 2002, Int J Exp Diabetes Res, V3, P171; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Qin BL, 2007, DIABETES, V56, P450, DOI 10.2337/db06-0518; Reis A, 2013, J LIPID RES, V54, P1812, DOI 10.1194/jlr.M034330; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Uchida Y, 2014, BBA-MOL CELL BIOL L, V1841, P453, DOI 10.1016/j.bbalip.2013.09.003; Ussher JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037703; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; van Greevenbroek MMJ, 1996, ATHEROSCLEROSIS, V121, P139, DOI 10.1016/0021-9150(95)05712-9; Veilleux A, 2014, ARTERIOSCL THROM VAS, V34, P644, DOI 10.1161/ATVBAHA.113.302993	52	24	24	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16328	16338		10.1074/jbc.M115.709626	http://dx.doi.org/10.1074/jbc.M115.709626			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27255710	Green Published, hybrid			2022-12-28	WOS:000380585400036
J	Sommerfeld, A; Mayer, PGK; Cantore, M; Haussinger, D				Sommerfeld, Annika; Mayer, Patrick G. K.; Cantore, Miriam; Haussinger, Dieter			Regulation of plasma membrane localization of the Na+-taurocholate cotransporting polypeptide (Ntcp) by hyperosmolarity and tauroursodeoxycholate (vol 290, pg 24237, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Sommerfeld A, 2015, J BIOL CHEM, V290, P24237, DOI 10.1074/jbc.M115.666883	1	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15908	15908		10.1074/jbc.A115.666883	http://dx.doi.org/10.1074/jbc.A115.666883			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27451430	Green Published, hybrid			2022-12-28	WOS:000380584200041
J	Viswanathan, R; True, JD; Auble, DT				Viswanathan, Ramya; True, Jason D.; Auble, David T.			Molecular Mechanism of Mot1, a TATA-binding Protein (TBP)-DNA Dissociating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; X-RAY STRUCTURES; DNA-BINDING; PREINITIATION COMPLEX; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURES; IN-VIVO; CHROMATIN INTERACTION; SWI2/SNF2 ATPASE; FAMILY-MEMBER	The essential Saccharomyces cerevisiae ATPase Mot1 globally regulates transcription by impacting the genomic distribution and activity of the TATA-binding protein (TBP). In vitro, Mot1 forms a ternary complex with TBP and DNA and can use ATP hydrolysis to dissociate the TBP-DNA complex. Prior work suggested an interaction between the ATPase domain and a functionally important segment of DNA flanking the TATA sequence. However, how ATP hydrolysis facilitates removal of TBP from DNA is not well understood, and several models have been proposed. To gain insight into the Mot1 mechanism, we dissected the role of the flanking DNA segment by biochemical analysis of complexes formed using DNAs with short single-stranded gaps. In parallel, we used a DNA tethered cleavage approach to map regions of Mot1 in proximity to the DNA under different conditions. Our results define non-equivalent roles for bases within a broad segment of flanking DNA required for Mot1 action. Moreover, we present biochemical evidence for two distinct conformations of the Mot1 ATPase, the detection of which can be modulated by ATP analogs as well as DNA sequence flanking the TATA sequence. We also show using purified complexes that Mot1 dissociation of a stable, high affinity TBP-DNA interaction is surprisingly inefficient, suggesting how other transcription factors that bind to TBP may compete with Mot1. Taken together, these results suggest that TBP-DNA affinity as well as other aspects of promoter sequence influence Mot1 function in vivo.	[Viswanathan, Ramya; True, Jason D.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Auble, DT (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	auble@virginia.edu	Viswanathan, Ramya/L-5935-2019		National Institutes of Health [GM55763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM55763 (to D. T. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamkewicz JI, 2000, J BIOL CHEM, V275, P21158, DOI 10.1074/jbc.M002639200; Adamkewicz JI, 2001, J BIOL CHEM, V276, P11883, DOI 10.1074/jbc.M010665200; Andrau JC, 2002, EMBO J, V21, P5173, DOI 10.1093/emboj/cdf485; Astumian RD, 2010, BIOPHYS J, V98, P2401, DOI 10.1016/j.bpj.2010.02.040; Auble DT, 1999, MOL CELL BIOL, V19, P412; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Butryn A., 2015, ELIFE, V4; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Geisberg JV, 2004, MOL CELL, V14, P479, DOI 10.1016/j.molcel.2004.05.003; Geisberg JV, 2002, MOL CELL BIOL, V22, P8122, DOI 10.1128/MCB.22.23.8122-8134.2002; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; GORBALENYA AE, 1988, FEBS LETT, V235, P16, DOI 10.1016/0014-5793(88)81226-2; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Gupta S, 2007, BIOCHEMISTRY-US, V46, P9886, DOI 10.1021/bi7003608; Hauk G, 2011, CURR OPIN STRUC BIOL, V21, P719, DOI 10.1016/j.sbi.2011.09.003; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Klejman MP, 2004, MOL CELL BIOL, V24, P10072, DOI 10.1128/MCB.24.22.10072-10082.2004; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Lewis R, 2008, NUCLEIC ACIDS RES, V36, P1881, DOI 10.1093/nar/gkn040; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Ludwigsen J, 2013, EMBO REP, V14, P1092, DOI 10.1038/embor.2013.160; MARUTA S, 1993, J BIOL CHEM, V268, P7093; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Montgomerie S, 2008, NUCLEIC ACIDS RES, V36, pW202, DOI 10.1093/nar/gkn255; Moyle-Heyrman G, 2012, J BIOL CHEM, V287, P9002, DOI 10.1074/jbc.M111.333484; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Mukherjee Srabani, 2003, Biological Procedures Online, V5, P78, DOI 10.1251/bpo49; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Nodelman IM, 2013, EMBO REP, V14, P1098, DOI 10.1038/embor.2013.158; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Poorey K, 2010, GENOME RES, V20, P1679, DOI 10.1101/gr.109504.110; Rana TM, 1990, BIOCONJUGATE CHEM, V1, P357, DOI 10.1021/bc00005a010; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Schmidt BD, 2002, BIOCHEMISTRY-US, V41, P4186, DOI 10.1021/bi015582r; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Sprouse RO, 2008, J BIOL CHEM, V283, P24935, DOI 10.1074/jbc.M803749200; Sprouse RO, 2006, EMBO J, V25, P1492, DOI 10.1038/sj.emboj.7601050; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Viswanathan R, 2011, BBA-GENE REGUL MECH, V1809, P488, DOI 10.1016/j.bbagrm.2011.05.012; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Zentner GE, 2013, MOL CELL BIOL, V33, P4996, DOI 10.1128/MCB.01218-13; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	68	4	5	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15714	15726		10.1074/jbc.M116.730366	http://dx.doi.org/10.1074/jbc.M116.730366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27255709	Green Published, hybrid			2022-12-28	WOS:000380584200025
J	Pegg, AE				Pegg, Anthony E.			Functions of Polyamines in Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SPERMINE SYNTHASE GENE; S-ADENOSYLMETHIONINE DECARBOXYLASE; RECTIFYING POTASSIUM CHANNEL; L-ORNITHINE DECARBOXYLASE; SNYDER-ROBINSON SYNDROME; TRANSLATION FACTOR EIF5A; REGENERATING RAT-LIVER; D-ASPARTATE RECEPTOR; FACTOR 5A EIF5A; GLUTAMATE RECEPTORS	The content of spermidine and spermine in mammalian cells has important roles in protein and nucleic acid synthesis and structure, protection from oxidative damage, activity of ion channels, cell proliferation, differentiation, and apoptosis. Spermidine is essential for viability and acts as the precursor of hypusine, a post-translational addition to eIF5A allowing the translation ofmRNAsencoding proteins containing polyproline tracts. Studies with Gy mice and human patients with the very rare X-linked genetic condition Snyder-Robinson syndrome that both lack spermine synthase show clearly that the correct spermine: spermidine ratio is critical for normal growth and development.	[Pegg, Anthony E.] Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Pegg, AE (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA.	apegg@psu.edu						Abela L, 2016, J INHERIT METAB DIS, V39, P131, DOI 10.1007/s10545-015-9876-y; Albert J., 2013, GENEREVIEWS; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; Benedikt J, 2012, NEUROREPORT, V23, P1021, DOI 10.1097/WNR.0b013e32835aa04b; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 1998, J NEUROSCI, V18, P8175; Bowie D, 2012, J PHYSIOL-LONDON, V590, P49, DOI 10.1113/jphysiol.2011.221689; Brenner S, 2015, J BIOL CHEM, V290, P27384, DOI 10.1074/jbc.M115.686980; Brown PMGE, 2016, J PHYSIOL-LONDON, V594, P1821, DOI 10.1113/JP271690; Caraglia M, 2013, AMINO ACIDS, V44, P103, DOI 10.1007/s00726-011-1182-x; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chao YN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081359; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; Domene C, 2005, BIOPHYS J, V89, pL1, DOI 10.1529/biophysj.105.060855; FOZARD JR, 1980, SCIENCE, V208, P505; Fujimura K, 2014, CANCER RES, V74, P6671, DOI 10.1158/0008-5472.CAN-14-1031; Gao JH, 2013, J PHYSIOL PHARMACOL, V64, P681; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Han X, 2008, J NEUROCHEM, V107, P1566, DOI 10.1111/j.1471-4159.2008.05729.x; HE Y, 1995, J BIOCHEM-TOKYO, V117, P824, DOI 10.1093/oxfordjournals.jbchem.a124782; Iacomino G, 2012, BBA-MOL CELL RES, V1823, P1745, DOI 10.1016/j.bbamcr.2012.05.033; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Ikeguchi Y, 2004, BIOCHEM J, V381, P701, DOI 10.1042/BJ20040419; Ishii I, 2012, AMINO ACIDS, V42, P619, DOI 10.1007/s00726-011-1037-5; Ivanov IP, 2010, NUCLEIC ACIDS RES, V38, P353, DOI 10.1093/nar/gkp1037; Jin LH, 2008, J PHARMACOL EXP THER, V327, P68, DOI 10.1124/jpet.108.140459; Kesler SR, 2009, NEUROGENETICS, V10, P299, DOI 10.1007/s10048-009-0184-2; Kim J, 2016, PFLUG ARCH EUR J PHY, V468, P551, DOI 10.1007/s00424-015-1753-x; Korhonen VP, 2001, MOL PHARMACOL, V59, P231, DOI 10.1124/mol.59.2.231; Kubo Y, 2005, PHARMACOL REV, V57, P509, DOI 10.1124/pr.57.4.11; Kurata HT, 2008, BIOPHYS J, V95, P3827, DOI 10.1529/biophysj.108.133256; Kurata HT, 2013, J BIOL CHEM, V288, P6591, DOI 10.1074/jbc.M112.383794; Kurata HT, 2010, J GEN PHYSIOL, V135, P495, DOI 10.1085/jgp.200910253; Lee MJ, 2013, J CELL BIOCHEM, V114, P2718, DOI 10.1002/jcb.24620; Lee SB, 2011, BIOCHEM J, V433, P205, DOI 10.1042/BJ20101322; Lefevre PLC, 2011, ENDOCR REV, V32, P694, DOI 10.1210/er.2011-0012; Lopatin AN, 2000, J MOL CELL CARDIOL, V32, P2007, DOI 10.1006/jmcc.2000.1232; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lorenz B, 1998, HUM MOL GENET, V7, P541, DOI 10.1093/hmg/7.3.541; Luchessi AD, 2009, J CELL PHYSIOL, V218, P480, DOI 10.1002/jcp.21619; LYON MF, 1986, P NATL ACAD SCI USA, V83, P4899, DOI 10.1073/pnas.83.13.4899; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; MAMONT PS, 1976, P NATL ACAD SCI USA, V73, P1626, DOI 10.1073/pnas.73.5.1626; MAMONT PS, 1984, EUR J BIOCHEM, V142, P457, DOI 10.1111/j.1432-1033.1984.tb08308.x; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Mandal S, 2015, BIOCHEM J, V468, P435, DOI 10.1042/BJ20150168; Mathews MB, 2015, BBA-GENE REGUL MECH, V1849, P836, DOI 10.1016/j.bbagrm.2015.05.002; McLaren CE, 2008, CANCER PREV RES, V1, P514, DOI 10.1158/1940-6207.CAPR-08-0074; Mendez-Gonzalez MP, 2016, J BIOL CHEM, V291, P7716, DOI 10.1074/jbc.M115.679910; Meyer RA, 1998, GENOMICS, V48, P289, DOI 10.1006/geno.1997.5169; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Mitchell JLA, 1996, BIOCHEM J, V320, P755, DOI 10.1042/bj3200755; Mott DD, 2003, J NEUROSCI, V23, P1179, DOI 10.1523/JNEUROSCI.23-04-01179.2003; Nilsson J, 2000, BIOCHEM J, V352, P381, DOI 10.1042/0264-6021:3520381; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Ojeda-Lopez MA, 2014, NAT MATER, V13, P195, DOI 10.1038/nmat3858; Pallmann N, 2015, J BIOL CHEM, V290, P18343, DOI 10.1074/jbc.M115.664490; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Park MH, 2013, BIOMOL THER, V21, P1, DOI 10.4062/biomolther.2012.097; PEGG AE, 1970, BIOCHEM J, V117, P17, DOI 10.1042/bj1170017; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pegg AE, 2014, IUBMB LIFE, V66, P8, DOI 10.1002/iub.1237; Pegg AE, 2013, CHEM RES TOXICOL, V26, P1782, DOI 10.1021/tx400316s; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; Pegg Anthony E, 2009, Commun Integr Biol, V2, P271; Pegg AE, 2010, CELL MOL LIFE SCI, V67, P113, DOI 10.1007/s00018-009-0165-5; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Peron A, 2013, AM J MED GENET A, V161, P2316, DOI 10.1002/ajmg.a.36116; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; RAINA A, 1966, BIOCHIM BIOPHYS ACTA, V123, P197, DOI 10.1016/0005-2787(66)90173-0; Rao JN, 2012, AM J PHYSIOL-CELL PH, V303, pC308, DOI 10.1152/ajpcell.00120.2012; Ray RM, 2007, AM J PHYSIOL-GASTR L, V292, pG983, DOI 10.1152/ajpgi.00356.2006; RUSSELL D, 1968, P NATL ACAD SCI USA, V60, P1420, DOI 10.1073/pnas.60.4.1420; Sakamoto A., PLOS ONE, V10; Sakamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124883; Schmidt C, 2016, NUCLEIC ACIDS RES, V44, P1944, DOI 10.1093/nar/gkv1517; Shin J, 2007, J PHYSIOL-LONDON, V581, P679, DOI 10.1113/jphysiol.2007.130963; Sievert H, 2014, DIS MODEL MECH, V7, P963, DOI 10.1242/dmm.014449; Skatchkov SN, 2015, NEUROREPORT, V26, P528, DOI 10.1097/WNR.0000000000000385; Sowell J, 2011, CLIN CHIM ACTA, V412, P655, DOI 10.1016/j.cca.2010.12.037; Stanfield PR, 2003, J GEN PHYSIOL, V122, P481, DOI 10.1085/jgp.200308957; TABOR CW, 1956, J PHARMACOL EXP THER, V116, P139; TABOR CW, 1964, J BIOL CHEM, V239, P2194; Terui Y, 2005, BIOCHEM J, V388, P427, DOI 10.1042/BJ20041778; Tolbert WD, 2003, BIOCHEMISTRY-US, V42, P2386, DOI 10.1021/bi0268854; Wang XJ, 2009, J BIOL CHEM, V284, P930, DOI 10.1074/jbc.M807758200; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; WILLIAMS K, 1989, MOL PHARMACOL, V36, P575; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Wu H, 2007, BIOCHEMISTRY-US, V46, P8331, DOI 10.1021/bi602498k; Yamashita T, 2013, INT J BIOCHEM CELL B, V45, P1042, DOI 10.1016/j.biocel.2013.02.021; Yeon JT, 2014, AMINO ACIDS, V46, P2605, DOI 10.1007/s00726-014-1797-9; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110884; Zhang Z, 2013, HUM MOL GENET, V22, P3789, DOI 10.1093/hmg/ddt229	98	322	342	9	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14904	14912		10.1074/jbc.R116.731661	http://dx.doi.org/10.1074/jbc.R116.731661			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27268251	hybrid, Green Published			2022-12-28	WOS:000380583200002
J	Gordillo, GM; Biswas, A; Khanna, S; Spieldenner, JM; Pan, XL; Sen, CK				Gordillo, Gayle M.; Biswas, Ayan; Khanna, Savita; Spieldenner, James M.; Pan, Xueliang; Sen, Chandan K.			Multidrug resistance-associated protein-1 (MRP-1)-dependent glutathione disulfide (GSSG) efflux as a critical survival factor for oxidant-enriched tumorigenic endothelial cells (vol 291, pg 10089, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108014] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM108014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Gordillo GM, 2016, J BIOL CHEM, V291, P10089, DOI 10.1074/jbc.M115.688879	1	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14394	14394		10.1074/jbc.A115.688879	http://dx.doi.org/10.1074/jbc.A115.688879			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371570	Green Published, hybrid			2022-12-28	WOS:000379975100048
J	Muramatsu, D; Singh, PB; Kimura, H; Tachibana, M; Shinkai, Y				Muramatsu, Daisuke; Singh, Prim B.; Kimura, Hiroshi; Tachibana, Makoto; Shinkai, Yoichi			RETRACTION: Pericentric heterochromatin generated by HP1 protein interaction-defective histone methyltransferase Suv39h1 (Retraction of vol 288, pg 25285, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Kimura, Hiroshi/B-9524-2015	Kimura, Hiroshi/0000-0003-0854-083X				Muramatsu D, 2013, J BIOL CHEM, V288, P25285, DOI 10.1074/jbc.M113.470724	1	0	0	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14393	14393		10.1074/jbc.A113.470724	http://dx.doi.org/10.1074/jbc.A113.470724			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371569	Green Published, hybrid			2022-12-28	WOS:000379975100047
J	Maqbool, A; Hughes, RK; Dagdas, YF; Tregidgo, N; Zess, E; Belhaj, K; Round, A; Bozkurt, TO; Kamoun, S; Banfield, MJ				Maqbool, Abbas; Hughes, Richard K.; Dagdas, Yasin F.; Tregidgo, Nicholas; Zess, Erin; Belhaj, Khaoula; Round, Adam; Bozkurt, Tolga O.; Kamoun, Sophien; Banfield, Mark J.			Structural Basis of Host Autophagy-related Protein 8 (ATG8) Binding by the Irish Potato Famine Pathogen Effector Protein PexRD54	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; host-pathogen interaction; plant molecular biology; protein structure; protein-protein interaction; effector protein; plant pathogen	X-RAY SOLUTION; RXLR EFFECTOR; SOLUTION SCATTERING; PLANT IMMUNITY; BIOLOGICAL MACROMOLECULES; ACTIVATION; SYSTEM; CRYSTALLOGRAPHY; RECOGNITION; RESOLUTION	Filamentous plant pathogens deliver effector proteins to host cells to promote infection. The Phytophthora infestans RXLR-type effector PexRD54 binds potato ATG8 via its ATG8 family-interacting motif (AIM) and perturbs host-selective autophagy. However, the structural basis of this interaction remains unknown. Here, we define the crystal structure of PexRD54, which includes a modular architecture, including five tandem repeat domains, with the AIM sequence presented at the disordered C terminus. To determine the interface between PexRD54 and ATG8, we solved the crystal structure of potato ATG8CL in complex with a peptide comprising the effector's AIM sequence, and we established a model of the full-length PexRD54-ATG8CL complex using small angle x-ray scattering. Structure-informed deletion of the PexRD54 tandem domains reveals retention of ATG8CL binding in vitro and in planta. This study offers new insights into structure/function relationships of oomycete RXLR effectors and how these proteins engage with host cell targets to promote disease.	[Maqbool, Abbas; Hughes, Richard K.; Tregidgo, Nicholas; Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Dagdas, Yasin F.; Zess, Erin; Belhaj, Khaoula; Kamoun, Sophien] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Bozkurt, Tolga O.] Imperial Coll, Dept Life Sci, London SW7 2AZ, England; [Round, Adam] EMBL Grenoble, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France; [Round, Adam] Keele Univ, EPSAM, Keele ST5 5GB, Staffs, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Imperial College London; European Molecular Biology Laboratory (EMBL); Keele University	Banfield, MJ (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	mark.banfield@jic.ac.uk	Maqbool, Abbas/ABF-8279-2021; Bozkurt, Tolga Osman/AAA-8014-2019; Bozkurt, Tolga O/C-9764-2014; Kamoun, Sophien/B-3529-2009; Maqbool, Abbas/AAA-9052-2020; Banfield, Mark/C-7453-2013; Maqbool, Abbas/G-3191-2016; Hughes, Richard/E-9642-2015	Bozkurt, Tolga Osman/0000-0003-0507-6875; Bozkurt, Tolga O/0000-0003-0507-6875; Kamoun, Sophien/0000-0002-0290-0315; Banfield, Mark/0000-0001-8921-3835; Maqbool, Abbas/0000-0002-6189-5560; Zess, Erin/0000-0001-6968-6336; Round, Adam/0000-0002-0723-8228; Hughes, Richard/0000-0001-9910-6566; Dagdas, Yasin/0000-0002-9502-355X	European Research Council Proposal "NGRB"; Biotechnology and Biological Sciences Research Council [BB/J00453, BB/M002462]; John Innes Foundation; Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA485, BBS/E/J/000C0624, BB/M002462/1] Funding Source: researchfish; BBSRC [BBS/E/J/000CA485, BBS/E/J/000C0624, BB/M002462/1] Funding Source: UKRI	European Research Council Proposal "NGRB"; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by European Research Council Proposal "NGRB," Biotechnology and Biological Sciences Research Council Grants BB/J00453 and BB/M002462, the John Innes Foundation, and the Gatsby Charitable Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Boevink PC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10311; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Bozkurt TO, 2011, P NATL ACAD SCI USA, V108, P20832, DOI 10.1073/pnas.1112708109; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng W, 2011, CELL HOST MICROBE, V10, P616, DOI 10.1016/j.chom.2011.10.013; Chou S, 2011, P NATL ACAD SCI USA, V108, P13323, DOI 10.1073/pnas.1109791108; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; CICCARIELLO S, 1988, J APPL CRYSTALLOGR, V21, P117, DOI 10.1107/S0021889887010409; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dagdas YF, 2016, ELIFE, V5, DOI 10.7554/eLife.10856; de Guillen K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005228; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Desveaux D, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030048; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong J, 2009, PLANT CELL, V21, P1846, DOI 10.1105/tpc.109.066878; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gilroy EM, 2011, NEW PHYTOL, V190, P653, DOI 10.1111/j.1469-8137.2011.03643.x; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hurley JH, 2014, CELL, V157, P300, DOI 10.1016/j.cell.2014.01.070; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; King SRF, 2014, PLANT CELL, V26, P1345, DOI 10.1105/tpc.113.120055; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; McLellan H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003670; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Niu H, 2012, P NATL ACAD SCI USA, V109, P20800, DOI 10.1073/pnas.1218674109; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Pedersen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-694; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Round A, 2015, ACTA CRYSTALLOGR D, V71, P67, DOI 10.1107/S1399004714026959; Saunders DGO, 2012, PLANT CELL, V24, P3420, DOI 10.1105/tpc.112.099861; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Wang XD, 2015, MOL PLANT, V8, P1385, DOI 10.1016/j.molp.2015.04.012; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wirthmueller L, 2013, NAT REV MICROBIOL, V11, P761, DOI 10.1038/nrmicro3118; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731	64	50	56	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20270	20282		10.1074/jbc.M116.744995	http://dx.doi.org/10.1074/jbc.M116.744995			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27458016	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000383243100045
J	Sanchez, MA; Tran, KD; Valli, J; Hobbs, S; Johnson, E; Gluenz, E; Landfear, SM				Sanchez, Marco A.; Tran, Khoa D.; Valli, Jessica; Hobbs, Sam; Johnson, Errin; Gluenz, Eva; Landfear, Scott M.			KHARON Is an Essential Cytoskeletal Protein Involved in the Trafficking of Flagellar Membrane Proteins and Cell Division in African Trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; cytoskeleton; membrane protein; mitotic spindle; trafficking; Trypanosoma brucei	BLOOD-STREAM FORMS; ADENYLATE CYCLASES; IN-VIVO; SOCIAL MOTILITY; PRIMARY CILIUM; BRUCEI GENES; CYTOKINESIS; MORPHOGENESIS; LEISHMANIA; SYSTEM	African trypanosomes and related kinetoplastid parasites selectively traffic specific membrane proteins to the flagellar membrane, but the mechanisms for this trafficking are poorly understood. We show here that KHARON, a protein originally identified in Leishmania parasites, interacts with a putative trypanosome calcium channel and is required for its targeting to the flagellar membrane. KHARON is located at the base of the flagellar axoneme, where it likely mediates targeting of flagellar membrane proteins, but is also on the subpellicular microtubules and the mitotic spindle. Hence, KHARON is probably a multifunctional protein that associates with several components of the trypanosome cytoskeleton. RNA interference-mediated knockdown of KHARON mRNA results in failure of the calcium channel to enter the flagellar membrane, detachment of the flagellum from the cell body, and disruption of mitotic spindles. Furthermore, knockdown of KHARON mRNA induces a lethal failure of cytokinesis in both bloodstream (mammalian host) and procyclic (insect vector) life cycle stages, and KHARON is thus critical for parasite viability.	[Sanchez, Marco A.; Tran, Khoa D.; Hobbs, Sam; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol Immunol, Portland, OR 97239 USA; [Valli, Jessica; Johnson, Errin; Gluenz, Eva] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Oregon Health & Science University; University of Oxford	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol Immunol, Portland, OR 97239 USA.	landfear@ohsu.edu		Valli, Jessica/0000-0003-4346-0317	National Institutes of Health [R21-AI114822, R01-AI121160]; Biotechnology and Biological Sciences Research Council [BB/C014122/1]; Shared Instrumentation Grant from the National Center for Research Resources, a component of the National Institutes of Health [S10-RR023432]; Medical Research Council; Sir William Dunn School of Pathology; Royal Society University Research Fellowship; Royal Society [RG130155]; Biotechnology and Biological Sciences Research Council [BB/D524567/1, BB/L014122/1] Funding Source: researchfish; Medical Research Council [1374928] Funding Source: researchfish; BBSRC [BB/L014122/1, BB/D524567/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114822, R01AI121160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Shared Instrumentation Grant from the National Center for Research Resources, a component of the National Institutes of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir William Dunn School of Pathology; Royal Society University Research Fellowship(Royal Society of London); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-AI114822 and R01-AI121160 (to S. M. L.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/C014122/1 and Shared Instrumentation Grant S10-RR023432 from the National Center for Research Resources, a component of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a studentship funded by the Medical Research Council and the Sir William Dunn School of Pathology.; Supported by a Royal Society University Research Fellowship and Royal Society Research Grant RG130155.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alexandre S, 1996, MOL BIOCHEM PARASIT, V77, P173, DOI 10.1016/0166-6851(96)02591-1; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bassarak B, 2011, CELL PHYSIOL BIOCHEM, V27, P411, DOI 10.1159/000327968; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; da Silva MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081397; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Farr H, 2012, CYTOSKELETON, V69, P931, DOI 10.1002/cm.21074; Forsythe GR, 2009, MOL BIOCHEM PARASIT, V164, P131, DOI 10.1016/j.molbiopara.2008.12.008; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Gluenz E, 2011, MOL CELL BIOL, V31, P1012, DOI 10.1128/MCB.01176-10; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hughes L, 2013, J CELL SCI, V126, P5748, DOI 10.1242/jcs.139139; Imhof Simon, 2016, F1000Res, V5, P682, DOI 10.12688/f1000research.8249.1; Imhof S, 2015, EUKARYOT CELL, V14, P588, DOI 10.1128/EC.00023-15; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Lopez MA, 2015, EUKARYOT CELL, V14, P104, DOI 10.1128/EC.00217-14; Luo SH, 2004, J BIOL CHEM, V279, P14427, DOI 10.1074/jbc.M309978200; Maric D, 2015, MOL BIOCHEM PARASIT, V201, P72, DOI 10.1016/j.molbiopara.2015.06.003; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Oberholzer M, 2015, MBIO, V6, DOI 10.1128/mBio.01954-14; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Ortiz D, 2009, MOL BIOCHEM PARASIT, V163, P67, DOI 10.1016/j.molbiopara.2008.09.011; Patel A, 2015, PFLUG ARCH EUR J PHY, V467, P157, DOI 10.1007/s00424-014-1516-0; Peacock L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-78; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Rotureau B, 2012, DEVELOPMENT, V139, P1842, DOI 10.1242/dev.072611; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saada EA, 2014, EUKARYOT CELL, V13, P1064, DOI 10.1128/EC.00019-14; Salmon D, 2012, SCIENCE, V337, P463, DOI 10.1126/science.1222753; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez MA, 2013, J BIOL CHEM, V288, P14428, DOI 10.1074/jbc.M113.473157; SASSE R, 1988, J CELL SCI, V90, P577; Serricchio M, 2015, BIOL OPEN, V4, P1143, DOI 10.1242/bio.011957; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Sun SY, 2013, J CELL SCI, V126, P520, DOI 10.1242/jcs.113621; Sunter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035167; Sunter JD, 2015, J CELL SCI, V128, P3117, DOI 10.1242/jcs.171645; Szempruch AJ, 2016, CELL, V164, P246, DOI 10.1016/j.cell.2015.11.051; Tran KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134432; Tran KD, 2013, J BIOL CHEM, V288, P22721, DOI 10.1074/jbc.M113.483461; van Deursen FJ, 2001, MOL BIOCHEM PARASIT, V112, P163, DOI 10.1016/S0166-6851(00)00359-5; WEBSTER P, 1993, PARASITOL TODAY, V9, P201, DOI 10.1016/0169-4758(93)90008-4; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wilke SA, 2013, J NEUROSCI, V33, P507, DOI 10.1523/JNEUROSCI.1600-12.2013; Wingard Jennifer N, 2008, J Biol Chem, V283, P23388, DOI 10.1074/jbc.M803178200	62	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19760	19773		10.1074/jbc.M116.739235	http://dx.doi.org/10.1074/jbc.M116.739235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27489106	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000383243100004
J	Soo, VWC; Yosaatmadja, Y; Squire, CJ; Patrick, WM				Soo, Valerie W. C.; Yosaatmadja, Yuliana; Squire, Christopher J.; Patrick, Wayne M.			Mechanistic and Evolutionary Insights from the Reciprocal Promiscuity of Two Pyridoxal Phosphate-dependent Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						directed evolution; enzyme mechanism; protein evolution; protein structure; pyridoxal phosphate	CYSTATHIONINE BETA-LYASE; ACTIVE-SITE MUTATION; ALANINE RACEMASE; ESCHERICHIA-COLI; BACILLUS-STEAROTHERMOPHILUS; CRYSTAL-STRUCTURE; STAPHYLOCOCCUS-AUREUS; LYSINE 39; E. COLI; X-RAY	Enzymes that utilize the cofactor pyridoxal 5-phosphate play essential roles in amino acid metabolism in all organisms. The cofactor is used by proteins that adopt at least five different folds, which raises questions about the evolutionary processes that might explain the observed distribution of functions among folds. In this study, we show that a representative of fold type III, the Escherichia coli alanine racemase (ALR), is a promiscuous cystathionine -lyase (CBL). Furthermore, E. coli CBL (fold type I) is a promiscuous alanine racemase. A single round of error-prone PCR and selection yielded variant ALR(Y274F), which catalyzes cystathionine -elimination with a near-native Michaelis constant (K-m = 3.3 mm) but a poor turnover number (k(cat) approximate to 10 h(-1)). In contrast, directed evolution also yielded CBL(P113S), which catalyzes l-alanine racemization with a poor K-m (58 mm) but a high k(cat) (22 s(-1)). The structures of both variants were solved in the presence and absence of the l-alanine analogue, (R)-1-aminoethylphosphonic acid. As expected, the ALR active site was enlarged by the Y274F substitution, allowing better access for cystathionine. More surprisingly, the favorable kinetic parameters of CBL(P113S) appear to result from optimizing the pK(a) of Tyr-111, which acts as the catalytic acid during l-alanine racemization. Our data emphasize the short mutational routes between the functions of pyridoxal 5-phosphate-dependent enzymes, regardless of whether or not they share the same fold. Thus, they confound the prevailing model of enzyme evolution, which predicts that overlapping patterns of promiscuity result from sharing a common multifunctional ancestor.	[Soo, Valerie W. C.] Massey Univ, Inst Nat & Math Sci, Auckland 0632, New Zealand; [Yosaatmadja, Yuliana; Squire, Christopher J.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Patrick, Wayne M.] Univ Otago, Dept Biochem, POB 56, Dunedin 9054, New Zealand	Massey University; University of Auckland; University of Otago	Patrick, WM (corresponding author), Univ Otago, Dept Biochem, POB 56, Dunedin 9054, New Zealand.	wayne.patrick@otago.ac.nz	Soo, Valerie WC/F-4998-2011	Soo, Valerie WC/0000-0003-0214-5070; Yosaatmadja, Yuliana/0000-0003-2875-5993; Patrick, Wayne/0000-0002-2718-8053; Squire, Christopher/0000-0001-9212-0461	Marsden Fund; Rutherford Discovery Fellowship	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Rutherford Discovery Fellowship	This work was supported by a grant from the Marsden Fund (to W. M. P.) and a Rutherford Discovery Fellowship (to W. M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams NE, 2014, MBIO, V5, DOI 10.1128/mBio.01378-14; Anthony KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020374; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bertoldi M, 2003, BIOCHEM J, V371, P473, DOI 10.1042/BJ20020875; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ciustea M, 2012, BIOCHEM PHARMACOL, V83, P368, DOI 10.1016/j.bcp.2011.11.021; Clausen T, 1997, BIOL CHEM, V378, P321; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; Copley SD, 2015, TRENDS BIOCHEM SCI, V40, P72, DOI 10.1016/j.tibs.2014.12.004; Denesyuk AI, 2002, J MOL BIOL, V316, P155, DOI 10.1006/jmbi.2001.5310; di Salvo ML, 2013, ARCH BIOCHEM BIOPHYS, V529, P55, DOI 10.1016/j.abb.2012.11.011; Ejim LJ, 2007, J MED CHEM, V50, P755, DOI 10.1021/jm061132r; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESAKI N, 1986, BIOCHEMISTRY-US, V25, P3261, DOI 10.1021/bi00359a027; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Firth AE, 2005, BIOINFORMATICS, V21, P3314, DOI 10.1093/bioinformatics/bti516; Firth AE, 2008, NUCLEIC ACIDS RES, V36, pW281, DOI 10.1093/nar/gkn226; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; INAGAKI K, 1986, BIOCHEMISTRY-US, V25, P3268, DOI 10.1021/bi00359a028; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LeMagueres P, 2005, BIOCHEMISTRY-US, V44, P1471, DOI 10.1021/bi0486583; Lodha PH, 2011, BIOCHEMISTRY-US, V50, P9876, DOI 10.1021/bi201090n; Lodha PH, 2010, PROTEIN SCI, V19, P383, DOI 10.1002/pro.308; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCune CD, 2016, ACS CENTRAL SCI, V2, P242, DOI 10.1021/acscentsci.6b00019; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nam SH, 2011, J BACTERIOL, V193, P1014, DOI [10.1128/JB.01394-10, 10.1128/JB.01027-10]; Newton MS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0036; Ondrechen MJ, 2001, J AM CHEM SOC, V123, P2830, DOI 10.1021/ja0029679; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patrick WM, 2008, J MOL BIOL, V377, P323, DOI 10.1016/j.jmb.2008.01.043; Patrick WM, 2007, MOL BIOL EVOL, V24, P2716, DOI 10.1093/molbev/msm204; Patrick WM, 2002, CHEMBIOCHEM, V3, P789, DOI 10.1002/1439-7633(20020802)3:8<789::AID-CBIC789>3.0.CO;2-D; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273; Raboni S, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P273; Richard JP, 2011, BBA-PROTEINS PROTEOM, V1814, P1419, DOI 10.1016/j.bbapap.2010.12.007; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Scaletti ER, 2012, ACTA CRYSTALLOGR D, V68, P82, DOI 10.1107/S0907444911050682; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Seebeck FP, 2003, J AM CHEM SOC, V125, P10158, DOI 10.1021/ja036707d; Setiyaputra S, 2011, J MOL BIOL, V408, P291, DOI 10.1016/j.jmb.2011.02.048; Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c; Somarowthu S, 2012, BIOINFORMATICS, V28, P2078, DOI 10.1093/bioinformatics/bts321; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Soo VWC, 2011, P NATL ACAD SCI USA, V108, P1484, DOI 10.1073/pnas.1012108108; Spies MA, 2003, BIOCHEMISTRY-US, V42, P5099, DOI 10.1021/bi0274064; Spies MA, 2004, J AM CHEM SOC, V126, P7464, DOI 10.1021/ja049579h; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Strych U, 2001, FEMS MICROBIOL LETT, V196, P93, DOI 10.1016/S0378-1097(01)00045-3; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; UREN JR, 1987, METHOD ENZYMOL, V143, P483; Vollmer J, 2013, INT J MED MICROBIOL, V303, P140, DOI 10.1016/j.ijmm.2013.01.002; Watababe A, 1999, J BIOL CHEM, V274, P4189, DOI 10.1074/jbc.274.7.4189; Watanabe A, 1999, J BIOCHEM-TOKYO, V126, P781, DOI 10.1093/oxfordjournals.jbchem.a022517; Watanabe A, 2002, J BIOL CHEM, V277, P19166, DOI 10.1074/jbc.M201615200; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Wu DL, 2008, PROTEIN SCI, V17, P1066, DOI 10.1110/ps.083495908; Yow GY, 2003, J MOL CATAL B-ENZYM, V23, P311, DOI 10.1016/S1381-1177(03)00094-8	70	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19873	19887		10.1074/jbc.M116.739557	http://dx.doi.org/10.1074/jbc.M116.739557			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27474741	Green Published, hybrid			2022-12-28	WOS:000383243100013
J	Chirasani, VR; Revanasiddappa, PD; Senapati, S				Chirasani, Venkat R.; Revanasiddappa, Prasanna D.; Senapati, Sanjib			Structural Plasticity of Cholesteryl Ester Transfer Protein Assists the Lipid Transfer Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; lipid binding protein; lipid transport; lipid-protein interaction; molecular dynamics; cholesteryl ester (CE); cholesteryl ester transfer protein (CETP); free energy; molecular dynamics simulations; tunnel mechanism	CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; MOLECULAR-DYNAMICS SIMULATIONS; HDL; ATHEROSCLEROSIS; TUNNEL; GENE; LIPOPROTEINS; DEFICIENCY; PREDICTION	Cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters (CEs) and triglycerides between different lipoproteins. Recent studies have shown that blocking the function of CETP can increase the level of HDL cholesterol in blood plasma and suppress the risk of cardiovascular disease. Hence, understanding the structure, dynamics, and mechanism by which CETP transfers the neutral lipids has received tremendous attention in last decade. Although the recent crystal structure has provided direct evidence of the existence of strongly bound CEs in the CETP core, very little is known about the mechanism of CE/triglyceride transfer by CETP. In this study, we explore the large scale dynamics of CETP by means of multimicrosecond molecular dynamics simulations and normal mode analysis, which provided a wealth of detailed information about the lipid transfer mechanism of CETP. Results show that the bound CEs intraconvert between bent and linear conformations in the CETP core tunnel as a consequence of the high degree of conformational flexibility of the protein. During the conformational switching, there occurred a significant reduction in hydrophobic contacts between the CEs and CETP, and a continuous tunnel traversing across the CETP long axis appeared spontaneously. Thus, our results support the recently proposed tunnel mechanism of CETP from cryo-EM studies for the transfer of neutral lipids between different lipoproteins. The detailed understanding obtained here could help in devising methods to prevent CETP function as a cardiovascular disease therapeutic.	[Senapati, Sanjib] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India; Indian Inst Technol Madras, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Senapati, S (corresponding author), Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India.	sanjibs@iitm.ac.in	Chirasani, Venkata Reddy/ABB-4967-2021; Chirasani, Venkata Reddy/AFN-6812-2022	Chirasani, Venkata Reddy/0000-0003-1416-0438; Chirasani, Venkata Reddy/0000-0003-1416-0438; Revanasiddappa, Prasanna D/0000-0002-8175-9750				Aijanen T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003987; Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chirasani VR, 2016, J PHYS CHEM B, V120, P8254, DOI 10.1021/acs.jpcb.6b01928; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; DeLano WL, 2011, PYMOL MOL GRAPH SYST; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Goldberg A, 2000, AM J CARDIOL, V85, P1100, DOI 10.1016/S0002-9149(00)00703-7; Gotto AM, 2012, EXPERT REV CARDIOVAS, V10, P955, DOI [10.1586/ERC.12.82, 10.1586/erc.12.82]; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Koivuniemi A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002299; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lauer ME, 2016, J STRUCT BIOL, V194, P191, DOI 10.1016/j.jsb.2016.02.016; Layten M, 2006, J AM CHEM SOC, V128, P13360, DOI 10.1021/ja065133k; Lei DS, 2016, J BIOL CHEM, V291, P14034, DOI 10.1074/jbc.M116.715565; Liu SP, 2012, J BIOL CHEM, V287, P37321, DOI 10.1074/jbc.M112.380063; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; Mantlo NB, 2014, J MED CHEM, V57, P1, DOI 10.1021/jm400574e; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Plump AS, 1999, ARTERIOSCL THROM VAS, V19, P1105, DOI 10.1161/01.ATV.19.4.1105; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Senapati S, 2003, J PHYS CHEM B, V107, P12906, DOI 10.1021/jp035128s; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Sikorski JA, 2006, J MED CHEM, V49, P1, DOI 10.1021/jm058224l; Sugano M, 1998, J BIOL CHEM, V273, P5033, DOI 10.1074/jbc.273.9.5033; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; TALL AR, 1993, J LIPID RES, V34, P1255; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WANG SK, 1995, J BIOL CHEM, V270, P612, DOI 10.1074/jbc.270.2.612; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	48	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19462	19473		10.1074/jbc.M116.744623	http://dx.doi.org/10.1074/jbc.M116.744623			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27445332	Green Published, hybrid			2022-12-28	WOS:000383242800024
J	Donaubauer, EM; Law, NC; Hunzicker-Dunn, ME				Donaubauer, Elyse M.; Law, Nathan C.; Hunzicker-Dunn, Mary E.			Follicle-Stimulating Hormone (FSH)-dependent Regulation of Extracellular Regulated Kinase (ERK) Phosphorylation by the Mitogen-activated Protein (MAP) Kinase Phosphatase MKP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dual specificity phosphoprotein phosphatase; ERK; FSH; gene expression; ovary; PKA; MAP kinase phosphatase 3 (MKP3); dual specificity phosphatase 6 (DUSP6); granulosa cells	OVARIAN GRANULOSA-CELLS; DUAL-SPECIFICITY PHOSPHATASES; NEGATIVE-FEEDBACK-REGULATION; PTP-SL; TYROSINE PHOSPHATASES; SUBSTRATE-SPECIFICITY; SIGNALING PATHWAY; INTERACTION MOTIF; MOUSE OOCYTES; CANCER-CELLS	Within the ovarian follicle, granulosa cells (GCs) surround and support immature oocytes. FSH promotes the differentiation and proliferation of GCs and is essential for fertility. We recently reported that ERK activation is necessary for FSH to induce key genes that define the preovulatory GC. This research focused on the phosphoregulation by FSH of ERK within GCs. FSH-stimulated ERK phosphorylation on Thr(202)/Tyr(204) was PKA-dependent, but MEK(Ser(217)/Ser(221)) phosphorylation was not regulated; rather, MEK was already active. However, treatment of GCs with the EGF receptor inhibitor AG1478, a dominant-negative RAS, an Src homology 2 domain-containing Tyr phosphatase inhibitor (NSC 87877), or the MEK inhibitor PD98059 blocked FSH-dependent ERK(Thr(202)/Tyr(204)) phosphorylation, demonstrating the requirement for upstream pathway components. We hypothesized that FSH via PKA enhances ERK phosphorylation by inhibiting the activity of a protein phosphatase that constitutively dephosphorylates ERK in the absence of FSH, allowing MEK-phosphorylated ERK to accumulate in the presence of FSH because of inactivation of the phosphatase. GCs treated with different phosphatase inhibitors permitted elimination of both Ser/Thr and Tyr phosphatases and implicated dual specificity phosphatases (DUSPs) in the dephosphorylation of ERK. Treatment with MAP kinase phosphatase (MKP3, DUSP6) inhibitors increased ERK(Thr(202)/Tyr(204)) phosphorylation in the absence of FSH to levels comparable with ERK phosphorylated in the presence of FSH. ERK co-immunoprecipitated with Myc-FLAG-tagged MKP3(DUSP6). GCs treated with MKP3(DUSP6) inhibitors blocked and PKA inhibitors enhanced dephosphorylation of recombinant ERK2-GST in an in vitro phosphatase assay. Together, these results suggest that FSH-stimulated ERK activation in GCs requires the PKA-dependent inactivation of MKP3(DUSP6).	[Donaubauer, Elyse M.; Law, Nathan C.; Hunzicker-Dunn, Mary E.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Hunzicker-Dunn, ME (corresponding author), Washington State Univ, Biotechnol Life Sci Bldg,Rm 202, Pullman, WA 99164 USA.	mehd@wsu.edu			National Institutes of Health [R01HD065859, R01HD62503]; NIGMS, National Institutes of Health Training [T32GM083864]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health Training; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HD065859 and R01HD62503 (to M. E. H. D.) and NIGMS, National Institutes of Health Training Grant T32GM083864 (to E. M. D). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andric N, 2006, MOL ENDOCRINOL, V20, P3308, DOI 10.1210/me.2006-0241; Arif M, 2014, J BIOL CHEM, V289, P27677, DOI 10.1074/jbc.M114.565358; Bermudez O, 2008, ONCOGENE, V27, P3685, DOI 10.1038/sj.onc.1211040; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bruss MD, 2008, J BIOL CHEM, V283, P22430, DOI 10.1074/jbc.M803306200; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; CARR DW, 1993, J BIOL CHEM, V268, P20729; Castelli M, 2004, J BIOL CHEM, V279, P44731, DOI 10.1074/jbc.M407669200; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; CHESNEL F, 1995, MOL REPROD DEV, V40, P503, DOI 10.1002/mrd.1080400414; Choi BH, 2002, AM J PHYSIOL-CELL PH, V282, pC1461, DOI 10.1152/ajpcell.00398.2001; Cottom J, 2003, J BIOL CHEM, V278, P7167, DOI 10.1074/jbc.M203901200; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Das S, 1996, ENDOCRINOLOGY, V137, P967, DOI 10.1210/en.137.3.967; Devi YS, 2011, J BIOL CHEM, V286, P7609, DOI 10.1074/jbc.M110.166603; Donaubauer EM, 2016, J BIOL CHEM, V291, P12145, DOI 10.1074/jbc.M115.705368; Dorfman K, 1996, ONCOGENE, V13, P925; Eblaghie MC, 2003, CURR BIOL, V13, P1009, DOI 10.1016/S0960-9822(03)00381-6; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; El-Hefnawy T, 2001, ENDOCRINOLOGY, V142, P4357, DOI 10.1210/en.142.10.4357; ERICKSON GF, 1974, J EXP ZOOL, V190, P123, DOI 10.1002/jez.1401900112; Escamilla-Hernandez R, 2008, MOL ENDOCRINOL, V22, P1842, DOI 10.1210/me.2008-0103; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Flynn MP, 2008, MOL ENDOCRINOL, V22, P1695, DOI 10.1210/me.2007-0457; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Herndon MK, 2016, MOL CELL ENDOCRINOL, V434, P116, DOI 10.1016/j.mce.2016.06.020; HIDAKA H, 1991, METHOD ENZYMOL, V201, P328; Hunzicker-Dunn M, 2015, PHYSL REPROD, P895; Hunzicker-Dunn ME, 2012, P NATL ACAD SCI USA, V109, pE2979, DOI 10.1073/pnas.1205661109; HUNZICKERDUNN M, 1981, J BIOL CHEM, V256, P2185; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; KEMP BE, 1988, METHOD ENZYMOL, V159, P173; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; Law NC, 2016, J BIOL CHEM, V291, P4547, DOI 10.1074/jbc.M115.698761; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lazo JS, 2001, J MED CHEM, V44, P4042, DOI 10.1021/jm0102046; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Miro F, 1996, ENDOCRINOLOGY, V137, P464, DOI 10.1210/en.137.2.464; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Muda M, 1996, J BIOL CHEM, V271, P4319; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Noordman YE, 2008, BBA-MOL CELL RES, V1783, P275, DOI 10.1016/j.bbamcr.2007.10.023; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; Ogata M, 1999, BIOCHEM BIOPH RES CO, V256, P52, DOI 10.1006/bbrc.1999.0278; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pestell KE, 2000, ONCOGENE, V19, P6607, DOI 10.1038/sj.onc.1204084; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Puri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28132; Resjo S, 1999, BIOCHEM J, V341, P839, DOI 10.1042/0264-6021:3410839; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roskoski R, 2012, BIOCHEM BIOPH RES CO, V417, P5, DOI 10.1016/j.bbrc.2011.11.145; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Serra-Nedelec AD, 2012, P NATL ACAD SCI USA, V109, P4257, DOI 10.1073/pnas.1119803109; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Srivastava N, 2011, J IMMUNOL, V186, P5863, DOI 10.4049/jimmunol.1003957; van den Maagdenberg AMJM, 1999, EUR J NEUROSCI, V11, P3832, DOI 10.1046/j.1460-9568.1999.00802.x; Vogt A, 2005, J BIOL CHEM, V280, P19078, DOI 10.1074/jbc.M501467200; Vogt A, 2003, CHEM BIOL, V10, P733, DOI 10.1016/S1074-5521(03)00170-4; Vogt A, 2008, MOL CANCER THER, V7, P330, DOI 10.1158/1535-7163.MCT-07-2165; Woods DC, 2006, ENDOCRINOLOGY, V147, P4931, DOI 10.1210/en.2006-0194; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	80	31	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19701	19712		10.1074/jbc.M116.733972	http://dx.doi.org/10.1074/jbc.M116.733972			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27422819	Green Published, hybrid			2022-12-28	WOS:000383242800042
J	Atwood, BL; Woolnough, JL; Lefevre, GM; Ribeiro, MS; Felsenfeld, G; Giles, KE				Atwood, Blake L.; Woolnough, Jessica L.; Lefevre, Gaelle M.; Ribeiro, Mariana Saint Just; Felsenfeld, Gary; Giles, Keith E.			Human Argonaute 2 Is Tethered to Ribosomal RNA through MicroRNA Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; ChIP-sequencing (ChIP-seq); Dicer; microRNA (miRNA); ribosomal ribonucleic acid (rRNA) (ribosomal RNA); miRNA; par-clip; rRNA	HUMAN-CELLS; GENE-EXPRESSION; BINDING-SITES; POLYMERASE I; PAR-CLIP; TARGET; NUCLEOLUS; PROTEIN; HETEROCHROMATIN; DICER	The primary role of the RNAi machinery is to promote mRNA degradation within the cytoplasm in a microRNA-dependent manner. However, both Dicer and the Argonaute protein family have expanded roles in gene regulation within the nucleus. To further our understanding of this role, we have identified chromatin binding sites for AGO2 throughout the 45S region of the human rRNA gene. The location of these sites was mirrored by the positions of AGO2 cross-linking sites identified via PAR-CLIP-seq. AGO2 binding to the rRNA within the nucleus was confirmed by RNA immunoprecipitation and quantitative-PCR. To explore a possible mechanism by which AGO2 could be recruited to the rRNA, we identified 1174 regions within the 45S rRNA transcript that have the ability to form a perfect duplex with position 2-6 (seed sequence) of each microRNA expressed in HEK293T cells. Of these potential AGO2 binding sites, 479 occurred within experimentally verified AGO2-rRNA cross-linking sites. The ability of AGO2 to cross-link to rRNA was almost completely lost in a DICER knock-out cell line. The transfection of miR-92a-2-3p into the noDICE cell line facilitated AGO2 cross-linking at a region of the rRNA that has a perfect seed match at positions 3-8, including a single G-U base pair. Knockdown of AGO2 within HEK293T cells causes a slight, but statistically significant increase in the overall rRNA synthesis rate but did not impact the ratio of processing intermediates or the recruitment of the Pol I transcription factor UBTF.	[Atwood, Blake L.; Woolnough, Jessica L.; Ribeiro, Mariana Saint Just; Giles, Keith E.] Univ Alabama Birmingham, UAB Stem Cell Inst, Dept Biochem & Mol Genet, Birmingham, AL 35209 USA; [Lefevre, Gaelle M.; Felsenfeld, Gary] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Giles, KE (corresponding author), Univ Alabama Birmingham, UAB Stem Cell Inst, Dept Biochem & Mol Genet, Birmingham, AL 35209 USA.	kegiles@uab.edu		Makofske, Jessica/0000-0002-6547-6451	National Institutes of Health, NIDDK Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health, NIDDK Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allo M, 2014, P NATL ACAD SCI USA, V111, P15622, DOI 10.1073/pnas.1416858111; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Ameyar-Zazoua M, 2012, NAT STRUCT MOL BIOL, V19, P998, DOI 10.1038/nsmb.2373; [Anonymous], 2014, Cancer Discov, V4, pOF5, DOI 10.1158/2159-8290.CD-NB2014-154; Bai BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107519; Bai BY, 2014, FEBS OPEN BIO, V4, P441, DOI 10.1016/j.fob.2014.04.010; Bailey T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003326; Bogerd HP, 2014, RNA, V20, P923, DOI 10.1261/rna.044545.114; Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Giles KE, 2010, NAT CELL BIOL, V12, P94, DOI 10.1038/ncb2010; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Haddach M, 2012, ACS MED CHEM LETT, V3, P602, DOI 10.1021/ml300110s; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hein N, 2013, TRENDS MOL MED, V19, P643, DOI 10.1016/j.molmed.2013.07.005; Huang V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003821; Ierusalimsky VN, 2016, BRAIN RES, V1633, P139, DOI 10.1016/j.brainres.2015.12.049; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Joseph TT, 2012, PROTEINS, V80, P1283, DOI 10.1002/prot.24025; Kanellopoulou C, 2009, P NATL ACAD SCI USA, V106, P1122, DOI 10.1073/pnas.0812210106; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Klinghoffer RA, 2010, RNA, V16, P879, DOI 10.1261/rna.1977810; KRAMER B, 1980, J ANAT, V130, P809; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Li ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070869; Liang XH, 2011, NUCLEIC ACIDS RES, V39, P4875, DOI 10.1093/nar/gkr076; MCELHONE MJ, 1971, BIOCHEM J, V125, P821, DOI 10.1042/bj1250821; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pickering BF, 2011, J BIOL CHEM, V286, P44095, DOI 10.1074/jbc.M111.265439; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roberts TC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.40; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Sudbery I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-175; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Woolnough JL, 2015, MOL CELL BIOL, V35, P2278, DOI 10.1128/MCB.00076-15; Yang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4818; Yilmazel B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-192; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; ZATSEPINA OV, 1993, CHROMOSOMA, V102, P599, DOI 10.1007/BF00352307; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17919	17928		10.1074/jbc.M116.725051	http://dx.doi.org/10.1074/jbc.M116.725051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27288410	hybrid, Green Published			2022-12-28	WOS:000383241300035
J	Hamlin, AN; Basford, JE; Jaeschke, A; Hui, DY				Hamlin, Allyson N.; Basford, Joshua E.; Jaeschke, Anja; Hui, David Y.			LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-1; MOLECULAR-MECHANISMS; VASCULAR WALL; FATTY-ACIDS; AUTOPHAGY; APOPTOSIS; METABOLISM; DISEASE; STORAGE; GENE	LRP1 (LDL receptor-related protein-1) is a ubiquitous receptor with both cell signaling and ligand endocytosis properties. In the liver, LRP1 serves as a chylomicron remnant receptor and also participates in the transport of extracellular cathepsin D to the lysosome for prosaposin activation. The current study showed that in comparison with wild type mice, hepatocyte-specific LRP1 knock-out (hLrp1(-/-)) mice were more susceptible to fasting-induced lipid accumulation in the liver. Primary hepatocytes isolated from hLrp1(-/-) mice also accumulated more intracellular lipids and experienced higher levels of endoplasmic reticulum (ER) stress after palmitate treatment compared with similarly treated hLrp1(+/+) hepatocytes. Palmitate-treated hLrp1(-/-) hepatocytes displayed similar LC3-II levels, but the levels of p62 were elevated in comparison with palmitate-treated hLrp1(+/+) hepatocytes, suggesting that the elevated lipid accumulation in LRP1-defective hepatocytes was not due to defects in autophagosome formation but was due to impairment of lipophagic lipid hydrolysis in the lysosome. Additional studies showed increased palmitate-induced oxidative stress, mitochondrial and lysosomal permeability, and cell death in hLrp1(-/-) hepatocytes. Importantly, the elevated cell death and ER stress observed in hLrp1(-/-) hepatocytes were abrogated by E64D treatment, whereas inhibiting ER stress diminished cell death but not lysosomal permeabilization. Taken together, these results documented that LRP1 deficiency in hepatocytes promotes lipid accumulation and lipotoxicity through lysosomal-mitochondrial permeabilization and ER stress that ultimately result in cell death. Hence, LRP1 dysfunction may be a major risk factor in fatty liver disease progression.	[Hamlin, Allyson N.] Univ Cincinnati, Coll Med, Metab Dis Res Ctr, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45237 USA; [Basford, Joshua E.; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Coll Med, Metab Dis Res Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Metab Dis Res Ctr, Dept Pathol ML0507, 2120 E Galbraith Rd, Cincinnati, OH 45267 USA.	huidy@ucmail.uc.edu			National Institutes of Health [RO1 DK074932]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1 DK074932 (to D. Y. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basford J. E., 2009, THROMB VASC BIOL, V29, P1772; Basford JE, 2011, J BIOL CHEM, V286, P13079, DOI 10.1074/jbc.M111.229369; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cai N, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-28; Caldwell Stephen H, 2004, Clin Liver Dis, V8, P595, DOI 10.1016/j.cld.2004.04.009; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Chatterjee TK, 2014, DIABETES, V63, P176, DOI 10.2337/db13-1148; Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009; Day CP, 2011, CLIN MED, V11, P176, DOI 10.7861/clinmedicine.11-2-176; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dong HQ, 2011, TRENDS ENDOCRIN MET, V22, P234, DOI 10.1016/j.tem.2011.02.003; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hu L, 2006, ARTERIOSCL THROM VAS, V26, P2710, DOI 10.1161/01.ATV.0000249641.96896.e6; Huang X, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-22; Kneeman JM, 2012, THER ADV GASTROENTER, V5, P199, DOI 10.1177/1756283X11430859; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Moller L, 2008, CLIN SCI, V114, P547, DOI 10.1042/CS20070217; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; ROBBINS E, 1963, J CELL BIOL, V18, P237, DOI 10.1083/jcb.18.2.237; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Steinberg D, 1963, Biochem Soc Symp, V24, P111; Sun Y, 2013, AUTOPHAGY, V9, P1115, DOI 10.4161/auto.24919; Tatti M, 2013, AUTOPHAGY, V9, P241, DOI 10.4161/auto.22557; Tatti M, 2012, HUM MOL GENET, V21, P5159, DOI 10.1093/hmg/dds367; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Wang YJ, 2010, HEPATOLOGY, V52, P266, DOI 10.1002/hep.23645; Yahiro K, 2012, J BIOL CHEM, V287, P31104, DOI 10.1074/jbc.M112.387498; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	41	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16610	16619		10.1074/jbc.M116.717744	http://dx.doi.org/10.1074/jbc.M116.717744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27317662	hybrid, Green Published			2022-12-28	WOS:000380826700020
J	Li, TZ; Tong, X; Yang, Q; Giddens, JP; Wang, LX				Li, Tiezheng; Tong, Xin; Yang, Qiang; Giddens, John P.; Wang, Lai-Xi			Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; EFFICIENT CHEMOENZYMATIC SYNTHESIS; DEPENDENT CELLULAR CYTOTOXICITY; MONOCLONAL-ANTIBODY; ANTIINFLAMMATORY ACTIVITY; THERAPEUTIC ACTIVITY; IGG FC; IMMUNOGLOBULIN-G; GLYCANS; GLYCOPROTEINS	Glycosylation can exert a profound impact on the structures and biological functions of antibodies. Glycosylation remodeling using the endoglycosidase-catalyzed deglycosylation and transglycosylation approach is emerging as a promising platform to produce homogeneous glycoforms of antibodies, but the broad application of this method will require the availability of highly efficient glycosynthase mutants. We describe in this paper a systematic site-directed mutagenesis of an endoglycosidase from Streptococcus pyogenes of serotype M49 (Endo-S2) and the evaluation of the resulting mutants for their hydrolysis and transglycosylation activities. We found that mutations at the Asp-184 residue gave mutants that demonstrated significantly different properties, some possessed potent transglycosylation activity with diminished hydrolysis activity but others did not, which would be otherwise difficult to predict without the comparative study. In contrast to the previously reported Endo-S mutants that are limited to action on complex type N-glycans, the Endo-S2 glycosynthases described here, including D184M and D184Q, were found to have remarkably relaxed substrate specificity and were capable of transferring three major types (complex, high-mannose, and hybrid type) of N-glycans for antibody glycosylation remodeling. In addition, the Endo-S2 glycosynthase mutants were found to be much more active in general than the Endo-S mutants for transglycosylation. The usefulness of these Endo-S2 glycosynthase mutants was exemplified by an efficient glycosylation remodeling of two therapeutic monoclonal antibodies, rituximab and trastuzumab (Herceptin).	[Li, Tiezheng; Tong, Xin; Yang, Qiang; Giddens, John P.; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Wang, LX (corresponding author), 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA.	wang518@umd.edu	Wang, Lai-Xi/E-8790-2019; Wang, Lai-Xi/E-8755-2019; Tong, Xin/AAP-7528-2020; Wang, Xin/GYU-1129-2022; wang, xiao/HGB-7081-2022; wang, xl/Y-8251-2019; Wang, Xin/AAN-8435-2021	Wang, Lai-Xi/0000-0003-4293-5819; wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Giddens, John/0000-0001-8123-8704	National Institutes of Health [R01 GM080374, R01 GM096973]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096973, R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM080374 and R01 GM096973 (to L. X. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Aggarwal SR, 2014, NAT BIOTECHNOL, V32, P323, DOI 10.1038/nbt.2864; Aggarwal S, 2012, NAT BIOTECHNOL, V30, P1191, DOI 10.1038/nbt.2437; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Giddens JP, 2016, J BIOL CHEM, V291, P9356, DOI 10.1074/jbc.M116.721597; Giddens JP, 2015, METHODS MOL BIOL, V1321, P375, DOI 10.1007/978-1-4939-2760-9_25; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2010, CHEMBIOCHEM, V11, P1350, DOI 10.1002/cbic.201000242; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Illidge T, 2014, EXPERT OPIN BIOL TH, V14, P1507, DOI 10.1517/14712598.2014.948414; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kurogochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132848; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Lin CW, 2015, P NATL ACAD SCI USA, V112, P10611, DOI 10.1073/pnas.1513456112; Liu RP, 2016, MABS-AUSTIN, V8, P340, DOI 10.1080/19420862.2015.1113361; Le NPL, 2016, BBA-GEN SUBJECTS, V1860, P1655, DOI 10.1016/j.bbagen.2016.04.016; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Park JE, 2002, J BIOCHEM MOL BIOL, V35, P330; Parsons TB, 2016, ANGEW CHEM INT EDIT, V55, P2361, DOI 10.1002/anie.201508723; Quast I, 2015, J CLIN INVEST, V125, P4160, DOI 10.1172/JCI82695; Rodriguez-Diaz J, 2011, APPL ENVIRON MICROB, V77, P703, DOI 10.1128/AEM.01906-10; Saribas AS, 2007, BIOCHEM BIOPH RES CO, V362, P381, DOI 10.1016/j.bbrc.2007.07.199; Schwab I, 2014, EUR J IMMUNOL, V44, P1444, DOI 10.1002/eji.201344230; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Sjogren J, 2015, GLYCOBIOLOGY, V25, P1053, DOI 10.1093/glycob/cwv047; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; Stanley P, 2005, GLYCOBIOLOGY, V15, P43, DOI 10.1093/glycob/cwh136; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; van de Bovenkamp FS, 2016, J IMMUNOL, V196, P1435, DOI 10.4049/jimmunol.1502136; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE1297, DOI 10.1073/pnas.1422481112; Wei YD, 2008, BIOCHEMISTRY-US, V47, P10294, DOI 10.1021/bi800874y; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yu H, 2006, ANGEW CHEM INT EDIT, V45, P3938, DOI 10.1002/anie.200600572; Zhou Q, 2008, BIOTECHNOL BIOENG, V99, P652, DOI 10.1002/bit.21598; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	46	76	83	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16508	16518		10.1074/jbc.M116.738765	http://dx.doi.org/10.1074/jbc.M116.738765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27288408	Green Published, hybrid			2022-12-28	WOS:000380826700011
J	Klaus, M; Ostrowski, MP; Austerjost, J; Robbins, T; Lowry, B; Cane, DE; Khosla, C				Klaus, Maja; Ostrowski, Matthew P.; Austerjost, Jonas; Robbins, Thomas; Lowry, Brian; Cane, David E.; Khosla, Chaitan			Protein-Protein Interactions, Not Substrate Recognition, Dominate the Turnover of Chimeric Assembly Line Polyketide Synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							6-DEOXYERYTHRONOLIDE B SYNTHASE; BIOSYNTHESIS; DOMAINS; MODULES; DESIGN; SPECIFICITY; MECHANISM; RAPAMYCIN; GENES	The potential for recombining intact polyketide synthase (PKS) modules has been extensively explored. Both enzyme-substrate and protein-protein interactions influence chimeric PKS activity, but their relative contributions are unclear. We now address this issue by studying a library of 11 bimodular and 8 trimodular chimeric PKSs harboring modules from the erythromycin, rifamycin, and rapamycin synthases. Although many chimeras yielded detectable products, nearly all had specific activities below 10% of the reference natural PKSs. Analysis of selected bimodular chimeras, each with the same upstream module, revealed that turnover correlated with the efficiency of intermodular chain translocation. Mutation of the acyl carrier protein (ACP) domain of the upstream module in one chimera at a residue predicted to influence ketosynthase-ACP recognition led to improved turnover. In contrast, replacement of the ketoreductase domain of the upstream module by a paralog that produced the enantiomeric ACP-bound diketide caused no changes in processing rates for each of six heterologous downstream modules compared with those of the native diketide. Taken together, these results demonstrate that protein-protein interactions play a larger role than enzyme-substrate recognition in the evolution or design of catalytically efficient chimeric PKSs.	[Klaus, Maja; Ostrowski, Matthew P.; Austerjost, Jonas; Robbins, Thomas; Lowry, Brian; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Klaus, Maja; Ostrowski, Matthew P.; Austerjost, Jonas; Robbins, Thomas; Lowry, Brian; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Klaus, Maja; Ostrowski, Matthew P.; Austerjost, Jonas; Robbins, Thomas; Lowry, Brian; Khosla, Chaitan] Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA; [Cane, David E.] Brown Univ, Dept Chem, Providence, RI 02912 USA	Stanford University; Stanford University; Stanford University; Brown University	Khosla, C (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA.	khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X	National Institutes of Health [GM 087934, GM 022172]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087934, R01GM022172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM 087934 (to C. K.) and GM 022172 (to D. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buchholz TJ, 2009, ACS CHEM BIOL, V4, P41, DOI 10.1021/cb8002607; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Hartung IV, 2005, J AM CHEM SOC, V127, P11202, DOI 10.1021/ja051430y; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; Jacobsen JR, 1998, BIOCHEMISTRY-US, V37, P4928, DOI 10.1021/bi9729920; Kapur S, 2012, P NATL ACAD SCI USA, V109, P4110, DOI 10.1073/pnas.1118734109; Kapur S, 2010, P NATL ACAD SCI USA, V107, P22066, DOI 10.1073/pnas.1014081107; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Khosla C, 2014, BIOCHEMISTRY-US, V53, P2875, DOI 10.1021/bi500290t; Lowry B, 2016, ACS CENTRAL SCI, V2, P14, DOI 10.1021/acscentsci.5b00321; Lowry B, 2013, J AM CHEM SOC, V135, P16809, DOI 10.1021/ja409048k; McDaniel R, 1997, CHEM BIOL, V4, P667, DOI 10.1016/S1074-5521(97)90222-2; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Menzella HG, 2007, CHEM BIOL, V14, P143, DOI 10.1016/j.chembiol.2006.12.002; Ostrowski MP, 2016, J ANTIBIOT, V69, P507, DOI 10.1038/ja.2016.41; Park SR, 2010, J ANTIBIOT, V63, P434, DOI 10.1038/ja.2010.71; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Ranganathan A, 1999, CHEM BIOL, V6, P731, DOI 10.1016/S1074-5521(00)80020-4; Robbins T, 2016, CURR OPIN STRUC BIOL, V41, P10, DOI 10.1016/j.sbi.2016.05.009; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2326, DOI 10.1021/bi002463n; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Watanabe K, 2003, J BIOL CHEM, V278, P42020, DOI 10.1074/jbc.M305339200; Wu N, 2001, J AM CHEM SOC, V123, P6465, DOI 10.1021/ja010219t; You YO, 2013, J AM CHEM SOC, V135, P7406, DOI 10.1021/ja4014776; Yu TW, 1999, P NATL ACAD SCI USA, V96, P9051, DOI 10.1073/pnas.96.16.9051	28	38	39	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16404	16415		10.1074/jbc.M116.730531	http://dx.doi.org/10.1074/jbc.M116.730531			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246853	Green Published, hybrid			2022-12-28	WOS:000380585400042
J	Rego, S; Heal, TJ; Pidwill, GR; Till, M; Robson, A; Lamont, RJ; Sessions, RB; Jenkinson, HF; Race, PR; Nobbs, AH				Rego, Sara; Heal, Timothy J.; Pidwill, Grace R.; Till, Marisa; Robson, Alice; Lamont, Richard J.; Sessions, Richard B.; Jenkinson, Howard F.; Race, Paul R.; Nobbs, Angela H.			Structural and Functional Analysis of Cell Wall-anchored Polypeptide Adhesin BspA in Streptococcus agalactiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; C-TERMINAL DOMAIN; GROUP-A STREPTOCOCCUS; RICH REPEAT PROTEINS; MUTANS ANTIGEN-I/II; CRYSTAL-STRUCTURE; BIOFILM FORMATION; CANDIDA-ALBICANS; PORPHYROMONAS-GINGIVALIS	Streptococcus agalactiae (group B Streptococcus, GBS) is the predominant cause of early-onset infectious disease in neonates and is responsible for life-threatening infections in elderly and immunocompromised individuals. Clinical manifestations of GBS infection include sepsis, pneumonia, and meningitis. Here, we describe BspA, a deviant antigen I/II family polypeptide that confers adhesive properties linked to pathogenesis in GBS. Heterologous expression of BspA on the surface of the non-adherent bacterium Lactococcus lactis confers adherence to scavenger receptor gp340, human vaginal epithelium, and to the fungus Candida albicans. Complementary crystallographic and biophysical characterization of BspA reveal a novel beta-sandwich adhesion domain and unique asparagine-dependent super-helical stalk. Collectively, these findings establish a new bacterial adhesin structure that has in effect been hijacked by a pathogenic Streptococcus species to provide competitive advantage in human mucosal infections.	[Rego, Sara; Pidwill, Grace R.; Jenkinson, Howard F.; Nobbs, Angela H.] Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England; [Rego, Sara; Heal, Timothy J.; Till, Marisa; Robson, Alice; Sessions, Richard B.; Race, Paul R.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Heal, Timothy J.] Univ Bristol, Bristol Ctr Funct Nanomat, Bristol BS8 1TL, Avon, England; [Till, Marisa; Sessions, Richard B.; Race, Paul R.] Univ Bristol, BrisSynBio Synthet Biol Res Ctr, Bristol BS8 1TQ, Avon, England; [Lamont, Richard J.] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA	University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Louisville	Nobbs, AH (corresponding author), Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.; Race, PR (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	paul.race@bristol.ac.uk	Jenkinson, Howard/AAD-9282-2022; Jenkinson, Howard/ABI-1842-2020; Nobbs, Angela/AAS-3926-2020	Pidwill, Grace/0000-0002-5193-3631; Robson, Alice/0000-0003-3338-2626; Jenkinson, Howard/0000-0002-9195-7945; Sessions, Richard/0000-0003-0320-0895; Nobbs, Angela/0000-0003-3813-4410	Biotechnology and Biological Sciences Research Council Grant [BB/I006478/I]; National Institutes of Health [DE016690, DE012505]; Royal Society University Research Fellowship Award [UF080534]; BBSRC [BB/I006478/1, BB/L01386X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016690, R01DE012505] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I006478/1, BB/L01386X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society University Research Fellowship Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in part by Biotechnology and Biological Sciences Research Council Grant BB/I006478/I (to P. R. R.), National Institutes of Health Grants DE016690 (to H. F. J. and R. J. L.) and DE012505 (to R. J. L.), and Royal Society University Research Fellowship Award UF080534 (to P. R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Al-Okla S, 1999, CELL MICROBIOL, V1, P157, DOI 10.1046/j.1462-5822.1999.00016.x; Back CR, 2015, MOL ORAL MICROBIOL, V30, P411, DOI 10.1111/omi.12106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bamford CV, 2009, INFECT IMMUN, V77, P3696, DOI 10.1128/IAI.00438-09; Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayo M., 2002, International Microbiology, V5, P87, DOI 10.1007/s10123-002-0064-1; Berner R, 2002, CURR OPIN INFECT DIS, V15, P307, DOI 10.1097/00001432-200206000-00015; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; Brittan JL, 2015, MICROBES INFECT, V17, P360, DOI 10.1016/j.micinf.2014.12.013; Brochet M, 2008, J BACTERIOL, V190, P6913, DOI 10.1128/JB.00824-08; Chuzeville S, 2015, MICROB PATHOGENESIS, V88, P1, DOI 10.1016/j.micpath.2015.07.018; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Cools P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148052; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Egland PG, 2001, INFECT IMMUN, V69, P7512, DOI 10.1128/IAI.69.12.7512-7516.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; Forsgren N, 2009, PROTEIN SCI, V18, P1896, DOI 10.1002/pro.200; Franklin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062433; Giglio KM, 2013, J BACTERIOL, V195, P3277, DOI 10.1128/JB.00374-13; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hall M, 2014, FEBS OPEN BIO, V4, P283, DOI 10.1016/j.fob.2014.02.012; Heim KP, 2014, P NATL ACAD SCI USA, V111, P15746, DOI 10.1073/pnas.1413018111; Hirt H, 2000, J BACTERIOL, V182, P2299, DOI 10.1128/JB.182.8.2299-2306.2000; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; JENKINSON HF, 1990, INFECT IMMUN, V58, P1429, DOI 10.1128/IAI.58.5.1429-1436.1990; JENKINSON HF, 1990, INFECT IMMUN, V58, P3689, DOI 10.1128/IAI.58.11.3689-3697.1990; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelly CG, 2000, EXPERT OPIN INV DRUG, V9, P1711, DOI 10.1517/13543784.9.8.1711; KOLENBRANDER PE, 1993, FASEB J, V7, P406, DOI 10.1096/fasebj.7.5.8462782; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Ligtenberg AJM, 2007, BIOL CHEM, V388, P1275, DOI 10.1515/BC.2007.158; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Maddocks SE, 2011, MOL MICROBIOL, V81, P1034, DOI 10.1111/j.1365-2958.2011.07749.x; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIntosh-Smith S, 2015, INT J HIGH PERFORM C, V29, P119, DOI 10.1177/1094342014528252; Monif G R, 1998, Infect Dis Obstet Gynecol, V6, P52, DOI 10.1155/S1064744998000131; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nobbs AH, 2007, CELL MICROBIOL, V9, P65, DOI 10.1111/j.1462-5822.2006.00768.x; Nylander A, 2011, ACTA CRYSTALLOGR F, V67, P23, DOI 10.1107/S174430911004443X; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Purushotham S, 2014, J BIOL CHEM, V289, P21877, DOI 10.1074/jbc.M114.565507; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Silverman RJ, 2010, INFECT IMMUN, V78, P4644, DOI 10.1128/IAI.00685-10; Sitkiewicz I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-65; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Wang NY, 2014, J INFECT DIS, V210, P982, DOI 10.1093/infdis/jiu151; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06	70	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15985	16000		10.1074/jbc.M116.726562	http://dx.doi.org/10.1074/jbc.M116.726562			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27311712	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000380585400006
J	Koppenol-Raab, M; Harwig, MC; Posey, AE; Egner, JM; MacKenzie, KR; Hill, RB				Koppenol-Raab, Marijke; Harwig, Megan Cleland; Posey, Ammon E.; Egner, John M.; MacKenzie, Kevin R.; Hill, R. Blake			A Targeted Mutation Identified through pK(a) Measurements Indicates a Postrecruitment Role for Fis1 in Yeast Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						confocal microscopy; mitochondria; nuclear magnetic resonance (NMR); protein assembly; protein-protein interaction; structural model; macromolecular machine; mitochondrial dynamics; pKa measurements; tetratricopeptide repeat (TPR) domains	PROTEIN-PROTEIN INTERACTIONS; WD REPEAT PROTEIN; SACCHAROMYCES-CEREVISIAE; MEMBRANE RECRUITMENT; RECOGNITION SITES; DRP1 RECRUITMENT; DIVISION; DYNAMICS; DNM1P; ADAPTER	The tail-anchored protein Fis1 is implicated as a passive tether in yeast mitochondrial fission. We probed the functional role of Fis1 Glu-78, whose elevated side chain pK(a) suggests participation in protein interactions. Fis1 binds partners Mdv1 or Dnm1 tightly, but mutation E78A weakens Fis1 interaction with Mdv1, alters mitochondrial morphology, and abolishes fission in a growth assay. In fis1 rescue experiments, Fis1-E78A causes a novel localization pattern in which Dnm1 uniformly coats the mitochondria. By contrast, Fis1-E78A at lower expression levels recruits Dnm1 into mitochondrial punctate structures but fails to support normal fission. Thus, Fis1 makes multiple interactions that support Dnm1 puncta formation and may be essential after this step, supporting a revised model for assembly of the mitochondrial fission machinery. The insights gained by mutating a residue with a perturbed pK(a) suggest that side chain pK(a) values inferred from routine NMR sample pH optimization could provide useful leads for functional investigations.	[Koppenol-Raab, Marijke; Posey, Ammon E.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Posey, Ammon E.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Harwig, Megan Cleland; Egner, John M.; Hill, R. Blake] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [MacKenzie, Kevin R.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Koppenol-Raab, Marijke] NIAID, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Posey, Ammon E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Johns Hopkins University; Johns Hopkins University; Medical College of Wisconsin; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL)	Hill, RB (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rbhill@mcw.edu		Hill, Blake/0000-0001-6228-3905; Harwig, Megan/0000-0003-2140-5739	National Institutes of Health [R01 GM067180]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM067180. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Bui HT, 2012, J CELL BIOL, V199, P613, DOI 10.1083/jcb.201207079; Castaneda CA, 2009, PROTEINS, V77, P570, DOI 10.1002/prot.22470; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; DuBoff B, 2013, TRENDS NEUROSCI, V36, P325, DOI 10.1016/j.tins.2013.03.002; Farrell D, 2010, PROTEINS, V78, P843, DOI 10.1002/prot.22611; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Guo Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053523; Hermann GJ, 1998, ANNU REV CELL DEV BI, V14, P265, DOI 10.1146/annurev.cellbio.14.1.265; Hill RB, 2000, J AM CHEM SOC, V122, P746, DOI 10.1021/ja9919332; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Lees JPB, 2012, J MOL BIOL, V423, P143, DOI 10.1016/j.jmb.2012.06.042; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Norel R, 2001, PROTEIN SCI, V10, P2147, DOI 10.1110/ps.12901; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211; Otera Hidenori, 2011, Small GTPases, V2, P167; Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Picton LK, 2009, BIOCHEMISTRY-US, V48, P6598, DOI 10.1021/bi802221h; Pierce BD, 2009, YEAST, V26, P349, DOI 10.1002/yea.1667; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rines Daniel R, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.top065482; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHALLER W, 1995, BIOCHEMISTRY-US, V34, P4714, DOI 10.1021/bi00014a028; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shaw JD, 2003, TRAFFIC, V4, P479, DOI 10.1034/j.1600-0854.2003.t01-1-00106.x; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Tooley JE, 2011, ACTA CRYSTALLOGR F, V67, P1310, DOI 10.1107/S1744309111029368; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Wells RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021384; Whitworth K, 2014, TRAFFIC, V15, P43, DOI 10.1111/tra.12125; Wilkens SJ, 1998, J AM CHEM SOC, V120, P4806, DOI 10.1021/ja973489d; Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zhang Y, 2012, J BIOL CHEM, V287, P9855, DOI 10.1074/jbc.M111.329359; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	72	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20329	20344		10.1074/jbc.M116.724005	http://dx.doi.org/10.1074/jbc.M116.724005			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27496949	Green Published, hybrid			2022-12-28	WOS:000384574800005
J	Nagano, S; Scheerer, P; Zubow, K; Michael, N; Inomata, K; Lamparter, T; Krauss, N				Nagano, Soshichiro; Scheerer, Patrick; Zubow, Kristina; Michael, Norbert; Inomata, Katsuhiko; Lamparter, Tilman; Krauss, Norbert			The Crystal Structures of the N-terminal Photosensory Core Module of Agrobacterium Phytochrome Agp1 as Parallel and Anti-parallel Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; crystal structure; histidine kinase; photoreceptor; signal transduction; tertiary structure; Agrobacterium; phytochrome; quaternary structure	RATIONAL PROTEIN CRYSTALLIZATION; INDUCED CONFORMATIONAL-CHANGES; CHROMOPHORE-BINDING DOMAIN; HISTIDINE KINASES; BACTERIAL PHYTOCHROMES; SIGNALING MECHANISM; SENSORY MODULE; LIGHT; BACTERIOPHYTOCHROME; PHOTOCONVERSION	Agp1 is a canonical biliverdin-binding bacteriophytochrome from the soil bacterium Agrobacterium fabrum that acts as a light-regulated histidine kinase. Crystal structures of the photosensory core modules (PCMs) of homologous phytochromes have provided a consistent picture of the structural changes that these proteins undergo during photoconversion between the parent red light-absorbing state (Pr) and the far-red light-absorbing state (Pfr). These changes include secondary structure rearrangements in the so-called tongue of the phytochrome-specific (PHY) domain and structural rearrangements within the long -helix that connects the cGMP-specific phosphodiesterase, adenylyl cyclase, and FhlA (GAF) and the PHY domains. We present the crystal structures of the PCM of Agp1 at 2.70 angstrom resolution and of a surface-engineered mutant of this PCM at 1.85 angstrom resolution in the dark-adapted Pr states. Whereas in the mutant structure the dimer subunits are in anti-parallel orientation, the wild-type structure contains parallel subunits. The relative orientations between the PAS-GAF bidomain and the PHY domain are different in the two structures, due to movement involving two hinge regions in the GAF-PHY connecting -helix and the tongue, indicating pronounced structural flexibility that may give rise to a dynamic Pr state. The resolution of the mutant structure enabled us to detect a sterically strained conformation of the chromophore at ring A that we attribute to the tight interaction with Pro-461 of the conserved PRXSF motif in the tongue. Based on this observation and on data from mutants where residues in the tongue region were replaced by alanine, we discuss the crucial roles of those residues in Pr-to-Pfr photoconversion.	[Nagano, Soshichiro; Zubow, Kristina; Krauss, Norbert] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Scheerer, Patrick] Charite, Inst Med Phys & Biophys CC2, Grp Prot Xray Crystallog & Signal Transduct, Charitepl 1, D-10117 Berlin, Germany; [Michael, Norbert] Tech Univ Berlin, Inst Chem, Sekretariat PC 14,Str 17 Juni 135, D-10623 Berlin, Germany; [Inomata, Katsuhiko] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa 9201192, Japan; [Lamparter, Tilman; Krauss, Norbert] Karlsruhe Inst Technol, Inst Bot, Kaiserstr 2, D-76131 Karlsruhe, Germany; [Nagano, Soshichiro] Univ Giessen, Inst Pflanzen Physiol, Senckenbergstr 3, D-35390 Giessen, Germany	University of London; Queen Mary University London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin; Kanazawa University; Helmholtz Association; Karlsruhe Institute of Technology; Justus Liebig University Giessen	Krauss, N (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.; Krauss, N (corresponding author), Karlsruhe Inst Technol, Inst Bot, Kaiserstr 2, D-76131 Karlsruhe, Germany.	norbert.krauss@kit.edu	Lamparter, Tilman/E-4421-2013	Lamparter, Tilman/0000-0003-4327-9737; Scheerer, Patrick/0000-0001-5028-2075; Krauss, Norbert/0000-0002-7128-4632	Deutsche Forschungsgemeinschaft [SFB498-B2, SFB1078-B6]; Cluster of Excellence "Unifying Concepts in Catalysis" [D3/E3-1]; Queen Mary University of London; University of London Central Research Fund AR/CRF/B	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Unifying Concepts in Catalysis"(German Research Foundation (DFG)); Queen Mary University of London; University of London Central Research Fund AR/CRF/B	This work was supported by Deutsche Forschungsgemeinschaft Research Grants SFB498-B2 (to T. L. and N. K.) and SFB1078-B6 (to P. S.), Cluster of Excellence "Unifying Concepts in Catalysis" Research Field D3/E3-1 (to P. S.), a Queen Mary University of London postgraduate research studentship (to S. N.), and by University of London Central Research Fund AR/CRF/B (to S. N.). The authors declare that they have no conflict of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Ashenberg O, 2013, J MOL BIOL, V425, P1198, DOI 10.1016/j.jmb.2013.01.011; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Bai YN, 2016, J PHOTOCH PHOTOBIO B, V161, P192, DOI 10.1016/j.jphotobiol.2016.05.014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellini D, 2012, STRUCTURE, V20, P1436, DOI 10.1016/j.str.2012.06.002; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Borucki B, 2009, J BIOL CHEM, V284, P26005, DOI 10.1074/jbc.M109.049056; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Casino P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4258; CHOU KC, 1984, J AM CHEM SOC, V106, P3161, DOI 10.1021/ja00323a017; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; DeLano W.L, PYMOL MOL GRAPHICS S; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Duanmu DQ, 2014, P NATL ACAD SCI USA, V111, P15827, DOI 10.1073/pnas.1416751111; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escobar FV, 2015, NAT CHEM, V7, P423, DOI [10.1038/NCHEM.2225, 10.1038/nchem.2225]; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee HS, 2007, PROTEIN J, V26, P556, DOI 10.1007/s10930-007-9097-9; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piwowarski P, 2010, CHEMPHYSCHEM, V11, P1207, DOI 10.1002/cphc.200901008; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rudiger W., 1986, Photomorphogenesis in plants, P17; Salewski J, 2013, J BIOL CHEM, V288, P16800, DOI 10.1074/jbc.M113.457531; Scheerer P, 2006, J STRUCT BIOL, V153, P97, DOI 10.1016/j.jsb.2005.11.002; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; Singer P, 2016, CHEMPHYSCHEM, V17, P1288, DOI 10.1002/cphc.201600199; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Strauss HM, 2005, FEBS LETT, V579, P3970, DOI 10.1016/j.febslet.2005.06.025; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Terauchi K, 2004, MOL MICROBIOL, V51, P567, DOI 10.1046/j.1365-2958.2003.03853.x; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; Ulijasz AT, 2011, CURR OPIN PLANT BIOL, V14, P498, DOI 10.1016/j.pbi.2011.06.002; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vierstra RD, 2011, TRENDS PLANT SCI, V16, P417, DOI 10.1016/j.tplants.2011.05.011; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2015, STRUCTURE, V23, P1179, DOI 10.1016/j.str.2015.04.022; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yoshihara S, 2006, BIOCHEMISTRY-US, V45, P3775, DOI 10.1021/bi051983l	77	32	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20674	20691		10.1074/jbc.M116.739136	http://dx.doi.org/10.1074/jbc.M116.739136			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27466363	Green Published, hybrid			2022-12-28	WOS:000384574800030
J	Zech, R; Kiontke, S; Mueller, U; Oeckinghaus, A; Kummel, D				Zech, Reinhard; Kiontke, Stephan; Mueller, Uwe; Oeckinghaus, Andrea; Kuemmel, Daniel			Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; protein-protein interaction; signaling; tuberous sclerosis complex (TSC); x-ray crystallography; hamartin; tuberin	TSC1-TSC2 COMPLEX; PATHOLOGICAL MUTATIONS; FUNCTIONAL ASSESSMENT; SWISS-MODEL; PROTEIN; DOMAIN; HAMARTIN; GTPASE; MTORC1; GROWTH	Tuberous sclerosis complex (TSC) is caused by mutations in the TSC1 and TSC2 tumor suppressor genes. The gene products hamartin and tuberin form the TSC complex that acts as GTPase-activating protein for Rheb and negatively regulates the mammalian target of rapamycin complex 1 (mTORC1). Tuberin contains a RapGAP homology domain responsible for inactivation of Rheb, but functions of other protein domains remain elusive. Here we show that the TSC2 N terminus interacts with the TSC1 C terminus to mediate complex formation. The structure of the TSC2 N-terminal domain from Chaetomium thermophilum and a homology model of the human tuberin N terminus are presented. We characterize the molecular requirements for TSC1-TSC2 interactions and analyze pathological point mutations in tuberin. Many mutations are structural and produce improperly folded protein, explaining their effect in pathology, but we identify one point mutant that abrogates complex formation without affecting protein structure. We provide the first structural information on TSC2/tuberin with novel insight into the molecular function.	[Zech, Reinhard; Kiontke, Stephan; Kuemmel, Daniel] Univ Osnabruck, Struct Biol Sect, Biol Chem FB5, D-49076 Osnabruck, Germany; [Mueller, Uwe] Helmholtz Zentrum Berlin Mat & Energie, Macromol Crystallog BESSY MX, D-12489 Berlin, Germany; [Oeckinghaus, Andrea] WWU Munster, Fac Med, Inst Mol Tumor Biol, D-48149 Munster, Germany	University Osnabruck; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Munster	Kummel, D (corresponding author), Univ Osnabruck, Biol Chem FB5, Barbarastr 13, D-49076 Osnabruck, Germany.	daniel.kuemmel@uos.de	Oeckinghaus, Andrea/AAW-9933-2020		Helmholtz-Zentrum Berlin	Helmholtz-Zentrum Berlin(Helmholtz Association)	We are grateful to Saskia Schuback and Nadine Lottmann for excellent technical support and the Ungermann lab for help and suggestions. We thank the staff at Beamline ID23-1 at the European Synchrotron Radiation Facility and BL 14.1 at BESSY II for assistance during data collection, the Helmholtz-Zentrum Berlin for the allocation of synchrotron radiation beamtime and acknowledge the financial support by Helmholtz-Zentrum Berlin.	Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Badri KR, 2013, AM J RESP CRIT CARE, V187, P663, DOI 10.1164/ajrccm.187.6.663; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cabrera M, 2014, J CELL SCI, V127, P1043, DOI 10.1242/jcs.140921; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gai ZC, 2016, J MOL CELL BIOL, V8, P411, DOI 10.1093/jmcb/mjw001; Gridley S, 2006, CELL SIGNAL, V18, P1626, DOI 10.1016/j.cellsig.2006.01.002; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hodges AK, 2001, HUM MOL GENET, V10, P2899, DOI 10.1093/hmg/10.25.2899; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hoogeveen-Westerveld M, 2013, HUM MUTAT, V34, P167, DOI 10.1002/humu.22202; Hoogeveen-Westerveld M, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-18; Hoogeveen-Westerveld M, 2012, HUM MUTAT, V33, P476, DOI 10.1002/humu.22007; Hoogeveen-Westerveld M, 2011, HUM MUTAT, V32, P424, DOI 10.1002/humu.21451; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Lima AJS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093940; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Miyazaki M, 2010, FEBS J, V277, P2180, DOI 10.1111/j.1742-4658.2010.07635.x; Momose S, 2007, BIOCHEM BIOPH RES CO, V356, P693, DOI 10.1016/j.bbrc.2007.03.036; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011; Napolioni V, 2008, CURR GENOMICS, V9, P475, DOI 10.2174/138920208786241243; NELLIST M, 1993, CELL, V75, P1305; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pumroy RA, 2015, STRUCTURE, V23, P374, DOI 10.1016/j.str.2014.11.015; Qin JY, 2016, J BIOL CHEM, V291, P8591, DOI 10.1074/jbc.M115.701870; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; Sun W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3135; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; von Ranke FM, 2015, LUNG, V193, P619, DOI 10.1007/s00408-015-9750-6; Yamashita Y, 2000, AM J MED GENET, V90, P123, DOI 10.1002/(SICI)1096-8628(20000117)90:2<123::AID-AJMG7>3.0.CO;2-L; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	60	16	24	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20008	20020		10.1074/jbc.M116.732446	http://dx.doi.org/10.1074/jbc.M116.732446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27493206	hybrid, Green Published			2022-12-28	WOS:000383243100024
J	Ma, F; Deng, LW; Secrest, P; Shi, LD; Zhao, JE; Gagneux, P				Ma, Fang; Deng, Liwen; Secrest, Patrick; Shi, Linda; Zhao, June; Gagneux, Pascal			A Mouse Model for Dietary Xenosialitis ANTIBODIES TO XENOGLYCAN CAN REDUCE FERTILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; autoimmunity; diet; sialic acid; spermatozoa; N-Glycolylneuraminic acid; anti-carbohydrate antibodies; infertility; xenoglycan	N-GLYCOLYLNEURAMINIC ACID; NONHUMAN SIALIC-ACID; HUMAN XENO-AUTOANTIBODIES; VERTEBRATE AMINO-SUGARS; ANTISPERM ANTIBODIES; MAMMALIAN SPERM; LEUKOCYTIC REACTION; MEAT CONSUMPTION; INFERTILITY; MECHANISM	Humans can incorporate the xenoglycan N-glycolylneuraminic acid (Neu5Gc) from the diet into reproductive tissues and secretions. Most humans also have circulating antibodies specific for this dietary xenoglycan. The potential for inflammation induced by incorporated Neu5Gc and circulating anti-Neu5Gc antibodies, termed xenosialitis, has been discussed as a factor influencing several human diseases. Potential effects of xenosialitis on human fertility remain unknown. Here, we investigate possible adverse effects of the presence of Neu5Gc on sperm or endometrium combined with anti-Neu5Gc antibodies in semen or uterine secretions in a mouse model. We use Cmah(-/-) mice, humanized for Neu5Gc deficiency. We find that the viability, migration, and capacitation of sperm with incorporated Neu5Gc are negatively affected when these are exposed to anti-Neu5Gc antibodies. In addition, we find that after copulation, activated uterine neutrophils and macrophages show increased phagocytosis of sperm in the presence of anti-Neu5Gc antibodies via the complement receptor 3 (C3R) and Fc I/II/III (Fc receptor). Furthermore, Neu5Gc in endometrial cells combined with the presence of anti-Neu5Gc antibodies alters the receptivity and decidualization of endometrial explants. These studies provide mechanistic insights on how Neu5Gc on sperm and/or endometrium combined with anti-Neu5Gc antibodies in semen and uterine fluid might contribute to unexplained human infertility.	[Ma, Fang] Sichuan Univ, West China Univ Hosp 2, Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Minist Educ,Key Lab Obstet Gynecol & Pediat Dis &, Chengdu 610041, Peoples R China; [Ma, Fang] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610041, Peoples R China; [Deng, Liwen; Secrest, Patrick; Gagneux, Pascal] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Deng, Liwen; Secrest, Patrick; Gagneux, Pascal] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Shi, Linda] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Zhao, June] Univ Calif San Diego, Transgen Mouse Core, La Jolla, CA 92093 USA	Chinese University of Hong Kong; Sichuan University; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Gagneux, P (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pgagneux@ucsd.edu		Ma, Fang/0000-0002-7781-821X; Deng, Liwen/0000-0002-7984-8471	National Institutes of Health [P30 NS047101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ajit Varki for the Cmah<SUP>-/-</SUP> mice, Nissi Varki for precious advice on histology, and Noritaka for help setting up the sperm migration assay. We gratefully acknowledge the UCSD Neuroscience Microscopy Facility (National Institutes of Health Grant P30 NS047101).	Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; Balasuriya A, 2011, REPROD BIOMED ONLINE, V22, P428, DOI 10.1016/j.rbmo.2011.01.012; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bergfeld AK, 2012, J BIOL CHEM, V287, P28898, DOI 10.1074/jbc.M112.363499; Buttke DE, 2006, BIOL REPROD, V74, P889, DOI 10.1095/biolreprod.105.046219; Chamley LW, 2007, SEMIN IMMUNOPATHOL, V29, P169, DOI 10.1007/s00281-007-0075-2; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Cisneros-Mejorado A, 2014, ANDROLOGY-US, V2, P145, DOI 10.1111/j.2047-2927.2013.00169.x; Colette S, 2011, HUM REPROD, V26, P1362, DOI 10.1093/humrep/der079; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; DCRUZ OJ, 1995, J ANDROL, V16, P432; Deng LQ, 2014, CELL, V159, P1290, DOI 10.1016/j.cell.2014.10.057; DEVINE PL, 1991, CANCER RES, V51, P5826; Diekman AB, 2000, AM J REPROD IMMUNOL, V43, P134, DOI 10.1111/j.8755-8920.2000.430302.x; Foote RH, 2003, ANIM REPROD SCI, V75, P119, DOI 10.1016/S0378-4320(02)00233-6; Francavilla F, 2007, FRONT BIOSCI-LANDMRK, V12, P2890, DOI 10.2741/2280; Ghaderi D, 2011, P NATL ACAD SCI USA, V108, P17743, DOI 10.1073/pnas.1102302108; Godbole G, 2011, FERTIL STERIL, V95, P1278, DOI 10.1016/j.fertnstert.2010.09.045; Hahn S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00362; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; HENDRY WF, 1989, REPROD FERT DEVELOP, V1, P205, DOI 10.1071/RD9890205; HIGASHI H, 1985, CANCER RES, V45, P3796; Jha KN, 2006, MOL HUM REPROD, V12, P781, DOI 10.1093/molehr/gal085; Kirchhoff C, 2001, CELLS TISSUES ORGANS, V168, P93, DOI 10.1159/000016810; Kombe A, 2003, STEROIDS, V68, P651, DOI 10.1016/S0039-128X(03)00094-1; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; KREMER J, 1992, HUM REPROD, V7, P781, DOI 10.1093/oxfordjournals.humrep.a137737; KUTTEH WH, 1994, AM J REPROD IMMUNOL, V31, P77, DOI 10.1111/j.1600-0897.1994.tb00850.x; Ma X, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137810; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Mantovani A, 2006, ANN NY ACAD SCI, V1076, P239, DOI 10.1196/annals.1371.063; Marquez B, 2007, BIOL REPROD, V76, P660, DOI 10.1095/biolreprod.106.055038; Minelli A, 2003, REPRODUCTION, V125, P827, DOI 10.1530/reprod/125.6.827; Mitchell LA, 2007, MOL HUM REPROD, V13, P605, DOI 10.1093/molehr/gam043; MIYOSHI I, 1986, MOL IMMUNOL, V23, P631, DOI 10.1016/0161-5890(86)90100-8; Naz RK, 2004, AM J REPROD IMMUNOL, V51, P390, DOI 10.1111/j.1600-0897.2004.00174.x; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Norat T, 2002, INT J CANCER, V98, P241, DOI 10.1002/ijc.10126; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; PANDYA IJ, 1985, FERTIL STERIL, V43, P417; PETERS AJ, 1992, AM J REPROD IMMUNOL, V27, P156, DOI 10.1111/j.1600-0897.1992.tb00743.x; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Ray A, 2012, REPROD BIOMED ONLINE, V24, P591, DOI 10.1016/j.rbmo.2012.02.021; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Smith C, 2012, J AM PHARM ASSOC, V52, pE27, DOI 10.1331/JAPhA.2012.12044; Sroga J. L., 2015, CLIN OBSTET GYNECOL, V1, P72, DOI DOI 10.15761/C0GRM.1000120; Sutovsky P, 2012, CELL TISSUE RES, V349, P631, DOI 10.1007/s00441-012-1480-y; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; Tecle E, 2015, MOL REPROD DEV, V82, P635, DOI 10.1002/mrd.22500; THOMPSON LA, 1992, AM J REPROD IMMUNOL, V28, P85, DOI 10.1111/j.1600-0897.1992.tb00765.x; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Willett WC, 1999, CA-CANCER J CLIN, V49, P331, DOI 10.3322/canjclin.49.6.331; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Zhang JJ, 2005, NUTR CANCER, V53, P65, DOI 10.1207/s15327914nc5301_8	63	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18222	18231		10.1074/jbc.M116.739169	http://dx.doi.org/10.1074/jbc.M116.739169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382056	Green Published, hybrid			2022-12-28	WOS:000383241800015
J	McCullough, CE; Song, SF; Shin, MH; Johnson, FB; Marmorstein, R				McCullough, Cheryl E.; Song, Shufei; Shin, Michael H.; Johnson, F. Brad; Marmorstein, Ronen			Structural and Functional Role of Acetyltransferase hMOF K274 Autoacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetylation; chemical modification; histone acetylase; post-translational modification (PTM)	HISTONE ACETYLTRANSFERASE; PROTEIN ACETYLATION; CATALYTIC MECHANISM; RECRUITMENT; GCN5	Many histone acetyltransferases undergo autoacetylation, either through chemical or enzymatic means, to potentiate enzymatic cognate substrate lysine acetylation, although the mode and molecular role of such autoacetylation is poorly understood. The MYST family of histone acetyltransferases is autoacetylated at an active site lysine residue to facilitate cognate substrate lysine binding and acetylation. Here, we report on a detailed molecular investigation of Lys-274 autoacetylation of the human MYST protein Males Absent on the First (hMOF). A mutational scan of hMOF Lys-274 reveals that all amino acid substitutions of this residue are able to bind cofactor but are significantly destabilized, both in vitro and in cells, and are catalytically inactive for cognate histone H4 peptide lysine acetylation. The x-ray crystal structure of a hMOF K274P mutant suggests that the reduced stability and catalytic activity stems from a disordering of the residue 274-harboring a 2-7 loop. We also provide structural evidence that a C316S/E350Q mutant, which is defective for cognate substrate lysine acetylation; and biochemical evidence that a K268M mutant, which is defective for Lys-274 chemical acetylation in the context of a K274-peptide, can still undergo quantitative K274 autoacetylation. Together, these studies point to the critical and specific role of hMOF Lys-274 autoacetylation in hMOF stability and cognate substrate acetylation and argues that binding of Ac-CoA to hMOF likely drives Lys-274 autoacetylation for subsequent cognate substrate acetylation.	[McCullough, Cheryl E.; Shin, Michael H.; Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Dept Biochem & Biophys, 421 Curie Blvd, Philadelphia, PA 19104 USA; [McCullough, Cheryl E.; Shin, Michael H.; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Song, Shufei; Johnson, F. Brad] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Song, Shufei; Johnson, F. Brad; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Marmorstein, R (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Dept Biochem & Biophys, 421 Curie Blvd, Philadelphia, PA 19104 USA.	marmor@mail.med.upenn.edu			National Institutes of Health [P30 CA010815, P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293, T32GM008275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank John Domsic and Adam Olia for helpful discussions regarding the crystal structure determination and refinement and programming for analysis of melting temperatures. We acknowledge support of the proteomics facility at the Wistar Institute (National Institutes of Health Grant P30 CA010815) and the DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (National Institutes of Health Grant P30 CA016520).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Herrera JE, 1997, J BIOL CHEM, V272, P27253, DOI 10.1074/jbc.272.43.27253; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Li Y, 2014, GENE DEV, V28, P1217, DOI 10.1101/gad.240531.114; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lu L, 2011, CELL RES, V21, P1182, DOI 10.1038/cr.2011.71; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullough CE, 2016, ACS CHEM BIOL, V11, P632, DOI 10.1021/acschembio.5b00841; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Smith KT, 2009, NAT BIOTECHNOL, V27, P917, DOI 10.1038/nbt1009-917; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Sun BF, 2011, CELL RES, V21, P1262, DOI 10.1038/cr.2011.105; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Wu H, 2012, P NATL ACAD SCI USA, V109, P8925, DOI 10.1073/pnas.1114117109; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	30	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18190	18198		10.1074/jbc.M116.736264	http://dx.doi.org/10.1074/jbc.M116.736264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382063	Green Published, hybrid			2022-12-28	WOS:000383241800012
J	Zheng, DL; Sabbagh, JJ; Blair, LJ; Darling, AL; Wen, XQ; Dickey, CA				Zheng, Dali; Sabbagh, Jonathan J.; Blair, Laura J.; Darling, April L.; Wen, Xiaoqi; Dickey, Chad A.			MicroRNA-511 Binds to FKBP5 mRNA, Which Encodes a Chaperone Protein, and Regulates Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						depression; glucocorticoid; microRNA (miRNA); neurodifferentiation; stress; FKBP5	LARGE GENE LISTS; GLUCOCORTICOID-RECEPTOR; FK506-BINDING PROTEIN-51; DEPRESSION; STRESS; TAU; POLYMORPHISMS; DYSREGULATION; EXPRESSION; VECTORS	Single nucleotide polymorphisms in the FKBP5 gene increase the expression of the FKBP51 protein and have been associated with increased risk for neuropsychiatric disorders such as major depression and post-traumatic stress disorder. Moreover, levels of FKBP51 are increased with aging and in Alzheimer disease, potentially contributing to disease pathogenesis. However, aside from its glucocorticoid responsiveness, little is known about what regulates FKBP5. In recent years, non-coding RNAs, and in particular microRNAs, have been shown to modulate disease-related genes and processes. The current study sought to investigate which miRNAs could target and functionally regulate FKBP5. Following in silico data mining and initial target expression validation, miR-511 was found to suppress FKBP5 mRNA and protein levels. Using luciferase p-miR-Report constructs and RNA pulldown assays, we confirmed that miR-511 bound directly to the 3-UTR of FKBP5, validating the predicted gene-microRNA interaction. miR-511 suppressed glucocorticoid-induced up-regulation of FKBP51 in cells and primary neurons, demonstrating functional, disease-relevant control of the protein. Consistent with a regulator of FKBP5, miR-511 expression in the mouse brain decreased with age but increased following chronic glucocorticoid treatment. Analysis of the predicted target genes of miR-511 revealed that neurogenesis, neuronal development, and neuronal differentiation were likely controlled by these genes. Accordingly, miR-511 increased neuronal differentiation in cells and enhanced neuronal development in primary neurons. Collectively, these findings show that miR-511 is a functional regulator of FKBP5 and can contribute to neuronal differentiation.	[Zheng, Dali; Sabbagh, Jonathan J.; Blair, Laura J.; Darling, April L.; Wen, Xiaoqi; Dickey, Chad A.] Univ S Florida, Byrd Alzheimers Res Inst, Dept Mol Med, Tampa, FL 33613 USA	State University System of Florida; University of South Florida	Dickey, CA (corresponding author), Univ S Florida, Dept Mol Med, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Zheng, Dali/J-2973-2019	Zheng, Dali/0000-0003-2345-4040; Blair, Laura/0000-0002-4981-5564	National Institutes of Mental Health [R01 MH103848]; National Institutes of Neurological Disease and Stroke [NS073899]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Neurological Disease and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Mental Health Grant R01 MH103848 and National Institutes of Neurological Disease and Stroke R01 Grant NS073899. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra JF, 2013, J NEUROSCI, V33, P9498, DOI 10.1523/JNEUROSCI.5397-12.2013; Balakathiresan NS, 2014, J PSYCHIATR RES, V57, P65, DOI 10.1016/j.jpsychires.2014.05.020; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Camkurt MA, 2015, J PSYCHIATR RES, V69, P67, DOI 10.1016/j.jpsychires.2015.07.023; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Denny WB, 2005, ENDOCRINOLOGY, V146, P3194, DOI 10.1210/en.2005-0027; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Dwivedi Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.175; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Femminella GD, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00040; Gillespie CF, 2005, PSYCHOSOM MED, V67, pS26, DOI 10.1097/01.psy.0000163456.22154.d2; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hartmann J, 2012, NEUROPHARMACOLOGY, V62, P332, DOI 10.1016/j.neuropharm.2011.07.041; Hassan T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1466; He Y, 2012, DNA CELL BIOL, V31, P1499, DOI 10.1089/dna.2012.1660; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Issler O, 2014, NEURON, V83, P344, DOI 10.1016/j.neuron.2014.05.042; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; Katnik C, 2006, J PHARMACOL EXP THER, V319, P1355, DOI 10.1124/jpet.106.107557; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah C, 2003, HUM GENE THER, V14, P143, DOI 10.1089/104303403321070838; O'Leary JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024840; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Puimege L, 2015, EMBO MOL MED, V7, P1004, DOI 10.15252/emmm.201405010; Sabbagh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107241; Schmidt MV, 2012, CHEMMEDCHEM, V7, P1351, DOI 10.1002/cmdc.201200137; Smalheiser NR, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00006; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Smalheiser NR, 2011, INT J NEUROPSYCHOPH, V14, P1315, DOI 10.1017/S1461145710001628; Song MF, 2015, J AFFECT DISORDERS, V178, P25, DOI 10.1016/j.jad.2015.02.022; Wan YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121975; Wang X, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0099-8; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	42	31	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17897	17906		10.1074/jbc.M116.727941	http://dx.doi.org/10.1074/jbc.M116.727941			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27334923	hybrid, Green Published			2022-12-28	WOS:000383241300033
J	Malmos, KG; Bjerring, M; Jessen, CM; Nielsen, EHT; Poulsen, ET; Christiansen, G; Vosegaard, T; Skrydstrup, T; Enghild, JJ; Pedersen, JS; Otzen, DE				Malmos, Kirsten Gade; Bjerring, Morten; Jessen, Christian Moestrup; Nielsen, Erik Holm Toustrup; Poulsen, Ebbe T.; Christiansen, Gunna; Vosegaard, Thomas; Skrydstrup, Troels; Enghild, Jan J.; Pedersen, Jan Skov; Otzen, Daniel E.			How Glycosaminoglycans Promote Fibrillation of Salmon Calcitonin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATED GLYCOSAMINOGLYCANS; PEPTIDE; IDENTIFICATION; ENHANCEMENT; PROLACTIN; OLIGOMERS; MECHANISM; GRANULES; PLAQUES; BINDING	Glycosaminoglycans (GAGs) bind all known amyloid plaques and help store protein hormones in (acidic) granular vesicles, but the molecular mechanisms underlying these important effects are unclear. Here we investigate GAG interactions with the peptide hormone salmon calcitonin (sCT). GAGs induce fast sCT fibrillation at acidic pH and only bind monomeric sCT at acidic pH, inducing sCT helicity. Increasing GAG sulfation expands the pH range for binding. Heparin, the most highly sulfated GAG, binds sCT in the pH interval 3-7. Small angle x-ray scattering indicates that sCT monomers densely decorate and pack single heparin chains, possibly via hydrophobic patches on helical sCT. sCT fibrillates without GAGs, but heparin binding accelerates the process by decreasing the otherwise long fibrillation lag times at low pH and accelerates fibril growth rates at neutral pH. sCT center dot heparin complexes form beta-sheet-rich heparin-covered fibrils. Solid-state NMR reveals that heparin does not alter the sCT fibrillary core around Lys(11) but makes changes to Val(8) on the exterior side of the beta-strand, possibly through contacts to Lys(18). Thus GAGs significantly modulate sCT fibrillation in a pH-dependent manner by interacting with both monomeric and aggregated sCT.	[Malmos, Kirsten Gade; Bjerring, Morten; Jessen, Christian Moestrup; Nielsen, Erik Holm Toustrup; Vosegaard, Thomas; Skrydstrup, Troels; Pedersen, Jan Skov; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Malmos, Kirsten Gade; Bjerring, Morten; Jessen, Christian Moestrup; Nielsen, Erik Holm Toustrup; Vosegaard, Thomas; Skrydstrup, Troels; Pedersen, Jan Skov; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Malmos, Kirsten Gade; Poulsen, Ebbe T.; Enghild, Jan J.; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 4, DK-8000 Aarhus, Denmark; [Bjerring, Morten; Vosegaard, Thomas; Pedersen, Jan Skov] Aarhus Univ, Dept Chem, Langelandsgade 140, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.	dao@inano.au.dk	Pedersen, Jan Skov/A-8346-2008	Pedersen, Jan Skov/0000-0002-7768-0206; Christiansen, Gunna/0000-0003-0540-1367; Enghild, Jan Johannes/0000-0001-9292-9172; Gade Malmos, Kirsten/0000-0002-4035-9048; Nielsen, Erik Nguyen/0000-0002-8810-1046; Skrydstrup, Troels/0000-0001-8090-5050; Vosegaard, Thomas/0000-0001-5414-4550; Toftgaard Poulsen, Ebbe/0000-0002-4416-0431	Danish Research Foundation inSPIN Grant [DNRF59]; Danish Ministry of Higher Education and Science [AU-2010-612-181]; Novo Nordisk Fonden [NNF14OC0012953] Funding Source: researchfish	Danish Research Foundation inSPIN Grant; Danish Ministry of Higher Education and Science; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Danish Research Foundation inSPIN Grant DNRF59 and Danish Ministry of Higher Education and Science Grant AU-2010-612-181. The authors declare that they have no conflicts of interest with the contents of this article.	Andreasen M, 2014, BIOCHEMISTRY-US, V53, P6968, DOI 10.1021/bi500674u; Andreotti G, 2004, J BIOL CHEM, V279, P6364, DOI 10.1074/jbc.M310882200; Andreotti G, 2011, J BIOL CHEM, V286, P2707, DOI 10.1074/jbc.M110.182014; Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; BEATY NB, 1987, J CHROMATOGR-BIOMED, V418, P187, DOI 10.1016/0378-4347(87)80009-9; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Bruinsma IB, 2010, ACTA NEUROPATHOL, V119, P211, DOI 10.1007/s00401-009-0577-1; BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Chan C., 2000, FMOC SOLID PHASE PEP; Chesnut CH, 2008, OSTEOPOROSIS INT, V19, P479, DOI 10.1007/s00198-007-0490-1; CUDD A, 1995, J PHARM SCI, V84, P717, DOI 10.1002/jps.2600840610; Dannies PS, 2012, ENDOCR REV, V33, P254, DOI 10.1210/er.2011-1002; De Carufel CA, 2013, BIOPOLYMERS, V100, P645, DOI 10.1002/bip.22243; Diociaiuti M, 2006, BIOPHYS J, V91, P2275, DOI 10.1529/biophysj.105.079475; Diociaiuti M, 2014, BBA-MOL BASIS DIS, V1842, P1622, DOI 10.1016/j.bbadis.2014.06.006; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; GALANTE L, 1971, CLIN SCI, V40, pP9; Gallagher JT, 2000, PROTEOGLYCANS STRUCT, P27; GIANNATTASIO G, 1980, J CELL BIOL, V86, P273, DOI 10.1083/jcb.86.1.273; Iannuzzi C, 2015, MOLECULES, V20, P2510, DOI 10.3390/molecules20022510; Iozzo R. V., 2000, PROTEOGLYCANS STRUCT, P1; Kamihira M, 2000, PROTEIN SCI, V9, P867, DOI 10.1110/ps.9.5.867; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lehri-Boufala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116641; Madine J, 2012, ANGEW CHEM INT EDIT, V51, P13140, DOI 10.1002/anie.201204459; Madine J, 2009, ORG BIOMOL CHEM, V7, P2414, DOI 10.1039/b820808e; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Malmos K.G., 2014, BIONANOIMAGING PROTE, P281; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Motamedi-Shad N, 2012, NAT STRUCT MOL BIOL, V19, P547, DOI 10.1038/nsmb.2286; NAGASAWA K, 1978, BIOCHIM BIOPHYS ACTA, V544, P430, DOI 10.1016/0304-4165(78)90110-1; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P2118, DOI 10.1002/anie.200804198; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Saridaki T, 2012, J MOL BIOL, V421, P616, DOI 10.1016/j.jmb.2012.02.007; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shi T, 2002, BIOORG MED CHEM LETT, V12, P2237, DOI 10.1016/S0960-894X(02)00344-X; SNOW AD, 1990, LAB INVEST, V63, P601; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Virchow R., 1855, ARCH PATHOL ANAT PH, V8, P140, DOI [10.1007/BF01935322, DOI 10.1007/BF01935322]; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	51	16	16	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16849	16862		10.1074/jbc.M116.715466	http://dx.doi.org/10.1074/jbc.M116.715466			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27281819	hybrid, Green Published			2022-12-28	WOS:000380826700040
J	Huang, X; Zheng, Y; Zhang, F; Wei, ZQ; Wang, YG; Carrell, RW; Read, RJ; Chen, GQ; Zhou, AW				Huang, Xin; Zheng, Ying; Zhang, Fei; Wei, Zhenquan; Wang, Yugang; Carrell, Robin W.; Read, Randy J.; Chen, Guo-Qiang; Zhou, Aiwu			Molecular Mechanism of Z alpha 1-Antitrypsin Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(1)-ANTITRYPSIN DEFICIENCY; SERPIN POLYMERIZATION; ALPHA-1-PROTEINASE INHIBITOR; CONFORMATIONAL DISEASE; ANGSTROM STRUCTURE; CRYSTAL-STRUCTURE; SALT BRIDGE; SECRETION; DEFECT; LOOP	The Z mutation (E342K) of alpha 1-antitrypsin (alpha 1-AT), carried by 4% of Northern Europeans, predisposes to early onset of emphysema due to decreased functional alpha 1-AT in the lung and to liver cirrhosis due to accumulation of polymers in hepatocytes. However, it remains unclear why the Z mutation causes intracellular polymerization of nascentZ alpha 1-AT and why 15% of the expressed Z alpha 1-AT is secreted into circulation as functional, but polymerogenic, monomers. Here, we solve the crystal structure of the Z-monomer and have engineered replacements to assess the conformational role of residue Glu-342 in alpha 1-AT. The results reveal that Z alpha 1-AT has a labile strand 5 of the central beta-sheet A (s5A) with a consequent equilibrium between a native inhibitory conformation, as in its crystal structure here, and an aberrant conformation with s5A only partially incorporated into the central beta-sheet. This aberrant conformation, induced by the loss of interactions from the Glu-342 side chain, explains why Z alpha 1-AT is prone to polymerization and readily binds to a 6-mer peptide, and it supports that annealing of s5A into the central beta-sheet is a crucial step in the serpins' metastable conformational formation. The demonstration that the aberrant conformation can be rectified through stabilization of the labile s5A by binding of a small molecule opens a potential therapeutic approach for Z alpha 1-AT deficiency.	[Huang, Xin; Chen, Guo-Qiang] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Huang, Xin; Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Huang, Xin; Chen, Guo-Qiang] Univ Chinese Acad Sci, Shanghai 200025, Peoples R China; [Zheng, Ying; Zhang, Fei; Wei, Zhenquan; Wang, Yugang; Chen, Guo-Qiang; Zhou, Aiwu] Shanghai Jiao Tong Univ, Hongqiao Int Inst Med,Shanghai Tongren Hosp,Sch M, Fac Basic Med,Chem Biol Div Shanghai Univ E Inst, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China; [Carrell, Robin W.; Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; University of Cambridge	Chen, GQ (corresponding author), Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China.; Chen, GQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China.; Chen, GQ (corresponding author), Univ Chinese Acad Sci, Shanghai 200025, Peoples R China.; Zhou, AW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Hongqiao Int Inst Med, 280 Chongqing Rd, Shanghai 200025, Peoples R China.	chengq@shsmu.edu.cn; aiwuzhou@gmail.com	Read, Randy J/L-1418-2013	Read, Randy J/0000-0001-8273-0047; ZHOU, Aiwu/0000-0002-2555-5091	National Basic Research Program of China 973 Program [2014CB910304]; National Natural Science Foundation of China [31370727, 31170724, 81572090]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program; Innovation Program of Shanghai Municipal Education Commission [12ZZ113]; Wellcome Trust [082961/Z/07/Z]; British Heart Foundation Senior Research Fellowship; British Heart Foundation [PG/09/072/27945] Funding Source: researchfish	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program(Shanghai Pujiang Program); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation Senior Research Fellowship; British Heart Foundation(British Heart Foundation)	This work was supported in part by National Basic Research Program of China 973 Program Grant 2014CB910304, National Natural Science Foundation of China Grants 31370727, 31170724, and 81572090, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai PuJiang Program, and Innovation Program of Shanghai Municipal Education Commission Grant 12ZZ113. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Principal Research Fellowship 082961/Z/07/Z from the Wellcome Trust.r Supported by a British Heart Foundation Senior Research Fellowship. To whom correspondence may be addressed: Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, 280 Chongqing Rd., Shanghai 200025, China. Tel.: 86-13916791990; E-mail: aiwuzhou@gmail.com.	Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BRANTLY M, 1988, SCIENCE, V242, P1700, DOI 10.1126/science.2904702; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; COX DW, 1986, FEBS LETT, V205, P255, DOI 10.1016/0014-5793(86)80908-5; Davies MJ, 2008, INT J BIOCHEM CELL B, V40, P1273, DOI 10.1016/j.biocel.2007.12.017; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Dolmer K, 2012, J BIOL CHEM, V287, P12425, DOI 10.1074/jbc.M111.315465; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Ekeowa UI, 2009, CLIN SCI, V116, P837, DOI 10.1042/CS20080484; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; FOREMAN RC, 1987, FEBS LETT, V216, P79, DOI 10.1016/0014-5793(87)80760-3; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Hughes VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102617; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; James EL, 1999, J BIOL CHEM, V274, P9482, DOI 10.1074/jbc.274.14.9482; Kass I, 2012, BIOPHYS J, V102, P2856, DOI 10.1016/j.bpj.2012.05.023; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Levina V, 2009, PROTEIN EXPRES PURIF, V68, P226, DOI 10.1016/j.pep.2009.06.011; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mahadeva R, 2002, J BIOL CHEM, V277, P6771, DOI 10.1074/jbc.C100722200; Mallyat M, 2007, J MED CHEM, V50, P5357, DOI 10.1021/jm070687z; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; OLSON ST, 1981, J BIOL CHEM, V256, P1065; Ordonez A, 2015, FASEB J, V29, P2667, DOI 10.1096/fj.14-267351; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; SHARP HL, 1969, J LAB CLIN MED, V73, P934; SIFERS RN, 1989, J BIOL CHEM, V264, P2997; Skinner R, 1998, J MOL BIOL, V283, P9, DOI 10.1006/jmbi.1998.2083; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Teckman JH, 2004, J PEDIATR GASTR NUTR, V39, P34, DOI 10.1097/00005176-200407000-00007; Tsutsui Y, 2012, P NATL ACAD SCI USA, V109, P4467, DOI 10.1073/pnas.1109125109; WU Y, 1990, FEBS LETT, V268, P21, DOI 10.1016/0014-5793(90)80962-I; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zhou AW, 2003, J BIOL CHEM, V278, P15116, DOI 10.1074/jbc.M211663200	54	19	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15674	15686		10.1074/jbc.M116.727826	http://dx.doi.org/10.1074/jbc.M116.727826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27246852	Green Published, hybrid			2022-12-28	WOS:000380584200022
J	Nie, LY; Grell, E; Malviya, VN; Xie, H; Wang, JK; Michel, H				Nie, Laiyin; Grell, Ernst; Malviya, Viveka Nand; Xie, Hao; Wang, Jingkang; Michel, Hartmut			Identification of the High-affinity Substrate-binding Site of the Multidrug and Toxic Compound Extrusion (MATE) Family Transporter from Pseudomonas stutzeri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONDING TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; VIBRIO-PARAHAEMOLYTICUS; LIGAND-BINDING; EFFLUX PUMPS; PROTEIN NORM; I-TASSER; FLUORESCENCE; SUPERFAMILY; ANTIPORTER	Multidrug and toxic compound extrusion (MATE) transporters exist in all three domains of life. They confer multidrug resistance by utilizing H+ or Na+ electrochemical gradients to extrude various drugs across the cell membranes. The substrate binding and the transport mechanism of MATE transporters is a fundamental process but so far not fully understood. Here we report a detailed substrate binding study of NorM_PS, a representative MATE transporter from Pseudomonas stutzeri. Our results indicate that NorM_PS is a proton-dependent multidrug efflux transporter. Detailed binding studies between NorM_PS and 4',6-diamidino-2-phenylindole (DAPI) were performed by isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), and spectrofluorometry. Two exothermic binding events were observed from ITC data, and the high-affinity event was directly correlated with the extrusion of DAPI. The affinities are about 1 mu M and 0.1 mM for the high and low affinity binding, respectively. Based on our homology model of NorM_PS, variants with mutations of amino acids that are potentially involved in substrate binding, were constructed. By carrying out the functional characterization of these variants, the critical amino acid residues (Glu-257 and Asp-373) for high-affinity DAPI binding were determined. Taken together, our results suggest a new substrate-binding site for MATE transporters.	[Nie, Laiyin; Wang, Jingkang] Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Collaborat Innovat Ctr Chem Sci & Chem Engn, Tianjin 300072, Peoples R China; [Nie, Laiyin; Grell, Ernst; Malviya, Viveka Nand; Xie, Hao; Michel, Hartmut] Max Planck Inst Biophys, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany	Tianjin University; Max Planck Society	Wang, JK (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Collaborat Innovat Ctr Chem Sci & Chem Engn, Tianjin 300072, Peoples R China.; Michel, H (corresponding author), Max Planck Inst Biophys, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	wangjkch@tju.edu.cn; hartmut.michel@biophys.mpg.de		Xie, Hao/0000-0002-2422-2527	Max Planck Society; Deutsche Forschungsgemeinschaft Cluster of Excellence Frankfurt on Macromolecular Complexes Frankfurt; International Science and Technology Cooperation Program of China [2013DFE43150]; China Scholarship Council;  [CRC 807]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft Cluster of Excellence Frankfurt on Macromolecular Complexes Frankfurt; International Science and Technology Cooperation Program of China; China Scholarship Council(China Scholarship Council); 	This work was supported in part by the Max Planck Society, Deutsche Forschungsgemeinschaft Cluster of Excellence Frankfurt on Macromolecular Complexes Frankfurt and CRC 807, and International Science and Technology Cooperation Program of China Grant 2013DFE43150. The authors declare that they have no conflict of interest with the contents of this article.r Supported by the China Scholarship Council and the Max Planck Society.	Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; COOLS AA, 1986, EXPERIENTIA, V42, P954, DOI 10.1007/BF01941777; Du DJ, 2015, TRENDS MICROBIOL, V23, P311, DOI 10.1016/j.tim.2015.01.010; FAVILLA R, 1993, BIOPHYS CHEM, V46, P217, DOI 10.1016/0301-4622(93)80015-B; Green FJ., 1990, SIGMA ALDRICH HDB ST, P626; HARD T, 1990, PHOTOCHEM PHOTOBIOL, V51, P77, DOI 10.1111/j.1751-1097.1990.tb01686.x; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Heng J, 2015, CELL RES, V25, P1060, DOI 10.1038/cr.2015.94; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jin Y, 2014, J BIOL CHEM, V289, P14624, DOI 10.1074/jbc.M113.546770; Kaur J, 2014, J BIOL CHEM, V289, P1377, DOI 10.1074/jbc.M113.510743; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Markham PN, 1996, J BACTERIOL, V178, P1473, DOI 10.1128/jb.178.5.1473-1475.1996; MAZZINI A, 1992, BIOPHYS CHEM, V42, P101, DOI 10.1016/0301-4622(92)80012-T; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; NOBLE RC, 1994, DIAGN MICR INFEC DIS, V19, P51, DOI 10.1016/0732-8893(94)90051-5; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rycovska A, 2012, BBA-BIOMEMBRANES, V1818, P1342, DOI 10.1016/j.bbamem.2012.02.004; Sikora CW, 2005, BIOPHYS J, V88, P475, DOI 10.1529/biophysj.104.049247; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Vasquez V, 2007, BIOCHEMISTRY-US, V46, P6766, DOI 10.1021/bi700322k; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wong K, 2014, TRENDS BIOCHEM SCI, V39, P8, DOI 10.1016/j.tibs.2013.11.002; Yang JY, 2016, PROTEINS, V84, P233, DOI 10.1002/prot.24918; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	41	20	20	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15503	15514		10.1074/jbc.M116.728618	http://dx.doi.org/10.1074/jbc.M116.728618			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27235402	hybrid, Green Published			2022-12-28	WOS:000380584200008
J	Hwang, J; Lee, JA; Pallas, DC				Hwang, Juyeon; Lee, Jocelyn A.; Pallas, David C.			Leucine Carboxyl Methyltransferase 1(LCMT-1) Methylates Protein Phosphatase 4(PP4) and Protein Phosphatase 6(PP6) and Differentially Regulates the Stable Formation of Different PP4 Holoenzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2A CATALYTIC SUBUNIT; DNA-DAMAGE CHECKPOINT; MIDDLE TUMOR-ANTIGEN; BOVINE BRAIN; DEPHOSPHORYLATES GAMMA-H2AX; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ALPHA4 PROTEIN; PP2A; ASSOCIATION	The protein phosphatase 2A (PP2A) subfamily of phosphatases, PP2A, PP4, and PP6, are multifunctional serine/threonine protein phosphatases involved in many cellular processes. Carboxyl methylation of the PP2A catalytic subunit (PP2Ac) C-terminal leucine is regulated by the opposing activities of leucine carboxyl methyltransferase 1 (LCMT-1) and protein phosphatase methylesterase 1 (PME-1) and regulates PP2A holoenzyme formation. The site of methylation on PP2Ac is conserved in the catalytic subunits of PP4 and PP6, and PP4 is also methylated on that site, but the identities of the methyltransferase enzyme for PP4 are not known. Whether PP6 is methylated is also not known. Here we use antibodies specific for the unmethylated phosphatases to show that PP6 is carboxyl-methylated and that LCMT-1 is the major methyltransferase for PP2A, PP4, and PP6 in mouse embryonic fibroblasts (MEFs). Analysis of PP2A and PP4 complexes by blue native polyacrylamide gel electrophoresis (BN-PAGE) indicates that PP4 holoenzyme complexes, like those of PP2A, are differentially regulated by LCMT-1, with the PP4 regulatory subunit 1 (PP4R1)-containing PP4 complex being the most dramatically affected by the LCMT-1 loss. MEFs derived from LCMT-1 knock-out mouse embryos have reduced levels of PP2A B regulatory subunit and PP4R1 relative to control MEFs, indicating that LCMT-1is important for maintaining normal levels of these subunits. Finally, LCMT-1 homozygous knock-out MEFs exhibited hyperphosphorylation of HDAC3, a reported target of the methylation-dependent PP4R1-PP4c complex. Collectively, our data suggest that LCMT-1 coordinately regulates the carboxyl methylation of PP2A-related phosphatases and, consequently, their holoenzyme assembly and function.	Emory Univ, Sch Med, Winship Canc Ctr, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Biochem Cell & Dev Grad Program, Atlanta, GA 30322 USA	Emory University; Emory University	Pallas, DC (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	dpallas@emory.edu			National Institutes of Health [R01 CA57327, 5F31CA123640]; Emory University Research Committee; NATIONAL CANCER INSTITUTE [R01CA057327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Research Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 CA57327 (NCI). This work was also supported by an award from the Emory University Research Committee. Dr. David Pallas is entitled to royalties from the sale of products related to the research described in this paper by Millipore Inc., Santa Cruz Biotechnologies Inc., Invitrogen, and Novus Biologicals Inc. In addition, this same author serves as a consultant to Millipore. The terms of these arrangements have been reviewed and approved by Emory University in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; \Supported by National Institutes of Health Predoctoral Fellowship Grant 5F31CA123640 (NCI).	Bartling B, 2005, LUNG CANCER-J IASLC, V49, P145, DOI 10.1016/j.lungcan.2005.02.006; Bastians H, 1996, J CELL SCI, V109, P2865; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Filali M, 1999, J CELL BIOCHEM, V73, P153, DOI 10.1002/(SICI)1097-4644(19990501)73:2<153::AID-JCB2>3.3.CO;2-Z; Gentry MS, 2005, EUKARYOT CELL, V4, P1029, DOI 10.1128/EC.4.6.1029-1040.2005; George RR, 2002, PROTEIN EXPRES PURIF, V26, P266, DOI 10.1016/S1046-5928(02)00540-5; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Hastie CJ, 2000, BIOCHEM J, V347, P845, DOI 10.1042/0264-6021:3470845; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Kloeker S, 1999, J BIOL CHEM, V274, P5339, DOI 10.1074/jbc.274.9.5339; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lee JA, 2007, J BIOL CHEM, V282, P30974, DOI 10.1074/jbc.M704861200; Lee J, 2014, BIOCHEM BIOPH RES CO, V452, P42, DOI 10.1016/j.bbrc.2014.08.045; Liby P, 2006, FOLIA BIOL-PRAGUE, V52, P21; Lillo C, 2014, PLANT CELL ENVIRON, V37, P2631, DOI 10.1111/pce.12364; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Rusin SF, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3138; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Wandzioch E, 2014, CANCER RES, V74, P4295, DOI 10.1158/0008-5472.CAN-13-3130; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981; Yoo SJS, 2008, J CELL BIOCHEM, V105, P290, DOI 10.1002/jcb.21830; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhong JN, 2011, CELL CYCLE, V10, P1411, DOI 10.4161/cc.10.9.15479	59	22	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21008	21019		10.1074/jbc.M116.739920	http://dx.doi.org/10.1074/jbc.M116.739920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27507813	Green Published, hybrid			2022-12-28	WOS:000385406200017
J	Sepuru, KM; Nagarajan, B; Desai, UR; Rajarathnam, K				Sepuru, Krishna Mohan; Nagarajan, Balaji; Desai, Umesh R.; Rajarathnam, Krishna			Molecular Basis of Chemokine CXCL5-Glycosaminoglycan Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; heparin; isothermal titration calorimetry (ITC); molecular dynamics; NMR	SOLUTION NMR CHARACTERIZATION; HEPARAN-SULFATE; GLYCOSAMINOGLYCAN INTERACTIONS; NEUTROPHIL TRAFFICKING; TERNARY COMPLEX; DIMER BINDING; HOST-DEFENSE; CXCL1 DIMER; RECEPTOR; DYNAMICS	Chemokines, a large family of highly versatile small soluble proteins, play crucial roles in defining innate and adaptive immune responses by regulating the trafficking of leukocytes, and also play a key role in various aspects of human physiology. Chemokines share the characteristic feature of reversibly existing as monomers and dimers, and their functional response is intimately coupled to interaction with glycosaminoglycans (GAGs). Currently, nothing is known regarding the structural basis or molecular mechanisms underlying CXCL5-GAG interactions. To address this missing knowledge, we characterized the interaction of a panel of heparin oligosaccharides to CXCL5 using solution NMR, isothermal titration calorimetry, and molecular dynamics simulations. NMR studies indicated that the dimer is the high-affinity GAG binding ligand and that lysine residues from the N-loop, 40s turn, (3) strand, and C-terminal helix mediate binding. Isothermal titration calorimetry indicated a stoichiometry of two oligosaccharides per CXCL5 dimer. NMR-based structural models reveal that these residues form a contiguous surface within a monomer and, interestingly, that the GAG-binding domain overlaps with the receptor-binding domain, indicating that a GAG-bound chemokine cannot activate the receptor. Molecular dynamics simulations indicate that the roles of the individual lysines are not equivalent and that helical lysines play a more prominent role in determining binding geometry and affinity. Further, binding interactions and GAG geometry in CXCL5 are novel and distinctly different compared with the related chemokines CXCL1 and CXCL8. We conclude that a finely tuned balance between the GAG-bound dimer and free soluble monomer regulates CXCL5-mediated receptor signaling and function.	[Sepuru, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sepuru, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Nagarajan, Balaji; Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA; [Nagarajan, Balaji; Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery & Dev, Richmond, VA 23219 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Virginia Commonwealth University; Virginia Commonwealth University	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	krrajara@utmb.edu	Nagarajan, Balaji/K-6924-2019; Desai, Umesh/D-3741-2013; Sepuru, Krishna Mohan/K-5321-2014	Desai, Umesh/0000-0002-1976-6597; Sepuru, Krishna Mohan/0000-0002-3675-6294; Nagarajan, Balaji/0000-0003-3892-6178	National Institutes of Health [P01 HL107152]; Sealy and Smith Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy and Smith Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant P01 HL107152 (to K. R. and U. R. D.) and a Sealy and Smith Foundation grant to the Sealy Center for Structural Biology and Molecular Biophysics. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Case D. A., 2012, AMBER 13; Case DA, 2014, AMBER 14; Chavey C, 2009, AGING-US, V1, P674, DOI 10.18632/aging.100064; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dutta AK, 2015, METHODS MOL BIOL, V1229, P315, DOI 10.1007/978-1-4939-1714-3_25; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph PRB, 2015, BIOCHEM J, V472, P121, DOI 10.1042/BJ20150059; Joseph PRB, 2015, PROTEIN SCI, V24, P81, DOI 10.1002/pro.2590; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; Kurupati P, 2010, MOL MICROBIOL, V76, P1387, DOI 10.1111/j.1365-2958.2010.07065.x; Leidal KG, 2003, J INTERF CYTOK RES, V23, P307, DOI 10.1089/107999003766628151; Li AH, 2011, AM J PATHOL, V178, P1340, DOI 10.1016/j.ajpath.2010.11.058; Li LY, 2012, MOL BIOSYST, V8, P1613, DOI 10.1039/c2mb25021g; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Migliorini E, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150046; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Pickens SR, 2011, ANGIOGENESIS, V14, P443, DOI 10.1007/s10456-011-9227-z; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Ravindran A, 2013, J BIOL CHEM, V288, P12244, DOI 10.1074/jbc.M112.443762; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Samsonov SA, 2011, J COMPUT AID MOL DES, V25, P477, DOI 10.1007/s10822-011-9433-1; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Sawant KV, 2015, J INNATE IMMUN, V7, P647, DOI 10.1159/000430914; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sepuru KM, 2016, J BIOL CHEM, V291, P4247, DOI 10.1074/jbc.M115.697888; Sepuru KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093228; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	52	35	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20539	20550		10.1074/jbc.M116.745265	http://dx.doi.org/10.1074/jbc.M116.745265			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27471273	hybrid, Green Published			2022-12-28	WOS:000384574800020
J	Ilyaskin, AV; Diakov, A; Korbmacher, C; Haerteis, S				Ilyaskin, Alexandr V.; Diakov, Alexei; Korbmacher, Christoph; Haerteis, Silke			Activation of the Human Epithelial Sodium Channel (ENaC) by Bile Acids Involves the Degenerin Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bile acid; electrophysiology; epithelial sodium channel (ENaC); ion channel; oocyte; patch clamp; Xenopus; ENaC activation; MTSET; degenerin site	SENSITIVE NA+ CHANNEL; COLLECTING DUCT CELLS; FUNCTIONAL EXPRESSION; DELTA-SUBUNIT; PROTEOLYTIC ACTIVATION; CAENORHABDITIS-ELEGANS; ALPHA-SUBUNIT; GAMMA-SUBUNIT; CONFORMATIONAL-CHANGE; MOLECULAR-CLONING	The epithelial sodium channel (ENaC) is a member of the ENaC/degenerin ion channel family, which also includes the bile acid-sensitive ion channel (BASIC). So far little is known about the effects of bile acids on ENaC function. ENaC is probably a heterotrimer consisting of three well characterized subunits (). In humans, but not in mice and rats, an additional -subunit exists. The aim of this study was to investigate the effects of chenodeoxycholic, cholic, and deoxycholic acid in unconjugated (CDCA, CA, and DCA) and tauro-conjugated (t-CDCA, t-CA, t-DCA) form on human ENaC in its - and -configuration. We demonstrated that tauro-conjugated bile acids significantly stimulate ENaC in the - and in the -configuration. In contrast, non-conjugated bile acids have a robust stimulatory effect only on ENaC. Bile acids stimulate ENaC-mediated currents by increasing the open probability of active channels without recruiting additional near-silent channels known to be activated by proteases. Stimulation of ENaC activity by bile acids is accompanied by a significant reduction of the single-channel current amplitude, indicating an interaction of bile acids with a region close to the channel pore. Analysis of the known ASIC1 (acid-sensing ion channel) crystal structure suggested that bile acids may bind to the pore region at the degenerin site of ENaC. Substitution of a single amino acid residue within the degenerin region of ENaC (N521C or N521A) significantly reduced the stimulatory effect of bile acids on ENaC, suggesting that this site is critical for the functional interaction of bile acids with the channel.	[Ilyaskin, Alexandr V.; Diakov, Alexei; Korbmacher, Christoph; Haerteis, Silke] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Korbmacher, C (corresponding author), Inst Zellulare & Mol Physiol, Waldstr 6, D-91054 Erlangen, Germany.	christoph.korbmacher@fau.de	Haerteis, Silke/AGS-5314-2022	Haerteis, Silke/0000-0002-9440-3307	Deutsche Forschungsgemeinschaft (DFG) [HA 6655/1-1]; Johannes and Frieda Marohn Foundation; Deutscher Akademischer Austauschdienst (DAAD)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Johannes and Frieda Marohn Foundation; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (HA 6655/1-1 to S. H.), the Johannes and Frieda Marohn Foundation (to C. K.), and Deutscher Akademischer Austauschdienst (DAAD) (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article. Part of this work has been published in abstract form (65-67).	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Canessa CM, 2007, NATURE, V449, P293, DOI 10.1038/449293a; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Diakov A., 2014, ACTA PHYSIOL OXF SUP, V210, pOS1; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Diakov A, 2010, CELL PHYSIOL BIOCHEM, V26, P913, DOI 10.1159/000324000; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Giraldez T, 2007, J NEUROCHEM, V102, P1304, DOI 10.1111/j.1471-4159.2007.04622.x; Giraldez Teresa, 2013, Curr Mol Pharmacol, V6, P44; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Haerteis S, 2014, J BIOL CHEM, V289, P19067, DOI 10.1074/jbc.M113.538470; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; Haerteis S, 2012, PFLUG ARCH EUR J PHY, V464, P353, DOI 10.1007/s00424-012-1138-3; Haerteis S, 2012, CELL PHYSIOL BIOCHEM, V29, P761, DOI 10.1159/000312590; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Ilyaskin A, 2015, ACTA PHYSIOL, V213, P41; Ilyaskin A., 2015, ACTA PHYSIOL OXF SUP, V213, pP80; Ilyaskin A., 2014, ACTA PHYSIOL OXF SUP, V210, pP344; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; KORBMACHER C, 1995, J MEMBRANE BIOL, V146, P29; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Lefevre CMT, 2014, PFLUG ARCH EUR J PHY, V466, P253, DOI 10.1007/s00424-013-1310-4; Li Q, 2016, HEPATOLOGY, V63, P538, DOI 10.1002/hep.28301; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Mano N, 2004, J LIPID RES, V45, P1741, DOI 10.1194/jlr.M400157-JLR200; Mello-Vieira J, 2013, BBA-BIOMEMBRANES, V1828, P2152, DOI 10.1016/j.bbamem.2013.05.021; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Schmidt A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111549; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Waldmann R, 1996, GENOMICS, V37, P269, DOI 10.1006/geno.1996.0558; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wesch D, 2010, AM J PHYSIOL-CELL PH, V299, pC779, DOI 10.1152/ajpcell.00184.2010; West TA, 2005, CELL PHYSIOL BIOCHEM, V16, P263, DOI 10.1159/000089852; Wiemuth D, 2014, PFLUG ARCH EUR J PHY, V466, P1725, DOI 10.1007/s00424-013-1403-0; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Yamamura H, 2005, MOL PHARMACOL, V68, P1142, DOI 10.1124/mol.104.010850; Yamamura H, 2004, J BIOL CHEM, V279, P44483, DOI 10.1074/jbc.M408929200; Yamamura H, 2008, BIOCHEM BIOPH RES CO, V373, P155, DOI 10.1016/j.bbrc.2008.06.008; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116	69	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19835	19847		10.1074/jbc.M116.726471	http://dx.doi.org/10.1074/jbc.M116.726471			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27489102	hybrid, Green Published			2022-12-28	WOS:000383243100010
J	Rauch, JN; Zuiderweg, ERP; Gestwicki, JE				Rauch, Jennifer N.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.			Non-canonical Interactions between Heat Shock Cognate Protein 70 (Hsc70) and Bcl2-associated Anthanogene (BAG) Co-Chaperones Are Important for Client Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70 kilodalton heat shock protein (Hsp70); molecular chaperone; nuclear magnetic resonance (NMR); protein complex; protein-protein interaction	NUCLEOTIDE EXCHANGE FACTORS; HSP70 CHAPERONE; HEAT-SHOCK-PROTEIN-70 HSP70; ALLOSTERIC MECHANISM; CRYSTAL-STRUCTURE; BINDING DOMAIN; FACTOR GRPE; CONFORMATIONAL-CHANGES; THERMUS-THERMOPHILUS; MOLECULAR CHAPERONES	Heat shock cognate protein 70 (Hsc70) regulates protein homeostasis through its reversible interactions with client proteins. Hsc70 has two major domains: a nucleotide-binding domain (NBD), that hydrolyzes ATP, and a substrate-binding domain (SBD), where clients are bound. Members of the BAG family of co-chaperones, including Bag1 and Bag3, are known to accelerate release of both ADP and client from Hsc70. The release of nucleotide is known to be mediated by interactions between the conserved BAG domain and the Hsc70 NBD. However, less is known about the regions required for client release, and it is often assumed that this activity also requires the BAG domain. It is important to better understand this step because it determines how long clients remain in the inactive, bound state. Here, we report the surprising observation that truncated versions of either human Bag1 or Bag3, comprised only the BAG domain, promoted rapid release of nucleotide, but not client, in vitro. Rather, we found that a non-canonical interaction between Bag1/3 and the Hsc70 SBD is sufficient for accelerating this step. Moreover, client release did not seem to require the BAG domain or Hsc70 NBD. These results suggest that Bag1 and Bag3 control the stability of the Hsc70-client complex using at least two distinct protein-protein contacts, providing a previously under-appreciated layer of molecular regulation in the human Hsc70 system.	[Rauch, Jennifer N.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Gestwicki, JE (corresponding author), Univ Calif San Francisco, Sandler Ctr, 675 Nelson Rising Lane, San Francisco, CA 94158 USA.	jason.gestwicki@ucsf.edu	Rauch, Jennifer/AGI-2683-2022	Rauch, Jennifer/0000-0001-6853-5915	National Institutes of Health [NS059690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS059690. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams JL, 2014, J BIOL CHEM, V289, P13155, DOI 10.1074/jbc.M113.530014; Amick J, 2014, PROTEIN SCI, V23, P833, DOI 10.1002/pro.2466; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Arakawa A, 2010, STRUCTURE, V18, P309, DOI 10.1016/j.str.2010.01.004; Assimon VA, 2015, BIOCHEMISTRY-US, V54, P7120, DOI 10.1021/acs.biochem.5b00801; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Cesa LC, 2013, ACS CHEM BIOL, V8, P1988, DOI 10.1021/cb400356m; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; General IJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003624; Groemping Y, 2001, J MOL BIOL, V305, P1173, DOI 10.1006/jmbi.2000.4373; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kalia LV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014695; Kettern N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016398; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kityk R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9308; Li X., 2015, MOL CANCER THER, V16, P643; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Melero R, 2015, J BIOL CHEM, V290, P10083, DOI 10.1074/jbc.M114.623371; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rampelt H, 2011, METHODS MOL BIOL, V787, P83, DOI 10.1007/978-1-61779-295-3_7; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Revington M, 2004, J BIOL CHEM, V279, P33958, DOI 10.1074/jbc.M313967200; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE2794, DOI 10.1073/pnas.1601846113; Siegenthaler RK, 2006, J BIOL CHEM, V281, P34448, DOI 10.1074/jbc.M606382200; Slepenkov SV, 1998, BIOCHEMISTRY-US, V37, P16749, DOI 10.1021/bi981738k; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Van Durme J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000475; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Williams JM, 2015, MOL BIOL CELL, V26, P2181, DOI 10.1091/mbc.E15-01-0014; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518	55	31	34	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19848	19857		10.1074/jbc.M116.742502	http://dx.doi.org/10.1074/jbc.M116.742502			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27474739	hybrid, Green Published			2022-12-28	WOS:000383243100011
J	Zhang, YQ; Du, YZ; Jiang, DX; Behnke, C; Nomura, Y; Zhorov, BS; Dong, K				Zhang, Yongqiang; Du, Yuzhe; Jiang, Dingxin; Behnke, Caitlyn; Nomura, Yoshiko; Zhorov, Boris S.; Dong, Ke			The Receptor Site and Mechanism of Action of Sodium Channel Blocker Insecticides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computer modeling; electrophysiology; insect; ion channel; molecular modeling; DCJW; metaflumizone; mutational analysis	STATE-DEPENDENT BLOCK; PYRAZOLINE-TYPE INSECTICIDES; LOCAL-ANESTHETIC RECEPTOR; CRYSTAL-STRUCTURE; K+ CHANNEL; INHIBITOR INSECTICIDES; MEMBRANE-PROTEIN; LIGAND ACTION; NA+ CHANNELS; DRUG-BINDING	Sodium channels are excellent targets of both natural and synthetic insecticides with high insect selectivity. Indoxacarb, its active metabolite DCJW, and metaflumizone (MFZ) belong to a relatively new class of sodium channel blocker insecticides (SCBIs) with a mode of action distinct from all other sodium channel-targeting insecticides, including pyrethroids. Electroneutral SCBIs preferably bind to and trap sodium channels in the inactivated state, a mechanism similar to that of cationic local anesthetics. Previous studies identified several SCBI-sensing residues that face the inner pore of sodium channels. However, the receptor site of SCBIs, their atomic mechanisms, and the cause of selective toxicity of MFZ remain elusive. Here, we have built a homology model of the open-state cockroach sodium channel BgNa(v)1-1a. Our computations predicted that SCBIs bind in the inner pore, interact with a sodium ion at the focus of P1 helices, and extend their aromatic moiety into the III/IV domain interface (fenestration). Using model-driven mutagenesis and electrophysiology, we identified five new SCBI-sensing residues, including insect-specific residues. Our study proposes the first three-dimensional models of channel-bound SCBIs, sheds light on the molecular basis of MFZ selective toxicity, and suggests that a sodium ion located in the inner pore contributes to the receptor site for electroneutral SCBIs.	[Zhang, Yongqiang] Southwest Univ, Coll Plant Protect, Chongqing 400716, Peoples R China; [Zhang, Yongqiang; Du, Yuzhe; Jiang, Dingxin; Behnke, Caitlyn; Nomura, Yoshiko; Dong, Ke] Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA; [Zhang, Yongqiang; Du, Yuzhe; Jiang, Dingxin; Behnke, Caitlyn; Nomura, Yoshiko; Dong, Ke] Michigan State Univ, Dept Entomol, Neurosci Program, E Lansing, MI 48824 USA; [Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Zhorov, Boris S.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia; [Jiang, Dingxin] South China Agr Univ, Key Lab Nat Pesticide & Chem Biol, Minist Educ, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China	Southwest University - China; Michigan State University; Michigan State University; McMaster University; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; South China Agricultural University	Dong, K (corresponding author), Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA.; Dong, K (corresponding author), Michigan State Univ, Dept Entomol, Neurosci Program, E Lansing, MI 48824 USA.; Zhorov, BS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada.; Zhorov, BS (corresponding author), Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia.	zhorov@mcmaster.ca; dongk@msu.edu	Zhorov, Boris S./V-8072-2019; Zhorov, Boris/T-9892-2019	Zhorov, Boris/0000-0002-3630-7114	National Institutes of Health from NIGMS [GM057440]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04894]; China Scholar Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); China Scholar Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM057440 from NIGMS (K. D. and B. S. Z.) and Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2014-04894 (to B. S. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the China Scholar Council.	Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Balser JR, 1996, J GEN PHYSIOL, V107, P643, DOI 10.1085/jgp.107.5.643; Balser JR, 1996, J CLIN INVEST, V98, P2874, DOI 10.1172/JCI119116; BENNETT PB, 1995, CIRC RES, V77, P584, DOI 10.1161/01.RES.77.3.584; Bruhova I, 2005, BIOPHYS J, V89, P1020, DOI 10.1529/biophysj.105.062240; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Du YZ, 2016, J BIOL CHEM, V291, P4638, DOI 10.1074/jbc.M115.678672; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Du Y, 2011, J BIOL CHEM, V286, P13151, DOI 10.1074/jbc.M110.208496; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Fozzard HA, 2005, CURR PHARM DESIGN, V11, P2671, DOI 10.2174/1381612054546833; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Jiang DX, 2015, INSECT BIOCHEM MOLEC, V66, P88, DOI 10.1016/j.ibmb.2015.09.011; Korkosh VS, 2016, EUR BIOPHYS J BIOPHY, V45, P321, DOI 10.1007/s00249-015-1098-6; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Lipkind GM, 2005, MOL PHARMACOL, V68, P1611, DOI 10.1124/mol.105.014803; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McCann SF, 2001, PEST MANAG SCI, V57, P153, DOI 10.1002/1526-4998(200102)57:2<153::AID-PS288>3.0.CO;2-O; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Mike Arpad, 2010, Curr Mol Pharmacol, V3, P129; Naylor CE, 2016, EMBO J, V35, P820, DOI 10.15252/embj.201593285; Ohanessian G, 2002, INT J MASS SPECTROM, V219, P577, DOI 10.1016/S1387-3806(02)00744-3; Omae I, 2004, COORDIN CHEM REV, V248, P995, DOI 10.1016/j.ccr.2004.05.011; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Payne GT, 1998, PESTIC BIOCHEM PHYS, V60, P177, DOI 10.1006/pest.1998.2350; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007; Silver K, 2005, NEUROTOXICOLOGY, V26, P397, DOI 10.1016/j.neuro.2005.03.001; Silver KS, 2007, NEUROTOXICOLOGY, V28, P655, DOI 10.1016/j.neuro.2007.02.001; Silver KS, 2014, ADV INSECT PHYSIOL, V46, P389, DOI 10.1016/B978-0-12-417010-0.00005-7; Silver KS, 2009, NEUROTOXICOLOGY, V30, P613, DOI 10.1016/j.neuro.2009.03.009; Talley JM, 2002, CHEM-EUR J, V8, P1377, DOI 10.1002/1521-3765(20020315)8:6<1377::AID-CHEM1377>3.0.CO;2-D; Tan J, 2002, INSECT BIOCHEM MOLEC, V32, P445, DOI 10.1016/S0965-1748(01)00122-9; TATEBAYASHI H, 1994, J PHARMACOL EXP THER, V270, P595; Tikhonov DB, 2005, FEBS LETT, V579, P4207, DOI 10.1016/j.febslet.2005.07.017; Tikhonov DB, 2004, BIOPHYS J, V87, P1526, DOI 10.1529/biophysj.103.037770; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; Tikhonov DB, 2006, FEBS LETT, V580, P6027, DOI 10.1016/j.febslet.2006.10.035; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; von Stein RT, 2013, PESTIC BIOCHEM PHYS, V106, P101, DOI 10.1016/j.pestbp.2013.03.004; von Stein RT, 2012, NEUROTOXICOLOGY, V33, P1381, DOI 10.1016/j.neuro.2012.09.003; von Stein RT, 2012, MOL PHARMACOL, V81, P366, DOI 10.1124/mol.111.075283; Wang P, 2008, J MASS SPECTROM, V43, P485, DOI 10.1002/jms.1336; Wang XL, 2016, INSECT SCI, V23, P50, DOI 10.1111/1744-7917.12226; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Wing K.D., 2005, COMPR MOL INSECT SCI, V6, P31; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhorov BS, 2013, TRENDS PHARMACOL SCI, V34, P154, DOI 10.1016/j.tips.2013.01.002; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	22	24	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20113	20124		10.1074/jbc.M116.742056	http://dx.doi.org/10.1074/jbc.M116.742056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27489108	Green Published, hybrid			2022-12-28	WOS:000383243100032
J	Zhuo, Y; Yang, JY; Moremen, KW; Prestegard, JH				Zhuo, You; Yang, Jeong-Yeh; Moremen, Kelley W.; Prestegard, James H.			Glycosylation Alters Dimerization Properties of a Cell-surface Signaling Protein, Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; dimerization; glycosylation; nuclear magnetic resonance (NMR); structural model	TUMOR-SUPPRESSOR CEACAM1; N-TERMINAL DOMAIN; HOMOPHILIC ADHESION; NEISSERIA-MENINGITIDIS; STRUCTURAL-ANALYSIS; IG SUPERFAMILY; OPA PROTEINS; EXPRESSION; BINDING; CANCER	Human carcinoembryonic antigen-related cell adhesion molecule 1 (C?/Au: EACAM1) is a cell-surface signaling molecule involved in cell adhesion, proliferation, and immune response. It is also implicated in cancer angiogenesis, progression, and metastasis. This diverse set of effects likely arises as a result of the numerous homophilic and heterophilic interactions that CEACAM1 can have with itself and other molecules. Its N-terminal Ig variable (Ig(V)) domain has been suggested to be a principal player in these interactions. Previous crystal structures of the -sandwich-like Ig(V) domain have been produced using Escherichia coli-expressed material, which lacks native glycosylation. These have led to distinctly different proposals for dimer interfaces, one involving interactions of ABED -strands and the other involving GFCCC -strands, with the former burying one prominent glycosylation site. These structures raise questions as to which form may exist in solution and what the effect of glycosylation may have on this form. Here, we use NMR cross-correlation measurements to examine the effect of glycosylation on CEACAM1-Ig(V) dimerization and use residual dipolar coupling (RDC) measurements to characterize the solution structure of the non-glycosylated form. Our findings demonstrate that even addition of a single N-linked GlcNAc at potential glycosylation sites inhibits dimer formation. Surprisingly, RDC data collected on E. coli expressed material in solution indicate that a dimer using the non-glycosylated GFCCC interface is preferred even in the absence of glycosylation. The results open new questions about what other factors may facilitate dimerization of CEACAM1 in vivo, and what roles glycosylation may play in heterophylic interactions.	[Zhuo, You; Yang, Jeong-Yeh; Moremen, Kelley W.; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Prestegard, JH (corresponding author), 315 Riverbend Rd, Athens, GA 30602 USA.	jpresteg@ccrc.uga.edu	Moremen, Kelley/AAD-4661-2019		National Institutes of Health [R01GM033225, P41GM103390]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM033225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM033225 and P41GM103390. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Bonsor DA, 2015, P NATL ACAD SCI USA, V112, P13561, DOI 10.1073/pnas.1509511112; Bucior I, 2004, J CELL BIOL, V165, P529, DOI 10.1083/jcb.200309005; Chen ZG, 2011, J EXP MED, V208, P2633, DOI 10.1084/jem.20102575; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Esteban-Martin S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003721; Fedarovich A, 2006, ACTA CRYSTALLOGR D, V62, P971, DOI 10.1107/S0907444906020737; Goddard D., 2008, SPARKY 3; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HSIEH JT, 1995, CANCER RES, V55, P190; Huang YH, 2016, NATURE, V536, P359, DOI 10.1038/nature17421; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Kang WY, 2007, INT J COLORECTAL DIS, V22, P869, DOI 10.1007/s00384-006-0247-x; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Korotkova N, 2008, MOL MICROBIOL, V67, P420, DOI 10.1111/j.1365-2958.2007.06054.x; Lawson EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029606; Lee HW, 2010, PROTEIN SCI, V19, P1673, DOI 10.1002/pro.447; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Liu YZ, 2008, J MAGN RESON, V193, P23, DOI 10.1016/j.jmr.2008.03.013; Liu YZ, 2009, J MAGN RESON, V200, P109, DOI 10.1016/j.jmr.2009.06.010; Markel G, 2004, J IMMUNOL, V173, P3732, DOI 10.4049/jimmunol.173.6.3732; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Markel G, 2010, CANCER IMMUNOL IMMUN, V59, P215, DOI 10.1007/s00262-009-0740-5; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Neumaier C, 2012, ONKOLOGIE, V35, P563, DOI 10.1159/000342673; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; Obrink B, 2008, LUNG CANCER, V60, P309, DOI 10.1016/j.lungcan.2008.03.020; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Patel PC, 2013, J BIOL CHEM, V288, P29654, DOI 10.1074/jbc.M113.504639; Pavlopoulou A, 2014, GENOME BIOL EVOL, V6, P1314, DOI 10.1093/gbe/evu103; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Sappino AP, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.7; Schmidt C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-302; Simeone DM, 2007, PANCREAS, V34, P436, DOI 10.1097/MPA.0b013e3180333ae3; Stern N, 2005, J IMMUNOL, V174, P6692, DOI 10.4049/jimmunol.174.11.6692; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Taheri M, 2000, J BIOL CHEM, V275, P26935; Tchoupa AK, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-27; Tilki D, 2010, EUR UROL, V57, P648, DOI 10.1016/j.eururo.2009.05.040; Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Virji M, 2000, TRENDS MICROBIOL, V8, P260, DOI 10.1016/S0966-842X(00)01772-8; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Volpert O, 2002, J BIOL CHEM, V277, P35696, DOI 10.1074/jbc.M205319200; Wang X, 2008, PROTEIN SCI, V17, P899, DOI 10.1110/ps.073395108; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; ZHOU H, 1993, J CELL BIOL, V122, P951, DOI 10.1083/jcb.122.4.951	59	24	25	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20085	20095		10.1074/jbc.M116.740050	http://dx.doi.org/10.1074/jbc.M116.740050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27471271	hybrid, Green Published			2022-12-28	WOS:000383243100030
J	Goyal, A; Gubbiotti, MA; Chery, DR; Han, L; Iozzo, RV				Goyal, Atul; Gubbiotti, Maria A.; Chery, Daphney R.; Han, Lin; Iozzo, Renato V.			Endorepellin-evoked Autophagy Contributes to Angiostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); angiogenesis; atomic force microscopy (AFM); Beclin-1 (BECN1); perlecan; proteoglycan	HEPARAN-SULFATE PROTEOGLYCAN; BASEMENT-MEMBRANE PROTEOGLYCANS; DENSITY-LIPOPROTEIN-RECEPTOR; ACTIVATED PROTEIN-KINASE; ATOMIC-FORCE; CELL-ADHESION; EXTRACELLULAR-MATRIX; HYALURONAN SYNTHESIS; REGULATE AUTOPHAGY; ENDOTHELIAL-CELLS	Endorepellin, the C-terminal domain of perlecan, is an angiostatic molecule that acts as a potent inducer of autophagy via its interaction with VEGFR2. In this study, we examined the effect of endorepellin on endothelial cells using atomic force microscopy. Soluble endorepellin caused morphological and biophysical changes such as an increase in cell surface roughness and cell height. Surprisingly, these changes were not accompanied by alterations in the endothelial cell elastic modulus. We discovered that endorepellin-induced autophagic flux led to co-localization of mammalian target of rapamycin with LC3-positive autophagosomes. Endorepellin functioned upstream of AMP-activated kinase , as compound C, an inhibitor of AMP-activated kinase , abrogated endorepellin-mediated activation and co-localization of Beclin 1 and LC3, thereby reducing autophagic progression. Functionally, we discovered that both endorepellin and Torin 1, a canonical autophagic inducer, blunted ex vivo angiogenesis. We conclude that autophagy is a novel mechanism by which endorepellin promotes angiostasis independent of nutrient deprivation.	[Goyal, Atul; Gubbiotti, Maria A.; Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Goyal, Atul; Gubbiotti, Maria A.; Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA; [Chery, Daphney R.; Han, Lin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Jefferson University; Jefferson University; Drexel University	Iozzo, RV (corresponding author), Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336 JAH, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Lin, Han/GRF-1081-2022; Iozzo, Renato/AAS-1980-2020; Han, Lin/D-2602-2014	Han, Lin/0000-0003-4180-1288; Iozzo, Renato/0000-0002-5908-5112	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA164462, T32 AA07463]; Department of Education GAANN Program; Drexel Interdisciplinary Collaboration and Research Enterprise (iCARE); Drexel; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA164462, R01CA047282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education GAANN Program(US Department of Education); Drexel Interdisciplinary Collaboration and Research Enterprise (iCARE); Drexel; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Training Grant T32 AA07463.; Supported by the Department of Education GAANN Program and a Drexel Interdisciplinary Collaboration and Research Enterprise (iCARE) for Healthcare fellowship.; Supported by a Drexel faculty startup grant.	Apte SS, 2015, MATRIX BIOL, V44-46, P1, DOI 10.1016/j.matbio.2015.04.005; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Braet F, 1998, J MICROSC-OXFORD, V190, P328, DOI 10.1046/j.1365-2818.1998.00333.x; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Cannon JE, 2010, BRIT J PHARMACOL, V161, P140, DOI 10.1111/j.1476-5381.2010.00871.x; CARSON DD, 1993, DEV BIOL, V155, P97, DOI 10.1006/dbio.1993.1010; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; COHEN IR, 1994, CANCER RES, V54, P5771; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Du JH, 2012, AM J PHYSIOL-CELL PH, V302, pC383, DOI 10.1152/ajpcell.00164.2011; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Goyal A, 2014, MATRIX BIOL, V34, P46, DOI 10.1016/j.matbio.2013.12.011; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Grindel BJ, 2014, MATRIX BIOL, V36, P64, DOI 10.1016/j.matbio.2014.04.005; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Gustafsson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053715; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Jochmann K, 2014, MATRIX BIOL, V34, P55, DOI 10.1016/j.matbio.2013.11.003; Jung M, 2013, J BIOL CHEM, V288, P3289, DOI 10.1074/jbc.M112.387811; Kaji T, 2006, BBA-GEN SUBJECTS, V1760, P1465, DOI 10.1016/j.bbagen.2006.06.010; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Kumar S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.399; Lee J.H., 2010, INT J TISSUE REGEN, V1, P1, DOI [DOI 10.1109/IPFA.2010.5532306, DOI 10.1371/J0URNAL.P0NE.0015394]; Lekka M, 2016, BIONANOSCIENCE, V6, P65, DOI 10.1007/s12668-016-0191-3; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20639; Lord MS, 2014, MATRIX BIOL, V35, P112, DOI 10.1016/j.matbio.2014.01.016; Lord MS, 2014, MATRIX BIOL, V35, P123, DOI 10.1016/j.matbio.2013.12.005; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathiak M, 1997, CANCER RES, V57, P2130; Mathur AB, 2000, BIOPHYS J, V78, P1725, DOI 10.1016/S0006-3495(00)76724-5; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, AM J PATHOL, V184, P2146, DOI 10.1016/j.ajpath.2014.05.010; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; Nikolaev NI, 2014, J BIOMECH, V47, P625, DOI 10.1016/j.jbiomech.2013.12.004; Ning L, 2015, MATRIX BIOL, V48, P26, DOI 10.1016/j.matbio.2015.08.002; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Pan C. C., 2016, ONCOTARGET, DOI 10.18632/oncotarget.9307; Peysselon F, 2014, MATRIX BIOL, V35, P73, DOI 10.1016/j.matbio.2013.11.001; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Sharma B, 1998, J BIOL CHEM, V273, P4642, DOI 10.1074/jbc.273.8.4642; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vadon-Le Goff S, 2015, MATRIX BIOL, V44-46, P14, DOI 10.1016/j.matbio.2015.02.006; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2014, MATRIX BIOL, V35, P8, DOI 10.1016/j.matbio.2013.10.002; Wang A, 2015, MATRIX BIOL, V48, P36, DOI 10.1016/j.matbio.2015.04.003; Wells JM, 2015, MATRIX BIOL, V44-46, P122, DOI 10.1016/j.matbio.2015.01.016; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Wilusz RE, 2014, MATRIX BIOL, V39, P25, DOI 10.1016/j.matbio.2014.08.009; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	85	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19245	19256		10.1074/jbc.M116.740266	http://dx.doi.org/10.1074/jbc.M116.740266			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27435676	hybrid, Green Published			2022-12-28	WOS:000383242800004
J	de Queiroz, RM; Madan, R; Chien, J; Dias, WB; Slawson, C				de Queiroz, Rafaela Muniz; Madan, Rashna; Chien, Jeremy; Dias, Wagner Barbosa; Slawson, Chad			Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MODIFICATION; HEXOSAMINE BIOSYNTHESIS; TUMOR SUPPRESSION; X-CHROMOSOME; GLCNACYLATION; PHOSPHORYLATION; GLYCOSYLATION; TRANSCRIPTION; TRANSFERASE; RESISTANCE	O-GlcNAcylation is a dynamic post-translational modification consisting of the addition of a single N-acetylglucosamine sugar to serine and threonine residues in proteins by the enzyme O-linked beta-N-acetylglucosamine transferase (OGT), whereas the enzyme O-GlcNAcase (OGA) removes the modification. In cancer, tumor samples present with altered O-GlcNAcylation; however, changes in O-GlcNAcylation are not consistent between tumor types. Interestingly, the tumor suppressor p53 is modified by O-GlcNAc, and most solid tumors contain mutations in p53 leading to the loss of p53 function. Because ovarian cancer has a high frequency of p53 mutation rates, we decided to investigate the relationship between O-GlcNAcylation and p53 function in ovarian cancer. We measured a significant decrease in O-GlcNAcylation of tumor tissue in an ovarian tumor microarray. Furthermore, O-GlcNAcylation was increased, and OGA protein and mRNA levels were decreased in ovarian tumor cell lines not expressing the protein p53. Treatment with the OGA inhibitor Thiamet-G (TMG), silencing of OGA, or overexpression of OGA and OGT led to p53 stabilization, increased nuclear localization, and increased protein and mRNA levels of p53 target genes. These data suggest that changes in O-GlcNAc homeostasis activate the p53 pathway. Combination treatment of the chemotherapeutic cisplatin with TMG decreased tumor cell growth and enhanced cell cycle arrest without impairing cytotoxicity. The effects of TMG on tumor cell growth were partially dependent on wild type p53 activation. In conclusion, changes in O-GlcNAc homeostasis activate the wild type p53 pathway in ovarian cancer cells, and OGA inhibition has the potential as an adjuvant treatment for ovarian carcinoma.	[de Queiroz, Rafaela Muniz; Dias, Wagner Barbosa] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, BR-21941902 Rio De Janeiro, RJ, Brazil; [Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Chien, Jeremy] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA; [Madan, Rashna] Univ Kansas, Med Ctr, Dept Pathol, Div Hematol Oncol, Kansas City, KS 66160 USA	Universidade Federal do Rio de Janeiro; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Dias, WB (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, BR-21941902 Rio De Janeiro, RJ, Brazil.; Slawson, C (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	diaswb@biof.ufrj.br; cslawson@kumc.edu	Dias, Wagner/B-1401-2016; Chien, Jeremy/AID-8939-2022	Dias, Wagner/0000-0002-8378-8846; Chien, Jeremy/0000-0003-4744-8374; Muniz de Queiroz, Rafaela/0000-0001-5962-9071	NCI Cancer Center Support Grant from National Institutes of Health [P30 CA168524]; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant from National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Biospecimen Core Resources was recipient of NCI Cancer Center Support Grant P30 CA168524 from the National Institutes of Health.	Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dashzeveg N, 2015, CANCER LETT, V367, P108, DOI 10.1016/j.canlet.2015.07.019; de Queiroz RM, 2014, CANCER INVEST, V32, P226, DOI 10.3109/07357907.2014.905587; de Queirozl RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00132; Dias WB, 2012, BIOCHEM BIOPH RES CO, V422, P224, DOI 10.1016/j.bbrc.2012.04.124; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Gurel Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095561; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Krzeslak A, 2010, INT J MOL MED, V25, P643, DOI 10.3892/ijmm_00000387; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Malaguarnera R, 2007, ENDOCR-RELAT CANCER, V14, P43, DOI 10.1677/erc.1.01223; Malmlof M, 2007, J BIOL CHEM, V282, P2288, DOI 10.1074/jbc.M604953200; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Peternelj TT, 2015, BIOCHEM CELL BIOL, V93, P63, DOI 10.1139/bcb-2014-0106; Peternelj TT, 2015, MOL CELL BIOCHEM, V400, P265, DOI 10.1007/s11010-014-2283-0; Schuijer M, 2003, HUM MUTAT, V21, P285, DOI 10.1002/humu.10181; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Van Maerken T, 2014, CANCER LETT, V344, P157, DOI 10.1016/j.canlet.2013.11.002; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; Venkatachalam S, 2001, TOXICOL PATHOL, V29, P147, DOI 10.1080/019262301753178555; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang XY, 2015, CANCER RES, V75, P5001, DOI 10.1158/0008-5472.CAN-15-0563; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zhang Cen, 2015, RNA Dis, V2, pe502; Zhang EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143814; Zhang X, 2014, ONCOTARGET, V5, P11365, DOI 10.18632/oncotarget.2497; Zhang XM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00094; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhong J, 2015, PROTEOMICS, V15, P591, DOI 10.1002/pmic.201400339	52	52	53	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18897	18914		10.1074/jbc.M116.734533	http://dx.doi.org/10.1074/jbc.M116.734533			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402830	Green Published, hybrid			2022-12-28	WOS:000383242300027
J	Gao, XF; Pham, TH; Feuerbacher, LA; Chen, KM; Hays, MP; Singh, G; Rueter, C; Hurtado-Guerrero, R; Hardwidge, PR				Gao, Xiaofei; Pham, Thanh H.; Feuerbacher, Leigh Ann; Chen, Kangming; Hays, Michael P.; Singh, Gyanendra; Rueter, Christian; Hurtado-Guerrero, Ramon; Hardwidge, Philip R.			Citrobacter rodentium NleB Protein Inhibits Tumor Necrosis Factor (TNF) Receptor-associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; infection; innate immunity; interferon; signal transduction	NF-KAPPA-B; ENTEROPATHOGENIC ESCHERICHIA-COLI; ANTIVIRAL RESPONSE; GENE-EXPRESSION; IKK-EPSILON; CELL-DEATH; ACTIVATION; EFFECTOR; LIPOPOLYSACCHARIDE; DEFENSE	Interferon signaling plays important roles in both intestinal homeostasis and in the host response to pathogen infection. The extent to which bacterial pathogens inhibit this host pathway is an understudied area of investigation. We characterized Citrobacter rodentium strains bearing deletions in individual type III secretion system effector genes to determine whether this pathogen inhibits the host type I IFN response and which effector is responsible. The NleB effector limited host IFN- production by inhibiting Lys(63)-linked ubiquitination of TNF receptor-associated factor 3 (TRAF3). Inhibition was dependent on the glycosyltransferase activity of NleB. GAPDH, a target of NleB during infection, bound to TRAF3 and was required for maximal TRAF3 ubiquitination. NleB glycosyltransferase activity inhibited GAPDH-TRAF3 binding, resulting in reduced TRAF3 ubiquitination. Collectively, our data reveal important interplay between GAPDH and TRAF3 and suggest a mechanism by which the NleB effector inhibits type I IFN signaling.	[Gao, Xiaofei] Whitehead Inst, Cambridge, MA 02142 USA; [Pham, Thanh H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Feuerbacher, Leigh Ann; Chen, Kangming; Hays, Michael P.; Hardwidge, Philip R.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Singh, Gyanendra] Natl Inst Occupat Hlth, Ahmadabad 380016, Gujarat, India; [Rueter, Christian] Univ Munster, Inst Infectiol, D-48149 Munster, Germany; [Hurtado-Guerrero, Ramon] Fdn ARAID, Edificio CEEI ARAGON, Zaragoza 50018, Spain; [Hurtado-Guerrero, Ramon] Univ Zaragoza, BIFI IQFR CSIC Joint Unit, Inst Biocomputat & Phys Complex Syst BIFI, Mariano Esquillor S-N,Campus Rio Ebro,Edificio I, Zaragoza 50018, Spain	Massachusetts Institute of Technology (MIT); Whitehead Institute; Case Western Reserve University; Kansas State University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Occupational Health (NIOH); University of Munster; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza	Hardwidge, PR (corresponding author), Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA.	hardwidg@vet.k-state.edu	Rüter, Christian/B-5127-2017	Rüter, Christian/0000-0003-1982-4811; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; PHAM, THANH/0000-0001-8959-7947	NIAID, National Institutes of Health [AI093913]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI127973, R21AI093913] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant AI093913. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BELARDELLI F, 1995, APMIS, V103, P161, DOI 10.1111/j.1699-0463.1995.tb01092.x; Caillaud A, 2005, J BIOL CHEM, V280, P17671, DOI 10.1074/jbc.M411389200; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Dang O, 2004, J IMMUNOL, V172, P747, DOI 10.4049/jimmunol.172.2.747; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Gold JA, 2004, INFECT IMMUN, V72, P1291, DOI 10.1128/IAI.72.3.1291-1297.2004; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Long TM, 2014, INFECT IMMUN, V82, P2802, DOI 10.1128/IAI.00105-14; Lung TWF, 2016, INFECT IMMUN, V84, P1346, DOI 10.1128/IAI.01523-15; Mogensen KE, 1999, J INTERF CYTOK RES, V19, P1069, DOI 10.1089/107999099313019; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Rani MRS, 2010, J INTERF CYTOK RES, V30, P163, DOI 10.1089/jir.2009.0032; Sanchez-Villamil J, 2015, FUTURE MICROBIOL, V10, P1009, DOI [10.2217/FMB.15.17, 10.2217/fmb.15.17]; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Wang XG, 2012, CELL MICROBIOL, V14, P1231, DOI 10.1111/j.1462-5822.2012.01793.x	35	14	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18232	18238		10.1074/jbc.M116.738278	http://dx.doi.org/10.1074/jbc.M116.738278			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387501	hybrid, Green Published			2022-12-28	WOS:000383241800016
J	Jain, K; Warmack, RA; Debler, EW; Hadjikyriacou, A; Stavropoulos, P; Clarke, SG				Jain, Kanishk; Warmack, Rebeccah A.; Debler, Erik W.; Hadjikyriacou, Andrea; Stavropoulos, Peter; Clarke, Steven G.			Protein Arginine Methyltransferase Product Specificity Is Mediated by Distinct Active-site Architectures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; epigenetics; histone methylation; post-translational modification (PTM); protein methylation; PRMT; PRMT product specificity; methyltransferase; protein arginine methylation	SYMMETRIC DIMETHYLATION; POSTTRANSLATIONAL MODIFICATIONS; EPIGENETIC REGULATION; TRYPANOSOMA-BRUCEI; BREAST-CANCER; HISTONE H4; 7 PRMT7; METHYLATION; EXPRESSION; BIOLOGY	In the family of protein arginine methyltransferases (PRMTs) that predominantly generate either asymmetric or symmetric dimethylarginine (SDMA), PRMT7 is unique in producing solely monomethylarginine (MMA) products. The type of methylation on histones and other proteins dictates changes in gene expression, and numerous studies have linked altered profiles of methyl marks with disease phenotypes. Given the importance of specific inhibitor development, it is crucial to understand the mechanisms by which PRMT product specificity is conferred. We have focused our attention on active-site residues of PRMT7 from the protozoan Trypanosoma brucei. We have designed 26 single and double mutations in the active site, including residues in the Glu-Xaa(8)-Glu (double E) loop and the Met-Gln-Trp sequence of the canonical Thr-His-Trp (THW) loop known to interact with the methyl-accepting substrate arginine. Analysis of the reaction products by high resolution cation exchange chromatography combined with the knowledge of PRMT crystal structures suggests a model where the size of two distinct subregions in the active site determines PRMT7 product specificity. A dual mutation of Glu-181 to Asp in the double E loop and Gln-329 to Ala in the canonical THW loop enables the enzyme to produce SDMA. Consistent with our model, the mutation of Cys-431 to His in the THW loop of human PRMT9 shifts its product specificity from SDMA toward MMA. Together with previous results, these findings provide a structural basis and a general model for product specificity in PRMTs, which will be useful for the rational design of specific PRMT inhibitors.	[Jain, Kanishk; Warmack, Rebeccah A.; Hadjikyriacou, Andrea; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA; [Jain, Kanishk; Warmack, Rebeccah A.; Hadjikyriacou, Andrea; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA; [Debler, Erik W.; Stavropoulos, Peter] Rockefeller Univ, Cell Biol Lab, New York, NY 10065 USA; [Stavropoulos, Peter] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rockefeller University; Rockefeller University	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.; Clarke, SG (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu		Jain, Kanishk/0000-0001-8039-0464; Debler, Erik/0000-0002-2587-2150; Clarke, Steven/0000-0002-7303-6632	National Institutes of Health [GM026020]; Ruth L. Kirschstein National Service Award [GM007185];  [DRG-1977-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM026020 (to S. G. C.) and Ruth L. Kirschstein National Service Award GM007185 (to K. J., R. A. W., and A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Frey Fellow of the Damon Runyon Cancer Research Foundation supported by Grant DRG-1977-08.	Baldwin RM, 2015, ONCOTARGET, V6, P3013, DOI 10.18632/oncotarget.3072; Bao XX, 2013, J HISTOCHEM CYTOCHEM, V61, P206, DOI 10.1369/0022155413475452; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Cura V, 2014, ACTA CRYSTALLOGR D, V70, P2401, DOI 10.1107/S1399004714014278; Debler EW, 2016, P NATL ACAD SCI USA, V113, P2068, DOI 10.1073/pnas.1525783113; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Ferreira TR, 2014, MOL MICROBIOL, V94, P1085, DOI 10.1111/mmi.12819; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Fuhrmann J, 2016, ACS CHEM BIOL, V11, P654, DOI 10.1021/acschembio.5b00942; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Gui SY, 2014, J BIOL CHEM, V289, P9320, DOI 10.1074/jbc.M113.535278; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Hu H, 2016, EXPERT OPIN INV DRUG, V25, P335, DOI 10.1517/13543784.2016.1144747; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Lott K, 2014, MICROBIOLOGYOPEN, V3, P595, DOI 10.1002/mbo3.191; Martens-Lobenhoffer J, 2016, ANAL BIOCHEM, V493, P14, DOI 10.1016/j.ab.2015.10.001; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Morales Y, 2016, ARCH BIOCHEM BIOPHYS, V590, P138, DOI 10.1016/j.abb.2015.11.030; Schapira M, 2016, CURR OPIN CHEM BIOL, V33, P81, DOI 10.1016/j.cbpa.2016.05.030; Schapira M, 2014, MEDCHEMCOMM, V5, P1779, DOI 10.1039/c4md00269e; Suarez-Calvet M, 2016, ACTA NEUROPATHOL, V131, P587, DOI 10.1007/s00401-016-1544-2; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Tarighat SS, 2016, LEUKEMIA, V30, P789, DOI 10.1038/leu.2015.308; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang CY, 2014, STRUCTURE, V22, P756, DOI 10.1016/j.str.2014.03.003; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wang YC, 2014, CELL RES, V24, P143, DOI 10.1038/cr.2013.151; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	40	28	29	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18299	18308		10.1074/jbc.M116.740399	http://dx.doi.org/10.1074/jbc.M116.740399			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387499	Green Published, hybrid			2022-12-28	WOS:000383241800022
J	Kountz, TS; Lee, KS; Aggarwal-Howarth, S; Curran, E; Park, JM; Harris, DA; Stewart, A; Hendrickson, J; Camp, ND; Wolf-Yadlin, A; Wang, EH; Scott, JD; Hague, C				Kountz, Timothy S.; Lee, Kyung-Soon; Aggarwal-Howarth, Stacey; Curran, Elizabeth; Park, Ji-Min; Harris, Dorathy-Ann; Stewart, Aaron; Hendrickson, Joseph; Camp, Nathan D.; Wolf-Yadlin, Alejandro; Wang, Edith H.; Scott, John D.; Hague, Chris			Endogenous N-terminal Domain Cleavage Modulates alpha(1D)-Adrenergic Receptor Pharmacodynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adrenergic receptor; catecholamine; cell signaling; cell surface receptor; G protein-coupled receptor (GPCR); molecular pharmacology; PDZ domain; N-terminus; alpha1D adre; label-free signaling	PROTEIN-COUPLED RECEPTORS; BLADDER OUTLET OBSTRUCTION; CELL-SURFACE EXPRESSION; VASCULAR SMOOTH-MUSCLE; ALPHA(1)-ADRENOCEPTOR SUBTYPES; BETA(1)-ADRENERGIC RECEPTOR; ALPHA-1D ADRENOCEPTOR; ANTAGONIST TAMSULOSIN; BINDING; LOCALIZATION	The (1D)-adrenergic receptor (ADRA1D) is a key regulator of cardiovascular, prostate, and central nervous system functions. This clinically relevant G protein-coupled receptor has proven difficult to study, as it must form an obligate modular homodimer containing the PDZ proteins scribble and syntrophin or become retained in the endoplasmic reticulum as non-functional protein. We previously determined that targeted removal of the N-terminal (NT) 79 amino acids facilitates ADRA1D plasma membrane expression and agonist-stimulated functional responses. However, whether such an event occurs in physiological contexts was unknown. Herein, we report the ADRA1D is subjected to innate NT processing in cultured human cells. SNAP near-infrared imaging and tandem-affinity purification revealed the ADRA1D is expressed as both full-length and NT truncated forms in multiple human cell lines. Serial truncation mapping identified the cleavage site as Leu(90)/Val(91) in the 95-amino acid ADRA1D NT domain, suggesting human cells express a 1-91 ADRA1D species. Tandem-affinity purification MS/MS and co-immunoprecipitation analysis indicate NT processing of ADRA1D is not required to form scribble-syntrophin macromolecular complexes. Yet, label-free dynamic mass redistribution signaling assays demonstrate that 1-91 ADRA1D agonist responses were greater than WT ADRA1D. Mutagenesis of the cleavage site nullified the processing event, resulting in ADRA1D agonist responses less than the WT receptor. Thus, we propose that processing of the ADRA1D NT domain is a physiological mechanism employed by cells to generate a functional ADRA1D isoform with optimal pharmacodynamic properties.	[Aggarwal-Howarth, Stacey; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Kountz, Timothy S.; Lee, Kyung-Soon; Aggarwal-Howarth, Stacey; Curran, Elizabeth; Park, Ji-Min; Harris, Dorathy-Ann; Stewart, Aaron; Hendrickson, Joseph; Wang, Edith H.; Scott, John D.; Hague, Chris] Univ Washington, Sch Med, Dept Pharmacol, 1959 Pacific Ave,Box 357280, Seattle, WA 98195 USA; [Camp, Nathan D.; Wolf-Yadlin, Alejandro] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hague, C (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, 1959 Pacific Ave,Box 357280, Seattle, WA 98195 USA.	chague@uw.edu	Wolf-Yadlin, Alejandro/E-6574-2011	Wolf-Yadlin, Alejandro/0000-0003-2909-3880	National Institutes of Health [RO1 GM100893, DK054441, DK105542]; National Institutes of Health, USPHS, National Research Service Award [T32GM007270]; National Institutes of Health Human Genome Research Institute [T32 HG00035]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441, R01DK105542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100893, T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, USPHS, National Research Service Award; National Institutes of Health Human Genome Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants RO1 GM100893 (to C. H.) and DK054441 and DK105542 (to J. D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health, USPHS, National Research Service Award, T32GM007270.; Supported by National Institutes of Health Human Genome Research Institute Grant T32 HG00035.	Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Aono Y, 2015, BEHAV PHARMACOL, V26, P73, DOI 10.1097/FBP.0000000000000113; Belmer A, 2014, MOL PHARMACOL, V85, P127, DOI 10.1124/mol.113.089086; Bouchelouche K, 2005, J UROLOGY, V173, P657, DOI 10.1097/01.ju.0000143198.16610.84; Camp ND, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.11; Chalothorn D, 2002, MOL PHARMACOL, V61, P1008, DOI 10.1124/mol.61.5.1008; Chen Q, 2005, J UROLOGY, V174, P370, DOI 10.1097/01.ju.0000161210.17365.cc; Chen ZJ, 2006, J BIOL CHEM, V281, P12414, DOI 10.1074/jbc.M508651200; Dunham JH, 2009, BIOCHEMISTRY-US, V48, P10286, DOI 10.1021/bi9013775; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Fan LL, 2009, ACTA PHARMACOL SIN, V30, P1585, DOI 10.1038/aps.2009.160; Fang Ye, 2007, Journal of Pharmacological and Toxicological Methods, V55, P314, DOI 10.1016/j.vascn.2006.11.001; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; Garcia-Cazarin Mary L, 2008, J Mol Signal, V3, P6, DOI 10.1186/1750-2187-3-6; Garcia-Sainz JA, 2004, EUR J PHARMACOL, V500, P113, DOI 10.1016/j.ejphar.2004.07.016; Gong HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034003; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Hague C, 2006, MOL PHARMACOL, V69, P45, DOI 10.1124/mol.105.014985; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Hague C, 2004, J PHARMACOL EXP THER, V309, P388, DOI 10.1124/jpet.103.060509; Hakalahti AE, 2013, MOL PHARMACOL, V83, P129, DOI 10.1124/mol.112.080440; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Hampel C, 2002, J UROLOGY, V167, P1513, DOI 10.1016/S0022-5347(05)65355-4; Jensen BC, 2009, J AM COLL CARDIOL, V54, P1137, DOI 10.1016/j.jacc.2009.05.056; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Kojima Y, 2011, J UROLOGY, V186, P1530, DOI 10.1016/j.juro.2011.05.048; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Levin MC, 2002, J BIOL CHEM, V277, P30429, DOI 10.1074/jbc.M200681200; Lin ZC, 2004, PHARMACOGENETICS, V14, P805, DOI 10.1097/00008571-200412000-00003; Lyssand JS, 2008, J BIOL CHEM, V283, P18792, DOI 10.1074/jbc.M801860200; Lyssand JS, 2010, P NATL ACAD SCI USA, V107, P21854, DOI 10.1073/pnas.1010819107; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; McCune DF, 2000, MOL PHARMACOL, V57, P659, DOI 10.1124/mol.57.4.659; Minneman KP, 2000, J NEUROCHEM, V74, P2392, DOI 10.1046/j.1471-4159.2000.0742392.x; Mishima K, 2004, BEHAV BRAIN RES, V152, P365, DOI 10.1016/j.bbr.2003.10.038; Morelli MB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-921; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Pace AJ, 1999, J BIOL CHEM, V274, P11629, DOI 10.1074/jbc.274.17.11629; PEREZ DM, 1991, MOL PHARMACOL, V40, P876; Petrovska R, 2005, BRIT J PHARMACOL, V144, P651, DOI 10.1038/sj.bjp.0706087; PIASCIK MT, 1994, MOL PHARMACOL, V46, P30; Piascik MT, 1995, J PHARMACOL EXP THER, V275, P1583; Pupo AS, 2003, EUR J PHARMACOL, V462, P1, DOI 10.1016/S0014-2999(03)01292-5; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Sadalge A, 2003, MOL PSYCHIATR, V8, P664, DOI 10.1038/sj.mp.4001351; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Strasser A, 2008, J PHARMACOL EXP THER, V326, P783, DOI 10.1124/jpet.108.140913; Tanoue A, 2002, HYPERTENSION, V40, P101, DOI 10.1161/01.HYP.0000022062.70639.1C; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; Walden PD, 1999, J UROLOGY, V161, P635, DOI 10.1016/S0022-5347(01)61986-4; Wang SY, 2007, ACTA PHARMACOL SIN, V28, P359, DOI 10.1111/j.1745-7254.2007.00509.x; Yang M, 1998, J PHARMACOL EXP THER, V286, P841	55	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18210	18221		10.1074/jbc.M116.729517	http://dx.doi.org/10.1074/jbc.M116.729517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382054	Green Published, hybrid			2022-12-28	WOS:000383241800014
J	Mei, ZZ; Chen, XY; Hu, SW; Wang, N; Ou, XL; Wang, J; Luo, HH; Liu, JH; Jiang, Y				Mei, Zhu-Zhong; Chen, Xin-Yu; Hu, Shui-Wang; Wang, Ni; Ou, Xiao-Li; Wang, Jing; Luo, Hai-Hua; Liu, Jinghua; Jiang, Yong			Kelch-like Protein 21 (KLHL21) Targets IB Kinase- to Regulate Nuclear Factor -Light Chain Enhancer of Activated B Cells (NF-kappa B) Signaling Negatively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; E3 ubiquitin ligase; NF-kappaB; protein-protein interaction; tumor necrosis factor (TNF); IKKbeta; KLHL21	IKK-BETA; ALPHA; EXPRESSION; TNF; PHOSPHORYLATION; DEGRADATION; DEFICIENCY; COMPLEX; INNATE; ROLES	Activation of IKK is the key step in canonical activation of NF-B signaling. Extensive work has provided insight into the mechanisms underlying IKK activation through the identification of context-specific regulators. However, the molecular processes responsible for its negative regulation are not completely understood. Here, we identified KLHL21, a member of the Kelch-like gene family, as a novel negative regulator of IKK. The expression of KLHL21 was rapidly down-regulated in macrophages upon treatment with proinflammatory stimuli. Overexpression of KLHL21 inhibited the activation of IKK and degradation of IB, whereas KLHL21 depletion via siRNA showed the opposite results. Coimmunoprecipitation assays revealed that KLHL21 specifically bound to the kinase domain of IKK via its Kelch domains and that this interaction was gradually attenuated upon TNF treatment. Furthermore, KLHL21 did not disrupt the interaction between IKK and TAK1, TRAF2, or IB. Also, KLHL21 did not require its E3 ubiquitin ligase activity for IKK inhibition. Our findings suggest that KLHL21 may exert its inhibitory function by binding to the kinase domain and sequestering the region from potential IKK inducers. Taken together, our data clearly demonstrate that KLHL21 negatively regulates TNF-activated NF-B signaling via targeting IKK, providing new insight into the mechanisms underlying NF-B regulation in cells.	[Mei, Zhu-Zhong; Chen, Xin-Yu; Hu, Shui-Wang; Wang, Ni; Ou, Xiao-Li; Wang, Jing; Luo, Hai-Hua; Liu, Jinghua; Jiang, Yong] Southern Med Univ, Dept Pathophysiol, Key Lab Transcript & Prote, Minist Educ China, Guangzhou 510515, Guangdong, Peoples R China	Ministry of Education, China; Southern Medical University - China	Mei, ZZ; Liu, JH; Jiang, Y (corresponding author), Southern Med Univ, Dept Pathophysiol, Key Lab Transcript & Prote, Minist Educ China, Guangzhou 510515, Guangdong, Peoples R China.	mzhuong@126.com; liujhua@163.com; jiang48231@163.com			National Natural Science Foundation of China [81272149, 81030055, 81372030]; Science and Technology Innovation Projects of the Department of Education of Guangdong Province [2013KJCX0040]; Guangdong Natural Science Foundation Grant [2015A030313294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Projects of the Department of Education of Guangdong Province; Guangdong Natural Science Foundation Grant	This work was supported by National Natural Science Foundation of China Grants 81272149 (to J. L.) and 81030055 and 81372030 (to Y. J.); Science and Technology Innovation Projects of the Department of Education of Guangdong Province Grant 2013KJCX0040 (to Z. Z. M.); and Project Supported by Guangdong Natural Science Foundation Grant 2015A030313294 (to Z. Z. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Bradford JW, 2014, ADV CANCER RES, V121, P125, DOI 10.1016/B978-0-12-800249-0.00003-2; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Djiane A, 2011, J CELL BIOL, V192, P189, DOI 10.1083/jcb.201007023; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Kane CM, 2004, J IMMUNOL, V173, P7454, DOI 10.4049/jimmunol.173.12.7454; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kim YL, 2008, CELL SIGNAL, V20, P2127, DOI 10.1016/j.cellsig.2008.08.001; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Li SZ, 2014, BBA-MOL CELL RES, V1843, P1365, DOI 10.1016/j.bbamcr.2014.03.028; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu JH, 2010, J IMMUNOL, V184, P5802, DOI 10.4049/jimmunol.0904127; Macagno A, 2006, J EXP MED, V203, P1481, DOI 10.1084/jem.20060136; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stolovitzky GA, 2005, P NATL ACAD SCI USA, V102, P1402, DOI 10.1073/pnas.0406555102; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yao F, 2014, CELL RES, V24, P359, DOI 10.1038/cr.2013.162; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576	36	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18176	18189		10.1074/jbc.M116.715854	http://dx.doi.org/10.1074/jbc.M116.715854			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387502	hybrid, Green Published			2022-12-28	WOS:000383241800011
J	Machovina, MM; Usselman, RJ; DuBois, JL				Machovina, Melodie M.; Usselman, Robert J.; DuBois, Jennifer L.			Monooxygenase Substrates Mimic Flavin to Catalyze Cofactorless Oxygenations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; flavin; Gram-positive bacteria; oxidase; radical; monooxygenase; oxygen	SEQUENCE-ANALYSIS; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; MOLECULAR-OXYGEN; HEME OXYGENASE; REDUCED FLAVIN; GENE-CLUSTER; BIOSYNTHESIS; ACTINORHODIN; DIOXYGENASES	Members of the antibiotic biosynthesis monooxygenase family catalyze O-2-dependent oxidations and oxygenations in the absence of any metallo- or organic cofactor. How these enzymes surmount the kinetic barrier to reactions between singlet substrates and triplet O-2 is unclear, but the reactions have been proposed to occur via a flavin-like mechanism, where the substrate acts in lieu of a flavin cofactor. To test this model, we monitored the uncatalyzed and enzymatic reactions of dithranol, a substrate for the nogalamycin monooxygenase (NMO) from Streptomyces nogalater. As with flavin, dithranol oxidation was faster at a higher pH, although the reaction did not appear to be base-catalyzed. Rather, conserved asparagines contributed to suppression of the substrate pK(a). The same residues were critical for enzymatic catalysis that, consistent with the flavoenzyme model, occurred via an O-2-dependent slow step. Evidence for a superoxide/substrate radical pair intermediate came from detection of enzyme-bound superoxide during turnover. Small molecule and enzymatic superoxide traps suppressed formation of the oxygenation product under uncatalyzed conditions, whereas only the small molecule trap had an effect in the presence of NMO. This suggested that NMO both accelerated the formation and directed the recombination of a superoxide/dithranyl radical pair. These catalytic strategies are in some ways flavin-like and stand in contrast to the mechanisms of urate oxidase and (1H)-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase, both cofactor-independent enzymes that surmount the barriers to direct substrate/O-2 reactivity via markedly different means.	[Machovina, Melodie M.; Usselman, Robert J.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, 221 Chem & Biochem Bldg, Bozeman, MT 59715 USA	Montana State University System; Montana State University Bozeman	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, 221 Chem & Biochem Bldg, Bozeman, MT 59715 USA.	jdubois@chemistry.montana.edu			National Institutes of Health [U54GM093342]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM093342, R01GM090260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Garrett Moraski and Prof. David P. Ballou, University of Michigan, for helpful discussions. The Enzyme Function Initiative (funded by National Institutes of Health Grant U54GM093342) is gratefully acknowledged for sequence network analysis tools publicly available at the Enzyme Function Initiative website (enzymefunction.org).	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; BALLOU D, 1969, BIOCHEM BIOPH RES CO, V36, P898, DOI 10.1016/0006-291X(69)90288-5; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; CABALLERO JL, 1991, MOL GEN GENET, V230, P401, DOI 10.1007/BF00280297; Chung JY, 2002, J BACTERIOL, V184, P6115, DOI 10.1128/JB.184.22.6115-6122.2002; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; Dikalov SI, 2011, FREE RADICAL RES, V45, P417, DOI 10.3109/10715762.2010.540242; Fetzner S, 2012, APPL ENVIRON MICROB, V78, P2505, DOI 10.1128/AEM.07651-11; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Fischer F, 1999, J BACTERIOL, V181, P5725, DOI 10.1128/JB.181.18.5725-5733.1999; Frerichs-Deeken U, 2004, BIOCHEMISTRY-US, V43, P14485, DOI 10.1021/bi048735u; Frerichs-Deeken U, 2005, CURR MICROBIOL, V51, P344, DOI 10.1007/s00284-005-0065-3; Frey P.A., 2007, ENZYMATIC REACTION M, P1; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; GRAY B, 1992, BIOCHEM J, V281, P795, DOI 10.1042/bj2810795; Grocholski T, 2012, J BACTERIOL, V194, P2829, DOI 10.1128/JB.00228-12; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Hernandez-Ortega A, 2015, J AM CHEM SOC, V137, P7474, DOI 10.1021/jacs.5b03836; Hernandez-Ortega A, 2014, J BIOL CHEM, V289, P8620, DOI 10.1074/jbc.M113.543033; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; KEMAL C, 1977, J AM CHEM SOC, V99, P7272, DOI 10.1021/ja00464a030; KEMAL C, 1979, J AM CHEM SOC, V101, P1635, DOI 10.1021/ja00500a066; Kendrew SG, 2000, ACTA CRYSTALLOGR D, V56, P481, DOI 10.1107/S0907444900001189; Kendrew SG, 1997, J BACTERIOL, V179, P4305, DOI 10.1128/jb.179.13.4305-4310.1997; Koskiniemi H, 2009, ACTA CRYSTALLOGR F, V65, P256, DOI 10.1107/S1744309109001389; Kralj M, 2015, PHOTOCH PHOTOBIO SCI, V14, P1082, DOI 10.1039/c5pp00099h; MASSEY V, 1994, J BIOL CHEM, V269, P22459; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Muller K, 1996, GEN PHARMACOL-VASC S, V27, P1325, DOI 10.1016/S0306-3623(96)00075-4; MULLER K, 1986, ARCH PHARM, V319, P1009, DOI 10.1002/ardp.19863191109; Muller K, 1997, BIOCHEM PHARMACOL, V53, P1215, DOI 10.1016/S0006-2952(96)00732-0; MULLER K, 1987, ARCH PHARM, V320, P59, DOI 10.1002/ardp.19873200110; MULLER K, 1995, ARCH PHARM, V328, P359, DOI 10.1002/ardp.19953280412; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Palfey BA, 2000, BIOCHEMISTRY-US, V39, P1556; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Que L. Q., 2007, BIOL INORGANIC CHEM, P1; Rafanan ER, 2001, J NAT PROD, V64, P444; Rivera M, 2005, J INORG BIOCHEM, V99, P337, DOI 10.1016/j.jinorgbio.2004.09.016; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Roth JP, 2004, J AM CHEM SOC, V126, P15120, DOI 10.1021/ja047050e; Roth JP, 2009, ACCOUNTS CHEM RES, V42, P399, DOI 10.1021/ar800169z; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Sellmer A, 1998, J PHOTOCH PHOTOBIO A, V116, P39, DOI 10.1016/S1010-6030(98)00277-9; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; Steiner RA, 2010, P NATL ACAD SCI USA, V107, P657, DOI 10.1073/pnas.0909033107; Streit BR, 2016, J BIOL CHEM, V291, P862, DOI 10.1074/jbc.M115.666560; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; Thierbach S, 2012, CHEMBIOCHEM, V13, P1125, DOI 10.1002/cbic.201200152; Ukpabi G, 2012, J BIOL CHEM, V287, P34179, DOI 10.1074/jbc.M112.393249; Usselman RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093065; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YE JS, 1994, J BACTERIOL, V176, P6270, DOI 10.1128/jb.176.20.6270-6280.1994; Ylihonko K, 1996, MOL GEN GENET, V251, P113; Zeng YH, 2005, J AM CHEM SOC, V127, P9794, DOI 10.1021/ja0425987	60	11	11	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17816	17828		10.1074/jbc.M116.730051	http://dx.doi.org/10.1074/jbc.M116.730051			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27307041	Green Published, hybrid			2022-12-28	WOS:000383241300028
J	Raltschev, C; Hetsch, F; Winkelmann, A; Meier, JC; Semtner, M				Raltschev, Constanze; Hetsch, Florian; Winkelmann, Aline; Meier, Jochen C.; Semtner, Marcus			Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; glycine receptor; patch clamp; receptor desensitization; recombinant protein expression; current-voltage relationship; desensitization; homomeric	RECTIFIER K+ CHANNELS; GATED ION CHANNELS; VOLTAGE-DEPENDENCE; FUNCTIONAL-CHARACTERIZATION; DESENSITIZATION BEHAVIOR; CHLORIDE CONDUCTANCE; HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; ANION PERMEATION; LIGAND-BINDING	Glycine receptors are chloride-permeable, ligand-gated ion channels and contribute to the inhibition of neuronal firing in the central nervous system or to facilitation of neurotransmitter release if expressed at presynaptic sites. Recent structure-function studies have provided detailed insights into the mechanisms of channel gating, desensitization, and ion permeation. However, most of the work has focused only on comparing a few isoforms, and among studies, different cellular expression systems were used. Here, we performed a series of experiments using recombinantly expressed homomeric and heteromeric glycine receptor channels, including their splice variants, in the same cellular expression system to investigate and compare their electrophysiological properties. Our data show that the current-voltage relationships of homomeric channels formed by the 2 or 3 subunits change upon receptor desensitization from a linear to an inwardly rectifying shape, in contrast to their heteromeric counterparts. The results demonstrate that inward rectification depends on a single amino acid (Ala(254)) at the inner pore mouth of the channels and is closely linked to chloride permeation. We also show that the current-voltage relationships of glycine-evoked currents in primary hippocampal neurons are inwardly rectifying upon desensitization. Thus, the alanine residue Ala(254) determines voltage-dependent rectification upon receptor desensitization and reveals a physio-molecular signature of homomeric glycine receptor channels, which provides unprecedented opportunities for the identification of these channels at the single cell level.	[Raltschev, Constanze] Univ Basel, Dept Biomed, Cellular Neurophysiol, Pestalozzistr 20, CH-4056 Basel, Switzerland; [Hetsch, Florian; Winkelmann, Aline; Meier, Jochen C.] Tech Univ Carolo Wilhelmina Braunschweig, Div Cell Physiol, Spielmannstr 7, D-38106 Braunschweig, Germany; [Semtner, Marcus] Max Delbruck Ctr Mol Med MDC, Cellular Neurosci, Robert Rossle Str 10, D-13092 Berlin, Germany; [Raltschev, Constanze] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Basel; Braunschweig University of Technology; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Zurich	Meier, JC (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Div Cell Physiol, Spielmannstr 7, D-38106 Braunschweig, Germany.; Semtner, M (corresponding author), Max Delbruck Ctr Mol Med MDC, Cellular Neurosci, Robert Rossle Str 10, D-13092 Berlin, Germany.	jochen.meier@tu-braunschweig.de; marcus.semtner@mdc-berlin.de		Meier, Jochen/0000-0001-5574-3336; , Florian/0000-0001-8743-3818	Bundesministerium fur Bildung und Forschung (BMBF); Helmholtz Association [VH-NG-246]; Deutsche Forschungsgemeinschaft (DFG) [SPP 1784 ME2075/7-1]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF) Grant Era-Net NEURON II CIPRESS (to J. C. M.), Helmholtz Association Grant VH-NG-246 (to J. C. M.), and Deutsche Forschungsgemeinschaft (DFG) Priority Programme SPP 1784 ME2075/7-1 (to J. C. M.). The authors declare that they have no conflicts of interest with the contents of the article.	AKAIKE N, 1989, J NEUROPHYSIOL, V62, P1400, DOI 10.1152/jn.1989.62.6.1400; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Breitinger HG, 2009, J BIOL CHEM, V284, P28624, DOI 10.1074/jbc.M109.043174; Breitinger HG, 2002, J NEUROCHEM, V83, P30, DOI 10.1046/j.1471-4159.2002.01109.x; Breitinger HG, 2001, J BIOL CHEM, V276, P29657, DOI 10.1074/jbc.M100446200; Breitinger U, 2004, J BIOL CHEM, V279, P1627, DOI 10.1074/jbc.M303811200; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Caliskan G, 2016, CEREB CORTEX, V26, P2325, DOI 10.1093/cercor/bhw001; Chen XB, 2009, NEUROPHARMACOLOGY, V56, P318, DOI 10.1016/j.neuropharm.2008.07.001; Chen Z, 2007, NEUROPHARMACOLOGY, V52, P1606, DOI 10.1016/j.neuropharm.2007.03.005; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Eichler SA, 2009, EUR J NEUROSCI, V30, P1077, DOI 10.1111/j.1460-9568.2009.06903.x; FABER DS, 1987, J NEUROSCI, V7, P807; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FATIMASHAD K, 1993, P ROY SOC B-BIOL SCI, V253, P69, DOI 10.1098/rspb.1993.0083; Forstera B, 2014, J CELL SCI, V127, P3687, DOI 10.1242/jcs.146662; Forstera B, 2010, BRAIN, V133, P3778, DOI 10.1093/brain/awq298; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; GUNDERSEN CB, 1984, PROC R SOC SER B-BIO, V221, P235, DOI 10.1098/rspb.1984.0032; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Heindl C, 2007, NEUROSCI LETT, V429, P59, DOI 10.1016/j.neulet.2007.10.001; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Karlsson U, 2011, J GEN PHYSIOL, V138, P609, DOI 10.1085/jgp.201110674; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; Kubota H, 2010, BIOCHEM BIOPH RES CO, V393, P587, DOI 10.1016/j.bbrc.2010.02.019; KUHSE J, 1991, FEBS LETT, V283, P73, DOI 10.1016/0014-5793(91)80557-J; Langlhofer G, 2015, NEUROSCI LETT, V600, P176, DOI 10.1016/j.neulet.2015.06.017; Legendre P, 2002, MOL PHARMACOL, V62, P817, DOI 10.1124/mol.62.4.817; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Legendre P, 1999, J NEUROPHYSIOL, V82, P2120, DOI 10.1152/jn.1999.82.5.2120; Legendre P, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.023.2009; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; Meiselbach H, 2014, J BIOL CHEM, V289, P29135, DOI 10.1074/jbc.M114.559138; Miller PS, 2004, BRIT J PHARMACOL, V143, P19, DOI 10.1038/sj.bjp.0705875; Moorhouse AJ, 2002, J GEN PHYSIOL, V119, P411, DOI 10.1085/jgp.20028553; Moroni M, 2011, J NEUROSCI, V31, P14095, DOI 10.1523/JNEUROSCI.1985-11.2011; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Papke D, 2014, J NEUROSCI, V34, P7238, DOI 10.1523/JNEUROSCI.5105-13.2014; Pilorge M, 2016, MOL PSYCHIATR, V21, P936, DOI 10.1038/mp.2015.139; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Saul B, 1999, J NEUROSCI, V19, P869; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Shan Q, 2012, J BIOL CHEM, V287, P21244, DOI 10.1074/jbc.M111.337741; Song YP, 2010, EUR J PHARMACOL, V636, P59, DOI 10.1016/j.ejphar.2010.03.020; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sugiharto S, 2008, BIOPHYS J, V95, P4698, DOI 10.1529/biophysj.107.125690; TABB JS, 1992, J BIOL CHEM, V267, P15412; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Weltzien F, 2012, J COMP NEUROL, V520, P3962, DOI 10.1002/cne.23139; Winkelmann A, 2014, J CLIN INVEST, V124, P696, DOI 10.1172/JCI71472; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x; Yevenes GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023886; ZHANG ZW, 1995, J PHYSIOL-LONDON, V487, P395, DOI 10.1113/jphysiol.1995.sp020888; Zhorov BS, 2000, BIOPHYS J, V78, P1786, DOI 10.1016/S0006-3495(00)76729-4	66	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					18030	18040		10.1074/jbc.M116.735084	http://dx.doi.org/10.1074/jbc.M116.735084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27382060	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000383241300044
J	Sircar, G; Jana, K; Dasgupta, A; Saha, S; Bhattacharya, SG				Sircar, Gaurab; Jana, Kuladip; Dasgupta, Angira; Saha, Sudipto; Bhattacharya, Swati Gupta			Epitope Mapping of Rhi o 1 and Generation of a Hypoallergenic Variant: A CANDIDATE MOLECULE FOR FUNGAL ALLERGY VACCINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergen; epitope mapping; immunoglobulin E (IgE); immunotherapy; mutagenesis; vaccine; asthma; mold allergy	B-CELL EPITOPES; BET V 1; MAJOR ALLERGEN; BIRCH POLLEN; IGE-BINDING; HYPERSENSITIVITY PNEUMONITIS; RECOMBINANT ALLERGENS; ASPERGILLUS-FUMIGATUS; RESPIRATORY ALLERGY; PREDICTION	Efficacy of allergen-specific immunotherapy is often severely impaired by detrimental IgE-mediated side effects of native allergen during vaccination. Here, we present the molecular determinants for IgE recognition of Rhi o 1 and eventually converting the allergen into a hypoallergenic immunogen to restrain health hazards during desensitization. Rhi o 1 is a respiratory fungal allergen. Despite having cross-reactivity with cockroach allergen, we observed that non-cross-reactive epitope predominantly determined IgE binding to Rhi o 1. Denaturation and refolding behavior of the allergen confirmed that its IgE reactivity was not essentially conformation-dependent. A combinatorial approach consisting of computational prediction and a peptide-based immunoassay identified two peptides ((44)TGEYLTQKYFNSQRNN and (311)GAEKNWAGQYVVDCNK) of Rhi o 1 that frequently reacted with IgE antibodies of sensitized patients. Interestingly, these peptides did not represent purely linear IgE epitopes but were presented in a conformational manner by forming a spatially clustered surface-exposed epitope conferring optimal IgE-binding capacity to the folded allergen. Site-directed alanine substitution identified four residues of the IgE epitope that were crucial for antibody binding. A multiple mutant (T49A/Y52A/K314A/W316A) showing 100-fold lower IgE binding and reduced allergenic activity was generated. The TYKW mutant retained T-cell epitopes, as evident from its lymphoproliferative capacity but down-regulated pro-allergic IL-5 secretion. The TYKW mutant induced enhanced focusing of blocking IgG antibodies specifically toward the IgE epitope of the allergen. Anti-TYKW mutant polyclonal IgG antibodies competitively inhibited binding of IgE antibodies to Rhi o 1 up to 70% and suppressed allergen-mediated histamine release by 10-fold. In conclusion, this is a simple yet rational strategy based on epitope mapping data to develop a genetically modified hypoallergenic variant showing protective antibody response for immunotherapeutic applications.	[Sircar, Gaurab; Bhattacharya, Swati Gupta] Bose Inst, Div Plant Biol, Main Campus,93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, India; [Jana, Kuladip] Bose Inst, Div Mol Med, Centenary Bldg,P 1-12,CIT Rd,Scheme VIIM, Kolkata 700054, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Centenary Bldg,P 1-12,CIT Rd,Scheme VIIM, Kolkata 700054, India; [Dasgupta, Angira] BR Singh Hosp, Dept Chest Med, Kolkata 700014, India; [Dasgupta, Angira] Ctr Med Educ & Res, Kolkata 700014, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Bhattacharya, SG (corresponding author), Bose Inst, Div Plant Biol, Main Campus,93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, India.	swati@jcbose.ac.in	Jana, Kuladip/GXG-3481-2022; Saha, Sudipto/AAF-1034-2020	Jana, Kuladip/0000-0003-4748-253X; Saha, Sudipto/0000-0001-9433-8894; Sircar, Gaurab/0000-0002-9067-4564	Department of Science and Technology, Government of India (Institutional Plan Project-1, Bose Institute); Council of Scientific and Industrial Research, Government of India [03/015(0414)/2011-EMR-I]; Department of Biotechnology, Government of India [BT/RLF/Re-entry/11/2011]	Department of Science and Technology, Government of India (Institutional Plan Project-1, Bose Institute); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by a grant from the Department of Science and Technology, Government of India (Institutional Plan Project-1, Bose Institute). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Ph.D. Fellowship 03/015(0414)/2011-EMR-I from the Council of Scientific and Industrial Research, Government of India.; Recipient of Ramalingaswamy Fellowship BT/RLF/Re-entry/11/2011 from the Department of Biotechnology, Government of India.	Agarwal K, 2015, MYCOSES, V58, P531, DOI 10.1111/myc.12352; Banerjee B, 1999, INFECT IMMUN, V67, P2284, DOI 10.1128/IAI.67.5.2284-2291.1999; Bohle B, 2004, J IMMUNOL, V172, P6642, DOI 10.4049/jimmunol.172.11.6642; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chan SL, 2006, J IMMUNOL, V176, P4852, DOI 10.4049/jimmunol.176.8.4852; Chen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034627; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Chow LP, 2000, BIOCHEM J, V346, P423, DOI 10.1042/0264-6021:3460423; Chowdhary A, 2014, CRIT REV MICROBIOL, V40, P30, DOI 10.3109/1040841X.2012.754401; Devars du Mayne Marie, 2015, Ear Nose Throat J, V94, pE17; Faerden K, 2014, INT J OCCUP ENV HEAL, V20, P167, DOI 10.1179/2049396714Y.0000000063; Flicker S, 2006, J ALLERGY CLIN IMMUN, V117, P1336, DOI 10.1016/j.jaci.2006.02.012; Focke-Tejkl M, 2015, J ALLERGY CLIN IMMUN, V135, P1207, DOI 10.1016/j.jaci.2014.09.012; Gafvelin G, 2007, J BIOL CHEM, V282, P3778, DOI 10.1074/jbc.M607938200; Ganguly HK, 2013, BIOCHEMISTRY-US, V52, P6348, DOI 10.1021/bi4007918; Garg A, 2005, PROTEINS, V61, P318, DOI 10.1002/prot.20630; Ghosh D, 2014, J BIOL CHEM, V289, P21374, DOI 10.1074/jbc.M114.559971; Gioulekas D, 2004, J INVEST ALLERG CLIN, V14, P225; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258; KARLSSONBORGA A, 1989, ANN ALLERGY, V63, P521; Klaric MS, 2012, ANN AGR ENV MED, V19, P213; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Kurup VP, 2003, PEPTIDES, V24, P179, DOI 10.1016/S0196-9781(03)00024-X; Kurup VP, 1998, PEPTIDES, V19, P1469, DOI 10.1016/S0196-9781(98)00113-2; Laffer S, 2003, BIOCHEM J, V373, P261, DOI 10.1042/BJ20030331; Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612; Linhart B, 2015, J IMMUNOL, V194, P4008, DOI 10.4049/jimmunol.1400402; Marth K, 2013, J IMMUNOL, V190, P3068, DOI 10.4049/jimmunol.1202441; Matsuse H, 2013, ANN ALLERG ASTHMA IM, V111, P190, DOI 10.1016/j.anai.2013.06.022; Mueller GA, 2015, J ALLERGY CLIN IMMUN, V136, P1369, DOI 10.1016/j.jaci.2015.03.015; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; OCONNELL MA, 1995, J ALLERGY CLIN IMMUN, V95, P779, DOI 10.1016/S0091-6749(95)70188-5; Osborne NJ, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0572-7; Pedraza-Escalona M, 2009, MOL IMMUNOL, V46, P668, DOI 10.1016/j.molimm.2008.08.282; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Saha B, 2015, J PROTEOME RES, V14, P4823, DOI 10.1021/acs.jproteome.5b00657; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Sharma V, 2009, J PROTEOME RES, V8, P2650, DOI 10.1021/pr800784q; Sircar G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144547; Sircar G, 2012, J PROTEOMICS, V77, P455, DOI 10.1016/j.jprot.2012.09.023; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Twaroch TE, 2015, ALLERGY ASTHMA IMMUN, V7, P205, DOI 10.4168/aair.2015.7.3.205; Valenta R, 2016, J ALLERGY CLIN IMMUN, V137, P351, DOI 10.1016/j.jaci.2015.12.1299; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; Woodfolk JA, 2016, J BIOL CHEM, V291, P2288, DOI 10.1074/jbc.M115.702324; Yu CJ, 2002, BIOCHEM J, V363, P707, DOI 10.1042/bj3630707; Zhang YX, 2005, J OCCUP HEALTH, V47, P181, DOI 10.1539/joh.47.181	51	20	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					18016	18029		10.1074/jbc.M116.732032	http://dx.doi.org/10.1074/jbc.M116.732032			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358405	hybrid, Green Published			2022-12-28	WOS:000383241300043
J	Zhang, RH; Chang, M; Zhang, M; Wu, YJ; Qu, XL; Huang, SJ				Zhang, Ruihui; Chang, Ming; Zhang, Meng; Wu, Youjun; Qu, Xiaolu; Huang, Shanjin			The Structurally Plastic CH2 Domain Is Linked to Distinct Functions of Fimbrins/Plastins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; Arabidopsis; Arp2; 3 complex; cytoskeleton; microfilaments; plant	POLLEN-TUBE GROWTH; ACTIN-BINDING-PROTEINS; CALPONIN HOMOLOGY DOMAINS; ALPHA-ACTININ; F-ACTIN; ARP2/3 COMPLEX; MUSCULAR-DYSTROPHY; MISSENSE MUTATIONS; FISSION YEAST; HUMAN FIMBRIN	Fimbrins/plastins have been implicated in the generation of distinct actin structures, which are linked to different cellular processes. Historically, fimbrins/plastins were mainly considered as generating tight actin bundles. Here, we demonstrate that different members of the fimbrin/plastin family have diverged biochemically during evolution to generate either tight actin bundles or loose networks with distinct biochemical and biophysical properties. Using the phylogenetically and functionally distinct Arabidopsis fimbrins FIM4 and FIM5 we found that FIM4 generates both actin bundles and cross-linked actin filaments, whereas FIM5 only generates actin bundles. The distinct functions of FIM4 and FIM5 are clearly observed at single-filament resolution. Domain swapping experiments showed that cooperation between the conformationally plastic calponin-homology domain 2 (CH2) and the N-terminal headpiece determines the function of the full-length protein. Our study suggests that the structural plasticity of fimbrins/plastins has biologically meaningful consequences, and provides novel insights into the structure-function relationship of fimbrins/plastins as well as shedding light on how cells generate distinct actin structures.	[Zhang, Ruihui; Zhang, Meng; Wu, Youjun; Huang, Shanjin] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China; [Chang, Ming; Qu, Xiaolu; Huang, Shanjin] Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Beijing 100084, Peoples R China; [Qu, Xiaolu] Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Zhang, Ruihui; Zhang, Meng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wu, Youjun] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Tsinghua University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Dartmouth College	Huang, SJ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China.; Huang, SJ (corresponding author), Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Beijing 100084, Peoples R China.	sjhuang@tsinghua.edu.cn	Huang, Shanjin/M-4112-2017	Huang, Shanjin/0000-0001-9517-2515; zhang, ruihui/0000-0003-1010-7242	Ministry of Science and Technology of China [2013CB945100]; National Natural Science Foundation of China [31125004]; Tsinghua-Peking Joint Center for Life Sciences; China Postdoctoral Science Foundation [2015M571028]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Joint Center for Life Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by Ministry of Science and Technology of China Grant 2013CB945100 and National Natural Science Foundation of China Grant 31125004. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by post-doctorate fellowships from Tsinghua-Peking Joint Center for Life Sciences and China Postdoctoral Science Foundation Grant 2015M571028.	ADAMS AEM, 1995, MOL CELL BIOL, V15, P69, DOI 10.1128/MCB.15.1.69; Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Bao CC, 2012, PLANT J, V71, P962, DOI 10.1111/j.1365-313X.2012.05044.x; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BRETSCHER A, 1980, J CELL BIOL, V86, P335, DOI 10.1083/jcb.86.1.335; Chang M, 2015, PLANT J, V83, P515, DOI 10.1111/tpj.12910; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Clement M, 2009, PLANT CELL, V21, P2963, DOI 10.1105/tpc.109.069104; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galkin VE, 2003, J MOL BIOL, V331, P967, DOI 10.1016/S0022-2836(03)00842-8; Galkin VE, 2002, J CELL BIOL, V157, P243, DOI 10.1083/jcb.200111097; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Galkin VE, 2006, J MOL BIOL, V359, P478, DOI 10.1016/j.jmb.2006.03.044; GLENNEY JR, 1981, J BIOL CHEM, V256, P9283; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; Hofer D, 1997, J CELL SCI, V110, P765; Hoffmann C, 2014, J CELL SCI, V127, P583, DOI 10.1242/jcs.134536; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; Huang SJ, 2015, J INTEGR PLANT BIOL, V57, P40, DOI 10.1111/jipb.12293; Huang SJ, 2003, J BIOL CHEM, V278, P44832, DOI 10.1074/jbc.M306670200; Hussey PJ, 2002, PHILOS T R SOC B, V357, P791, DOI 10.1098/rstb.2002.1086; Jorde S, 2011, MICROBIOL RES, V166, P137, DOI 10.1016/j.micres.2010.09.003; Ketelaar T, 2002, PLANT CELL, V14, P2941, DOI 10.1105/tpc.005892; Klein MG, 2004, STRUCTURE, V12, P999, DOI 10.1016/j.str.2004.04.010; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lee JY, 2005, PLANT CELL, V17, P2817, DOI 10.1105/tpc.105.034330; LIN CS, 1994, MOL CELL BIOL, V14, P2457, DOI 10.1128/MCB.14.4.2457; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; Liu XN, 2015, MOL PLANT, V8, P1694, DOI 10.1016/j.molp.2015.09.013; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; MATSUDAIRA P, 1994, J CELL BIOL, V126, P285, DOI 10.1083/jcb.126.2.285; Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021; Michelot A, 2011, CURR BIOL, V21, pR560, DOI 10.1016/j.cub.2011.06.019; MOOSEKER MS, 1983, CELL, V35, P11, DOI 10.1016/0092-8674(83)90202-7; Morley SC, 2013, IMMUNOL REV, V256, P48, DOI 10.1111/imr.12102; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2001, J CELL SCI, V114, P3; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Prassler J, 1997, MOL BIOL CELL, V8, P83, DOI 10.1091/mbc.8.1.83; PREVOST MC, 1992, INFECT IMMUN, V60, P4088; Qu XL, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00786; Qu XL, 2013, PLANT CELL, V25, P1803, DOI 10.1105/tpc.113.110940; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Schmidt SM, 2007, PHYSIOL MOL PLANT P, V71, P135, DOI 10.1016/j.pmpp.2008.01.001; Shi M, 2013, PLANT J, V73, P747, DOI 10.1111/tpj.12065; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Skau CT, 2011, J BIOL CHEM, V286, P26964, DOI 10.1074/jbc.M111.239004; Staiger CJ, 2004, ANNU PLANT REV, V10, P32; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; Su H, 2012, PLANT CELL, V24, P4539, DOI 10.1105/tpc.112.099358; THIMANN KV, 1992, PROTOPLASMA, V171, P153, DOI 10.1007/BF01403730; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389; TWELL D, 1989, PLANT PHYSIOL, V91, P1270, DOI 10.1104/pp.91.4.1270; Waller F, 2002, PROTOPLASMA, V219, P72, DOI 10.1007/s007090200007; Wang C, 2010, J IMMUNOL, V185, P7487, DOI 10.4049/jimmunol.1001424; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; Wear MA, 2000, CURR BIOL, V10, pR891, DOI 10.1016/S0960-9822(00)00845-9; Wu JQ, 2001, MOL BIOL CELL, V12, P1061, DOI 10.1091/mbc.12.4.1061; Wu YJ, 2010, PLANT CELL, V22, P3745, DOI 10.1105/tpc.110.080283; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200; Yang CS, 2011, CELL ADHES MIGR, V5, P402, DOI 10.4161/cam.5.5.16971; Young P, 2000, EMBO J, V19, P6331, DOI 10.1093/emboj/19.23.6331; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhang M, 2016, J EXP BOT, V67, P3407, DOI 10.1093/jxb/erw160; Zheng YY, 2013, PLANT CELL, V25, P3405, DOI 10.1105/tpc.113.117820	73	13	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17881	17896		10.1074/jbc.M116.730069	http://dx.doi.org/10.1074/jbc.M116.730069			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27261463	Green Published, hybrid			2022-12-28	WOS:000383241300032
J	Holzer, G; Morishita, Y; Fini, JB; Lorin, T; Gillet, B; Hughes, S; Tohme, M; Deleage, G; Demeneix, B; Arvan, P; Laudet, V				Holzer, Guillaume; Morishita, Yoshiaki; Fini, Jean-Baptiste; Lorin, Thibault; Gillet, Benjamin; Hughes, Sandrine; Tohme, Marie; Deleage, Gilbert; Demeneix, Barbara; Arvan, Peter; Laudet, Vincent			Thyroglobulin Represents a Novel Molecular Architecture of Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; THYROID-HORMONE FORMATION; AMINO-ACID-SEQUENCE; BOVINE THYROGLOBULIN; COMPLEMENTARY-DNA; AMPHIBIAN METAMORPHOSIS; EVOLUTION; PROTEIN; ENDOSTYLE; LAMPREY	Thyroid hormones modulate not only multiple functions in vertebrates (energy metabolism, central nervous system function, seasonal changes in physiology, and behavior) but also in some non-vertebrates where they control critical post-embryonic developmental transitions such as metamorphosis. Despite their obvious biological importance, the thyroid hormone precursor protein, thyroglobulin (Tg), has been experimentally investigated only in mammals. This may bias our view of how thyroid hormones are produced in other organisms. In this study we searched genomic databases and found Tg orthologs in all vertebrates including the sea lamprey (Petromyzon marinus). We cloned a full-size Tg coding sequence from western clawed frog (Xenopus tropicalis) and zebrafish (Danio rerio). Comparisons between the representative mammal, amphibian, teleost fish, and basal vertebrate indicate that all of the different domains of Tg, as well as Tg regional structure, are conserved throughout the vertebrates. Indeed, in Xenopus, zebrafish, and lamprey Tgs, key residues, including the hormonogenic tyrosines and the disulfide bond-forming cysteines critical for Tg function, are well conserved despite overall divergence of amino acid sequences. We uncovered upstream sequences that include start codons of zebrafish and Xenopus Tgs and experimentally proved that these are full-length secreted proteins, which are specifically recognized by antibodies against rat Tg. By contrast, we have not been able to find any orthologs of Tg among non-vertebrate species. Thus, Tg appears to be a novel protein elaborated as a single event at the base of vertebrates and virtually unchanged thereafter.	[Holzer, Guillaume; Lorin, Thibault; Gillet, Benjamin; Hughes, Sandrine; Tohme, Marie; Laudet, Vincent] Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS,UMR 5242, 46 Allee Italie, F-69364 Lyon 07, France; [Morishita, Yoshiaki; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Demeneix, Barbara] Museum Natl Hist Nat, Evolut Regulat Endocriniennes, Dept Regulat Dev & Divers Mol, CNRS,UMR 7221, 7 Rue Cuvier, F-75231 Paris 05, France; [Deleage, Gilbert] Univ Lyon 1, Lab Biol Tissulaire & Ingn Therapeut, Inst Biol & Chim Prot, CNRS,UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Arvan, P (corresponding author), Brehm Tower,Rm 5112,1000 Wall St, Ann Arbor, MI 48105 USA.; Laudet, V (corresponding author), Observ Oceanol Banyuls Sur Mer, 1 Ave Fontaule, F-66650 Banyuls Sur Mer, France.	parvan@umich.edu; vincent.laudet@obs-banyuls.fr	Morishita, Yoshiaki/AAX-6552-2021; Gillet, Benjamin/ABD-6704-2020; Morishita, Yoshiaki/GWQ-6726-2022; Deléage, Gilbert/F-7163-2010	Morishita, Yoshiaki/0000-0003-4733-7981; Deléage, Gilbert/0000-0003-1939-1614; FINI, Jean-Baptiste/0000-0002-5620-2600; Laudet, Vincent/0000-0003-4022-4175; Holzer, Guillaume/0000-0002-5778-8500	National Institutes of Health [R01 DK40344]; Ecole Normale Superieure de Lyon (ENS); CNRS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ecole Normale Superieure de Lyon (ENS); CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK40344 (to P. A.). We also thank the Ecole Normale Superieure de Lyon (ENS) and CNRS for financial support. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Arvan P, 1997, THYROID, V7, P89, DOI 10.1089/thy.1997.7.89; Baisse B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-166; BARRINGTON EJW, 1958, J MAR BIOL ASSOC UK, V37, P117, DOI 10.1017/S0025315400014879; Belkadi A, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-3; BERG G, 1975, BIOCHIM BIOPHYS ACTA, V386, P422, DOI 10.1016/0005-2795(75)90285-8; Brix K, 1996, ENDOCRINOLOGY, V137, P1963, DOI 10.1210/en.137.5.1963; Brown DD, 1997, P NATL ACAD SCI USA, V94, P13011, DOI 10.1073/pnas.94.24.13011; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Cortesi F, 2015, P NATL ACAD SCI USA, V112, P1493, DOI 10.1073/pnas.1417803112; Dardente H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00019; Di Jeso B, 2016, ENDOCR REV, V37, P2, DOI 10.1210/er.2015-1090; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; DUNN JT, 1975, J BIOL CHEM, V250, P5801; Dunn JT, 1999, BIOCHIMIE, V81, P505, DOI 10.1016/S0300-9084(99)80102-3; DUNN JT, 1987, J BIOL CHEM, V262, P16948; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faber J, 1994, NORMAL TABLE XENOPUS; Fini JB, 2012, ENDOCRINOLOGY, V153, P5068, DOI 10.1210/en.2012-1463; FORMISANO S, 1983, ARCH BIOCHEM BIOPHYS, V227, P351, DOI 10.1016/0003-9861(83)90463-0; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gibert Y, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2764; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hiruta J, 2005, DEV DYNAM, V233, P1031, DOI 10.1002/dvdy.20401; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Holzer G, 2015, CURR BIOL, V25, pR344, DOI 10.1016/j.cub.2015.02.026; KIM PS, 1991, J BIOL CHEM, V266, P12412; Kim PS, 2000, MOL ENDOCRINOL, V14, P1944, DOI 10.1210/me.14.12.1944; Kimura S, 1996, TRENDS ENDOCRIN MET, V7, P247, DOI 10.1016/S1043-2760(96)00115-4; Kluge B, 2005, DEV GENES EVOL, V215, P32, DOI 10.1007/s00427-004-0450-0; KREJCI E, 1991, P NATL ACAD SCI USA, V88, P6647, DOI 10.1073/pnas.88.15.6647; LAMAS L, 1989, J BIOL CHEM, V264, P13541; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Lee JY, 2007, DOMEST ANIM ENDOCRIN, V32, P178, DOI 10.1016/j.domaniend.2006.02.005; Lee J, 2011, J BIOL CHEM, V286, P26327, DOI 10.1074/jbc.M111.242099; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Little AG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-26; MALTHIERY Y, 1987, EUR J BIOCHEM, V165, P491, DOI 10.1111/j.1432-1033.1987.tb11466.x; MERCKEN L, 1985, NATURE, V316, P647, DOI 10.1038/316647a0; Miller AEM, 2013, J EXP BIOL, V216, P915, DOI 10.1242/jeb.077958; MONACO F, 1981, COMP BIOCHEM PHYS B, V70, P341, DOI 10.1016/0305-0491(81)90054-7; MONACO F, 1978, COMP BIOCHEM PHYS B, V60, P87, DOI 10.1016/0305-0491(78)90033-0; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; NEUENSCHWANDER P, 1972, Z ZELLFORSCH MIK ANA, V130, P553, DOI 10.1007/BF00307007; Novinec M, 2006, MOL BIOL EVOL, V23, P744, DOI 10.1093/molbev/msj082; Ogasawara M, 2001, GENESIS, V30, P51, DOI 10.1002/gene.1032; OHMIYA Y, 1990, J BIOL CHEM, V265, P9066; PALUMBO G, 1990, J BIOL CHEM, V265, P8887; Paris M, 2008, CURR BIOL, V18, P825, DOI 10.1016/j.cub.2008.04.078; Paris M, 2008, DEV GENES EVOL, V218, P667, DOI 10.1007/s00427-008-0255-7; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Patricolo E, 2001, J EXP ZOOL, V290, P426, DOI 10.1002/jez.1084; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ris-Stalpers C, 2010, MOL CELL ENDOCRINOL, V322, P38, DOI 10.1016/j.mce.2010.02.008; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Rubio IGS, 2009, CURR OPIN ENDOCRINOL, V16, P373, DOI 10.1097/MED.0b013e32832ff218; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Sommerfeld D, 2009, FUTURE GENER COMP SY, V25, P337, DOI 10.1016/j.future.2008.05.010; SUZUKI S, 1973, GEN COMP ENDOCR, V21, P451, DOI 10.1016/0016-6480(73)90104-4; Tata JR, 2013, BBA-GEN SUBJECTS, V1830, P3860, DOI 10.1016/j.bbagen.2012.02.017; van de Graaf SAR, 2001, J ENDOCRINOL, V170, P307, DOI 10.1677/joe.0.1700307; VANHERLE AJ, 1979, NEW ENGL J MED, V301, P307, DOI 10.1056/NEJM197908093010605; VANHERLE AJ, 1979, NEW ENGL J MED, V301, P239, DOI 10.1056/NEJM197908023010504; Williams GR, 2014, ENDOCRINOLOGY, V155, P2747, DOI 10.1210/en.2014-1527; WRIGHT GM, 1980, GEN COMP ENDOCR, V42, P187, DOI 10.1016/0016-6480(80)90187-2; Wu H, 2009, BIOCHEM BIOPH RES CO, V389, P269, DOI 10.1016/j.bbrc.2009.08.129; Yang SX, 1996, ARCH BIOCHEM BIOPHYS, V327, P61, DOI 10.1006/abbi.1996.0093; Youson JH, 1997, AM ZOOL, V37, P441	73	27	27	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16553	16566		10.1074/jbc.M116.719047	http://dx.doi.org/10.1074/jbc.M116.719047			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27311711	Green Published, hybrid			2022-12-28	WOS:000380826700015
J	Del Prete, D; Rice, RC; Rajadhyaksha, AM; D'Adamio, L				Del Prete, Dolores; Rice, Richard C.; Rajadhyaksha, Anjali M.; D'Adamio, Luciano			Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4(CRBN) and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); E3 ubiquitin ligase; neurodegenerative disease; ubiquitylation (ubiquitination); CRL4CRBN; Cereblon; Intellectual disability	JNK-INTERACTING PROTEIN-1; LINKED MENTAL-RETARDATION; A-BETA-PP; PHOSPHOTYROSINE-BINDING DOMAIN; ALZHEIMERS-DISEASE BRAIN; ONSET PARKINSON-DISEASE; GAMMA-SECRETASE COMPLEX; C-TERMINAL FRAGMENTS; INTRACELLULAR DOMAIN; INTELLECTUAL DISABILITY	The amyloid precursor protein (APP), whose mutations cause Alzheimer disease, plays an important in vivo role and facilitates transmitter release. Because the APP cytosolic region (ACR) is essential for these functions, we have characterized its brain interactome. We found that the ACR interacts with proteins that regulate the ubiquitin-proteasome system, predominantly with the E3 ubiquitin-protein ligases Stub1, which binds the NH2 terminus of the ACR, and CRL4(CRBN), which is formed by Cul4a/b, Ddb1, and Crbn, and interacts with the COOH terminus of the ACR via Crbn. APP shares essential functions with APP-like protein-2 (APLP2) but not APP-like protein-1 (APLP1). Noteworthy, APLP2, but not APLP1, interacts with Stub1 and CRL4(CRBN), pointing to a functional pathway shared only by APP and APLP2. In vitro ubiquitination/ubiquitome analysis indicates that these E3 ligases are enzymatically active and ubiquitinate the ACR residues Lys(649/650/651/676/688). Deletion of Crbn reduces ubiquitination of Lys(676) suggesting that Lys(676) is physiologically ubiquitinated by CRL4(CRBN). The ACR facilitated in vitro ubiquitination of presynaptic proteins that regulate exocytosis, suggesting a mechanism by which APP tunes transmitter release. Other dementia-related proteins, namely Tau and apoE, interact with and are ubiquitinated via the ACR in vitro. This, and the evidence that CRBN and CUL4B are linked to intellectual disability, prompts us to hypothesize a pathogenic mechanism, in which APP acts as a modulator of E3 ubiquitin-protein ligase(s), shared by distinct neuronal disorders. The well described accumulation of ubiquitinated protein inclusions in neurodegenerative diseases and the link between the ubiquitin-proteasome system and neurodegeneration make this concept plausible.	[Del Prete, Dolores; D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Rice, Richard C.; Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Dept Pediat, Div Pediat Neurol, New York, NY 10065 USA; [Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Weill Cornell Autism Res Program, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA	Yeshiva University; Albert Einstein College of Medicine; Cornell University; Cornell University	D'Adamio, L (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.	luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-9820-4882; D'Adamio, Luciano/0000-0002-2204-9441	National Institutes of Health from NIA [R01AG033007, R01AG041531, R21AG048971, R01AG052286]; Hartwell Foundation; BrightFocus; NATIONAL INSTITUTE ON AGING [R01AG052286, R01AG033007, R21AG048971, R01AG041531] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Hartwell Foundation; BrightFocus(BrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01AG033007, R01AG041531, R21AG048971, and R01AG052286 from NIA (to L. D.), The Hartwell Foundation (to A. M. R.), and The BrightFocus (to D. D. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annaert W, 2000, ANN NY ACAD SCI, V920, P158; Badura-Stronka M, 2010, CLIN GENET, V77, P141, DOI 10.1111/j.1399-0004.2009.01331.x; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Baizabal-Carvallo JF, 2016, NAT REV NEUROL, V12, P175, DOI 10.1038/nrneurol.2016.14; Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Barbagallo APM, 2011, J BIOL CHEM, V286, P8717, DOI 10.1074/jbc.C111.219873; Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bertrand E, 2001, MOL CELL NEUROSCI, V18, P503, DOI 10.1006/mcne.2001.1030; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Borchelt DR, 2002, NEUROBIOL AGING, V23, P171, DOI 10.1016/S0197-4580(01)00280-9; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bourassa CV, 2012, AM J HUM GENET, V91, P548, DOI 10.1016/j.ajhg.2012.07.018; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Ciarlo E, 2013, DIS MODEL MECH, V6, P424, DOI 10.1242/dmm.009761; Clark LN, 2006, ARCH NEUROL-CHICAGO, V63, P548, DOI 10.1001/archneur.63.4.548; Clark LN, 2004, MOVEMENT DISORD, V19, P796, DOI 10.1002/mds.20131; Cordoba M, 2014, NEUROLOGY, V83, P287, DOI 10.1212/WNL.0000000000000600; Coyne ES, 2016, F1000RES, V5, DOI [10.12688/f1000research.7220.1, DOI 10.12688/F1000RESEARCH.7220.1]; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Dahlmann B, 2016, ARCH BIOCHEM BIOPHYS, V591, P132, DOI 10.1016/j.abb.2015.12.012; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; De Strooper B, 2012, NATURE, V488, P38, DOI 10.1038/488038a; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Del Prete D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108576; Depondt C, 2014, NEUROLOGY, V82, P1749, DOI 10.1212/WNL.0000000000000416; Dijkhuizen T, 2006, AM J MED GENET A, V140A, P2482, DOI 10.1002/ajmg.a.31487; Dlamini N, 2013, NEUROMUSCULAR DISORD, V23, P391, DOI 10.1016/j.nmd.2013.02.001; Duilio A, 1998, BIOCHEM J, V330, P513, DOI 10.1042/bj3300513; Egashira N, 2005, BRAIN RES, V1059, P7, DOI 10.1016/j.brainres.2005.08.004; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Finsterer J, 2014, EUR J MED GENET, V57, P103, DOI 10.1016/j.ejmg.2014.01.002; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Garringer HJ, 2010, BRAIN STRUCT FUNCT, V214, P235, DOI 10.1007/s00429-009-0221-9; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Ghersi E, 2004, J ALZHEIMERS DIS, V6, P67; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hartmann MD, 2014, J STRUCT BIOL, V188, P225, DOI 10.1016/j.jsb.2014.10.010; Heber S, 2000, J NEUROSCI, V20, P7951; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; Heimdal K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0146-0; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Herrmann DN, 2014, AM J HUM GENET, V95, P332, DOI 10.1016/j.ajhg.2014.08.007; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Homan CC, 2014, AM J HUM GENET, V94, P470, DOI 10.1016/j.ajhg.2014.02.004; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Iqbal Z, 2015, AM J HUM GENET, V96, P386, DOI 10.1016/j.ajhg.2015.01.010; Islam K, 1997, AM J PATHOL, V151, P265; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Klein CJ, 2014, NEUROLOGY, V82, P873, DOI 10.1212/WNL.0000000000000206; Klevanski M, 2015, J NEUROSCI, V35, P16018, DOI 10.1523/JNEUROSCI.2009-15.2015; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Lee DY, 2012, BIOL CHEM, V393, P441, DOI 10.1515/hsz-2012-0120; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Li M, 2015, NEUROBIOL AGING, V36, P2725, DOI 10.1016/j.neurobiolaging.2015.06.021; Lim KL, 2007, EXPERT REV PROTEOMIC, V4, P769, DOI 10.1586/14789450.4.6.769; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu WM, 2015, TOXICOL APPL PHARM, V287, P98, DOI 10.1016/j.taap.2015.05.003; Lombino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057120; Londin ER, 2014, AM J MED GENET A, V164, P2294, DOI 10.1002/ajmg.a.36629; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lu PJ, 1999, NATURE, V399, P784; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Matrone C, 2012, AGING CELL, V11, P1084, DOI 10.1111/acel.12009; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2009, J BIOL CHEM, V284, P15815, DOI 10.1074/jbc.M109.006403; McLoughlin DM, 1996, FEBS LETT, V397, P197; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Norstrom EM, 2010, J NEUROSCI, V30, P15677, DOI 10.1523/JNEUROSCI.4464-10.2010; Noviello C, 2003, J BIOL CHEM, V278, P31843, DOI 10.1074/jbc.M304133200; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer BJ, 1999, J BIOL CHEM, V274, P24007, DOI 10.1074/jbc.274.34.24007; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Rajadhyaksha AM, 2012, BEHAV BRAIN RES, V226, P428, DOI 10.1016/j.bbr.2011.09.039; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Russo C, 2005, BRAIN RES REV, V48, P257, DOI 10.1016/j.brainresrev.2004.12.016; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Sabbagh JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00003; Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633; Sang YZ, 2015, ONCOTARGET, V6, P42590, DOI 10.18632/oncotarget.6052; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Schoser BGH, 2005, ANN NEUROL, V57, P591, DOI 10.1002/ana.20441; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Sell GL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00322; Shen XM, 2014, NEUROLOGY, V83, P2247, DOI 10.1212/WNL.0000000000001079; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081884; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tanzi R. E., 2012, COLD SPRING HARB PER, V2; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Thomas SN, 2009, METHODS MOL BIOL, V566, P109, DOI 10.1007/978-1-59745-562-6_8; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Wenner C, 2001, BIOCHEM BIOPH RES CO, V282, P608, DOI 10.1006/bbrc.2001.4611; Yang G, 2005, NEUROSCI LETT, V384, P66, DOI 10.1016/j.neulet.2005.04.040; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	142	49	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17209	17227		10.1074/jbc.M116.733626	http://dx.doi.org/10.1074/jbc.M116.733626			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325702	Green Published, hybrid			2022-12-28	WOS:000382643800024
J	Fukui, K; Baba, S; Kumasaka, T; Yano, T				Fukui, Kenji; Baba, Seiki; Kumasaka, Takashi; Yano, Takato			Structural Features and Functional Dependency on -Clamp Define Distinct Subfamilies of Bacterial Mismatch Repair Endonuclease MutL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; DNA binding protein; DNA mismatch repair; endonuclease; x-ray crystallography; MutL; clamp	C-TERMINAL DOMAIN; STRAND-DISCRIMINATION; ALPHA; PROTEIN; RIBONUCLEOTIDES; REPLICATION; ACTIVATION; MLH1-MLH3; SIGNALS; SYSTEM	In early reactions of DNA mismatch repair, MutS recognizes mismatched bases and activates MutL endonuclease to incise the error-containing strand of the duplex. DNA sliding clamp is responsible for directing the MutL-dependent nicking to the newly synthesized/error-containing strand. In Bacillus subtilis MutL, the -clamp-interacting motif ( motif) of the C-terminal domain (CTD) is essential for both in vitro direct interaction with -clamp and in vivo repair activity. A large cluster of negatively charged residues on the B. subtilis MutL CTD prevents nonspecific DNA binding until clamp interaction neutralizes the negative charge. We found that there are some bacterial phyla whose MutL endonucleases lack the motif. For example, the region corresponding to the motif is completely missing in Aquifex aeolicus MutL, and critical amino acid residues in the motif are not conserved in Thermus thermophilus MutL. We then revealed the 1.35 -resolution crystal structure of A. aeolicus MutL CTD, which lacks the motif but retains the metal-binding site for the endonuclease activity. Importantly, there was no negatively charged cluster on its surface. It was confirmed that CTDs of motif-lacking MutLs, A. aeolicus MutL and T. thermophilus MutL, efficiently incise DNA even in the absence of -clamp and that -clamp shows no detectable enhancing effect on their activity. In contrast, CTD of Streptococcus mutans, a motif-containing MutL, required -clamp for the digestion of DNA. We propose that MutL endonucleases are divided into three subfamilies on the basis of their structural features and dependence on -clamp.	[Fukui, Kenji; Yano, Takato] Osaka Med Coll, Dept Biochem, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan; [Baba, Seiki; Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst JASRI, SPring 8, Sayo, Hyogo 6795198, Japan	Osaka Medical College; Japan Synchrotron Radiation Research Institute	Fukui, K; Yano, T (corresponding author), 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	k.fukui@osaka-med.ac.jp; med013@osaka-med.ac.jp	Kumasaka, Takashi/D-7428-2018	Kumasaka, Takashi/0000-0001-9289-1557; baba, seiki/0000-0002-2589-232X; Fukui, Kenji/0000-0003-2463-7578	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26850050]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research 26850050 (to K. F.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banasik M, 2014, MUTAT RES-FUND MOL M, V769, P69, DOI 10.1016/j.mrfmmm.2014.07.006; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Correa EME, 2011, DNA REPAIR, V10, P1106, DOI 10.1016/j.dnarep.2011.08.007; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Duppatla V, 2009, BIOCHEM J, V423, P265, DOI 10.1042/BJ20090626; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142; Friedhoff P, 2016, DNA REPAIR, V38, P50, DOI 10.1016/j.dnarep.2015.11.013; Fukui K, 2011, DNA REPAIR PATHWAY F, P123; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Georgescu RE, 2008, P NATL ACAD SCI USA, V105, P11116, DOI 10.1073/pnas.0804754105; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Guarne A, 2015, PROG BIOPHYS MOL BIO, V117, P149, DOI 10.1016/j.pbiomolbio.2015.02.002; Guarne A, 2012, PROG MOL BIOL TRANSL, V110, P41, DOI 10.1016/B978-0-12-387665-2.00003-1; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Iino H, 2011, BIOSCIENCE REP, V31, P309, DOI 10.1042/BSR20100116; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrova LY, 2016, DNA REPAIR, V38, P42, DOI 10.1016/j.dnarep.2015.11.023; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; LYNCH HT, 1985, CANCER, V56, P934, DOI 10.1002/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Mizushima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098554; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Morita R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/179594; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Namadurai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013726; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pillon MC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv918; Pillon MC, 2011, DNA REPAIR, V10, P87, DOI 10.1016/j.dnarep.2010.10.003; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Ranjha L, 2014, J BIOL CHEM, V289, P5674, DOI 10.1074/jbc.M113.533810; Repmann S, 2015, J BIOL CHEM, V290, P9986, DOI 10.1074/jbc.M114.629907; Rogacheva MV, 2014, J BIOL CHEM, V289, P5664, DOI 10.1074/jbc.M113.534644; Shimada A, 2013, FEBS J, V280, P3467, DOI 10.1111/febs.12344; Smith CE, 2015, J BIOL CHEM, V290, P21580, DOI 10.1074/jbc.M115.662189; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto T, 2011, J BIOL CHEM, V286, P42337, DOI 10.1074/jbc.M111.277335; Yang W, 2007, DNA REPAIR, V6, P135, DOI 10.1016/j.dnarep.2006.10.021; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	59	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16990	17000		10.1074/jbc.M116.739664	http://dx.doi.org/10.1074/jbc.M116.739664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27369079	hybrid, Green Published			2022-12-28	WOS:000382643800006
J	Volz, P; Krause, N; Balke, J; Schneider, C; Walter, M; Schneider, F; Schlesinger, R; Alexiev, U				Volz, Pierre; Krause, Nils; Balke, Jens; Schneider, Constantin; Walter, Maria; Schneider, Franziska; Schlesinger, Ramona; Alexiev, Ulrike			Light and pH-induced Changes in Structure and Accessibility of Transmembrane Helix B and Its Immediate Environment in Channelrhodopsin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; fluorescence anisotropy; membrane protein; optogenetics; protein conformation; channelrhodopsin; fluorescence quenching	TIME-RESOLVED DETECTION; COBRA ALPHA-TOXIN; SURFACE-CHARGE; FLUORESCENCE SPECTROSCOPY; ACETYLCHOLINE-RECEPTOR; CYTOPLASMIC SURFACE; TRANSIENT MOVEMENT; SENSORY RHODOPSIN; GPCR RHODOPSIN; BACTERIORHODOPSIN	A variant of the cation channel channelrhodopsin-2 from Chlamydomonas reinhardtii (CrChR2) was selectively labeled at position Cys-79 at the end of the first cytoplasmic loop and the beginning of transmembrane helix B with the fluorescent dye fluorescein (acetamidofluorescein). We utilized (i) time-resolved fluorescence anisotropy experiments to monitor the structural dynamics at the cytoplasmic surface close to the inner gate in the dark and after illumination in the open channel state and (ii) time-resolved fluorescence quenching experiments to observe the solvent accessibility of helix B at pH 6.0 and 7.4. The light-induced increase in final anisotropy for acetamidofluorescein bound to the channel variant with a prolonged conducting state clearly shows that the formation of the open channel state is associated with a large conformational change at the cytoplasmic surface, consistent with an outward tilt of helix B. Furthermore, results from solute accessibility studies of the cytoplasmic end of helix B suggest a pH-dependent structural heterogeneity that appears below pH 7. At pH 7.4 conformational homogeneity was observed, whereas at pH 6.0 two protein fractions exist, including one in which residue 79 is buried. This inaccessible fraction amounts to 66% in nanodiscs and 82% in micelles. Knowledge about pH-dependent structural heterogeneity may be important for CrChR2 applications in optogenetics.	[Volz, Pierre; Krause, Nils; Balke, Jens; Schneider, Constantin; Walter, Maria; Schlesinger, Ramona; Alexiev, Ulrike] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; [Schneider, Franziska] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Schneider, Franziska] Univ Freiburg, Univ Herzzentrum Freiburg Bad Krozingen, Elsasser Str 2q, D-79110 Freiburg, Germany; [Schneider, Franziska] Univ Freiburg, Fak Med, Elsasser Str 2q, D-79110 Freiburg, Germany; [Alexiev, Ulrike] Free Univ Berlin, Dept Phys, Arnimallee 14, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Universitats Herzzentrum Freiburg; University of Freiburg; University of Freiburg; Free University of Berlin	Alexiev, U (corresponding author), Free Univ Berlin, Dept Phys, Arnimallee 14, D-14195 Berlin, Germany.	ulrike.alexiev@fu-berlin.de	Schlesinger, Ramona/W-2620-2018; Alexiev, Ulrike/L-8478-2016	Schlesinger, Ramona/0000-0002-7716-4439; 	Deutsche Forschungsgemeinschaft [Sfb1078, Sfb1112]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft: Sfb1078, project A2 (to U. A.), project B4 (to R. S.), project B2 (to P. Hegemann), and Sfb1112, project B03 to (U. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexiev U, 2000, J BIOL CHEM, V275, P13431, DOI 10.1074/jbc.275.18.13431; Alexiev U, 2003, J MOL BIOL, V328, P705, DOI 10.1016/S0022-2836(03)00326-7; ALEXIEV U, 1995, P NATL ACAD SCI USA, V92, P372, DOI 10.1073/pnas.92.2.372; ALEXIEV U, 1994, BIOCHEMISTRY-US, V33, P13693, DOI 10.1021/bi00250a020; ALEXIEV U, 1995, FEBS LETT, V373, P81, DOI 10.1016/0014-5793(95)00985-I; Alexiev U, 2014, BBA-BIOENERGETICS, V1837, P694, DOI 10.1016/j.bbabio.2013.10.008; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bockmann RA, 2005, BIOPHYS J, V88, P3191, DOI 10.1529/biophysj.105.060426; Boreham A, 2011, ACS MED CHEM LETT, V2, P724, DOI 10.1021/ml200092m; DICKOPF S, 1995, P NATL ACAD SCI USA, V92, P11519, DOI 10.1073/pnas.92.25.11519; Dutta A, 2010, BIOCHEMISTRY-US, V49, P6329, DOI 10.1021/bi100339x; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; JOHNSON DA, 1985, BIOPHYS J, V48, P949, DOI 10.1016/S0006-3495(85)83858-3; JOHNSON DA, 1990, J BIOL CHEM, V265, P7360; Kato HE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8177; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kim TY, 2007, PHOTOCHEM PHOTOBIOL, V83, P378, DOI 10.1562/2006-06-21-RA-943; Kim TY, 2012, EUR J CELL BIOL, V91, P300, DOI 10.1016/j.ejcb.2011.03.009; Kim TY, 2009, PHOTOCHEM PHOTOBIOL, V85, P570, DOI 10.1111/j.1751-1097.2008.00525.x; Kirchberg K, 2013, BBA-BIOENERGETICS, V1827, P276, DOI 10.1016/j.bbabio.2012.10.014; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Krause N, 2013, FEBS LETT, V587, P3309, DOI 10.1016/j.febslet.2013.08.043; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lorenz-Fonfria VA, 2015, P NATL ACAD SCI USA, V112, pE5796, DOI 10.1073/pnas.1511462112; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Moller M, 2009, PHOTOCHEM PHOTOBIOL, V85, P501, DOI 10.1111/j.1751-1097.2008.00528.x; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Muller M, 2015, J MOL BIOL, V427, P341, DOI 10.1016/j.jmb.2014.11.004; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Pieper J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228103; Radzwill N, 2001, BIOPHYS J, V80, P2856, DOI 10.1016/S0006-3495(01)76252-2; Richter C, 2015, PHYS CHEM CHEM PHYS, V17, P30590, DOI 10.1039/c5cp05454k; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Ritter E, 2013, J BIOL CHEM, V288, P10451, DOI 10.1074/jbc.M112.446427; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Sattig T, 2013, ANGEW CHEM INT EDIT, V52, P9705, DOI 10.1002/anie.201301698; Schneider F, 2015, ANNU REV BIOPHYS, V44, P167, DOI 10.1146/annurev-biophys-060414-034014; Schroder GF, 2005, BIOPHYS J, V89, P3757, DOI 10.1529/biophysj.105.069500; Sineshchekov OA, 2009, PHOTOCHEM PHOTOBIOL, V85, P556, DOI 10.1111/j.1751-1097.2008.00524.x; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; WATT RM, 1979, J BIOL CHEM, V254, P1684; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008	45	12	12	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17382	17393		10.1074/jbc.M115.711200	http://dx.doi.org/10.1074/jbc.M115.711200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27268055	Green Published, hybrid			2022-12-28	WOS:000382643800037
J	Duan, YJ; Ma, GE; Huang, XG; D'Amore, PA; Zhang, F; Lei, HT				Duan, Yajian; Ma, Gaoen; Huang, Xionggao; D'Amore, Patricia A.; Zhang, Feng; Lei, Hetian			The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-STEP GENERATION; CRISPR-CAS9 SYSTEM; P53; POLYMORPHISM; CANCER; PROTEIN; GENES; MICE; IDENTIFICATION; METAANALYSIS	The G309 allele of SNPs in the mouse double minute (MDM2) promoter locus is associated with a higher risk of cancer and proliferative vitreoretinopathy (PVR), but whether SNP G309 contributes to the pathogenesis of PVR is to date unknown. The clustered regularly interspaced short palindromic repeats (CRISPR)-associated endonuclease (Cas) 9 from Streptococcus pyogenes (SpCas9) can be harnessed to manipulate a single or multiple nucleotides in mammalian cells. Here we delivered SpCas9 and guide RNAs using dual adeno-associated virus-derived vectors to target theMDM2genomic locus together with a homologous repair template for creating the mutation of MDM2 T309G in human primary retinal pigment epithelial (hPRPE) cells whose genotype is MDM2 T309T. The next-generation sequencing results indicated that there was 42.51% MDM2 G309 in the edited hPRPE cells using adeno-associated viral CRISPR/Cas9. Our data showed that vitreous induced an increase in MDM2 and subsequent attenuation of p53 expression in MDM2 T309G hPRPE cells. Furthermore, our experimental results demonstrated that MDM2 T309G in hPRPE cells enhanced vitreous-induced cell proliferation and survival, suggesting that this SNP contributes to the pathogenesis of PVR.	[Duan, Yajian; Ma, Gaoen; Huang, Xionggao; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Schepens Eye Res Inst, Boston, MA 02114 USA; [Duan, Yajian; Ma, Gaoen; Huang, Xionggao; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Massachusetts Eye & Ear, Boston, MA 02114 USA; [Duan, Yajian; Ma, Gaoen; Huang, Xionggao; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02114 USA; [D'Amore, Patricia A.] Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA; [Zhang, Feng] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA 02142 USA; [Duan, Yajian] Shanxi Eye Hosp, Taiyuan 030000, Shanxi, Peoples R China	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Shanxi Medical University	Lei, HT (corresponding author), Harvard Med Sch, Schepens Eye Res Inst, Massachusetts Eye & Ear, Dept Ophthalmol, 20 Staniford St, Boston, MA 02114 USA.	Hetian_lei@meei.harvard.edu	D'Amore, Patricia A/G-5660-2017; Macrae, Rhiannon/AAX-1536-2020	D'Amore, Patricia A/0000-0001-9652-8974; Lei, Hetian/0000-0003-4091-1936	National Institutes of Health, NEI Grant [R01 EY012509]; National Institutes of Health, NEI Core Grant [P30EY003790]; NATIONAL EYE INSTITUTE [R01EY012509, P30EY003790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	National Institutes of Health, NEI Grant; National Institutes of Health, NEI Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in whole by the National Institutes of Health, NEI Grant R01 EY012509 (to H. L.) and in part by the National Institutes of Health, NEI Core Grant P30EY003790. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.037952; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Cui J, 2009, EXP EYE RES, V88, P438, DOI 10.1016/j.exer.2008.10.020; Gao J, 2014, THER CLIN RISK MANAG, V10, P269, DOI 10.2147/TCRM.S60680; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEAVER PK, 1989, GRAEF ARCH CLIN EXP, V227, P323, DOI 10.1007/BF02169405; Lei HT, 2015, MOL CELL BIOL, V35, P1673, DOI 10.1128/MCB.01248-14; Lei HT, 2012, AM J PATHOL, V181, P866, DOI 10.1016/j.ajpath.2012.05.036; Lei HT, 2011, MOL CELL BIOL, V31, P1788, DOI 10.1128/MCB.01321-10; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUNA RMD, 1995, NATURE, V378, P203; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Morescalchi F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/269787; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pastor-Idoate S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082283; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Scherer SE, 2006, NATURE, V440, P346, DOI 10.1038/nature04569; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LH, 2014, TUMOR BIOL, V35, P3167, DOI 10.1007/s13277-013-1413-8; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yu HP, 2011, MOL CARCINOGEN, V50, P697, DOI 10.1002/mc.20806; Zarrin AA, 1999, BBA-GENE STRUCT EXPR, V1446, P135, DOI 10.1016/S0167-4781(99)00067-6	47	23	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16339	16347		10.1074/jbc.M116.729467	http://dx.doi.org/10.1074/jbc.M116.729467			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246850	Green Published, hybrid			2022-12-28	WOS:000380585400037
J	Clouet, S; Di Pietrantonio, L; Daskalopoulos, EP; Esfahani, H; Horckmans, M; Vanorle, M; Lemaire, A; Balligand, JL; Beauloye, C; Boeynaems, JM; Communi, D				Clouet, Sophie; Di Pietrantonio, Larissa; Daskalopoulos, Evangelos-Panagiotis; Esfahani, Hrag; Horckmans, Michael; Vanorle, Marion; Lemaire, Anne; Balligand, Jean-Luc; Beauloye, Christophe; Boeynaems, Jean-Marie; Communi, Didier			Loss of Mouse P2Y(6) Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTP REDUCES INFARCT; MYOCARDIAL HYPERTROPHY; KNOCKOUT MICE; NATRIURETIC PEPTIDES; HEART FUNCTION; RAT-HEART; CARDIOMYOCYTES; EXPRESSION; ISCHEMIA; PROTEINS	The study of the mechanisms leading to cardiac hypertrophy is essential to better understand cardiac development and regeneration. Pathological conditions such as ischemia or pressure overload can induce a release of extracellular nucleotides within the heart. We recently investigated the potential role of nucleotide P2Y receptors in cardiac development. We showed that adult P2Y(4)-null mice displayed microcardia resulting from defective cardiac angiogenesis. Here we show that loss of another P2Y subtype called P2Y(6), a UDP receptor, was associated with a macrocardia phenotype and amplified pathological cardiac hypertrophy. Cardiomyocyte proliferation and size were increased in vivo in hearts of P2Y(6)-null neonates, resulting in enhanced postnatal heart growth. We then observed that loss of P2Y(6) receptor enhanced pathological cardiac hypertrophy induced after isoproterenol injection. We identified an inhibitory effect of UDP on in vitro isoproterenol-induced cardiomyocyte hyperplasia and hypertrophy. The present study identifies mouse P2Y(6) receptor as a regulator of cardiac development and cardiomyocyte function. P2Y(6) receptor could constitute a therapeutic target to regulate cardiac hypertrophy.	[Clouet, Sophie; Di Pietrantonio, Larissa; Horckmans, Michael; Vanorle, Marion; Lemaire, Anne; Boeynaems, Jean-Marie; Communi, Didier] Univ Libre Bruxelles, IRIBHM, Inst Interdisciplinary Res, B-1070 Brussels, Belgium; [Daskalopoulos, Evangelos-Panagiotis; Beauloye, Christophe] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Cardiovasc Res, B-1200 Brussels, Belgium; [Esfahani, Hrag; Balligand, Jean-Luc] Catholic Univ Louvain, Unit Pharmacol & Therapeut, UCL FATH 5349, B-1200 Brussels, Belgium; [Boeynaems, Jean-Marie] Univ Libre Bruxelles, Erasme Hosp, Dept Lab Med, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles	Communi, D (corresponding author), Bldg C,5th Fl,Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	communid@ulb.ac.be	Daskalopoulos, Evangelos/AAE-2815-2020; Balligand, Jean-Luc J/D-7543-2012	BALLIGAND, Jean-Luc/0000-0002-0522-4156	Fonds de la Recherche Scientifique Medicale of Belgium; Action de Recherche Concertee of the Communaute Francaise de Belgique, an Interuniversity Attraction Pole grant from the Politique Scientifique Federale [IAP-P7/40]; Prime Minister's Office, Federal Service for Science, Technology and Culture; Fonds Lokumo; European Community [LSHB-2003-503337]; Fonds National de la Recherche Scientifique/FRIA, Belgium; Universite libre de Bruxelles, Belgium	Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Action de Recherche Concertee of the Communaute Francaise de Belgique, an Interuniversity Attraction Pole grant from the Politique Scientifique Federale; Prime Minister's Office, Federal Service for Science, Technology and Culture; Fonds Lokumo; European Community(European Commission); Fonds National de la Recherche Scientifique/FRIA, Belgium(Fonds de la Recherche Scientifique - FNRS); Universite libre de Bruxelles, Belgium	This work was supported in part by the Fonds de la Recherche Scientifique Medicale of Belgium, Action de Recherche Concertee of the Communaute Francaise de Belgique, an Interuniversity Attraction Pole grant from the Politique Scientifique Federale (IAP-P7/40), the Prime Minister's Office, Federal Service for Science, Technology and Culture, by Fonds Lokumo, managed by the Fondation Roi Baudouin, grants from the Fonds de la Recherche Scientifique Medicale (F.R.S.M.), the Fonds d'Encouragement a la Recherche (F.E.R.), the Fonds Emile DEFAY, the Walloon Region (Programme d'Excellence CIBLES), and LifeSciHealth program of the European Community Grant LSHB-2003-503337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Fonds National de la Recherche Scientifique/FRIA, Belgium.r Supported by Universite libre de Bruxelles, Belgium.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Belge C, 2014, CIRCULATION, V129, P451, DOI 10.1161/CIRCULATIONAHA.113.004940; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; BOLUYT MO, 1995, AM J PHYSIOL-HEART C, V269, pH638; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Cheung KK, 2015, PURINERG SIGNAL, V11, P127, DOI 10.1007/s11302-014-9441-4; Cohen R, 2011, BIOCHEM PHARMACOL, V82, P1126, DOI 10.1016/j.bcp.2011.07.094; Ellmers LJ, 2002, AM J PHYSIOL-HEART C, V283, pH707, DOI 10.1152/ajpheart.00677.2001; Erkens R, 2015, FREE RADICAL BIO MED, V89, P906, DOI 10.1016/j.freeradbiomed.2015.10.409; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Garcia RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111385; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Horckmans M, 2015, J IMMUNOL, V194, P1874, DOI 10.4049/jimmunol.1401364; Horckmans M, 2012, AM J PHYSIOL-HEART C, V303, pH835, DOI 10.1152/ajpheart.00256.2012; Horckmans M, 2012, ANGIOGENESIS, V15, P349, DOI 10.1007/s10456-012-9265-1; Hudlicka O, 1996, J VASC RES, V33, P266, DOI 10.1159/000159155; JACKSON T, 1990, MOL CELL BIOL, V10, P3709, DOI 10.1128/MCB.10.7.3709; Lu J, 2012, GENE THER, V19, P522, DOI 10.1038/gt.2011.133; Mitsuyama S, 2013, J MOL CELL CARDIOL, V59, P95, DOI 10.1016/j.yjmcc.2013.02.012; Murad N, 2000, CLIN EXP PHARMACOL P, V27, P352, DOI 10.1046/j.1440-1681.2000.03254.x; Nahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Ozakca I, 2013, AM J PHYSIOL-HEART C, V304, pH1267, DOI 10.1152/ajpheart.00352.2012; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Prasad V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/251598; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Stachon P, 2014, ARTERIOSCL THROM VAS, V34, P2237, DOI 10.1161/ATVBAHA.114.303585; Stansfield WE, 2009, ANN THORAC SURG, V88, P1916, DOI 10.1016/j.athoracsur.2009.07.038; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wihlborg AK, 2006, CIRC RES, V98, P970, DOI 10.1161/01.RES.0000217402.73402.cd; Yitzhaki S, 2005, BIOCHEM PHARMACOL, V69, P1215, DOI 10.1016/j.bcp.2005.01.018; Yitzhaki S, 2006, BIOCHEM PHARMACOL, V72, P949, DOI 10.1016/j.bcp.2006.07.019; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	39	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15841	15852		10.1074/jbc.M115.684118	http://dx.doi.org/10.1074/jbc.M115.684118			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231349	Green Published, hybrid			2022-12-28	WOS:000380584200036
J	Inoue, A; Anraku, M; Nakagawa, S; Ojima, T				Inoue, Akira; Anraku, Moe; Nakagawa, Satoshi; Ojima, Takao			Discovery of a Novel Alginate Lyase from Nitratiruptor sp SB155-2 Thriving at Deep-sea Hydrothermal Vents and Identification of the Residues Responsible for Its Heat Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-DEOXY-L-ERYTHRO-5-HEXOSEULOSE URONIC-ACID; PSEUDOMONAS-AERUGINOSA; SEQUENCE-ANALYSIS; SP-NOV.; CRYSTAL-STRUCTURE; CLONING; METABOLISM; EXPRESSION; STRAIN; VIBRIO	Extremophiles are expected to represent a source of enzymes having unique functional properties. The hypothetical protein NIS_0185, termed NitAly in this study, was identified as an alginate lyase-homolog protein in the genomic database of epsilon-Proteobacteria Nitratiruptor sp.SB155-2, which was isolated from deep-sea hydrothermal vents at a water depth of 1,000 m. Among the characterized alginate lyases in the polysaccharide lyase family 7 (PL-7), the amino acid sequence of NitAly showed the highest identity (39%) with that of red alga Pyropia yezoensis alginate lyase PyAly. Recombinant NitAly (rNitAly) was successfully expressed in Escherichia coli. Purified rNitAly degraded alginate in an endolytic manner. Among alginate block types, polyM was preferable to polyG and polyMG as a substrate, and its end degradation products were mainly tri-, tetra-, and penta-saccharides. The optimum temperature and pH values were 70 degrees C and around 6, respectively. Ahigh concentration of NaCl (0.8-1.4 M) was required for maximum activity. In addition, a 50% loss of activity was observed after incubation at 67 degrees C for 30 min. Heat stability was decreased in the presence of 5 mM DTT, and Cys-80 and Cys-232 were identified as the residues responsible for heat stability but not lyase activity. Introducing two cysteines into PyAly based on homology modeling using Pseudomonas aeruginosa alginate lyase PA1167 as the template enhanced its heat stability. Thus, NitAly is a functional alginate lyase, with its unique optimum conditions adapted to its environment. These insights into the heat stability of NitAly could be applied to improve that of other PL-7 alginate lyases.	[Inoue, Akira; Anraku, Moe; Nakagawa, Satoshi; Ojima, Takao] Hokkaido Univ, Grad Sch Fisheries Sci, Div Appl Marine Life Sci, Lab Marine Biotechnol & Microbiol, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan	Hokkaido University	Inoue, A (corresponding author), Hokkaido Univ, Grad Sch Fisheries Sci, Div Appl Marine Life Sci, Lab Marine Biotechnol & Microbiol, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	inouea21@fish.hokudai.ac.jp			Program for Constructing "Tohoku Marine Science Bases" - Ministry of Education, Culture, Sports, Science and Technology, Japan	Program for Constructing "Tohoku Marine Science Bases" - Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for Constructing "Tohoku Marine Science Bases" supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht MT, 2005, J BACTERIOL, V187, P3869, DOI 10.1128/JB.187.11.3869-3872.2005; BARON AJ, 1994, GENE, V143, P61, DOI 10.1016/0378-1119(94)90605-X; BOYD A, 1995, J IND MICROBIOL, V15, P162, DOI 10.1007/BF01569821; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN BJ, 1991, APPL ENVIRON MICROB, V57, P1870, DOI 10.1128/AEM.57.6.1870-1872.1991; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Duan GF, 2009, CAN J MICROBIOL, V55, P1113, DOI [10.1139/W09-051, 10.1139/w09-051]; Flores GE, 2012, INT J SYST EVOL MICR, V62, P1252, DOI 10.1099/ijs.0.033001-0; GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265, DOI 10.1128/AEM.56.7.2265-2267.1990; Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Gutsche J, 2006, BIOCHIMIE, V88, P245, DOI 10.1016/j.biochi.2005.06.003; HAUG A, 1970, ACTA CHEM SCAND, V24, P843, DOI 10.3891/acta.chem.scand.24-0843; HAUG A, 1967, NATURE, V215, P757, DOI 10.1038/215757a0; Huang LS, 2013, J IND MICROBIOL BIOT, V40, P113, DOI 10.1007/s10295-012-1210-1; Inoue Akira, 2015, Curr Biotechnol, V4, P240, DOI 10.2174/2211550104666150915210434; Inoue A, 2016, ALGAL RES, V19, P355, DOI 10.1016/j.algal.2016.03.008; Inoue A, 2015, MAR DRUGS, V13, P493, DOI 10.3390/md13010493; Inoue A, 2014, MAR DRUGS, V12, P4693, DOI 10.3390/md12084693; Inoue A, 2011, MAR BIOTECHNOL, V13, P256, DOI 10.1007/s10126-010-9290-2; Kassab BH, 2004, PROTEIN EXPRES PURIF, V35, P344, DOI 10.1016/j.pep.2004.02.012; Kawamoto H, 2006, MAR BIOTECHNOL, V8, P481, DOI 10.1007/s10126-005-6157-z; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2009, MAR BIOTECHNOL, V11, P10, DOI 10.1007/s10126-008-9114-9; Kim HT, 2012, BIOTECHNOL LETT, V34, P1087, DOI 10.1007/s10529-012-0876-9; 정기철, 2007, [Journal of Life Science, 생명과학회지], V17, P625; Kobayashi T, 2009, EXTREMOPHILES, V13, P121, DOI 10.1007/s00792-008-0201-7; LE M, 1995, ANAL BIOCHEM, V229, P264, DOI 10.1006/abio.1995.1411; Li SY, 2015, J MICROBIOL BIOTECHN, V25, P681, DOI 10.4014/jmb.1409.09031; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Matsubara Y, 1998, BIOSCI BIOTECH BIOCH, V62, P1055, DOI 10.1271/bbb.62.1055; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; Miyake O, 2004, J BACTERIOL, V186, P2891, DOI 10.1128/JB.186.9.2891-2896.2004; Moradali MF, 2015, MBIO, V6, DOI 10.1128/mBio.00453-15; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Oates CG, 1990, FOOD HYDROCOLLOID, V4, P215, DOI 10.1016/S0268-005X(09)80154-9; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; PREISS J, 1962, J BIOL CHEM, V237, P309; PREISS J, 1962, J BIOL CHEM, V237, P317; Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x; Schwertfeger M, 1999, ADVANCES IN HIGH PRESSURE BIOSCIENCE AND BIOTECHNOLOGY, P337; Sim SJ, 2012, J IND MICROBIOL BIOT, V39, P585, DOI 10.1007/s10295-011-1054-0; SMIDSROD O, 1975, FARADAY DISCUSS, V57, P263; Smith JL, 2008, INT J SYST EVOL MICR, V58, P1598, DOI 10.1099/ijs.0.65435-0; Sugimura I, 2000, MAR BIOTECHNOL, V2, P65; Takase R, 2014, J BIOL CHEM, V289, P33198, DOI 10.1074/jbc.M114.585661; Takase R, 2010, BBA-PROTEINS PROTEOM, V1804, P1925, DOI 10.1016/j.bbapap.2010.05.010; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Uchimura K, 2010, MAR BIOTECHNOL, V12, P526, DOI 10.1007/s10126-009-9237-7; Voordeckers JW, 2005, INT J SYST EVOL MICR, V55, P773, DOI 10.1099/ijs.0.63430-0; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Zhu BW, 2015, INT J BIOL MACROMOL, V75, P330, DOI 10.1016/j.ijbiomac.2015.01.053; 김희숙, 2010, [Journal of Life Science, 생명과학회지], V20, P1582	65	53	58	5	45	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15551	15563		10.1074/jbc.M115.713230	http://dx.doi.org/10.1074/jbc.M115.713230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231344	Green Published, hybrid			2022-12-28	WOS:000380584200012
J	Marin-Argany, M; Lin, Y; Misra, P; Williams, A; Wall, JS; Howell, KG; Elsbernd, LR; McClure, M; Ramirez-Alvarado, M				Marin-Argany, Marta; Lin, Yi; Misra, Pinaki; Williams, Angela; Wall, Jonathan S.; Howell, Kyle G.; Elsbernd, Laura R.; McClure, Megan; Ramirez-Alvarado, Marina			Cell Damage in Light Chain Amyloidosis FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; apoptosis; endocytosis; in vivo imaging; protein aggregation; toxicity; cardiomyocytes; cell internalization; fibril fragmentation; light chain amyloidosis	SULFATE PROTEOGLYCANS MEDIATE; AMYOTROPHIC-LATERAL-SCLEROSIS; THIOFLAVIN-T-BINDING; SYSTEMIC AMYLOIDOSIS; NEURODEGENERATIVE DISEASES; CARDIAC FIBROBLASTS; DYNAMIN INHIBITORS; THERMAL-STABILITY; DIMER INTERFACE; CONSTANT-REGION	Light chain (AL) amyloidosis is an incurable human disease characterized by the misfolding, aggregation, and systemic deposition of amyloid composed of immunoglobulin light chains (LC). This work describes our studies on potential mechanisms of AL cytotoxicity. We have studied the internalization of AL soluble proteins and amyloid fibrils into human AC16 cardiomyocytes by using real time live cell image analysis. Our results show how external amyloid aggregates rapidly surround the cells and act as a recruitment point for soluble protein, triggering the amyloid fibril elongation. Soluble protein and external aggregates are internalized into AC16 cells via macropinocytosis. AL amyloid fibrils are shown to be highly cytotoxic at low concentrations. Additionally, caspase assays revealed soluble protein induces apoptosis, demonstrating different cytotoxic mechanisms between soluble protein and amyloid aggregates. This study emphasizes the complex immunoglobulin light chain-cell interactions that result in fibril internalization, protein recruitment, and cytotoxicity that may occur in AL amyloidosis.	[Marin-Argany, Marta; Misra, Pinaki; Ramirez-Alvarado, Marina] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Elsbernd, Laura R.; Ramirez-Alvarado, Marina] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Lin, Yi] Mayo Clin, Div Hematol, Rochester, MN 55905 USA; [Lin, Yi] Mayo Clin, Div Transfus Med, Human Cell Therapy Lab, Rochester, MN 55905 USA; [Howell, Kyle G.] Mayo Clin, Dept Microscopy, Rochester, MN 55905 USA; [Howell, Kyle G.] Mayo Clin, Cell Anal Core Facil, Rochester, MN 55905 USA; [McClure, Megan] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA; [Williams, Angela; Wall, Jonathan S.] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37920 USA; [Wall, Jonathan S.] Univ Tennessee, Grad Sch Med, Dept Radiol, Knoxville, TN 37920 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Ramirez-Alvarado, M (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	ramirezalvarado.marina@mayo.edu	Misra, Pinaki/U-1524-2019; Lin, Yi/K-1510-2013	Misra, Pinaki/0000-0001-5185-1890; Ramirez-Alvarado, Marina/0000-0003-2325-6773; Lin, Yi/0000-0002-1556-6416; Wall, Jonathan/0000-0002-5516-8578; Argany, Meysam/0000-0001-6577-4443	National Institutes of Health [R01 GM071514, R01 DK079984]; Seidler Professorship; Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seidler Professorship; Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM071514 (to M. R.-A.) and R01 DK079984 (to J. S. W.) and by Dr. Morie Gertz, the Seidler Professorship, and the Mayo Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersen CB, 2009, BIOPHYS J, V96, P1529, DOI 10.1016/j.bpj.2008.11.024; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Baden EM, 2009, CURR PROTEIN PEPT SC, V10, P500, DOI 10.2174/138920309789351949; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Blancas-Mejia LM, 2016, BIOCHEMISTRY-US, V55, P2967, DOI 10.1021/acs.biochem.6b00090; Blancas-Mejia LM, 2015, BIOPHYS CHEM, V207, P13, DOI 10.1016/j.bpc.2015.07.005; Brenner DA, 2004, CIRC RES, V94, P1008, DOI 10.1161/01.RES.0000126569.75419.74; Calvet CM, 2003, J EUKARYOT MICROBIOL, V50, P97, DOI 10.1111/j.1550-7408.2003.tb00240.x; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; DiCostanzo AC, 2012, J BIOL CHEM, V287, P27997, DOI 10.1074/jbc.M112.362921; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Furukawa Y, 2013, FEBS LETT, V587, P2500, DOI 10.1016/j.febslet.2013.06.046; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GLENNER GG, 1969, J HISTOCHEM CYTOCHEM, V17, P769, DOI 10.1177/17.12.769; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Guan J, 2014, EMBO MOL MED, V6, P1493, DOI 10.15252/emmm.201404190; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Joshi S, 2010, MOL CANCER THER, V9, P1995, DOI 10.1158/1535-7163.MCT-10-0161; Kameyama S, 2007, BIOPOLYMERS, V88, P98, DOI 10.1002/bip.20689; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kieninger B, 2010, VIRCHOWS ARCH, V456, P523, DOI 10.1007/s00428-010-0909-5; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; Kumar SK, 2011, MAYO CLIN PROC, V86, P12, DOI 10.4065/mcp.2010.0480; Lavatelli F, 2008, MOL CELL PROTEOMICS, V7, P1570, DOI 10.1074/mcp.M700545-MCP200; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; Levinson RT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01278; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; McWilliams-Koeppen HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137716; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Monis GF, 2006, AM J PATHOL, V169, P1939, DOI 10.2353/ajpath.2006.060183; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V251, P642, DOI 10.1006/bbrc.1998.9508; Poshusta TL, 2013, INT J MOL SCI, V14, P22604, DOI 10.3390/ijms141122604; Potter KJ, 2015, AM J TRANSPLANT, V15, P1519, DOI 10.1111/ajt.13134; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; Sethi S, 2012, KIDNEY INT, V82, P226, DOI 10.1038/ki.2012.108; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Sikkink LA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.75; Sundaramoorthy V, 2013, CELL MOL LIFE SCI, V70, P4181, DOI 10.1007/s00018-013-1385-2; Tang WH, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0129-7; Teng JM, 2004, LAB INVEST, V84, P440, DOI 10.1038/labinvest.3700069; Trinkaus-Randall V, 2005, AM J PATHOL, V166, P197, DOI 10.1016/S0002-9440(10)62244-4; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zeineddine R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00277	69	38	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19813	19825		10.1074/jbc.M116.736736	http://dx.doi.org/10.1074/jbc.M116.736736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27462073	hybrid, Green Published			2022-12-28	WOS:000383243100008
J	Oide, M; Okajima, K; Kashojiya, S; Takayama, Y; Oroguchi, T; Hikima, T; Yamamoto, M; Nakasako, M				Oide, Mao; Okajima, Koji; Kashojiya, Sachiko; Takayama, Yuki; Oroguchi, Tomotaka; Hikima, Takaaki; Yamamoto, Masaki; Nakasako, Masayoshi			Blue Light-excited Light-Oxygen-Voltage-sensing Domain 2 (LOV2) Triggers a Rearrangement of the Kinase Domain to Induce Phosphorylation Activity in Arabidopsis Phototropin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photobiology; photoreceptor; plant molecular biology; protein kinase; x-ray scattering; blue light; phototropin	PLANT PHOTORECEPTOR DOMAIN; INDUCED STRUCTURAL-CHANGES; CONFORMATIONAL-CHANGES; BINDING DOMAINS; PRIMARY STEP; PROTEIN; NPL1; PHOTOREACTION; DIMERIZATION; ACTIVATION	Phototropin1 is a blue light (BL) receptor in plants and shows BL-dependent kinase activation. The BL-excited light-oxygen-voltage-sensing domain 2 (LOV2) is primarily responsible for the activation of the kinase domain; however, the molecular mechanism by which conformational changes in LOV2 are transmitted to the kinase domain remains unclear. Here, we investigated BL-induced structural changes of a minimum functional fragment of Arabidopsis phototropin1 composed of LOV2, the kinase domain, and a linker connecting the two domains using small-angle x-ray scattering (SAXS). The fragment existed as a dimer and displayed photoreversible SAXS changes reflected in the radii of gyration of 42.9 angstrom in the dark and 48.8 angstrom under BL irradiation. In the dark, the molecular shape reconstructed from the SAXS profiles appeared as two bean-shaped lobes in a twisted arrangement that was 170 angstrom long, 80 angstrom wide, and 50 angstrom thick. The molecular shape under BL became slightly elongated from that in the dark. By fitting the crystal structure of the LOV2 dimer and a homology model of the kinase domain to their inferred shapes, the BL-dependent change could be interpreted as the positional shift in the kinase domain relative to that of the LOV2 dimer. In addition, we found that lysine 475, a functionally important residue, in the N-terminal region of LOV2 plays a critical role in transmitting the structural changes in LOV2 to the kinase domain. The interface between the domains is critical for signaling, suitably changing the structure to activate the kinase in response to conformational changes in the adjoining LOV2.	[Oide, Mao; Okajima, Koji; Takayama, Yuki; Oroguchi, Tomotaka; Nakasako, Masayoshi] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Oide, Mao; Okajima, Koji; Kashojiya, Sachiko; Takayama, Yuki; Oroguchi, Tomotaka; Hikima, Takaaki; Yamamoto, Masaki; Nakasako, Masayoshi] RIKEN SPring 8 Ctr, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan; [Kashojiya, Sachiko] Osaka Prefecture Univ, Dept Biol Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan	Keio University; RIKEN; Osaka Metropolitan University	Okajima, K (corresponding author), Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	okajima@phys.keio.ac.jp	Yamamoto, Masaki/B-7844-2015	Yamamoto, Masaki/0000-0002-1311-1768	Ministry of Education, Culture, Sports, Science and Technology, Japan [jp15076210, jp20050030, jp1920402, jp22018027, jp22244054, jp23120525, jp24654140, jp25120725, jp15H01647, jp16H02218, jp24113723, jp15K18559]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research jp15076210, jp20050030, jp1920402, jp22018027, jp22244054, jp23120525, jp24654140, jp25120725, jp15H01647, and jp16H02218 (to M. N.); jp24113723 (to T. O.); and jp15K18559 (to K. O.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Aihara Y, 2012, J BIOL CHEM, V287, P9901, DOI 10.1074/jbc.M111.324723; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Guinier A., 1955, SMALL ANGLE SCATTERI; Halavaty AS, 2013, ACTA CRYSTALLOGR F, V69, P1316, DOI 10.1107/S1744309113029199; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Iwata T, 2003, BIOCHEMISTRY-US, V42, P8183, DOI 10.1021/bi0345135; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kashojiya S, 2016, FEBS LETT, V590, P139, DOI 10.1002/1873-3468.12028; Kashojiya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124284; Katsura H, 2009, FEBS LETT, V583, P526, DOI 10.1016/j.febslet.2009.01.019; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nakasone Y, 2007, J MOL BIOL, V367, P432, DOI 10.1016/j.jmb.2006.12.074; Okajima K, 2016, J PLANT RES, V129, P149, DOI 10.1007/s10265-016-0783-6; Okajima K, 2014, J BIOL CHEM, V289, P413, DOI 10.1074/jbc.M113.515403; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094	41	10	10	0	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19975	19984		10.1074/jbc.M116.735787	http://dx.doi.org/10.1074/jbc.M116.735787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27484797	Green Published, hybrid			2022-12-28	WOS:000383243100021
J	Xu, Q; Choksi, S; Qu, JH; Jang, J; Choe, M; Banfi, B; Engelhardt, JF; Liu, ZG				Xu, Qing; Choksi, Swati; Qu, Jianhui; Jang, Jonathan; Choe, Moran; Banfi, Botond; Engelhardt, John F.; Liu, Zheng-gang			NADPH Oxidases Are Essential for Macrophage Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell differentiation; macrophage; NADPH oxidase; reactive oxygen species (ROS)	TUMOR-ASSOCIATED MACROPHAGES; ALTERNATIVELY ACTIVATED MACROPHAGES; CHRONIC GRANULOMATOUS-DISEASE; CRUCIAL ROLE; REPAIR; CELLS; POLARIZATION; INFLAMMATION; EXPRESSION; AUTOPHAGY	NADPH oxidases (NOXs) are involved in inflammation, angiogenesis, tumor growth, and osteoclast differentiation. However, the role of NOX1 and NOX2 in macrophage differentiation and tumor progression is still elusive. Here we report that NOX1 and NOX2 are critical for the differentiation of monocytes to macrophages, the polarization of M2-type but not M1-type macrophages, and the occurrence of tumor-associated macrophages (TAMs). We found that deletion of both NOX1 and NOX2 led to a dramatic decrease in ROS production in macrophages and resulted in impaired efficiency in monocyte-to-macrophage differentiation and M2-type macrophage polarization. We further showed that NOX1 and NOX2 were critical for the activation of the MAPKs JNK and ERK during macrophage differentiation and that the deficiency of JNK and ERK activation was responsible for the failure of monocyte-to-macrophage differentiation, in turn affecting M2 macrophage polarization. Furthermore, we demonstrated that the decrease in M2 macrophages and TAMs, concomitant with the reduction of cytokine and chemokine secretion, contributed to the delay in wound healing and the inhibition of tumor growth and metastasis in NOX1/2 double knockout mice compared with WT mice. Collectively, these data provide direct evidence that NOX1 and NOX2 deficiency impairs macrophage differentiation and the occurrence of M2-type TAMs during tumor development.	[Xu, Qing; Choksi, Swati; Qu, Jianhui; Jang, Jonathan; Choe, Moran; Liu, Zheng-gang] NCI, Ctr Canc Res, NIH, Bldg 37,Rm 1130,37 Convent Dr, Bethesda, MD 20892 USA; [Banfi, Botond; Engelhardt, John F.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa	Liu, ZG (corresponding author), NCI, Ctr Canc Res, NIH, Bldg 37,Rm 1130,37 Convent Dr, Bethesda, MD 20892 USA.	zgliu@helix.nih.gov		Engelhardt, John/0000-0003-2389-9277; Banfi, Botond/0000-0001-9273-1318	Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bourette RP, 2000, GROWTH FACTORS, V17, P155, DOI 10.3109/08977190009001065; Chan EC, 2009, PHARMACOL THERAPEUT, V122, P97, DOI 10.1016/j.pharmthera.2009.02.005; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; Efron PA, 2004, J BURN CARE REHABIL, V25, P149, DOI 10.1097/01.BCR.0000111766.97335.34; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Holland JA, 1998, ENDOTHELIUM-NEW YORK, V6, P113, DOI 10.3109/10623329809072198; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nakai K, 2008, J DERMATOL SCI, V51, P181, DOI 10.1016/j.jdermsci.2008.03.004; Nakanishi A, 2013, INT J MOL MED, V31, P874, DOI 10.3892/ijmm.2013.1258; Nakano Y, 2008, J CLIN INVEST, V118, P1176, DOI 10.1172/JCI33835; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; QUIE PG, 1967, J CLIN INVEST, V46, P668, DOI 10.1172/JCI105568; Sen CK, 2003, WOUND REPAIR REGEN, V11, P431, DOI 10.1046/j.1524-475X.2003.11607.x; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Spencer NY, 2013, AM J PHYSIOL-GASTR L, V305, pG84, DOI 10.1152/ajpgi.00430.2012; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Yeligar SM, 2012, J IMMUNOL, V188, P3648, DOI 10.4049/jimmunol.1101278; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75; Zhang Y, 2012, BLOOD, V119, P2895, DOI 10.1182/blood-2011-08-372383	37	100	104	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20030	20041		10.1074/jbc.M116.731216	http://dx.doi.org/10.1074/jbc.M116.731216			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27489105	Green Published, hybrid			2022-12-28	WOS:000383243100026
J	Irani, S; Pan, XY; Peck, BCE; Iqbal, J; Sethupathy, P; Hussain, MM				Irani, Sara; Pan, Xiaoyue; Peck, Bailey C. E.; Iqbal, Jahangir; Sethupathy, Praveen; Hussain, M. Mahmood			MicroRNA-30c Mimic Mitigates Hypercholesterolemia and Atherosclerosis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; atherosclerosis; high density lipoprotein (HDL); low density lipoprotein (LDL); microRNA (miRNA); microRNA mechanism; apoB; lipids	TRIGLYCERIDE TRANSFER PROTEIN; FAMILIAL HYPERCHOLESTEROLEMIA; PCSK9 INHIBITION; APOLIPOPROTEIN-B; CHOLESTEROL; STATINS; HYPERLIPIDEMIA; METABOLISM; MIPOMERSEN; EFFICACY	High plasma cholesterol levels are a major risk factor for atherosclerosis. Plasma cholesterol can be reduced by inhibiting lipoprotein production; however, this is associated with steatosis. Previously we showed that lentivirally mediated hepatic expression of microRNA-30c (miR-30c) reduced hyperlipidemia and atherosclerosis in mice without causing hepatosteatosis. Because viral therapy would be formidable, we examined whether a miR-30c mimic can be used to mitigate hyperlipidemia and atherosclerosis without inducing steatosis. Delivery of a miR-30c mimic to the liver diminished diet-induced hypercholesterolemia in C57BL/6J mice. Reductions in plasma cholesterol levels were significantly correlated with increases in hepatic miR-30c levels. Long term dose escalation studies showed that miR-30c mimic caused sustained reductions in plasma cholesterol with no obvious side effects. Furthermore, miR-30c mimic significantly reduced hypercholesterolemia and atherosclerosis in Apoe(-/-) mice. Mechanistic studies showed that miR-30c mimic had no effect on LDL clearance but reduced lipoprotein production by down-regulating microsomal triglyceride transfer protein expression. MiR-30c had no effect on fatty acid oxidation but reduced lipid synthesis. Additionally, whole transcriptome analysis revealed that miR-30c mimic significantly down-regulated hepatic lipid synthesis pathways. Therefore, miR-30c lowers plasma cholesterol and mitigates atherosclerosis by reducing microsomal triglyceride transfer protein expression and lipoprotein production and avoids steatosis by diminishing lipid syntheses. It mitigates atherosclerosis most likely by reducing lipoprotein production and plasma cholesterol. These findings establish that increasing hepatic miR-30c levels is a viable treatment option for reducing hypercholesterolemia and atherosclerosis.	[Irani, Sara] Suny Downstate Med Ctr, Sch Grad Studies, Mol & Cell Biol Program, Brooklyn, NY 11203 USA; [Irani, Sara; Pan, Xiaoyue; Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Irani, Sara; Pan, Xiaoyue; Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Peck, Bailey C. E.; Sethupathy, Praveen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Peck, Bailey C. E.; Sethupathy, Praveen] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hussain, M. Mahmood] Vet Affairs New York Harbor Healthcare Syst, Brooklyn, NY 11422 USA; [Hussain, M. Mahmood] Winthrop Univ Hosp, Mineola, NY 11501 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Winthrop University Hospital	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	Mahmood.Hussain@downstate.edu	Iqbal, Jahangir/B-3903-2014	Iqbal, Jahangir/0000-0002-9021-2271; Peck, Bailey/0000-0002-4316-0966	National Institutes of Health Genetics and Molecular Biology Training Grant [T32GM-709239]; National Institutes of Health [DK-091318, DK-46900, DK-081879]; American Heart Association; Veterans Affairs Merit Award [BX001728]; SUNY Research Foundation; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046900, R29DK046900, R00DK091318, P30DK056350, R56DK046900, R01DK081879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001728] Funding Source: NIH RePORTER	National Institutes of Health Genetics and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Veterans Affairs Merit Award(US Department of Veterans Affairs); SUNY Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Genetics and Molecular Biology Training Grant T32GM-709239 (to B. C. E. P.); National Institutes of Health Grant DK-091318 (to P. S.); an American Heart Association predoctoral fellowship (to S. I.); and National Institutes of Health Grants DK-46900 and DK-081879, Veterans Affairs Merit Award BX001728, and a technology accelerator fund grant from SUNY Research Foundation (to M. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blumenthal RS, 2000, AM HEART J, V139, P577, DOI 10.1016/S0002-8703(00)90033-4; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Cornier MA, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0475-4; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Cuchel M, 2013, CURR OPIN LIPIDOL, V24, P246, DOI 10.1097/MOL.0b013e32836139df; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Finkel JB, 2015, TRENDS CARDIOVAS MED, V25, P340, DOI 10.1016/j.tcm.2014.10.015; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Iqbal J, 2012, CIRC RES, V110, P1575, DOI 10.1161/CIRCRESAHA.112.264283; Irani S, 2015, CURR OPIN LIPIDOL, V26, P139, DOI 10.1097/MOL.0000000000000162; Izaurralde E, 2015, SCIENCE, V349, P380, DOI 10.1126/science.1260969; Khatun I, 2012, HEPATOLOGY, V55, P1356, DOI 10.1002/hep.25504; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lipinski MJ, 2016, EUR HEART J, V37, P536, DOI 10.1093/eurheartj/ehv563; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Pan XY, 2013, CIRCULATION, V128, P1758, DOI 10.1161/CIRCULATIONAHA.113.002885; Qiu ZH, 2014, EXPERT OPIN INV DRUG, V23, P347, DOI 10.1517/13543784.2014.867327; Raal FJ, 2015, LANCET, V385, P331, DOI 10.1016/S0140-6736(14)61399-4; Rader DJ, 2014, CIRCULATION, V129, P1022, DOI 10.1161/CIRCULATIONAHA.113.001292; Ricotta DN, 2012, CARDIOL REV, V20, P90, DOI 10.1097/CRD.0b013e31823424be; Rizzo M, 2011, CURR PHARM DESIGN, V17, P943, DOI 10.2174/138161211795428768; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Robinson JG, 2014, J AM COLL CARDIOL, V63, P2779, DOI 10.1016/j.jacc.2014.04.009; Samaha FF, 2008, NAT CLIN PRACT CARD, V5, P497, DOI 10.1038/ncpcardio1250; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Stoekenbroek RM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0503-4; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019; van Rooij E, 2014, EMBO MOL MED, V6, P851, DOI 10.15252/emmm.201100899; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	40	35	37	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18397	18409		10.1074/jbc.M116.728451	http://dx.doi.org/10.1074/jbc.M116.728451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27365390	Green Published, hybrid			2022-12-28	WOS:000383241800030
J	Zhao, YP; Zhang, T; Huo, HH; Ye, YH; Liu, YF				Zhao, Yupeng; Zhang, Ting; Huo, Huanhuan; Ye, Yihong; Liu, Yanfen			Lunapark Is a Component of a Ubiquitin Ligase Complex Localized to the Endoplasmic Reticulum Three-way Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic-reticulum-associated protein degradation (ERAD); protein misfolding; ubiquitin; ubiquitin ligase; ubiquitin-conjugating enzyme (E2 enzyme); Atlastin; ER three-way junction; Lunapark; Lnp; gp78; misfolded	ER-ASSOCIATED DEGRADATION; MEMBRANE-PROTEINS; POLYUBIQUITIN CHAINS; GP78; REQUIRES; CYTOSOL; GENERATION; MORPHOLOGY; NETWORK; ENZYMES	The endoplasmic reticulum (ER) network comprises sheets and tubules that are connected by dynamic three-way junctions. Lunapark (Lnp) localizes to and stabilizes ER three-way junctions by antagonizing the small GTPase Atlastin, but how Lnp shapes the ER network is unclear. Here, we used an affinity purification approach and mass spectrometry to identify Lnp as an interacting partner of the ER protein quality control ubiquitin ligase gp78. Accordingly, Lnp purified from mammalian cells has a ubiquitin ligase activity in vitro. Intriguingly, biochemical analyses show that this activity can be attributed not only to associated ubiquitin ligase, but also to an intrinsic ubiquitin ligase activity borne by Lnp itself. This activity is contained in the N-terminal 45 amino acids of Lnp although this segment does not share homology to any known ubiquitin ligase motifs. Despite its interaction with gp78, Lnp does not seem to have a broad function in degradation of misfolded ER proteins. On the other hand, the N-terminal ubiquitin ligase-bearing motif is required for the ER three-way junction localization of Lnp. Our study identifies a new type of ubiquitin ligase and reveals a potential link between ubiquitin and ER morphology regulation.	[Zhao, Yupeng; Huo, Huanhuan; Liu, Yanfen] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China; [Zhang, Ting; Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	ShanghaiTech University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liu, YF (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.; Ye, YH (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov; liuyf@shanghaitech.edu.cn			National Institutes of Health Intramural Research Program NIDDK Grant [1ZIADK033008-06]; National Natural Science Foundation of China [31570781]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program NIDDK Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program NIDDK Grant 1ZIADK033008-06 and National Natural Science Foundation of China Grant 31570781. The authors declare no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballar P, 2010, INT J BIOCHEM CELL B, V42, P167, DOI 10.1016/j.biocel.2009.10.005; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Casey AK, 2015, MOL BIOL CELL, V26, P2833, DOI 10.1091/mbc.E15-01-0053; Chen S, 2015, P NATL ACAD SCI USA, V112, P418, DOI 10.1073/pnas.1423026112; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Liu YF, 2014, ELIFE, V3, DOI 10.7554/eLife.01369; Maculins T, 2016, CELL RES, V26, P499, DOI 10.1038/cr.2016.30; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Moriya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078235; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Shemesh T, 2014, P NATL ACAD SCI USA, V111, pE5243, DOI 10.1073/pnas.1419997111; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang Y, 2014, ONCOTARGET, V5, P2044, DOI 10.18632/oncotarget.1478; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354	48	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18252	18262		10.1074/jbc.M116.737783	http://dx.doi.org/10.1074/jbc.M116.737783			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387505	Green Published, hybrid			2022-12-28	WOS:000383241800018
J	Haas, LT; Strittmatter, SM				Haas, Laura T.; Strittmatter, Stephen M.			Oligomers of Amyloid Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid; Ca2+; calmodulin-dependent protein kinase II (CaMKII); metabotropic glutamate receptor (mGluR); prion; homer; pyk2	TRANSGENIC MOUSE MODEL; OPERATED CALCIUM-ENTRY; SYNAPTIC PLASTICITY; BETA OLIGOMERS; A-BETA; MEMORY IMPAIRMENT; HOMER-PROTEINS; MICE; FYN; NEURONS	The dysfunction and loss of synapses in Alzheimer disease are central to dementia symptoms. We have recently demonstrated that pathological Amyloid oligomer (Ao) regulates the association between intracellular protein mediators and the synaptic receptor complex composed of cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5). Here we sought to determine whether Ao alters the physiological signaling of the PrPC-mGluR5 complex upon glutamate activation. We provide evidence that acute exposure to Ao as well as chronic expression of familial Alzheimer disease mutant transgenes in model mice prevents protein-protein interaction changes of the complex induced by the glutamate analog 3,5-dihydroxyphenylglycine. We further show that 3,5-dihydroxyphenylglycine triggers the phosphorylation and activation of protein-tyrosine kinase 2- (PTK2B, also referred to as Pyk2) and of calcium/calmodulin-dependent protein kinase II in wild-type brain slices but not in Alzheimer disease transgenic brain slices or wild-type slices incubated with Ao. This study further distinguishes two separate Ao-dependent signaling cascades, one dependent on extracellular Ca2+ and Fyn kinase activation and the other dependent on the release of Ca2+ from intracellular stores. Thus, Ao triggers multiple distinct PrPC-mGluR5-dependent events implicated in neurodegeneration and dementia. We propose that targeting the PrPC-mGluR5 complex will reverse aberrant Ao-triggered states of the complex to allow physiological fluctuations of glutamate signaling.	[Haas, Laura T.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Haas, Laura T.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurosci, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA; [Haas, Laura T.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany	Yale University; Yale University; Eberhard Karls University of Tubingen	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, BCMM 436,295 Congress Ave, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health; BrightFocus Foundation; Alzheimer's Association; Falk Medical Research Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034924, P50AG047270, RF1AG053000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); Falk Medical Research Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health, BrightFocus Foundation, Alzheimer's Association, and the Falk Medical Research Trust (to S. M. S.). S. M. S. is a co-founder of Axerion Therapeutics, seeking to develop PrP-based therapeutics for Alzheimer disease. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Haas LT, 2016, BRAIN, V139, P526, DOI 10.1093/brain/awv356; Haas LT, 2014, J BIOL CHEM, V289, P28460, DOI 10.1074/jbc.M114.584342; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heidinger V, 2002, J NEUROSCI, V22, P5452; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jin DZ, 2013, J NEUROCHEM, V127, P620, DOI 10.1111/jnc.12434; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khondoker M, 2015, J ALZHEIMERS DIS, V45, P851, DOI 10.3233/JAD-142214; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; Nygaard HB, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0119-0; Nygaard HB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt238; Park JH, 2006, J NEUROSCI, V26, P13279, DOI 10.1523/JNEUROSCI.4504-06.2006; Pignatelli M, 2014, J NEUROSCI, V34, P4558, DOI 10.1523/JNEUROSCI.1846-13.2014; Raka F, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0111-4; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wang X, 2015, J ALZHEIMERS DIS, V43, P649, DOI 10.3233/JAD-140729; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Zhang H, 2015, J NEUROSCI, V35, P13275, DOI 10.1523/JNEUROSCI.1034-15.2015	50	55	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17112	17121		10.1074/jbc.M116.720664	http://dx.doi.org/10.1074/jbc.M116.720664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325698	hybrid, Green Published			2022-12-28	WOS:000382643800017
J	Montagner, C; Nigen, M; Jacquin, O; Willet, N; Dumoulin, M; Karsisiotis, AI; Roberts, GCK; Damblon, C; Redfield, C; Matagne, A				Montagner, Caroline; Nigen, Michael; Jacquin, Olivier; Willet, Nicolas; Dumoulin, Mireille; Karsisiotis, Andreas Ioannis; Roberts, Gordon C. K.; Damblon, Christian; Redfield, Christina; Matagne, Andre			The Role of Active Site Flexible Loops in Catalysis and of Zinc in Conformational Stability of Bacillus cereus 569/H/9 beta-Lactamase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROAD-SPECTRUM INHIBITOR; TIGHT-BINDING INHIBITOR; STANDARD NUMBERING SCHEME; BACTEROIDES-FRAGILIS; CRYSTAL-STRUCTURE; SUBSTRATE-BINDING; ANTIBIOTIC-RESISTANCE; POTENT INHIBITORS; THIOMANDELIC ACID; NMR-SPECTROSCOPY	Metallo-beta-lactamases catalyze the hydrolysis of most beta-lactam antibiotics and hence represent a major clinical concern. The development of inhibitors for these enzymes is complicated by the diversity and flexibility of their substrate-binding sites, motivating research into their structure and function. In this study, we examined the conformational properties of the Bacillus cereus beta-lactamase II in the presence of chemical denaturants using a variety of biochemical and biophysical techniques. The apoenzyme was found to unfold cooperatively, with a Gibbs free energy of stabilization (Delta G(0)) of 32 +/- 2kJ.mol(-1). For holoBcII, a first non-cooperative transition leads to multiple interconverting native-like states, in which both zinc atoms remain bound in an apparently unaltered active site, and the protein displays a well organized compact hydrophobic core with structural changes confined to the enzyme surface, but with no catalytic activity. Two-dimensional NMR data revealed that the loss of activity occurs concomitantly with perturbations in two loops that border the enzyme active site. A second cooperative transition, corresponding to global unfolding, is observed at higher denaturant concentrations, with Delta G(0) value of 65 +/- 1.4 kJ.mol(-1). These combined data highlight the importance of the two zinc ions in maintaining structure as well as a relatively well defined conformation for both active site loops to maintain enzymatic activity.	[Montagner, Caroline; Nigen, Michael; Jacquin, Olivier; Willet, Nicolas; Dumoulin, Mireille; Matagne, Andre] Univ Liege, Inst Chim B6, Ctr Ingn Prot, Lab Enzymol & Repliement Prot, B-4000 Liege, Sart Tilman, Belgium; [Damblon, Christian] Univ Liege, Inst Chim B6, Dept Chim, B-4000 Liege, Sart Tilman, Belgium; [Karsisiotis, Andreas Ioannis] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Roberts, Gordon C. K.] Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England; [Redfield, Christina] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England; [Nigen, Michael] UMII, Montpellier SupAgro, CIRAD, INRA,UMR Ingn Agropolymeres & Technol Emergentes, F-34060 Montpellier 01, France; [Willet, Nicolas] Univ Liege, Dept Chim, B-4000 Liege, Sart Tilman, Belgium	University of Liege; University of Liege; University of Essex; University of Leicester; University of Oxford; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; University of Liege	Matagne, A (corresponding author), Univ Liege, Inst Chim B6, Ctr Ingn Prot, Lab Enzymol & Repliement Prot, B-4000 Liege, Sart Tilman, Belgium.	amatagne@ulg.ac.be	Karsisiotis, Andreas Ioannis/G-3622-2013	Matagne, Andre/0000-0001-6417-6791; Redfield, Christina/0000-0001-7297-7708; Karsisiotis, Andreas Ioannis/0000-0001-7413-5045	European Commission [228461]; BioNMR projects [261863]	European Commission(European CommissionEuropean Commission Joint Research Centre); BioNMR projects	We acknowledge Prof Jean-Marie Frere critical reading of the manuscript and Prof: Roger H. Pain for his suggestion of a 'punchy" title. Also, we are grateful to Dr. Catherine Goodman (acting on behalf of the Journal of Biological Chemistry) for valuable suggestions to improve the manuscript Some NMR experiments in Oxford, United Kingdom, were collected with access provided by the European Commission's Framework Program 7 (FP7) East-NMR (Contract 228461) and BioNMR projects (Contract 261863).	Baier F, 2014, J MOL BIOL, V426, P2442, DOI 10.1016/j.jmb.2014.04.013; Bebrone C., 2012, BETA LACTAMASES, P41; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Creighton TE., 2010, BIOPHYSICAL CHEM NUC; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Damblon C, 1999, J AM CHEM SOC, V121, P11575, DOI 10.1021/ja992896h; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Dragani B, 1999, J MOL BIOL, V291, P481, DOI 10.1006/jmbi.1999.2965; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; FELICI A, 1993, BIOCHEM J, V291, P151, DOI 10.1042/bj2910151; Fink A. L., 2012, BETA LACTAMASES, P41; Fitzgerald M. D., 2004, HDB METALLOPROTEINS, V3, P217; Fitzgerald PMD, 1998, BIOCHEMISTRY-US, V37, P6791, DOI 10.1021/bi9730339; Frere J. M., 2012, BETA LACTAMASES, P41; Frere J.-M., 2012, BETA LACTAMASES; Frere JM, 2005, J ANTIMICROB CHEMOTH, V55, P1051, DOI 10.1093/jac/dki155; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Gonzalez JM, 2010, BIOCHEMISTRY-US, V49, P7930, DOI 10.1021/bi100894r; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; Hubbard SJ., 1993, COMPUTER PROGRAM; Huntley JJA, 2000, BIOCHEMISTRY-US, V39, P13356, DOI 10.1021/bi001210r; Huntley JJA, 2003, PROTEIN SCI, V12, P1368, DOI 10.1110/ps.0305303; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jacquin O., 2011, THESIS; Jacquin O, 2009, J MOL BIOL, V392, P1278, DOI 10.1016/j.jmb.2009.07.092; Karsisiotis AI, 2014, METALLOMICS, V6, P1181, DOI 10.1039/c4mt00066h; Karsisiotis AI, 2014, BIOMOL NMR ASSIGN, V8, P313, DOI 10.1007/s12104-013-9507-1; Karsisiotis AI, 2013, BIOCHEM J, V456, P397, DOI 10.1042/BJ20131003; Kim Y, 2013, FASEB J, V27, P1917, DOI 10.1096/fj.12-224014; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Krauss M, 2003, J PHYS CHEM B, V107, P1215, DOI 10.1021/jp027097r; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lakowitcz J.R, 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6_8; Lassaux P, 2011, ANTIMICROB AGENTS CH, V55, P1248, DOI 10.1128/AAC.01486-09; Lehninger A. L., 2013, PRINCIPLES BIOCH; Livermore DM, 2000, CURR OPIN MICROBIOL, V3, P489, DOI 10.1016/S1369-5274(00)00128-4; Matagne A, 1999, NAT PROD REP, V16, P1, DOI 10.1039/a705983c; MATAGNE A, 1990, BIOCHEM J, V265, P131, DOI 10.1042/bj2650131; Meini MR, 2014, ANTIBIOTICS-BASEL, V3, P285, DOI 10.3390/antibiotics3030285; Moali C, 2003, CHEM BIOL, V10, P319, DOI 10.1016/S1074-5521(03)00070-X; Mollard C, 2001, J BIOL CHEM, V276, P45015, DOI 10.1074/jbc.M107054200; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665; Nozaki Y, 1972, Methods Enzymol, V26, P43; Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Page MI, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/576297; Palm-Espling ME, 2012, BBA-MOL CELL RES, V1823, P1594, DOI 10.1016/j.bbamcr.2012.01.013; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; PAYNE DJ, 1993, J MED MICROBIOL, V39, P93, DOI 10.1099/00222615-39-2-93; Payne DJ, 2002, ANTIMICROB AGENTS CH, V46, P1880, DOI 10.1128/AAC.46.6.1880-1886.2002; Pfeil W., 1998, PROTEIN STABILITY FO; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Rasia RM, 2004, J BIOL CHEM, V279, P26046, DOI 10.1074/jbc.M311373200; Rasia RM, 2002, BIOCHEMISTRY-US, V41, P1853, DOI 10.1021/bi010933n; Rasmussen BA, 1997, ANTIMICROB AGENTS CH, V41, P223, DOI 10.1128/AAC.41.2.223; Redfield C, 1999, CURR BIOL, V9, pR313, DOI 10.1016/S0960-9822(99)80199-7; Rossolini GM, 2006, FUTURE MICROBIOL, V1, P295, DOI 10.2217/17460913.1.3.295; Rydzik AM, 2014, ANGEW CHEM INT EDIT, V53, P3129, DOI 10.1002/anie.201310866; SABATH LD, 1966, BIOCHEM J, V98, pC11, DOI 10.1042/bj0980011C; Salsbury FR, 2009, J MOL MODEL, V15, P133, DOI 10.1007/s00894-008-0410-0; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scrofani SDB, 1999, BIOCHEMISTRY-US, V38, P14507, DOI 10.1021/bi990986t; Selevsek N, 2009, J BIOL CHEM, V284, P16419, DOI 10.1074/jbc.M109.001305; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Spencer J, 2006, ANGEW CHEM INT EDIT, V45, P1022, DOI 10.1002/anie.200502984; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Toney JH, 1998, CHEM BIOL, V5, P185, DOI 10.1016/S1074-5521(98)90632-9; Toney JH, 2001, J BIOL CHEM, V276, P31913, DOI 10.1074/jbc.M104742200; Valdez CE, 2013, J CHEM THEORY COMPUT, V9, P730, DOI 10.1021/ct300712j; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Vandenameele J, 2010, BIOCHEMISTRY-US, V49, P4264, DOI 10.1021/bi100369d; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waley SG, 1992, CHEM BLACTAMS, P198; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Whitford D., 2005, PROTEINS STRUCTURE F; Wittung-Stafshede P, 2002, ACCOUNTS CHEM RES, V35, P201, DOI 10.1021/ar010106e; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200; Yang YJ, 1999, J BIOL CHEM, V274, P15706, DOI 10.1074/jbc.274.22.15706; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	102	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16124	16137		10.1074/jbc.M116.719005	http://dx.doi.org/10.1074/jbc.M116.719005			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27235401	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000380585400018
J	Michael, AJ				Michael, Anthony J.			Polyamines in Eukaryotes, Bacteria, and Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							S-ADENOSYLMETHIONINE DECARBOXYLASE; QUINOLIZIDINE ALKALOID BIOSYNTHESIS; DEPENDENT ARGININE DECARBOXYLASE; HYPUSINE-CONTAINING PROTEIN; LONG-CHAIN POLYAMINES; ELONGATION-FACTOR P; SPERMINE SYNTHASE; LYSINE DECARBOXYLASE; CELLULAR POLYAMINE; NEUROSPORA-CRASSA	Polyamines are primordial polycations found in most cells and perform different functions in different organisms. Although polyamines are mainly known for their essential roles in cell growth and proliferation, their functions range from a critical role in cellular translation in eukaryotes and archaea, to bacterial biofilm formation and specialized roles in natural product biosynthesis. At first glance, the diversity of polyamine structures in different organisms appears chaotic; however, biosynthetic flexibility and evolutionary and ecological processes largely explain this heterogeneity. In this review, I discuss the biosynthetic, evolutionary, and physiological processes that constrain or expand polyamine structural and functional diversity.	[Michael, Anthony J.] Univ Texas Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Michael, AJ (corresponding author), Univ Texas Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA.	anthony.michael@utsouthwestern.edu			University of Texas Southwestern Medical Center	University of Texas Southwestern Medical Center	This work was supported by a Seed Grant from University of Texas Southwestern Medical Center. The author declares that he has no conflicts of interest with the contents of this article.	Archibald JM, 2015, CURR BIOL, V25, pR911, DOI 10.1016/j.cub.2015.07.055; BAGGA S, 1991, PLANT CELL REP, V10, P550, DOI 10.1007/BF00232509; Bagga S, 1997, PLANT PHYSIOL, V114, P445, DOI 10.1104/pp.114.2.445; BARTIG D, 1992, EUR J BIOCHEM, V204, P751, DOI 10.1111/j.1432-1033.1992.tb16690.x; BORRELL A, 1995, PLANT PHYSIOL, V109, P771, DOI 10.1104/pp.109.3.771; Bunsupa S, 2012, PLANT CELL, V24, P1202, DOI 10.1105/tpc.112.095885; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; Burrell M, 2012, MOL MICROBIOL, V86, P485, DOI 10.1111/j.1365-2958.2012.08208.x; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; CACCIAPUOTI G, 1986, EUR J BIOCHEM, V161, P263, DOI 10.1111/j.1432-1033.1986.tb10442.x; CACCIAPUOTI G, 1991, EUR J BIOCHEM, V199, P395, DOI 10.1111/j.1432-1033.1991.tb16136.x; Clark K, 2010, AMINO ACIDS, V38, P633, DOI 10.1007/s00726-009-0424-7; Colotti G, 2011, AMINO ACIDS, V40, P269, DOI 10.1007/s00726-010-0630-3; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; Ding YZ, 2014, APPL ENVIRON MICROB, V80, P1498, DOI 10.1128/AEM.03461-13; Dorrell RG, 2015, P NATL ACAD SCI USA, V112, P10247, DOI 10.1073/pnas.1421380112; Durak GM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10543; Fincato P, 2011, J EXP BOT, V62, P1155, DOI 10.1093/jxb/erq341; FUJIHARA S, 1995, J BIOL CHEM, V270, P9932, DOI 10.1074/jbc.270.17.9932; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Giles TN, 2008, J BIOL CHEM, V283, P25829, DOI 10.1074/jbc.M802674200; Goda S, 2005, BBA-PROTEINS PROTEOM, V1748, P110, DOI 10.1016/j.bbapap.2004.12.010; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hamana K, 2004, J GEN APPL MICROBIOL, V50, P297, DOI 10.2323/jgam.50.297; Hamana K, 2004, J GEN APPL MICROBIOL, V50, P289, DOI 10.2323/jgam.50.289; HAMANA K, 1984, J BIOCHEM-TOKYO, V95, P1105, DOI 10.1093/oxfordjournals.jbchem.a134698; Hamana K, 2003, J GEN APPL MICROBIOL, V49, P287, DOI 10.2323/jgam.49.287; HAMANA K, 1985, J BIOCHEM-TOKYO, V97, P1595, DOI 10.1093/oxfordjournals.jbchem.a135216; HAMANA K, 1992, CRIT REV MICROBIOL, V18, P261, DOI 10.3109/10408419209113518; Hamana K, 2001, J GEN APPL MICROBIOL, V47, P99, DOI 10.2323/jgam.47.99; Hamana K, 2006, J GEN APPL MICROBIOL, V52, P235, DOI 10.2323/jgam.52.235; Hamasaki-Katagiri N, 1998, GENE, V210, P195, DOI 10.1016/S0378-1119(98)00027-4; Hanfrey CC, 2011, J BIOL CHEM, V286, P43301, DOI 10.1074/jbc.M111.307835; Hanzawa Y, 2000, EMBO J, V19, P4248, DOI 10.1093/emboj/19.16.4248; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P271, DOI 10.2323/jgam.50.271; Hoyt MA, 2000, MOL CELL BIOL, V20, P2760, DOI 10.1128/MCB.20.8.2760-2773.2000; Hoyt MA, 2000, MOL GEN GENET, V263, P664, DOI 10.1007/s004380051215; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; Ikai H, 1997, J BACTERIOL, V179, P5118, DOI 10.1128/jb.179.16.5118-5125.1997; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Illingworth C, 2003, FEBS LETT, V549, P26, DOI 10.1016/S0014-5793(03)00756-7; Janowitz T, 2003, FEBS LETT, V544, P258, DOI 10.1016/S0014-5793(03)00515-5; Jansson BPM, 2000, J BACTERIOL, V182, P1158, DOI 10.1128/JB.182.4.1158-1161.2000; Kaiser A, 1999, PLANT J, V19, P195, DOI 10.1046/j.1365-313X.1999.00509.x; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; Kim SH, 2016, ACS CHEM BIOL, V11, P491, DOI 10.1021/acschembio.5b00893; Knott JM, 2007, FEBS LETT, V581, P3081, DOI 10.1016/j.febslet.2007.05.074; Knott JM, 2009, FEBS LETT, V583, P3519, DOI 10.1016/j.febslet.2009.10.014; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Li B, 2015, MOL MICROBIOL, V97, P791, DOI 10.1111/mmi.13066; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Matsunaga S, 2007, CHEMBIOCHEM, V8, P1729, DOI 10.1002/cbic.200700305; Michael AJ, 2011, FEBS LETT, V585, P2627, DOI 10.1016/j.febslet.2011.07.038; Miller D, 2012, BIOCHEMISTRY-US, V51, P3067, DOI 10.1021/bi300039f; Minguet EG, 2008, MOL BIOL EVOL, V25, P2119, DOI 10.1093/molbev/msn161; Morimoto N, 2010, J BACTERIOL, V192, P4991, DOI 10.1128/JB.00279-10; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; NICKERSON KW, 1977, J BACTERIOL, V129, P173, DOI 10.1128/JB.129.1.173-176.1977; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Ober D, 1999, P NATL ACAD SCI USA, V96, P14777, DOI 10.1073/pnas.96.26.14777; Ober D, 2009, PHYTOCHEMISTRY, V70, P1687, DOI 10.1016/j.phytochem.2009.05.017; Ohnuma M, 2005, J BIOL CHEM, V280, P30073, DOI 10.1074/jbc.M413332200; Ohnuma M, 2011, J MOL BIOL, V408, P971, DOI 10.1016/j.jmb.2011.03.025; Panicot M, 2002, PLANT CELL, V14, P2539, DOI 10.1105/tpc.004077; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; PAULUS TJ, 1982, J BACTERIOL, V152, P291; PEGG AE, 1981, BIOCHEM J, V197, P315, DOI 10.1042/bj1970315; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pegg AE, 2014, IUBMB LIFE, V66, P8, DOI 10.1002/iub.1237; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; Pegg AE, 2010, CELL MOL LIFE SCI, V67, P113, DOI 10.1007/s00018-009-0165-5; Piotrowski M, 2003, J BIOL CHEM, V278, P1708, DOI 10.1074/jbc.M205699200; Pohnert G, 2002, ANGEW CHEM INT EDIT, V41, P3167, DOI 10.1002/1521-3773(20020902)41:17<3167::AID-ANIE3167>3.0.CO;2-R; Sagor GHM, 2015, FEBS LETT, V589, P3071, DOI 10.1016/j.febslet.2015.08.045; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; SCHERER P, 1983, J BACTERIOL, V154, P1315, DOI 10.1128/JB.154.3.1315-1322.1983; Schmidt C, 2016, NUCLEIC ACIDS RES, V44, P1944, DOI 10.1093/nar/gkv1517; Shaw FL, 2010, J BIOL CHEM, V285, P14711, DOI 10.1074/jbc.M110.107219; Sumper M, 2002, SCIENCE, V295, P2430, DOI 10.1126/science.1070026; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TAIT GH, 1976, BIOCHEM SOC T, V4, P610, DOI 10.1042/bst0040610; Takano A, 2012, PLANT CELL PHYSIOL, V53, P606, DOI 10.1093/pcp/pcs019; Tanaka T., 2002, ANN GUNMA HLTH SCI, V23, P137; Tolbert WD, 2003, STRUCTURE, V11, P285, DOI 10.1016/S0969-2126(03)00026-1; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; WINK M, 1979, FEBS LETT, V101, P343, DOI 10.1016/0014-5793(79)81040-6; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Wu H, 2007, BIOCHEMISTRY-US, V46, P8331, DOI 10.1021/bi602498k; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889	95	148	159	5	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14896	14903		10.1074/jbc.R116.734780	http://dx.doi.org/10.1074/jbc.R116.734780			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27268252	Green Published, hybrid			2022-12-28	WOS:000380583200001
J	Malhotra, R; D'Souza, KM; Staron, ML; Birukov, KG; Bodi, I; Akhter, SA				Malhotra, Ricky; D'Souza, Karen M.; Staron, Michelle L.; Birukov, Konstantin G.; Bodi, Ilona; Akhter, Shahab A.			RETRACTION: G alpha(q)-mediated activation of GRK2 by mechanical stretch in cardiac myocytes. THE ROLE OF PROTEIN KINASE C. (Retraction of vol 285, pg 13748, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Birukov, Konstantin/FJB-5755-2022					Malhotra R, 2010, J BIOL CHEM, V285, P13748, DOI 10.1074/jbc.M110.109272	1	0	0	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14390	14390		10.1074/jbc.A110.109272	http://dx.doi.org/10.1074/jbc.A110.109272			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371566	Green Published, hybrid			2022-12-28	WOS:000379975100044
J	Qiao, DH; Meyer, K; Friedl, A				Qiao, Dianhua; Meyer, Kristy; Friedl, Andreas			RETRACTION: Glypican-1 stimulates Skp2 autoinduction loop and G(1)/S transition in endothelial cells (Retraction of vol 287, pg 5898, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Qiao DH, 2012, J BIOL CHEM, V287, P5898, DOI 10.1074/jbc.M111.325282	1	0	0	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14389	14389		10.1074/jbc.A111.325282	http://dx.doi.org/10.1074/jbc.A111.325282			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371565	Green Published, hybrid			2022-12-28	WOS:000379975100043
J	Shulga, N; Pastorino, JG				Shulga, Nataly; Pastorino, John G.			RETRACTION: Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposure (Retraction of vol 289, pg 26213, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Shulga N, 2014, J BIOL CHEM, V289, P26213, DOI 10.1074/jbc.M114.580175	1	2	2	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12574	12574		10.1074/jbc.A114.580175	http://dx.doi.org/10.1074/jbc.A114.580175			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27288522	Green Published, hybrid			2022-12-28	WOS:000378119900014
J	Nazmi, AR; Lang, EJM; Bai, Y; Allison, TM; Othman, MH; Panjikar, S; Arcus, VL; Parker, EJ				Nazmi, Ali Reza; Lang, Eric J. M.; Bai, Yu; Allison, Timothy M.; Othman, Mohamad H.; Panjikar, Santosh; Arcus, Vickery L.; Parker, Emily J.			Interdomain Conformational Changes Provide Allosteric Regulation en Route to Chorismate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; Bacillus; crystal structure; inhibition mechanism; multifunctional enzyme; X-ray scattering; DAHPS; aromatic amino acid; chorismate mutase; shikimate	3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; MM3 FORCE-FIELD; AMINO-ACID BIOSYNTHESIS; ACTIVE-SITE RESIDUES; ESCHERICHIA-COLI; MOLECULAR-MECHANICS; PREPHENATE DEHYDROGENASE; SYNERGISTIC ALLOSTERY; MUTASE; PROTEIN	Multifunctional proteins play a variety of roles in metabolism. Here, we examine the catalytic function of the combined 3-deoxy-d-arabino heptulosonate-7-phosphate synthase (DAH7PS) and chorismate mutase (CM) from Geobacillus sp. DAH7PS operates at the start of the biosynthetic pathway for aromatic metabolites, whereas CM operates in a dedicated branch of the pathway for the biosynthesis of amino acids tyrosine and phenylalanine. In line with sequence predictions, the two catalytic functions are located in distinct domains, and these two activities can be separated and retain functionality. For the full-length protein, prephenate, the product of the CM reaction, acts as an allosteric inhibitor for the DAH7PS. The crystal structure of the full-length protein with prephenate bound and the accompanying small angle x-ray scattering data reveal the molecular mechanism of the allostery. Prephenate binding results in the tighter association between the dimeric CM domains and the tetrameric DAH7PS, occluding the active site and therefore disrupting DAH7PS function. Acquisition of a physical gating mechanism to control catalytic function through gene fusion appears to be a general mechanism for providing allostery for this enzyme.	[Nazmi, Ali Reza; Lang, Eric J. M.; Bai, Yu; Othman, Mohamad H.] Univ Canterbury, Biomol Interact Ctr, POB 4800, Christchurch 8140, New Zealand; [Nazmi, Ali Reza; Lang, Eric J. M.; Bai, Yu; Othman, Mohamad H.; Parker, Emily J.] Univ Canterbury, Dept Chem, POB 4800, Christchurch 8140, New Zealand; [Allison, Timothy M.] Univ Oxford, Dept Chem, South Parks Rd, Oxford OX1 5QY, England; [Panjikar, Santosh] Australian Synchrotron, Melbourne, Vic 3168, Australia; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Clayton, Vic 3800, Australia; [Arcus, Vickery L.] Univ Waikato, Sch Sci, Hamilton 3240, New Zealand; [Parker, Emily J.] Univ Canterbury, Maurice Wilkins Ctr, Biomol Interact Ctr, POB 4800, Christchurch 8140, New Zealand	University of Canterbury; University of Canterbury; University of Oxford; Monash University; University of Waikato; University of Canterbury	Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Private Bag 4800, Christchurch, New Zealand.	emily.parker@canterbury.ac.nz	Panjikar, Santosh/D-2709-2012; Lang, Eric J. M./N-3777-2019	Panjikar, Santosh/0000-0001-7429-3879; Lang, Eric J. M./0000-0002-3808-054X; Parker, Emily/0000-0002-9571-9987; Bai, Yu/0000-0002-5698-0023; Nazmi, Ali Reza/0000-0003-1262-5078	New Zealand Marsden Fund Grant [UOC1105]; Biomolecular Interaction Centre; University of Canterbury High Performance Computing	New Zealand Marsden Fund Grant(Royal Society of New ZealandMarsden Fund (NZ)); Biomolecular Interaction Centre; University of Canterbury High Performance Computing	This work was supported by New Zealand Marsden Fund Grant UOC1105, the Biomolecular Interaction Centre, and the University of Canterbury High Performance Computing. The authors declare that they have no conflicts of interest with the contents of this article.	ALLINGER NL, 1989, J AM CHEM SOC, V111, P8551, DOI 10.1021/ja00205a001; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Elleuche S, 2015, APPL MICROBIOL BIOT, V99, P1545, DOI 10.1007/s00253-014-6315-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hur S, 2002, P NATL ACAD SCI USA, V99, P1176, DOI 10.1073/pnas.022628599; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knaggs AR, 2003, NAT PROD REP, V20, P119, DOI 10.1039/b100399m; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Lang EJM, 2016, J AM CHEM SOC, V138, P2036, DOI 10.1021/jacs.5b13134; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Lassila JK, 2007, BIOCHEMISTRY-US, V46, P6883, DOI 10.1021/bi700215x; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Light SH, 2012, PROTEIN SCI, V21, P887, DOI 10.1002/pro.2075; LII JH, 1989, J AM CHEM SOC, V111, P8576, DOI 10.1021/ja00205a003; LII JH, 1989, J AM CHEM SOC, V111, P8566, DOI 10.1021/ja00205a002; Liu DR, 1996, J AM CHEM SOC, V118, P1789, DOI 10.1021/ja953151o; Lutke-Eversloh T, 2005, APPL ENVIRON MICROB, V71, P7224, DOI 10.1128/AEM.71.11.7224-7228.2005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schofield LR, 2004, PROTEIN EXPRES PURIF, V34, P17, DOI 10.1016/j.pep.2003.11.008; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; TURNBULL J, 1990, BIOCHEMISTRY-US, V29, P10245, DOI 10.1021/bi00496a014; Tzin V, 2009, PLANT J, V60, P156, DOI 10.1111/j.1365-313X.2009.03945.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vincent S, 2002, BIOORG MED CHEM LETT, V12, P929, DOI 10.1016/S0960-894X(02)00053-7; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Wu J, 2005, BIOCHEM J, V390, P583, DOI 10.1042/BJ20050294; Zhang S, 1998, J BIOL CHEM, V273, P6248, DOI 10.1074/jbc.273.11.6248; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	51	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21836	21847		10.1074/jbc.M116.741637	http://dx.doi.org/10.1074/jbc.M116.741637			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27502275	Green Published, hybrid			2022-12-28	WOS:000386332600001
J	Kubota, Y; Nomura, K; Katoh, Y; Yamashita, R; Kaneko, K; Furuyama, K				Kubota, Yoshiko; Nomura, Kazumi; Katoh, Yasutake; Yamashita, Rina; Kaneko, Kiriko; Furuyama, Kazumichi			Novel Mechanisms for Heme-dependent Degradation of ALAS1 Protein as a Component of Negative Feedback Regulation of Heme Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; heme; mass spectrometry (MS); mitochondria; post-translational modification (PTM); protein degradation; 5-aminolevulinate synthase	DELTA-AMINOLEVULINATE SYNTHASE; 5-AMINOLEVULINATE SYNTHASE; LON PROTEASE; SIDEROBLASTIC ANEMIA; MITOCHONDRIAL; ENZYME; CELLS; MOTIF; RECOGNITION; GENE	In eukaryotic cells, heme production is tightly controlled by heme itself through negative feedback-mediated regulation of nonspecific 5-aminolevulinate synthase (ALAS1), which is a rate-limiting enzyme for heme biosynthesis. However, the mechanism driving the heme-dependent degradation of the ALAS1 protein in mitochondria is largely unknown. In the current study, we provide evidence that the mitochondrial ATP-dependent protease ClpXP, which is a heteromultimer of CLPX and CLPP, is involved in the heme-dependent degradation of ALAS1 in mitochondria. We found that ALAS1 forms a complex with ClpXP in a heme-dependent manner and that siRNA-mediated suppression of either CLPX or CLPP expression induced ALAS1 accumulation in the HepG2 human hepatic cell line. We also found that a specific heme-binding motif on ALAS1, located at the N-terminal end of the mature protein, is required for the heme-dependent formation of this protein complex. Moreover, hemin-mediated oxidative modification of ALAS1 resulted in the recruitment of LONP1, another ATP-dependent protease in the mitochondrial matrix, into the ALAS1 protein complex. Notably, the heme-binding site in the N-terminal region of the mature ALAS1 protein is also necessary for the heme-dependent oxidation of ALAS1. These results suggest that ALAS1 undergoes a conformational change following the association of heme to the heme-binding motif on this protein. This change in the structure of ALAS1 may enhance the formation of complexes between ALAS1 and ATP-dependent proteases in the mitochondria, thereby accelerating the degradation of ALAS1 protein to maintain appropriate intracellular heme levels.	[Kubota, Yoshiko; Nomura, Kazumi; Yamashita, Rina; Kaneko, Kiriko; Furuyama, Kazumichi] Iwate Med Univ, Dept Mol Biochem, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan; [Katoh, Yasutake] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan	Iwate Medical University; Tohoku University	Furuyama, K (corresponding author), Iwate Med Univ, Dept Mol Biochem, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	furuyama@iwate-med.ac.jp		Furuyama, Kazumichi/0000-0002-1376-4080	Japan Society for the Promotion of Science [23590353]; Health Labor Sciences Research Grant from Ministry of Health Labor and Welfare in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research Grant from Ministry of Health Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grant-in-aid for Scientific Research (C) 23590353 from the Japan Society for the Promotion of Science and by a Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare in Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Furuyama K, 1997, BLOOD, V90, P822, DOI 10.1182/blood.V90.2.822.822_822_830; Furuyama K, 2000, J CLIN INVEST, V105, P757, DOI 10.1172/JCI6816; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Furuyama K, 2014, HANDB PORPHYR SCI, V27, P1; Garcia-Nafria J, 2010, PROTEIN SCI, V19, P987, DOI 10.1002/pro.376; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kadirvel S, 2012, EXP HEMATOL, V40, P477, DOI 10.1016/j.exphem.2012.01.013; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Kardon JR, 2015, CELL, V161, P858, DOI 10.1016/j.cell.2015.04.017; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lowth BR, 2012, J STRUCT BIOL, V179, P193, DOI 10.1016/j.jsb.2012.06.001; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247; YAMAUCHI K, 1980, FEBS LETT, V115, P15, DOI 10.1016/0014-5793(80)80716-2	31	52	53	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20516	20529		10.1074/jbc.M116.719161	http://dx.doi.org/10.1074/jbc.M116.719161			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27496948	Green Published, hybrid			2022-12-28	WOS:000384574800018
J	Hirohashi, N; Tamura-Nakano, M; Nakaya, F; Iida, T; Iwata, Y				Hirohashi, Noritaka; Tamura-Nakano, Miwa; Nakaya, Fumio; Iida, Tomohiro; Iwata, Yoko			Sneaker Male Squid Produce Long-lived Spermatozoa by Modulating Their Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell motility; glucose metabolism; glycogen; reproduction; spermatozoa; alternative reproductive tactics; cephalopods; male dimorphism; postcopulatory sexual selection	SPERM SWIMMING SPEED; REPRODUCTIVE-TRACT; STORAGE; COMPETITION; MOTILITY; LACTATE; DEHYDROGENASE; GLYCOLYSIS; EVOLUTION; OXYGEN	Spermatozoa released by males should remain viable until fertilization. Hence, sperm longevity is governed by intrinsic and environmental factors in accordance with the male mating strategy. However, whether intraspecific variation of insemination modes can impact sperm longevity remains to be elucidated. In the squid Heterololigo bleekeri, male dimorphism (consort and sneaker) is linked to two discontinuous insemination modes that differ in place and time. Notably, only sneaker male spermatozoa inseminated long before egg spawning can be stored in the seminal receptacle. We found that sneaker spermatozoa exhibited greater persistence in fertilization competence and flagellar motility than consort ones because of a larger amount of flagellar glycogen. Sneaker spermatozoa also showed higher capacities in glucose uptake and lactate efflux. Lactic acidosis was considered to stabilize CO2-triggered self-clustering of sneaker spermatozoa, thus establishing hypoxia-induced metabolic changes and sperm survival. These results, together with comparative omics analyses, suggest that postcopulatory reproductive contexts define sperm longevity by modulating the inherent energy levels and metabolic pathways.	[Hirohashi, Noritaka; Iida, Tomohiro] Shimane Univ, Oki Marine Biol Stn, Educ & Res Ctr Biol Resources, Oki 6850024, Japan; [Tamura-Nakano, Miwa] Natl Ctr Global Hlth & Med, Res Inst, Tokyo 1628655, Japan; [Nakaya, Fumio] Osaka Kyoiku Univ, Ctr Sci Educ, Osaka 582858, Japan; [Iwata, Yoko] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778564, Japan	Shimane University; National Center for Global Health & Medicine - Japan; Osaka University of Education; University of Tokyo	Hirohashi, N (corresponding author), Shimane Univ, Oki Marine Biol Stn, Educ & Res Ctr Biol Resources, Oki 6850024, Japan.	hiro@life.shimane-u.ac.jp		Tamura-Nakano, Miwa/0000-0002-8502-6474				Amaral A, 2013, MOL CELL PROTEOMICS, V12, P330, DOI 10.1074/mcp.M112.020552; AUSTIN CR, 1964, PROC R SOC SER B-BIO, V161, P143, DOI 10.1098/rspb.1964.0085; Bennison C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1897; Binet MT, 2014, J EXP MAR BIOL ECOL, V452, P91, DOI 10.1016/j.jembe.2013.12.008; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Burness G, 2004, BEHAV ECOL SOCIOBIOL, V56, P65, DOI 10.1007/s00265-003-0752-7; CHRISTEN R, 1983, J BIOL CHEM, V258, P5392; Drew GA, 1911, J MORPHOL, V22, P327, DOI 10.1002/jmor.1050220207; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Gasparini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012146; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Hanlon RT, 2002, B MAR SCI, V71, P331; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirohashi Noritaka, 2013, Communicative & Integrative Biology, V6, pe26729, DOI 10.4161/cib.26729; Hirohashi N, 2013, CURR BIOL, V23, P775, DOI 10.1016/j.cub.2013.03.040; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Iwata Y, 2005, MAR ECOL PROG SER, V298, P219, DOI 10.3354/meps298219; Iwata Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-236; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Konno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126005; LEVITAN DR, 1991, BIOL BULL, V181, P371, DOI 10.2307/1542357; Lindemann CB, 1996, CELL MOTIL CYTOSKEL, V34, P258, DOI 10.1002/(SICI)1097-0169(1996)34:4<258::AID-CM1>3.0.CO;2-4; MANN T, 1946, BIOCHEM J, V40, P481, DOI 10.1042/bj0400481; MANN T, 1974, SCIENCE, V185, P453, DOI 10.1126/science.185.4149.453; Matsuzaki M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17643; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; MITA M, 1982, BIOL REPROD, V26, P445, DOI 10.1095/biolreprod26.3.445; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Nascimento JM, 2008, J CELL PHYSIOL, V217, P745, DOI 10.1002/jcp.21549; Orr TJ, 2015, TRENDS ECOL EVOL, V30, P261, DOI 10.1016/j.tree.2015.03.006; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Sasanami T, 2013, J REPROD DEVELOP, V59, P334, DOI 10.1262/jrd.2013-038; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; THORNHILL R, 1983, AM NAT, V122, P765, DOI 10.1086/284170; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Yoshida MA, 2014, BIOCHEM BIOPH RES CO, V450, P1218, DOI 10.1016/j.bbrc.2014.04.076; Zhang LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16096	41	19	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19324	19334		10.1074/jbc.M116.737494	http://dx.doi.org/10.1074/jbc.M116.737494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27385589	Green Published, hybrid			2022-12-28	WOS:000383242800013
J	Morante, K; Bellomio, A; Gil-Carton, D; Redondo-Morata, L; Sot, J; Scheuring, S; Valle, M; Gonzalez-Manas, JM; Tsumoto, K; Caaveiro, JMM				Morante, Koldo; Bellomio, Augusto; Gil-Carton, David; Redondo-Morata, Lorena; Sot, Jesus; Scheuring, Simon; Valle, Mikel; Manuel Gonzalez-Manas, Juan; Tsumoto, Kouhei; Caaveiro, Jose M. M.			Identification of a Membrane-bound Prepore Species Clarifies the Lytic Mechanism of Actinoporins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); cryo-electron microscopy; lipid vesicle; lipid-protein interaction; oligomerization; protein structure; cytolysin; pore forming protein	PORE-FORMING TOXIN; ATOMIC-FORCE MICROSCOPY; EQUINATOXIN-II; SEA-ANEMONE; MODEL MEMBRANES; ASSEMBLY MECHANISM; PARTICLE ANALYSIS; ACTINIA-FRAGACEA; LIPID-MEMBRANES; PROTEIN	Pore-forming toxins (PFTs) are cytolytic proteins belonging to the molecular warfare apparatus of living organisms. The assembly of the functional transmembrane pore requires several intermediate steps ranging from a water-soluble monomeric species to the multimeric ensemble inserted in the cell membrane. The non-lytic oligomeric intermediate known as prepore plays an essential role in the mechanism of insertion of the class of -PFTs. However, in the class of -PFTs, like the actinoporins produced by sea anemones, evidence of membrane-bound prepores is still lacking. We have employed single-particle cryo-electron microscopy (cryo-EM) and atomic force microscopy to identify, for the first time, a prepore species of the actinoporin fragaceatoxin C bound to lipid vesicles. The size of the prepore coincides with that of the functional pore, except for the transmembrane region, which is absent in the prepore. Biochemical assays indicated that, in the prepore species, the N terminus is not inserted in the bilayer but is exposed to the aqueous solution. Our study reveals the structure of the prepore in actinoporins and highlights the role of structural intermediates for the formation of cytolytic pores by an -PFT.	[Morante, Koldo; Tsumoto, Kouhei; Caaveiro, Jose M. M.] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan; [Morante, Koldo; Bellomio, Augusto; Sot, Jesus; Manuel Gonzalez-Manas, Juan] Univ Basque Country, Dept Biochem & Mol Biol, UPV EHU, CSIC, POB 644, Bilbao 48080, Spain; [Morante, Koldo; Bellomio, Augusto; Sot, Jesus] Univ Basque Country, Biofis Inst, UPV EHU, CSIC, POB 644, Bilbao 48080, Spain; [Gil-Carton, David; Valle, Mikel] CICbiogune, Ctr Cooperat Res Biosci, Struct Biol Unit, Derio 48160, Spain; [Redondo-Morata, Lorena; Scheuring, Simon] Aix Marseille Univ, INSERM, U1006, Parc Sci & Technol Luminy,163 Ave Luminy, F-13009 Marseille, France; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; CIC bioGUNE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Tokyo	Tsumoto, K; Caaveiro, JMM (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan.	tsumoto@bioeng.t.u-tokyo.ac.jp; jose@bioeng.t.tokyo.ac.jp	Redondo-Morata, Lorena/A-3111-2015; Carton, David Gil/M-9332-2019; Scheuring, Simon/L-9843-2018; Valle, Mikel/F-7598-2011; Carton, David Gil/G-2404-2011; Caaveiro, Jose/J-2790-2013	Redondo-Morata, Lorena/0000-0002-6254-8261; Carton, David Gil/0000-0003-4241-1302; Scheuring, Simon/0000-0003-3534-069X; Valle, Mikel/0000-0001-8268-6912; Carton, David Gil/0000-0003-4241-1302; Caaveiro, Jose/0000-0001-5568-2369; Morante, Koldo/0000-0002-9877-9168; Sot, Jesus/0000-0001-9508-6596; GONZALEZ MANAS, JUAN MANUEL/0000-0002-1833-6982	Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT [25249115, 16H02420, 15K06962]; European Research Council [310080]; MEM-STRUCT-AFM; Spanish Ministry of Economy and Competitiveness [BFU2015-66326-P]; Grants-in-Aid for Scientific Research [16H02420] Funding Source: KAKEN	Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT; European Research Council(European Research Council (ERC)European Commission); MEM-STRUCT-AFM; Spanish Ministry of Economy and Competitiveness(Spanish Government); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Grants-in-aid for Scientific Research A 25249115 and 16H02420 (to K. T.), Grant-in-aid for Scientific Research C 15K06962 (to J. M. M. C.), European Research Council Grant 310080, MEM-STRUCT-AFM (to the Scheuring laboratory), and Grant BFU2015-66326-P from the Spanish Ministry of Economy and Competitiveness (to M. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Alegre-Cebollada J, 2007, CURR PROTEIN PEPT SC, V8, P558, DOI 10.2174/138920307783018686; Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Antonini V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110824; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Baxter WT, 2007, J STRUCT BIOL, V157, P56, DOI 10.1016/j.jsb.2006.07.019; Bayley H, 2009, NATURE, V459, P651, DOI 10.1038/459651a; Bellomio A, 2009, TOXICON, V54, P869, DOI 10.1016/j.toxicon.2009.06.022; Caaveiro JMM, 2001, BIOPHYS J, V80, P1343, DOI 10.1016/S0006-3495(01)76107-3; Calvez P, 2009, BIOCHIMIE, V91, P718, DOI 10.1016/j.biochi.2009.03.018; Chiaruttini N, 2015, CELL, V163, P866, DOI 10.1016/j.cell.2015.10.017; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Fahie M, 2013, J BIOL CHEM, V288, P31042, DOI 10.1074/jbc.M113.475350; Fang Y, 1997, BIOCHEMISTRY-US, V36, P9518, DOI 10.1021/bi970600j; Gilbert RJC, 2016, BBA-BIOMEMBRANES, V1858, P487, DOI 10.1016/j.bbamem.2015.11.026; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Gutierrez-Aguirre I, 2004, BIOCHEM J, V384, P421, DOI 10.1042/BJ20040601; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Husain M, 2012, J MOL RECOGNIT, V25, P292, DOI 10.1002/jmr.2187; KAKIUCHI T, 1992, J COLLOID INTERF SCI, V149, P279, DOI 10.1016/0021-9797(92)90415-I; Leung C, 2014, ELIFE, V3, DOI 10.7554/eLife.04247; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mancheno JA, 2006, BIOPHYS CHEM, V119, P219, DOI 10.1016/j.bpc.2005.09.021; Mechaly AE, 2012, J STRUCT BIOL, V180, P312, DOI 10.1016/j.jsb.2012.06.003; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; Montes LR, 2010, METHODS MOL BIOL, V606, P105, DOI 10.1007/978-1-60761-447-0_9; Morante K, 2015, FEBS LETT, V589, P1840, DOI 10.1016/j.febslet.2015.06.012; Morante K, 2015, J BIOL CHEM, V290, P10850, DOI 10.1074/jbc.M114.615211; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Palacios-Ortega J, 2016, LANGMUIR, V32, P3476, DOI 10.1021/acs.langmuir.6b00082; Pedrera L, 2014, BBA-BIOMEMBRANES, V1838, P1752, DOI 10.1016/j.bbamem.2014.03.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rojko N, 2016, BBA-BIOMEMBRANES, V1858, P446, DOI 10.1016/j.bbamem.2015.09.007; Rojko N, 2015, ACCOUNTS CHEM RES, V48, P3073, DOI 10.1021/acs.accounts.5b00403; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scherfeld D, 2003, BIOPHYS J, V85, P3758, DOI 10.1016/S0006-3495(03)74791-2; Sonnen AFP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140044; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Subburaj Y, 2015, J BIOL CHEM, V290, P4856, DOI 10.1074/jbc.M114.600676; Tanaka K, 2015, BIOCHEMISTRY-US, V54, P6863, DOI 10.1021/acs.biochem.5b01112; Tanaka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7337; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wacklin HP, 2016, BBA-BIOMEMBRANES, V1858, P640, DOI 10.1016/j.bbamem.2015.12.019; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yilmaz N, 2013, BIOPHYS J, V105, P1397, DOI 10.1016/j.bpj.2013.07.052	54	21	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19210	19219		10.1074/jbc.M116.734053	http://dx.doi.org/10.1074/jbc.M116.734053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27445331	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000383242800001
J	Ray, MK; Wiskow, O; King, MJ; Ismail, N; Ergun, A; Wang, YQ; Plys, AJ; Davis, CP; Kathrein, K; Sadreyev, R; Borowsky, ML; Eggan, K; Zon, L; Galloway, JL; Kingston, RE				Ray, Mridula K.; Wiskow, Ole; King, Matthew J.; Ismail, Nidha; Ergun, Ayla; Wang, Yanqun; Plys, Aaron J.; Davis, Christopher P.; Kathrein, Katie; Sadreyev, Ruslan; Borowsky, Mark L.; Eggan, Kevin; Zon, Leonard; Galloway, Jenna L.; Kingston, Robert E.			CAT7 and cat7l Long Non-coding RNAs Tune Polycomb Repressive Complex 1 Function during Human and Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin regulation; development; gene expression; long noncoding RNA (long ncRNA; lncRNA); mammal; polycomb; zebrafish; CsCl density gradient; PRC1	METHYLATED HISTONE H3; GENE-EXPRESSION; PRC2 RECRUITMENT; CHROMATIN; PROTEINS; DATABASE; TRANSCRIPTION; MECHANISMS; REGULATORS; COMPACTION	The essential functions of polycomb repressive complex 1 (PRC1) in development and gene silencing are thought to involve long non-coding RNAs (lncRNAs), but few specific lncRNAs that guide PRC1 activity are known. We screened for lncRNAs, which co-precipitate with PRC1 from chromatin and found candidates that impact polycomb group protein (PcG)-regulated gene expression in vivo. A novel lncRNA from this screen, CAT7, regulates expression and polycomb group binding at the MNX1 locus during early neuronal differentiation. CAT7 contains a unique tandem repeat domain that shares high sequence similarity to a non-syntenic zebrafish analog, cat7l. Defects caused by interference of cat7l RNA during zebrafish embryogenesis were rescued by human CAT7 RNA, enhanced by interference of a PRC1 component, and suppressed by interference of a known PRC1 target gene, demonstrating cat7l genetically interacts with a PRC1. We propose a model whereby PRC1 acts in concert with specific lncRNAs and that CAT7/cat7l represents convergent lncRNAs that independently evolved to tune PRC1 repression at individual loci.	[Ray, Mridula K.; Ergun, Ayla; Wang, Yanqun; Plys, Aaron J.; Davis, Christopher P.; Sadreyev, Ruslan; Borowsky, Mark L.; Kingston, Robert E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ray, Mridula K.; Wang, Yanqun; Plys, Aaron J.; Davis, Christopher P.; Borowsky, Mark L.; Kingston, Robert E.] Harvard Med Sch, Dept Genet, Boston, MA 02114 USA; [Wiskow, Ole; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Wiskow, Ole; Eggan, Kevin] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02138 USA; [King, Matthew J.; Ismail, Nidha; Galloway, Jenna L.] Harvard Med Sch, Harvard Stem Cell Inst, Massachusetts Gen Hosp, Ctr Regenerat Med,Dept Orthopaed Surg, Boston, MA 02114 USA; [Ergun, Ayla; Sadreyev, Ruslan] Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA; [Kathrein, Katie; Zon, Leonard] Boston Childrens Hosp, Dana Farber Canc Inst, Harvard Stem Cell Inst, Div Hematol Oncol, Boston, MA 02115 USA; [Eggan, Kevin] Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Kingston, RE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Kingston, RE (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02114 USA.; Galloway, JL (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Massachusetts Gen Hosp, Ctr Regenerat Med,Dept Orthopaed Surg, Boston, MA 02114 USA.	jenna_galloway@hms.harvard.edu; kingston@molbio.mgh.harvard.edu	Eggan, Kevin/P-7119-2018	Davis, Christopher/0000-0003-0112-9458	National Institutes of Health [RO1-GM043901]; ALS Association; Eunice Kennedy Shriver NICHD, National Institutes of Health [R00HD069533]; Harvard Stem Cell Institute (HSCI); National Research Service Award fellowship from the National Institutes of Health [F32GM109693]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048405, R01GM048405, R01GM043901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Harvard Stem Cell Institute (HSCI); National Research Service Award fellowship from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-GM043901 (to R. E. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the ALS Association.; Supported by funding from the Eunice Kennedy Shriver NICHD, National Institutes of Health Grant R00HD069533 and the Harvard Stem Cell Institute (HSCI).; Supported by a National Research Service Award fellowship from the National Institutes of Health (F32GM109693).; Supported by a graduate research fellowship from the National Science Foundation.	Anderson E, 2014, DEVELOPMENT, V141, P3934, DOI 10.1242/dev.108480; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Blum M, 2015, DEV CELL, V35, P145, DOI 10.1016/j.devcel.2015.09.017; Bonnefond A, 2013, DIABETES METAB, V39, P276, DOI 10.1016/j.diabet.2013.02.007; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Chambers SM, 2016, METHODS MOL BIOL, V1307, P329, DOI 10.1007/7651_2013_59; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Davidovich C, 2015, MOL CELL, V57, P552, DOI 10.1016/j.molcel.2014.12.017; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; He W, 2013, BBA-MOL BASIS DIS, V1832, P1528, DOI 10.1016/j.bbadis.2013.05.010; Head SR, 2011, BIOTECHNIQUES, V50, P177, DOI 10.2144/000113613; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kaneko S, 2014, GENE DEV, V28, P1983, DOI 10.1101/gad.247940.114; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kochling J, 2001, EUR J HUM GENET, V9, P599, DOI 10.1038/sj.ejhg.5200683; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meng S, 2010, J BIOL CHEM, V285, P33219, DOI 10.1074/jbc.M110.133686; Mochida GH, 2012, NAT GENET, V44, P1260, DOI 10.1038/ng.2425; Nagano T, 2009, MAMM GENOME, V20, P557, DOI 10.1007/s00335-009-9218-1; Nie L, 2012, AM J TRANSL RES, V4, P127; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Tolstorukov MY, 2012, MOL CELL, V47, P596, DOI 10.1016/j.molcel.2012.06.011; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Yang LM, 2011, C IND ELECT APPL, P2011, DOI 10.1109/ICIEA.2011.5975922; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	54	26	28	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19558	19572		10.1074/jbc.M116.730853	http://dx.doi.org/10.1074/jbc.M116.730853			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27405765	hybrid, Green Published			2022-12-28	WOS:000383242800031
J	Hsiao, JJ; Smits, MM; Ng, BH; Lee, J; Wright, ME				Hsiao, Jordy J.; Smits, Melinda M.; Ng, Brandon H.; Lee, Jinhee; Wright, Michael E.			Discovery Proteomics Identifies a Molecular Link between the Coatomer Protein Complex I and Androgen Receptor-dependent Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-BINDING CHARACTERISTICS; RESISTANT PROSTATE-CANCER; LNCAP CELLS; GENE-EXPRESSION; NUCLEAR IMPORT; BREFELDIN-A; PROTEASOME ACTIVITY; MASS-SPECTROMETRY; COACTIVATOR; DATABASE	Aberrant androgen receptor (AR)-dependent transcription is a hallmark of human prostate cancers. At the molecular level, ligand-mediated AR activation is coordinated through spatial and temporal protein-protein interactions involving AR-interacting proteins, which we designate the "AR-interactome." Despite many years of research, the ligand-sensitive protein complexes involved in ligand-mediated AR activation in prostate tumor cells have not been clearly defined. Here, we describe the development, characterization, and utilization of a novel human LNCaP prostate tumor cell line, N-AR, which stably expresses wild-type AR tagged at its N terminus with the streptavidin-binding peptide epitope (streptavidin-binding peptide-tagged wild-type androgen receptor; SBP-AR). A bio-analytical workflow involving streptavidin chromatography and label-free quantitative mass spectrometry was used to identify SBP-AR and associated ligand-sensitive cytosolic proteins/protein complexes linked to AR activation in prostate tumor cells. Functional studies verified that ligand-sensitive proteins identified in the proteomic screen encoded modulators of AR-mediated transcription, suggesting that these novel proteins were putative SBP-AR-interacting proteins in N-AR cells. This was supported by biochemical associations between recombinant SBP-AR and the ligand-sensitive coatomer protein complex I (COPI) retrograde trafficking complex in vitro. Extensive biochemical and molecular experiments showed that the COPI retrograde complex regulates ligand-mediated AR transcriptional activation, which correlated with the mobilization of the Golgilocalized ARA160 coactivator to the nuclear compartment of prostate tumor cells. Collectively, this study provides a bioanalytical strategy to validate the AR-interactome and define novel AR-interacting proteins involved in ligand-mediated AR activation in prostate tumor cells. Moreover, we describe a cellular system to study how compartment-specific AR-interacting proteins influence AR activation and contribute to aberrant AR-dependent transcription that underlies the majority of human prostate cancers.	[Hsiao, Jordy J.; Smits, Melinda M.; Ng, Brandon H.; Lee, Jinhee; Wright, Michael E.] Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA		Wright, ME (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, 51 Newton Rd,Bowen Sci Bldg 5-630, Iowa City, IA 52242 USA.	michael-e-wright@uiowa.edu		Hsiao, Jordy/0000-0002-2487-5034; Wright, Michael/0000-0002-4243-2931	University of Iowa	University of Iowa	This work was supported by University of Iowa startup funds (to M. E. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander B, 2013, UROL ONCOL-SEMIN ORI, V31, P104, DOI 10.1016/j.urolonc.2010.11.009; An J, 2014, CELL REP, V6, P657, DOI 10.1016/j.celrep.2014.01.013; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Bahl A, 2014, CANCER TREAT REV, V40, P170, DOI 10.1016/j.ctrv.2013.06.008; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Cookson MS, 2013, J UROLOGY, V190, P429, DOI 10.1016/j.juro.2013.05.005; Cosson P, 1997, CURR OPIN CELL BIOL, V9, P484, DOI 10.1016/S0955-0674(97)80023-3; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; Eichholz A, 2012, MOL CELL ENDOCRINOL, V360, P68, DOI 10.1016/j.mce.2011.09.038; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hsiao PW, 1999, J BIOL CHEM, V274, P22373, DOI 10.1074/jbc.274.32.22373; Johnson KY, 2002, BIOTECHNIQUES, V32, P1270, DOI 10.2144/02326st02; Kabler RL, 1996, J STEROID BIOCHEM, V59, P431, DOI 10.1016/S0960-0760(96)00126-4; Kaku N, 2008, ENDOCRINOLOGY, V149, P3960, DOI 10.1210/en.2008-0137; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Landry JP, 2012, ASSAY DRUG DEV TECHN, V10, P250, DOI 10.1089/adt.2011.0406; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LIANG T, 1975, P NATL ACAD SCI USA, V72, P706, DOI 10.1073/pnas.72.2.706; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lipman NS, 2005, ILAR J, V46, P258, DOI 10.1093/ilar.46.3.258; Loikkanen I, 2009, ONCOL REP, V22, P991, DOI 10.3892/or_00000526; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Magee JA, 2001, CANCER RES, V61, P5692; Martinez HD, 2008, J BIOL CHEM, V283, P29938, DOI 10.1074/jbc.M800534200; Martinez Harryl D, 2011, Genes Cancer, V2, P956, DOI 10.1177/1947601912436422; Miyajima N, 2008, CANCER RES, V68, P3486, DOI 10.1158/0008-5472.CAN-07-6059; MONTGOMERY BT, 1992, PROSTATE, V21, P63, DOI 10.1002/pros.2990210107; Moore SM, 2002, J ANDROL, V23, P163; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Mori K, 2002, FEBS LETT, V520, P127, DOI 10.1016/S0014-5793(02)02803-X; Ni L, 2013, MOL CELL BIOL, V33, P4766, DOI 10.1128/MCB.00647-13; Omasits U, 2013, GENOME RES, V23, P1916, DOI 10.1101/gr.151035.112; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Paliouras M, 2011, INTEGR BIOL-UK, V3, P1020, DOI 10.1039/c1ib00038a; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powers GL, 2010, ONCOGENE, V29, P1509, DOI 10.1038/onc.2009.434; Prescott J, 2006, CANCER LETT, V231, P12, DOI 10.1016/j.canlet.2004.12.037; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rudomin EL, 2009, J PROTEOME RES, V8, P3154, DOI 10.1021/pr801017a; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schmidt A, 2009, CURR OPIN CHEM BIOL, V13, P510, DOI 10.1016/j.cbpa.2009.08.016; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheflin L, 2000, BIOCHEM BIOPH RES CO, V276, P144, DOI 10.1006/bbrc.2000.3424; Shi ZA, 2013, NAT METHODS, V10, P597, DOI 10.1038/nmeth.2517; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tosoian J, 2010, THESCIENTIFICWORLDJO, V10, P1919, DOI 10.1100/tsw.2010.182; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Vanaja DK, 2003, CANCER RES, V63, P3877; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Vivithanaporn P, 2006, J BIOL CHEM, V281, P15475, DOI 10.1074/jbc.M512098200; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wallen E, 2000, J UROLOGY, V164, P836, DOI 10.1016/S0022-5347(05)67323-5; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Welsh JB, 2001, CANCER RES, V61, P5974; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Zaman N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113190; Zhu ML, 2010, CANCER RES, V70, P7992, DOI 10.1158/0008-5472.CAN-10-0585	104	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18818	18842		10.1074/jbc.M116.732313	http://dx.doi.org/10.1074/jbc.M116.732313			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27365400	hybrid, Green Published			2022-12-28	WOS:000383242300019
J	Ibarra, R; Sandoval, D; Fredrickson, EK; Gardner, RG; Kleiger, G				Ibarra, Rebeca; Sandoval, Daniella; Fredrickson, Eric K.; Gardner, Richard G.; Kleiger, Gary			The San1 Ubiquitin Ligase Functions Preferentially with Ubiquitin-conjugating Enzyme Ubc1 during Protein Quality Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC MISFOLDED PROTEINS; CONTROL DEGRADATION; ENDOPLASMIC-RETICULUM; EXPOSED HYDROPHOBICITY; PROTEASOME SYSTEM; E3 LIGASE; MECHANISM; SUBSTRATE; E2; CHAINS	Protein quality control (PQC) is a critical process wherein misfolded or damaged proteins are cleared from the cell to maintain protein homeostasis. In eukaryotic cells, the removal of misfolded proteins is primarily accomplished by the ubiquitin-proteasome system. In the ubiquitin-proteasome system, ubiquitin-conjugating enzymes and ubiquitin ligases append polyubiquitin chains onto misfolded protein substrates signaling for their degradation. The kinetics of protein ubiquitylation are paramount as a balance must be achieved between the rapid removal of misfolded proteins versus providing sufficient time for protein chaperones to attempt refolding. To uncover the molecular basis for how PQC substrate ubiquitylation rates are controlled, the reaction catalyzed by nuclear ubiquitin ligase San1 was reconstituted in vitro. Our results demonstrate that San1. can function with two ubiquitin-conjugating enzymes, Cdc34 and Ubc1. Although Cdc34 and Ubc1 are both sufficient for promoting Sanl activity, Sanl functions preferentially with Ubc1, including when both Ubc1 and Cdc34 are present. Notably, a homogeneous peptide that mimics a misfolded PQC substrate was developed and enabled quantification of the kinetics of Sanl-catalyzed ubiquitylation reactions. We discuss how these results may have broad implications for the regulation of PQC-mediated protein degradation.	[Ibarra, Rebeca; Sandoval, Daniella; Kleiger, Gary] Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA; [Fredrickson, Eric K.; Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Washington; University of Washington Seattle	Kleiger, G (corresponding author), Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA.	gary.kleiger@unlv.edu		Gardner, Richard/0000-0003-2162-6275	National Institutes of Health (NIGMS) [P20 GM103440, R15 GM117555-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750, P20GM103440, R15GM117555] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 GM103440 and R15 GM117555-01 (NIGMS; to G. K. and R. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Fredrickson EK, 2013, MOL BIOL CELL, V24, P1041, DOI 10.1091/mbc.E12-11-0811; Fredrickson EK, 2013, J BIOL CHEM, V288, P6130, DOI 10.1074/jbc.M112.406710; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Gallagher PS, 2014, J CELL SCI, V127, P1980, DOI 10.1242/jcs.141838; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Kim HG, 2015, ALTERNAT MED, P1, DOI DOI 10.3171/2014.11.JNS141382; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rosenbaum JC, 2011, NUCLEUS-PHILA, V2, P264, DOI 10.4161/nucl.2.4.16118; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tramutola A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2756068; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Woulfe J, 2008, BBA-MOL CELL RES, V1783, P2195, DOI 10.1016/j.bbamcr.2008.05.005; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	58	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18778	18790		10.1074/jbc.M116.737619	http://dx.doi.org/10.1074/jbc.M116.737619			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27405755	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000383242300015
J	Ramirez, VT; Ramos-Fernandez, E; Henriquez, JP; Lorenzo, A; Inestrosa, NC				Ramirez, Valerie T.; Ramos-Fernandez, Eva; Pablo Henriquez, Juan; Lorenzo, Alfredo; Inestrosa, Nibaldo C.			Wnt-5a/Frizzled9 Receptor Signaling through the G alpha(o)-G beta gamma Complex Regulates Dendritic Spine Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; WNT RECEPTOR; SYNAPTIC-TRANSMISSION; WNT/BETA-CATENIN; PERTUSSIS-TOXIN; NMDA-RECEPTOR; GROWTH CONES; HIPPOCAMPAL; ACTIVATION; FRIZZLED-9	Wnt ligands play crucial roles in the development and regulation of synapse structure and function. Specifically, Wnt-5a acts as a secreted growth factor that regulates dendritic spine formation in rodent hippocampal neurons, resulting in postsynaptic development that promotes the clustering of the PSD-95 (postsynaptic density protein 95). Here, we focused on the early events occurring after the interaction between Wnt-5a and its Frizzled receptor at the neuronal cell surface. Additionally, we studied the role of heterotrimeric G proteins in Wnt-5a-dependent synaptic development. We report that FZD9 (Frizzled9), a Wnt receptor related to Williams syndrome, is localized in the postsynaptic region, where it interacts with Wnt-5a. Functionally, FZD9 is required for the Wnt-5a-mediated increase in dendritic spine density. FZD9 forms a precoupled complex with G alpha(o) under basal conditions that dissociates after Wnt-5a stimulation. Accordingly, we found that G protein inhibition abrogates the Wnt-5a-dependent pathway in hippocampal neurons. In particular, the activation of G alpha(o) appears to be a key factor controlling the Wnt-5a-induced dendritic spine density. In addition, we found that G beta gamma is required for the Wnt-5a-mediated increase in cytosolic calcium levels and spinogenesis. Our findings reveal that FZD9 and heterotrimeric G proteins regulate Wnt-5a signaling and dendritic spines in cultured hippocampal neurons.	[Ramirez, Valerie T.; Ramos-Fernandez, Eva; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac, Alameda 340,POB 114-D, Santiago 8331150, Chile; [Pablo Henriquez, Juan] Univ Concepcion, Ctr Microscop Avanzada, Nucleo Milenio Biol Regenerat, Fac Ciencias Biol,Lab Neurobiol Desarrollo,Dept B, Concepcion 4089100, Chile; [Lorenzo, Alfredo] Univ Nacl Cordoba, INIMEC CONICET, Inst Invest Med Mercedes & Martin Ferreyra, Lab Neuropatol Expt, RA-5016 Cordoba, Argentina; [Inestrosa, Nibaldo C.] Univ New South Wales, Fac Med, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW 2031, Australia; [Inestrosa, Nibaldo C.] Univ Magallanes, Ctr Excelencia Biomed Magallanes, Punta Arenas 6200000, Chile	Pontificia Universidad Catolica de Chile; Universidad de Concepcion; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; University of New South Wales Sydney; Universidad de Magallanes	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac, Alameda 340,POB 114-D, Santiago 8331150, Chile.	ninestrosa@bio.puc.cl			FONDECYT [1120156, 1160724]; Basal Center of Excellence in Science and Technology [CONICYT-PFB12/2007]; CONICYT [3140355]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Basal Center of Excellence in Science and Technology(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT Grant 1120156, FONDECYT Grant 1160724 and Basal Center of Excellence in Science and Technology Grant CONICYT-PFB12/2007 (to N. C. I.), a predoctoral grant (to V. T. R.), and CONICYT Postdoctoral Fellowship 3140355 (to E. R.-F.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Alfaro IE, 2015, MOL CELL NEUROSCI, V67, P22, DOI 10.1016/j.mcn.2015.05.002; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Aviles EC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00110; Beaumont V, 2007, MOL CELL NEUROSCI, V35, P513, DOI 10.1016/j.mcn.2007.03.004; Belkouch M, 2011, J NEUROSCI, V31, P18381, DOI 10.1523/JNEUROSCI.3386-11.2011; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; CACERES A, 1984, J NEUROSCI, V4, P394; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Cerpa W, 2015, P NATL ACAD SCI USA, V112, P4797, DOI 10.1073/pnas.1417053112; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Exner T, 1999, P NATL ACAD SCI USA, V96, P1327, DOI 10.1073/pnas.96.4.1327; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Halleskog C, 2013, CELL SIGNAL, V25, P822, DOI 10.1016/j.cellsig.2012.12.006; Halleskog C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-111; Hiester BG, 2013, MOL CELL NEUROSCI, V56, P115, DOI 10.1016/j.mcn.2013.04.006; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Li YP, 2011, GENESIS, V49, P919, DOI 10.1002/dvg.20765; Ma L, 2006, J BIOL CHEM, V281, P30990, DOI 10.1074/jbc.M603603200; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Momoi A, 2003, MECH DEVELOP, V120, P477, DOI 10.1016/S0925-4773(03)00003-0; Munoz FJ, 2014, BIOCHEM BIOPH RES CO, V444, P189, DOI 10.1016/j.bbrc.2014.01.031; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nialbon C. C., 2005, SCI STKE, V2005, ppe35; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Nusse O, 1996, J CELL SCI, V109, P221; Oliva CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00224; Oliva CA, 2013, AGEING RES REV, V12, P786, DOI 10.1016/j.arr.2013.03.006; Onishi K, 2013, J NEUROSCI, V33, P19071, DOI 10.1523/JNEUROSCI.2800-13.2013; Park M, 2012, EMBO J, V31, P2697, DOI 10.1038/emboj.2012.145; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Plaut RD, 2008, CELL MICROBIOL, V10, P1130, DOI 10.1111/j.1462-5822.2007.01115.x; Purro SA, 2014, J MOL CELL BIOL, V6, P75, DOI 10.1093/jmcb/mjt049; Ramirez VT, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4258171; Runnenburger K, 2002, EUR J CELL BIOL, V81, P539, DOI 10.1078/0171-9335-00277; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Shah SM, 2009, NEUROSCIENCE, V164, P478, DOI 10.1016/j.neuroscience.2009.08.049; Silva-Alvarez C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00097; Vigo FS, 2009, NEUROBIOL AGING, V30, P1379, DOI 10.1016/j.neurobiolaging.2007.11.017; Spalloni A, 2011, CEREB CORTEX, V21, P796, DOI 10.1093/cercor/bhq152; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Varela-Nallar L, 2012, CYTOSKELETON, V69, P528, DOI 10.1002/cm.21022; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871; Zhao CJ, 2004, GENESIS, V40, P32, DOI 10.1002/gene.20058; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	75	36	37	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19092	19107		10.1074/jbc.M116.722132	http://dx.doi.org/10.1074/jbc.M116.722132			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402827	hybrid, Green Published			2022-12-28	WOS:000383242300042
J	Kim, S; Natesan, S; Cornilescu, G; Carlson, S; Tonelli, M; McClurg, UL; Binda, O; Robson, CN; Markley, JL; Balaz, S; Glass, KC				Kim, Sophia; Natesan, Senthil; Cornilescu, Gabriel; Carlson, Samuel; Tonelli, Marco; McClurg, Urszula L.; Binda, Olivier; Robson, Craig N.; Markley, John L.; Balaz, Stefan; Glass, Karen C.			Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone methylation; isothermal titration calorimetry (ITC); nuclear magnetic resonance (NMR); PHD finger; Inhibitor of Growth 3; histone acetyltransferase; plant homeodomain	TUMOR-SUPPRESSOR GENE; PHD-FINGER; DNA-DAMAGE; CRYSTAL-STRUCTURE; PROSTATE-CANCER; PROTEIN; CHROMATIN; EXPRESSION; ING4; METHYLATION	Aberrant access to genetic information disrupts cellular homeostasis and can lead to cancer development. One molecular mechanism that regulates access to genetic information includes recognition of histone modifications, which is carried out by protein modules that interact with chromatin and serve as landing pads for enzymatic activities that regulate gene expression. The ING3 tumor suppressor protein contains a plant homeodomain (PHD) that reads the epigenetic code via recognition of histone H3 tri-methylated at lysine 4 (H3K4me3), and this domain is lost or mutated in various human cancers. However, the molecular mechanisms targeting ING3 to histones and the role of this interaction in the cell remain elusive. Thus, we employed biochemical and structural biology approaches to investigate the interaction of the ING3 PHD finger (ING3(PHD)) with the active transcription mark H3K4me3. Our results demonstrate that association of the ING3(PHD) with H3K4me3 is in the sub-micromolar range (K-D ranging between 0.63 and 0.93 m) and is about 200-fold stronger than with the unmodified histone H3. NMR and computational studies revealed an aromatic cage composed of Tyr-362, Ser-369, and Trp-385 that accommodate the tri-methylated side chain of H3K4. Mutational analysis confirmed the critical importance of Tyr-362 and Trp-385 in mediating the ING3(PHD)-H3K4me3 interaction. Finally, the biological relevance of ING3(PHD)-H3K4me3 binding was demonstrated by the failure of ING3(PHD) mutant proteins to enhance ING3-mediated DNA damage-dependent cell death. Together, our results reveal the molecular mechanism of H3K4me3 selection by the ING3(PHD) and suggest that this interaction is important for mediating ING3 tumor suppressive activities.	[Kim, Sophia; Natesan, Senthil; Carlson, Samuel; Balaz, Stefan; Glass, Karen C.] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 261 Mt View Dr, Colchester, VT 05446 USA; [Cornilescu, Gabriel; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Cornilescu, Gabriel; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [McClurg, Urszula L.; Binda, Olivier; Robson, Craig N.] Newcastle Univ, Northern Inst Canc Res, Newcastle Canc Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Albany College of Pharmacy & Health Sciences; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Newcastle University - UK	Glass, KC (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 261 Mt View Dr, Colchester, VT 05446 USA.	karen.glass@acphs.edu	Glass, Karen C./AAV-1076-2021; Balaz, Stefan/K-6776-2019; Cornilescu, Gabriel/H-3113-2011; Balaz, Stefan/B-2965-2008	Glass, Karen C./0000-0002-2761-733X; Balaz, Stefan/0000-0003-4378-8945; Cornilescu, Gabriel/0000-0002-1204-8904; Balaz, Stefan/0000-0003-4378-8945; Natesan, Senthil/0000-0001-5347-6940; Binda, Olivier/0000-0002-1539-0828; McClurg, Urszula/0000-0003-2631-4174; Carlson, Samuel/0000-0001-9881-4210	National Institutes of Health [P41GM103399, P41RR002301, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; University of Wisconsin-Madison; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301, S10RR025062, S10RR029220, S10RR023438, S10RR008438, S10RR002781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, R01GM080508] Funding Source: NIH RePORTER; Breast Cancer Campaign [2013MaySP005] Funding Source: researchfish; Prostate Cancer UK [PG09-23] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison; National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Breast Cancer Campaign; Prostate Cancer UK	Isolated cDNA from human ING3 (Q9NXR8) was kindly provided by Dr. Jacques Cote at Universite Laval. This study made use of the National Magnetic Resonance Facility at Madison, WI, which is supported by National Institutes of Health Grants P41GM103399 (NIGMS), original Grant Number P41RR002301. NMRFAM equipment was purchased with funds from the University of Wisconsin-Madison; National Institutes of Health Grants P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, and S10RR029220; National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394; and the United States Department of Agriculture. DNA sequencing was performed in the University of Vermont Cancer Center DNA Analysis Facility.	Almami A., 2016, TUMOUR BIOL IN PRESS; Bahrami A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033173; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bismar TA, 2014, BJU INT, V113, P309, DOI 10.1111/bju.12262; Bua DJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02137; Bua DJ, 2009, CURR DRUG TARGETS, V10, P418, DOI 10.2174/138945009788185112; Carlson S, 2014, J CELL PHYSIOL, V229, P1571, DOI 10.1002/jcp.24617; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2014, AMBER 14; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Champagne KS, 2006, BIOCHEMISTRY-US, V45, P14933, DOI 10.1021/bi061802v; Champagne KS, 2009, CURR DRUG TARGETS, V10, P432, DOI 10.2174/138945009788185040; Clos LJ, 2013, METABOLOMICS, V9, P558, DOI 10.1007/s11306-012-0490-9; Colla S, 2007, BLOOD, V110, P4464, DOI 10.1182/blood-2007-02-074617; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Edelson MI, 1997, ONCOGENE, V14, P2979, DOI 10.1038/sj.onc.1201271; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Gou WF, 2014, INDIAN J MED RES, V139, P561; Grigoletto A, 2011, BBA-REV CANCER, V1815, P147, DOI 10.1016/j.bbcan.2010.11.002; Guerillon C, 2014, CANCER LETT, V345, P1, DOI 10.1016/j.canlet.2013.11.016; Gunduz M, 2002, ONCOGENE, V21, P4462, DOI 10.1038/sj.onc.1205540; Gunduz M, 2008, CANCER SCI, V99, P531, DOI 10.1111/j.1349-7006.2007.00708.x; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Latil A, 1995, CLIN CANCER RES, V1, P1385; Lee JS, 2011, P NATL ACAD SCI USA, V108, P13510, DOI 10.1073/pnas.1106106108; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Lee W, 2013, BIOINFORMATICS, V29, P515, DOI 10.1093/bioinformatics/bts692; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Musselman CA, 2014, BBA-GENE REGUL MECH, V1839, P686, DOI 10.1016/j.bbagrm.2014.04.001; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Nabbi A, 2015, EUR J CELL BIOL, V94, P214, DOI 10.1016/j.ejcb.2015.03.002; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Neklason DW, 2008, CANCER RES, V68, P8993, DOI 10.1158/0008-5472.CAN-08-1376; O'Neill DJ, 2014, EPIGENETICS-US, V9, P942, DOI 10.4161/epi.28864; Obri A, 2014, NATURE, V505, P648, DOI 10.1038/nature12922; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Poplawski A, 2014, J MOL BIOL, V426, P1661, DOI 10.1016/j.jmb.2013.12.007; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shiseki M, 2003, CANCER RES, V63, P2373; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Tallen G, 2014, FEBS LETT, V588, P2728, DOI 10.1016/j.febslet.2014.03.011; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	68	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18326	18341		10.1074/jbc.M115.690651	http://dx.doi.org/10.1074/jbc.M115.690651			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27281824	hybrid, Green Published			2022-12-28	WOS:000383241800025
J	Agarwal, S; Yadav, A; Tiwari, SK; Seth, B; Chauhan, LKS; Khare, P; Ray, RS; Chaturvedi, RK				Agarwal, Swati; Yadav, Anuradha; Tiwari, Shashi Kant; Seth, Brashket; Chauhan, Lalit Kumar Singh; Khare, Puneet; Ray, Ratan Singh; Chaturvedi, Rajnish Kumar			Dynamin-related Protein 1 Inhibition Mitigates Bisphenol A-mediated Alterations in Mitochondrial Dynamics and Neural Stem Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL NEUROGENESIS; CYTOCHROME-C; FISSION; AUTOPHAGY; DISEASE; FUSION; EXPOSURE; BRAIN; DRP1; DISRUPTION	The regulatory dynamics of mitochondria comprises well orchestrated distribution and mitochondrial turnover to maintain the mitochondrial circuitry and homeostasis inside the cells. Several pieces of evidence suggested impaired mitochondrial dynamics and its association with the pathogenesis of neurodegenerative disorders. We found that chronic exposure of synthetic xenoestrogen bisphenolA(BPA), a component of consumer plastic products, impaired autophagy-mediated mitochondrial turnover, leading to increased oxidative stress, mitochondrial fragmentation, and apoptosis in hippocampal neural stem cells (NSCs). It also inhibited hippocampal derived NSC proliferation and differentiation, as evident by the decreased number of BrdU-and beta-III tubulin-positive cells. All these effects were reversed by the inhibition of oxidative stress using N-acetyl cysteine. BPA up-regulated the levels of Drp-1 (dynamin-related protein 1) and enhanced its mitochondrial translocation, with no effect on Fis-1, Mfn-1, Mfn-2, and Opa-1 in vitro and in the hippocampus. Moreover, transmission electron microscopy studies suggested increased mitochondrial fission and accumulation of fragmented mitochondria and decreased elongated mitochondria in the hippocampus of the rat brain. Impaired mitochondrial dynamics by BPA resulted in increased reactive oxygen species and malondialdehyde levels, disruption of mitochondrial membrane potential, and ATP decline. Pharmacological (Mdivi-1) and genetic (Drp-1siRNA) inhibition of Drp-1 reversed BPA-induced mitochondrial dysfunctions, fragmentation, and apoptosis. Interestingly, BPA-mediated inhibitory effects on NSC proliferation and neuronal differentiations were also mitigated by Drp-1 inhibition. On the other hand, Drp-1 inhibition blocked BPA-mediated Drp-1 translocation, leading to decreased apoptosis of NSC. Overall, our studies implicate Drp-1 as a potential therapeutic target against BPA-mediated impaired mitochondrial dynamics and neurodegeneration in the hippocampus.	[Agarwal, Swati; Yadav, Anuradha; Tiwari, Shashi Kant; Seth, Brashket; Khare, Puneet; Chaturvedi, Rajnish Kumar] IITR, CSIR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; [Ray, Ratan Singh] IITR, CSIR, Photobiol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; [Agarwal, Swati; Yadav, Anuradha; Tiwari, Shashi Kant; Seth, Brashket; Chaturvedi, Rajnish Kumar] IITR, CSIR, Acad Sci & Innovat Res, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; [Chauhan, Lalit Kumar Singh] IITR, CSIR, Cent Instrumentat Facil, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Chaturvedi, RK (corresponding author), IITR, CSIR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.	rajnish@iitr.res.in	Tiwari, Shashi Kant/R-8533-2018; Chaturvedi, Rajnish/AAZ-9955-2020	Tiwari, Shashi Kant/0000-0002-6121-6249; Chaturvedi, Rajnish Kumar/0000-0001-9591-7636	Council of Scientific and Industrial Research-Network Grant InDepth [BSC0111]; Lady Tata Memorial Trust Young Scientist Grant; Council of Scientific and Industrial Research, New Delhi	Council of Scientific and Industrial Research-Network Grant InDepth; Lady Tata Memorial Trust Young Scientist Grant; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research-Network Grant InDepth BSC0111, a Lady Tata Memorial Trust Young Scientist Grant (to R. K. C.), and Senior Research Fellowships from the Council of Scientific and Industrial Research, New Delhi (to S. A. and B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal S, 2015, J BIOL CHEM, V290, P21163, DOI 10.1074/jbc.M115.648998; Alaimo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091848; Alaimo A, 2013, NEUROSCI LETT, V554, P76, DOI 10.1016/j.neulet.2013.08.061; Arrazola MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00166; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bonet-Ponce L, 2015, BBA-MOL BASIS DIS, V1852, P1400, DOI 10.1016/j.bbadis.2015.03.006; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410; Carvalho C, 2015, EXPERT REV NEUROTHER, V15, P867, DOI 10.1586/14737175.2015.1058160; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cereghetti GM, 2010, CELL DEATH DIFFER, V17, P1785, DOI 10.1038/cdd.2010.61; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chaturvedi RK, 2012, HUM MOL GENET, V21, P3474, DOI 10.1093/hmg/dds178; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cui Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23300; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Egnaczyk GF, 2001, BIOCHEMISTRY-US, V40, P11706, DOI 10.1021/bi002852h; Fehlberg S, 2002, BIOCHEM J, V362, P573, DOI 10.1042/0264-6021:3620573; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Godoy JA, 2014, J BIOL CHEM, V289, P36179, DOI 10.1074/jbc.M114.557009; Guedes-Dias P, 2016, NEUROBIOL DIS, V90, P51, DOI 10.1016/j.nbd.2015.09.008; Hroudova J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175062; Huang BX, 2014, MED HYPOTHESES, V82, P245, DOI 10.1016/j.mehy.2013.10.023; Huc L, 2012, TOXICOL IN VITRO, V26, P709, DOI 10.1016/j.tiv.2012.03.017; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jiang Y, 2014, J APPL TOXICOL, V34, P1012, DOI 10.1002/jat.2924; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mao CP, 2014, J CELL MOL MED, V18, P2404, DOI 10.1111/jcmm.12420; Masuo Y, 2011, J TOXICOL ENV HEAL B, V14, P346, DOI 10.1080/10937404.2011.578557; Mishra D, 2012, TOXICOL SCI, V127, P84, DOI 10.1093/toxsci/kfs004; Mistry SK, 2002, P NATL ACAD SCI USA, V99, P1621, DOI 10.1073/pnas.022646599; Mizushima N, 2011, COLD SH Q B, V76, P397, DOI 10.1101/sqb.2011.76.011023; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Pahuja R, 2015, ACS NANO, V9, P4850, DOI 10.1021/nn506408v; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Pla-Martin D, 2013, NEUROBIOL DIS, V55, P140, DOI 10.1016/j.nbd.2013.03.010; Purnell PR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-86; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Reddy PH, 2014, J ALZHEIMERS DIS, V40, P245, DOI 10.3233/JAD-132060; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sheridan C, 2010, MITOCHONDRION, V10, P640, DOI 10.1016/j.mito.2010.08.005; Singhal NK, 2015, J BIOMED NANOTECHNOL, V11, P2211, DOI 10.1166/jbn.2015.2107; Su YC, 2013, HUM MOL GENET, V22, P4545, DOI 10.1093/hmg/ddt301; Tiwari MN, 2013, FREE RADICAL BIO MED, V65, P704, DOI 10.1016/j.freeradbiomed.2013.07.042; Tiwari SK, 2016, MOL NEUROBIOL, V53, P3010, DOI 10.1007/s12035-015-9197-z; Tiwari SK, 2015, MOL NEUROBIOL, V52, P1735, DOI 10.1007/s12035-014-8940-1; Tiwari SK, 2015, MOL NEUROBIOL, V51, P1395, DOI 10.1007/s12035-014-8817-3; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Wisniewski P, 2015, TOXICOLOGY, V329, P1, DOI 10.1016/j.tox.2015.01.002; Xia W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090443; Xie Meina, 2014, Wei Sheng Yan Jiu, V43, P962; Yoshii SR, 2015, BBA-MOL CELL RES, V1853, P2797, DOI 10.1016/j.bbamcr.2015.01.013	70	65	71	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15923	15939		10.1074/jbc.M115.709493	http://dx.doi.org/10.1074/jbc.M115.709493			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27252377	hybrid, Green Published			2022-12-28	WOS:000380585400002
J	Ratner, D; Orning, MPA; Starheim, KK; Marty-Roix, R; Proulx, MK; Goguen, JD; Lien, E				Ratner, Dmitry; Orning, M. Pontus A.; Starheim, Kristian K.; Marty-Roix, Robyn; Proulx, Megan K.; Goguen, Jon D.; Lien, Egil			Manipulation of interleukin-1 beta and interleukin-18 production by Yersinia pestis effectors YopJ and YopM and redundant impact on virulence (vol 291, pg 9894, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Orning, Pontus/0000-0002-6177-6916; Proulx, Megan/0000-0002-9524-8302	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM107000] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI095213] Funding Source: Medline; NIGMS NIH HHS [T32 GM107000] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ratner D, 2016, J BIOL CHEM, V291, P9894, DOI 10.1074/jbc.M115.697698	1	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16417	16417		10.1074/jbc.A115.697698	http://dx.doi.org/10.1074/jbc.A115.697698			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27474778	hybrid, Green Published			2022-12-28	WOS:000380585400046
J	Silva, JL; Cordeiro, Y				Silva, Jerson L.; Cordeiro, Yraima			The "Jekyll and Hyde" Actions of Nucleic Acids on the Prion-like Aggregation of Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TUMOR-SUPPRESSOR P53; RNA-BINDING PROTEINS; MUTANT P53; AMYLOID FORMATION; ALPHA-SYNUCLEIN; PHASE-TRANSITION; STRESS GRANULES; LIQUID DROPLETS; APLYSIA CPEB; IN-VITRO	Protein misfolding results in devastating degenerative diseases and cancer. Among the culprits involved in these illnesses are prions and prion-like proteins, which can propagate by converting normal proteins to the wrong conformation. For spongiform encephalopathies, a real prion can be transmitted among individuals. In other disorders, the bona fide prion characteristics are still under investigation. Besides inducing misfolding of native proteins, prions bind nucleic acids and other polyanions. Here, we discuss how nucleic acid binding might influence protein misfolding for both disease-related and benign, functional prions and why the line between bad and good amyloids might be more subtle than previously thought.	[Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Biol Estrutural & Bioimagem, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Programa Biol Estrutural,Inst Bioquim Med Leopold, BR-21941902 Rio De Janeiro, RJ, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, BR-21941902 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Biol Estrutural & Bioimagem, Inst Bioquim Med Leopoldo de Meis, Ilha Fundao, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, RJ, Brazil.	jerson@bioqmed.ufrj.br	Silva, Jerson/J-8984-2014; Cordeiro, Yraima/J-7619-2012; SILVA, JERSON Lima/GRF-1442-2022	Silva, Jerson/0000-0001-9523-9441; Cordeiro, Yraima/0000-0003-4278-212X; SILVA, JERSON Lima/0000-0001-9523-9441	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Instituto Nacional de Ciencia e Tecnologia (INCT) Program); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Instituto Nacional de Ciencia e Tecnologia (INCT) Program); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq awards and the Instituto Nacional de Ciencia e Tecnologia (INCT) Program), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The authors declare that they have no conflicts of interest with the contents of this article.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bera A, 2007, ARCH VIROL, V152, P655, DOI 10.1007/s00705-006-0907-8; Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Botsios S, 2016, J CELL BIOCHEM, V117, P1947, DOI 10.1002/jcb.25495; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bykov VJN, 2014, FEBS LETT, V588, P2622, DOI 10.1016/j.febslet.2014.04.017; Cavaliere P, 2013, NUCLEIC ACIDS RES, V41, P327, DOI 10.1093/nar/gks970; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cherny D, 2004, J MOL BIOL, V344, P929, DOI 10.1016/j.jmb.2004.09.096; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colombrita C, 2012, J BIOL CHEM, V287, P15635, DOI 10.1074/jbc.M111.333450; Cordeiro Y, 2005, PROTEIN PEPTIDE LETT, V12, P251, DOI 10.2174/0929866053587138; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Cordeiro Yraima, 2014, Biophys Rev, V6, P97, DOI 10.1007/s12551-013-0132-0; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Drisaldi B, 2015, CELL REP, V11, P1694, DOI 10.1016/j.celrep.2015.04.061; Fioriti L, 2015, NEURON, V86, P1433, DOI 10.1016/j.neuron.2015.05.021; Forget KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069242; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Giraldo R, 2007, P NATL ACAD SCI USA, V104, P17388, DOI 10.1073/pnas.0702006104; Gomes MPB, 2012, WIRES RNA, V3, P415, DOI 10.1002/wrna.118; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hegde ML, 2010, FRONT BIOSCI-LANDMRK, V15, P418, DOI 10.2741/3628; Hervas R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002361; Herzog G, 2015, BIOCHEMISTRY-US, V54, P3729, DOI 10.1021/bi501092p; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Khan MR, 2015, CELL, V163, P1468, DOI 10.1016/j.cell.2015.11.020; King DJ, 2007, J MOL BIOL, V369, P1001, DOI 10.1016/j.jmb.2007.02.004; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Ladner-Keay CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098753; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lasagna-Reeves CA, 2013, BIOCHEM BIOPH RES CO, V430, P963, DOI 10.1016/j.bbrc.2012.11.130; Lee AS, 2003, J MOL BIOL, V327, P699, DOI 10.1016/S0022-2836(03)00175-X; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu CL, 2011, ADV PROTEIN CHEM STR, V84, P1, DOI 10.1016/B978-0-12-386483-3.00005-7; Macedo B, 2012, BIOCHEMISTRY-US, V51, P5402, DOI 10.1021/bi300440e; Mashima T, 2009, NUCLEIC ACIDS RES, V37, P6249, DOI 10.1093/nar/gkp647; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Meng F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010024; Morales R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09349; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Nandi PK, 1998, ARCH VIROL, V143, P1251, DOI 10.1007/s007050050373; Nandi PK, 1997, ARCH VIROL, V142, P2537, DOI 10.1007/s007050050261; Olsthoorn RCL, 2014, NUCLEIC ACIDS RES, V42, P9327, DOI 10.1093/nar/gku559; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Radulescu RT, 1996, MED HYPOTHESES, V46, P225, DOI 10.1016/S0306-9877(96)90245-5; Rainov NG, 2007, EXPERT OPIN BIOL TH, V7, P713, DOI 10.1517/14712598.7.5.713; Rangel L, 2014, FASEB J, V28; Rangel LP, 2014, PRION, V8, P75, DOI 10.4161/pri.27776; Rigacci S, 2008, BIOPHYS J, V94, P3635, DOI 10.1529/biophysj.107.122283; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Schwartz K, 2016, MOL MICROBIOL, V99, P123, DOI 10.1111/mmi.13219; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2015, ANNU REV CELL DEV BI, V31, P149, DOI 10.1146/annurev-cellbio-100913-013409; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Silva JL, 2010, FRONT BIOSCI-LANDMRK, V15, P132, DOI 10.2741/3611; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Simoneau S, 2015, VIRULENCE, V6, P132, DOI 10.4161/21505594.2014.989795; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Srivastava S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130283; Toretsky JA, 2014, J CELL BIOL, V206, P579, DOI 10.1083/jcb.201404124; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Vanderweyde T, 2013, GERONTOLOGY, V59, P524, DOI 10.1159/000354170; Vieira TCRG, 2014, FASEB J, V28, P2667, DOI 10.1096/fj.13-246777; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2443, DOI 10.1073/pnas.1500262112; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; Wickner RB, 2015, MICROBIOL MOL BIOL R, V79, P1, DOI 10.1128/MMBR.00041-14; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yin S, 2008, J BIOL CHEM, V283, P25446, DOI 10.1074/jbc.M800814200; Yu HJ, 2007, BIOPHYS J, V92, P185, DOI 10.1529/biophysj.106.093559; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	100	42	42	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15482	15490		10.1074/jbc.R116.733428	http://dx.doi.org/10.1074/jbc.R116.733428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27288413	hybrid, Green Published			2022-12-28	WOS:000380584200006
J	Roy, A; Kim, JH				Roy, Adhiraj; Kim, Jeong-Ho			RETRACTION: Endocytosis and vacuolar degradation of the yeast cell surface glucose sensors Rgt2 and Snf3 (Retraction of vol 289, pg 7247, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Roy A, 2014, J BIOL CHEM, V289, P7247, DOI 10.1074/jbc.M113.539411	1	1	1	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14913	14913		10.1074/jbc.A113.539411	http://dx.doi.org/10.1074/jbc.A113.539411			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27422977	Green Published, hybrid			2022-12-28	WOS:000380583200003
J	Safa, L; Gueddouda, NM; Thiebaut, F; Delagoutte, E; Petruseva, I; Lavrik, O; Mendoza, O; Bourdoncle, A; Alberti, P; Riou, JF; Saintome, C				Safa, Layal; Gueddouda, Nassima Meriem; Thiebaut, Frederic; Delagoutte, Emmanuelle; Petruseva, Irina; Lavrik, Olga; Mendoza, Oscar; Bourdoncle, Anne; Alberti, Patrizia; Riou, Jean-Francois; Saintome, Carole			5 ' to 3 ' Unfolding Directionality of DNA Secondary Structures by Replication Protein A G-QUADRUPLEXES AND DUPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; TELOMERIC G-QUADRUPLEX; CHROMOSOME ENDS; MACROMOLECULAR MACHINES; HELICASE MECHANISMS; BINDING-PROTEINS; RPA; CELLS; POLARITY; LIGANDS	The replication protein A (RPA) is a single-stranded DNA-binding protein that plays an essential role in DNA metabolism. RPA is able to unfold G-quadruplex (G4) structures formed by telomeric DNA sequences, a function important for telomere maintenance. To elucidate the mechanism through which RPA unfolds telomeric G4s, we studied its interaction with oligonucleotides that adopt a G4 structure extended with a single-stranded tail on either side of the G4. Binding and unfolding was characterized using several biochemical and biophysical approaches and in the presence of specific G4 ligands, such as telomestatin and 360A. Our data show that RPA can bind on each side of the G4 but it unwinds the G4 only from 5' toward 3'. Weexplain the 5' to 3' unfolding directionality in terms of the 5' to 3' oriented laying out of hRPA subunits along single-stranded DNA. Furthermore, we demonstrate by kinetics experiments that RPA proceeds with the same directionality for duplex unfolding.	[Safa, Layal; Thiebaut, Frederic; Delagoutte, Emmanuelle; Alberti, Patrizia; Riou, Jean-Francois; Saintome, Carole] Sorbonne Univ, Museum Natl Hist Nat, Struct & Instabil Genomes, INSERM U1154,CNRS UMR 7196, CP26,57 Rue Cuvier, F-75005 Paris, France; [Safa, Layal; Thiebaut, Frederic; Saintome, Carole] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Gueddouda, Nassima Meriem; Mendoza, Oscar; Bourdoncle, Anne] Inst Europeen Chim & Biol, Lab ARNA INSERM U1212, UMR 5320, 2 Rue Robert Escarpit, F-33607 Pessac, France; [Thiebaut, Frederic] PSL Res Univ, Ecole Normale Super, Dept Chim, CNRS,UMR LBM 7203, 24 Rue Lhomond, F-75005 Paris, France; [Petruseva, Irina; Lavrik, Olga] Russian Acad Sci, Siberian Div, Novosibirsk Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Alberti, P (corresponding author), Sorbonne Univ, Museum Natl Hist Nat, Struct & Instabil Genomes, INSERM U1154,CNRS UMR 7196, CP26,57 Rue Cuvier, F-75005 Paris, France.; Saintome, C (corresponding author), Museum Natl Hist Nat, INSERM U1154, CNRS UMR 7196, F-75005 Paris, France.	alberti@mnhn.fr; carole.saintome@mnhn.fr	Petruseva, Irina/AAE-8923-2021; Lavrik, Olga I/G-4641-2013; saintome, carole/A-3703-2015	Alberti, Patrizia/0000-0002-5231-3768; saintome, carole/0000-0002-7609-6913; riou, jean-francois/0000-0002-0055-6506	Ligue Nationale contre le Cancer, Equipe Labelisee; Agence Nationale de la Recherche [ANR-09-BLAN-0355]; Institut National du Cancer [TP53-INTRON3]; Program on Molecular Cellular Biology RAS; Programme Doctoral Interfaces pour le Vivant, Sorbonne Universites, UPMC Univ Paris	Ligue Nationale contre le Cancer, Equipe Labelisee(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Program on Molecular Cellular Biology RAS; Programme Doctoral Interfaces pour le Vivant, Sorbonne Universites, UPMC Univ Paris	This work was supported in part by grants from the "Ligue Nationale contre le Cancer, Equipe Labelisee 2010," Agence Nationale de la Recherche Grant ANR-09-BLAN-0355, Institut National du Cancer Grant TP53-INTRON3 (to J. F. R., E. D., P. A., and C. S.), and a grant from the Program on Molecular Cellular Biology RAS (to O. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a doctoral fellowship from the "Ligue Nationale contre le Cancer."; Supported by a doctoral fellowship from the "Programme Doctoral Interfaces pour le Vivant 2014, Sorbonne Universites, UPMC Univ Paris 06."	Audry J, 2015, EMBO J, V34, P1942, DOI 10.15252/embj.201490773; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Boncina M, 2012, J AM CHEM SOC, V134, P9657, DOI 10.1021/ja300605n; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Cai LF, 2007, BIOCHEMISTRY-US, V46, P8226, DOI 10.1021/bi7004976; Cohen S, 2004, BBA-GENE STRUCT EXPR, V1679, P129, DOI 10.1016/j.bbaexp.2004.06.002; Davis JT, 2007, CHEM SOC REV, V36, P296, DOI 10.1039/b600282j; De Cian A, 2008, BIOCHIMIE, V90, P131, DOI 10.1016/j.biochi.2007.07.011; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Delagoutte E, 2011, BIOCHEMISTRY-US, V50, P932, DOI 10.1021/bi101583e; Favre A, 1998, J PHOTOCH PHOTOBIO B, V42, P109, DOI 10.1016/S1011-1344(97)00116-4; Favre A, 1990, BIOORG PHOTOCHEM, V1, P379; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P5586, DOI 10.1021/bi9526995; Gomez D, 2004, J BIOL CHEM, V279, P41487, DOI 10.1074/jbc.M406123200; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Iftode C, 2000, BIOCHEMISTRY-US, V39, P11970, DOI 10.1021/bi0005761; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Kibe T, 2007, MOL BIOL CELL, V18, P2378, DOI 10.1091/mbc.E06-12-1084; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P382, DOI 10.1271/bbb.90496; Kolpashchikov DM, 2001, NUCLEIC ACIDS RES, V29, P373, DOI 10.1093/nar/29.2.373; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Lavrik OI, 1998, FEBS LETT, V441, P186, DOI 10.1016/S0014-5793(98)01544-0; Lavrik OI, 1999, NUCLEIC ACIDS RES, V27, P4235, DOI 10.1093/nar/27.21.4235; Le DD, 2015, CHEM COMMUN, V51, P8048, DOI 10.1039/c5cc02252e; Li W, 2013, J AM CHEM SOC, V135, P6423, DOI 10.1021/ja4019176; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Luciano P, 2012, EMBO J, V31, P2034, DOI 10.1038/emboj.2012.40; Mendoza O, 2015, NUCLEIC ACIDS RES, V43, pE71, DOI 10.1093/nar/gkv193; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Pennarun G, 2005, ONCOGENE, V24, P2917, DOI 10.1038/sj.onc.1208468; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Prakash A., 2011, J NUCL ACIDS, V2011, P896; Qureshi MH, 2012, J PHYS CHEM B, V116, P5588, DOI 10.1021/jp300546u; Ray S, 2013, BIOPHYS J, V104, P2235, DOI 10.1016/j.bpj.2013.04.004; Safa L, 2014, BIOCHIMIE, V103, P80, DOI 10.1016/j.biochi.2014.04.006; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Salas TR, 2009, NUCLEIC ACIDS RES, V37, P38, DOI 10.1093/nar/gkn895; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Sidibe A, 2012, BIOCHIMIE, V94, P2559, DOI 10.1016/j.biochi.2012.07.003; Smith J, 2000, BIOCHIMIE, V82, P71, DOI 10.1016/S0300-9084(00)00183-8; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu CG, 2013, ADV EXP MED BIOL, V973, P1, DOI 10.1007/978-1-4614-5037-5_1	56	30	30	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21246	21256		10.1074/jbc.M115.709667	http://dx.doi.org/10.1074/jbc.M115.709667			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27440048	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000385406200037
J	Vashishtha, AK; Wang, JM; Konigsberg, WH				Vashishtha, Ashwani Kumar; Wang, Jimin; Konigsberg, William H.			Different Divalent Cations Alter the Kinetics and Fidelity of DNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RARE TAUTOMER HYPOTHESIS; IN-VITRO; NUCLEOTIDE INCORPORATION; SULFOLOBUS-SOLFATARICUS; EXONUCLEASE ACTIVITIES; BASE SELECTIVITY; METAL ACTIVATION; KLENOW FRAGMENT; REPLICATION; MANGANESE	Divalent metal ions are essential components of DNA polymerases both for catalysis of the nucleotidyl transfer reaction and for base excision. They occupy two sites, A and B, for DNA synthesis. Recently, a third metal ion was shown to be essential for phosphoryl transfer reaction. The metal ion in the A site is coordinated by the carboxylate of two highly conserved acidic residues, water molecules, and the 3'-hydroxyl group of the primer so that the A metal is in an octahedral complex. Its catalytic function is to lower the pK(a) of the hydroxyl group, making it a highly effective nucleophile that can attack the alpha phosphorous atom of the incoming dNTP. The metal ion in the B site is coordinated by the same two carboxylates that are affixed to the A metal ion as well as the non-bridging oxygen atoms of the incoming dNTP. The carboxyl oxygen of an adjacent peptide bond serves as the sixth ligand that completes the octahedral coordination geometry of the B metal ion. Similarly, two metal ions are required for proofreading; one helps to lower the pK(a) of the attacking water molecule, and the other helps to stabilize the transition state for nucleotide excision. The role of different divalent cations are discussed in relation to these two activities as well as their influence on base selectivity and misincorporation by DNA polymerases. Some, but not all, of the effects of these different metal ions can be rationalized based on their intrinsic properties, which are tabulated in this review.	[Vashishtha, Ashwani Kumar; Wang, Jimin; Konigsberg, William H.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Konigsberg, WH (corresponding author), Yale Univ, Dept Biophys & Biochem, 333 Cedar St,SHM CE-14, New Haven, CT 06520 USA.	William.konigsberg@yale.edu	Vashishtha, Ashwani/D-7622-2016		Frank and Suzanne Konigsberg Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Frank and Suzanne Konigsberg Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Frank and Suzanne Konigsberg Research Fund. This is the fourth article in the Thematic Minireview series "Metals in Biology 2016: Molecular Basis of Selection of Metals by Enzymes." The authors declare that they have no conflicts of interest with the contents of this article.	Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; Beard WA, 2014, BIOCHEMISTRY-US, V53, P2768, DOI 10.1021/bi500139h; Bebenek K, 2011, P NATL ACAD SCI USA, V108, P1862, DOI 10.1073/pnas.1012825108; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; CHIN YE, 1994, CANCER RES, V54, P2337; Cotton F. A., 1999, ADV INORG CHEM, P692; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DRAKE JW, 1969, NATURE, V221, P1132, DOI 10.1038/2211132a0; DUBE DK, 1975, BIOCHEM BIOPH RES CO, V67, P1041, DOI 10.1016/0006-291X(75)90779-2; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; Gao Y, 2016, SCIENCE, V352, P1334, DOI 10.1126/science.aad9633; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; GOODMAN MF, 1983, J BIOL CHEM, V258, P3469; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Hariharan C, 2006, BIOCHEMISTRY-US, V45, P2836, DOI 10.1021/bi051644s; Harris VH, 2003, J MOL BIOL, V326, P1389, DOI 10.1016/S0022-2836(03)00051-2; Hays H, 2002, BIOCHEMISTRY-US, V41, P4771, DOI 10.1021/bi0120648; HORI K, 1979, J BIOL CHEM, V254, P1598; Irimia A, 2006, BIOCHEMISTRY-US, V45, P5949, DOI 10.1021/bi052511+; Irimia A, 2010, ACTA CRYSTALLOGR F, V66, P1013, DOI 10.1107/S1744309110029374; Jain R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094835; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; JOYCE CM, 1989, J BIOL CHEM, V264, P10858; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; MILDVAN AS, 1979, CRC CR REV BIOCH MOL, V6, P219, DOI 10.3109/10409237909102564; MIYAKI M, 1977, BIOCHEM BIOPH RES CO, V77, P854, DOI 10.1016/S0006-291X(77)80056-9; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; SEAL G, 1979, J BIOL CHEM, V254, P5229; SIROVER MA, 1976, SCIENCE, V194, P1434, DOI 10.1126/science.1006310; SIROVER MA, 1977, J BIOL CHEM, V252, P3605; SIROVER MA, 1979, J BIOL CHEM, V254, P107; SIROVER MA, 1976, BIOCHEM BIOPH RES CO, V70, P812, DOI 10.1016/0006-291X(76)90664-1; SIROVER MA, 1976, P NATL ACAD SCI USA, V73, P2331, DOI 10.1073/pnas.73.7.2331; SNOW ET, 1993, CHEM-BIOL INTERACT, V88, P155, DOI 10.1016/0009-2797(93)90089-H; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; TOPAL MD, 1976, NATURE, V263, P285, DOI 10.1038/263285a0; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vashishtha AK, 2016, BIOCHEMISTRY-US, V55, P2661, DOI 10.1021/acs.biochem.5b01350; Vashishtha AK, 2016, BIOCHEMISTRY-US, V55, P1168, DOI 10.1021/acs.biochem.6b00065; Vashishtha AK, 2015, BIOCHEMISTRY-US, V54, P240, DOI 10.1021/bi500840v; VENKITARAMAN AR, 1989, NUCLEIC ACIDS RES, V17, P3314, DOI 10.1093/nar/17.8.3314; Villani G, 2002, NUCLEIC ACIDS RES, V30, P3323, DOI 10.1093/nar/gkf463; Wang WN, 2011, P NATL ACAD SCI USA, V108, P17644, DOI 10.1073/pnas.1114496108; Xia SL, 2014, BIOCHEMISTRY-US, V53, P2752, DOI 10.1021/bi4014215; Xia SL, 2013, J AM CHEM SOC, V135, P193, DOI 10.1021/ja3079048; Xia SL, 2011, BIOCHEMISTRY-US, V50, P9114, DOI 10.1021/bi201260h; Yang LJ, 2004, J AM CHEM SOC, V126, P8441, DOI 10.1021/ja049412o; Zhang H, 2007, NUCLEIC ACIDS RES, V35, P6052, DOI 10.1093/nar/gkm587	57	57	58	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20869	20875		10.1074/jbc.R116.742494	http://dx.doi.org/10.1074/jbc.R116.742494			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27462081	Green Published, hybrid			2022-12-28	WOS:000385406200006
J	Kreger, BT; Dougherty, AL; Greene, KS; Cerione, RA; Antonyak, MA				Kreger, Bridget T.; Dougherty, Andrew L.; Greene, Kai Su; Cerione, Richard A.; Antonyak, Marc A.			Microvesicle Cargo and Function Changes upon Induction of Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; exosome (vesicle); extracellular vesicles; microparticles; PTK2 protein tyrosine kinase 2 (PTK2); focal adhesion kinase (FAK); transformation; intercellular communication; microvesicles	FOCAL ADHESION KINASE; BREAST-CANCER CELLS; EXTRACELLULAR VESICLES; LARGE ONCOSOMES; FAK-SRC; GROWTH; GLIOBLASTOMA; APOPTOSIS; SURVIVAL; GTPASES	Extracellular vesicles (EVs), including exosomes and microvesicles (MVs), have emerged as a major form of intercellular communication, playing important roles in several physiological processes and diseases, including cancer. EVs generated by cancer cells contain a variety of proteins and RNA species that can be transferred between cancer cells as well as between cancer and non-transformed (normal) cells, thereby impacting a number of aspects of cancer progression. Here we show how oncogenic transformation influences the biogenesis and function of EVs using a mouse embryonic fibroblast (MEF) cell line that can be induced to express an oncogenic form of diffuse B cell lymphoma (Dbl). Although MEFs induced to express onco-Dbl generated a similar amount of MVs as uninduced control cells, we found that MVs isolated from onco-Dbl-transformed cells contain a unique signaling protein, the ubiquitously expressed non-receptor tyrosine kinase focal adhesion kinase. The addition of MVs isolated from MEFs expressing onco-Dbl to cultures of fibroblasts strongly promoted their survival and induced their ability to grow under anchorage-independent conditions, outcomes that could be reversed by knocking down focal adhesion kinase and depleting it from the MVs or by inhibiting its kinase activity using a specific inhibitor. We then showed the same to be true for MVs isolated from aggressive MDAMB231 breast cancer cells. Together, these findings demonstrate that the induction of oncogenic transformation gives rise to MVs, which uniquely contain a signaling protein kinase that helps propagate the transformed phenotype and thus may offer a specific diagnostic marker of malignant disease.	[Kreger, Bridget T.; Dougherty, Andrew L.; Greene, Kai Su; Cerione, Richard A.; Antonyak, Marc A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			National Science Foundation MRSEC Award [NSF DMR-1120296]; NATIONAL CANCER INSTITUTE [R01CA201402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R35GM122575, R01GM040654, P41GM103485] Funding Source: NIH RePORTER	National Science Foundation MRSEC Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cindy Westmiller for help with preparing the manuscript. The FEI T12 Spirit 120-kV field emission TEM at the Cornell Center for Materials Research is supported by National Science Foundation MRSEC Award NSF DMR-1120296.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Antonyak MA, 2014, METHODS MOL BIOL, V1165, P147, DOI 10.1007/978-1-4939-0856-1_11; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Bordeleau F, 2016, J BIOMECH, V49, P1272, DOI 10.1016/j.jbiomech.2015.10.003; Chatzizacharias NA, 2007, EXPERT OPIN THER TAR, V11, P1315, DOI 10.1517/14728222.11.10.1315; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Di Vizio D, 2012, AM J PATHOL, V181, P1573, DOI 10.1016/j.ajpath.2012.07.030; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fujita Y, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28388; Garces CA, 2006, CANCER RES, V66, P1446, DOI 10.1158/0008-5472.CAN-05-1661; Gercel-Taylor C., 2009, J CELL PHYSL, V218, P460; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Heneberg P, 2016, CRIT REV ONCOL HEMAT, V97, P303, DOI 10.1016/j.critrevonc.2015.09.008; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hopkins S, 2012, DEV CELL, V23, P547, DOI 10.1016/j.devcel.2012.08.001; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Liu Z, 2008, CELL MICROBIOL, V10, P1787, DOI 10.1111/j.1462-5822.2008.01165.x; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mahmoudi K, 2015, MOL ASPECTS MED, V45, P97, DOI 10.1016/j.mam.2015.06.008; Minciacchi VR, 2015, SEMIN CELL DEV BIOL, V40, P41, DOI 10.1016/j.semcdb.2015.02.010; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nickerson NK, 2012, ONCOL RES, V20, P303, DOI 10.3727/096504013X13639794277761; Olivo C, 2000, ONCOGENE, V19, P1428, DOI 10.1038/sj.onc.1203440; OWENS LV, 1995, CANCER RES, V55, P2752; Rak J, 2012, BIOESSAYS, V34, P489, DOI 10.1002/bies.201100169; Santana SM, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/6/065001; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Takahashi R, 2007, BBA-GEN SUBJECTS, V1770, P518, DOI 10.1016/j.bbagen.2006.11.011; Tomita N, 2013, BIOORG MED CHEM LETT, V23, P1779, DOI 10.1016/j.bmcl.2013.01.047; Ward KK, 2013, CLIN EXP METASTAS, V30, P579, DOI 10.1007/s10585-012-9562-5; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhao XP, 2015, CANCER LETT, V360, P125, DOI 10.1016/j.canlet.2015.01.032	44	32	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19774	19785		10.1074/jbc.M116.725705	http://dx.doi.org/10.1074/jbc.M116.725705			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27440046	Green Published, hybrid			2022-12-28	WOS:000383243100005
J	Anta, B; Martin-Rodriguez, C; Gomis-Perez, C; Calvo, L; Lopez-Benito, S; Calderon-Garcia, AA; Vicente-Garcia, C; Villarroel, A; Arevalo, JC				Anta, Begona; Martin-Rodriguez, Carlos; Gomis-Perez, Carolina; Calvo, Laura; Lopez-Benito, Saray; Calderon-Garcia, Andres A.; Vicente-Garcia, Cristina; Villarroel, Alvaro; Arevalo, Juan C.			Ubiquitin-specific Protease 36 (USP36) Controls Neuronal Precursor Cell-expressed Developmentally Down-regulated 4-2 (Nedd4-2) Actions over the Neurotrophin Receptor TrkA and Potassium Voltage-gated Channels 7.2/3 (Kv7.2/3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; NGF-MEDIATED FUNCTIONS; SODIUM-CHANNEL; LIGASE NEDD4-2; DIFFERENTIATION; SERUM; GENE; STABILITY; GROWTH; TRANSCRIPTION	Ubiquitination of the TrkA neurotrophin receptor in response to NGF is critical in the regulation of TrkA activation and functions. TrkA is ubiquitinated, among other E3 ubiquitin ligases, by Nedd4-2. To understand mechanistically how TrkA ubiquitination is regulated, we performed a siRNA screening to identify deubiquitinating enzymes and found that USP36 acts as an important regulator of TrkA activation kinetics and ubiquitination. However, USP36 action on TrkA was indirect because it does not deubiquitinate TrkA. Instead, USP36 binds to Nedd4-2 and regulates the association of TrkA and Nedd4-2. In addition, depletion of USP36 increases TrkA.Nedd4-2 complex formation, whereas USP36 expression disrupts the complex, resulting in an enhancement or impairment of Nedd4-2-dependent TrkA ubiquitination, respectively. Moreover, USP36 depletion leads to enhanced total and surface TrkA expression that results in increased NGF-mediated TrkA activation and signaling that augments PC12 cell differentiation. USP36 actions extend beyond TrkA because the presence of USP36 interferes with Nedd4-2-dependent Kv7.2/3 channel regulation. Our results demonstrate that USP36 binds to and regulates the actions of Nedd4-2 over different substrates affecting their expression and functions.	[Anta, Begona; Martin-Rodriguez, Carlos; Calvo, Laura; Lopez-Benito, Saray; Calderon-Garcia, Andres A.; Vicente-Garcia, Cristina; Arevalo, Juan C.] Univ Salamanca, Inst Neurociencias Castilla & Leon, Dept Biol Celular & Patol, Salamanca 37007, Spain; [Anta, Begona; Martin-Rodriguez, Carlos; Calvo, Laura; Lopez-Benito, Saray; Vicente-Garcia, Cristina; Arevalo, Juan C.] Inst Biomed Res Salamanca, Salamanca 47195, Spain; [Gomis-Perez, Carolina; Villarroel, Alvaro] Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, Barrio Sarriena S-N, Leoia 48940, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Arevalo, JC (corresponding author), Univ Salamanca, INCyL, C Pintor Fernando Gallego 1, Salamanca 37007, Spain.	arevalojc@usal.es	García, Andrés Ángel Calderón/M-4958-2018; Calvo, Laura/GWQ-8682-2022; Gomis-Perez, Carolina/J-6472-2012; Arévalo, Juan Carlos/J-8154-2014	García, Andrés Ángel Calderón/0000-0002-5993-5973; Gomis-Perez, Carolina/0000-0002-6818-4403; Arévalo, Juan Carlos/0000-0003-1994-3095; Calvo Enrique, Laura/0000-0002-9428-3974	Spanish Ministry of Science and Innovation [BFU2008-00162]; Spanish Ministry of Economy and Competitivity [BFU2011-22898, BFU2014-51846-R]; FP7-PAINCAGE Integrative Project [603191]; Spanish Ministry of Science and Innovation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitivity(Spanish Government); FP7-PAINCAGE Integrative Project; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Spanish Ministry of Science and Innovation Grant BFU2008-00162, by Spanish Ministry of Economy and Competitivity Grants BFU2011-22898 and BFU2014-51846-R, and in part by FP7-PAINCAGE Integrative Project Grant Agreement 603191 (to J. C. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Formacion Personal Investigador (FPI) Fellowship from the Spanish Ministry of Science and Innovation.	Araki N, 2008, HYPERTENSION, V51, P773, DOI 10.1161/HYPERTENSIONAHA.107.102061; Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; Boehmer C, 2003, CARDIOVASC RES, V57, P1079, DOI 10.1016/S0008-6363(02)00837-4; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Buus R, 2009, CURR BIOL, V19, P1463, DOI 10.1016/j.cub.2009.07.040; Calvo L, 2015, J NEUROSCI, V35, P7190, DOI 10.1523/JNEUROSCI.4646-14.2015; Arevalo JC, 2010, MOL CELL NEUROSCI, V45, P92, DOI 10.1016/j.mcn.2010.06.002; Ceriani M, 2015, EXP CELL RES, V333, P49, DOI 10.1016/j.yexcr.2015.01.019; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Donovan P, 2013, INT J BIOCHEM CELL B, V45, P706, DOI 10.1016/j.biocel.2012.12.006; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Emdal KB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005769; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Gallego-Sanchez A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002826; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Georgieva MV, 2011, J NEUROCHEM, V117, P479, DOI 10.1111/j.1471-4159.2011.07218.x; Gomis-Perez C, 2015, J CELL SCI, V128, P3155, DOI 10.1242/jcs.174128; Harvey K. F., 2002, BIOL CHEM, V277, P9307; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kim MS, 2011, J CELL BIOCHEM, V112, P498, DOI 10.1002/jcb.22940; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Krzystanek K, 2012, HEART RHYTHM, V9, P440, DOI 10.1016/j.hrthm.2011.10.026; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Laedermann CJ, 2013, J CLIN INVEST, V123, P3002, DOI 10.1172/JCI68996; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Oberfeld B, 2011, AM J PHYSIOL-RENAL, V301, pF189, DOI 10.1152/ajprenal.00487.2010; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Sambrook J, 2001, MOL CLONING LAB MANU; Savio MG, 2016, CURR BIOL, V26, P173, DOI 10.1016/j.cub.2015.11.050; Schuetz F, 2008, AM J PHYSIOL-CELL PH, V295, pC73, DOI 10.1152/ajpcell.00146.2008; Smeyne R. J., 1994, NATURE, V368, P246; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; SOBREVIELA T, 1994, J COMP NEUROL, V350, P587, DOI 10.1002/cne.903500407; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Sun XX, 2015, P NATL ACAD SCI USA, V112, P3734, DOI 10.1073/pnas.1411713112; Takahashi Y, 2011, FEBS LETT, V585, P1741, DOI 10.1016/j.febslet.2011.04.056; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yu T, 2014, J NEUROSCI, V34, P6098, DOI 10.1523/JNEUROSCI.4271-13.2014; Yu T, 2011, TRAFFIC, V12, P521, DOI 10.1111/j.1600-0854.2010.01156.x	54	10	12	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19132	19145		10.1074/jbc.M116.722637	http://dx.doi.org/10.1074/jbc.M116.722637			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27445338	Green Published, hybrid			2022-12-28	WOS:000383242300045
J	San Martin, L; Cerda, F; Jin, CY; Jimenez, V; Yevenes, GE; Hernandez, T; Nova, D; Fuentealba, J; Aguayo, LG; Guzman, L				San Martin, Loreto; Cerda, Fabian; Jin, Chunyang; Jimenez, Veronica; Yevenes, Gonzalo E.; Hernandez, Tania; Nova, Daniela; Fuentealba, Jorge; Aguayo, Luis G.; Guzman, Leonardo			Reversal of Ethanol-induced Intoxication by a Novel Modulator of G beta gamma Protein Potentiation of the Glycine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE DISRUPTION; ACTIVATED CL-CURRENT; ALPHA-1 SUBUNIT; ION-CHANNEL; NEURONS; MICE; ALCOHOL; SENSITIVITY; EXPRESSION; CURRENTS	The acute intoxicating effects of ethanol in the central nervous system result from the modulation of several molecular targets. It is widely accepted that ethanol enhances the activity of the glycine receptor (GIyR), thus enhancing inhibitory neurotransmission, leading to motor effects, sedation, and respiratory depression. We previously reported that small peptides interfered with the binding of G beta gamma to the GlyR and consequently inhibited the ethanol-induced potentiation of the receptor. Now, using virtual screening, we identified a subset of small molecules capable of interacting with the binding site of G beta gamma. One of these compounds, M554, inhibited the ethanol potentiation of the GIyR in both evoked currents and synaptic transmission in vitro. When this compound was tested in vivo in mice treated with ethanol (1-3.5 g/kg), it was found to induce a faster recovery of motor incoordination in rotarod experiments and a shorter sedative effect in loss of righting reflex assays. This study describes a novel molecule that might be relevant for the design of useful therapeutic compounds in the treatment of acute alcohol intoxication.	[San Martin, Loreto; Cerda, Fabian; Yevenes, Gonzalo E.; Hernandez, Tania; Nova, Daniela; Fuentealba, Jorge; Guzman, Leonardo] Univ Concepcion, Dept Physiol, Lab Mol Neurobiol, Concepcion 403901, Chile; [Aguayo, Luis G.] Univ Concepcion, Dept Physiol, Labs Neurophysiol, Concepcion 403901, Chile; [Jin, Chunyang] Res Triangle Inst, Ctr Drug Discovery, POB 12194, Res Triangle Pk, NC 27709 USA; [Jimenez, Veronica] Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Concepcion 403901, Chile	Universidad de Concepcion; Universidad de Concepcion; Research Triangle Institute; Universidad Andres Bello	Guzman, L (corresponding author), Univ Concepcion, Dept Fisiol, Casilla 160-C, Concepcion, Chile.	joleguzman@gmail.com	Jiménez, Verónica A/B-8789-2017; Guzman, Jose/AAM-7649-2020	Guzman, Jose/0000-0001-9596-5494; Jin, Chunyang/0000-0001-6733-3094	CONICYT FONDECYT [1131004]; FONDEF IDeA Grant [CA12i10280]; National Institutes of Health [R01-AA15150]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015150] Funding Source: NIH RePORTER	CONICYT FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDEF IDeA Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by CONICYT FONDECYT Grant 1131004, FONDEF IDeA Grant CA12i10280 (to L. G.), and National Institutes of Health Grant R01-AA15150 (to L. G. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguayo LG, 1996, J PHARMACOL EXP THER, V279, P1116; AGUAYO LG, 1994, J PHARMACOL EXP THER, V270, P61; Aguayo LG, 2014, NEUROPSYCHOPHARMACOL, V39, P2538, DOI 10.1038/npp.2014.100; Blednov YA, 2015, J PHARMACOL EXP THER, V353, P181, DOI 10.1124/jpet.114.221895; Blednov YA, 2012, J PHARMACOL EXP THER, V340, P317, DOI 10.1124/jpet.111.185124; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Findlay GS, 2002, J PHARMACOL EXP THER, V300, P526, DOI 10.1124/jpet.300.2.526; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Guzman L, 2009, J PHARMACOL EXP THER, V331, P933, DOI 10.1124/jpet.109.160440; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lovinger DM, 2013, CURR TOP BEHAV NEURO, V13, P31, DOI 10.1007/7854_2011_143; Mariqueo TA, 2014, J NEUROPHYSIOL, V111, P1940, DOI 10.1152/jn.00789.2013; Mathews JL, 2008, J NEUROSCI, V28, P12183, DOI 10.1523/JNEUROSCI.2326-08.2008; McCracken LM, 2013, J PHARMACOL EXP THER, V344, P489, DOI 10.1124/jpet.112.197707; San Martin L, 2012, J BIOL CHEM, V287, P40713, DOI DOI 10.1074/JBC.M112.393603; Wells CA, 2012, ACS CHEM NEUROSCI, V3, P69, DOI 10.1021/cn200102d; Welsh BT, 2009, J PHARMACOL EXP THER, V330, P198, DOI 10.1124/jpet.109.154344; WILLIAMS KL, 1995, PHARMACOL BIOCHEM BE, V50, P199, DOI 10.1016/0091-3057(94)00288-T; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385; Ye JH, 2009, ALCOHOL CLIN EXP RES, V33, P1069, DOI 10.1111/j.1530-0277.2009.00928.x; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Zhu L, 2005, BRAIN RES, V1033, P102, DOI 10.1016/j.brainres.2004.11.027	29	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18791	18798		10.1074/jbc.M116.740555	http://dx.doi.org/10.1074/jbc.M116.740555			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402845	Green Published, hybrid			2022-12-28	WOS:000383242300016
J	Yang, H; Ni, HM; Guo, FL; Ding, YF; Shi, YH; Lahiri, P; Frohlich, LF; Rulicke, T; Smole, C; Schmidt, VC; Zatloukal, K; Cui, Y; Komatsu, M; Fan, J; Ding, WX				Yang, Hua; Ni, Hong-Min; Guo, Fengli; Ding, Yifeng; Shi, Ying-Hong; Lahiri, Pooja; Froehlich, Leopold F.; Ruelicke, Thomas; Smole, Claudia; Schmidt, Volker C.; Zatloukal, Kurt; Cui, Yue; Komatsu, Masaaki; Fan, Jia; Ding, Wen-Xing			Sequestosome 1/p62 Protein Is Associated with Autophagic Removal of Excess Hepatic Endoplasmic Reticulum in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; P62/SQSTM1; MITOPHAGY; MITOCHONDRIA; REDUCTASE; RECEPTOR; PARKIN; LIVER; UBIQUITINATION; PEROXISOMES	Xenobiotics exposure increases endoplasmic reticulum (ER) proliferation and cytochrome P-450 (CYP) induction to sustain metabolic requirements. Whether autophagy is essential for the removal of excess ER and CYP and whether an autophagy receptor is involved in this process in mammals remains elusive. In this study, we show that autophagy is induced in mouse livers after withdrawal of the hepatic mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP). Although isolated autophagosomes, autolysosomes, and lysosomes from mouse livers after withdrawal of TCPOBOP contained ER proteins, those in control mouse livers did not, Liver-specific Atg5 knockout mice had higher basal hepatic ER content that was further increased and sustained after withdrawal of TCPOBOP compared with wild type mice. In addition to regulating ER degradation, our results also suggest that autophagy plays a role in regulating the homeostasis of hepatic CYP because blocking autophagy led to increased CYP2B10 accumulation either at the basal level or following TCPOBOP withdrawal. Furthermore, we found that the autophagy receptor protein sequestosome 1 (SQSTM1)/p62 is associated with the ER. After withdrawal of TCPOBOP, p62 knockout mice had increased ER content in the liver compared with wild-type mice. These results suggest that p62 may act as an autophagy receptor for the autophagic removal of excess ER in the mouse liver. Taken together, our results indicate that autophagy is important for the removal of excess ER and hepatic CYP enzymes in mouse livers, a process associated with the autophagy receptor protein p62.	[Yang, Hua; Shi, Ying-Hong; Fan, Jia] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, 108 Fenglin Rd, Shanghai 20032, Peoples R China; [Yang, Hua; Ni, Hong-Min; Ding, Yifeng; Ding, Wen-Xing] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Guo, Fengli] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Lahiri, Pooja; Smole, Claudia; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria; [Froehlich, Leopold F.] Univ Munster, Dept Craniomaxillofacial Surg, Albert Schweitzer Campus 1, D-48149 Munster, Germany; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci & Biomodels Austria, A-1210 Vienna, Austria; [Cui, Yue] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98159 USA; [Komatsu, Masaaki] Niigata Univ, Sch Med, Dept Biochem, Chuo Ku, Niigata 9518510, Japan	Fudan University; University of Kansas; University of Kansas Medical Center; Stowers Institute for Medical Research; Medical University of Graz; University of Munster; University of Veterinary Medicine Vienna; University of Washington; University of Washington Seattle; Niigata University	Fan, J (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, 108 Fenglin Rd, Shanghai 20032, Peoples R China.; Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	wxding@kumc.edu	Lahiri, Pooja/AAE-6663-2019; Komatsu, Masaaki/B-8321-2011; Shi, Ying-Hong/B-7063-2017	Komatsu, Masaaki/0000-0001-7672-7722; Lahiri, Pooja/0000-0002-6305-9451	National Institutes of Health COBRE Grant [9P20GM104936]; National Institutes of Health [S10RR027564]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940, S10RR027564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, P20GM103549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020518, R37AA020518] Funding Source: NIH RePORTER	National Institutes of Health COBRE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We wish to acknowledge the Electron Microscopy Research Laboratory (EMRL) facility for assistance with electron microscopy. The EMRL is supported in part by National Institutes of Health COBRE Grant 9P20GM104936. The JEOL JEM-14.00 transmission electron microscope used in the study was purchased with funds from National Institutes of Health Grant S10RR027564. We thank Dr, Noboru Mizushima (University of Tokyo, Japan) for providing reagents and Dr. Ana Maria Cuervo (Albeit Einstein College of Medicine) for providing guidance on the isolation of lysosomes. Y. D. was a summer intern from Blue Valley North High School in Kansas.	Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Cribb AE, 2005, DRUG METAB REV, V37, P405, DOI 10.1080/03602530500205135; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Ding WX, 2012, J BIOL CHEM, V287, P42379, DOI 10.1074/jbc.M112.413682; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; FELDMAN D, 1980, J HISTOCHEM CYTOCHEM, V28, P997, DOI 10.1177/28.9.7410819; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Koning AJ, 1996, MOL BIOL CELL, V7, P769, DOI 10.1091/mbc.7.5.769; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; LUM PY, 1995, J CELL BIOL, V131, P81, DOI 10.1083/jcb.131.1.81; Manley S, 2013, EXP BIOL MED, V238, P525, DOI 10.1177/1535370213489446; MASAKI R, 1987, J CELL BIOL, V104, P1207, DOI 10.1083/jcb.104.5.1207; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Ni HM, 2016, J HEPATOL, V65, P354, DOI 10.1016/j.jhep.2016.04.025; Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Park C, 2013, CELL BIOCHEM BIOPHYS, V67, P3, DOI 10.1007/s12013-013-9623-7; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112	41	42	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18663	18674		10.1074/jbc.M116.739821	http://dx.doi.org/10.1074/jbc.M116.739821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27325701	hybrid, Green Published			2022-12-28	WOS:000383242300006
J	Scholl, ZN; Li, Q; Yang, WT; Marszalek, PE				Scholl, Zackary N.; Li, Qing; Yang, Weitao; Marszalek, Piotr E.			Single-molecule Force Spectroscopy Reveals the Calcium Dependence of the Alternative Conformations in the Native State of a -Crystallin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); calcium; crystallin; molecular dynamics; protein folding	BETA-GAMMA-CRYSTALLINS; MYXOCOCCUS-XANTHUS; BINDING-PROPERTIES; ENERGY LANDSCAPES; DOMAIN STABILITY; CA2+ BINDING; ION BINDING; EYE LENS; EVOLUTION; STABILIZATION	Although multidomain proteins predominate the proteome of all organisms and are expected to display complex folding behaviors and significantly greater structural dynamics as compared with single-domain proteins, their conformational heterogeneity and its impact on their interaction with ligands are poorly understood due to a lack of experimental techniques. The multidomain calcium-binding -crystallin proteins are particularly important because their deterioration and misfolding/aggregation are associated with melanoma tumors and cataracts. Here we investigate the mechanical stability and conformational dynamics of a model calcium-binding -crystallin protein, Protein S, and elaborate on its interactions with calcium. We ask whether domain interactions and calcium binding affect Protein S folding and potential structural heterogeneity. Our results from single-molecule force spectroscopy show that the N-terminal (but not the C-terminal) domain is in equilibrium with an alternative conformation in the absence of Ca2+, which is mechanically stable in contrast to other proteins that were observed to sample a molten globule under similar conditions. Mutagenesis experiments and computer simulations reveal that the alternative conformation of the N-terminal domain is caused by structural instability produced by the high charge density of a calcium binding site. We find that this alternative conformation in the N-terminal domain is diminished in the presence of calcium and can also be partially eliminated with a hitherto unrecognized compensatory mechanism that uses the interaction of the C-terminal domain to neutralize the electronegative site. We find that up to 1% of all identified multidomain calcium-binding proteins contain a similarly highly charged site and therefore may exploit a similar compensatory mechanism to prevent structural instability in the absence of ligand.	[Scholl, Zackary N.] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27708 USA; [Li, Qing; Marszalek, Piotr E.] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Yang, Weitao] Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Scholl, ZN (corresponding author), Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27708 USA.; Marszalek, PE (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA.; Yang, WT (corresponding author), Duke Univ, Dept Chem, Durham, NC 27708 USA.	zns@duke.edu; weitao.yang@duke.edu; pemar@duke.edu	Yang, Weitao/C-1109-2008; Li, Qing/AAE-5788-2019	Yang, Weitao/0000-0001-5576-2828; 	National Science Foundation (NSF) [GRFP 1106401]; Katherine Goodman Stern Fellowship; NSF [MCB-1052208, MCB-1517245]; Div Of Molecular and Cellular Bioscience [1517245] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Katherine Goodman Stern Fellowship; NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) Grant GRFP 1106401 and the Katherine Goodman Stern Fellowship (to Z. N. S.) and by NSF Grants MCB-1052208 (to P. E. M.) and MCB-1517245 (to P. E. M. and W. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Aravind P, 2008, J MOL BIOL, V381, P509, DOI 10.1016/j.jmb.2008.06.019; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; BAGBY S, 1994, STRUCTURE, V2, P107, DOI 10.1016/S0969-2126(00)00013-7; Bagby S, 1998, J MOL BIOL, V276, P669, DOI 10.1006/jmbi.1997.1563; Barnwal RP, 2009, J MOL BIOL, V386, P675, DOI 10.1016/j.jmb.2008.12.058; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; Cao Y, 2008, P NATL ACAD SCI USA, V105, P11152, DOI 10.1073/pnas.0803446105; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2001, J MOL BIOL, V311, P879, DOI 10.1006/jmbi.2001.4871; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Fitter J, 2009, CELL MOL LIFE SCI, V66, P1672, DOI 10.1007/s00018-009-8771-9; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Garai A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869869; Garcia-Manyes S, 2016, J BIOL CHEM, V291, P4226, DOI 10.1074/jbc.M115.673871; Giancola C, 2005, FEBS J, V272, P1023, DOI 10.1111/j.1742-4658.2004.04536.x; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hoffmann T, 2012, CHEM SOC REV, V41, P4781, DOI 10.1039/c2cs35033e; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jobby MK, 2005, J BIOL CHEM, V280, P1209, DOI 10.1074/jbc.M409253200; Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023; Kotamarthi HC, 2013, BIOPHYS J, V104, P2273, DOI [10.1016/j.bpj.2013.04.008, 10.1016/J.BPJ.2013.04.008]; Kretschmar W, 1999, J MOL BIOL, V289, P701, DOI 10.1006/jmbi.1999.2833; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Lee W, 2010, J BIOL CHEM, V285, P38167, DOI 10.1074/jbc.M110.179697; Lewis KM, 2015, J BIOL CHEM, V290, P28665, DOI 10.1074/jbc.M115.686261; LOWRY CL, 1992, PROTEINS, V12, P42, DOI 10.1002/prot.340120106; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; Ma ZW, 2009, BIOCHEMISTRY-US, V48, P7334, DOI 10.1021/bi900467a; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Noy A, 2013, METHODS, V60, P142, DOI 10.1016/j.ymeth.2013.03.014; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Permyakov EA, 2000, FEBS LETT, V473, P269, DOI 10.1016/S0014-5793(00)01546-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Ray ME, 1997, P NATL ACAD SCI USA, V94, P3229, DOI 10.1073/pnas.94.7.3229; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Scholl ZN, 2015, ACS NANO, V9, P1189, DOI 10.1021/nn504686f; Scholl ZN, 2014, J BIOL CHEM, V289, P28607, DOI 10.1074/jbc.M114.582049; Scholl ZN, 2014, WIRES NANOMED NANOBI, V6, P211, DOI 10.1002/wnan.1253; Scholl ZN, 2014, ULTRAMICROSCOPY, V136, P7, DOI 10.1016/j.ultramic.2013.07.020; SHARMA Y, 1989, J BIOL CHEM, V264, P12794; Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229; Sotomayor-Perez AC, 2011, J BIOL CHEM, V286, P16997, DOI 10.1074/jbc.M110.210393; Spurway TD, 1997, J BIOL CHEM, V272, P17523, DOI 10.1074/jbc.272.28.17523; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Srivastava SS, 2014, J BIOL CHEM, V289, P10958, DOI 10.1074/jbc.O113.539569; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Takeuchi Y, 2009, BIOCHEMISTRY-US, V48, P10637, DOI 10.1021/bi901334b; TEINTZE M, 1988, J BIOL CHEM, V263, P1199; Tompa P, 2012, NAT CHEM BIOL, V8, P597, DOI 10.1038/nchembio.1009; Wenk M, 1999, J MOL BIOL, V286, P1533, DOI 10.1006/jmbi.1999.2582; Wenk M, 1998, FEBS LETT, V438, P127, DOI 10.1016/S0014-5793(98)01287-3; Wenk M, 1999, J MOL BIOL, V293, P117, DOI 10.1006/jmbi.1999.3146; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940; Xu AJ, 2012, P NATL ACAD SCI USA, V109, P3742, DOI 10.1073/pnas.1121261109; Yamniuk AP, 2007, BIOCHEMISTRY-US, V46, P7088, DOI 10.1021/bi700200z; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Zoldak G, 2013, CURR OPIN STRUC BIOL, V23, P48, DOI 10.1016/j.sbi.2012.11.007	74	10	11	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18263	18275		10.1074/jbc.M116.729525	http://dx.doi.org/10.1074/jbc.M116.729525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27378818	hybrid, Green Published			2022-12-28	WOS:000383241800019
J	Wongsamitkul, N; Baur, R; Sigel, E				Wongsamitkul, Nisa; Baur, Roland; Sigel, Erwin			Toward Understanding Functional Properties and Subunit Arrangement of alpha(4)beta(2)delta gamma-Aminobutyric Acid, Type A (GABA(A)) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; GABA; ion channel; neurotransmitter receptor; Xenopus; -aminobutyric acid type A; subunit; GABA(A) receptor	DELTA-SUBUNIT; STOICHIOMETRY; PHARMACOLOGY; RECOMBINANT; MODULATION; ALPHA-4; SENSITIVITY; ACTIVATION; EXPRESSION; CHANNELS	GABA(A) receptors are pentameric ligand-gated channels mediating inhibitory neurotransmission in the CNS. (4x) GABA(A) receptors are extrasynaptic receptors important for tonic inhibition. The functional properties and subunit arrangement of these receptors are controversial. We predefined subunit arrangement by using subunit concatenation. (4), (2), and subunits were concatenated to dimeric, trimeric, and, in some cases, pentameric subunits. We constructed in total nine different receptor pentamers in at least two different ways and expressed them in Xenopus oocytes. The subunit was substituted in any of the five positions in the (12) receptor. In addition, we investigated all receptors with the 2:2:1 subunit stoichiometry for (4), (2), and . Several functional receptors were obtained. Interestingly, all of these receptors had very similar EC50 values for GABA in the presence of the neurosteroid 3, 21-dihydroxy-5-pregnan-20-one (THDOC). All functional receptors containing subunits were sensitive to 4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridin-3-yl]benzamide (DS2). Moreover, none of the receptors was affected by ethanol up to 30 mm. These properties recapitulate those of non-concatenated receptors expressed from a cRNA ratio of 1:1:5 coding for (4), (2), and subunits. We conclude that the subunit arrangement of (42) GABA(A) receptors is not strongly predefined but is mostly satisfying the 2:2:1 subunit stoichiometry for (4), (2), and subunits and that several subunit arrangements result in receptors with similar functional properties tuned to physiological conditions.	[Wongsamitkul, Nisa; Baur, Roland; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland	University of Bern	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	erwin.sigel@ibmm.unibe.ch			Swiss National Science Foundation Grant [315230_156929/1]	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation Grant 315230_156929/1. The authors declare that they have no conflicts of interest with the contents of this article.	ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Baumann SW, 2003, J NEUROSCI, V23, P11158; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Baur R, 2010, J BIOL CHEM, V285, P17398, DOI 10.1074/jbc.M110.108670; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bianchi MT, 2003, J NEUROSCI, V23, P10934; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Chang YC, 1996, J NEUROSCI, V16, P5415; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Hartiadi LY, 2016, BIOCHEM PHARMACOL, V103, P98, DOI 10.1016/j.bcp.2015.12.021; Jensen ML, 2013, BRIT J PHARMACOL, V168, P1118, DOI 10.1111/bph.12001; Jones A, 1997, J NEUROSCI, V17, P1350; Karim N, 2012, BIOCHEM PHARMACOL, V84, P549, DOI 10.1016/j.bcp.2012.05.017; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; Patel B, 2016, J NEUROSCI, V36, P607, DOI 10.1523/JNEUROSCI.2047-15.2016; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Shu HJ, 2012, BRIT J PHARMACOL, V165, P2228, DOI 10.1111/j.1476-5381.2011.01690.x; Sigel E, 2005, MOL NUTR FOOD RES, V49, P228, DOI 10.1002/mnfr.200400104; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sigel E, 2009, BIOCHEM SOC T, V37, P1338, DOI 10.1042/BST0371338; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Tretter V, 1997, J NEUROSCI, V17, P2728; Ueno S, 1996, MOL PHARMACOL, V50, P931; Wafford KA, 2009, NEUROPHARMACOLOGY, V56, P182, DOI 10.1016/j.neuropharm.2008.08.004; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021; You H, 2007, J NEUROCHEM, V103, P1092, DOI 10.1111/j.1471-4159.2007.04817.x; Zheleznova N, 2008, BRIT J PHARMACOL, V153, P1062, DOI 10.1038/sj.bjp.0707665	45	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18474	18483		10.1074/jbc.M116.738906	http://dx.doi.org/10.1074/jbc.M116.738906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382064	Green Published, hybrid			2022-12-28	WOS:000383241800037
J	La Venuta, G; Wegehingel, S; Sehr, P; Muller, HM; Dimou, E; Steringer, JP; Grotwinkel, M; Hentze, N; Mayer, MP; Will, DW; Uhrig, U; Lewis, JD; Nickel, W				La Venuta, Giuseppe; Wegehingel, Sabine; Sehr, Peter; Mueller, Hans-Michael; Dimou, Eleni; Steringer, Julia P.; Grotwinkel, Mareike; Hentze, Nikolai; Mayer, Matthias P.; Will, David W.; Uhrig, Ulrike; Lewis, Joe D.; Nickel, Walter			Small Molecule Inhibitors Targeting Tec Kinase Block Unconventional Secretion of Fibroblast Growth Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor (FGF); phosphoinositide; protein phosphorylation; protein secretion; protein translocation; FGF2; protein translocation across membranes; Tec kinase; unconventional protein secretion	PROTEIN SECRETION; CELL-SURFACE; MAMMALIAN-CELLS; PLASMA-MEMBRANE; HIV-1 TAT; ESSENTIAL COMPONENTS; SIGNALING PATHWAYS; TYROSINE KINASES; EXPORT MACHINERY; FGF-2	Fibroblast growth factor 2 (FGF2) is a potent mitogen promoting both tumor cell survival and tumor-induced angiogenesis. It is secreted by an unconventional secretory mechanism that is based upon direct translocation across the plasma membrane. Key steps of this process are (i) phosphoinositide-dependent membrane recruitment, (ii) FGF2 oligomerization and membrane pore formation, and (iii) extracellular trapping mediated by membrane-proximal heparan sulfate proteoglycans. Efficient secretion of FGF2 is supported by Tec kinase that stimulates membrane pore formation based upon tyrosine phosphorylation of FGF2. Here, we report the biochemical characterization of the direct interaction between FGF2 and Tec kinase as well as the identification of small molecules that inhibit (i) the interaction of FGF2 with Tec, (ii) tyrosine phosphorylation of FGF2 mediated by Tec in vitro and in a cellular context, and (iii) unconventional secretion of FGF2 from cells. We further demonstrate the specificity of these inhibitors for FGF2 because tyrosine phosphorylation of a different substrate of Tec is unaffected in their presence. Building on previous evidence using RNA interference, the identified compounds corroborate the role of Tec kinase in unconventional secretion of FGF2. In addition, they are valuable lead compounds with great potential for drug development aiming at the inhibition of FGF2-dependent tumor growth and metastasis.	[La Venuta, Giuseppe; Wegehingel, Sabine; Mueller, Hans-Michael; Dimou, Eleni; Steringer, Julia P.; Grotwinkel, Mareike; Nickel, Walter] Heidelberg Univ Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany; [Sehr, Peter; Will, David W.; Uhrig, Ulrike; Lewis, Joe D.] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Hentze, Nikolai; Mayer, Matthias P.] Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Nickel, W (corresponding author), Heidelberg Univ Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Lewis, Joe/0000-0002-9926-1328; Sehr, Peter/0000-0002-4348-5066; Dimou, Eleni/0000-0003-4885-135X; Muller, Hans-Michael/0000-0002-2384-7285	Baden-Wurttemberg Stiftung (Stuttgart, Germany); German Research Council [DFG-SFB 638, DFG-SFB/TRR 186, DFG-SFB/TRR 83, DFG Ni 423/6-1, DFG Ni 423/7-1]; AID-NET program of the Federal Ministry for Education and Research of Germany; DFG Cluster of Excellence, Cell-Networks	Baden-Wurttemberg Stiftung (Stuttgart, Germany); German Research Council(German Research Foundation (DFG)); AID-NET program of the Federal Ministry for Education and Research of Germany; DFG Cluster of Excellence, Cell-Networks(German Research Foundation (DFG))	This work was supported by the Baden-Wurttemberg Stiftung (Stuttgart, Germany). In addition, funds were received from the German Research Council (DFG-SFB 638, DFG-SFB/TRR 186, DFG-SFB/TRR 83, DFG Ni 423/6-1, and DFG Ni 423/7-1), the AID-NET program of the Federal Ministry for Education and Research of Germany, and the DFG Cluster of Excellence, Cell-Networks. The authors declare that they have no conflicts of interest with the contents of this article.	Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Contreras-Gomez A, 2014, BIOTECHNOL PROGR, V30, P1, DOI 10.1002/btpr.1842; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; FISCHERFANTUZZI L, 1988, MOL CELL BIOL, V8, P5495, DOI 10.1128/MCB.8.12.5495; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; Jameson DM, 1999, METHODS, V19, P222, DOI 10.1006/meth.1999.0853; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; La Venuta G, 2015, J BIOL CHEM, V290, P27015, DOI 10.1074/jbc.R115.689257; Lewis CM, 2001, CURR OPIN IMMUNOL, V13, P317, DOI 10.1016/S0952-7915(00)00221-1; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Malhotra V, 2013, EMBO J, V32, P1660, DOI 10.1038/emboj.2013.104; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Martin-Sanchez F, 2016, CELL DEATH DIFFER, V23, P1219, DOI 10.1038/cdd.2015.176; Muller HM, 2015, J BIOL CHEM, V290, P8925, DOI 10.1074/jbc.M114.622456; NGUYEN M, 1994, J NATL CANCER I, V86, P356, DOI 10.1093/jnci/86.5.356; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W., 2016, [No title captured], Patent No. [GB1605173, 16051732]; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Ohya K, 1999, P NATL ACAD SCI USA, V96, P11976, DOI 10.1073/pnas.96.21.11976; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Piccioli P, 2013, SEMIN IMMUNOL, V25, P425, DOI 10.1016/j.smim.2013.10.007; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Takesono A, 2002, J CELL SCI, V115, P3039; Taouji S, 2009, CURR GENOMICS, V10, P93, DOI 10.2174/138920209787847041; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Thrall SH, 1996, BIOCHEMISTRY-US, V35, P4609, DOI 10.1021/bi9526387; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Trudel C, 2000, J CELL PHYSIOL, V185, P260, DOI 10.1002/1097-4652(200011)185:2<260::AID-JCP11>3.0.CO;2-X; Yokohari K, 2001, BIOCHEM BIOPH RES CO, V289, P414, DOI 10.1006/bbrc.2001.6008; Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zeitler M, 2015, J BIOL CHEM, V290, P21976, DOI 10.1074/jbc.M115.667097; Zhang M, 2015, ELIFE, V4, DOI 10.7554/eLife.11205; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	58	23	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17787	17803		10.1074/jbc.M116.729384	http://dx.doi.org/10.1074/jbc.M116.729384			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27382052	Green Published, hybrid			2022-12-28	WOS:000383241300026
J	Erbil, S; Oral, O; Mitou, G; Kig, C; Durmaz-Timucin, E; Guven-Maiorov, E; Gulacti, F; Gokce, G; Dengjel, J; Sezerman, OU; Gozuacik, D				Erbil, Secil; Oral, Ozlem; Mitou, Geraldine; Kig, Cenk; Durmaz-Timucin, Emel; Guven-Maiorov, Emine; Gulacti, Ferah; Gokce, Gokcen; Dengjel, Jorn; Sezerman, Osman Ugur; Gozuacik, Devrim			RACK1 Is an Interaction Partner of ATG5 and a Novel Regulator of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; PROTEIN; COMPLEX; MTOR; PHOSPHORYLATION; IDENTIFICATION; MECHANISMS; PROTEOMICS; CONJUGATE; FIELDS	Autophagy is biological mechanism allowing recycling of long-lived proteins, abnormal protein aggregates, and damaged organelles under cellular stress conditions. Following sequestration in double-or multimembrane autophagic vesicles, the cargo is delivered to lysosomes for degradation. ATG5 is a key component of an E3-like ATG12-ATG5-ATG16 protein complex that catalyzes conjugation of the MAP1LC3 protein to lipids, thus controlling autophagic vesicle formation and expansion. Accumulating data indicate that ATG5 is a convergence point for autophagy regulation. Here, we describe the scaffold protein RACK1 (receptor activated C-kinase 1, GNB2L1) as a novel ATG5 interactor and an autophagy protein. Using several independent techniques, we showed that RACK1 interacted with ATG5. Importantly, classical autophagy inducers (starvation or mammalian target of rapamycin blockage) stimulated RACK1-ATG5 interaction. Knockdown of RACK1 or prevention of its binding to ATG5 using mutagenesis blocked autophagy activation. Therefore, the scaffold protein RACK1 is a new ATG5-interacting protein and an important and novel component of the autophagy pathways.	[Erbil, Secil; Oral, Ozlem; Mitou, Geraldine; Kig, Cenk; Durmaz-Timucin, Emel; Gulacti, Ferah; Gokce, Gokcen; Gozuacik, Devrim] Sabanci Univ, Mol Biol Genet & Bioengn Program, TR-34956 Istanbul, Turkey; [Guven-Maiorov, Emine] Koc Univ, Dept Chem & Biol Engn, TR-34450 Istanbul, Turkey; [Guven-Maiorov, Emine] Koc Univ, Ctr Computat Biol & Bioinformat, TR-34450 Istanbul, Turkey; [Dengjel, Jorn] Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland; [Sezerman, Osman Ugur] Acibadem Univ, Sch Med, Dept Biostat & Med Informat, TR-34752 Istanbul, Turkey; [Oral, Ozlem] Sabanci Univ, Nanotechnol Res & Applicat Ctr, TR-34956 Istanbul, Turkey; [Mitou, Geraldine] Inserm UMR1037 CRCT, F-31000 Toulouse, France; [Guven-Maiorov, Emine] NCI, Ctr Canc Res, NIH, Bldg 542,Rm 603, Frederick, MD 21702 USA; [Gulacti, Ferah] Duzce Ataturk Publ Hosp, Aziziye Str, TR-81010 Duzce, Turkey; [Gokce, Gokcen] Santa Farma Drug Co, Borucicegi Str 16, TR-34382 Istanbul, Turkey	Sabanci University; Koc University; Koc University; University of Fribourg; Acibadem University; Sabanci University; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duzce Ataturk State Hospital; Santa Farma Ilac	Gozuacik, D (corresponding author), Sabanci Univ, Mol Biol Genet & Bioengn Program, TR-34956 Istanbul, Turkey.	dgozuacik@sabanciuniv.edu	Dengjel, Joern/AAI-3682-2020; kig, cenk/ABI-4009-2020; Timucin, Emel/AHE-5258-2022; Timucin, Emel/N-7446-2017; SEZERMAN, OSMAN U/X-6441-2018; Devrim, Gozuacik/C-3330-2008	kig, cenk/0000-0002-6318-5001; Timucin, Emel/0000-0003-0048-0668; Timucin, Emel/0000-0003-0048-0668; Devrim, Gozuacik/0000-0001-7739-2346; Erbil Bilir, Secil/0000-0001-5250-1972; Dengjel, Joern/0000-0002-9453-4614; Guven Maiorov, Emine/0000-0002-7388-9811	Scientific and Technological Research Council of Turkey (TUBITAK) [107T153]; Sabanci University; Swiss National Science Foundation [31003A-166482/1]; TUBITAK [BIDEB 2211]; IKU Prof. Onder Oztunali Science Award; TGC Sedat Simavi Health Sciences Award; Elginkan Foundation Technology Award	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Sabanci University(Sabanci University); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); IKU Prof. Onder Oztunali Science Award; TGC Sedat Simavi Health Sciences Award; Elginkan Foundation Technology Award	This work was supported in part by Scientific and Technological Research Council of Turkey (TUBITAK) 1001 Grant 107T153, the Sabanci University (to D. G.), and Swiss National Science Foundation Grant 31003A-166482/1 (to J. D.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a TUBITAK BIDEB 2211 Scholarship for Ph.D. studies.r Recipient of IKU Prof. Onder Oztunali Science Award, TGC Sedat Simavi Health Sciences Award, and Elginkan Foundation Technology Award. To whom correspondence should be addressed. Tel.: 90-216-4839617; E-mail: dgozuacik@sabanciuniv.edu.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Dengjel J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014035; Dengjel J, 2010, METHODS MOL BIOL, V658, P267, DOI 10.1007/978-1-60761-780-8_16; Erdi B, 2012, AUTOPHAGY, V8, P1124, DOI 10.4161/auto.20069; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Ishibashi K, 2011, AUTOPHAGY, V7, P1500, DOI 10.4161/auto.7.12.18025; Itah Z, 2013, EXP BIOL MED, V238, P1242, DOI 10.1177/1535370213503273; Jastrzebski K, 2011, CELL SIGNAL, V23, P1338, DOI 10.1016/j.cellsig.2011.03.016; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Korkmaz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082556; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JJ, 2015, ONCOGENE, V34, P1890, DOI 10.1038/onc.2014.127; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Nanes BA, 2015, BIOTECHNIQUES, V59, P269, DOI 10.2144/000114351; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Oral O, 2015, ANN BIOMED ENG, V43, P2816, DOI 10.1007/s10439-015-1331-6; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Tooze Sharon A, 2015, Methods Mol Biol, V1270, P155, DOI 10.1007/978-1-4939-2309-0_12; Walker S, 2008, AUTOPHAGY, V4, P1093, DOI 10.4161/auto.7141; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhao YW, 2015, CELL REP, V13, P1407, DOI 10.1016/j.celrep.2015.10.011; Zhu JJ, 2016, LIFE SCI, V151, P115, DOI 10.1016/j.lfs.2016.02.014	39	35	36	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16753	16765		10.1074/jbc.M115.708081	http://dx.doi.org/10.1074/jbc.M115.708081			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27325703	Green Published, hybrid			2022-12-28	WOS:000380826700032
J	Chang, CY; Chang, CP; Chakraborty, S; Wang, SW; Tseng, YK; Wang, CC				Chang, Chih-Yao; Chang, Chia-Pei; Chakraborty, Shruti; Wang, Shao-Win; Tseng, Yi-Kuan; Wang, Chien-Chia			Modulating the Structure and Function of an Aminoacyl-tRNA Synthetase Cofactor by Biotinylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; biotin; post-translational modification (PTM); protein synthesis; transfer RNA (tRNA)	ACETYL-COA-CARBOXYLASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; IN-VIVO; HOLOCARBOXYLASE SYNTHETASE; PROTEIN ARC1P; GENE ENCODES; YEAST; BIOTIN; MITOCHONDRIAL	Arc1p is a yeast-specific tRNA-binding protein that forms a ternary complex with glutamyl-tRNA synthetase (GluRS(c)) and methionyl-tRNA synthetase (MetRS) in the cytoplasm to regulate their catalytic activities and subcellular distributions. Despite Arc1p not being involved in any known biotin-dependent reaction, it is a natural target of biotin modification. Results presented herein show that biotin modification had no obvious effect on the growth-supporting activity, subcellular distribution, tRNA binding, or interactions of Arc1p with GluRS(c) and MetRS. Nevertheless, biotinylation of Arc1p was temperature dependent; raising the growth temperature from 30 to 37 degrees C drastically reduced its biotinylation level. As a result, Arc1p purified from a yeast culture that had been grown overnight at 37 degrees C was essentially biotin free. Non-biotinylated Arc1p was more heat stable, more flexible in structure, and more effective than its biotinylated counterpart in promoting glutamylation activity of the otherwise inactive GluRS(c) at 37 degrees C in vitro. Our study suggests that the structure and function of Arc1p can be modulated via biotinylation in response to temperature changes.	[Chang, Chih-Yao; Chang, Chia-Pei; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Taoyuan 32001, Taiwan; [Tseng, Yi-Kuan] Natl Cent Univ, Grad Inst Stat, Taoyuan 32001, Taiwan; [Chakraborty, Shruti] Univ Calcutta, Dept Biotechnol, Kolkata 700019, India; [Wang, Shao-Win] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli 35053, Taiwan	National Central University; National Central University; University of Calcutta; National Health Research Institutes - Taiwan	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan 32001, Taiwan.	dukewang@cc.ncu.edu.tw		Wang, Chien-Chia/0000-0002-7104-1307	Ministry of Science and Technology (Taipei, Taiwan) [MOST 103-2311-B-008-003-MY3, MOST 103-2923-B-008-001-MY3, NSC 102-2311-B-008-004-MY3]	Ministry of Science and Technology (Taipei, Taiwan)	This work was supported by Grants MOST 103-2311-B-008-003-MY3, MOST 103-2923-B-008-001-MY3, and NSC 102-2311-B-008-004-MY3 (to C. C. W.) from the Ministry of Science and Technology (Taipei, Taiwan). The authors declare that they have no conflicts of interest with the contents of this article.	BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang CP, 2012, NUCLEIC ACIDS RES, V40, P314, DOI 10.1093/nar/gkr724; Chang Chia-Pei, 2008, J Biol Chem, V283, P30699, DOI 10.1074/jbc.M805339200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Chapman-Smith A, 1999, BIOMOL ENG, V16, P119, DOI 10.1016/S1050-3862(99)00046-7; CHATTON B, 1988, J BIOL CHEM, V263, P52; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Dassanayake RP, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0651-6; Frechin M, 2014, MOL CELL, V56, P763, DOI 10.1016/j.molcel.2014.10.015; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; Graindorge JS, 2005, BIOCHEMISTRY-US, V44, P1344, DOI 10.1021/bi049024z; Grant TD, 2012, NUCLEIC ACIDS RES, V40, P3723, DOI 10.1093/nar/gkr1223; Hasim S, 2013, FEMS YEAST RES, V13, P529, DOI 10.1111/1567-1364.12056; Hoja U, 1998, EUR J BIOCHEM, V254, P520, DOI 10.1046/j.1432-1327.1998.2540520.x; Huang HY, 2006, MOL MICROBIOL, V60, P189, DOI 10.1111/j.1365-2958.2006.05083.x; Karanasios E, 2010, FEBS LETT, V584, P3842, DOI 10.1016/j.febslet.2010.08.023; Kim HS, 2004, J BIOL CHEM, V279, P42445, DOI 10.1074/jbc.M407137200; Kuroishi T, 2011, MOL GENET METAB, V104, P537, DOI 10.1016/j.ymgme.2011.08.030; Ladror US, 1998, PROTEIN SCI, V7, P2595, DOI 10.1002/pro.5560071213; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; Liao CC, 2012, NUCLEIC ACIDS RES, V40, P9171, DOI 10.1093/nar/gks689; Lin CH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-85; Mirande M, 2010, FEBS LETT, V584, P443, DOI 10.1016/j.febslet.2009.11.027; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Pick H, 2014, BBA-GENE REGUL MECH, V1839, P644, DOI 10.1016/j.bbagrm.2014.04.016; Polyak SW, 1999, J BIOL CHEM, V274, P32847, DOI 10.1074/jbc.274.46.32847; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; SUMPER M, 1972, EUR J BIOCHEM, V29, P237, DOI 10.1111/j.1432-1033.1972.tb01980.x; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Tissot G, 1998, EUR J BIOCHEM, V258, P586, DOI 10.1046/j.1432-1327.1998.2580586.x; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Wang CC, 1999, J BIOL CHEM, V274, P16508, DOI 10.1074/jbc.274.23.16508; Yao X, 1997, BIOCHEMISTRY-US, V36, P15089, DOI 10.1021/bi971485f; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	38	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17102	17111		10.1074/jbc.M116.734343	http://dx.doi.org/10.1074/jbc.M116.734343			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27330079	Green Published, hybrid			2022-12-28	WOS:000382643800016
J	Elks, CM; Zhao, P; Grant, RW; Hang, H; Bailey, JL; Burk, DH; McNulty, MA; Mynatt, RL; Stephens, JM				Elks, Carrie M.; Zhao, Peng; Grant, Ryan W.; Hang, Hardy; Bailey, Jennifer L.; Burk, David H.; McNulty, Margaret A.; Mynatt, Randall L.; Stephens, Jacqueline M.			Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; adipose tissue; inflammation; insulin resistance; obesity; STATs; oncostatin M	CILIARY NEUROTROPHIC FACTOR; M RECEPTOR-BETA; MATRIX METALLOPROTEINASES; ACTIVATOR INHIBITOR-1; METABOLIC-DISORDERS; GROWTH-REGULATOR; OBESITY; ACCUMULATION; PROLIFERATION; ADIPOGENESIS	Oncostatin M (OSM) is a multifunctional gp130 cytokine. Although OSM is produced in adipose tissue, it is not produced by adipocytes. OSM expression is significantly induced in adipose tissue from obese mice and humans. The OSM-specific receptor, OSM receptor (OSMR), is expressed in adipocytes, but its function remains largely unknown. To better understand the effects of OSM in adipose tissue, we knocked down Osmr expression in adipocytes in vitro using siRNA. In vivo, we generated a mouse line lacking Osmr in adiponectin-expressing cells (OSMRFKO mice). The effects of OSM on gene expression were also assessed in vitro and in vivo. OSM exerts proinflammatory effects on cultured adipocytes that are partially rescued by Osmr knockdown. Osm expression is significantly increased in adipose tissue T cells of high fat-fed mice. In addition, adipocyte Osmr expression is increased following high fat feeding. OSMRFKO mice exhibit increased insulin resistance and adipose tissue inflammation and have increased lean mass, femoral length, and bone volume. Also, OSMRFKO mice exhibit increased expression of Osm, the T cell markers Cd4 and Cd8, and the macrophage markers F4/80 and Cd11c. Interestingly, the same proinflammatory genes induced by OSM in adipocytes are induced in the adipose tissue of the OSMRFKO mouse, suggesting that increased expression of proinflammatory genes in adipose tissue arises both from adipocytes and other cell types. These findings suggest that adipocyte OSMR signaling is involved in the regulation of adipose tissue homeostasis and that, in obesity, OSMR ablation may exacerbate insulin resistance by promoting adipose tissue inflammation.	[Elks, Carrie M.; Bailey, Jennifer L.] Louisiana State Univ, Pennington Biomed Res Ctr, Matrix Biol Lab, Baton Rouge, LA 70808 USA; [Hang, Hardy; Stephens, Jacqueline M.] Louisiana State Univ, Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA; [Burk, David H.] Louisiana State Univ, Pennington Biomed Res Ctr, Cell Biol & Bioimaging Core, Baton Rouge, LA 70808 USA; [Mynatt, Randall L.] Louisiana State Univ, Pennington Biomed Res Ctr, Transgen Core, Baton Rouge, LA 70808 USA; [Zhao, Peng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Grant, Ryan W.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [McNulty, Margaret A.] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Stephens, Jacqueline M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of California System; University of California San Diego; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Stephens, JM (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	jsteph1@lsu.edu	Elks, Carrie Marie/N-1961-2017; Mynatt, Randall L/N-1980-2017; Zhao, Peng/G-3562-2019; Stephens, Jacqueline M/R-5217-2018; Burk, David/D-2056-2009	Mynatt, Randall L/0000-0003-4399-0019; McNulty, Margaret/0000-0001-6638-253X; Hang, Hardy/0000-0003-0794-3514; Grant, Ryan/0000-0002-8940-4196; Stephens, Jacqueline/0000-0002-3796-9531	National Institutes of Health [R01DK052968]; National Institutes of Health Nutrition Obesity Research Centers [P30DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052968, P30DK057521, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Nutrition Obesity Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant R01DK052968 (to J. M. S.) and National Institutes of Health Nutrition Obesity Research Centers Grant P30DK072476 entitled "Nutritional Programming: Environmental and Molecular Interactions." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albasanz-Puig A, 2011, ATHEROSCLEROSIS, V216, P292, DOI 10.1016/j.atherosclerosis.2011.02.003; Alessi MC, 2007, CURR OPIN LIPIDOL, V18, P240, DOI 10.1097/MOL.0b013e32814e6d29; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bamber B, 1998, J MOL MED-JMM, V76, P61, DOI 10.1007/s109-1998-8105-3; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Chan SSY, 2005, J CLIN ENDOCR METAB, V90, P6588, DOI 10.1210/jc.2005-0595; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Elks CM, 2015, OBESITY, V23, P573, DOI 10.1002/oby.20926; Ettinger MP, 2003, JAMA-J AM MED ASSOC, V289, P1826, DOI 10.1001/jama.289.14.1826; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Grant Ryan, 2013, Methods Mol Biol, V1040, P195, DOI 10.1007/978-1-62703-523-1_15; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Henkel J, 2011, LAB INVEST, V91, P1107, DOI 10.1038/labinvest.2011.47; Hui W, 1997, ANN RHEUM DIS, V56, P184, DOI 10.1136/ard.56.3.184; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Komori T, 2015, DIABETOLOGIA, V58, P1868, DOI 10.1007/s00125-015-3613-9; Komori T, 2014, J BIOL CHEM, V289, P13821, DOI 10.1074/jbc.M113.542399; Komori T, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461905; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Lawler HM, 2016, J CLIN ENDOCR METAB, V101, P1422, DOI 10.1210/jc.2015-4125; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Okaya A, 2005, AM J PATHOL, V166, P709, DOI 10.1016/S0002-9440(10)62292-4; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Rega G, 2005, CIRCULATION, V111, P1938, DOI 10.1161/01.CIR.0000161823.55935.BE; Sanchez-Infantes D, 2014, J CLIN ENDOCR METAB, V99, pE217, DOI 10.1210/jc.2013-3555; Schnittker D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/317503; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Silha JV, 2002, AM J PHYSIOL-ENDOC M, V283, pE937, DOI 10.1152/ajpendo.00014.2002; Tamura S, 2002, MECH DEVELOP, V115, P127, DOI 10.1016/S0925-4773(02)00081-3; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Vollmer S, 2009, HEPATOLOGY, V50, P253, DOI 10.1002/hep.22928; Wallace PM, 1999, J IMMUNOL, V162, P5547; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White UA, 2008, J BIOL CHEM, V283, P22505, DOI 10.1074/jbc.M710462200; White UA, 2011, OBESITY, V19, P903, DOI 10.1038/oby.2010.293; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	53	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17066	17076		10.1074/jbc.M116.739110	http://dx.doi.org/10.1074/jbc.M116.739110			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325693	hybrid, Green Published			2022-12-28	WOS:000382643800013
J	Gholkar, AA; Cheung, K; Williams, KJ; Lo, YC; Hamideh, SA; Nnebe, C; Khuu, C; Bensinger, SJ; Torres, JZ				Gholkar, Ankur A.; Cheung, Keith; Williams, Kevin J.; Lo, Yu-Chen; Hamideh, Shadia A.; Nnebe, Chelsea; Khuu, Cindy; Bensinger, Steven J.; Torres, Jorge Z.			Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell death; cell division; lipid metabolism; mitosis; Betulin; Fatostatin; PF-429242; SREBP	STEROL-REGULATORY-ELEMENT; PROSTATE-CANCER; SMALL-MOLECULE; SREBP; PROTEIN; IDENTIFICATION; TRANSCRIPTION; METABOLISM; BIOLOGY; BINDING	The sterol regulatory element-binding protein (SREBP) transcription factors have become attractive targets for pharmacological inhibition in the treatment of metabolic diseases and cancer. SREBPs are critical for the production and metabolism of lipids and cholesterol, which are essential for cellular homeostasis and cell proliferation. Fatostatin was recently discovered as a specific inhibitor of SREBP cleavage-activating protein (SCAP), which is required for SREBP activation. Fatostatin possesses antitumor properties including the inhibition of cancer cell proliferation, invasion, and migration, and it arrests cancer cells in G(2)/M phase. Although Fatostatin has been viewed as an antitumor agent due to its inhibition of SREBP and its effect on lipid metabolism, we show that Fatostatin's anticancer properties can also be attributed to its inhibition of cell division. We analyzed the effect of SREBP activity inhibitors including Fatostatin, PF-429242, and Betulin on the cell cycle and determined that only Fatostatin possessed antimitotic properties. Fatostatin inhibited tubulin polymerization, arrested cells in mitosis, activated the spindle assembly checkpoint, and triggered mitotic catastrophe and reduced cell viability. Thus Fatostatin's ability to inhibit SREBP activity and cell division could prove beneficial in treating aggressive types of cancers such as glioblastomas that have elevated lipid metabolism and fast proliferation rates and often develop resistance to current anticancer therapies.	[Gholkar, Ankur A.; Cheung, Keith; Lo, Yu-Chen; Hamideh, Shadia A.; Nnebe, Chelsea; Khuu, Cindy; Torres, Jorge Z.] Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA; [Williams, Kevin J.; Bensinger, Steven J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Bensinger, Steven J.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Torres, Jorge Z.] Univ Calif Los Angeles, Inst Mol Biol, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA; [Bensinger, Steven J.; Torres, Jorge Z.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Torres, JZ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	torres@chem.ucla.edu		Torres, Jorge/0000-0002-2158-889X; Gholkar, Ankur/0000-0002-3490-234X	NCI, National Institutes of Health [P30CA016042]; Jonsson Comprehensive Cancer Center (JCCC) seed; University of California Cancer Research Coordinating Committee (UC-CRCC) grants; Cottrell Scholar Award from the Research Corporation for Science Advancement; National Institutes of Health [AI093768, HL126556]; Whitcome fellowship; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL126556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093768] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jonsson Comprehensive Cancer Center (JCCC) seed; University of California Cancer Research Coordinating Committee (UC-CRCC) grants; Cottrell Scholar Award from the Research Corporation for Science Advancement; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NCI, National Institutes of Health Grant P30CA016042, Jonsson Comprehensive Cancer Center (JCCC) seed and University of California Cancer Research Coordinating Committee (UC-CRCC) grants, and a Cottrell Scholar Award from the Research Corporation for Science Advancement (to J.Z.T.); National Institutes of Health Grants AI093768 and HL126556 (to S.J.B.); and a Whitcome fellowship (to K.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Choi YM, 2003, J BIOL CHEM, V278, P7320, DOI 10.1074/jbc.M210283200; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Gholkar AA, 2016, CELL REP, V14, P180, DOI 10.1016/j.celrep.2015.12.035; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Hay BA, 2007, BIOORG MED CHEM LETT, V17, P4411, DOI 10.1016/j.bmcl.2007.06.031; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Li XY, 2015, ONCOTARGET, V6, P41018, DOI 10.18632/oncotarget.5879; Li XY, 2014, MOL CANCER THER, V13, P855, DOI 10.1158/1535-7163.MCT-13-0797; Lo YC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004153; Murai T, 2015, BIOL CHEM, V396, P1, DOI 10.1515/hsz-2014-0194; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Notarnicola M, 2014, CURR MED CHEM, V21, P2729, DOI 10.2174/0929867321666140303122426; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Senese S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.420; Singh A, 2014, CELL CYCLE, V13, P157, DOI 10.4161/cc.26951; Soyal SM, 2015, TRENDS PHARMACOL SCI, V36, P406, DOI 10.1016/j.tips.2015.04.010; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Torres JZ, 2010, MOL BIOL CELL, V21, P897, DOI 10.1091/mbc.E09-07-0598; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T	27	31	34	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17001	17008		10.1074/jbc.C116.737346	http://dx.doi.org/10.1074/jbc.C116.737346			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27378817	Green Published, hybrid			2022-12-28	WOS:000382643800007
J	Zhang, Q; Harding, R; Hou, F; Dong, AP; Walker, JR; Bteich, J; Tong, YF				Zhang, Qi; Harding, Rachel; Hou, Feng; Dong, Aiping; Walker, John R.; Bteich, Joseph; Tong, Yufeng			Structural Basis of the Recruitment of Ubiquitin-specific Protease USP15 by Spliceosome Recycling Factor SART3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; dimerization; protein-protein interaction; site-directed mutagenesis; ubiquitin-dependent protease; deubiquitinase; half-a-tetratricopeptide repeats	CANCER-PATIENTS; POSTTRANSLATIONAL MODIFICATIONS; MACROMOLECULAR CRYSTALLOGRAPHY; DEUBIQUITINATING ENZYME; SART3-DERIVED PEPTIDES; CRYSTAL-STRUCTURE; DOMAINS; COMPLEX; IDENTIFICATION; RECOGNITION	Ubiquitin-specific proteases (USPs) USP15 and USP4 belong to a subset of USPs featuring an N-terminal tandem domain in USP (DUSP) and ubiquitin-like (UBL) domain. Squamous cell carcinoma antigen recognized by T-cell 3 (SART3), a spliceosome recycling factor, binds to the DUSP-UBL domain of USP15 and USP4, recruiting them to the nucleus from the cytosol to control deubiquitination of histone H2B and spliceosomal proteins, respectively. To provide structural insight, we solved crystal structures of SART3 in the apo-form and in complex with the DUSP-UBL domain of USP15 at 2.0 and 3.0 , respectively. Structural analysis reveals SART3 contains 12 half-a-tetratricopeptide (HAT) repeats, organized into two subdomains, HAT-N and HAT-C. SART3 dimerizes through the concave surface of HAT-C, whereas the HAT-C convex surface binds USP15 in a novel bipartite mode. Isothermal titration calorimetry measurements and mutagenesis analysis confirmed key residues of USP15 involved in the interaction and indicated USP15 binds 20-fold stronger than USP4.	[Zhang, Qi; Harding, Rachel; Hou, Feng; Dong, Aiping; Walker, John R.; Tong, Yufeng] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Bteich, Joseph] Ontario Inst Canc Res, Drug Discovery Program, Toronto, ON M5G 0A3, Canada; [Tong, Yufeng] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L7, Canada	University of Toronto; Structural Genomics Consortium; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto	Tong, YF (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Tong, YF (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L7, Canada.	yufeng.tong@utoronto.ca		Zhang, Qi/0000-0003-1121-8817; /0000-0002-5255-895X; Harding, Rachel/0000-0002-1134-391X; Tong, Yufeng/0000-0001-7740-1812	AbbVie [1097737]; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute; Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD) [115766]; Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute, Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant 115766), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust. X-ray diffraction data were collected at the Canadian Light Source (14) and at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, which is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Bai Y, 2007, MOL CELL, V25, P863, DOI 10.1016/j.molcel.2007.01.034; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clerici M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6399; Elliott PR, 2011, FEBS LETT, V585, P3385, DOI 10.1016/j.febslet.2011.09.040; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furugaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101854; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hammani K, 2012, P NATL ACAD SCI USA, V109, P5651, DOI 10.1073/pnas.1200318109; Harada K, 2001, INT J CANCER, V93, P623, DOI 10.1002/ijc.1391; Harper S, 2014, BIOCHEMISTRY-US, V53, P2966, DOI 10.1021/bi500116x; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; Ito M, 2000, INT J CANCER, V88, P633, DOI 10.1002/1097-0215(20001115)88:4<633::AID-IJC18>3.3.CO;2-E; Kabiri M, 2014, BIOMACROMOLECULES, V15, P3463, DOI 10.1021/bm5004515; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Long L, 2014, J BIOL CHEM, V289, P8916, DOI 10.1074/jbc.M114.551754; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Park JK, 2016, NUCLEIC ACIDS RES, V44, P5424, DOI 10.1093/nar/gkw218; Paulson AR, 2012, RNA, V18, P1154, DOI 10.1261/rna.032524.112; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Preker PJ, 1998, TRENDS BIOCHEM SCI, V23, P15, DOI 10.1016/S0968-0004(97)01156-0; Rader SD, 2002, RNA, V8, P1378, DOI 10.1017/s1355838202020010; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Suefuji Y, 2001, BRIT J CANCER, V84, P915, DOI 10.1054/bjoc.2000.1690; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vlasschaert C, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0511-1; Whitmill A, 2016, LIFE SCI, V149, P79, DOI 10.1016/j.lfs.2016.02.062; Yang D, 1999, CANCER RES, V59, P4056	42	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17283	17292		10.1074/jbc.M116.740787	http://dx.doi.org/10.1074/jbc.M116.740787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27255711	Green Published, hybrid			2022-12-28	WOS:000382643800029
J	Lee, SM; Hay, DL; Pioszak, AA				Lee, Sang-Min; Hay, Debbie L.; Pioszak, Augen A.			Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS (vol 291, pg 8686, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Hay, Debbie L/D-4441-2009	Hay, Debbie L/0000-0002-9558-5122				Lee SM, 2016, J BIOL CHEM, V291, P8686, DOI 10.1074/jbc.M115.713628	1	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16416	16416		10.1074/jbc.A115.713628	http://dx.doi.org/10.1074/jbc.A115.713628			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27474777	Green Published, hybrid			2022-12-28	WOS:000380585400045
J	Raychaudhuri, K; Chaudhary, N; Gurjar, M; D'Souza, R; Limzerwala, J; Maddika, S; Dalal, SN				Raychaudhuri, Kumarkrishna; Chaudhary, Neelam; Gurjar, Mansa; D'Souza, Roseline; Limzerwala, Jazeel; Maddika, Subbareddy; Dalal, Sorab N.			14-3-3 sigma Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; STRUCTURAL BASIS; NUCLEAR EXPORT; CANCER-CELLS; HUMAN CDC25C; SIGMA GENE; IN-VITRO; EXPRESSION; BINDING	Loss of 14-3-3 sigma has been observed in multiple tumor types; however, the mechanisms by which 14-3-3 sigma loss leads to tumor progression are not understood. The experiments in this report demonstrate that loss of 14-3-3 sigma leads to a decrease in the expression of epithelial markers and an increase in the expression of mesenchymal markers, which is indicative of an induction of the epithelial to mesenchymal transition (EMT). The EMTwas accompanied by an increase in migration and invasion in the 14-3-3 sigma(-/-) cells. 14-3-3 sigma(-/-) cells show increased stabilization of c-Jun, resulting in an increase in the expression of the EMT transcription factor slug. 14-3-3 sigma induces the ubiquitination and degradation of c-Jun in an FBW7-dependent manner. c-Jun ubiquitination is dependent on the presence of an intact nuclear export pathway as c-Jun is stabilized and localized to the nucleus in the presence of a nuclear export inhibitor. Furthermore, the absence of 14-3-3 sigma leads to the nuclear accumulation and stabilization of c-Jun, suggesting that 14-3-3 sigma regulates the subcellular localization of c-Jun. Our results have identified a novel mechanism by which 14-3-3 sigma maintains the epithelial phenotype by inhibiting EMT and suggest that this property of 14-3-3 sigma might contribute to its function as a tumor suppressor gene.	[Raychaudhuri, Kumarkrishna; Gurjar, Mansa; D'Souza, Roseline; Limzerwala, Jazeel; Dalal, Sorab N.] Tata Mem Hosp, ACTREC, KS215, Sect 22, Kharghar 410210, Navi Mumbai, India; [Chaudhary, Neelam; Maddika, Subbareddy] CDFD, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India; [Chaudhary, Neelam] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Dalal, SN (corresponding author), Tata Mem Hosp, ACTREC, KS215, Sect 22, Kharghar 410210, Navi Mumbai, India.	sdalal@actrec.gov.in	Raychaudhuri, Kumarkrishna/AAB-4589-2021	Raychaudhuri, Kumarkrishna/0000-0001-5198-8651; Limzerwala, Jazeel/0000-0002-4309-9173; Chaudhary, Neelam/0000-0002-0327-2824; Gurjar, Mansa/0000-0002-1613-5191	Advanced Center for Treatment, Research and Education in Cancer, Tata Memorial Centre	Advanced Center for Treatment, Research and Education in Cancer, Tata Memorial Centre	This work was supported in part by an intramural grant from the Advanced Center for Treatment, Research and Education in Cancer, Tata Memorial Centre (to S. N. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Akahira J, 2004, CLIN CANCER RES, V10, P2687, DOI 10.1158/1078-0432.CCR-03-0510; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Basu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123979; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chandra S, 2013, J CELL SCI, V126, P3782, DOI 10.1242/jcs.124719; Chaudhary N, 2014, MOL CELL BIOL, V34, P3754, DOI 10.1128/MCB.00101-14; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chen Y, 2013, BIOCHEM BIOPH RES CO, V435, P356, DOI 10.1016/j.bbrc.2013.04.086; Dalal SN, 2004, CELL CYCLE, V3, P672; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Ding XM, 2013, J BIOL CHEM, V288, P10241, DOI 10.1074/jbc.M112.443655; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Fan LC, 2015, ONCOGENE, V34, P5252, DOI 10.1038/onc.2014.445; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Hajra KM, 2002, CANCER RES, V62, P1613; He QT, 2013, BBA-GEN SUBJECTS, V1830, P5258, DOI 10.1016/j.bbagen.2013.07.028; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Herron BJ, 2005, NAT GENET, V37, P1210, DOI 10.1038/ng1652; Hosing A.S., 2009, THESIS; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Howe LR, 2003, CANCER RES, V63, P1906; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; JONES DH, 1995, FEBS LETT, V368, P55, DOI 10.1016/0014-5793(95)00598-4; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khapare N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038561; Kundu ST, 2008, INT J CANCER, V123, P2303, DOI 10.1002/ijc.23797; Kusewitt DF, 2009, J INVEST DERMATOL, V129, P491, DOI 10.1038/jid.2008.222; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Lee MY, 2012, AM J TRANSL RES, V4, P1; Phan L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8530; Ling C, 2010, GENE DEV, V24, P947, DOI 10.1101/gad.1896810; Liu TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057968; Lodygin D, 2004, ONCOGENE, V23, P9034, DOI 10.1038/sj.onc.1208004; Lodygin D, 2003, ONCOGENE, V22, P5519, DOI 10.1038/sj.onc.1206854; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Luanpitpong S, 2016, ONCOGENE, V35, P2824, DOI 10.1038/onc.2015.351; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Osada H, 2002, ONCOGENE, V21, P2418, DOI 10.1038/sj.onc.1205303; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; PRASAD GL, 1992, CELL GROWTH DIFFER, V3, P507; Roberts BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077012; Sehgal L, 2014, J CELL SCI, V127, P2174, DOI 10.1242/jcs.125807; Spector D. L., 1998, CELLS LAB MANUAL, V2, P862; Steinacker P, 2005, MOL CELL BIOL, V25, P1339, DOI 10.1128/MCB.25.4.1339-1346.2005; Su CH, 2011, CANCER RES, V71, P884, DOI 10.1158/0008-5472.CAN-10-2518; Su CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-243; Suzuki H, 2000, CANCER RES, V60, P4353; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Tanno B, 2010, J BIOL CHEM, V285, P29434, DOI 10.1074/jbc.M109.089045; Telles E, 2011, CELL CYCLE, V10, P776, DOI 10.4161/cc.10.5.14954; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Urano T, 2004, BIOCHEM BIOPH RES CO, V319, P795, DOI 10.1016/j.bbrc.2004.05.056; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wang L, 2015, J PATHOL, V237, P411, DOI 10.1002/path.4582; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang HL, 2006, MOL CANCER THER, V5, P253, DOI 10.1158/1535-7163.MCT-05-0395; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu J, 2014, HEPATOB PANCREAT DIS, V13, P184, DOI 10.1016/S1499-3872(14)60029-1; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200; Zhang Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-145; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	101	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16068	16081		10.1074/jbc.M116.723767	http://dx.doi.org/10.1074/jbc.M116.723767			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27261462	Green Published, hybrid			2022-12-28	WOS:000380585400013
J	Xu, LH; Venkataramani, P; Ding, YC; Liu, Y; Deng, YY; Yong, GL; Xin, LY; Ye, RJ; Zhang, LH; Yang, L; Liang, ZX				Xu, Linghui; Venkataramani, Prabhadevi; Ding, Yichen; Liu, Yang; Deng, Yinyue; Yong, Grace Lisi; Xin, Lingyi; Ye, Ruijuan; Zhang, Lianhui; Yang, Liang; Liang, Zhao-Xun			A Cyclic di-GMP-binding Adaptor Protein Interacts with Histidine Kinase to Regulate Two-component Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PILZ DOMAIN PROTEINS; MEDIATED MULTISTEP PHOSPHORELAY; PSEUDOMONAS-AERUGINOSA; SWARMING MOTILITY; BIOFILM FORMATION; DIGUANYLATE CYCLASE; XANTHOMONAS-CAMPESTRIS; TWITCHING MOTILITY; GENE-EXPRESSION; HD-GYP	The bacterial messenger cyclic di-GMP (c-di-GMP) binds to a diverse range of effectors to exert its biological effect. Despite the fact that free-standing PilZ proteins are by far the most prevalent c-di-GMP effectors known to date, their physiological function and mechanism of action remain largely unknown. Here we report that the free-standing PilZ protein PA2799 from the opportunistic pathogen Pseudomonas aeruginosa interacts directly with the hybrid histidine kinase SagS. We show that PA2799 (named as HapZ: histidine kinase associated PilZ) binds directly to the phosphoreceiver (REC) domain of SagS, and that the SagS-HapZ interaction is further enhanced at elevated c-di-GMP concentration. We demonstrate that binding of HapZ to SagS inhibits the phosphotransfer between SagS and the downstream protein HptB in a c-di-GMP-dependent manner. In accordance with the role of SagS as a motile-sessile switch and biofilm growth factor, we show that HapZ impacts surface attachment and biofilm formation most likely by regulating the expression of a large number of genes. The observations suggest a previously unknown mechanism whereby c-di-GMP mediates two-component signaling through a PilZ adaptor protein.	[Xu, Linghui; Venkataramani, Prabhadevi; Ding, Yichen; Yong, Grace Lisi; Xin, Lingyi; Ye, Ruijuan; Yang, Liang; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Ding, Yichen; Liu, Yang; Yang, Liang] Nanyang Technol Univ, SCELSE, 60 Nanyang Dr, Singapore 637551, Singapore; [Xu, Linghui; Deng, Yinyue] South China Agr Univ, Guangdong Innovat & Entrepreneurial Res Team Soci, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Lianhui] South China Agr Univ, Integrat Microbiol Res Ctr, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou 510642, Guangdong, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; South China Agricultural University; South China Agricultural University	Yang, L; Liang, ZX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.; Yang, L (corresponding author), Nanyang Technol Univ, SCELSE, 60 Nanyang Dr, Singapore 637551, Singapore.	yangliang@ntu.edu.sg; zxliang@ntu.edu.sg	Yang, Liang/C-8487-2011; Yichen, Ding/R-5036-2019; Liang, Zhao-Xun/A-2191-2011; yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022	Yang, Liang/0000-0002-2362-0128; Venkataramani, Prabhadevi/0000-0001-9106-0102; Liang, Zhao-Xun/0000-0002-3128-1330	NIH [P30 DK089507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Pseudomonas mutant strains were obtained from the mutant library supported by Grant NIH P30 DK089507.	Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; An SQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004429; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Bhuwan M, 2012, J BIOL CHEM, V287, P1903, DOI 10.1074/jbc.M111.256586; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Chambers JR, 2014, MOL MICROBIOL, V92, P471, DOI 10.1111/mmi.12562; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gupta K, 2013, J BACTERIOL, V195, P4975, DOI 10.1128/JB.00732-13; Gupta R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-30; Ha DG, 2011, J BACTERIOL, V193, P6770, DOI 10.1128/JB.05929-11; Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; He M, 2014, INFECT IMMUN, V82, P445, DOI 10.1128/IAI.01238-13; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Ho CL, 2013, J AM CHEM SOC, V135, P566, DOI 10.1021/ja310497x; Hsu JL, 2008, J BIOL CHEM, V283, P9933, DOI 10.1074/jbc.M708836200; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Kong WN, 2013, MOL MICROBIOL, V88, P784, DOI 10.1111/mmi.12223; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Li Z, 2012, J BIOL CHEM, V287, P30191, DOI 10.1074/jbc.M112.378273; Liao JL, 2012, J BACTERIOL, V194, P4823, DOI 10.1128/JB.00765-12; Lin CT, 2006, RES MICROBIOL, V157, P169, DOI 10.1016/j.resmic.2005.06.012; Lori C, 2015, NATURE, V523, P236, DOI 10.1038/nature14473; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pasunooti S, 2010, J MOL CATAL B-ENZYM, V67, P98, DOI 10.1016/j.molcatb.2010.07.012; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Petrova OE, 2011, J BACTERIOL, V193, P6614, DOI 10.1128/JB.00305-11; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Petters T, 2012, MOL MICROBIOL, V84, P147, DOI 10.1111/j.1365-2958.2012.08015.x; Pitzer JE, 2011, INFECT IMMUN, V79, P1815, DOI 10.1128/IAI.00075-11; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Qi YN, 2011, J BIOL CHEM, V286, P2910, DOI 10.1074/jbc.M110.196220; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Rasmussen TB, 2005, J BACTERIOL, V187, P1799, DOI 10.1128/JB.187.5.1799-1814.2005; Russell MH, 2013, MBIO, V4, DOI 10.1128/mBio.00001-13; Ryan RP, 2012, MOL MICROBIOL, V86, P557, DOI 10.1111/mmi.12000; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Tian ZX, 2009, MICROB PATHOGENESIS, V47, P237, DOI 10.1016/j.micpath.2009.08.003; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Tolker-Nielsen T., 2011, CURR PROTOC MICROBIO, V21; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Whitney JC, 2015, J BIOL CHEM, V290, P12451, DOI 10.1074/jbc.M115.645051; Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Yang FH, 2015, APPL ENVIRON MICROB, V81, P4358, DOI 10.1128/AEM.04044-14; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yang L, 2009, ANTIMICROB AGENTS CH, V53, P2432, DOI 10.1128/AAC.01283-08	71	22	22	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16112	16123		10.1074/jbc.M116.730887	http://dx.doi.org/10.1074/jbc.M116.730887			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27231351	Green Published, hybrid			2022-12-28	WOS:000380585400017
J	Girer, NG; Murray, IA; Omiecinski, CJ; Perdew, GH				Girer, Nathaniel G.; Murray, Iain A.; Omiecinski, Curtis J.; Perdew, Gary H.			Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; MESSENGER-RNA; TARGET GENE; ER STRESS; LIVER; MICE; LIGAND; ALPHA; FGF21	The Aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor involved in many physiological processes. Several studies indicate that AHR is also involved in energy homeostasis. Fibroblast growth factor 21 (FGF21) is an important regulator of the fasting and feeding responses. When administered to various genetic and diet-induced mouse models of obesity, FGF21 can attenuate obesity-associated morbidities. Here, we explore the role of AHR in hepatic Fgf21 expression through the use of a conditional, hepatocyte-targeted AHR knock-out mouse model (Cre(Alb)Ahr(Fx/Fx)). Compared with the congenic parental strain (Ahr(Fx/Fx)), non-fasted Cre(Alb)Ahr(Fx/Fx) mice exhibit a 4-fold increase in hepatic Fgf21 expression, as well as elevated expression of the FGF21-target gene Igfbp1. Furthermore, in vivo agonist activation of AHR reduces hepatic Fgf21 expression during a fast. The Fgf21 promoter contains several putative dioxin response elements (DREs). Using EMSA, we demonstrate that the AHR-ARNT heterodimer binds to a specific DRE that overlaps binding sequences for peroxisome proliferator-activated receptor alpha (PPAR alpha), carbohydrate response element-binding protein (ChREBP), and cAMP response element-binding protein, hepatocyte specific (CREBH). In addition, we reveal that agonist-activated AHR impairs PPAR alpha-, ChREBP-, and CREBH-mediated promoter activity in Hepa-1 cells. Accordingly, agonist treatment in Hepa-1 cells ablates potent ER stress-driven Fgf21 expression, and pre-treatment with AHR antagonist blocks this effect. Finally, we show that pre-treatment of primary human hepatocytes with AHR agonist diminishes PPAR alpha-, glucose-, and ER stress-driven induction of FGF21 expression, indicating the effect is not mouse-specific. Together, our data show that AHR contributes to hepatic energy homeostasis, partly through the regulation of FGF21 expression and signaling.	[Girer, Nathaniel G.] Penn State Univ, Grad Program Microbiol & Mol Biol, University Pk, PA 16802 USA; [Murray, Iain A.; Omiecinski, Curtis J.; Perdew, Gary H.] Penn State Univ, Dept Vet & Biomed Sci, 309 Life Sci Bldg, University Pk, PA 16802 USA; [Murray, Iain A.; Omiecinski, Curtis J.; Perdew, Gary H.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Perdew, GH (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 309 Life Sci Bldg, University Pk, PA 16802 USA.	ghp2@psu.edu		Girer, Nathaniel/0000-0003-4327-1786	National Institutes of Health [HHSN276201200017C]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019964, R01ES004869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Denise Coslo for technical assistance with maintaining primary human hepatocyte cultures and Kelly Wagner for assistance with animal husbandry. The Liver Tissue Cell Distribution System at the University of Pittsburgh, Pittsburg, PA, is funded by National Institutes of Health Contract HHSN276201200017C.	Angrish MM, 2012, TOXICOL SCI, V128, P377, DOI 10.1093/toxsci/kfs155; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Cheng XG, 2014, TOXICOL APPL PHARM, V278, P65, DOI 10.1016/j.taap.2014.04.013; Chiaro CR, 2007, MOL PHARMACOL, V72, P1369, DOI 10.1124/mol.107.038968; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; Duan ZQ, 2014, NEUROTOXICOLOGY, V44, P149, DOI 10.1016/j.neuro.2014.06.005; Flaveny CA, 2009, MOL PHARMACOL, V75, P1412, DOI 10.1124/mol.109.054825; Hsu HF, 2010, J HAZARD MATER, V182, P649, DOI 10.1016/j.jhazmat.2010.06.081; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Lu PP, 2015, HEPATOLOGY, V61, P1908, DOI 10.1002/hep.27719; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; Meyer BK, 2000, CELL STRESS CHAPERON, V5, P243, DOI 10.1379/1466-1268(2000)005<0243:AHARLA>2.0.CO;2; Page JL, 2007, TOXICOL SCI, V97, P384, DOI 10.1093/toxsci/kfm034; POLAND A, 1990, MOL PHARMACOL, V38, P306; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Smith KJ, 2011, J PHARMACOL EXP THER, V338, P318, DOI 10.1124/jpet.110.178392; Tanos R, 2012, HEPATOLOGY, V55, P1994, DOI 10.1002/hep.25571; von Holstein-Rathlou S, 2016, CELL METAB, V23, P335, DOI 10.1016/j.cmet.2015.12.003; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	32	30	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15378	15387		10.1074/jbc.M116.715151	http://dx.doi.org/10.1074/jbc.M116.715151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226639	Green Published, hybrid			2022-12-28	WOS:000380583200041
J	Chen, GY; Mickolajczyk, KJ; Hancock, WO				Chen, Geng-Yuan; Mickolajczyk, Keith J.; Hancock, William O.			The Kinesin-5 Chemomechanical Cycle Is Dominated by a Two-heads-bound State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; kinesin; microtubule; mitotic spindle; molecular motor; single-molecule biophysics	STIMULATED ATP HYDROLYSIS; MITOTIC KINESIN; CHROMOSOME CONGRESSION; MOLECULAR MOTORS; DIMERIC EG5; FRONT HEAD; IN-VIVO; PROCESSIVITY; KINETICS; MICROTUBULES	Single-molecule microscopy and stopped-flow kinetics assays were carried out to understand the microtubule polymerase activity of kinesin-5 (Eg5). Four lines of evidence argue that the motor primarily resides in a two-heads-bound (2HB) state. First, upon microtubule binding, dimeric Eg5 releases both bound ADPs. Second, microtubule dissociation in saturating ADP is 20-fold slower for the dimer than for the monomer. Third, ATP-triggered mant-ADP release is 5-fold faster than the stepping rate. Fourth, ATP binding is relatively fast when the motor is locked in a 2HB state. Shortening the neck-linker does not facilitate rear-head detachment, suggesting a minimal role for rear-head-gating. This 2HB state may enable Eg5 to stabilize incoming tubulin at the growing microtubule plus-end. The finding that slowly hydrolyzable ATP analogs trigger slower nucleotide release than ATP suggests that ATP hydrolysis in the bound head precedes stepping by the tethered head, leading to a mechanochemical cycle in which processivity is determined by the race between unbinding of the bound head and attachment of the tethered head.	[Chen, Geng-Yuan; Mickolajczyk, Keith J.; Hancock, William O.] Penn State Univ, Dept Biomed Engn, 205 Hallowell Bldg, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hancock, WO (corresponding author), Penn State Univ, Dept Biomed Engn, 205 Hallowell Bldg, University Pk, PA 16802 USA.	wohbio@engr.psu.edu	; Hancock, William/E-7653-2016	Mickolajczyk, Keith/0000-0001-9445-0325; Hancock, William/0000-0001-5547-8755; Chen, Geng-Yuan/0000-0002-0103-4494	National Institutes of Health [R01 GM076476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076476 (to W. O. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arpag G, 2014, BIOPHYS J, V107, P1896, DOI 10.1016/j.bpj.2014.09.009; Avunie-Masala R, 2011, J CELL SCI, V124, P873, DOI 10.1242/jcs.077396; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Chen GY, 2015, J BIOL CHEM, V290, P10274, DOI 10.1074/jbc.M114.628032; Chen YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9160; Chen Y, 2014, MOL BIOL CELL, V25, P3630, DOI 10.1091/mbc.E14-06-1146; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Fridman V, 2013, J CELL SCI, V126, P4147, DOI 10.1242/jcs.125153; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Gerson-Gurwitz A, 2011, EMBO J, V30, P4942, DOI 10.1038/emboj.2011.403; Goulet A, 2014, P NATL ACAD SCI USA, V111, P1837, DOI 10.1073/pnas.1319848111; Goulet A, 2013, INT REV CEL MOL BIO, V304, P419, DOI 10.1016/B978-0-12-407696-9.00008-7; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; HACKNEY DD, 1989, J BIOL CHEM, V264, P15943; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Jiang W, 1997, J BIOL CHEM, V272, P7626, DOI 10.1074/jbc.272.12.7626; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kaseda K, 2008, EMBO REP, V9, P761, DOI 10.1038/embor.2008.96; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Larson J, 2014, NAT PROTOC, V9, P2317, DOI 10.1038/nprot.2014.155; Lebel P, 2014, NAT METHODS, V11, P456, DOI 10.1038/nmeth.2854; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mccoy KM, 2015, MOL BIOL CELL, V26, P3999, DOI 10.1091/mbc.E14-10-1454; Mickolajczyk KJ, 2015, P NATL ACAD SCI USA, V112, pE7186, DOI 10.1073/pnas.1517638112; Milic B, 2014, P NATL ACAD SCI USA, V111, P14136, DOI 10.1073/pnas.1410943111; Murata JM, 2013, J BIOL CHEM, V288, P34839, DOI 10.1074/jbc.M113.518845; Muretta JM, 2015, P NATL ACAD SCI USA, V112, pE6606, DOI 10.1073/pnas.1512305112; Myers KA, 2007, J CELL BIOL, V178, P1081, DOI 10.1083/jcb.200702074; Nadar VC, 2008, CURR BIOL, V18, P1972, DOI 10.1016/j.cub.2008.11.021; Roostalu J, 2011, SCIENCE, V332, P94, DOI 10.1126/science.1199945; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Scholey JE, 2014, ELIFE, V3, DOI 10.7554/eLife.02217; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Shimamoto Y, 2015, DEV CELL, V34, P669, DOI 10.1016/j.devcel.2015.08.017; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Talapatra SK, 2012, ACTA CRYSTALLOGR D, V68, P1311, DOI 10.1107/S0907444912027965; Valentine MT, 2009, BIOPHYS J, V97, P1671, DOI 10.1016/j.bpj.2009.07.013; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Verbrugge S, 2009, BIOPHYS J, V97, P2287, DOI 10.1016/j.bpj.2009.08.001	58	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20283	20294		10.1074/jbc.M116.730697	http://dx.doi.org/10.1074/jbc.M116.730697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27402829	Green Published, hybrid			2022-12-28	WOS:000384574800001
J	Johnson, PM; Gucinski, GC; Garza-Sanchez, F; Wong, T; Hung, LW; Hayes, CS; Goulding, CW				Johnson, Parker M.; Gucinski, Grant C.; Garza-Sanchez, Fernando; Wong, Timothy; Hung, Li-Wei; Hayes, Christopher S.; Goulding, Celia W.			Functional Diversity of Cytotoxic tRNase/Immunity Protein Complexes from Burkholderia pseudomallei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; protein complex; ribonuclease; small-angle x-ray scattering (SAXS); toxin; Burkholderia pseudomallei; toxin; immunity complexes; tRNase	DEPENDENT GROWTH-INHIBITION; TOXIN DELIVERY-SYSTEMS; HOJA-BLANCA-TENUIVIRUS; ANGLE SCATTERING DATA; TRANSFER-RNA; FILAMENTOUS HEMAGGLUTININ; RESTRICTION ENDONUCLEASES; BORDETELLA-PERTUSSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	Contact-dependent growth inhibition (CDI) is a widespread mechanism of inter-bacterial competition. CDI+ bacteria deploy large CdiA effector proteins, which carry variable C-terminal toxin domains (CdiA-CT). CDI+ cells also produce CdiI immunity proteins that specifically neutralize cognate CdiA-CT toxins to prevent auto-inhibition. Here, we present the crystal structure of the CdiA-CT/CdiI(E479) toxin/immunity protein complex from Burkholderia pseudomallei isolate E479. The CdiA-CTE479 tRNase domain contains a core /-fold that is characteristic of PD(D/E)XK superfamily nucleases. Unexpectedly, the closest structural homolog of CdiA-CTE479 is another CDI toxin domain from B. pseudomallei 1026b. Although unrelated in sequence, the two B. pseudomallei nuclease domains share similar folds and active-site architectures. By contrast, the CdiI(E479) and CdiI(1026b) immunity proteins share no significant sequence or structural homology. CdiA-CTE479 and CdiA-CT1026b are both tRNases; however, each nuclease cleaves tRNA at a distinct position. We used a molecular docking approach to model each toxin bound to tRNA substrate. The resulting models fit into electron density envelopes generated by small-angle x-ray scattering analysis of catalytically inactive toxin domains bound stably to tRNA. CdiA-CTE479 is the third CDI toxin found to have structural homology to the PD(D/E)XK superfamily. We propose that CDI systems exploit the inherent sequence variability and active-site plasticity of PD(D/E)XK nucleases to generate toxin diversity. These findings raise the possibility that many other uncharacterized CDI toxins may belong to the PD(D/E)XK superfamily.	[Johnson, Parker M.; Wong, Timothy; Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Goulding, Celia W.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Gucinski, Grant C.; Hayes, Christopher S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Garza-Sanchez, Fernando; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hung, Li-Wei] Los Alamos Natl Lab, Div Phys, Los Alamos, NM 87545 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Los Alamos National Laboratory	Goulding, CW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.; Goulding, CW (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA.; Hayes, CS (corresponding author), Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.; Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu; celia.goulding@uci.edu		Hung, Li-Wei/0000-0001-6690-8458	Department of Energy, Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, U01GM102318] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Synchrotron Radiation Lightsource for their invaluable help in data collection. We thank the beam line staff members at the beam lines 12.3.1 (BL12.3.1) at the Advanced Light Source for their help in SAXS data collection. The Advanced Light Source is operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies program, supported by Department of Energy, Office of Biological and Environmental Research.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Aoki SK, 2011, VIRULENCE, V2, P356, DOI 10.4161/viru.2.4.16463; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Beck CM, 2014, STRUCTURE, V22, P707, DOI 10.1016/j.str.2014.02.012; BECKWITH JR, 1966, J MOL BIOL, V19, P254, DOI 10.1016/S0022-2836(66)80003-7; Bujnicki JM, 2001, PROTEIN SCI, V10, P656, DOI 10.1110/ps.37101; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Chantratita N, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000182; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Feder M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-21; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Gupta R, 2012, APPL MICROBIOL BIOT, V94, P583, DOI 10.1007/s00253-012-3961-z; Hashimoto H, 2005, J BIOL CHEM, V280, P5605, DOI 10.1074/jbc.M411684200; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Kachalova GS, 2008, J MOL BIOL, V384, P489, DOI 10.1016/j.jmb.2008.09.033; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; Knizewski L, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-40; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kosinski J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-172; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; MAKHOV AM, 1994, J MOL BIOL, V241, P110, DOI 10.1006/jmbi.1994.1478; MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0; Morse RP, 2015, J MOL BIOL, V427, P3766, DOI 10.1016/j.jmb.2015.09.020; Morse RP, 2012, P NATL ACAD SCI USA, V109, P21480, DOI 10.1073/pnas.1216238110; Ngamdee W, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0395-7; Nikolakakis K, 2012, MOL MICROBIOL, V84, P516, DOI 10.1111/j.1365-2958.2012.08039.x; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Ogawa T, 1999, SCIENCE, V283, P2097, DOI 10.1126/science.283.5410.2097; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Ritchie DW, 2003, PROTEINS, V52, P98, DOI 10.1002/prot.10379; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Ruhe ZC, 2015, MOL MICROBIOL, V98, P175, DOI 10.1111/mmi.13114; Ruhe ZC, 2013, MBIO, V4, DOI 10.1128/mBio.00480-13; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Stovgaard K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-429; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Webb JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057609; Willett JLE, 2015, J MOL BIOL, V427, P3754, DOI 10.1016/j.jmb.2015.09.010; Willett JLE, 2015, P NATL ACAD SCI USA, V112, P11341, DOI 10.1073/pnas.1512124112; Yang X, 2011, RNA, V17, P903, DOI 10.1261/rna.2552811; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036	61	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19387	19400		10.1074/jbc.M116.736074	http://dx.doi.org/10.1074/jbc.M116.736074			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27445337	hybrid, Green Published			2022-12-28	WOS:000383242800018
J	Walseng, E; Nelson, CG; Qi, JP; Nanna, AR; Roush, WR; Goswami, RK; Sinha, SC; Burke, TR; Rader, C				Walseng, Even; Nelson, Christopher G.; Qi, Junpeng; Nanna, Alex R.; Roush, William R.; Goswami, Rajib K.; Sinha, Subhash. C.; Burke, Terrence R., Jr.; Rader, Christoph			Chemically Programmed Bispecific Antibodies in Diabody Format	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; cancer therapy; chemical modification; folate; immunotherapy; ovarian cancer; T-cell	CELL-ENGAGING ANTIBODY; T-CELLS; FOLATE-RECEPTOR; TUMOR-CELLS; ADAPTER IMMUNOTHERAPY; OVARIAN-CARCINOMA; MONOCLONAL-ANTIBODY; CANCER-THERAPY; SOLID TUMORS; PHASE-I	Chemically programmed bispecific antibodies (biAbs) endow target cell-binding small molecules with the ability to recruit and activate effector cells of the immune system. Here we report a platform of chemically programmed biAbs aimed at redirecting cytotoxic T cells to eliminate cancer cells. Two different antibody technologies were merged together to make a novel chemically programmed biAb. This was achieved by combining the humanized anti-hapten monoclonal antibody (mAb) h38C2 with the humanized anti-human CD3 mAb v9 in a clinically investigated diabody format known as Dual-Affinity Re-Targeting (DART). We show that h38C2 x v9 DARTs can readily be equipped with tumor-targeting hapten-derivatized small molecules without causing a systemic response harming healthy tissues. As a proof of concept, we chemically programmed h38C2 x v9 with hapten-folate and demonstrated its selectivity and potency against folate receptor 1 (FOLR1)-expressing ovarian cancer cells in vitro and in vivo. Unlike conventional biAbs, chemically programmed biAbs in DART format are highly modular with broad utility in terms of both target and effector cell engagement. Most importantly, they provide tumor-targeting compounds access to the power of cancer immunotherapy.	[Walseng, Even; Qi, Junpeng; Nanna, Alex R.; Rader, Christoph] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Nanna, Alex R.; Roush, William R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Rader, Christoph] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Goswami, Rajib K.; Sinha, Subhash. C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Nelson, Christopher G.; Burke, Terrence R., Jr.] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Walseng, Even] NCI, NIH, Bethesda, MD 20892 USA; [Nelson, Christopher G.] Bristol Myers Squibb Co, New York, NY 10154 USA; [Goswami, Rajib K.] Indian Assoc Cultivat Sci, Kolkata, India; [Sinha, Subhash. C.] Rockefeller Univ, New York, NY USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Bristol-Myers Squibb; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; Rockefeller University	Rader, C (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.; Rader, C (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	crader@scripps.edu	Qi, Junpeng/AAH-5525-2020; Qi, Junpeng/G-6949-2019	Burke, Terrence/0000-0001-9925-8586; Rader, Christoph/0000-0001-9955-3454	National Institutes of Health [R01 CA181258]; Intramural Research Program, Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA181258, U01CA174844, ZIABC006198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program, Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA181258 (to C. R.) and the Intramural Research Program, Center for Cancer Research, NCI, National Institutes of Health (to T. R. B., Jr.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almasbak H, 2011, CYTOTHERAPY, V13, P629, DOI 10.3109/14653249.2010.542461; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Bacac M, 2016, CLIN CANCER RES, V22, P3286, DOI 10.1158/1078-0432.CCR-15-1696; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; BEVERLEY PCL, 1981, EUR J IMMUNOL, V11, P329, DOI 10.1002/eji.1830110412; Chichili GR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5693; CLAASEN HHV, 1993, INT J CANCER, V55, P128, DOI 10.1002/ijc.2910550123; Cui HT, 2012, J BIOL CHEM, V287, P28206, DOI 10.1074/jbc.M112.384594; De Cesare M, 2008, CLIN CANCER RES, V14, P5512, DOI 10.1158/1078-0432.CCR-08-0445; Doppalapudi VR, 2010, P NATL ACAD SCI USA, V107, P22611, DOI 10.1073/pnas.1016478108; Ebel W., 2007, CANC IMMUN, V7, P6; Frankel SR, 2013, CURR OPIN CHEM BIOL, V17, P385, DOI 10.1016/j.cbpa.2013.03.029; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; Huang HH, 2011, CLIN CANCER RES, V17, P1001, DOI 10.1158/1078-0432.CCR-10-2317; Johnson S, 2010, J MOL BIOL, V399, P436, DOI 10.1016/j.jmb.2010.04.001; Kamen BA, 2012, CANCER CHEMOTH PHARM, V70, P113, DOI 10.1007/s00280-012-1890-2; Kim CH, 2013, P NATL ACAD SCI USA, V110, P17796, DOI 10.1073/pnas.1316026110; Konner JA, 2010, CLIN CANCER RES, V16, P5288, DOI 10.1158/1078-0432.CCR-10-0700; Kontermann RE, 2015, DRUG DISCOV TODAY, V20, P838, DOI 10.1016/j.drudis.2015.02.008; KRANZ DM, 1995, P NATL ACAD SCI USA, V92, P9057, DOI 10.1073/pnas.92.20.9057; Kranz DR, 1998, J CONTROL RELEASE, V53, P77, DOI 10.1016/S0168-3659(97)00239-3; Kularatne SA, 2013, ANGEW CHEM INT EDIT, V52, P12101, DOI 10.1002/anie.201306866; Li LS, 2004, J MED CHEM, V47, P5630, DOI 10.1021/jm049666k; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; List B, 1998, P NATL ACAD SCI USA, V95, P15351, DOI 10.1073/pnas.95.26.15351; Liu Y, 2015, AFR J TRADIT COMPLEM, V12, P12, DOI 10.4314/ajtcam.v12i2.3; LoRusso PM, 2012, J CLIN ONCOL, V30, P4011, DOI 10.1200/JCO.2011.41.4946; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; Moore PA, 2011, BLOOD, V117, P4542, DOI 10.1182/blood-2010-09-306449; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; PEREZ P, 1985, NATURE, V316, P354, DOI 10.1038/316354a0; Popkov M, 2006, INT J CANCER, V119, P1194, DOI 10.1002/ijc.21924; Przepiorka D, 2015, CLIN CANCER RES, V21, P4035, DOI 10.1158/1078-0432.CCR-15-0612; Rader C, 2003, J MOL BIOL, V332, P889, DOI 10.1016/S0022-2836(03)00992-6; Rader C, 2003, P NATL ACAD SCI USA, V100, P5396, DOI 10.1073/pnas.0931308100; Rader C, 2014, TRENDS BIOTECHNOL, V32, P186, DOI 10.1016/j.tibtech.2014.02.003; Rader C, 2011, BLOOD, V117, P4403, DOI 10.1182/blood-2011-02-337691; RODRIGUES ML, 1992, INT J CANCER, P45; Roy EJ, 2004, ADV DRUG DELIVER REV, V56, P1219, DOI 10.1016/j.addr.2004.01.006; Schreiner J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1062969; Sinha SC, 2007, NAT PROTOC, V2, P449, DOI 10.1038/nprot.2007.3; Smith EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17943; Sommariva M, 2011, CANCER RES, V71, P6382, DOI 10.1158/0008-5472.CAN-11-1285; Spannuth WA, 2010, EXPERT OPIN BIOL TH, V10, P431, DOI 10.1517/14712591003592069; Teng LS, 2012, EXPERT OPIN DRUG DEL, V9, P901, DOI 10.1517/17425247.2012.694863; Thompson S, 2009, MABS-AUSTIN, V1, P348, DOI 10.4161/mabs.1.4.9045; Tibben JG, 1996, INT J CANCER, V66, P477; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Vergote IB, 2015, CANCER METAST REV, V34, P41, DOI 10.1007/s10555-014-9539-8; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; Wuellner U, 2010, ANGEW CHEM INT EDIT, V49, P5934, DOI 10.1002/anie.201001736; Xia W, 2010, J MED CHEM, V53, P6811, DOI 10.1021/jm100509v; Zhu M, 2016, CLIN PHARMACOKINET; Zhu XY, 2009, J AM CHEM SOC, V131, P18206, DOI 10.1021/ja907271a; ZHU ZP, 1995, INT J CANCER, V62, P319, DOI 10.1002/ijc.2910620315; Zhukovsky EA, 2016, CURR OPIN IMMUNOL, V40, P24, DOI 10.1016/j.coi.2016.02.006	58	26	28	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19661	19673		10.1074/jbc.M116.745588	http://dx.doi.org/10.1074/jbc.M116.745588			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27445334	hybrid, Green Published			2022-12-28	WOS:000383242800039
J	Ahmad, S; Ytterberg, AJ; Thulasingam, M; Tholander, F; Bergman, T; Zubarev, R; Wetterholm, A; Rinaldo-Matthis, A; Haeggstrom, JZ				Ahmad, Shabbir; Ytterberg, A. Jimmy; Thulasingam, Madhuranayaki; Tholander, Fredrik; Bergman, Tomas; Zubarev, Roman; Wetterholm, Anders; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.			Phosphorylation of Leukotriene C-4 Synthase at Serine 36 Impairs Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug development; eicosanoid specific enzyme; leukotriene; membrane enzyme; phosphoproteomics; MAPEG; cysteinyl leukotrienes; leukotriene C4 synthase; p70S6k; phosphoregulation	MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEIN; RECEPTOR; PARAMETERIZATION; GLUTATHIONE; PREDICTION; MEDIATORS; SITES	Leukotriene C-4 synthase (LTC4S) catalyzes the formation of the proinflammatory lipid mediator leukotriene C-4 (LTC4). LTC4 is the parent molecule of the cysteinyl leukotrienes, which are recognized for their pathogenic role in asthma and allergic diseases. Cellular LTC4S activity is suppressed by PKC-mediated phosphorylation, and recently a downstream p70S6k was shown to play an important role in this process. Here, we identified Ser(36) as the major p70S6k phosphorylation site, along with a low frequency site at Thr(40), using an in vitro phosphorylation assay combined with mass spectrometry. The functional consequences of p70S6k phosphorylation were tested with the phosphomimetic mutant S36E, which displayed only about 20% (20 mol/min/mg) of the activity of WT enzyme (95 mol/min/mg), whereas the enzyme activity of T40E was not significantly affected. The enzyme activity of S36E increased linearly with increasing LTA(4) concentrations during the steady-state kinetics analysis, indicating poor lipid substrate binding. The Ser(36) is located in a loop region close to the entrance of the proposed substrate binding pocket. Comparative molecular dynamics indicated that Ser(36) upon phosphorylation will pull the first luminal loop of LTC4S toward the neighboring subunit of the functional homotrimer, thereby forming hydrogen bonds with Arg(104) in the adjacent subunit. Because Arg(104) is a key catalytic residue responsible for stabilization of the glutathione thiolate anion, this phosphorylation-induced interaction leads to a reduction of the catalytic activity. In addition, the positional shift of the loop and its interaction with the neighboring subunit affect active site access. Thus, our mutational and kinetic data, together with molecular simulations, suggest that phosphorylation of Ser(36) inhibits the catalytic function of LTC4S by interference with the catalytic machinery.	[Ahmad, Shabbir; Thulasingam, Madhuranayaki; Wetterholm, Anders; Rinaldo-Matthis, Agnes; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, SE-17177 Stockholm, Sweden; [Ytterberg, A. Jimmy; Bergman, Tomas; Zubarev, Roman] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 1, SE-17177 Stockholm, Sweden; [Tholander, Fredrik] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden; [Ytterberg, A. Jimmy] Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Haeggstrom, JZ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, SE-17177 Stockholm, Sweden.	jesper.haeggstrom@ki.se	Zubarev, Roman A/W-7891-2018	Zubarev, Roman A/0000-0001-9839-2089; Ahmad, Shabbir/0000-0003-2374-1197	Swedish Research Council [10350, 2301153]; Stockholm County Council; NovoNordisk Foundation [NNF15CC0018346]; Karolinska Institutet; Novo Nordisk Fonden [NNF15SA0018346] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); NovoNordisk Foundation(Novo Nordisk Foundation); Karolinska Institutet(Karolinska Institutet); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by Swedish Research Council Grants 10350 and 2301153, Stockholm County Council (Cardiovascular Program), and NovoNordisk Foundation Grant NNF15CC0018346. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a distinguished professor award from Karolinska Institutet. To whom correspondence should be addressed. Tel.: 46-8-524-87612 or 46-8-524-87648; Fax: 46-8-736-0439; E-mail: jesper.haeggstrom@ki.se.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; ALI A, 1994, J IMMUNOL, V153, P776; Austen KF, 2008, NAT IMMUNOL, V9, P113, DOI 10.1038/ni0208-113; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Esser J, 2011, FASEB J, V25, P1417, DOI 10.1096/fj.10-175828; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fleckenstein DS, 2003, LEUKEMIA RES, V27, P687, DOI 10.1016/S0145-2126(02)00325-9; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gupta N, 1999, FEBS LETT, V449, P66, DOI 10.1016/S0014-5793(99)00397-X; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; Kleinschmidt TK, 2015, J PHARMACOL EXP THER, V355, P108, DOI 10.1124/jpet.115.227157; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Lam BK, 2003, PROSTAG LEUKOTR ESS, V69, P111, DOI 10.1016/S0952-3278(03)00071-1; Lepley RA, 1996, J BIOL CHEM, V271, P6179, DOI 10.1074/jbc.271.11.6179; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyutvinskiy Y, 2013, MOL CELL PROTEOMICS, V12, P2324, DOI 10.1074/mcp.O112.023804; Maekawa A, 2009, P NATL ACAD SCI USA, V106, P11685, DOI 10.1073/pnas.0905364106; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Marionneau C, 2015, J MOL CELL CARDIOL, V82, P36, DOI 10.1016/j.yjmcc.2015.02.013; McSorley T, 2008, FEBS LETT, V582, P720, DOI 10.1016/j.febslet.2008.01.048; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Niegowski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096763; Niegowski D, 2014, J BIOL CHEM, V289, P5199, DOI 10.1074/jbc.M113.534628; Rinaldo-Matthis A, 2012, BIOCHEMISTRY-US, V51, P848, DOI 10.1021/bi201402s; Rinaldo-Matthis A, 2010, J BIOL CHEM, V285, P40771, DOI 10.1074/jbc.M110.105940; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Sjogren T, 2013, P NATL ACAD SCI USA, V110, P3806, DOI 10.1073/pnas.1218504110; Smith KP, 2015, PROTEINS, V83, P25, DOI 10.1002/prot.24605; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WETTERHOLM A, 1991, BIOCHIM BIOPHYS ACTA, V1080, P96, DOI 10.1016/0167-4838(91)90134-L; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083	45	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18410	18418		10.1074/jbc.M116.735647	http://dx.doi.org/10.1074/jbc.M116.735647			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27365393	Green Published, hybrid			2022-12-28	WOS:000383241800031
J	Baumann, S; Hennet, T				Baumann, Stephan; Hennet, Thierry			Collagen Accumulation in Osteosarcoma Cells lacking GLT25D1 Collagen Galactosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; CRISPR; Cas; endoplasmic reticulum (ER); glycosylation; osteosarcoma; protein trafficking (Golgi)	LYSYL HYDROXYLASE 3; GLYCOSYLATION; MUTATIONS; IDENTIFICATION; DEFICIENCY; SECRETION; GLUCOSYLTRANSFERASE; ENZYMES; GENES; CHAIN	Collagen is post-translationally modified by prolyl and lysyl hydroxylation and subsequently by glycosylation of hydroxylysine. Despite the widespread occurrence of the glycan structure Glc(1-2)Gal linked to hydroxylysine in animals, the functional significance of collagen glycosylation remains elusive. To address the role of glycosylation in collagen expression, folding, and secretion, we used the CRISPR/Cas9 system to inactivate the collagen galactosyltransferase GLT25D1 and GLT25D2 genes in osteosarcoma cells. Loss of GLT25D1 led to increased expression and intracellular accumulation of collagen type I, whereas loss of GLT25D2 had no effect on collagen secretion. Inactivation of the GLT25D1 gene resulted in a compensatory induction of GLT25D2 expression. Loss of GLT25D1 decreased collagen glycosylation by up to 60% but did not alter collagen folding and thermal stability. Whereas cells harboring individually inactivated GLT25D1 and GLT25D2 genes could be recovered and maintained in culture, cell clones with simultaneously inactive GLT25D1 and GLT25D2 genes could be not grown and studied, suggesting that a complete loss of collagen glycosylation impairs osteosarcoma cell proliferation and viability.	[Baumann, Stephan; Hennet, Thierry] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland	University of Zurich	Hennet, T (corresponding author), Univ Zurich, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	thierry.hennet@uzh.ch		Hennet, Thierry/0000-0002-7276-737X	Research Credit of the University of Zurich; Swiss National Foundation [310030_149949]	Research Credit of the University of Zurich; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Research Credit of the University of Zurich (to S. B.) and by Swiss National Foundation Grant 310030_149949 (to T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bank RA, 1996, ANAL BIOCHEM, V240, P167, DOI 10.1006/abio.1996.0346; Brinckmann J, 1998, ARCH DERMATOL RES, V290, P181, DOI 10.1007/s004030050287; Burger W., 2008, DIGITAL IMAGE PROCES, P469; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; COLLEY KJ, 1987, J BIOL CHEM, V262, P10290; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Gardner H, 1999, J CELL SCI, V112, P263; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607; HARWOOD R, 1975, BIOCHEM J, V152, P291, DOI 10.1042/bj1520291; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Heise CT, 2000, J IMMUNOL, V165, P1403, DOI 10.4049/jimmunol.165.3.1403; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; JUNQUA S, 1974, CONNECT TISSUE RES, V2, P193, DOI 10.3109/03008207409152244; Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200; Liefhebber JMP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-33; Malhotra V, 2011, EMBO J, V30, P3475, DOI 10.1038/emboj.2011.255; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; MCQUILLAN DJ, 1995, BONE, V16, P415; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443; Pautke C, 2004, ANTICANCER RES, V24, P3743; Peake PW, 2007, J MOL ENDOCRINOL, V39, P45, DOI 10.1677/JME-07-0030; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rauch F, 2015, AM J HUM GENET, V96, P425, DOI 10.1016/j.ajhg.2014.12.027; Rossert J, 2000, NEPHROL DIAL TRANSPL, V15, P66, DOI 10.1093/ndt/15.suppl_6.66; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; ROWE DW, 1985, J CLIN INVEST, V76, P604, DOI 10.1172/JCI112012; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; SHINKAI H, 1979, BIOCHEM J, V177, P847, DOI 10.1042/bj1770847; SPIRO RG, 1967, J BIOL CHEM, V242, P4813; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Stawikowski MJ, 2014, J BIOL CHEM, V289, P21591, DOI 10.1074/jbc.M114.572073; Terajima M, 2014, J BIOL CHEM, V289, P22636, DOI 10.1074/jbc.M113.528513; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van Dijk FS, 2011, MOL SYNDROMOL, V2, P1, DOI 10.1159/000332228; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshikawa K, 2001, J BIOCHEM-TOKYO, V129, P929, DOI 10.1093/oxfordjournals.jbchem.a002939	51	37	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18514	18524		10.1074/jbc.M116.723379	http://dx.doi.org/10.1074/jbc.M116.723379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402836	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000383241800041
J	Pan, X; Cang, XH; Dan, SS; Li, JC; Cheng, J; Kang, B; Duan, XT; Shen, BH; Wang, YJ				Pan, Xiao; Cang, Xiaohui; Dan, Songsong; Li, Jingchao; Cheng, Jie; Kang, Bo; Duan, Xiaotao; Shen, Binghui; Wang, Ying-Jie			Site-specific Disruption of the Oct4/Sox2 Protein Interaction Reveals Coordinated Mesendodermal Differentiation and the Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; differentiation; epithelial-mesenchymal transition (EMT); pluripotency; post-translational modification (PTM); stem cells; transcription factor; tumor cell biology	EMBRYONIC STEM-CELLS; SIGNALING PATHWAYS; SELF-RENEWAL; CANCER-CELLS; OCT4; PROMOTES; SOX2; TRANSCRIPTION; PLURIPOTENCY; ENDODERM	Although the Oct4/Sox2 complex is crucial for maintaining the pluripotency of stem cells, the molecular basis underlying its regulation during lineage-specific differentiation remains unknown. Here, we revealed that the highly conserved Oct4/Lys-156 is important for maintaining the stability of the Oct4 protein and the intermolecular salt bridge between Oct4/Lys-151 and Sox2/Asp-107 that contributes to the Oct4/Sox2 interaction. Post-translational modifications at Lys-156 and K156N, a somatic mutation detected in bladder cancer patients, both impaired the Lys-151-Asp-107 salt bridge and the Oct4/Sox2 interaction. When produced as a recombinant protein or overexpressed in pluripotent stem cells, Oct4/K156N, with reduced binding to Sox2, significantly down-regulated the stemness genes that are cooperatively controlled by the Oct4/Sox2 complex and specifically up-regulated the mesendodermal genes and the SNAIL family genes that promote the epithelial-mesenchymal transition. Thus, we conclude that Oct4/Lys-156-modulated Oct4/Sox2 interaction coordinately controls the epithelial-mesenchymal transition and mesendoderm specification induced by specific differentiation signals.	[Pan, Xiao; Cang, Xiaohui; Li, Jingchao; Cheng, Jie] Zhejiang Univ, Coll Life Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Dan, Songsong; Cheng, Jie; Kang, Bo; Wang, Ying-Jie] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Affiliated Hosp 1, 79 QingChun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Duan, Xiaotao] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing 100850, Peoples R China; [Shen, Binghui] City Hope Natl Med Ctr, Dept Radiat Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Shen, Binghui] Beckman Res Inst, Duarte, CA 91010 USA	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Academy of Military Medical Sciences - China; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Wang, YJ (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Affiliated Hosp 1, 79 QingChun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	yingjiewang@zju.edu.cn		Duan, Xiaotao/0000-0001-9962-1234; Shen, Binghui/0000-0002-4408-407X; Kang, Bo/0000-0001-7864-252X	National Natural Science Foundation of China [31271465]; First Affiliated Hospital, School of Medicine, Zhejiang University [b2697]; Fundamental Research Funds for the Central Universities [2014QNA6004]; Scientific Research Fund of Zhejiang Provincial Education Department Grant [Y201432207]; NATIONAL CANCER INSTITUTE [R01CA085344] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); First Affiliated Hospital, School of Medicine, Zhejiang University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Fund of Zhejiang Provincial Education Department Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Natural Science Foundation of China Grant 31271465 (to Y.-J. W.), First Affiliated Hospital, School of Medicine, Zhejiang University Intramural Grant b2697 (to Y.-J. W.), Fundamental Research Funds for the Central Universities Grant 2014QNA6004 (to X. C.), and Scientific Research Fund of Zhejiang Provincial Education Department Grant Y201432207 (to X. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aksoy I, 2013, EMBO J, V32, P938, DOI 10.1038/emboj.2013.31; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050432; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8209; Dan SS, 2015, BIOCHEM BIOPH RES CO, V456, P714, DOI 10.1016/j.bbrc.2014.12.043; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Heisenberg CP, 2008, CURR OPIN GENET DEV, V18, P311, DOI 10.1016/j.gde.2008.07.011; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Iovino N, 2011, CELL, V145, P815, DOI 10.1016/j.cell.2011.05.027; Izarzugaza JMG, 2009, PROTEINS, V77, P892, DOI 10.1002/prot.22512; Jerabek S, 2014, BBA-GENE REGUL MECH, V1839, P138, DOI 10.1016/j.bbagrm.2013.10.001; Jin WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20818; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lam CS, 2012, BIOCHEM J, V448, P21, DOI 10.1042/BJ20120725; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu QM, 2013, MOL CELL PROTEOMICS, V12, P473, DOI 10.1074/mcp.M112.022319; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Merino F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004287; Merino F, 2014, STRUCTURE, V22, P1274, DOI 10.1016/j.str.2014.06.014; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Richter A, 2014, STEM CELLS, V32, P636, DOI 10.1002/stem.1592; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Shu XD, 2014, CURR OPIN GENET DEV, V28, P32, DOI 10.1016/j.gde.2014.08.005; Slawny N, 2013, STEM CELLS DEV, V22, P1177, DOI 10.1089/scd.2012.0050; Sui L, 2013, INT J DEV BIOL, V57, P1, DOI [10.1387/ijdb.1201151s, 10.1387/ijdb.120115ls]; Sun C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0503-1; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; You JS, 2009, CANCER RES, V69, P5716, DOI 10.1158/0008-5472.CAN-08-4953; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	45	19	21	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18353	18369		10.1074/jbc.M116.745414	http://dx.doi.org/10.1074/jbc.M116.745414			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27369080	Green Published, hybrid			2022-12-28	WOS:000383241800027
J	Wang, JB; Galvao, J; Beach, KM; Luo, WJ; Urrutia, RA; Goldberg, JL; Otteson, DC				Wang, Jianbo; Galvao, Joana; Beach, Krista M.; Luo, Weijia; Urrutia, Raul A.; Goldberg, Jeffrey L.; Otteson, Deborah C.			Novel Roles and Mechanism for Kruppel-like Factor 16 (KLF16) Regulation of Neurite Outgrowth and Ephrin Receptor A5 (EphA5) Expression in Retinal Ganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChIP); DNA methylation; gene regulation; Kruppel-like factor (KLF); mouse; neurite outgrowth; neurodevelopment; promoter; protein expression; retina	FINGER TRANSCRIPTION FACTOR; MOUSE RETINA; FUNCTIONAL-ANALYSIS; GROWTH CONES; OPTIC-NERVE; CYCLIC-AMP; AXON REGENERATION; ADENOVIRUS TYPE-5; TYROSINE KINASES; GENE-EXPRESSION	Regenerative medicine holds great promise for the treatment of degenerative retinal disorders. Kruppel-like factors (KLFs) are transcription factors that have recently emerged as key tools in regenerative medicine because some of them can function as epigenetic reprogrammers in stem cell biology. Here, we show that KLF16, one of the least understood members of this family, is a POU4F2 independent transcription factor in retinal ganglion cells (RGCs) as early as embryonic day 15. When overexpressed, KLF16 inhibits RGC neurite outgrowth and enhances RGC growth cone collapse in response to exogenous ephrinA5 ligands. Ephrin/EPH signaling regulates RGC connectivity. The EphA5 promoter contains multiple GC- and GT-rich KLF-binding sites, which, as shown by ChIP-assays, bind KLF16 in vivo. In electrophoretic mobility shift assays, KLF16 binds specifically to a single KLF site near the EphA5 transcription start site that is required for KLF16 transactivation. Interestingly, methylation of only six of 98 CpG dinucleotides within the EphA5 promoter blocks its transactivation by KLF16 but enables transactivation by KLF2 and KLF15. These data demonstrate a role for KLF16 in regulation of RGC neurite outgrowth and as a methylation-sensitive transcriptional regulator of EphA5 expression. Together, these data identify differential low level methylation as a novel mechanism for regulating KLF16-mediated EphA5 expression across the retina. Because of the critical role of ephrin/EPH signaling in patterning RGC connectivity, understanding the role of KLFs in regulating neurite outgrowth and Eph receptor expression will be vital for successful restoration of functional vision through optic nerve regenerative therapies.	[Wang, Jianbo; Beach, Krista M.; Otteson, Deborah C.] Univ Houston, Dept Physiol Opt & Vis Sci, Houston, TX 77204 USA; [Luo, Weijia; Otteson, Deborah C.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Galvao, Joana; Goldberg, Jeffrey L.] Stanford Univ, Sch Med, Byers Eye Inst, Palo Alto, CA 94303 USA; [Galvao, Joana; Goldberg, Jeffrey L.] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA; [Urrutia, Raul A.] Mayo Clin, Lab Epigenet & Chromatin Dynam, Gastroenterol Res Unit, Dept Med,Epigen Translat Program,Ctr Individualiz, Rochester, MN 55905 USA; [Urrutia, Raul A.] Mayo Clin, Lab Epigenet & Chromatin Dynam, Ctr Individualized Med, Dept Biochem,Gastroenterol Res Unit,Epigen Transl, Rochester, MN 55905 USA; [Urrutia, Raul A.] Mayo Clin, Lab Epigenet & Chromatin Dynam, Ctr Individualized Med, Dept Mol Biol,Gastroenterol Res Unit,Epigen Trans, Rochester, MN 55905 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Stanford University; University of California System; University of California San Diego; Mayo Clinic; Mayo Clinic; Mayo Clinic	Otteson, DC (corresponding author), Univ Houston, Coll Optometry, JD Armistead Bldg,Rm 2195,4901 Calhoun Rd, Houston, TX 77204 USA.	dotteson@central.uh.edu	Wang, Jianbo/D-9991-2011; Wang, Jianbo/AAQ-3235-2020	Wang, Jianbo/0000-0002-3315-3105; Wang, Jianbo/0000-0002-3315-3105; Luo, Weijia/0000-0002-4261-5084; Otteson, Deborah/0000-0001-6093-6837; Goldberg, Jeffrey/0000-0002-1390-7360	Cancer Center Support Grant (National Institutes of Health NCI) [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA102701] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020913, P30EY022589, P30EY007551, R01EY021792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, P30DK084567] Funding Source: NIH RePORTER	Cancer Center Support Grant (National Institutes of Health NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	STR DNA fingerprinting was done by the Cancer Center Support Grant-funded Characterized Cell Line Core (National Institutes of Health NCI Grant P30 CA016672). We thank Dr. William Klein (M. D. Anderson Cancer Center, Houston TX) for the Pou4f2 knock-out mice, Dr. Robert Schwartz (University of Houston, Houston TX) for use of the imaging system, and Micah Mesko-Smith for expert technical assistance.	Alewijnse AE, 1997, FEBS LETT, V419, P171, DOI 10.1016/S0014-5793(97)01440-3; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Buensuceso AV, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.100123; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Chen J, 2015, CYTOKINE GROWTH F R, V26, P1, DOI 10.1016/j.cytogfr.2014.05.001; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; Clancy JP, 1999, AM J PHYSIOL-CELL PH, V276, pC361, DOI 10.1152/ajpcell.1999.276.2.C361; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; Corredor RG, 2012, J NEUROSCI, V32, P7734, DOI 10.1523/JNEUROSCI.5288-11.2012; D'Souza UM, 2002, MECH DEVELOP, V110, P197, DOI 10.1016/S0925-4773(01)00564-0; Daftary GS, 2012, J BIOL CHEM, V287, P7010, DOI 10.1074/jbc.M111.266007; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; Dhande OS, 2012, J COMP NEUROL, V520, P1562, DOI 10.1002/cne.23000; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; Fu XY, 2009, DEV DYNAM, V238, P2309, DOI 10.1002/dvdy.21974; Funk SD, 2013, PHARMACOL RES, V67, P42, DOI 10.1016/j.phrs.2012.10.008; Gamble JA, 2005, J NEUROSCI, V25, P3142, DOI 10.1523/JNEUROSCI.4759-04.2005; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gao PP, 2000, J NEUROSCI RES, V60, P427, DOI 10.1002/(SICI)1097-4547(20000515)60:4<427::AID-JNR1>3.3.CO;2-4; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grassot J, 2003, NUCLEIC ACIDS RES, V31, P353, DOI 10.1093/nar/gkg036; HARRISON T, 1977, VIROLOGY, V77, P319, DOI 10.1016/0042-6822(77)90428-7; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hu Y, 2007, MOL CELL NEUROSCI, V34, P88, DOI 10.1016/j.mcn.2006.10.005; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P7558, DOI 10.1073/pnas.121635798; Jassen AK, 2006, MOL PHARMACOL, V70, P71, DOI 10.1124/mol.105.021998; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kober P, 2011, MOL CARCINOGEN, V50, P846, DOI 10.1002/mc.20763; Li SB, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1025-3; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; Meng F, 2013, NEUROSCIENCE, V250, P381, DOI 10.1016/j.neuroscience.2013.07.001; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mojumder DK, 2008, MOL VIS, V14, P1600; Monsul NT, 2004, EXP NEUROL, V186, P124, DOI 10.1016/S0014-4886(03)00311-X; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Moshiri A, 2008, DEV BIOL, V316, P214, DOI 10.1016/j.ydbio.2008.01.015; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Otteson D. C., 2014, GANGLION CELLS MORPH, P1; Park I, 2015, MOL CELLS, V38, P14, DOI 10.14348/molcells.2015.2116; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Petkova TD, 2011, VISION RES, V51, P260, DOI 10.1016/j.visres.2010.09.022; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Polozov RV, 2015, J BIOMOL STRUCT DYN, V33, P253, DOI 10.1080/07391102.2013.879074; Qiu F, 2008, J NEUROSCI, V28, P3392, DOI 10.1523/JNEUROSCI.0043-08.2008; Rodger J, 2001, EUR J NEUROSCI, V14, P1929, DOI 10.1046/j.0953-816x.2001.01822.x; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; SIMON DK, 1992, J NEUROSCI, V12, P1212; Simpson D, 2000, MOL VIS, V6, P178; Singleton BK, 2011, BLOOD, V118, P3137, DOI 10.1182/blood-2011-04-349985; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; Steketee MB, 2014, INVEST OPHTH VIS SCI, V55, P4369, DOI 10.1167/iovs.14-13882; Steketee MB, 2011, P NATL ACAD SCI USA, V108, P19042, DOI 10.1073/pnas.1019624108; Thakar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1445; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tiwari S, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-30; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang SW, 2002, DEVELOPMENT, V129, P467; Washburn Christopher P, 2007, Neurosci Bull, V23, P249, DOI 10.1007/s12264-007-0037-7; White BEP, 2014, CELL ADHES MIGR, V8, P327, DOI 10.4161/19336918.2014.970012; Wilson DM, 1999, J HISTOCHEM CYTOCHEM, V47, P1095, DOI 10.1177/002215549904700814; Xie BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112175; Zhu Kuichun, 2003, Curr Opin Investig Drugs, V4, P1428	77	15	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18084	18095		10.1074/jbc.M116.732339	http://dx.doi.org/10.1074/jbc.M116.732339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402841	hybrid, Green Published			2022-12-28	WOS:000383241800003
J	Szabo, A; Pilsak, C; Bence, M; Witt, H; Sahin-Toth, M				Szabo, Andras; Pilsak, Claudia; Bence, Melinda; Witt, Heiko; Sahin-Toth, Miklos			Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complex; metalloprotease; pancreas; proteolytic enzyme; serine protease; elastase; pancreatitis; zymogen activation	HUMAN CATIONIC TRYPSINOGEN; BOVINE PANCREATIC PROCARBOXYPEPTIDASE; A-S6 TERNARY COMPLEX; CHYMOTRYPSIN-C; BINARY-COMPLEX; PROPROTEINASE-E; HEREDITARY PANCREATITIS; SUBUNIT-III; PROTEASE-E; ACTIVATION PROCESSES	The pancreas secretes digestive proenzymes typically in their monomeric form. A notable exception is the ternary complex formed by proproteinase E, chymotrypsinogen C, and procarboxypeptidase A (proCPA) in cattle and other ruminants. In the human and pig pancreas binary complexes of proCPA with proelastases were found. To characterize complex formation among human pancreatic protease zymogens in a systematic manner, we performed binding experiments using recombinant proelastases CELA2A, CELA3A, and CELA3B; chymotrypsinogens CTRB1, CTRB2, CTRC, and CTRL1; and procarboxypeptidases CPA1, CPA2, and CPB1. We found that proCELA3B bound not only to proCPA1 (K-D 43 nm) but even more tightly to proCPA2 (K-D 18 nm), whereas proCELA2A bound weakly to proCPA1 only (K-D 152 nm). Surprisingly, proCELA3A, which shares 92% identity with proCELA3B, did not form stable complexes due to the evolutionary replacement of Ala(241) with Gly. The polymorphic nature of position 241 in both CELA3A (approximate to 4% Ala(241) alleles) and CELA3B (approximate to 2% Gly(241) alleles) points to individual variations in complex formation. The functional effect of complex formation was delayed procarboxypeptidase activation due to increased affinity of the inhibitory activation peptide, whereas proelastase activation was unchanged. We conclude that complex formation among human pancreatic protease zymogens is limited to a subset of proelastases and procarboxypeptidases. Complex formation stabilizes the inhibitory activation peptide of procarboxypeptidases and thereby increases zymogen stability and controls activation.	[Szabo, Andras; Pilsak, Claudia; Bence, Melinda; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Ctr Exocrine Disorders, Boston, MA 02118 USA; [Pilsak, Claudia; Witt, Heiko] Tech Univ Munich, Paediat Nutr Med, Klinikum Rechts Isar MRI, Else Kroner Fresenius Zentrum Ernahrungsmed EKFZ, D-85354 Freising Weihenstephan, Germany; [Witt, Heiko] ZIEL Inst Food & Hlth, D-85354 Freising Weihenstephan, Germany	Boston University; Boston University; Technical University of Munich	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu		Sahin-Toth, Miklos/0000-0003-4513-9922; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01 DK095753, R01 DK082412, R01 DK058088]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088, R01DK095753, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK095753, R01 DK082412, and R01 DK058088. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AVILES FX, 1989, BIOCHEM BIOPH RES CO, V163, P1191, DOI 10.1016/0006-291X(89)91104-2; AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; Balazs A, 2016, AM J PHYSIOL-GASTR L, V310, pG477, DOI 10.1152/ajpgi.00444.2015; BROWN JR, 1963, BIOCHEMISTRY-US, V2, P877, DOI 10.1021/bi00904a041; BROWN JR, 1961, P NATL ACAD SCI USA, V47, P1554, DOI 10.1073/pnas.47.10.1554; BROWN JR, 1963, BIOCHEMISTRY-US, V2, P867, DOI 10.1021/bi00904a040; CHAPUS C, 1988, BIOCHIMIE, V70, P1143, DOI 10.1016/0300-9084(88)90179-4; Gomis-Ruth FX, 1998, EUR J BIOCHEM, V251, P839, DOI 10.1046/j.1432-1327.1998.2510839.x; GomisRuth FX, 1997, J MOL BIOL, V269, P861, DOI 10.1006/jmbi.1997.1040; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; GRANON S, 1990, J BIOL CHEM, V265, P10383; KELLER PJ, 1958, J BIOL CHEM, V230, P905; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; KERFELEC B, 1985, EUR J BIOCHEM, V151, P515, DOI 10.1111/j.1432-1033.1985.tb09132.x; KOBAYASHI R, 1978, J BIOL CHEM, V253, P5526; KOBAYASHI Y, 1981, J BIOL CHEM, V256, P2466; MARTINEZ MC, 1981, BIOCHEM J, V197, P141, DOI 10.1042/bj1970141; MICHON T, 1991, BIOCHEM BIOPH RES CO, V181, P449, DOI 10.1016/S0006-291X(05)81440-8; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; MOULARD M, 1990, FEBS LETT, V261, P179, DOI 10.1016/0014-5793(90)80665-6; MOULARD M, 1989, FEBS LETT, V250, P166, DOI 10.1016/0014-5793(89)80712-4; Nakano E, 2015, AM J PHYSIOL-GASTR L, V309, pG688, DOI 10.1152/ajpgi.00241.2015; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; OPPEZZO O, 1994, EUR J BIOCHEM, V222, P55, DOI 10.1111/j.1432-1033.1994.tb18841.x; PASCUAL R, 1989, EUR J BIOCHEM, V179, P609, DOI 10.1111/j.1432-1033.1989.tb14590.x; PASCUAL R, 1990, FEBS LETT, V277, P37, DOI 10.1016/0014-5793(90)80804-R; PIGNOL D, 1994, EMBO J, V13, P1763, DOI 10.1002/j.1460-2075.1994.tb06444.x; PUIGSERVER A, 1977, BIOCHEMISTRY-US, V16, P2497, DOI 10.1021/bi00630a028; PUIGSERVER A, 1972, BIOCHIM BIOPHYS ACTA, V276, P519, DOI 10.1016/0005-2744(72)91012-1; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rose SD, 1997, HUM MOL GENET, V6, P897, DOI 10.1093/hmg/6.6.897; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; SHIRASU Y, 1988, J BIOCHEM-TOKYO, V104, P259, DOI 10.1093/oxfordjournals.jbchem.a122454; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szepessy E, 2006, PANCREATOLOGY, V6, P117, DOI 10.1159/000090031; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2011, J BIOL CHEM, V286, P1819, DOI 10.1074/jbc.M110.187369; TANI T, 1987, J BIOCHEM-TOKYO, V101, P591, DOI 10.1093/jb/101.3.591; TANI T, 1988, J BIOL CHEM, V263, P1231; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; VENDRELL J, 1982, BIOCHEM J, V205, P449, DOI 10.1042/bj2050449; Ventura S, 1997, BIOL CHEM, V378, P161; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; YAMASAKI M, 1963, BIOCHEMISTRY-US, V2, P859, DOI 10.1021/bi00904a039; YONEDA T, 1980, COMP BIOCHEM PHYS B, V67, P81, DOI 10.1016/0305-0491(80)90272-2	51	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17706	17716		10.1074/jbc.M116.743237	http://dx.doi.org/10.1074/jbc.M116.743237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358403	hybrid, Green Published			2022-12-28	WOS:000383241300020
J	Mortensen, S; Jensen, JK; Andersen, GR				Mortensen, Sofia; Jensen, Jan K.; Andersen, Gregers R.			Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPONENT C2; CONVERTASE FORMATION; ALTERNATIVE PATHWAY; CLASSICAL PATHWAY; PROVIDES INSIGHTS; C-3 CONVERTASE; C3; BINDING; SCATTERING; RECOGNITION	The lectin (LP) and classical (CP) pathways are two of the three main activation cascades of the complement system. These pathways start with recognition of different pathogen-or danger-associated molecular patterns and include identical steps of proteolytic activation of complement component C4, formation of the C3 proconvertase C4b2, followed by cleavage of complement component C2 within C4b2 resulting in the C3 convertase C4b2a. Here, we describe the solution structures of the two central complexes of the pathways, C3 proconvertase and C3 convertase, as well as the unbound zymogen C2 obtained by small angle x-ray scattering analysis. We analyzed both native and enzymatically deglycosylated C4b2 and C2 and showed that the resulting structural models were independent of the glycans. The small angle x-ray scattering-derived models suggest a different activation mode for the CP/LP C3 proconvertase as compared with that established for the alternative pathway proconvertase C3bB. This is likely due to the rather different structural and functional properties of the proteases activating the proconvertases. The solution structure of a stabilized form of the active CP/LP C3 convertase C4b2a is strikingly similar to the crystal structure of the alternative pathway C3 convertase C3bBb, which is in accordance with their identical functions in cleaving the complement proteins C3 and C5.	[Mortensen, Sofia; Jensen, Jan K.; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-800 Aarhus, Denmark	Aarhus University	Andersen, GR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	gra@mbg.au.dk		Andersen, Gregers Rom/0000-0001-6292-3319; Jensen, Jan Kristian/0000-0002-7131-1418; Mortensen, Sofia/0000-0003-1631-6651	LUNA Nanomedicine Center; Lundbeck Foundation; Novo-Nordisk Foundation through Hallas-Moller Fellowship	LUNA Nanomedicine Center; Lundbeck Foundation(Lundbeckfonden); Novo-Nordisk Foundation through Hallas-Moller Fellowship	We thank the beamline staff at Petra P12 for support during data collection and in particular Dr. Cy Jeffries for help with data collection and analysis of the SAXS in-line and the RALS/RI experiments. We also thank Trine Gadeberg for practical assistance. Gregers R. Andersen was supported by the LUNA Nanomedicine Center, the Lundbeck Foundation, and by the Novo-Nordisk Foundation through a Hallas-Moller Fellowship.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Bernet J, 2004, J VIROL, V78, P9446, DOI 10.1128/JVI.78.17.9446-9457.2004; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; Degn SE, 2014, P NATL ACAD SCI USA, V111, P13445, DOI 10.1073/pnas.1406849111; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Felix J, 2013, STRUCTURE, V21, P528, DOI 10.1016/j.str.2013.01.018; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; HORIUCHI T, 1991, J IMMUNOL, V147, P584; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Kjaer TR, 2013, MOL IMMUNOL, V56, P222, DOI 10.1016/j.molimm.2013.05.220; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krishnan V, 2007, J MOL BIOL, V367, P224, DOI 10.1016/j.jmb.2006.12.039; Krishnan V, 2009, ACTA CRYSTALLOGR D, V65, P266, DOI 10.1107/S0907444909000389; Laich A, 2001, BBA-PROTEIN STRUCT M, V1544, P96, DOI 10.1016/S0167-4838(00)00208-9; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Martini PGV, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-43; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Milder FJ, 2006, STRUCTURE, V14, P1587, DOI 10.1016/j.str.2006.08.008; MILLER JA, 1968, P SOC EXP BIOL MED, V129, P127; Moharana K, 2014, STRUCTURE, V22, P866, DOI 10.1016/j.str.2014.04.012; Mortensen S, 2015, J IMMUNOL, V194, P5488, DOI 10.4049/jimmunol.1500087; MULLEREBERHARD HJ, 1967, J EXP MED, V125, P359, DOI 10.1084/jem.125.2.359; NAGASAWA S, 1977, P NATL ACAD SCI USA, V74, P2998, DOI 10.1073/pnas.74.7.2998; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Roumenina LT, 2009, BLOOD, V114, P2837, DOI 10.1182/blood-2009-01-197640; SITOMER G, 1966, IMMUNOCHEMISTRY, V3, P57, DOI 10.1016/0019-2791(66)90282-5; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; VILLIERS MB, 1985, BIOCHEM J, V226, P429, DOI 10.1042/bj2260429; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Wallis R, 2007, J BIOL CHEM, V282, P7844, DOI 10.1074/jbc.M606326200	40	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16494	16507		10.1074/jbc.M116.722017	http://dx.doi.org/10.1074/jbc.M116.722017			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27252379	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000380826700010
J	Sung, B; Park, B; Yadav, VR; Aggarwal, BB				Sung, Bokyung; Park, Byoungduck; Yadav, Vivek R.; Aggarwal, Bharat B.			RETRACTION: Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors (Retraction of vol 285, pg 11498, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209	1	6	7	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16920	16920		10.1074/jbc.A109.090209	http://dx.doi.org/10.1074/jbc.A109.090209			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27496961	Green Published, hybrid			2022-12-28	WOS:000380826700047
J	Weider, E; Susan-Resiga, D; Essalmani, R; Hamelin, J; Asselin, MC; Nimesh, S; Ashraf, Y; Wycoff, KL; Zhang, JB; Prat, A; Seidah, NG				Weider, Elodie; Susan-Resiga, Delia; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Nimesh, Surendra; Ashraf, Yahya; Wycoff, Keith L.; Zhang, Jianbing; Prat, Annik; Seidah, Nabil G.			Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; LDL CHOLESTEROL LEVELS; C-TERMINAL DOMAIN; MONOCLONAL-ANTIBODY; FAMILIAL HYPERCHOLESTEROLEMIA; LIVER-REGENERATION; NONHUMAN-PRIMATES; TARGETING PCSK9; EGF(A) DOMAIN; MOUSE-LIVER	Single domain antibodies (sdAbs) correspond to the antigen-binding domains of camelid antibodies. They have the same antigen-binding properties and specificity as monoclonal antibodies (mAbs) but are easier and cheaper to produce. We report here the development of sdAbs targeting human PCSK9 (proprotein convertase subtilisin/kexin type 9) as an alternative to anti-PCSK9 mAbs. After immunizing a llama with human PCSK9, we selected four sdAbs that bind PCSK9 with a high affinity and produced them as fusion proteins with a mouse Fc. All four sdAb-Fcs recognize the C-terminal Cys-His-rich domain of PCSK9. We performed multiple cellular assays and demonstrated that the selected sdAbs efficiently blocked PCSK9-mediated low density lipoprotein receptor (LDLR) degradation in cell lines, in human hepatocytes, and in mouse primary hepatocytes. We further showed that the sdAb-Fcs do not affect binding of PCSK9 to the LDLR but rather block its induced cellular LDLR degradation. Pcsk9 knock-out mice expressing a human bacterial artificial chromosome (BAC) transgene were generated, resulting in plasma levels of similar to 300 ng/ml human PCSK9. Mice were singly or doubly injected with the best sdAb-Fc and analyzed at day 4 or 11, respectively. After 4 days, mice exhibited a 32 and 44% decrease in the levels of total cholesterol and apolipoprotein B and similar to 1.8-fold higher liver LDLR protein levels. At 11 days, the equivalent values were 24 and 46% and similar to 2.3-fold higher LDLR proteins. These data constitute a proof-of-principle for the future usage of sdAbs as PCSK9-targeting drugs that can efficiently reduce LDL-cholesterol, and as tools to study the Cys-His-rich domain-dependent sorting the PCSK9-LDLR complex to lysosomes.	[Weider, Elodie; Susan-Resiga, Delia; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Nimesh, Surendra; Ashraf, Yahya; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Wycoff, Keith L.] Planet Biotechnol Inc, Hayward, CA 94545 USA; [Zhang, Jianbing] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; National Research Council Canada	Seidah, NG (corresponding author), Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Nimesh, Surendra/T-8894-2019; Seidah, Nabil/I-3596-2013; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X	Canadian Institutes of Health Research [PP2-125775, MOP 102741]; Pfizer; Amorchem; Canada Research Chair [216684]; Fondation Leducq Grant [13CVD03]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer(Pfizer); Amorchem; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Fondation Leducq Grant(Leducq Foundation)	This work was supported by Canadian Institutes of Health Research Grants PP2-125775 and MOP 102741, Pfizer cardiovascular research awards, a grant from Amorchem, Canada Research Chair 216684, and Fondation Leducq Grant 13CVD03.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bartunek J, 2013, J CARDIOVASC TRANSL, V6, P355, DOI 10.1007/s12265-012-9435-y; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Cortez-Retamozo V, 2002, INT J CANCER, V98, P456, DOI 10.1002/ijc.10212; Crossey E, 2015, VACCINE, V33, P5747, DOI 10.1016/j.vaccine.2015.09.044; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; dos Santos C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010501; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Galabova G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114469; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Guella I, 2010, J LIPID RES, V51, P3342, DOI 10.1194/jlr.M010009; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Huang S, 2010, J LIPID RES, V51, P297, DOI 10.1194/jlr.M000422; Huang Y, 2012, GENOME MED, V4, DOI 10.1186/gm358; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kratz F, 2012, J CONTROL RELEASE, V161, P429, DOI 10.1016/j.jconrel.2011.11.028; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Lundin J, 2002, BLOOD, V100, P768, DOI 10.1182/blood-2002-01-0159; Ly K, 2014, J BIOL CHEM, V289, P17732, DOI 10.1074/jbc.M113.541094; Maclean J, 2007, J GEN VIROL, V88, P1460, DOI 10.1099/vir.0.82718-0; MARCINKIEWICZ M, 1994, ENDOCRINOLOGY, V135, P1651, DOI 10.1210/en.135.4.1651; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Mitchell T, 2014, J PHARMACOL EXP THER, V350, P412, DOI 10.1124/jpet.114.214221; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Pedersen NB, 2014, J BIOL CHEM, V289, P17312, DOI 10.1074/jbc.M113.545053; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Powers DB, 2001, J IMMUNOL METHODS, V251, P123, DOI 10.1016/S0022-1759(00)00290-8; Roubtsova A, 2015, J LIPID RES, V56, P2133, DOI 10.1194/jlr.M061952; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Sarker SA, 2013, GASTROENTEROLOGY, V145, P740, DOI 10.1053/j.gastro.2013.06.053; Schiele F, 2014, J MOL BIOL, V426, P843, DOI 10.1016/j.jmb.2013.11.011; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Shrank WH, 2015, JAMA-J AM MED ASSOC, V314, P1443, DOI 10.1001/jama.2015.10017; Stein EA, 2014, ANNU REV MED, V65, P417, DOI 10.1146/annurev-med-022613-090402; Sun XW, 2012, NEOPLASIA, V14, P1122, DOI 10.1593/neo.121252; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; van der Linden R, 2000, J IMMUNOL METHODS, V240, P185, DOI 10.1016/S0022-1759(00)00188-5; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yamamoto T, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.16; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang YN, 2012, J MOL BIOL, V422, P685, DOI 10.1016/j.jmb.2012.06.018	73	24	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16659	16671		10.1074/jbc.M116.717736	http://dx.doi.org/10.1074/jbc.M116.717736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27284008	hybrid, Green Published			2022-12-28	WOS:000380826700024
J	Yi, GH; Ybe, JA; Saha, SS; Caviness, G; Raymond, E; Ganesan, R; Mbow, ML; Kao, CC				Yi, Guanghui; Ybe, Joel A.; Saha, Siddhartha S.; Caviness, Gary; Raymond, Ernest; Ganesan, Rajkumar; Mbow, M. Lamine; Kao, C. Cheng			Structural and Functional Attributes of the Interleukin-36 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IL-36 RECEPTOR; ANTAGONIST; ACTIVATION; AGONIST; SIGNAL; EXPRESSION; INSIGHTS; MEMBERS; ADAPTER	Signal transduction by the IL-36 receptor (IL-36R) is linked to several human diseases. However, the structure and function of the IL-36R is not well understood. A molecular model of the IL-36R complex was generated and a cell-based reporter assay was established to assess the signal transduction of recombinant subunits of the IL-36R. Mutational analyses and functional assays have identified residues of the receptor subunit IL-1Rrp2 needed for cytokine recognition, stable protein expression, disulfide bond formation and glycosylation that are critical for signal transduction. We also observed that, overexpression of ectodomain (ECD) of Il-1Rrp2 or IL-1RAcP exhibited dominant-negative effect on IL-36R signaling. The presence of IL-36 cytokine significantly increased the interaction of IL-1Rrp2 ECD with the co-receptor IL-1RAcP. Finally, we found that single nucleotide polymorphism A471T in the Toll-interleukin 1 receptor domain (TIR) of the IL-1Rrp2 that is present in similar to 2% of the human population, down-regulated IL-36R signaling by a decrease of interaction with IL-1RAcP.	[Yi, Guanghui; Saha, Siddhartha S.; Kao, C. Cheng] Indiana Univ, Sch Publ Hlth, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Ybe, Joel A.] Indiana Univ, Sch Publ Hlth, Dept Environm Hlth, Bloomington, IN 47405 USA; [Caviness, Gary; Raymond, Ernest; Ganesan, Rajkumar; Mbow, M. Lamine] Boehringer Ingelheim Pharmaceut, Ridgefield, CT 06877 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Boehringer Ingelheim	Kao, CC (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu	Ganesan, Rajkumar/B-1093-2008	Ganesan, Rajkumar/0000-0002-3431-9664				Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Gabay C, 2015, J LEUKOCYTE BIOL, V97, P645, DOI 10.1189/jlb.3RI1014-495R; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gresnigt MS, 2013, SEMIN IMMUNOL, V25, P458, DOI 10.1016/j.smim.2013.11.003; Gunther S, 2014, J IMMUNOL, V193, P921, DOI 10.4049/jimmunol.1400538; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kuznetsov IB, 2008, BIOINFORMATION, V3, P134, DOI 10.6026/97320630003134; Latiano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062144; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina-Contreras O, 2016, J IMMUNOL, V196, P34, DOI 10.4049/jimmunol.1501312; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Saha SS, 2015, J BIOL CHEM, V290, P23997, DOI 10.1074/jbc.M115.653378; Thomas C, 2012, NAT STRUCT MOL BIOL, V19, P455, DOI 10.1038/nsmb.2260; Towne JE, 2012, CURR OPIN PHARMACOL, V12, P486, DOI 10.1016/j.coph.2012.02.009; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; Tsutsumi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6340; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1	30	30	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16597	16609		10.1074/jbc.M116.723064	http://dx.doi.org/10.1074/jbc.M116.723064			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27307043	hybrid, Green Published			2022-12-28	WOS:000380826700019
J	Correa-Galvis, V; Redekop, P; Guan, K; Griess, A; Truong, TB; Wakao, S; Niyogi, KK; Jahns, P				Correa-Galvis, Viviana; Redekop, Petra; Guan, Katharine; Griess, Annika; Truong, Thuy B.; Wakao, Setsuko; Niyogi, Krishna K.; Jahns, Peter			Photosystem II Subunit PsbS Is Involved in the Induction of LHCSR Protein-dependent Energy Dissipation in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydomonas; light-harvesting complex (antenna complex); pH regulation; photosynthesis; photosystem II; light acclimation; NPQ; Photoprotection; PsbS	LIGHT-HARVESTING COMPLEXES; PHYSCOMITRELLA-PATENS; CARBONIC-ANHYDRASE; XANTHOPHYLL-CYCLE; SUPRAMOLECULAR ORGANIZATION; FLUORESCENCE; PHOTOSYNTHESIS; MUTANTS; ARABIDOPSIS; MECHANISMS	Non-photochemical quenching of excess excitation energy is an important photoprotective mechanism in photosynthetic organisms. In Arabidopsis thaliana, a high quenching capacity is constitutively present and depends on the PsbS protein. In the green alga Chlamydomonas reinhardtii, non-photochemical quenching becomes activated upon high light acclimation and requires the accumulation of light harvesting complex stress-related (LHCSR) proteins. Expression of the PsbS protein in C. reinhardtii has not been reported yet. Here, we show that PsbS is a light-induced protein in C. reinhardtii, whose accumulation under high light is further controlled by CO2 availability. PsbS accumulated after several hours of high light illumination at low CO2. At high CO2, however, PsbS was only transiently expressed under high light and was degraded after 1 h of high light exposure. PsbS accumulation correlated with an enhanced non-photochemical quenching capacity in high light-acclimated cells grown at low CO2. However, PsbS could not compensate for the function of LHCSR in an LHCSR-deficient mutant. Knockdown of PsbS accumulation led to reduction of both non-photochemical quenching capacity and LHCSR3 accumulation. Our data suggest that PsbS is essential for the activation of non-photochemical quenching in C. reinhardtii, possibly by promoting conformational changes required for activation of LHCSR3-dependent quenching in the antenna of photosystem II.	[Correa-Galvis, Viviana; Redekop, Petra; Griess, Annika; Jahns, Peter] Univ Dusseldorf, Plant Biochem, D-40225 Dusseldorf, Germany; [Guan, Katharine; Truong, Thuy B.; Wakao, Setsuko; Niyogi, Krishna K.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Niyogi, Krishna K.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Correa-Galvis, Viviana] Max Planck Inst Mol Plant Physiol, Muhlenberg 1, D-14476 Potsdam, Germany; [Truong, Thuy B.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Niyogi, Krishna K.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Niyogi, Krishna K.] Gordon & Betty Moore Fdn, Palo Alto, CA USA	Heinrich Heine University Dusseldorf; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Max Planck Society; Donald Danforth Plant Science Center; Howard Hughes Medical Institute	Jahns, P (corresponding author), Univ Dusseldorf, Plant Biochem, D-40225 Dusseldorf, Germany.	pjahns@hhu.de			Deutsche Forschungsgemeinschaft [GRK 1525, JA 665/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (GRK 1525 and JA 665/11-1; to P. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Amarnath K, 2012, P NATL ACAD SCI USA, V109, P8405, DOI 10.1073/pnas.1205303109; Anwaruzzaman M, 2004, PHOTOSYNTH RES, V82, P265, DOI 10.1007/s11120-004-2439-y; Ballottari M, 2016, J BIOL CHEM, V291, P7334, DOI 10.1074/jbc.M115.704601; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Correa-Galvis V, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.225, 10.1038/nplants.2015.225]; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; Farber A, 1997, PLANT PHYSIOL, V115, P1609, DOI 10.1104/pp.115.4.1609; Forster B, 2001, PHOTOSYNTH RES, V67, P5, DOI 10.1023/A:1010611509209; Gerotto C, 2015, PLANT PHYSIOL, V168, P1747, DOI 10.1104/pp.15.00361; Gerotto C, 2012, NEW PHYTOL, V196, P763, DOI 10.1111/j.1469-8137.2012.04345.x; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Johnson MP, 2011, J BIOL CHEM, V286, P19973, DOI 10.1074/jbc.M111.237255; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Karlsson J, 1998, EMBO J, V17, P1208, DOI 10.1093/emboj/17.5.1208; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Krause GH, 2004, ADV PHOTO RESPIRAT, V19, P463; Kucho K, 2003, PLANT PHYSIOL, V133, P783, DOI 10.1104/pp.103.026492; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Maruyama S, 2014, PLANT CELL PHYSIOL, V55, P1304, DOI 10.1093/pcp/pcu068; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mettler T, 2014, PLANT CELL, V26, P2310, DOI 10.1105/tpc.114.124537; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Minagawa J, 2015, PLANT J, V82, P413, DOI 10.1111/tpj.12805; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Park YI, 1999, FEBS LETT, V444, P102, DOI 10.1016/S0014-5793(99)00037-X; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; Schwarz N, 2015, PLANT CELL PHYSIOL, V56, P346, DOI 10.1093/pcp/pcu167; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Teramoto H, 2002, PLANT PHYSIOL, V130, P325, DOI 10.1104/pp.004622; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Xue HD, 2015, PLANT PHYSIOL, V167, P1566, DOI 10.1104/pp.15.00094; Zones JM, 2015, PLANT CELL, V27, P2743, DOI 10.1105/tpc.15.00498	54	67	72	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17478	17487		10.1074/jbc.M116.737312	http://dx.doi.org/10.1074/jbc.M116.737312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27358399	Green Published, hybrid			2022-12-28	WOS:000382643800045
J	Yoshimoto, FK; Gonzalez, E; Auchus, RJ; Guengerich, FP				Yoshimoto, Francis K.; Gonzalez, Eric; Auchus, Richard J.; Guengerich, F. Peter			Mechanism of 17,20-Lyase and New Hydroxylation Reactions of Human Cytochrome P450 17A1: O-18 LABELING AND OXYGEN SURROGATE EVIDENCE FOR A ROLE OF A PERFERRYL OXYGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; enzyme catalysis; enzyme mechanism; mass spectrometry (MS); nuclear magnetic resonance (NMR); steroid; steroidogenesis; oxygenase	H BOND ACTIVATION; COMPOUND I; REGIOSELECTIVE HYDROXYLATION; ESTROGEN BIOSYNTHESIS; ANDROGEN FORMATION; ESCHERICHIA-COLI; HUMAN P450C17; OXIDATION; EXPRESSION; CLEAVAGE	Cytochrome P450 (P450) reactions can involve C-C bond cleavage, and several of these are critical in steroid and sterol biosynthesis. The mechanisms of P450s 11A1, 17A1, 19A1, and 51A1 have been controversial, in the context of the role of ferric peroxide (FeO2-) versus perferryl (FeO3+, compound I) chemistry. We reinvestigated the 17-hydroxyprogesterone and 17-hydroxypregnenolone 17,20-lyase reactions of human P450 17A1 and found incorporation of one O-18 atom (from O-18(2)) into acetic acid, consonant with proposals for a ferric peroxide mechanism (Akhtar, M., Lee-Robichaud, P., Akhtar, M. E., and Wright, J. N. (1997) J. Steroid Biochem. Mol. Biol. 61, 127-132; Akhtar, M., Wright, J. N., and Lee-Robichaud, P. (2011) J. Steroid Biochem. Mol. Biol. 125, 2-12). However, the reactions were supported by iodosylbenzene (a precursor of the FeO3+ species) but not by H2O2. We propose three mechanisms that can involve the FeO3+ entity and that explain the O-18 label in the acetic acid, two involving the intermediacy of an acetyl radical and one a steroid 17,20-dioxetane. P450 17A1 was found to perform 16-hydroxylation reactions on its 17-hydroxylated products to yield 16,17-dihydroxypregnenolone and progesterone, suggesting the presence of an active perferryloxo active species of P450 17A1 when its lyase substrate is bound. The 6-hydroxylation of 16,17-dihydroxyprogesterone and the oxidation of both 16,17-dihydroxyprogesterone and 16,17-dihydroxypregnenolone to 16-hydroxy lyase products were also observed. We provide evidence for the contribution of a compound I mechanism, although contribution of a ferric peroxide pathway in the 17,20-lyase reaction cannot be excluded.	[Yoshimoto, Francis K.; Gonzalez, Eric; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Yoshimoto, Francis K.; Auchus, Richard J.] Univ Michigan, Dept Internal Med, Div Metab Diabet & Endocrinol, Ann Arbor, MI 48019 USA; [Yoshimoto, Francis K.; Auchus, Richard J.] Univ Michigan, Dept Pharmacol, Div Metab Diabet & Endocrinol, Ann Arbor, MI 48019 USA	Vanderbilt University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Yoshimoto, Francis/0000-0002-2308-2999	National Institutes of Health [R37 CA090426, R01 GM118122, R01 GM103937, R01 GM086596]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103937, R01GM086596, R01GM118122, R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426, R01 GM118122, and R01 GM103937 (to F. P. G.) and R01 GM086596 (to R. J. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKHTAR M, 1976, J CHEM SOC CHEM COMM, P854, DOI 10.1039/c39760000854; AKHTAR M, 1994, BIOCHEMISTRY-US, V33, P4410, DOI 10.1021/bi00180a039; Akhtar M, 1997, J STEROID BIOCHEM, V61, P127; AKHTAR M, 1994, J CHEM SOC PERK T 1, P263, DOI 10.1039/p19940000263; AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; Akhtar M, 2015, ADV EXP MED BIOL, V851, P107, DOI 10.1007/978-3-319-16009-2_4; Akhtar M, 2011, J STEROID BIOCHEM, V125, P2, DOI 10.1016/j.jsbmb.2010.11.003; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Bakac A, 2002, J AM CHEM SOC, V124, P9136, DOI 10.1021/ja026365w; Basran J, 2011, J AM CHEM SOC, V133, P16251, DOI 10.1021/ja207066z; Bell SR, 2009, J AM CHEM SOC, V131, P9640, DOI 10.1021/ja903394s; BETANCOR C, 1988, J CHEM SOC CHEM COMM, P947, DOI 10.1039/c39880000947; Cai HL, 1999, J AM CHEM SOC, V121, P11656, DOI 10.1021/ja9914240; CASPI E, 1986, J AM CHEM SOC, V108, P1847, DOI 10.1021/ja00268a023; CASPI E, 1984, J AM CHEM SOC, V106, P7282, DOI 10.1021/ja00335a090; Cheng Q, 2012, J BIOL CHEM, V287, P29554, DOI 10.1074/jbc.M112.390047; Chowdhury G, 2012, BIOCHEMISTRY-US, V51, P9995, DOI 10.1021/bi301092c; Chowdhury G, 2010, J BIOL CHEM, V285, P8031, DOI 10.1074/jbc.M109.088039; COLE PA, 1990, J MED CHEM, V33, P2933, DOI 10.1021/jm00173a001; Davydov R, 2015, BIOCHEMISTRY-US, V54, P7089, DOI 10.1021/acs.biochem.5b00903; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; FISHMAN J, 1982, CANCER RES, V42, P3277; FOUST GP, 1969, ANAL BIOCHEM, V27, P530, DOI 10.1016/0003-2697(69)90066-9; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; GOTO J, 1977, SCIENCE, V195, P80, DOI 10.1126/science.831259; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Gregory M, 2013, ANGEW CHEM INT EDIT, V52, P5342, DOI 10.1002/anie.201300760; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2011, ARCH BIOCHEM BIOPHYS, V507, P126, DOI 10.1016/j.abb.2010.08.017; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Guengerich FP, 1997, MOL PHARMACOL, V51, P147, DOI 10.1124/mol.51.1.147; Hackett JC, 2005, J AM CHEM SOC, V127, P5224, DOI 10.1021/ja044716w; HAHN EF, 1984, J BIOL CHEM, V259, P1689; Hamilton NM, 2012, J MED CHEM, V55, P4431, DOI 10.1021/jm300317k; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HAYAMIZU K, 1990, MAGN RESON CHEM, V28, P250, DOI 10.1002/mrc.1260280311; HOLM KA, 1985, ARCH BIOCHEM BIOPHYS, V237, P477, DOI 10.1016/0003-9861(85)90301-7; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Jencks W. P., 1969, CATALYSIS CHEM ENZYM, P253; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; KADLUBAR FF, 1973, BIOCHEM BIOPH RES CO, V54, P1255, DOI 10.1016/0006-291X(73)91122-4; Khatri Y, 2014, BIOCHEM BIOPH RES CO, V443, P179, DOI 10.1016/j.bbrc.2013.11.094; KIRK DN, 1990, J CHEM SOC PERK T 2, P1567, DOI 10.1039/p29900001567; KIRSCHNER MA, 1966, ACTA ENDOCRINOL-COP, V53, P584, DOI 10.1530/acta.0.0530584; Krauser JA, 2004, EUR J BIOCHEM, V271, P3962, DOI 10.1111/j.1432-1033.2004.04339.x; Krest CM, 2013, J BIOL CHEM, V288, P17074, DOI 10.1074/jbc.R113.473108; Lacroix D, 1997, EUR J BIOCHEM, V247, P625, DOI 10.1111/j.1432-1033.1997.00625.x; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; LEEROBICHAUD P, 1995, BIOCHEMISTRY-US, V34, P14104, DOI 10.1021/bi00043a015; LICHTENBERGER F, 1976, BIOCHEM BIOPH RES CO, V70, P939, DOI 10.1016/0006-291X(76)90682-3; MACDONALD TL, 1989, BIOCHEMISTRY-US, V28, P2071, DOI 10.1021/bi00431a016; Mak PJ, 2015, P NATL ACAD SCI USA, V112, P15856, DOI 10.1073/pnas.1519376113; Mak PJ, 2014, J AM CHEM SOC, V136, P4825, DOI 10.1021/ja500054c; MANSUY D, 1982, TETRAHEDRON LETT, V23, P2781, DOI 10.1016/S0040-4039(00)87457-2; MILLER SL, 1991, J CHEM SOC CHEM COMM, P157, DOI 10.1039/c39910000157; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; MORAND P, 1975, BIOCHEMISTRY-US, V14, P635, DOI 10.1021/bi00674a027; Niwa T, 1998, XENOBIOTICA, V28, P539, DOI 10.1080/004982598239290; NORDBLOM GD, 1977, ARCH BIOCHEM BIOPHYS, V180, P343, DOI 10.1016/0003-9861(77)90047-9; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Ortiz de Montellano PR, 1986, CYTOCHROME P450 STRU, P217; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Paraskevas PD, 2014, J PHYS CHEM A, V118, P9296, DOI 10.1021/jp503570e; Pechurskaya TA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P806, DOI 10.1134/S0006297908070092; Pestovsky O, 2004, J AM CHEM SOC, V126, P13757, DOI 10.1021/ja0457112; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; RENNEBERG R, 1981, BIOCHEM PHARMACOL, V30, P843, DOI 10.1016/S0006-2952(81)80005-6; RENNEBERG R, 1978, FEBS LETT, V96, P349, DOI 10.1016/0014-5793(78)80434-7; RENNEBERG R, 1983, BIOCHEM BIOPH RES CO, V113, P332, DOI 10.1016/0006-291X(83)90470-9; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Saltzman H., 1963, ORG SYNTH, V43, P60, DOI 10.15227/orgsyn.043.0060; SANDHU P, 1993, ARCH BIOCHEM BIOPHYS, V306, P443, DOI 10.1006/abbi.1993.1536; Sen K, 2012, BIOCHEMISTRY-US, V51, P3039, DOI 10.1021/bi300017p; STEVENSON DE, 1988, J CHEM SOC PERK T 1, P2043, DOI 10.1039/p19880002043; SWINNEY DC, 1994, BIOCHEMISTRY-US, V33, P2185, DOI 10.1021/bi00174a027; Vijaykumar D, 2002, J ORG CHEM, V67, P4904, DOI 10.1021/jo020190r; Walsh C., 1979, ENZYMATIC REACTION M, P121; Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373; Yoshimoto FK, 2015, J STEROID BIOCHEM, V151, P52, DOI 10.1016/j.jsbmb.2014.11.026; Yoshimoto FK, 2014, BIOCHEMISTRY-US, V53, P7531, DOI 10.1021/bi5011865; Yoshimoto FK, 2014, J AM CHEM SOC, V136, P15016, DOI 10.1021/ja508185d; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w	93	43	44	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17143	17164		10.1074/jbc.M116.732966	http://dx.doi.org/10.1074/jbc.M116.732966			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339894	Green Published, hybrid			2022-12-28	WOS:000382643800020
J	Guengerich, FP; Olson, JS; Ballou, DP; Palmer, G; Massey, V				Guengerich, F. Peter; Olson, J. S.; Ballou, D. P.; Palmer, G.; Massey, V			International Man of Enzymology: Vince Massey's Work on Flavin Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Guengerich, F. Peter] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA	Vanderbilt University; Johns Hopkins University	Guengerich, FP (corresponding author), Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.	alexandraataylor@gmail.com							0	0	0	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15404	+		10.1074/jbc.O116.000004	http://dx.doi.org/10.1074/jbc.O116.000004			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27422979	Green Published, hybrid			2022-12-28	WOS:000380583200043
J	Amin, E; Jaiswal, M; Derewenda, U; Reis, K; Nouri, K; Koessmeier, KT; Aspenstrom, P; Somlyo, AV; Dvorsky, R; Ahmadian, MR				Amin, Ehsan; Jaiswal, Mamta; Derewenda, Urszula; Reis, Katarina; Nouri, Kazem; Koessmeier, Katja T.; Aspenstrom, Pontus; Somlyo, Avril V.; Dvorsky, Radovan; Ahmadian, Mohammad R.			Deciphering the Molecular and Functional Basis of RHOGAP Family Proteins: A SYSTEMATIC APPROACH TOWARD SELECTIVE INACTIVATION OF RHO FAMILY PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arginine finger; crystal structure; deleted in liver cancer 1 (DLC1); GTPase; GTPase-activating protein (GAP); protein-protein interaction; RAC (RAC GTPase); Ras homolog gene family; member A (RHOA); signal transduction; substrate specificity	GTPASE-ACTIVATING-PROTEIN; ROCK-REGULATED GAP; ACTIN CYTOSKELETON; TUMOR-SUPPRESSOR; HYDROLYSIS REACTION; CRYSTAL-STRUCTURE; BINDING-PROTEIN; CDC42 GTPASE; RAC-GTPASE; E-CADHERIN	RHO GTPase-activating proteins (RHOGAPs) are one of the major classes of regulators of the RHO-related protein family that are crucial in many cellular processes, motility, contractility, growth, differentiation, and development. Using database searches, we extracted 66 distinct human RHOGAPs, from which 57 have a common catalytic domain capable of terminating RHO protein signaling by stimulating the slow intrinsic GTP hydrolysis (GTPase) reaction. The specificity of the majority of the members of RHOGAP family is largely uncharacterized. Here, we comprehensively investigated the sequence-structure-function relationship between RHOGAPs and RHO proteins by combining our in vitro data with in silico data. The activity of 14 representatives of the RHOGAP family toward 12 RHO family proteins was determined in real time. We identified and structurally verified hot spots in the interface between RHOGAPs and RHO proteins as critical determinants for binding and catalysis. We have found that the RHOGAP domain itself is nonselective and in some cases rather inefficient under cell-free conditions. Thus, we propose that other domains of RHOGAPs confer substrate specificity and fine-tune their catalytic efficiency in cells.	[Amin, Ehsan; Jaiswal, Mamta; Nouri, Kazem; Koessmeier, Katja T.; Dvorsky, Radovan; Ahmadian, Mohammad R.] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany; [Derewenda, Urszula; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Reis, Katarina; Aspenstrom, Pontus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Jaiswal, Mamta] Max Planck Inst, Struct Biol Grp, D-44227 Dortmund, Germany	Heinrich Heine University Dusseldorf; University of Virginia; Karolinska Institutet; Max Planck Society	Dvorsky, R; Ahmadian, MR (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany.	radovan.dvorsky@uni-duesseldorf.de; reza.ahmadian@uni-duesseldorf.de	Dvorsky, Radovan/ABE-3042-2020; jaiswal, mamta/E-5148-2016	jaiswal, mamta/0000-0002-5862-7506; Nouri, Kazem/0000-0001-7787-1304; Amin, Ehsan/0000-0003-2995-8864	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Billuart, N. Nassar, M. A. Olayioye, K. Rittinger, I. Whitehead, and L. van Aelst for sharing reagents, cDNA, and plasmids; M. A. Olayioye and B. Vanhaesebroeck for discussions, and Ilse Meyer and Natalya Olekhnovich for technical assistance. The University of Chicago Argonne LLC operates Argonne National Laboratory for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by United States Department of Energy under Contract DE-AC02-06CH11357.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Ahmadian MR, 1997, FEBS LETT, V408, P315, DOI 10.1016/S0014-5793(97)00422-5; AHMED S, 1993, J BIOL CHEM, V268, P10709; Aitsebaomo J, 2004, J BIOL CHEM, V279, P17963, DOI 10.1074/jbc.M311721200; Asnaghi L, 2010, ONCOGENE, V29, P2760, DOI 10.1038/onc.2010.39; Aspenstrom P, 2014, BIOL CHEM, V395, P477, DOI 10.1515/hsz-2013-0296; Barras D, 2014, CANCER METAST REV, V33, P87, DOI 10.1007/s10555-013-9458-0; Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Bernards A, 2005, GROWTH FACTORS, V23, P143, DOI 10.1080/08977190500130480; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bigarella CL, 2012, FEBS LETT, V586, P3522, DOI 10.1016/j.febslet.2012.08.012; Boulter E, 2012, FASEB J, V26, P469, DOI 10.1096/fj.11-192252; Brandao Marcelo M, 2006, Genomics Proteomics Bioinformatics, V4, P182, DOI 10.1016/S1672-0229(06)60031-4; Braun AC, 2015, J CELL SCI, V128, P1386, DOI 10.1242/jcs.163857; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Cao X, 2012, P NATL ACAD SCI USA, V109, P1455, DOI 10.1073/pnas.1114368109; Chang Garry H K, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.975002; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chen BE, 2010, MOL BIOSYST, V6, P2143, DOI 10.1039/c005148a; Chiang SH, 2003, EMBO J, V22, P2679, DOI 10.1093/emboj/cdg262; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Csepanyi-Komi R, 2012, MOL CELL ENDOCRINOL, V353, P10, DOI 10.1016/j.mce.2011.11.005; Csepanyi-Komi Roland, 2013, Small GTPases, V4, P90, DOI 10.4161/sgtp.23708; Csepanyi-Komi Roland, 2012, Small GTPases, V3, P178, DOI 10.4161/sgtp.20040; DeLano W.L, PYMOL MOL GRAPHICS S; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Eberth A, 2005, BIOL CHEM, V386, P1105, DOI 10.1515/BC.2005.127; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Evdokimov AG, 2002, PROTEIN SCI, V11, P401, DOI 10.1110/ps.34102; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Fan LF, 2012, BIOCHEM SOC T, V40, P268, DOI 10.1042/BST20110625; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Faucherre A, 2003, HUM MOL GENET, V12, P2449, DOI 10.1093/hmg/ddg250; Fidyk NJ, 2002, BIOCHEMISTRY-US, V41, P15644, DOI 10.1021/bi026413p; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Fotinos A, 2015, J THROMB HAEMOST, V13, P619, DOI 10.1111/jth.12834; GARRETT MD, 1989, J BIOL CHEM, V264, P10; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Guo X, 2011, P NATL ACAD SCI USA, V108, P18649, DOI 10.1073/pnas.1113170108; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; HART MJ, 1991, J BIOL CHEM, V266, P20840; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Jaiswal M, 2014, J BIOL CHEM, V289, P6839, DOI 10.1074/jbc.M113.527655; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jaiswal M, 2013, BIOL CHEM, V394, P89, DOI 10.1515/hsz-2012-0207; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Jenna S, 2002, J BIOL CHEM, V277, P6366, DOI 10.1074/jbc.M105516200; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kandpal RP, 2006, CURR PROTEIN PEPT SC, V7, P355; Kannan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050735; Karimzadeh F, 2012, J BIOL CHEM, V287, P19610, DOI 10.1074/jbc.M112.344606; Kotting C, 2013, FEBS LETT, V587, P2025, DOI 10.1016/j.febslet.2013.05.021; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lazarini M, 2013, BBA-MOL BASIS DIS, V1832, P365, DOI 10.1016/j.bbadis.2012.11.010; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lua BL, 2004, MOL BIOL CELL, V15, P2873, DOI 10.1091/mbc.E04-02-0141; Marchesi S, 2014, DEV CELL, V31, P420, DOI 10.1016/j.devcel.2014.09.009; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Moskwa P, 2005, J BIOL CHEM, V280, P6716, DOI 10.1074/jbc.M412563200; Naji L, 2011, BIOCHEM BIOPH RES CO, V409, P96, DOI 10.1016/j.bbrc.2011.04.116; Nakahara S, 2015, J CELL SCI, V128, P2047, DOI 10.1242/jcs.160192; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Okada H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002189; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; Rack PG, 2014, P NATL ACAD SCI USA, V111, P11061, DOI 10.1073/pnas.1322362111; Radu M, 2013, J BIOL CHEM, V288, P21117, DOI 10.1074/jbc.M113.459719; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schlam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9623; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Shang X, 2003, J BIOL CHEM, V278, P45903, DOI 10.1074/jbc.M304514200; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sirokmany G, 2006, J BIOL CHEM, V281, P6096, DOI 10.1074/jbc.M510619200; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Toure A, 1998, J BIOL CHEM, V273, P6019, DOI 10.1074/jbc.273.11.6019; Tripathi BK, 2014, J CELL BIOL, V207, P627, DOI 10.1083/jcb.201405105; Tripathi V, 2014, ONCOGENE, V33, P724, DOI 10.1038/onc.2013.7; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wirth JA, 1996, J CELL SCI, V109, P653; Wurtele M, 2001, NAT STRUCT BIOL, V8, P23; Xu Y, 2014, J IMMUNOL, V192, P3559, DOI 10.4049/jimmunol.1300695; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Zhang BL, 1998, BIOCHEMISTRY-US, V37, P5249, DOI 10.1021/bi9718447; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	112	60	61	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20353	20371		10.1074/jbc.M116.736967	http://dx.doi.org/10.1074/jbc.M116.736967			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27481945	Green Published, hybrid			2022-12-28	WOS:000384574800007
J	Botzolakis, EJ; Gurba, KN; Lagrange, AH; Feng, HJ; Stanic, AK; Hu, NN; Macdonald, RL				Botzolakis, Emmanuel J.; Gurba, Katharine N.; Lagrange, Andre H.; Feng, Hua-Jun; Stanic, Aleksandar K.; Hu, Ningning; Macdonald, Robert L.			Comparison of gamma-Aminobutyric Acid, Type A (GABAA), Receptor alpha beta gamma and alpha beta delta Expression Using Flow Cytometry and Electrophysiology EVIDENCE FOR ALTERNATIVE SUBUNIT STOICHIOMETRIES AND ARRANGEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; flow cytometry; fluorescence resonance energy transfer (FRET); GABA receptor; recombinant protein expression; stoichiometry; Cys loop; Forster; ion channel	BENZODIAZEPINE-RECEPTOR; SURFACE EXPRESSION; RAT CEREBELLUM; CELL-SURFACE; ION CHANNELS; IN-VITRO; SUBTYPES; PHARMACOLOGY; MODULATION; MUTATIONS	The subunit stoichiometry and arrangement of synaptic GABA(A) receptors are generally accepted as 2:2:1 with a counterclockwise configuration, respectively. Whether extrasynaptic receptors adopt the analogous subunit configuration remains controversial. Using flow cytometry, we evaluated expression levels of human recombinant 2 and subunits when co-transfected with 1 and/or 2 subunits in HEK293T cells. Nearly identical patterns of 2 and subunit expression were observed as follows: both required co-transfection with 1 and 2 subunits for maximal expression; both were incorporated into receptors primarily at the expense of 2 subunits; and both yielded similar FRET profiles when probed for subunit adjacency, suggesting similar underlying subunit arrangements. However, because of a slower rate of subunit degradation, 10-fold less subunit cDNA was required to recapitulate 2 subunit expression patterns and to eliminate the functional signature of 12 receptors. Interestingly, titrating 2 or subunit cDNA levels progressively altered GABA-evoked currents, revealing more than one kinetic profile for both and receptors. This raised the possibility of alternative receptor isoforms, a hypothesis confirmed using concatameric constructs for receptors. Taken together, our results suggest a limited cohort of alternative subunit arrangements in addition to canonical receptors, including receptors at lower levels of 2/ expression and receptors at higher levels of expression. These findings provide important insight into the role of GABA(A) receptor subunit under- or overexpression in disease states such as genetic epilepsies.	[Botzolakis, Emmanuel J.; Gurba, Katharine N.] Vanderbilt Univ, Med Scientist Training Program, Nashville, TN 37240 USA; [Lagrange, Andre H.; Feng, Hua-Jun; Hu, Ningning; Macdonald, Robert L.] Vanderbilt Univ, Dept Neurol, Nashville, TN 37240 USA; [Lagrange, Andre H.; Macdonald, Robert L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37240 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37240 USA; [Lagrange, Andre H.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Stanic, Aleksandar K.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53792 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Wisconsin System; University of Wisconsin Madison	Macdonald, RL (corresponding author), Vanderbilt Univ, Med Ctr, 6140 Med Res Bldg 3,465 21st Ave South, Nashville, TN 37240 USA.	robert.macdonald@vanderbilt.edu	; Lagrange, Andre/B-1227-2008	Feng, Huajun/0000-0003-1544-4248; Lagrange, Andre/0000-0003-0147-7778; Stanic-Kostic, Aleksandar/0000-0003-1946-6436	National Institutes of Health Research [R01 33300]; Veterans Affairs Grant [1I01BX001189]; National Institutes of Health [T32-GM07347]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033300] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001189] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Grant(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Research Grant R01 33300 (to R. L. M.), Veterans Affairs Grant 1I01BX001189 (to A. H. L.), and National Institutes of Health Grant T32-GM07347 (to Vanderbilt University Medical Scientist Training Program). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Department of Veterans Affairs, or the United States government.	ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; BACKUS KH, 1993, NEUROREPORT, V5, P285, DOI 10.1097/00001756-199312000-00026; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Baumann SW, 2003, J NEUROSCI, V23, P11158; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Benke D, 1996, NEUROPHARMACOLOGY, V35, P1413, DOI 10.1016/S0028-3908(96)00068-8; Bianchi MT, 2002, J NEUROSCI, V22, P5321; Boileau AJ, 2005, J NEUROSCI, V25, P11219, DOI 10.1523/JNEUROSCI.3751-05.2005; Boileau AJ, 2003, NEUROPHARMACOLOGY, V44, P1003, DOI 10.1016/S0028-3908(03)00114-X; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; Boileau AJ, 2010, J NEUROSCI, V30, P4895, DOI 10.1523/JNEUROSCI.5039-09.2010; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Bracamontes JR, 2008, J BIOL CHEM, V283, P26128, DOI 10.1074/jbc.M801292200; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Ericksen SS, 2007, MOL NEUROBIOL, V35, P113, DOI 10.1007/BF02700627; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2014, BRIT J PHARMACOL, V171, P789, DOI 10.1111/bph.12507; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Greenfield LJ, 1997, NEUROPHARMACOLOGY, V36, P63, DOI 10.1016/S0028-3908(96)00150-5; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Haas KF, 1999, J PHYSIOL-LONDON, V514, P27, DOI 10.1111/j.1469-7793.1999.027af.x; Hackam AS, 1997, NEUROREPORT, V8, P1425, DOI 10.1097/00001756-199704140-00020; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Johnston AJ, 2014, NEUROBIOL DIS, V64, P131, DOI 10.1016/j.nbd.2013.12.013; Kang JQ, 2010, J NEUROSCI, V30, P13895, DOI 10.1523/JNEUROSCI.2320-10.2010; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Kellenberger S, 1996, NEUROPHARMACOLOGY, V35, P1403, DOI 10.1016/S0028-3908(96)00034-2; KHAN ZU, 1994, J NEUROCHEM, V63, P1466; KHAN ZU, 1994, J NEUROCHEM, V63, P371; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; QUIRK K, 1994, J BIOL CHEM, V269, P16020; Rula EY, 2008, J NEUROSCI, V28, P6196, DOI 10.1523/JNEUROSCI.0443-08.2008; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shrestha D, 2015, INT J MOL SCI, V16, P6718, DOI 10.3390/ijms16046718; SIGEL E, 1984, J BIOL CHEM, V259, P7219; Taylor PM, 1999, J NEUROSCI, V19, P6360; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tretter V, 1997, J NEUROSCI, V17, P2728; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Zhao JL, 2008, J NEUROSCI, V28, P13938, DOI 10.1523/JNEUROSCI.4668-08.2008	53	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20440	20461		10.1074/jbc.M115.698860	http://dx.doi.org/10.1074/jbc.M115.698860			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27493204	Green Published, hybrid			2022-12-28	WOS:000384574800013
J	Kim, J; Okla, M; Erickson, A; Carr, T; Natarajan, SK; Chung, S				Kim, Jiyoung; Okla, Meshail; Erickson, Anjeza; Carr, Timothy; Natarajan, Sathish Kumar; Chung, Soonkyu			Eicosapentaenoic Acid Potentiates Brown Thermogenesis through FFAR4-dependent Up-regulation of miR-30b and miR-378	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue metabolism; insulin resistance; microRNA (miRNA); obesity; polyunsaturated fatty acid (PUFA); uncoupling protein; free fatty acid receptor 4; brown adipogenesis; brown fat	RECEPTOR COREPRESSOR RIP140; PROTEIN-COUPLED RECEPTORS; WHITE ADIPOSE-TISSUE; INSULIN-RESISTANCE; FATTY-ACIDS; BEIGE FAT; GENE-EXPRESSION; GPR120; DIFFERENTIATION; INFLAMMATION	Emerging evidence suggests that n-3 polyunsaturated fatty acids (PUFA) promote brown adipose tissue thermogenesis. However, the underlying mechanisms remain elusive. Here, we hypothesize that n-3 PUFA promotes brown adipogenesis by modulating miRNAs. To test this hypothesis, murine brown preadipocytes were induced to differentiate the fatty acids of palmitic, oleate, or eicosapentaenoic acid (EPA). The increases of brown-specific signature genes and oxygen consumption rate by EPA were concurrent with up-regulation of miR-30b and 378 but not by oleate or palmitic acid. Next, we hypothesize that free fatty acid receptor 4 (Ffar4), a functional receptor for n-3 PUFA, modulates miR-30b and 378. Treatment of Ffar4 agonist (GW9508) recapitulated the thermogenic activation of EPA by increasing oxygen consumption rate, brown-specific marker genes, and miR-30b and 378, which were abrogated in Ffar4-silenced cells. Intriguingly, addition of the miR-30b mimic was unable to restore EPA-induced Ucp1 expression in Ffar4-depleted cells, implicating that Ffar4 signaling activity is required for up-regulating the brown adipogenic program. Moreover, blockage of miR-30b or 378 by locked nucleic acid inhibitors significantly attenuated Ffar4 as well as brown-specific signature gene expression, suggesting the signaling interplay between Ffar4 and miR-30b/378. The association between miR-30b/378 and brown thermogenesis was also confirmed in fish oil-fed C57/BL6 mice. Interestingly, the Ffar4 agonism-mediated signaling axis of Ffar4-miR-30b/378-Ucp1 was linked with an elevation of cAMP in brown adipocytes, similar to cold-exposed or fish oil-fed brown fat. Taken together, our work identifies a novel function of Ffar4 in modulating brown adipogenesis partly through a mechanism involving cAMP activation and up-regulation of miR-30b and miR-378.	[Kim, Jiyoung; Okla, Meshail; Erickson, Anjeza; Carr, Timothy; Natarajan, Sathish Kumar; Chung, Soonkyu] Univ Nebraska, Dept Nutr & Hlth Sci, 316G Ruth Leverton Hall,POB 830806, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Chung, S (corresponding author), Univ Nebraska, Dept Nutr & Hlth Sci, 316G Ruth Leverton Hall,POB 830806, Lincoln, NE 68583 USA.	schung4@unl.edu	Okla, Meshail S/E-9317-2017	Chung, Soonkyu/0000-0001-6279-7017	National Institutes of Health [1P20GM104320]; Nebraska Tobacco Settlement Biomedical Research Enhancement Funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Enhancement Funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1P20GM104320 (Project 5) (to S. C.) and in part by Nebraska Tobacco Settlement Biomedical Research Enhancement Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antal O, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-142; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Chakraborty C, 2014, WIRES RNA, V5, P697, DOI 10.1002/wrna.1240; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Fleckenstein-Elsen M, 2016, MOL NUTR FOOD RES, V60, P2065, DOI 10.1002/mnfr.201500892; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hu F, 2015, DIABETES, V64, P2056, DOI 10.2337/db14-1117; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Karbiener M, 2014, COMPUT STRUCT BIOTEC, V11, P101, DOI 10.1016/j.csbj.2014.09.005; Kim HJ, 2014, DIABETES, V63, P4045, DOI 10.2337/db14-0466; Kim M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18013; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li XZ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001856; Bargut TCL, 2016, EUR J NUTR, V55, P159, DOI 10.1007/s00394-015-0834-0; Martinez-Fernandez L, 2015, PROSTAG OTH LIPID M, V121, P24, DOI 10.1016/j.prostaglandins.2015.07.003; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; Moniri NH, 2016, BIOCHEM PHARMACOL, V110, P1, DOI 10.1016/j.bcp.2016.01.021; Moran BM, 2014, DIABETES OBES METAB, V16, P1128, DOI 10.1111/dom.12330; Mori MA, 2014, J CLIN INVEST, V124, P3339, DOI 10.1172/JCI73468; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Okla M, 2015, J BIOL CHEM, V290, P26476, DOI 10.1074/jbc.M115.677724; Ortega FJ, 2015, J NUTR BIOCHEM, V26, P1095, DOI 10.1016/j.jnutbio.2015.05.001; Pan DN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5725; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosell M, 2011, BBA-MOL BASIS DIS, V1812, P919, DOI 10.1016/j.bbadis.2010.12.016; Seale P, 2010, INT J OBESITY, V34, pS17, DOI 10.1038/ijo.2010.178; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Sun L, 2014, METABOLISM, V63, P272, DOI 10.1016/j.metabol.2013.10.004; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Trajkovski M, 2013, TRENDS ENDOCRIN MET, V24, P442, DOI 10.1016/j.tem.2013.05.002; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Ulven T, 2015, ANNU REV NUTR, V35, P239, DOI 10.1146/annurev-nutr-071714-034410; Vargovic P, 2011, FEBS LETT, V585, P2279, DOI 10.1016/j.febslet.2011.06.001; Wu Y, 2013, BIOCHEM BIOPH RES CO, V438, P575, DOI 10.1016/j.bbrc.2013.08.016; Xu SH, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150155; Zhang LL, 2014, NAT PROD RES, V28, P1637, DOI 10.1080/14786419.2014.923998; Zhao M, 2014, BIOCHEM BIOPH RES CO, V450, P1446, DOI 10.1016/j.bbrc.2014.07.010; Zhou JY, 2014, BBA-MOL CELL BIOL L, V1841, P1590, DOI 10.1016/j.bbalip.2014.08.009	51	71	74	2	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20551	20562		10.1074/jbc.M116.721480	http://dx.doi.org/10.1074/jbc.M116.721480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27489163	hybrid, Green Published			2022-12-28	WOS:000384574800021
J	Woll, KA; Murlidaran, S; Pinch, BJ; Henin, J; Wang, XS; Salari, R; Covarrubias, M; Dailey, WP; Brannigan, G; Garcia, BA; Eckenhoff, RG				Woll, Kellie A.; Murlidaran, Sruthi; Pinch, Benika J.; Henin, Jerome; Wang, Xiaoshi; Salari, Reza; Covarrubias, Manuel; Dailey, William P.; Brannigan, Grace; Garcia, Benjamin A.; Eckenhoff, Roderic G.			A Novel Bifunctional Alkylphenol Anesthetic Allows Characterization of gamma-Aminobutyric Acid, Type A (GABA(A)), Receptor Subunit Binding Selectivity in Synaptosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anesthesia; anesthetic; click chemistry; GABA receptor; photoaffinity labeling	GATED ION CHANNELS; PROPOFOL ANALOGS; COMPUTER-SIMULATIONS; INHIBITORY SYNAPSES; GENERAL-ANESTHETICS; HIPPOCAMPAL-NEURONS; MOLECULAR-DYNAMICS; SITES; ACTIVATION; PROTEIN	Propofol, an intravenous anesthetic, is a positive modulator of the GABA(A) receptor, but the mechanistic details, including the relevant binding sites and alternative targets, remain disputed. Here we undertook an in-depth study of alkylphenol-based anesthetic binding to synaptic membranes. We designed, synthesized, and characterized a chemically active alkylphenol anesthetic (2-((prop-2-yn-1-yloxy)methyl)-5-(3-(trifluoromethyl)-3H-diazirin-3-yl)phenol, AziPm-click (1)), for affinity-based protein profiling (ABPP) of propofol-binding proteins in their native state within mouse synaptosomes. The ABPP strategy captured approximate to 4% of the synaptosomal proteome, including the unbiased capture of five or GABA(A) receptor subunits. Lack of 2 subunit capture was not due to low abundance. Consistent with this, independent molecular dynamics simulations with alchemical free energy perturbation calculations predicted selective propofol binding to interfacial sites, with higher affinities for / than -containing interfaces. The simulations indicated hydrogen bonding is a key component leading to propofol-selective binding within GABA(A) receptor subunit interfaces, with stable hydrogen bonds observed between propofol and / cavity residues but not cavity residues. We confirmed this by introducing a hydrogen bond-null propofol analogue as a protecting ligand for targeted-ABPP and observed a lack of GABA(A) receptor subunit protection. This investigation demonstrates striking interfacial GABA(A) receptor subunit selectivity in the native milieu, suggesting that asymmetric occupancy of heteropentameric ion channels by alkylphenol-based anesthetics is sufficient to induce modulation of activity.	[Woll, Kellie A.; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Woll, Kellie A.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Xiaoshi; Garcia, Benjamin A.; Eckenhoff, Roderic G.] Univ Penn, Epigenet Program, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Murlidaran, Sruthi; Salari, Reza; Brannigan, Grace] Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA; [Salari, Reza; Brannigan, Grace] Rutgers State Univ, Dept Phys, Camden, NJ 08102 USA; [Pinch, Benika J.; Dailey, William P.] Univ Penn, Dept Chem, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Henin, Jerome] CNRS, UMR 8251, Lab Biochim Theor, Inst Biol Physicochim, F-5013 Paris, France; [Henin, Jerome] Univ Paris Diderot, F-5013 Paris, France; [Covarrubias, Manuel] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurosci, Philadelphia, PA 19107 USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Farber Inst Neurosci, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick; University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Jefferson University; Jefferson University	Eckenhoff, RG (corresponding author), 311A John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu	Murlidaran, Sruthi/ABA-3890-2020; Murlidaran, Sruthi/ABB-1586-2020; Hénin, Jérôme/A-7080-2008; Brannigan, Grace/ABA-2750-2021; Hénin, Jérôme/AAX-5604-2020	Murlidaran, Sruthi/0000-0002-8915-6911; Hénin, Jérôme/0000-0003-2540-4098; Brannigan, Grace/0000-0001-8949-2694; Eckenhoff, Roderic/0000-0002-5581-746X; Covarrubias, Manuel/0000-0002-0881-4143	National Institutes of Health [GM055876, GM107174]; Department of Defense [BC123187P1]; National Science Foundation Graduate Research Fellowship [DGE-1321851]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107117, P01GM055876, R01GM110174] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1330728] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health Grants GM055876 and GM107174, Department of Defense Grant BC123187P1, and National Science Foundation Graduate Research Fellowship DGE-1321851. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barber AF, 2012, J BIOL CHEM, V287, P40425, DOI 10.1074/jbc.M112.405787; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Bertaccini EJ, 2013, ANESTHESIOLOGY, V119, P1087, DOI 10.1097/ALN.0b013e31829e47e3; Best RB, 2012, BIOPHYS J, V103, P1045, DOI 10.1016/j.bpj.2012.07.042; Breton GW, 1997, J ORG CHEM, V62, P8952, DOI 10.1021/jo971367y; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Chang CSS, 2003, J BIOL CHEM, V278, P42821, DOI 10.1074/jbc.M306978200; Eaton MM, 2015, MOL PHARMACOL, V88, P736, DOI 10.1124/mol.115.100347; Eckenhoff RG, 2010, METHODS MOL BIOL, V617, P437, DOI 10.1007/978-1-60327-323-7_31; Eckle VS, 2015, BRIT J ANAESTH, V114, P491, DOI 10.1093/bja/aeu269; Fagerlund MJ, 2010, BRIT J ANAESTH, V104, P472, DOI 10.1093/bja/aeq023; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fassl J, 2011, J CLIN PHARMACOL, V51, P719, DOI 10.1177/0091270010373098; Frisch M. J., 2009, GAUSSAIN 09 REVISION; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Grasshoff C, 2005, CURR OPIN ANESTHESIO, V18, P386, DOI 10.1097/01.aco.0000174961.90135.dc; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Henin J, 2014, BIOPHYS J, V106, P1938, DOI 10.1016/j.bpj.2014.03.024; Hentschke H, 2009, J NEUROPHYSIOL, V102, P3643, DOI 10.1152/jn.00651.2009; Herring BE, 2011, J PHYSIOL-LONDON, V589, P1103, DOI 10.1113/jphysiol.2010.200964; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Hirata K, 2008, BRAIN DEV-JPN, V30, P238, DOI 10.1016/j.braindev.2007.08.007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAMES R, 1980, J MED CHEM, V23, P1350, DOI 10.1021/jm00186a013; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jiang W, 2014, COMPUT PHYS COMMUN, V185, P908, DOI 10.1016/j.cpc.2013.12.014; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krasowski MD, 2002, J MED CHEM, V45, P3210, DOI 10.1021/jm010461a; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lea WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007150; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Leon I, 2012, PHYS CHEM CHEM PHYS, V14, P8956, DOI 10.1039/c2cp40656j; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maldifassi MC, 2016, NEUROPHARMACOLOGY, V105, P207, DOI 10.1016/j.neuropharm.2016.01.003; McDougall SJ, 2008, NEUROPHARMACOLOGY, V54, P552, DOI 10.1016/j.neuropharm.2007.11.001; McKinstry-Wu AR, 2015, ANESTHESIOLOGY, V122, P325, DOI 10.1097/ALN.0000000000000505; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Nishikawa Koichi, 2011, Masui, V60, P534; Nymann-Andersen J, 2002, J NEUROCHEM, V80, P815, DOI 10.1046/j.0022-3042.2002.00762.x; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen Richard W, 2015, Adv Pharmacol, V73, P167, DOI 10.1016/bs.apha.2014.11.005; Olsen RW, 2014, ALCOHOL CLIN EXP RES, V38, P595, DOI 10.1111/acer.12283; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; ORSER BA, 1994, J NEUROSCI, V14, P7747; ORSER BA, 1995, BRIT J PHARMACOL, V116, P1761, DOI 10.1111/j.1476-5381.1995.tb16660.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sanchis-Segura C, 2007, NEUROSCI LETT, V416, P275, DOI 10.1016/j.neulet.2007.02.024; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; Szychowski J, 2010, J AM CHEM SOC, V132, P18351, DOI 10.1021/ja1083909; Tibbs GR, 2013, J PHARMACOL EXP THER, V345, P363, DOI 10.1124/jpet.113.203620; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Weiser BP, 2014, FEBS LETT, V588, P4398, DOI 10.1016/j.febslet.2014.10.009; Weiser Brian P, 2014, Curr Anesthesiol Rep, V4, P57; Weiser BP, 2013, J BIOL CHEM, V288, P1279, DOI 10.1074/jbc.M112.413989; Westergard T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142514; Weyermann P, 1999, ANGEW CHEM INT EDIT, V38, P3215, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3215::AID-ANIE3215>3.0.CO;2-S; Woll KA, 2015, ACS CHEM NEUROSCI, V6, P927, DOI 10.1021/acschemneuro.5b00078; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Wu X, 2012, J BIOL CHEM, V287, P27417, DOI 10.1074/jbc.M112.360461; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Zecharia AY, 2009, J NEUROSCI, V29, P2177, DOI 10.1523/JNEUROSCI.4997-08.2009; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	77	21	22	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20473	20486		10.1074/jbc.M116.736975	http://dx.doi.org/10.1074/jbc.M116.736975			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27462076	hybrid, Green Published			2022-12-28	WOS:000384574800015
J	Smith, D; Tikhonova, IG; Jewhurst, HL; Drysdale, OC; Dvorak, J; Robinson, MW; Cwiklinski, K; Dalton, JP				Smith, David; Tikhonova, Irina G.; Jewhurst, Heather L.; Drysdale, Orla C.; Dvorak, Jan; Robinson, Mark W.; Cwiklinski, Krystyna; Dalton, John P.			Unexpected Activity of a Novel Kunitz-type Inhibitor INHIBITION OF CYSTEINE PROTEASES BUT NOT SERINE PROTEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine protease; enzyme inhibitor; enzyme kinetics; host-pathogen interaction; molecular modeling; parasite; protease inhibitor; protein-protein interaction; serine protease	FASCIOLA-HEPATICA; ELECTRON-MICROSCOPE; PROTEIN INHIBITORS; FUNCTIONAL-CHARACTERIZATION; HELMINTH PATHOGEN; TRYPSIN-INHIBITOR; LIVER FLUKE; PURIFICATION; ENVIRONMENT; EXPRESSION	Kunitz-type (KT) protease inhibitors are low molecular weight proteins classically defined as serine protease inhibitors. We identified a novel secreted KT inhibitor associated with the gut and parenchymal tissues of the infective juvenile stage of Fasciola hepatica, a helminth parasite of medical and veterinary importance. Unexpectedly, recombinant KT inhibitor (rFhKT1) exhibited no inhibitory activity toward serine proteases but was a potent inhibitor of the major secreted cathepsin L cysteine proteases of F. hepatica, FhCL1 and FhCL2, and of human cathepsins L and K (K-i = 0.4-27 nm). FhKT1 prevented the auto-catalytic activation of FhCL1 and FhCL2 and formed stable complexes with the mature enzymes. Pulldown experiments from adult parasite culture medium showed that rFhKT1 interacts specifically with native secreted FhCL1, FhCL2, and FhCL5. Substitution of the unusual P1 Leu(15) within the exposed reactive loop of FhKT1 for the more commonly found Arg (FhKT1Leu(15)/Arg(15)) had modest adverse effects on the cysteine protease inhibition but conferred potent activity against the serine protease trypsin (K-i = 1.5 nm). Computational docking and sequence analysis provided hypotheses for the exclusive binding of FhKT1 to cysteine proteases, the importance of the Leu(15) in anchoring the inhibitor into the S2 active site pocket, and the inhibitor's selectivity toward FhCL1, FhCL2, and human cathepsins L and K. FhKT1 represents a novel evolutionary adaptation of KT protease inhibitors by F. hepatica, with its prime purpose likely in the regulation of the major parasite-secreted proteases and/or cathepsin L-like proteases of its host.	[Smith, David; Jewhurst, Heather L.; Drysdale, Orla C.; Dvorak, Jan; Robinson, Mark W.; Cwiklinski, Krystyna; Dalton, John P.] Queens Univ Belfast, Sch Biol Sci, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Smith, D (corresponding author), Queens Univ Belfast, Sch Biol Sci, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	dsmith37@qub.ac.uk	Smith, David/AAH-4738-2020; Dvorak, Jan/AAJ-2426-2020	Robinson, Mark/0000-0001-7191-0034; Dvorak, Jan/0000-0002-6824-9000; Smith, David/0000-0002-5158-0522	Department for Employment and Learning (DEL), Northern Ireland grant; European Research Council Advanced Grant HELIVAC [European Research Council Advanced Grant HELIVAC 322725]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L019612/1]; BBSRC [BB/L019612/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L019612/1] Funding Source: researchfish	Department for Employment and Learning (DEL), Northern Ireland grant; European Research Council Advanced Grant HELIVAC; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a Department for Employment and Learning (DEL), Northern Ireland grant. To whom correspondence should be addressed: School of Biological Sciences, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Rd., Belfast BT9 7BL, Northern Ireland, United Kingdom. E-mail: dsmith37@qub.ac.uk.; Supported by European Research Council Advanced Grant HELIVAC 322725 (to J. P. D.).; Supported by Grant BB/L019612/1 from the Biotechnology and Biological Sciences Research Council (BBSRC).	Abreu PA, 2014, BIOCHEM BIOPH RES CO, V449, P69, DOI 10.1016/j.bbrc.2014.04.154; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Azzolini SS, 2005, EXP PARASITOL, V111, P30, DOI 10.1016/j.exppara.2005.03.013; Barrett A. J., 2012, HDB PROTEOLYTIC ENZY, P1097; BENNETT JL, 1977, INT J PARASITOL, V7, P221, DOI 10.1016/0020-7519(77)90051-0; Bozas SE, 1995, MOL BIOCHEM PARASIT, V74, P19, DOI 10.1016/0166-6851(95)02478-6; Ceraul SM, 2008, INFECT IMMUN, V76, P5429, DOI 10.1128/IAI.00866-08; CERWINSKY EW, 1967, BIOCHEMISTRY-US, V6, P3175, DOI 10.1021/bi00862a027; Chu D, 2004, INFECT IMMUN, V72, P2214, DOI 10.1128/IAI.72.4.2214-2221.2004; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; Cwiklinski K, 2015, MOL CELL PROTEOMICS, V14, P3258, DOI 10.1074/mcp.M115.053934; Cwiklinski K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0632-2; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; Eng W. S., 2015, VENOMOUS REPTILES TH, P281; Falcon CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114505; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Gil DF, 2011, FEMS YEAST RES, V11, P575, DOI 10.1111/j.1567-1364.2011.00749.x; Gonzalez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007009; HANNA REB, 1976, EXP PARASITOL, V39, P204, DOI 10.1016/0014-4894(76)90120-X; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Howell A, 2015, PREV VET MED, V121, P41, DOI 10.1016/j.prevetmed.2015.05.013; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Ishidoh K, 1998, BIOL CHEM, V379, P131; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jefferies JR, 2001, PROTEOMICS, V1, P1128, DOI 10.1002/1615-9861(200109)1:9<1128::AID-PROT1128>3.0.CO;2-0; Jin XA, 2011, PARASITOL RES, V108, P287, DOI 10.1007/s00436-010-2055-z; Kawamura K, 2011, ACTA CRYSTALLOGR D, V67, P140, DOI 10.1107/S0907444910053382; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Li B., 2013, AFRICAN J BIOTECHNOL, V10, P19464; Lowther J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000369; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Mathews C. K., 2012, BIOCHEMISTRY-US, P192; McGonigle L, 2008, INT J PARASITOL, V38, P149, DOI 10.1016/j.ijpara.2007.10.007; Milstone AM, 2000, J BIOL CHEM, V275, P29391, DOI 10.1074/jbc.M002715200; Molina-Hernandez V, 2015, VET PARASITOL, V208, P101, DOI 10.1016/j.vetpar.2015.01.004; Muino L, 2011, MOL BIOCHEM PARASIT, V179, P80, DOI 10.1016/j.molbiopara.2011.06.003; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; Ranasinghe S, 2013, DEV COMP IMMUNOL, V39, P219, DOI 10.1016/j.dci.2012.10.005; Ranasinghe SL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004268; Ranasinghe SL, 2015, PARASITOLOGY, V142, P1663, DOI 10.1017/S0031182015001328; Ranasinghe SL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1022-z; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2009, MOL CELL PROTEOMICS, V8, P1891, DOI 10.1074/mcp.M900045-MCP200; Sasaki SD, 2006, BIOCHEM BIOPH RES CO, V341, P266, DOI 10.1016/j.bbrc.2005.12.178; Smooker PM, 2000, PROTEIN SCI, V9, P2567, DOI 10.1110/ps.9.12.2567; Soares TS, 2012, VET PARASITOL, V187, P521, DOI 10.1016/j.vetpar.2012.01.027; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; THREADGOLD LT, 1966, PARASITOLOGY, V56, P299, DOI 10.1017/S0031182000070888; THREADGOLD LT, 1974, EXP PARASITOL, V35, P389, DOI 10.1016/0014-4894(74)90045-9; Torgerson P, 1999, FASCIOLOSIS, P113; Tsujimoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029964; Wan Hu, 2013, PLoS One, V8, pe53343, DOI 10.1371/journal.pone.0053343; Wang H, 2012, BIOCHIMIE, V94, P891, DOI 10.1016/j.biochi.2011.12.008; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003; Zavasnik-Bergant T, 2008, FRONT BIOSCI-LANDMRK, V13, P4625, DOI 10.2741/3028	63	23	23	3	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19220	19234		10.1074/jbc.M116.724344	http://dx.doi.org/10.1074/jbc.M116.724344			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27422822	Green Published, hybrid			2022-12-28	WOS:000383242800002
J	Imae, K; Saito, Y; Kizaki, H; Ryuno, H; Mao, H; Miyashita, A; Suzuki, Y; Sekimizu, K; Kaito, C				Imae, Kenta; Saito, Yuki; Kizaki, Hayato; Ryuno, Hiroki; Mao, Han; Miyashita, Atsushi; Suzuki, Yutaka; Sekimizu, Kazuhisa; Kaito, Chikara			Novel Nucleoside Diphosphatase Contributes to Staphylococcus aureus Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROINVASIVE ESCHERICHIA-COLI; GENE REGULATOR AGR; EXOPROTEIN SYNTHESIS; CRYSTAL-STRUCTURE; SILKWORM MODEL; EXPRESSION; IDENTIFICATION; APYRASE; PROTEIN; SYSTEM	We identified SA1684 as a Staphylococcus aureus virulence gene using a silkworm infection model. The SA1684 gene product carried the DUF402 domain, which is found in RNA-binding proteins, and had amino acid sequence similarity with a nucleoside diphosphatase, Streptomyces coelicolor SC4828 protein. The SA1684-deletion mutant exhibited drastically decreased virulence, in which the LD50 against silkworms was more than 10 times that of the parent strain. The SA1684-deletion mutant also exhibited decreased exotoxin production and colony-spreading ability. Purified SA1684 protein had Mn2+ -or Co2+-dependent hydrolyzing activity against nucleoside diphosphates. Alanine substitutions of Tyr-88, Asp-106, and Asp-123/Glu-124, which are conserved between SA1684 and SC4828, diminished the nucleoside diphosphatase activity. Introduction of the wild-type SA1684 gene restored the hemolysin production of the SA1684-deletion mutant, whereas none of the alanine-substituted SA1684 mutant genes restored the hemolysin production. RNA sequence analysis revealed that SA1684 is required for the expression of the virulence regulatory genes agr, sarZ, and sarX, as well as metabolic genes involved in glycolysis and fermentation pathways. These findings suggest that the novel nucleoside diphosphatase SA1684 links metabolic-pathways and virulence gene expression and plays an important role in S. aureus virulence.	[Imae, Kenta; Saito, Yuki; Kizaki, Hayato; Ryuno, Hiroki; Mao, Han; Miyashita, Atsushi; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan	University of Tokyo; University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Miyashita, Atsushi/0000-0002-9076-0569	Ministry of Education, Culture, Sports, Science and Technology KAKENHI [22150002]; KANAE Foundation; Genome Pharmaceutical Institute;  [15H04727];  [15H05783]	Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KANAE Foundation; Genome Pharmaceutical Institute; ; 	This work was supported by Grants-in-aid for Scientific Research 15H04727 and 15H05783, Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grant 22150002, and in part by The KANAE Foundation and the Genome Pharmaceutical Institute. The authors declare that they have no conflicts of interest with the contents of this article.	AMANO T, 1993, J BIOCHEM-TOKYO, V114, P329, DOI 10.1093/oxfordjournals.jbchem.a124176; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Berlutti F, 1998, INFECT IMMUN, V66, P4957, DOI 10.1128/IAI.66.10.4957-4964.1998; Besier S, 2007, INT J MED MICROBIOL, V297, P217, DOI 10.1016/j.ijmm.2007.02.003; BHARGAVA T, 1995, CURR SCI INDIA, V68, P293; CARTER SG, 1982, J BIOCHEM BIOPH METH, V7, P7, DOI 10.1016/0165-022X(82)90031-8; Chatterjee I, 2008, J BACTERIOL, V190, P834, DOI 10.1128/JB.00912-07; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Geiger T, 2014, INT J MED MICROBIOL, V304, P150, DOI 10.1016/j.ijmm.2013.11.013; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Hansen JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042645; Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x; Ikuo M, 2010, MICROB PATHOGENESIS, V49, P1, DOI 10.1016/j.micpath.2010.03.010; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2012, ISJ-INVERT SURVIV J, V9, P163; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2002, FEMS MICROBIOL LETT, V210, P157, DOI 10.1016/S0378-1097(02)00603-1; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kaito C, 2011, MICROB PATHOGENESIS, V51, P142, DOI 10.1016/j.micpath.2011.04.007; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2007, DRUG DISCOV THER, V1, P89; Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005; Khemici V, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005577, 10.1371/journal.pgen.1006320]; Kohler C, 2008, J BACTERIOL, V190, P6351, DOI 10.1128/JB.00505-08; Kriegeskorte A, 2014, MBIO, V5, DOI 10.1128/mBio.01447-14; Kyuma T, 2015, BIOCHIMIE, V119, P166, DOI 10.1016/j.biochi.2015.10.027; Kyuma T, 2015, FEBS J, V282, P2570, DOI 10.1111/febs.13302; Lee S, 2008, J BIOL CHEM, V283, P15232, DOI 10.1074/jbc.M800479200; Li D, 2008, PROTEINS, V72, P1071, DOI 10.1002/prot.22093; Maierczyk C. D., 2008, J BACTERIOL, V190, P2257; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Manna AC, 2006, J BACTERIOL, V188, P4288, DOI 10.1128/JB.00297-06; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Matsumoto Y, 2010, STRUCTURE, V18, P537, DOI 10.1016/j.str.2010.02.007; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Nagarajan V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-351; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; Nasr F, 2000, NUCLEIC ACIDS RES, V28, P1676, DOI 10.1093/nar/28.8.1676; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Numata S, 2014, J BIOL CHEM, V289, P8420, DOI 10.1074/jbc.M114.554329; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Roux A, 2014, J BACTERIOL, V196, P1184, DOI 10.1128/JB.00128-13; Ryan RP, 2013, MICROBIOL-SGM, V159, P1286, DOI 10.1099/mic.0.068189-0; Sambrook J., 2001, MOL CLONING LAB MANU; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Sarli S, 2005, MICROBIOL-SGM, V151, P2853, DOI 10.1099/mic.0.28142-0; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stenz L, 2011, FEMS IMMUNOL MED MIC, V62, P123, DOI 10.1111/j.1574-695X.2011.00812.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueda T, 2011, MICROB PATHOGENESIS, V51, P178, DOI 10.1016/j.micpath.2011.04.003; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002	59	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18608	18619		10.1074/jbc.M116.721845	http://dx.doi.org/10.1074/jbc.M116.721845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27422825	Green Published, hybrid			2022-12-28	WOS:000383242300002
J	Ortega, E; Manso, JA; Buey, RM; Carballido, AM; Carabias, A; Sonnenberg, A; de Pereda, JM				Ortega, Esther; Manso, Jose A.; Buey, Ruben M.; Carballido, Ana M.; Carabias, Arturo; Sonnenberg, Arnoud; de Pereda, Jose M.			The Structure of the Plakin Domain of Plectin Reveals an Extended Rod-like Shape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY/DYSPLASIA; INTEGRIN BETA-4 SUBUNIT; RAY SOLUTION SCATTERING; ACTIN-BINDING DOMAIN; SPECTRIN-REPEATS; MACROMOLECULAR CRYSTALLOGRAPHY; BIOLOGICAL MACROMOLECULES; MOLECULAR REPLACEMENT; CRYSTAL-STRUCTURE; F-ACTIN	Plakins are large multi-domain proteins that interconnect cytoskeletal structures. Plectin is a prototypical plakin that tethers intermediate filaments to membrane-associated complexes. Most plakins contain a plakin domain formed by up to nine spectrin repeats (SR1-SR9) and an SH3 domain. The plakin domains of plectin and other plakins harbor binding sites for junctional proteins. We have combined x-ray crystallography with small angle x-ray scattering (SAXS) to elucidate the structure of the plakin domain of plectin, extending our previous analysis of the SR1 to SR5 region. Two crystal structures of the SR5-SR6 region allowed us to characterize its uniquely wide inter-repeat conformational variability. We also report the crystal structures of the SR7-SR8 region, refined to 1.8 angstrom, and the SR7-SR9 at lower resolution. The SR7-SR9 region, which is conserved in all other plakin domains, forms a rigid segment stabilized by uniquely extensive inter-repeat contacts mediated by unusually long helices in SR8 and SR9. Using SAXS we show that in solution the SR3-SR6 and SR7-SR9 regions are rod-like segments and that SR3-SR9 of plectin has an extended shape with a small central kink. Other plakins, such as bullous pemphigoid antigen 1 and microtubule and actin cross-linking factor 1, are likely to have similar extended plakin domains. In contrast, desmoplakin has a two-segment structure with a central flexible hinge. The continuous versus segmented structures of the plakin domains of plectin and desmoplakin give insight into how different plakins might respond to tension and transmit mechanical signals.	[Ortega, Esther; Manso, Jose A.; Buey, Ruben M.; Carballido, Ana M.; Carabias, Arturo; de Pereda, Jose M.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Campus Unamuno, E-37007 Salamanca, Spain; [Buey, Ruben M.] Univ Salamanca, Dept Genet & Microbiol, Metab Engn Grp, E-37007 Salamanca, Spain; [Sonnenberg, Arnoud] Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Netherlands Cancer Institute	de Pereda, JM (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Campus Unamuno, E-37007 Salamanca, Spain.	pereda@usal.es	Manso, José/GWV-5180-2022; Martinez-Buey, Ruben/K-4296-2014; de Pereda, Jose M/AAE-5226-2022; del Rey, Arturo Carabias/A-4191-2019; Manso, José Antonio/S-3983-2019; Ortega, Esther/AAB-1836-2020; de Pereda, Jose M/F-1733-2010	Martinez-Buey, Ruben/0000-0003-1263-0221; de Pereda, Jose M/0000-0002-8912-6739; del Rey, Arturo Carabias/0000-0001-6286-2309; Manso, José Antonio/0000-0002-2565-6239; de Pereda, Jose M/0000-0002-8912-6739; Ortega Portero, Esther/0000-0003-1263-4409; Sonnenberg, Arnoud/0000-0001-9585-468X	Spanish Ministry of Economy and Competitiveness (MINECO); European Regional Development Fund [BFU2012-32847, BFU2015-69499-P]; Netherlands Science Foundation; Dutch Cancer Society; European Community under BioStruct-X Grant [283570]; MINECO [BES-2007-16463, BES-2010-038674, FPU14/ 06259]; MINECO	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); European Regional Development Fund(European Commission); Netherlands Science Foundation(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); European Community under BioStruct-X Grant; MINECO(Spanish Government); MINECO(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) and the European Regional Development Fund, Grants BFU2012-32847 and BFU2015-69499-P (to J. M. dP), as well as by the Netherlands Science Foundation and the Dutch Cancer Society (to A. S.). This work also was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X Grant Agreement 283570. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of Fellowships BES-2007-16463, BES-2010-038674, and FPU14/ 06259 from MINECO.; Supported by a "Ramon y Cajal" contract from MINECO.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adamovic I, 2008, BIOPHYS J, V94, P3779, DOI 10.1529/biophysj.107.122028; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ai-Jassar C, 2013, J MOL BIOL, V425, P4006, DOI 10.1016/j.jmb.2013.07.035; Al-Jassar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069767; Al-Jassar C, 2011, J MOL BIOL, V411, P1049, DOI 10.1016/j.jmb.2011.06.047; Alonso-Garcia N, 2009, ACTA CRYSTALLOGR D, V65, P858, DOI 10.1107/S0907444909018745; BABCOCK MS, 1994, J MOL BIOL, V237, P125, DOI 10.1006/jmbi.1994.1213; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bouameur JE, 2014, J INVEST DERMATOL, V134, P885, DOI 10.1038/jid.2013.498; Boyden LM, 2016, HUM MOL GENET, V25, P348, DOI 10.1093/hmg/ddv481; Choi HJ, 2011, J MOL BIOL, V409, P800, DOI 10.1016/j.jmb.2011.04.046; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elliott P, 2010, CIRC-CARDIOVASC GENE, V3, P314, DOI 10.1161/CIRCGENETICS.110.937805; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fontao L, 2001, J CELL SCI, V114, P2065; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; Jefferson JJ, 2007, J MOL BIOL, V366, P244, DOI 10.1016/j.jmb.2006.11.036; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kapplinger JD, 2011, J AM COLL CARDIOL, V57, P2317, DOI 10.1016/j.jacc.2010.12.036; Ketema M, 2015, MOL BIOL CELL, V26, P2402, DOI 10.1091/mbc.E15-01-0043; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lunter PC, 2002, BIOCHEM BIOPH RES CO, V296, P904, DOI 10.1016/S0006-291X(02)02007-7; Manso JA, 2016, METHOD ENZYMOL, V569, P177, DOI 10.1016/bs.mie.2015.05.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Natsuga K, 2015, J DERMATOL SCI, V77, P139, DOI 10.1016/j.jdermsci.2014.11.005; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; Ohno S, 2013, CIRC J, V77, P1534, DOI 10.1253/circj.CJ-12-1446; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Ortega E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197467; Osmani N, 2015, CURR OPIN CELL BIOL, V32, P30, DOI 10.1016/j.ceb.2014.10.004; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Quarta G, 2011, CIRCULATION, V123, P2701, DOI 10.1161/CIRCULATIONAHA.110.976936; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Samuelov L, 2015, CELL TISSUE RES, V360, P457, DOI 10.1007/s00441-014-2062-y; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Sonnenberg A, 2007, J MOL BIOL, V368, P1379, DOI 10.1016/j.jmb.2007.02.090; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Theobald DL, 2012, BIOINFORMATICS, V28, P1972, DOI 10.1093/bioinformatics/bts243; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wiche G, 2015, CURR OPIN CELL BIOL, V32, P21, DOI 10.1016/j.ceb.2014.10.002; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083	73	19	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18643	18662		10.1074/jbc.M116.732909	http://dx.doi.org/10.1074/jbc.M116.732909			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27413182	Green Published, hybrid			2022-12-28	WOS:000383242300005
J	Trashin, S; de Jong, M; Luyckx, E; Dewilde, S; De Wael, K				Trashin, Stanislav; de Jong, Mats; Luyckx, Evi; Dewilde, Sylvia; De Wael, Karolien			Electrochemical Evidence for Neuroglobin Activity on NO at Physiological Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; HORSE HEART MYOGLOBIN; NITRIC-OXIDE; ELECTRON-TRANSFER; CYTOCHROME-C; TEMPERATURE-DEPENDENCE; BINDING-PROPERTIES; MOUSE NEUROGLOBIN; OXYGEN-BINDING; MESSENGER-RNA	The true function of neuroglobin (Ngb) and, particularly, human Ngb (NGB) has been under debate since its discovery 15 years ago. It has been expected to play a role in oxygen binding/supply, but a variety of other functions have been put forward, including NO dioxygenase activity. However, in vitro studies that could unravel these potential roles have been hampered by the lack of an Ngb-specific reductase. In this work, we used electrochemical measurements to investigate the role of an intermittent internal disulfide bridge in determining NO oxidation kinetics at physiological NO concentrations. The use of a polarized electrode to efficiently interconvert the ferric (Fe3+) and ferrous (Fe2+) forms of an immobilized NGB showed that the disulfide bridge both defines the kinetics of NO dioxygenase activity and regulates appearance of the free ferrous deoxy-NGB, which is the redox active form of the protein in contrast to oxy-NGB. Our studies further identified a role for the distal histidine, interacting with the hexacoordinated iron atom of the heme, in oxidation kinetics. These findings may be relevant in vivo, for example, in blocking apoptosis by reduction of ferric cytochrome c, and gentle tuning of NO concentration in the tissues.	[Trashin, Stanislav; de Jong, Mats; De Wael, Karolien] Univ Antwerp, Dept Chem, B-2010 Antwerp, Belgium; [Luyckx, Evi; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2010 Antwerp, Belgium	University of Antwerp; University of Antwerp	De Wael, K (corresponding author), Univ Antwerp, Dept Chem, AXES Res Grp, Groenenborgerlaan 171, B-2010 Antwerp, Belgium.	karolien.dewael@uantwerpen.be	De Wael, Karolien/U-5545-2018; Trashin, Stanislav A./C-9824-2013; Trashin, Stanislav A./S-3506-2019; de Jong, Mats/N-8095-2015	Trashin, Stanislav A./0000-0002-4089-4251; de Jong, Mats/0000-0001-8930-7962; De Wael, Karolien/0000-0003-4495-0748	Fonds Wetenschappelijk Onderzoek (FWO) [G.0687.13]; Universiteit Antwerpen GOA BOF [28312]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Universiteit Antwerpen GOA BOF	This work was supported by Fonds Wetenschappelijk Onderzoek (FWO) Grant G.0687.13 and Universiteit Antwerpen GOA BOF 28312. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1981, SOLUBILITY DATA SERI; Armstrong FA, 1997, CHEM SOC REV, V26, P169, DOI 10.1039/cs9972600169; Ascenzi P, 2014, IUBMB LIFE, V66, P268, DOI 10.1002/iub.1267; Balland V, 2009, LANGMUIR, V25, P6532, DOI 10.1021/la900062y; Bonding SH, 2008, INT J BIOL MACROMOL, V43, P295, DOI 10.1016/j.ijbiomac.2008.07.003; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2014, ACTA PHYSIOL, V211, P501, DOI 10.1111/apha.12312; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chen H, 2008, J AM CHEM SOC, V130, P14778, DOI 10.1021/ja805434m; Chen LM, 2012, J NEUROCHEM, V120, P157, DOI 10.1111/j.1471-4159.2011.07275.x; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dewilde S, 2008, METHOD ENZYMOL, V436, P341, DOI 10.1016/S0076-6879(08)36019-4; Emara M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-33; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Fan CH, 2000, PHYS CHEM CHEM PHYS, V2, P4409, DOI 10.1039/b005527l; Ferrer I, 2011, J ALZHEIMERS DIS, V23, P537, DOI 10.3233/JAD-2010-101485; Fiocchetti M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.418; Fiocchetti M, 2013, BBA-PROTEINS PROTEOM, V1834, P1744, DOI 10.1016/j.bbapap.2013.01.015; Fordel E, 2007, FEBS J, V274, P1312, DOI 10.1111/j.1742-4658.2007.05679.x; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gulaboski R, 2005, ELECTROCHEM COMMUN, V7, P515, DOI 10.1016/j.elecom.2005.03.009; Gulaboski R, 2012, J SOLID STATE ELECTR, V16, P2315, DOI 10.1007/s10008-011-1397-5; Haines B, 2012, NEUROSCI LETT, V514, P137, DOI 10.1016/j.neulet.2012.01.080; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hundahl CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034462; Hundahl CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028160; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Jain K. K., 2013, APPL BIOTECHNOLOGY N, P249; Juodkazis K, 1999, ELECTROCHEM COMMUN, V1, P315, DOI 10.1016/S1388-2481(99)00062-4; Khan AA, 2008, FASEB J, V22, P1737, DOI 10.1096/fj.07-100784; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Kiger L, 2004, IUBMB LIFE, V56, P709, DOI 10.1080/15216540500037711; Kiger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020478; KING BC, 1992, J AM CHEM SOC, V114, P10603, DOI 10.1021/ja00052a066; Kroning S, 2004, ELECTROANAL, V16, P253, DOI 10.1002/elan.200402780; Lim MD, 2005, METHOD ENZYMOL, V396, P3, DOI 10.1016/S0076-6879(05)96001-1; Mao X. O, 2008, NEUROSCI LETT, V430, P135, DOI DOI 10.1016/j.neulet.2007.10.031; PIELA B, 1995, J ELECTROANAL CHEM, V388, P69, DOI 10.1016/0022-0728(94)03848-W; Raida Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076565; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Schaming D, 2012, LANGMUIR, V28, P14065, DOI 10.1021/la302913j; Scheller FW, 2005, ADV COLLOID INTERFAC, V116, P111, DOI 10.1016/j.cis.2005.05.006; Schmidt-Kastner R, 2006, BRAIN RES, V1103, P173, DOI 10.1016/j.brainres.2006.05.047; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; TANIGUCHI I, 1992, J ELECTROANAL CHEM, V333, P331, DOI 10.1016/0022-0728(92)80402-P; Tejero J, 2015, BIOCHEMISTRY-US, V54, P722, DOI 10.1021/bi501196k; Tejero J, 2014, BIOL CHEM, V395, P631, DOI 10.1515/hsz-2013-0289; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Tiwari PB, 2015, INORG CHEM COMMUN, V62, P37, DOI 10.1016/j.inoche.2015.10.010; Trashin S, 2016, CHEMELECTROCHEM, V3, P1035, DOI 10.1002/celc.201600021; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Van Doorslaer S, 2014, BIOPHYS CHEM, V190, P8, DOI 10.1016/j.bpc.2014.03.007; Vinck E, 2006, J BIOL INORG CHEM, V11, P467, DOI 10.1007/s00775-006-0100-2; Wakasugi K, 2004, BIOCHEM BIOPH RES CO, V318, P453, DOI 10.1016/j.bbrc.2004.04.045; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Walker FA, 2006, J BIOL INORG CHEM, V11, P391, DOI 10.1007/s00775-006-0095-8; Wang YZ, 2006, BIOSENS BIOELECTRON, V22, P10, DOI 10.1016/j.bios.2005.11.012; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Yu ZY, 2016, MOL NEUROBIOL, V53, P3249, DOI 10.1007/s12035-015-9273-4; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015	67	15	16	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18959	18966		10.1074/jbc.M116.730176	http://dx.doi.org/10.1074/jbc.M116.730176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402851	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000383242300031
J	Li, K; Tian, L; Guo, ZJ; Guo, SY; Zhang, JZ; Gu, SH; Palli, SR; Cao, Y; Li, S				Li, Kang; Tian, Ling; Guo, Zhongjian; Guo, Sanyou; Zhang, Jianzhen; Gu, Shi-Hong; Palli, Subba R.; Cao, Yang; Li, Sheng			20-Hydroxyecdysone (20E) Primary Response Gene E75 Isoforms Mediate Steroidogenesis Autoregulation and Regulate Developmental Timing in Bombyx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; nuclear receptor; protein-protein interaction; signal transduction; steroidogenesis; Halloween genes; ROREs; feedback regulation; isoform-specific	NUCLEAR RECEPTOR E75; PROGRAMMED CELL-DEATH; DROSOPHILA METAMORPHOSIS; JUVENILE-HORMONE; FAT-BODY; REV-ERB; ORPHAN RECEPTOR; EGG CHAMBER; HEME; MORI	The temporal control mechanisms that precisely control animal development remain largely elusive. The timing of major developmental transitions in insects, including molting and metamorphosis, is coordinated by the steroid hormone 20-hydroxyecdysone (20E). 20E involves feedback loops to maintain pulses of ecdysteroid biosynthesis leading to its upsurge, whereas the underpinning molecular mechanisms are not well understood. Using the silkworm Bombyx mori as a model, we demonstrated that E75, the 20E primary response gene, mediates a regulatory loop between ecdysteroid biosynthesis and 20E signaling. E75 isoforms A and C directly bind to retinoic acid receptor-related response elements in Halloween gene promoter regions to induce gene expression thus promoting ecdysteroid biosynthesis and developmental transition, whereas isoform B antagonizes the transcriptional activity of isoform A/C through physical interaction. As the expression of E75 isoforms is differentially induced by 20E, the E75-mediated regulatory loop represents a fine autoregulation of steroidogenesis, which contributes to the precise control of developmental timing.	[Li, Kang; Li, Sheng] South China Normal Univ, Inst Insect Sci, Guangzhou Key Lab Insect Dev Regulat & Applicat R, Guangzhou 510631, Guangdong, Peoples R China; [Li, Kang; Li, Sheng] South China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China; [Li, Kang; Tian, Ling; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Tian, Ling; Guo, Sanyou; Cao, Yang] South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Lab Insect Mol Biol & Biotechnol, Guangzhou 510642, Guangdong, Peoples R China; [Guo, Zhongjian] Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Jiangsu, Peoples R China; [Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China; [Zhang, Jianzhen] Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China; [Gu, Shi-Hong] Natl Museum Nat Sci, Dept Biol, 1 Kuan Chien Rd, Taichung 404, Taiwan; [Palli, Subba R.] Univ Kentucky, Coll Agr, Dept Entomol, Lexington, KY 40546 USA	South China Normal University; South China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; South China Agricultural University; Jiangsu University; Shanxi University; Shanxi University; University of Kentucky	Li, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	lisheng@scnu.edu.cn	PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13030700]; 973 Program [2012CB114600]; National Science Foundation of China [31572325, 31472042]; National Program for the Development of New Transgenic Species of China [2014ZX08010-016B]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for the Development of New Transgenic Species of China	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB13030700 (to S. L.), 973 Program 2012CB114600 (to S. L. and Y. C.), National Science Foundation of China Grants 31572325 (to S. L.) and 31472042 (to L. T.), and National Program for the Development of New Transgenic Species of China Grant 2014ZX08010-016B (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aicart-Ramos C, 2012, BIOCHEMISTRY-US, V51, P7403, DOI 10.1021/bi300848x; Bernardo TJ, 2009, J MOL BIOL, V387, P794, DOI 10.1016/j.jmb.2009.02.013; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Cruz J, 2012, MOL CELL ENDOCRINOL, V349, P262, DOI 10.1016/j.mce.2011.11.006; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; FEIGL G, 1989, NUCLEIC ACIDS RES, V17, P7167, DOI 10.1093/nar/17.18.7167; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Guo ZJ, 2010, VIRUS RES, V151, P185, DOI 10.1016/j.virusres.2010.05.003; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kostrouchova M, 2015, BBA-GENE REGUL MECH, V1849, P224, DOI 10.1016/j.bbagrm.2014.06.016; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam GT, 1997, DEVELOPMENT, V124, P1757; Li K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12114; Li ZQ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0513; Liu X, 2015, J BIOL CHEM, V290, P27370, DOI 10.1074/jbc.M115.687293; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Marchal E, 2012, J INSECT PHYSIOL, V58, P890, DOI 10.1016/j.jinsphys.2012.03.013; Moeller ME, 2013, DEVELOPMENT, V140, P4730, DOI 10.1242/dev.099739; Niwa R, 2014, BIOSCI BIOTECH BIOCH, V78, P1283, DOI 10.1080/09168451.2014.942250; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Parvy JP, 2014, DEVELOPMENT, V141, P3955, DOI 10.1242/dev.102020; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Swevers L, 2002, J BIOL CHEM, V277, P41637, DOI 10.1074/jbc.M203581200; Swevers L, 2002, INSECT BIOCHEM MOLEC, V32, P1643, DOI 10.1016/S0965-1748(02)00104-2; Terashima J, 2006, CELL DEATH DIFFER, V13, P454, DOI 10.1038/sj.cdd.4401745; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007	43	32	38	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18163	18175		10.1074/jbc.M116.737072	http://dx.doi.org/10.1074/jbc.M116.737072			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27365399	hybrid, Green Published			2022-12-28	WOS:000383241800010
J	Sun, L; Zhang, Y; Zhang, ZQ; Zheng, Y; Du, LL; Zhu, B				Sun, Lue; Zhang, Yan; Zhang, Zhuqiang; Zheng, Yong; Du, Lilin; Zhu, Bing			Preferential Protection of Genetic Fidelity within Open Chromatin by the Mismatch Repair Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin regulation; DNA repair; heterochromatin; mutagenesis mechanism	YEAST SCHIZOSACCHAROMYCES-POMBE; MUTATION-RATE VARIATION; FISSION YEAST; HUMAN GENOME; DNA-REPLICATION; SEQUENCING DATA; TUMOR-CELLS; HETEROCHROMATIN; CANCER; RATES	Epigenetic systems are well known for the roles they play in regulating the differential expression of the same genome in different cell types. However, epigenetic systems can also directly impact genomic integrity by protecting genetic sequences. Using an experimental evolutionary approach, we studied rates of mutation in the fission yeast Schizosaccharomyces pombe strains that lacked genes encoding several epigenetic regulators or mismatch repair components. We report that loss of a functional mismatch repair pathway in S. pombe resulted in the preferential enrichment of mutations in euchromatin, indicating that the mismatch repair machinery preferentially protected genetic fidelity in euchromatin. This preference is probably determined by differences in the accessibility of chromatin at distinct chromatin regions, which is supported by our observations that chromatin accessibility positively correlated with mutation rates in S. pombe or human cancer samples with deficiencies in mismatch repair. Importantly, such positive correlation was not observed in S. pombe strains or human cancer samples with functional mismatch repair machinery.	[Sun, Lue] Tsinghua Univ, Tsinghua Univ Peking Univ Natl Inst Biol Sci Join, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Lue; Zhang, Yan; Zhang, Zhuqiang; Zheng, Yong; Zhu, Bing] Chinese Acad Sci, Natl Lab Biomacromol, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Sun, Lue; Du, Lilin] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhu, Bing] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, B (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing 100101, Peoples R China.; Zhu, B (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.	zhubing@ibp.ac.cn	Zhang, Zhuqiang/P-7329-2019	Zhang, Zhuqiang/0000-0001-6513-2854; Zhang, Yan/0000-0002-5644-4765; Du, Li-Lin/0000-0002-1028-7397	Chinese Ministry of Science and Technology [2015CB856200]; China National Science Foundation [31401114, 31501059, 31425013, 31530037, 31521002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010103]; Howard Hughes Medical Institute International Early Career Scientist Program	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); China National Science Foundation(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Howard Hughes Medical Institute International Early Career Scientist Program	This work was supported by Chinese Ministry of Science and Technology Grant 2015CB856200. This work was also supported by China National Science Foundation Grant 31401114 (to Z.Z.), Grant 31501059 (to Y. Zhang), and Grants 31425013, 31530037, and 31521002 (to B.Z.); Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08010103; and the Howard Hughes Medical Institute International Early Career Scientist Program. The authors declare that they have no conflicts of interest with the contents of this article.	Allis C. D., 2007, EPIGENETICS, P16; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; ALMER A, 1986, EMBO J, V5, P2681, DOI 10.1002/j.1460-2075.1986.tb04551.x; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; BLUMENTH.AB, 1973, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/SQB.1974.038.01.024; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; CLARKE L, 1990, MOL CELL BIOL, V10, P1863, DOI 10.1128/MCB.10.5.1863; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, ANNU REV GENET, V25, P125, DOI 10.1146/annurev.ge.25.120191.001013; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egel R., 2013, MOL BIOL SCHIZOSACCH, P149; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Farlow A, 2015, GENETICS, V201, P737, DOI 10.1534/genetics.115.177329; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Gaffney DJ, 2005, GENOME RES, V15, P1086, DOI 10.1101/gr.3895005; Garcia JF, 2010, GENE DEV, V24, P1758, DOI 10.1101/gad.1946410; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hormozdiari F, 2011, GENOME RES, V21, P840, DOI 10.1101/gr.115956.110; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; KOI M, 1994, CANCER RES, V54, P4308; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lang GI, 2011, GENOME BIOL EVOL, V3, P799, DOI 10.1093/gbe/evr054; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Martin M, 2011, EMBNET J; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ngan VK, 1997, MOL CELL BIOL, V17, P3305, DOI 10.1128/MCB.17.6.3305; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Peltomaki P, 2001, MUTAT RES-REV MUTAT, V488, P77, DOI 10.1016/S1383-5742(00)00058-2; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Price AL, 2004, GENOME RES, V14, P2245, DOI 10.1101/gr.2693004; Ramachandran S, 2016, CELL, V165, P580, DOI 10.1016/j.cell.2016.02.062; Romanova NV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003920; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; SEGA GA, 1984, MUTAT RES, V134, P113, DOI 10.1016/0165-1110(84)90007-1; Serero A, 2014, P NATL ACAD SCI USA, V111, P1897, DOI 10.1073/pnas.1314423111; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Smith NGC, 2002, GENOME RES, V12, P1350, DOI 10.1101/gr.220502; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; Su M, 2014, CELL REP, V7, P376, DOI 10.1016/j.celrep.2014.03.011; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; TAKAHASHI K, 1991, J MOL BIOL, V218, P13, DOI 10.1016/0022-2836(91)90867-6; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Tian L, 2009, J BIOL CHEM, V284, P11557, DOI 10.1074/jbc.M900908200; Tornier C, 2001, GENETICS, V158, P65; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014; Zanders S, 2010, GENETICS, V186, P493, DOI 10.1534/genetics.110.120105	88	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17692	17705		10.1074/jbc.M116.719971	http://dx.doi.org/10.1074/jbc.M116.719971			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27382058	hybrid, Green Published			2022-12-28	WOS:000383241300019
J	Galiani, S; Waithe, D; Reglinski, K; Cruz-Zaragoza, LD; Garcia, E; Clausen, MP; Schliebs, W; Erdmann, R; Eggeling, C				Galiani, Silvia; Waithe, Dominic; Reglinski, Katharina; Cruz-Zaragoza, Luis Daniel; Garcia, Esther; Clausen, Mathias P.; Schliebs, Wolfgang; Erdmann, Ralf; Eggeling, Christian			Super-resolution Microscopy Reveals Compartmentalization of Peroxisomal Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; membrane trafficking; microscopy; peroxisome; protein import; STED microscopy; super-resolution optical microscopy	RECEPTOR PEX5; STRUCTURAL BASIS; PTS1 RECEPTOR; IMPORT; BIOGENESIS; DISORDERS; DIVISION; PROLIFERATION; ELONGATION; METABOLISM	Membrane-associated events during peroxisomal protein import processes play an essential role in peroxisome functionality. Many details of these processes are not known due to missing spatial resolution of technologies capable of investigating peroxisomes directly in the cell. Here, we present the use of super-resolution optical stimulated emission depletion microscopy to investigate with sub-60-nm resolution the heterogeneous spatial organization of the peroxisomal proteins PEX5, PEX14, and PEX11 around actively importing peroxisomes, showing distinct differences between these peroxins. Moreover, imported protein sterol carrier protein 2 (SCP2) occupies only a subregion of larger peroxisomes, highlighting the heterogeneous distribution of proteins even within the peroxisome. Finally, our data reveal subpopulations of peroxisomes showing only weak colocalization between PEX14 and PEX5 or PEX11 but at the same time a clear compartmentalized organization. This compartmentalization, which was less evident in cases of strong colocalization, indicates dynamic protein reorganization linked to changes occurring in the peroxisomes. Through the use of multicolor stimulated emission depletion microscopy, we have been able to characterize peroxisomes and their constituents to a yet unseen level of detail while maintaining a highly statistical approach, paving the way for equally complex biological studies in the future.	[Galiani, Silvia; Reglinski, Katharina; Clausen, Mathias P.; Eggeling, Christian] Univ Oxford, Med Res Council Human Immunol Unit, Headley Way, Oxford OX3 9DS, England; [Waithe, Dominic; Garcia, Esther; Eggeling, Christian] Univ Oxford, Weatherall Inst Mol Med, Wolfson Imaging Ctr, Headley Way, Oxford OX3 9DS, England; [Cruz-Zaragoza, Luis Daniel; Schliebs, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Inst Physiol Chem, Syst Biochem, Univ Str 150, D-44801 Bochum, Germany; [Clausen, Mathias P.] Univ Southern Denmark, Dept Phys Chem & Pharm, MEMPHYS, Ctr Biomembrane Phys, Campusvej 55, DK-5230 Odense, Denmark	University of Oxford; University of Oxford; Ruhr University Bochum; University of Southern Denmark	Eggeling, C (corresponding author), Univ Oxford, Med Res Council Human Immunol Unit, Headley Way, Oxford OX3 9DS, England.; Eggeling, C (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Wolfson Imaging Ctr, Headley Way, Oxford OX3 9DS, England.	christian.eggeling@rdm.ox.ac.uk	Garcia, Esther/AAH-3794-2020; Clausen, Mathias P./AAE-6487-2020	Garcia, Esther/0000-0002-6424-5379; Clausen, Mathias P./0000-0003-1196-6241; Waithe, Dominic/0000-0003-2685-4226; Reglinski, Katharina/0000-0001-8994-067X; Schliebs, Wolfgang/0000-0003-2762-3403; Cruz-Zaragoza, Luis Daniel/0000-0001-9568-0245	Deutsche Forschungsgemeinschaft [1905]; Wolfson Foundation, Medical Research Council (MRC) [MC_UU_12010, G0902418, MC_UU_12025]; MRC/Biotechnology and Biological Sciences Research Council/Engineering and Physical Sciences Research Council Grant [MR/K01577X/1]; Wellcome Trust [104924/14/Z/14]; Biotechnology and Biological Sciences Research Council [BB/L00433X/1] Funding Source: researchfish; Medical Research Council [MR/K01577X/1, G0902418, MC_UU_12010/9] Funding Source: researchfish; MRC [MR/K01577X/1, G0902418, MC_UU_12010/9] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wolfson Foundation, Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/Biotechnology and Biological Sciences Research Council/Engineering and Physical Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Deutsche Forschungsgemeinschaft (Research unit 1905 "Structure and function of the peroxisomal translocon"), the Wolfson Foundation, Medical Research Council (MRC) Grants MC_UU_12010/Unit Programs G0902418 and MC_UU_12025, MRC/Biotechnology and Biological Sciences Research Council/Engineering and Physical Sciences Research Council Grant MR/K01577X/1, and Wellcome Trust Grant 104924/14/Z/14. The authors declare that they have no conflicts of interest with the contents of this article.	Bharti P, 2011, J CELL SCI, V124, P1759, DOI 10.1242/jcs.079368; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Cizmowski C, 2011, HYBRIDOMA, V30, P387, DOI 10.1089/hyb.2011.0038; Clausen M. P., 2013, NANOBIOIMAGING, V1, P1; Delille HK, 2010, J CELL SCI, V123, P2750, DOI 10.1242/jcs.062109; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; Gould TJ, 2012, OPT EXPRESS, V20, P20998, DOI 10.1364/OE.20.020998; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Kunau W, 2006, BBA-MOL CELL RES, V1763, P1363, DOI 10.1016/j.bbamcr.2006.09.021; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Nagotu S, 2012, BBA-MOL BASIS DIS, V1822, P1326, DOI 10.1016/j.bbadis.2012.05.010; Neufeld C, 2009, EMBO J, V28, P745, DOI 10.1038/emboj.2009.7; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2016, BBA-MOL CELL RES, V1863, P971, DOI 10.1016/j.bbamcr.2015.09.024; Schrader M, 2012, HISTOCHEM CELL BIOL, V138, P541, DOI 10.1007/s00418-012-1010-8; Shai N, 2016, BBA-MOL CELL RES, V1863, P1061, DOI 10.1016/j.bbamcr.2015.09.016; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Will GK, 1999, MOL CELL BIOL, V19, P2265; Wurm CA, 2011, P NATL ACAD SCI USA, V108, P13546, DOI 10.1073/pnas.1107553108; YAMAMOTO K, 1987, J CELL BIOL, V105, P713, DOI 10.1083/jcb.105.2.713	39	44	44	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16948	16962		10.1074/jbc.M116.734038	http://dx.doi.org/10.1074/jbc.M116.734038			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27311714	hybrid, Green Published			2022-12-28	WOS:000382643800003
J	Herrema, H; Zhou, YJ; Zhang, DY; Lee, J; Hernandez, MAS; Shulman, GI; Ozcan, U				Herrema, Hilde; Zhou, Yingjiang; Zhang, Dongyan; Lee, Justin; Hernandez, Mario Andres Salazar; Shulman, Gerald I.; Ozcan, Umut			XBP1s Is an Anti-lipogenic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); insulin resistance; liver; obesity; unfolded protein response (UPR)	FATTY LIVER-DISEASE; HEPATIC INSULIN-RESISTANCE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; GLUCOSE-HOMEOSTASIS; UNITED-STATES; REGULATORY SUBUNITS; OBESE SUBJECTS; MICE; STEATOSIS	Endoplasmic reticulum (ER) stress has been shown to contribute to various metabolic diseases, including non-alcoholic fatty liver disease and type 2 diabetes. Reduction of ER stress by treatment with chemical chaperones or overexpression of ER chaperone proteins alleviates hepatic steatosis. Nonetheless, X-box binding protein 1s (XBP1s), a key transcription factor that reduces ER stress, has been proposed as a lipogenic transcription factor. In this report, we document that XBP1s leads to suppression of lipogenic gene expression and reduction of hepatic triglyceride and diacylglycerol content in livers of diet-induced obese and genetically obese and insulin-resistant ob/ob mice. Furthermore, we also show that PKCE activity, which correlates with fatty liver and which causes insulin resistance, was significantly reduced in diet-induced obese mice. Finally, we have shown that XBP1s reduces the hepatic fatty acid synthesis rate and enhances macrolipophagy, an initiating step in lipolysis. Our results reveal that XBP1s reduces hepatic lipogenic gene expression and improves hepatosteatosis in mouse models of obesity and insulin resistance, which leads us to conclude that XBP1s has anti-lipogenic properties in the liver.	[Herrema, Hilde; Zhou, Yingjiang; Lee, Justin; Hernandez, Mario Andres Salazar; Ozcan, Umut] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Zhang, Dongyan; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Herrema, H; Ozcan, U (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.	hilde.herrema@childrens.harvard.edu; umut.ozcan@childrens.harvard.edu	Salazar, Mario/GSN-2646-2022; Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Herrema, Hilde/0000-0002-0112-6348	Department of Medicine, Boston Children's Hospital; National Institutes of Health [R01DK081009, R01DK098496, R01 DK-40936, U24 DK-059635]; American Diabetes Association Career Development Grant [7-09-CD-10]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, R01DK081009, U24DK059635, R01DK098496] Funding Source: NIH RePORTER	Department of Medicine, Boston Children's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Career Development Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the Department of Medicine, Boston Children's Hospital (to U. O.); National Institutes of Health Grants R01DK081009 and R01DK098496 (to U. O.), R01 DK-40936, and U24 DK-059635; and by American Diabetes Association Career Development Grant 7-09-CD-10. U. O. is a scientific founder, shareholder, and member of the scientific advisory board and board of directors of ERX Pharmaceuticals, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; HARWOOD HJ, 1993, J LIPID RES, V34, P377; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lee JS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep126; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Papackova Z, 2012, PHYSIOL RES, V61, pS67, DOI 10.33549/physiolres.932394; Park SW, 2014, CELL METAB, V20, P73, DOI 10.1016/j.cmet.2014.04.006; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Raddatz K, 2011, DIABETOLOGIA, V54, P1447, DOI 10.1007/s00125-011-2073-0; Ratziu V, 2015, J HEPATOL, V62, pS65, DOI 10.1016/j.jhep.2015.02.041; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Sharma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025269; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smits MM, 2013, J GASTROEN HEPATOL, V28, P664, DOI 10.1111/jgh.12106; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Upadhyay J, 2014, NEW ENGL J MED, V371, P285, DOI 10.1056/NEJMc1406009; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293; Zoppini G, 2014, AM J GASTROENTEROL, V109, P1020, DOI 10.1038/ajg.2014.132	51	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17394	17404		10.1074/jbc.M116.728949	http://dx.doi.org/10.1074/jbc.M116.728949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325692	Green Published, hybrid			2022-12-28	WOS:000382643800038
J	Jensen, MR; Bajic, G; Zhang, XW; Laustsen, AK; Koldso, H; Skeby, KK; Schiott, B; Andersen, GR; Vorup-Jensen, T				Jensen, Maria Risager; Bajic, Goran; Zhang, Xianwei; Laustsen, Anne Kjaer; Koldso, Heidi; Skeby, Katrine Kirkeby; Schiott, Birgit; Andersen, Gregers R.; Vorup-Jensen, Thomas			Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; complement; inflammation; integrin; molecular dynamics; protein drug interaction; receptor structure-function; surface plasmon resonance (SPR); anti-inflammatory therapy; statin	I-DOMAIN; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; BETA-PROPELLER; A-DOMAIN; INTEGRIN; BINDING; RECOGNITION; STATINS; LIGAND	The complement system is an important part of the innate immune response to infection but may also cause severe complications during inflammation. Small molecule antagonists to complement receptor 3 (CR3) have been widely sought, but a structural basis for their mode of action is not available. We report here on the structure of the human CR3 ligand-binding I domain in complex with simvastatin. Simvastatin targets the metal ion-dependent adhesion site of the open, ligand-binding conformation of the CR3 I domain by direct contact with the chelated Mg2+ ion. Simvastatin antagonizes I domain binding to the complement fragments iC3b and C3d but not to intercellular adhesion molecule-1. By virtue of the I domain's wide distribution in binding kinetics to ligands, it was possible to identify ligand binding kinetics as discriminator for simvastatin antagonism. In static cellular experiments, 15-25 m simvastatin reduced adhesion by K562 cells expressing recombinant CR3 and by primary human monocytes, with an endogenous expression of this receptor. Application of force to adhering monocytes potentiated the effects of simvastatin where only a 50-100 nm concentration of the drug reduced the adhesion by 20-40% compared with untreated cells. The ability of simvastatin to target CR3 in its ligand binding-activated conformation is a novel mechanism to explain the known anti-inflammatory effects of this compound, in particular because this CR3 conformation is found in pro-inflammatory environments. Our report points to new designs of CR3 antagonists and opens new perspectives and identifies druggable receptors from characterization of the ligand binding kinetics in the presence of antagonists.	[Jensen, Maria Risager; Zhang, Xianwei; Vorup-Jensen, Thomas] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Bajic, Goran; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Laustsen, Anne Kjaer; Koldso, Heidi; Skeby, Katrine Kirkeby; Schiott, Birgit] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Laustsen, Anne Kjaer; Koldso, Heidi; Skeby, Katrine Kirkeby; Schiott, Birgit; Vorup-Jensen, Thomas] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Koldso, Heidi; Skeby, Katrine Kirkeby; Schiott, Birgit] Aarhus Univ, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus C, Denmark; [Bajic, Goran; Andersen, Gregers R.; Vorup-Jensen, Thomas] Aarhus Univ, Lundbeck Fdn Nanomed Ctr Individualized Managemen, DK-8000 Aarhus C, Denmark; [Vorup-Jensen, Thomas] Aarhus Univ, MEMBRANES Res Ctr, DK-8000 Aarhus C, Denmark; [Jensen, Maria Risager] DE Shaw Res, New York, NY 10036 USA	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Lundbeckfonden; Aarhus University; D. E. Shaw Research	Vorup-Jensen, T (corresponding author), Aarhus Univ, Dept Biomed, Biophys Immunol Lab, Bartholin Bldg 1240,Bartholins Alle 6, DK-8000 Aarhus C, Denmark.	vorup-jensen@biomed.au.dk	Schiott, Birgit/F-5067-2011; Vorup-Jensen, Thomas/N-9082-2016	Schiott, Birgit/0000-0001-9937-1562; Vorup-Jensen, Thomas/0000-0002-4140-6563; Bajic, Goran/0000-0003-0480-4324; Andersen, Gregers Rom/0000-0001-6292-3319	Danish Multiple Sclerosis Association; Aarhus University Research Foundation; Lundbeck Foundation; Danish Council for Independent Research: Technology and Production Sciences; Danish National Research Foundation [DNFR59]; Novo Nordisk Fonden [NNF12OC0002082, NNF14OC0012261] Funding Source: researchfish	Danish Multiple Sclerosis Association; Aarhus University Research Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research: Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Multiple Sclerosis Association, the Aarhus University Research Foundation (to T.V.-J.), the Lundbeck Foundation (to T.V.-J. and G.R.A.), the Danish Council for Independent Research: Technology and Production Sciences (to B.S.), and Danish National Research Foundation Grant DNFR59 (to B.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Alvarez-Lueje A, 2005, J AOAC INT, V88, P1631; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Silveira AAA, 2013, INFLAMM RES, V62, P127, DOI 10.1007/s00011-012-0579-7; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Bajic G, 2013, P NATL ACAD SCI USA, V110, P16426, DOI 10.1073/pnas.1311261110; Bergman E, 2006, EUR J PHARM SCI, V29, P205, DOI 10.1016/j.ejps.2006.04.015; Bjorkhem-Bergman L, 2011, BRIT J CLIN PHARMACO, V72, P164, DOI 10.1111/j.1365-2125.2011.03907.x; Canalli AA, 2011, HAEMATOL-HEMATOL J, V96, P526, DOI 10.3324/haematol.2010.032912; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Chello M, 2003, HEART, V89, P538, DOI 10.1136/heart.89.5.538; Curley GP, 1999, CELL MOL LIFE SCI, V56, P427, DOI 10.1007/s000180050443; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fossati-Jimack L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057082; Gao C, 2009, J CLIN INVEST, V119, P504, DOI 10.1172/JCI36745; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Gorshkova II, 2008, LANGMUIR, V24, P11577, DOI 10.1021/la801186w; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huang CC, 2000, J BIOL CHEM, V275, P21514, DOI 10.1074/jbc.M002286200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; KENAKIN TP, 1982, CAN J PHYSIOL PHARM, V60, P249, DOI 10.1139/y82-036; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li Y, 2003, J BIOL CHEM, V278, P34395, DOI 10.1074/jbc.M304190200; Liddington RC, 2014, ADV EXP MED BIOL, V819, P111, DOI 10.1007/978-94-017-9153-3_8; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Mahalingam B, 2014, J BIOL CHEM, V289, P13801, DOI 10.1074/jbc.M113.546929; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Nunez S, 2012, DRUG DISCOV TODAY, V17, P10, DOI 10.1016/j.drudis.2011.06.013; Orr Y, 2007, J LEUKOCYTE BIOL, V82, P1115, DOI 10.1189/jlb.0906545; Petruzzelli L., 1995, LEUCOCYTE TYPING, P1581; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7; Tsai NW, 2009, J NEUROL, V256, P1296, DOI 10.1007/s00415-009-5117-3; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Vorup-Jensen T, 2012, ADV DRUG DELIVER REV, V64, P1759, DOI 10.1016/j.addr.2012.06.003; Vorup-Jensen T, 2011, METHODS MOL BIOL, V757, P55, DOI 10.1007/978-1-61779-166-6_5; Wang Y, 2009, BIOL BLOOD MARROW TR, V15, P1513, DOI 10.1016/j.bbmt.2009.08.013; Weetall M, 2001, ANAL BIOCHEM, V293, P277, DOI 10.1006/abio.2001.5140; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199; Zhang J, 2013, CYTOKINE, V61, P540, DOI 10.1016/j.cyto.2012.12.006; Zhang XW, 2016, BBA-PROTEINS PROTEOM, V1864, P471, DOI 10.1016/j.bbapap.2016.02.013; Zhao HY, 2013, METHODS, V59, P328, DOI 10.1016/j.ymeth.2012.12.007	65	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					16963	16976		10.1074/jbc.M116.732222	http://dx.doi.org/10.1074/jbc.M116.732222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27339893	Green Published, hybrid			2022-12-28	WOS:000382643800004
J	Khatlani, T; Pradhan, S; Da, Q; Shaw, T; Buchman, VL; Cruz, MA; Vijayan, KV				Khatlani, Tanvir; Pradhan, Subhashree; Da, Qi; Shaw, Tanner; Buchman, Vladimir L.; Cruz, Miguel A.; Vijayan, K. Vinod			A Novel Interaction of the Catalytic Subunit of Protein Phosphatase 2A with the Adaptor Protein CIN85 Suppresses Phosphatase Activity and Facilitates Platelet Outside-in (IIb3) Integrin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; adhesion; fibrinogen; integrin; platelet; protein phosphatase 2A	CHRONIC LYMPHOCYTIC-LEUKEMIA; OKADAIC ACID; PI 3-KINASE; ALPHA(IIB)BETA(3); ADHESION; ISOFORMS; PP2A; AGGREGATION; EXPRESSION; RUK/CIN85	The transduction of signals generated by protein kinases and phosphatases are critical for the ability of integrin (IIb3) to support stable platelet adhesion and thrombus formation. Unlike kinases, it remains unclear how serine/threonine phosphatases engage the signaling networks that are initiated following integrin ligation. Because protein-protein interactions form the backbone of signal transduction, we searched for proteins that interact with the catalytic subunit of protein phosphatase 2A (PP2Ac). In a yeast two-hybrid study, we identified a novel interaction between PP2Ac and an adaptor protein CIN85 (Cbl-interacting protein of 85 kDa). Truncation and alanine mutagenesis studies revealed that PP2Ac binds to the P3 block ((396)PAIPPKKPRP(405)) of the proline-rich region in CIN85. The interaction of purified PP2Ac with CIN85 suppressed phosphatase activity. Human embryonal kidney 293 (IIb3) cells overexpressing a CIN85 P3 mutant, which cannot support PP2Ac binding, displayed decreased adhesion to immobilized fibrinogen. Platelets contain the approximate to 85 kDa CIN85 protein along with the PP2Ac-CIN85 complex. A myristylated cell-permeable peptide derived from residues 395-407 of CIN85 protein (P3 peptide) disrupted the platelet PP2Ac-CIN85 complex and decreased (IIb3) signaling dependent functions such as platelet spreading on fibrinogen and thrombin-mediated fibrin clot retraction. In a phospho-profiling study P3 peptide treated platelets also displayed decreased phosphorylation of several signaling proteins including Src and GSK3. Taken together, these data support a role for the novel PP2Ac-CIN85 complex in supporting integrin-dependent platelet function by dampening the phosphatase activity.	[Khatlani, Tanvir; Pradhan, Subhashree; Da, Qi; Shaw, Tanner; Cruz, Miguel A.; Vijayan, K. Vinod] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Cruz, Miguel A.; Vijayan, K. Vinod] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Cruz, Miguel A.; Vijayan, K. Vinod] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Cruz, Miguel A.; Vijayan, K. Vinod] Baylor Coll Med, Houston, TX 77030 USA; MEDVAMC, CTRID, Houston, TX 77030 USA; [Buchman, Vladimir L.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Cardiff University	Vijayan, KV (corresponding author), Baylor Coll Med, Cardiovasc Res Sect, Rm 146,Bldg 109,2002 Holcombe Blvd, Houston, TX 77030 USA.; Vijayan, KV (corresponding author), MEDVAMC, Rm 146,Bldg 109,2002 Holcombe Blvd, Houston, TX 77030 USA.	vvijayan@bcm.edu	Buchman, Vladimir L/A-4814-2010	Buchman, Vladimir L/0000-0002-7631-8352	National Institutes of Health [HL081613, GM112806]; American Heart Association [13 GRNT17260021]; Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081613 and GM112806 and American Heart Association Grant 13 GRNT17260021. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Mary R. Gibson Foundation.	Alrehani N, 2013, THROMB HAEMOSTASIS, V109, P118, DOI 10.1160/TH12-04-0237; Borinstein SC, 2000, CELL SIGNAL, V12, P769, DOI 10.1016/S0898-6568(00)00129-7; Borthwick EB, 2004, J MOL BIOL, V343, P1135, DOI 10.1016/j.jmb.2004.08.075; Buchman VL, 2002, GENE, V295, P13, DOI 10.1016/S0378-1119(02)00821-1; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Christensen DJ, 2011, BLOOD, V118, P4150, DOI 10.1182/blood-2011-04-351072; Ciccone M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00021; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Estevez B, 2015, ARTERIOSCL THROM VAS, V35, P24, DOI 10.1161/ATVBAHA.114.303411; Finniss S, 2004, BIOCHEM BIOPH RES CO, V325, P174, DOI 10.1016/j.bbrc.2004.10.007; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Haesen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00347; Havrylov S, 2010, TRAFFIC, V11, P721, DOI 10.1111/j.1600-0854.2010.01061.x; HOYT CH, 1995, BIOCHEMISTRY-US, V34, P9565, DOI 10.1021/bi00029a033; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Lambrecht C, 2013, METHODS MOL BIOL, V1053, P283, DOI 10.1007/978-1-62703-562-0_17; Lerea KM, 1999, J BIOL CHEM, V274, P1914, DOI 10.1074/jbc.274.4.1914; Li M, 1998, METH MOL B, V93, P59; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Mauco G, 1997, CELL SIGNAL, V9, P117, DOI 10.1016/S0898-6568(96)00119-2; Mayevska O., 2006, Experimental Oncology, V28, P275; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Narita T, 2001, CYTOGENET CELL GENET, V93, P133, DOI 10.1159/000056966; NISHIKAWA M, 1994, CELL SIGNAL, V6, P59, DOI 10.1016/0898-6568(94)90061-2; Pradhan S, 2010, J BIOL CHEM, V285, P29059, DOI 10.1074/jbc.M109.085167; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Shattil SJ, 2009, J THROMB HAEMOST, V7, P210, DOI 10.1111/j.1538-7836.2009.03397.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Stalker TJ, 2014, CURR OPIN HEMATOL, V21, P410, DOI 10.1097/MOH.0000000000000070; Switzer CH, 2011, ONCOGENE, V30, P2504, DOI 10.1038/onc.2010.622; Vijayan KV, 2000, J CLIN INVEST, V105, P793, DOI 10.1172/JCI6982	39	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17360	17368		10.1074/jbc.M115.704296	http://dx.doi.org/10.1074/jbc.M115.704296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27334924	Green Published, hybrid			2022-12-28	WOS:000382643800035
J	Ullrich, F; Reincke, SM; Voss, FK; Stauber, T; Jentsch, TJ				Ullrich, Florian; Reincke, S. Momsen; Voss, Felizia K.; Stauber, Tobias; Jentsch, Thomas J.			Inactivation and Anion Selectivity of Volume-regulated Anion Channels (VRACs) Depend on C-terminal Residues of the First Extracellular Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anion transport; chloride channel; electrophysiology; gating; ion channel; structure-function; ICl; swell; VSOAC; VSOR	CELL-CELL COMMUNICATION; LEUCINE-RICH REPEAT; ESSENTIAL COMPONENT; MAMMALIAN-CELLS; K+ CHANNELS; IDENTIFICATION; CONDUCTANCE; MECHANISMS; PROTEIN; DRUGS	Canonical volume-regulated anion channels (VRACs) are crucial for cell volume regulation and have many other important roles, including tumor drug resistance and release of neurotransmitters. Although VRAC-mediated swelling-activated chloride currents (I-Cl,I-vol) have been studied for decades, exploration of the structure-function relationship of VRAC has become possible only after the recent discovery that VRACs are formed by differently composed heteromers of LRRC8 proteins. Inactivation of I-Cl,I-vol at positive potentials, a typical hallmark of VRACs, strongly varies between native cell types. Exploiting the large differences in inactivation between different LRRC8 heteromers, we now used chimeras assembled from isoforms LRRC8C and LRRC8E to uncover a highly conserved extracellular region preceding the second LRRC8 transmembrane domain as a major determinant of I-Cl,I-vol inactivation. Point mutations identified two amino acids (Lys-98 and Asp-100 in LRRC8A and equivalent residues in LRRC8C and -E), which upon charge reversal strongly altered the kinetics and voltage dependence of inactivation. Importantly, charge reversal at the first position also reduced the iodide > chloride permeability of I-Cl,I-vol. This change in selectivity was stronger when both the obligatory LRRC8A subunit and the other co-expressed isoform (LRR8C or -E) carried such mutations. Hence, the C-terminal part of the first extracellular loop not only determines VRAC inactivation but might also participate in forming its outer pore. Inactivation of VRACs may involve a closure of the extracellular mouth of the permeation pathway.	[Ullrich, Florian; Reincke, S. Momsen; Voss, Felizia K.; Stauber, Tobias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Ullrich, Florian; Reincke, S. Momsen; Voss, Felizia K.; Stauber, Tobias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Ullrich, Florian] Free Univ Berlin, Grad Program, D-14195 Berlin, Germany; [Jentsch, Thomas J.] Charite, Neurocure, D-10117 Berlin, Germany; [Stauber, Tobias] Free Univ Berlin, Inst Chem & Biochem, Thielallee 63, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Ullrich, Florian/AAA-6043-2019; Stauber, Tobias/E-4005-2010	Ullrich, Florian/0000-0002-1153-2040; Stauber, Tobias/0000-0003-0727-6109; Jentsch, Thomas/0000-0002-3509-2553; Reincke, Momsen/0000-0002-8132-3527	European Research Council (ERC) [294435]; DFG (Exc) [257]	European Research Council (ERC)(European Research Council (ERC)); DFG (Exc)(German Research Foundation (DFG))	This work was supported by European Research Council (ERC) Advanced Grant (FP/2007-2013) 294435 "Cytovolion" and the DFG (Exc 257 "Neurocure") (to T. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jackson PS, 1996, KIDNEY INT, V49, P1695, DOI 10.1038/ki.1996.250; JACKSON PS, 1995, J GEN PHYSIOL, V105, P661, DOI 10.1085/jgp.105.5.661; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Lee CC, 2014, J BIOL CHEM, V289, P17124, DOI 10.1074/jbc.M114.571257; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; OKADA Y, 1994, JPN J PHYSIOL, V44, P403, DOI 10.2170/jjphysiol.44.403; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; Pedersen SF, 2015, ACTA PHYSIOL, V213, P868, DOI 10.1111/apha.12450; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Qiu F, 2012, PURINERG SIGNAL, V8, P81, DOI 10.1007/s11302-011-9263-6; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Syeda R, 2016, CELL, V164, P499, DOI 10.1016/j.cell.2015.12.031; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Voets T, 1997, J GEN PHYSIOL, V110, P313, DOI 10.1085/jgp.110.3.313; Voets T, 2015, EMBO J, V34, P2985, DOI 10.15252/embj.201593357; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440	29	43	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17040	17048		10.1074/jbc.M116.739342	http://dx.doi.org/10.1074/jbc.M116.739342			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27325695	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000382643800011
J	Yao, JJ; Zhao, QR; Liu, DD; Chow, CW; Mei, YA				Yao, Jin-jing; Zhao, Qian-Ru; Liu, Dong-Dong; Chow, Chi-Wing; Mei, Yan-Ai			Neuritin Up-regulates Kv4.2-Subunit of Potassium Channel Expression and Affects Neuronal Excitability by Regulating the Calcium-Calcineurin-NFATc4 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcineurin; calcium; neurotrophic factor; potassium channel; transcription factor	ACTIVATED T-CELLS; CORTICAL PYRAMIDAL NEURONS; CEREBELLAR GRANULE CELLS; NUCLEAR FACTOR; K+ CURRENTS; IN-VIVO; TRANSCRIPTIONAL REGULATION; INSULIN-RECEPTOR; PROTEIN-KINASE; AXON GROWTH	Neuritin is an important neurotrophin that regulates neural development, synaptic plasticity, and neuronal survival. Elucidating the downstream molecular signaling is important for potential therapeutic applications of neuritin in neuronal dysfunctions. We previously showed that neuritin up-regulates transient potassium outward current (I-A) subunit Kv4.2 expression and increases I-A densities, in part by activating the insulin receptor signaling pathway. Molecular mechanisms of neuritin-induced Kv4.2 expression remain elusive. Here, we report that the Ca2+/calcineurin (CaN)/nuclear factor of activated T-cells (NFAT) c4 axis is required for neuritin-induced Kv4.2 transcriptional expression and potentiation of I-A densities in cerebellum granule neurons. We found that neuritin elevates intracellular Ca2+ and increases Kv4.2 expression and I-A densities; this effect was sensitive to CaN inhibition and was eliminated in Nfatc4(-/-) mice but not in Nfatc2(-/-) mice. Stimulation with neuritin significantly increased nuclear accumulation of NFATc4 in cerebellum granule cells and HeLa cells, which expressed IR. Furthermore, NFATc4 was recruited to the Kv4.2 gene promoter loci detected by luciferase reporter and chromatin immunoprecipitation assays. More importantly, data obtained from cortical neurons following adeno-associated virus-mediated overexpression of neuritin indicated that reduced neuronal excitability and increased formation of dendritic spines were abrogated in the Nfatc4(-/-) mice. Together, these data demonstrate an indispensable role for the CaN/NFATc4 signaling pathway in neuritin-regulated neuronal functions.	[Yao, Jin-jing; Zhao, Qian-Ru; Liu, Dong-Dong; Mei, Yan-Ai] Fudan Univ, Inst Brain Sci, Sch Life Sci, Shanghai 200433, Peoples R China; [Yao, Jin-jing; Zhao, Qian-Ru; Liu, Dong-Dong; Mei, Yan-Ai] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY 10461 USA	Fudan University; Fudan University; Yeshiva University	Chow, CW (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.; Mei, YA (corresponding author), Fudan Univ, Sch Life Sci, 220 Handan Rd, Shanghai 200433, Peoples R China.; Mei, YA (corresponding author), Fudan Univ, Inst Brain Sci, 220 Handan Rd, Shanghai 200433, Peoples R China.	chi-wing.chow@einstein.yu.edu; yamei@fudan.edu.cn			National Natural Science Foundation of China [NSFC 31428003, 31370827]; Shanghai Leading Academic Discipline Project [B111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation of China Grants NSFC 31428003 and 31370827 and Shanghai Leading Academic Discipline Project B111. The authors declare that they have no conflicts of interest with the contents of this article.	Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Bradley DC, 2005, J NEUROPHYSIOL, V93, P1659, DOI 10.1152/jn.01213.2003; Buffo A, 2000, J NEUROSCI, V20, P2275; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Carrasquillo Y, 2012, J PHYSIOL-LONDON, V590, P3877, DOI 10.1113/jphysiol.2012.229013; Chandrasekar B, 2008, J BIOL CHEM, V283, P4200, DOI 10.1074/jbc.M708142200; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Ding BJ, 2013, J NEUROSCI, V33, P2860, DOI 10.1523/JNEUROSCI.3533-12.2013; Gong NL, 2006, J BIOL CHEM, V281, P38498, DOI 10.1074/jbc.M607774200; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo NN, 2007, NEUROSCIENCE, V146, P298, DOI 10.1016/j.neuroscience.2007.01.013; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jackson JG, 2007, MOL PHARMACOL, V72, P303, DOI 10.1124/mol.107.035048; Jacques C, 2012, J BIOL CHEM, V287, P15100, DOI 10.1074/jbc.M112.350215; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Ji XH, 2008, CEREB CORTEX, V18, P1506, DOI 10.1093/cercor/bhm177; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Lunde IG, 2011, J APPL PHYSIOL, V111, P1278, DOI 10.1152/japplphysiol.01383.2010; Luoma JI, 2008, J NEUROSCI, V28, P3159, DOI 10.1523/JNEUROSCI.5227-07.2008; Mei YA, 2000, BRAIN RES, V873, P46, DOI 10.1016/S0006-8993(00)02469-0; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; O'Neill KM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00285; Petrecca K, 2000, J NEUROSCI, V20, P8736; Quadrato G, 2014, J NEUROSCI, V34, P8630, DOI 10.1523/JNEUROSCI.0047-14.2014; Quadrato G, 2012, P NATL ACAD SCI USA, V109, pE1499, DOI 10.1073/pnas.1202068109; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rossow CF, 2004, CIRC RES, V94, P1340, DOI 10.1161/01.RES.0000128406.08418.34; Rossow CF, 2009, J MOL CELL CARDIOL, V46, P249, DOI 10.1016/j.yjmcc.2008.10.016; Sato M, 2005, P NATL ACAD SCI USA, V102, P5874, DOI 10.1073/pnas.0501972102; Shibata R, 2000, J NEUROSCI, V20, P4145; Son H, 2012, P NATL ACAD SCI USA, V109, P11378, DOI 10.1073/pnas.1201191109; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Velazquez-Marrero C, 2014, J NEUROSCI, V34, P3733, DOI 10.1523/JNEUROSCI.2505-13.2014; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Xiong JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083561; Yang TTC, 2005, MOL CELL BIOL, V25, P907, DOI 10.1128/MCB.25.3.907-920.2005; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Yao JJ, 2012, J BIOL CHEM, V287, P41534, DOI 10.1074/jbc.M112.390260; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019; Zhao QR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11768; Zhou S, 2014, CURR MED CHEM, V21, P1212, DOI 10.2174/0929867321666131218093327	54	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17369	17381		10.1074/jbc.M115.708883	http://dx.doi.org/10.1074/jbc.M115.708883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27307045	Green Published, hybrid			2022-12-28	WOS:000382643800036
J	Lawrence, CF; Margetts, MB; Menting, JG; Smith, NA; Smith, BJ; Ward, CW; Lawrence, MC				Lawrence, Callum F.; Margetts, Mai B.; Menting, John G.; Smith, Nicholas A.; Smith, Brian J.; Ward, Colin W.; Lawrence, Michael C.			Insulin Mimetic Peptide Disrupts the Primary Binding Site of the Insulin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST 3 DOMAINS; LIGAND-BINDING; SYSTEM; CRYSTALLIZATION; ACTIVATION; RESOLUTION; TOOLS; MODEL	Sets of synthetic peptides that interact with the insulin receptor ectodomain have been discovered by phage display and reported in the literature. These peptides were grouped into three classes termed Site 1, Site 2, and Site 3 based on their mutual competition of binding to the receptor. Further refinement has yielded, in particular, a 36-residue Site 2-Site 1 fusion peptide, S519, that binds the insulin receptor with subnanomolar affinity and exhibits agonist activity in both lipogenesis and glucose uptake assays. Here, we report three-dimensional crystallographic detail of the interaction of the C-terminal, 16-residue Site 1 component (S519C16) of S519 with the first leucine-rich repeat domain (L1) of the insulin receptor. Our structure shows that S519C16 binds to the same site on the L1 surface as that occupied by a critical component of the primary binding site, namely the helical C-terminal segment of the insulin receptor alpha-chain (termed alpha CT). In particular, the two phenylalanine residues within the FYXWF motif of S519C16 are seen to engage the insulin receptor L1 domain surface in a fashion almost identical to the respective alpha CT residues Phe701 and Phe705. The structure provides a platform for the further development of peptidic and/or small molecule agents directed toward the insulin receptor and/or the type 1 insulin-like growth factor receptor.	[Lawrence, Callum F.; Margetts, Mai B.; Menting, John G.; Ward, Colin W.; Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Smith, Nicholas A.; Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; La Trobe University; University of Melbourne	Lawrence, MC (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	lawrence@wehi.edu.au	Smith, Brian J/F-8282-2011; Lawrence, Michael C/A-5357-2009; Smith, Nicholas A/I-7422-2016	Smith, Brian J/0000-0003-0498-1910; Smith, Nicholas A/0000-0001-8894-4249; Menting, John/0000-0003-3638-3544; Lawrence, Michael/0000-0003-1999-0801	Australian National Health and Medical Research Council (NHMRC) [1005896, 1058233]; Hazel and Pip Appel Fund; NHMRC Independent Research Institutes Infrastructure Support Scheme Grant [361646]; Victorian State Government; Sanofi (Germany); Australian Postgraduate Awards	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hazel and Pip Appel Fund; NHMRC Independent Research Institutes Infrastructure Support Scheme Grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Sanofi (Germany)(Sanofi-Aventis); Australian Postgraduate Awards(Australian Government)	This work was supported in part by Australian National Health and Medical Research Council (NHMRC) Project Grants 1005896 and 1058233 and the Hazel and Pip Appel Fund (to M.C.L.) and by NHMRC Independent Research Institutes Infrastructure Support Scheme Grant 361646 and Victorian State Government operational infrastructure support grant (to the Walter and Eliza Hall Institute of Medical Research). Part of the research of M.C.L. was funded by Sanofi (Germany).r Recipients of Australian Postgraduate Awards.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bricogne G., 2011, BUSTER VERSION 2 10; CLARK S, 1983, J BIOL CHEM, V258, P1434; CLARK S, 1982, J BIOL CHEM, V257, P2239; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Griffin L, 2011, CLIN EXP IMMUNOL, V165, P285, DOI 10.1111/j.1365-2249.2011.04427.x; Jensen M, 2008, BIOCHEM J, V412, P435, DOI 10.1042/BJ20080279; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; McKern NM, 1997, PROTEIN SCI, V6, P2663; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Menting JG, 2009, BIOCHEMISTRY-US, V48, P5492, DOI 10.1021/bi900261q; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pillutla R., 2007, U. S. Patent, Patent No. [7,173,005 B2, 7173005]; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; Sparrow LG, 2008, PROTEINS, V71, P426, DOI 10.1002/prot.21768; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zuercher WJ, 2016, CELL CHEM BIOL, V23, P173, DOI 10.1016/j.chembiol.2015.12.005	39	25	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15473	15481		10.1074/jbc.M116.732180	http://dx.doi.org/10.1074/jbc.M116.732180			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27281820	Green Published, hybrid			2022-12-28	WOS:000380584200005
J	Miki, Y; Kidoguchi, Y; Sato, M; Taketomi, Y; Taya, C; Muramatsu, K; Gelb, MH; Yamamoto, K; Murakami, M				Miki, Yoshimi; Kidoguchi, Yuh; Sato, Mariko; Taketomi, Yoshitaka; Taya, Choji; Muramatsu, Kazuaki; Gelb, Michael H.; Yamamoto, Kei; Murakami, Makoto			Dual Roles of Group IID Phospholipase A(2) in Inflammation and Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; REGULATORY T-CELLS; LIPID MEDIATORS; GROUP-V; CONTACT HYPERSENSITIVITY; GROUP-X; DOCOSAHEXAENOIC ACID; HUMAN MACROPHAGES; TRANSGENIC MICE; RESOLVIN D2	Phospholipase A(2) enzymes have long been implicated in the promotion of inflammation by mobilizing pro-inflammatory lipid mediators, yet recent evidence suggests that they also contribute to anti-inflammatory or pro-resolving programs. Group IID-secreted phospholipase A(2) (sPLA(2)-IID) is abundantly expressed in dendritic cells in lymphoid tissues and resolves the Th1 immune response by controlling the steady-state levels of anti-inflammatory lipids such as docosahexaenoic acid and its metabolites. Here, we show that psoriasis and contact dermatitis were exacerbated in Pla2g2d-null mice, whereas they were ameliorated in Pla2g2d-overexpressing transgenic mice, relative to littermate wild-type mice. These phenotypes were associated with concomitant alterations in the tissue levels of omega 3 polyunsaturated fatty acid (PUFA) metabolites, which had the capacity to reduce the expression of pro-inflammatory and Th1/Th17type cytokines in dendritic cells or lymph node cells. In the context of cancer, however, Pla2g2d deficiency resulted in marked attenuation of skin carcinogenesis, likely because of the augmented anti-tumor immunity. Altogether, these results underscore a general role of sPLA(2)-IID as an immunosuppressive sPLA(2) that allows the microenvironmental lipid balance toward an anti-inflammatory state, exerting beneficial or detrimental impact depending upon distinct pathophysiological contexts in inflammation and cancer.	[Miki, Yoshimi; Kidoguchi, Yuh; Sato, Mariko; Taketomi, Yoshitaka; Yamamoto, Kei; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo 1568506, Japan; [Taya, Choji] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo 1568506, Japan; [Kidoguchi, Yuh; Sato, Mariko; Muramatsu, Kazuaki] Tokyo Denki Univ, Sch Sci & Engn, Saitama 3500394, Japan; [Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Yamamoto, Kei] Univ Tokushima, Fac Biosci & Bioind, Tokushima 7708513, Japan; [Yamamoto, Kei] Japan Agcy Med Res & Dev, PRIME, Tokyo 1000004, Japan; [Murakami, Makoto] Japan Agcy Med Res & Dev, AMED CREST, Tokyo 1000004, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Denki University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tokushima University	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Kamikitazawa 2-1-6, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp		gelb, michael/0000-0001-7000-5219	Ministry of Education, Culture, Sports, Science and Technology of Japan [15H05905, 16H02613, 26461671, 25460087, 26860051]; Terumo Foundation; Takeda Foundation; Kowa Foundation; PRIME from Agency for Medical Research and Development; AMED-CREST from Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [26461671, 16H02613, 16K15122] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Terumo Foundation; Takeda Foundation(Takeda Science Foundation (TSF)); Kowa Foundation; PRIME from Agency for Medical Research and Development; AMED-CREST from Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 15H05905 and 16H02613 (to M. M.), 26461671 (to K. Y.), 25460087 (to Y. T.), and 26860051 (to Y. M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Terumo Foundation (to M. M.), Takeda and Kowa Foundations (to Y. T.), and by PRIME (to K. Y.) and AMED-CREST (to M. M.) from the Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Barnes MJ, 2015, J EXP MED, V212, P1011, DOI 10.1084/jem.20141827; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Diep QN, 2000, HYPERTENSION, V36, P851, DOI 10.1161/01.HYP.36.5.851; Endo J, 2014, J EXP MED, V211, P1673, DOI 10.1084/jem.20132011; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Kim W, 2010, PROG LIPID RES, V49, P250, DOI 10.1016/j.plipres.2010.01.002; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Murase R, 2016, J BIOL CHEM, V291, P6895, DOI 10.1074/jbc.M116.715672; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohta S, 2013, J IMMUNOL, V190, P5927, DOI 10.4049/jimmunol.1203202; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Ohtsuki T, 2016, J VIROL, V90, P300, DOI 10.1128/JVI.02293-15; Pernet E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6105; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Rubio JM, 2015, J IMMUNOL, V194, P3327, DOI 10.4049/jimmunol.1401026; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sawada Y, 2015, J EXP MED, V212, P1921, DOI 10.1084/jem.20150381; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Takeshita K, 2004, INT IMMUNOL, V16, P947, DOI 10.1093/intimm/dxh096; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Ueno N, 2011, J BIOL CHEM, V286, P37249, DOI 10.1074/jbc.M111.290312; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Vijay R, 2015, J EXP MED, V212, P1851, DOI 10.1084/jem.20150632; von Allmen CE, 2009, P NATL ACAD SCI USA, V106, P11673, DOI 10.1073/pnas.0812569106; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yamamoto Y, 2011, AM J PATHOL, V179, P302, DOI 10.1016/j.ajpath.2011.03.047; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015	61	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15588	15601		10.1074/jbc.M116.734624	http://dx.doi.org/10.1074/jbc.M116.734624			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27226632	hybrid, Green Published			2022-12-28	WOS:000380584200015
J	Carafoli, E; Krebs, J				Carafoli, Ernesto; Krebs, Joachim			Why Calcium? How Calcium Became the Best Communicator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HAND CA2+-BINDING PROTEINS; BINDING PROTEINS; INTRACELLULAR CALCIUM; ESSENTIAL COMPONENT; MITOCHONDRIA; EVOLUTION; UNIPORTER; MEMBRANE; HOMEOSTASIS; CALMODULIN	Calcium carries messages to virtually all important functions of cells. Although it was already active in unicellular organisms, its role became universally important after the transition to multicellular life. In this Minireview, we explore how calcium ended up in this privileged position. Most likely its unique coordination chemistry was a decisive factor as it makes its binding by complex molecules particularly easy even in the presence of large excesses of other cations, e.g. magnesium. Its free concentration within cells can thus be maintained at the very low levels demanded by the signaling function. A large cadre of proteins has evolved to bind or transport calcium. They all contribute to buffer it within cells, but a number of them also decode its message for the benefit of the target. The most important of these "calcium sensors" are the EF-hand proteins. Calcium is an ambivalent messenger. Although essential to the correct functioning of cell processes, if not carefully controlled spatially and temporally within cells, it generates variously severe cell dysfunctions, and even cell death.	[Carafoli, Ernesto] Univ Padua, Venetian Inst Mol Med, I-35131 Padua, Italy; [Krebs, Joachim] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany	University of Padua; Veneto Institute Molecular Medicine; Max Planck Society	Carafoli, E (corresponding author), Univ Padua, Venetian Inst Mol Med, I-35131 Padua, Italy.	ernesto.carafoli@unipd.it	Krebs, Joachim/CAF-0460-2022					Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Brini M., 2007, CALCIUM SIGNALING DI; Brini Marisa, 2013, Met Ions Life Sci, V13, P81, DOI 10.1007/978-94-007-7500-8_4; Brini M, 2013, METAL IONS LIFE SCI, V12, P119, DOI 10.1007/978-94-007-5561-1_5; Brown EM, 1999, CALCIUM AS A CELLULAR REGULATOR, P295; Cai XJ, 2015, CELL CALCIUM, V57, P166, DOI 10.1016/j.ceca.2014.11.007; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; Carafoli E., 1978, CURR TOP MEMBR TRANS, V10, P151; Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001; Collins SR, 2011, TRENDS CELL BIOL, V21, P202, DOI 10.1016/j.tcb.2011.01.002; Copley RR, 1999, CURR OPIN STRUC BIOL, V9, P408, DOI 10.1016/S0959-440X(99)80055-4; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; De Stefani D, 2015, BBA-MOL CELL RES, V1853, P2006, DOI 10.1016/j.bbamcr.2015.04.008; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON RM, 1980, FEBS LETT, V119, P1, DOI 10.1016/0014-5793(80)80986-0; Dominguez DC, 2015, CELL CALCIUM, V57, P151, DOI 10.1016/j.ceca.2014.12.006; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; El Albani A, 2010, NATURE, V466, P100, DOI 10.1038/nature09166; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayes M. J., 2007, V45, P1; HEIZMANN CW, 1982, P NATL ACAD SCI-BIOL, V79, P7243, DOI 10.1073/pnas.79.23.7243; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krebs J, 2007, N COMP BIOC, V41, P1; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Kretsinger RH, 1975, CALCIUM TRANSPORT CO, P469; Lauritzen SP, 2015, SEMIN CELL DEV BIOL, V45, P32, DOI 10.1016/j.semcdb.2015.10.028; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lopreiato R, 2014, J BIOL CHEM, V289, P10261, DOI 10.1074/jbc.O114.555565; LOTSCHER HR, 1979, P NATL ACAD SCI USA, V76, P4340, DOI 10.1073/pnas.76.9.4340; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M, 2012, FEBS J, V279, P1414, DOI 10.1111/j.1742-4658.2012.08560.x; Marshall CB, 2015, BIOCHEM BIOPH RES CO, V460, P5, DOI 10.1016/j.bbrc.2015.01.106; Mohamed TMA, 2011, J BIOL CHEM, V286, P41520, DOI 10.1074/jbc.M111.290411; Moncrief N.D., 1988, CALCIUM CHANNEL STRU, P16; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Murgia M, 2015, CELL CALCIUM, V58, P11, DOI 10.1016/j.ceca.2014.11.001; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Plattner H, 2015, CELL CALCIUM, V57, P123, DOI 10.1016/j.ceca.2014.12.004; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rigden DJ, 2003, TRENDS MICROBIOL, V11, P295, DOI 10.1016/S0966-842X(03)00153-7; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Williams RJP, 1999, CALCIUM AS A CELLULAR REGULATOR, P3; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Xue RH, 2015, P NATL ACAD SCI USA, V112, pE4316, DOI 10.1073/pnas.1502288112; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139	59	188	194	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20849	20857		10.1074/jbc.R116.735894	http://dx.doi.org/10.1074/jbc.R116.735894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27462077	Green Published, hybrid			2022-12-28	WOS:000385406200004
J	Ejby, M; Fredslund, F; Andersen, JM; Zagar, AV; Henriksen, JR; Andersen, TL; Svensson, B; Slotboom, DJ; Abou Hachem, M				Ejby, Morten; Fredslund, Folmer; Andersen, Joakim Mark; Zagar, Andreja Vujicic; Henriksen, Jonas Rosager; Andersen, Thomas Lars; Svensson, Birte; Slotboom, Dirk Jan; Abou Hachem, Maher			An ATP Binding Cassette Transporter Mediates the Uptake of alpha-(1,6)-Linked Dietary Oligosaccharides in Bifidobacterium and Correlates with Competitive Growth on These Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; carbohydrate-binding protein; crystal structure; probiotic; surface plasmon resonance (SPR); Bifidobacterium; gut microbiota; isomalto-oligosaccharide; oligosaccharide uptake; raffinose	GUT MICROBIOTA; STREPTOCOCCUS-MUTANS; ALPHA-GALACTOSIDASE; STRUCTURAL BASIS; MODEL; DIVERSITY; MICROORGANISMS; PERFORMANCE; METABOLISM; RAFFINOSE	The molecular details and impact of oligosaccharide uptake by distinct human gut microbiota (HGM) are currently not well understood. Non-digestible dietary galacto- and gluco--(1,6)-oligosaccharides from legumes and starch, respectively, are preferentially fermented by mainly bifidobacteria and lactobacilli in the human gut. Here we show that the solute binding protein (BlG16BP) associated with an ATP binding cassette (ABC) transporter from the probiotic Bifidobacterium animalis subsp. lactis Bl-04 binds -(1,6)-linked glucosides and galactosides of varying size, linkage, and monosaccharide composition with preference for the trisaccharides raffinose and panose. This preference is also reflected in the -(1,6)-galactoside uptake profile of the bacterium. Structures of BlG16BP in complex with raffinose and panose revealed the basis for the remarkable ligand binding plasticity of BlG16BP, which recognizes the non-reducing -(1,6)-diglycoside in its ligands. BlG16BP homologues occur predominantly in bifidobacteria and a few Firmicutes but lack in other HGMs. Among seven bifidobacterial taxa, only those possessing this transporter displayed growth on -(1,6)-glycosides. Competition assays revealed that the dominant HGM commensal Bacteroides ovatus was out-competed by B. animalis subsp. lactis Bl-04 in mixed cultures growing on raffinose, the preferred ligand for the BlG16BP. By comparison, B. ovatus mono-cultures grew very efficiently on this trisaccharide. These findings suggest that the ABC-mediated uptake of raffinose provides an important competitive advantage, particularly against dominant Bacteroides that lack glycan-specific ABC-transporters. This novel insight highlights the role of glycan transport in defining the metabolic specialization of gut bacteria.	[Ejby, Morten; Andersen, Joakim Mark; Svensson, Birte; Abou Hachem, Maher] Tech Univ Denmark, Prot Glycosci & Biotechnol, Dept Bioengn, Bldg 375, DK-2800 Lyngby, Denmark; [Henriksen, Jonas Rosager] Tech Univ Denmark, Dept Chem, Kemitorvet Bldg 206, DK-2800 Lyngby, Denmark; [Andersen, Thomas Lars] Tech Univ Denmark, Dept Microtechnol & Nanotechnol, Prod Storvet Bldg 423, DK-2800 Lyngby, Denmark; [Fredslund, Folmer] Lund Univ, MAX Lab 4, MaxLab, Ole Romers Vag 1, S-22100 Lund, Sweden; [Zagar, Andreja Vujicic; Slotboom, Dirk Jan] Univ Groningen, Inst Biomol Sci & Biotechnol, Membrane Enzymol, Nijenborgh 4, NL-9747 AG Groningen, Netherlands	Technical University of Denmark; Technical University of Denmark; Technical University of Denmark; Lund University; University of Groningen	Abou Hachem, M (corresponding author), Tech Univ Denmark, Prot Glycosci & Biotechnol, Dept Bioengn, Bldg 375, DK-2800 Lyngby, Denmark.	maha@bio.dtu.dk	Fredslund, Folmer/ABH-5821-2020; Abou Hachem, Maher/M-4772-2019	Fredslund, Folmer/0000-0003-0881-1927; Abou Hachem, Maher/0000-0001-8250-1842; Svensson, Birte/0000-0002-2993-8196; Henriksen, Jonas Rosager/0000-0001-9154-6639; Andresen, Thomas Lars/0000-0002-1048-127X; Ejby, Morten/0000-0003-2099-3591; Andersen, Joakim/0000-0001-8902-8162	Danish Strategic Research Council; FoSu committee; Danish Research Council for Independent Research Natural Sciences [4002-00297]; Biacore T100 instrument; Carlsberg Foundation [2011-01-0598]; Technical University of Denmark; European Research Council; EDICT program; Netherlands Organisation for Scientific Research (NWO)	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); FoSu committee; Danish Research Council for Independent Research Natural Sciences; Biacore T100 instrument; Carlsberg Foundation(Carlsberg Foundation); Technical University of Denmark; European Research Council(European Research Council (ERC)European Commission); EDICT program; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Danish Strategic Research Council, the FoSu committee to the project "Gene discovery and molecular interactions in pre/probiotics systems, Focus on carbohydrate prebiotics"; Danish Research Council for Independent Research Natural Sciences (Grant 4002-00297) and the Biacore T100 instrument; the Carlsberg Foundation for isothermal titration calorimetry equipment (2011-01-0598); Ph.D. stipends from the Technical University of Denmark (to M.E. and J.M.A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Research Council starting grant (to D. J. S.), the EDICT program, and the Netherlands Organisation for Scientific Research (NWO).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-312; Andersen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044409; Andersen KE, 2005, J AGR FOOD CHEM, V53, P5809, DOI 10.1021/jf040471v; Ao ZH, 2007, J AGR FOOD CHEM, V55, P4540, DOI 10.1021/jf063123x; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; Barrangou R, 2003, P NATL ACAD SCI USA, V100, P8957, DOI 10.1073/pnas.1332765100; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Brown K, 2012, NUTRIENTS, V4, P1095, DOI [10.3390/nu4081095, 10.3390/nu4111552]; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ejby M, 2013, MOL MICROBIOL, V90, P1100, DOI 10.1111/mmi.12419; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gilad O, 2010, APPL ENVIRON MICROB, V76, P7285, DOI 10.1128/AEM.00738-10; Goffin D, 2011, CRIT REV FOOD SCI, V51, P394, DOI 10.1080/10408391003628955; Goh YJ, 2015, ANNU REV FOOD SCI T, V6, P137, DOI 10.1146/annurev-food-022814-015706; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishizuka S, 2009, MOL NUTR FOOD RES, V53, pS62, DOI 10.1002/mnfr.200800041; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Makelainen H, 2009, LETT APPL MICROBIOL, V49, P666, DOI 10.1111/j.1472-765X.2009.02698.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oldham ML, 2013, P NATL ACAD SCI USA, V110, P18132, DOI 10.1073/pnas.1311407110; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Studts JM, 1999, PROTEIN EXPRES PURIF, V16, P109, DOI 10.1006/prep.1999.1067; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Swennen K, 2006, CRIT REV FOOD SCI, V46, P459, DOI 10.1080/10408390500215746; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; van den Broek LAM, 2003, APPL MICROBIOL BIOT, V61, P55, DOI 10.1007/s00253-002-1179-1; van Zanten GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047212; Ventura M, 2007, INT J FOOD MICROBIOL, V120, P2, DOI 10.1016/j.ijfoodmicro.2007.06.011; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42	56	35	36	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20220	20231		10.1074/jbc.M116.746529	http://dx.doi.org/10.1074/jbc.M116.746529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27502277	Green Published, hybrid			2022-12-28	WOS:000383243100041
J	Sui, XW; Zhang, JY; Golczak, M; Palczewski, K; Kiser, PD				Sui, Xuewu; Zhang, Jianye; Golczak, Marcin; Palczewski, Krzysztof; Kiser, Philip D.			Key Residues for Catalytic Function and Metal Coordination in a Carotenoid Cleavage Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mutation; metalloenzyme; rhodopsin; site-directed mutagenesis; x-ray crystallography; Leber congenital amaurosis; RPE65; non-heme iron; regioselectivity; retinal	APOCAROTENOID OXYGENASE ACO; LEBER CONGENITAL AMAUROSIS; RETINAL-PIGMENT EPITHELIUM; IN-VITRO CHARACTERIZATION; VISUAL CYCLE; BETA-CAROTENE; VITAMIN-A; SUBSTRATE-SPECIFICITY; ACTIVE-SITE; ISOMEROHYDROLASE ACTIVITY	Carotenoid cleavage dioxygenases (CCDs) are non-heme iron-containing enzymes found in all domains of life that generate biologically important apocarotenoids. Prior studies have revealed a critical role for a conserved 4-His motif in forming the CCD iron center. By contrast, the roles of other active site residues in catalytic function, including maintenance of the stringent regio- and stereo-selective cleavage activity, typically exhibited by these enzymes have not been thoroughly investigated. Here, we examined the functional and structural importance of active site residues in an apocarotenoid-cleaving oxygenase (ACO) from Synechocystis. Most active site substitutions variably lowered maximal catalytic activity without markedly affecting the K-m value for the all-trans-8-apocarotenol substrate. Native C15-C15 cleavage activity was retained in all ACO variants examined suggesting that multiple active site residues contribute to the enzyme's regioselectivity. Crystallographic analysis of a nearly inactive W149A-substituted ACO revealed marked disruption of the active site structure, including loss of iron coordination by His-238 apparently from an altered conformation of the conserved second sphere Glu-150 residue. Gln- and Asp-150-substituted versions of ACO further confirmed the structural/functional requirement for a Glu side chain at this position, which is homologous to Glu-148 in RPE65, a site in which substitution to Asp has been associated with loss of enzymatic function in Leber congenital amaurosis. The novel links shown here between ACO active site structure and catalytic activity could be broadly applicable to other CCD members and provide insights into the molecular pathogenesis of vision loss associated with an RPE65 point mutation.	[Sui, Xuewu; Zhang, Jianye; Golczak, Marcin; Palczewski, Krzysztof; Kiser, Philip D.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Kiser, Philip D.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Palczewski, K; Kiser, PD (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; pdk7@case.edu			Department of Veterans Affairs Career Development Award [IK2BX002683]; National Institutes of Health [EY009339, EY020551, EY023948]; National Institutes of Health from the NCRR [GM103403]; NATIONAL EYE INSTITUTE [R01EY023948, R01EY020551, R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	Department of Veterans Affairs Career Development Award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NCRR; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by Department of Veterans Affairs Career Development Award IK2BX002683 (to P. D. K.) and National Institutes of Health Grants EY009339 and EY020551 (to K. P.) and EY023948 (to M. G.) A portion of this work was based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by National Institutes of Health Grant GM103403 from the NCRR. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Al-Babili S, 2015, ANNU REV PLANT BIOL, V66, P161, DOI 10.1146/annurev-arplant-043014-114759; Alvarez R, 2014, CHEM REV, V114, P1, DOI 10.1021/cr400126u; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Babino D, 2016, ACS CHEM BIOL, V11, P1049, DOI 10.1021/acschembio.5b00967; Beil S, 1998, J BACTERIOL, V180, P5520, DOI 10.1128/JB.180.21.5520-5528.1998; BENDICH A, 1989, FASEB J, V3, P1927, DOI 10.1096/fasebj.3.8.2656356; BENDICH A, 1989, J NUTR, V119, P112, DOI 10.1093/jn/119.1.112; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; Brkic H, 2012, J BIOL INORG CHEM, V17, P801, DOI 10.1007/s00775-012-0898-8; Buongiorno D, 2013, COORDIN CHEM REV, V257, P541, DOI 10.1016/j.ccr.2012.04.028; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chander P, 2012, J BIOL CHEM, V287, P30552, DOI 10.1074/jbc.M112.364596; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; dela Sena C, 2013, J BIOL CHEM, V288, P37094, DOI 10.1074/jbc.M113.507160; Diebold AR, 2010, BIOCHEMISTRY-US, V49, P6945, DOI 10.1021/bi100892w; Eleftheriadis N, 2015, J MED CHEM, V58, P7850, DOI 10.1021/acs.jmedchem.5b01121; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frusciante S, 2014, P NATL ACAD SCI USA, V111, P12246, DOI 10.1073/pnas.1404629111; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMODA S, 1989, AGR BIOL CHEM TOKYO, V53, P2757, DOI 10.1080/00021369.1989.10869724; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kiser PD, 2015, NAT CHEM BIOL, V11, P409, DOI [10.1038/NCHEMBIO.1799, 10.1038/nchembio.1799]; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Marasco EK, 2008, CHEMBIOCHEM, V9, P1450, DOI 10.1002/cbic.200700724; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Mullangi V, 2012, BIOCHEMISTRY-US, V51, P7202, DOI 10.1021/bi300911d; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nikolaeva O, 2010, BIOCHEM BIOPH RES CO, V391, P1757, DOI 10.1016/j.bbrc.2009.12.149; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; OLSON JA, 1989, J NUTR, V119, P105, DOI 10.1093/jn/119.1.105; Parales RE, 2000, J BACTERIOL, V182, P1641, DOI 10.1128/JB.182.6.1641-1649.2000; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Pikus JD, 1997, BIOCHEMISTRY-US, V36, P9283, DOI 10.1021/bi971049t; Poliakov E, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-31; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 2009, EXP EYE RES, V88, P846, DOI 10.1016/j.exer.2008.07.015; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.04460.x; Scherzinger D, 2006, BIOCHEM J, V398, P361, DOI 10.1042/BJ20060592; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwartz SH, 2003, BBA-GEN SUBJECTS, V1619, P9, DOI 10.1016/S0304-4165(02)00422-1; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Sui XW, 2015, J BIOL CHEM, V290, P30212, DOI 10.1074/jbc.M115.696799; Sui XW, 2014, J BIOL CHEM, V289, P12286, DOI 10.1074/jbc.M114.552836; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Takahashi Y, 2012, BIOCHEMISTRY-US, V51, P4217, DOI 10.1021/bi300144n; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; von Lintig J, 2005, BBA-MOL BASIS DIS, V1740, P122, DOI 10.1016/j.bbadis.2004.11.010; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811	71	20	20	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19401	19412		10.1074/jbc.M116.744912	http://dx.doi.org/10.1074/jbc.M116.744912			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27453555	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000383242800019
J	Yang, YT; Ting, YH; Liang, KJ; Lo, KY				Yang, Yi-Ting; Ting, Ya-Han; Liang, Kei-Jen; Lo, Kai-Yin			The Roles of Puf6 and Loc1 in 60S Biogenesis Are Interdependent, and Both Are Required for Efficient Accommodation of Rpl43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; mRNA; precursor ribosomal RNA (pre-rRNA); ribosome; ribosome assembly; asymmetric mRNA distribution; ribosomal protein	MESSENGER-RNA LOCALIZATION; SHWACHMAN-DIAMOND SYNDROME; RIBOSOMAL-PROTEIN RPS3; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; BINDING PROTEIN; NUCLEAR EXPORT; TRANSLATIONAL REPRESSION; EUKARYOTIC RIBOSOME; YEAST	Puf6 and Loc1 have two important functional roles in the cells, asymmetric mRNA distribution and ribosome biogenesis. Puf6 and Loc1 are localized predominantly in the nucleolus. They bind ASH1 mRNA, repress its translation, and facilitate the transport to the daughter cells. Asymmetric mRNA distribution is important for cell differentiation. Besides their roles in mRNA localization, Puf6 and Loc1 have been shown to be involved in 60S biogenesis. In puf6 or loc1 cells, pre-rRNA processing and 60S export are impaired and 60S subunits are underaccumulated. The functional studies of Puf6 and Loc1 have been focused on ASH1 mRNA pathway, but their roles in 60S biogenesis are still not clear. In this study, we found that Puf6 and Loc1 interact directly with each other and both proteins interact with the ribosomal protein Rpl43 (L43e). Notably, the roles of Puf6 and Loc1 in 60S biogenesis are interdependent, and both are required for efficient accommodation of Rpl43. Loc1 is further required to maintain the protein level of Rpl43. Additionally, the recruitment of Rpl43 is required for the release of Puf6 and Loc1. We propose that Puf6 and Loc1 facilitate Rpl43 loading and are sequentially released from 60S after incorporation of Rpl43 into ribosomes in yeast.	[Yang, Yi-Ting; Ting, Ya-Han; Liang, Kei-Jen; Lo, Kai-Yin] Natl Taiwan Univ, Dept Agr Chem, 1 Sec 4,Roosevelt Rd, Taipei 10617, Taiwan	National Taiwan University	Lo, KY (corresponding author), Natl Taiwan Univ, Dept Agr Chem, 1 Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	kaiyin@ntu.edu.tw		LO, KAI-YIN/0000-0003-0440-6836	Ministry of Science and Technology of Taiwan [MOST 104-2311-B-002-026]; National Taiwan University Career Development Project [103R7818]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Career Development Project	This work was supported by the Ministry of Science and Technology of Taiwan under Contract MOST 104-2311-B-002-026 and by National Taiwan University Career Development Project 103R7818. The authors declare that they have no conflicts of interest with the contents of this article.	Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Buu LM, 2004, J BIOL CHEM, V279, P453, DOI 10.1074/jbc.M309278200; Calvino FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7510; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Demoinet E, 2007, RNA, V13, P1570, DOI 10.1261/rna.585007; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Eisinger DP, 1997, MOL CELL BIOL, V17, P5146, DOI 10.1128/MCB.17.9.5146; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavis ER, 2001, NAT STRUCT BIOL, V8, P387, DOI 10.1038/87535; Gerhardy S, 2014, CHROMOSOMA, V123, P327, DOI 10.1007/s00412-014-0463-z; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gijsbers A, 2013, BIOCHEM BIOPH RES CO, V437, P349, DOI 10.1016/j.bbrc.2013.06.077; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Hasan A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004684; Holzer S, 2013, J MOL BIOL, V425, P4154, DOI 10.1016/j.jmb.2013.08.022; Hung NJ, 2006, MOL CELL BIOL, V26, P3718, DOI 10.1128/MCB.26.10.3718-3727.2006; Iouk TL, 2001, MOL CELL BIOL, V21, P1260, DOI 10.1128/MCB.21.4.1260-1271.2001; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Koch B, 2012, J BIOL CHEM, V287, P21806, DOI 10.1074/jbc.M112.365791; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kressler D, 2012, SCIENCE, V338, P666, DOI 10.1126/science.1226960; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Long RM, 2001, J CELL BIOL, V153, P307, DOI 10.1083/jcb.153.2.307; Maxon ME, 2001, P NATL ACAD SCI USA, V98, P1495, DOI 10.1073/pnas.98.4.1495; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Niedner A, 2013, P NATL ACAD SCI USA, V110, pE5049, DOI 10.1073/pnas.1315289111; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Pillet B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005565; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Qiu C, 2014, P NATL ACAD SCI USA, V111, P18554, DOI 10.1073/pnas.1407634112; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Schutz S, 2014, ELIFE, V3, DOI 10.7554/eLife.03473; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shahbabian K, 2014, NUCLEIC ACIDS RES, V42, P8692, DOI 10.1093/nar/gku597; Shen Z, 2009, MOL BIOL CELL, V20, P2265, DOI 10.1091/mbc.E08-11-1151; Shimoji K, 2012, NUCLEIC ACIDS RES, V40, P4574, DOI 10.1093/nar/gks057; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Sykes MT, 2009, ANNU REV BIOPHYS, V38, P197, DOI 10.1146/annurev.biophys.050708.133615; Urbinati CR, 2006, MOL GENET GENOMICS, V276, P369, DOI 10.1007/s00438-006-0151-7; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Wong CC, 2011, BLOOD, V118, P4305, DOI 10.1182/blood-2011-06-353938; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197	55	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19312	19323		10.1074/jbc.M116.732800	http://dx.doi.org/10.1074/jbc.M116.732800			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27458021	Green Published, hybrid			2022-12-28	WOS:000383242800012
J	Martfeld, AN; Greathouse, DV; Koeppe, RE				Martfeld, Ashley N.; Greathouse, Denise V.; Koeppe, Roger E., II			Ionization Properties of Histidine Residues in the Lipid Bilayer Membrane Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON LOADING SITE; M2 ION-CHANNEL; TRANSMEMBRANE PEPTIDE; AMINO-ACIDS; ARGININE RESIDUES; PK(A); MECHANISM; PROTEIN; DOMAIN; H-2	We address the critically important ionization properties of histidine side chains of membrane proteins, when exposed directly to lipid acyl chains within lipid bilayer membranes. The problem is important for addressing general principles that may underlie membrane protein function. To this end, we have employed a favorable host peptide framework provided by GWALP23 (acetyl-GGALW(5)LALALALALALALW(19)LAGA-amide). We inserted His residues into position 12 or 14 of GWALP23 (replacing either Leu(12) or Leu(14)) and incorporated specific [H-2] Ala labels within the helical core sequence. Solid-state H-2 NMR spectra report the folding and orientation of the core sequence, revealing marked differences in the histidinecontaining transmembrane helix behavior between acidic and neutral pH conditions. At neutral pH, the GWALP23-H12 and GWALP23-H14 helices exhibit well defined tilted transmembrane orientations in dioleoylphosphatidylcholine (DOPC) and dilauroylphosphatidylcholine (DLPC) bilayer membranes. Under acidic conditions, when His(12) is protonated and charged, the GWALP23-H12 helix exhibits a major population that moves to the DOPC bilayer surface and a minor population that occupies multiple transmembrane states. The response to protonation of His(14) is an increase in helix tilt, but GWALP23-H14 remains in a transmembrane orientation. The results suggest pK(a) values of less than 3 for His(12) and about 3-5 for His(14) in DOPC membranes. In the thinner DLPC bilayers, with increased water access, the helices are less responsive to changes in pH. The combined results enable us to compare the ionization properties of lipid-exposed His, Lys, and Arg side chains in lipid bilayer membranes.	[Martfeld, Ashley N.; Greathouse, Denise V.; Koeppe, Roger E., II] Univ Arkansas, Dept Chem & Biochem, 119 Chem Bldg, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Koeppe, RE (corresponding author), Univ Arkansas, Dept Chem & Biochem, 119 Chem Bldg, Fayetteville, AR 72701 USA.	rk2@uark.edu		Koeppe, Roger/0000-0003-0676-6413	National Institutes of Health [GM103429, GM103450]; Div Of Molecular and Cellular Bioscience [1327611] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429, P30GM103450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The peptide, NMR, and mass spectrometry facilities were supported in part by National Institutes of Health Grants GM103429 and GM103450. We thank Vitaly Vostrikov for software for semi-static GALA and modified Gaussian methods for analysis of helix orientations and dynamics.	Achilonu I, 2012, BIOCHEMISTRY-US, V51, P995, DOI 10.1021/bi201541w; Baran KL, 2008, J MOL BIOL, V379, P1045, DOI 10.1016/j.jmb.2008.04.021; Bechinger B, 1996, J MOL BIOL, V263, P768, DOI 10.1006/jmbi.1996.0614; BENDER ML, 1964, J AM CHEM SOC, V86, P3704, DOI 10.1021/ja01072a020; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Chaloupka R, 2005, BIOCHEMISTRY-US, V44, P726, DOI 10.1021/bi048014v; Colvin MT, 2014, BIOCHEMISTRY-US, V53, P5987, DOI 10.1021/bi5005393; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Edgcomb SP, 2002, PROTEINS, V49, P1, DOI 10.1002/prot.10177; Fitch CA, 2015, PROTEIN SCI, V24, P752, DOI 10.1002/pro.2647; Gleason NJ, 2013, P NATL ACAD SCI USA, V110, P1692, DOI 10.1073/pnas.1215400110; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hu FH, 2012, J AM CHEM SOC, V134, P3703, DOI 10.1021/ja2081185; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Illergard K, 2011, PROTEINS, V79, P79, DOI 10.1002/prot.22859; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P80, DOI 10.1016/j.bbabio.2010.08.014; Larson CA, 2010, MOL PHARMACOL, V78, P333, DOI 10.1124/mol.110.064766; Li L, 2008, BIOPHYS J, V94, pL11, DOI 10.1529/biophysj.107.121566; Lu JX, 2014, P NATL ACAD SCI USA, V111, P12414, DOI 10.1073/pnas.1407187111; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MONCELLI MR, 1994, BIOPHYS J, V66, P1969, DOI 10.1016/S0006-3495(94)80990-7; Mortazavi A, 2016, CHEMBIOCHEM, V17, P462, DOI 10.1002/cbic.201500656; Nagai H, 2008, J CHEM ENG DATA, V53, P619, DOI 10.1021/je700067a; Nanga R. P. R., 2008, BIOCHEMISTRY-US, V47, P12689; Okada A, 2001, BIOCHEMISTRY-US, V40, P6053, DOI 10.1021/bi0028441; Paddock ML, 2003, BIOCHEMISTRY-US, V42, P9626, DOI 10.1021/bi0346648; Panahi A, 2015, J PHYS CHEM B, V119, P4601, DOI 10.1021/acs.jpcb.5b00289; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Plesniak LA, 1996, PROTEIN SCI, V5, P2319, DOI 10.1002/pro.5560051118; Rehwald M, 1999, FEBS LETT, V443, P357, DOI 10.1016/S0014-5793(99)00007-1; Reisser S, 2014, BIOPHYS J, V106, P2385, DOI 10.1016/j.bpj.2014.04.020; Rodnin MV, 2010, J MOL BIOL, V402, P1, DOI 10.1016/j.jmb.2010.07.024; Roux B, 2007, J GEN PHYSIOL, V130, P233, DOI 10.1085/jgp.200709819; SCHOELLMANN G, 1963, BIOCHEMISTRY-US, V2, P252, DOI 10.1021/bi00902a008; Sparks KA, 2014, BIOCHEMISTRY-US, V53, P3637, DOI 10.1021/bi500439x; Strandberg E, 2004, BIOPHYS J, V86, P3709, DOI 10.1529/biophysj.103.035402; Strandberg E, 2012, BBA-BIOMEMBRANES, V1818, P1242, DOI 10.1016/j.bbamem.2012.01.023; Thibado JK, 2015, BIOPHYS J, V108, p553A, DOI 10.1016/j.bpj.2014.11.3034; Tishmack PA, 1997, BIOCHEMISTRY-US, V36, P11984, DOI 10.1021/bi9712448; van der Wel PCA, 2002, BIOPHYS J, V83, P1479, DOI 10.1016/S0006-3495(02)73918-0; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200; Vostrikov VV, 2008, J AM CHEM SOC, V130, P12584, DOI 10.1021/ja803734k; Vostrikov VV, 2012, J PHYS CHEM B, V116, P12980, DOI 10.1021/jp308182b; Vostrikov VV, 2011, BIOPHYS J, V101, P2939, DOI 10.1016/j.bpj.2011.11.008; Vostrikov VV, 2010, J BIOL CHEM, V285, P31723, DOI 10.1074/jbc.M110.152470; Vostrikov VV, 2010, J AM CHEM SOC, V132, P5803, DOI 10.1021/ja100598e; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; Yoo J, 2008, BIOPHYS J, V94, pL61, DOI 10.1529/biophysj.107.122945	50	20	20	0	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19146	19156		10.1074/jbc.M116.738583	http://dx.doi.org/10.1074/jbc.M116.738583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27440045	Green Published, hybrid			2022-12-28	WOS:000383242300046
J	Schuler, MH; Di Bartolomeo, F; Martensson, CU; Daum, G; Becker, T				Schuler, Max-Hinderk; Di Bartolomeo, Francesca; Martensson, Christoph U.; Daum, Guenther; Becker, Thomas			Phosphatidylcholine Affects Inner Membrane Protein Translocases of Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; PHOSPHATIDYLETHANOLAMINE METHYLATION PATHWAY; RESPIRATORY-CHAIN SUPERCOMPLEXES; YEAST SACCHAROMYCES-CEREVISIAE; OUTER-MEMBRANE; PHOSPHATIDYLSERINE DECARBOXYLASE; CONTACT SITES; PRESEQUENCE TRANSLOCASE; MAMMALIAN MITOCHONDRIA; PREPROTEIN TRANSLOCASE	Two protein translocases transport precursor proteins into or across the inner mitochondrial membrane. The presequence translocase (TIM23 complex) sorts precursor proteins with a cleavable presequence either into the matrix or into the inner membrane. The carrier translocase (TIM22 complex) inserts multispanning proteins into the inner membrane. Both protein import pathways depend on the presence of a membrane potential, which is generated by the activity of the respiratory chain. The non-bilayer-forming phospholipids cardiolipin and phosphatidylethanolamine are required for the activity of the respiratory chain and therefore to maintain the membrane potential for protein import. Depletion of cardiolipin further affects the stability of the TIM23 complex. The role of bilayer-forming phospholipids like phosphatidylcholine (PC) in protein transport into the inner membrane and the matrix is unknown. Here, we report that import of presequence-containing precursors and carrier proteins is impaired in PC-deficient mitochondria. Surprisingly, depletion of PC does not affect stability and activity of respiratory supercomplexes, and the membrane potential is maintained. Instead, the dynamic TIM23 complex is destabilized when the PC levels are reduced, whereas the TIM22 complex remains intact. Our analysis further revealed that initial precursor binding to the TIM23 complex is impaired in PC-deficient mitochondria. We conclude that reduced PC levels differentially affect the TIM22 and TIM23 complexes in mitochondrial protein transport.	[Schuler, Max-Hinderk; Martensson, Christoph U.; Becker, Thomas] Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany; [Martensson, Christoph U.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Becker, Thomas] Univ Freiburg, BIGSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Di Bartolomeo, Francesca; Daum, Guenther] Graz Univ Technol, Inst Biochem, NaWi Graz, A-8010 Graz, Austria; [Daum, Guenther] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	University of Freiburg; University of Freiburg; University of Freiburg; Graz University of Technology; Utah System of Higher Education; University of Utah	Becker, T (corresponding author), Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.becker@biochemie.uni-freiburg.de	Schuler, Max-Hinderk/AAZ-8376-2021; Schuler, Max-Hinderk/AAZ-8388-2021	Schuler, Max-Hinderk/0000-0002-6734-8250; Di Bartolomeo, Francesca/0000-0002-4302-0701	Deutsche Forschungsgemeinschaft [BE4679/2-1, Sonderforschungsbereich 746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]; Austrian Science Fund Project [P-26133]; Austrian Science Fund (FWF) [P 26133] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Austrian Science Fund Project(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Deutsche Forschungsgemeinschaft Grant BE4679/2-1, Sonderforschungsbereich 746 and the Excellence Initiative of the German Federal and State Governments EXC 294 BIOSS, and by the Austrian Science Fund Project P-26133 (to G. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker CD, 2016, MOL BIOL CELL, V27, P2161, DOI 10.1091/mbc.E15-12-0865; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Becker T, 2013, J BIOL CHEM, V288, P16451, DOI 10.1074/jbc.M112.442392; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Bottinger L, 2016, J BIOENERG BIOMEMBR, V48, P125, DOI 10.1007/s10863-015-9599-7; Bottinger L, 2013, MOL BIOL CELL, V24, P2609, DOI 10.1091/mbc.E13-02-0106; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Bornhovd C, 2006, J BIOL CHEM, V281, P13990, DOI 10.1074/jbc.M512334200; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dimmer KS, 2012, BBA-BIOMEMBRANES, V1818, P1085, DOI 10.1016/j.bbamem.2011.08.027; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gebert M, 2012, J CELL BIOL, V197, P595, DOI 10.1083/jcb.201110047; Gebert N, 2011, MOL CELL, V44, P811, DOI 10.1016/j.molcel.2011.09.025; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; GREENBERG ML, 1983, J BACTERIOL, V153, P791, DOI 10.1128/JB.153.2.791-799.1983; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Ieva R, 2014, MOL CELL, V56, P641, DOI 10.1016/j.molcel.2014.10.010; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; KODAKI T, 1987, J BIOL CHEM, V262, P15428; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; Koehler CM, 2000, MOL CELL BIOL, V20, P1187, DOI 10.1128/MCB.20.4.1187-1193.2000; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Marom M, 2011, BBA-BIOMEMBRANES, V1808, P990, DOI 10.1016/j.bbamem.2010.07.011; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Peixoto PMV, 2007, J BIOL CHEM, V282, P18694, DOI 10.1074/jbc.M700775200; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; PREITSCHOPF W, 1993, CURR GENET, V23, P95, DOI 10.1007/BF00352006; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Sauerwald J, 2015, MOL CELL BIOL, V35, P3200, DOI 10.1128/MCB.00107-15; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Schuler MH, 2015, J BIOL CHEM, V290, P26523, DOI 10.1074/jbc.M115.687921; Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Song JY, 2014, EMBO REP, V15, P670, DOI 10.1002/embr.201338142; SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5; SUMMERS EF, 1988, GENETICS, V120, P909; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Waegemann K, 2015, J MOL BIOL, V427, P1075, DOI 10.1016/j.jmb.2014.07.015; Wagner K, 2010, MOL BIOL CELL, V21, P1494, DOI 10.1091/mbc.E09-12-1023; Wenz LS, 2015, J CELL BIOL, V210, P1047, DOI 10.1083/jcb.201504119; Wenz LS, 2014, EMBO REP, V15, P678, DOI 10.1002/embr.201338144; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283; Ye CQ, 2016, J BIOENERG BIOMEMBR, V48, P113, DOI 10.1007/s10863-014-9591-7; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	97	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18718	18729		10.1074/jbc.M116.722694	http://dx.doi.org/10.1074/jbc.M116.722694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402832	Green Published, hybrid			2022-12-28	WOS:000383242300010
J	Strenkert, D; Limso, CA; Fatihi, A; Schmollinger, S; Basset, GJ; Merchant, SS				Strenkert, Daniela; Limso, Clariss Ann; Fatihi, Abdelhak; Schmollinger, Stefan; Basset, Gilles J.; Merchant, Sabeeha S.			Genetically Programmed Changes in Photosynthetic Cofactor Metabolism in Copper-deficient Chlamydomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-I; IRON-DEFICIENCY; HEAT-SHOCK; HIGH LIGHT; VITAMIN-E; PROTEIN; BIOSYNTHESIS; STRESS; SYNECHOCYSTIS; PLASTOCYANIN	Genetic and genomic studies indicate that copper deficiency triggers changes in the expression of genes encoding key enzymes in various chloroplast-localized lipid/pigment biosynthetic pathways. Among these are CGL78 involved in chlorophyll biosynthesis and HPPD1, encoding 4-hydroxyphenylpyruvate dioxygenase catalyzing the committed step of plastoquinone and tocopherol biosyntheses. Copper deficiency in wild-type cells does not change the chlorophyll content, but a survey of chlorophyll protein accumulation in this situation revealed increased accumulation of LHCSR3, which is blocked at the level of mRNA accumulation when either CGL78 expression is reduced or in the crd1 mutant, which has a copper-nutrition conditional defect at the same step in chlorophyll biosynthesis. Again, like copper-deficient crd1 strains, cgl78 knock-down lines also have reduced chlorophyll content concomitant with loss of PSI-LHCI super-complexes and reduced abundance of a chlorophyll binding subunit of PSI, PSAK, which connects LHCI to PSI. For HPPD1, increased mRNA results in increased abundance of the corresponding protein in copper-deficient cells concomitant with CRR1-dependent increased accumulation of gamma-tocopherols, but not plastoquinone-9 nor total tocopherols. In crr1 mutants, where increased HPPD1 expression is blocked, plastochromanol-8, derived from plastoquinone-9 and purported to also have an antioxidant function, is found instead. Although not previously found in algae, this metabolite may occur only in stress conditions.	[Strenkert, Daniela; Schmollinger, Stefan; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Strenkert, Daniela; Limso, Clariss Ann; Schmollinger, Stefan; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East,Box 951569, Los Angeles, CA 90095 USA; [Fatihi, Abdelhak] INRA AgroParisTech, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France; [Basset, Gilles J.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; State University System of Florida; University of Florida	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East,Box 951569, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu		Schmollinger, Stefan/0000-0002-7487-8014; Limso, Clariss Ann/0000-0002-7464-7865; Strenkert, Daniela/0000-0002-3420-1332; Basset, Gilles/0000-0001-5275-9797	National Institutes of Health [GM42143]; National Science Foundation [MCB-1148968]; European Molecular Biology Organization [ALTF 653-2013]; German Academic Exchange Service (DAAD); Div Of Molecular and Cellular Bioscience [1608088] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM042143, R01GM042143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42143 (to S. M.) and National Science Foundation Grant MCB-1148968 (to G. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by European Molecular Biology Organization Grant ALTF 653-2013.; Supported by a fellowship within the Postdoc-Program of the German Academic Exchange Service (DAAD).	Albus CA, 2012, PLANT PHYSIOL, V160, P1923, DOI 10.1104/pp.112.206045; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Ballottari M, 2016, J BIOL CHEM, V291, P7334, DOI 10.1074/jbc.M115.704601; Bergner SV, 2015, PLANT PHYSIOL, V168, P615, DOI 10.1104/pp.15.00072; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Block A, 2013, J BIOL CHEM, V288, P27594, DOI 10.1074/jbc.M113.492769; Bollivar D, 2014, FEBS J, V281, P2377, DOI 10.1111/febs.12790; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Correa-Galvis V., 2016, J BIOL CHEM, DOI [10.1074/jbc.116.737312, DOI 10.1074/JBC.116.737312]; Fatihi A, 2015, PLANT CELL, V27, P1730, DOI 10.1105/tpc.15.00103; Formighieri C, 2012, MOL PLANT, V5, P1242, DOI 10.1093/mp/sss051; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hemschemeier A, 2013, PLANT CELL, V25, P3186, DOI 10.1105/tpc.113.115741; HILL KL, 1991, J BIOL CHEM, V266, P15060; Hollingshead S, 2012, J BIOL CHEM, V287, P27823, DOI 10.1074/jbc.M112.352526; Hsieh SI, 2013, MOL CELL PROTEOMICS, V12, P65, DOI 10.1074/mcp.M112.021840; Hussain N, 2013, J AGR FOOD CHEM, V61, P6137, DOI 10.1021/jf4010302; Jose Huertas Maria, 2014, Life-Basel, V4, P865, DOI 10.3390/life4040865; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kobayashi N, 2008, PLANT J, V55, P607, DOI 10.1111/j.1365-313X.2008.03539.x; Krieger-Liszkay A, 2006, J EXP BOT, V57, P1677, DOI 10.1093/jxb/erl002; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Kruk J, 2014, PHYTOCHEMISTRY, V108, P9, DOI 10.1016/j.phytochem.2014.09.011; Li ZR, 2012, PLANT PHYSIOL, V158, P313, DOI 10.1104/pp.111.181230; Maeda H, 2005, PLANT PHYSIOL, V138, P1422, DOI 10.1104/pp.105.061135; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Martinis J, 2013, PLANT PHYSIOL, V162, P652, DOI 10.1104/pp.113.218644; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; MERCHANT S, 1995, J CELL BIOCHEM, P241; Merchant SS, 2012, ADV MICROB PHYSIOL, V60, P91, DOI 10.1016/B978-0-12-398264-3.00002-4; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Page MD, 2009, PLANT CELL, V21, P928, DOI 10.1105/tpc.108.064907; Penarrubia L, 2010, J BIOL INORG CHEM, V15, P29, DOI 10.1007/s00775-009-0591-8; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Piller LE, 2012, J EXP BOT, V63, P1609, DOI 10.1093/jxb/ers016; Pinnola A, 2015, PLANT CELL, V27, P3213, DOI 10.1105/tpc.15.00443; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quinn JM, 2000, J BIOL CHEM, V275, P6080, DOI 10.1074/jbc.275.9.6080; SANDMANN G, 1983, ARCH MICROBIOL, V134, P23, DOI 10.1007/BF00429401; Schmollinger S, 2010, CURR GENET, V56, P383, DOI 10.1007/s00294-010-0304-4; Sommer F, 2010, PLANT CELL, V22, P4098, DOI 10.1105/tpc.110.080069; Strenkert D, 2011, PLANT CELL, V23, P2285, DOI 10.1105/tpc.111.085266; Trebst A, 2002, FEBS LETT, V516, P156, DOI 10.1016/S0014-5793(02)02526-7; Urzica EI, 2012, PLANT CELL, V24, P3921, DOI 10.1105/tpc.112.102491; Williams RJP, 2003, CHEM COMMUN, P1109, DOI 10.1039/b211281g; WOLLMAN FA, 1982, BIOCHIM BIOPHYS ACTA, V680, P352, DOI 10.1016/0005-2728(82)90149-9; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Zingg JM, 2015, ANNU REV NUTR, V35, P135, DOI 10.1146/annurev-nutr-071714-034347	60	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19118	19131		10.1074/jbc.M116.717413	http://dx.doi.org/10.1074/jbc.M116.717413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27440043	Green Published, hybrid			2022-12-28	WOS:000383242300044
J	Gregg, CM; Goetzl, S; Jeoung, JH; Dobbek, H				Gregg, Christina M.; Goetzl, Sebastian; Jeoung, Jae-Hun; Dobbek, Holger			AcsF Catalyzes the ATP-dependent Insertion of Nickel into the Ni,Ni-[4Fe4S] Cluster of Acetyl-CoA Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; biosynthesis; iron-sulfur protein; metal ion-protein interaction; metalloenzyme; nickel	CARBON-MONOXIDE DEHYDROGENASE; MULTIENZYME COMPLEX; CFD1-NBP35 COMPLEX; PROTEIN FAMILIES; BIOSYNTHESIS; BINDING; SUBUNIT; METALLOPROTEINS; CLASSIFICATION; MUTAGENESIS	Acetyl-CoA synthase (ACS) catalyzes the reversible condensation of CO, CoA, and a methyl-cation to form acetyl-CoA at a unique Ni,Ni-[4Fe4S] cluster (the A-cluster). However, it was unknown which proteins support the assembly of the A-cluster. We analyzed the product of a gene from the cluster containing the ACS gene, cooC2 from Carboxydothermus hydrogenoformans, named AcsF(Ch), and showed that it acts as a maturation factor of ACS. AcsF(Ch) and inactive ACS form a stable 2:1 complex that binds two nickel ions with higher affinity than the individual components. The nickel-bound ACS-AcsF(Ch) complex remains inactive until MgATP is added, thereby converting inactive to active ACS. AcsF(Ch) is a MinD-type ATPase and belongs to the CooC protein family, which can be divided into homologous subgroups. We propose that proteins of one subgroup are responsible for assembling the Ni,Ni-[4Fe4S] cluster of ACS, whereas proteins of a second subgroup mature the [Ni4Fe4S] cluster of carbon monoxide dehydrogenases.	[Gregg, Christina M.; Goetzl, Sebastian; Jeoung, Jae-Hun; Dobbek, Holger] Humboldt Univ, Inst Biol, Strukturbiol Biochem, Unter den Linden 6, D-10099 Berlin, Germany	Humboldt University of Berlin	Dobbek, H (corresponding author), Humboldt Univ, Inst Biol, Strukturbiol Biochem, Unter den Linden 6, D-10099 Berlin, Germany.	Holger.Dobbek@biologie.hu-berlin.de		Gregg, Christina/0000-0003-4440-4624	Deutsche Forschungsgemeinschaft [DO 785/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Project Grant DO 785/6-1. The authors declare that they have no conflicts of interest with the contents of this article.	Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bange G, 2013, NAT STRUCT MOL BIOL, V20, P776, DOI 10.1038/nsmb.2605; Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; Boer JL, 2010, BIOCHEMISTRY-US, V49, P5859, DOI 10.1021/bi1004987; Can M, 2014, CHEM REV, V114, P4149, DOI 10.1021/cr400461p; Chung KCC, 2011, FEBS LETT, V585, P291, DOI 10.1016/j.febslet.2010.12.024; Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; Demchak Barry, 2014, F1000Res, V3, P151, DOI 10.12688/f1000research.4492.2; Denny JA, 2015, CHEM REV, V115, P5248, DOI 10.1021/cr500659u; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Farrugia MA, 2013, J BIOL CHEM, V288, P13178, DOI 10.1074/jbc.R112.446526; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fong YH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001678; Frazzon J, 2002, MET IONS BIOL SYST, V39, P163; Gencic S, 2003, J BIOL CHEM, V278, P6101, DOI 10.1074/jbc.M210484200; Gencic S, 2010, J BIOL CHEM, V285, P15450, DOI 10.1074/jbc.M109.080994; George SJ, 2005, J AM CHEM SOC, V127, P13500, DOI 10.1021/ja0528329; Hadj-Said J, 2015, BBA-BIOENERGETICS, V1847, P1574, DOI 10.1016/j.bbabio.2015.08.002; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2013, BBA-BIOENERGETICS, V1827, P1112, DOI 10.1016/j.bbabio.2012.12.001; Inoue T, 2014, BIOSCI BIOTECH BIOCH, V78, P582, DOI 10.1080/09168451.2014.890027; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Jeoung JH, 2007, SCIENCE, V318, P1461, DOI 10.1126/science.1148481; Jeoung JH, 2014, METAL IONS LIFE SCI, V14, P37, DOI 10.1007/978-94-017-9269-1_3; Jeoung JH, 2010, J MOL BIOL, V396, P1165, DOI 10.1016/j.jmb.2009.12.062; Jeoung JH, 2009, BIOCHEMISTRY-US, V48, P11505, DOI 10.1021/bi901443z; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kerby RL, 1997, J BACTERIOL, V179, P2259, DOI 10.1128/jb.179.7.2259-2266.1997; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lindsley JE, 2000, METH MOL B, V95, P57; Loke HK, 2003, J INORG BIOCHEM, V93, P33, DOI 10.1016/S0162-0134(02)00457-9; Loke HK, 2002, J AM CHEM SOC, V124, P8667, DOI 10.1021/ja025924w; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Netz DJA, 2012, J BIOL CHEM, V287, P12365, DOI 10.1074/jbc.M111.328914; Ribbe MW, 2014, CHEM REV, V114, P4063, DOI 10.1021/cr400463x; Robertson WD, 2013, J BIOL INORG CHEM, V18, P701, DOI 10.1007/s00775-013-1015-3; Seravalli J, 2004, BIOCHEMISTRY-US, V43, P3944, DOI 10.1021/bi036194n; SHIN WS, 1992, BIOCHEMISTRY-US, V31, P12870, DOI 10.1021/bi00166a023; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; Su Gang, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0813s47; Svetlitchnyi V, 2004, P NATL ACAD SCI USA, V101, P446, DOI 10.1073/pnas.0304262101; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Watanabe S, 2012, BIOL CHEM, V393, P1089, DOI 10.1515/hsz-2012-0197; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Zamble DB, 2015, METALLOMICS, V7, P588, DOI 10.1039/c5mt90013a; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; ZOU XA, 1995, INORG CHEM, V34, P1634, DOI 10.1021/ic00111a003	59	12	12	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18129	18138		10.1074/jbc.M116.731638	http://dx.doi.org/10.1074/jbc.M116.731638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382049	Green Published, hybrid			2022-12-28	WOS:000383241800007
J	Reichard, EL; Chirico, GG; Dewey, WJ; Nassif, ND; Bard, KE; Millas, NE; Kraut, DA				Reichard, Eden L.; Chirico, Giavanna G.; Dewey, William J.; Nassif, Nicholas D.; Bard, Katelyn E.; Millas, Nickolas E.; Kraut, Daniel A.			Substrate Ubiquitination Controls the Unfolding Ability of the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; ATPases associated with diverse cellular activities (AAA); enzyme kinetics; enzyme mechanism; pre-steady-state kinetics; proteasome; protein degradation; protein unfolding	ATP-DEPENDENT PROTEASES; NF-KAPPA-B; FLUORESCENT PROTEIN TIMERS; 26S PROTEASOME; POLYUBIQUITIN CHAIN; ADAPTER PROTEIN; SINGLE-MOLECULE; DEGRADATION; PATHWAY; SYSTEM	In eukaryotic cells, proteins are targeted to the proteasome for degradation by polyubiquitination. These proteins bind to ubiquitin receptors, are engaged and unfolded by proteasomal ATPases, and are processively degraded. The factors determining to what extent the proteasome can successfully unfold and degrade a substrate are still poorly understood. We find that the architecture of polyubiquitin chains attached to a substrate affects the ability of the proteasome to unfold and degrade the substrate, with K48- or mixed-linkage chains leading to greater processivity than K63-linked chains. Ubiquitin-independent targeting of substrates to the proteasome gave substantially lower processivity of degradation than ubiquitin-dependent targeting. Thus, even though ubiquitin chains are removed early in degradation, during substrate engagement, remarkably they dramatically affect the later unfolding of a protein domain. Our work supports a model in which a polyubiquitin chain associated with a substrate switches the proteasome into an activated state that persists throughout the degradation process.	[Reichard, Eden L.; Chirico, Giavanna G.; Dewey, William J.; Nassif, Nicholas D.; Bard, Katelyn E.; Millas, Nickolas E.; Kraut, Daniel A.] Villanova Univ, Dept Chem, Villanova, PA 19085 USA	Villanova University	Kraut, DA (corresponding author), Mendel Hall 214D,800 Lancaster Ave, Villanova, PA 19085 USA.	daniel.kraut@villanova.edu		Kraut, Daniel/0000-0002-4428-5832	National Science Foundation [1515229]; Direct For Biological Sciences [1515229] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 1515229. The authors declare that they have no conflicts of interest with the contents of this article.	Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Baird L, 2014, BIOTECHNOL ADV, V32, P1133, DOI 10.1016/j.biotechadv.2014.03.004; Baraibar MA, 2012, PROG MOL BIOL TRANSL, V109, P249, DOI 10.1016/B978-0-12-397863-9.00007-9; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Cannon JR, 2015, ANAL CHEM, V87, P1812, DOI 10.1021/ac5038363; Carvalho AF, 2012, MOL BIOTECHNOL, V51, P254, DOI 10.1007/s12033-011-9463-x; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Gavrilov Y, 2015, PROTEIN SCI, V24, P1580, DOI 10.1002/pro.2688; Godderz D, 2011, J MOL BIOL, V407, P354, DOI 10.1016/j.jmb.2011.01.051; Ha SW, 2012, BIOCHEM BIOPH RES CO, V419, P226, DOI 10.1016/j.bbrc.2012.01.152; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hospenthal MK, 2015, NAT PROTOC, V10, P349, DOI 10.1038/nprot.2015.018; Huang L, 2009, CURR MED CHEM, V16, P931, DOI 10.2174/092986709787581860; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Khmelinskii A, 2016, MOL BIOL CELL, V27, P360, DOI 10.1091/mbc.E15-07-0525; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Kraut DA, 2007, TRENDS CELL BIOL, V17, P419, DOI 10.1016/j.tcb.2007.06.008; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Kraut DA, 2011, ACS CHEM BIOL, V6, P1087, DOI 10.1021/cb2002285; Kravtsova-Ivantsiv Y, 2015, CELL, V161, P333, DOI 10.1016/j.cell.2015.03.001; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Li YF, 2011, BBA-GENE REGUL MECH, V1809, P141, DOI 10.1016/j.bbagrm.2010.09.001; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Min W, 2005, ACCOUNTS CHEM RES, V38, P923, DOI 10.1021/ar040133f; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Nassif ND, 2014, IUBMB LIFE, V66, P309, DOI 10.1002/iub.1271; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Raasi Shahri, 2005, V301, P47; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schrader EK, 2011, J BIOL CHEM, V286, P39051, DOI 10.1074/jbc.M111.274993; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Small E, 2010, BIOCHEM BIOPH RES CO, V400, P471, DOI 10.1016/j.bbrc.2010.08.062; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takahashi K, 2015, ACS CHEM BIOL, V10, P2537, DOI 10.1021/acschembio.5b00554; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Vu ND, 2004, BIOCHEMISTRY-US, V43, P3346, DOI 10.1021/bi0362267; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	81	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18547	18561		10.1074/jbc.M116.720151	http://dx.doi.org/10.1074/jbc.M116.720151			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405762	Green Published, hybrid			2022-12-28	WOS:000383241800044
J	Rezabkova, L; Kraatz, SHW; Akhmanova, A; Steinmetz, MO; Kammerer, RA				Rezabkova, Lenka; Kraatz, Sebastian H. W.; Akhmanova, Anna; Steinmetz, Michel O.; Kammerer, Richard A.			Biophysical and Structural Characterization of the Centriolar Protein Cep104 Interaction Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; centriole; cilia; circular dichroism (CD); x-ray crystallography; Cep104; TOG domain	PLUS-END TRACKING; TOG DOMAIN; SEDIMENTATION; XMAP215; PHENIX; CILIA; SIZE	Dysfunction of cilia is associated with common genetic disorders termed ciliopathies. Knowledge on the interaction networks of ciliary proteins is therefore key for understanding the processes that are underlying these severe diseases and the mechanisms of ciliogenesis in general. Cep104 has recently been identified as a key player in the regulation of cilia formation. Using a combination of sequence analysis, biophysics, and x-ray crystallography, we obtained new insights into the domain architecture and interaction network of the Cep104 protein. We solved the crystal structure of the tumor overexpressed gene (TOG) domain, identified Cep104 as a novel tubulin-binding protein, and biophysically characterized the interaction of Cep104 with CP110, Cep97, end-binding (EB) protein, and tubulin. Our results represent a solid platform for the further investigation of the microtubule-EB-Cep104-tubulin-CP110-Cep97 network of proteins. Ultimately, such studies should be of importance for understanding the process of cilia formation and the mechanisms underlying different ciliopathies.	[Rezabkova, Lenka; Kraatz, Sebastian H. W.; Steinmetz, Michel O.; Kammerer, Richard A.] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Akhmanova, Anna] Univ Utrecht, Dept Biol, Fac Sci, Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Utrecht University	Kammerer, RA (corresponding author), Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland.	richard.kammerer@psi.ch	Rezabkova, Lenka/O-8229-2017; Steinmetz, Michel O/AAA-3349-2022	Rezabkova, Lenka/0000-0002-7274-8080; Steinmetz, Michel O/0000-0001-6157-3687; Kraatz, Sebastian/0000-0003-2265-9052; Kammerer, Richard/0000-0003-4570-5197	Swiss National Science Foundation [310030B_138659, 31003A_163449]; EMBO; Marie Curie IEF fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie IEF fellowship(European Commission)	The work was supported in part by Swiss National Science Foundation Grants 310030B_138659 (to M. O. S.) and 31003A_163449 (to R. A. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by EMBO long-term and Marie Curie IEF fellowships.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreu Jose Manuel, 2007, Methods Mol Med, V137, P17, DOI 10.1007/978-1-59745-442-1_2; Ayaz P, 2014, ELIFE, V3, DOI 10.7554/eLife.03069; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Bhogaraju S, 2011, EMBO J, V30, P1907, DOI 10.1038/emboj.2011.110; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Das A, 2015, MOL BIOL CELL, V26, P4248, DOI 10.1091/mbc.E15-08-0603; De la Mora-Rey T, 2013, ACTA CRYSTALLOGR F, V69, P723, DOI 10.1107/S1744309113015182; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fox JC, 2014, MOL BIOL CELL, V25, P2375, DOI 10.1091/mbc.E13-08-0501; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Izawa Ichiro, 2015, Cilia, V4, P12, DOI 10.1186/s13630-015-0021-1; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Leano JB, 2013, STRUCTURE, V21, P939, DOI 10.1016/j.str.2013.04.018; Mahjoub MR, 2013, ORGANOGENESIS, V9, P61, DOI 10.4161/org.25144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nachury MV, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0465; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2009, BIOCHEM SOC T, V37, P1002, DOI 10.1042/BST0371002; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Srour M, 2015, AM J HUM GENET, V97, P744, DOI 10.1016/j.ajhg.2015.09.009; Tammana TVS, 2013, J CELL SCI, V126, P5018, DOI 10.1242/jcs.133439; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011	38	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18496	18504		10.1074/jbc.M116.739771	http://dx.doi.org/10.1074/jbc.M116.739771			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402853	Green Published, hybrid			2022-12-28	WOS:000383241800039
J	Bausewein, D; Engel, J; Jank, T; Schoedl, M; Strahl, S				Bausewein, Daniela; Engel, Jakob; Jank, Thomas; Schoedl, Maria; Strahl, Sabine			Functional Similarities between the Protein O-Mannosyltransferases Pmt4 from Bakers' Yeast and Human POMT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mutation; glycosylation; glycosyltransferase; human; yeast; dystroglycanopathy; O-mannosylation; PMT4; POMT1	WALKER-WARBURG-SYNDROME; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MANNOSE GLYCOPROTEOME; MUSCULAR-DYSTROPHY; MENTAL-RETARDATION; ENZYMATIC-ACTIVITY; GENE FAMILY; MANNOSYLATION; GLYCOSYLATION	Protein O-mannosylation is an essential post-translational modification. It is initiated in the endoplasmic reticulum by a family of protein O-mannosyltransferases that are conserved from yeast (PMTs) to human (POMTs). The degree of functional conservation between yeast and human protein O-mannosyltransferases is uncharacterized. In bakers' yeast, the main in vivo activities are due to heteromeric Pmt1-Pmt2 and homomeric Pmt4 complexes. Here we describe an enzymatic assay that allowed us to monitor Pmt4 activity in vitro. We demonstrate that detergent requirements and acceptor substrates of yeast Pmt4 are different from Pmt1-Pmt2, but resemble that of human POMTs. Furthermore, we mimicked two POMT1 amino acid exchanges (G76R and V428D) that result in severe congenital muscular dystrophies in humans, in yeast Pmt4 (I112R and I435D). In vivo and in vitro analyses showed that general features such as protein stability of the Pmt4 variants were not significantly affected, however, the mutants proved largely enzymatically inactive. Our results demonstrate functional and biochemical similarities between POMT1 and its orthologue from bakers' yeast Pmt4.	[Bausewein, Daniela; Engel, Jakob; Jank, Thomas; Schoedl, Maria; Strahl, Sabine] Heidelberg Univ, Ctr Organismal Studies, Cell Chem, Neuenheimer Feld 360, D-69120 Heidelberg, Germany; [Engel, Jakob] Boehringer Ingelheim GmbH & Co KG, Lab Analyt Dev, D-88400 Biberach, Germany; [Jank, Thomas] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Schoedl, Maria] Roche Diagnost GmbH, Dept Med & Sci Affairs, D-82377 Penzberg, Germany	Ruprecht Karls University Heidelberg; Boehringer Ingelheim; University of Freiburg; Roche Holding	Strahl, S (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Cell Chem, Neuenheimer Feld 360, D-69120 Heidelberg, Germany.	sabine.strahl@cos.uni-heidelberg.de	Jank, Thomas/R-9627-2017		Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 638]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 638, project A18. The authors declare that they have no conflicts of interest with the contents of this article.	Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Akasaka-Manya K, 2011, BIOCHEM BIOPH RES CO, V411, P721, DOI 10.1016/j.bbrc.2011.07.012; BABCZINSKI P, 1973, BIOCHEM BIOPH RES CO, V54, P1119, DOI 10.1016/0006-291X(73)90808-5; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Beltran-Valero D, 2002, AM J HUM GENET, V71, P165; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Ecker M, 2003, EMBO REP, V4, P628, DOI 10.1038/sj.embor.embor864; GENTZSCH M, 1995, GLYCOBIOLOGY, V5, P77, DOI 10.1093/glycob/5.1.77; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Hutzler J, 2007, P NATL ACAD SCI USA, V104, P7827, DOI 10.1073/pnas.0700374104; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; IMMERVOLL T, 1995, YEAST, V11, P1345, DOI 10.1002/yea.320111403; Judas M, 2009, NEUROPEDIATRICS, V40, P6, DOI 10.1055/s-0029-1224099; Loibl M, 2014, J BIOL CHEM, V289, P8599, DOI 10.1074/jbc.M113.543116; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Lommel M, 2010, NEUROLOGY, V74, P157, DOI 10.1212/WNL.0b013e3181c919d6; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2010, METHOD ENZYMOL, V479, P323, DOI 10.1016/S0076-6879(10)79018-2; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Neubert P, 2016, MOL CELL PROTEOMICS, V15, P1323, DOI 10.1074/mcp.M115.057505; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schott A, 2010, J BIOL CHEM, V285, P18113, DOI 10.1074/jbc.M110.117176; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; STRAHLBOLSINGER S, 1993, P NATL ACAD SCI USA, V90, P8164, DOI 10.1073/pnas.90.17.8164; STRAHLBOLSINGER S, 1991, EUR J BIOCHEM, V196, P185, DOI 10.1111/j.1432-1033.1991.tb15802.x; Van Reeuwijk J, 2006, HUM MUTAT, V27, P453, DOI 10.1002/humu.20313; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Winterhalter PR, 2013, FEBS LETT, V587, P3715, DOI 10.1016/j.febslet.2013.09.041; Xu CC, 2015, SEMIN CELL DEV BIOL, V41, P129, DOI 10.1016/j.semcdb.2015.01.014; Yang HP, 2016, J HUM GENET, V61, P753, DOI 10.1038/jhg.2016.42	47	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					18006	18015		10.1074/jbc.M116.739128	http://dx.doi.org/10.1074/jbc.M116.739128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27358400	hybrid, Green Published			2022-12-28	WOS:000383241300042
J	Byrd, AK; Zybailov, BL; Maddukuri, L; Gao, J; Marecki, JC; Jaiswal, M; Bell, MR; Griffin, WC; Reed, MR; Chib, S; Mackintosh, SG; MacNicol, AM; Baldini, G; Eoff, RL; Raney, KD				Byrd, Alicia K.; Zybailov, Boris L.; Maddukuri, Leena; Gao, Jun; Marecki, John C.; Jaiswal, Mihir; Bell, Matthew R.; Griffin, Wezley C.; Reed, Megan R.; Chib, Shubeena; Mackintosh, Samuel G.; MacNicol, Angus M.; Baldini, Giulia; Eoff, Robert L.; Raney, Kevin D.			Evidence That G-quadruplex DNA Accumulates in the Cytoplasm and Participates in Stress Granule Assembly in Response to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; G-quadruplex; oxidative stress; signaling; stress granule; stress response; telomere	RNA HELICASE RHAU; TELOMERASE REVERSE-TRANSCRIPTASE; SACCHAROMYCES-CEREVISIAE; HYDROGEN-PEROXIDE; GENE-EXPRESSION; RESOLVASE 1; TETRAMOLECULAR QUADRUPLEX; DELETION BREAKPOINTS; SHORTENS TELOMERES; PROTEOMIC ANALYSIS	Cells engage numerous signaling pathways in response to oxidative stress that together repair macromolecular damage or direct the cell toward apoptosis. As a result of DNA damage, mitochondrial DNA or nuclear DNA has been shown to enter the cytoplasm where it binds to DNA sensors, which in turn initiate signaling cascades. Here we report data that support a novel signaling pathway in response to oxidative stress mediated by specific guanine-rich sequences that can fold into G-quadruplex DNA (G4DNA). In response to oxidative stress, we demonstrate that sequences capable of forming G4DNA appear at increasing levels in the cytoplasm and participate in assembly of stress granules. Identified proteins that bind to endogenous G4DNA in the cytoplasm are known to modulate mRNA translation and participate in stress granule formation. Consistent with these findings, stress granule formation is known to regulate mRNA translation during oxidative stress. We propose a signaling pathway whereby cells can rapidly respond to DNA damage caused by oxidative stress. Guanine-rich sequences that are excised from damaged genomic DNA are proposed to enter the cytoplasm where they can regulate translation through stress granule formation. This newly proposed role for G4DNA provides an additional molecular explanation for why such sequences are prevalent in the human genome.	[Byrd, Alicia K.; Zybailov, Boris L.; Maddukuri, Leena; Gao, Jun; Marecki, John C.; Bell, Matthew R.; Griffin, Wezley C.; Reed, Megan R.; Chib, Shubeena; Mackintosh, Samuel G.; Baldini, Giulia; Eoff, Robert L.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham St, Little Rock, AR 72205 USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Slot 516,4301 W Markham St, Little Rock, AR 72205 USA; [Mackintosh, Samuel G.; MacNicol, Angus M.; Eoff, Robert L.; Raney, Kevin D.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Zybailov, Boris L.; Jaiswal, Mihir] Univ Arkansas, Univ Arkansas Little Rock Univ Arkansas Med Sci U, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham St, Little Rock, AR 72205 USA.	RaneyKevinD@uams.edu		Zybailov, Boris/0000-0003-2432-9145; Byrd, Alicia/0000-0001-5484-0759; Reed, Megan/0000-0001-5086-7938; Bell, Matthew/0000-0003-4313-2989	Arkansas IDeA Network for Biomedical Research Excellence (National Institutes of Health) [P20GM103429]; University of Arkansas Center for Protein Structure and Function (National Institutes of Health) [P30GM103450]; UAMS Center for Microbial Pathogenesis and Host Inflammatory Responses (National Institutes of Health) [P20GM103625]; UAMS Translational Research Institute (National Institutes of Health) [UL1TR000039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD082793, R01HD087057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098922, P20GM103625, R01GM117439, P20GM103429, P30GM110702, P30GM103450] Funding Source: NIH RePORTER	Arkansas IDeA Network for Biomedical Research Excellence (National Institutes of Health); University of Arkansas Center for Protein Structure and Function (National Institutes of Health); UAMS Center for Microbial Pathogenesis and Host Inflammatory Responses (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS Translational Research Institute (National Institutes of Health); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Arkansas for Medical Sciences (UAMS) Proteomics Core is supported by the Arkansas IDeA Network for Biomedical Research Excellence (National Institutes of Health Grant P20GM103429), the University of Arkansas Center for Protein Structure and Function (National Institutes of Health Grant P30GM103450), the UAMS Center for Microbial Pathogenesis and Host Inflammatory Responses (National Institutes of Health Grant P20GM103625), and the UAMS Translational Research Institute (National Institutes of Health Grant UL1TR000039). We thank Shankar Balasubramanian, University of Cambridge, for the gift of the pSANG10-3F-BG4 plasmid encoding the BG4 single chain antibody. Monoclonal antibody 1H6 was kindly provided by Peter Lansdorp, European Research Institute for the Biology of Aging, University of Groningen. We thank Timothy Chambers for helpful discussions and Andrea Edwards for technical assistance.	An N, 2016, ACS CHEM BIOL, V11, P500, DOI 10.1021/acschembio.5b00844; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Benson BK, 2008, PROTEIN SCI, V17, P34, DOI 10.1110/ps.073186408; Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073; Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Byrum SD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt822; Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chalupnikova K, 2008, J BIOL CHEM, V283, P35186, DOI 10.1074/jbc.M804857200; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chen QM, 2000, J CELL SCI, V113, P4087; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Fernando H, 2009, NUCLEIC ACIDS RES, V37, P6716, DOI 10.1093/nar/gkp740; Fleming AM, 2015, ACS CENTRAL SCI, V1, P226, DOI 10.1021/acscentsci.5b00202; Fleming AM, 2013, CHEM RES TOXICOL, V26, P593, DOI 10.1021/tx400028y; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Gao J, 2015, CHEM COMMUN, V51, P7242, DOI 10.1039/c5cc00742a; Nguyen GH, 2014, P NATL ACAD SCI USA, V111, P9905, DOI 10.1073/pnas.1404807111; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Hatzakis E, 2010, BIOCHEMISTRY-US, V49, P9152, DOI 10.1021/bi100946g; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Islam MA, 2014, J BIOL CHEM, V289, P8521, DOI 10.1074/jbc.M113.505073; Ivanov P, 2014, P NATL ACAD SCI USA, V111, P18201, DOI 10.1073/pnas.1407361111; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Jing NJ, 2006, MOL CANCER THER, V5, P279, DOI 10.1158/1535-7163.MCT-05-0302; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kaminski JJ, 2013, J IMMUNOL, V191, P3876, DOI 10.4049/jimmunol.1300530; Kawane K, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016394; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kim HN, 2011, J BONE MINER RES, V26, P2161, DOI 10.1002/jbmr.426; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Klinman DM, 2009, ANN NY ACAD SCI, V1175, P80, DOI 10.1111/j.1749-6632.2009.04970.x; Lai JC, 2012, BLOOD, V119, P4291, DOI 10.1182/blood-2011-08-362954; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lemos H, 2014, J IMMUNOL, V192, P5571, DOI 10.4049/jimmunol.1303258; Leung CH, 2011, ANAL CHEM, V83, P463, DOI 10.1021/ac1025896; Lian XJ, 2009, J BIOL CHEM, V284, P8868, DOI 10.1074/jbc.M806372200; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Ming X, 2014, J AM CHEM SOC, V136, P4223, DOI 10.1021/ja411636j; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Oliveira PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059907; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; PHILLIPS LL, 1956, SCIENCE, V124, P889, DOI 10.1126/science.124.3227.889; Qi HY, 2006, CANCER RES, V66, P11808, DOI 10.1158/0008-5472.CAN-06-1225; Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sedoris KC, 2012, MOL CANCER THER, V11, P66, DOI 10.1158/1535-7163.MCT-11-0515; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Shih JW, 2014, CLIN CHIM ACTA, V436, P45, DOI 10.1016/j.cca.2014.05.003; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Simone R, 2015, FEBS LETT, V589, P1653, DOI 10.1016/j.febslet.2015.05.003; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Vasilyev N, 2015, P NATL ACAD SCI USA, V112, pE5391, DOI 10.1073/pnas.1515737112; Vatovec S, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.015; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Vorlickova M, 2012, FEBS J, V279, P29, DOI 10.1111/j.1742-4658.2011.08396.x; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802; Waris S, 2014, INT J MOL SCI, V15, P23377, DOI 10.3390/ijms151223377; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Xiao S, 2014, ANGEW CHEM INT EDIT, V53, P13110, DOI 10.1002/anie.201407045; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhou J, 2015, NUCLEIC ACIDS RES, V43, P4039, DOI 10.1093/nar/gkv252; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n; Zybailov B, 2009, MOL CELL PROTEOMICS, V8, P1789, DOI 10.1074/mcp.M900104-MCP200	113	51	51	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					18041	18057		10.1074/jbc.M116.718478	http://dx.doi.org/10.1074/jbc.M116.718478			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27369081	Green Published, hybrid			2022-12-28	WOS:000383241300045
J	Harsman, A; Schock, A; Hemmis, B; Wahl, V; Jeshen, I; Bartsch, P; Schlereth, A; Pertl-Obermeyer, H; Goetze, TA; Soll, J; Philippar, K; Wagner, R				Harsman, Anke; Schock, Annette; Hemmis, Birgit; Wahl, Vanessa; Jeshen, Ingrid; Bartsch, Philipp; Schlereth, Armin; Pertl-Obermeyer, Heidi; Goetze, Tom Alexander; Soll, Juergen; Philippar, Katrin; Wagner, Richard			OEP40, a Regulated Glucose-permeable -Barrel Solute Channel in the Chloroplast Outer Envelope Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; glucose transport; ion channel; membrane transport; outer membrane; beta-barrel protein; metabolite transport; solute channel	TREHALOSE 6-PHOSPHATE; SECONDARY STRUCTURE; STARCH DEGRADATION; DYNAMIC INTERFACE; COLD-ACCLIMATION; ARABIDOPSIS; METABOLISM; PREDICTION; TRANSCRIPTOME; TRANSPORTERS	Chloroplasts and mitochondria are unique endosymbiotic cellular organelles surrounded by two membranes. Essential metabolic networking between these compartments and their hosting cells requires the exchange of a large number of biochemical pathway intermediates in a directed and coordinated fashion across their inner and outer envelope membranes. Here, we describe the identification and functional characterization of a highly specific, regulated solute channel in the outer envelope of chloroplasts, named OEP40. Loss of OEP40 function in Arabidopsis thaliana results in early flowering under cold temperature. The reconstituted recombinant OEP40 protein forms a high conductance -barrel ion channel with subconductant states in planar lipid bilayers. The OEP40 channel is slightly cation-selective PK+/PCl- approximate to 4:1 and rectifying (i?/i? 2) with a slope conductance of G(max) 690 picosiemens. The OEP40 channel has a restriction zone diameter of 1.4 nm and is permeable for glucose, glucose 1-phosphate and glucose 6-phosphate, but not for maltose. Moreover, channel properties are regulated by trehalose 6-phosphate, which cannot permeate. Altogether, our results indicate that OEP40 is a glucose-gate in the outer envelope membrane of chloroplasts, facilitating selective metabolite exchange between chloroplasts and the surrounding cell.	[Harsman, Anke; Hemmis, Birgit; Bartsch, Philipp; Wagner, Richard] Univ Osnabruck, Inst Biophys, Dept Biol, Barbarastr 13, D-49076 Osnabruck, Germany; [Schock, Annette; Jeshen, Ingrid; Pertl-Obermeyer, Heidi; Goetze, Tom Alexander; Soll, Juergen; Philippar, Katrin] Univ Munich, Chair Plant Biochem & Physiol, Dept Biol Bot 1, Grosshadernerstr 2-4, D-82152 Planegg Martinsried, Germany; [Schock, Annette; Jeshen, Ingrid; Pertl-Obermeyer, Heidi; Goetze, Tom Alexander; Soll, Juergen; Philippar, Katrin] Univ Munich, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Wahl, Vanessa; Schlereth, Armin] Max Planck Inst Mol Plant Physiol, Dept Metab Networks, Muhlenberg 1, D-14476 Potsdam, Germany	University Osnabruck; University of Munich; University of Munich; Max Planck Society	Philippar, K (corresponding author), Univ Munich, Dept Biol Bot 1, Grosshadernerstr 2-4, D-82152 Planegg Martinsried, Germany.; Wagner, R (corresponding author), Jacobs Univ Bremen gGmbH, Inst Biophys Life Sci & Chem, Campus Ring 1, D-28759 Bremen, Germany.	philippar@lmu.de; ri.wagner@jacobs-university.de	Pertl-Obermeyer, Heidi/I-5849-2015; Philippar, Katrin/F-7942-2018; Wahl, Vanessa/ABC-3341-2020	Pertl-Obermeyer, Heidi/0000-0001-9180-5995; Wahl, Vanessa/0000-0001-7421-8801; Philippar, Katrin/0000-0002-2140-4907	Heisenberg Fellowship of the Deutsche Forschungsgemeinschaft [PH73/6-1]	Heisenberg Fellowship of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by a Heisenberg Fellowship PH73/6-1 of the Deutsche Forschungsgemeinschaft.	Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; BlachlyDyson E, 1997, MOL CELL BIOL, V17, P5727, DOI 10.1128/MCB.17.10.5727; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; Blumel M, 2015, CURR OPIN BIOTECH, V32, P121, DOI 10.1016/j.copbio.2014.11.023; Bolter B, 1999, EMBO J, V18, P5505, DOI 10.1093/emboj/18.20.5505; Bolter B, 2001, EMBO J, V20, P935, DOI 10.1093/emboj/20.5.935; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Breuers FKH, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00097; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Capovilla G, 2015, J EXP BOT, V66, P59, DOI 10.1093/jxb/eru416; Carillo P, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-21; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Duy D, 2007, BIOL CHEM, V388, P879, DOI 10.1515/BC.2007.120; Duy D, 2007, PLANT CELL, V19, P986, DOI 10.1105/tpc.106.047407; Fellerer C, 2011, MOL PLANT, V4, P1133, DOI 10.1093/mp/ssr037; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; Figueroa CM, 2016, PLANT J, V85, P410, DOI 10.1111/tpj.13114; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Goetze TA, 2006, J BIOL CHEM, V281, P17989, DOI 10.1074/jbc.M600700200; Harsman A, 2011, EUR J CELL BIOL, V90, P721, DOI 10.1016/j.ejcb.2011.04.012; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Kammerer B, 1998, PLANT CELL, V10, P105, DOI 10.1105/tpc.10.1.105; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Klemens PAW, 2014, NEW PHYTOL, V202, P188, DOI 10.1111/nph.12642; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Nagele T, 2013, NEW PHYTOL, V198, P777, DOI 10.1111/nph.12201; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Nunes C, 2013, PLANT PHYSIOL, V162, P1720, DOI 10.1104/pp.113.220657; PATLAK JB, 1993, BIOPHYS J, V65, P29, DOI 10.1016/S0006-3495(93)81041-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philippar K, 2007, PLANT SOLUTE TRANSPO, P133, DOI DOI 10.1002/9780470988862.CH7; Philippar K, 2007, P NATL ACAD SCI USA, V104, P678, DOI 10.1073/pnas.0610062104; Pohlmeyer K, 1998, PLANT CELL, V10, P1207, DOI 10.1105/tpc.10.7.1207; Pudelski B, 2012, J EXP BOT, V63, P1919, DOI 10.1093/jxb/err375; Purdy SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079412; Randall A, 2008, BIOINFORMATICS, V24, P513, DOI 10.1093/bioinformatics/btm548; Roussel G, 2013, BIOTECHNOL BIOENG, V110, P417, DOI 10.1002/bit.24722; SCHAFER G, 1977, PLANT PHYSIOL, V60, P286, DOI 10.1104/pp.60.2.286; Schleiff E, 2003, PROTEIN SCI, V12, P748, DOI 10.1110/ps.0237503; Schmedt D, 2010, THESIS; Schneider T, 2009, PLANT CELL PHYSIOL, V50, P2174, DOI 10.1093/pcp/pcp151; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Siriwardana NS, 2012, INT J DEV BIOL, V56, P207, DOI 10.1387/ijdb.113450ns; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Tsai AYL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00119; WAEGEMANN K, 1992, PLANTA, V187, P89, DOI 10.1007/BF00201628; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Weber APM, 2011, ANNU REV PLANT BIOL, V62, P53, DOI 10.1146/annurev-arplant-042110-103903; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wiese A, 1999, FEBS LETT, V461, P13, DOI 10.1016/S0014-5793(99)01417-9; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Yang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00260; Yu S, 2013, ELIFE, V2, DOI 10.7554/eLife.00269; Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	70	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17848	17860		10.1074/jbc.M115.712398	http://dx.doi.org/10.1074/jbc.M115.712398			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27339897	Green Published, hybrid			2022-12-28	WOS:000383241300030
J	Lorinczi, E; Helliwell, M; Finch, A; Stansfeld, PJ; Davies, NW; Mahaut-Smith, M; Muskett, FW; Mitcheson, JS				Lorinczi, Eva; Helliwell, Matthew; Finch, Alina; Stansfeld, Phillip J.; Davies, Noel W.; Mahaut-Smith, Martyn; Muskett, Frederick W.; Mitcheson, John S.			Calmodulin Regulates Human Ether a Go-Go 1 (hEAG1) Potassium Channels through Interactions of the Eag Domain with the Cyclic Nucleotide Binding Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; calmodulin (CaM); electrophysiology; gating; potassium channel	C-TERMINAL REGION; ION CHANNELS; CELL-CYCLE; HERG; RAT; DEACTIVATION; PIP2; DETERMINANTS; INHIBITION; EXPRESSION	The ether a go-go family of voltage-gated potassium channels is structurally distinct. The N terminus contains an eag domain (eagD) that contains a Per-Arnt-Sim (PAS) domain that is preceded by a conserved sequence of 25-27 amino acids known as the PAS-cap. The C terminus contains a region with homology to cyclic nucleotide binding domains (cNBHD), which is directly linked to the channel pore. The human EAG1 (hEAG1) channel is remarkably sensitive to inhibition by intracellular calcium (Ca-i(2+)) through binding of Ca2+-calmodulin to three sites adjacent to the eagD and cNBHD. Here, we show that the eagD and cNBHD interact to modulate Ca2+-calmodulin as well as voltage-dependent gating. Sustained elevation of Ca-i(2+) resulted in an initial profound inhibition of hEAG1 currents, which was followed by a phase when current amplitudes partially recovered, but activation gating was slowed and shifted to depolarized potentials. Deletion of either the eagD or cNBHD abolished the inhibition by Ca-i(2+). However, deletion of just the PAS-cap resulted in a >15-fold potentiation in response to elevated Ca-i(2+). Mutations of residues at the interface between the eagD and cNBHD have been linked to human cancer. Glu-600 on the cNBHD, when substituted with residues with a larger volume, resulted in hEAG1 currents that were profoundly potentiated by Ca-i(2+) in a manner similar to the PAS-cap mutant. These findings provide the first evidence that eagD and cNBHD interactions are regulating Ca2+-dependent gating and indicate that the binding of the PAS-cap with the cNBHD is required for the closure of the channels upon CaM binding.	[Lorinczi, Eva; Helliwell, Matthew; Finch, Alina; Davies, Noel W.; Mahaut-Smith, Martyn; Muskett, Frederick W.; Mitcheson, John S.] Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Helliwell, Matthew] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS5 1TD, Avon, England; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Leicester; University of Bristol; University of Oxford	Mitcheson, JS (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	jm109@le.ac.uk	Stansfeld, Phillip James/AAA-9228-2020; Stansfeld, Phill/C-6213-2011	Stansfeld, Phillip James/0000-0001-8800-7669; Stansfeld, Phill/0000-0001-8800-7669; Finch, Alina/0000-0002-5021-2111; Mitcheson, John/0000-0002-2683-2839	British Heart Foundation [PG/11/38/28886]; Biotechnology and Biological Sciences Research Council, United Kingdom [BB/K000128/1]; Biotechnology and Biological Sciences Research Council [BB/K000128/1] Funding Source: researchfish; BBSRC [BB/K000128/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by British Heart Foundation Project Grant PG/11/38/28886 and the Biotechnology and Biological Sciences Research Council, United Kingdom, Grant BB/K000128/1. The authors declare that they have no conflicts of interest with the contents of this article.	Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chuang CC, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-23; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Darby N.J., 1993, PROTEIN STRUCTURE; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Garg V, 2012, J GEN PHYSIOL, V140, P307, DOI 10.1085/jgp.201210826; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Gomez-Varela D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008858; Goncalves JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010873; Gustina AS, 2013, J GEN PHYSIOL, V141, P229, DOI 10.1085/jgp.201210870; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Han B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23417; Huang X, 2012, GENE DEV, V26, P1780, DOI 10.1101/gad.193789.112; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kovalevskaya NV, 2013, PFLUG ARCH EUR J PHY, V465, P1507, DOI 10.1007/s00424-013-1278-0; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Meyer R, 1998, J PHYSIOL-LONDON, V508, P49, DOI 10.1111/j.1469-7793.1998.049br.x; Mortensen LS, 2015, J PHYSIOL-LONDON, V593, P181, DOI 10.1113/jphysiol.2014.281600; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2014, J BIOL CHEM, V289, P25822, DOI 10.1074/jbc.M114.558379; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Pardo LA, 2008, CANCER RES, V68, P1611, DOI 10.1158/0008-5472.CAN-07-5710; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Perry M, 2006, MOL PHARMACOL, V69, P509, DOI 10.1124/mol.105.016741; Perry M, 2004, MOL PHARMACOL, V66, P240, DOI 10.1124/mol.104.000117; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez A, 2016, EMBO REP, V17, P708, DOI 10.15252/embr.201541082; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Stansfeld CE, 1996, P NATL ACAD SCI USA, V93, P9910, DOI 10.1073/pnas.93.18.9910; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500008; Zhang M, 2014, NAT CHEM BIOL, V10, P753, DOI [10.1038/NCHEMBIO.1592, 10.1038/nchembio.1592]; Zhang T, 2010, HUM MUTAT, V31, pE1801, DOI 10.1002/humu.21341; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	58	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17907	17918		10.1074/jbc.M116.733576	http://dx.doi.org/10.1074/jbc.M116.733576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27325704	Green Published, hybrid			2022-12-28	WOS:000383241300034
J	Natali, A; Gruber, JM; Dietzel, L; Stuart, MCA; van Grondelle, R; Croce, R				Natali, Alberto; Gruber, J. Michael; Dietzel, Lars; Stuart, Marc C. A.; van Grondelle, Rienk; Croce, Roberta			Light-harvesting Complexes (LHCs) Cluster Spontaneously in Membrane Environment Leading to Shortening of Their Excited State Lifetimes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; ALGA CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-II; CHLOROPLAST MEMBRANES; CIRCULAR-DICHROISM; XANTHOPHYLL CYCLE; ION-TRANSPORT; PROTEIN; FLUORESCENCE; AGGREGATION	The light reactions of photosynthesis, which include light-harvesting and charge separation, take place in the amphiphilic environment of the thylakoid membrane. The light-harvesting complex II (LHCII) is the main responsible for light absorption in plants and green algae and is involved in photoprotective mechanisms that regulate the amount of excited states in the membrane. The dual function of LHCII has been extensively studied in detergent micelles, but recent results have indicated that the properties of this complex differ in a lipid environment. In this work we checked these suggestions by studying LHCII in liposomes. By combining bulk and single molecule measurements, we monitored the fluorescence characteristics of liposomes containing single complexes up to densely packed proteoliposomes. We show that the natural lipid environment per se does not alter the properties of LHCII, which for single complexes remain very similar to that in detergent. However, we show that LHCII has the strong tendency to cluster in the membrane and that protein interactions and the extent of crowding modulate the lifetimes of the excited state in the membrane. Finally, the presence of LHCII monomers at low concentrations of complexes per liposome is discussed.	[Natali, Alberto; Gruber, J. Michael; van Grondelle, Rienk; Croce, Roberta] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Dietzel, Lars] Goethe Univ Frankfurt M, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Stuart, Marc C. A.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Electron Microscopy, NL-9747 AG Groningen, Netherlands	Vrije Universiteit Amsterdam; Goethe University Frankfurt; University of Groningen	Croce, R (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	r.croce@vu.nl	Croce, Roberta/N-4067-2014; Dietzel, Lars/E-5249-2016; Croce, Roberta/HGU-9554-2022; Croce, Roberta/ABG-3595-2021; Gruber, Michael/C-8523-2015	Croce, Roberta/0000-0003-3469-834X; Dietzel, Lars/0000-0002-0579-2065; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Gruber, Michael/0000-0002-5427-6542	European Research Council (ERC) [281341]; Dutch organization for scientific research NWO via a Vici grant; ERC [267333]; Humboldt Foundation	European Research Council (ERC)(European Research Council (ERC)European Commission); Dutch organization for scientific research NWO via a Vici grant; ERC(European Research Council (ERC)European Commission); Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the European Research Council (ERC) Consolidator Grant 281341 (ASAP) and by the Dutch organization for scientific research NWO via a Vici grant (to R. C.). The work was also supported by ERC Advanced Investigation Grant 267333 (to R. v. G.) and by the Humboldt Foundation in the course of a Feodor-Lynen fellowship (to L. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Akashi K, 1998, BIOPHYS J, V74, P2973, DOI 10.1016/S0006-3495(98)78004-X; Armbruster U, 2013, PLANT CELL, V25, P2661, DOI 10.1105/tpc.113.113118; Bassi R, 2000, PHOTOSYNTH RES, V64, P243, DOI 10.1023/A:1006409506272; Belgio E, 2012, BIOPHYS J, V102, P2761, DOI 10.1016/j.bpj.2012.05.004; Bell AJ, 2015, J BIOL CHEM, V290, P18429, DOI 10.1074/jbc.M115.663872; Bielczynski LW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00105; Borch J, 2009, BIOL CHEM, V390, P805, DOI 10.1515/BC.2009.091; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; Fischer N, 1997, BIOCHEMISTRY-US, V36, P93, DOI 10.1021/bi962244v; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gruber JM, 2015, PHYS CHEM CHEM PHYS, V17, P19844, DOI 10.1039/c5cp01806d; Gundermann K, 2012, BBA-BIOENERGETICS, V1817, P1044, DOI 10.1016/j.bbabio.2012.03.008; Haferkamp S, 2008, PHOTOSYNTH RES, V95, P129, DOI 10.1007/s11120-007-9253-2; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Iwaszko E, 2004, J PHOTOCH PHOTOBIO B, V74, P13, DOI 10.1016/j.jphotobiol.2004.01.005; Jahns P, 2000, PLANT PHYSIOL BIOCH, V38, P371, DOI 10.1016/S0981-9428(00)00753-1; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; Kruger TPJ, 2014, BBA-BIOENERGETICS, V1837, P1027, DOI 10.1016/j.bbabio.2014.02.014; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Liu C, 2016, PHOTOSYNTH RES, V127, P109, DOI 10.1007/s11120-015-0176-z; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Natali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119211; Natali A, 2014, JOVE-J VIS EXP, DOI 10.3791/51852; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Puthiyaveetil S, 2014, P NATL ACAD SCI USA, V111, P15839, DOI 10.1073/pnas.1413739111; Roach T, 2014, CURR PROTEIN PEPT SC, V15, P351, DOI 10.2174/1389203715666140327105143; Rochaix JD, 2014, ANNU REV PLANT BIOL, V65, P287, DOI 10.1146/annurev-arplant-050213-040226; Rossetti FF, 2004, BIOPHYS J, V87, P1711, DOI 10.1529/biophysj.104.041780; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Suorsa M, 2015, PLANT J, V84, P360, DOI 10.1111/tpj.13004; Tian LJ, 2015, J PHYS CHEM LETT, V6, P2339, DOI 10.1021/acs.jpclett.5b00944; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Vieler A, 2007, CHEM PHYS LIPIDS, V150, P143, DOI 10.1016/j.chemphyslip.2007.06.224; Wardak A, 2000, J PHOTOCH PHOTOBIO B, V56, P12, DOI 10.1016/S1011-1344(00)00050-6; Wentworth M, 2000, FEBS LETT, V471, P71, DOI 10.1016/S0014-5793(00)01369-7; Wilk L, 2013, P NATL ACAD SCI USA, V110, P5452, DOI 10.1073/pnas.1205561110; Yang CH, 2006, BBA-BIOENERGETICS, V1757, P1642, DOI 10.1016/j.bbabio.2006.08.010; Zhou F, 2009, PHOTOSYNTH RES, V99, P185, DOI 10.1007/s11120-008-9388-9	50	54	57	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16730	16739		10.1074/jbc.M116.730101	http://dx.doi.org/10.1074/jbc.M116.730101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27252376	hybrid, Green Published			2022-12-28	WOS:000380826700030
J	Ramachandran, A; Nandakumar, D; Deshpande, AP; Lucas, TP; R-Bhojappa, R; Tang, GQ; Raney, K; Yin, YW; Patel, SS				Ramachandran, Aparna; Nandakumar, Divya; Deshpande, Aishwarya P.; Lucas, Thomas P.; R-Bhojappa, Ramanagouda; Tang, Guo-Qing; Raney, Kevin; Yin, Y. Whitney; Patel, Smita S.			The Yeast Mitochondrial RNA Polymerase and Transcriptio Factor Complex Catalyzes Efficient Priming of DNA Synthesis on Single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 DEOXYRIBONUCLEIC-ACID; STALLED REPLICATION FORKS; BINDING-PROTEIN; SACCHAROMYCES-CEREVISIAE; PURIFIED PROTEINS; INITIATION SITES; PRIMARY ORIGIN; HUMAN PRIMPOL; WILD-TYPE; IN-VITRO	Primases use single-stranded (ss) DNAs as templates to synthesize short oligoribonucleotide primers that initiate lagging strand DNA synthesis or reprime DNA synthesis after replication fork collapse, but the origin of this activity in the mitochondria remains unclear. Herein, we show that the Saccharomyces cerevisiae mitochondrial RNA polymerase (Rpo41) and its transcription factor (Mtf1) is an efficient primase that initiates DNA synthesis on ssDNA coated with the yeast mitochondrial ssDNA-binding protein, Rim1. Both Rpo41 and Rpo41-Mtf1 can synthesize short and long RNAs on ssDNA template and prime DNA synthesis by the yeast mitochondrial DNA polymerase Mip1. However, the ssDNA-binding protein Rim1 severely inhibits the RNA synthesis activity of Rpo41, but not the Rpo41-Mtf1 complex, which continues to prime DNA synthesis efficiently in the presence of Rim1. We show that RNAs as short as 10-12 nt serve as primers for DNA synthesis. Characterization of the RNA-DNA products shows that Rpo41 and Rpo41-Mtf1 have slightly different priming specificity. However, both prefer to initiate with ATP from short priming sequences such as 3'-TCC, TTC, and TTT, and the consensus sequence is 3'-Pu(Py)(2-3). Based on our studies, we propose that Rpo41-Mtf1 is an attractive candidate for serving as the primase to initiate lagging strand DNA synthesis during normal replication and/or to restart stalled replication from downstream ssDNA.	[Ramachandran, Aparna; Nandakumar, Divya; Deshpande, Aishwarya P.; Tang, Guo-Qing; Patel, Smita S.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Nandakumar, Divya] Robert Wood Johnson Med Sch, Grad Sch Biomed Sci, Piscataway, NJ USA; [Lucas, Thomas P.; Yin, Y. Whitney] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [R-Bhojappa, Ramanagouda; Raney, Kevin] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Texas System; University of Texas Medical Branch Galveston; University of Arkansas System; University of Arkansas Medical Sciences	Patel, SS (corresponding author), Rutgers, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ USA.	patelss@rutgers.edu	Ramanagoudr Bhojappa, Ramanagouda/ABG-3444-2021; Nandakumar, Divya/K-6250-2014	Ramanagoudr Bhojappa, Ramanagouda/0000-0002-3122-3827; Nandakumar, Divya/0000-0001-7672-0213	National Institutes of Health [R37 GM51966, RO1 GM 083703, RO1 GM 110591, RO1 GM098922]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083703, R01GM110591, R37GM051966, R35GM118086, R01GM098922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (R37 GM51966, to S. S. P.; RO1 GM 083703 and RO1 GM 110591, to Y. W. Y.; and RO1 GM098922, to K. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], SCI; BALDACCI G, 1982, EMBO J, V1, P987, DOI 10.1002/j.1460-2075.1982.tb01282.x; BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Biswas TK, 1999, BIOCHEMISTRY-US, V38, P9693, DOI 10.1021/bi982804l; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; DAVEY SK, 1990, J BIOL CHEM, V265, P3611; DEZAMAROCZY M, 1984, GENE, V32, P439, DOI 10.1016/0378-1119(84)90019-2; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; FULLER CW, 1985, J BIOL CHEM, V260, P3197; FULLER CW, 1985, J BIOL CHEM, V260, P3185; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Gerhold JM, 2014, J BIOL CHEM, V289, P22659, DOI 10.1074/jbc.M114.552828; Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002; Ghosh S, 2010, J BIOL CHEM, V285, P18103, DOI 10.1074/jbc.M110.107656; Ghosh S, 2009, J BIOL CHEM, V284, P30339, DOI 10.1074/jbc.M109.024059; Graves T, 1998, NUCLEIC ACIDS RES, V26, P1309, DOI 10.1093/nar/26.5.1309; Guilliam TA, 2015, NUCLEIC ACIDS RES, V43, P1056, DOI 10.1093/nar/gku1321; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Helleday T, 2013, NAT STRUCT MOL BIOL, V20, P1348, DOI 10.1038/nsmb.2727; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HOLMES AM, 1985, J BIOL CHEM, V260, P840; Im JS, 2013, EMBO REP, V14, P1032, DOI 10.1038/embor.2013.171; Keen BA, 2014, NUCLEIC ACIDS RES, V42, P5830, DOI 10.1093/nar/gku214; Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Nilsen Timothy W, 2014, Cold Spring Harb Protoc, V2014, P677, DOI 10.1101/pdb.prot080788; PARKER WB, 1987, MOL PHARMACOL, V31, P146; Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088; Sanchez-Sandoval E, 2015, MITOCHONDRION, V24, P22, DOI 10.1016/j.mito.2015.06.004; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Turk EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078105; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; VISHWANATHA JK, 1986, NUCLEIC ACIDS RES, V14, P7305, DOI 10.1093/nar/14.18.7305; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; YAMAGUCHI M, 1985, MOL CELL BIOL, V5, P1170, DOI 10.1128/MCB.5.5.1170; Yang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136879	46	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16828	16839		10.1074/jbc.M116.740282	http://dx.doi.org/10.1074/jbc.M116.740282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27311715	hybrid, Green Published			2022-12-28	WOS:000380826700038
J	Yadav, VR; Prasad, S; Gupta, SC; Sung, B; Phatak, SS; Zhang, SX; Aggarwal, BB				Yadav, Vivek R.; Prasad, Sahdeo; Gupta, Subash C.; Sung, Bokyung; Phatak, Sharangdhar S.; Zhang, Shuxing; Aggarwal, Bharat B.			RETRACTION: 3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in I kappa B alpha kinase, leading to down-regulation of nuclear factor-kappa B (NF-kappa B)-regulated gene products and sensitization of tumor cells (Retraction of vol 287, pg 245, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Yadav VR, 2012, J BIOL CHEM, V287, P245, DOI 10.1074/jbc.M111.274613	1	0	0	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16926	16926		10.1074/jbc.A111.274613	http://dx.doi.org/10.1074/jbc.A111.274613			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27496967	Green Published, hybrid			2022-12-28	WOS:000380826700053
J	Yang, XM; Bam, M; Nagarkatti, PS; Nagarkatti, M				Yang, Xiaoming; Bam, Marpe; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			RNA-seq Analysis of delta 9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; INFLAMMATORY LUNG INJURY; FARNESOID X RECEPTOR; BREAST-CANCER CELLS; ALZHEIMERS-DISEASE; SUPPRESSOR-CELLS; TUMOR-SUPPRESSOR; DOWN-REGULATION; ACTIVATION; MICRORNA-146A	Marijuana has drawn significant public attention and concern both for its medicinal and recreational use. Delta 9-Tetrahydrocannabinol (THC), which is the main bioactive component in marijuana, has also been shown to possess potent anti-inflammatory properties by virtue of its ability to activate cannabinoid receptor-2 (CB-2) expressed on immune cells. In this study, we used RNA-seq to quantify the transcriptomes and transcript variants that are differentially regulated by THC in super antigen-activated lymph node cells and CD4(+) T cells. We found that the expressions of many transcripts were altered by THC in both total lymph node cells and CD4(+) T cells. Furthermore, the abundance of many miRNA precursors and long non-coding RNAs was dramatically altered in THC-treated mice. For example, the expression of miR-17/92 cluster and miR-374b/421 cluster was down-regulated by THC. On the other hand miR-146a, which has been shown to induce apoptosis, was up-regulated by THC. Long non-coding RNAs that are expressed from the opposite strand of CD27 and Appbp2 were induced by THC. In addition, THC treatment also caused alternative promoter usage and splicing. The functions of those altered transcripts were mainly related to immune response and cell proliferation.	[Yang, Xiaoming; Bam, Marpe; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA	University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA.	Mitzi.Nagarkatti@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Nagarkatti, Mitzi/0000-0002-5977-5615	National Institutes of Health [P01AT003961, P20GM103641, R01AT006888, R01ES019313, R01MH094755]; National Center for Complementary & Integrative Health [R01AT006888, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AT003961, P20GM103641, R01AT006888, R01ES019313, and R01MH094755. The authors declare that they have no conflict of interest with the contents of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Aso E, 2016, J ALZHEIMERS DIS, V51, P489, DOI 10.3233/JAD-150913; Aso E, 2015, J ALZHEIMERS DIS, V43, P977, DOI 10.3233/JAD-141014; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Busbee PB, 2014, TOXICOL APPL PHARM, V274, P7, DOI 10.1016/j.taap.2013.10.022; Camacho IA, 2002, ARCH TOXICOL, V76, P570, DOI 10.1007/s00204-002-0390-2; Chen L, 2013, BIOCHEM BIOPH RES CO, V435, P745, DOI 10.1016/j.bbrc.2013.05.056; Dhainaut M, 2015, EMBO J, V34, P1336, DOI 10.15252/embj.201490312; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Eubanks LM, 2006, MOL PHARMACEUT, V3, P773, DOI 10.1021/mp060066m; Gaffal E, 2013, ALLERGY, V68, P994, DOI 10.1111/all.12183; Hao J, 2011, BIOCHEM BIOPH RES CO, V406, P552, DOI 10.1016/j.bbrc.2011.02.086; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Hegde VL, 2013, J BIOL CHEM, V288, P36810, DOI 10.1074/jbc.M113.503037; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199; Himes BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056179; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Jiang Z, 2010, J GASTROENTEROL, V45, P17, DOI 10.1007/s00535-009-0135-6; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulhankova K, 2014, IMMUNOL RES, V59, P182, DOI 10.1007/s12026-014-8538-8; Kumaraswamy E, 2015, ONCOGENE, V34, P4333, DOI 10.1038/onc.2014.363; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; McKallip RJ, 2005, J IMMUNOL, V174, P3281, DOI 10.4049/jimmunol.174.6.3281; Morris KV, 2010, CELL CYCLE, V9, P2544, DOI 10.4161/cc.9.13.12145; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; NEWTON CA, 1994, INFECT IMMUN, V62, P4015, DOI 10.1128/IAI.62.9.4015-4020.1994; Ocampo TL, 2015, ANN ALLERG ASTHMA IM, V114, P187, DOI 10.1016/j.anai.2015.01.004; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Pandey R, 2011, J PHARMACOL EXP THER, V338, P819, DOI 10.1124/jpet.111.182717; Park H, 2015, J BIOL CHEM, V290, P2831, DOI 10.1074/jbc.M114.591420; Rao GK, 2004, J LEUKOCYTE BIOL, V75, P884, DOI 10.1189/jlb.1203638; Rao R, 2015, BRIT J PHARMACOL, V172, P1792, DOI 10.1111/bph.13026; Rao R, 2015, TOXICOL SCI, V144, P284, DOI 10.1093/toxsci/kfu315; Rieder SA, 2012, BRIT J PHARMACOL, V167, P1244, DOI 10.1111/j.1476-5381.2012.02063.x; Rieder SA, 2011, INFECT IMMUN, V79, P3141, DOI 10.1128/IAI.00177-11; Rieder SA, 2010, IMMUNOBIOLOGY, V215, P598, DOI 10.1016/j.imbio.2009.04.001; Saeed AI, 2012, MICROSC MICROANAL, V18, P445, DOI 10.1017/S1431927612000190; Sandhu R, 2014, CARCINOGENESIS, V35, P2567, DOI 10.1093/carcin/bgu175; Sido JM, 2015, J LEUKOCYTE BIOL, V98, P435, DOI 10.1189/jlb.3A0115-030RR; Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang XM, 2014, J BIOL CHEM, V289, P18707, DOI 10.1074/jbc.M113.545210; Zhang Y, 2012, MOL CANCER RES, V10, P516, DOI 10.1158/1541-7786.MCR-11-0473; Zhao JL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00219; Zhao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109782; Zhong XY, 2012, GENE, V493, P44, DOI 10.1016/j.gene.2011.11.028	54	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15460	15472		10.1074/jbc.M116.719179	http://dx.doi.org/10.1074/jbc.M116.719179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27268054	hybrid, Green Published			2022-12-28	WOS:000380584200004
J	Zhang, Z; Costa, FC; Tan, EP; Bushue, N; DiTacchio, L; Costello, CE; McComb, ME; Whelan, SA; Peterson, KR; Slawson, C				Zhang, Zhen; Costa, Flavia C.; Ee Phie Tan; Bushue, Nathan; DiTacchio, Luciano; Costello, Catherine E.; McComb, Mark E.; Whelan, Stephen A.; Peterson, Kenneth R.; Slawson, Chad			O-Linked N-Acetylglucosamine (O-GicNAc) Transferase and O-GicNAcase Interact with Mi2 beta Protein at the (A)gamma-Globin Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT ERYTHROID-CELLS; LOCUS-CONTROL REGIONS; RNA-POLYMERASE-II; GLCNAC TRANSFERASE; GENE-EXPRESSION; GLOBIN GENE; EPIGENETIC REGULATION; CHRONIC DISEASE; HISTONE CODE; GLCNACYLATION	One mode of gamma-globin gene silencing involves a GATA-1.FOG-1.Mi2 beta repressor complex that binds to the - 566 GATA site relative to the (A)gamma-globin gene cap site, However, the mechanism of how this repressor complex is assembled at the 566 GATA site is unknown. In this study, we demonstrate that the O-linked N-acetylglucosamine (O-GleNAc) processing enzymes, O-GlcNAc-transferase (OGT) and O-GIcNAcase (OGA), interact with the (A)gamma-globin promoter at the 566 GATA repressor site; however, mutation of the GATA site to GAGA significantly reduces OGT and OGA promoter interactions in /3-globin locus yeast artificial chromosome ((3-YAC) bone marrow cells. When WT (1-YAC bone marrow cells are treated with the OGA inhibitor Thiamet-G, the occupancy of OGT, OGA, and Mi2 beta at the (A)gamma-globin promoter is increased. In addition, OGT and Mi2 beta recruitment is increased at the (A)gamma-globin promoter when beta-globin becomes repressed in postconception day E18 human beta-YAC transgenic mouse fetal liver. Furthermore, we show that Mi2 beta is modified with O-GlcNAc, and both OGT and OGA interact with Mi2 beta, GATA-1, and FOG-1. Taken together, our data suggest that O-GlcNAcylation is a novel mechanism of gamma-globin gene regulation mediated by modulating the assembly of the GATA-1-FOG-1.Mi2 beta repressor complex at the 566 GATA motif within the promoter.	[Zhang, Zhen; Ee Phie Tan; Bushue, Nathan; Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Peterson, Kenneth R.] Univ Kansas, Med Ctr, Anat & Cell Biol, Kansas City, KS 66160 USA; [DiTacchio, Luciano] Univ Kansas, Med Ctr, Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA; [Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Slawson, Chad] Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Kansas City, KS 66160 USA; [Costello, Catherine E.; McComb, Mark E.; Whelan, Stephen A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Costello, Catherine E.; McComb, Mark E.; Whelan, Stephen A.] Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA; [Costa, Flavia C.] IntelligeneDx Canc Genom, Olathe, KS 66061 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Boston University; Boston University	Peterson, KR; Slawson, C (corresponding author), Univ Kansas, Med Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	kpeterson@kumc.edu; cslawson@kumc.edu	Tan, Ee Phie/AAC-8378-2021	/0000-0002-4249-485X; Costello, Catherine/0000-0003-1594-5122; Whelan, Stephen A/0000-0002-5439-6501	NIGMS from National Institutes of Health [P20GM104936, P41 GM104603]; NIDDK from National Institutes of Health [R01 DK100595]; NHLBI from National Institutes of Health [RO1HL111264, HHSN268201000031C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, P41GM104603] Funding Source: NIH RePORTER	NIGMS from National Institutes of Health; NIDDK from National Institutes of Health; NHLBI from National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an institutional development award from the NIGMS under Grant P20GM104936 and NIDDK Grant R01 DK100595 (to C. S. and K. R. P.), NHLBI Grant RO1HL111264 (to K. R. P.), and NHLBI Contract HHSN268201000031C and NIGMS Grant P41 GM104603 (to C. E. C.) all from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akan I, 2016, J BIOL CHEM, V291, P9906, DOI 10.1074/jbc.M115.704783; Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Bauer DE, 2011, CURR OPIN PEDIATR, V23, P1, DOI 10.1097/MOP.0b013e3283420fd0; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; CIOE L, 1981, CANCER RES, V41, P237; Costa FC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003155; Dehennaut V, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00155; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fraser P, 1998, CURR OPIN CELL BIOL, V10, P361, DOI 10.1016/S0955-0674(98)80012-4; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Ginder GD, 2015, TRANSL RES, V165, P115, DOI 10.1016/j.trsl.2014.05.002; Gladwin MT, 2012, J AM COLL CARDIOL, V59, P1123, DOI 10.1016/j.jacc.2011.10.900; Harju-Baker S, 2008, MOL CELL BIOL, V28, P3101, DOI 10.1128/MCB.01858-07; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Lanza C, 2016, CELL CYCLE, V15, P1363, DOI 10.1080/15384101.2016.1167297; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; Peterson KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107006; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sankaran VG, 2011, HEMATOL-AM SOC HEMAT, P459, DOI 10.1182/asheducation-2011.1.459; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Verduzco LA, 2009, BLOOD, V114, P5117, DOI 10.1182/blood-2009-05-220921; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	55	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15628	15640		10.1074/jbc.M116.721928	http://dx.doi.org/10.1074/jbc.M116.721928			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231347	hybrid, Green Published			2022-12-28	WOS:000380584200018
J	True, JD; Muldoon, JJ; Carver, MN; Poorey, K; Shetty, SJ; Bekiranov, S; Auble, DT				True, Jason D.; Muldoon, Joseph J.; Carver, Melissa N.; Poorey, Kunal; Shetty, Savera J.; Bekiranov, Stefan; Auble, David T.			The Modifier of Transcription 1 (Mott) ATPase and Spt16 Histone Chaperone Co-regulate Transcription through Preinitiation Complex Assembly and Nucleosome Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; YEAST SACCHAROMYCES-CEREVISIAE; INTEGRATIVE GENOMICS VIEWER; IN-VIVO; BASAL TRANSCRIPTION; GENE-EXPRESSION; TBP RECRUITMENT; DNA-BINDING; FACT	Modifier of transcription 1 (Mot1) is a conserved and essential Swi2/Snf2 ATPase that can remove TATA-binding protein (TBP) from DNA using ATP hydrolysis and in so doing exerts global effects on transcription. Sptl6 is also essential and functions globally in transcriptional regulation as a component of the facilitates chromatin transcription (FACT) histone chaperone complex. Here we demonstrate that Motl and Spt16 regulate a largely overlapping set of genes in Saccharotnyces cerevisiae. As expected, Motl was found to control TBP levels at co-regulated promoters. In contrast, Spt16 did not affect TBP recruitment. On a global scale, Spt16 was required for Mott promoter localization, and Motl also affected Spt16 localization to genes. Interestingly, we found that Motl has an unanticipated role in establishing or maintaining the occupancy and positioning of nucleosomes at the 5' ends of genes. Spt16 has a broad role in regulating chromatin organization in gene bodies, including those nucleosomes affected by Motl. These results suggest that the large scale overlap in Motl and Spt16 function arises from a combination of both their unique and shared functions in transcription complex assembly and chromatin structure regulation.	[True, Jason D.; Muldoon, Joseph J.; Carver, Melissa N.; Poorey, Kunal; Shetty, Savera J.; Bekiranov, Stefan; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Auble, DT (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	auble@virginia.edu			National Institutes of Health [GM55763, 5-T32-GM008136]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, R01GM055763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM55763 (to D. T. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Cell and Molecular Training Grant 5-T32-GM008136.	Adamkewicz JI, 2000, J BIOL CHEM, V275, P21158, DOI 10.1074/jbc.M002639200; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Andrau JC, 2002, EMBO J, V21, P5173, DOI 10.1093/emboj/cdf485; Arnett DR, 2008, MOL CELL PROTEOMICS, V7, P2090, DOI 10.1074/mcp.M800221-MCP200; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2006, GENETICS, V172, P837, DOI 10.1534/genetics.105.050245; Biswas D., 2005, MOL CELL BIOL, V25, P5812; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Collart MA, 1996, MOL CELL BIOL, V16, P6668; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Dasgupta A, 2005, EMBO J, V24, P1717, DOI 10.1038/sj.emboj.7600646; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; DAVIS JL, 1992, MOL CELL BIOL, V12, P1879, DOI 10.1128/MCB.12.4.1879; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Foltman M, 2013, CELL REP, V3, P892, DOI 10.1016/j.celrep.2013.02.028; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Geisberg JV, 2002, MOL CELL BIOL, V22, P8122, DOI 10.1128/MCB.22.23.8122-8134.2002; GoldmanLevi R, 1996, NUCLEIC ACIDS RES, V24, P3121, DOI 10.1093/nar/24.16.3121; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Han JH, 2010, GENE DEV, V24, P1485, DOI 10.1101/gad.1887310; Helenius K, 2011, NUCLEIC ACIDS RES, V39, P5025, DOI 10.1093/nar/gkr107; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Jiang YW, 1996, GENE DEV, V10, P604, DOI 10.1101/gad.10.5.604; Kang SW, 2000, GENES CELLS, V5, P251, DOI 10.1046/j.1365-2443.2000.00323.x; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KARNITZ L, 1992, GENETICS, V132, P351; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Madison JM, 1997, MOL CELL BIOL, V17, P287, DOI 10.1128/MCB.17.1.287; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; PIATTI S, 1992, CHROMOSOMA, V102, pS107, DOI 10.1007/BF02451793; Poorey K, 2010, GENOME RES, V20, P1679, DOI 10.1101/gr.109504.110; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shimojima T, 2003, GENE DEV, V17, P1605, DOI 10.1101/gad.1086803; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sprouse RO, 2009, J BIOL CHEM, V284, P4525, DOI 10.1074/jbc.M808951200; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TIMMERS HTM, 1992, P NATL ACAD SCI USA, V89, P8140, DOI 10.1073/pnas.89.17.8140; Topalidou I, 2004, EMBO J, V23, P1943, DOI 10.1038/sj.emboj.7600199; Tsunaka Y, 2016, GENE DEV, V30, P673, DOI 10.1101/gad.274183.115; van Bakel H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003479; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Venters BJ, 2011, MOL CELL BIOL, V31, P2253, DOI 10.1128/MCB.01464-10; Wal M, 2012, METHOD ENZYMOL, V513, P233, DOI 10.1016/B978-0-12-391938-0.00010-0; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101; Zentner GE, 2013, MOL CELL BIOL, V33, P4996, DOI 10.1128/MCB.01218-13; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003	82	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15307	15319		10.1074/jbc.M116.735134	http://dx.doi.org/10.1074/jbc.M116.735134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27226635	hybrid, Green Published			2022-12-28	WOS:000380583200036
J	He, Q; Wang, F; Liu, SH; Zhu, DY; Cong, HJ; Gao, F; Li, BQ; Wang, HW; Lin, Z; Liao, J; Gu, LC				He, Qing; Wang, Feng; Liu, Shiheng; Zhu, Deyu; Cong, Hengjiang; Gao, Fei; Li, Bingqing; Wang, Hongwei; Lin, Zong; Liao, Jun; Gu, Lichuan			Structural and biochemical insight into the mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP phosphodiesterase (vol 291, pg 3668, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Cong, Hengjiang/ABA-2924-2020; Cong, Hengjiang/ABA-2928-2020	Cong, Hengjiang/0000-0002-9225-0095; Liao, Jun/0000-0001-7487-5545				He Q, 2016, J BIOL CHEM, V291, P14386, DOI [10.1074/jbc.A115.699801, 10.1074/jbc.M115.699801]	1	40	43	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14386	14387		10.1074/jbc.A115.699801	http://dx.doi.org/10.1074/jbc.A115.699801			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371563	Green Published, hybrid			2022-12-28	WOS:000379975100041
J	He, Q; Wang, F; Liu, SH; Zhu, DY; Cong, HJ; Gao, F; Li, BQ; Wang, HW; Lin, Z; Liao, J; Gu, LC				He, Qing; Wang, Feng; Liu, Shiheng; Zhu, Deyu; Cong, Hengjiang; Gao, Fei; Li, Bingqing; Wang, Hongwei; Lin, Zong; Liao, Jun; Gu, Lichuan			Structural and Biochemical Insight into the Mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP Phosphodiesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic diadenosine monophosphate (c-di-AMP); enzyme degradation; Mycobacterium tuberculosis; phosphodiesterases; structure-function	AFFECT BACTERIAL-GROWTH; LONG-TERM SURVIVAL; AMP PHOSPHODIESTERASE; GMP; IDENTIFICATION; SPORULATION; RESOLUTION; REVEALS; PROTEIN; LEADS	The intracellular infections of Mycobacterium tuberculosis, which is the causative agent of tuberculosis, are regulated by many cyclic dinucleotide signaling. Rv2837c from M. tuberculosis is a soluble, stand-alone DHH-DHHA1 domain phosphodiesterase that down-regulates c-di-AMP through catalytic degradation and plays an important role in M. tuberculosis infections. Here, we report the crystal structure of Rv2837c (2.0 angstrom), and its complex with hydrolysis intermediate 5-pApA (2.35 angstrom). Our structures indicate that both DHH and DHHA1 domains are essential for c-di-AMP degradation. Further structural analysis shows that Rv2837c does not distinguish adenine from guanine, which explains why Rv2837c hydrolyzes all linear dinucleotides with almost the same efficiency. We observed that Rv2837c degraded other c-di-NMPs at a lower rate than it did on c-di-AMP. Nevertheless, our data also showed that Rv2837c significantly decreases concentrations of both c-di-AMP and c-di-GMP in vivo. Our results suggest that beside its major role in c-di-AMP degradation Rv2837c could also regulate c-di-GMP signaling pathways in bacterial cell.	[He, Qing; Wang, Feng; Liu, Shiheng; Zhu, Deyu; Cong, Hengjiang; Gao, Fei; Li, Bingqing; Wang, Hongwei; Gu, Lichuan] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Lin, Zong] Tsinghua Univ, Yangtze Delta Reg Inst, Dept Biotechnol & Biomed, Jiaxing 314006, Zhejiang, Peoples R China; [Liao, Jun] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Shandong University; Tsinghua University; ShanghaiTech University	Gu, LC (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	lcgu@sdu.edu.cn	Cong, Hengjiang/ABA-2924-2020; Cong, Hengjiang/ABA-2928-2020	Cong, Hengjiang/0000-0002-9225-0095; Liao, Jun/0000-0001-7487-5545	National Natural Science Foundation of China [31470732]; Shandong Provincial Funds for Distinguished Young Scientists Grant [JQ201307]; Zhejiang Natural Science Foundation [LR12C05001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Funds for Distinguished Young Scientists Grant; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grant 31470732 (to L.G.) and Shandong Provincial Funds for Distinguished Young Scientists Grant JQ201307 (to L.G.), This work was also supported by Zhejiang Natural Science Foundation Grant LR12C05001 (to Z.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Burhenne Heike, 2013, Methods Mol Biol, V1016, P27, DOI 10.1007/978-1-62703-441-8_3; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao J, 2015, CELL RES, V25, P539, DOI 10.1038/cr.2015.40; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; GUAN Y, 1993, J BIOMOL STRUCT DYN, V11, P253, DOI 10.1080/07391102.1993.10508725; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Postic G, 2012, RNA, V18, P155, DOI 10.1261/rna.029132.111; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Srivastav R, 2014, NUCLEIC ACIDS RES, V42, P7894, DOI 10.1093/nar/gku425; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Tang Q, 2015, INT J BIOL SCI, V11, P813, DOI 10.7150/ijbs.11797; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zhu DY, 2014, MOL CELL, V55, P931, DOI 10.1016/j.molcel.2014.08.001; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	41	40	43	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3668	3681		10.1074/jbc.M115.699801	http://dx.doi.org/10.1074/jbc.M115.699801			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	27371563	Green Published, hybrid			2022-12-28	WOS:000370854500044
